,category,over_represented_pvalue,under_represented_pvalue,numDEInCat,numInCat,term,ontology,foreground_genes
10970,GO:0043005,5.17680275633349e-13,1,35,1264,neuron projection,CC,USH1C;CAMK1G;SYT13;GABRA1;PTPRN;LZTS1;SYT1;CAMK2A;TPX2;RPH3A;KIF4A;STMN2;NEFM;SLC17A7;DNM1;NEURL1;CRYAB;GABRG2;SLC30A3;CNR1;HPCA;SNAP25;SYT4;CHRM3;SLC4A10;GABRB2;TENM2;NRGN;KCNC2;NPTX1;PCSK1;DDN;SV2B;NMB;GRIN2B
11819,GO:0045202,1.74979266201416e-12,1,34,1258,synapse,CC,USH1C;SYT13;GABRA1;PTPRN;LZTS1;SYT1;CAMK2A;RPH3A;EEF1A2;SLC17A7;NPTX2;DNM1;NEURL1;CRYAB;GABRG2;SLC30A3;CNR1;HPCA;SNAP25;SYT4;CHRM3;SLC4A10;GABRB2;TENM2;NRGN;IGFN1;ADCY1;KCNC2;KCNK9;NPTX1;DDN;SV2B;SLC6A17;GRIN2B
3669,GO:0007268,1.33024580702326e-10,0.999999999982426,23,661,chemical synaptic transmission,BP,CD38;GABRA1;LZTS1;SYT1;CAMK2A;RPH3A;SLC17A7;NPTX2;DNM1;NEURL1;GABRG2;CNR1;VGF;SNAP25;SYT4;CHRM3;SLC4A10;GABRB2;NRGN;ADCY1;NPTX1;SV2B;GRIN2B
17969,GO:0098916,1.33024580702326e-10,0.999999999982426,23,661,anterograde trans-synaptic signaling,BP,CD38;GABRA1;LZTS1;SYT1;CAMK2A;RPH3A;SLC17A7;NPTX2;DNM1;NEURL1;GABRG2;CNR1;VGF;SNAP25;SYT4;CHRM3;SLC4A10;GABRB2;NRGN;ADCY1;NPTX1;SV2B;GRIN2B
18159,GO:0099537,1.7214947221309e-10,0.999999999976975,23,669,trans-synaptic signaling,BP,CD38;GABRA1;LZTS1;SYT1;CAMK2A;RPH3A;SLC17A7;NPTX2;DNM1;NEURL1;GABRG2;CNR1;VGF;SNAP25;SYT4;CHRM3;SLC4A10;GABRB2;NRGN;ADCY1;NPTX1;SV2B;GRIN2B
18158,GO:0099536,2.79352704101243e-10,0.999999999961762,23,688,synaptic signaling,BP,CD38;GABRA1;LZTS1;SYT1;CAMK2A;RPH3A;SLC17A7;NPTX2;DNM1;NEURL1;GABRG2;CNR1;VGF;SNAP25;SYT4;CHRM3;SLC4A10;GABRB2;NRGN;ADCY1;NPTX1;SV2B;GRIN2B
3668,GO:0007267,3.79867183857924e-10,0.999999999930642,34,1587,cell-cell signaling,BP,CD38;SYT13;GABRA1;PTPRN;LZTS1;ASPM;SYT1;CAMK2A;RPH3A;SYTL4;SLC17A7;NPTX2;DNM1;NEURL1;GABRG2;IGFBP2;CNR1;VGF;SNAP25;SYT4;CHRM3;SLC4A10;SFRP2;GABRB2;DAAM2;NRGN;VSNL1;ADCY1;KCNC2;NPTX1;PCSK1;SV2B;NMB;GRIN2B
7162,GO:0030133,4.5449365685754e-10,0.999999999953304,17,381,transport vesicle,CC,SYT13;PTPRN;SYT1;RPH3A;SYTL4;SLC17A7;DNM1;SLC30A3;VGF;SNAP25;SYT4;NRGN;KCNK9;NPTX1;PCSK1;SV2B;SLC6A17
10961,GO:0042995,7.2200046618411e-10,0.999999999828216,40,2092,cell projection,CC,USH1C;CAMK1G;SYT13;GABRA1;PTPRN;LZTS1;SYT1;CAMK2A;TPX2;RPH3A;KIF4A;STMN2;NEFM;SLC17A7;DNM1;NEURL1;CRYAB;GABRG2;SLC30A3;CENPF;CNR1;PRLHR;HPCA;SNAP25;SYT4;CHRM3;SLC4A10;GABRB2;TENM2;NRGN;FABP7;KCNC2;NPTX1;PCSK1;DDN;SV2B;SPRY4;SLC6A17;NMB;GRIN2B
17403,GO:0097060,1.72574842316694e-09,0.999999999787973,17,373,synaptic membrane,CC,GABRA1;LZTS1;SYT1;RPH3A;DNM1;CRYAB;GABRG2;CNR1;SNAP25;CHRM3;GABRB2;TENM2;NRGN;ADCY1;KCNC2;DDN;GRIN2B
17882,GO:0098794,2.27797163505002e-09,0.999999999639823,21,612,postsynapse,CC,GABRA1;LZTS1;CAMK2A;RPH3A;SLC17A7;DNM1;NEURL1;CRYAB;GABRG2;HPCA;SNAP25;CHRM3;SLC4A10;GABRB2;TENM2;NRGN;ADCY1;KCNC2;DDN;SLC6A17;GRIN2B
18434,GO:0120025,2.80107905033095e-09,0.999999999292057,38,1998,plasma membrane bounded cell projection,CC,USH1C;CAMK1G;SYT13;GABRA1;PTPRN;LZTS1;SYT1;CAMK2A;TPX2;RPH3A;KIF4A;STMN2;NEFM;SLC17A7;DNM1;NEURL1;CRYAB;GABRG2;SLC30A3;CENPF;CNR1;PRLHR;HPCA;SNAP25;SYT4;CHRM3;SLC4A10;GABRB2;TENM2;NRGN;KCNC2;NPTX1;PCSK1;DDN;SV2B;SPRY4;NMB;GRIN2B
7123,GO:0030054,3.96284693357486e-09,0.999999998997903,37,1935,cell junction,CC,USH1C;SYT13;GABRA1;PTPRN;LZTS1;SYT1;CAMK2A;RPH3A;EEF1A2;SLC17A7;NPTX2;DNM1;NEURL1;CRYAB;GABRG2;SLC30A3;CNR1;TJP2;HPCA;SNAP25;SYT4;CHRM3;SLC4A10;GABRB2;TENM2;NRGN;IGFN1;FABP7;ADCY1;KCNC2;KCNK9;NPTX1;DDN;SV2B;SPRY4;SLC6A17;GRIN2B
15614,GO:0070382,1.56393642631861e-08,0.999999998579341,12,210,exocytic vesicle,CC,SYT13;SYT1;RPH3A;SYTL4;SLC17A7;DNM1;SLC30A3;SNAP25;SYT4;KCNK9;SV2B;SLC6A17
7349,GO:0030424,1.72979904594674e-08,0.9999999970031,20,612,axon,CC,SYT13;PTPRN;SYT1;TPX2;KIF4A;STMN2;NEFM;SLC17A7;DNM1;CRYAB;GABRG2;CNR1;HPCA;SNAP25;SYT4;CHRM3;SLC4A10;TENM2;NRGN;KCNC2
13363,GO:0050804,6.80192353586897e-08,0.999999989710466,16,430,modulation of chemical synaptic transmission,BP,CD38;LZTS1;SYT1;CAMK2A;NPTX2;DNM1;NEURL1;CNR1;VGF;SNAP25;SYT4;SLC4A10;NRGN;ADCY1;NPTX1;GRIN2B
18109,GO:0099177,6.89601393428114e-08,0.999999989556906,16,431,regulation of trans-synaptic signaling,BP,CD38;LZTS1;SYT1;CAMK2A;NPTX2;DNM1;NEURL1;CNR1;VGF;SNAP25;SYT4;SLC4A10;NRGN;ADCY1;NPTX1;GRIN2B
11824,GO:0045211,8.99299648594516e-08,0.999999989220159,13,269,postsynaptic membrane,CC,GABRA1;LZTS1;RPH3A;DNM1;GABRG2;CHRM3;GABRB2;TENM2;NRGN;ADCY1;KCNC2;DDN;GRIN2B
12827,GO:0048167,1.00535439813447e-07,0.999999990439273,11,183,regulation of synaptic plasticity,BP,CD38;LZTS1;CAMK2A;NEURL1;VGF;SNAP25;SYT4;SLC4A10;NRGN;ADCY1;GRIN2B
10271,GO:0036477,1.82089550779358e-07,0.999999961561405,21,810,somatodendritic compartment,CC,PTPRN;LZTS1;CAMK2A;TPX2;RPH3A;EEF1A2;STMN2;DNM1;NEURL1;CRYAB;HPCA;SNAP25;SYT4;CHRM3;SLC4A10;TENM2;NRGN;FABP7;KCNC2;ENC1;DDN
3817,GO:0008021,5.90894370282794e-07,0.999999940914673,10,192,synaptic vesicle,CC,SYT1;RPH3A;SLC17A7;DNM1;SLC30A3;SNAP25;SYT4;KCNK9;SV2B;SLC6A17
7443,GO:0030658,6.294210596716e-07,0.999999936597635,10,194,transport vesicle membrane,CC,PTPRN;SYT1;RPH3A;SYTL4;SLC17A7;SLC30A3;SYT4;NRGN;SV2B;SLC6A17
17779,GO:0098590,1.12877762502425e-06,0.999999705195121,24,1133,plasma membrane region,CC,CD38;GABRA1;LZTS1;ASPM;SYT1;RPH3A;DNM1;CRYAB;GABRG2;IGFBP2;CNR1;HPCA;SNAP25;CHRM3;SLC14A1;SLC4A10;GABRB2;TENM2;NRGN;ADCY1;KCNC2;DDN;SPRY4;GRIN2B
18013,GO:0098978,1.59821057497546e-06,0.999999750045316,13,348,glutamatergic synapse,CC,SYT1;NPTX2;DNM1;SLC30A3;CNR1;HPCA;SNAP25;SYT4;CHRM3;NRGN;ADCY1;NPTX1;SLC6A17
17881,GO:0098793,1.63111727656363e-06,0.99999970226863,15,495,presynapse,CC,PTPRN;SYT1;RPH3A;SLC17A7;DNM1;SLC30A3;CNR1;SNAP25;SYT4;CHRM3;SLC4A10;KCNC2;KCNK9;SV2B;SLC6A17
7086,GO:0023061,1.69939530845635e-06,0.999999688595175,15,513,signal release,BP,CD38;SYT13;PTPRN;SYT1;CAMK2A;RPH3A;SYTL4;CNR1;VGF;SNAP25;SYT4;VSNL1;ADCY1;KCNC2;NMB
7275,GO:0030285,2.28682234902886e-06,0.999999933096225,5,33,integral component of synaptic vesicle membrane,CC,SYT1;SLC17A7;SLC30A3;SYT4;SLC6A17
3415,GO:0006836,3.34750869701653e-06,0.999999591268789,10,218,neurotransmitter transport,BP,SYT1;CAMK2A;RPH3A;SLC17A7;CNR1;SNAP25;SYT4;ADCY1;SV2B;SLC6A17
11081,GO:0043197,4.1788259163585e-06,0.999999548871767,9,169,dendritic spine,CC,LZTS1;CAMK2A;RPH3A;DNM1;NEURL1;CRYAB;HPCA;TENM2;NRGN
11535,GO:0044309,4.71243787502776e-06,0.999999483371364,9,171,neuron spine,CC,LZTS1;CAMK2A;RPH3A;DNM1;NEURL1;CRYAB;HPCA;TENM2;NRGN
16474,GO:0071944,4.7315313220991e-06,0.999998189622648,52,4460,cell periphery,CC,CD38;USH1C;CAMK1G;SYT13;GABRA1;PTPRN;LZTS1;ASPM;SYT1;PTPN3;RPH3A;SYTL4;SLC17A7;DNM1;NEURL1;CRYAB;GABRG2;SLC30A3;IGFBP2;CNR1;TJP2;PRLHR;HPCA;SNAP25;SYT4;GPR12;CHRM3;MRAP2;SLC14A1;STAC2;SLC4A10;GABRB2;TENM2;FREM2;NRGN;FABP7;ADCY1;MELK;FOLR2;KCNC2;TMEM130;KCNK9;NPTX1;UBE2C;DDN;SV2B;SPRY4;C2ORF88;SELL;CPNE4;SLC6A17;GRIN2B
7453,GO:0030672,4.77780458800376e-06,0.999999652222396,7,100,synaptic vesicle membrane,CC,SYT1;RPH3A;SLC17A7;SLC30A3;SYT4;SV2B;SLC6A17
18127,GO:0099501,4.77780458800376e-06,0.999999652222396,7,100,exocytic vesicle membrane,CC,SYT1;RPH3A;SLC17A7;SLC30A3;SYT4;SV2B;SLC6A17
12887,GO:0048285,5.2492686299185e-06,0.999999079546083,13,419,organelle fission,BP,KIFC1;ASPM;TPX2;BIRC5;KIF4A;MYBL2;DNM1;NCAPG;CENPF;NCAPH;TOP2A;MKI67;UBE2C
2799,GO:0005886,5.87698929759935e-06,0.999997735289579,51,4367,plasma membrane,CC,CD38;USH1C;CAMK1G;SYT13;GABRA1;PTPRN;LZTS1;ASPM;SYT1;PTPN3;RPH3A;SYTL4;SLC17A7;DNM1;NEURL1;CRYAB;GABRG2;SLC30A3;IGFBP2;CNR1;TJP2;PRLHR;HPCA;SNAP25;SYT4;GPR12;CHRM3;MRAP2;SLC14A1;STAC2;SLC4A10;GABRB2;TENM2;FREM2;NRGN;ADCY1;MELK;FOLR2;KCNC2;TMEM130;KCNK9;NPTX1;UBE2C;DDN;SV2B;SPRY4;C2ORF88;SELL;CPNE4;SLC6A17;GRIN2B
19679,GO:1903047,6.86847670544661e-06,0.999998347648769,18,820,mitotic cell cycle process,BP,USH1C;KIFC1;BCAT1;LZTS1;CAMK2A;TPX2;BIRC5;KIF4A;MYBL2;NCAPG;FOXM1;CENPF;NCAPH;TOP2A;MKI67;MELK;RRM2;UBE2C
7444,GO:0030659,7.15565384034478e-06,0.9999983495061,17,725,cytoplasmic vesicle membrane,CC,CD38;GABRA1;PTPRN;SYT1;CAMK2A;RPH3A;SYTL4;SLC17A7;GABRG2;SLC30A3;SNAP25;SYT4;GABRB2;NRGN;SV2B;SELL;SLC6A17
11525,GO:0044297,7.58550907563003e-06,0.999998419990289,15,566,cell body,CC,PTPRN;LZTS1;TPX2;EEF1A2;STMN2;NEURL1;CRYAB;HPCA;SYT4;SLC4A10;NRGN;FABP7;KCNC2;ENC1;DDN
18078,GO:0099095,8.45562143785048e-06,0.999999828652258,4,18,ligand-gated anion channel activity,MF,GABRA1;SLC17A7;GABRG2;GABRB2
17767,GO:0098563,9.35774834648552e-06,0.99999962214108,5,46,intrinsic component of synaptic vesicle membrane,CC,SYT1;SLC17A7;SLC30A3;SYT4;SLC6A17
134,GO:0000280,9.47533480240305e-06,0.999998380914217,12,377,nuclear division,BP,KIFC1;ASPM;TPX2;BIRC5;KIF4A;MYBL2;NCAPG;CENPF;NCAPH;TOP2A;MKI67;UBE2C
10985,GO:0043025,9.69938624200764e-06,0.999998061671906,14,499,neuronal cell body,CC,PTPRN;TPX2;EEF1A2;STMN2;NEURL1;CRYAB;HPCA;SYT4;SLC4A10;NRGN;FABP7;KCNC2;ENC1;DDN
5083,GO:0012506,1.0373779206378e-05,0.99999753495997,17,745,vesicle membrane,CC,CD38;GABRA1;PTPRN;SYT1;CAMK2A;RPH3A;SYTL4;SLC17A7;GABRG2;SLC30A3;SNAP25;SYT4;GABRB2;NRGN;SV2B;SELL;SLC6A17
8491,GO:0032590,1.09000020353907e-05,0.999999548763481,5,42,dendrite membrane,CC,GABRA1;GABRG2;HPCA;KCNC2;DDN
18508,GO:0140014,1.45780352563442e-05,0.999997879227219,10,266,mitotic nuclear division,BP,KIFC1;TPX2;BIRC5;KIF4A;MYBL2;NCAPG;CENPF;NCAPH;MKI67;UBE2C
2605,GO:0005544,1.50206482045288e-05,0.99999932933564,5,47,calcium-dependent phospholipid binding,MF,SYT13;SYT1;RPH3A;SYT4;CPNE4
13671,GO:0051291,1.52493734968085e-05,0.999999631074053,4,21,protein heterooligomerization,BP,SYT1;KCNC2;RRM2;GRIN2B
133,GO:0000278,1.55540553443321e-05,0.999995857521053,19,956,mitotic cell cycle,BP,USH1C;KIFC1;BCAT1;LZTS1;PTPN3;CAMK2A;TPX2;BIRC5;KIF4A;MYBL2;NCAPG;FOXM1;CENPF;NCAPH;TOP2A;MKI67;MELK;RRM2;UBE2C
16162,GO:0071420,1.65820249339419e-05,0.999999871717512,3,7,cellular response to histamine,BP,GABRA1;GABRG2;GABRB2
3715,GO:0007399,2.03575789711668e-05,0.999992594496397,33,2236,nervous system development,BP,CD38;USH1C;GABRA1;LZTS1;ASPM;SYT1;CAMK2A;STMN2;SLC17A7;NEURL1;GABRG2;CENPF;CNR1;HPCA;SNAP25;SYT4;CHRM3;SLC4A10;SFRP2;GABRB2;TENM2;DAAM2;NRGN;IGFN1;FABP7;ADCY1;KCNC2;NPTX1;ENC1;MYT1L;HAPLN4;SLC6A17;GRIN2B
16066,GO:0071277,2.29206425723621e-05,0.999998363790139,6,80,cellular response to calcium ion,BP,SYT13;SYT1;HPCA;SYT4;ADCY1;CPNE4
4930,GO:0010817,3.22572653399789e-05,0.999993730753591,12,448,regulation of hormone levels,BP,CD38;PTPRN;SYTL4;CNR1;PRLHR;VGF;SNAP25;CHST9;VSNL1;KCNC2;PCSK1;NMB
9507,GO:0034776,3.89582943484533e-05,0.999999533710966,3,10,response to histamine,BP,GABRA1;GABRG2;GABRB2
11548,GO:0044327,4.45115314200567e-05,0.99999942735288,3,11,dendritic spine head,CC,DNM1;HPCA;NRGN
18186,GO:0099572,4.81814788476748e-05,0.999991042090257,11,347,postsynaptic specialization,CC,GABRA1;LZTS1;CAMK2A;DNM1;NEURL1;CRYAB;CHRM3;GABRB2;NRGN;ADCY1;GRIN2B
17210,GO:0090307,5.44341690016938e-05,0.999996765541101,5,59,mitotic spindle assembly,BP,KIFC1;TPX2;BIRC5;KIF4A;MYBL2
18017,GO:0098984,5.58439393163392e-05,0.99998944118517,11,351,neuron to neuron synapse,CC,LZTS1;SYT1;CAMK2A;DNM1;NEURL1;CRYAB;SLC30A3;CHRM3;NRGN;ADCY1;GRIN2B
7133,GO:0030073,5.66162191805441e-05,0.999992574803333,8,195,insulin secretion,BP,CD38;PTPRN;SYTL4;CNR1;VGF;SNAP25;VSNL1;KCNC2
5118,GO:0014046,6.12339339947678e-05,0.999997759782304,4,34,dopamine secretion,BP,SYT13;SYT1;CNR1;SYT4
5130,GO:0014059,6.12339339947678e-05,0.999997759782304,4,34,regulation of dopamine secretion,BP,SYT13;SYT1;CNR1;SYT4
11088,GO:0043204,7.3215178036627e-05,0.999991699089371,7,151,perikaryon,CC,PTPRN;NEURL1;CRYAB;HPCA;SLC4A10;KCNC2;DDN
8490,GO:0032589,8.05503596836219e-05,0.999994801434802,5,58,neuron projection membrane,CC,GABRA1;GABRG2;HPCA;KCNC2;DDN
3815,GO:0008017,9.3668100327543e-05,0.99998477726547,9,245,microtubule binding,MF,KIFC1;LZTS1;TPX2;BIRC5;KIF4A;NEFM;DNM1;CRYAB;CENPF
5634,GO:0016020,9.47501390189408e-05,0.99995942924918,69,7600,membrane,CC,CD38;USH1C;CAMK1G;SYT13;GABRA1;PTPRN;KIFC1;LZTS1;ASPM;SYT1;PTPN3;CAMK2A;RPH3A;KIF4A;EEF1A2;ST8SIA5;SYTL4;STMN2;SLC17A7;DNM1;NEURL1;NCAPG;CRYAB;PTPN5;GABRG2;SLC30A3;IGFBP2;CNR1;TJP2;PRLHR;NCAPH;HPCA;SNAP25;SYT4;GPR12;CHRM3;FAM189A2;MRAP2;SLC14A1;STAC2;SLC4A10;GABRB2;TENM2;MKI67;FREM2;CHST9;NRGN;CREB3L1;VSNL1;ADCY1;MELK;FOLR2;KCNC2;TMEM130;KCNK9;NPTX1;UBE2C;PCSK1;DDN;SV2B;C11ORF87;SPRY4;C2ORF88;SELL;CPNE4;SLC6A17;PPP1R14C;TMEM158;GRIN2B
7057,GO:0022851,9.59374635140882e-05,0.999998363169236,3,12,GABA-gated chloride ion channel activity,MF,GABRA1;GABRG2;GABRB2
13624,GO:0051225,9.96836191572829e-05,0.999990611590435,6,104,spindle assembly,BP,KIFC1;ASPM;TPX2;BIRC5;KIF4A;MYBL2
2478,GO:0005230,0.000103922723052445,0.999992865415913,5,67,extracellular ligand-gated ion channel activity,MF,GABRA1;SLC17A7;GABRG2;GABRB2;GRIN2B
12547,GO:0046879,0.000111436589275395,0.999981421664986,9,282,hormone secretion,BP,CD38;PTPRN;SYTL4;CNR1;VGF;SNAP25;VSNL1;KCNC2;NMB
7322,GO:0030348,0.000134780049006716,0.999999701399284,2,3,syntaxin-3 binding,MF,SYT1;SYT4
4592,GO:0009914,0.000135747075971823,0.999976752394642,9,290,hormone transport,BP,CD38;PTPRN;SYTL4;CNR1;VGF;SNAP25;VSNL1;KCNC2;NMB
2481,GO:0005237,0.000140746749148249,0.999997173944902,3,14,inhibitory extracellular ligand-gated ion channel activity,MF,GABRA1;GABRG2;GABRB2
3726,GO:0007417,0.000143062842126075,0.999956132713227,18,965,central nervous system development,BP,ASPM;SYT1;SLC17A7;NEURL1;CENPF;HPCA;SYT4;SLC4A10;SFRP2;DAAM2;NRGN;FABP7;ADCY1;KCNC2;NPTX1;HAPLN4;SLC6A17;GRIN2B
3728,GO:0007420,0.000158429594427503,0.999956534213277,15,701,brain development,BP,ASPM;SYT1;SLC17A7;NEURL1;CENPF;HPCA;SYT4;SLC4A10;SFRP2;NRGN;FABP7;ADCY1;KCNC2;SLC6A17;GRIN2B
3553,GO:0007059,0.000158670429924474,0.999972249673497,9,290,chromosome segregation,BP,KIFC1;BIRC5;KIF4A;NCAPG;CENPF;NCAPH;TOP2A;MKI67;UBE2C
5443,GO:0015631,0.00016114069221306,0.99996852205286,10,336,tubulin binding,MF,KIFC1;LZTS1;TPX2;BIRC5;KIF4A;STMN2;NEFM;DNM1;CRYAB;CENPF
17829,GO:0098693,0.000162885005497885,0.999983173206395,6,110,regulation of synaptic vesicle cycle,BP,SYT1;SLC17A7;DNM1;CNR1;SYT4;ADCY1
18025,GO:0099003,0.000162913225417949,0.999975032525565,8,212,vesicle-mediated transport in synapse,BP,SYT1;SLC17A7;DNM1;CNR1;HPCA;SNAP25;SYT4;ADCY1
18129,GO:0099503,0.000174553576977135,0.999949435814289,16,911,secretory vesicle,CC,CD38;SYT13;PTPRN;SYT1;RPH3A;SYTL4;SLC17A7;DNM1;SLC30A3;SNAP25;SYT4;KCNK9;PCSK1;SV2B;SELL;SLC6A17
7132,GO:0030072,0.000175219498663219,0.99997280977583,8,233,peptide hormone secretion,BP,CD38;PTPRN;SYTL4;CNR1;VGF;SNAP25;VSNL1;KCNC2
440,GO:0001505,0.000189638153791091,0.999970241516692,8,226,regulation of neurotransmitter levels,BP,SYT1;CAMK2A;RPH3A;SLC17A7;CNR1;SNAP25;SYT4;ADCY1
311,GO:0000819,0.000198200537822729,0.999973485047518,7,175,sister chromatid segregation,BP,KIFC1;KIF4A;NCAPG;CENPF;NCAPH;TOP2A;UBE2C
3670,GO:0007269,0.000200594384799029,0.999973138739605,7,167,neurotransmitter secretion,BP,SYT1;CAMK2A;RPH3A;CNR1;SNAP25;SYT4;ADCY1
18224,GO:0099643,0.000200594384799029,0.999973138739605,7,167,signal release from synapse,BP,SYT1;CAMK2A;RPH3A;CNR1;SNAP25;SYT4;ADCY1
14405,GO:0060199,0.000217825391230876,0.999999131638287,2,4,clathrin-sculpted glutamate transport vesicle,CC,SYT1;SLC17A7
14408,GO:0060203,0.000217825391230876,0.999999131638287,2,4,clathrin-sculpted glutamate transport vesicle membrane,CC,SYT1;SLC17A7
5567,GO:0015872,0.000218532431514639,0.999988586289239,4,48,dopamine transport,BP,SYT13;SYT1;CNR1;SYT4
2280,GO:0004890,0.000221206517871953,0.999994646907451,3,17,GABA-A receptor activity,MF,GABRA1;GABRG2;GABRB2
19520,GO:1902711,0.000221206517871953,0.999994646907451,3,17,GABA-A receptor complex,CC,GABRA1;GABRG2;GABRB2
20598,GO:1904862,0.000225426271602453,0.999994559640949,3,16,inhibitory synapse assembly,BP,GABRA1;GABRG2;GABRB2
13230,GO:0050433,0.000225445065109038,0.999988114894112,4,49,regulation of catecholamine secretion,BP,SYT13;SYT1;CNR1;SYT4
18015,GO:0098982,0.000244291837308573,0.999979763879207,5,72,GABA-ergic synapse,CC,GABRA1;GABRG2;CNR1;GABRB2;SLC6A17
3400,GO:0006811,0.000246603259669246,0.999911802735635,22,1473,ion transport,BP,SYT13;GABRA1;SYT1;PTPN3;CAMK2A;SLC17A7;GABRG2;SLC30A3;CNR1;HPCA;SNAP25;SYT4;CHRM3;STAC2;SLC4A10;GABRB2;FOLR2;KCNC2;KCNK9;SLC6A17;NMB;GRIN2B
5119,GO:0014047,0.00025043814918309,0.999986528986177,4,43,glutamate secretion,BP,SYT1;SLC17A7;SNAP25;SYT4
3885,GO:0008144,0.00026053488442743,0.999977922513205,5,91,drug binding,MF,GABRA1;CNR1;TOP2A;CHRM3;FOLR2
7350,GO:0030425,0.000263748378748945,0.999931425025882,13,579,dendrite,CC,LZTS1;CAMK2A;RPH3A;DNM1;NEURL1;CRYAB;HPCA;SYT4;CHRM3;SLC4A10;TENM2;NRGN;KCNC2
12120,GO:0045921,0.000267493418116808,0.999977254952051,5,85,positive regulation of exocytosis,BP,SYT1;SYTL4;CNR1;SYT4;VSNL1
17606,GO:0097447,0.00027027998010801,0.999929542644068,13,581,dendritic tree,CC,LZTS1;CAMK2A;RPH3A;DNM1;NEURL1;CRYAB;HPCA;SYT4;CHRM3;SLC4A10;TENM2;NRGN;KCNC2
19519,GO:1902710,0.00027397468869972,0.999992808398088,3,18,GABA receptor complex,CC,GABRA1;GABRG2;GABRB2
13229,GO:0050432,0.000279499252777774,0.999984372836757,4,51,catecholamine secretion,BP,SYT13;SYT1;CNR1;SYT4
14488,GO:0060322,0.000294127784747021,0.999914358393559,15,743,head development,BP,ASPM;SYT1;SLC17A7;NEURL1;CENPF;HPCA;SYT4;SLC4A10;SFRP2;NRGN;FABP7;ADCY1;KCNC2;SLC6A17;GRIN2B
4631,GO:0010038,0.000320125360179063,0.999938270735324,9,335,response to metal ion,BP,SYT13;SYT1;SLC30A3;IGFBP2;HPCA;SYT4;ADCY1;KCNC2;CPNE4
13995,GO:0051932,0.000341469178488967,0.999980007711428,4,45,synaptic transmission, GABAergic,BP,GABRA1;GABRG2;CNR1;GABRB2
14926,GO:0061025,0.000355548003811595,0.999957198420347,6,143,membrane fusion,BP,SYT13;SYT1;DNM1;SNAP25;SYT4;FOLR2
15271,GO:0061792,0.000361209319431714,0.999998141580062,2,4,secretory granule maturation,BP,PTPRN;SYT4
7421,GO:0030594,0.000375961139811891,0.999965483459308,5,91,neurotransmitter receptor activity,MF,GABRA1;GABRG2;CHRM3;GABRB2;GRIN2B
6107,GO:0016917,0.000383754638701671,0.999988539248839,3,20,GABA receptor activity,MF,GABRA1;GABRG2;GABRB2
7048,GO:0022836,0.000383982998177622,0.999924149386165,9,310,gated channel activity,MF,GABRA1;SLC17A7;GABRG2;CNR1;SNAP25;GABRB2;KCNC2;KCNK9;GRIN2B
11532,GO:0044306,0.000393212421951945,0.999951787287154,6,139,neuron projection terminus,CC,PTPRN;SYT1;SYT4;CHRM3;SLC4A10;KCNC2
16047,GO:0071241,0.000395529484119366,0.999940496836909,7,201,cellular response to inorganic substance,BP,SYT13;SYT1;HPCA;SYT4;ADCY1;KCNC2;CPNE4
13826,GO:0051592,0.000401196395114429,0.99995063792717,6,137,response to calcium ion,BP,SYT13;SYT1;HPCA;SYT4;ADCY1;CPNE4
5141,GO:0014070,0.000402033149917921,0.999879232515376,15,833,response to organic cyclic compound,BP,CD38;GABRA1;PTPRN;CRYAB;GABRG2;IGFBP2;CNR1;HPCA;VGF;CHRM3;GABRB2;ADCY1;FOLR2;KCNC2;SELL
4629,GO:0010035,0.000415230461486333,0.999900384001577,11,507,response to inorganic substance,BP,SYT13;SYT1;EEF1A2;CRYAB;SLC30A3;IGFBP2;HPCA;SYT4;ADCY1;KCNC2;CPNE4
3588,GO:0007154,0.000417094280213207,0.999801957731879,53,5427,cell communication,BP,CD38;SYT13;GABRA1;PTPRN;LZTS1;ASPM;SYT1;PTPN3;CAMK2A;TPX2;RPH3A;BIRC5;SYTL4;SLC17A7;NPTX2;DNM1;NEURL1;CRYAB;FOXM1;GABRG2;IGFBP2;CNR1;TJP2;PRLHR;DUSP4;HPCA;VGF;SNAP25;SYT4;GPR12;CHRM3;MRAP2;STAC2;HUNK;SLC4A10;SFRP2;GABRB2;TENM2;DAAM2;FREM2;NRGN;CREB3L1;VSNL1;ADCY1;MELK;FOLR2;KCNC2;NPTX1;PCSK1;SV2B;SPRY4;NMB;GRIN2B
19916,GO:1903530,0.000420952670608991,0.999891549542767,12,573,regulation of secretion by cell,BP,CD38;SYT13;SYT1;CAMK2A;SYTL4;CNR1;SNAP25;SYT4;VSNL1;ADCY1;KCNC2;NMB
19762,GO:1903233,0.000428938064091997,0.9999975929411,2,4,regulation of calcium ion-dependent exocytosis of neurotransmitter,BP,SYT1;SYT4
3790,GO:0007611,0.000432813841808948,0.999923032840532,8,245,learning or memory,BP,SLC17A7;NPTX2;CNR1;SNAP25;SYT4;NRGN;ADCY1;GRIN2B
13413,GO:0050877,0.000489764491342506,0.999843889681221,16,920,nervous system process,BP,USH1C;GABRA1;BIRC5;SLC17A7;NPTX2;GABRG2;CNR1;SNAP25;SYT4;SLC4A10;GABRB2;NRGN;FABP7;ADCY1;NPTX1;GRIN2B
2836,GO:0005954,0.000510662558470554,0.99999636644198,2,5,calcium- and calmodulin-dependent protein kinase complex,CC,CAMK1G;CAMK2A
6214,GO:0017157,0.000513233387586114,0.999919298091494,7,206,regulation of exocytosis,BP,SYT13;SYT1;SYTL4;CNR1;SYT4;VSNL1;ADCY1
3414,GO:0006835,0.000533024792533342,0.999947118552344,5,93,dicarboxylic acid transport,BP,SYT1;SLC17A7;SNAP25;SYT4;FOLR2
18130,GO:0099504,0.000543243580362877,0.999913863587061,7,192,synaptic vesicle cycle,BP,SYT1;SLC17A7;DNM1;CNR1;SNAP25;SYT4;ADCY1
7008,GO:0022402,0.000555517846480556,0.999802864899446,19,1239,cell cycle process,BP,USH1C;KIFC1;BCAT1;LZTS1;ASPM;CAMK2A;TPX2;BIRC5;KIF4A;MYBL2;NCAPG;FOXM1;CENPF;NCAPH;TOP2A;MKI67;MELK;RRM2;UBE2C
5367,GO:0015267,0.000568467639424185,0.999869302366088,10,404,channel activity,MF,GABRA1;SLC17A7;GABRG2;CNR1;SNAP25;SLC14A1;GABRB2;KCNC2;KCNK9;GRIN2B
7040,GO:0022803,0.000568467639424185,0.999869302366088,10,404,passive transmembrane transporter activity,MF,GABRA1;SLC17A7;GABRG2;CNR1;SNAP25;SLC14A1;GABRB2;KCNC2;KCNK9;GRIN2B
34,GO:0000070,0.000578272759883555,0.999923573837937,6,150,mitotic sister chromatid segregation,BP,KIFC1;KIF4A;NCAPG;CENPF;NCAPH;UBE2C
12828,GO:0048168,0.000580550017909815,0.999960543626112,4,52,regulation of neuronal synaptic plasticity,BP,CAMK2A;NEURL1;SYT4;SLC4A10
17814,GO:0098660,0.000591323391986531,0.999823463505685,14,753,inorganic ion transmembrane transport,BP,GABRA1;PTPN3;SLC17A7;GABRG2;SLC30A3;HPCA;SNAP25;STAC2;SLC4A10;GABRB2;KCNC2;KCNK9;SLC6A17;GRIN2B
3789,GO:0007610,0.000597174681626953,0.999839910448576,12,559,behavior,BP,SLC17A7;NPTX2;GABRG2;CNR1;PRLHR;SNAP25;SYT4;MRAP2;SLC4A10;NRGN;ADCY1;GRIN2B
7043,GO:0022824,0.00063578541229679,0.999955644290857,4,54,transmitter-gated ion channel activity,MF,GABRA1;GABRG2;GABRB2;GRIN2B
7047,GO:0022835,0.00063578541229679,0.999955644290857,4,54,transmitter-gated channel activity,MF,GABRA1;GABRG2;GABRB2;GRIN2B
3407,GO:0006821,0.000662153791351268,0.999930943440206,5,99,chloride transport,BP,GABRA1;SLC17A7;GABRG2;SLC4A10;GABRB2
5140,GO:0014069,0.000675623500314464,0.999855478268067,9,324,postsynaptic density,CC,LZTS1;CAMK2A;DNM1;NEURL1;CRYAB;CHRM3;NRGN;ADCY1;GRIN2B
13999,GO:0051937,0.000704536631239569,0.999949040274653,4,66,catecholamine transport,BP,SYT13;SYT1;CNR1;SYT4
7819,GO:0031410,0.000724043675919798,0.999694287551883,27,2189,cytoplasmic vesicle,CC,CD38;SYT13;GABRA1;PTPRN;KIFC1;SYT1;CAMK2A;RPH3A;SYTL4;STMN2;SLC17A7;DNM1;GABRG2;SLC30A3;IGFBP2;VGF;SNAP25;SYT4;GABRB2;NRGN;KCNK9;NPTX1;PCSK1;SV2B;SELL;SLC6A17;GRIN2B
15388,GO:0065008,0.000731029869556211,0.999656612134079,39,3602,regulation of biological quality,BP,CD38;USH1C;GABRA1;PTPRN;LZTS1;ASPM;SYT1;PTPN3;CAMK2A;RPH3A;SYTL4;SLC17A7;DNM1;NEURL1;CRYAB;GABRG2;SLC30A3;CNR1;TJP2;PRLHR;HPCA;VGF;SNAP25;SYT4;GPR12;CHRM3;MRAP2;SLC4A10;GABRB2;CHST9;NRGN;VSNL1;ADCY1;KCNC2;KCNK9;UBE2C;PCSK1;NMB;GRIN2B
13043,GO:0048666,0.000731235775080183,0.999741621540277,18,1073,neuron development,BP,CD38;USH1C;LZTS1;SYT1;CAMK2A;STMN2;NEURL1;CNR1;SNAP25;SYT4;SLC4A10;SFRP2;GABRB2;TENM2;ADCY1;NPTX1;ENC1;MYT1L
18197,GO:0099590,0.000733735836472654,0.999971766601273,3,27,neurotransmitter receptor internalization,BP,DNM1;HPCA;SNAP25
18439,GO:0120035,0.000740295915247183,0.999784682101423,13,641,regulation of plasma membrane bounded cell projection organization,BP,CD38;USH1C;LZTS1;SYT1;STMN2;NEURL1;CNR1;SNAP25;SYT4;SFRP2;TENM2;ENC1;GRIN2B
17715,GO:0097708,0.000748981926757141,0.999682987608485,27,2193,intracellular vesicle,CC,CD38;SYT13;GABRA1;PTPRN;KIFC1;SYT1;CAMK2A;RPH3A;SYTL4;STMN2;SLC17A7;DNM1;GABRG2;SLC30A3;IGFBP2;VGF;SNAP25;SYT4;GABRB2;NRGN;KCNK9;NPTX1;PCSK1;SV2B;SELL;SLC6A17;GRIN2B
12564,GO:0046903,0.000756199851492599,0.99971734847393,20,1415,secretion,BP,CD38;SYT13;PTPRN;SYT1;CAMK2A;RPH3A;SYTL4;SLC17A7;NEURL1;CNR1;VGF;SNAP25;SYT4;CHRM3;CREB3L1;VSNL1;ADCY1;KCNC2;SELL;NMB
8271,GO:0032279,0.000776317865672255,0.999830599742056,9,330,asymmetric synapse,CC,LZTS1;CAMK2A;DNM1;NEURL1;CRYAB;CHRM3;NRGN;ADCY1;GRIN2B
17998,GO:0098960,0.00080001483693088,0.999940355166942,4,60,postsynaptic neurotransmitter receptor activity,MF,GABRA1;GABRG2;CHRM3;GABRB2
3639,GO:0007214,0.00081231641252797,0.999967836220889,3,25,gamma-aminobutyric acid signaling pathway,BP,GABRA1;GABRG2;GABRB2
12576,GO:0046928,0.000818230542995766,0.999910523367524,5,100,regulation of neurotransmitter secretion,BP,SYT1;CAMK2A;CNR1;SYT4;ADCY1
7785,GO:0031344,0.000837241187134236,0.999753126307466,13,650,regulation of cell projection organization,BP,CD38;USH1C;LZTS1;SYT1;STMN2;NEURL1;CNR1;SNAP25;SYT4;SFRP2;TENM2;ENC1;GRIN2B
13520,GO:0051046,0.000844723783759023,0.999764054693361,12,622,regulation of secretion,BP,CD38;SYT13;SYT1;CAMK2A;SYTL4;CNR1;SNAP25;SYT4;VSNL1;ADCY1;KCNC2;NMB
3854,GO:0008092,0.000845331307925068,0.999716104124401,16,908,cytoskeletal protein binding,MF,USH1C;PTPRN;KIFC1;LZTS1;PTPN3;TPX2;BIRC5;KIF4A;STMN2;NEFM;DNM1;CRYAB;CENPF;HPCA;DAAM2;ENC1
6169,GO:0017075,0.000906839854254451,0.999962566348022,3,26,syntaxin-1 binding,MF,SYT1;SNAP25;SYT4
13358,GO:0050796,0.000925224918088301,0.999865883423613,6,166,regulation of insulin secretion,BP,CD38;SYTL4;CNR1;SNAP25;VSNL1;KCNC2
13422,GO:0050890,0.00095205342491794,0.999808521512253,8,279,cognition,BP,SLC17A7;NPTX2;CNR1;SNAP25;SYT4;NRGN;ADCY1;GRIN2B
1365,GO:0003008,0.00100031976367204,0.999600561100339,22,1606,system process,BP,CD38;USH1C;GABRA1;BIRC5;SLC17A7;NPTX2;CRYAB;GABRG2;CNR1;TJP2;SNAP25;SYT4;CHRM3;STAC2;SLC4A10;GABRB2;NRGN;FABP7;PI16;ADCY1;NPTX1;GRIN2B
12551,GO:0046883,0.00101886668674403,0.999819494150375,7,239,regulation of hormone secretion,BP,CD38;SYTL4;CNR1;SNAP25;VSNL1;KCNC2;NMB
3550,GO:0007052,0.00103048881485012,0.999881061166823,5,109,mitotic spindle organization,BP,KIFC1;TPX2;BIRC5;KIF4A;MYBL2
10849,GO:0042734,0.00104405972396819,0.999845300113389,6,154,presynaptic membrane,CC,SYT1;DNM1;CNR1;SNAP25;CHRM3;KCNC2
17896,GO:0098813,0.00105887457293322,0.99981122541576,7,233,nuclear chromosome segregation,BP,KIFC1;KIF4A;NCAPG;CENPF;NCAPH;TOP2A;UBE2C
2494,GO:0005254,0.00111300606447678,0.999908942035915,4,66,chloride channel activity,MF,GABRA1;SLC17A7;GABRG2;GABRB2
13678,GO:0051301,0.00111614797008333,0.999697489216291,11,543,cell division,BP,KIFC1;ASPM;TPX2;BIRC5;KIF4A;NCAPG;CENPF;NCAPH;TOP2A;SFRP2;UBE2C
15211,GO:0061669,0.00116082518046788,0.999985615586424,2,7,spontaneous neurotransmitter secretion,BP,SYT1;RPH3A
16052,GO:0071248,0.00118720502874796,0.999819155678187,6,177,cellular response to metal ion,BP,SYT13;SYT1;HPCA;SYT4;ADCY1;CPNE4
13365,GO:0050806,0.00120453367779856,0.999816212592152,6,166,positive regulation of synaptic transmission,BP,SYT1;CNR1;SNAP25;NRGN;ADCY1;GRIN2B
7258,GO:0030261,0.00121847829384534,0.999944079983301,3,27,chromosome condensation,BP,NCAPG;NCAPH;TOP2A
3549,GO:0007051,0.00127600467621645,0.999803059208776,6,168,spindle organization,BP,KIFC1;ASPM;TPX2;BIRC5;KIF4A;MYBL2
18615,GO:0150034,0.00130989535201555,0.999722862820468,8,293,distal axon,CC,PTPRN;STMN2;CNR1;SNAP25;CHRM3;SLC4A10;TENM2;KCNC2
13088,GO:0048731,0.0013266113214176,0.999339824269604,44,4260,system development,BP,CD38;USH1C;GABRA1;PTPRN;LZTS1;ASPM;SYT1;PTPN3;CAMK2A;STMN2;SLC17A7;NEURL1;CRYAB;FOXM1;GABRG2;CENPF;CNR1;HPCA;VGF;TOP2A;SNAP25;SYT4;CHRM3;SLC4A10;SFRP2;GABRB2;TENM2;DAAM2;FREM2;NRGN;CREB3L1;IGFN1;FABP7;PI16;ADCY1;MELK;KCNC2;NPTX1;ENC1;MYT1L;HAPLN4;SPRY4;SLC6A17;GRIN2B
13822,GO:0051588,0.00134780231137092,0.999834550011038,5,114,regulation of neurotransmitter transport,BP,SYT1;CAMK2A;CNR1;SYT4;ADCY1
5548,GO:0015844,0.0013528435141788,0.999882626867273,4,78,monoamine transport,BP,SYT13;SYT1;CNR1;SYT4
3401,GO:0006812,0.00137010823164009,0.999517150833281,16,1031,cation transport,BP,SYT13;SYT1;PTPN3;CAMK2A;SLC17A7;SLC30A3;CNR1;HPCA;SNAP25;SYT4;STAC2;SLC4A10;KCNC2;KCNK9;SLC6A17;GRIN2B
17824,GO:0098686,0.00138434509919524,0.999932873681436,3,31,hippocampal mossy fiber to CA3 synapse,CC,SYT1;SLC30A3;ADCY1
2467,GO:0005216,0.00142539397520795,0.999660128159482,9,371,ion channel activity,MF,GABRA1;SLC17A7;GABRG2;CNR1;SNAP25;GABRB2;KCNC2;KCNK9;GRIN2B
4445,GO:0009306,0.00146875585761482,0.999647953774832,9,404,protein secretion,BP,CD38;PTPRN;SYTL4;CNR1;VGF;SNAP25;SYT4;VSNL1;KCNC2
9804,GO:0035592,0.00146875585761482,0.999647953774832,9,404,establishment of protein localization to extracellular region,BP,CD38;PTPRN;SYTL4;CNR1;VGF;SNAP25;SYT4;VSNL1;KCNC2
7720,GO:0031256,0.00154955885092056,0.999751607883274,6,166,leading edge membrane,CC,GABRA1;GABRG2;HPCA;KCNC2;DDN;SPRY4
295,GO:0000796,0.00157008842902503,0.999976436600788,2,8,condensin complex,CC,NCAPG;NCAPH
5516,GO:0015800,0.00159264807023818,0.999856137724322,4,69,acidic amino acid transport,BP,SYT1;SLC17A7;SNAP25;SYT4
9212,GO:0034220,0.00162349221226005,0.99941808102035,16,1026,ion transmembrane transport,BP,GABRA1;PTPN3;SLC17A7;GABRG2;SLC30A3;HPCA;SNAP25;CHRM3;STAC2;SLC4A10;GABRB2;FOLR2;KCNC2;KCNK9;SLC6A17;GRIN2B
7082,GO:0023052,0.00162505076575768,0.999168830826183,51,5417,signaling,BP,CD38;SYT13;GABRA1;PTPRN;LZTS1;ASPM;SYT1;PTPN3;CAMK2A;TPX2;RPH3A;BIRC5;SYTL4;SLC17A7;NPTX2;DNM1;NEURL1;CRYAB;FOXM1;GABRG2;IGFBP2;CNR1;TJP2;PRLHR;DUSP4;HPCA;VGF;SNAP25;SYT4;GPR12;CHRM3;MRAP2;STAC2;HUNK;SLC4A10;SFRP2;GABRB2;TENM2;DAAM2;NRGN;CREB3L1;VSNL1;ADCY1;MELK;KCNC2;NPTX1;PCSK1;SV2B;SPRY4;NMB;GRIN2B
7704,GO:0031226,0.00162777503108765,0.999349889661326,20,1458,intrinsic component of plasma membrane,CC,SYT13;GABRA1;GABRG2;SLC30A3;CNR1;PRLHR;SNAP25;GPR12;CHRM3;SLC14A1;GABRB2;TENM2;ADCY1;FOLR2;KCNC2;TMEM130;KCNK9;SELL;SLC6A17;GRIN2B
5669,GO:0016079,0.00162924808503856,0.999791081095943,5,117,synaptic vesicle exocytosis,BP,SYT1;CNR1;SNAP25;SYT4;ADCY1
3406,GO:0006820,0.00163630876900373,0.999534330217894,11,574,anion transport,BP,GABRA1;SYT1;SLC17A7;GABRG2;SNAP25;SYT4;SLC4A10;GABRB2;FOLR2;SLC6A17;NMB
19917,GO:1903531,0.00168548632149394,0.999781405147942,5,138,negative regulation of secretion by cell,BP,SYTL4;CNR1;SYT4;VSNL1;NMB
16344,GO:0071692,0.0016872944808182,0.999587226213836,9,411,protein localization to extracellular region,BP,CD38;PTPRN;SYTL4;CNR1;VGF;SNAP25;SYT4;VSNL1;KCNC2
10409,GO:0038171,0.0017268190609296,0.999972022434509,2,9,cannabinoid signaling pathway,BP,CAMK2A;CNR1
292,GO:0000793,0.00174425263105321,0.999713172616245,6,188,condensed chromosome,CC,BIRC5;NCAPG;CENPF;NCAPH;TOP2A;MKI67
17183,GO:0090276,0.00176466162023953,0.999709074056145,6,191,regulation of peptide hormone secretion,BP,CD38;SYTL4;CNR1;SNAP25;VSNL1;KCNC2
4670,GO:0010243,0.00176739567263086,0.999382813786838,15,951,response to organonitrogen compound,BP,GABRA1;PTPRN;CAMK2A;DNM1;NEURL1;GABRG2;CNR1;HPCA;VGF;CHRM3;GABRB2;ADCY1;FOLR2;KCNC2;SELL
8720,GO:0032940,0.00177936123147978,0.999317107686628,18,1302,secretion by cell,BP,CD38;SYT13;PTPRN;SYT1;CAMK2A;RPH3A;SYTL4;SLC17A7;CNR1;VGF;SNAP25;SYT4;CREB3L1;VSNL1;ADCY1;KCNC2;SELL;NMB
16710,GO:0072341,0.00179234889220767,0.99983184075399,4,82,modified amino acid binding,MF,SYT13;SYT1;SYT4;FOLR2
18216,GO:0099634,0.00181297381387409,0.999761843714094,5,116,postsynaptic specialization membrane,CC,GABRA1;CHRM3;GABRB2;ADCY1;GRIN2B
14009,GO:0051952,0.00187214633401119,0.999822183651756,4,83,regulation of amine transport,BP,SYT13;SYT1;CNR1;SYT4
2493,GO:0005253,0.001900991117258,0.999819101049097,4,77,anion channel activity,MF,GABRA1;SLC17A7;GABRG2;GABRB2
18054,GO:0099060,0.00200278459953501,0.999807095052905,4,72,integral component of postsynaptic specialization membrane,CC,GABRA1;CHRM3;GABRB2;ADCY1
10675,GO:0042391,0.00207746660841296,0.999476082076599,9,402,regulation of membrane potential,BP,GABRA1;PTPN3;SLC17A7;GABRG2;CNR1;GABRB2;KCNC2;KCNK9;GRIN2B
5281,GO:0015103,0.00213119374389359,0.999708841699903,5,128,inorganic anion transmembrane transporter activity,MF,GABRA1;SLC17A7;GABRG2;SLC4A10;GABRB2
9008,GO:0033604,0.00220024587362244,0.99995807051667,2,11,negative regulation of catecholamine secretion,BP,CNR1;SYT4
4105,GO:0008503,0.00224173640726155,0.999957605565559,2,10,benzodiazepine receptor activity,MF,GABRA1;GABRG2
2800,GO:0005887,0.00225690865356434,0.999092261910878,19,1385,integral component of plasma membrane,CC,SYT13;GABRA1;GABRG2;SLC30A3;CNR1;PRLHR;SNAP25;GPR12;CHRM3;SLC14A1;GABRB2;TENM2;ADCY1;KCNC2;TMEM130;KCNK9;SELL;SLC6A17;GRIN2B
21616,GO:2000300,0.00228449676942756,0.99977135003414,4,77,regulation of synaptic vesicle exocytosis,BP,SYT1;CNR1;SYT4;ADCY1
14404,GO:0060198,0.00228486868640757,0.999954986778478,2,12,clathrin-sculpted vesicle,CC,SYT1;SLC17A7
17990,GO:0098948,0.00229720056758848,0.999769921348156,4,75,intrinsic component of postsynaptic specialization membrane,CC,GABRA1;CHRM3;GABRB2;ADCY1
5372,GO:0015276,0.00244656875847929,0.99965504490396,5,127,ligand-gated ion channel activity,MF,GABRA1;SLC17A7;GABRG2;GABRB2;GRIN2B
7046,GO:0022834,0.00244656875847929,0.99965504490396,5,127,ligand-gated channel activity,MF,GABRA1;SLC17A7;GABRG2;GABRB2;GRIN2B
14708,GO:0060627,0.0024721017775049,0.999306186146931,10,507,regulation of vesicle-mediated transport,BP,SYT13;SYT1;SYTL4;SLC17A7;DNM1;CNR1;HPCA;SYT4;VSNL1;ADCY1
5544,GO:0015837,0.00252694613930097,0.999738692105842,4,91,amine transport,BP,SYT13;SYT1;CNR1;SYT4
1261,GO:0002790,0.0025665626500794,0.999331522916412,9,440,peptide secretion,BP,CD38;PTPRN;SYTL4;CNR1;VGF;SNAP25;SYT4;VSNL1;KCNC2
19918,GO:1903532,0.0025780473926546,0.999461338198695,7,282,positive regulation of secretion by cell,BP,CD38;SYT1;SYTL4;CNR1;SYT4;VSNL1;NMB
7200,GO:0030182,0.00258015034650001,0.998949493771268,19,1314,neuron differentiation,BP,CD38;USH1C;LZTS1;ASPM;SYT1;CAMK2A;STMN2;NEURL1;CNR1;SNAP25;SYT4;SLC4A10;SFRP2;GABRB2;TENM2;ADCY1;NPTX1;ENC1;MYT1L
17970,GO:0098917,0.00259796720382594,0.999947026221313,2,10,retrograde trans-synaptic signaling,BP,CNR1;SYT4
13523,GO:0051049,0.0025991041605609,0.99889575006708,21,1631,regulation of transport,BP,CD38;SYT13;SYT1;PTPN3;CAMK2A;SYTL4;SLC17A7;DNM1;CRYAB;SLC30A3;CNR1;HPCA;SNAP25;SYT4;CHRM3;STAC2;VSNL1;ADCY1;KCNC2;NMB;GRIN2B
11656,GO:0044772,0.00265483920374606,0.999247099949694,10,541,mitotic cell cycle phase transition,BP,USH1C;BCAT1;LZTS1;CAMK2A;TPX2;FOXM1;CENPF;MELK;RRM2;UBE2C
19569,GO:1902850,0.00267707609557174,0.999614130347519,5,135,microtubule cytoskeleton organization involved in mitosis,BP,KIFC1;TPX2;BIRC5;KIF4A;MYBL2
18585,GO:0140352,0.00271350361925271,0.998915695632783,18,1351,export from cell,BP,CD38;SYT13;PTPRN;SYT1;CAMK2A;RPH3A;SYTL4;SLC17A7;CNR1;VGF;SNAP25;SYT4;CREB3L1;VSNL1;ADCY1;KCNC2;SELL;NMB
13681,GO:0051304,0.00271929944648432,0.999713482436292,4,86,chromosome separation,BP,CENPF;NCAPH;TOP2A;UBE2C
7053,GO:0022843,0.0027243747997782,0.999605963847739,5,131,voltage-gated cation channel activity,MF,CNR1;SNAP25;KCNC2;KCNK9;GRIN2B
13522,GO:0051048,0.00287982402494644,0.999576693800964,5,156,negative regulation of secretion,BP,SYTL4;CNR1;SYT4;VSNL1;NMB
9468,GO:0034707,0.00291270270258579,0.999813240472283,3,42,chloride channel complex,CC,GABRA1;GABRG2;GABRB2
19140,GO:1901698,0.00295173446778382,0.998911066816006,15,1005,response to nitrogen compound,BP,GABRA1;PTPRN;CAMK2A;DNM1;NEURL1;GABRG2;CNR1;HPCA;VGF;CHRM3;GABRB2;ADCY1;FOLR2;KCNC2;SELL
6215,GO:0017158,0.00300777933051014,0.999805172895751,3,41,regulation of calcium ion-dependent exocytosis,BP,SYT13;SYT1;SYT4
3461,GO:0006906,0.0030225707893891,0.999671464411487,4,92,vesicle fusion,BP,SYT13;SYT1;SNAP25;SYT4
3431,GO:0006865,0.0030344409458215,0.999549360934068,5,141,amino acid transport,BP,SYT1;SLC17A7;SNAP25;SYT4;SLC6A17
3616,GO:0007186,0.00303805435722827,0.999008627743469,12,774,G protein-coupled receptor signaling pathway,BP,GABRA1;CAMK2A;DNM1;GABRG2;CNR1;PRLHR;GPR12;CHRM3;MRAP2;GABRB2;ADCY1;NMB
2461,GO:0005184,0.0031397013784944,0.999922315506607,2,22,neuropeptide hormone activity,MF,VGF;NMB
5061,GO:0010975,0.00316871070217857,0.999079615302898,10,486,regulation of neuron projection development,BP,CD38;LZTS1;SYT1;STMN2;NEURL1;CNR1;SNAP25;SYT4;SFRP2;ENC1
19431,GO:1902476,0.00322336827715136,0.999644085919942,4,85,chloride transmembrane transport,BP,GABRA1;SLC17A7;GABRG2;GABRB2
6993,GO:0022008,0.00322687678757646,0.998602648163282,21,1553,neurogenesis,BP,CD38;USH1C;LZTS1;ASPM;SYT1;CAMK2A;STMN2;NEURL1;CNR1;SNAP25;SYT4;SLC4A10;SFRP2;GABRB2;TENM2;DAAM2;FABP7;ADCY1;NPTX1;ENC1;MYT1L
14332,GO:0060078,0.00331571163223951,0.999497623035348,5,137,regulation of postsynaptic membrane potential,BP,GABRA1;SLC17A7;GABRG2;GABRB2;GRIN2B
17897,GO:0098814,0.00332839092153213,0.999920528458398,2,12,spontaneous synaptic transmission,BP,SYT1;RPH3A
14461,GO:0060291,0.00338726700868627,0.999621048049791,4,83,long-term synaptic potentiation,BP,SNAP25;NRGN;ADCY1;GRIN2B
13071,GO:0048699,0.0034787998425823,0.99851205759774,20,1455,generation of neurons,BP,CD38;USH1C;LZTS1;ASPM;SYT1;CAMK2A;STMN2;NEURL1;CNR1;SNAP25;SYT4;SLC4A10;SFRP2;GABRB2;TENM2;DAAM2;ADCY1;NPTX1;ENC1;MYT1L
3675,GO:0007275,0.00349206876273344,0.998143842306666,46,4743,multicellular organism development,BP,CD38;USH1C;GABRA1;PTPRN;LZTS1;ASPM;SYT1;PTPN3;CAMK2A;STMN2;SLC17A7;NEURL1;CRYAB;FOXM1;GABRG2;CENPF;CNR1;DUSP4;HPCA;VGF;TOP2A;SNAP25;SYT4;CHRM3;HUNK;SLC4A10;SFRP2;GABRB2;TENM2;DAAM2;FREM2;NRGN;CREB3L1;IGFN1;FABP7;PI16;ADCY1;MELK;KCNC2;NPTX1;ENC1;MYT1L;HAPLN4;SPRY4;SLC6A17;GRIN2B
7990,GO:0031710,0.0034964205296918,1,1,1,neuromedin B receptor binding,MF,NMB
11130,GO:0043269,0.00350658520509168,0.998897343516599,11,632,regulation of ion transport,BP,SYT13;SYT1;PTPN3;CAMK2A;CNR1;HPCA;SYT4;CHRM3;STAC2;KCNC2;GRIN2B
18170,GO:0099550,0.0035088064342132,0.999913923801194,2,12,trans-synaptic signaling, modulating synaptic transmission,BP,CNR1;SYT4
5390,GO:0015318,0.00355518742812165,0.998817483392235,12,708,inorganic molecular entity transmembrane transporter activity,MF,GABRA1;SLC17A7;GABRG2;SLC30A3;CNR1;SNAP25;SLC14A1;SLC4A10;GABRB2;KCNC2;KCNK9;GRIN2B
7060,GO:0022857,0.00365332217181,0.998669071840742,14,914,transmembrane transporter activity,MF,GABRA1;SLC17A7;GABRG2;SLC30A3;CNR1;SNAP25;SLC14A1;SLC4A10;GABRB2;KCNC2;KCNK9;SV2B;SLC6A17;GRIN2B
21618,GO:2000302,0.00366990662474299,0.999907875726585,2,12,positive regulation of synaptic vesicle exocytosis,BP,SYT1;CNR1
17107,GO:0090174,0.00370166276683938,0.999573736524625,4,97,organelle membrane fusion,BP,SYT13;SYT1;SNAP25;SYT4
20310,GO:1904315,0.00372756149382448,0.999738543300333,3,44,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,MF,GABRA1;GABRG2;GABRB2
13521,GO:0051047,0.00384277421649011,0.999136444744935,7,305,positive regulation of secretion,BP,CD38;SYT1;SYTL4;CNR1;SYT4;VSNL1;NMB
5283,GO:0015108,0.00387467553241501,0.999548939820941,4,90,chloride transmembrane transporter activity,MF,GABRA1;SLC17A7;GABRG2;GABRB2
8442,GO:0032501,0.00387908208152459,0.997904579093004,56,6269,multicellular organismal process,BP,CD38;USH1C;GABRA1;PTPRN;KIFC1;LZTS1;ASPM;SYT1;PTPN3;CAMK2A;BIRC5;STMN2;SLC17A7;NPTX2;NEURL1;CRYAB;FOXM1;GABRG2;IGFBP2;CENPF;CNR1;TJP2;PRLHR;DUSP4;NCAPH;HPCA;VGF;TOP2A;SNAP25;SYT4;CHRM3;MRAP2;STAC2;HUNK;SLC4A10;SFRP2;GABRB2;TENM2;DAAM2;FREM2;NRGN;CREB3L1;IGFN1;FABP7;PI16;ADCY1;MELK;FOLR2;KCNC2;NPTX1;ENC1;MYT1L;HAPLN4;SPRY4;SLC6A17;GRIN2B
18218,GO:0099637,0.00393127602921211,0.999718411485425,3,46,neurotransmitter receptor transport,BP,DNM1;HPCA;SNAP25
13524,GO:0051050,0.00398515213206305,0.998591263229109,13,843,positive regulation of transport,BP,CD38;SYT1;CAMK2A;SYTL4;DNM1;SLC30A3;CNR1;HPCA;SYT4;STAC2;VSNL1;KCNC2;NMB
13334,GO:0050767,0.00399073332492663,0.998589694765744,13,777,regulation of neurogenesis,BP,CD38;LZTS1;ASPM;SYT1;CAMK2A;STMN2;NEURL1;CNR1;SNAP25;SYT4;SFRP2;DAAM2;ENC1
11654,GO:0044770,0.00399509815863556,0.998799441874742,10,572,cell cycle phase transition,BP,USH1C;BCAT1;LZTS1;CAMK2A;TPX2;FOXM1;CENPF;MELK;RRM2;UBE2C
19228,GO:1901986,0.00405512360234886,1,1,1,response to ketamine,BP,HPCA
20171,GO:1904008,0.00405512360234886,1,1,1,response to monosodium glutamate,BP,HPCA
20172,GO:1904009,0.00405512360234886,1,1,1,cellular response to monosodium glutamate,BP,HPCA
20173,GO:1904010,0.00405512360234886,1,1,1,response to Aroclor 1254,BP,HPCA
12585,GO:0046942,0.00415061744476807,0.999054176610764,7,302,carboxylic acid transport,BP,SYT1;SLC17A7;SNAP25;SYT4;FOLR2;SLC6A17;NMB
19795,GO:1903305,0.0041616213651464,0.999333617393896,5,154,regulation of regulated secretory pathway,BP,SYT13;SYT1;CNR1;SYT4;ADCY1
2587,GO:0005516,0.00418499023289512,0.99917948275141,6,189,calmodulin binding,MF,CAMK1G;ASPM;SYT1;CAMK2A;NRGN;ADCY1
14457,GO:0060284,0.00435739871263567,0.998380392394046,14,884,regulation of cell development,BP,CD38;LZTS1;ASPM;SYT1;CAMK2A;STMN2;NEURL1;CNR1;SNAP25;SYT4;SFRP2;DAAM2;PI16;ENC1
5550,GO:0015849,0.00436280261834185,0.998996619583797,7,305,organic acid transport,BP,SYT1;SLC17A7;SNAP25;SYT4;FOLR2;SLC6A17;NMB
18152,GO:0099529,0.00447521822800993,0.999663962059659,3,47,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential,MF,GABRA1;GABRG2;GABRB2
5469,GO:0015698,0.00450692889344292,0.999264755325684,5,153,inorganic anion transport,BP,GABRA1;SLC17A7;GABRG2;SLC4A10;GABRB2
6692,GO:0019932,0.00452314234262666,0.998826721252405,8,390,second-messenger-mediated signaling,BP,CNR1;HPCA;GPR12;CHRM3;MRAP2;ADCY1;KCNC2;GRIN2B
13311,GO:0050708,0.00454811268740814,0.998945928586836,7,307,regulation of protein secretion,BP,CD38;SYTL4;CNR1;SNAP25;SYT4;VSNL1;KCNC2
708,GO:0001917,0.00457453887595099,0.999653188441071,3,49,photoreceptor inner segment,CC,USH1C;DNM1;SNAP25
3619,GO:0007189,0.0047067065221917,0.999418945792372,4,107,adenylate cyclase-activating G protein-coupled receptor signaling pathway,BP,CNR1;GPR12;MRAP2;ADCY1
18104,GO:0099171,0.0047084582227914,0.999861638921788,2,15,presynaptic modulation of chemical synaptic transmission,BP,SYT1;CNR1
12556,GO:0046888,0.00474874477350086,0.999633498051558,3,55,negative regulation of hormone secretion,BP,SYTL4;VSNL1;NMB
18226,GO:0099699,0.00483311086527858,0.999198720881167,5,150,integral component of synaptic membrane,CC,GABRA1;CNR1;CHRM3;GABRB2;ADCY1
9667,GO:0035335,0.00505024644265145,0.999365628338719,4,96,peptidyl-tyrosine dephosphorylation,BP,PTPRN;PTPN3;PTPN5;DUSP4
15024,GO:0061185,0.00510129573792461,1,1,1,negative regulation of dermatome development,BP,SFRP2
110,GO:0000226,0.00518040661573959,0.99838492500509,10,534,microtubule cytoskeleton organization,BP,KIFC1;ASPM;TPX2;BIRC5;KIF4A;MYBL2;STMN2;NEURL1;CRYAB;MAP7D2
19797,GO:1903307,0.00526644845624708,0.999578768112413,3,53,positive regulation of regulated secretory pathway,BP,SYT1;CNR1;SYT4
4095,GO:0008483,0.00530612748875088,0.999831944807852,2,17,transaminase activity,MF,BCAT1;ETNPPL
5444,GO:0015633,0.00531246676690222,1,1,1,ATPase-coupled zinc transmembrane transporter activity,MF,SLC30A3
13670,GO:0051290,0.00532396467006756,0.999833338269659,2,15,protein heterotetramerization,BP,RRM2;GRIN2B
14234,GO:0055085,0.00533221734992042,0.997722011789295,18,1399,transmembrane transport,BP,GABRA1;PTPN3;SLC17A7;GABRG2;SLC30A3;HPCA;SNAP25;CHRM3;SLC14A1;STAC2;SLC4A10;GABRB2;FOLR2;KCNC2;KCNK9;SV2B;SLC6A17;GRIN2B
614,GO:0001786,0.00546929095351932,0.999556567975099,3,53,phosphatidylserine binding,MF,SYT13;SYT1;SYT4
5651,GO:0016050,0.0055206923346751,0.998673748290089,7,313,vesicle organization,BP,SYT13;PTPRN;SYT1;SLC17A7;DNM1;SNAP25;SYT4
10497,GO:0040037,0.00580357786927604,0.999808699249345,2,16,negative regulation of fibroblast growth factor receptor signaling pathway,BP,CREB3L1;SPRY4
6695,GO:0019935,0.00589128760527892,0.99897367861229,5,176,cyclic-nucleotide-mediated signaling,BP,CNR1;GPR12;MRAP2;ADCY1;KCNC2
12901,GO:0048306,0.00598025399199142,0.999495172202685,3,68,calcium-dependent protein binding,MF,SYT1;STMN2;SNAP25
16413,GO:0071855,0.00598520677481573,0.99979142591295,2,26,neuropeptide receptor binding,MF,MRAP2;NMB
17816,GO:0098662,0.00598883372238391,0.997975054925461,11,673,inorganic cation transmembrane transport,BP,PTPN3;SLC17A7;SLC30A3;HPCA;SNAP25;STAC2;SLC4A10;KCNC2;KCNK9;SLC6A17;GRIN2B
3972,GO:0008289,0.00606237337025947,0.99794654165742,11,685,lipid binding,MF,SYT13;SYT1;RPH3A;SYTL4;SYT4;GPR12;NRGN;FABP7;MELK;SELL;CPNE4
11985,GO:0045664,0.00607949240896559,0.997940980217552,11,631,regulation of neuron differentiation,BP,CD38;LZTS1;ASPM;SYT1;STMN2;NEURL1;CNR1;SNAP25;SYT4;SFRP2;ENC1
6014,GO:0016769,0.00632791852897715,0.999778239891593,2,19,transferase activity, transferring nitrogenous groups,MF,BCAT1;ETNPPL
12831,GO:0048172,0.00647456086421309,0.999774179330832,2,16,regulation of short-term neuronal synaptic plasticity,BP,SYT4;SLC4A10
20217,GO:1904106,0.00650117077030954,1,1,1,protein localization to microvillus,BP,USH1C
11806,GO:0045183,0.00651459974831313,1,1,1,translation factor activity, non-nucleic acid binding,MF,NEURL1
13235,GO:0050459,0.00651459974831313,1,1,1,ethanolamine-phosphate phospho-lyase activity,MF,ETNPPL
3547,GO:0007049,0.00659876982735247,0.996999940366189,20,1658,cell cycle,BP,USH1C;KIFC1;BCAT1;LZTS1;ASPM;PTPN3;CAMK2A;TPX2;BIRC5;KIF4A;MYBL2;NCAPG;FOXM1;CENPF;NCAPH;TOP2A;MKI67;MELK;RRM2;UBE2C
18121,GO:0099240,0.00660340891465271,0.998819367450784,5,162,intrinsic component of synaptic membrane,CC,GABRA1;CNR1;CHRM3;GABRB2;ADCY1
1262,GO:0002791,0.00664444347771269,0.998346844609828,7,332,regulation of peptide secretion,BP,CD38;SYTL4;CNR1;SNAP25;SYT4;VSNL1;KCNC2
3618,GO:0007188,0.00669900662395188,0.998795386796187,5,189,adenylate cyclase-modulating G protein-coupled receptor signaling pathway,BP,CNR1;GPR12;CHRM3;MRAP2;ADCY1
21258,GO:1990439,0.00673793025796054,1,1,1,MAP kinase serine/threonine phosphatase activity,MF,DUSP4
3842,GO:0008068,0.00677499149656129,1,1,1,extracellularly glutamate-gated chloride channel activity,MF,SLC17A7
5391,GO:0015319,0.00677499149656129,1,1,1,sodium:inorganic phosphate symporter activity,MF,SLC17A7
17586,GO:0097401,0.00677499149656129,1,1,1,synaptic vesicle lumen acidification,BP,SLC17A7
12148,GO:0045956,0.00681648478549209,0.999752965737728,2,18,positive regulation of calcium ion-dependent exocytosis,BP,SYT1;SYT4
72,GO:0000149,0.0069205770891149,0.999046663799364,4,109,SNARE binding,MF,SYT13;SYT1;SNAP25;SYT4
18799,GO:1900242,0.00702255711679657,0.99974295999587,2,17,regulation of synaptic vesicle endocytosis,BP,SLC17A7;DNM1
10345,GO:0038060,0.00706967958014391,1,1,1,nitric oxide-cGMP-mediated signaling pathway,BP,KCNC2
17815,GO:0098661,0.0071072979093717,0.999014060687971,4,106,inorganic anion transmembrane transport,BP,GABRA1;SLC17A7;GABRG2;GABRB2
15231,GO:0061714,0.00714645703421668,0.999987314719026,1,2,folic acid receptor activity,MF,FOLR2
16044,GO:0071231,0.00714645703421668,0.999987314719026,1,2,cellular response to folic acid,BP,FOLR2
8364,GO:0032412,0.00725247231590635,0.998400984956116,6,244,regulation of ion transmembrane transporter activity,BP,PTPN3;HPCA;CHRM3;STAC2;KCNC2;GRIN2B
12832,GO:0048174,0.00742748638423084,1,1,1,negative regulation of short-term neuronal synaptic plasticity,BP,SYT4
15268,GO:0061782,0.00742748638423084,1,1,1,vesicle fusion with vesicle,BP,SYT4
18101,GO:0099161,0.00742748638423084,1,1,1,regulation of presynaptic dense core granule exocytosis,BP,SYT4
20877,GO:1905414,0.00742748638423084,1,1,1,negative regulation of dense core granule exocytosis,BP,SYT4
20878,GO:1905415,0.00742748638423084,1,1,1,positive regulation of dense core granule exocytosis,BP,SYT4
20884,GO:1905432,0.00742748638423084,1,1,1,regulation of retrograde trans-synaptic signaling by neuropeptide,BP,SYT4
20885,GO:1905433,0.00742748638423084,1,1,1,negative regulation of retrograde trans-synaptic signaling by neuropeptide,BP,SYT4
10594,GO:0042221,0.00760907790500978,0.99588410771713,36,3796,response to chemical,BP,CD38;SYT13;GABRA1;PTPRN;SYT1;CAMK2A;BIRC5;MYBL2;EEF1A2;STMN2;DNM1;NEURL1;CRYAB;PTPN5;GABRG2;SLC30A3;IGFBP2;CENPF;CNR1;HPCA;VGF;SYT4;CHRM3;SFRP2;GABRB2;HSPB8;CREB3L1;VSNL1;ADCY1;MELK;FOLR2;KCNC2;SPRY4;SELL;CPNE4;GRIN2B
11678,GO:0044815,0.00762169764743489,0.999707350764971,2,18,DNA packaging complex,CC,NCAPG;NCAPH
16813,GO:0072586,0.00767436979363378,1,1,1,DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) regulator activity,MF,NCAPH
16814,GO:0072587,0.00767436979363378,1,1,1,DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activator activity,MF,NCAPH
6066,GO:0016849,0.00778461581203838,0.999699450815564,2,17,phosphorus-oxygen lyase activity,MF,CD38;ADCY1
18000,GO:0098962,0.00780038080407756,0.999698526128092,2,17,regulation of postsynaptic neurotransmitter receptor activity,BP,NPTX2;NPTX1
3560,GO:0007076,0.00786258265617259,0.999698909783943,2,15,mitotic chromosome condensation,BP,NCAPG;NCAPH
16453,GO:0071911,0.00789688390032024,1,1,1,synchronous neurotransmitter secretion,BP,SYT1
17857,GO:0098746,0.00789688390032024,1,1,1,fast, calcium ion-dependent exocytosis of neurotransmitter,BP,SYT1
19763,GO:1903235,0.00789688390032024,1,1,1,positive regulation of calcium ion-dependent exocytosis of neurotransmitter,BP,SYT1
12542,GO:0046873,0.00796932249755878,0.997724497039301,8,391,metal ion transmembrane transporter activity,MF,SLC17A7;SLC30A3;CNR1;SNAP25;SLC4A10;KCNC2;KCNK9;GRIN2B
13684,GO:0051307,0.00810412988734852,0.999675800358701,2,20,meiotic chromosome separation,BP,NCAPH;TOP2A
7066,GO:0022898,0.0083713556157444,0.998096862069738,6,253,regulation of transmembrane transporter activity,BP,PTPN3;HPCA;CHRM3;STAC2;KCNC2;GRIN2B
2604,GO:0005543,0.00854634426923769,0.997529084689007,8,411,phospholipid binding,MF,SYT13;SYT1;RPH3A;SYTL4;SYT4;GPR12;NRGN;CPNE4
2756,GO:0005819,0.00863289605974114,0.997743394223743,7,334,spindle,CC,KIFC1;ASPM;TPX2;BIRC5;KIF4A;CENPF;CKAP2L
4454,GO:0009330,0.00867132103880506,1,1,1,DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) complex,CC,TOP2A
8030,GO:0031780,0.0087366304710041,0.999981026069371,1,2,corticotropin hormone receptor binding,MF,MRAP2
8033,GO:0031783,0.0087366304710041,0.999981026069371,1,2,type 5 melanocortin receptor binding,MF,MRAP2
12886,GO:0048284,0.00883446925697445,0.998691076483757,4,126,organelle fusion,BP,SYT13;SYT1;SNAP25;SYT4
8104,GO:0031982,0.00885119628495597,0.995238074798054,33,3437,vesicle,CC,CD38;SYT13;GABRA1;PTPRN;KIFC1;SYT1;CAMK2A;RPH3A;SYTL4;STMN2;SLC17A7;DNM1;CRYAB;GABRG2;SLC30A3;IGFBP2;VGF;SNAP25;SYT4;GABRB2;DAAM2;FREM2;NRGN;ADCY1;KCNC2;KCNK9;NPTX1;PCSK1;SV2B;SELL;CPNE4;SLC6A17;GRIN2B
7936,GO:0031629,0.00894816032697188,0.999619128163535,2,23,synaptic vesicle fusion to presynaptic active zone membrane,BP,SYT1;SNAP25
18126,GO:0099500,0.00894816032697188,0.999619128163535,2,23,vesicle fusion to plasma membrane,BP,SYT1;SNAP25
17941,GO:0098884,0.00896466950856541,0.999622087913504,2,20,postsynaptic neurotransmitter receptor internalization,BP,DNM1;HPCA
18565,GO:0140239,0.00896466950856541,0.999622087913504,2,20,postsynaptic endocytosis,BP,DNM1;HPCA
3617,GO:0007187,0.00915113108596195,0.9982238928723,5,206,G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,BP,CNR1;GPR12;CHRM3;MRAP2;ADCY1
17601,GO:0097440,0.0091689288239031,0.999612495431277,2,18,apical dendrite,CC,NEURL1;SLC4A10
4668,GO:0010226,0.00928078889233868,0.999597407189174,2,23,response to lithium ion,BP,IGFBP2;ADCY1
3818,GO:0008022,0.00928672706387165,0.998193793264327,5,184,protein C-terminus binding,MF,SYT1;DNM1;CENPF;TOP2A;MKI67
7688,GO:0031175,0.00934670482950356,0.996195515813213,14,947,neuron projection development,BP,CD38;USH1C;LZTS1;SYT1;CAMK2A;STMN2;NEURL1;CNR1;SNAP25;SYT4;SFRP2;ADCY1;NPTX1;ENC1
7087,GO:0030001,0.00938676827891961,0.996456690345614,12,814,metal ion transport,BP,PTPN3;CAMK2A;SLC17A7;SLC30A3;HPCA;SNAP25;STAC2;SLC4A10;KCNC2;KCNK9;SLC6A17;GRIN2B
6213,GO:0017156,0.0094604373301515,0.999060572922816,3,60,calcium-ion regulated exocytosis,BP,SYT13;SYT1;SYT4
14010,GO:0051953,0.00959611156150761,0.999575199734314,2,24,negative regulation of amine transport,BP,CNR1;SYT4
18051,GO:0099055,0.00966763820340308,0.998532393841434,4,115,integral component of postsynaptic membrane,CC,GABRA1;CHRM3;GABRB2;ADCY1
13142,GO:0048856,0.0096804909982279,0.994479257100458,47,5145,anatomical structure development,BP,CD38;USH1C;GABRA1;PTPRN;LZTS1;ASPM;SYT1;PTPN3;CAMK2A;STMN2;SLC17A7;NEURL1;CRYAB;FOXM1;GABRG2;CENPF;CNR1;TJP2;DUSP4;HPCA;VGF;TOP2A;SNAP25;SYT4;CHRM3;HUNK;SLC4A10;SFRP2;GABRB2;TENM2;DAAM2;FREM2;NRGN;CREB3L1;IGFN1;FABP7;PI16;ADCY1;MELK;KCNC2;NPTX1;ENC1;MYT1L;HAPLN4;SPRY4;SLC6A17;GRIN2B
18059,GO:0099072,0.00968326660946312,0.999028265867742,3,64,regulation of postsynaptic membrane neurotransmitter receptor levels,BP,DNM1;HPCA;SNAP25
11365,GO:0043679,0.00976252049669683,0.998512120006917,4,122,axon terminus,CC,PTPRN;CHRM3;SLC4A10;KCNC2
11216,GO:0043407,0.00979518817824248,0.999010730956457,3,69,negative regulation of MAP kinase activity,BP,DUSP4;SFRP2;SPRY4
2466,GO:0005215,0.00992369517982636,0.995929401005645,14,1034,transporter activity,MF,GABRA1;SLC17A7;GABRG2;SLC30A3;CNR1;SNAP25;SLC14A1;SLC4A10;GABRB2;KCNC2;KCNK9;SV2B;SLC6A17;GRIN2B
13328,GO:0050757,0.00992861263348834,0.999975480603016,1,2,thymidylate synthase biosynthetic process,BP,FOLR2
13329,GO:0050758,0.00992861263348834,0.999975480603016,1,2,regulation of thymidylate synthase biosynthetic process,BP,FOLR2
5475,GO:0015711,0.00997473653436222,0.997035654069957,8,447,organic anion transport,BP,SYT1;SLC17A7;SNAP25;SYT4;SLC4A10;FOLR2;SLC6A17;NMB
8361,GO:0032409,0.0100442662407093,0.997625282102587,6,264,regulation of transporter activity,BP,PTPN3;HPCA;CHRM3;STAC2;KCNC2;GRIN2B
4819,GO:0010646,0.0100466279045962,0.994575760383368,32,3188,regulation of cell communication,BP,CD38;SYT13;LZTS1;ASPM;SYT1;PTPN3;CAMK2A;TPX2;SYTL4;NPTX2;DNM1;NEURL1;FOXM1;IGFBP2;CNR1;DUSP4;VGF;SNAP25;SYT4;MRAP2;SLC4A10;SFRP2;DAAM2;NRGN;CREB3L1;VSNL1;ADCY1;KCNC2;NPTX1;SPRY4;NMB;GRIN2B
20096,GO:1903861,0.0101346930741215,0.999542837002689,2,21,positive regulation of dendrite extension,BP,SYT1;SYT4
15374,GO:0062111,0.0102064379128889,0.999974085523168,1,2,zinc ion import into organelle,BP,SLC30A3
18112,GO:0099180,0.0102064379128889,0.999974085523168,1,2,zinc ion import into synaptic vesicle,BP,SLC30A3
12955,GO:0048488,0.010335931179618,0.998939304006238,3,61,synaptic vesicle endocytosis,BP,SYT1;SLC17A7;DNM1
18564,GO:0140238,0.010335931179618,0.998939304006238,3,61,presynaptic endocytosis,BP,SYT1;SLC17A7;DNM1
4821,GO:0010648,0.0103743617372855,0.995465053360608,16,1281,negative regulation of cell communication,BP,CD38;PTPN3;SYTL4;DNM1;NEURL1;FOXM1;IGFBP2;CNR1;DUSP4;SYT4;MRAP2;SFRP2;CREB3L1;VSNL1;SPRY4;NMB
20501,GO:1904692,0.010421572813426,0.999972978581935,1,2,positive regulation of type B pancreatic cell proliferation,BP,PTPRN
2484,GO:0005244,0.0105052811064336,0.997894704357027,5,182,voltage-gated ion channel activity,MF,CNR1;SNAP25;KCNC2;KCNK9;GRIN2B
7045,GO:0022832,0.0105052811064336,0.997894704357027,5,182,voltage-gated channel activity,MF,CNR1;SNAP25;KCNC2;KCNK9;GRIN2B
7084,GO:0023057,0.0105780797922854,0.995365717857857,16,1284,negative regulation of signaling,BP,CD38;PTPN3;SYTL4;DNM1;NEURL1;FOXM1;IGFBP2;CNR1;DUSP4;SYT4;MRAP2;SFRP2;CREB3L1;VSNL1;SPRY4;NMB
3792,GO:0007613,0.0106113801747612,0.998345030291978,4,115,memory,BP,SLC17A7;CNR1;SYT4;ADCY1
14017,GO:0051960,0.0106859408467835,0.995729068733961,13,878,regulation of nervous system development,BP,CD38;LZTS1;ASPM;SYT1;CAMK2A;STMN2;NEURL1;CNR1;SNAP25;SYT4;SFRP2;DAAM2;ENC1
5193,GO:0014829,0.0111067148216636,0.999470962183153,2,23,vascular associated smooth muscle contraction,BP,CD38;CHRM3
17983,GO:0098936,0.0112493533724893,0.998214020864912,4,120,intrinsic component of postsynaptic membrane,CC,GABRA1;CHRM3;GABRB2;ADCY1
16849,GO:0072686,0.0112594620343942,0.998211672147596,4,121,mitotic spindle,CC,KIFC1;ASPM;TPX2;CKAP2L
13312,GO:0050709,0.0113117185425135,0.998793013034677,3,75,negative regulation of protein secretion,BP,SYTL4;SYT4;VSNL1
2793,GO:0005880,0.0113528219612189,0.999967918461527,1,2,nuclear microtubule,CC,TPX2
7267,GO:0030276,0.0113583893080271,0.998791531899589,3,64,clathrin binding,MF,SYT13;SYT1;SYT4
20504,GO:1904695,0.0114120130651109,0.999967582079952,1,2,positive regulation of vascular associated smooth muscle contraction,BP,CHRM3
20094,GO:1903859,0.0114836923257212,0.999443392221749,2,23,regulation of dendrite extension,BP,SYT1;SYT4
7450,GO:0030667,0.0115531162040985,0.99718361007264,6,280,secretory granule membrane,CC,CD38;SYT1;SYTL4;SNAP25;SYT4;SELL
10892,GO:0042802,0.0115687076922683,0.994535037163671,19,1711,identical protein binding,MF,CD38;BCAT1;SYT1;CAMK2A;LNX1;BIRC5;DNM1;CRYAB;CENPF;CNR1;HPCA;SULT4A1;TOP2A;SYT4;MRAP2;TENM2;HSPB8;RRM2;PCSK1
10562,GO:0042137,0.0116810615353103,0.99996603084253,1,2,sequestering of neurotransmitter,BP,SLC17A7
21262,GO:1990443,0.0117587268655304,0.99996557626878,1,2,peptidyl-threonine autophosphorylation,BP,CAMK2A
5646,GO:0016043,0.0120882660481895,0.992970598382735,50,5635,cellular component organization,BP,CD38;USH1C;SYT13;GABRA1;PTPRN;KIFC1;LZTS1;ASPM;SYT1;CAMK2A;TPX2;BIRC5;KIF4A;MYBL2;SYTL4;STMN2;NEFM;SLC17A7;DNM1;NEURL1;NCAPG;CRYAB;GABRG2;CENPF;CNR1;TJP2;NCAPH;HPCA;TOP2A;SNAP25;SYT4;SFRP2;LIX1;GABRB2;TENM2;DAAM2;MKI67;ABI3BP;CREB3L1;IGFN1;PI16;ADCY1;FOLR2;KCNC2;NPTX1;ENC1;RRM2;UBE2C;MAP7D2;GRIN2B
7081,GO:0023051,0.0121393358633404,0.993344735802291,32,3228,regulation of signaling,BP,CD38;SYT13;LZTS1;ASPM;SYT1;PTPN3;CAMK2A;TPX2;SYTL4;NPTX2;DNM1;NEURL1;FOXM1;IGFBP2;CNR1;DUSP4;VGF;SNAP25;SYT4;MRAP2;SLC4A10;SFRP2;DAAM2;NRGN;CREB3L1;VSNL1;ADCY1;KCNC2;NPTX1;SPRY4;NMB;GRIN2B
17819,GO:0098675,0.0121856337732228,0.999963023307533,1,2,intrinsic component of neuronal dense core vesicle membrane,CC,SYT4
17995,GO:0098956,0.0121856337732228,0.999963023307533,1,2,intrinsic component of dense core granule membrane,CC,SYT4
18057,GO:0099066,0.0121856337732228,0.999963023307533,1,2,integral component of neuronal dense core vesicle membrane,CC,SYT4
13686,GO:0051309,0.0122756336422937,0.999962473368934,1,2,female meiosis chromosome separation,BP,NCAPH
14954,GO:0061054,0.0124029529746952,0.999961688414986,1,2,dermatome development,BP,SFRP2
15022,GO:0061183,0.0124029529746952,0.999961688414986,1,2,regulation of dermatome development,BP,SFRP2
15947,GO:0070996,0.0125498749134078,0.999947733635865,1,3,type 1 melanocortin receptor binding,MF,MRAP2
739,GO:0001956,0.0125528918879994,0.999362586517035,2,23,positive regulation of neurotransmitter secretion,BP,SYT1;CNR1
21480,GO:2000050,0.0126374958298495,0.999356030744616,2,23,regulation of non-canonical Wnt signaling pathway,BP,SFRP2;DAAM2
12108,GO:0045907,0.0126802361668508,0.999346057325499,2,27,positive regulation of vasoconstriction,BP,CD38;CHRM3
21472,GO:2000040,0.0127083302798777,0.999959772362611,1,2,regulation of planar cell polarity pathway involved in axis elongation,BP,SFRP2
21473,GO:2000041,0.0127083302798777,0.999959772362611,1,2,negative regulation of planar cell polarity pathway involved in axis elongation,BP,SFRP2
14505,GO:0060341,0.0127370026001925,0.994790468293205,13,939,regulation of cellular localization,BP,SYT1;CAMK2A;SLC17A7;DNM1;CRYAB;SLC30A3;CNR1;HPCA;SYT4;MRAP2;STAC2;VSNL1;ADCY1
11054,GO:0043154,0.0128278440447131,0.998564092652857,3,80,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,BIRC5;CRYAB;SFRP2
12039,GO:0045769,0.01299998972349,1,1,1,negative regulation of asymmetric cell division,BP,ASPM
11017,GO:0043086,0.0132306412803834,0.99524922620131,10,686,negative regulation of catalytic activity,BP,CAMK2A;BIRC5;CRYAB;CNR1;DUSP4;HPCA;SFRP2;PI16;SPRY4;PPP1R14C
7894,GO:0031536,0.0134394521799198,0.999940037227704,1,3,positive regulation of exit from mitosis,BP,UBE2C
19861,GO:1903421,0.013445977773481,0.999290165779666,2,24,regulation of synaptic vesicle recycling,BP,SLC17A7;DNM1
10817,GO:0042662,0.0134689596377849,0.999939772826327,1,3,negative regulation of mesodermal cell fate specification,BP,SFRP2
21030,GO:1905771,0.0134689596377849,0.999939772826327,1,3,negative regulation of mesodermal cell differentiation,BP,SFRP2
21088,GO:1905903,0.0134689596377849,0.999939772826327,1,3,negative regulation of mesoderm formation,BP,SFRP2
1263,GO:0002792,0.0135467731325913,0.998452312761507,3,81,negative regulation of peptide secretion,BP,SYTL4;SYT4;VSNL1
18812,GO:1900273,0.0135757207801829,0.999284048565398,2,22,positive regulation of long-term synaptic potentiation,BP,NRGN;ADCY1
1577,GO:0003407,0.0136195237019577,0.998448546912791,3,67,neural retina development,BP,USH1C;SLC17A7;IGFN1
13114,GO:0048791,0.01368912377891,0.999272612198498,2,23,calcium ion-regulated exocytosis of neurotransmitter,BP,SYT1;SYT4
3584,GO:0007143,0.0138002145568835,0.999257706665937,2,26,female meiotic nuclear division,BP,NCAPH;TOP2A
9051,GO:0033693,0.0138815161861088,0.999951973465238,1,2,neurofilament bundle assembly,BP,NEFM
6059,GO:0016838,0.01397196855955,0.999935175581736,1,3,carbon-oxygen lyase activity, acting on phosphates,MF,ETNPPL
2846,GO:0005971,0.0140024566897851,0.999951129956368,1,2,ribonucleoside-diphosphate reductase complex,CC,RRM2
5366,GO:0015265,0.0141958467796515,0.999949765772693,1,2,urea channel activity,MF,SLC14A1
7779,GO:0031338,0.0142016599039536,0.999221184628614,2,28,regulation of vesicle fusion,BP,SYT1;SYT4
17810,GO:0098656,0.0144205000764714,0.996311464748529,6,280,anion transmembrane transport,BP,GABRA1;SLC17A7;GABRG2;SLC4A10;GABRB2;FOLR2
13952,GO:0051870,0.0144398021094107,0.999930747083738,1,3,methotrexate binding,MF,FOLR2
2480,GO:0005234,0.0145254769015991,0.999947396940459,1,2,extracellularly glutamate-gated ion channel activity,MF,SLC17A7
18423,GO:0110165,0.0147381674103202,1,100,14761,cellular anatomical entity,CC,CD38;USH1C;CAMK1G;SYT13;GABRA1;PTPRN;KIFC1;BCAT1;LZTS1;ASPM;SYT1;PTPN3;CAMK2A;LNX1;TPX2;RPH3A;BIRC5;KIF4A;MYBL2;EEF1A2;ST8SIA5;SYTL4;STMN2;NEFM;SLC17A7;NPTX2;DNM1;NEURL1;NCAPG;CRYAB;PTPN5;FOXM1;GABRG2;SLC30A3;IGFBP2;CENPF;CNR1;TJP2;PRLHR;DUSP4;NCAPH;HPCA;VGF;SULT4A1;TOP2A;SNAP25;SYT4;GPR12;CHRM3;FAM189A2;MRAP2;SLC14A1;STAC2;HUNK;SLC4A10;SFRP2;LIX1;GABRB2;TENM2;DAAM2;MKI67;FREM2;HSPB8;CHST9;NRGN;ABI3BP;CREB3L1;VSNL1;IGFN1;ETNPPL;FABP7;PI16;ADCY1;MELK;FOLR2;KCNC2;TMEM130;KCNK9;CKAP2L;NPTX1;ENC1;RRM2;ZCCHC12;UBE2C;PCSK1;DDN;MAP7D2;SV2B;C11ORF87;MYT1L;HAPLN4;SPRY4;C2ORF88;SELL;CPNE4;SLC6A17;NMB;PPP1R14C;TMEM158;GRIN2B
18067,GO:0099082,0.0147634943961514,0.999945652281729,1,2,retrograde trans-synaptic signaling by neuropeptide,BP,SYT4
10262,GO:0036465,0.0150001315311054,0.998226164185699,3,71,synaptic vesicle recycling,BP,SYT1;SLC17A7;DNM1
8966,GO:0033500,0.0150021824737863,0.99670922339405,5,218,carbohydrate homeostasis,BP,PTPRN;CNR1;VGF;VSNL1;NMB
10784,GO:0042593,0.0150021824737863,0.99670922339405,5,218,glucose homeostasis,BP,PTPRN;CNR1;VGF;VSNL1;NMB
3986,GO:0008306,0.0151100142547314,0.998207653722184,3,72,associative learning,BP,NPTX2;SNAP25;NRGN
6684,GO:0019905,0.0151266735058186,0.998203665949079,3,74,syntaxin binding,MF,SYT1;SNAP25;SYT4
3806,GO:0007631,0.0151724985866545,0.998190238354739,3,85,feeding behavior,BP,CNR1;PRLHR;MRAP2
8443,GO:0032502,0.0152279281391691,0.991005158382792,49,5572,developmental process,BP,CD38;USH1C;GABRA1;PTPRN;KIFC1;LZTS1;ASPM;SYT1;PTPN3;CAMK2A;STMN2;SLC17A7;NEURL1;CRYAB;FOXM1;GABRG2;IGFBP2;CENPF;CNR1;TJP2;DUSP4;HPCA;VGF;TOP2A;SNAP25;SYT4;CHRM3;HUNK;SLC4A10;SFRP2;GABRB2;TENM2;DAAM2;FREM2;NRGN;CREB3L1;IGFN1;FABP7;PI16;ADCY1;MELK;KCNC2;NPTX1;ENC1;MYT1L;HAPLN4;SPRY4;SLC6A17;GRIN2B
1799,GO:0004084,0.0152404330824393,0.999942070016876,1,2,branched-chain-amino-acid transaminase activity,MF,BCAT1
4300,GO:0009098,0.0152404330824393,0.999942070016876,1,2,leucine biosynthetic process,BP,BCAT1
14106,GO:0052654,0.0152404330824393,0.999942070016876,1,2,L-leucine transaminase activity,MF,BCAT1
14107,GO:0052655,0.0152404330824393,0.999942070016876,1,2,L-valine transaminase activity,MF,BCAT1
14108,GO:0052656,0.0152404330824393,0.999942070016876,1,2,L-isoleucine transaminase activity,MF,BCAT1
13427,GO:0050896,0.0153784449873178,0.990925651751518,60,7419,response to stimulus,BP,CD38;SYT13;GABRA1;PTPRN;ASPM;SYT1;PTPN3;CAMK2A;TPX2;BIRC5;MYBL2;EEF1A2;SYTL4;STMN2;SLC17A7;NPTX2;DNM1;NEURL1;CRYAB;PTPN5;FOXM1;GABRG2;SLC30A3;IGFBP2;CENPF;CNR1;TJP2;PRLHR;DUSP4;HPCA;VGF;TOP2A;SNAP25;SYT4;GPR12;CHRM3;MRAP2;STAC2;HUNK;SLC4A10;SFRP2;GABRB2;TENM2;DAAM2;HSPB8;NRGN;CREB3L1;VSNL1;FABP7;PI16;ADCY1;MELK;FOLR2;KCNC2;NPTX1;SPRY4;SELL;CPNE4;NMB;GRIN2B
8029,GO:0031779,0.0154475461325158,0.999910834644398,1,4,melanocortin receptor binding,MF,MRAP2
8031,GO:0031781,0.0154475461325158,0.999910834644398,1,4,type 3 melanocortin receptor binding,MF,MRAP2
8032,GO:0031782,0.0154475461325158,0.999910834644398,1,4,type 4 melanocortin receptor binding,MF,MRAP2
21519,GO:2000117,0.0155335972139893,0.998130420693447,3,86,negative regulation of cysteine-type endopeptidase activity,BP,BIRC5;CRYAB;SFRP2
8639,GO:0032809,0.0156010257298758,0.9991011522005,2,28,neuronal cell body membrane,CC,HPCA;KCNC2
13571,GO:0051128,0.0156490131301093,0.991809227280787,24,2212,regulation of cellular component organization,BP,CD38;USH1C;LZTS1;SYT1;TPX2;SYTL4;STMN2;SLC17A7;DNM1;NEURL1;CRYAB;CENPF;CNR1;HPCA;TOP2A;SNAP25;SYT4;SFRP2;TENM2;MKI67;PI16;ENC1;UBE2C;GRIN2B
5062,GO:0010976,0.0156518662743771,0.995925331864328,6,271,positive regulation of neuron projection development,BP,SYT1;STMN2;NEURL1;CNR1;SYT4;ENC1
5267,GO:0015075,0.0157824523653171,0.993873383210939,11,761,ion transmembrane transporter activity,MF,GABRA1;SLC17A7;GABRG2;SLC30A3;CNR1;SNAP25;SLC4A10;GABRB2;KCNC2;KCNK9;GRIN2B
13824,GO:0051590,0.0158442032979506,0.999081585597013,2,27,positive regulation of neurotransmitter transport,BP,SYT1;CNR1
18672,GO:1900034,0.0159687576705125,0.998064408751877,3,75,regulation of cellular response to heat,BP,CAMK2A;CRYAB;HSPB8
2140,GO:0004683,0.0161281512321957,0.999054393170669,2,28,calmodulin-dependent protein kinase activity,MF,CAMK1G;CAMK2A
3532,GO:0007026,0.0165798957694899,0.99902026707852,2,25,negative regulation of microtubule depolymerization,BP,TPX2;STMN2
10496,GO:0040036,0.0167187228469969,0.999001025211583,2,28,regulation of fibroblast growth factor receptor signaling pathway,BP,CREB3L1;SPRY4
1688,GO:0003918,0.0168278193489354,0.999929316692092,1,2,DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity,MF,TOP2A
6381,GO:0019035,0.0168278193489354,0.999929316692092,1,2,viral integration complex,CC,TOP2A
12092,GO:0045870,0.0168278193489354,0.999929316692092,1,2,positive regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,TOP2A
17809,GO:0098655,0.0169362020488862,0.993356032567168,11,777,cation transmembrane transport,BP,PTPN3;SLC17A7;SLC30A3;HPCA;SNAP25;STAC2;SLC4A10;KCNC2;KCNK9;SLC6A17;GRIN2B
7610,GO:0031045,0.0171340292594442,0.998965020981261,2,27,dense core granule,CC,SYT1;SYT4
7739,GO:0031283,0.0171797739669487,0.999901849880225,1,3,negative regulation of guanylate cyclase activity,BP,HPCA
7787,GO:0031346,0.0172958361365985,0.994822671683554,7,361,positive regulation of cell projection organization,BP,SYT1;STMN2;NEURL1;CNR1;SYT4;TENM2;ENC1
9463,GO:0034702,0.0173651386868981,0.995373476663665,6,278,ion channel complex,CC,GABRA1;GABRG2;SNAP25;GABRB2;KCNC2;GRIN2B
18198,GO:0099601,0.0173841188012318,0.997826521271536,3,73,regulation of neurotransmitter receptor activity,BP,NPTX2;NPTX1;GRIN2B
13777,GO:0051491,0.0174235669056518,0.998935995140805,2,28,positive regulation of filopodium assembly,BP,NEURL1;TENM2
14541,GO:0060384,0.0178298091599885,0.998902581237738,2,26,innervation,BP,GABRB2;NPTX1
17811,GO:0098657,0.0178985083905714,0.995896237159226,5,217,import into cell,BP,DNM1;HPCA;SNAP25;FOLR2;KCNK9
14406,GO:0060200,0.0179353441171546,0.999892989949281,1,3,clathrin-sculpted acetylcholine transport vesicle,CC,SYT1
14407,GO:0060201,0.0179353441171546,0.999892989949281,1,3,clathrin-sculpted acetylcholine transport vesicle membrane,CC,SYT1
21346,GO:1990742,0.0179584289214155,0.999892713177642,1,3,microvesicle,CC,SYT4
8936,GO:0033363,0.0179616094484603,0.998883256944992,2,29,secretory granule organization,BP,PTPRN;SYT4
7751,GO:0031301,0.0182800092899121,0.99506546147476,6,339,integral component of organelle membrane,CC,SYT1;SLC17A7;SLC30A3;CNR1;SYT4;SLC6A17
3772,GO:0007584,0.018290306798537,0.996634611540559,4,156,response to nutrient,BP,IGFBP2;CNR1;SFRP2;FOLR2
2489,GO:0005249,0.0184690485056084,0.997631963307506,3,81,voltage-gated potassium channel activity,MF,SNAP25;KCNC2;KCNK9
4721,GO:0010469,0.0186255285283384,0.996557216264424,4,147,regulation of signaling receptor activity,BP,NPTX2;NEURL1;NPTX1;GRIN2B
12469,GO:0046676,0.0186683403606599,0.998807758507419,2,33,negative regulation of insulin secretion,BP,SYTL4;VSNL1
7987,GO:0031705,0.018737997126096,0.999868619087041,1,4,bombesin receptor binding,MF,NMB
42,GO:0000086,0.0189096125371894,0.995599213329091,5,239,G2/M transition of mitotic cell cycle,BP,USH1C;TPX2;FOXM1;CENPF;MELK
19142,GO:1901700,0.018939867088961,0.990917720225592,17,1515,response to oxygen-containing compound,BP,CD38;PTPRN;CAMK2A;DNM1;NEURL1;CRYAB;IGFBP2;CNR1;HPCA;VGF;CHRM3;VSNL1;ADCY1;FOLR2;KCNC2;SELL;GRIN2B
19015,GO:1901385,0.0189698241093555,0.998776536135401,2,34,regulation of voltage-gated calcium channel activity,BP,HPCA;STAC2
11526,GO:0044298,0.0190101255355419,0.998777907917946,2,31,cell body membrane,CC,HPCA;KCNC2
11636,GO:0044703,0.019112436881448,0.992364034509714,11,828,multi-organism reproductive process,BP,CD38;KIFC1;ASPM;NEURL1;IGFBP2;CNR1;PRLHR;NCAPH;VGF;TOP2A;FOLR2
15312,GO:0061891,0.0191365771563606,0.999878109169071,1,3,calcium ion sensor activity,MF,SYT1
2776,GO:0005853,0.0192537226721045,0.999861257053576,1,4,eukaryotic translation elongation factor 1 complex,CC,EEF1A2
6693,GO:0019933,0.0192764821370601,0.996397360132937,4,155,cAMP-mediated signaling,BP,CNR1;GPR12;MRAP2;ADCY1
4834,GO:0010665,0.0193335970314151,0.998742203919975,2,33,regulation of cardiac muscle cell apoptotic process,BP,CAMK2A;SFRP2
7169,GO:0030141,0.0195422285325222,0.992537859703014,10,759,secretory granule,CC,CD38;PTPRN;SYT1;RPH3A;SYTL4;SNAP25;SYT4;PCSK1;SV2B;SELL
4627,GO:0010033,0.0195638858204038,0.989138328191292,28,2931,response to organic substance,BP,CD38;GABRA1;PTPRN;CAMK2A;BIRC5;MYBL2;STMN2;DNM1;NEURL1;CRYAB;PTPN5;GABRG2;IGFBP2;CNR1;HPCA;VGF;CHRM3;SFRP2;GABRB2;HSPB8;CREB3L1;VSNL1;ADCY1;FOLR2;KCNC2;SPRY4;SELL;GRIN2B
20906,GO:1905463,0.0196802981914568,0.999871052366034,1,3,negative regulation of DNA duplex unwinding,BP,TOP2A
7375,GO:0030507,0.020063488230997,0.998682624703723,2,27,spectrin binding,MF,USH1C;PTPRN
335,GO:0000922,0.0203597023362604,0.996133808550983,4,150,spindle pole,CC,ASPM;TPX2;CENPF;CKAP2L
16408,GO:0071840,0.0203951367427002,0.987678005654907,50,5809,cellular component organization or biogenesis,BP,CD38;USH1C;SYT13;GABRA1;PTPRN;KIFC1;LZTS1;ASPM;SYT1;CAMK2A;TPX2;BIRC5;KIF4A;MYBL2;SYTL4;STMN2;NEFM;SLC17A7;DNM1;NEURL1;NCAPG;CRYAB;GABRG2;CENPF;CNR1;TJP2;NCAPH;HPCA;TOP2A;SNAP25;SYT4;SFRP2;LIX1;GABRB2;TENM2;DAAM2;MKI67;ABI3BP;CREB3L1;IGFN1;PI16;ADCY1;FOLR2;KCNC2;NPTX1;ENC1;RRM2;UBE2C;MAP7D2;GRIN2B
7291,GO:0030307,0.0203958569973562,0.996125629568128,4,148,positive regulation of cell growth,BP,CD38;SYT1;SYT4;SFRP2
14521,GO:0060359,0.0204202346110684,0.999861126985063,1,3,response to ammonium ion,BP,KCNC2
16048,GO:0071242,0.0204202346110684,0.999861126985063,1,3,cellular response to ammonium ion,BP,KCNC2
19617,GO:1902951,0.0204716217702543,0.999860423894583,1,3,negative regulation of dendritic spine maintenance,BP,GRIN2B
14011,GO:0051954,0.0204893716144319,0.998623531261797,2,34,positive regulation of amine transport,BP,SYT1;SYT4
15408,GO:0070050,0.0205515132321207,0.998621019468203,2,32,neuron cellular homeostasis,BP,SLC17A7;CNR1
2316,GO:0004949,0.0206015777594889,0.999858637811566,1,3,cannabinoid receptor activity,MF,CNR1
12943,GO:0048468,0.020670846561595,0.989143556111827,22,1970,cell development,BP,CD38;USH1C;LZTS1;ASPM;SYT1;CAMK2A;STMN2;NEURL1;CNR1;TJP2;SNAP25;SYT4;SLC4A10;SFRP2;GABRB2;TENM2;DAAM2;PI16;ADCY1;NPTX1;ENC1;MYT1L
4619,GO:0009996,0.0206858507238981,0.999839751570389,1,4,negative regulation of cell fate specification,BP,SFRP2
4538,GO:0009719,0.0207082096948427,0.989966876238032,17,1466,response to endogenous stimulus,BP,CD38;GABRA1;PTPRN;CAMK2A;STMN2;NEURL1;GABRG2;IGFBP2;VGF;CHRM3;SFRP2;GABRB2;CREB3L1;ADCY1;FOLR2;KCNC2;SPRY4
7885,GO:0031523,0.0207524744690507,0.999856549542344,1,3,Myb complex,CC,MYBL2
4301,GO:0009099,0.0208811320136354,0.999854756834271,1,3,valine biosynthetic process,BP,BCAT1
2584,GO:0005509,0.0209359563497247,0.99237475588334,9,563,calcium ion binding,MF,SYT13;SYT1;RPH3A;HPCA;SYT4;TENM2;VSNL1;MELK;SELL
11218,GO:0043409,0.021195259822637,0.995924284454161,4,155,negative regulation of MAPK cascade,BP,FOXM1;DUSP4;SFRP2;SPRY4
15402,GO:0070032,0.0212305044201708,0.999831162587633,1,4,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex,CC,SNAP25
14956,GO:0061056,0.0213104361480384,0.999829883056207,1,4,sclerotome development,BP,SFRP2
21524,GO:2000124,0.0213120660126813,0.999848670342143,1,3,regulation of endocannabinoid signaling pathway,BP,CAMK2A
21091,GO:1905907,0.0215044377420056,0.999826757243618,1,4,negative regulation of amyloid fibril formation,BP,CRYAB
3976,GO:0008294,0.0215464797803314,0.999883838049252,1,2,calcium- and calmodulin-responsive adenylate cyclase activity,MF,ADCY1
21000,GO:1905684,0.0216469007632225,0.999843854056314,1,3,regulation of plasma membrane repair,BP,SYTL4
4861,GO:0010721,0.0216865075799147,0.993923632203676,6,305,negative regulation of cell development,BP,CD38;ASPM;STMN2;SYT4;DAAM2;PI16
4831,GO:0010662,0.0217136708829925,0.99849376612039,2,35,regulation of striated muscle cell apoptotic process,BP,CAMK2A;SFRP2
2187,GO:0004748,0.0218685807383783,0.999840623472213,1,3,ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor,MF,RRM2
5995,GO:0016728,0.0218685807383783,0.999840623472213,1,3,oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor,MF,RRM2
15238,GO:0061731,0.0218685807383783,0.999840623472213,1,3,ribonucleoside-diphosphate reductase activity,MF,RRM2
14298,GO:0060041,0.0219235993943443,0.995746929065967,4,141,retina development in camera-type eye,BP,USH1C;SLC17A7;HPCA;IGFN1
4828,GO:0010659,0.022281964443035,0.998432994499151,2,35,cardiac muscle cell apoptotic process,BP,CAMK2A;SFRP2
7663,GO:0031114,0.0225123097236385,0.99842244288578,2,29,regulation of microtubule depolymerization,BP,TPX2;STMN2
17625,GO:0097484,0.0226718935864375,0.998395037241093,2,33,dendrite extension,BP,SYT1;SYT4
19437,GO:1902495,0.0227844871128068,0.993545753707259,6,299,transmembrane transporter complex,CC,GABRA1;GABRG2;SNAP25;GABRB2;KCNC2;GRIN2B
17645,GO:0097512,0.0228981159822793,0.999790435951322,1,5,cardiac myofibril,CC,CRYAB
20660,GO:1904970,0.0234075152266666,0.999817274643004,1,3,brush border assembly,BP,USH1C
3766,GO:0007565,0.0234819641737516,0.995337722273706,4,168,female pregnancy,BP,CD38;IGFBP2;CNR1;PRLHR
21278,GO:1990502,0.0237353095056334,0.999812092980555,1,3,dense core granule maturation,BP,PTPRN
13835,GO:0051602,0.0237620617043643,0.998266721392917,2,37,response to electrical stimulus,BP,EEF1A2;HPCA
11687,GO:0044839,0.0243476116761688,0.993952000501545,5,255,cell cycle G2/M phase transition,BP,USH1C;TPX2;FOXM1;CENPF;MELK
7666,GO:0031117,0.0243487648625319,0.999777627414086,1,4,positive regulation of microtubule depolymerization,BP,STMN2
17769,GO:0098574,0.0244474422559474,0.999775811884296,1,4,cytoplasmic side of lysosomal membrane,CC,EEF1A2
18161,GO:0099540,0.024515465359199,0.999799465873894,1,3,trans-synaptic signaling by neuropeptide,BP,SYT4
21220,GO:1990351,0.0246612601161313,0.992886301515645,6,307,transporter complex,CC,GABRA1;GABRG2;SNAP25;GABRB2;KCNC2;GRIN2B
4827,GO:0010658,0.0248037138909485,0.998148915635411,2,37,striated muscle cell apoptotic process,BP,CAMK2A;SFRP2
17185,GO:0090278,0.02489728199089,0.998134314448176,2,39,negative regulation of peptide hormone secretion,BP,SYTL4;VSNL1
21617,GO:2000301,0.0249776524595022,0.999765929002517,1,4,negative regulation of synaptic vesicle exocytosis,BP,SYT4
17603,GO:0097442,0.0250258660408763,0.999790980135682,1,3,CA3 pyramidal cell dendrite,CC,SLC4A10
5792,GO:0016323,0.0251100792310153,0.993720027781171,5,227,basolateral plasma membrane,CC,CD38;CHRM3;SLC14A1;SLC4A10;KCNC2
11131,GO:0043270,0.0252192716772844,0.993679085556948,5,252,positive regulation of ion transport,BP,SYT1;CAMK2A;SYT4;STAC2;KCNC2
17580,GO:0097386,0.0252757701729998,0.998104042098004,2,33,glial cell projection,CC,PRLHR;SYT4
18133,GO:0099508,0.0254954440542467,0.999783015983054,1,3,voltage-gated ion channel activity involved in regulation of presynaptic membrane potential,MF,KCNC2
7064,GO:0022890,0.0255052455406318,0.991011292062805,8,503,inorganic cation transmembrane transporter activity,MF,SLC17A7;SLC30A3;CNR1;SNAP25;SLC4A10;KCNC2;KCNK9;GRIN2B
7750,GO:0031300,0.0260063589774849,0.992396516750467,6,368,intrinsic component of organelle membrane,CC,SYT1;SLC17A7;SLC30A3;CNR1;SYT4;SLC6A17
20838,GO:1905335,0.0260835725618124,0.999772828641353,1,3,regulation of aggrephagy,BP,HSPB8
20839,GO:1905337,0.0260835725618124,0.999772828641353,1,3,positive regulation of aggrephagy,BP,HSPB8
6594,GO:0019725,0.0261608401654174,0.989035874634083,11,871,cellular homeostasis,BP,CD38;PTPRN;SLC17A7;SLC30A3;CNR1;GPR12;SLC4A10;VSNL1;UBE2C;NMB;GRIN2B
7645,GO:0031090,0.0262859057334408,0.984893307464018,29,3179,organelle membrane,CC,CD38;CAMK1G;GABRA1;PTPRN;SYT1;CAMK2A;RPH3A;EEF1A2;ST8SIA5;SYTL4;SLC17A7;DNM1;PTPN5;GABRG2;SLC30A3;CNR1;SNAP25;SYT4;CHRM3;MRAP2;GABRB2;CHST9;NRGN;CREB3L1;TMEM130;DDN;SV2B;SELL;SLC6A17
18172,GO:0099552,0.0263745120292171,0.999767701657212,1,3,trans-synaptic signaling by lipid, modulating synaptic transmission,BP,CNR1
18173,GO:0099553,0.0263745120292171,0.999767701657212,1,3,trans-synaptic signaling by endocannabinoid, modulating synaptic transmission,BP,CNR1
14972,GO:0061088,0.0263969688454816,0.999738412658411,1,4,regulation of sequestering of zinc ion,BP,SLC30A3
11060,GO:0043168,0.0264022984701526,0.985174332279492,26,2551,anion binding,MF,CAMK1G;SYT13;KIFC1;SYT1;CAMK2A;RPH3A;KIF4A;EEF1A2;SYTL4;DNM1;TOP2A;SYT4;GPR12;HUNK;MKI67;NRGN;ABI3BP;ETNPPL;ADCY1;MELK;FOLR2;UBE2C;HAPLN4;SELL;CPNE4;GRIN2B
13892,GO:0051716,0.0266481165420108,0.98355705303565,51,6196,cellular response to stimulus,BP,CD38;SYT13;GABRA1;PTPRN;ASPM;SYT1;PTPN3;CAMK2A;TPX2;BIRC5;MYBL2;STMN2;SLC17A7;NPTX2;DNM1;NEURL1;CRYAB;PTPN5;FOXM1;GABRG2;IGFBP2;CNR1;TJP2;PRLHR;DUSP4;HPCA;VGF;TOP2A;SYT4;GPR12;CHRM3;MRAP2;STAC2;HUNK;SFRP2;GABRB2;TENM2;DAAM2;HSPB8;NRGN;CREB3L1;VSNL1;ADCY1;MELK;FOLR2;KCNC2;NPTX1;SPRY4;CPNE4;NMB;GRIN2B
6861,GO:0021759,0.0270806291880557,0.999724606630002,1,4,globus pallidus development,BP,KCNC2
3794,GO:0007616,0.027745931233102,0.997809449693815,2,34,long-term memory,BP,SLC17A7;ADCY1
7718,GO:0031253,0.0278096704718601,0.991753636119648,6,315,cell projection membrane,CC,GABRA1;GABRG2;HPCA;KCNC2;DDN;SPRY4
18160,GO:0099538,0.0282671512344578,0.999699792678595,1,4,synaptic signaling via neuropeptide,BP,SYT4
5037,GO:0010942,0.0282853791599878,0.989137802557512,9,659,positive regulation of cell death,BP,CAMK2A;MYBL2;EEF1A2;NEURL1;CNR1;TOP2A;SFRP2;MELK;GRIN2B
20656,GO:1904956,0.0287629462353847,0.999668539260899,1,5,regulation of midbrain dopaminergic neuron differentiation,BP,SFRP2
15429,GO:0070081,0.0287747752624713,0.999668264954152,1,5,clathrin-sculpted monoamine transport vesicle,CC,SYT1
15430,GO:0070083,0.0287747752624713,0.999668264954152,1,5,clathrin-sculpted monoamine transport vesicle membrane,CC,SYT1
7367,GO:0030496,0.0288287013418468,0.993907642981871,4,166,midbody,CC,ASPM;BIRC5;KIF4A;CENPF
7938,GO:0031632,0.0288357563851493,0.999687517307177,1,4,positive regulation of synaptic vesicle fusion to presynaptic active zone membrane,BP,SYT1
18128,GO:0099502,0.0288357563851493,0.999687517307177,1,4,calcium-dependent activation of synaptic vesicle fusion,BP,SYT1
22137,GO:2001257,0.0289267619672762,0.993880081364447,4,167,regulation of cation channel activity,BP,HPCA;STAC2;KCNC2;GRIN2B
10816,GO:0042661,0.0290113909234703,0.999662753886384,1,5,regulation of mesodermal cell fate specification,BP,SFRP2
14351,GO:0060119,0.0290815103121226,0.997636975880546,2,37,inner ear receptor cell development,BP,USH1C;GABRB2
4290,GO:0009082,0.0291272774375738,0.999660037985513,1,5,branched-chain amino acid biosynthetic process,BP,BCAT1
14034,GO:0051983,0.0292313121904681,0.995525927977355,3,94,regulation of chromosome segregation,BP,CENPF;MKI67;UBE2C
4060,GO:0008430,0.0292838059579044,0.999656352103201,1,5,selenium binding,MF,RPH3A
17160,GO:0090244,0.0295436402993545,0.999671887020672,1,4,Wnt signaling pathway involved in somitogenesis,BP,SFRP2
7260,GO:0030263,0.0295862232080569,0.99967093445994,1,4,apoptotic chromosome condensation,BP,TOP2A
462,GO:0001537,0.0296432375085511,0.999647812192554,1,5,N-acetylgalactosamine 4-O-sulfotransferase activity,MF,CHST9
18114,GO:0099183,0.0297460595822255,0.999667346515925,1,4,trans-synaptic signaling by BDNF, modulating synaptic transmission,BP,SYT4
18120,GO:0099191,0.0297460595822255,0.999667346515925,1,4,trans-synaptic signaling by BDNF,BP,SYT4
13630,GO:0051234,0.0297547281365555,0.981804522918231,40,4644,establishment of localization,BP,CD38;SYT13;GABRA1;PTPRN;KIFC1;SYT1;PTPN3;CAMK2A;RPH3A;KIF4A;SYTL4;SLC17A7;DNM1;NEURL1;CRYAB;GABRG2;SLC30A3;CENPF;CNR1;TJP2;HPCA;VGF;SNAP25;SYT4;CHRM3;SLC14A1;STAC2;SLC4A10;GABRB2;CREB3L1;VSNL1;ADCY1;FOLR2;KCNC2;KCNK9;SV2B;SELL;SLC6A17;NMB;GRIN2B
12026,GO:0045744,0.0298010276349808,0.997530797402304,2,44,negative regulation of G protein-coupled receptor signaling pathway,BP,DNM1;MRAP2
7913,GO:0031584,0.0298488288197616,0.999642879744311,1,5,activation of phospholipase D activity,BP,HPCA
18155,GO:0099533,0.0300126086764482,0.999661319294409,1,4,positive regulation of presynaptic cytosolic calcium concentration,BP,CNR1
18217,GO:0099635,0.0300126086764482,0.999661319294409,1,4,voltage-gated calcium channel activity involved in positive regulation of presynaptic cytosolic calcium levels,MF,CNR1
18227,GO:0099703,0.0300126086764482,0.999661319294409,1,4,induction of synaptic vesicle exocytosis by positive regulation of presynaptic cytosolic calcium ion concentration,BP,CNR1
2170,GO:0004725,0.0303022742212727,0.995297520697972,3,94,protein tyrosine phosphatase activity,MF,PTPN3;PTPN5;DUSP4
7717,GO:0031252,0.030530791753672,0.989734496080276,7,399,cell leading edge,CC,GABRA1;STMN2;GABRG2;HPCA;KCNC2;DDN;SPRY4
18003,GO:0098967,0.0305373171894995,0.999626108944339,1,5,exocytic insertion of neurotransmitter receptor to postsynaptic membrane,BP,SNAP25
17777,GO:0098588,0.0307129653141464,0.983612299375332,20,1941,bounding membrane of organelle,CC,CD38;CAMK1G;PTPRN;SYT1;CAMK2A;RPH3A;EEF1A2;ST8SIA5;SYTL4;SLC17A7;SLC30A3;CNR1;SNAP25;SYT4;CHST9;NRGN;TMEM130;SV2B;SELL;SLC6A17
9006,GO:0033602,0.0309649386042497,0.999639337218817,1,4,negative regulation of dopamine secretion,BP,CNR1
17766,GO:0098562,0.0310036718174651,0.99329403681087,4,178,cytoplasmic side of membrane,CC,PTPN3;EEF1A2;SNAP25;STAC2
17209,GO:0090306,0.0312321063770837,0.999633044529652,1,4,spindle assembly involved in meiosis,BP,ASPM
5134,GO:0014063,0.031342468134623,0.999606001910779,1,5,negative regulation of serotonin secretion,BP,CNR1
18029,GO:0099012,0.0315872337752324,0.99962459470385,1,4,neuronal dense core vesicle membrane,CC,SYT4
11892,GO:0045471,0.0316607561044705,0.994988461252968,3,111,response to ethanol,BP,CNR1;KCNC2;GRIN2B
9619,GO:0035249,0.0316760330499183,0.995000812120145,3,93,synaptic transmission, glutamatergic,BP,SYT1;SLC17A7;CNR1
7660,GO:0031111,0.0317805397293772,0.997291582189717,2,37,negative regulation of microtubule polymerization or depolymerization,BP,TPX2;STMN2
13887,GO:0051704,0.0319859038126584,0.986167490128205,11,894,multi-organism process,BP,CD38;KIFC1;ASPM;NEURL1;IGFBP2;CNR1;PRLHR;NCAPH;VGF;TOP2A;FOLR2
298,GO:0000799,0.0320140222506197,0.999614310779776,1,4,nuclear condensin complex,CC,NCAPH
19141,GO:1901699,0.032029158816103,0.987429446699075,9,634,cellular response to nitrogen compound,BP,GABRA1;CAMK2A;NEURL1;GABRG2;CHRM3;GABRB2;ADCY1;FOLR2;KCNC2
9897,GO:0035725,0.0320691203026717,0.992999469008413,4,161,sodium ion transmembrane transport,BP,PTPN3;SLC17A7;SLC4A10;SLC6A17
8193,GO:0032133,0.0320769696107596,0.999570150556828,1,6,chromosome passenger complex,CC,BIRC5
12089,GO:0045861,0.032166306535388,0.991401416666096,5,283,negative regulation of proteolysis,BP,PTPN3;BIRC5;CRYAB;SFRP2;PI16
17912,GO:0098839,0.0328577027170604,0.994743961989575,3,90,postsynaptic density membrane,CC,CHRM3;ADCY1;GRIN2B
8012,GO:0031749,0.0329997886381621,0.999562933448675,1,5,D2 dopamine receptor binding,MF,DNM1
3399,GO:0006810,0.033083236135786,0.979647510341993,39,4536,transport,BP,CD38;SYT13;GABRA1;PTPRN;SYT1;PTPN3;CAMK2A;RPH3A;KIF4A;SYTL4;SLC17A7;DNM1;NEURL1;CRYAB;GABRG2;SLC30A3;CENPF;CNR1;TJP2;HPCA;VGF;SNAP25;SYT4;CHRM3;SLC14A1;STAC2;SLC4A10;GABRB2;CREB3L1;VSNL1;ADCY1;FOLR2;KCNC2;KCNK9;SV2B;SELL;SLC6A17;NMB;GRIN2B
11606,GO:0044547,0.0330839217337692,0.999560686714252,1,5,DNA topoisomerase binding,MF,NCAPH
10893,GO:0042803,0.0331670796854903,0.987704123560566,8,578,protein homodimerization activity,MF,CAMK2A;CRYAB;CENPF;TOP2A;SYT4;TENM2;HSPB8;RRM2
5076,GO:0010994,0.0332582754827819,0.999537687781097,1,6,free ubiquitin chain polymerization,BP,UBE2C
17892,GO:0098805,0.0332849732117867,0.982924152675213,17,1589,whole membrane,CC,CD38;PTPRN;SYT1;CAMK2A;RPH3A;EEF1A2;SYTL4;SLC17A7;SLC30A3;CNR1;SNAP25;SYT4;NRGN;ADCY1;SV2B;SELL;SLC6A17
868,GO:0002141,0.0333069911708149,0.999582294919305,1,4,stereocilia ankle link,CC,USH1C
869,GO:0002142,0.0333069911708149,0.999582294919305,1,4,stereocilia ankle link complex,CC,USH1C
8670,GO:0032873,0.0336143264177564,0.997033278613855,2,42,negative regulation of stress-activated MAPK cascade,BP,FOXM1;SFRP2
15570,GO:0070303,0.0336143264177564,0.997033278613855,2,42,negative regulation of stress-activated protein kinase signaling cascade,BP,FOXM1;SFRP2
11766,GO:0045110,0.0339023571894999,0.999538526012558,1,5,intermediate filament bundle assembly,BP,NEFM
14993,GO:0061133,0.0341377522314667,0.999498959079428,1,7,endopeptidase activator activity,MF,SFRP2
7930,GO:0031623,0.0341729446300447,0.994433306064148,3,106,receptor internalization,BP,DNM1;HPCA;SNAP25
4718,GO:0010466,0.0343322408545774,0.992326147520742,4,200,negative regulation of peptidase activity,BP,BIRC5;CRYAB;SFRP2;PI16
5339,GO:0015204,0.03454689569613,0.999500909704108,1,6,urea transmembrane transporter activity,MF,SLC14A1
16457,GO:0071918,0.03454689569613,0.999500909704108,1,6,urea transmembrane transport,BP,SLC14A1
20905,GO:1905462,0.0347731764924802,0.999494304189969,1,6,regulation of DNA duplex unwinding,BP,TOP2A
2611,GO:0005575,0.0347804665403315,1,100,14892,cellular_component,CC,CD38;USH1C;CAMK1G;SYT13;GABRA1;PTPRN;KIFC1;BCAT1;LZTS1;ASPM;SYT1;PTPN3;CAMK2A;LNX1;TPX2;RPH3A;BIRC5;KIF4A;MYBL2;EEF1A2;ST8SIA5;SYTL4;STMN2;NEFM;SLC17A7;NPTX2;DNM1;NEURL1;NCAPG;CRYAB;PTPN5;FOXM1;GABRG2;SLC30A3;IGFBP2;CENPF;CNR1;TJP2;PRLHR;DUSP4;NCAPH;HPCA;VGF;SULT4A1;TOP2A;SNAP25;SYT4;GPR12;CHRM3;FAM189A2;MRAP2;SLC14A1;STAC2;HUNK;SLC4A10;SFRP2;LIX1;GABRB2;TENM2;DAAM2;MKI67;FREM2;HSPB8;CHST9;NRGN;ABI3BP;CREB3L1;VSNL1;IGFN1;ETNPPL;FABP7;PI16;ADCY1;MELK;FOLR2;KCNC2;TMEM130;KCNK9;CKAP2L;NPTX1;ENC1;RRM2;ZCCHC12;UBE2C;PCSK1;DDN;MAP7D2;SV2B;C11ORF87;MYT1L;HAPLN4;SPRY4;C2ORF88;SELL;CPNE4;SLC6A17;NMB;PPP1R14C;TMEM158;GRIN2B
279,GO:0000779,0.0348034819092818,0.99428769332358,3,109,condensed chromosome, centromeric region,CC,BIRC5;NCAPG;CENPF
13704,GO:0051346,0.0349653865684437,0.989053559950421,6,377,negative regulation of hydrolase activity,BP,CAMK2A;BIRC5;CRYAB;SFRP2;PI16;PPP1R14C
18356,GO:0106071,0.034993677623742,0.999508115829753,1,5,positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway,BP,MRAP2
7448,GO:0030665,0.0352854671609153,0.994176785434838,3,110,clathrin-coated vesicle membrane,CC,SYT1;SLC17A7;NRGN
10485,GO:0040016,0.0353178205783493,0.999498893794069,1,5,embryonic cleavage,BP,TOP2A
21674,GO:2000371,0.0355439824752463,0.999492407895244,1,5,regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,NCAPH
21675,GO:2000373,0.0355439824752463,0.999492407895244,1,5,positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,NCAPH
21029,GO:1905770,0.0357239441849375,0.999466068296082,1,6,regulation of mesodermal cell differentiation,BP,SFRP2
21087,GO:1905902,0.0357239441849375,0.999466068296082,1,6,regulation of mesoderm formation,BP,SFRP2
2517,GO:0005315,0.0358815146791541,0.999482649383125,1,5,inorganic phosphate transmembrane transporter activity,MF,SLC17A7
6106,GO:0016907,0.0359646165703643,0.999458797389101,1,6,G protein-coupled acetylcholine receptor activity,MF,CHRM3
17593,GO:0097418,0.0360268259933567,0.999478419198349,1,5,neurofibrillary tangle,CC,NEFM
17973,GO:0098920,0.0360352765827202,0.999478172653778,1,5,retrograde trans-synaptic signaling by lipid,BP,CNR1
17974,GO:0098921,0.0360352765827202,0.999478172653778,1,5,retrograde trans-synaptic signaling by endocannabinoid,BP,CNR1
17957,GO:0098902,0.0360579268247328,0.999477511545022,1,5,regulation of membrane depolarization during action potential,BP,PTPN3
5456,GO:0015672,0.0363874847299337,0.987293938999646,7,467,monovalent inorganic cation transport,BP,PTPN3;SLC17A7;SNAP25;SLC4A10;KCNC2;KCNK9;SLC6A17
11637,GO:0044706,0.036569528399058,0.991666474300539,4,194,multi-multicellular organism process,BP,CD38;IGFBP2;CNR1;PRLHR
5790,GO:0016321,0.0365856854543401,0.99943980386907,1,6,female meiosis chromosome segregation,BP,NCAPH
7929,GO:0031622,0.0365991006299271,0.999439389938783,1,6,positive regulation of fever generation,BP,CNR1
6205,GO:0017145,0.0366395831118188,0.996615100527635,2,41,stem cell division,BP,ASPM;SFRP2
12555,GO:0046887,0.0368502714755993,0.99381012537456,3,116,positive regulation of hormone secretion,BP,CD38;VSNL1;NMB
7487,GO:0030809,0.0369615303214738,0.99942814831645,1,6,negative regulation of nucleotide biosynthetic process,BP,HPCA
18826,GO:1900372,0.0369615303214738,0.99942814831645,1,6,negative regulation of purine nucleotide biosynthetic process,BP,HPCA
3886,GO:0008146,0.0370170377671438,0.996545447284372,2,47,sulfotransferase activity,MF,SULT4A1;CHST9
13130,GO:0048839,0.0370484017287403,0.991531029735681,4,178,inner ear development,BP,USH1C;HPCA;GABRB2;FREM2
4556,GO:0009786,0.0370839266837319,0.99944711934312,1,5,regulation of asymmetric cell division,BP,ASPM
5808,GO:0016363,0.0373490559133621,0.993703572910739,3,105,nuclear matrix,CC,KIF4A;CENPF;ENC1
2498,GO:0005267,0.0374036651771108,0.993685013286006,3,111,potassium channel activity,MF,SNAP25;KCNC2;KCNK9
20972,GO:1905605,0.0374908241211227,0.999434824587079,1,5,positive regulation of blood-brain barrier permeability,BP,TJP2
3696,GO:0007342,0.037501084620902,0.999372397496585,1,9,fusion of sperm to egg plasma membrane involved in single fertilization,BP,FOLR2
19268,GO:1902075,0.0375025311821767,0.999394518154998,1,7,cellular response to salt,BP,HPCA
9007,GO:0033603,0.0375843908846313,0.999408564159833,1,6,positive regulation of dopamine secretion,BP,SYT1
12830,GO:0048170,0.0376894389439863,0.999428773395099,1,5,positive regulation of long-term neuronal synaptic plasticity,BP,NEURL1
5546,GO:0015840,0.0377184460059311,0.999387473905417,1,7,urea transport,BP,SLC14A1
17916,GO:0098844,0.0377398490758567,0.999427232343675,1,5,postsynaptic endocytic zone membrane,CC,DNM1
3997,GO:0008324,0.0377920157120647,0.985635536140752,8,547,cation transmembrane transporter activity,MF,SLC17A7;SLC30A3;CNR1;SNAP25;SLC4A10;KCNC2;KCNK9;GRIN2B
13775,GO:0051489,0.037852597031651,0.996437765785935,2,42,regulation of filopodium assembly,BP,NEURL1;TENM2
612,GO:0001784,0.0378685764424019,0.99643544679964,2,42,phosphotyrosine residue binding,MF,PTPN3;PTPN5
8116,GO:0031999,0.0380150186763345,0.999418783162315,1,5,negative regulation of fatty acid beta-oxidation,BP,CNR1
7018,GO:0022412,0.0381118860680479,0.989344957985107,5,280,cellular process involved in reproduction in multicellular organism,BP,ASPM;NEURL1;NCAPH;TOP2A;FOLR2
7702,GO:0031224,0.0381515851606638,0.976477259596312,36,4199,intrinsic component of membrane,CC,CD38;SYT13;GABRA1;PTPRN;SYT1;ST8SIA5;SLC17A7;PTPN5;GABRG2;SLC30A3;CNR1;PRLHR;SNAP25;SYT4;GPR12;CHRM3;FAM189A2;MRAP2;SLC14A1;SLC4A10;GABRB2;TENM2;FREM2;CHST9;CREB3L1;ADCY1;FOLR2;KCNC2;TMEM130;KCNK9;SV2B;C11ORF87;SELL;SLC6A17;TMEM158;GRIN2B
8459,GO:0032532,0.0384863840192848,0.999379609856297,1,6,regulation of microvillus length,BP,USH1C
14559,GO:0060405,0.0387460046252131,0.999371145694893,1,6,regulation of penile erection,BP,CNR1
3725,GO:0007416,0.0389163053823669,0.990978410476098,4,159,synapse assembly,BP,GABRA1;GABRG2;GABRB2;IGFN1
20385,GO:1904447,0.0390926552949391,0.99938508871226,1,5,folate import across plasma membrane,BP,FOLR2
3918,GO:0008199,0.0392850475883438,0.999335124151656,1,7,ferric iron binding,MF,RRM2
21682,GO:2000381,0.039811310194684,0.99931704929773,1,7,negative regulation of mesoderm development,BP,SFRP2
5635,GO:0016021,0.0398652677071792,0.975419745685859,35,4061,integral component of membrane,CC,CD38;SYT13;GABRA1;PTPRN;SYT1;ST8SIA5;SLC17A7;PTPN5;GABRG2;SLC30A3;CNR1;PRLHR;SNAP25;SYT4;GPR12;CHRM3;FAM189A2;MRAP2;SLC14A1;SLC4A10;GABRB2;TENM2;FREM2;CHST9;CREB3L1;ADCY1;KCNC2;TMEM130;KCNK9;SV2B;C11ORF87;SELL;SLC6A17;TMEM158;GRIN2B
13622,GO:0051223,0.0402449546719902,0.984510393650323,8,574,regulation of protein transport,BP,CD38;SYTL4;CNR1;HPCA;SNAP25;SYT4;VSNL1;KCNC2
3626,GO:0007197,0.0406535456269025,0.999287609597263,1,7,adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway,BP,CHRM3
21786,GO:2000542,0.0409918332263469,0.999295493591694,1,6,negative regulation of gastrulation,BP,SFRP2
6925,GO:0021873,0.0413162350148163,0.999312512015361,1,5,forebrain neuroblast division,BP,ASPM
18136,GO:0099511,0.0413231857228003,0.999283962029715,1,6,voltage-gated calcium channel activity involved in regulation of cytosolic calcium levels,MF,CNR1
18211,GO:0099626,0.0413231857228003,0.999283962029715,1,6,voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels,MF,CNR1
3234,GO:0006573,0.0413736510524111,0.999261938148474,1,7,valine metabolic process,BP,BCAT1
13525,GO:0051051,0.0416332907895769,0.986414786925192,6,399,negative regulation of transport,BP,SYTL4;CRYAB;CNR1;SYT4;VSNL1;NMB
13647,GO:0051256,0.0419390161636594,0.999241459400329,1,7,mitotic spindle midzone assembly,BP,KIF4A
7780,GO:0031339,0.0419793517109442,0.999260845536146,1,6,negative regulation of vesicle fusion,BP,SYT4
2697,GO:0005737,0.0420543678238834,0.974347812271933,74,10035,cytoplasm,CC,CD38;USH1C;CAMK1G;SYT13;GABRA1;PTPRN;KIFC1;BCAT1;LZTS1;ASPM;SYT1;PTPN3;CAMK2A;LNX1;TPX2;RPH3A;BIRC5;KIF4A;EEF1A2;ST8SIA5;SYTL4;STMN2;NEFM;SLC17A7;DNM1;NEURL1;NCAPG;CRYAB;GABRG2;SLC30A3;IGFBP2;CENPF;CNR1;TJP2;DUSP4;NCAPH;HPCA;VGF;SULT4A1;TOP2A;SNAP25;SYT4;GPR12;MRAP2;STAC2;HUNK;LIX1;GABRB2;TENM2;HSPB8;CHST9;NRGN;CREB3L1;VSNL1;IGFN1;ETNPPL;FABP7;ADCY1;MELK;TMEM130;KCNK9;CKAP2L;NPTX1;ENC1;RRM2;UBE2C;PCSK1;DDN;SV2B;SPRY4;SELL;SLC6A17;PPP1R14C;GRIN2B
13485,GO:0051001,0.0420838077403468,0.999236168907898,1,7,negative regulation of nitric-oxide synthase activity,BP,CNR1
16462,GO:0071926,0.042170314208844,0.999254047824642,1,6,endocannabinoid signaling pathway,BP,CAMK2A
8190,GO:0032119,0.0422550600267614,0.99922988744536,1,7,sequestering of zinc ion,BP,SLC30A3
4044,GO:0008406,0.0424384911024438,0.989868185295606,4,191,gonad development,BP,PTPRN;ASPM;VGF;SFRP2
21090,GO:1905906,0.0424801775355637,0.999221590437225,1,7,regulation of amyloid fibril formation,BP,CRYAB
1686,GO:0003916,0.0427116894730462,0.999234604359749,1,6,DNA topoisomerase activity,MF,TOP2A
1307,GO:0002866,0.0427354017251891,0.999195925709552,1,8,positive regulation of acute inflammatory response to antigenic stimulus,BP,CNR1
3528,GO:0007019,0.0428401634640428,0.995684378954414,2,43,microtubule depolymerization,BP,TPX2;STMN2
7658,GO:0031109,0.042852807323713,0.992372485638489,3,109,microtubule polymerization or depolymerization,BP,TPX2;STMN2;CRYAB
866,GO:0002139,0.0430966130711037,0.999251430954728,1,5,stereocilia coupling link,CC,USH1C
13335,GO:0050768,0.0431020905259948,0.987550129699566,5,268,negative regulation of neurogenesis,BP,CD38;ASPM;STMN2;SYT4;DAAM2
2560,GO:0005436,0.0431285083830647,0.99919744269499,1,7,sodium:phosphate symporter activity,MF,SLC17A7
11987,GO:0045666,0.0432119249868856,0.985785929770734,6,353,positive regulation of neuron differentiation,BP,SYT1;STMN2;NEURL1;CNR1;SYT4;ENC1
13336,GO:0050769,0.0433569418757566,0.984287388504535,7,450,positive regulation of neurogenesis,BP,ASPM;SYT1;STMN2;NEURL1;CNR1;SYT4;ENC1
11008,GO:0043065,0.0434881203533093,0.983001195702032,8,602,positive regulation of apoptotic process,BP,CAMK2A;MYBL2;EEF1A2;NEURL1;CNR1;TOP2A;SFRP2;MELK
2342,GO:0004983,0.0434950549068737,0.999166838560637,1,8,neuropeptide Y receptor activity,MF,PRLHR
3530,GO:0007021,0.0435483032278998,0.999151698612537,1,9,tubulin complex assembly,BP,CRYAB
1574,GO:0003402,0.0437383528873236,0.999197032590262,1,6,planar cell polarity pathway involved in axis elongation,BP,SFRP2
18810,GO:1900271,0.043791228208449,0.995528705038369,2,45,regulation of long-term synaptic potentiation,BP,NRGN;ADCY1
7928,GO:0031620,0.0438590406476637,0.999169783595331,1,7,regulation of fever generation,BP,CNR1
14542,GO:0060385,0.0439733566423596,0.999188303521218,1,6,axonogenesis involved in innervation,BP,NPTX1
17909,GO:0098835,0.0442773899511837,0.999153729512884,1,7,presynaptic endocytic zone membrane,CC,DNM1
7351,GO:0030426,0.0442819211398145,0.989295308731845,4,175,growth cone,CC,STMN2;CNR1;SNAP25;TENM2
3685,GO:0007292,0.0443682496115423,0.991985379301274,3,117,female gamete generation,BP,ASPM;NCAPH;TOP2A
10511,GO:0042025,0.0445289419402913,0.999167475590345,1,6,host cell nucleus,CC,TOP2A
13623,GO:0051224,0.0446889860178049,0.99189589904667,3,126,negative regulation of protein transport,BP,SYTL4;SYT4;VSNL1
523,GO:0001654,0.0447769728076373,0.985145327198622,6,354,eye development,BP,USH1C;SLC17A7;CRYAB;HPCA;FREM2;IGFN1
17822,GO:0098684,0.0450362568125715,0.999124208722246,1,7,photoreceptor ribbon synapse,CC,DNM1
11783,GO:0045137,0.0454289001101884,0.98891491632246,4,196,development of primary sexual characteristics,BP,PTPRN;ASPM;VGF;SFRP2
13159,GO:0048878,0.0455302035507598,0.978422007639236,12,1052,chemical homeostasis,BP,CD38;PTPRN;PTPN3;SLC30A3;CNR1;VGF;GPR12;SLC4A10;VSNL1;ADCY1;NMB;GRIN2B
17911,GO:0098838,0.0456473665118735,0.999124732764407,1,6,folate transmembrane transport,BP,FOLR2
11011,GO:0043068,0.0458529554507794,0.981887096875923,8,608,positive regulation of programmed cell death,BP,CAMK2A;MYBL2;EEF1A2;NEURL1;CNR1;TOP2A;SFRP2;MELK
5133,GO:0014062,0.046188144403722,0.99905948092831,1,8,regulation of serotonin secretion,BP,CNR1
18622,GO:0150063,0.0464595911268805,0.984449234304221,6,358,visual system development,BP,USH1C;SLC17A7;CRYAB;HPCA;FREM2;IGFN1
7138,GO:0030100,0.0465124628724639,0.988565783793865,4,195,regulation of endocytosis,BP,SLC17A7;DNM1;HPCA;SYT4
3526,GO:0007017,0.0465299373017164,0.979485771923777,10,764,microtubule-based process,BP,KIFC1;ASPM;TPX2;BIRC5;KIF4A;MYBL2;STMN2;NEURL1;CRYAB;MAP7D2
6677,GO:0019898,0.0465956270367189,0.986248865701276,5,281,extrinsic component of membrane,CC,RPH3A;SYTL4;HPCA;SNAP25;STAC2
12031,GO:0045759,0.0467528254981443,0.9990361304187,1,8,negative regulation of action potential,BP,CNR1
478,GO:0001558,0.0467753223483927,0.984311087575405,6,383,regulation of cell growth,BP,CD38;SYT1;CRYAB;SYT4;SFRP2;PI16
7055,GO:0022849,0.046793734184735,0.9991161249326,1,5,glutamate-gated calcium ion channel activity,MF,GRIN2B
2459,GO:0005179,0.0468315417473827,0.994979956844107,2,72,hormone activity,MF,VGF;NMB
14287,GO:0060028,0.0468855921647603,0.999050108327054,1,7,convergent extension involved in axis elongation,BP,SFRP2
11527,GO:0044300,0.0469548084897303,0.999047275413801,1,7,cerebellar mossy fiber,CC,SLC17A7
7118,GO:0030046,0.0469574833432115,0.999047165850096,1,7,parallel actin filament bundle assembly,BP,USH1C
15033,GO:0061200,0.0471099400885152,0.999021212603231,1,8,clathrin-sculpted gamma-aminobutyric acid transport vesicle,CC,SYT1
15034,GO:0061202,0.0471099400885152,0.999021212603231,1,8,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,CC,SYT1
9398,GO:0034605,0.0471644757797934,0.991274832370034,3,115,cellular response to heat,BP,CAMK2A;CRYAB;HSPB8
13465,GO:0050957,0.0473387692634729,0.99905802069846,1,6,equilibrioception,BP,USH1C
20517,GO:1904714,0.0477414523060062,0.998994546657275,1,8,regulation of chaperone-mediated autophagy,BP,EEF1A2
11087,GO:0043203,0.0481137304454949,0.998978655934289,1,8,axon hillock,CC,TPX2
17834,GO:0098700,0.0483083592065428,0.99897029765306,1,8,neurotransmitter loading into synaptic vesicle,BP,SLC17A7
13868,GO:0051661,0.0483559712754442,0.999055505770883,1,5,maintenance of centrosome location,BP,ASPM
5992,GO:0016725,0.0484407468229912,0.998985421379394,1,7,oxidoreductase activity, acting on CH or CH2 groups,MF,RRM2
20651,GO:1904950,0.0485060834487907,0.99091076002879,3,130,negative regulation of establishment of protein localization,BP,SYTL4;SYT4;VSNL1
2603,GO:0005542,0.0487922428181362,0.998919802214207,1,10,folic acid binding,MF,FOLR2
15508,GO:0070201,0.0488022956307865,0.980482642146938,8,598,regulation of establishment of protein localization,BP,CD38;SYTL4;CNR1;HPCA;SNAP25;SYT4;VSNL1;KCNC2
6457,GO:0019229,0.0488235605344745,0.994686372075489,2,52,regulation of vasoconstriction,BP,CD38;CHRM3
16447,GO:0071901,0.048895825882429,0.990812551815415,3,126,negative regulation of protein serine/threonine kinase activity,BP,DUSP4;SFRP2;SPRY4
13160,GO:0048880,0.0490958055971309,0.983345770321645,6,363,sensory system development,BP,USH1C;SLC17A7;CRYAB;HPCA;FREM2;IGFN1
17051,GO:0090087,0.0491114532893891,0.980333721457427,8,601,regulation of peptide transport,BP,CD38;SYTL4;CNR1;HPCA;SNAP25;SYT4;VSNL1;KCNC2
8314,GO:0032355,0.0491218569826561,0.990751223039287,3,128,response to estradiol,BP,CD38;CRYAB;IGFBP2
21481,GO:2000051,0.0493115539206218,0.998977053070868,1,6,negative regulation of non-canonical Wnt signaling pathway,BP,SFRP2
1640,GO:0003828,0.049780498943249,0.998957305503112,1,6,alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity,MF,ST8SIA5
21518,GO:2000116,0.0499015636313402,0.987438660226125,4,222,regulation of cysteine-type endopeptidase activity,BP,BIRC5;CRYAB;SFRP2;GRIN2B
3212,GO:0006551,0.0500477730007644,0.998894056732783,1,8,leucine metabolic process,BP,BCAT1
18801,GO:1900244,0.0501291910157428,0.998912729528564,1,7,positive regulation of synaptic vesicle endocytosis,BP,DNM1
15214,GO:0061676,0.050407966832461,0.998900480756784,1,7,importin-alpha family protein binding,MF,TPX2
17538,GO:0097305,0.0505436116177826,0.987231987897452,4,209,response to alcohol,BP,CNR1;ADCY1;KCNC2;GRIN2B
20970,GO:1905603,0.0505671438787973,0.998893455487514,1,7,regulation of blood-brain barrier permeability,BP,TJP2
13827,GO:0051593,0.0506801742322626,0.998847923039905,1,9,response to folic acid,BP,FOLR2
11725,GO:0045026,0.0508218806405501,0.998815494872096,1,11,plasma membrane fusion,BP,FOLR2
18440,GO:0120036,0.0508391753522256,0.972975885613395,16,1426,plasma membrane bounded cell projection organization,BP,CD38;USH1C;LZTS1;SYT1;CAMK2A;STMN2;NEURL1;CNR1;SNAP25;SYT4;SFRP2;TENM2;ADCY1;NPTX1;ENC1;GRIN2B
7352,GO:0030427,0.0508523665803436,0.987147089445523,4,182,site of polarized growth,CC,STMN2;CNR1;SNAP25;TENM2
15874,GO:0070887,0.0508878246935354,0.969456736347742,26,2911,cellular response to chemical stimulus,BP,SYT13;GABRA1;PTPRN;SYT1;CAMK2A;BIRC5;MYBL2;STMN2;NEURL1;PTPN5;GABRG2;IGFBP2;HPCA;SYT4;CHRM3;SFRP2;GABRB2;HSPB8;CREB3L1;VSNL1;ADCY1;MELK;FOLR2;KCNC2;SPRY4;CPNE4
18131,GO:0099505,0.051023088423589,0.998904047364772,1,6,regulation of presynaptic membrane potential,BP,KCNC2
4111,GO:0008510,0.0510376138283719,0.998903416789964,1,6,sodium:bicarbonate symporter activity,MF,SLC4A10
18589,GO:0140410,0.0510376138283719,0.998903416789964,1,6,solute:bicarbonate symporter activity,MF,SLC4A10
11,GO:0000022,0.0514948237246607,0.998828513769725,1,8,mitotic spindle elongation,BP,KIF4A
2268,GO:0004865,0.0515418644698297,0.998793353577915,1,10,protein serine/threonine phosphatase inhibitor activity,MF,PPP1R14C
11080,GO:0043196,0.0516238408777829,0.998822576575725,1,8,varicosity,CC,DNM1
8191,GO:0032127,0.0518132874823002,0.998869474353332,1,6,dense core granule membrane,CC,SYT4
10776,GO:0042584,0.0520466697195477,0.998827064012237,1,7,chromaffin granule membrane,CC,SYT1
4007,GO:0008343,0.0521716703498663,0.99876338557002,1,10,adult feeding behavior,BP,PRLHR
4626,GO:0010032,0.0522228818037584,0.998819025172822,1,7,meiotic chromosome condensation,BP,NCAPH
7131,GO:0030071,0.0523702516586583,0.994067632487833,2,55,regulation of mitotic metaphase/anaphase transition,BP,CENPF;UBE2C
21150,GO:1990089,0.0524366428588782,0.994068073602117,2,51,response to nerve growth factor,BP,STMN2;KCNC2
14349,GO:0060113,0.0524795602035354,0.994063880486723,2,50,inner ear receptor cell differentiation,BP,USH1C;GABRB2
5188,GO:0014824,0.0525357037434707,0.998761126425746,1,9,artery smooth muscle contraction,BP,CD38
13519,GO:0051045,0.0526860330625902,0.998773113706493,1,8,negative regulation of membrane protein ectodomain proteolysis,BP,PTPN3
14232,GO:0055082,0.0528929757788431,0.97723678321684,9,735,cellular chemical homeostasis,BP,CD38;PTPRN;SLC30A3;CNR1;GPR12;SLC4A10;VSNL1;NMB;GRIN2B
5380,GO:0015293,0.0530492095583906,0.989708768971253,3,122,symporter activity,MF,SLC17A7;SLC4A10;SLC6A17
18028,GO:0099011,0.0533967132170633,0.998798544761057,1,6,neuronal dense core vesicle exocytosis,BP,SYT4
18148,GO:0099525,0.0533967132170633,0.998798544761057,1,6,presynaptic dense core vesicle exocytosis,BP,SYT4
18357,GO:0106072,0.0534764364982982,0.998715892336087,1,9,negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway,BP,MRAP2
12398,GO:0046541,0.0536264606911826,0.99869272810083,1,10,saliva secretion,BP,CHRM3
19277,GO:1902099,0.0536272605513816,0.993842529414665,2,56,regulation of metaphase/anaphase transition of cell cycle,BP,CENPF;UBE2C
3963,GO:0008277,0.0536565802855074,0.989534531359478,3,130,regulation of G protein-coupled receptor signaling pathway,BP,CAMK2A;DNM1;MRAP2
18055,GO:0099061,0.0537467744671349,0.993843706509835,2,49,integral component of postsynaptic density membrane,CC,CHRM3;ADCY1
11015,GO:0043084,0.0537942168598901,0.99872040138882,1,8,penile erection,BP,CNR1
16160,GO:0071417,0.0540910146606771,0.977916517902175,8,591,cellular response to organonitrogen compound,BP,GABRA1;CAMK2A;NEURL1;GABRG2;CHRM3;GABRB2;ADCY1;FOLR2
17602,GO:0097441,0.0541257939924662,0.998730426855247,1,7,basal dendrite,CC,SLC4A10
4435,GO:0009266,0.0542551490295068,0.985976898988829,4,212,response to temperature stimulus,BP,CAMK2A;CRYAB;VGF;HSPB8
1384,GO:0003056,0.0542825341493948,0.99872298319291,1,7,regulation of vascular associated smooth muscle contraction,BP,CHRM3
11322,GO:0043583,0.0544022330200731,0.985931084131395,4,205,ear development,BP,USH1C;HPCA;GABRB2;FREM2
12613,GO:0046982,0.0546405859465345,0.985841380457912,4,218,protein heterodimerization activity,MF,SYT1;TOP2A;SYT4;TENM2
11090,GO:0043208,0.054748909391993,0.998674081898888,1,8,glycosphingolipid binding,MF,SELL
8112,GO:0031995,0.0547667519653287,0.998673208209361,1,8,insulin-like growth factor II binding,MF,IGFBP2
20319,GO:1904338,0.0554023616956194,0.998620701752732,1,9,regulation of dopaminergic neuron differentiation,BP,SFRP2
11860,GO:0045309,0.0555171721839615,0.993511929565996,2,53,protein phosphorylated amino acid binding,MF,PTPN3;PTPN5
5576,GO:0015884,0.0556334995260419,0.998630412429858,1,8,folic acid transport,BP,FOLR2
9031,GO:0033647,0.0557553899512364,0.998624338392238,1,8,host intracellular organelle,CC,TOP2A
9032,GO:0033648,0.0557553899512364,0.998624338392238,1,8,host intracellular membrane-bounded organelle,CC,TOP2A
5075,GO:0010992,0.0558029006800287,0.998600467954182,1,9,ubiquitin recycling,BP,UBE2C
15677,GO:0070492,0.0559459272850655,0.998561794700128,1,11,oligosaccharide binding,MF,SELL
5533,GO:0015820,0.0560979565793537,0.998607194072016,1,8,leucine transport,BP,SLC6A17
13687,GO:0051310,0.0562293505831009,0.993364209145059,2,59,metaphase plate congression,BP,KIFC1;CENPF
12472,GO:0046683,0.0563152449494434,0.988805252366924,3,127,response to organophosphorus,BP,PTPRN;VGF;SELL
3567,GO:0007091,0.0564248513619785,0.993333979652678,2,57,metaphase/anaphase transition of mitotic cell cycle,BP,CENPF;UBE2C
4709,GO:0010454,0.0564724128459976,0.998534303763183,1,11,negative regulation of cell fate commitment,BP,SFRP2
17955,GO:0098900,0.0566839472093323,0.993313714071288,2,49,regulation of action potential,BP,PTPN3;CNR1
5013,GO:0010911,0.0568636916381561,0.998568479039058,1,8,regulation of isomerase activity,BP,NCAPH
5014,GO:0010912,0.0568636916381561,0.998568479039058,1,8,positive regulation of isomerase activity,BP,NCAPH
12147,GO:0045955,0.0569582369124421,0.998563661256698,1,8,negative regulation of calcium ion-dependent exocytosis,BP,SYT4
13633,GO:0051238,0.0569657689771068,0.998508301337848,1,11,sequestering of metal ion,BP,SLC30A3
16850,GO:0072687,0.0570156146522371,0.998538287622452,1,9,meiotic spindle,CC,ASPM
2496,GO:0005261,0.057041967564677,0.982205006214103,5,283,cation channel activity,MF,CNR1;SNAP25;KCNC2;KCNK9;GRIN2B
13627,GO:0051231,0.0570522640512033,0.998536386964727,1,9,spindle elongation,BP,KIF4A
3147,GO:0006470,0.0570770708647579,0.982183201286002,5,300,protein dephosphorylation,BP,PTPRN;PTPN3;PTPN5;DUSP4;PPP1R14C
5054,GO:0010965,0.0572398419088589,0.993180953893253,2,58,regulation of mitotic sister chromatid separation,BP,CENPF;UBE2C
529,GO:0001660,0.0573640499339675,0.998520166519558,1,9,fever generation,BP,CNR1
14018,GO:0051961,0.0574876887388071,0.982023419028518,5,291,negative regulation of nervous system development,BP,CD38;ASPM;STMN2;SYT4;DAAM2
11663,GO:0044784,0.0577155226313866,0.993092738184001,2,58,metaphase/anaphase transition of cell cycle,BP,CENPF;UBE2C
5551,GO:0015850,0.0578342836809433,0.984733561803586,4,222,organic hydroxy compound transport,BP,SYT13;SYT1;CNR1;SYT4
4829,GO:0010660,0.0578952778725972,0.993053648278792,2,60,regulation of muscle cell apoptotic process,BP,CAMK2A;SFRP2
11801,GO:0045177,0.0581931621961928,0.979419298680392,6,383,apical part of cell,CC,USH1C;LZTS1;ASPM;IGFBP2;SLC4A10;KCNC2
7738,GO:0031282,0.0583484088615679,0.998449557669356,1,10,regulation of guanylate cyclase activity,BP,HPCA
9930,GO:0035773,0.0584196674121152,0.992955664183282,2,60,insulin secretion involved in cellular response to glucose stimulus,BP,PTPRN;VSNL1
5715,GO:0016185,0.0587404263308608,0.998471296056951,1,8,synaptic vesicle budding from presynaptic endocytic zone membrane,BP,DNM1
6604,GO:0019755,0.0588269185503574,0.998408104539388,1,11,one-carbon compound transport,BP,SLC14A1
18151,GO:0099528,0.058854469752619,0.998441365083084,1,9,G protein-coupled neurotransmitter receptor activity,MF,CHRM3
14330,GO:0060076,0.0588564825315782,0.992903305740486,2,51,excitatory synapse,CC,SYT1;SLC17A7
13650,GO:0051259,0.0590091465893567,0.984325303657038,4,216,protein complex oligomerization,BP,SYT1;KCNC2;RRM2;GRIN2B
18090,GO:0099146,0.0590512007981519,0.992862957766252,2,52,intrinsic component of postsynaptic density membrane,CC,CHRM3;ADCY1
7020,GO:0022414,0.059190088477871,0.96991978664245,13,1224,reproductive process,BP,CD38;PTPRN;KIFC1;ASPM;NEURL1;IGFBP2;CNR1;PRLHR;NCAPH;VGF;TOP2A;SFRP2;FOLR2
9311,GO:0034399,0.0593296848878802,0.987956834137921,3,127,nuclear periphery,CC,KIF4A;CENPF;ENC1
4522,GO:0009642,0.0594562092116469,0.998408957227514,1,9,response to light intensity,BP,KCNC2
10848,GO:0042733,0.0595856072677809,0.992748202554099,2,56,embryonic digit morphogenesis,BP,SFRP2;FREM2
3016,GO:0006265,0.0596373619444529,0.998399134062492,1,9,DNA topological change,BP,TOP2A
6024,GO:0016782,0.0597757822757919,0.992686728350255,2,65,transferase activity, transferring sulfur-containing groups,MF,SULT4A1;CHST9
2,GO:0000003,0.0598308228011803,0.969543685234572,13,1227,reproduction,BP,CD38;PTPRN;KIFC1;ASPM;NEURL1;IGFBP2;CNR1;PRLHR;NCAPH;VGF;TOP2A;SFRP2;FOLR2
17908,GO:0098833,0.0598899629731777,0.998385384899676,1,9,presynaptic endocytic zone,CC,DNM1
1567,GO:0003373,0.060159017507298,0.998395668758668,1,8,dynamin family protein polymerization involved in membrane fission,BP,DNM1
1568,GO:0003374,0.060159017507298,0.998395668758668,1,8,dynamin family protein polymerization involved in mitochondrial fission,BP,DNM1
4000,GO:0008330,0.0604040710831818,0.998337067080035,1,10,protein tyrosine/threonine phosphatase activity,MF,DUSP4
7106,GO:0030030,0.060535946909457,0.967047529916823,16,1465,cell projection organization,BP,CD38;USH1C;LZTS1;SYT1;CAMK2A;STMN2;NEURL1;CNR1;SNAP25;SYT4;SFRP2;TENM2;ADCY1;NPTX1;ENC1;GRIN2B
10824,GO:0042670,0.0606496825008438,0.998343670369329,1,9,retinal cone cell differentiation,BP,USH1C
12404,GO:0046549,0.0606496825008438,0.998343670369329,1,9,retinal cone cell development,BP,USH1C
5121,GO:0014049,0.0608000617515138,0.998335348796363,1,9,positive regulation of glutamate secretion,BP,SYT4
7954,GO:0031652,0.0608244888928814,0.998313564198311,1,10,positive regulation of heat generation,BP,CNR1
1304,GO:0002863,0.0618293252043618,0.998225055637928,1,12,positive regulation of inflammatory response to antigenic stimulus,BP,CNR1
13683,GO:0051306,0.0619354719172908,0.99228274637257,2,61,mitotic sister chromatid separation,BP,CENPF;UBE2C
21259,GO:1990440,0.0624043443396158,0.998206144574221,1,11,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,CREB3L1
474,GO:0001553,0.0625585924694454,0.998236450899022,1,9,luteinization,BP,PTPRN
2796,GO:0005883,0.0628246551656701,0.998248497367321,1,8,neurofilament,CC,NEFM
14952,GO:0061052,0.0628376526894159,0.998198679525143,1,10,negative regulation of cell growth involved in cardiac muscle cell development,BP,PI16
640,GO:0001820,0.062949491265174,0.998174284465756,1,11,serotonin secretion,BP,CNR1
17075,GO:0090129,0.0629542051515104,0.998241176180017,1,8,positive regulation of synapse maturation,BP,NEURL1
10630,GO:0042301,0.0630445428806609,0.998186653229676,1,10,phosphate ion binding,MF,RPH3A
4110,GO:0008509,0.063084050333205,0.979746347201123,5,312,anion transmembrane transporter activity,MF,GABRA1;SLC17A7;GABRG2;SLC4A10;GABRB2
15119,GO:0061469,0.0631670854792083,0.998161487355743,1,11,regulation of type B pancreatic cell proliferation,BP,PTPRN
19912,GO:1903524,0.0631791380334569,0.992031712011191,2,64,positive regulation of blood circulation,BP,CD38;CHRM3
14299,GO:0060042,0.0632244834748771,0.992055234878775,2,54,retina morphogenesis in camera-type eye,BP,USH1C;IGFN1
17171,GO:0090263,0.0632934586246528,0.986797904749157,3,139,positive regulation of canonical Wnt signaling pathway,BP,ASPM;SFRP2;DAAM2
19616,GO:1902950,0.0634252033096337,0.998164418749031,1,10,regulation of dendritic spine maintenance,BP,GRIN2B
10783,GO:0042592,0.0634395311463091,0.964639370273024,17,1727,homeostatic process,BP,CD38;USH1C;PTPRN;PTPN3;SLC17A7;SLC30A3;CNR1;TJP2;VGF;GPR12;MRAP2;SLC4A10;VSNL1;ADCY1;UBE2C;NMB;GRIN2B
9009,GO:0033605,0.0641419011089604,0.99810359449027,1,11,positive regulation of catecholamine secretion,BP,SYT1
21049,GO:1905818,0.0641492586666386,0.991846232986327,2,62,regulation of chromosome separation,BP,CENPF;UBE2C
4826,GO:0010657,0.0641658405168929,0.991840022341166,2,63,muscle cell apoptotic process,BP,CAMK2A;SFRP2
21470,GO:2000035,0.0642228275210812,0.998117378942989,1,10,regulation of stem cell division,BP,SFRP2
10032,GO:0035973,0.0642706994757267,0.998137352946834,1,9,aggrephagy,BP,HSPB8
10252,GO:0036449,0.0642978539675323,0.998201067128327,1,7,microtubule minus-end,CC,ASPM
2465,GO:0005212,0.0643055509887442,0.998035459349845,1,16,structural constituent of eye lens,MF,CRYAB
18162,GO:0099541,0.0643349741878028,0.998162172608526,1,8,trans-synaptic signaling by lipid,BP,CNR1
18163,GO:0099542,0.0643349741878028,0.998162172608526,1,8,trans-synaptic signaling by endocannabinoid,BP,CNR1
17915,GO:0098843,0.0645677687347678,0.998096847099264,1,10,postsynaptic endocytic zone,CC,DNM1
13851,GO:0051640,0.0650608127075029,0.972411296520147,8,612,organelle localization,BP,KIFC1;ASPM;SYT1;SYTL4;DNM1;CENPF;SNAP25;SYT4
10733,GO:0042490,0.0650799915186467,0.99167784926049,2,57,mechanoreceptor differentiation,BP,USH1C;GABRB2
5184,GO:0014820,0.0653120622774128,0.998032885253915,1,11,tonic smooth muscle contraction,BP,CD38
5082,GO:0012505,0.0653301209739904,0.95796016920564,34,4056,endomembrane system,CC,CD38;CAMK1G;SYT13;PTPRN;KIFC1;SYT1;RPH3A;ST8SIA5;SYTL4;STMN2;SLC17A7;DNM1;CRYAB;PTPN5;SLC30A3;CENPF;VGF;SNAP25;SYT4;CHRM3;MRAP2;TENM2;CHST9;NRGN;CREB3L1;TMEM130;KCNK9;NPTX1;PCSK1;DDN;SV2B;SELL;SLC6A17;GRIN2B
12965,GO:0048513,0.0653346666395462,0.959180460815031,28,3112,animal organ development,BP,USH1C;PTPRN;ASPM;SYT1;PTPN3;SLC17A7;NEURL1;CRYAB;CENPF;HPCA;VGF;TOP2A;SYT4;SLC4A10;SFRP2;GABRB2;DAAM2;FREM2;NRGN;IGFN1;FABP7;PI16;ADCY1;MELK;KCNC2;SPRY4;SLC6A17;GRIN2B
6139,GO:0017017,0.0660399422265942,0.997988232142339,1,11,MAP kinase tyrosine/serine/threonine phosphatase activity,MF,DUSP4
12529,GO:0046847,0.0661270020833605,0.991472127547479,2,56,filopodium assembly,BP,NEURL1;TENM2
20206,GO:1904062,0.0663386800668494,0.97839502228991,5,320,regulation of cation transmembrane transport,BP,PTPN3;HPCA;STAC2;KCNC2;GRIN2B
19267,GO:1902074,0.0665080719601955,0.997942595342923,1,12,response to salt,BP,HPCA
7027,GO:0022607,0.0666385365704241,0.95945490083342,24,2601,cellular component assembly,BP,USH1C;GABRA1;KIFC1;ASPM;SYT1;TPX2;BIRC5;KIF4A;MYBL2;STMN2;NEFM;DNM1;NEURL1;CRYAB;GABRG2;CENPF;SNAP25;GABRB2;TENM2;IGFN1;KCNC2;RRM2;UBE2C;GRIN2B
5268,GO:0015077,0.066726194895604,0.9782331782351,5,320,monovalent inorganic cation transmembrane transporter activity,MF,SLC17A7;SNAP25;SLC4A10;KCNC2;KCNK9
15554,GO:0070278,0.066794640006643,0.997961547950737,1,10,extracellular matrix constituent secretion,BP,CREB3L1
1940,GO:0004385,0.0670518011507057,0.997970454863367,1,9,guanylate kinase activity,MF,TJP2
12490,GO:0046710,0.0670518011507057,0.997970454863367,1,9,GDP metabolic process,BP,TJP2
5537,GO:0015824,0.0671239354048477,0.997966028196642,1,9,proline transport,BP,SLC6A17
8762,GO:0033004,0.0671260866005804,0.99790368635083,1,12,negative regulation of mast cell activation,BP,CNR1
12884,GO:0048278,0.0672342177425506,0.991218235214294,2,65,vesicle docking,BP,SYT1;SNAP25
19863,GO:1903423,0.0675054829608431,0.997942531400936,1,9,positive regulation of synaptic vesicle recycling,BP,DNM1
6924,GO:0021872,0.0675099499139297,0.991177873472707,2,60,forebrain generation of neurons,BP,ASPM;SLC4A10
8602,GO:0032769,0.0675718386515568,0.997892575185833,1,11,negative regulation of monooxygenase activity,BP,CNR1
13646,GO:0051255,0.0676197688775019,0.997889545473971,1,11,spindle midzone assembly,BP,KIF4A
18507,GO:0140013,0.067707103911957,0.985482710694154,3,142,meiotic nuclear division,BP,ASPM;NCAPH;TOP2A
19017,GO:1901387,0.0678107379439743,0.99786014540478,1,12,positive regulation of voltage-gated calcium channel activity,BP,STAC2
16056,GO:0071257,0.0681064600439991,0.997879612829258,1,10,cellular response to electrical stimulus,BP,HPCA
2547,GO:0005372,0.068379680343376,0.997823613629717,1,12,water transmembrane transporter activity,MF,SLC14A1
8130,GO:0032024,0.0689032419342785,0.990870243544894,2,67,positive regulation of insulin secretion,BP,CD38;VSNL1
6919,GO:0021860,0.0689373465088517,0.997853116983348,1,9,pyramidal neuron development,BP,SLC4A10
5405,GO:0015370,0.0691670368632655,0.990837968829108,2,60,solute:sodium symporter activity,MF,SLC17A7;SLC4A10
16758,GO:0072503,0.0692817331029493,0.974395036349843,6,440,cellular divalent inorganic cation homeostasis,BP,CD38;SLC30A3;CNR1;GPR12;NMB;GRIN2B
3745,GO:0007501,0.0693391716209108,0.997761285604354,1,12,mesodermal cell fate specification,BP,SFRP2
10775,GO:0042583,0.0693405718164629,0.997801017592285,1,10,chromaffin granule,CC,SYT1
12044,GO:0045779,0.069515618183145,0.997749725383671,1,12,negative regulation of bone resorption,BP,CD38
7781,GO:0031340,0.069524525512926,0.997767334966165,1,11,positive regulation of vesicle fusion,BP,SYT1
18575,GO:0140299,0.0696472512828055,0.997781258595808,1,10,small molecule sensor activity,MF,SYT1
2791,GO:0005876,0.0699889640564291,0.990660590086658,2,62,spindle microtubule,CC,BIRC5;KIF4A
7937,GO:0031630,0.0703744135802081,0.99771166553808,1,11,regulation of synaptic vesicle fusion to presynaptic active zone membrane,BP,SYT1
2336,GO:0004972,0.0704812691773794,0.997788848561805,1,8,NMDA glutamate receptor activity,MF,GRIN2B
5927,GO:0016595,0.0707745612290582,0.99770784682698,1,10,glutamate binding,MF,GRIN2B
11348,GO:0043627,0.0708640521085711,0.9904533385994,2,70,response to estrogen,BP,PTPRN;IGFBP2
10404,GO:0038166,0.0709185841458465,0.997675651354471,1,11,angiotensin-activated signaling pathway,BP,CAMK2A
2789,GO:0005874,0.0711674156049672,0.973535639990221,6,397,microtubule,CC,KIFC1;ASPM;TPX2;BIRC5;KIF4A;DNM1
12034,GO:0045762,0.0711986505295407,0.997742962979565,1,8,positive regulation of adenylate cyclase activity,BP,HPCA
19264,GO:1902065,0.0715616941499978,0.997632716584955,1,11,response to L-glutamate,BP,HPCA
12287,GO:0046322,0.0719500084528295,0.997606596706778,1,11,negative regulation of fatty acid oxidation,BP,CNR1
3403,GO:0006814,0.0721029673824699,0.979544386608965,4,218,sodium ion transport,BP,PTPN3;SLC17A7;SLC4A10;SLC6A17
14019,GO:0051962,0.0724023660703266,0.970590513324869,7,508,positive regulation of nervous system development,BP,ASPM;SYT1;STMN2;NEURL1;CNR1;SYT4;ENC1
5529,GO:0015816,0.0724302167796798,0.997574091826367,1,11,glycine transport,BP,SLC6A17
8976,GO:0033549,0.0729940878611775,0.997515577420651,1,12,MAP kinase phosphatase activity,MF,DUSP4
8462,GO:0032536,0.0731667716334069,0.997523796929761,1,11,regulation of cell projection size,BP,USH1C
12023,GO:0045741,0.0732095137733867,0.997500684578687,1,12,positive regulation of epidermal growth factor-activated receptor activity,BP,NEURL1
16205,GO:0071479,0.0733232424383562,0.989943328781095,2,66,cellular response to ionizing radiation,BP,CRYAB;SFRP2
6052,GO:0016829,0.0734101790675336,0.983702884230237,3,168,lyase activity,MF,CD38;ETNPPL;ADCY1
5522,GO:0015807,0.0736171173294512,0.989886963795544,2,64,L-amino acid transport,BP,SLC17A7;SLC6A17
5270,GO:0015079,0.0737236042391029,0.983631803258207,3,144,potassium ion transmembrane transporter activity,MF,SNAP25;KCNC2;KCNK9
8677,GO:0032880,0.0739258446703412,0.964584840287293,10,869,regulation of protein localization,BP,CD38;SYTL4;CNR1;HPCA;SNAP25;SYT4;MRAP2;STAC2;VSNL1;KCNC2
1305,GO:0002864,0.0744437172567132,0.997381708093433,1,14,regulation of acute inflammatory response to antigenic stimulus,BP,CNR1
7638,GO:0031083,0.0745276460861367,0.997375717248936,1,14,BLOC-1 complex,CC,SNAP25
10975,GO:0043010,0.074632649055391,0.974876055352336,5,308,camera-type eye development,BP,USH1C;SLC17A7;CRYAB;HPCA;IGFN1
9784,GO:0035567,0.074693528663343,0.983323539615916,3,147,non-canonical Wnt signaling pathway,BP,CAMK2A;SFRP2;DAAM2
10577,GO:0042166,0.0747760485903085,0.997391009601429,1,12,acetylcholine binding,MF,CHRM3
7952,GO:0031650,0.0748662564749713,0.99738462025468,1,12,regulation of heat generation,BP,CNR1
18011,GO:0098976,0.0750569894096194,0.997448897911152,1,9,excitatory chemical synaptic transmission,BP,GRIN2B
794,GO:0002031,0.0752058478637567,0.997327048775296,1,14,G protein-coupled receptor internalization,BP,DNM1
4860,GO:0010720,0.0752938570577445,0.969138514111189,7,517,positive regulation of cell development,BP,ASPM;SYT1;STMN2;NEURL1;CNR1;SYT4;ENC1
3455,GO:0006897,0.0756060322379059,0.968977250506421,7,531,endocytosis,BP,SYT1;SLC17A7;DNM1;HPCA;SNAP25;SYT4;FOLR2
12577,GO:0046929,0.0757739998453862,0.997367450204605,1,10,negative regulation of neurotransmitter secretion,BP,SYT4
22139,GO:2001259,0.0757925715171369,0.989405964847206,2,67,positive regulation of cation channel activity,BP,STAC2;KCNC2
11269,GO:0043508,0.0758669078580192,0.99729487471418,1,13,negative regulation of JUN kinase activity,BP,SFRP2
15610,GO:0070373,0.0758793403965524,0.989383783246981,2,68,negative regulation of ERK1 and ERK2 cascade,BP,DUSP4;SPRY4
3056,GO:0006323,0.0761667243013541,0.982866139028711,3,141,DNA packaging,BP,NCAPG;NCAPH;TOP2A
8676,GO:0032879,0.0764504020799729,0.953137243080238,23,2496,regulation of localization,BP,CD38;SYT13;SYT1;PTPN3;CAMK2A;SYTL4;SLC17A7;DNM1;CRYAB;SLC30A3;CNR1;HPCA;SNAP25;SYT4;CHRM3;MRAP2;STAC2;SFRP2;VSNL1;ADCY1;KCNC2;NMB;GRIN2B
6698,GO:0019953,0.0765486282705655,0.966404068347341,8,677,sexual reproduction,BP,KIFC1;ASPM;NEURL1;CNR1;NCAPH;VGF;TOP2A;FOLR2
7051,GO:0022841,0.0767944882125993,0.997211244341579,1,14,potassium ion leak channel activity,MF,KCNK9
21279,GO:1990504,0.0769386444834459,0.997317391607739,1,9,dense core granule exocytosis,BP,SYT4
19592,GO:1902904,0.0771664528734879,0.982554036930777,3,137,negative regulation of supramolecular fiber organization,BP,TPX2;STMN2;CRYAB
101,GO:0000212,0.0774299258829985,0.997249351764189,1,10,meiotic spindle organization,BP,ASPM
15470,GO:0070142,0.0778019803998487,0.997195085280843,1,11,synaptic vesicle budding,BP,DNM1
8794,GO:0033047,0.0779519176134592,0.98893380216085,2,66,regulation of mitotic sister chromatid segregation,BP,CENPF;UBE2C
9030,GO:0033646,0.0779839818920431,0.997158847376358,1,12,host intracellular part,CC,TOP2A
11362,GO:0043656,0.0779839818920431,0.997158847376358,1,12,host intracellular region,CC,TOP2A
6918,GO:0021859,0.07830416777576,0.997185924664556,1,10,pyramidal neuron differentiation,BP,SLC4A10
5793,GO:0016324,0.0785371491681692,0.973166546496014,5,320,apical plasma membrane,CC,LZTS1;ASPM;IGFBP2;SLC4A10;KCNC2
18355,GO:0106070,0.0785598129790088,0.997116094456705,1,12,regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway,BP,MRAP2
4731,GO:0010499,0.0786606052145855,0.997014249168975,1,19,proteasomal ubiquitin-independent protein catabolic process,BP,ENC1
5143,GO:0014074,0.07874066909872,0.982043463845613,3,141,response to purine-containing compound,BP,PTPRN;VGF;SELL
13314,GO:0050714,0.0788174383745794,0.982003457034314,3,152,positive regulation of protein secretion,BP,CD38;SYTL4;VSNL1
17662,GO:0097539,0.0788913487664379,0.997142905646921,1,10,ciliary transition fiber,CC,CENPF
3786,GO:0007605,0.0792564121487422,0.981878708387935,3,140,sensory perception of sound,BP,USH1C;BIRC5;GABRB2
4432,GO:0009263,0.0793906803526134,0.997001642857886,1,15,deoxyribonucleotide biosynthetic process,BP,RRM2
3599,GO:0007165,0.0794605827295354,0.94693704238558,40,4951,signal transduction,BP,CD38;GABRA1;PTPRN;ASPM;PTPN3;CAMK2A;TPX2;BIRC5;SLC17A7;NPTX2;DNM1;NEURL1;CRYAB;FOXM1;GABRG2;IGFBP2;CNR1;TJP2;PRLHR;DUSP4;HPCA;VGF;GPR12;CHRM3;MRAP2;STAC2;HUNK;SFRP2;GABRB2;TENM2;DAAM2;NRGN;CREB3L1;ADCY1;MELK;KCNC2;NPTX1;SPRY4;NMB;GRIN2B
13367,GO:0050808,0.0797179099950166,0.969494962024081,6,393,synapse organization,BP,GABRA1;NEURL1;GABRG2;GABRB2;IGFN1;GRIN2B
14091,GO:0052547,0.0800368961813787,0.972479237162855,5,374,regulation of peptidase activity,BP,BIRC5;CRYAB;SFRP2;PI16;GRIN2B
5085,GO:0012510,0.0803161099005509,0.996963115913058,1,13,trans-Golgi network transport vesicle membrane,CC,NRGN
20485,GO:1904668,0.0804335853680704,0.99695408822491,1,13,positive regulation of ubiquitin protein ligase activity,BP,UBE2C
7303,GO:0030322,0.0804552150030352,0.996919449325092,1,15,stabilization of membrane potential,BP,KCNK9
11780,GO:0045132,0.0804941271692419,0.988346890931135,2,71,meiotic chromosome segregation,BP,NCAPH;TOP2A
17302,GO:0090557,0.0807056072752884,0.997007859034621,1,10,establishment of endothelial intestinal barrier,BP,TJP2
4832,GO:0010663,0.0807256261778415,0.996952344067438,1,12,positive regulation of striated muscle cell apoptotic process,BP,CAMK2A
4835,GO:0010666,0.0807256261778415,0.996952344067438,1,12,positive regulation of cardiac muscle cell apoptotic process,BP,CAMK2A
10637,GO:0042310,0.0811574224907118,0.988199500125807,2,70,vasoconstriction,BP,CD38;CHRM3
8296,GO:0032328,0.0813297166300513,0.996905838747267,1,12,alanine transport,BP,SLC6A17
13362,GO:0050803,0.0813349796168989,0.975977653888645,4,220,regulation of synapse structure or activity,BP,SLC17A7;DNM1;NEURL1;GRIN2B
17617,GO:0097470,0.0814171654017692,0.99692404186871,1,11,ribbon synapse,CC,DNM1
16761,GO:0072507,0.0814612180777791,0.968629917684306,6,457,divalent inorganic cation homeostasis,BP,CD38;SLC30A3;CNR1;GPR12;NMB;GRIN2B
7664,GO:0031115,0.0815780744301593,0.996865413975512,1,13,negative regulation of microtubule polymerization,BP,STMN2
9840,GO:0035641,0.0819422362023539,0.996858313522398,1,12,locomotory exploration behavior,BP,SLC4A10
18092,GO:0099149,0.0824179890478422,0.996821142055329,1,12,regulation of postsynaptic neurotransmitter receptor internalization,BP,HPCA
3730,GO:0007423,0.0824542455745339,0.965485352262906,7,528,sensory organ development,BP,USH1C;SLC17A7;CRYAB;HPCA;GABRB2;FREM2;IGFN1
5519,GO:0015803,0.0825259924282958,0.996812672123148,1,12,branched-chain amino acid transport,BP,SLC6A17
8458,GO:0032530,0.0826655580933292,0.996801709760425,1,12,regulation of microvillus organization,BP,USH1C
13085,GO:0048715,0.0827057253892924,0.996776760167326,1,13,negative regulation of oligodendrocyte differentiation,BP,DAAM2
13173,GO:0050000,0.0827336778693502,0.987832034027005,2,72,chromosome localization,BP,KIFC1;CENPF
13680,GO:0051303,0.0827336778693502,0.987832034027005,2,72,establishment of chromosome localization,BP,KIFC1;CENPF
10736,GO:0042493,0.0831812432578825,0.971084790457524,5,361,response to drug,BP,CD38;IGFBP2;CENPF;SFRP2;ADCY1
12614,GO:0046983,0.0832440057847844,0.960881647316381,9,825,protein dimerization activity,MF,SYT1;CAMK2A;CRYAB;CENPF;TOP2A;SYT4;TENM2;HSPB8;RRM2
17303,GO:0090559,0.0832704334787192,0.987690172574398,2,78,regulation of membrane permeability,BP,CAMK2A;TJP2
12126,GO:0045927,0.0833157066519133,0.97518278241295,4,231,positive regulation of growth,BP,CD38;SYT1;SYT4;SFRP2
3791,GO:0007612,0.083331623036557,0.980551630404847,3,138,learning,BP,NPTX2;SNAP25;NRGN
5671,GO:0016081,0.0834845668350434,0.996763240075174,1,11,synaptic vesicle docking,BP,SNAP25
13865,GO:0051657,0.0835018636590733,0.996793407773355,1,10,maintenance of organelle location,BP,ASPM
12533,GO:0046851,0.0835166988219063,0.996693173922117,1,14,negative regulation of bone remodeling,BP,CD38
3764,GO:0007548,0.0839477936600936,0.974923166882617,4,240,sex differentiation,BP,PTPRN;ASPM;VGF;SFRP2
3968,GO:0008284,0.0840655581765454,0.960419887434338,9,815,positive regulation of cell population proliferation,BP,CD38;PTPRN;ASPM;BIRC5;FOXM1;IGFBP2;SFRP2;FOLR2;NMB
3643,GO:0007218,0.0842804118204211,0.987424132681751,2,91,neuropeptide signaling pathway,BP,PRLHR;NMB
4473,GO:0009408,0.0844833933848273,0.980148602362944,3,152,response to heat,BP,CAMK2A;CRYAB;HSPB8
10814,GO:0042659,0.0848166237376441,0.996607373025672,1,13,regulation of cell fate specification,BP,SFRP2
342,GO:0000940,0.0851370870436886,0.996581265991832,1,13,condensed chromosome outer kinetochore,CC,CENPF
9029,GO:0033643,0.0852162848954959,0.996574798087753,1,13,host cell part,CC,TOP2A
14994,GO:0061134,0.0852968235357708,0.979852445727358,3,172,peptidase regulator activity,MF,BIRC5;SFRP2;PI16
2585,GO:0005513,0.0854502183963464,0.99655565640849,1,13,detection of calcium ion,BP,SYT1
3565,GO:0007088,0.0855291127434425,0.97979867478501,3,153,regulation of mitotic nuclear division,BP,CENPF;MKI67;UBE2C
16215,GO:0071495,0.0860746749347651,0.953598844266095,13,1237,cellular response to endogenous stimulus,BP,GABRA1;CAMK2A;STMN2;NEURL1;GABRG2;IGFBP2;CHRM3;SFRP2;GABRB2;CREB3L1;ADCY1;FOLR2;SPRY4
15074,GO:0061351,0.0861405402748536,0.979610954566183,3,142,neural precursor cell proliferation,BP,ASPM;FABP7;MELK
19678,GO:1903046,0.0862185720846729,0.979563640622024,3,156,meiotic cell cycle process,BP,ASPM;NCAPH;TOP2A
19193,GO:1901880,0.0862557780162685,0.987045790967002,2,63,negative regulation of protein depolymerization,BP,TPX2;STMN2
17194,GO:0090288,0.0863360448572119,0.979542143875729,3,144,negative regulation of cellular response to growth factor stimulus,BP,SFRP2;CREB3L1;SPRY4
1748,GO:0004016,0.0863838533408447,0.996564349630452,1,10,adenylate cyclase activity,MF,ADCY1
2969,GO:0006171,0.0863838533408447,0.996564349630452,1,10,cAMP biosynthetic process,BP,ADCY1
8444,GO:0032504,0.0864706707885376,0.961047792192326,8,695,multicellular organism reproduction,BP,PTPRN;KIFC1;ASPM;NEURL1;CNR1;NCAPH;TOP2A;FOLR2
8261,GO:0032269,0.0865174882936617,0.957314555887569,10,925,negative regulation of cellular protein metabolic process,BP,PTPN3;BIRC5;CRYAB;FOXM1;DUSP4;SFRP2;PI16;ENC1;SPRY4;PPP1R14C
5049,GO:0010959,0.0867599449601909,0.969473418915949,5,356,regulation of metal ion transport,BP,PTPN3;CAMK2A;HPCA;STAC2;KCNC2
2607,GO:0005546,0.0870608566720321,0.986827045181103,2,70,phosphatidylinositol-4,5-bisphosphate binding,MF,SYT1;RPH3A
5716,GO:0016188,0.0873728167817193,0.996420574773648,1,12,synaptic vesicle maturation,BP,SLC17A7
606,GO:0001778,0.0876182144613975,0.996400097163988,1,12,plasma membrane repair,BP,SYTL4
13572,GO:0051129,0.0877574789706602,0.960349709202588,8,662,negative regulation of cellular component organization,BP,CD38;TPX2;STMN2;CRYAB;CENPF;TOP2A;SYT4;GRIN2B
3292,GO:0006646,0.0880670509268678,0.99631659847679,1,14,phosphatidylethanolamine biosynthetic process,BP,ETNPPL
3571,GO:0007096,0.0881749500610081,0.996289023276721,1,15,regulation of exit from mitosis,BP,UBE2C
18021,GO:0098992,0.0883825608717016,0.996335927815426,1,12,neuronal dense core vesicle,CC,SYT4
4589,GO:0009898,0.0886674895144456,0.978736975563679,3,156,cytoplasmic side of plasma membrane,CC,PTPN3;SNAP25;STAC2
16207,GO:0071481,0.0889512291568161,0.99628780572027,1,12,cellular response to X-ray,BP,SFRP2
5120,GO:0014048,0.0890504323723887,0.996232456751535,1,14,regulation of glutamate secretion,BP,SYT4
2562,GO:0005452,0.0890669135231221,0.996277976459644,1,12,inorganic anion exchanger activity,MF,SLC4A10
5926,GO:0016594,0.0894079763038602,0.996201620282878,1,14,glycine binding,MF,GRIN2B
11409,GO:0043950,0.0897703274223064,0.99615117302822,1,15,positive regulation of cAMP-mediated signaling,BP,MRAP2
17740,GO:0097756,0.0899125172733469,0.986129135207019,2,74,negative regulation of blood vessel diameter,BP,CD38;CHRM3
16369,GO:0071732,0.090135060505415,0.996119292570614,1,15,cellular response to nitric oxide,BP,KCNC2
562,GO:0001710,0.0902986331313563,0.996088077900281,1,16,mesodermal cell fate commitment,BP,SFRP2
3456,GO:0006898,0.0905012098412976,0.972262722419267,4,248,receptor-mediated endocytosis,BP,DNM1;HPCA;SNAP25;FOLR2
7022,GO:0022600,0.0906422178760108,0.985929700625761,2,81,digestive system process,BP,TJP2;CHRM3
9499,GO:0034765,0.0907459566598773,0.964075546871801,6,446,regulation of ion transmembrane transport,BP,PTPN3;HPCA;CHRM3;STAC2;KCNC2;GRIN2B
12182,GO:0046037,0.0907529209252299,0.996084460073737,1,14,GMP metabolic process,BP,TJP2
3017,GO:0006266,0.0908099653717256,0.996042876940716,1,16,DNA ligation,BP,TOP2A
792,GO:0002029,0.0909219559295505,0.99601785062532,1,17,desensitization of G protein-coupled receptor signaling pathway,BP,DNM1
7007,GO:0022401,0.0909219559295505,0.99601785062532,1,17,negative adaptation of signaling pathway,BP,DNM1
7085,GO:0023058,0.0909219559295505,0.99601785062532,1,17,adaptation of signaling pathway,BP,DNM1
5650,GO:0016049,0.0913715509327921,0.963762639154683,6,448,cell growth,BP,CD38;SYT1;CRYAB;SYT4;SFRP2;PI16
3391,GO:0006796,0.0916655927075201,0.941673936232315,25,2904,phosphate-containing compound metabolic process,BP,CAMK1G;PTPRN;PTPN3;CAMK2A;TPX2;BIRC5;EEF1A2;NEURL1;CRYAB;PTPN5;FOXM1;TJP2;DUSP4;HPCA;SULT4A1;HUNK;SFRP2;HSPB8;ETNPPL;ADCY1;MELK;RRM2;SPRY4;PPP1R14C;GRIN2B
20313,GO:1904321,0.0916869730502168,0.996083430983238,1,11,response to forskolin,BP,ADCY1
20314,GO:1904322,0.0916869730502168,0.996083430983238,1,11,cellular response to forskolin,BP,ADCY1
3681,GO:0007288,0.0917419304056648,0.995997130119986,1,14,sperm axoneme assembly,BP,NEURL1
7050,GO:0022840,0.0917700305861824,0.995957282550446,1,16,leak channel activity,MF,KCNK9
7052,GO:0022842,0.0917700305861824,0.995957282550446,1,16,narrow pore channel activity,MF,KCNK9
11772,GO:0045120,0.0920015047817961,0.995997157124729,1,13,pronucleus,CC,CENPF
251,GO:0000712,0.0924016896217397,0.995938318344534,1,14,resolution of meiotic recombination intermediates,BP,TOP2A
13364,GO:0050805,0.0929583338037205,0.985395414352999,2,71,negative regulation of synaptic transmission,BP,CD38;SYT4
7791,GO:0031362,0.0932566417305861,0.995822872219657,1,16,anchored component of external side of plasma membrane,CC,FOLR2
3798,GO:0007620,0.0933759390492687,0.99581198738838,1,16,copulation,BP,CNR1
6206,GO:0017146,0.0934612965086394,0.99592754366147,1,11,NMDA selective glutamate receptor complex,CC,GRIN2B
13154,GO:0048871,0.0936451679561758,0.962618744461958,6,459,multicellular organismal homeostasis,BP,CD38;USH1C;CNR1;TJP2;MRAP2;ADCY1
9742,GO:0035497,0.0938408417753596,0.995808488107658,1,14,cAMP response element binding,MF,CREB3L1
10708,GO:0042445,0.0943510533685006,0.976749300221156,3,178,hormone metabolic process,BP,PRLHR;CHST9;PCSK1
12507,GO:0046785,0.0946660096919044,0.984963648870792,2,73,microtubule polymerization,BP,TPX2;STMN2
7089,GO:0030003,0.0952937888436653,0.958714934443663,7,596,cellular cation homeostasis,BP,CD38;SLC30A3;CNR1;GPR12;SLC4A10;NMB;GRIN2B
17112,GO:0090179,0.0953856640453366,0.995691615389264,1,13,planar cell polarity pathway involved in neural tube closure,BP,SFRP2
21681,GO:2000380,0.095435089139576,0.995621793844356,1,16,regulation of mesoderm development,BP,SFRP2
13823,GO:0051589,0.0954923140009435,0.995681796960008,1,13,negative regulation of neurotransmitter transport,BP,SYT4
8253,GO:0032253,0.0959160850950739,0.995706666310435,1,11,dense core granule localization,BP,SYT4
18143,GO:0099519,0.0959160850950739,0.995706666310435,1,11,dense core granule cytoskeletal transport,BP,SYT4
19212,GO:1901950,0.0959160850950739,0.995706666310435,1,11,dense core granule transport,BP,SYT4
20649,GO:1904948,0.0961683233646853,0.995572152337544,1,15,midbrain dopaminergic neuron differentiation,BP,SFRP2
14023,GO:0051966,0.0963199901243013,0.984556537447939,2,71,regulation of synaptic transmission, glutamatergic,BP,SYT1;CNR1
8871,GO:0033194,0.0965101626866566,0.995520754022702,1,16,response to hydroperoxide,BP,CD38
2640,GO:0005614,0.0966890207150889,0.99557083033081,1,13,interstitial matrix,CC,ABI3BP
1264,GO:0002793,0.0968858310197979,0.975869283019182,3,169,positive regulation of peptide secretion,BP,CD38;SYTL4;VSNL1
17935,GO:0098877,0.0971326986634653,0.995481226417468,1,15,neurotransmitter receptor transport to plasma membrane,BP,SNAP25
18005,GO:0098969,0.0971326986634653,0.995481226417468,1,15,neurotransmitter receptor transport to postsynaptic membrane,BP,SNAP25
17760,GO:0098552,0.0971994379528592,0.960808271729756,6,493,side of membrane,CC,PTPN3;EEF1A2;SNAP25;STAC2;FOLR2;SELL
17074,GO:0090128,0.0972864945178756,0.995514881646172,1,13,regulation of synapse maturation,BP,NEURL1
8792,GO:0033045,0.0973321070215547,0.984280782480294,2,76,regulation of sister chromatid segregation,BP,CENPF;UBE2C
1476,GO:0003214,0.0974294412723282,0.995501441773432,1,13,cardiac left ventricle morphogenesis,BP,SFRP2
7446,GO:0030662,0.0974710457925018,0.975660637067698,3,170,coated vesicle membrane,CC,SYT1;SLC17A7;NRGN
21121,GO:1990000,0.0975070832638915,0.995408631761869,1,17,amyloid fibril formation,BP,CRYAB
6827,GO:0021675,0.0975237114151357,0.984239640969356,2,74,nerve development,BP,GABRB2;NPTX1
3638,GO:0007213,0.0978266166262824,0.99537792618462,1,17,G protein-coupled acetylcholine receptor signaling pathway,BP,CHRM3
17184,GO:0090277,0.0979547856408969,0.984092414847822,2,85,positive regulation of peptide hormone secretion,BP,CD38;VSNL1
19453,GO:1902532,0.0981084607493912,0.96035484613758,6,468,negative regulation of intracellular signal transduction,BP,FOXM1;DUSP4;MRAP2;SFRP2;CREB3L1;SPRY4
13482,GO:0050998,0.0982377444073832,0.995398693762721,1,14,nitric-oxide synthase binding,MF,DNM1
1626,GO:0003746,0.0984093887754216,0.995321651159435,1,17,translation elongation factor activity,MF,EEF1A2
3622,GO:0007193,0.0986326333093213,0.983934742676742,2,80,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway,BP,CHRM3;ADCY1
7951,GO:0031649,0.098704348851802,0.995310822075833,1,16,heat generation,BP,CNR1
15216,GO:0061684,0.0990049234019809,0.995281675449905,1,16,chaperone-mediated autophagy,BP,EEF1A2
18509,GO:0140029,0.0991832046170169,0.983789991771063,2,81,exocytic process,BP,SYT1;SNAP25
3390,GO:0006793,0.0991995818699628,0.936283553118721,25,2929,phosphorus metabolic process,BP,CAMK1G;PTPRN;PTPN3;CAMK2A;TPX2;BIRC5;EEF1A2;NEURL1;CRYAB;PTPN5;FOXM1;TJP2;DUSP4;HPCA;SULT4A1;HUNK;SFRP2;HSPB8;ETNPPL;ADCY1;MELK;RRM2;SPRY4;PPP1R14C;GRIN2B
21501,GO:2000095,0.0993674730879665,0.995266832180112,1,15,regulation of Wnt signaling pathway, planar cell polarity pathway,BP,SFRP2
19194,GO:1901881,0.0995980192616397,0.995223888019267,1,16,positive regulation of protein depolymerization,BP,STMN2
11530,GO:0044304,0.0996004907947284,0.983744195177457,2,66,main axon,CC,DNM1;KCNC2
10519,GO:0042043,0.0996061260735568,0.995267109309549,1,14,neurexin family protein binding,MF,SYTL4
20026,GO:1903729,0.0996347193299368,0.995240848278046,1,15,regulation of plasma membrane organization,BP,SYTL4
14285,GO:0060026,0.099803597362556,0.995224390454776,1,15,convergent extension,BP,SFRP2
18052,GO:0099056,0.100347835009078,0.983519352100873,2,73,integral component of presynaptic membrane,CC,CNR1;CHRM3
13923,GO:0051782,0.100462814669864,0.995159864666812,1,15,negative regulation of cell division,BP,ASPM
2279,GO:0004888,0.100497009877469,0.953218575063833,8,734,transmembrane signaling receptor activity,MF,GABRA1;GABRG2;CNR1;PRLHR;GPR12;CHRM3;GABRB2;GRIN2B
2515,GO:0005313,0.100558444144463,0.995174396088367,1,14,L-glutamate transmembrane transporter activity,MF,SLC17A7
13721,GO:0051382,0.100905770078899,0.995116254349548,1,15,kinetochore assembly,BP,CENPF
11756,GO:0045091,0.10095893436851,0.995071296519747,1,17,regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,TOP2A
19923,GO:1903540,0.101055270471425,0.995080350647073,1,16,establishment of protein localization to postsynaptic membrane,BP,SNAP25
3447,GO:0006887,0.101392742735491,0.950413467281647,9,850,exocytosis,BP,SYT13;SYT1;SYTL4;CNR1;SNAP25;SYT4;VSNL1;ADCY1;SELL
20072,GO:1903818,0.101645375608096,0.995042984754734,1,15,positive regulation of voltage-gated potassium channel activity,BP,KCNC2
464,GO:0001540,0.101988450052992,0.983084579416448,2,75,amyloid-beta binding,MF,CRYAB;GRIN2B
3435,GO:0006873,0.102398886250056,0.954869081269327,7,606,cellular ion homeostasis,BP,CD38;SLC30A3;CNR1;GPR12;SLC4A10;NMB;GRIN2B
17111,GO:0090178,0.102399576192955,0.994992500064302,1,14,regulation of establishment of planar polarity involved in neural tube closure,BP,SFRP2
3413,GO:0006833,0.102884452004664,0.99486054497087,1,18,water transport,BP,SLC14A1
9729,GO:0035461,0.103067436003863,0.994900512863489,1,15,vitamin transmembrane transport,BP,FOLR2
18103,GO:0099170,0.103068692366386,0.994925526915283,1,14,postsynaptic modulation of chemical synaptic transmission,BP,NRGN
13463,GO:0050954,0.103206958812703,0.973616499004343,3,159,sensory perception of mechanical stimulus,BP,USH1C;BIRC5;GABRB2
1375,GO:0003018,0.103260470091875,0.973576906732717,3,172,vascular process in circulatory system,BP,CD38;TJP2;CHRM3
3983,GO:0008301,0.103362101731997,0.994829102920733,1,17,DNA binding, bending,MF,TOP2A
11033,GO:0043117,0.103391590377751,0.994826093507124,1,17,positive regulation of vascular permeability,BP,TJP2
8377,GO:0032426,0.103440903856224,0.994840597704338,1,16,stereocilium tip,CC,USH1C
22125,GO:2001243,0.103572468568817,0.982614139811149,2,91,negative regulation of intrinsic apoptotic signaling pathway,BP,SFRP2;CREB3L1
6848,GO:0021700,0.103723111994467,0.966685445271483,4,254,developmental maturation,BP,PTPRN;SLC17A7;NEURL1;SYT4
1710,GO:0003953,0.103758715550102,0.994808210172362,1,16,NAD+ nucleosidase activity,MF,CD38
13187,GO:0050135,0.103758715550102,0.994808210172362,1,16,NAD(P)+ nucleosidase activity,MF,CD38
15275,GO:0061809,0.103758715550102,0.994808210172362,1,16,NAD+ nucleotidase, cyclic ADP-ribose generating,MF,CD38
13347,GO:0050780,0.103759053867953,0.994788516271257,1,17,dopamine receptor binding,MF,DNM1
3776,GO:0007589,0.104116254104698,0.982501823423586,2,81,body fluid secretion,BP,NEURL1;CHRM3
8111,GO:0031994,0.104173108831949,0.994843616797473,1,13,insulin-like growth factor I binding,MF,IGFBP2
10526,GO:0042058,0.104888013644601,0.982293303710466,2,82,regulation of epidermal growth factor receptor signaling pathway,BP,PTPN3;NEURL1
11110,GO:0043242,0.10493661920532,0.982320579945663,2,72,negative regulation of protein-containing complex disassembly,BP,TPX2;STMN2
11559,GO:0044342,0.105045384949693,0.994621934846492,1,19,type B pancreatic cell proliferation,BP,PTPRN
10468,GO:0039692,0.105046029685429,0.9946378859497,1,18,single stranded viral RNA replication via double stranded DNA intermediate,BP,TOP2A
6735,GO:0021516,0.105448570011948,0.994579736912867,1,19,dorsal spinal cord development,BP,DAAM2
14214,GO:0055057,0.105598665100235,0.994668109239111,1,14,neuroblast division,BP,ASPM
17110,GO:0090177,0.105787342616074,0.994622159170171,1,15,establishment of planar polarity involved in neural tube closure,BP,SFRP2
18134,GO:0099509,0.105933677254473,0.99458373255239,1,16,regulation of presynaptic cytosolic calcium ion concentration,BP,CNR1
17088,GO:0090148,0.106209447760678,0.994578270682594,1,15,membrane fission,BP,DNM1
14000,GO:0051938,0.106233189934824,0.994602507557181,1,14,L-glutamate import,BP,SLC17A7
18883,GO:1901019,0.106343918703848,0.981904090991315,2,82,regulation of calcium ion transmembrane transporter activity,BP,HPCA;STAC2
2521,GO:0005326,0.106781612310108,0.994474053676135,1,17,neurotransmitter transmembrane transporter activity,MF,SLC17A7
7637,GO:0031082,0.107158034435741,0.994398914407124,1,19,BLOC complex,CC,SNAP25
16354,GO:0071705,0.107363214996617,0.933946302708239,19,2159,nitrogen compound transport,BP,CD38;SYT13;PTPRN;SYT1;RPH3A;SYTL4;SLC17A7;DNM1;CENPF;CNR1;HPCA;VGF;SNAP25;SYT4;SLC14A1;VSNL1;FOLR2;KCNC2;SLC6A17
2551,GO:0005385,0.107402338573375,0.994389566154522,1,18,zinc ion transmembrane transporter activity,MF,SLC30A3
7292,GO:0030308,0.107458883327417,0.972029528692521,3,175,negative regulation of cell growth,BP,CRYAB;SFRP2;PI16
14362,GO:0060134,0.10769488168365,0.994422344366248,1,15,prepulse inhibition,BP,FABP7
19338,GO:1902236,0.107752434295606,0.994352171723692,1,18,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,CREB3L1
7198,GO:0030177,0.10776721299956,0.971921072353438,3,171,positive regulation of Wnt signaling pathway,BP,ASPM;SFRP2;DAAM2
5427,GO:0015464,0.107991620499455,0.994326549360869,1,18,acetylcholine receptor activity,MF,CHRM3
10544,GO:0042104,0.10816386241632,0.994275793624441,1,20,positive regulation of activated T cell proliferation,BP,IGFBP2
7816,GO:0031406,0.108359528221169,0.971678330529264,3,187,carboxylic acid binding,MF,FOLR2;HAPLN4;GRIN2B
11315,GO:0043567,0.108484233540989,0.994273588760884,1,18,regulation of insulin-like growth factor receptor signaling pathway,BP,IGFBP2
10951,GO:0042981,0.108587442281019,0.939159866759645,13,1375,regulation of apoptotic process,BP,CD38;CAMK2A;BIRC5;MYBL2;EEF1A2;NEURL1;CRYAB;CNR1;TOP2A;SFRP2;GABRB2;CREB3L1;MELK
3844,GO:0008076,0.10872908983693,0.981255731700951,2,83,voltage-gated potassium channel complex,CC,SNAP25;KCNC2
14439,GO:0060259,0.108729135704194,0.99424716402217,1,18,regulation of feeding behavior,BP,CNR1
11463,GO:0044092,0.108962029911923,0.943804136658572,10,988,negative regulation of molecular function,BP,CAMK2A;BIRC5;CRYAB;CNR1;DUSP4;HPCA;SFRP2;PI16;SPRY4;PPP1R14C
15349,GO:0062014,0.10909960120399,0.981147663010274,2,85,negative regulation of small molecule metabolic process,BP,CNR1;HPCA
15781,GO:0070679,0.109219553153767,0.994320732168736,1,13,inositol 1,4,5 trisphosphate binding,MF,RPH3A
16368,GO:0071731,0.109337866321616,0.994163852259274,1,19,response to nitric oxide,BP,KCNC2
8492,GO:0032591,0.10951012139507,0.994228668432685,1,15,dendritic spine membrane,CC,DDN
5036,GO:0010941,0.109568322956746,0.937227536925176,14,1511,regulation of cell death,BP,CD38;CAMK2A;BIRC5;MYBL2;EEF1A2;NEURL1;CRYAB;CNR1;TOP2A;SFRP2;GABRB2;CREB3L1;MELK;GRIN2B
11739,GO:0045055,0.109674742788235,0.947947175545587,8,749,regulated exocytosis,BP,SYT13;SYT1;SYTL4;CNR1;SNAP25;SYT4;ADCY1;SELL
13653,GO:0051262,0.110325057236668,0.980819411968511,2,83,protein tetramerization,BP,RRM2;GRIN2B
7647,GO:0031092,0.110388698554034,0.994108460038627,1,16,platelet alpha granule membrane,CC,SYTL4
9024,GO:0033630,0.111102818453206,0.993953711462964,1,20,positive regulation of cell adhesion mediated by integrin,BP,SFRP2
19224,GO:1901981,0.11130499708506,0.970612744275799,3,162,phosphatidylinositol phosphate binding,MF,SYT1;RPH3A;NRGN
3503,GO:0006978,0.111584138573683,0.993954637786546,1,17,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,FOXM1
20732,GO:1905114,0.111781959395322,0.949690326542663,7,586,cell surface receptor signaling pathway involved in cell-cell signaling,BP,ASPM;CAMK2A;SLC17A7;IGFBP2;SFRP2;DAAM2;GRIN2B
5317,GO:0015172,0.111803630417245,0.993953147483126,1,16,acidic amino acid transmembrane transporter activity,MF,SLC17A7
9141,GO:0034104,0.111888318942616,0.993882424992419,1,19,negative regulation of tissue remodeling,BP,CD38
12461,GO:0046655,0.111903724439073,0.993898884670455,1,18,folic acid metabolic process,BP,FOLR2
13649,GO:0051258,0.111971066689277,0.963051594853746,4,272,protein polymerization,BP,TPX2;STMN2;DNM1;UBE2C
3504,GO:0006979,0.112080008265048,0.957440512370258,5,407,response to oxidative stress,BP,CD38;PTPRN;CRYAB;MELK;KCNC2
7710,GO:0031233,0.112153736272222,0.993836308408019,1,20,intrinsic component of external side of plasma membrane,CC,FOLR2
4812,GO:0010639,0.112227160150587,0.957390588027348,5,367,negative regulation of organelle organization,BP,TPX2;STMN2;CENPF;TOP2A;SYT4
5042,GO:0010951,0.112301823537024,0.970189687188747,3,193,negative regulation of endopeptidase activity,BP,BIRC5;CRYAB;SFRP2
19301,GO:1902170,0.112545495358401,0.993827178901941,1,18,cellular response to reactive nitrogen species,BP,KCNC2
7659,GO:0031110,0.112592023356386,0.980209042500124,2,79,regulation of microtubule polymerization or depolymerization,BP,TPX2;STMN2
13924,GO:0051783,0.112606722203988,0.970102466455062,3,173,regulation of nuclear division,BP,CENPF;MKI67;UBE2C
14827,GO:0060828,0.112721634143802,0.962716262222617,4,273,regulation of canonical Wnt signaling pathway,BP,ASPM;IGFBP2;SFRP2;DAAM2
16762,GO:0072509,0.112993002468098,0.970000314744313,3,149,divalent inorganic cation transmembrane transporter activity,MF,SLC30A3;CNR1;GRIN2B
13360,GO:0050801,0.113122159993332,0.945942912785845,8,733,ion homeostasis,BP,CD38;PTPN3;SLC30A3;CNR1;GPR12;SLC4A10;NMB;GRIN2B
13639,GO:0051248,0.113469720190654,0.941016360599557,10,971,negative regulation of protein metabolic process,BP,PTPN3;BIRC5;CRYAB;FOXM1;DUSP4;SFRP2;PI16;ENC1;SPRY4;PPP1R14C
9112,GO:0034035,0.113641649453425,0.993652809508564,1,21,purine ribonucleoside bisphosphate metabolic process,BP,SULT4A1
13225,GO:0050427,0.113641649453425,0.993652809508564,1,21,3'-phosphoadenosine 5'-phosphosulfate metabolic process,BP,SULT4A1
10213,GO:0036342,0.114281543020277,0.993652214244065,1,17,post-anal tail morphogenesis,BP,SFRP2
2672,GO:0005680,0.114406048156495,0.993565253499524,1,21,anaphase-promoting complex,CC,UBE2C
2166,GO:0004721,0.114437592441657,0.96941611447651,3,167,phosphoprotein phosphatase activity,MF,PTPN3;PTPN5;DUSP4
3769,GO:0007568,0.114556768898484,0.961886117192753,4,283,aging,BP,CRYAB;FOXM1;IGFBP2;CNR1
10875,GO:0042772,0.114836670582156,0.993567613245794,1,18,DNA damage response, signal transduction resulting in transcription,BP,FOXM1
1044,GO:0002438,0.11486875680666,0.993497776466215,1,22,acute inflammatory response to antigenic stimulus,BP,CNR1
14950,GO:0061050,0.11488343924846,0.99356225669517,1,18,regulation of cell growth involved in cardiac muscle cell development,BP,PI16
21908,GO:2000726,0.11631924045591,0.993418638341513,1,17,negative regulation of cardiac muscle cell differentiation,BP,PI16
12776,GO:0048013,0.116724376179476,0.979015644387399,2,87,ephrin receptor signaling pathway,BP,DNM1;GRIN2B
11010,GO:0043067,0.117284285443262,0.933422241774607,13,1393,regulation of programmed cell death,BP,CD38;CAMK2A;BIRC5;MYBL2;EEF1A2;NEURL1;CRYAB;CNR1;TOP2A;SFRP2;GABRB2;CREB3L1;MELK
10598,GO:0042249,0.118334685588281,0.993183269667827,1,17,establishment of planar polarity of embryonic epithelium,BP,SFRP2
11765,GO:0045109,0.118687655165318,0.993118737070521,1,18,intermediate filament organization,BP,NEFM
1594,GO:0003674,0.118798911855,0.962818278255639,98,14660,molecular_function,MF,CD38;USH1C;CAMK1G;SYT13;GABRA1;PTPRN;KIFC1;BCAT1;LZTS1;ASPM;SYT1;PTPN3;CAMK2A;LNX1;TPX2;RPH3A;BIRC5;KIF4A;MYBL2;EEF1A2;ST8SIA5;SYTL4;STMN2;NEFM;SLC17A7;NPTX2;DNM1;NEURL1;NCAPG;CRYAB;PTPN5;FOXM1;GABRG2;SLC30A3;IGFBP2;CENPF;CNR1;TJP2;PRLHR;DUSP4;NCAPH;HPCA;VGF;SULT4A1;TOP2A;SNAP25;SYT4;GPR12;CHRM3;FAM189A2;MRAP2;SLC14A1;STAC2;HUNK;SLC4A10;SFRP2;LIX1;GABRB2;TENM2;DAAM2;MKI67;FREM2;HSPB8;CHST9;NRGN;ABI3BP;CREB3L1;VSNL1;IGFN1;ETNPPL;FABP7;PI16;ADCY1;MELK;FOLR2;KCNC2;TMEM130;KCNK9;NPTX1;ENC1;RRM2;ZCCHC12;UBE2C;PCSK1;DDN;SV2B;C11ORF87;MYT1L;HAPLN4;SPRY4;C2ORF88;SELL;CPNE4;SLC6A17;NMB;PPP1R14C;TMEM158;GRIN2B
6679,GO:0019900,0.11887349240012,0.942566857486575,8,702,kinase binding,MF,TPX2;EEF1A2;DNM1;FOXM1;TJP2;DUSP4;HPCA;TOP2A
13240,GO:0050482,0.118877835865609,0.99302529359407,1,22,arachidonic acid secretion,BP,NMB
20146,GO:1903963,0.118877835865609,0.99302529359407,1,22,arachidonate transport,BP,NMB
18241,GO:0101031,0.11903555515277,0.99299245689604,1,23,chaperone complex,CC,HSPB8
11068,GO:0043177,0.119224541077804,0.967523669853046,3,198,organic acid binding,MF,FOLR2;HAPLN4;GRIN2B
2744,GO:0005794,0.119388905735288,0.930642227603838,14,1454,Golgi apparatus,CC,CAMK1G;PTPRN;SYT1;RPH3A;ST8SIA5;STMN2;DNM1;CRYAB;VGF;SNAP25;SYT4;TENM2;CHST9;TMEM130
7875,GO:0031503,0.119627625735906,0.959600301566974,4,272,protein-containing complex localization,BP,BIRC5;DNM1;HPCA;SNAP25
16263,GO:0071577,0.119651110405547,0.992964464487212,1,20,zinc ion transmembrane transport,BP,SLC30A3
2348,GO:0004993,0.119698681667016,0.992926416013599,1,22,G protein-coupled serotonin receptor activity,MF,CHRM3
17817,GO:0098664,0.119698681667016,0.992926416013599,1,22,G protein-coupled serotonin receptor signaling pathway,BP,CHRM3
18196,GO:0099589,0.119698681667016,0.992926416013599,1,22,serotonin receptor activity,MF,CHRM3
5381,GO:0015294,0.119787452177979,0.978153158395531,2,83,solute:cation symporter activity,MF,SLC17A7;SLC4A10
17946,GO:0098889,0.120183557325218,0.978042873062749,2,82,intrinsic component of presynaptic membrane,CC,CNR1;CHRM3
12973,GO:0048523,0.120247274772148,0.917286327207843,35,4362,negative regulation of cellular process,BP,CD38;LZTS1;ASPM;PTPN3;TPX2;BIRC5;SYTL4;STMN2;DNM1;NEURL1;CRYAB;FOXM1;IGFBP2;CENPF;CNR1;DUSP4;HPCA;TOP2A;SYT4;MRAP2;SFRP2;GABRB2;TENM2;DAAM2;CREB3L1;VSNL1;FABP7;PI16;ENC1;RRM2;MYT1L;SPRY4;NMB;PPP1R14C;GRIN2B
10477,GO:0040008,0.120456434780715,0.944781691656472,7,610,regulation of growth,BP,CD38;SYT1;CRYAB;IGFBP2;SYT4;SFRP2;PI16
18138,GO:0099513,0.120642608794736,0.944685770554493,7,581,polymeric cytoskeletal fiber,CC,KIFC1;ASPM;TPX2;BIRC5;KIF4A;NEFM;DNM1
1302,GO:0002861,0.120851769142274,0.992746763613578,1,25,regulation of inflammatory response to antigenic stimulus,BP,CNR1
13619,GO:0051219,0.121059866224745,0.977784361118579,2,83,phosphoprotein binding,MF,PTPN3;PTPN5
560,GO:0001708,0.121131931223977,0.977735913021625,2,90,cell fate specification,BP,SFRP2;MYT1L
19114,GO:1901654,0.121151204019144,0.966788801872983,3,185,response to ketone,BP,CD38;HPCA;ADCY1
7786,GO:0031345,0.121225555492428,0.966780918074991,3,172,negative regulation of cell projection organization,BP,CD38;STMN2;GRIN2B
15389,GO:0065009,0.121371307138125,0.921211315106908,23,2700,regulation of molecular function,BP,PTPN3;CAMK2A;TPX2;BIRC5;EEF1A2;NPTX2;NEURL1;CRYAB;CNR1;DUSP4;NCAPH;HPCA;CHRM3;STAC2;SFRP2;PI16;ADCY1;KCNC2;NPTX1;UBE2C;SPRY4;PPP1R14C;GRIN2B
20483,GO:1904666,0.121714252820068,0.992666004798192,1,23,regulation of ubiquitin protein ligase activity,BP,UBE2C
4611,GO:0009975,0.121730858190294,0.992803925457769,1,16,cyclase activity,MF,ADCY1
20911,GO:1905475,0.122222557466679,0.966370788184268,3,183,regulation of protein localization to membrane,BP,HPCA;MRAP2;STAC2
4836,GO:0010667,0.122691189620127,0.99257594060692,1,21,negative regulation of cardiac muscle cell apoptotic process,BP,SFRP2
18925,GO:1901184,0.122701110990598,0.97728462732376,2,88,regulation of ERBB signaling pathway,BP,PTPN3;NEURL1
18849,GO:1900543,0.122903962773069,0.992587147433288,1,19,negative regulation of purine nucleotide metabolic process,BP,HPCA
10576,GO:0042165,0.123018780725032,0.992553187156468,1,20,neurotransmitter binding,MF,CHRM3
11457,GO:0044085,0.123224877947446,0.919266084311525,24,2823,cellular component biogenesis,BP,USH1C;GABRA1;KIFC1;ASPM;SYT1;TPX2;BIRC5;KIF4A;MYBL2;STMN2;NEFM;DNM1;NEURL1;CRYAB;GABRG2;CENPF;SNAP25;GABRB2;TENM2;IGFN1;KCNC2;RRM2;UBE2C;GRIN2B
18137,GO:0099512,0.123735914724398,0.936936006819925,9,800,supramolecular fiber,CC,KIFC1;ASPM;TPX2;BIRC5;KIF4A;NEFM;DNM1;CRYAB;IGFN1
4854,GO:0010714,0.123800099486338,0.992437903889582,1,21,positive regulation of collagen metabolic process,BP,CREB3L1
8737,GO:0032967,0.123800099486338,0.992437903889582,1,21,positive regulation of collagen biosynthetic process,BP,CREB3L1
18942,GO:1901216,0.124007972388154,0.976888448763016,2,91,positive regulation of neuron death,BP,MYBL2;GRIN2B
13479,GO:0050995,0.124025624985968,0.99244794673326,1,19,negative regulation of lipid catabolic process,BP,CNR1
13326,GO:0050750,0.124050681959425,0.992467168128762,1,18,low-density lipoprotein particle receptor binding,MF,SYT1
3416,GO:0006837,0.124120846257298,0.992397728914292,1,21,serotonin transport,BP,CNR1
4516,GO:0009628,0.124315987362817,0.932137818116106,11,1125,response to abiotic stimulus,BP,CD38;CAMK2A;EEF1A2;CRYAB;IGFBP2;HPCA;VGF;SLC4A10;SFRP2;HSPB8;KCNC2
3774,GO:0007586,0.124449593506718,0.976724606535876,2,101,digestion,BP,TJP2;CHRM3
275,GO:0000775,0.124586147335681,0.965440589237499,3,180,chromosome, centromeric region,CC,BIRC5;NCAPG;CENPF
11029,GO:0043112,0.124744832530726,0.965375856080726,3,181,receptor metabolic process,BP,DNM1;HPCA;SNAP25
7737,GO:0031281,0.124768329119215,0.992377634301191,1,18,positive regulation of cyclase activity,BP,HPCA
7165,GO:0030136,0.124802137854792,0.965353068251682,3,181,clathrin-coated vesicle,CC,SYT1;SLC17A7;NRGN
3523,GO:0007010,0.124811369123635,0.928405373249222,13,1262,cytoskeleton organization,BP,USH1C;KIFC1;ASPM;TPX2;BIRC5;KIF4A;MYBL2;STMN2;NEFM;NEURL1;CRYAB;DAAM2;MAP7D2
9202,GO:0034199,0.124881827997075,0.992388742045236,1,17,activation of protein kinase A activity,BP,ADCY1
19192,GO:1901879,0.124887890232772,0.976674196879086,2,80,regulation of protein depolymerization,BP,TPX2;STMN2
15567,GO:0070300,0.125018122021155,0.992323643099998,1,19,phosphatidic acid binding,MF,NRGN
20806,GO:1905276,0.125019435924176,0.992346175104825,1,18,regulation of epithelial tube formation,BP,SFRP2
13707,GO:0051349,0.125153890410225,0.992329302419213,1,18,positive regulation of lyase activity,BP,HPCA
17405,GO:0097062,0.125263924651438,0.992315479726215,1,18,dendritic spine maintenance,BP,GRIN2B
7454,GO:0030673,0.125573848118438,0.992363548702218,1,15,axolemma,CC,KCNC2
4016,GO:0008356,0.125654886360962,0.992243331996297,1,19,asymmetric cell division,BP,ASPM
4149,GO:0008585,0.125717190590298,0.976388763886953,2,89,female gonad development,BP,PTPRN;VGF
12157,GO:0045980,0.125894712016532,0.992192260947177,1,20,negative regulation of nucleotide metabolic process,BP,HPCA
7711,GO:0031234,0.126080856705435,0.976261705072196,2,94,extrinsic component of cytoplasmic side of plasma membrane,CC,SNAP25;STAC2
14014,GO:0051957,0.12616793000098,0.992178305964565,1,19,positive regulation of amino acid transport,BP,SYT4
13825,GO:0051591,0.126198656729064,0.976253166442701,2,87,response to cAMP,BP,PTPRN;VGF
12438,GO:0046625,0.126342706625893,0.992116364602867,1,21,sphingolipid binding,MF,SELL
4379,GO:0009190,0.126656404196541,0.992139425389729,1,18,cyclic nucleotide biosynthetic process,BP,ADCY1
14105,GO:0052652,0.126656404196541,0.992139425389729,1,18,cyclic purine nucleotide metabolic process,BP,ADCY1
537,GO:0001671,0.126809571898323,0.992009062998072,1,24,ATPase activator activity,MF,NCAPH
11140,GO:0043281,0.127436074201658,0.964269835439643,3,201,regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,BIRC5;CRYAB;SFRP2
3437,GO:0006875,0.127512514314183,0.944713859018606,6,523,cellular metal ion homeostasis,BP,CD38;SLC30A3;CNR1;GPR12;NMB;GRIN2B
13517,GO:0051043,0.127550388824031,0.991961178830839,1,21,regulation of membrane protein ectodomain proteolysis,BP,PTPN3
277,GO:0000777,0.127742461756787,0.975759706219635,2,95,condensed chromosome kinetochore,CC,BIRC5;CENPF
4560,GO:0009791,0.127925931663249,0.97578269700972,2,77,post-embryonic development,BP,GABRG2;SLC4A10
3631,GO:0007204,0.128244771344992,0.955594579775907,4,290,positive regulation of cytosolic calcium ion concentration,BP,CD38;CNR1;NMB;GRIN2B
9466,GO:0034705,0.128693515316555,0.975487370180099,2,91,potassium channel complex,CC,SNAP25;KCNC2
3636,GO:0007210,0.128817453391524,0.99174763966556,1,24,serotonin receptor signaling pathway,BP,CHRM3
8132,GO:0032026,0.129250431529372,0.991832992156175,1,17,response to magnesium ion,BP,KCNC2
12972,GO:0048522,0.1294816404645,0.909315104434681,39,4959,positive regulation of cellular process,BP,CD38;PTPRN;ASPM;SYT1;CAMK2A;TPX2;BIRC5;MYBL2;EEF1A2;SYTL4;STMN2;DNM1;NEURL1;FOXM1;IGFBP2;CNR1;HPCA;TOP2A;SNAP25;SYT4;MRAP2;STAC2;SFRP2;TENM2;DAAM2;HSPB8;NRGN;ABI3BP;CREB3L1;VSNL1;ADCY1;MELK;FOLR2;KCNC2;ENC1;ZCCHC12;UBE2C;NMB;GRIN2B
17607,GO:0097449,0.129573535063509,0.991763812030402,1,18,astrocyte projection,CC,SYT4
8252,GO:0032252,0.129575521843699,0.991856271089038,1,15,secretory granule localization,BP,SYT4
7399,GO:0030545,0.129697663190045,0.954856417554066,4,363,receptor regulator activity,MF,VGF;MRAP2;SFRP2;NMB
8623,GO:0032793,0.12985175431914,0.991727506846468,1,18,positive regulation of CREB transcription factor activity,BP,ADCY1
18066,GO:0099081,0.130149884382207,0.932948237437154,9,807,supramolecular polymer,CC,KIFC1;ASPM;TPX2;BIRC5;KIF4A;NEFM;DNM1;CRYAB;IGFN1
4021,GO:0008373,0.130410488103061,0.99160742100818,1,20,sialyltransferase activity,MF,ST8SIA5
17640,GO:0097503,0.130410488103061,0.99160742100818,1,20,sialylation,BP,ST8SIA5
13722,GO:0051383,0.131091299475545,0.991517322546718,1,20,kinetochore organization,BP,CENPF
18469,GO:0120111,0.131432133015467,0.974674639228391,2,86,neuron projection cytoplasm,CC,KIF4A;HPCA
4291,GO:0009083,0.13195540982461,0.991362949710112,1,22,branched-chain amino acid catabolic process,BP,BCAT1
19796,GO:1903306,0.132205879265093,0.991329289544276,1,22,negative regulation of regulated secretory pathway,BP,SYT4
13947,GO:0051861,0.132415737231448,0.991283838254953,1,23,glycolipid binding,MF,SELL
3164,GO:0006491,0.132447963895541,0.991384674155593,1,18,N-glycan processing,BP,ST8SIA5
13547,GO:0051093,0.13251983422067,0.931450201521095,9,859,negative regulation of developmental process,BP,CD38;ASPM;STMN2;FOXM1;SYT4;SFRP2;DAAM2;CREB3L1;PI16
2602,GO:0005540,0.133265821814654,0.991226155822886,1,20,hyaluronic acid binding,MF,HAPLN4
12299,GO:0046337,0.133399537694811,0.991167929450252,1,22,phosphatidylethanolamine metabolic process,BP,ETNPPL
12401,GO:0046545,0.133514157644133,0.974004192802326,2,93,development of primary female sexual characteristics,BP,PTPRN;VGF
7736,GO:0031280,0.133780815470653,0.991116057982504,1,22,negative regulation of cyclase activity,BP,HPCA
2601,GO:0005539,0.133940989979983,0.961640979577952,3,190,glycosaminoglycan binding,MF,ABI3BP;HAPLN4;SELL
20774,GO:1905208,0.133965097952681,0.991131424285911,1,20,negative regulation of cardiocyte differentiation,BP,PI16
10030,GO:0035970,0.133987617337342,0.991087856469465,1,22,peptidyl-threonine dephosphorylation,BP,DUSP4
19695,GO:1903076,0.134098983540843,0.9738151539244,2,95,regulation of protein localization to plasma membrane,BP,MRAP2;STAC2
10986,GO:0043027,0.135734614037771,0.990829671596321,1,23,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,MF,BIRC5
10052,GO:0036003,0.135979184331801,0.990795723158375,1,23,positive regulation of transcription from RNA polymerase II promoter in response to stress,BP,CREB3L1
11998,GO:0045686,0.136008019347271,0.990791716259157,1,23,negative regulation of glial cell differentiation,BP,DAAM2
13189,GO:0050145,0.136308141869636,0.990788140598506,1,21,nucleoside monophosphate kinase activity,MF,TJP2
12027,GO:0045745,0.136346281896383,0.990727933042563,1,24,positive regulation of G protein-coupled receptor signaling pathway,BP,MRAP2
148,GO:0000302,0.136620624815856,0.960502955918673,3,210,response to reactive oxygen species,BP,PTPRN;CRYAB;KCNC2
18438,GO:0120034,0.136727149314386,0.973010134472105,2,91,positive regulation of plasma membrane bounded cell projection assembly,BP,NEURL1;TENM2
3436,GO:0006874,0.136727578338921,0.944839748372863,5,410,cellular calcium ion homeostasis,BP,CD38;CNR1;GPR12;NMB;GRIN2B
20349,GO:1904385,0.136910109524338,0.990684281763345,1,22,cellular response to angiotensin,BP,CAMK2A
7959,GO:0031667,0.13760246389145,0.944370346031767,5,421,response to nutrient levels,BP,IGFBP2;CNR1;VGF;SFRP2;FOLR2
7544,GO:0030900,0.13780947713334,0.944296585112414,5,369,forebrain development,BP,ASPM;SLC4A10;NRGN;FABP7;KCNC2
12133,GO:0045936,0.137815746085315,0.938964285863034,6,517,negative regulation of phosphate metabolic process,BP,FOXM1;DUSP4;HPCA;SFRP2;SPRY4;PPP1R14C
10326,GO:0038023,0.137906971179858,0.928038916179286,9,905,signaling receptor activity,MF,GABRA1;GABRG2;CNR1;PRLHR;GPR12;CHRM3;GABRB2;FOLR2;GRIN2B
14342,GO:0060089,0.137906971179858,0.928038916179286,9,905,molecular transducer activity,MF,GABRA1;GABRG2;CNR1;PRLHR;GPR12;CHRM3;GABRB2;FOLR2;GRIN2B
4764,GO:0010563,0.138541235145483,0.938553603270196,6,518,negative regulation of phosphorus metabolic process,BP,FOXM1;DUSP4;HPCA;SFRP2;SPRY4;PPP1R14C
98,GO:0000188,0.138793418003943,0.990383009131419,1,24,inactivation of MAPK activity,BP,DUSP4
785,GO:0002021,0.138962182416586,0.990395273255416,1,22,response to dietary excess,BP,VGF
16352,GO:0071702,0.139404378081651,0.909294161597711,21,2510,organic substance transport,BP,CD38;SYT13;PTPRN;SYT1;RPH3A;SYTL4;SLC17A7;DNM1;CENPF;CNR1;HPCA;VGF;SNAP25;SYT4;SLC14A1;SLC4A10;VSNL1;FOLR2;KCNC2;SLC6A17;NMB
14433,GO:0060249,0.139617593240736,0.943311048902042,5,405,anatomical structure homeostasis,BP,CD38;USH1C;SLC17A7;CNR1;TJP2
2778,GO:0005856,0.139862045830535,0.911645613427105,18,1955,cytoskeleton,CC,USH1C;KIFC1;ASPM;PTPN3;TPX2;BIRC5;KIF4A;NEFM;DNM1;CRYAB;CENPF;CNR1;TOP2A;SNAP25;CKAP2L;ENC1;MAP7D2;GRIN2B
8115,GO:0031998,0.139879582937135,0.990334284416952,1,19,regulation of fatty acid beta-oxidation,BP,CNR1
15933,GO:0070979,0.139927587717965,0.990175932725224,1,27,protein K11-linked ubiquitination,BP,UBE2C
19696,GO:1903077,0.140015896631387,0.990225833488023,1,23,negative regulation of protein localization to plasma membrane,BP,MRAP2
5672,GO:0016082,0.14006789528443,0.990281886780126,1,20,synaptic vesicle priming,BP,SNAP25
5612,GO:0015949,0.140380896865745,0.99011044638874,1,27,nucleobase-containing small molecule interconversion,BP,RRM2
19481,GO:1902600,0.140572984239665,0.971707325730682,2,115,proton transmembrane transport,BP,SLC17A7;SLC4A10
11930,GO:0045596,0.140654585801403,0.932985127210619,7,631,negative regulation of cell differentiation,BP,CD38;ASPM;STMN2;SYT4;SFRP2;DAAM2;PI16
5282,GO:0015106,0.140667129532898,0.99022211907017,1,19,bicarbonate transmembrane transporter activity,MF,SLC4A10
16167,GO:0071425,0.140822598872879,0.990109780199163,1,23,hematopoietic stem cell proliferation,BP,SFRP2
4833,GO:0010664,0.141250017766991,0.990030064339525,1,24,negative regulation of striated muscle cell apoptotic process,BP,SFRP2
17365,GO:0095500,0.141291865077397,0.990007487985264,1,25,acetylcholine receptor signaling pathway,BP,CHRM3
3481,GO:0006939,0.141526658453596,0.971456434176087,2,98,smooth muscle contraction,BP,CD38;CHRM3
6680,GO:0019901,0.142713328800987,0.931759189697062,7,620,protein kinase binding,MF,TPX2;EEF1A2;DNM1;FOXM1;TJP2;DUSP4;TOP2A
13708,GO:0051350,0.14313649079755,0.989754470277679,1,24,negative regulation of lyase activity,BP,HPCA
10520,GO:0042044,0.143345963286591,0.989723623687147,1,24,fluid transport,BP,SLC14A1
1631,GO:0003777,0.143690656346473,0.970882509611847,2,74,microtubule motor activity,MF,KIFC1;KIF4A
2303,GO:0004930,0.143930441359129,0.948009519655094,4,348,G protein-coupled receptor activity,MF,CNR1;PRLHR;GPR12;CHRM3
4289,GO:0009081,0.144211731359254,0.989578416994097,1,25,branched-chain amino acid metabolic process,BP,BCAT1
13609,GO:0051179,0.144299290923418,0.896835025557712,45,5892,localization,BP,CD38;USH1C;SYT13;GABRA1;PTPRN;KIFC1;ASPM;SYT1;PTPN3;CAMK2A;RPH3A;BIRC5;KIF4A;SYTL4;SLC17A7;DNM1;NEURL1;CRYAB;GABRG2;SLC30A3;CENPF;CNR1;TJP2;HPCA;VGF;SNAP25;SYT4;CHRM3;MRAP2;SLC14A1;STAC2;SLC4A10;SFRP2;GABRB2;CREB3L1;VSNL1;ADCY1;FOLR2;KCNC2;KCNK9;SV2B;SELL;SLC6A17;NMB;GRIN2B
14230,GO:0055080,0.14493089111561,0.930413111869997,7,661,cation homeostasis,BP,CD38;SLC30A3;CNR1;GPR12;SLC4A10;NMB;GRIN2B
3412,GO:0006829,0.144986281056193,0.989480378362575,1,24,zinc ion transport,BP,SLC30A3
4135,GO:0008543,0.14545486374705,0.970182589405921,2,98,fibroblast growth factor receptor signaling pathway,BP,CREB3L1;SPRY4
4830,GO:0010661,0.145534486224374,0.989398413394287,1,24,positive regulation of muscle cell apoptotic process,BP,CAMK2A
1177,GO:0002675,0.145583259411097,0.989328533493161,1,28,positive regulation of acute inflammatory response,BP,CNR1
8455,GO:0032526,0.145736459127669,0.970078752617662,2,101,response to retinoic acid,BP,CD38;IGFBP2
14666,GO:0060561,0.146182836045343,0.989320249610687,1,23,apoptotic process involved in morphogenesis,BP,CRYAB
3664,GO:0007263,0.147055266665019,0.989151391776941,1,25,nitric oxide mediated signal transduction,BP,KCNC2
3405,GO:0006817,0.147794625645932,0.989056933284636,1,24,phosphate ion transport,BP,SLC17A7
532,GO:0001664,0.147927025325117,0.955683161215052,3,231,G protein-coupled receptor binding,MF,DNM1;MRAP2;NMB
6694,GO:0019934,0.148215405326208,0.988974562432473,1,25,cGMP-mediated signaling,BP,KCNC2
14225,GO:0055074,0.14828656224768,0.938638869843692,5,421,calcium ion homeostasis,BP,CD38;CNR1;GPR12;NMB;GRIN2B
4596,GO:0009931,0.148291241541196,0.989022467591324,1,22,calcium-dependent protein serine/threonine kinase activity,MF,CAMK2A
15841,GO:0070840,0.148801193074895,0.988994594371155,1,20,dynein complex binding,MF,CENPF
16155,GO:0071407,0.148808198270324,0.932675599759139,6,521,cellular response to organic cyclic compound,BP,GABRA1;GABRG2;CHRM3;GABRB2;ADCY1;FOLR2
8366,GO:0032414,0.148866177518417,0.96905841005221,2,98,positive regulation of ion transmembrane transporter activity,BP,STAC2;KCNC2
7697,GO:0031210,0.149370204307644,0.988835546595139,1,23,phosphatidylcholine binding,MF,GPR12
13481,GO:0050997,0.149370204307644,0.988835546595139,1,23,quaternary ammonium group binding,MF,GPR12
4357,GO:0009165,0.149440510151967,0.955048121114223,3,216,nucleotide biosynthetic process,BP,HPCA;ADCY1;RRM2
3371,GO:0006760,0.149559700610979,0.988750701515525,1,26,folic acid-containing compound metabolic process,BP,FOLR2
2334,GO:0004970,0.150412913737344,0.988777322282586,1,19,ionotropic glutamate receptor activity,MF,GRIN2B
17870,GO:0098771,0.151116190417641,0.926666721785746,7,669,inorganic ion homeostasis,BP,CD38;SLC30A3;CNR1;GPR12;SLC4A10;NMB;GRIN2B
4712,GO:0010458,0.151441460324576,0.988457378873523,1,26,exit from mitosis,BP,UBE2C
12121,GO:0045922,0.151449333773163,0.988492610633662,1,24,negative regulation of fatty acid metabolic process,BP,CNR1
20341,GO:1904376,0.151706542035371,0.988433299508293,1,25,negative regulation of protein localization to cell periphery,BP,MRAP2
3326,GO:0006688,0.151941134114583,0.988396435550159,1,25,glycosphingolipid biosynthetic process,BP,ST8SIA5
15584,GO:0070325,0.152586007882765,0.988382810370889,1,21,lipoprotein particle receptor binding,MF,SYT1
13712,GO:0051354,0.152626713224467,0.98827057077339,1,26,negative regulation of oxidoreductase activity,BP,CNR1
9496,GO:0034762,0.152678112520152,0.930427559881321,6,519,regulation of transmembrane transport,BP,PTPN3;HPCA;CHRM3;STAC2;KCNC2;GRIN2B
18970,GO:1901293,0.15281424100556,0.953571434438409,3,219,nucleoside phosphate biosynthetic process,BP,HPCA;ADCY1;RRM2
17236,GO:0090344,0.152949670815562,0.988277615480533,1,23,negative regulation of cell aging,BP,FOXM1
5861,GO:0016486,0.152966727633183,0.988216687445714,1,26,peptide hormone processing,BP,PCSK1
18592,GO:0140448,0.152966727633183,0.988216687445714,1,26,signaling receptor ligand precursor processing,BP,PCSK1
1369,GO:0003012,0.153004452812967,0.936068315917648,5,410,muscle system process,BP,CD38;CRYAB;CHRM3;STAC2;PI16
14353,GO:0060122,0.153043338491966,0.988241767660157,1,24,inner ear receptor cell stereocilium organization,BP,USH1C
19333,GO:1902230,0.15337131681773,0.988105992595801,1,29,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,SFRP2
3672,GO:0007271,0.153409293871993,0.988146356158103,1,26,synaptic transmission, cholinergic,BP,CHRM3
16388,GO:0071805,0.153483216063083,0.953315379720766,3,196,potassium ion transmembrane transport,BP,SNAP25;KCNC2;KCNK9
14203,GO:0055022,0.153511874305547,0.988148005384614,1,25,negative regulation of cardiac muscle tissue growth,BP,PI16
14992,GO:0061117,0.153511874305547,0.988148005384614,1,25,negative regulation of heart growth,BP,PI16
4966,GO:0010857,0.153712631970347,0.988156826513782,1,23,calcium-dependent protein kinase activity,MF,CAMK2A
4708,GO:0010453,0.153918806461482,0.988048374790249,1,27,regulation of cell fate commitment,BP,SFRP2
16132,GO:0071377,0.154025125227198,0.988107164151791,1,23,cellular response to glucagon stimulus,BP,ADCY1
13992,GO:0051928,0.154437662122738,0.967147064286948,2,108,positive regulation of calcium ion transport,BP,CAMK2A;STAC2
3442,GO:0006882,0.15463815261416,0.987876358820234,1,31,cellular zinc ion homeostasis,BP,SLC30A3
14925,GO:0061024,0.154923780903205,0.920405421468816,8,778,membrane organization,BP,SYT13;SYT1;CAMK2A;SYTL4;DNM1;SNAP25;SYT4;FOLR2
8883,GO:0033218,0.154943931361312,0.942527954449704,4,330,amide binding,MF,CRYAB;FOLR2;TMEM158;GRIN2B
807,GO:0002052,0.156069827673093,0.987779490172251,1,23,positive regulation of neuroblast proliferation,BP,ASPM
5528,GO:0015813,0.156493573973835,0.987710990869659,1,23,L-glutamate transmembrane transport,BP,SLC17A7
14333,GO:0060079,0.15664247677922,0.966429391325479,2,99,excitatory postsynaptic potential,BP,SLC17A7;GRIN2B
2590,GO:0005520,0.15721224538857,0.987594351294256,1,23,insulin-like growth factor binding,MF,IGFBP2
18882,GO:1901018,0.157420821279805,0.987538114227083,1,24,positive regulation of potassium ion transmembrane transporter activity,BP,KCNC2
11410,GO:0043951,0.157510037450573,0.98752354732592,1,24,negative regulation of cAMP-mediated signaling,BP,MRAP2
12160,GO:0045987,0.157753862309074,0.987426543451207,1,27,positive regulation of smooth muscle contraction,BP,CHRM3
9839,GO:0035640,0.158027033059679,0.987461403735507,1,23,exploration behavior,BP,SLC4A10
21369,GO:1990776,0.158536246491358,0.987334560048379,1,25,response to angiotensin,BP,CAMK2A
2479,GO:0005231,0.158841685999572,0.987230559633842,1,28,excitatory extracellular ligand-gated ion channel activity,MF,SLC17A7
20741,GO:1905144,0.158949153292183,0.987229307448467,1,27,response to acetylcholine,BP,CHRM3
20742,GO:1905145,0.158949153292183,0.987229307448467,1,27,cellular response to acetylcholine,BP,CHRM3
14324,GO:0060070,0.159407227328907,0.940272173182382,4,312,canonical Wnt signaling pathway,BP,ASPM;IGFBP2;SFRP2;DAAM2
12165,GO:0045992,0.15952475548397,0.987171140470357,1,25,negative regulation of embryonic development,BP,SFRP2
6592,GO:0019722,0.159807041001612,0.950499303099398,3,201,calcium-mediated signaling,BP,HPCA;CHRM3;GRIN2B
11084,GO:0043200,0.159839471534671,0.965299927186999,2,105,response to amino acid,BP,NEURL1;HPCA
14418,GO:0060219,0.159915341990362,0.98712740591547,1,24,camera-type eye photoreceptor cell differentiation,BP,USH1C
13692,GO:0051321,0.160093674044243,0.950363521285259,3,205,meiotic cell cycle,BP,ASPM;NCAPH;TOP2A
3676,GO:0007276,0.160498696311,0.925808618162691,6,554,gamete generation,BP,KIFC1;ASPM;NEURL1;CNR1;NCAPH;TOP2A
13284,GO:0050671,0.16088187385977,0.964874608139496,2,123,positive regulation of lymphocyte proliferation,BP,CD38;IGFBP2
4431,GO:0009262,0.160905728156956,0.986816507997197,1,33,deoxyribonucleotide metabolic process,BP,RRM2
14220,GO:0055069,0.161092942883766,0.986797024177354,1,32,zinc ion homeostasis,BP,SLC30A3
21048,GO:1905809,0.161496474603884,0.986863411249886,1,24,negative regulation of synapse organization,BP,GRIN2B
4313,GO:0009117,0.161781044391794,0.931165646283872,5,456,nucleotide metabolic process,BP,TJP2;HPCA;SULT4A1;ADCY1;RRM2
12193,GO:0046058,0.162408211594974,0.986787807551464,1,21,cAMP metabolic process,BP,ADCY1
8457,GO:0032528,0.162794383052794,0.986644572153134,1,24,microvillus organization,BP,USH1C
8725,GO:0032946,0.162977852918331,0.964135266440569,2,124,positive regulation of mononuclear cell proliferation,BP,CD38;IGFBP2
10476,GO:0040007,0.163031120892406,0.911753964544783,9,883,growth,BP,CD38;ASPM;SYT1;CRYAB;IGFBP2;SYT4;SLC4A10;SFRP2;PI16
4795,GO:0010614,0.164039413491975,0.98641058984158,1,25,negative regulation of cardiac muscle hypertrophy,BP,PI16
7832,GO:0031430,0.164117337778048,0.986419527250768,1,24,M band,CC,CRYAB
6526,GO:0019433,0.164535859718353,0.986251468524415,1,29,triglyceride catabolic process,BP,FABP7
8363,GO:0032411,0.164648550882045,0.963606854772679,2,106,positive regulation of transporter activity,BP,STAC2;KCNC2
750,GO:0001968,0.165039864734911,0.986238891247876,1,25,fibronectin binding,MF,SFRP2
19337,GO:1902235,0.165101305387116,0.986138205407798,1,30,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,CREB3L1
14092,GO:0052548,0.165563086260582,0.937058234926333,4,349,regulation of endopeptidase activity,BP,BIRC5;CRYAB;SFRP2;GRIN2B
13356,GO:0050794,0.165643253227093,0.881419444788722,67,9292,regulation of cellular process,BP,CD38;USH1C;SYT13;GABRA1;PTPRN;LZTS1;ASPM;SYT1;PTPN3;CAMK2A;TPX2;BIRC5;MYBL2;EEF1A2;SYTL4;STMN2;SLC17A7;NPTX2;DNM1;NEURL1;CRYAB;FOXM1;GABRG2;SLC30A3;IGFBP2;CENPF;CNR1;TJP2;PRLHR;DUSP4;HPCA;VGF;TOP2A;SNAP25;SYT4;GPR12;CHRM3;MRAP2;STAC2;HUNK;SLC4A10;SFRP2;GABRB2;TENM2;DAAM2;MKI67;HSPB8;NRGN;ABI3BP;CREB3L1;VSNL1;FABP7;PI16;ADCY1;MELK;FOLR2;KCNC2;NPTX1;ENC1;RRM2;ZCCHC12;UBE2C;MYT1L;SPRY4;NMB;PPP1R14C;GRIN2B
17594,GO:0097421,0.166090632324429,0.985951432612086,1,31,liver regeneration,BP,PTPN3
15839,GO:0070838,0.166178643736504,0.928710903758676,5,422,divalent metal ion transport,BP,CAMK2A;SLC30A3;HPCA;STAC2;GRIN2B
5142,GO:0014072,0.166188103990818,0.985949118764167,1,30,response to isoquinoline alkaloid,BP,CNR1
11137,GO:0043278,0.166188103990818,0.985949118764167,1,30,response to morphine,BP,CNR1
14328,GO:0060074,0.16672364483709,0.985970304998163,1,24,synapse maturation,BP,NEURL1
3935,GO:0008227,0.166769279843707,0.985832621522479,1,31,G protein-coupled amine receptor activity,MF,CHRM3
8292,GO:0032309,0.166828476984211,0.985822232556933,1,31,icosanoid secretion,BP,NMB
12042,GO:0045777,0.167146158135922,0.985766410849223,1,31,positive regulation of blood pressure,BP,CNR1
13433,GO:0050905,0.167302195387208,0.962692381467037,2,99,neuromuscular process,BP,USH1C;FABP7
5387,GO:0015301,0.167331559531367,0.985841252828674,1,25,anion:anion antiporter activity,MF,SLC4A10
18580,GO:0140323,0.167331559531367,0.985841252828674,1,25,solute:anion antiporter activity,MF,SLC4A10
1522,GO:0003298,0.167397910067538,0.985808267991198,1,26,physiological muscle hypertrophy,BP,PI16
1525,GO:0003301,0.167397910067538,0.985808267991198,1,26,physiological cardiac muscle hypertrophy,BP,PI16
14949,GO:0061049,0.167397910067538,0.985808267991198,1,26,cell growth involved in cardiac muscle cell development,BP,PI16
13013,GO:0048609,0.167459886269019,0.916553121407746,7,687,multicellular organismal reproductive process,BP,PTPRN;KIFC1;ASPM;NEURL1;CNR1;NCAPH;TOP2A
3367,GO:0006753,0.167461988078821,0.927955504364766,5,463,nucleoside phosphate metabolic process,BP,TJP2;HPCA;SULT4A1;ADCY1;RRM2
12829,GO:0048169,0.167736866806369,0.985770297742739,1,25,regulation of long-term neuronal synaptic plasticity,BP,NEURL1
12464,GO:0046660,0.168273504837761,0.962312205443279,2,106,female sex differentiation,BP,PTPRN;VGF
4616,GO:0009991,0.168837870169809,0.927180102706477,5,452,response to extracellular stimulus,BP,IGFBP2;CNR1;VGF;SFRP2;FOLR2
1962,GO:0004435,0.168852805171051,0.985597530466436,1,24,phosphatidylinositol phospholipase C activity,MF,CHRM3
16707,GO:0072337,0.168944612241225,0.985535961970069,1,26,modified amino acid transport,BP,FOLR2
6647,GO:0019842,0.169011530461637,0.96199706991701,2,119,vitamin binding,MF,ETNPPL;FOLR2
13772,GO:0051480,0.169117709764288,0.935224748058746,4,323,regulation of cytosolic calcium ion concentration,BP,CD38;CNR1;NMB;GRIN2B
5442,GO:0015630,0.169348515600218,0.901820639827448,11,1135,microtubule cytoskeleton,CC,KIFC1;ASPM;TPX2;BIRC5;KIF4A;DNM1;CRYAB;CENPF;TOP2A;CKAP2L;MAP7D2
3724,GO:0007413,0.170601148064156,0.985313685511888,1,23,axonal fasciculation,BP,CNR1
18340,GO:0106030,0.170601148064156,0.985313685511888,1,23,neuron projection fasciculation,BP,CNR1
19605,GO:1902936,0.170734560946493,0.961427139998861,2,105,phosphatidylinositol bisphosphate binding,MF,SYT1;RPH3A
13029,GO:0048640,0.17075395859514,0.961424547887243,2,104,negative regulation of developmental growth,BP,SFRP2;PI16
15387,GO:0065007,0.170836257230629,0.879532977201745,73,10303,biological regulation,BP,CD38;USH1C;SYT13;GABRA1;PTPRN;LZTS1;ASPM;SYT1;PTPN3;CAMK2A;TPX2;RPH3A;BIRC5;MYBL2;EEF1A2;SYTL4;STMN2;SLC17A7;NPTX2;DNM1;NEURL1;CRYAB;FOXM1;GABRG2;SLC30A3;IGFBP2;CENPF;CNR1;TJP2;PRLHR;DUSP4;NCAPH;HPCA;VGF;TOP2A;SNAP25;SYT4;GPR12;CHRM3;MRAP2;STAC2;HUNK;SLC4A10;SFRP2;GABRB2;TENM2;DAAM2;MKI67;HSPB8;CHST9;NRGN;ABI3BP;CREB3L1;VSNL1;FABP7;PI16;ADCY1;MELK;FOLR2;KCNC2;KCNK9;NPTX1;ENC1;RRM2;ZCCHC12;UBE2C;PCSK1;MYT1L;SPRY4;SELL;NMB;PPP1R14C;GRIN2B
3146,GO:0006469,0.171414581468737,0.945176940828227,3,215,negative regulation of protein kinase activity,BP,DUSP4;SFRP2;SPRY4
19994,GO:1903671,0.171453320244779,0.985088407499765,1,26,negative regulation of sprouting angiogenesis,BP,CREB3L1
8735,GO:0032965,0.171517511584185,0.98498639240774,1,31,regulation of collagen biosynthetic process,BP,CREB3L1
12119,GO:0045920,0.172450405296874,0.984832895083079,1,30,negative regulation of exocytosis,BP,SYT4
4954,GO:0010842,0.172557400676267,0.984992436213048,1,22,retina layer formation,BP,IGFN1
16206,GO:0071480,0.17296869869985,0.984773776206175,1,28,cellular response to gamma radiation,BP,CRYAB
17217,GO:0090314,0.173061459321812,0.984721535086421,1,30,positive regulation of protein targeting to membrane,BP,HPCA
16763,GO:0072511,0.173582559958958,0.924481414053426,5,428,divalent inorganic cation transport,BP,CAMK2A;SLC30A3;HPCA;STAC2;GRIN2B
7041,GO:0022804,0.173719103453386,0.932814745527903,4,306,active transmembrane transporter activity,MF,SLC17A7;SLC30A3;SLC4A10;SLC6A17
9931,GO:0035774,0.174277787357411,0.984498571352548,1,30,positive regulation of insulin secretion involved in cellular response to glucose stimulus,BP,VSNL1
5378,GO:0015291,0.174373074245659,0.943816022984158,3,205,secondary active transmembrane transporter activity,MF,SLC17A7;SLC4A10;SLC6A17
13430,GO:0050901,0.17446600588342,0.984481254870399,1,29,leukocyte tethering or rolling,BP,SELL
6929,GO:0021884,0.174616430833113,0.984513704002363,1,26,forebrain neuron development,BP,SLC4A10
3609,GO:0007176,0.174851827277758,0.984410161120965,1,29,regulation of epidermal growth factor-activated receptor activity,BP,NEURL1
8660,GO:0032838,0.175156176835759,0.943478831247949,3,191,plasma membrane bounded cell projection cytoplasm,CC,KIF4A;CENPF;HPCA
7059,GO:0022853,0.175301583037119,0.943386742549377,3,202,active ion transmembrane transporter activity,MF,SLC17A7;SLC30A3;SLC4A10
4614,GO:0009987,0.175317229686843,0.903435486573723,93,13730,cellular process,BP,CD38;USH1C;CAMK1G;SYT13;GABRA1;PTPRN;KIFC1;BCAT1;LZTS1;ASPM;SYT1;PTPN3;CAMK2A;LNX1;TPX2;RPH3A;BIRC5;KIF4A;MYBL2;EEF1A2;ST8SIA5;SYTL4;STMN2;NEFM;SLC17A7;NPTX2;DNM1;NEURL1;NCAPG;CRYAB;PTPN5;FOXM1;GABRG2;SLC30A3;IGFBP2;CENPF;CNR1;TJP2;PRLHR;DUSP4;NCAPH;HPCA;VGF;SULT4A1;TOP2A;SNAP25;SYT4;GPR12;CHRM3;MRAP2;SLC14A1;STAC2;HUNK;SLC4A10;SFRP2;LIX1;GABRB2;TENM2;DAAM2;MKI67;FREM2;HSPB8;CHST9;NRGN;ABI3BP;CREB3L1;VSNL1;IGFN1;ETNPPL;FABP7;PI16;ADCY1;MELK;FOLR2;KCNC2;KCNK9;NPTX1;ENC1;RRM2;ZCCHC12;UBE2C;PCSK1;MAP7D2;SV2B;MYT1L;HAPLN4;SPRY4;SELL;CPNE4;SLC6A17;NMB;PPP1R14C;GRIN2B
14811,GO:0060795,0.175380432179417,0.984278563435412,1,31,cell fate commitment involved in formation of primary germ layer,BP,SFRP2
8721,GO:0032941,0.175921645402224,0.984177999262903,1,31,secretion by tissue,BP,CHRM3
17452,GO:0097150,0.17601943780377,0.984332171481011,1,23,neuronal stem cell population maintenance,BP,ASPM
18180,GO:0099565,0.176051817356657,0.959472305388273,2,106,chemical synaptic transmission, postsynaptic,BP,SLC17A7;GRIN2B
7218,GO:0030206,0.177064744187383,0.984060877485007,1,26,chondroitin sulfate biosynthetic process,BP,CHST9
5167,GO:0014741,0.17714214136943,0.984024283869628,1,27,negative regulation of muscle hypertrophy,BP,PI16
16077,GO:0071295,0.177423801741436,0.983931785597211,1,29,cellular response to vitamin,BP,FOLR2
20912,GO:1905476,0.177444633845834,0.983909942715196,1,30,negative regulation of protein localization to membrane,BP,MRAP2
14909,GO:0060996,0.177511351407387,0.958980648431745,2,96,dendritic spine development,BP,CAMK2A;NEURL1
10757,GO:0042558,0.178192251300955,0.983736489011902,1,32,pteridine-containing compound metabolic process,BP,FOLR2
13621,GO:0051222,0.178518055202372,0.930225351679934,4,330,positive regulation of protein transport,BP,CD38;SYTL4;HPCA;VSNL1
2099,GO:0004629,0.179159615778287,0.983667865578114,1,26,phospholipase C activity,MF,CHRM3
12968,GO:0048518,0.179707400569779,0.8690151850026,41,5420,positive regulation of biological process,BP,CD38;PTPRN;ASPM;SYT1;CAMK2A;TPX2;BIRC5;MYBL2;EEF1A2;SYTL4;STMN2;DNM1;NEURL1;FOXM1;SLC30A3;IGFBP2;CNR1;HPCA;TOP2A;SNAP25;SYT4;CHRM3;MRAP2;STAC2;SFRP2;TENM2;DAAM2;HSPB8;NRGN;ABI3BP;CREB3L1;VSNL1;ADCY1;MELK;FOLR2;KCNC2;ENC1;ZCCHC12;UBE2C;NMB;GRIN2B
13424,GO:0050892,0.180175815630625,0.983392843338211,1,30,intestinal absorption,BP,TJP2
15897,GO:0070925,0.180960901411304,0.903493583059237,8,785,organelle assembly,BP,KIFC1;ASPM;TPX2;BIRC5;KIF4A;MYBL2;NEURL1;CENPF
2491,GO:0005251,0.181137400793997,0.983227385923272,1,29,delayed rectifier potassium channel activity,MF,KCNC2
13042,GO:0048665,0.181582445431828,0.983089064341011,1,32,neuron fate specification,BP,MYT1L
3606,GO:0007173,0.181834593479808,0.9572839088395,2,111,epidermal growth factor receptor signaling pathway,BP,PTPN3;NEURL1
17726,GO:0097731,0.182438880847152,0.957046278583896,2,113,9+0 non-motile cilium,CC,USH1C;PRLHR
13990,GO:0051924,0.182562015603093,0.939900175448863,3,224,regulation of calcium ion transport,BP,CAMK2A;HPCA;STAC2
15770,GO:0070665,0.182793050435677,0.956840387840105,2,133,positive regulation of leukocyte proliferation,BP,CD38;IGFBP2
19332,GO:1902229,0.182868471302656,0.982782414467385,1,36,regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,SFRP2
8686,GO:0032892,0.182896052421608,0.982851263881324,1,31,positive regulation of organic acid transport,BP,SYT4
3603,GO:0007169,0.183239458795992,0.906517175826568,7,668,transmembrane receptor protein tyrosine kinase signaling pathway,BP,PTPN3;DNM1;NEURL1;IGFBP2;CREB3L1;SPRY4;GRIN2B
7168,GO:0030140,0.183254367983271,0.982818573669645,1,29,trans-Golgi network transport vesicle,CC,NRGN
2573,GO:0005484,0.183383349490573,0.982709006402873,1,34,SNAP receptor activity,MF,SNAP25
7259,GO:0030262,0.183628184992039,0.982691823764839,1,32,apoptotic nuclear changes,BP,TOP2A
20340,GO:1904375,0.183680250019583,0.956565669449711,2,115,regulation of protein localization to cell periphery,BP,MRAP2;STAC2
3489,GO:0006953,0.184030975055385,0.982554785999318,1,36,acute-phase response,BP,CNR1
12913,GO:0048333,0.184281639364158,0.982598944969989,1,30,mesodermal cell differentiation,BP,SFRP2
5785,GO:0016311,0.184820488802516,0.917935653921195,5,435,dephosphorylation,BP,PTPRN;PTPN3;PTPN5;DUSP4;PPP1R14C
1573,GO:0003401,0.184838539103914,0.982530043777939,1,28,axis elongation,BP,SFRP2
4859,GO:0010719,0.185797815058798,0.982248916039643,1,33,negative regulation of epithelial to mesenchymal transition,BP,SFRP2
14218,GO:0055065,0.186226667781041,0.910144783082029,6,584,metal ion homeostasis,BP,CD38;SLC30A3;CNR1;GPR12;NMB;GRIN2B
6207,GO:0017147,0.186511186482963,0.982159489216748,1,30,Wnt-protein binding,MF,SFRP2
16100,GO:0071333,0.186619439668872,0.955426531263767,2,118,cellular response to glucose stimulus,BP,PTPRN;VSNL1
16239,GO:0071542,0.186779973676398,0.9820701033567,1,32,dopaminergic neuron differentiation,BP,SFRP2
2586,GO:0005515,0.186983549918994,0.871478888947829,80,11691,protein binding,MF,CD38;USH1C;CAMK1G;SYT13;PTPRN;KIFC1;BCAT1;LZTS1;ASPM;SYT1;PTPN3;CAMK2A;LNX1;TPX2;RPH3A;BIRC5;KIF4A;MYBL2;EEF1A2;ST8SIA5;SYTL4;STMN2;NEFM;NPTX2;DNM1;NCAPG;CRYAB;PTPN5;FOXM1;GABRG2;SLC30A3;IGFBP2;CENPF;CNR1;TJP2;PRLHR;DUSP4;NCAPH;HPCA;VGF;SULT4A1;TOP2A;SNAP25;SYT4;CHRM3;FAM189A2;MRAP2;STAC2;HUNK;SFRP2;LIX1;TENM2;DAAM2;MKI67;FREM2;HSPB8;NRGN;CREB3L1;VSNL1;IGFN1;PI16;ADCY1;MELK;KCNC2;TMEM130;ENC1;RRM2;ZCCHC12;UBE2C;PCSK1;DDN;SV2B;C11ORF87;SPRY4;C2ORF88;SELL;CPNE4;SLC6A17;NMB;GRIN2B
9609,GO:0035235,0.187244354857078,0.982129559476093,1,25,ionotropic glutamate receptor signaling pathway,BP,GRIN2B
13027,GO:0048638,0.187508306065684,0.925367197898849,4,312,regulation of developmental growth,BP,SYT1;SYT4;SFRP2;PI16
8791,GO:0033044,0.187567661020697,0.925326025731704,4,319,regulation of chromosome organization,BP,CENPF;TOP2A;MKI67;UBE2C
3402,GO:0006813,0.188531749595644,0.937025434900483,3,218,potassium ion transport,BP,SNAP25;KCNC2;KCNK9
20913,GO:1905477,0.188647174897639,0.954634014980031,2,120,positive regulation of protein localization to membrane,BP,HPCA;STAC2
695,GO:0001894,0.188778880951564,0.936895512977692,3,223,tissue homeostasis,BP,CD38;USH1C;TJP2
12170,GO:0046006,0.188882696331223,0.981601426161447,1,35,regulation of activated T cell proliferation,BP,IGFBP2
816,GO:0002063,0.189055988489879,0.98169285631194,1,28,chondrocyte development,BP,SFRP2
6036,GO:0016799,0.189067308433441,0.98157896377459,1,34,hydrolase activity, hydrolyzing N-glycosyl compounds,MF,CD38
17978,GO:0098926,0.189183906861375,0.981571177106604,1,33,postsynaptic signal transduction,BP,CHRM3
10771,GO:0042578,0.189214536614219,0.924416355663653,4,323,phosphoric ester hydrolase activity,MF,PTPN3;PTPN5;DUSP4;CHRM3
4852,GO:0010712,0.189442805880821,0.981488020227989,1,35,regulation of collagen metabolic process,BP,CREB3L1
9219,GO:0034237,0.189543752259112,0.981671010027705,1,25,protein kinase A regulatory subunit binding,MF,C2ORF88
13652,GO:0051261,0.189759165462457,0.95426369863245,2,106,protein depolymerization,BP,TPX2;STMN2
10860,GO:0042752,0.190374553156845,0.953981714458677,2,115,regulation of circadian rhythm,BP,TOP2A;ADCY1
3479,GO:0006936,0.19053394016977,0.923681890104642,4,329,muscle contraction,BP,CD38;CRYAB;CHRM3;STAC2
16098,GO:0071331,0.190988913826321,0.953720758294384,2,120,cellular response to hexose stimulus,BP,PTPRN;VSNL1
5801,GO:0016339,0.192062558978093,0.981060620688993,1,29,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,BP,SELL
11986,GO:0045665,0.192361104275433,0.935163949951997,3,211,negative regulation of neuron differentiation,BP,CD38;ASPM;STMN2
3470,GO:0006921,0.1924973344909,0.980878374844885,1,34,cellular component disassembly involved in execution phase of apoptosis,BP,TOP2A
21944,GO:2000781,0.192977505426068,0.980895448063172,1,28,positive regulation of double-strand break repair,BP,FOXM1
7345,GO:0030414,0.193202747435522,0.952796629487603,2,135,peptidase inhibitor activity,MF,BIRC5;PI16
556,GO:0001704,0.193364570261086,0.952821264246637,2,112,formation of primary germ layer,BP,DUSP4;SFRP2
16361,GO:0071715,0.193436981677524,0.980668420325505,1,35,icosanoid transport,BP,NMB
19075,GO:1901571,0.193436981677524,0.980668420325505,1,35,fatty acid derivative transport,BP,NMB
16096,GO:0071326,0.193565454201106,0.952703214105965,2,121,cellular response to monosaccharide stimulus,BP,PTPRN;VSNL1
18825,GO:1900371,0.193573195521759,0.980672260405756,1,33,regulation of purine nucleotide biosynthetic process,BP,HPCA
746,GO:0001964,0.193665459538671,0.980778257634031,1,27,startle response,BP,FABP7
3529,GO:0007020,0.193803342911374,0.980725182215151,1,28,microtubule nucleation,BP,TPX2
10469,GO:0039694,0.194016442802781,0.980580200444786,1,33,viral RNA genome replication,BP,TOP2A
12033,GO:0045761,0.194031888139179,0.98063349924224,1,30,regulation of adenylate cyclase activity,BP,HPCA
484,GO:0001569,0.194159006843558,0.980568220633275,1,32,branching involved in blood vessel morphogenesis,BP,SFRP2
12125,GO:0045926,0.194222931589763,0.934206047913687,3,231,negative regulation of growth,BP,CRYAB;SFRP2;PI16
9649,GO:0035296,0.194570642974717,0.95228603611443,2,126,regulation of tube diameter,BP,CD38;CHRM3
17733,GO:0097746,0.194570642974717,0.95228603611443,2,126,regulation of blood vessel diameter,BP,CD38;CHRM3
41,GO:0000083,0.194754516597791,0.980409642932317,1,34,regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,RRM2
13752,GO:0051443,0.19478311988572,0.980420408595732,1,33,positive regulation of ubiquitin-protein transferase activity,BP,UBE2C
17216,GO:0090313,0.194853520713299,0.980388943255284,1,34,regulation of protein targeting to membrane,BP,HPCA
4359,GO:0009167,0.194951188609734,0.980368511393253,1,34,purine ribonucleoside monophosphate metabolic process,BP,TJP2
6910,GO:0021846,0.19502239974808,0.980497290276492,1,27,cell proliferation in forebrain,BP,FABP7
10734,GO:0042491,0.196064593052243,0.98020944266374,1,30,inner ear auditory receptor cell differentiation,BP,USH1C
9590,GO:0035150,0.19607748279784,0.951683023542697,2,127,regulation of tube size,BP,CD38;CHRM3
10717,GO:0042462,0.196483942432135,0.980121341890149,1,30,eye photoreceptor cell development,BP,USH1C
7486,GO:0030808,0.196663109727226,0.980008516157764,1,34,regulation of nucleotide biosynthetic process,BP,HPCA
11805,GO:0045182,0.196953949738525,0.951332980804851,2,127,translation regulator activity,MF,EEF1A2;NEURL1
9036,GO:0033673,0.197182393228968,0.932735425325862,3,231,negative regulation of kinase activity,BP,DUSP4;SFRP2;SPRY4
17598,GO:0097431,0.197383344804099,0.979953861540367,1,29,mitotic spindle pole,CC,ASPM
397,GO:0001101,0.197500835410304,0.951137482259043,2,121,response to acid chemical,BP,NEURL1;HPCA
7534,GO:0030890,0.197616245080165,0.979774961507639,1,36,positive regulation of B cell proliferation,BP,CD38
13899,GO:0051726,0.197767513378992,0.88464288973434,10,1098,regulation of cell cycle,BP,ASPM;PTPN3;TPX2;MYBL2;FOXM1;CENPF;TOP2A;MKI67;RRM2;UBE2C
3910,GO:0008188,0.197987701591212,0.979641948286768,1,40,neuropeptide receptor activity,MF,PRLHR
20652,GO:1904951,0.198342777637954,0.919312617195489,4,346,positive regulation of establishment of protein localization,BP,CD38;SYTL4;HPCA;VSNL1
13265,GO:0050650,0.198500304200638,0.979673783643493,1,31,chondroitin sulfate proteoglycan biosynthetic process,BP,CHST9
4820,GO:0010647,0.198793829981735,0.87382127423002,14,1651,positive regulation of cell communication,BP,CD38;ASPM;SYT1;NEURL1;CNR1;SNAP25;MRAP2;SFRP2;DAAM2;NRGN;VSNL1;ADCY1;NMB;GRIN2B
18895,GO:1901068,0.199137853859424,0.979449778882761,1,36,guanosine-containing compound metabolic process,BP,TJP2
14995,GO:0061135,0.199222080586247,0.950380941873753,2,139,endopeptidase regulator activity,MF,BIRC5;SFRP2
12570,GO:0046915,0.199423387668794,0.979420614730403,1,34,transition metal ion transmembrane transporter activity,MF,SLC30A3
8873,GO:0033198,0.199883527488448,0.979321715025904,1,34,response to ATP,BP,SELL
4722,GO:0010470,0.200191035968662,0.979291957015069,1,32,regulation of gastrulation,BP,SFRP2
16545,GO:0072089,0.200310397611402,0.95002855852146,2,116,stem cell proliferation,BP,ASPM;SFRP2
11561,GO:0044344,0.200435696484061,0.949951867463528,2,122,cellular response to fibroblast growth factor stimulus,BP,CREB3L1;SPRY4
4654,GO:0010165,0.200656190652007,0.979211816511942,1,31,response to X-ray,BP,SFRP2
12024,GO:0045742,0.200811028963087,0.979158288431422,1,32,positive regulation of epidermal growth factor receptor signaling pathway,BP,NEURL1
19258,GO:1902042,0.201469897145271,0.978930868583284,1,37,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,SFRP2
5876,GO:0016504,0.201577582550232,0.978907427984305,1,37,peptidase activator activity,MF,SFRP2
4675,GO:0010259,0.202179373650256,0.978882036849202,1,31,multicellular organism aging,BP,CRYAB
9065,GO:0033762,0.202805066820949,0.978725221444556,1,32,response to glucagon,BP,ADCY1
12285,GO:0046320,0.203077456721218,0.978686277851075,1,31,regulation of fatty acid oxidation,BP,CNR1
13853,GO:0051642,0.203511192018388,0.978662300076174,1,28,centrosome localization,BP,ASPM
7083,GO:0023056,0.203560601258569,0.870231162502791,14,1659,positive regulation of signaling,BP,CD38;ASPM;SYT1;NEURL1;CNR1;SNAP25;MRAP2;SFRP2;DAAM2;NRGN;VSNL1;ADCY1;NMB;GRIN2B
13499,GO:0051019,0.203605613301224,0.9785305617001,1,33,mitogen-activated protein kinase binding,MF,DUSP4
4148,GO:0008584,0.203618663577134,0.948665722392974,2,120,male gonad development,BP,ASPM;SFRP2
6172,GO:0017080,0.203646565737629,0.978454317001456,1,37,sodium channel regulator activity,MF,PTPN3
17854,GO:0098742,0.20390332587787,0.929418621773048,3,201,cell-cell adhesion via plasma-membrane adhesion molecules,BP,TENM2;IGFN1;SELL
3569,GO:0007094,0.203955296866465,0.978435357593891,1,34,mitotic spindle assembly checkpoint,BP,CENPF
7908,GO:0031577,0.203955296866465,0.978435357593891,1,34,spindle checkpoint,BP,CENPF
16019,GO:0071173,0.203955296866465,0.978435357593891,1,34,spindle assembly checkpoint,BP,CENPF
16020,GO:0071174,0.203955296866465,0.978435357593891,1,34,mitotic spindle checkpoint,BP,CENPF
4825,GO:0010656,0.204342589903875,0.978332630428359,1,35,negative regulation of muscle cell apoptotic process,BP,SFRP2
3841,GO:0008066,0.204346488068739,0.978506863944641,1,27,glutamate receptor activity,MF,GRIN2B
3699,GO:0007346,0.204616867382747,0.898489684255864,6,599,regulation of mitotic cell cycle,BP,PTPN3;TPX2;CENPF;TOP2A;MKI67;UBE2C
12772,GO:0048009,0.2046369437567,0.978366326063614,1,30,insulin-like growth factor receptor signaling pathway,BP,IGFBP2
14462,GO:0060292,0.205494795623592,0.978154492950051,1,31,long-term synaptic depression,BP,CD38
14012,GO:0051955,0.205550172235553,0.978082681520832,1,34,regulation of amino acid transport,BP,SYT4
4319,GO:0009126,0.205681462478525,0.978003577799432,1,37,purine nucleoside monophosphate metabolic process,BP,TJP2
5745,GO:0016242,0.206006622020188,0.978040985415961,1,31,negative regulation of macroautophagy,BP,LZTS1
12348,GO:0046461,0.206525838820432,0.977815058506262,1,37,neutral lipid catabolic process,BP,FABP7
12351,GO:0046464,0.206525838820432,0.977815058506262,1,37,acylglycerol catabolic process,BP,FABP7
12402,GO:0046546,0.206567512639855,0.947449664724172,2,121,development of primary male sexual characteristics,BP,ASPM;SFRP2
15291,GO:0061842,0.207571005009089,0.977739551172793,1,29,microtubule organizing center localization,BP,ASPM
276,GO:0000776,0.207614514902386,0.946995396297291,2,126,kinetochore,CC,BIRC5;CENPF
13594,GO:0051154,0.207962826332922,0.97754326682089,1,34,negative regulation of striated muscle cell differentiation,BP,PI16
14207,GO:0055026,0.208102379997876,0.977511847961433,1,34,negative regulation of cardiac muscle tissue development,BP,PI16
3620,GO:0007190,0.208146936403247,0.97750181159032,1,34,activation of adenylate cyclase activity,BP,ADCY1
9834,GO:0035633,0.208485974054207,0.977444541311088,1,33,maintenance of blood-brain barrier,BP,TJP2
17559,GO:0097352,0.208724212067837,0.977320142244107,1,37,autophagosome maturation,BP,LIX1
7772,GO:0031330,0.208730108424762,0.92689180749999,3,229,negative regulation of cellular catabolic process,BP,LZTS1;PTPN3;CNR1
9464,GO:0034703,0.208738256171973,0.926931235320905,3,209,cation channel complex,CC,SNAP25;KCNC2;GRIN2B
19518,GO:1902692,0.208836340489195,0.97740767333832,1,31,regulation of neuroblast proliferation,BP,ASPM
8761,GO:0033003,0.208929919218741,0.977243594766585,1,39,regulation of mast cell activation,BP,CNR1
21597,GO:2000273,0.209253312144293,0.977251819349731,1,34,positive regulation of signaling receptor activity,BP,NEURL1
1400,GO:0003091,0.20963330911159,0.977227539926651,1,31,renal water homeostasis,BP,ADCY1
11112,GO:0043244,0.210110414103363,0.946021867175189,2,112,regulation of protein-containing complex disassembly,BP,TPX2;STMN2
18927,GO:1901186,0.210240306765228,0.977027535035829,1,34,positive regulation of ERBB signaling pathway,BP,NEURL1
3782,GO:0007600,0.210244968442011,0.902547989515301,5,485,sensory perception,BP,USH1C;BIRC5;CNR1;SLC4A10;GABRB2
18200,GO:0099604,0.210359210468035,0.977232549437287,1,25,ligand-gated calcium channel activity,MF,GRIN2B
14688,GO:0060590,0.21047087492457,0.976892313552817,1,39,ATPase regulator activity,MF,NCAPH
15192,GO:0061631,0.21124464557624,0.976729715139687,1,38,ubiquitin conjugating enzyme activity,MF,UBE2C
9547,GO:0035036,0.21145434635709,0.976613842764371,1,43,sperm-egg recognition,BP,FOLR2
9373,GO:0034508,0.211538697438937,0.976677857129426,1,37,centromere complex assembly,BP,CENPF
7184,GO:0030162,0.211623223664646,0.893937082374825,6,632,regulation of proteolysis,BP,PTPN3;BIRC5;CRYAB;SFRP2;PI16;GRIN2B
12294,GO:0046329,0.211979786903761,0.97662934310383,1,34,negative regulation of JNK cascade,BP,SFRP2
12028,GO:0045746,0.211979889401528,0.976576289829409,1,37,negative regulation of Notch signaling pathway,BP,NEURL1
13359,GO:0050798,0.212090502676828,0.976519944381108,1,39,activated T cell proliferation,BP,IGFBP2
12434,GO:0046621,0.21216874252551,0.976605723992821,1,33,negative regulation of organ growth,BP,PI16
9406,GO:0034620,0.212184143891061,0.945051821478706,2,135,cellular response to unfolded protein,BP,HSPB8;CREB3L1
16094,GO:0071322,0.212940062246611,0.944756306945541,2,129,cellular response to carbohydrate stimulus,BP,PTPRN;VSNL1
3796,GO:0007618,0.212951569868866,0.976368596758392,1,36,mating,BP,CNR1
16486,GO:0071985,0.213127822521162,0.976294914554889,1,38,multivesicular body sorting pathway,BP,SYTL4
2267,GO:0004864,0.213447858048973,0.976220587228397,1,38,protein phosphatase inhibitor activity,MF,PPP1R14C
19531,GO:1902742,0.213754949551828,0.976219143133656,1,34,apoptotic process involved in development,BP,CRYAB
7145,GO:0030111,0.213960001670702,0.910384976844355,4,348,regulation of Wnt signaling pathway,BP,ASPM;IGFBP2;SFRP2;DAAM2
11111,GO:0043243,0.214035079332017,0.976174266159375,1,33,positive regulation of protein-containing complex disassembly,BP,STMN2
12080,GO:0045841,0.214087496930346,0.976104805376435,1,36,negative regulation of mitotic metaphase/anaphase transition,BP,CENPF
19278,GO:1902100,0.214087496930346,0.976104805376435,1,36,negative regulation of metaphase/anaphase transition of cell cycle,BP,CENPF
16375,GO:0071774,0.214382620983014,0.944154650742037,2,127,response to fibroblast growth factor,BP,CREB3L1;SPRY4
22124,GO:2001242,0.214813916337318,0.943889886081662,2,150,regulation of intrinsic apoptotic signaling pathway,BP,SFRP2;CREB3L1
3824,GO:0008037,0.215871638694805,0.943505775186787,2,131,cell recognition,BP,CNR1;FOLR2
2497,GO:0005262,0.216045296271377,0.943543173702614,2,108,calcium channel activity,MF,CNR1;GRIN2B
21050,GO:1905819,0.216523644539025,0.975516275527487,1,37,negative regulation of chromosome separation,BP,CENPF
21966,GO:2000816,0.216523644539025,0.975516275527487,1,37,negative regulation of mitotic sister chromatid separation,BP,CENPF
14428,GO:0060236,0.216613914860969,0.975550324023736,1,34,regulation of mitotic spindle organization,BP,TPX2
13007,GO:0048593,0.216676841317158,0.943230315725893,2,116,camera-type eye morphogenesis,BP,USH1C;IGFN1
8661,GO:0032839,0.216700403678029,0.975529933496219,1,34,dendrite cytoplasm,CC,HPCA
3880,GO:0008138,0.216743730562539,0.975432075082074,1,39,protein tyrosine/serine/threonine phosphatase activity,MF,DUSP4
15202,GO:0061650,0.217068870952916,0.975340119603205,1,40,ubiquitin-like protein conjugating enzyme activity,MF,UBE2C
6019,GO:0016776,0.217134163659962,0.975339575573996,1,39,phosphotransferase activity, phosphate group as acceptor,MF,TJP2
13610,GO:0051180,0.217321281025883,0.975327556178811,1,37,vitamin transport,BP,FOLR2
1175,GO:0002673,0.217978061704815,0.975095963054955,1,42,regulation of acute inflammatory response,BP,CNR1
40,GO:0000082,0.217993455277122,0.922047017682975,3,244,G1/S transition of mitotic cell cycle,BP,BCAT1;CAMK2A;RRM2
8238,GO:0032228,0.218222713120801,0.975190523368464,1,33,regulation of synaptic transmission, GABAergic,BP,CNR1
12130,GO:0045933,0.218406115024668,0.975021794451021,1,40,positive regulation of muscle contraction,BP,CHRM3
4175,GO:0008631,0.218531573341038,0.974991815408642,1,40,intrinsic apoptotic signaling pathway in response to oxidative stress,BP,MELK
4636,GO:0010043,0.218619432272975,0.974882833948444,1,47,response to zinc ion,BP,SLC30A3
9407,GO:0034622,0.218732320267725,0.877665603641662,8,912,cellular protein-containing complex assembly,BP,USH1C;TPX2;STMN2;DNM1;CRYAB;CENPF;SNAP25;UBE2C
5097,GO:0014014,0.218993282320259,0.97491252647451,1,38,negative regulation of gliogenesis,BP,DAAM2
10987,GO:0043028,0.219146481895286,0.974859819880888,1,39,cysteine-type endopeptidase regulator activity involved in apoptotic process,MF,BIRC5
2574,GO:0005488,0.219162659766032,0.866301858953753,91,13523,binding,MF,CD38;USH1C;CAMK1G;SYT13;GABRA1;PTPRN;KIFC1;BCAT1;LZTS1;ASPM;SYT1;PTPN3;CAMK2A;LNX1;TPX2;RPH3A;BIRC5;KIF4A;MYBL2;EEF1A2;ST8SIA5;SYTL4;STMN2;NEFM;NPTX2;DNM1;NEURL1;NCAPG;CRYAB;PTPN5;FOXM1;GABRG2;SLC30A3;IGFBP2;CENPF;CNR1;TJP2;PRLHR;DUSP4;NCAPH;HPCA;VGF;SULT4A1;TOP2A;SNAP25;SYT4;GPR12;CHRM3;FAM189A2;MRAP2;STAC2;HUNK;SFRP2;LIX1;TENM2;DAAM2;MKI67;FREM2;HSPB8;NRGN;ABI3BP;CREB3L1;VSNL1;IGFN1;ETNPPL;FABP7;PI16;ADCY1;MELK;FOLR2;KCNC2;TMEM130;NPTX1;ENC1;RRM2;ZCCHC12;UBE2C;PCSK1;DDN;SV2B;C11ORF87;MYT1L;HAPLN4;SPRY4;C2ORF88;SELL;CPNE4;SLC6A17;NMB;TMEM158;GRIN2B
17142,GO:0090218,0.219324776808568,0.974867911436111,1,36,positive regulation of lipid kinase activity,BP,EEF1A2
17369,GO:0097009,0.219812887925456,0.97476987108388,1,35,energy homeostasis,BP,MRAP2
15384,GO:0065003,0.220132595336266,0.86237112005399,12,1437,protein-containing complex assembly,BP,USH1C;SYT1;TPX2;STMN2;DNM1;CRYAB;CENPF;SNAP25;KCNC2;RRM2;UBE2C;GRIN2B
7661,GO:0031112,0.220192215732001,0.974720342988193,1,33,positive regulation of microtubule polymerization or depolymerization,BP,STMN2
11751,GO:0045070,0.220233511940249,0.974668870943476,1,35,positive regulation of viral genome replication,BP,TOP2A
21907,GO:2000725,0.22026445884726,0.974661431279992,1,35,regulation of cardiac muscle cell differentiation,BP,PI16
8345,GO:0032391,0.220376512910106,0.974676099029034,1,33,photoreceptor connecting cilium,CC,USH1C
16084,GO:0071310,0.220614751265049,0.848888404330352,19,2389,cellular response to organic substance,BP,GABRA1;PTPRN;CAMK2A;BIRC5;MYBL2;STMN2;NEURL1;PTPN5;GABRG2;IGFBP2;CHRM3;SFRP2;GABRB2;HSPB8;CREB3L1;VSNL1;ADCY1;FOLR2;SPRY4
2962,GO:0006163,0.220687318476274,0.906418738384453,4,375,purine nucleotide metabolic process,BP,TJP2;HPCA;SULT4A1;ADCY1
3145,GO:0006468,0.220758588911979,0.855113455041939,15,1764,protein phosphorylation,BP,CAMK1G;CAMK2A;TPX2;BIRC5;NEURL1;CRYAB;FOXM1;DUSP4;HUNK;SFRP2;HSPB8;ADCY1;MELK;SPRY4;GRIN2B
9252,GO:0034330,0.220886777060035,0.881489990113868,7,650,cell junction organization,BP,GABRA1;NEURL1;GABRG2;TJP2;GABRB2;IGFN1;GRIN2B
19238,GO:1901998,0.220930879037913,0.974430181499937,1,39,toxin transport,BP,DNM1
5723,GO:0016202,0.221067059221648,0.941300900678126,2,125,regulation of striated muscle tissue development,BP,CENPF;PI16
1366,GO:0003009,0.221265731074629,0.974333595315731,1,40,skeletal muscle contraction,BP,STAC2
7307,GO:0030326,0.221461165659291,0.94115391983919,2,120,embryonic limb morphogenesis,BP,SFRP2;FREM2
9580,GO:0035113,0.221461165659291,0.94115391983919,2,120,embryonic appendage morphogenesis,BP,SFRP2;FREM2
7775,GO:0031333,0.221473055285995,0.941107497396419,2,129,negative regulation of protein-containing complex assembly,BP,STMN2;CRYAB
22132,GO:2001251,0.22154385061772,0.941099007394157,2,124,negative regulation of chromosome organization,BP,CENPF;TOP2A
2271,GO:0004869,0.221843445659415,0.974138025826244,1,44,cysteine-type endopeptidase inhibitor activity,MF,BIRC5
13083,GO:0048713,0.222580809485464,0.974029380240399,1,39,regulation of oligodendrocyte differentiation,BP,DAAM2
13004,GO:0048588,0.222617992113477,0.919656432332386,3,218,developmental cell growth,BP,SYT1;SYT4;PI16
12041,GO:0045776,0.222960443331487,0.973920920524628,1,40,negative regulation of blood pressure,BP,CNR1
13353,GO:0050790,0.223411581498875,0.849551211473272,17,2100,regulation of catalytic activity,BP,CAMK2A;TPX2;BIRC5;EEF1A2;NEURL1;CRYAB;CNR1;DUSP4;NCAPH;HPCA;SFRP2;PI16;ADCY1;UBE2C;SPRY4;PPP1R14C;GRIN2B
7857,GO:0031463,0.223903501857111,0.973758590237225,1,36,Cul3-RING ubiquitin ligase complex,CC,ENC1
5520,GO:0015804,0.224480314072958,0.973598270940375,1,37,neutral amino acid transport,BP,SLC6A17
8734,GO:0032964,0.224826092726153,0.97346245875825,1,40,collagen biosynthetic process,BP,CREB3L1
6437,GO:0019205,0.225157613082312,0.97335069849208,1,42,nucleobase-containing compound kinase activity,MF,TJP2
19112,GO:1901652,0.225231305176053,0.893160099487502,5,474,response to peptide,BP,PTPRN;CAMK2A;DNM1;VGF;ADCY1
21582,GO:2000241,0.225280915826816,0.939403093662794,2,140,regulation of reproductive process,BP,ASPM;CNR1
6792,GO:0021591,0.225317992148957,0.97349781257324,1,32,ventricular system development,BP,CENPF
18885,GO:1901021,0.225753455194594,0.97328402752442,1,37,positive regulation of calcium ion transmembrane transporter activity,BP,STAC2
6031,GO:0016791,0.226296188319404,0.917648214562198,3,238,phosphatase activity,MF,PTPN3;PTPN5;DUSP4
20208,GO:1904064,0.226472082700053,0.938902838877846,2,134,positive regulation of cation transmembrane transport,BP,STAC2;KCNC2
5470,GO:0015701,0.226911875170705,0.972944724011757,1,40,bicarbonate transport,BP,SLC4A10
75,GO:0000152,0.227206594769896,0.972871126860519,1,40,nuclear ubiquitin ligase complex,CC,UBE2C
13024,GO:0048634,0.227543713681736,0.938456043852669,2,128,regulation of muscle organ development,BP,CENPF;PI16
6444,GO:0019212,0.227867333447437,0.972690078708892,1,41,phosphatase inhibitor activity,MF,PPP1R14C
13141,GO:0048854,0.228041752544367,0.97279837225554,1,33,brain morphogenesis,BP,SLC4A10
11775,GO:0045124,0.228560252444551,0.972565669753731,1,38,regulation of bone resorption,BP,CD38
2514,GO:0005310,0.22891525973561,0.972514257347529,1,36,dicarboxylic acid transmembrane transporter activity,MF,SLC17A7
19185,GO:1901861,0.230194872515399,0.937280600701976,2,128,regulation of muscle tissue development,BP,CENPF;PI16
4664,GO:0010212,0.230765167321641,0.937000161087872,2,134,response to ionizing radiation,BP,CRYAB;SFRP2
17485,GO:0097193,0.232200877157528,0.914404060476092,3,267,intrinsic apoptotic signaling pathway,BP,SFRP2;CREB3L1;MELK
21624,GO:2000310,0.232983971048475,0.971524658249841,1,34,regulation of NMDA receptor activity,BP,GRIN2B
21468,GO:2000026,0.233057648941136,0.843628016587886,16,1889,regulation of multicellular organismal development,BP,CD38;LZTS1;ASPM;SYT1;CAMK2A;STMN2;NEURL1;CENPF;CNR1;SNAP25;SYT4;SFRP2;DAAM2;CREB3L1;PI16;ENC1
543,GO:0001678,0.23349164217467,0.935774635799243,2,135,cellular glucose homeostasis,BP,PTPRN;VSNL1
3920,GO:0008201,0.233891697984477,0.9355782169394,2,139,heparin binding,MF,ABI3BP;SELL
19727,GO:1903169,0.234624597062051,0.93525174204198,2,138,regulation of calcium ion transmembrane transport,BP,HPCA;STAC2
15579,GO:0070317,0.234964089717069,0.970949755122774,1,37,negative regulation of G0 to G1 transition,BP,RRM2
3175,GO:0006509,0.235394452672497,0.970782537661198,1,40,membrane protein ectodomain proteolysis,BP,PTPN3
9569,GO:0035094,0.236383423722268,0.970507665554338,1,41,response to nicotine,BP,CNR1
13483,GO:0050999,0.236553361410817,0.970431811213949,1,43,regulation of nitric-oxide synthase activity,BP,CNR1
8481,GO:0032570,0.236589386580392,0.970437679178107,1,42,response to progesterone,BP,CD38
7963,GO:0031672,0.236797563229352,0.970515081584101,1,35,A band,CC,CRYAB
128,GO:0000266,0.236807406075101,0.970469686658701,1,37,mitochondrial fission,BP,DNM1
439,GO:0001504,0.237042830436482,0.970334831389148,1,41,neurotransmitter uptake,BP,SNAP25
20701,GO:1905039,0.237322413903634,0.934054834419984,2,132,carboxylic acid transmembrane transport,BP,SLC17A7;FOLR2
4376,GO:0009187,0.237666488928992,0.970287603756266,1,35,cyclic nucleotide metabolic process,BP,ADCY1
7191,GO:0030170,0.237788196600688,0.97009234146327,1,44,pyridoxal phosphate binding,MF,ETNPPL
15555,GO:0070279,0.237788196600688,0.97009234146327,1,44,vitamin B6 binding,MF,ETNPPL
17725,GO:0097730,0.238397855520383,0.933551551541057,2,135,non-motile cilium,CC,USH1C;PRLHR
13706,GO:0051348,0.238616879010638,0.910900387635813,3,259,negative regulation of transferase activity,BP,DUSP4;SFRP2;SPRY4
8795,GO:0033048,0.23870409495411,0.969914108994986,1,40,negative regulation of mitotic sister chromatid segregation,BP,CENPF
17146,GO:0090224,0.23872477893546,0.969945698284492,1,38,regulation of spindle organization,BP,TPX2
10616,GO:0042277,0.239360337364348,0.910476875070447,3,266,peptide binding,MF,CRYAB;TMEM158;GRIN2B
11082,GO:0043198,0.239509833748638,0.969758040131075,1,37,dendritic shaft,CC,LZTS1
20075,GO:1903825,0.239791395759145,0.932923061385585,2,133,organic acid transmembrane transport,BP,SLC17A7;FOLR2
11896,GO:0045494,0.240273332303717,0.969555292000503,1,37,photoreceptor cell maintenance,BP,USH1C
7962,GO:0031670,0.240325211489305,0.969466225074928,1,41,cellular response to nutrient,BP,FOLR2
21352,GO:1990752,0.240759902076364,0.969546743584489,1,32,microtubule end,CC,ASPM
3468,GO:0006915,0.240862295694483,0.841498653662847,14,1743,apoptotic process,BP,CD38;CAMK2A;TPX2;BIRC5;MYBL2;EEF1A2;NEURL1;CRYAB;CNR1;TOP2A;SFRP2;GABRB2;CREB3L1;MELK
5656,GO:0016055,0.241178238885476,0.882876837022576,5,485,Wnt signaling pathway,BP,ASPM;CAMK2A;IGFBP2;SFRP2;DAAM2
10383,GO:0038127,0.24151109519979,0.932137593872655,2,132,ERBB signaling pathway,BP,PTPN3;NEURL1
14665,GO:0060560,0.241529353356629,0.909359595407923,3,225,developmental growth involved in morphogenesis,BP,SYT1;SYT4;SFRP2
19012,GO:1901381,0.24216451402641,0.969049869084918,1,37,positive regulation of potassium ion transmembrane transport,BP,KCNC2
7946,GO:0031644,0.242199407559879,0.931815675319962,2,133,regulation of nervous system process,BP,NPTX2;NPTX1
7216,GO:0030204,0.242920831015978,0.968825712640148,1,38,chondroitin sulfate metabolic process,BP,CHST9
7394,GO:0030534,0.243084832830875,0.931415846536164,2,131,adult behavior,BP,GABRG2;PRLHR
9659,GO:0035315,0.243276591300411,0.968729715613975,1,38,hair cell differentiation,BP,USH1C
18653,GO:0198738,0.243629026950343,0.881271276330283,5,487,cell-cell signaling by wnt,BP,ASPM;CAMK2A;IGFBP2;SFRP2;DAAM2
2608,GO:0005547,0.243840655956619,0.968643470886241,1,35,phosphatidylinositol-3,4,5-trisphosphate binding,MF,NRGN
11688,GO:0044843,0.244095355611031,0.907857735006313,3,258,cell cycle G1/S phase transition,BP,BCAT1;CAMK2A;RRM2
4474,GO:0009409,0.244791096435485,0.968228636107113,1,43,response to cold,BP,VGF
15255,GO:0061756,0.244993794667529,0.968189738271675,1,42,leukocyte adhesion to vascular endothelial cell,BP,SELL
10918,GO:0042886,0.245806974335936,0.835432511129201,15,1882,amide transport,BP,CD38;PTPRN;RPH3A;SYTL4;DNM1;CENPF;CNR1;HPCA;VGF;SNAP25;SYT4;SLC14A1;VSNL1;FOLR2;KCNC2
8793,GO:0033046,0.245947384391755,0.967946285131683,1,41,negative regulation of sister chromatid segregation,BP,CENPF
14036,GO:0051985,0.245947384391755,0.967946285131683,1,41,negative regulation of chromosome segregation,BP,CENPF
1043,GO:0002437,0.246364281420716,0.967712609923785,1,49,inflammatory response to antigenic stimulus,BP,CNR1
14235,GO:0055086,0.247504653947568,0.878683390759427,5,536,nucleobase-containing small molecule metabolic process,BP,TJP2;HPCA;SULT4A1;ADCY1;RRM2
3750,GO:0007517,0.248972512314052,0.889303442144581,4,356,muscle organ development,BP,NEURL1;CRYAB;CENPF;PI16
19922,GO:1903539,0.249124239472377,0.967069373525553,1,41,protein localization to postsynaptic membrane,BP,SNAP25
9022,GO:0033628,0.250192091453031,0.966704659994353,1,45,regulation of cell adhesion mediated by integrin,BP,SFRP2
12956,GO:0048489,0.250192119096352,0.966753711595164,1,42,synaptic vesicle transport,BP,DNM1
3563,GO:0007080,0.250432923103576,0.966607910654245,1,47,mitotic metaphase plate congression,BP,KIFC1
4609,GO:0009968,0.250701852116841,0.845714299730682,10,1168,negative regulation of signal transduction,BP,PTPN3;DNM1;NEURL1;FOXM1;IGFBP2;DUSP4;MRAP2;SFRP2;CREB3L1;SPRY4
16768,GO:0072521,0.250720850196935,0.888162799169656,4,398,purine-containing compound metabolic process,BP,TJP2;HPCA;SULT4A1;ADCY1
2963,GO:0006164,0.25088294042001,0.927666781642445,2,155,purine nucleotide biosynthetic process,BP,HPCA;ADCY1
8611,GO:0032781,0.251107638852727,0.966343370536733,1,53,positive regulation of ATPase activity,BP,NCAPH
15578,GO:0070316,0.251218917402363,0.966503014518376,1,40,regulation of G0 to G1 transition,BP,RRM2
3460,GO:0006904,0.251946167308887,0.966227316669686,1,44,vesicle docking involved in exocytosis,BP,SNAP25
7691,GO:0031201,0.252309177244566,0.966079212500304,1,47,SNARE complex,CC,SNAP25
3647,GO:0007223,0.252454643970122,0.966196616765185,1,38,Wnt signaling pathway, calcium modulating pathway,BP,CAMK2A
7099,GO:0030018,0.252502563712699,0.927047442251874,2,122,Z disc,CC,CRYAB;IGFN1
442,GO:0001508,0.253283894802607,0.926642723599616,2,128,action potential,BP,PTPN3;CNR1
1499,GO:0003254,0.253430942106984,0.965841226295681,1,42,regulation of membrane depolarization,BP,PTPN3
6581,GO:0019674,0.253824910418898,0.965663449287798,1,46,NAD metabolic process,BP,CD38
11723,GO:0045023,0.254473660484328,0.965563110730119,1,41,G0 to G1 transition,BP,RRM2
4353,GO:0009161,0.254951435326827,0.965326857421431,1,47,ribonucleoside monophosphate metabolic process,BP,TJP2
719,GO:0001933,0.255917430111432,0.884921722821511,4,380,negative regulation of protein phosphorylation,BP,FOXM1;DUSP4;SFRP2;SPRY4
18065,GO:0099080,0.256094373331609,0.841630384614846,10,1099,supramolecular complex,CC,KIFC1;ASPM;TPX2;BIRC5;KIF4A;NEFM;DNM1;CRYAB;CENPF;IGFN1
7735,GO:0031279,0.256239878811258,0.965020803961045,1,43,regulation of cyclase activity,BP,HPCA
10593,GO:0042220,0.256604330763944,0.964898697270441,1,44,response to cocaine,BP,CNR1
11031,GO:0043114,0.256918023693829,0.964808201814155,1,44,regulation of vascular permeability,BP,TJP2
4130,GO:0008536,0.257076011917559,0.964879674210974,1,38,Ran GTPase binding,MF,BIRC5
13754,GO:0051445,0.257476228343221,0.964630323824652,1,45,regulation of meiotic cell cycle,BP,ASPM
13734,GO:0051403,0.257519102935072,0.900236726546848,3,259,stress-activated MAPK cascade,BP,CRYAB;FOXM1;SFRP2
15995,GO:0071103,0.257903335736435,0.900032032177426,3,251,DNA conformation change,BP,NCAPG;NCAPH;TOP2A
9566,GO:0035091,0.258723776887796,0.899578934007054,3,242,phosphatidylinositol binding,MF,SYT1;RPH3A;NRGN
3591,GO:0007157,0.258736446716825,0.964377363515344,1,39,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,BP,TENM2
13697,GO:0051339,0.259048337576728,0.964190214453094,1,44,regulation of lyase activity,BP,HPCA
585,GO:0001754,0.259134879312754,0.964220105015595,1,41,eye photoreceptor cell differentiation,BP,USH1C
19945,GO:1903573,0.259267491117243,0.964063481461207,1,48,negative regulation of response to endoplasmic reticulum stress,BP,CREB3L1
12465,GO:0046661,0.260131812755185,0.923276168285013,2,143,male sex differentiation,BP,ASPM;SFRP2
10919,GO:0042887,0.260514057172922,0.963728454465039,1,46,amide transmembrane transporter activity,MF,SLC14A1
9501,GO:0034767,0.260671234599168,0.922996779728712,2,147,positive regulation of ion transmembrane transport,BP,STAC2;KCNC2
5784,GO:0016310,0.261018353944027,0.819370596106074,17,2136,phosphorylation,BP,CAMK1G;CAMK2A;TPX2;BIRC5;EEF1A2;NEURL1;CRYAB;FOXM1;DUSP4;HUNK;SFRP2;HSPB8;ADCY1;MELK;SPRY4;PPP1R14C;GRIN2B
7023,GO:0022602,0.261126042762483,0.963599510149995,1,43,ovulation cycle process,BP,PTPRN
12781,GO:0048018,0.261287937548009,0.897937688408811,3,334,receptor ligand activity,MF,VGF;SFRP2;NMB
18183,GO:0099568,0.261397267691776,0.898053127047035,3,233,cytoplasmic region,CC,KIF4A;CENPF;HPCA
10029,GO:0035967,0.261598851373856,0.922516809533774,2,154,cellular response to topologically incorrect protein,BP,HSPB8;CREB3L1
21864,GO:2000648,0.261760829833737,0.963412550538072,1,43,positive regulation of stem cell proliferation,BP,ASPM
10527,GO:0042059,0.261869798090817,0.963345426420513,1,45,negative regulation of epidermal growth factor receptor signaling pathway,BP,PTPN3
5144,GO:0014075,0.262533655813615,0.963132634488321,1,46,response to amine,BP,KCNC2
13269,GO:0050654,0.262657242560017,0.963147627894108,1,43,chondroitin sulfate proteoglycan metabolic process,BP,CHST9
17234,GO:0090342,0.262964296943701,0.963004888105346,1,46,regulation of cell aging,BP,FOXM1
11019,GO:0043090,0.26344859847937,0.962931834561692,1,42,amino acid import,BP,SLC17A7
5041,GO:0010950,0.263453173806451,0.92158714499116,2,160,positive regulation of endopeptidase activity,BP,SFRP2;GRIN2B
12532,GO:0046850,0.264393145073335,0.962595927634282,1,45,regulation of bone remodeling,BP,CD38
13321,GO:0050732,0.264610805388507,0.962498218475469,1,47,negative regulation of peptidyl-tyrosine phosphorylation,BP,SFRP2
20056,GO:1903793,0.264903102447028,0.962395354198664,1,48,positive regulation of anion transport,BP,SYT4
7855,GO:0031461,0.264982864411507,0.920865056588046,2,152,cullin-RING ubiquitin ligase complex,CC,ENC1;UBE2C
5272,GO:0015085,0.265238516322674,0.92087585384185,2,124,calcium ion transmembrane transporter activity,MF,CNR1;GRIN2B
5466,GO:0015695,0.265351007744278,0.962260965944524,1,48,organic cation transport,BP,CNR1
10716,GO:0042461,0.265983237757268,0.962174692146574,1,42,photoreceptor cell development,BP,USH1C
11761,GO:0045104,0.267087328704681,0.961884120601858,1,40,intermediate filament cytoskeleton organization,BP,NEFM
13352,GO:0050789,0.268160677567983,0.797099438588402,68,9758,regulation of biological process,BP,CD38;USH1C;SYT13;GABRA1;PTPRN;LZTS1;ASPM;SYT1;PTPN3;CAMK2A;TPX2;BIRC5;MYBL2;EEF1A2;SYTL4;STMN2;SLC17A7;NPTX2;DNM1;NEURL1;CRYAB;FOXM1;GABRG2;SLC30A3;IGFBP2;CENPF;CNR1;TJP2;PRLHR;DUSP4;HPCA;VGF;TOP2A;SNAP25;SYT4;GPR12;CHRM3;MRAP2;STAC2;HUNK;SLC4A10;SFRP2;GABRB2;TENM2;DAAM2;MKI67;HSPB8;NRGN;ABI3BP;CREB3L1;VSNL1;FABP7;PI16;ADCY1;MELK;FOLR2;KCNC2;NPTX1;ENC1;RRM2;ZCCHC12;UBE2C;MYT1L;SPRY4;SELL;NMB;PPP1R14C;GRIN2B
5805,GO:0016358,0.268694744385213,0.893773282977202,3,237,dendrite development,BP,LZTS1;CAMK2A;NEURL1
3404,GO:0006816,0.269265941245738,0.876399929262932,4,381,calcium ion transport,BP,CAMK2A;HPCA;STAC2;GRIN2B
22108,GO:2001222,0.269545085152179,0.96118611871788,1,38,regulation of neuron migration,BP,CAMK2A
7400,GO:0030546,0.269953667259851,0.892847822019166,3,339,signaling receptor activator activity,MF,VGF;SFRP2;NMB
3777,GO:0007595,0.269994479532871,0.960958982569229,1,42,lactation,BP,NEURL1
2163,GO:0004715,0.270156202497529,0.960852369993801,1,45,non-membrane spanning protein tyrosine kinase activity,MF,MELK
17193,GO:0090287,0.271187952320213,0.892256278774674,3,255,regulation of cellular response to growth factor stimulus,BP,SFRP2;CREB3L1;SPRY4
16938,GO:0086010,0.271802362804733,0.960577668153928,1,35,membrane depolarization during action potential,BP,PTPN3
21679,GO:2000378,0.271827825232175,0.960257366946726,1,50,negative regulation of reactive oxygen species metabolic process,BP,CRYAB
11408,GO:0043949,0.271991500979207,0.960270168765042,1,46,regulation of cAMP-mediated signaling,BP,MRAP2
11760,GO:0045103,0.272331001046486,0.960262173242988,1,41,intermediate filament-based process,BP,NEFM
14929,GO:0061028,0.273050446700928,0.959978551122256,1,44,establishment of endothelial barrier,BP,TJP2
16769,GO:0072522,0.273234024139603,0.916704409116589,2,165,purine-containing compound biosynthetic process,BP,HPCA;ADCY1
3580,GO:0007131,0.273748531986761,0.95970811278298,1,47,reciprocal meiotic recombination,BP,TOP2A
15381,GO:0062237,0.273834344772832,0.95971634233007,1,45,protein localization to postsynapse,BP,SNAP25
13679,GO:0051302,0.274179484880127,0.916285693154525,2,150,regulation of cell division,BP,ASPM;SFRP2
12236,GO:0046128,0.274203375250304,0.959477041883651,1,53,purine ribonucleoside metabolic process,BP,TJP2
11929,GO:0045595,0.274547112452098,0.814643002520005,14,1685,regulation of cell differentiation,BP,CD38;LZTS1;ASPM;SYT1;CAMK2A;STMN2;NEURL1;CNR1;SNAP25;SYT4;SFRP2;DAAM2;PI16;ENC1
5271,GO:0015081,0.276202640886279,0.915322916426443,2,137,sodium ion transmembrane transporter activity,MF,SLC17A7;SLC4A10
5063,GO:0010977,0.277082944533007,0.91484092763818,2,144,negative regulation of neuron projection development,BP,CD38;STMN2
465,GO:0001541,0.277104628420681,0.958606876301851,1,50,ovarian follicle development,BP,VGF
7965,GO:0031674,0.277417396390643,0.914727089104903,2,133,I band,CC,CRYAB;IGFN1
8601,GO:0032768,0.277471538459261,0.958461531572694,1,52,regulation of monooxygenase activity,BP,CNR1
13005,GO:0048589,0.277546509871304,0.84875537383637,6,603,developmental growth,BP,ASPM;SYT1;SYT4;SLC4A10;SFRP2;PI16
3568,GO:0007093,0.27773314480829,0.914453316285187,2,157,mitotic cell cycle checkpoint,BP,CENPF;TOP2A
21678,GO:2000377,0.277750328846367,0.914421524320776,2,163,regulation of reactive oxygen species metabolic process,BP,CRYAB;FOXM1
9624,GO:0035254,0.278228971706133,0.958335122663273,1,45,glutamate receptor binding,MF,CAMK2A
9960,GO:0035825,0.278408649300382,0.958225029097387,1,48,homologous recombination,BP,TOP2A
7164,GO:0030135,0.279306988975693,0.88735475976906,3,277,coated vesicle,CC,SYT1;SLC17A7;NRGN
13751,GO:0051438,0.27970829698813,0.957748958542522,1,52,regulation of ubiquitin-protein transferase activity,BP,UBE2C
11129,GO:0043268,0.280038987481274,0.957778163922183,1,44,positive regulation of potassium ion transport,BP,KCNC2
8372,GO:0032420,0.280240262009672,0.95767555703294,1,46,stereocilium,CC,USH1C
7651,GO:0031098,0.280338953193636,0.886743640710874,3,271,stress-activated protein kinase signaling cascade,BP,CRYAB;FOXM1;SFRP2
12463,GO:0046658,0.280501766168857,0.95749454485383,1,52,anchored component of plasma membrane,CC,FOLR2
4449,GO:0009311,0.281049936999422,0.95734821459386,1,50,oligosaccharide metabolic process,BP,ST8SIA5
3851,GO:0008089,0.281082853822355,0.957405334005157,1,46,anterograde axonal transport,BP,KIF4A
12986,GO:0048546,0.281384655916785,0.95732716273144,1,45,digestive tract morphogenesis,BP,SFRP2
12078,GO:0045839,0.281511839734757,0.957199470023577,1,50,negative regulation of mitotic nuclear division,BP,CENPF
18926,GO:1901185,0.281810851169919,0.957118995967695,1,49,negative regulation of ERBB signaling pathway,BP,PTPN3
2262,GO:0004857,0.282212589586844,0.88555162800194,3,302,enzyme inhibitor activity,MF,BIRC5;PI16;PPP1R14C
2485,GO:0005245,0.282288003192279,0.957098485833263,1,42,voltage-gated calcium channel activity,MF,CNR1
3678,GO:0007283,0.282443608479052,0.867749432059813,4,412,spermatogenesis,BP,KIFC1;ASPM;NEURL1;CNR1
21297,GO:1990573,0.283084464597966,0.956759531167981,1,46,potassium ion import across plasma membrane,BP,KCNK9
13696,GO:0051338,0.283118106913073,0.830535048418119,8,927,regulation of transferase activity,BP,TPX2;EEF1A2;NEURL1;DUSP4;SFRP2;ADCY1;UBE2C;SPRY4
13478,GO:0050994,0.284366700589691,0.956289926161503,1,49,regulation of lipid catabolic process,BP,CNR1
4452,GO:0009314,0.284722176592466,0.866249360488359,4,404,response to radiation,BP,CRYAB;SLC4A10;SFRP2;KCNC2
3512,GO:0006996,0.284756187481695,0.78734506084331,27,3534,organelle organization,BP,USH1C;SYT13;PTPRN;KIFC1;ASPM;SYT1;CAMK2A;TPX2;BIRC5;KIF4A;MYBL2;STMN2;NEFM;SLC17A7;DNM1;NEURL1;NCAPG;CRYAB;CENPF;NCAPH;TOP2A;SNAP25;SYT4;DAAM2;MKI67;UBE2C;MAP7D2
13780,GO:0051494,0.285283710198083,0.910613345450362,2,146,negative regulation of cytoskeleton organization,BP,TPX2;STMN2
12082,GO:0045843,0.285675516144992,0.955845502796278,1,50,negative regulation of striated muscle tissue development,BP,PI16
17853,GO:0098739,0.286086332952075,0.910195618095788,2,146,import across plasma membrane,BP,FOLR2;KCNK9
14912,GO:0060999,0.286170733838254,0.955836611037038,1,42,positive regulation of dendritic spine development,BP,NEURL1
8452,GO:0032515,0.286627282873954,0.955486865787816,1,53,negative regulation of phosphoprotein phosphatase activity,BP,PPP1R14C
11106,GO:0043235,0.28665018253351,0.865009787518947,4,372,receptor complex,CC,GABRA1;GABRG2;GABRB2;GRIN2B
1347,GO:0002931,0.286967863338819,0.95542041988521,1,50,response to ischemia,BP,CAMK2A
10617,GO:0042278,0.287325257770088,0.955215354861189,1,56,purine nucleoside metabolic process,BP,TJP2
13012,GO:0048608,0.287546709784167,0.864382545324085,4,394,reproductive structure development,BP,PTPRN;ASPM;VGF;SFRP2
2390,GO:0005080,0.287550754325089,0.955261880891235,1,48,protein kinase C binding,MF,TOP2A
9577,GO:0035107,0.287580238158087,0.909435733020533,2,142,appendage morphogenesis,BP,SFRP2;FREM2
9578,GO:0035108,0.287580238158087,0.909435733020533,2,142,limb morphogenesis,BP,SFRP2;FREM2
20773,GO:1905207,0.287695884312074,0.955213918608594,1,48,regulation of cardiocyte differentiation,BP,PI16
11915,GO:0045576,0.288190302265832,0.954941867171888,1,55,mast cell activation,BP,CNR1
11234,GO:0043434,0.288285174042767,0.863887184885962,4,396,response to peptide hormone,BP,PTPRN;CAMK2A;VGF;ADCY1
12127,GO:0045930,0.288903303637756,0.881469732830618,3,298,negative regulation of mitotic cell cycle,BP,PTPN3;CENPF;TOP2A
3934,GO:0008219,0.289537310787103,0.799969123362213,15,1961,cell death,BP,CD38;CAMK2A;TPX2;BIRC5;MYBL2;EEF1A2;NEURL1;CRYAB;CNR1;TOP2A;SFRP2;GABRB2;CREB3L1;MELK;GRIN2B
6678,GO:0019899,0.289786308715251,0.79561727180281,17,2096,enzyme binding,MF,PTPRN;PTPN3;TPX2;RPH3A;BIRC5;EEF1A2;SYTL4;DNM1;FOXM1;TJP2;DUSP4;NCAPH;HPCA;TOP2A;DAAM2;UBE2C;SELL
7381,GO:0030514,0.290168730151386,0.954429806620456,1,46,negative regulation of BMP signaling pathway,BP,SFRP2
3508,GO:0006986,0.290690774145088,0.907677405645146,2,171,response to unfolded protein,BP,HSPB8;CREB3L1
15017,GO:0061178,0.290711153984307,0.954129090409671,1,53,regulation of insulin secretion involved in cellular response to glucose stimulus,BP,VSNL1
13025,GO:0048635,0.290850201610218,0.954113270422523,1,51,negative regulation of muscle organ development,BP,PI16
9662,GO:0035329,0.29085773678382,0.9542858376424,1,42,hippo signaling,BP,TJP2
4615,GO:0009988,0.2913397149968,0.953826117469834,1,60,cell-cell recognition,BP,FOLR2
21550,GO:2000179,0.291902511719644,0.953829708822995,1,47,positive regulation of neural precursor cell proliferation,BP,ASPM
19286,GO:1902108,0.291978891123981,0.953634674595567,1,58,regulation of mitochondrial membrane permeability involved in apoptotic process,BP,CAMK2A
17062,GO:0090102,0.292440400048265,0.953612067835887,1,49,cochlea development,BP,GABRB2
11405,GO:0043933,0.292472309345663,0.802711136185838,13,1694,protein-containing complex subunit organization,BP,USH1C;SYT1;TPX2;STMN2;DNM1;CRYAB;CENPF;SNAP25;LIX1;KCNC2;RRM2;UBE2C;GRIN2B
14668,GO:0060563,0.293096534332139,0.953373227105082,1,50,neuroepithelial cell differentiation,BP,USH1C
15115,GO:0061458,0.293126940824516,0.860638159408847,4,398,reproductive system development,BP,PTPRN;ASPM;VGF;SFRP2
20477,GO:1904645,0.294569525728922,0.952927988151698,1,47,response to amyloid-beta,BP,DNM1
11283,GO:0043525,0.294720668514546,0.952758660727757,1,54,positive regulation of neuron apoptotic process,BP,MYBL2
17054,GO:0090090,0.295100517628842,0.905340750303043,2,170,negative regulation of canonical Wnt signaling pathway,BP,IGFBP2;SFRP2
8342,GO:0032387,0.295464284585703,0.952504737539876,1,54,negative regulation of intracellular transport,BP,CRYAB
10709,GO:0042446,0.29566709510067,0.952420866872275,1,55,hormone biosynthetic process,BP,CHST9
5929,GO:0016597,0.295974498615956,0.952330068821538,1,54,amino acid binding,MF,GRIN2B
21151,GO:1990090,0.296055316358094,0.952402230176968,1,48,cellular response to nerve growth factor stimulus,BP,STMN2
13006,GO:0048592,0.296093623219441,0.904924412635321,2,144,eye morphogenesis,BP,USH1C;IGFN1
11061,GO:0043169,0.296159861240986,0.775962887472945,29,3786,cation binding,MF,SYT13;SYT1;CAMK2A;LNX1;RPH3A;BIRC5;KIF4A;SYTL4;NPTX2;NEURL1;CRYAB;HPCA;TOP2A;SYT4;GPR12;CHRM3;STAC2;TENM2;FREM2;VSNL1;ADCY1;MELK;NPTX1;RRM2;ZCCHC12;MYT1L;SELL;CPNE4;GRIN2B
13420,GO:0050885,0.296524162903593,0.952280878274839,1,46,neuromuscular process controlling balance,BP,USH1C
1630,GO:0003774,0.296568388160212,0.904791574404222,2,124,motor activity,MF,KIFC1;KIF4A
7766,GO:0031324,0.297481475336025,0.787331564742747,18,2317,negative regulation of cellular metabolic process,BP,CD38;LZTS1;PTPN3;BIRC5;CRYAB;FOXM1;CENPF;CNR1;DUSP4;HPCA;SFRP2;TENM2;CREB3L1;PI16;ENC1;MYT1L;SPRY4;PPP1R14C
8373,GO:0032421,0.29762292199689,0.951827836755878,1,50,stereocilium bundle,CC,USH1C
12079,GO:0045840,0.298126394847401,0.951637024278482,1,51,positive regulation of mitotic nuclear division,BP,UBE2C
1363,GO:0003006,0.298350649172599,0.825434803414561,7,811,developmental process involved in reproduction,BP,PTPRN;KIFC1;ASPM;NEURL1;CNR1;VGF;SFRP2
5740,GO:0016236,0.299673299638488,0.874789287223458,3,289,macroautophagy,BP,LZTS1;LIX1;HSPB8
8684,GO:0032890,0.299754429027371,0.9510247110341,1,54,regulation of organic acid transport,BP,SYT4
6641,GO:0019829,0.299830846124044,0.951029616754283,1,52,ATPase-coupled cation transmembrane transporter activity,MF,SLC30A3
19186,GO:1901862,0.299849783562025,0.951006977776422,1,53,negative regulation of muscle tissue development,BP,PI16
5081,GO:0012501,0.300130261144853,0.793655199776463,14,1831,programmed cell death,BP,CD38;CAMK2A;TPX2;BIRC5;MYBL2;EEF1A2;NEURL1;CRYAB;CNR1;TOP2A;SFRP2;GABRB2;CREB3L1;MELK
7662,GO:0031113,0.30031818925487,0.950912165971868,1,49,regulation of microtubule polymerization,BP,STMN2
13415,GO:0050879,0.300673785932342,0.950735874597987,1,52,multicellular organismal movement,BP,STAC2
13416,GO:0050881,0.300673785932342,0.950735874597987,1,52,musculoskeletal movement,BP,STAC2
7532,GO:0030888,0.301221960403756,0.950469028127098,1,57,regulation of B cell proliferation,BP,CD38
5321,GO:0015179,0.301366090841683,0.950510728251188,1,51,L-amino acid transmembrane transporter activity,MF,SLC17A7
3482,GO:0006940,0.301661576603846,0.950343433051269,1,55,regulation of smooth muscle contraction,BP,CHRM3
6927,GO:0021879,0.301805969215424,0.950356667646425,1,51,forebrain neuron differentiation,BP,SLC4A10
15413,GO:0070059,0.301913441958926,0.950226446074388,1,57,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,CREB3L1
15904,GO:0070936,0.302086439060318,0.950209393948891,1,54,protein K48-linked ubiquitination,BP,UBE2C
12047,GO:0045786,0.302582070196606,0.840672607423549,5,563,negative regulation of cell cycle,BP,PTPN3;FOXM1;CENPF;TOP2A;RRM2
8749,GO:0032984,0.303058755292342,0.872622941962937,3,306,protein-containing complex disassembly,BP,TPX2;STMN2;LIX1
13588,GO:0051148,0.303332827511465,0.949786308999374,1,53,negative regulation of muscle cell differentiation,BP,PI16
840,GO:0002090,0.303333309357157,0.949802560939621,1,52,regulation of receptor internalization,BP,HPCA
10646,GO:0042326,0.303696942892279,0.853438020997306,4,414,negative regulation of phosphorylation,BP,FOXM1;DUSP4;SFRP2;SPRY4
13862,GO:0051653,0.304200330235734,0.949569102448234,1,48,spindle localization,BP,ASPM
2790,GO:0005875,0.304903123653141,0.900163299690523,2,144,microtubule associated complex,CC,KIFC1;BIRC5
5043,GO:0010952,0.305003998112087,0.899955729187197,2,179,positive regulation of peptidase activity,BP,SFRP2;GRIN2B
6259,GO:0018105,0.306446110010792,0.870540988102364,3,272,peptidyl-serine phosphorylation,BP,CAMK1G;CAMK2A;SFRP2
13143,GO:0048857,0.306619755314648,0.948571972133883,1,56,neural nucleus development,BP,KCNC2
18436,GO:0120032,0.30706893344009,0.898897899885098,2,160,regulation of plasma membrane bounded cell projection assembly,BP,NEURL1;TENM2
11931,GO:0045597,0.307284531731199,0.811871079189713,8,927,positive regulation of cell differentiation,BP,ASPM;SYT1;STMN2;NEURL1;CNR1;SYT4;SFRP2;ENC1
19257,GO:1902041,0.307324271699552,0.948304961315471,1,57,regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,SFRP2
14977,GO:0061098,0.30809399954649,0.948090038942874,1,53,positive regulation of protein tyrosine kinase activity,BP,NEURL1
13864,GO:0051656,0.308339826578744,0.850259616896436,4,402,establishment of organelle localization,BP,KIFC1;DNM1;CENPF;SYT4
4688,GO:0010332,0.308486146943773,0.947965876063361,1,52,response to gamma radiation,BP,CRYAB
13925,GO:0051784,0.309299596926038,0.947607888171578,1,56,negative regulation of nuclear division,BP,CENPF
13788,GO:0051536,0.309450227828533,0.947484513329547,1,61,iron-sulfur cluster binding,MF,KIF4A
13792,GO:0051540,0.309450227828533,0.947484513329547,1,61,metal cluster binding,MF,KIF4A
3999,GO:0008328,0.310332546529159,0.947354345266313,1,49,ionotropic glutamate receptor complex,CC,GRIN2B
16204,GO:0071478,0.310468819494016,0.896978697083697,2,170,cellular response to radiation,BP,CRYAB;SFRP2
4586,GO:0009895,0.310588223408111,0.867873363464835,3,281,negative regulation of catabolic process,BP,LZTS1;PTPN3;CNR1
12969,GO:0048519,0.310888424137961,0.759550495240966,35,4863,negative regulation of biological process,BP,CD38;LZTS1;ASPM;PTPN3;TPX2;BIRC5;SYTL4;STMN2;DNM1;NEURL1;CRYAB;FOXM1;IGFBP2;CENPF;CNR1;DUSP4;HPCA;TOP2A;SYT4;MRAP2;SFRP2;GABRB2;TENM2;DAAM2;CREB3L1;VSNL1;FABP7;PI16;ENC1;RRM2;MYT1L;SPRY4;NMB;PPP1R14C;GRIN2B
12854,GO:0048232,0.312423096239086,0.84739551902549,4,430,male gamete generation,BP,KIFC1;ASPM;NEURL1;CNR1
14625,GO:0060491,0.312517564075413,0.895873455090624,2,162,regulation of cell projection assembly,BP,NEURL1;TENM2
9656,GO:0035308,0.312684669856144,0.946345905937484,1,58,negative regulation of protein dephosphorylation,BP,PPP1R14C
7194,GO:0030173,0.312972931613523,0.946240149222741,1,58,integral component of Golgi membrane,CC,SYT4
15500,GO:0070192,0.313363084058257,0.946142198995134,1,55,chromosome organization involved in meiotic cell cycle,BP,NCAPH
21865,GO:2000649,0.314321758176498,0.945805714140336,1,54,regulation of sodium ion transmembrane transporter activity,BP,PTPN3
2787,GO:0005871,0.314573408463351,0.945825507335643,1,48,kinesin complex,CC,KIFC1
4742,GO:0010518,0.314629986343546,0.945644616527591,1,57,positive regulation of phospholipase activity,BP,HPCA
558,GO:0001706,0.314808931680505,0.945660650971965,1,52,endoderm formation,BP,DUSP4
16915,GO:0080135,0.314863680324732,0.821164266784806,6,687,regulation of cellular response to stress,BP,CAMK2A;CRYAB;FOXM1;SFRP2;HSPB8;CREB3L1
6676,GO:0019897,0.315215824378324,0.894360610543478,2,163,extrinsic component of plasma membrane,CC,SNAP25;STAC2
5744,GO:0016241,0.315237780054953,0.894339549297902,2,165,regulation of macroautophagy,BP,LZTS1;HSPB8
13340,GO:0050773,0.315338133707746,0.894370621713724,2,147,regulation of dendrite development,BP,LZTS1;NEURL1
13498,GO:0051018,0.315495874455186,0.9455068694034,1,47,protein kinase A binding,MF,C2ORF88
12379,GO:0046503,0.315556537411956,0.945258858841679,1,60,glycerolipid catabolic process,BP,FABP7
11450,GO:0044057,0.315736089344525,0.831140724094129,5,544,regulation of system process,BP,CD38;NPTX2;CHRM3;PI16;NPTX1
4548,GO:0009749,0.316427547900285,0.893650109842454,2,170,response to glucose,BP,PTPRN;VSNL1
11079,GO:0043195,0.316478323341779,0.945042470967248,1,52,terminal bouton,CC,KCNC2
7810,GO:0031400,0.317128381260298,0.830109190926649,5,556,negative regulation of protein modification process,BP,FOXM1;DUSP4;SFRP2;SPRY4;PPP1R14C
4314,GO:0009119,0.317155959376104,0.944600371607345,1,65,ribonucleoside metabolic process,BP,TJP2
9015,GO:0033619,0.317274031242661,0.94464802425,1,58,membrane protein proteolysis,BP,PTPN3
17936,GO:0098878,0.317493965570206,0.944683097670575,1,51,neurotransmitter receptor complex,CC,GRIN2B
12413,GO:0046580,0.317695651200585,0.944627324166674,1,50,negative regulation of Ras protein signal transduction,BP,SPRY4
19086,GO:1901607,0.318212740046007,0.944254844881512,1,61,alpha-amino acid biosynthetic process,BP,BCAT1
12963,GO:0048511,0.31830426813106,0.862871415430731,3,287,rhythmic process,BP,PTPRN;TOP2A;ADCY1
11890,GO:0045453,0.318577881288242,0.94416012829219,1,58,bone resorption,BP,CD38
18940,GO:1901214,0.318816222322191,0.862519183451945,3,296,regulation of neuron death,BP,MYBL2;GABRB2;GRIN2B
13392,GO:0050853,0.319157462688461,0.943913716472367,1,60,B cell receptor signaling pathway,BP,CD38
5585,GO:0015909,0.319213702757191,0.943865661270039,1,62,long-chain fatty acid transport,BP,NMB
7681,GO:0031145,0.320176913346752,0.943344380347896,1,77,anaphase-promoting complex-dependent catabolic process,BP,UBE2C
4792,GO:0010611,0.320435045314732,0.943542976734244,1,53,regulation of cardiac muscle hypertrophy,BP,PI16
11391,GO:0043900,0.320512798547425,0.943388797893156,1,61,regulation of multi-organism process,BP,CNR1
4595,GO:0009925,0.3206225681593,0.94352937489552,1,50,basal plasma membrane,CC,CHRM3
10798,GO:0042625,0.320971308285354,0.943289281654809,1,56,ATPase-coupled ion transmembrane transporter activity,MF,SLC30A3
17440,GO:0097120,0.321015886693619,0.943305886240184,1,54,receptor localization to synapse,BP,SNAP25
11059,GO:0043167,0.32178943280826,0.747703321769085,41,5549,ion binding,MF,CAMK1G;SYT13;KIFC1;SYT1;CAMK2A;LNX1;RPH3A;BIRC5;KIF4A;EEF1A2;SYTL4;NPTX2;DNM1;NEURL1;CRYAB;HPCA;TOP2A;SYT4;GPR12;CHRM3;STAC2;HUNK;TENM2;MKI67;FREM2;NRGN;ABI3BP;VSNL1;ETNPPL;ADCY1;MELK;FOLR2;NPTX1;RRM2;ZCCHC12;UBE2C;MYT1L;HAPLN4;SELL;CPNE4;GRIN2B
6057,GO:0016835,0.322076209793469,0.942698992127184,1,69,carbon-oxygen lyase activity,MF,ETNPPL
20114,GO:1903902,0.322290768837053,0.942742423126992,1,59,positive regulation of viral life cycle,BP,TOP2A
593,GO:0001764,0.32232837807183,0.890396004905259,2,151,neuron migration,BP,ASPM;CAMK2A
4420,GO:0009247,0.322345059994178,0.942666869854147,1,63,glycolipid biosynthetic process,BP,ST8SIA5
13859,GO:0051649,0.322999073891813,0.763808091716556,19,2552,establishment of localization in cell,BP,PTPRN;KIFC1;SYT1;CAMK2A;RPH3A;KIF4A;SYTL4;SLC17A7;DNM1;CRYAB;CENPF;CNR1;HPCA;SNAP25;SYT4;VSNL1;ADCY1;SELL;GRIN2B
4765,GO:0010564,0.323116639293525,0.814884781028725,6,694,regulation of cell cycle process,BP,TPX2;FOXM1;CENPF;MKI67;RRM2;UBE2C
18524,GO:0140056,0.323453053497079,0.889667643832082,2,169,organelle localization by membrane tethering,BP,SYT1;SNAP25
19430,GO:1902475,0.323634512791368,0.942276374048937,1,56,L-alpha-amino acid transmembrane transport,BP,SLC17A7
3825,GO:0008038,0.32459348298891,0.942020002886596,1,50,neuron recognition,BP,CNR1
696,GO:0001895,0.326313426581913,0.941184873898179,1,60,retina homeostasis,BP,USH1C
18880,GO:1901016,0.326802952411533,0.941057878177154,1,56,regulation of potassium ion transmembrane transporter activity,BP,KCNC2
11303,GO:0043549,0.327805579580069,0.802650802289056,7,824,regulation of kinase activity,BP,TPX2;EEF1A2;NEURL1;DUSP4;SFRP2;ADCY1;SPRY4
4547,GO:0009746,0.328554409914884,0.886705330328583,2,175,response to hexose,BP,PTPRN;VSNL1
19697,GO:1903078,0.329393899425058,0.940050577601304,1,56,positive regulation of protein localization to plasma membrane,BP,STAC2
16029,GO:0071214,0.329815069012426,0.855254554784872,3,305,cellular response to abiotic stimulus,BP,CRYAB;HPCA;SFRP2
18323,GO:0104004,0.329815069012426,0.855254554784872,3,305,cellular response to environmental stimulus,BP,CRYAB;HPCA;SFRP2
17624,GO:0097479,0.329963904600146,0.93984500210161,1,55,synaptic vesicle localization,BP,DNM1
7211,GO:0030199,0.330343778105964,0.939752399399846,1,52,collagen fibril organization,BP,SFRP2
7706,GO:0031228,0.330382973684476,0.939570908190248,1,62,intrinsic component of Golgi membrane,CC,SYT4
5169,GO:0014743,0.331108341898244,0.939396100938723,1,55,regulation of muscle hypertrophy,BP,PI16
15739,GO:0070588,0.33155391172748,0.854139803545036,3,284,calcium ion transmembrane transport,BP,HPCA;STAC2;GRIN2B
13040,GO:0048663,0.332149673744752,0.938874868452759,1,62,neuron fate commitment,BP,MYT1L
13283,GO:0050670,0.332177738061966,0.884506857713763,2,200,regulation of lymphocyte proliferation,BP,CD38;IGFBP2
3325,GO:0006687,0.332384166487183,0.938782138073315,1,62,glycosphingolipid metabolic process,BP,ST8SIA5
12021,GO:0045739,0.332430564349775,0.938824075880608,1,58,positive regulation of DNA repair,BP,FOXM1
13357,GO:0050795,0.332499737136471,0.938765558215124,1,60,regulation of behavior,BP,CNR1
9980,GO:0035869,0.333233002744903,0.938506369668335,1,58,ciliary transition zone,CC,USH1C
6374,GO:0018995,0.3333489722339,0.938429050856362,1,60,host cellular component,CC,TOP2A
11363,GO:0043657,0.3333489722339,0.938429050856362,1,60,host cell,CC,TOP2A
6202,GO:0017137,0.333496969269805,0.883913789115531,2,156,Rab GTPase binding,MF,RPH3A;SYTL4
7330,GO:0030374,0.334114416494402,0.938226244480917,1,54,nuclear receptor transcription coactivator activity,MF,ZCCHC12
13028,GO:0048639,0.33424868368057,0.883452606332378,2,160,positive regulation of developmental growth,BP,SYT1;SYT4
8723,GO:0032944,0.334355840909337,0.883226908993654,2,201,regulation of mononuclear cell proliferation,BP,CD38;IGFBP2
9778,GO:0035556,0.334923027471704,0.753459687311275,19,2507,intracellular signal transduction,BP,TPX2;CRYAB;FOXM1;CNR1;TJP2;DUSP4;HPCA;GPR12;CHRM3;MRAP2;STAC2;HUNK;SFRP2;CREB3L1;ADCY1;MELK;KCNC2;SPRY4;GRIN2B
9561,GO:0035082,0.334974285951595,0.937847572765701,1,56,axoneme assembly,BP,NEURL1
4698,GO:0010389,0.335010006779532,0.882889822178896,2,187,regulation of G2/M transition of mitotic cell cycle,BP,TPX2;CENPF
4316,GO:0009123,0.335037743405919,0.937660884867265,1,67,nucleoside monophosphate metabolic process,BP,TJP2
17600,GO:0097435,0.335159073012164,0.805635493784667,6,656,supramolecular fiber organization,BP,USH1C;TPX2;STMN2;NEFM;CRYAB;SFRP2
11990,GO:0045669,0.335599701954884,0.937563794524349,1,58,positive regulation of osteoblast differentiation,BP,SFRP2
11304,GO:0043550,0.336316657171309,0.937260410991031,1,59,regulation of lipid kinase activity,BP,EEF1A2
11774,GO:0045123,0.336958443503683,0.936956983126756,1,62,cellular extravasation,BP,SELL
15321,GO:0061912,0.33710387984058,0.936994740578715,1,56,selective autophagy,BP,HSPB8
6138,GO:0017016,0.337106971692486,0.829960128173978,4,383,Ras GTPase binding,MF,RPH3A;BIRC5;SYTL4;DAAM2
4673,GO:0010256,0.338790985154753,0.828693544452051,4,415,endomembrane system organization,BP,PTPRN;SYTL4;DNM1;SYT4
12563,GO:0046902,0.339866342804032,0.935687966698385,1,69,regulation of mitochondrial membrane permeability,BP,CAMK2A
6294,GO:0018209,0.340330343661227,0.848216635822839,3,291,peptidyl-serine modification,BP,CAMK1G;CAMK2A;SFRP2
17825,GO:0098687,0.340646024142131,0.847980683951494,3,301,chromosomal region,CC,BIRC5;NCAPG;CENPF
13462,GO:0050953,0.340835260297413,0.87945423432468,2,183,sensory perception of light stimulus,BP,USH1C;SLC4A10
9240,GO:0034284,0.340890764665856,0.879433080334741,2,180,response to monosaccharide,BP,PTPRN;VSNL1
3707,GO:0007369,0.341150442774779,0.879330304731893,2,168,gastrulation,BP,DUSP4;SFRP2
14363,GO:0060135,0.34139478882996,0.935157186585876,1,62,maternal process involved in female pregnancy,BP,CNR1
12392,GO:0046530,0.342121871470044,0.934940576674782,1,57,photoreceptor cell differentiation,BP,USH1C
14202,GO:0055021,0.342438524654091,0.934776610701499,1,59,regulation of cardiac muscle tissue growth,BP,PI16
4503,GO:0009593,0.342531624299383,0.934520511106631,1,76,detection of chemical stimulus,BP,SYT1
13631,GO:0051235,0.342828957659279,0.846506288070974,3,296,maintenance of location,BP,ASPM;SLC17A7;SLC30A3
18630,GO:0150076,0.343239509720154,0.934400144814141,1,62,neuroinflammatory response,BP,ADCY1
11411,GO:0043954,0.343794889510713,0.934290137041375,1,55,cellular component maintenance,BP,GRIN2B
13410,GO:0050871,0.343817498628295,0.934079492025776,1,68,positive regulation of B cell activation,BP,CD38
13500,GO:0051020,0.343952846502759,0.8100894101748,5,508,GTPase binding,MF,PTPRN;RPH3A;BIRC5;SYTL4;DAAM2
10028,GO:0035966,0.344252794511669,0.877374045910496,2,192,response to topologically incorrect protein,BP,HSPB8;CREB3L1
7012,GO:0022406,0.344871158552473,0.877056628227599,2,178,membrane docking,BP,SYT1;SNAP25
10555,GO:0042127,0.345320593656165,0.765749122041138,11,1452,regulation of cell population proliferation,BP,CD38;PTPRN;ASPM;BIRC5;NEURL1;FOXM1;IGFBP2;SFRP2;FABP7;FOLR2;NMB
14402,GO:0060193,0.345746363283852,0.933305960465103,1,66,positive regulation of lipase activity,BP,HPCA
11243,GO:0043462,0.346435472247319,0.932901898437428,1,76,regulation of ATPase activity,BP,NCAPH
20220,GO:1904115,0.346719062347866,0.933060075408543,1,56,axon cytoplasm,CC,KIF4A
8493,GO:0032592,0.348036360170781,0.932274827196634,1,72,integral component of mitochondrial membrane,CC,CNR1
17981,GO:0098930,0.348641802606675,0.932237966885161,1,57,axonal transport,BP,KIF4A
13532,GO:0051058,0.34916893736668,0.93203537672805,1,56,negative regulation of small GTPase mediated signal transduction,BP,SPRY4
20374,GO:1904427,0.350582808199584,0.931277031419001,1,66,positive regulation of calcium ion transmembrane transport,BP,STAC2
11798,GO:0045171,0.350950156593598,0.93112147844224,1,66,intercellular bridge,CC,TPX2
13695,GO:0051336,0.351061592750074,0.770586510211521,9,1136,regulation of hydrolase activity,BP,CAMK2A;BIRC5;CRYAB;NCAPH;HPCA;SFRP2;PI16;PPP1R14C;GRIN2B
13423,GO:0050891,0.351649891295034,0.930916333550464,1,60,multicellular organismal water homeostasis,BP,ADCY1
7177,GO:0030154,0.352447607948745,0.727873262825469,27,3636,cell differentiation,BP,CD38;USH1C;LZTS1;ASPM;SYT1;CAMK2A;STMN2;NEURL1;FOXM1;CENPF;CNR1;TJP2;TOP2A;SNAP25;SYT4;SLC4A10;SFRP2;GABRB2;TENM2;DAAM2;CREB3L1;FABP7;PI16;ADCY1;NPTX1;ENC1;MYT1L
11214,GO:0043405,0.352759734489827,0.839639757918668,3,313,regulation of MAP kinase activity,BP,DUSP4;SFRP2;SPRY4
17768,GO:0098573,0.353110662418906,0.93011383039692,1,73,intrinsic component of mitochondrial membrane,CC,CNR1
9251,GO:0034329,0.35443141507364,0.817255722056252,4,392,cell junction assembly,BP,GABRA1;GABRG2;GABRB2;IGFN1
4741,GO:0010517,0.355240202904417,0.929304057008308,1,65,regulation of phospholipase activity,BP,HPCA
13926,GO:0051785,0.355544164546625,0.92918809586108,1,64,positive regulation of nuclear division,BP,UBE2C
559,GO:0001707,0.355849127720405,0.929072085724879,1,63,mesoderm formation,BP,SFRP2
7653,GO:0031100,0.355914262120722,0.928945641427358,1,70,animal organ regeneration,BP,PTPN3
3719,GO:0007405,0.356026040897202,0.929080714011156,1,58,neuroblast proliferation,BP,ASPM
10828,GO:0042698,0.356159022829548,0.928908149340294,1,65,ovulation cycle,BP,PTPRN
8370,GO:0032418,0.356459313186636,0.928736287871924,1,68,lysosome localization,BP,SYTL4
686,GO:0001885,0.356603346933687,0.928779006640922,1,61,endothelial cell development,BP,TJP2
7728,GO:0031267,0.357132243536028,0.815243738501929,4,394,small GTPase binding,MF,RPH3A;BIRC5;SYTL4;DAAM2
11997,GO:0045685,0.358225437083235,0.927970431219043,1,68,regulation of glial cell differentiation,BP,DAAM2
19369,GO:1902305,0.358636178527303,0.927865059546377,1,63,regulation of sodium ion transmembrane transport,BP,PTPN3
13091,GO:0048736,0.360157927987483,0.867736787417394,2,169,appendage development,BP,SFRP2;FREM2
14389,GO:0060173,0.360157927987483,0.867736787417394,2,169,limb development,BP,SFRP2;FREM2
21167,GO:1990138,0.360731364057373,0.867394556959847,2,166,neuron projection extension,BP,SYT1;SYT4
9140,GO:0034103,0.361092037062559,0.926731150966128,1,67,regulation of tissue remodeling,BP,CD38
587,GO:0001756,0.361629062114255,0.9265888868631,1,61,somitogenesis,BP,SFRP2
20342,GO:1904377,0.362280642020555,0.92626868457703,1,63,positive regulation of protein localization to cell periphery,BP,STAC2
19821,GO:1903350,0.362305879073766,0.926142777273672,1,71,response to dopamine,BP,CHRM3
19822,GO:1903351,0.362305879073766,0.926142777273672,1,71,cellular response to dopamine,BP,CHRM3
9021,GO:0033627,0.362628864291018,0.926083675820448,1,65,cell adhesion mediated by integrin,BP,SFRP2
3601,GO:0007167,0.362694770307335,0.767121397497485,8,965,enzyme linked receptor protein signaling pathway,BP,PTPN3;DNM1;NEURL1;IGFBP2;SFRP2;CREB3L1;SPRY4;GRIN2B
11934,GO:0045600,0.363535498355732,0.925653047129961,1,67,positive regulation of fat cell differentiation,BP,SFRP2
12087,GO:0045859,0.363589013250651,0.783131885477049,6,726,regulation of protein kinase activity,BP,TPX2;NEURL1;DUSP4;SFRP2;ADCY1;SPRY4
3282,GO:0006635,0.363870892198454,0.925449928371409,1,71,fatty acid beta-oxidation,BP,CNR1
13852,GO:0051641,0.364661651210255,0.721219382286072,23,3175,cellular localization,BP,PTPRN;KIFC1;ASPM;SYT1;CAMK2A;RPH3A;KIF4A;SYTL4;SLC17A7;DNM1;CRYAB;SLC30A3;CENPF;CNR1;HPCA;SNAP25;SYT4;MRAP2;STAC2;VSNL1;ADCY1;SELL;GRIN2B
11043,GO:0043130,0.36618498512589,0.924418488461753,1,71,ubiquitin binding,MF,TOP2A
15768,GO:0070663,0.366661436307975,0.863469295430342,2,216,regulation of leukocyte proliferation,BP,CD38;IGFBP2
3177,GO:0006513,0.367275957924994,0.924030868516979,1,64,protein monoubiquitination,BP,NEURL1
12912,GO:0048332,0.368003716791179,0.923688016716313,1,65,mesoderm morphogenesis,BP,SFRP2
16043,GO:0071230,0.368547198278035,0.923459230762015,1,64,cellular response to amino acid stimulus,BP,NEURL1
19538,GO:1902749,0.368551858171255,0.862321193675678,2,201,regulation of cell cycle G2/M phase transition,BP,TPX2;CENPF
6752,GO:0021536,0.368663205079085,0.923331751201282,1,69,diencephalon development,BP,KCNC2
2135,GO:0004674,0.368972178956751,0.80632151126717,4,406,protein serine/threonine kinase activity,MF,CAMK1G;CAMK2A;HUNK;MELK
10541,GO:0042100,0.36909239446799,0.923072783137303,1,74,B cell proliferation,BP,CD38
11345,GO:0043624,0.36946019522539,0.861709112973663,2,211,cellular protein complex disassembly,BP,TPX2;STMN2
1632,GO:0003779,0.370182080641917,0.805404406322508,4,405,actin binding,MF,USH1C;HPCA;DAAM2;ENC1
19993,GO:1903670,0.370200186484449,0.922680454092231,1,66,regulation of sprouting angiogenesis,BP,CREB3L1
16546,GO:0072091,0.371613281721197,0.922038172074774,1,66,regulation of stem cell proliferation,BP,ASPM
9498,GO:0034764,0.372484696948105,0.859867611463807,2,187,positive regulation of transmembrane transport,BP,STAC2;KCNC2
5742,GO:0016239,0.372920252291198,0.921525705191937,1,61,positive regulation of macroautophagy,BP,HSPB8
21191,GO:1990204,0.37345043398639,0.920891282622585,1,94,oxidoreductase complex,CC,RRM2
18838,GO:1900449,0.373769664698686,0.92111870673078,1,62,regulation of glutamate receptor signaling pathway,BP,GRIN2B
11499,GO:0044242,0.374613911191934,0.858416568979602,2,209,cellular lipid catabolic process,BP,CNR1;FABP7
7141,GO:0030104,0.374973152867119,0.920498438021989,1,66,water homeostasis,BP,ADCY1
13604,GO:0051172,0.375335751140986,0.723958607279225,16,2143,negative regulation of nitrogen compound metabolic process,BP,CD38;PTPN3;BIRC5;CRYAB;FOXM1;CENPF;DUSP4;HPCA;SFRP2;TENM2;CREB3L1;PI16;ENC1;MYT1L;SPRY4;PPP1R14C
14569,GO:0060420,0.375460349199827,0.920273692759774,1,66,regulation of heart growth,BP,PI16
22026,GO:2001021,0.377226985196438,0.919367898324024,1,72,negative regulation of response to DNA damage stimulus,BP,SFRP2
4343,GO:0009150,0.37846290708523,0.82133867444121,3,339,purine ribonucleotide metabolic process,BP,TJP2;SULT4A1;ADCY1
13573,GO:0051130,0.378509638871142,0.747444453007873,9,1118,positive regulation of cellular component organization,BP,SYT1;STMN2;DNM1;NEURL1;CNR1;SYT4;TENM2;ENC1;UBE2C
3537,GO:0007032,0.378529221898348,0.918774769331842,1,71,endosome organization,BP,DNM1
7199,GO:0030178,0.378762533202028,0.855751418163051,2,204,negative regulation of Wnt signaling pathway,BP,IGFBP2;SFRP2
17486,GO:0097194,0.379244476960418,0.918375373738818,1,76,execution phase of apoptosis,BP,TOP2A
7769,GO:0031327,0.379658781725934,0.736327340862555,11,1426,negative regulation of cellular biosynthetic process,BP,CD38;BIRC5;CRYAB;FOXM1;CENPF;HPCA;SFRP2;TENM2;CREB3L1;ENC1;MYT1L
12948,GO:0048477,0.381369483065583,0.917414762756417,1,73,oogenesis,BP,ASPM
15829,GO:0070821,0.381799816693764,0.91725341094984,1,70,tertiary granule membrane,CC,SNAP25
11281,GO:0043523,0.382249711644609,0.85349658554394,2,199,regulation of neuron apoptotic process,BP,MYBL2;GABRB2
22116,GO:2001234,0.382661952249203,0.853179268815981,2,212,negative regulation of apoptotic signaling pathway,BP,SFRP2;CREB3L1
2588,GO:0005518,0.383513193895513,0.916504341858466,1,66,collagen binding,MF,ABI3BP
12099,GO:0045892,0.384018158422797,0.7427128069745,9,1150,negative regulation of transcription, DNA-templated,BP,CD38;BIRC5;CRYAB;FOXM1;CENPF;SFRP2;TENM2;CREB3L1;MYT1L
3677,GO:0007281,0.384494403623771,0.852012455054076,2,202,germ cell development,BP,ASPM;NEURL1
135,GO:0000281,0.38503387847638,0.9157183377606,1,70,mitotic cytokinesis,BP,KIF4A
6673,GO:0019888,0.385363851108031,0.915479122438484,1,76,protein phosphatase regulator activity,MF,PPP1R14C
7187,GO:0030166,0.385677273410739,0.915508096648164,1,64,proteoglycan biosynthetic process,BP,CHST9
7299,GO:0030317,0.385877790259731,0.915272392328713,1,73,flagellated sperm motility,BP,NEURL1
17721,GO:0097722,0.385877790259731,0.915272392328713,1,73,sperm motility,BP,NEURL1
5719,GO:0016192,0.386149514554193,0.719731755707516,14,1878,vesicle-mediated transport,BP,SYT13;SYT1;KIF4A;SYTL4;SLC17A7;DNM1;CNR1;HPCA;SNAP25;SYT4;VSNL1;ADCY1;FOLR2;SELL
5316,GO:0015171,0.386248108400601,0.915137662314662,1,70,amino acid transmembrane transporter activity,MF,SLC17A7
22025,GO:2001020,0.386310997050787,0.850823139755907,2,200,regulation of response to DNA damage stimulus,BP,FOXM1;SFRP2
8383,GO:0032432,0.386665521645152,0.915000612173101,1,66,actin filament bundle,CC,CRYAB
15683,GO:0070507,0.386789994224642,0.850584008665151,2,182,regulation of microtubule cytoskeleton organization,BP,TPX2;STMN2
21371,GO:1990778,0.386959839477203,0.815162518586333,3,320,protein localization to cell periphery,BP,SNAP25;MRAP2;STAC2
2167,GO:0004722,0.386972369148954,0.914790173360836,1,70,protein serine/threonine phosphatase activity,MF,DUSP4
6970,GO:0021953,0.387480619601203,0.850104414655387,2,187,central nervous system neuron differentiation,BP,SLC4A10;SFRP2
584,GO:0001750,0.387658023284462,0.914475595535787,1,69,photoreceptor outer segment,CC,USH1C
3878,GO:0008135,0.387731239258111,0.914317828070395,1,78,translation factor activity, RNA binding,MF,EEF1A2
4183,GO:0008652,0.388157572712112,0.914124354302526,1,77,cellular amino acid biosynthetic process,BP,BCAT1
13152,GO:0048869,0.388810138266388,0.694867064366218,27,3702,cellular developmental process,BP,CD38;USH1C;LZTS1;ASPM;SYT1;CAMK2A;STMN2;NEURL1;FOXM1;CENPF;CNR1;TJP2;TOP2A;SNAP25;SYT4;SLC4A10;SFRP2;GABRB2;TENM2;DAAM2;CREB3L1;FABP7;PI16;ADCY1;NPTX1;ENC1;MYT1L
8264,GO:0032272,0.389626192681099,0.913494796675926,1,71,negative regulation of protein polymerization,BP,STMN2
15948,GO:0070997,0.389762416482974,0.813066128052534,3,333,neuron death,BP,MYBL2;GABRB2;GRIN2B
4733,GO:0010506,0.389773365937319,0.813074435713077,3,325,regulation of autophagy,BP,LZTS1;EEF1A2;HSPB8
16042,GO:0071229,0.390058778075071,0.913315228115028,1,69,cellular response to acid chemical,BP,NEURL1
12072,GO:0045833,0.391990722232356,0.912274764180217,1,76,negative regulation of lipid metabolic process,BP,CNR1
3373,GO:0006767,0.392860064226419,0.911823767690586,1,78,water-soluble vitamin metabolic process,BP,FOLR2
3804,GO:0007626,0.394690934054549,0.845310512452053,2,184,locomotory behavior,BP,SNAP25;SLC4A10
7282,GO:0030295,0.394874163177957,0.910858264117434,1,76,protein kinase activator activity,MF,TPX2
11069,GO:0043178,0.396509750997043,0.910075959702443,1,74,alcohol binding,MF,RPH3A
1471,GO:0003208,0.39682450718954,0.910011132194501,1,68,cardiac ventricle morphogenesis,BP,SFRP2
10327,GO:0038024,0.397100491963381,0.909874122894118,1,68,cargo receptor activity,MF,FOLR2
11802,GO:0045178,0.397189541951719,0.909864125984503,1,66,basal part of cell,CC,CHRM3
14497,GO:0060333,0.397486178777593,0.909456279044437,1,85,interferon-gamma-mediated signaling pathway,BP,CAMK2A
21942,GO:2000779,0.397565686821097,0.909610564128867,1,70,regulation of double-strand break repair,BP,FOXM1
838,GO:0002088,0.397800910241105,0.909493475102125,1,70,lens development in camera-type eye,BP,CRYAB
12411,GO:0046578,0.398215082707793,0.84293856020492,2,183,regulation of Ras protein signal transduction,BP,FOXM1;SPRY4
4114,GO:0008514,0.398317184046914,0.842781874930342,2,203,organic anion transmembrane transporter activity,MF,SLC17A7;SLC4A10
19919,GO:1903533,0.398668556694554,0.908947459245706,1,78,regulation of protein targeting,BP,HPCA
6262,GO:0018108,0.398995444114925,0.80618676833102,3,329,peptidyl-tyrosine phosphorylation,BP,NEURL1;SFRP2;MELK
35,GO:0000075,0.39903958189453,0.842288227059987,2,204,cell cycle checkpoint,BP,CENPF;TOP2A
3850,GO:0008088,0.399218784307748,0.90881836346677,1,68,axo-dendritic transport,BP,KIF4A
11521,GO:0044291,0.399312302873432,0.908771583850428,1,68,cell-cell contact zone,CC,TJP2
4581,GO:0009890,0.40093287804803,0.7176381267099,11,1454,negative regulation of biosynthetic process,BP,CD38;BIRC5;CRYAB;FOXM1;CENPF;HPCA;SFRP2;TENM2;CREB3L1;ENC1;MYT1L
4545,GO:0009743,0.401871358903752,0.840357371360122,2,205,response to carbohydrate,BP,PTPRN;VSNL1
4428,GO:0009259,0.402955177102975,0.803150648403751,3,354,ribonucleotide metabolic process,BP,TJP2;SULT4A1;ADCY1
10267,GO:0036473,0.403117474986131,0.906706910705217,1,78,cell death in response to oxidative stress,BP,MELK
5584,GO:0015908,0.403274950194128,0.906589456145535,1,81,fatty acid transport,BP,NMB
19234,GO:1901992,0.403632459548704,0.906432587391854,1,79,positive regulation of mitotic cell cycle phase transition,BP,UBE2C
6297,GO:0018212,0.403969392929175,0.802425619107465,3,332,peptidyl-tyrosine modification,BP,NEURL1;SFRP2;MELK
13861,GO:0051651,0.404883855820217,0.838327705160034,2,197,maintenance of location in cell,BP,ASPM;SLC30A3
13760,GO:0051453,0.406197300319631,0.905110962623292,1,80,regulation of intracellular pH,BP,SLC4A10
10106,GO:0036094,0.406609010806041,0.693460546864942,17,2277,small molecule binding,MF,CAMK1G;KIFC1;CAMK2A;RPH3A;KIF4A;EEF1A2;DNM1;TOP2A;HUNK;MKI67;ETNPPL;ADCY1;MELK;FOLR2;UBE2C;HAPLN4;GRIN2B
7545,GO:0030901,0.406827607105777,0.904787579386064,1,80,midbrain development,BP,SFRP2
518,GO:0001649,0.40691921951802,0.836901840371296,2,203,osteoblast differentiation,BP,SFRP2;CREB3L1
10543,GO:0042102,0.407802911521256,0.904173676371668,1,90,positive regulation of T cell proliferation,BP,IGFBP2
13003,GO:0048585,0.409029257391411,0.7104271486477,11,1498,negative regulation of response to stimulus,BP,PTPN3;DNM1;NEURL1;FOXM1;IGFBP2;DUSP4;MRAP2;SFRP2;CREB3L1;FABP7;SPRY4
5254,GO:0015031,0.409540950372397,0.702019357894948,13,1814,protein transport,BP,CD38;PTPRN;RPH3A;SYTL4;DNM1;CENPF;CNR1;HPCA;VGF;SNAP25;SYT4;VSNL1;KCNC2
11009,GO:0043066,0.409878357005302,0.74484893968528,6,797,negative regulation of apoptotic process,BP,CD38;BIRC5;CRYAB;SFRP2;GABRB2;CREB3L1
3288,GO:0006641,0.410262728764447,0.902988577213961,1,82,triglyceride metabolic process,BP,FABP7
7474,GO:0030705,0.410747866544703,0.834326735574063,2,186,cytoskeleton-dependent intracellular transport,BP,KIF4A;SYT4
7250,GO:0030246,0.411164709519036,0.833868808936272,2,228,carbohydrate binding,MF,NPTX2;SELL
11355,GO:0043648,0.411387580687594,0.902345618241501,1,87,dicarboxylic acid metabolic process,BP,FOLR2
3589,GO:0007155,0.412521554002283,0.71221399661227,10,1261,cell adhesion,BP,IGFBP2;TJP2;SFRP2;TENM2;FREM2;ABI3BP;IGFN1;FOLR2;HAPLN4;SELL
3527,GO:0007018,0.41253322080255,0.795911943119295,3,321,microtubule-based movement,BP,KIFC1;KIF4A;NEURL1
9143,GO:0034109,0.414444975575228,0.900881708845626,1,76,homotypic cell-cell adhesion,BP,TJP2
536,GO:0001669,0.414969033797424,0.900477868227884,1,86,acrosomal vesicle,CC,SV2B
4170,GO:0008625,0.415314186508306,0.900330848444392,1,83,extrinsic apoptotic signaling pathway via death domain receptors,BP,SFRP2
13001,GO:0048583,0.415517138456896,0.671178001410701,26,3708,regulation of response to stimulus,BP,CD38;ASPM;PTPN3;CAMK2A;TPX2;SYTL4;NPTX2;DNM1;NEURL1;CRYAB;FOXM1;IGFBP2;CNR1;DUSP4;MRAP2;SFRP2;DAAM2;HSPB8;CREB3L1;VSNL1;FABP7;PI16;NPTX1;SPRY4;SELL;GRIN2B
3801,GO:0007623,0.415807394503725,0.830705647394229,2,205,circadian rhythm,BP,TOP2A;ADCY1
13561,GO:0051117,0.416321441168152,0.899810501451421,1,82,ATPase binding,MF,PTPN3
8904,GO:0033273,0.416597809265981,0.899651679463507,1,83,response to vitamin,BP,FOLR2
6586,GO:0019693,0.416905664357483,0.792450101176042,3,364,ribose phosphate metabolic process,BP,TJP2;SULT4A1;ADCY1
21082,GO:1905897,0.417121272108287,0.899338431263423,1,86,regulation of response to endoplasmic reticulum stress,BP,CREB3L1
13860,GO:0051650,0.417656666771257,0.82943806113263,2,197,establishment of vesicle localization,BP,DNM1;SYT4
7646,GO:0031091,0.418123832057703,0.898828452775328,1,84,platelet alpha granule,CC,SYTL4
7028,GO:0022610,0.418257461026042,0.70709762547268,10,1267,biological adhesion,BP,IGFBP2;TJP2;SFRP2;TENM2;FREM2;ABI3BP;IGFN1;FOLR2;HAPLN4;SELL
1103,GO:0002526,0.418637250126731,0.898447011610403,1,94,acute inflammatory response,BP,CNR1
5384,GO:0015297,0.419276588019038,0.898319966696472,1,76,antiporter activity,MF,SLC4A10
19897,GO:1903507,0.419513302410993,0.711683786413356,9,1186,negative regulation of nucleic acid-templated transcription,BP,CD38;BIRC5;CRYAB;FOXM1;CENPF;SFRP2;TENM2;CREB3L1;MYT1L
4312,GO:0009116,0.419945350261061,0.897746748690935,1,94,nucleoside metabolic process,BP,TJP2
2942,GO:0006112,0.420030021543243,0.897931936391709,1,75,energy reserve metabolic process,BP,MRAP2
7098,GO:0030017,0.420166466611693,0.827677127857601,2,194,sarcomere,CC,CRYAB;IGFN1
18142,GO:0099518,0.420504793410053,0.897814131531116,1,67,vesicle cytoskeletal trafficking,BP,SYT4
6441,GO:0019209,0.420652544507493,0.89750052433981,1,82,kinase activator activity,MF,TPX2
19509,GO:1902679,0.420751437559531,0.710582446844128,9,1188,negative regulation of RNA biosynthetic process,BP,CD38;BIRC5;CRYAB;FOXM1;CENPF;SFRP2;TENM2;CREB3L1;MYT1L
3449,GO:0006890,0.421212763393275,0.897212353128086,1,81,retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum,BP,KIF4A
5738,GO:0016234,0.422560633451768,0.896571264233201,1,75,inclusion body,CC,NEFM
3737,GO:0007492,0.422727029380881,0.896481411699365,1,75,endoderm development,BP,DUSP4
21516,GO:2000113,0.422754482923839,0.703051048039235,10,1328,negative regulation of cellular macromolecule biosynthetic process,BP,CD38;BIRC5;CRYAB;FOXM1;CENPF;SFRP2;TENM2;CREB3L1;ENC1;MYT1L
14400,GO:0060191,0.423193508132584,0.896105198660762,1,84,regulation of lipase activity,BP,HPCA
13636,GO:0051241,0.4233199227701,0.715079815525722,8,1081,negative regulation of multicellular organismal process,BP,CD38;ASPM;STMN2;SYT4;SFRP2;DAAM2;CREB3L1;PI16
1428,GO:0003151,0.423551124515871,0.896020442215434,1,76,outflow tract morphogenesis,BP,SFRP2
12541,GO:0046872,0.424636381528168,0.661641499265583,27,3712,metal ion binding,MF,SYT13;SYT1;CAMK2A;LNX1;RPH3A;BIRC5;KIF4A;SYTL4;NPTX2;NEURL1;CRYAB;HPCA;TOP2A;SYT4;STAC2;TENM2;FREM2;VSNL1;ADCY1;MELK;NPTX1;RRM2;ZCCHC12;MYT1L;SELL;CPNE4;GRIN2B
18657,GO:1900006,0.424723963184651,0.895465097697443,1,71,positive regulation of dendrite development,BP,NEURL1
13319,GO:0050730,0.424879400224042,0.824208274650408,2,221,regulation of peptidyl-tyrosine phosphorylation,BP,NEURL1;SFRP2
19591,GO:1902903,0.425087144106771,0.786126136806868,3,336,regulation of supramolecular fiber organization,BP,TPX2;STMN2;CRYAB
6448,GO:0019217,0.425713024199933,0.894774143784501,1,81,regulation of fatty acid metabolic process,BP,CNR1
14464,GO:0060294,0.425950744664226,0.894593296902224,1,85,cilium movement involved in cell motility,BP,NEURL1
1542,GO:0003333,0.426507918466435,0.894367411650478,1,79,amino acid transmembrane transport,BP,SLC17A7
11012,GO:0043069,0.427010625052699,0.730160720681874,6,811,negative regulation of programmed cell death,BP,CD38;BIRC5;CRYAB;SFRP2;GABRB2;CREB3L1
4734,GO:0010507,0.427246815667794,0.893977189080724,1,78,negative regulation of autophagy,BP,LZTS1
17262,GO:0090407,0.427571473244255,0.759767415884203,4,516,organophosphate biosynthetic process,BP,HPCA;ETNPPL;ADCY1;RRM2
14196,GO:0055013,0.427635409676363,0.893931218769557,1,68,cardiac muscle cell development,BP,PI16
8669,GO:0032872,0.428009612301719,0.821997813252319,2,211,regulation of stress-activated MAPK cascade,BP,FOXM1;SFRP2
8832,GO:0033138,0.428122866350118,0.89339043838149,1,86,positive regulation of peptidyl-serine phosphorylation,BP,SFRP2
2095,GO:0004620,0.42885300604218,0.893025758056426,1,83,phospholipase activity,MF,CHRM3
19143,GO:1901701,0.429175362312849,0.709890071162401,8,1080,cellular response to oxygen-containing compound,BP,PTPRN;CAMK2A;NEURL1;CHRM3;VSNL1;ADCY1;FOLR2;KCNC2
11264,GO:0043502,0.429254939203017,0.892903133739984,1,76,regulation of muscle adaptation,BP,PI16
17511,GO:0097237,0.429748410172001,0.892305807062658,1,105,cellular response to toxic substance,BP,KCNC2
13109,GO:0048786,0.430022390864581,0.892511270070996,1,74,presynaptic active zone,CC,SLC17A7
12531,GO:0046849,0.430162309358271,0.892289717267261,1,84,bone remodeling,BP,CD38
7437,GO:0030641,0.430285226242037,0.892184860175645,1,87,regulation of cellular pH,BP,SLC4A10
17924,GO:0098858,0.430564778907709,0.820207887882264,2,198,actin-based cell projection,CC,USH1C;TENM2
14205,GO:0055024,0.432026070344712,0.891323127838521,1,79,regulation of cardiac muscle tissue development,BP,PI16
3467,GO:0006914,0.432418224909027,0.755772072261243,4,500,autophagy,BP,LZTS1;EEF1A2;LIX1;HSPB8
15322,GO:0061919,0.432418224909027,0.755772072261243,4,500,process utilizing autophagic mechanism,BP,LZTS1;EEF1A2;LIX1;HSPB8
19010,GO:1901379,0.432846473363077,0.890851648988872,1,80,regulation of potassium ion transmembrane transport,BP,KCNC2
3813,GO:0008015,0.432972221408083,0.755317697427194,4,495,blood circulation,BP,CD38;CNR1;TJP2;CHRM3
15195,GO:0061640,0.432991982187287,0.890729429490744,1,83,cytoskeleton-dependent cytokinesis,BP,KIF4A
19135,GO:1901681,0.43340400720305,0.818042617265919,2,223,sulfur compound binding,MF,ABI3BP;SELL
17166,GO:0090257,0.434459600303978,0.8173110053781,2,213,regulation of muscle system process,BP,CHRM3;PI16
16419,GO:0071868,0.434914959451916,0.889613911765705,1,86,cellular response to monoamine stimulus,BP,CHRM3
16421,GO:0071870,0.434914959451916,0.889613911765705,1,86,cellular response to catecholamine stimulus,BP,CHRM3
15569,GO:0070302,0.435032649789671,0.816888322624434,2,214,regulation of stress-activated protein kinase signaling cascade,BP,FOXM1;SFRP2
14976,GO:0061097,0.435340503549374,0.889413163816989,1,83,regulation of protein tyrosine kinase activity,BP,NEURL1
12458,GO:0046651,0.435405901681308,0.816504064892223,2,246,lymphocyte proliferation,BP,CD38;IGFBP2
13286,GO:0050673,0.435420670278231,0.777907172339168,3,355,epithelial cell proliferation,BP,PTPRN;SFRP2;FABP7
14953,GO:0061053,0.43670291181962,0.888716423896211,1,78,somite development,BP,SFRP2
2795,GO:0005882,0.436837351105315,0.888569186406846,1,83,intermediate filament,CC,NEFM
485,GO:0001570,0.437213246672057,0.888428059908738,1,78,vasculogenesis,BP,FOXM1
16820,GO:0072593,0.437431548656399,0.815046818526623,2,237,reactive oxygen species metabolic process,BP,CRYAB;FOXM1
13705,GO:0051347,0.437460288888612,0.734165295746411,5,637,positive regulation of transferase activity,BP,TPX2;EEF1A2;NEURL1;ADCY1;UBE2C
293,GO:0000794,0.437708241534821,0.88806304045709,1,84,condensed nuclear chromosome,CC,NCAPH
5543,GO:0015833,0.438225881591797,0.675850608871365,13,1851,peptide transport,BP,CD38;PTPRN;RPH3A;SYTL4;DNM1;CENPF;CNR1;HPCA;VGF;SNAP25;SYT4;VSNL1;KCNC2
11267,GO:0043506,0.43840191200929,0.887710475432777,1,81,regulation of JUN kinase activity,BP,SFRP2
3967,GO:0008283,0.438881800583568,0.67907467434462,12,1698,cell population proliferation,BP,CD38;PTPRN;ASPM;BIRC5;NEURL1;FOXM1;IGFBP2;SFRP2;FABP7;MELK;FOLR2;NMB
14199,GO:0055017,0.438906113685472,0.887438353535704,1,80,cardiac muscle tissue growth,BP,PI16
7017,GO:0022411,0.439170115327044,0.750108055545914,4,523,cellular component disassembly,BP,TPX2;STMN2;TOP2A;LIX1
11750,GO:0045069,0.439714699406708,0.886848147669921,1,90,regulation of viral genome replication,BP,TOP2A
8722,GO:0032943,0.439846531402888,0.813233116731022,2,248,mononuclear cell proliferation,BP,CD38;IGFBP2
12043,GO:0045778,0.440520309796692,0.886475800210387,1,83,positive regulation of ossification,BP,SFRP2
11464,GO:0044093,0.440546088725046,0.677553225630244,12,1652,positive regulation of molecular function,BP,CAMK2A;TPX2;EEF1A2;NEURL1;NCAPH;HPCA;STAC2;SFRP2;ADCY1;KCNC2;UBE2C;GRIN2B
8733,GO:0032963,0.442851182238494,0.885038150006409,1,91,collagen metabolic process,BP,CREB3L1
13660,GO:0051276,0.443148688162398,0.697398010779835,8,1047,chromosome organization,BP,KIFC1;KIF4A;NCAPG;CENPF;NCAPH;TOP2A;MKI67;UBE2C
791,GO:0002028,0.444573500604773,0.884117132696035,1,85,regulation of sodium ion transport,BP,PTPN3
7186,GO:0030165,0.444930222871698,0.883995964791939,1,79,PDZ domain binding,MF,LNX1
6459,GO:0019233,0.444974623911501,0.88383417189226,1,89,sensory perception of pain,BP,CNR1
16418,GO:0071867,0.445514986054863,0.883520550939295,1,89,response to monoamine,BP,CHRM3
16420,GO:0071869,0.445514986054863,0.883520550939295,1,89,response to catecholamine,BP,CHRM3
2463,GO:0005200,0.446403070248303,0.883054872639013,1,85,structural constituent of cytoskeleton,MF,NEFM
14911,GO:0060998,0.446669068569597,0.883086376568352,1,73,regulation of dendritic spine development,BP,NEURL1
21548,GO:2000177,0.44674311232711,0.882912794456037,1,81,regulation of neural precursor cell proliferation,BP,ASPM
3848,GO:0008081,0.447453237542564,0.882484055854964,1,82,phosphoric diester hydrolase activity,MF,CHRM3
19231,GO:1901989,0.447810188734178,0.882158705425424,1,91,positive regulation of cell cycle phase transition,BP,UBE2C
13537,GO:0051082,0.448178349849605,0.881828290459617,1,102,unfolded protein binding,MF,CRYAB
3888,GO:0008150,0.44950957314921,0.704541370252878,94,14293,biological_process,BP,CD38;USH1C;CAMK1G;SYT13;GABRA1;PTPRN;KIFC1;BCAT1;LZTS1;ASPM;SYT1;PTPN3;CAMK2A;LNX1;TPX2;RPH3A;BIRC5;KIF4A;MYBL2;EEF1A2;ST8SIA5;SYTL4;STMN2;NEFM;SLC17A7;NPTX2;DNM1;NEURL1;NCAPG;CRYAB;PTPN5;FOXM1;GABRG2;SLC30A3;IGFBP2;CENPF;CNR1;TJP2;PRLHR;DUSP4;NCAPH;HPCA;VGF;SULT4A1;TOP2A;SNAP25;SYT4;GPR12;CHRM3;FAM189A2;MRAP2;SLC14A1;STAC2;HUNK;SLC4A10;SFRP2;LIX1;GABRB2;TENM2;DAAM2;MKI67;FREM2;HSPB8;CHST9;NRGN;ABI3BP;CREB3L1;VSNL1;IGFN1;ETNPPL;FABP7;PI16;ADCY1;MELK;FOLR2;KCNC2;KCNK9;NPTX1;ENC1;RRM2;ZCCHC12;UBE2C;PCSK1;MAP7D2;SV2B;MYT1L;HAPLN4;SPRY4;SELL;CPNE4;SLC6A17;NMB;PPP1R14C;GRIN2B
11340,GO:0043618,0.449779522491717,0.880878019978803,1,103,regulation of transcription from RNA polymerase II promoter in response to stress,BP,CREB3L1
6671,GO:0019886,0.45012060777568,0.880767819561395,1,94,antigen processing and presentation of exogenous peptide antigen via MHC class II,BP,KIF4A
9793,GO:0035579,0.450541071576274,0.880590892212759,1,88,specific granule membrane,CC,SNAP25
11456,GO:0044070,0.451431617953389,0.880040058443507,1,90,regulation of anion transport,BP,SYT4
7147,GO:0030117,0.451477866581204,0.880024976473199,1,89,membrane coat,CC,DNM1
12946,GO:0048475,0.451477866581204,0.880024976473199,1,89,coated membrane,CC,DNM1
12131,GO:0045934,0.451530502796144,0.676887250904658,10,1360,negative regulation of nucleobase-containing compound metabolic process,BP,CD38;BIRC5;CRYAB;FOXM1;CENPF;HPCA;SFRP2;TENM2;CREB3L1;MYT1L
13593,GO:0051153,0.451780934083219,0.879833306612817,1,90,regulation of striated muscle cell differentiation,BP,PI16
14189,GO:0055006,0.452025147272282,0.879943845085106,1,73,cardiac cell development,BP,PI16
17934,GO:0098876,0.452081217632335,0.879747817182092,1,83,vesicle-mediated transport to the plasma membrane,BP,SNAP25
13733,GO:0051402,0.453060037783562,0.803411852106419,2,228,neuron apoptotic process,BP,MYBL2;GABRB2
17823,GO:0098685,0.453154784158154,0.879140336424769,1,81,Schaffer collateral - CA1 synapse,CC,ADCY1
6440,GO:0019208,0.453385363032817,0.878880846783878,1,90,phosphatase regulator activity,MF,PPP1R14C
4857,GO:0010717,0.45347540937829,0.878865259709029,1,87,regulation of epithelial to mesenchymal transition,BP,SFRP2
17568,GO:0097367,0.453556943032689,0.655155119857185,15,2013,carbohydrate derivative binding,MF,CAMK1G;KIFC1;CAMK2A;KIF4A;EEF1A2;DNM1;TOP2A;HUNK;MKI67;ABI3BP;ADCY1;MELK;UBE2C;HAPLN4;SELL
13699,GO:0051341,0.453805629320095,0.878561618697372,1,96,regulation of oxidoreductase activity,BP,CNR1
1083,GO:0002495,0.453907679130756,0.878500771961696,1,96,antigen processing and presentation of peptide antigen via MHC class II,BP,KIF4A
2812,GO:0005902,0.454152535115673,0.878502731223343,1,84,microvillus,CC,USH1C
8208,GO:0032182,0.45457405137605,0.878184619606192,1,89,ubiquitin-like protein binding,MF,TOP2A
6971,GO:0021954,0.455500474494198,0.877741626745402,1,81,central nervous system neuron development,BP,SLC4A10
12571,GO:0046916,0.455557491817595,0.877462869555044,1,101,cellular transition metal ion homeostasis,BP,SLC30A3
5148,GO:0014706,0.455719829124046,0.7614633056265,3,343,striated muscle tissue development,BP,NEURL1;CENPF;PI16
3577,GO:0007127,0.45671040794923,0.876856032666944,1,93,meiosis I,BP,TOP2A
7597,GO:0031012,0.456717043464691,0.73523689148732,4,502,extracellular matrix,CC,SFRP2;FREM2;ABI3BP;HAPLN4
1087,GO:0002504,0.458711384711633,0.875604234234365,1,97,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,KIF4A
14512,GO:0060349,0.458816964625139,0.87566053406908,1,87,bone morphogenesis,BP,SFRP2
1524,GO:0003300,0.459807562485017,0.875195645294679,1,78,cardiac muscle hypertrophy,BP,PI16
22027,GO:2001022,0.460416154276206,0.874639335620438,1,91,positive regulation of response to DNA damage stimulus,BP,FOXM1
3114,GO:0006414,0.460955218636403,0.874005588671853,1,125,translational elongation,BP,EEF1A2
7960,GO:0031668,0.460979546419555,0.797348685608341,2,231,cellular response to extracellular stimulus,BP,SFRP2;FOLR2
3445,GO:0006885,0.461349030544397,0.874012688358859,1,96,regulation of pH,BP,SLC4A10
81,GO:0000165,0.461568605505959,0.699671037880215,6,820,MAPK cascade,BP,CRYAB;FOXM1;DUSP4;SFRP2;SPRY4;GRIN2B
9713,GO:0035418,0.461951462033819,0.873827708640656,1,82,protein localization to synapse,BP,SNAP25
17539,GO:0097306,0.462307651889252,0.873610209157559,1,82,cellular response to alcohol,BP,ADCY1
13366,GO:0050807,0.46292912724591,0.795934649418551,2,209,regulation of synapse organization,BP,NEURL1;GRIN2B
7173,GO:0030148,0.463390559602974,0.872786527354912,1,94,sphingolipid biosynthetic process,BP,ST8SIA5
12297,GO:0046332,0.463416425130605,0.872979578123653,1,79,SMAD binding,MF,CREB3L1
4539,GO:0009725,0.464018817507133,0.697471901484269,6,809,response to hormone,BP,CD38;PTPRN;CAMK2A;IGFBP2;VGF;ADCY1
7377,GO:0030510,0.464234653829372,0.872414215809935,1,83,regulation of BMP signaling pathway,BP,SFRP2
13542,GO:0051087,0.464567008959569,0.872029176562031,1,97,chaperone binding,MF,BIRC5
13858,GO:0051648,0.4648842438628,0.794398189396766,2,214,vesicle localization,BP,DNM1;SYT4
17404,GO:0097061,0.465110390952563,0.871938854344323,1,79,dendritic spine organization,BP,GRIN2B
4174,GO:0008630,0.465556797394176,0.871396898837167,1,99,intrinsic apoptotic signaling pathway in response to DNA damage,BP,SFRP2
19115,GO:1901655,0.465843604051432,0.871312341876737,1,91,cellular response to ketone,BP,ADCY1
17482,GO:0097190,0.465965297319508,0.727174229643727,4,560,apoptotic signaling pathway,BP,CD38;SFRP2;CREB3L1;MELK
1370,GO:0003013,0.466364083952615,0.726876879579696,4,516,circulatory system process,BP,CD38;CNR1;TJP2;CHRM3
5231,GO:0014897,0.467571720944208,0.870400546303858,1,80,striated muscle hypertrophy,BP,PI16
5655,GO:0016054,0.468118193347332,0.791708235119724,2,262,organic acid catabolic process,BP,BCAT1;CNR1
12324,GO:0046395,0.468118193347332,0.791708235119724,2,262,carboxylic acid catabolic process,BP,BCAT1;CNR1
10998,GO:0043043,0.468475938354288,0.724941674389167,4,606,peptide biosynthetic process,BP,EEF1A2;NEURL1;ENC1;PCSK1
4759,GO:0010558,0.468604599848507,0.661052479998431,10,1377,negative regulation of macromolecule biosynthetic process,BP,CD38;BIRC5;CRYAB;FOXM1;CENPF;SFRP2;TENM2;CREB3L1;ENC1;MYT1L
14568,GO:0060419,0.469102087529565,0.869328319322979,1,88,heart growth,BP,PI16
17043,GO:0090079,0.46911948182669,0.869173139972511,1,100,translation regulator activity, nucleic acid binding,MF,EEF1A2
7097,GO:0030016,0.469565763156199,0.790752939785316,2,213,myofibril,CC,CRYAB;IGFN1
16010,GO:0071156,0.470503265337399,0.868307110136243,1,100,regulation of cell cycle arrest,BP,FOXM1
9644,GO:0035282,0.471021037211912,0.868100650740773,1,90,segmentation,BP,SFRP2
11342,GO:0043620,0.471257731661528,0.867754373639564,1,108,regulation of DNA-templated transcription in response to stress,BP,CREB3L1
491,GO:0001578,0.471507725847765,0.867850216900229,1,86,microtubule bundle formation,BP,NEURL1
13973,GO:0051899,0.472491918305353,0.867291816574827,1,82,membrane depolarization,BP,PTPN3
2402,GO:0005102,0.47253594160481,0.663368834934938,9,1316,signaling receptor binding,MF,SYT1;CAMK2A;SYTL4;DNM1;IGFBP2;VGF;MRAP2;SFRP2;NMB
5230,GO:0014896,0.47272675054247,0.867143839203286,1,82,muscle hypertrophy,BP,PI16
7069,GO:0023014,0.472768369454918,0.68953394184361,6,828,signal transduction by protein phosphorylation,BP,CRYAB;FOXM1;DUSP4;SFRP2;SPRY4;GRIN2B
19232,GO:1901990,0.472798495345382,0.747086992194247,3,394,regulation of mitotic cell cycle phase transition,BP,TPX2;CENPF;UBE2C
21373,GO:1990782,0.473308265257646,0.866621618957703,1,93,protein tyrosine kinase binding,MF,TJP2
5023,GO:0010923,0.473455273977035,0.866554135096123,1,91,negative regulation of phosphatase activity,BP,PPP1R14C
15338,GO:0061982,0.473933468137646,0.866166866491977,1,98,meiosis I cell cycle process,BP,TOP2A
3519,GO:0007006,0.474877109363684,0.865456714975665,1,109,mitochondrial membrane organization,BP,CAMK2A
22119,GO:2001237,0.475094965584994,0.865429782785491,1,98,negative regulation of extrinsic apoptotic signaling pathway,BP,SFRP2
17813,GO:0098659,0.475226061782448,0.865444830847054,1,90,inorganic cation import across plasma membrane,BP,KCNK9
18194,GO:0099587,0.475226061782448,0.865444830847054,1,90,inorganic ion import across plasma membrane,BP,KCNK9
21386,GO:1990823,0.47547762869141,0.86524595968583,1,93,response to leukemia inhibitory factor,BP,MYBL2
21390,GO:1990830,0.47547762869141,0.86524595968583,1,93,cellular response to leukemia inhibitory factor,BP,MYBL2
3306,GO:0006664,0.475553321343302,0.865084416687514,1,103,glycolipid metabolic process,BP,ST8SIA5
6512,GO:0019395,0.475712754592144,0.864993211299455,1,102,fatty acid oxidation,BP,CNR1
7445,GO:0030660,0.476183081073927,0.864683023609724,1,103,Golgi-associated vesicle membrane,CC,NRGN
15849,GO:0070848,0.476844912133757,0.699476764565431,5,651,response to growth factor,BP,STMN2;SFRP2;CREB3L1;KCNC2;SPRY4
13637,GO:0051246,0.47699953971925,0.627642785243826,17,2473,regulation of protein metabolic process,BP,PTPN3;TPX2;BIRC5;EEF1A2;NEURL1;CRYAB;FOXM1;DUSP4;SFRP2;PI16;ADCY1;FOLR2;ENC1;UBE2C;SPRY4;PPP1R14C;GRIN2B
19899,GO:1903509,0.47866111488933,0.863086015518507,1,104,liposaccharide metabolic process,BP,ST8SIA5
15609,GO:0070372,0.478697846808326,0.783392392741478,2,250,regulation of ERK1 and ERK2 cascade,BP,DUSP4;SPRY4
2885,GO:0006029,0.478765141082799,0.863211499855343,1,88,proteoglycan metabolic process,BP,CHST9
10720,GO:0042472,0.478835800863908,0.863098864107983,1,93,inner ear morphogenesis,BP,USH1C
8680,GO:0032886,0.479066391989689,0.783198770570338,2,223,regulation of microtubule-based process,BP,TPX2;STMN2
12872,GO:0048259,0.480122165507981,0.862270726024322,1,93,regulation of receptor-mediated endocytosis,BP,HPCA
13384,GO:0050839,0.480922164088281,0.714100700804378,4,500,cell adhesion molecule binding,MF,TJP2;SFRP2;TENM2;SELL
14325,GO:0060071,0.481011264242687,0.861570255914018,1,104,Wnt signaling pathway, planar cell polarity pathway,BP,SFRP2
8488,GO:0032587,0.481281748478182,0.861575218467027,1,89,ruffle membrane,CC,SPRY4
2724,GO:0005770,0.4818168998733,0.780900078775548,2,249,late endosome,CC,SLC30A3;GRIN2B
13642,GO:0051251,0.482124292757043,0.78061778678293,2,260,positive regulation of lymphocyte activation,BP,CD38;IGFBP2
13355,GO:0050793,0.482529692187638,0.622349503772629,17,2379,regulation of developmental process,BP,CD38;LZTS1;ASPM;SYT1;CAMK2A;STMN2;NEURL1;FOXM1;CENPF;CNR1;SNAP25;SYT4;SFRP2;DAAM2;CREB3L1;PI16;ENC1
11807,GO:0045184,0.482702401711245,0.634115856224213,13,1898,establishment of protein localization,BP,CD38;PTPRN;RPH3A;SYTL4;DNM1;CENPF;CNR1;HPCA;VGF;SNAP25;SYT4;VSNL1;KCNC2
662,GO:0001843,0.483661251403697,0.860030223230939,1,89,neural tube closure,BP,SFRP2
19117,GO:1901657,0.484215159702784,0.859375065599464,1,116,glycosyl compound metabolic process,BP,TJP2
15766,GO:0070661,0.48423910256839,0.778885872235366,2,270,leukocyte proliferation,BP,CD38;IGFBP2
11138,GO:0043279,0.485016550002227,0.859028987184079,1,98,response to alkaloid,BP,CNR1
14701,GO:0060606,0.485213219896416,0.859002583132113,1,90,tube closure,BP,SFRP2
17728,GO:0097733,0.485943606099146,0.858483364085266,1,93,photoreceptor cell cilium,CC,USH1C
11142,GO:0043292,0.486747267777911,0.77702326572142,2,223,contractile fiber,CC,CRYAB;IGFN1
11127,GO:0043266,0.487191562652058,0.857637212476065,1,95,regulation of potassium ion transport,BP,KCNC2
2813,GO:0005903,0.487399103210547,0.857539541141956,1,92,brush border,CC,USH1C
12058,GO:0045807,0.487416373082991,0.857489080114082,1,95,positive regulation of endocytosis,BP,DNM1
17108,GO:0090175,0.488434473934839,0.856692181986788,1,106,regulation of establishment of planar polarity,BP,SFRP2
463,GO:0001539,0.488723767491977,0.856613121694865,1,96,cilium or flagellum-dependent cell motility,BP,NEURL1
14458,GO:0060285,0.488723767491977,0.856613121694865,1,96,cilium-dependent cell motility,BP,NEURL1
7455,GO:0030674,0.488847881887628,0.775273340340634,2,234,protein-macromolecule adaptor activity,MF,TJP2;SNAP25
12433,GO:0046620,0.488924433522048,0.85650567753893,1,94,regulation of organ growth,BP,PI16
13079,GO:0048709,0.489239748128039,0.856223659348784,1,100,oligodendrocyte differentiation,BP,DAAM2
12974,GO:0048524,0.489354054472564,0.856103767615901,1,104,positive regulation of viral process,BP,TOP2A
9330,GO:0034440,0.489795070336283,0.855780087646238,1,107,lipid oxidation,BP,CNR1
14651,GO:0060537,0.489843251992654,0.73251869567732,3,361,muscle tissue development,BP,NEURL1;CENPF;PI16
5998,GO:0016740,0.490449709147594,0.623194231591697,14,1986,transferase activity,MF,CD38;CAMK1G;BCAT1;CAMK2A;LNX1;ST8SIA5;NEURL1;TJP2;SULT4A1;HUNK;CHST9;ETNPPL;MELK;UBE2C
4153,GO:0008593,0.49081107947447,0.855227659394945,1,96,regulation of Notch signaling pathway,BP,NEURL1
12046,GO:0045785,0.491765828777699,0.73077388608506,3,396,positive regulation of cell adhesion,BP,IGFBP2;SFRP2;ABI3BP
3770,GO:0007569,0.49193054792641,0.854432841202237,1,100,cell aging,BP,FOXM1
15350,GO:0062023,0.492172580610865,0.730447245170107,3,381,collagen-containing extracellular matrix,CC,SFRP2;FREM2;ABI3BP
11658,GO:0044774,0.492440719702335,0.854080219767971,1,101,mitotic DNA integrity checkpoint,BP,TOP2A
4177,GO:0008637,0.49248716198268,0.853918119150381,1,114,apoptotic mitochondrial changes,BP,CAMK2A
16704,GO:0072331,0.492488218479354,0.772236040211454,2,252,signal transduction by p53 class mediator,BP,TPX2;FOXM1
4274,GO:0009062,0.492656252175633,0.853861414318511,1,108,fatty acid catabolic process,BP,CNR1
19070,GO:1901566,0.494042370721609,0.63698780583671,10,1556,organonitrogen compound biosynthetic process,BP,BCAT1;EEF1A2;ST8SIA5;NEURL1;HPCA;CHST9;ADCY1;FOLR2;ENC1;PCSK1
6035,GO:0016798,0.494602630038716,0.852563922634907,1,107,hydrolase activity, acting on glycosyl bonds,MF,CD38
1868,GO:0004252,0.495617857543978,0.851760076668599,1,120,serine-type endopeptidase activity,MF,PCSK1
4275,GO:0009063,0.495622601232278,0.851799406192477,1,115,cellular amino acid catabolic process,BP,BCAT1
2252,GO:0004842,0.497161797486206,0.726072297736622,3,382,ubiquitin-protein transferase activity,MF,LNX1;NEURL1;UBE2C
5936,GO:0016605,0.497184061864988,0.850932130618001,1,97,PML body,CC,TENM2
7311,GO:0030330,0.497769617781047,0.850474720021143,1,102,DNA damage response, signal transduction by p53 class mediator,BP,FOXM1
5777,GO:0016298,0.497966983258382,0.850329243917595,1,103,lipase activity,MF,CHRM3
12945,GO:0048471,0.497988584681587,0.68015221416158,5,674,perinuclear region of cytoplasm,CC,STMN2;NEURL1;CENPF;SNAP25;SYT4
11795,GO:0045165,0.498664061566592,0.767173806348745,2,244,cell fate commitment,BP,SFRP2;MYT1L
11262,GO:0043500,0.499717317899728,0.84918249613988,1,99,muscle adaptation,BP,PI16
13545,GO:0051091,0.500645229123128,0.765509979451342,2,249,positive regulation of DNA-binding transcription factor activity,BP,CAMK2A;ADCY1
7210,GO:0030198,0.500847132665864,0.722864746963881,3,361,extracellular matrix organization,BP,SFRP2;ABI3BP;CREB3L1
5887,GO:0016525,0.500893303856798,0.848365274191975,1,100,negative regulation of angiogenesis,BP,CREB3L1
18337,GO:0106027,0.501075161014537,0.84841980463829,1,87,neuron projection organization,BP,GRIN2B
9653,GO:0035305,0.50138630879908,0.848051415377566,1,98,negative regulation of dephosphorylation,BP,PPP1R14C
3680,GO:0007286,0.502355742434043,0.847281301850061,1,107,spermatid development,BP,NEURL1
11006,GO:0043062,0.502846996321258,0.72109029887032,3,362,extracellular structure organization,BP,SFRP2;ABI3BP;CREB3L1
3285,GO:0006638,0.504096295916592,0.846089623190428,1,106,neutral lipid metabolic process,BP,FABP7
3286,GO:0006639,0.504096295916592,0.846089623190428,1,106,acylglycerol metabolic process,BP,FABP7
3692,GO:0007338,0.504247214363722,0.845904764716847,1,114,single fertilization,BP,FOLR2
2684,GO:0005694,0.504627917222572,0.617030404961351,12,1735,chromosome,CC,BIRC5;KIF4A;MYBL2;NCAPG;FOXM1;CENPF;NCAPH;TOP2A;MKI67;CREB3L1;ENC1;MYT1L
815,GO:0002062,0.504664140797038,0.845802474250171,1,97,chondrocyte differentiation,BP,SFRP2
13644,GO:0051253,0.505356269451684,0.632323086504153,9,1273,negative regulation of RNA metabolic process,BP,CD38;BIRC5;CRYAB;FOXM1;CENPF;SFRP2;TENM2;CREB3L1;MYT1L
13123,GO:0048814,0.505483411098148,0.845331661064134,1,90,regulation of dendrite morphogenesis,BP,LZTS1
13403,GO:0050864,0.505727245165773,0.844905671546505,1,111,regulation of B cell activation,BP,CD38
7090,GO:0030004,0.505779814975911,0.844920940615478,1,106,cellular monovalent inorganic cation homeostasis,BP,SLC4A10
5101,GO:0014020,0.506457183421615,0.844569378359499,1,96,primary neural tube formation,BP,SFRP2
1694,GO:0003924,0.506999294994333,0.760081363664755,2,283,GTPase activity,MF,EEF1A2;DNM1
3457,GO:0006900,0.508180231554309,0.843244729739143,1,106,vesicle budding from membrane,BP,DNM1
21552,GO:2000181,0.508917849066769,0.842773000664248,1,102,negative regulation of blood vessel morphogenesis,BP,CREB3L1
11888,GO:0045446,0.509329422673248,0.842533386131999,1,98,endothelial cell differentiation,BP,TJP2
10799,GO:0042626,0.510026424660946,0.842083084061245,1,95,ATPase-coupled transmembrane transporter activity,MF,SLC30A3
12503,GO:0046777,0.510117877802084,0.757632168480839,2,229,protein autophosphorylation,BP,CAMK2A;MELK
3849,GO:0008083,0.512597656468462,0.839934379789434,1,127,growth factor activity,MF,VGF
19229,GO:1901987,0.513258165894407,0.711665295700575,3,418,regulation of cell cycle phase transition,BP,TPX2;CENPF;UBE2C
11364,GO:0043666,0.513655633672535,0.839366495230097,1,107,regulation of phosphoprotein phosphatase activity,BP,PPP1R14C
818,GO:0002065,0.514118351270876,0.839059275582479,1,105,columnar/cuboidal epithelial cell differentiation,BP,USH1C
6729,GO:0021510,0.514202125605951,0.839022842640566,1,103,spinal cord development,BP,DAAM2
11708,GO:0044877,0.514683793580371,0.630662051342097,8,1116,protein-containing complex binding,MF,USH1C;PTPRN;RPH3A;DNM1;CRYAB;CENPF;SFRP2;ABI3BP
14660,GO:0060548,0.51650664797153,0.648722454981052,6,889,negative regulation of cell death,BP,CD38;BIRC5;CRYAB;SFRP2;GABRB2;CREB3L1
20078,GO:1903828,0.516970746064098,0.836984214132765,1,108,negative regulation of cellular protein localization,BP,MRAP2
15608,GO:0070371,0.517732806500303,0.750989838258505,2,267,ERK1 and ERK2 cascade,BP,DUSP4;SPRY4
18848,GO:1900542,0.518041307937376,0.836270968427741,1,103,regulation of purine nucleotide metabolic process,BP,HPCA
22,GO:0000041,0.518169510361504,0.836039588216401,1,116,transition metal ion transport,BP,SLC30A3
7808,GO:0031398,0.518381856348757,0.835957085185467,1,109,positive regulation of protein ubiquitination,BP,UBE2C
3372,GO:0006766,0.519431927392548,0.835117650291498,1,117,vitamin metabolic process,BP,FOLR2
1371,GO:0003014,0.519836352955337,0.834916121108839,1,108,renal system process,BP,ADCY1
4125,GO:0008528,0.521380606996034,0.833592204596245,1,130,G protein-coupled peptide receptor activity,MF,PRLHR
18077,GO:0099094,0.521393990947736,0.833906969358168,1,98,ligand-gated cation channel activity,MF,GRIN2B
2954,GO:0006140,0.521544489736286,0.833709487238597,1,105,regulation of nucleotide metabolic process,BP,HPCA
5417,GO:0015399,0.521944537254702,0.833479724567008,1,100,primary active transmembrane transporter activity,MF,SLC30A3
14227,GO:0055076,0.522244382118166,0.833045124342789,1,120,transition metal ion homeostasis,BP,SLC30A3
8448,GO:0032508,0.522966824568071,0.832695845012785,1,103,DNA duplex unwinding,BP,TOP2A
12967,GO:0048515,0.522987404879322,0.832569141628893,1,113,spermatid differentiation,BP,NEURL1
69,GO:0000139,0.524089344401026,0.655615595360557,5,708,Golgi membrane,CC,CAMK1G;ST8SIA5;SYT4;CHST9;TMEM130
17090,GO:0090150,0.52578386777634,0.743880711453699,2,314,establishment of protein localization to membrane,BP,HPCA;SNAP25
3522,GO:0007009,0.525885448534405,0.830566063161753,1,102,plasma membrane organization,BP,SYTL4
7578,GO:0030968,0.525985405584921,0.830336960600038,1,116,endoplasmic reticulum unfolded protein response,BP,CREB3L1
3640,GO:0007215,0.526109851541381,0.830453228809635,1,98,glutamate receptor signaling pathway,BP,GRIN2B
7196,GO:0030175,0.526265537411279,0.830352255305926,1,97,filopodium,CC,TENM2
1600,GO:0003682,0.526855154485086,0.672019393988046,4,529,chromatin binding,MF,CENPF;NCAPH;TOP2A;CREB3L1
522,GO:0001653,0.528275862589342,0.828503299019751,1,132,peptide receptor activity,MF,PRLHR
6621,GO:0019787,0.528722196240681,0.697578461639382,3,402,ubiquitin-like protein transferase activity,MF,LNX1;NEURL1;UBE2C
17310,GO:0090596,0.529547687681126,0.740783278797649,2,247,sensory organ morphogenesis,BP,USH1C;IGFN1
6402,GO:0019079,0.529764323245377,0.827543901154995,1,115,viral genome replication,BP,TOP2A
3143,GO:0006464,0.530534539313003,0.561555415055823,25,3675,cellular protein modification process,BP,CAMK1G;PTPRN;PTPN3;CAMK2A;LNX1;TPX2;BIRC5;ST8SIA5;NEURL1;CRYAB;PTPN5;FOXM1;DUSP4;VGF;CHRM3;HUNK;SFRP2;HSPB8;ADCY1;MELK;ENC1;UBE2C;SPRY4;PPP1R14C;GRIN2B
10158,GO:0036211,0.530534539313003,0.561555415055823,25,3675,protein modification process,BP,CAMK1G;PTPRN;PTPN3;CAMK2A;LNX1;TPX2;BIRC5;ST8SIA5;NEURL1;CRYAB;PTPN5;FOXM1;DUSP4;VGF;CHRM3;HUNK;SFRP2;HSPB8;ADCY1;MELK;ENC1;UBE2C;SPRY4;PPP1R14C;GRIN2B
9395,GO:0034599,0.530781242886943,0.739590629816404,2,278,cellular response to oxidative stress,BP,MELK;KCNC2
2882,GO:0006024,0.531840486987721,0.826102165005584,1,105,glycosaminoglycan biosynthetic process,BP,CHST9
9084,GO:0033865,0.532078682279033,0.825727715343236,1,124,nucleoside bisphosphate metabolic process,BP,SULT4A1
9090,GO:0033875,0.532078682279033,0.825727715343236,1,124,ribonucleoside bisphosphate metabolic process,BP,SULT4A1
9109,GO:0034032,0.532078682279033,0.825727715343236,1,124,purine nucleoside bisphosphate metabolic process,BP,SULT4A1
13121,GO:0048812,0.532157120660439,0.647952467487572,5,636,neuron projection morphogenesis,BP,LZTS1;SYT1;SYT4;ADCY1;NPTX1
19407,GO:1902414,0.532740524189459,0.825490599172346,1,100,protein localization to cell junction,BP,SNAP25
18108,GO:0099175,0.532980869672395,0.825309938270605,1,100,regulation of postsynapse organization,BP,GRIN2B
5096,GO:0014013,0.533441903716842,0.824807891681053,1,113,regulation of gliogenesis,BP,DAAM2
10905,GO:0042826,0.533646871839278,0.824697233379413,1,109,histone deacetylase binding,MF,TOP2A
9838,GO:0035639,0.533824382299635,0.588457407455112,12,1654,purine ribonucleoside triphosphate binding,MF,CAMK1G;KIFC1;CAMK2A;KIF4A;EEF1A2;DNM1;TOP2A;HUNK;MKI67;ADCY1;MELK;UBE2C
578,GO:0001736,0.534582851535349,0.823886460280915,1,119,establishment of planar polarity,BP,SFRP2
3598,GO:0007164,0.534582851535349,0.823886460280915,1,119,establishment of tissue polarity,BP,SFRP2
19900,GO:1903510,0.534663867512083,0.823941085681527,1,108,mucopolysaccharide metabolic process,BP,CHST9
2582,GO:0005506,0.534734657181358,0.823734655104188,1,123,iron ion binding,MF,RRM2
8063,GO:0031902,0.53592569826142,0.822814365931046,1,125,late endosome membrane,CC,SLC30A3
8666,GO:0032868,0.536014930187195,0.735011788982588,2,260,response to insulin,BP,PTPRN;VGF
660,GO:0001841,0.536222636890486,0.822808753744238,1,104,neural tube formation,BP,SFRP2
11988,GO:0045667,0.536411505878234,0.822582731636478,1,111,regulation of osteoblast differentiation,BP,SFRP2
10719,GO:0042471,0.536729166035058,0.822319539797149,1,113,ear morphogenesis,BP,USH1C
6753,GO:0021537,0.538138674339645,0.733185412256388,2,242,telencephalon development,BP,ASPM;NRGN
3742,GO:0007498,0.539028944187672,0.820554214481796,1,114,mesoderm development,BP,SFRP2
2612,GO:0005576,0.539683915256456,0.558161308153213,21,3370,extracellular region,CC,CD38;TPX2;NPTX2;DNM1;CRYAB;IGFBP2;VGF;SYT4;SFRP2;GABRB2;DAAM2;FREM2;CHST9;ABI3BP;PI16;ADCY1;FOLR2;PCSK1;HAPLN4;CPNE4;NMB
3856,GO:0008094,0.539788807694594,0.8201275802682,1,101,DNA-dependent ATPase activity,MF,TOP2A
1127,GO:0002576,0.541384486072765,0.81869401450703,1,119,platelet degranulation,BP,SYTL4
9037,GO:0033674,0.541401325915479,0.65812542149013,4,560,positive regulation of kinase activity,BP,TPX2;EEF1A2;NEURL1;ADCY1
3028,GO:0006282,0.541734316932553,0.818497110728264,1,112,regulation of DNA repair,BP,FOXM1
74,GO:0000151,0.542153332757563,0.729486016353334,2,268,ubiquitin ligase complex,CC,ENC1;UBE2C
5645,GO:0016042,0.54215798361261,0.729416286420034,2,289,lipid catabolic process,BP,CNR1;FABP7
2269,GO:0004866,0.543157518986072,0.817216738304684,1,131,endopeptidase inhibitor activity,MF,BIRC5
11016,GO:0043085,0.543546227057045,0.595004021331023,9,1326,positive regulation of catalytic activity,BP,TPX2;EEF1A2;NEURL1;NCAPH;HPCA;SFRP2;ADCY1;UBE2C;GRIN2B
8830,GO:0033135,0.543666649466182,0.816949410160392,1,117,regulation of peptidyl-serine phosphorylation,BP,SFRP2
6067,GO:0016853,0.543670183899928,0.816772486576514,1,137,isomerase activity,MF,TOP2A
4613,GO:0009986,0.544170589529553,0.636222023657664,5,730,cell surface,CC,CD38;CRYAB;FOLR2;SELL;GRIN2B
13318,GO:0050729,0.544278594516374,0.816371577499085,1,128,positive regulation of inflammatory response,BP,CNR1
16826,GO:0072657,0.544953692608641,0.654643682440519,4,613,protein localization to membrane,BP,HPCA;SNAP25;MRAP2;STAC2
6574,GO:0019637,0.545093630280657,0.620998342817532,6,913,organophosphate metabolic process,BP,TJP2;HPCA;SULT4A1;ETNPPL;ADCY1;RRM2
802,GO:0002040,0.545709713632072,0.815425100140438,1,111,sprouting angiogenesis,BP,CREB3L1
17884,GO:0098796,0.546947867452066,0.608018738444324,7,1064,membrane protein complex,CC,GABRA1;DNM1;GABRG2;SNAP25;GABRB2;KCNC2;GRIN2B
12037,GO:0045765,0.547222854690398,0.724893391294405,2,269,regulation of angiogenesis,BP,SFRP2;CREB3L1
8346,GO:0032392,0.547634842367494,0.813919608833834,1,111,DNA geometric change,BP,TOP2A
16702,GO:0072329,0.547758932013602,0.813644309599727,1,129,monocarboxylic acid catabolic process,BP,CNR1
2722,GO:0005768,0.548181718629814,0.617967964333351,6,888,endosome,CC,PTPRN;KIFC1;SYTL4;STMN2;SLC30A3;GRIN2B
18997,GO:1901343,0.548294859335585,0.813367948756863,1,114,negative regulation of vasculature development,BP,CREB3L1
10750,GO:0042542,0.548727307578508,0.812883090309383,1,129,response to hydrogen peroxide,BP,CRYAB
18913,GO:1901137,0.548868025034473,0.650876619513357,4,589,carbohydrate derivative biosynthetic process,BP,ST8SIA5;CHST9;ADCY1;RRM2
2881,GO:0006023,0.549244810334466,0.812654315897956,1,111,aminoglycan biosynthetic process,BP,CHST9
3858,GO:0008104,0.549779484874881,0.55621935891236,17,2541,protein localization,BP,CD38;USH1C;PTPRN;RPH3A;BIRC5;SYTL4;DNM1;CENPF;CNR1;HPCA;VGF;SNAP25;SYT4;MRAP2;STAC2;VSNL1;KCNC2
3174,GO:0006508,0.550202848255538,0.582092853988853,10,1537,proteolysis,BP,PTPN3;LNX1;BIRC5;CRYAB;SFRP2;PI16;ENC1;UBE2C;PCSK1;GRIN2B
16828,GO:0072659,0.550799670482203,0.721649831708132,2,263,protein localization to plasma membrane,BP,MRAP2;STAC2
18441,GO:0120039,0.551077621252167,0.629522772294984,5,650,plasma membrane bounded cell projection morphogenesis,BP,LZTS1;SYT1;SYT4;ADCY1;NPTX1
3940,GO:0008236,0.5522650184932,0.810019504824894,1,137,serine-type peptidase activity,MF,PCSK1
6261,GO:0018107,0.552714427731763,0.809956505866755,1,107,peptidyl-threonine phosphorylation,BP,CAMK2A
14190,GO:0055007,0.553094843412136,0.809719906182027,1,102,cardiac muscle cell differentiation,BP,PI16
2754,GO:0005815,0.553239680674432,0.627331895093676,5,716,microtubule organizing center,CC,KIFC1;ASPM;CENPF;TOP2A;CKAP2L
13010,GO:0048598,0.553618275292801,0.646289295602085,4,554,embryonic morphogenesis,BP,USH1C;DUSP4;SFRP2;FREM2
13144,GO:0048858,0.555216161216783,0.625435829862477,5,654,cell projection morphogenesis,BP,LZTS1;SYT1;SYT4;ADCY1;NPTX1
4924,GO:0010811,0.555391324454135,0.807725316254568,1,115,positive regulation of cell-substrate adhesion,BP,ABI3BP
2822,GO:0005923,0.555434434280475,0.807748193443767,1,110,bicellular tight junction,CC,TJP2
13292,GO:0050680,0.556035884037981,0.80719731245309,1,116,negative regulation of epithelial cell proliferation,BP,SFRP2
3706,GO:0007368,0.556037049929159,0.807196376242665,1,116,determination of left/right symmetry,BP,DAAM2
10584,GO:0042177,0.556054955505577,0.807150360730531,1,119,negative regulation of protein catabolic process,BP,PTPN3
2826,GO:0005930,0.55645127012594,0.807008603160627,1,104,axoneme,CC,CENPF
1197,GO:0002696,0.556824399730269,0.715990150532717,2,298,positive regulation of leukocyte activation,BP,CD38;IGFBP2
11767,GO:0045111,0.55770159950281,0.805856627792668,1,116,intermediate filament cytoskeleton,CC,NEFM
6985,GO:0021987,0.559269916536801,0.804682593768641,1,108,cerebral cortex development,BP,ASPM
1431,GO:0003158,0.559439718712881,0.804462038257905,1,115,endothelium development,BP,TJP2
17374,GO:0097014,0.559696753732571,0.804375655281013,1,105,ciliary plasm,CC,CENPF
19910,GO:1903522,0.560030713755431,0.71309833278969,2,270,regulation of blood circulation,BP,CD38;CHRM3
5779,GO:0016301,0.560982477604055,0.619688695319185,5,680,kinase activity,MF,CAMK1G;CAMK2A;TJP2;HUNK;MELK
1549,GO:0003341,0.561150219133295,0.803008310385265,1,121,cilium movement,BP,NEURL1
6222,GO:0017171,0.561433891026076,0.802610996272088,1,140,serine hydrolase activity,MF,PCSK1
13723,GO:0051384,0.562466560292621,0.801831540670561,1,132,response to glucocorticoid,BP,IGFBP2
2594,GO:0005524,0.562793140648788,0.569474800615825,10,1358,ATP binding,MF,CAMK1G;KIFC1;CAMK2A;KIF4A;TOP2A;HUNK;MKI67;ADCY1;MELK;UBE2C
2635,GO:0005604,0.563006462786632,0.801781064488611,1,98,basement membrane,CC,FREM2
7242,GO:0030234,0.563606284718833,0.602593230212048,6,914,enzyme regulator activity,MF,TPX2;BIRC5;NCAPH;SFRP2;PI16;PPP1R14C
13414,GO:0050878,0.566167823343923,0.661927811938619,3,435,regulation of body fluid levels,BP,NEURL1;CHRM3;ADCY1
2133,GO:0004672,0.566376420670591,0.633751339042937,4,528,protein kinase activity,MF,CAMK1G;CAMK2A;HUNK;MELK
10873,GO:0042770,0.570317133549526,0.79541327627402,1,124,signal transduction in response to DNA damage,BP,FOXM1
7703,GO:0031225,0.571367266555871,0.794393298618775,1,140,anchored component of membrane,CC,FOLR2
12073,GO:0045834,0.571428584233064,0.79443501058409,1,129,positive regulation of lipid metabolic process,BP,EEF1A2
4588,GO:0009897,0.57155544922789,0.702150302251351,2,299,external side of plasma membrane,CC,FOLR2;SELL
12354,GO:0046467,0.571655296769652,0.794217864989757,1,132,membrane lipid biosynthetic process,BP,ST8SIA5
14941,GO:0061041,0.571726301477225,0.794203934653337,1,127,regulation of wound healing,BP,SYTL4
784,GO:0002020,0.572510837722749,0.793594352087885,1,122,protease binding,MF,SELL
12168,GO:0045995,0.57325071649406,0.793048340195704,1,115,regulation of embryonic development,BP,SFRP2
15475,GO:0070160,0.573759704360931,0.792607717821782,1,116,tight junction,CC,TJP2
19807,GO:1903322,0.573889061464261,0.792373949094369,1,128,positive regulation of protein modification by small protein conjugation or removal,BP,UBE2C
8753,GO:0032990,0.574003671927394,0.606631397202446,5,672,cell part morphogenesis,BP,LZTS1;SYT1;SYT4;ADCY1;NPTX1
17061,GO:0090101,0.574740580240439,0.791767721561524,1,117,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,SFRP2
4479,GO:0009416,0.575586334899528,0.698333197689486,2,287,response to light stimulus,BP,SLC4A10;KCNC2
1195,GO:0002694,0.576818615885982,0.651361945120662,3,477,regulation of leukocyte activation,BP,CD38;IGFBP2;CNR1
4345,GO:0009152,0.577309800166867,0.789400462131837,1,136,purine ribonucleotide biosynthetic process,BP,ADCY1
4573,GO:0009855,0.577620809734148,0.789246180498889,1,124,determination of bilateral symmetry,BP,DAAM2
5039,GO:0010948,0.578978044748725,0.6950120561219,2,306,negative regulation of cell cycle process,BP,CENPF;RRM2
11932,GO:0045598,0.57901985211364,0.788030487766031,1,126,regulation of fat cell differentiation,BP,SFRP2
13406,GO:0050867,0.579185337214007,0.694800828061551,2,310,positive regulation of cell activation,BP,CD38;IGFBP2
4564,GO:0009799,0.579626063590991,0.787520903618002,1,125,specification of symmetry,BP,DAAM2
5748,GO:0016247,0.580005675348001,0.787076703450046,1,138,channel regulator activity,MF,PTPN3
8472,GO:0032555,0.580998481021096,0.54085095754246,12,1712,purine ribonucleotide binding,MF,CAMK1G;KIFC1;CAMK2A;KIF4A;EEF1A2;DNM1;TOP2A;HUNK;MKI67;ADCY1;MELK;UBE2C
6295,GO:0018210,0.581214859455304,0.786253082905414,1,116,peptidyl-threonine modification,BP,CAMK2A
9652,GO:0035304,0.58145062537938,0.785912796930244,1,129,regulation of protein dephosphorylation,BP,PPP1R14C
20112,GO:1903900,0.58191211996088,0.78544309387587,1,137,regulation of viral life cycle,BP,TOP2A
657,GO:0001838,0.582900035539359,0.784741900134714,1,121,embryonic epithelial tube formation,BP,SFRP2
4328,GO:0009135,0.583129751836167,0.784511303278288,1,124,purine nucleoside diphosphate metabolic process,BP,TJP2
4369,GO:0009179,0.583129751836167,0.784511303278288,1,124,purine ribonucleoside diphosphate metabolic process,BP,TJP2
12995,GO:0048565,0.583512515049811,0.784200643602176,1,122,digestive tract development,BP,SFRP2
11581,GO:0044389,0.58384044289927,0.690312083632845,2,300,ubiquitin-like protein ligase binding,MF,PTPRN;UBE2C
1469,GO:0003206,0.58471252837955,0.783180412668153,1,120,cardiac chamber morphogenesis,BP,SFRP2
4497,GO:0009566,0.584893963103088,0.782824556260817,1,141,fertilization,BP,FOLR2
6186,GO:0017111,0.586031100417118,0.594341061545616,5,720,nucleoside-triphosphatase activity,MF,KIFC1;KIF4A;EEF1A2;DNM1;TOP2A
4735,GO:0010508,0.587052468728584,0.781149993476222,1,119,positive regulation of autophagy,BP,HSPB8
11132,GO:0043271,0.588140695988305,0.780053450011836,1,133,negative regulation of ion transport,BP,CNR1
10556,GO:0042129,0.588755974590745,0.779375014422398,1,150,regulation of T cell proliferation,BP,IGFBP2
4374,GO:0009185,0.590284353939209,0.778222528246104,1,127,ribonucleoside diphosphate metabolic process,BP,TJP2
6170,GO:0017076,0.590956257818134,0.530574877156102,12,1726,purine nucleotide binding,MF,CAMK1G;KIFC1;CAMK2A;KIF4A;EEF1A2;DNM1;TOP2A;HUNK;MKI67;ADCY1;MELK;UBE2C
22050,GO:2001056,0.59111887699555,0.777357327285415,1,141,positive regulation of cysteine-type endopeptidase activity,BP,GRIN2B
8470,GO:0032553,0.592225245906998,0.529259704392402,12,1727,ribonucleotide binding,MF,CAMK1G;KIFC1;CAMK2A;KIF4A;EEF1A2;DNM1;TOP2A;HUNK;MKI67;ADCY1;MELK;UBE2C
3590,GO:0007156,0.594923356364719,0.774384662338518,1,104,homophilic cell adhesion via plasma membrane adhesion molecules,BP,IGFN1
11098,GO:0043226,0.595765253496511,0.498482503831816,77,11824,organelle,CC,CD38;USH1C;CAMK1G;SYT13;GABRA1;PTPRN;KIFC1;BCAT1;LZTS1;ASPM;SYT1;PTPN3;CAMK2A;TPX2;RPH3A;BIRC5;KIF4A;MYBL2;EEF1A2;ST8SIA5;SYTL4;STMN2;NEFM;SLC17A7;DNM1;NEURL1;NCAPG;CRYAB;PTPN5;FOXM1;GABRG2;SLC30A3;IGFBP2;CENPF;CNR1;TJP2;PRLHR;DUSP4;NCAPH;VGF;TOP2A;SNAP25;SYT4;CHRM3;MRAP2;HUNK;GABRB2;TENM2;DAAM2;MKI67;FREM2;HSPB8;CHST9;NRGN;CREB3L1;IGFN1;ETNPPL;FABP7;ADCY1;MELK;KCNC2;TMEM130;KCNK9;CKAP2L;NPTX1;ENC1;ZCCHC12;UBE2C;PCSK1;DDN;MAP7D2;SV2B;MYT1L;SELL;CPNE4;SLC6A17;GRIN2B
8790,GO:0033043,0.596958717954214,0.548141911966852,8,1196,regulation of organelle organization,BP,SYT1;TPX2;STMN2;CENPF;TOP2A;SYT4;MKI67;UBE2C
13634,GO:0051239,0.59769411874888,0.502799931474591,19,2873,regulation of multicellular organismal process,BP,CD38;LZTS1;ASPM;SYT1;CAMK2A;STMN2;NPTX2;NEURL1;CENPF;CNR1;SNAP25;SYT4;CHRM3;SFRP2;DAAM2;CREB3L1;PI16;NPTX1;ENC1
14343,GO:0060090,0.59796520355329,0.676421086325394,2,282,molecular adaptor activity,MF,TJP2;SNAP25
6208,GO:0017148,0.598750010227953,0.770645658925378,1,128,negative regulation of translation,BP,ENC1
6644,GO:0019838,0.600103240126561,0.769461772645218,1,124,growth factor binding,MF,IGFBP2
16216,GO:0071496,0.600527090382839,0.673787859222519,2,302,cellular response to external stimulus,BP,SFRP2;FOLR2
2595,GO:0005525,0.60216273684112,0.6720743602638,2,326,GTP binding,MF,EEF1A2;DNM1
1488,GO:0003231,0.602434132824101,0.767384834990217,1,120,cardiac ventricle development,BP,SFRP2
16603,GO:0072175,0.602456507636161,0.767266571843677,1,129,epithelial tube formation,BP,SFRP2
690,GO:0001889,0.603363087937975,0.76637000247809,1,136,liver development,BP,PTPN3
8094,GO:0031960,0.603566852672341,0.766082705837761,1,148,response to corticosteroid,BP,IGFBP2
8260,GO:0032268,0.60381914921526,0.506298138687234,15,2347,regulation of cellular protein metabolic process,BP,PTPN3;TPX2;BIRC5;NEURL1;CRYAB;FOXM1;DUSP4;SFRP2;PI16;ADCY1;ENC1;UBE2C;SPRY4;PPP1R14C;GRIN2B
2753,GO:0005814,0.605055608641562,0.764914854584128,1,126,centriole,CC,TOP2A
579,GO:0001738,0.605717332539156,0.764170697424666,1,140,morphogenesis of a polarized epithelium,BP,SFRP2
3593,GO:0007159,0.60661046982033,0.667582460555505,2,321,leukocyte cell-cell adhesion,BP,IGFBP2;SELL
3389,GO:0006790,0.606657287233804,0.667509008047339,2,331,sulfur compound metabolic process,BP,SULT4A1;CHST9
12586,GO:0046943,0.607435517378314,0.762609281063314,1,137,carboxylic acid transmembrane transporter activity,MF,SLC17A7
16108,GO:0071346,0.607439277770938,0.762447157327029,1,157,cellular response to interferon-gamma,BP,CAMK2A
8468,GO:0032550,0.608399123851022,0.665736811734996,2,330,purine ribonucleoside binding,MF,EEF1A2;DNM1
6194,GO:0017124,0.60867856960759,0.761554210343725,1,127,SH3 domain binding,MF,DNM1
14259,GO:0055123,0.608881006951948,0.761324820570006,1,131,digestive system development,BP,SFRP2
10092,GO:0036064,0.60895079182173,0.761211807613652,1,136,ciliary basal body,CC,CENPF
8476,GO:0032559,0.608969837394422,0.52181428161134,10,1413,adenyl ribonucleotide binding,MF,CAMK1G;KIFC1;CAMK2A;KIF4A;TOP2A;HUNK;MKI67;ADCY1;MELK;UBE2C
11282,GO:0043524,0.609050618585152,0.761091722417697,1,139,negative regulation of neuron apoptotic process,BP,GABRB2
14957,GO:0061061,0.609232358270588,0.589863926658002,4,593,muscle structure development,BP,NEURL1;CRYAB;CENPF;PI16
17788,GO:0098609,0.609618548454036,0.569790265802802,5,747,cell-cell adhesion,BP,IGFBP2;TJP2;TENM2;IGFN1;SELL
4429,GO:0009260,0.609916870062689,0.760201678581567,1,149,ribonucleotide biosynthetic process,BP,ADCY1
2529,GO:0005342,0.610080858006766,0.76014062118495,1,138,organic acid transmembrane transporter activity,MF,SLC17A7
3307,GO:0006665,0.610326384810851,0.759851228394452,1,145,sphingolipid metabolic process,BP,ST8SIA5
10852,GO:0042742,0.610331865388483,0.759671670406781,1,170,defense response to bacterium,BP,VGF
18996,GO:1901342,0.61076692933118,0.663392708825398,2,302,regulation of vasculature development,BP,SFRP2;CREB3L1
11546,GO:0044325,0.611127225678995,0.759249987877904,1,129,ion channel binding,MF,KCNC2
14919,GO:0061008,0.612947781815577,0.757445673837361,1,139,hepaticobiliary system development,BP,PTPN3
685,GO:0001883,0.613046913428942,0.660965284024274,2,333,purine nucleoside binding,MF,EEF1A2;DNM1
11145,GO:0043296,0.613051395088387,0.757455457345826,1,128,apical junction complex,CC,TJP2
7523,GO:0030879,0.613083877791485,0.757414395732434,1,129,mammary gland development,BP,NEURL1
17669,GO:0097553,0.613286482360751,0.757223762586509,1,129,calcium ion transmembrane import into cytosol,BP,GRIN2B
656,GO:0001837,0.613457354745628,0.756984283596192,1,137,epithelial to mesenchymal transition,BP,SFRP2
14219,GO:0055067,0.613580966140348,0.756806209006723,1,144,monovalent inorganic cation homeostasis,BP,SLC4A10
16130,GO:0071375,0.613601337920138,0.660501726142216,2,295,cellular response to peptide hormone stimulus,BP,CAMK2A;ADCY1
8467,GO:0032549,0.614563973149701,0.659401282344594,2,333,ribonucleoside binding,MF,EEF1A2;DNM1
9402,GO:0034614,0.61501704757244,0.755386533831619,1,152,cellular response to reactive oxygen species,BP,KCNC2
8202,GO:0032147,0.615131179926584,0.65889822143836,2,303,activation of protein kinase activity,BP,TPX2;ADCY1
16446,GO:0071900,0.615691191104406,0.6115699845329,3,476,regulation of protein serine/threonine kinase activity,BP,DUSP4;SFRP2;SPRY4
1073,GO:0002478,0.615885936883251,0.75446641542287,1,166,antigen processing and presentation of exogenous peptide antigen,BP,KIF4A
9105,GO:0033993,0.615933528243479,0.563055880048473,5,815,response to lipid,BP,CD38;CRYAB;IGFBP2;CNR1;ADCY1
7408,GO:0030554,0.617544772193865,0.5127541276917,10,1425,adenyl nucleotide binding,MF,CAMK1G;KIFC1;CAMK2A;KIF4A;TOP2A;HUNK;MKI67;ADCY1;MELK;UBE2C
12985,GO:0048545,0.617576703548435,0.65632729760012,2,316,response to steroid hormone,BP,CD38;IGFBP2
5477,GO:0015718,0.618123117885558,0.752474257476268,1,147,monocarboxylic acid transport,BP,NMB
4325,GO:0009132,0.618541320491213,0.752117163116217,1,142,nucleoside diphosphate metabolic process,BP,TJP2
15828,GO:0070820,0.619392385838806,0.751198999563648,1,155,tertiary granule,CC,SNAP25
13290,GO:0050678,0.619784756090073,0.654065262631659,2,304,regulation of epithelial cell proliferation,BP,PTPRN;SFRP2
3236,GO:0006575,0.620280090110924,0.750298461348246,1,162,cellular modified amino acid metabolic process,BP,FOLR2
10773,GO:0042581,0.620839368380005,0.749817861346713,1,154,specific granule,CC,SNAP25
13587,GO:0051147,0.621337739810004,0.749427015997736,1,143,regulation of muscle cell differentiation,BP,PI16
2642,GO:0005622,0.621785764242131,0.478549417845605,81,12466,intracellular,CC,CD38;USH1C;CAMK1G;SYT13;GABRA1;PTPRN;KIFC1;BCAT1;LZTS1;ASPM;SYT1;PTPN3;CAMK2A;LNX1;TPX2;RPH3A;BIRC5;KIF4A;MYBL2;EEF1A2;ST8SIA5;SYTL4;STMN2;NEFM;SLC17A7;DNM1;NEURL1;NCAPG;CRYAB;PTPN5;FOXM1;GABRG2;SLC30A3;IGFBP2;CENPF;CNR1;TJP2;DUSP4;NCAPH;HPCA;VGF;SULT4A1;TOP2A;SNAP25;SYT4;GPR12;MRAP2;STAC2;HUNK;LIX1;GABRB2;TENM2;MKI67;HSPB8;CHST9;NRGN;CREB3L1;VSNL1;IGFN1;ETNPPL;FABP7;ADCY1;MELK;TMEM130;KCNK9;CKAP2L;NPTX1;ENC1;RRM2;ZCCHC12;UBE2C;PCSK1;DDN;MAP7D2;SV2B;MYT1L;SPRY4;SELL;SLC6A17;PPP1R14C;GRIN2B
2458,GO:0005178,0.622328691602569,0.748565483501868,1,133,integrin binding,MF,SFRP2
16914,GO:0080134,0.622659793232906,0.520998634245126,8,1297,regulation of response to stress,BP,CAMK2A;SYTL4;CRYAB;FOXM1;CNR1;SFRP2;HSPB8;CREB3L1
684,GO:0001882,0.623519629977157,0.65006224469425,2,339,nucleoside binding,MF,EEF1A2;DNM1
427,GO:0001227,0.623804593381411,0.649829354923493,2,314,DNA-binding transcription repressor activity, RNA polymerase II-specific,MF,CREB3L1;MYT1L
3266,GO:0006612,0.6241383547346,0.746406540152348,1,191,protein targeting to membrane,BP,HPCA
13546,GO:0051092,0.624419231030255,0.746389843230625,1,150,positive regulation of NF-kappaB transcription factor activity,BP,CAMK2A
17925,GO:0098862,0.624860695497612,0.74608401991544,1,136,cluster of actin-based cell projections,CC,USH1C
9552,GO:0035051,0.625340982970407,0.745699544808068,1,128,cardiocyte differentiation,BP,PI16
12321,GO:0046390,0.625417744057398,0.745373019395354,1,156,ribose phosphate biosynthetic process,BP,ADCY1
6029,GO:0016788,0.625682616421014,0.572323786818313,4,646,hydrolase activity, acting on ester bonds,MF,PTPN3;PTPN5;DUSP4;CHRM3
420,GO:0001217,0.625733579349641,0.647796628539002,2,315,DNA-binding transcription repressor activity,MF,CREB3L1;MYT1L
3181,GO:0006518,0.625996500585646,0.571915211797882,4,728,peptide metabolic process,BP,EEF1A2;NEURL1;ENC1;PCSK1
7449,GO:0030666,0.626327697514198,0.744516257485989,1,152,endocytic vesicle membrane,CC,CAMK2A
4583,GO:0009892,0.626909911913853,0.474272739072004,18,2850,negative regulation of metabolic process,BP,CD38;LZTS1;PTPN3;BIRC5;CRYAB;FOXM1;CENPF;CNR1;DUSP4;HPCA;SFRP2;TENM2;CREB3L1;PI16;ENC1;MYT1L;SPRY4;PPP1R14C
11217,GO:0043408,0.627412775978812,0.570464573649459,4,644,regulation of MAPK cascade,BP,FOXM1;DUSP4;SFRP2;SPRY4
15377,GO:0062197,0.627767802382315,0.645612230960689,2,328,cellular response to chemical stress,BP,MELK;KCNC2
11220,GO:0043412,0.628070537949791,0.461629921792802,25,3857,macromolecule modification,BP,CAMK1G;PTPRN;PTPN3;CAMK2A;LNX1;TPX2;BIRC5;ST8SIA5;NEURL1;CRYAB;PTPN5;FOXM1;DUSP4;VGF;CHRM3;HUNK;SFRP2;HSPB8;ADCY1;MELK;ENC1;UBE2C;SPRY4;PPP1R14C;GRIN2B
3752,GO:0007519,0.628495747453023,0.742460039360502,1,144,skeletal muscle tissue development,BP,NEURL1
18911,GO:1901135,0.628614789026849,0.534933861351811,6,991,carbohydrate derivative metabolic process,BP,ST8SIA5;TJP2;SULT4A1;CHST9;ADCY1;RRM2
4303,GO:0009101,0.62863908010829,0.644748823991759,2,307,glycoprotein biosynthetic process,BP,ST8SIA5;CHST9
5852,GO:0016462,0.629551057320274,0.548508388417119,5,763,pyrophosphatase activity,MF,KIFC1;KIF4A;EEF1A2;DNM1;TOP2A
22118,GO:2001236,0.630288680917045,0.740637036644576,1,151,regulation of extrinsic apoptotic signaling pathway,BP,SFRP2
3933,GO:0008217,0.630444895304553,0.74042946206155,1,158,regulation of blood pressure,BP,CNR1
13404,GO:0050865,0.630815992985492,0.595385380122627,3,513,regulation of cell activation,BP,CD38;IGFBP2;CNR1
11773,GO:0045121,0.632064780002278,0.641099997467577,2,309,membrane raft,CC,CNR1;ADCY1
6669,GO:0019884,0.632229354243244,0.738563099231693,1,173,antigen processing and presentation of exogenous antigen,BP,KIF4A
10674,GO:0042383,0.632887750574499,0.738238204199861,1,132,sarcolemma,CC,STAC2
6047,GO:0016817,0.633032214654452,0.544739294304623,5,766,hydrolase activity, acting on acid anhydrides,MF,KIFC1;KIF4A;EEF1A2;DNM1;TOP2A
6048,GO:0016818,0.633032214654452,0.544739294304623,5,766,hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,MF,KIFC1;KIF4A;EEF1A2;DNM1;TOP2A
1196,GO:0002695,0.633099781922108,0.73776329218801,1,163,negative regulation of leukocyte activation,BP,CNR1
6375,GO:0019001,0.633577299276172,0.639392004457528,2,343,guanyl nucleotide binding,MF,EEF1A2;DNM1
8478,GO:0032561,0.633577299276172,0.639392004457528,2,343,guanyl ribonucleotide binding,MF,EEF1A2;DNM1
534,GO:0001666,0.633904850046565,0.639074405161872,2,330,response to hypoxia,BP,CD38;CRYAB
17923,GO:0098857,0.634536900158055,0.638453556248457,2,310,membrane microdomain,CC,CNR1;ADCY1
16124,GO:0071363,0.635735726148623,0.561471762372003,4,624,cellular response to growth factor stimulus,BP,STMN2;SFRP2;CREB3L1;SPRY4
12090,GO:0045862,0.635827249304062,0.637002076519754,2,334,positive regulation of proteolysis,BP,SFRP2;GRIN2B
7904,GO:0031570,0.636646009070306,0.73433430709827,1,148,DNA integrity checkpoint,BP,TOP2A
4766,GO:0010565,0.637559728403072,0.733293494127217,1,164,regulation of cellular ketone metabolic process,BP,CNR1
3480,GO:0006937,0.637611240718705,0.733355558742414,1,149,regulation of muscle contraction,BP,CHRM3
7771,GO:0031329,0.638450817731039,0.53881720252822,5,803,regulation of cellular catabolic process,BP,LZTS1;PTPN3;EEF1A2;CNR1;HSPB8
17033,GO:0090066,0.638522820043899,0.587081468476482,3,472,regulation of anatomical structure size,BP,CD38;USH1C;CHRM3
329,GO:0000910,0.638641527520527,0.732360353897069,1,144,cytokinesis,BP,KIF4A
15385,GO:0065004,0.638685711772029,0.732208701544388,1,157,protein-DNA complex assembly,BP,CENPF
13108,GO:0048771,0.638788061714397,0.732177461067095,1,148,tissue remodeling,BP,CD38
10645,GO:0042325,0.639299325811707,0.495667813061683,9,1436,regulation of phosphorylation,BP,TPX2;EEF1A2;NEURL1;FOXM1;DUSP4;SFRP2;ADCY1;SPRY4;PPP1R14C
11333,GO:0043604,0.639344021083575,0.557429972038631,4,739,amide biosynthetic process,BP,EEF1A2;NEURL1;ENC1;PCSK1
7376,GO:0030509,0.63979263471944,0.731262905163568,1,137,BMP signaling pathway,BP,SFRP2
9260,GO:0034341,0.640382621275743,0.730374879692934,1,174,response to interferon-gamma,BP,CAMK2A
9632,GO:0035264,0.640889302221135,0.730131312011788,1,139,multicellular organism growth,BP,SLC4A10
2161,GO:0004713,0.641029359765281,0.730049890885212,1,133,protein tyrosine kinase activity,MF,MELK
12128,GO:0045931,0.64235176133567,0.728560959112442,1,148,positive regulation of mitotic cell cycle,BP,UBE2C
3830,GO:0008047,0.642842381524008,0.582346740382202,3,474,enzyme activator activity,MF,TPX2;NCAPH;SFRP2
919,GO:0002244,0.643031888540546,0.727749638799827,1,163,hematopoietic progenitor cell differentiation,BP,TOP2A
9230,GO:0034249,0.64340522180349,0.727511461580627,1,145,negative regulation of cellular amide metabolic process,BP,ENC1
13635,GO:0051240,0.643432541860891,0.484956298710213,10,1586,positive regulation of multicellular organismal process,BP,CD38;ASPM;SYT1;STMN2;NEURL1;CNR1;SYT4;CHRM3;SFRP2;ENC1
7215,GO:0030203,0.646321604066868,0.7244904521504,1,148,glycosaminoglycan metabolic process,BP,CHST9
12767,GO:0048002,0.646750488438382,0.72381965264798,1,180,antigen processing and presentation of peptide antigen,BP,KIF4A
14652,GO:0060538,0.647354560346115,0.723390140973196,1,152,skeletal muscle organ development,BP,NEURL1
9589,GO:0035148,0.647989867816228,0.722793288209061,1,145,tube formation,BP,SFRP2
9137,GO:0034097,0.648152476474313,0.513628882355195,6,1051,response to cytokine,BP,CD38;PTPRN;CAMK2A;BIRC5;MYBL2;PTPN5
13548,GO:0051094,0.648956186903198,0.492573069564354,8,1271,positive regulation of developmental process,BP,ASPM;SYT1;STMN2;NEURL1;CNR1;SYT4;SFRP2;ENC1
12038,GO:0045766,0.64924581017365,0.721421336183078,1,153,positive regulation of angiogenesis,BP,SFRP2
16821,GO:0072594,0.64955572544501,0.574834261508743,3,542,establishment of protein localization to organelle,BP,DNM1;HPCA;SNAP25
19668,GO:1903034,0.649905887480789,0.720718479166424,1,155,regulation of response to wounding,BP,SYTL4
14557,GO:0060402,0.651169512407234,0.719476903467311,1,146,calcium ion transport into cytosol,BP,GRIN2B
5796,GO:0016331,0.651464115677066,0.719169001890561,1,146,morphogenesis of embryonic epithelium,BP,SFRP2
12088,GO:0045860,0.652417790806514,0.571718428254332,3,491,positive regulation of protein kinase activity,BP,TPX2;NEURL1;ADCY1
6672,GO:0019887,0.652738110815743,0.717668271173701,1,167,protein kinase regulator activity,MF,TPX2
6451,GO:0019220,0.653894849106061,0.473554696769866,10,1608,regulation of phosphate metabolic process,BP,TPX2;EEF1A2;NEURL1;FOXM1;DUSP4;HPCA;SFRP2;ADCY1;SPRY4;PPP1R14C
17778,GO:0098589,0.653932554115217,0.617247077006841,2,321,membrane region,CC,CNR1;ADCY1
15715,GO:0070555,0.654590744603944,0.715646905348234,1,178,response to interleukin-1,BP,CD38
13606,GO:0051174,0.654658044074487,0.472719001891593,10,1609,regulation of phosphorus metabolic process,BP,TPX2;EEF1A2;NEURL1;FOXM1;DUSP4;HPCA;SFRP2;ADCY1;SPRY4;PPP1R14C
10181,GO:0036293,0.655374889646529,0.615586941653079,2,341,response to decreased oxygen levels,BP,CD38;CRYAB
8785,GO:0033036,0.655438669980916,0.443765842148274,18,2853,macromolecule localization,BP,CD38;USH1C;PTPRN;RPH3A;BIRC5;SYTL4;DNM1;CENPF;CNR1;HPCA;VGF;SNAP25;SYT4;MRAP2;STAC2;VSNL1;KCNC2;NMB
13101,GO:0048754,0.65635723183172,0.714027613756443,1,145,branching morphogenesis of an epithelial tube,BP,SFRP2
10540,GO:0042098,0.657777178754085,0.712269839857929,1,178,T cell proliferation,BP,IGFBP2
13497,GO:0051017,0.658321548861002,0.711913015634038,1,148,actin filament bundle assembly,BP,USH1C
15160,GO:0061572,0.658321548861002,0.711913015634038,1,148,actin filament bundle organization,BP,USH1C
20079,GO:1903829,0.658687695255948,0.61193301850938,2,322,positive regulation of cellular protein localization,BP,HPCA;STAC2
13320,GO:0050731,0.660546774658513,0.709412254345229,1,163,positive regulation of peptidyl-tyrosine phosphorylation,BP,NEURL1
19084,GO:1901605,0.662372653858697,0.707334709848056,1,180,alpha-amino acid metabolic process,BP,BCAT1
3112,GO:0006412,0.662444147341051,0.560326071076986,3,586,translation,BP,EEF1A2;NEURL1;ENC1
2748,GO:0005798,0.663045589326299,0.706687226622831,1,168,Golgi-associated vesicle,CC,NRGN
13122,GO:0048813,0.664741437751274,0.705088763346929,1,140,dendrite morphogenesis,BP,LZTS1
14186,GO:0055002,0.665571336697602,0.704129279272531,1,146,striated muscle cell development,BP,PI16
3116,GO:0006417,0.666339583497067,0.603235202304207,2,340,regulation of translation,BP,NEURL1;ENC1
16373,GO:0071772,0.667188444895421,0.702340041837884,1,149,response to BMP,BP,SFRP2
16374,GO:0071773,0.667188444895421,0.702340041837884,1,149,cellular response to BMP stimulus,BP,SFRP2
8341,GO:0032386,0.669630119216183,0.599492922033033,2,334,regulation of intracellular transport,BP,CRYAB;HPCA
5058,GO:0010970,0.669661430093087,0.699612762291269,1,151,transport along microtubule,BP,KIF4A
2700,GO:0005741,0.669869299584406,0.699234938257497,1,170,mitochondrial outer membrane,CC,CNR1
13377,GO:0050821,0.670939921878346,0.698076480472133,1,167,protein stabilization,BP,CRYAB
2880,GO:0006022,0.671137906078743,0.697910911308343,1,160,aminoglycan metabolic process,BP,CHST9
5859,GO:0016482,0.672090197831836,0.696951715319764,1,149,cytosolic transport,BP,SYT4
6639,GO:0019827,0.672758717357234,0.696158406221624,1,155,stem cell population maintenance,BP,ASPM
19161,GO:1901796,0.673167303533895,0.695603609195559,1,168,regulation of signal transduction by p53 class mediator,BP,TPX2
20834,GO:1905330,0.673437578719905,0.69527524175117,1,172,regulation of morphogenesis of an epithelium,BP,SFRP2
13651,GO:0051260,0.67492429156498,0.693655207814649,1,167,protein homooligomerization,BP,KCNC2
528,GO:0001659,0.675395281705961,0.693159372979486,1,163,temperature homeostasis,BP,CNR1
8097,GO:0031966,0.675523442535321,0.545319415998884,3,620,mitochondrial membrane,CC,DNM1;CNR1;NRGN
22115,GO:2001233,0.675702382170847,0.59239320572955,2,376,regulation of apoptotic signaling pathway,BP,SFRP2;CREB3L1
5021,GO:0010921,0.676273782061348,0.692216520881425,1,158,regulation of phosphatase activity,BP,PPP1R14C
2719,GO:0005765,0.676469565322361,0.591573525465557,2,346,lysosomal membrane,CC,EEF1A2;SLC30A3
17920,GO:0098852,0.676469565322361,0.591573525465557,2,346,lytic vacuole membrane,CC,EEF1A2;SLC30A3
7652,GO:0031099,0.677837109347162,0.690342560459991,1,174,regeneration,BP,PTPN3
17846,GO:0098727,0.678141045758018,0.690128502558394,1,157,maintenance of cell number,BP,ASPM
8752,GO:0032989,0.678939647495959,0.493562182450912,5,756,cellular component morphogenesis,BP,LZTS1;SYT1;SYT4;ADCY1;NPTX1
13405,GO:0050866,0.679879327368706,0.687980407243749,1,183,negative regulation of cell activation,BP,CNR1
7025,GO:0022604,0.680347372731618,0.53991110560354,3,470,regulation of cell morphogenesis,BP,LZTS1;SYT1;SYT4
3483,GO:0006941,0.681472398534712,0.686320814192208,1,162,striated muscle contraction,BP,STAC2
3666,GO:0007265,0.683077637917019,0.583904922597453,2,327,Ras protein signal transduction,BP,FOXM1;SPRY4
6950,GO:0021915,0.683484842452233,0.684086228098334,1,155,neural tube development,BP,SFRP2
11514,GO:0044272,0.68368237092437,0.683713726807951,1,174,sulfur compound biosynthetic process,BP,CHST9
13530,GO:0051056,0.686088672165243,0.58041280704273,2,308,regulation of small GTPase mediated signal transduction,BP,FOXM1;SPRY4
16443,GO:0071897,0.688657756691364,0.677979235709372,1,175,DNA biosynthetic process,BP,CENPF
6016,GO:0016773,0.689243374564841,0.501049138138979,4,624,phosphotransferase activity, alcohol group as acceptor,MF,CAMK1G;CAMK2A;HUNK;MELK
15670,GO:0070482,0.689597428961363,0.57609459892838,2,364,response to oxygen levels,BP,CD38;CRYAB
9633,GO:0035265,0.690312373760084,0.676161984831852,1,161,organ growth,BP,PI16
6015,GO:0016772,0.691139230414004,0.479428059645098,5,808,transferase activity, transferring phosphorus-containing groups,MF,CAMK1G;CAMK2A;TJP2;HUNK;MELK
7185,GO:0030163,0.691959754041838,0.478436662515086,5,861,protein catabolic process,BP,PTPN3;LNX1;EEF1A2;ENC1;UBE2C
14556,GO:0060401,0.69218213296913,0.673963218673439,1,163,cytosolic calcium ion transport,BP,GRIN2B
6152,GO:0017048,0.692671925712688,0.673493340411923,1,151,Rho GTPase binding,MF,DAAM2
2816,GO:0005912,0.692922395969412,0.673154551221975,1,156,adherens junction,CC,TJP2
3140,GO:0006457,0.694625599189775,0.670845943402151,1,201,protein folding,BP,CRYAB
6759,GO:0021543,0.694772908518341,0.670961581175427,1,158,pallium development,BP,ASPM
20176,GO:1904018,0.695267745075204,0.670260446329745,1,173,positive regulation of vasculature development,BP,SFRP2
3783,GO:0007601,0.697347401687927,0.667749648689768,1,180,visual perception,BP,SLC4A10
2464,GO:0005201,0.698131702106354,0.667066142896097,1,149,extracellular matrix structural constituent,MF,ABI3BP
14185,GO:0055001,0.698940126131179,0.66600369923642,1,160,muscle cell development,BP,PI16
5860,GO:0016485,0.70003853728878,0.664496587707286,1,187,protein processing,BP,PCSK1
13291,GO:0050679,0.700576719417909,0.663931443604383,1,175,positive regulation of epithelial cell proliferation,BP,PTPRN
3290,GO:0006643,0.701527007224745,0.662693334878421,1,190,membrane lipid metabolic process,BP,ST8SIA5
12293,GO:0046328,0.702241337139986,0.661961109724731,1,171,regulation of JNK cascade,BP,SFRP2
11332,GO:0043603,0.7031788132592,0.465202800583661,5,982,cellular amide metabolic process,BP,EEF1A2;NEURL1;FOLR2;ENC1;PCSK1
13528,GO:0051054,0.703424425245859,0.660477559808377,1,179,positive regulation of DNA metabolic process,BP,FOXM1
13354,GO:0050792,0.703446443172503,0.660368574217216,1,192,regulation of viral process,BP,TOP2A
13703,GO:0051345,0.70390815657727,0.483627122081042,4,697,positive regulation of hydrolase activity,BP,NCAPH;HPCA;SFRP2;GRIN2B
13618,GO:0051216,0.704398331955863,0.659327390841529,1,175,cartilage development,BP,SFRP2
17219,GO:0090316,0.706235608808978,0.657075233172815,1,178,positive regulation of intracellular protein transport,BP,HPCA
6556,GO:0019538,0.707518381814237,0.370420193997266,31,5028,protein metabolic process,BP,CAMK1G;PTPRN;PTPN3;CAMK2A;LNX1;TPX2;BIRC5;EEF1A2;ST8SIA5;NEURL1;CRYAB;PTPN5;FOXM1;IGFBP2;DUSP4;VGF;CHRM3;HUNK;SFRP2;HSPB8;CHST9;PI16;ADCY1;MELK;FOLR2;ENC1;UBE2C;PCSK1;SPRY4;PPP1R14C;GRIN2B
13409,GO:0050870,0.707525807042811,0.655382507502589,1,197,positive regulation of T cell activation,BP,IGFBP2
1468,GO:0003205,0.709112958171311,0.653680271090655,1,162,cardiac chamber development,BP,SFRP2
20077,GO:1903827,0.709950710373079,0.504503758094342,3,527,regulation of cellular protein localization,BP,HPCA;MRAP2;STAC2
3644,GO:0007219,0.711512258366541,0.650589227562316,1,180,Notch signaling pathway,BP,NEURL1
7269,GO:0030278,0.711609617241463,0.650462097829819,1,181,regulation of ossification,BP,SFRP2
2699,GO:0005740,0.712325939976263,0.501451679193256,3,659,mitochondrial envelope,CC,DNM1;CNR1;NRGN
19113,GO:1901653,0.712432250277637,0.548308147294393,2,356,cellular response to peptide,BP,CAMK2A;ADCY1
6447,GO:0019216,0.712470842554062,0.548228643094492,2,369,regulation of lipid metabolic process,BP,EEF1A2;CNR1
6439,GO:0019207,0.712844981539638,0.648856091774406,1,193,kinase regulator activity,MF,TPX2
11519,GO:0044282,0.713625287692247,0.546699383716467,2,412,small molecule catabolic process,BP,BCAT1;CNR1
18106,GO:0099173,0.713874243953873,0.647789850367071,1,163,postsynapse organization,BP,GRIN2B
2462,GO:0005198,0.715387920680161,0.497765135635818,3,580,structural molecule activity,MF,NEFM;CRYAB;ABI3BP
13640,GO:0051249,0.715961556863307,0.543795512472553,2,402,regulation of lymphocyte activation,BP,CD38;IGFBP2
4520,GO:0009636,0.716850381020825,0.643730667287122,1,217,response to toxic substance,BP,KCNC2
6667,GO:0019882,0.717615618394076,0.642769323605092,1,217,antigen processing and presentation,BP,KIF4A
19359,GO:1902275,0.717813511632752,0.642791095781743,1,172,regulation of chromatin organization,BP,MKI67
7806,GO:0031396,0.718396702460732,0.641926913412465,1,191,regulation of protein ubiquitination,BP,UBE2C
16399,GO:0071824,0.718873914517524,0.641325164279603,1,191,protein-DNA complex subunit organization,BP,CENPF
10583,GO:0042176,0.719431560015263,0.539499963668237,2,369,regulation of protein catabolic process,BP,PTPN3;EEF1A2
17890,GO:0098802,0.719804059499116,0.640229092165645,1,179,plasma membrane signaling receptor complex,CC,GRIN2B
12367,GO:0046486,0.720581593184079,0.538032273659655,2,375,glycerolipid metabolic process,BP,ETNPPL;FABP7
5652,GO:0016051,0.721009719614349,0.638628224753235,1,190,carbohydrate biosynthetic process,BP,CHST9
11511,GO:0044267,0.721464271928649,0.357282092320387,28,4589,cellular protein metabolic process,BP,CAMK1G;PTPRN;PTPN3;CAMK2A;LNX1;TPX2;BIRC5;EEF1A2;ST8SIA5;NEURL1;CRYAB;PTPN5;FOXM1;IGFBP2;DUSP4;VGF;CHRM3;HUNK;SFRP2;HSPB8;PI16;ADCY1;MELK;ENC1;UBE2C;SPRY4;PPP1R14C;GRIN2B
569,GO:0001726,0.722163053459974,0.63729424007119,1,171,ruffle,CC,SPRY4
4302,GO:0009100,0.722858959349592,0.535157361233357,2,369,glycoprotein metabolic process,BP,ST8SIA5;CHST9
14997,GO:0061138,0.723075101971463,0.63610101879219,1,175,morphogenesis of a branching epithelium,BP,SFRP2
438,GO:0001503,0.723714258272675,0.534076158993241,2,366,ossification,BP,SFRP2;CREB3L1
11394,GO:0043903,0.724252323650075,0.634410689152629,1,204,regulation of symbiotic process,BP,TOP2A
4591,GO:0009913,0.724299055139816,0.634426709969956,1,191,epidermal cell differentiation,BP,USH1C
17885,GO:0098797,0.724978072879372,0.485901478112585,3,538,plasma membrane protein complex,CC,SNAP25;KCNC2;GRIN2B
4607,GO:0009966,0.725213724095893,0.368621770928773,17,2802,regulation of signal transduction,BP,ASPM;PTPN3;CAMK2A;TPX2;NPTX2;DNM1;NEURL1;FOXM1;IGFBP2;DUSP4;MRAP2;SFRP2;DAAM2;CREB3L1;NPTX1;SPRY4;GRIN2B
2825,GO:0005929,0.725230062992515,0.485580609960434,3,542,cilium,CC,USH1C;CENPF;PRLHR
8099,GO:0031968,0.725530268766617,0.632833907018967,1,193,organelle outer membrane,CC,CNR1
18083,GO:0099111,0.729048966043545,0.628386745797589,1,178,microtubule-based transport,BP,KIF4A
15347,GO:0062012,0.730006538323887,0.525951212798418,2,393,regulation of small molecule metabolic process,BP,CNR1;HPCA
18941,GO:1901215,0.730022580017756,0.627013930508549,1,194,negative regulation of neuron death,BP,GABRB2
19593,GO:1902905,0.730781791897204,0.626048997672708,1,190,positive regulation of supramolecular fiber organization,BP,STMN2
6662,GO:0019867,0.730936323730437,0.625816132390502,1,195,outer membrane,CC,CNR1
16107,GO:0071345,0.732469295864696,0.429927342003869,5,973,cellular response to cytokine stimulus,BP,PTPRN;CAMK2A;BIRC5;MYBL2;PTPN5
15152,GO:0061564,0.732525237565594,0.476442294762628,3,502,axon development,BP,CNR1;ADCY1;NPTX1
3956,GO:0008270,0.733707910620548,0.447221314442894,4,717,zinc ion binding,MF,RPH3A;ZCCHC12;MYT1L;GRIN2B
82,GO:0000166,0.734718688938091,0.372571402113392,12,1945,nucleotide binding,MF,CAMK1G;KIFC1;CAMK2A;KIF4A;EEF1A2;DNM1;TOP2A;HUNK;MKI67;ADCY1;MELK;UBE2C
2752,GO:0005813,0.734850116253107,0.473421778845023,3,550,centrosome,CC,ASPM;CENPF;CKAP2L
18967,GO:1901265,0.735045405892745,0.372189733475525,12,1946,nucleoside phosphate binding,MF,CAMK1G;KIFC1;CAMK2A;KIF4A;EEF1A2;DNM1;TOP2A;HUNK;MKI67;ADCY1;MELK;UBE2C
936,GO:0002274,0.735629473278303,0.47235427737775,3,616,myeloid leukocyte activation,BP,CNR1;SNAP25;SELL
2727,GO:0005774,0.736284801522397,0.517801765128891,2,393,vacuolar membrane,CC,EEF1A2;SLC30A3
10586,GO:0042180,0.737050016870491,0.617621142116125,1,221,cellular ketone metabolic process,BP,CNR1
18538,GO:0140097,0.738182733126561,0.616260172950241,1,194,catalytic activity, acting on DNA,MF,TOP2A
19936,GO:1903561,0.738199713877133,0.37760974557848,10,1845,extracellular vesicle,CC,CD38;DNM1;CRYAB;IGFBP2;SYT4;GABRB2;DAAM2;FREM2;ADCY1;CPNE4
19233,GO:1901991,0.738664222008422,0.615499956331485,1,215,negative regulation of mitotic cell cycle phase transition,BP,CENPF
11102,GO:0043230,0.739010962657186,0.376649003521515,10,1847,extracellular organelle,CC,CD38;DNM1;CRYAB;IGFBP2;SYT4;GABRB2;DAAM2;FREM2;ADCY1;CPNE4
14511,GO:0060348,0.739583618635595,0.614447332667522,1,185,bone development,BP,SFRP2
2698,GO:0005739,0.741028906629606,0.39521423109702,7,1424,mitochondrion,CC,BCAT1;CAMK2A;DNM1;CRYAB;CNR1;NRGN;ETNPPL
11099,GO:0043227,0.741496098540168,0.333729464763271,69,10968,membrane-bounded organelle,CC,CD38;CAMK1G;SYT13;GABRA1;PTPRN;KIFC1;BCAT1;ASPM;SYT1;CAMK2A;TPX2;RPH3A;BIRC5;KIF4A;MYBL2;EEF1A2;ST8SIA5;SYTL4;STMN2;SLC17A7;DNM1;NCAPG;CRYAB;PTPN5;FOXM1;GABRG2;SLC30A3;IGFBP2;CENPF;CNR1;TJP2;DUSP4;NCAPH;VGF;TOP2A;SNAP25;SYT4;CHRM3;MRAP2;HUNK;GABRB2;TENM2;DAAM2;MKI67;FREM2;HSPB8;CHST9;NRGN;CREB3L1;IGFN1;ETNPPL;FABP7;ADCY1;MELK;KCNC2;TMEM130;KCNK9;NPTX1;ENC1;ZCCHC12;UBE2C;PCSK1;DDN;SV2B;MYT1L;SELL;CPNE4;SLC6A17;GRIN2B
4601,GO:0009952,0.742427120183157,0.61053568076575,1,199,anterior/posterior pattern specification,BP,SFRP2
2740,GO:0005789,0.745192329961267,0.414180972285249,5,963,endoplasmic reticulum membrane,CC,PTPN5;CHRM3;MRAP2;CREB3L1;DDN
9229,GO:0034248,0.745651145951539,0.505448509773594,2,393,regulation of cellular amide metabolic process,BP,NEURL1;ENC1
19673,GO:1903039,0.745844303456851,0.605806435338162,1,216,positive regulation of leukocyte cell-cell adhesion,BP,IGFBP2
137,GO:0000287,0.745964317107324,0.605730596398653,1,200,magnesium ion binding,MF,TOP2A
11828,GO:0045216,0.746331543951609,0.605305278370319,1,188,cell-cell junction organization,BP,TJP2
7961,GO:0031669,0.746457652648734,0.605051429376678,1,201,cellular response to nutrient levels,BP,FOLR2
9651,GO:0035303,0.747518177478505,0.603656301464701,1,192,regulation of dephosphorylation,BP,PPP1R14C
4511,GO:0009612,0.748365071330571,0.602457183344071,1,198,response to mechanical stimulus,BP,IGFBP2
3417,GO:0006839,0.748930220804242,0.601522043231226,1,228,mitochondrial transport,BP,CAMK2A
11236,GO:0043436,0.751074789921645,0.406786795118908,5,1005,oxoacid metabolic process,BP,BCAT1;CNR1;SULT4A1;CHST9;FOLR2
12966,GO:0048514,0.751201757027748,0.452318780440107,3,548,blood vessel morphogenesis,BP,FOXM1;SFRP2;CREB3L1
8668,GO:0032870,0.751286095604202,0.452192107948034,3,561,cellular response to hormone stimulus,BP,CAMK2A;IGFBP2;ADCY1
592,GO:0001763,0.752292933285712,0.597089891812498,1,189,morphogenesis of a branching structure,BP,SFRP2
3658,GO:0007254,0.75238023545402,0.596904820908697,1,199,JNK cascade,BP,SFRP2
5620,GO:0015980,0.752742070206969,0.596199995467292,1,239,energy derivation by oxidation of organic compounds,BP,MRAP2
13544,GO:0051090,0.752839423116509,0.495786441249901,2,402,regulation of DNA-binding transcription factor activity,BP,CAMK2A;ADCY1
17483,GO:0097191,0.75377890579899,0.594867533987491,1,215,extrinsic apoptotic signaling pathway,BP,SFRP2
13390,GO:0050851,0.755645735319679,0.59217340868331,1,232,antigen receptor-mediated signaling pathway,BP,CD38
2925,GO:0006091,0.756688249114806,0.490474739379477,2,451,generation of precursor metabolites and energy,BP,VGF;MRAP2
7104,GO:0030027,0.757090807224863,0.590378656084349,1,189,lamellipodium,CC,STMN2
19230,GO:1901988,0.75785053748853,0.58909749692913,1,226,negative regulation of cell cycle phase transition,BP,CENPF
11518,GO:0044281,0.758735553805314,0.358649742331668,9,1726,small molecule metabolic process,BP,BCAT1;CNR1;TJP2;HPCA;SULT4A1;CHST9;ADCY1;FOLR2;RRM2
3747,GO:0007507,0.760725278933462,0.439776942252564,3,529,heart development,BP,SFRP2;FREM2;PI16
11119,GO:0043254,0.761032374761405,0.484611656249707,2,405,regulation of protein-containing complex assembly,BP,STMN2;CRYAB
5905,GO:0016567,0.761052074575349,0.412364546636702,4,770,protein ubiquitination,BP,LNX1;NEURL1;ENC1;UBE2C
2918,GO:0006082,0.762395549091381,0.392421821415591,5,1019,organic acid metabolic process,BP,BCAT1;CNR1;SULT4A1;CHST9;FOLR2
3490,GO:0006954,0.763062420950928,0.436532826867521,3,642,inflammatory response,BP,CNR1;ADCY1;FOLR2
4923,GO:0010810,0.764426152090107,0.579880372371538,1,197,regulation of cell-substrate adhesion,BP,ABI3BP
8263,GO:0032271,0.764931985853937,0.579074615137023,1,210,regulation of protein polymerization,BP,STMN2
12569,GO:0046914,0.765215822652727,0.388848395484902,5,939,transition metal ion binding,MF,RPH3A;RRM2;ZCCHC12;MYT1L;GRIN2B
19068,GO:1901564,0.765359484029154,0.303339870987548,35,5851,organonitrogen compound metabolic process,BP,CAMK1G;PTPRN;BCAT1;PTPN3;CAMK2A;LNX1;TPX2;BIRC5;EEF1A2;ST8SIA5;NEURL1;CRYAB;PTPN5;FOXM1;IGFBP2;TJP2;DUSP4;HPCA;VGF;SULT4A1;CHRM3;HUNK;SFRP2;HSPB8;CHST9;PI16;ADCY1;MELK;FOLR2;ENC1;UBE2C;PCSK1;SPRY4;PPP1R14C;GRIN2B
10582,GO:0042175,0.76586787958145,0.38798916496459,5,983,nuclear outer membrane-endoplasmic reticulum membrane network,CC,PTPN5;CHRM3;MRAP2;CREB3L1;DDN
10549,GO:0042113,0.766045793830319,0.577417919275975,1,219,B cell activation,BP,CD38
11886,GO:0045444,0.766312810250117,0.577068474703452,1,212,fat cell differentiation,BP,SFRP2
13781,GO:0051495,0.766915563712923,0.576194992374398,1,212,positive regulation of cytoskeleton organization,BP,STMN2
19805,GO:1903320,0.767219309971899,0.575717149962137,1,219,regulation of protein modification by small protein conjugation or removal,BP,UBE2C
718,GO:0001932,0.767441250988965,0.362699878642225,7,1283,regulation of protein phosphorylation,BP,TPX2;NEURL1;FOXM1;DUSP4;SFRP2;ADCY1;SPRY4
3548,GO:0007050,0.768055669723915,0.574501386402386,1,219,cell cycle arrest,BP,FOXM1
2641,GO:0005615,0.769421985894867,0.324740939884431,14,2632,extracellular space,CC,CD38;DNM1;CRYAB;IGFBP2;VGF;SFRP2;GABRB2;DAAM2;FREM2;ABI3BP;PI16;ADCY1;PCSK1;CPNE4
12139,GO:0045944,0.770949075886595,0.368368571428428,6,1097,positive regulation of transcription by RNA polymerase II,BP,PTPRN;MYBL2;FOXM1;TOP2A;SFRP2;CREB3L1
13076,GO:0048705,0.771058075928835,0.570160301811404,1,210,skeletal system morphogenesis,BP,SFRP2
8343,GO:0032388,0.771747637645083,0.569135512670135,1,212,positive regulation of intracellular transport,BP,HPCA
4811,GO:0010638,0.772194286368576,0.424290647000504,3,587,positive regulation of organelle organization,BP,SYT1;STMN2;UBE2C
817,GO:0002064,0.772340692991914,0.568338433801942,1,199,epithelial cell development,BP,TJP2
12359,GO:0046474,0.772627978184148,0.567822015258778,1,215,glycerophospholipid biosynthetic process,BP,ETNPPL
13104,GO:0048762,0.773573083406579,0.566447467621602,1,211,mesenchymal cell differentiation,BP,SFRP2
10647,GO:0042327,0.773968850554749,0.377539603102327,5,952,positive regulation of phosphorylation,BP,TPX2;EEF1A2;NEURL1;SFRP2;ADCY1
4620,GO:0010001,0.77410689838364,0.565624413651291,1,217,glial cell differentiation,BP,DAAM2
11160,GO:0043312,0.774989914563512,0.465034004532292,2,461,neutrophil degranulation,BP,SNAP25;SELL
13495,GO:0051015,0.777265867042714,0.561077040460214,1,191,actin filament binding,MF,USH1C
4786,GO:0010605,0.777314166425962,0.312595583302591,15,2635,negative regulation of macromolecule metabolic process,BP,CD38;PTPN3;BIRC5;CRYAB;FOXM1;CENPF;DUSP4;SFRP2;TENM2;CREB3L1;PI16;ENC1;MYT1L;SPRY4;PPP1R14C
6452,GO:0019221,0.777646021476884,0.416765817454592,3,677,cytokine-mediated signaling pathway,BP,PTPRN;CAMK2A;BIRC5
945,GO:0002283,0.777650357220785,0.46124993715319,2,464,neutrophil activation involved in immune response,BP,SNAP25;SELL
4585,GO:0009894,0.778199947162585,0.372028985516132,5,946,regulation of catabolic process,BP,LZTS1;PTPN3;EEF1A2;CNR1;HSPB8
3969,GO:0008285,0.778242169835227,0.415995294166441,3,625,negative regulation of cell population proliferation,BP,NEURL1;SFRP2;FABP7
2750,GO:0005802,0.779197212464593,0.558016809223011,1,218,trans-Golgi network,CC,SNAP25
13092,GO:0048738,0.779799688732049,0.55723186512188,1,197,cardiac muscle tissue development,BP,PI16
3159,GO:0006486,0.783149081866816,0.552007428551821,1,223,protein glycosylation,BP,ST8SIA5
11221,GO:0043413,0.783149081866816,0.552007428551821,1,223,macromolecule glycosylation,BP,ST8SIA5
6009,GO:0016757,0.784169349836037,0.550407004240252,1,232,transferase activity, transferring glycosyl groups,MF,ST8SIA5
3044,GO:0006302,0.786559730828869,0.546811023552971,1,218,double-strand break repair,BP,FOXM1
1052,GO:0002446,0.786659812441068,0.448273768111408,2,473,neutrophil mediated immunity,BP,SNAP25;SELL
13089,GO:0048732,0.786669286224662,0.448364033432532,2,412,gland development,BP,PTPN3;NEURL1
10553,GO:0042119,0.786956880923204,0.447840496030685,2,474,neutrophil activation,BP,SNAP25;SELL
13838,GO:0051606,0.788371062493428,0.543882809828122,1,246,detection of stimulus,BP,SYT1
21469,GO:2000027,0.788640071691568,0.54350539194727,1,237,regulation of animal organ morphogenesis,BP,SFRP2
13837,GO:0051604,0.788964166928649,0.542951437204969,1,249,protein maturation,BP,PCSK1
19898,GO:1903508,0.789011387028119,0.327568197353716,8,1461,positive regulation of nucleic acid-templated transcription,BP,CD38;PTPRN;MYBL2;FOXM1;TOP2A;SFRP2;CREB3L1;ZCCHC12
3713,GO:0007389,0.789404788886511,0.444352508806624,2,425,pattern specification process,BP,SFRP2;DAAM2
19510,GO:1902680,0.789617477477354,0.326797498534114,8,1462,positive regulation of RNA biosynthetic process,BP,CD38;PTPRN;MYBL2;FOXM1;TOP2A;SFRP2;CREB3L1;ZCCHC12
3518,GO:0007005,0.789828015971174,0.443641006715991,2,482,mitochondrion organization,BP,CAMK2A;DNM1
10165,GO:0036230,0.791794478935196,0.440761603802897,2,479,granulocyte activation,BP,SNAP25;SELL
7256,GO:0030258,0.792018082607478,0.538268042105301,1,232,lipid modification,BP,CNR1
4730,GO:0010498,0.793155214373962,0.43879859359611,2,453,proteasomal protein catabolic process,BP,ENC1;UBE2C
18537,GO:0140096,0.795816643744507,0.302952427961624,11,1923,catalytic activity, acting on a protein,MF,CAMK1G;PTPN3;CAMK2A;LNX1;NEURL1;PTPN5;DUSP4;HUNK;MELK;UBE2C;PCSK1
7809,GO:0031399,0.797289528046722,0.310747979165448,9,1659,regulation of protein modification process,BP,TPX2;NEURL1;FOXM1;DUSP4;SFRP2;ADCY1;UBE2C;SPRY4;PPP1R14C
161,GO:0000323,0.797653263234461,0.388855458974599,3,648,lytic vacuole,CC,EEF1A2;SLC30A3;GRIN2B
2718,GO:0005764,0.797653263234461,0.388855458974599,3,648,lysosome,CC,EEF1A2;SLC30A3;GRIN2B
15432,GO:0070085,0.799288032470196,0.526743880630415,1,235,glycosylation,BP,ST8SIA5
111,GO:0000228,0.805043339436964,0.314485415026744,7,1344,nuclear chromosome,CC,BIRC5;FOXM1;NCAPH;TOP2A;CREB3L1;ENC1;MYT1L
17056,GO:0090092,0.805520216560382,0.516694594940427,1,229,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,SFRP2
3279,GO:0006629,0.806430166340044,0.322049038860962,6,1221,lipid metabolic process,BP,EEF1A2;ST8SIA5;CNR1;SULT4A1;ETNPPL;FABP7
11502,GO:0044248,0.807099775465354,0.288773657537569,11,2099,cellular catabolic process,BP,BCAT1;LZTS1;PTPN3;LNX1;EEF1A2;CNR1;LIX1;HSPB8;FABP7;ENC1;UBE2C
15113,GO:0061448,0.807371424124671,0.513628847513013,1,236,connective tissue development,BP,SFRP2
19069,GO:1901565,0.807971162338834,0.319994037488031,6,1201,organonitrogen compound catabolic process,BP,BCAT1;PTPN3;LNX1;EEF1A2;ENC1;UBE2C
7015,GO:0022409,0.808891519636556,0.511043460334912,1,255,positive regulation of cell-cell adhesion,BP,IGFBP2
11720,GO:0045017,0.81101915876019,0.507569530197068,1,243,glycerolipid biosynthetic process,BP,ETNPPL
7316,GO:0030336,0.812114932479931,0.505767602660132,1,238,negative regulation of cell migration,BP,SFRP2
4513,GO:0009617,0.814357241294766,0.406713291733994,2,498,response to bacterium,BP,CNR1;VGF
4763,GO:0010562,0.81552886304767,0.321839308550446,5,1010,positive regulation of phosphorus metabolic process,BP,TPX2;EEF1A2;NEURL1;SFRP2;ADCY1
12134,GO:0045937,0.81552886304767,0.321839308550446,5,1010,positive regulation of phosphate metabolic process,BP,TPX2;EEF1A2;NEURL1;SFRP2;ADCY1
13044,GO:0048667,0.815801752114279,0.362667709918469,3,573,cell morphogenesis involved in neuron differentiation,BP,LZTS1;ADCY1;NPTX1
3600,GO:0007166,0.817953868774191,0.262988456637102,15,2692,cell surface receptor signaling pathway,BP,CD38;PTPRN;ASPM;PTPN3;CAMK2A;BIRC5;SLC17A7;DNM1;NEURL1;IGFBP2;SFRP2;DAAM2;CREB3L1;SPRY4;GRIN2B
6091,GO:0016887,0.818170879382783,0.400974461180319,2,388,ATPase activity,MF,KIFC1;TOP2A
11147,GO:0043299,0.81925836926014,0.399074606310294,2,506,leukocyte degranulation,BP,SNAP25;SELL
4185,GO:0008654,0.819283671993832,0.493613392993326,1,251,phospholipid biosynthetic process,BP,ETNPPL
8393,GO:0032446,0.820716607032341,0.330965568324754,4,844,protein modification by small protein conjugation,BP,LNX1;NEURL1;ENC1;UBE2C
3182,GO:0006520,0.820725857918431,0.490991966794183,1,294,cellular amino acid metabolic process,BP,BCAT1
3052,GO:0006310,0.820861966295742,0.490920236828056,1,249,DNA recombination,BP,TOP2A
9505,GO:0034774,0.822928437262392,0.487184680819583,1,299,secretory granule lumen,CC,PCSK1
8848,GO:0033157,0.823488898765762,0.486384055036679,1,251,regulation of intracellular protein transport,BP,HPCA
15416,GO:0070062,0.824964827800322,0.274981610078222,9,1827,extracellular exosome,CC,CD38;DNM1;CRYAB;IGFBP2;GABRB2;DAAM2;FREM2;ADCY1;CPNE4
21533,GO:2000146,0.825099057144112,0.483593528281974,1,250,negative regulation of cell motility,BP,SFRP2
14409,GO:0060205,0.826116447240066,0.481637804774669,1,302,cytoplasmic vesicle lumen,CC,PCSK1
3921,GO:0008202,0.826631747639022,0.480826627529331,1,274,steroid metabolic process,BP,SULT4A1
13836,GO:0051603,0.827092408321402,0.345757837255446,3,668,proteolysis involved in cellular protein catabolic process,BP,LNX1;ENC1;UBE2C
3013,GO:0006260,0.827486990402333,0.479392345045561,1,257,DNA replication,BP,RRM2
1613,GO:0003713,0.827682603457638,0.47906537619607,1,253,transcription coactivator activity,MF,ZCCHC12
4559,GO:0009790,0.82871403480943,0.303435357487707,5,979,embryo development,BP,USH1C;DUSP4;TOP2A;SFRP2;FREM2
937,GO:0002275,0.828824660143677,0.383911975104453,2,517,myeloid cell activation involved in immune response,BP,SNAP25;SELL
8105,GO:0031983,0.829918553567473,0.474949838396903,1,304,vesicle lumen,CC,PCSK1
1364,GO:0003007,0.830993621178847,0.473287118522384,1,238,heart morphogenesis,BP,SFRP2
9519,GO:0034976,0.832575078587818,0.470332983209077,1,272,response to endoplasmic reticulum stress,BP,CREB3L1
483,GO:0001568,0.833098119459298,0.336691751304394,3,627,blood vessel development,BP,FOXM1;SFRP2;CREB3L1
1050,GO:0002444,0.834185317802294,0.375260393050549,2,523,myeloid leukocyte mediated immunity,BP,SNAP25;SELL
15191,GO:0061630,0.834237974416982,0.467426448529982,1,254,ubiquitin protein ligase activity,MF,NEURL1
454,GO:0001525,0.83473819297163,0.37444862826404,2,460,angiogenesis,BP,SFRP2;CREB3L1
7949,GO:0031647,0.837155751445905,0.462101918773237,1,270,regulation of protein stability,BP,CRYAB
17035,GO:0090068,0.837455613072126,0.461584408089658,1,263,positive regulation of cell cycle process,BP,UBE2C
8437,GO:0032496,0.837784657288746,0.460877039532026,1,295,response to lipopolysaccharide,BP,CNR1
13586,GO:0051146,0.837948740188421,0.460741668820798,1,250,striated muscle cell differentiation,BP,PI16
4803,GO:0010629,0.839319796384673,0.251301963722044,10,1945,negative regulation of gene expression,BP,CD38;BIRC5;CRYAB;FOXM1;CENPF;SFRP2;TENM2;CREB3L1;ENC1;MYT1L
7024,GO:0022603,0.839591705536258,0.287928337695622,5,1004,regulation of anatomical structure morphogenesis,BP,LZTS1;SYT1;SYT4;SFRP2;CREB3L1
13645,GO:0051254,0.840318411772273,0.260204600933607,8,1547,positive regulation of RNA metabolic process,BP,CD38;PTPRN;MYBL2;FOXM1;TOP2A;SFRP2;CREB3L1;ZCCHC12
7178,GO:0030155,0.840594222410446,0.325140514936998,3,660,regulation of cell adhesion,BP,IGFBP2;SFRP2;ABI3BP
428,GO:0001228,0.840694395498753,0.36467610312442,2,472,DNA-binding transcription activator activity, RNA polymerase II-specific,MF,MYBL2;CREB3L1
14619,GO:0060485,0.842844935717711,0.451714492608462,1,263,mesenchyme development,BP,SFRP2
419,GO:0001216,0.842960451953572,0.360921978009374,2,475,DNA-binding transcription activator activity,MF,MYBL2;CREB3L1
15206,GO:0061659,0.843166455775495,0.45111981899725,1,263,ubiquitin-like protein ligase activity,MF,NEURL1
436,GO:0001501,0.843257903035394,0.360436991609058,2,469,skeletal system development,BP,SFRP2;HAPLN4
19671,GO:1903037,0.844365897998816,0.44879752808183,1,291,regulation of leukocyte cell-cell adhesion,BP,IGFBP2
2815,GO:0005911,0.845781676960949,0.356263026381325,2,449,cell-cell junction,CC,TJP2;FABP7
720,GO:0001934,0.846994210151604,0.292392730797091,4,883,positive regulation of protein phosphorylation,BP,TPX2;NEURL1;SFRP2;ADCY1
60,GO:0000122,0.847074245446367,0.292283286577679,4,862,negative regulation of transcription by RNA polymerase II,BP,FOXM1;TENM2;CREB3L1;MYT1L
12100,GO:0045893,0.847343229681874,0.257287469736027,7,1389,positive regulation of transcription, DNA-templated,BP,CD38;PTPRN;MYBL2;FOXM1;TOP2A;SFRP2;CREB3L1
13402,GO:0050863,0.848916723191992,0.440238627585373,1,302,regulation of T cell activation,BP,IGFBP2
11861,GO:0045321,0.84899830548122,0.27424682022551,5,1137,leukocyte activation,BP,CD38;IGFBP2;CNR1;SNAP25;SELL
6683,GO:0019904,0.849023844111016,0.311962070056977,3,661,protein domain specific binding,MF,LNX1;DNM1;TJP2
2739,GO:0005788,0.849156819561164,0.439875785235295,1,274,endoplasmic reticulum lumen,CC,VGF
11101,GO:0043229,0.849330332608513,0.207248184151752,68,10994,intracellular organelle,CC,CD38;USH1C;CAMK1G;SYT13;GABRA1;PTPRN;KIFC1;BCAT1;ASPM;SYT1;PTPN3;CAMK2A;TPX2;RPH3A;BIRC5;KIF4A;MYBL2;EEF1A2;ST8SIA5;SYTL4;STMN2;NEFM;SLC17A7;DNM1;NCAPG;CRYAB;PTPN5;FOXM1;GABRG2;SLC30A3;IGFBP2;CENPF;CNR1;TJP2;DUSP4;NCAPH;VGF;TOP2A;SNAP25;SYT4;MRAP2;HUNK;GABRB2;TENM2;MKI67;HSPB8;CHST9;NRGN;CREB3L1;IGFN1;ETNPPL;FABP7;ADCY1;MELK;TMEM130;KCNK9;CKAP2L;NPTX1;ENC1;ZCCHC12;UBE2C;PCSK1;MAP7D2;SV2B;MYT1L;SELL;SLC6A17;GRIN2B
917,GO:0002237,0.851442870988206,0.43542929088117,1,308,response to molecule of bacterial origin,BP,CNR1
16721,GO:0072359,0.85242231858578,0.269281772923698,5,993,circulatory system development,BP,FOXM1;SFRP2;FREM2;CREB3L1;PI16
729,GO:0001944,0.854220486971158,0.303720321189858,3,657,vasculature development,BP,FOXM1;SFRP2;CREB3L1
4529,GO:0009653,0.854839590347258,0.218348804661134,14,2472,anatomical structure morphogenesis,BP,USH1C;LZTS1;SYT1;CRYAB;FOXM1;DUSP4;SYT4;SLC4A10;SFRP2;FREM2;CREB3L1;IGFN1;ADCY1;NPTX1
5441,GO:0015629,0.854926643103092,0.340769291405379,2,464,actin cytoskeleton,CC,CRYAB;CNR1
6028,GO:0016787,0.856050521417711,0.225193438846184,11,2132,hydrolase activity,MF,CD38;KIFC1;PTPN3;KIF4A;EEF1A2;DNM1;PTPN5;DUSP4;TOP2A;CHRM3;PCSK1
642,GO:0001822,0.856133573398277,0.426568506041755,1,262,kidney development,BP,CENPF
10529,GO:0042063,0.857306426093123,0.424217882940116,1,282,gliogenesis,BP,DAAM2
12993,GO:0048562,0.858054257105004,0.422767218699861,1,280,embryonic organ morphogenesis,BP,USH1C
11504,GO:0044255,0.858670732077425,0.274614195545733,4,936,cellular lipid metabolic process,BP,ST8SIA5;CNR1;ETNPPL;FABP7
10482,GO:0040013,0.860607016593854,0.417761855981901,1,280,negative regulation of locomotion,BP,SFRP2
327,GO:0000902,0.860933068094774,0.256679652839334,5,979,cell morphogenesis,BP,LZTS1;SYT1;SYT4;ADCY1;NPTX1
7167,GO:0030139,0.860966846387694,0.417000584544294,1,296,endocytic vesicle,CC,CAMK2A
12323,GO:0046394,0.861412635922464,0.416065678267037,1,315,carboxylic acid biosynthetic process,BP,BCAT1
2726,GO:0005773,0.861496750057489,0.291956565020632,3,734,vacuole,CC,EEF1A2;SLC30A3;GRIN2B
7811,GO:0031401,0.862229862742021,0.254699800862419,5,1088,positive regulation of protein modification process,BP,TPX2;NEURL1;SFRP2;ADCY1;UBE2C
5654,GO:0016053,0.862320471003298,0.41426619355802,1,316,organic acid biosynthetic process,BP,BCAT1
11104,GO:0043232,0.862543537147986,0.192902205337403,26,4543,intracellular non-membrane-bounded organelle,CC,USH1C;KIFC1;ASPM;PTPN3;TPX2;BIRC5;KIF4A;MYBL2;NEFM;DNM1;NCAPG;CRYAB;FOXM1;CENPF;CNR1;NCAPH;TOP2A;SNAP25;MKI67;CREB3L1;IGFN1;CKAP2L;ENC1;MAP7D2;MYT1L;GRIN2B
13316,GO:0050727,0.863701067644111,0.411524789274204,1,315,regulation of inflammatory response,BP,CNR1
13658,GO:0051271,0.865100879902112,0.408824610632804,1,283,negative regulation of cellular component movement,BP,SFRP2
11460,GO:0044089,0.865419994792737,0.322504611534788,2,494,positive regulation of cellular component biogenesis,BP,NEURL1;TENM2
11100,GO:0043228,0.865432453930898,0.189284036541495,26,4552,non-membrane-bounded organelle,CC,USH1C;KIFC1;ASPM;PTPN3;TPX2;BIRC5;KIF4A;MYBL2;NEFM;DNM1;NCAPG;CRYAB;FOXM1;CENPF;CNR1;NCAPH;TOP2A;SNAP25;MKI67;CREB3L1;IGFN1;CKAP2L;ENC1;MAP7D2;MYT1L;GRIN2B
16490,GO:0072001,0.866060147146033,0.406941662412559,1,271,renal system development,BP,CENPF
7790,GO:0031349,0.866219781606245,0.406463366136969,1,322,positive regulation of defense response,BP,CNR1
13343,GO:0050776,0.867413291632482,0.282260110230264,3,788,regulation of immune response,BP,CD38;CNR1;SELL
4136,GO:0008544,0.868189650704182,0.402565498819059,1,294,epidermis development,BP,USH1C
11505,GO:0044257,0.868612591352941,0.280322974998098,3,726,cellular protein catabolic process,BP,LNX1;ENC1;UBE2C
13345,GO:0050778,0.868867555601494,0.316320124080927,2,566,positive regulation of immune response,BP,CD38;CNR1
3721,GO:0007409,0.869141818450264,0.315960183835254,2,461,axonogenesis,BP,ADCY1;NPTX1
6391,GO:0019058,0.873472813285058,0.391705041165614,1,309,viral life cycle,BP,TOP2A
2827,GO:0005938,0.874162287487832,0.390391914146046,1,273,cell cortex,CC,MELK
4789,GO:0010608,0.876666097655932,0.302314115044292,2,547,posttranscriptional regulation of gene expression,BP,NEURL1;ENC1
3665,GO:0007264,0.876843133231233,0.30206413328496,2,486,small GTPase mediated signal transduction,BP,FOXM1;SPRY4
3294,GO:0006650,0.877307686591595,0.383720069272737,1,307,glycerophospholipid metabolic process,BP,ETNPPL
11458,GO:0044087,0.877914897614239,0.244442365672677,4,884,regulation of cellular component biogenesis,BP,STMN2;NEURL1;CRYAB;TENM2
2847,GO:0005975,0.877949708013822,0.299979362483918,2,543,carbohydrate metabolic process,BP,ST8SIA5;CHST9
1036,GO:0002429,0.880257444362428,0.377418183951645,1,335,immune response-activating cell surface receptor signaling pathway,BP,CD38
1240,GO:0002757,0.880257444362428,0.377418183951645,1,335,immune response-activating signal transduction,BP,CD38
3280,GO:0006631,0.880736913099987,0.376382432531884,1,342,fatty acid metabolic process,BP,CNR1
5935,GO:0016604,0.882206097212285,0.257525859485555,3,733,nuclear body,CC,TENM2;MKI67;HSPB8
99,GO:0000209,0.882374505841061,0.372942468395491,1,319,protein polyubiquitination,BP,UBE2C
11368,GO:0043687,0.882656748772982,0.372299826145526,1,334,post-translational protein modification,BP,VGF
13779,GO:0051493,0.883018896106018,0.290691024613512,2,511,regulation of cytoskeleton organization,BP,TPX2;STMN2
778,GO:0002009,0.884132131952083,0.288616105494019,2,518,morphogenesis of an epithelium,BP,SFRP2;FREM2
3434,GO:0006869,0.884219655899506,0.368983068486526,1,316,lipid transport,BP,NMB
18435,GO:0120031,0.88424069236077,0.288421199510506,2,512,plasma membrane bounded cell projection assembly,BP,NEURL1;TENM2
13526,GO:0051052,0.885879363197261,0.365394325209014,1,314,regulation of DNA metabolic process,BP,FOXM1
8978,GO:0033554,0.886358385882976,0.190858231739841,9,1882,cellular response to stress,BP,CAMK2A;CRYAB;FOXM1;TOP2A;SFRP2;HSPB8;CREB3L1;MELK;KCNC2
11858,GO:0045296,0.886977830145752,0.363018679368493,1,308,cadherin binding,MF,TJP2
8181,GO:0032102,0.887358354953306,0.362122385523862,1,333,negative regulation of response to external stimulus,BP,FABP7
1858,GO:0004175,0.888537566680149,0.359526393580922,1,338,endopeptidase activity,MF,PCSK1
13603,GO:0051171,0.891183919481656,0.154918122083226,29,5140,regulation of nitrogen compound metabolic process,BP,CD38;PTPRN;PTPN3;CAMK2A;TPX2;BIRC5;MYBL2;EEF1A2;NEURL1;CRYAB;FOXM1;CENPF;DUSP4;HPCA;TOP2A;SFRP2;TENM2;CREB3L1;PI16;ADCY1;FOLR2;ENC1;RRM2;ZCCHC12;UBE2C;MYT1L;SPRY4;PPP1R14C;GRIN2B
3500,GO:0006974,0.891312809632976,0.24179304107892,3,771,cellular response to DNA damage stimulus,BP,FOXM1;TOP2A;SFRP2
16906,GO:0080090,0.891957566827883,0.153473678844893,30,5300,regulation of primary metabolic process,BP,CD38;PTPRN;PTPN3;CAMK2A;TPX2;BIRC5;MYBL2;EEF1A2;NEURL1;CRYAB;FOXM1;CENPF;CNR1;DUSP4;HPCA;TOP2A;SFRP2;TENM2;CREB3L1;PI16;ADCY1;FOLR2;ENC1;RRM2;ZCCHC12;UBE2C;MYT1L;SPRY4;PPP1R14C;GRIN2B
7107,GO:0030031,0.892689805799044,0.272481169245687,2,527,cell projection assembly,BP,NEURL1;TENM2
8098,GO:0031967,0.893163147512938,0.21953035840356,4,1067,organelle envelope,CC,DNM1;CENPF;CNR1;NRGN
8102,GO:0031975,0.893163147512938,0.21953035840356,4,1067,envelope,CC,DNM1;CENPF;CNR1;NRGN
4758,GO:0010557,0.894369151537537,0.183716566218506,8,1685,positive regulation of macromolecule biosynthetic process,BP,CD38;PTPRN;MYBL2;FOXM1;TOP2A;SFRP2;CREB3L1;ZCCHC12
6281,GO:0018193,0.894752942397989,0.204433042855448,5,1135,peptidyl-amino acid modification,BP,CAMK1G;CAMK2A;NEURL1;SFRP2;MELK
17879,GO:0098791,0.895008765185243,0.345147455628765,1,325,Golgi apparatus subcompartment,CC,SNAP25
1362,GO:0003002,0.896188624015696,0.342462322223473,1,331,regionalization,BP,SFRP2
524,GO:0001655,0.896426893682775,0.341986748735696,1,306,urogenital system development,BP,CENPF
4906,GO:0010769,0.897244769744426,0.340157941050931,1,295,regulation of cell morphogenesis involved in differentiation,BP,LZTS1
4757,GO:0010556,0.89891308255907,0.152112223478505,19,3554,regulation of macromolecule biosynthetic process,BP,CD38;PTPRN;CAMK2A;BIRC5;MYBL2;NEURL1;CRYAB;FOXM1;CENPF;TOP2A;SFRP2;TENM2;CREB3L1;ADCY1;FOLR2;ENC1;RRM2;ZCCHC12;MYT1L
12132,GO:0045935,0.899014964136891,0.176816764537985,8,1689,positive regulation of nucleobase-containing compound metabolic process,BP,CD38;PTPRN;MYBL2;FOXM1;TOP2A;SFRP2;CREB3L1;ZCCHC12
14667,GO:0060562,0.900181769112805,0.333365750200629,1,314,epithelial tube morphogenesis,BP,SFRP2
14254,GO:0055114,0.900782480458036,0.224996206237998,3,881,oxidation-reduction process,BP,CNR1;MRAP2;RRM2
3610,GO:0007178,0.900943742729396,0.331587686786215,1,320,transmembrane receptor protein serine/threonine kinase signaling pathway,BP,SFRP2
7765,GO:0031323,0.902652874916139,0.13932232591534,31,5500,regulation of cellular metabolic process,BP,CD38;PTPRN;LZTS1;PTPN3;CAMK2A;TPX2;BIRC5;MYBL2;EEF1A2;NEURL1;CRYAB;FOXM1;CENPF;CNR1;DUSP4;HPCA;TOP2A;SFRP2;TENM2;HSPB8;CREB3L1;PI16;ADCY1;ENC1;RRM2;ZCCHC12;UBE2C;MYT1L;SPRY4;PPP1R14C;GRIN2B
1250,GO:0002768,0.90291419863258,0.326899486606676,1,366,immune response-regulating cell surface receptor signaling pathway,BP,CD38
1247,GO:0002764,0.904223645582703,0.323824417569225,1,369,immune response-regulating signaling pathway,BP,CD38
3176,GO:0006511,0.904841429108908,0.248763281188765,2,580,ubiquitin-dependent protein catabolic process,BP,LNX1;UBE2C
4580,GO:0009889,0.905534735905007,0.142223295149609,20,3754,regulation of biosynthetic process,BP,CD38;PTPRN;CAMK2A;BIRC5;MYBL2;NEURL1;CRYAB;FOXM1;CENPF;HPCA;TOP2A;SFRP2;TENM2;CREB3L1;ADCY1;FOLR2;ENC1;RRM2;ZCCHC12;MYT1L
10825,GO:0042692,0.906727476687808,0.317995520333504,1,327,muscle cell differentiation,BP,PI16
7506,GO:0030855,0.90678420017292,0.244896961385025,2,572,epithelial cell differentiation,BP,USH1C;TJP2
6696,GO:0019941,0.90783221054115,0.242784558802843,2,586,modification-dependent protein catabolic process,BP,LNX1;UBE2C
7135,GO:0030097,0.907880875340796,0.212179103457675,3,816,hemopoiesis,BP,TOP2A;SFRP2;MELK
19896,GO:1903506,0.907942863550215,0.143517801221488,16,3092,regulation of nucleic acid-templated transcription,BP,CD38;PTPRN;CAMK2A;BIRC5;MYBL2;CRYAB;FOXM1;CENPF;TOP2A;SFRP2;TENM2;CREB3L1;ADCY1;RRM2;ZCCHC12;MYT1L
328,GO:0000904,0.907957966713383,0.212095137797271,3,710,cell morphogenesis involved in differentiation,BP,LZTS1;ADCY1;NPTX1
22068,GO:2001141,0.909078137132494,0.141948878883896,16,3097,regulation of RNA biosynthetic process,BP,CD38;PTPRN;CAMK2A;BIRC5;MYBL2;CRYAB;FOXM1;CENPF;TOP2A;SFRP2;TENM2;CREB3L1;ADCY1;RRM2;ZCCHC12;MYT1L
14687,GO:0060589,0.909119305087078,0.312286233355133,1,323,nucleoside-triphosphatase regulator activity,MF,NCAPH
8106,GO:0031984,0.909396123972689,0.311564601266387,1,347,organelle subcompartment,CC,SNAP25
12457,GO:0046649,0.910190478365657,0.238003418529879,2,620,lymphocyte activation,BP,CD38;IGFBP2
2713,GO:0005759,0.910632347313295,0.308434440988181,1,431,mitochondrial matrix,CC,ETNPPL
11351,GO:0043632,0.911054839718259,0.236271338324301,2,594,modification-dependent macromolecule catabolic process,BP,LNX1;UBE2C
14449,GO:0060271,0.911130850196608,0.307398092115762,1,335,cilium assembly,BP,NEURL1
2723,GO:0005769,0.91137334563473,0.306793372003197,1,342,early endosome,CC,KIFC1
4981,GO:0010876,0.91153952527401,0.306357639977229,1,357,lipid localization,BP,NMB
12048,GO:0045787,0.911656504336304,0.306083383088469,1,352,positive regulation of cell cycle,BP,UBE2C
3261,GO:0006605,0.912443955097726,0.304052555975184,1,415,protein targeting,BP,HPCA
1185,GO:0002684,0.913469322693618,0.20185235773813,3,869,positive regulation of immune system process,BP,CD38;IGFBP2;CNR1
2653,GO:0005654,0.914254041796139,0.131356791171834,19,3641,nucleoplasm,CC,CAMK2A;TPX2;BIRC5;KIF4A;MYBL2;DNM1;CRYAB;PTPN5;FOXM1;CENPF;TJP2;DUSP4;NCAPH;TOP2A;TENM2;MKI67;HSPB8;ENC1;UBE2C
12840,GO:0048193,0.914278058559132,0.299679621184801,1,345,Golgi vesicle transport,BP,KIF4A
3012,GO:0006259,0.914318843658104,0.200290167019631,3,823,DNA metabolic process,BP,FOXM1;CENPF;TOP2A
1184,GO:0002683,0.914936620117121,0.297970275791829,1,389,negative regulation of immune system process,BP,CNR1
15761,GO:0070647,0.915053899899991,0.18223944120366,4,1006,protein modification by small protein conjugation or removal,BP,LNX1;NEURL1;ENC1;UBE2C
603,GO:0001775,0.915434494083475,0.170556339324865,5,1277,cell activation,BP,CD38;IGFBP2;CNR1;SNAP25;SELL
2693,GO:0005730,0.915568034493334,0.197945509361325,3,849,nucleolus,CC,TOP2A;MKI67;ENC1
7917,GO:0031589,0.915592638704216,0.296464171301343,1,330,cell-substrate adhesion,BP,ABI3BP
1000,GO:0002366,0.915789839819135,0.226533470156835,2,650,leukocyte activation involved in immune response,BP,SNAP25;SELL
15476,GO:0070161,0.917241045831629,0.194839211095351,3,776,anchoring junction,CC,TJP2;FABP7;SPRY4
930,GO:0002263,0.918048523249259,0.221846652962098,2,653,cell activation involved in immune response,BP,SNAP25;SELL
7770,GO:0031328,0.918465893849968,0.147235742827343,8,1767,positive regulation of cellular biosynthetic process,BP,CD38;PTPRN;MYBL2;FOXM1;TOP2A;SFRP2;CREB3L1;ZCCHC12
13429,GO:0050900,0.918902363237845,0.288053648688038,1,401,leukocyte migration,BP,SELL
2760,GO:0005829,0.920495763900352,0.118526121447755,25,4688,cytosol,CC,USH1C;BCAT1;CAMK2A;TPX2;RPH3A;BIRC5;KIF4A;NCAPG;CRYAB;CENPF;TJP2;NCAPH;HPCA;SULT4A1;SNAP25;STAC2;GABRB2;HSPB8;NRGN;VSNL1;FABP7;CKAP2L;RRM2;UBE2C;SPRY4
8461,GO:0032535,0.920843345862964,0.283224108103021,1,353,regulation of cellular component size,BP,USH1C
11661,GO:0044782,0.921504562843786,0.281538469768346,1,353,cilium organization,BP,NEURL1
926,GO:0002253,0.922119855959741,0.279877725608842,1,402,activation of immune response,BP,CD38
4161,GO:0008610,0.922435918548849,0.212640930820467,2,639,lipid biosynthetic process,BP,ST8SIA5;ETNPPL
12978,GO:0048534,0.923339672571927,0.183216004074393,3,855,hematopoietic or lymphoid organ development,BP,TOP2A;SFRP2;MELK
4578,GO:0009887,0.923596267533037,0.167078292674813,4,988,animal organ morphogenesis,BP,USH1C;SLC4A10;SFRP2;IGFN1
8262,GO:0032270,0.923754753508733,0.149040688405309,6,1437,positive regulation of cellular protein metabolic process,BP,TPX2;NEURL1;SFRP2;ADCY1;UBE2C;GRIN2B
3877,GO:0008134,0.924898300002653,0.207419581860543,2,611,transcription factor binding,MF,PTPRN;CENPF
7013,GO:0022407,0.924930149560664,0.272647984472831,1,389,regulation of cell-cell adhesion,BP,IGFBP2
8754,GO:0032991,0.924968638568011,0.113026894012723,24,4582,protein-containing complex,CC,USH1C;CAMK1G;GABRA1;KIFC1;CAMK2A;RPH3A;BIRC5;MYBL2;EEF1A2;DNM1;NCAPG;CRYAB;GABRG2;CENPF;NCAPH;TOP2A;SNAP25;GABRB2;HSPB8;KCNC2;ENC1;RRM2;UBE2C;GRIN2B
4579,GO:0009888,0.924994184841136,0.137039988978471,8,1738,tissue development,BP,USH1C;NEURL1;CENPF;TJP2;DUSP4;SFRP2;FREM2;PI16
4269,GO:0009056,0.925370087507086,0.127437490162327,11,2415,catabolic process,BP,BCAT1;LZTS1;PTPN3;LNX1;EEF1A2;CNR1;LIX1;HSPB8;FABP7;ENC1;UBE2C
7767,GO:0031325,0.925556001178487,0.120122940308334,15,3000,positive regulation of cellular metabolic process,BP,CD38;PTPRN;TPX2;MYBL2;EEF1A2;NEURL1;FOXM1;TOP2A;SFRP2;HSPB8;CREB3L1;ADCY1;ZCCHC12;UBE2C;GRIN2B
13002,GO:0048584,0.925628982627032,0.132483209626657,9,2035,positive regulation of response to stimulus,BP,CD38;ASPM;NEURL1;FOXM1;CNR1;MRAP2;SFRP2;DAAM2;VSNL1
4582,GO:0009891,0.925770281270091,0.135811379451846,8,1794,positive regulation of biosynthetic process,BP,CD38;PTPRN;MYBL2;FOXM1;TOP2A;SFRP2;CREB3L1;ZCCHC12
7773,GO:0031331,0.925844896144998,0.270312762693868,1,362,positive regulation of cellular catabolic process,BP,HSPB8
1637,GO:0003824,0.925859688043045,0.110790015624917,26,4902,catalytic activity,MF,CD38;CAMK1G;KIFC1;BCAT1;PTPN3;CAMK2A;LNX1;KIF4A;EEF1A2;ST8SIA5;DNM1;NEURL1;PTPN5;TJP2;DUSP4;SULT4A1;TOP2A;CHRM3;HUNK;CHST9;ETNPPL;ADCY1;MELK;RRM2;UBE2C;PCSK1
9611,GO:0035239,0.926275998297692,0.177584038610151,3,782,tube morphogenesis,BP,FOXM1;SFRP2;CREB3L1
7768,GO:0031326,0.926547562021683,0.114371468361997,19,3679,regulation of cellular biosynthetic process,BP,CD38;PTPRN;CAMK2A;BIRC5;MYBL2;NEURL1;CRYAB;FOXM1;CENPF;HPCA;TOP2A;SFRP2;TENM2;CREB3L1;ADCY1;ENC1;RRM2;ZCCHC12;MYT1L
11056,GO:0043161,0.926834627663321,0.267654438363742,1,401,proteasome-mediated ubiquitin-dependent protein catabolic process,BP,UBE2C
6603,GO:0019752,0.927094630950181,0.175939320200015,3,924,carboxylic acid metabolic process,BP,BCAT1;CNR1;FOLR2
13035,GO:0048646,0.929812196362564,0.155794841877982,4,998,anatomical structure formation involved in morphogenesis,BP,DUSP4;SFRP2;CREB3L1;IGFN1
3488,GO:0006952,0.930383559424074,0.144957262087513,5,1367,defense response,BP,CAMK2A;CNR1;VGF;ADCY1;FOLR2
3291,GO:0006644,0.930723895193834,0.257348309889453,1,394,phospholipid metabolic process,BP,ETNPPL
3072,GO:0006355,0.934796029124712,0.10676170325263,15,3038,regulation of transcription, DNA-templated,BP,CD38;PTPRN;CAMK2A;BIRC5;MYBL2;CRYAB;FOXM1;CENPF;TOP2A;SFRP2;TENM2;CREB3L1;ADCY1;RRM2;MYT1L
13086,GO:0048729,0.935903639658969,0.183340527277901,2,612,tissue morphogenesis,BP,SFRP2;FREM2
4270,GO:0009057,0.935908230983928,0.13523556591489,5,1303,macromolecule catabolic process,BP,PTPN3;LNX1;EEF1A2;ENC1;UBE2C
8938,GO:0033365,0.936938318720636,0.15647455780798,3,903,protein localization to organelle,BP,DNM1;HPCA;SNAP25
1049,GO:0002443,0.937700936630567,0.179236996104457,2,721,leukocyte mediated immunity,BP,SNAP25;SELL
19452,GO:1902531,0.937956252324871,0.120183387086755,7,1643,regulation of intracellular signal transduction,BP,TPX2;FOXM1;DUSP4;MRAP2;SFRP2;CREB3L1;SPRY4
285,GO:0000785,0.938488088811929,0.130637282162413,5,1284,chromatin,CC,FOXM1;CENPF;CREB3L1;ENC1;MYT1L
10548,GO:0042110,0.938518343239143,0.23593496608642,1,431,T cell activation,BP,IGFBP2
17701,GO:0097659,0.938717697905694,0.099900815963637,16,3242,nucleic acid-templated transcription,BP,CD38;PTPRN;CAMK2A;BIRC5;MYBL2;CRYAB;FOXM1;CENPF;TOP2A;SFRP2;TENM2;CREB3L1;ADCY1;RRM2;ZCCHC12;MYT1L
1097,GO:0002520,0.939198857857307,0.151902448406486,3,900,immune system development,BP,TOP2A;SFRP2;MELK
2823,GO:0005925,0.939362518613848,0.233601293158606,1,403,focal adhesion,CC,SPRY4
8606,GO:0032774,0.940882116769015,0.0967370533917949,16,3255,RNA biosynthetic process,BP,CD38;PTPRN;CAMK2A;BIRC5;MYBL2;CRYAB;FOXM1;CENPF;TOP2A;SFRP2;TENM2;CREB3L1;ADCY1;RRM2;ZCCHC12;MYT1L
8182,GO:0032103,0.940905753542596,0.22917185324492,1,451,positive regulation of response to external stimulus,BP,CNR1
14577,GO:0060429,0.941054494297143,0.134792906226838,4,1063,epithelium development,BP,USH1C;TJP2;SFRP2;FREM2
7124,GO:0030055,0.941875254967156,0.226460642373219,1,409,cell-substrate junction,CC,SPRY4
13638,GO:0051247,0.944084374802714,0.114459174168633,6,1511,positive regulation of protein metabolic process,BP,TPX2;NEURL1;SFRP2;ADCY1;UBE2C;GRIN2B
3525,GO:0007015,0.944219467375806,0.219726813162198,1,395,actin filament organization,BP,USH1C
12998,GO:0048568,0.94576470485237,0.215187907805641,1,418,embryonic organ development,BP,USH1C
6453,GO:0019222,0.947987978670483,0.0783944229341447,33,6103,regulation of metabolic process,BP,CD38;PTPRN;LZTS1;PTPN3;CAMK2A;TPX2;BIRC5;MYBL2;EEF1A2;NEURL1;CRYAB;FOXM1;CENPF;CNR1;DUSP4;HPCA;TOP2A;GPR12;SFRP2;TENM2;HSPB8;CREB3L1;PI16;ADCY1;FOLR2;ENC1;RRM2;ZCCHC12;UBE2C;MYT1L;SPRY4;PPP1R14C;GRIN2B
4587,GO:0009896,0.949957569613786,0.202729531812731,1,417,positive regulation of catabolic process,BP,HSPB8
21515,GO:2000112,0.949990864154388,0.082393778875135,17,3462,regulation of cellular macromolecule biosynthetic process,BP,CD38;PTPRN;CAMK2A;BIRC5;MYBL2;NEURL1;CRYAB;FOXM1;CENPF;TOP2A;SFRP2;TENM2;CREB3L1;ADCY1;ENC1;RRM2;MYT1L
2644,GO:0005635,0.950087854340421,0.202318197880046,1,432,nuclear envelope,CC,CENPF
289,GO:0000790,0.951919732740653,0.113675539332757,4,1142,nuclear chromatin,CC,FOXM1;CREB3L1;ENC1;MYT1L
3487,GO:0006950,0.952164487517031,0.0799934664134391,16,3430,response to stress,BP,CD38;PTPRN;CAMK2A;SYTL4;CRYAB;FOXM1;CNR1;VGF;TOP2A;SFRP2;HSPB8;CREB3L1;ADCY1;MELK;FOLR2;KCNC2
11507,GO:0044260,0.953017717365488,0.0705116677586772,40,7240,cellular macromolecule metabolic process,BP,CD38;CAMK1G;PTPRN;PTPN3;CAMK2A;LNX1;TPX2;BIRC5;MYBL2;EEF1A2;ST8SIA5;DNM1;NEURL1;CRYAB;PTPN5;FOXM1;IGFBP2;CENPF;DUSP4;HPCA;VGF;TOP2A;SNAP25;CHRM3;HUNK;SFRP2;TENM2;HSPB8;CHST9;CREB3L1;PI16;ADCY1;MELK;ENC1;RRM2;UBE2C;MYT1L;SPRY4;PPP1R14C;GRIN2B
19076,GO:1901575,0.953154180376246,0.0910636229326424,8,1993,organic substance catabolic process,BP,BCAT1;PTPN3;LNX1;EEF1A2;CNR1;FABP7;ENC1;UBE2C
7112,GO:0030036,0.953401585134452,0.142463474509563,2,650,actin cytoskeleton organization,BP,USH1C;DAAM2
11513,GO:0044271,0.953973622103194,0.0739282015168299,21,4289,cellular nitrogen compound biosynthetic process,BP,CD38;PTPRN;CAMK2A;BIRC5;MYBL2;EEF1A2;NEURL1;CRYAB;FOXM1;CENPF;HPCA;TOP2A;SFRP2;TENM2;CREB3L1;ADCY1;ENC1;RRM2;ZCCHC12;PCSK1;MYT1L
21194,GO:1990234,0.954652395212301,0.139368830680372,2,717,transferase complex,CC,ENC1;UBE2C
4622,GO:0010008,0.957539723964772,0.179203977553644,1,469,endosome membrane,CC,SLC30A3
13605,GO:0051173,0.958229760134679,0.0736819577311322,13,2840,positive regulation of nitrogen compound metabolic process,BP,CD38;PTPRN;TPX2;MYBL2;NEURL1;FOXM1;TOP2A;SFRP2;CREB3L1;ADCY1;ZCCHC12;UBE2C;GRIN2B
4272,GO:0009059,0.958484945601906,0.066859367113802,22,4441,macromolecule biosynthetic process,BP,CD38;PTPRN;CAMK2A;BIRC5;MYBL2;EEF1A2;ST8SIA5;NEURL1;CRYAB;FOXM1;CENPF;TOP2A;SFRP2;TENM2;CHST9;CREB3L1;ADCY1;FOLR2;ENC1;RRM2;ZCCHC12;MYT1L
13643,GO:0051252,0.958922813552294,0.0697432671253713,16,3341,regulation of RNA metabolic process,BP,CD38;PTPRN;CAMK2A;BIRC5;MYBL2;CRYAB;FOXM1;CENPF;TOP2A;SFRP2;TENM2;CREB3L1;ADCY1;RRM2;ZCCHC12;MYT1L
10528,GO:0042060,0.959178360415344,0.173971365355098,1,455,wound healing,BP,SYTL4
3068,GO:0006351,0.959349517756483,0.0699184400778536,15,3198,transcription, DNA-templated,BP,CD38;PTPRN;CAMK2A;BIRC5;MYBL2;CRYAB;FOXM1;CENPF;TOP2A;SFRP2;TENM2;CREB3L1;ADCY1;RRM2;MYT1L
12566,GO:0046907,0.960513345871633,0.0848372340794977,6,1593,intracellular transport,BP,RPH3A;KIF4A;SYTL4;CRYAB;HPCA;SYT4
1612,GO:0003712,0.960819343055961,0.168640992186406,1,464,transcription coregulator activity,MF,ZCCHC12
3937,GO:0008233,0.962377209136454,0.163494095688505,1,498,peptidase activity,MF,PCSK1
3027,GO:0006281,0.963404374354237,0.160092435318519,1,488,DNA repair,BP,FOXM1
11496,GO:0044237,0.963822976020737,0.0553236637631717,52,9298,cellular metabolic process,BP,CD38;CAMK1G;PTPRN;BCAT1;LZTS1;PTPN3;CAMK2A;LNX1;TPX2;BIRC5;MYBL2;EEF1A2;ST8SIA5;DNM1;NEURL1;CRYAB;PTPN5;FOXM1;IGFBP2;CENPF;CNR1;TJP2;DUSP4;HPCA;VGF;SULT4A1;TOP2A;SNAP25;CHRM3;MRAP2;HUNK;SFRP2;LIX1;TENM2;HSPB8;CHST9;CREB3L1;ETNPPL;FABP7;PI16;ADCY1;MELK;FOLR2;ENC1;RRM2;ZCCHC12;UBE2C;PCSK1;MYT1L;SPRY4;PPP1R14C;GRIN2B
17871,GO:0098772,0.963905365511768,0.0628160871924602,15,3282,molecular function regulator,MF,PTPN3;TPX2;BIRC5;MYBL2;FOXM1;NCAPH;VGF;MRAP2;SFRP2;CREB3L1;PI16;ZCCHC12;MYT1L;NMB;PPP1R14C
6450,GO:0019219,0.965719794202461,0.0585776218038496,17,3567,regulation of nucleobase-containing compound metabolic process,BP,CD38;PTPRN;CAMK2A;BIRC5;MYBL2;CRYAB;FOXM1;CENPF;HPCA;TOP2A;SFRP2;TENM2;CREB3L1;ADCY1;RRM2;ZCCHC12;MYT1L
9401,GO:0034613,0.966913920158125,0.069598197467623,7,1825,cellular protein localization,BP,RPH3A;SYTL4;DNM1;HPCA;SNAP25;MRAP2;STAC2
15799,GO:0070727,0.967974182437959,0.0676391721332292,7,1834,cellular macromolecule localization,BP,RPH3A;SYTL4;DNM1;HPCA;SNAP25;MRAP2;STAC2
14438,GO:0060255,0.968376665235679,0.0503062793436138,29,5629,regulation of macromolecule metabolic process,BP,CD38;PTPRN;PTPN3;CAMK2A;TPX2;BIRC5;MYBL2;EEF1A2;NEURL1;CRYAB;FOXM1;CENPF;DUSP4;HPCA;TOP2A;SFRP2;TENM2;CREB3L1;PI16;ADCY1;FOLR2;ENC1;RRM2;ZCCHC12;UBE2C;MYT1L;SPRY4;PPP1R14C;GRIN2B
2734,GO:0005783,0.968555077428617,0.0793675034521845,4,1255,endoplasmic reticulum,CC,VGF;MRAP2;TENM2;CREB3L1
9429,GO:0034654,0.968605591382175,0.054086066985587,17,3647,nucleobase-containing compound biosynthetic process,BP,CD38;PTPRN;CAMK2A;BIRC5;MYBL2;CRYAB;FOXM1;CENPF;HPCA;TOP2A;SFRP2;TENM2;CREB3L1;ADCY1;RRM2;ZCCHC12;MYT1L
1183,GO:0002682,0.969290762484032,0.0777760339002859,4,1313,regulation of immune system process,BP,CD38;IGFBP2;CNR1;SELL
9648,GO:0035295,0.970683207310108,0.0830900393652333,3,961,tube development,BP,FOXM1;SFRP2;CREB3L1
1009,GO:0002376,0.971657262821757,0.0552496582944078,10,2560,immune system process,BP,CD38;CAMK2A;KIF4A;IGFBP2;CNR1;TOP2A;SNAP25;SFRP2;MELK;SELL
16147,GO:0071396,0.972061437940627,0.130054606869566,1,526,cellular response to lipid,BP,ADCY1
4608,GO:0009967,0.972193309264459,0.0662463532429403,5,1479,positive regulation of signal transduction,BP,ASPM;NEURL1;MRAP2;SFRP2;DAAM2
17757,GO:0098542,0.972426907088357,0.0931198760486504,2,882,defense response to other organism,BP,CAMK2A;VGF
6269,GO:0018130,0.973610581959224,0.0461888184018794,17,3704,heterocycle biosynthetic process,BP,CD38;PTPRN;CAMK2A;BIRC5;MYBL2;CRYAB;FOXM1;CENPF;HPCA;TOP2A;SFRP2;TENM2;CREB3L1;ADCY1;RRM2;ZCCHC12;MYT1L
5639,GO:0016032,0.973721302370982,0.0895265496966152,2,855,viral process,BP,TOP2A;CREB3L1
7105,GO:0030029,0.974679832916644,0.0868652240350512,2,741,actin filament-based process,BP,USH1C;DAAM2
6527,GO:0019438,0.974687130535859,0.0444703996375016,17,3714,aromatic compound biosynthetic process,BP,CD38;PTPRN;CAMK2A;BIRC5;MYBL2;CRYAB;FOXM1;CENPF;HPCA;TOP2A;SFRP2;TENM2;CREB3L1;ADCY1;RRM2;ZCCHC12;MYT1L
364,GO:0000978,0.97491020795254,0.07287942829409,3,1015,RNA polymerase II cis-regulatory region sequence-specific DNA binding,MF,MYBL2;CREB3L1;MYT1L
8617,GO:0032787,0.975414428035258,0.11769837898034,1,581,monocarboxylic acid metabolic process,BP,CNR1
3446,GO:0006886,0.975415868027369,0.0716262750355128,3,1096,intracellular protein transport,BP,RPH3A;SYTL4;HPCA
11510,GO:0044265,0.975832468194369,0.0706002298032676,3,1094,cellular macromolecule catabolic process,BP,LNX1;ENC1;UBE2C
21418,GO:1990904,0.976209558171536,0.114682237877567,1,641,ribonucleoprotein complex,CC,TOP2A
7314,GO:0030334,0.976831627398362,0.0807268620937423,2,792,regulation of cell migration,BP,CAMK2A;SFRP2
363,GO:0000977,0.977008717521146,0.0607105370482393,4,1257,RNA polymerase II transcription regulatory region sequence-specific DNA binding,MF,MYBL2;FOXM1;CREB3L1;MYT1L
5864,GO:0016491,0.977225956258395,0.110819241063753,1,646,oxidoreductase activity,MF,RRM2
367,GO:0000987,0.977934287110062,0.0653777475655004,3,1038,cis-regulatory region sequence-specific DNA binding,MF,MYBL2;CREB3L1;MYT1L
8103,GO:0031981,0.978074500599775,0.0375754117373553,21,4451,nuclear lumen,CC,CAMK2A;TPX2;BIRC5;KIF4A;MYBL2;DNM1;CRYAB;PTPN5;FOXM1;CENPF;TJP2;DUSP4;NCAPH;TOP2A;TENM2;MKI67;HSPB8;CREB3L1;ENC1;UBE2C;MYT1L
7788,GO:0031347,0.978232153405105,0.106971388016836,1,596,regulation of defense response,BP,CNR1
13153,GO:0048870,0.97858492638722,0.0528063555829898,5,1462,cell motility,BP,ASPM;CAMK2A;NEURL1;SFRP2;SELL
13873,GO:0051674,0.97858492638722,0.0528063555829898,5,1462,localization of cell,BP,ASPM;CAMK2A;NEURL1;SFRP2;SELL
11585,GO:0044403,0.979163804397444,0.0739273679939448,2,900,symbiotic process,BP,TOP2A;CREB3L1
13888,GO:0051707,0.979379190731274,0.0617118237270766,3,1183,response to other organism,BP,CAMK2A;CNR1;VGF
9422,GO:0034645,0.979480773809647,0.0356495903898131,20,4326,cellular macromolecule biosynthetic process,BP,CD38;PTPRN;CAMK2A;BIRC5;MYBL2;EEF1A2;ST8SIA5;NEURL1;CRYAB;FOXM1;CENPF;TOP2A;SFRP2;TENM2;CHST9;CREB3L1;ADCY1;ENC1;RRM2;MYT1L
11089,GO:0043207,0.979541437460677,0.0612991121572451,3,1185,response to external biotic stimulus,BP,CAMK2A;CNR1;VGF
19077,GO:1901576,0.979875568981017,0.0336314581872991,26,5395,organic substance biosynthetic process,BP,CD38;PTPRN;BCAT1;CAMK2A;BIRC5;MYBL2;EEF1A2;ST8SIA5;NEURL1;CRYAB;FOXM1;CENPF;HPCA;TOP2A;SFRP2;TENM2;CHST9;CREB3L1;ETNPPL;ADCY1;FOLR2;ENC1;RRM2;ZCCHC12;PCSK1;MYT1L
4584,GO:0009893,0.98002319207096,0.0367473415479084,15,3394,positive regulation of metabolic process,BP,CD38;PTPRN;TPX2;MYBL2;EEF1A2;NEURL1;FOXM1;TOP2A;SFRP2;HSPB8;CREB3L1;ADCY1;ZCCHC12;UBE2C;GRIN2B
4510,GO:0009611,0.980423750874918,0.0983897919411903,1,563,response to wounding,BP,SYTL4
11520,GO:0044283,0.981893719256427,0.0924531765725588,1,636,small molecule biosynthetic process,BP,BCAT1
8180,GO:0032101,0.982377954645365,0.0643197094199882,2,910,regulation of response to external stimulus,BP,CNR1;FABP7
4507,GO:0009607,0.982500987827568,0.0536630354493755,3,1212,response to biotic stimulus,BP,CAMK2A;CNR1;VGF
21532,GO:2000145,0.982664884616283,0.0634571080065627,2,843,regulation of cell motility,BP,CAMK2A;SFRP2
366,GO:0000981,0.982935933443009,0.046931419462148,4,1324,DNA-binding transcription factor activity, RNA polymerase II-specific,MF,MYBL2;FOXM1;CREB3L1;MYT1L
19003,GO:1901362,0.982991148340028,0.030932457340574,17,3838,organic cyclic compound biosynthetic process,BP,CD38;PTPRN;CAMK2A;BIRC5;MYBL2;CRYAB;FOXM1;CENPF;HPCA;TOP2A;SFRP2;TENM2;CREB3L1;ADCY1;RRM2;ZCCHC12;MYT1L
3491,GO:0006955,0.983364431315012,0.0423387239823932,5,1706,immune response,BP,CD38;CAMK2A;CNR1;SNAP25;SELL
4271,GO:0009058,0.983849727283616,0.0274490414731764,26,5463,biosynthetic process,BP,CD38;PTPRN;BCAT1;CAMK2A;BIRC5;MYBL2;EEF1A2;ST8SIA5;NEURL1;CRYAB;FOXM1;CENPF;HPCA;TOP2A;SFRP2;TENM2;CHST9;CREB3L1;ETNPPL;ADCY1;FOLR2;ENC1;RRM2;ZCCHC12;PCSK1;MYT1L
11503,GO:0044249,0.984375145868774,0.0267714702670504,25,5302,cellular biosynthetic process,BP,CD38;PTPRN;BCAT1;CAMK2A;BIRC5;MYBL2;EEF1A2;ST8SIA5;NEURL1;CRYAB;FOXM1;CENPF;HPCA;TOP2A;SFRP2;TENM2;CHST9;CREB3L1;ETNPPL;ADCY1;ENC1;RRM2;ZCCHC12;PCSK1;MYT1L
5856,GO:0016477,0.985016673954488,0.0419236400379922,4,1323,cell migration,BP,ASPM;CAMK2A;SFRP2;SELL
3473,GO:0006928,0.985563734303512,0.033432133040537,7,1898,movement of cell or subcellular component,BP,KIFC1;ASPM;CAMK2A;KIF4A;NEURL1;SFRP2;SELL
362,GO:0000976,0.985748195737419,0.0401365739765216,4,1345,transcription regulatory region sequence-specific DNA binding,MF,MYBL2;FOXM1;CREB3L1;MYT1L
384,GO:0001067,0.985840407120229,0.0399104445846013,4,1346,regulatory region nucleic acid binding,MF,MYBL2;FOXM1;CREB3L1;MYT1L
4785,GO:0010604,0.986189438829935,0.0271049148663725,13,3138,positive regulation of macromolecule metabolic process,BP,CD38;PTPRN;TPX2;MYBL2;NEURL1;FOXM1;TOP2A;SFRP2;CREB3L1;ADCY1;ZCCHC12;UBE2C;GRIN2B
10481,GO:0040012,0.98631886904209,0.0520450153872657,2,880,regulation of locomotion,BP,CAMK2A;SFRP2
10974,GO:0043009,0.986319221636593,0.0738901542192912,1,601,chordate embryonic development,BP,SFRP2
2643,GO:0005634,0.986537813388956,0.0225353148547637,33,6572,nucleus,CC,CD38;PTPRN;KIFC1;ASPM;CAMK2A;TPX2;BIRC5;KIF4A;MYBL2;DNM1;NCAPG;CRYAB;PTPN5;FOXM1;CENPF;TJP2;DUSP4;NCAPH;TOP2A;HUNK;TENM2;MKI67;HSPB8;NRGN;CREB3L1;IGFN1;FABP7;ADCY1;MELK;ENC1;ZCCHC12;UBE2C;MYT1L
1609,GO:0003700,0.987363860403196,0.0361398466229192,4,1382,DNA-binding transcription factor activity,MF,MYBL2;FOXM1;CREB3L1;MYT1L
4802,GO:0010628,0.987765756442151,0.0288378171539309,7,2037,positive regulation of gene expression,BP,CD38;PTPRN;MYBL2;FOXM1;TOP2A;SFRP2;CREB3L1
4561,GO:0009792,0.987939022935046,0.0667351491038371,1,618,embryo development ending in birth or egg hatching,BP,SFRP2
11753,GO:0045087,0.988331049938111,0.0649458632570633,1,719,innate immune response,BP,CAMK2A
1617,GO:0003723,0.988926362168798,0.0321977125274543,4,1507,RNA binding,MF,EEF1A2;DNM1;TOP2A;MKI67
3889,GO:0008152,0.989255784276202,0.0180349828252886,54,9980,metabolic process,BP,CD38;CAMK1G;PTPRN;BCAT1;LZTS1;PTPN3;CAMK2A;LNX1;TPX2;BIRC5;MYBL2;EEF1A2;ST8SIA5;DNM1;NEURL1;CRYAB;PTPN5;FOXM1;IGFBP2;CENPF;CNR1;TJP2;PRLHR;DUSP4;HPCA;VGF;SULT4A1;TOP2A;SNAP25;GPR12;CHRM3;MRAP2;HUNK;SFRP2;LIX1;TENM2;HSPB8;CHST9;CREB3L1;ETNPPL;FABP7;PI16;ADCY1;MELK;FOLR2;ENC1;RRM2;ZCCHC12;UBE2C;PCSK1;MYT1L;SPRY4;PPP1R14C;GRIN2B
13657,GO:0051270,0.98998070728647,0.0400043241565522,2,920,regulation of cellular component movement,BP,CAMK2A;SFRP2
11590,GO:0044419,0.990338120999572,0.0262296916014616,5,1801,interspecies interaction between organisms,BP,CAMK2A;CNR1;VGF;TOP2A;CREB3L1
19436,GO:1902494,0.990655128216327,0.0312812861805903,3,1272,catalytic complex,CC,ENC1;RRM2;UBE2C
11103,GO:0043231,0.991037640758594,0.0151760682511055,51,9529,intracellular membrane-bounded organelle,CC,CD38;CAMK1G;SYT13;PTPRN;KIFC1;BCAT1;ASPM;SYT1;CAMK2A;TPX2;RPH3A;BIRC5;KIF4A;MYBL2;EEF1A2;ST8SIA5;STMN2;DNM1;NCAPG;CRYAB;PTPN5;FOXM1;SLC30A3;CENPF;CNR1;TJP2;DUSP4;NCAPH;VGF;TOP2A;SNAP25;SYT4;MRAP2;HUNK;TENM2;MKI67;HSPB8;CHST9;NRGN;CREB3L1;IGFN1;ETNPPL;FABP7;ADCY1;MELK;TMEM130;ENC1;ZCCHC12;UBE2C;MYT1L;GRIN2B
21395,GO:1990837,0.991114181660108,0.0265486209496503,4,1439,sequence-specific double-stranded DNA binding,MF,MYBL2;FOXM1;CREB3L1;MYT1L
11062,GO:0043170,0.991302721372657,0.0147378460436033,43,8271,macromolecule metabolic process,BP,CD38;CAMK1G;PTPRN;PTPN3;CAMK2A;LNX1;TPX2;BIRC5;MYBL2;EEF1A2;ST8SIA5;DNM1;NEURL1;CRYAB;PTPN5;FOXM1;IGFBP2;CENPF;DUSP4;HPCA;VGF;TOP2A;SNAP25;CHRM3;HUNK;SFRP2;TENM2;HSPB8;CHST9;CREB3L1;PI16;ADCY1;MELK;FOLR2;ENC1;RRM2;ZCCHC12;UBE2C;PCSK1;MYT1L;SPRY4;PPP1R14C;GRIN2B
10480,GO:0040011,0.991599868876322,0.0231731929740032,5,1638,locomotion,BP,ASPM;CAMK2A;NEURL1;SFRP2;SELL
925,GO:0002252,0.991614991272009,0.0343714162561389,2,1064,immune effector process,BP,SNAP25;SELL
3057,GO:0006325,0.991714536824081,0.0491174214886528,1,656,chromatin organization,BP,MKI67
3074,GO:0006357,0.992279569440593,0.018274097867991,8,2311,regulation of transcription by RNA polymerase II,BP,PTPRN;MYBL2;FOXM1;TOP2A;SFRP2;TENM2;CREB3L1;MYT1L
11497,GO:0044238,0.993364938056272,0.0114353446807824,47,9012,primary metabolic process,BP,CD38;CAMK1G;PTPRN;BCAT1;PTPN3;CAMK2A;LNX1;TPX2;BIRC5;MYBL2;EEF1A2;ST8SIA5;NEURL1;CRYAB;PTPN5;FOXM1;IGFBP2;CENPF;CNR1;TJP2;DUSP4;HPCA;VGF;SULT4A1;TOP2A;CHRM3;HUNK;SFRP2;TENM2;HSPB8;CHST9;CREB3L1;ETNPPL;FABP7;PI16;ADCY1;MELK;FOLR2;ENC1;RRM2;ZCCHC12;UBE2C;PCSK1;MYT1L;SPRY4;PPP1R14C;GRIN2B
1604,GO:0003690,0.993866408512568,0.0191442827791822,4,1508,double-stranded DNA binding,MF,MYBL2;FOXM1;CREB3L1;MYT1L
8101,GO:0031974,0.99477387276615,0.00974698476358674,24,5447,membrane-enclosed lumen,CC,CAMK2A;TPX2;BIRC5;KIF4A;MYBL2;DNM1;CRYAB;PTPN5;FOXM1;CENPF;TJP2;DUSP4;NCAPH;VGF;TOP2A;TENM2;MKI67;HSPB8;CREB3L1;ETNPPL;ENC1;UBE2C;PCSK1;MYT1L
11105,GO:0043233,0.99477387276615,0.00974698476358674,24,5447,organelle lumen,CC,CAMK2A;TPX2;BIRC5;KIF4A;MYBL2;DNM1;CRYAB;PTPN5;FOXM1;CENPF;TJP2;DUSP4;NCAPH;VGF;TOP2A;TENM2;MKI67;HSPB8;CREB3L1;ETNPPL;ENC1;UBE2C;PCSK1;MYT1L
15398,GO:0070013,0.99477387276615,0.00974698476358674,24,5447,intracellular organelle lumen,CC,CAMK2A;TPX2;BIRC5;KIF4A;MYBL2;DNM1;CRYAB;PTPN5;FOXM1;CENPF;TJP2;DUSP4;NCAPH;VGF;TOP2A;TENM2;MKI67;HSPB8;CREB3L1;ETNPPL;ENC1;UBE2C;PCSK1;MYT1L
3396,GO:0006807,0.995045850560074,0.00870256551866077,44,8631,nitrogen compound metabolic process,BP,CD38;CAMK1G;PTPRN;BCAT1;PTPN3;CAMK2A;LNX1;TPX2;BIRC5;MYBL2;EEF1A2;ST8SIA5;NEURL1;CRYAB;PTPN5;FOXM1;IGFBP2;CENPF;TJP2;DUSP4;HPCA;VGF;SULT4A1;TOP2A;CHRM3;HUNK;SFRP2;TENM2;HSPB8;CHST9;CREB3L1;PI16;ADCY1;MELK;FOLR2;ENC1;RRM2;ZCCHC12;UBE2C;PCSK1;MYT1L;SPRY4;PPP1R14C;GRIN2B
11314,GO:0043565,0.995099939642931,0.0156885229387188,4,1541,sequence-specific DNA binding,MF,MYBL2;FOXM1;CREB3L1;MYT1L
1596,GO:0003677,0.995126763464827,0.0125945843977139,7,2178,DNA binding,MF,KIF4A;MYBL2;FOXM1;TOP2A;MKI67;CREB3L1;MYT1L
3081,GO:0006366,0.995597368147406,0.0109771928664271,8,2442,transcription by RNA polymerase II,BP,PTPRN;MYBL2;FOXM1;TOP2A;SFRP2;TENM2;CREB3L1;MYT1L
18544,GO:0140110,0.995663981693617,0.0128409737035675,5,1809,transcription regulator activity,MF,MYBL2;FOXM1;CREB3L1;ZCCHC12;MYT1L
16353,GO:0071704,0.996551343049196,0.00620205948368165,49,9498,organic substance metabolic process,BP,CD38;CAMK1G;PTPRN;BCAT1;PTPN3;CAMK2A;LNX1;TPX2;BIRC5;MYBL2;EEF1A2;ST8SIA5;DNM1;NEURL1;CRYAB;PTPN5;FOXM1;IGFBP2;CENPF;CNR1;TJP2;DUSP4;HPCA;VGF;SULT4A1;TOP2A;SNAP25;CHRM3;HUNK;SFRP2;TENM2;HSPB8;CHST9;CREB3L1;ETNPPL;FABP7;PI16;ADCY1;MELK;FOLR2;ENC1;RRM2;ZCCHC12;UBE2C;PCSK1;MYT1L;SPRY4;PPP1R14C;GRIN2B
5660,GO:0016070,0.996784922854535,0.00673912439191613,16,4103,RNA metabolic process,BP,CD38;PTPRN;CAMK2A;BIRC5;MYBL2;CRYAB;FOXM1;CENPF;TOP2A;SFRP2;TENM2;CREB3L1;ADCY1;RRM2;ZCCHC12;MYT1L
4506,GO:0009605,0.996829392231929,0.00852421695955108,7,2383,response to external stimulus,BP,CAMK2A;IGFBP2;CNR1;VGF;SFRP2;FABP7;FOLR2
9419,GO:0034641,0.996951862087809,0.00589070150607277,24,5606,cellular nitrogen compound metabolic process,BP,CD38;PTPRN;CAMK2A;BIRC5;MYBL2;EEF1A2;NEURL1;CRYAB;FOXM1;CENPF;TJP2;HPCA;SULT4A1;TOP2A;SFRP2;TENM2;CREB3L1;ADCY1;FOLR2;ENC1;RRM2;ZCCHC12;PCSK1;MYT1L
4720,GO:0010468,0.997070948766939,0.00609189741593199,17,4265,regulation of gene expression,BP,CD38;PTPRN;CAMK2A;BIRC5;MYBL2;NEURL1;CRYAB;FOXM1;CENPF;TOP2A;SFRP2;TENM2;CREB3L1;ADCY1;ENC1;RRM2;MYT1L
19454,GO:1902533,0.998135455801266,0.0140007852991336,1,926,positive regulation of intracellular signal transduction,BP,MRAP2
12365,GO:0046483,0.998949545356816,0.00225009912607071,20,5114,heterocycle metabolic process,BP,CD38;PTPRN;CAMK2A;BIRC5;MYBL2;CRYAB;FOXM1;CENPF;TJP2;HPCA;SULT4A1;TOP2A;SFRP2;TENM2;CREB3L1;ADCY1;FOLR2;RRM2;ZCCHC12;MYT1L
2953,GO:0006139,0.999126854192993,0.00191371032622976,19,4966,nucleobase-containing compound metabolic process,BP,CD38;PTPRN;CAMK2A;BIRC5;MYBL2;CRYAB;FOXM1;CENPF;TJP2;HPCA;SULT4A1;TOP2A;SFRP2;TENM2;CREB3L1;ADCY1;RRM2;ZCCHC12;MYT1L
3350,GO:0006725,0.999132977591443,0.00187886466983621,20,5156,cellular aromatic compound metabolic process,BP,CD38;PTPRN;CAMK2A;BIRC5;MYBL2;CRYAB;FOXM1;CENPF;TJP2;HPCA;SULT4A1;TOP2A;SFRP2;TENM2;CREB3L1;ADCY1;FOLR2;RRM2;ZCCHC12;MYT1L
4719,GO:0010467,0.999465654248335,0.00120592516028904,19,5091,gene expression,BP,CD38;PTPRN;CAMK2A;BIRC5;MYBL2;EEF1A2;NEURL1;CRYAB;FOXM1;CENPF;TOP2A;SFRP2;TENM2;CREB3L1;ADCY1;ENC1;RRM2;PCSK1;MYT1L
17207,GO:0090304,0.999540988043665,0.00109237902487039,16,4529,nucleic acid metabolic process,BP,CD38;PTPRN;CAMK2A;BIRC5;MYBL2;CRYAB;FOXM1;CENPF;TOP2A;SFRP2;TENM2;CREB3L1;ADCY1;RRM2;ZCCHC12;MYT1L
19001,GO:1901360,0.999612869338664,0.000879242684485805,20,5341,organic cyclic compound metabolic process,BP,CD38;PTPRN;CAMK2A;BIRC5;MYBL2;CRYAB;FOXM1;CENPF;TJP2;HPCA;SULT4A1;TOP2A;SFRP2;TENM2;CREB3L1;ADCY1;FOLR2;RRM2;ZCCHC12;MYT1L
1595,GO:0003676,0.99981568916226,0.000538839353326447,10,3512,nucleic acid binding,MF,KIF4A;MYBL2;EEF1A2;DNM1;FOXM1;TOP2A;MKI67;CREB3L1;ZCCHC12;MYT1L
19004,GO:1901363,0.999870872101427,0.00031540548116316,19,5231,heterocyclic compound binding,MF,CAMK1G;KIFC1;CAMK2A;KIF4A;MYBL2;EEF1A2;DNM1;FOXM1;TOP2A;HUNK;MKI67;CREB3L1;ETNPPL;ADCY1;MELK;FOLR2;ZCCHC12;UBE2C;MYT1L
17461,GO:0097159,0.999908744788439,0.000226998604234015,19,5302,organic cyclic compound binding,MF,CAMK1G;KIFC1;CAMK2A;KIF4A;MYBL2;EEF1A2;DNM1;FOXM1;TOP2A;HUNK;MKI67;CREB3L1;ETNPPL;ADCY1;MELK;FOLR2;ZCCHC12;UBE2C;MYT1L
13389,GO:0050850,0.999999999999991,0.784665707816542,0,38,positive regulation of calcium-mediated signaling,BP,
5087,GO:0014003,0.999999999999992,0.751011117753852,0,44,oligodendrocyte development,BP,
10352,GO:0038083,0.999999999999993,0.745792978253909,0,40,peptidyl-tyrosine autophosphorylation,BP,
15484,GO:0070169,0.999999999999994,0.750629685026115,0,41,positive regulation of biomineral tissue development,BP,
18420,GO:0110151,0.999999999999994,0.750629685026115,0,41,positive regulation of biomineralization,BP,
13375,GO:0050819,0.999999999999999,0.752004336475576,0,47,negative regulation of coagulation,BP,
18669,GO:1900027,0.999999999999999,0.851668811596444,0,26,regulation of ruffle assembly,BP,
7384,GO:0030517,0.999999999999999,0.730449778470235,0,42,negative regulation of axon extension,BP,
3788,GO:0007608,1,0.806084324120406,0,37,sensory perception of smell,BP,
48,GO:0000101,1,0.959286240849729,0,6,sulfur amino acid transport,BP,
1948,GO:0004402,1,0.700856989275995,0,48,histone acetyltransferase activity,MF,
17153,GO:0090235,1,0.935494617272646,0,8,regulation of metaphase plate congression,BP,
1,GO:0000002,1,0.856981049621012,0,23,mitochondrial genome maintenance,BP,
3,GO:0000009,1,0.988342362487258,0,2,alpha-1,6-mannosyltransferase activity,MF,
4,GO:0000010,1,0.988428160009469,0,2,trans-hexaprenyltranstransferase activity,MF,
5,GO:0000012,1,0.933183195531904,0,10,single strand break repair,BP,
6,GO:0000014,1,0.940589412733545,0,9,single-stranded DNA endodeoxyribonuclease activity,MF,
7,GO:0000015,1,0.978700064858602,0,4,phosphopyruvate hydratase complex,CC,
8,GO:0000017,1,0.986382830719601,0,2,alpha-glucoside transport,BP,
9,GO:0000018,1,0.558328077766546,0,83,regulation of DNA recombination,BP,
10,GO:0000019,1,0.967864395188138,0,5,regulation of mitotic recombination,BP,
12,GO:0000023,1,0.975863320992585,0,3,maltose metabolic process,BP,
13,GO:0000026,1,0.973011242247794,0,4,alpha-1,2-mannosyltransferase activity,MF,
14,GO:0000027,1,0.877700426056898,0,25,ribosomal large subunit assembly,BP,
15,GO:0000028,1,0.921372600550347,0,18,ribosomal small subunit assembly,BP,
16,GO:0000030,1,0.836104146560566,0,28,mannosyltransferase activity,MF,
17,GO:0000032,1,0.995309928040927,0,1,cell wall mannoprotein biosynthetic process,BP,
18,GO:0000033,1,0.984565880082495,0,3,alpha-1,3-mannosyltransferase activity,MF,
19,GO:0000035,1,0.990157811759078,0,2,acyl binding,MF,
20,GO:0000036,1,0.99696671272875,0,1,acyl carrier activity,MF,
21,GO:0000038,1,0.81598378714847,0,32,very long-chain fatty acid metabolic process,BP,
23,GO:0000045,1,0.548808994431613,0,88,autophagosome assembly,BP,
24,GO:0000048,1,0.981852885177212,0,3,peptidyltransferase activity,MF,
25,GO:0000049,1,0.715052206824618,0,54,tRNA binding,MF,
26,GO:0000050,1,0.942313788170773,0,11,urea cycle,BP,
27,GO:0000052,1,0.943714270818628,0,8,citrulline metabolic process,BP,
28,GO:0000053,1,0.995211344546038,0,1,argininosuccinate metabolic process,BP,
29,GO:0000054,1,0.924259685977105,0,14,ribosomal subunit export from nucleus,BP,
30,GO:0000055,1,0.9614569525397,0,7,ribosomal large subunit export from nucleus,BP,
31,GO:0000056,1,0.958384884814592,0,8,ribosomal small subunit export from nucleus,BP,
32,GO:0000062,1,0.892867453706089,0,20,fatty-acyl-CoA binding,MF,
33,GO:0000064,1,0.963098022959988,0,5,L-ornithine transmembrane transporter activity,MF,
36,GO:0000076,1,0.905864577938453,0,16,DNA replication checkpoint,BP,
37,GO:0000077,1,0.389133635726799,0,138,DNA damage checkpoint,BP,
38,GO:0000079,1,0.559571122233734,0,94,regulation of cyclin-dependent protein serine/threonine kinase activity,BP,
39,GO:0000080,1,0.984638596256118,0,2,mitotic G1 phase,BP,
43,GO:0000095,1,0.994425789488496,0,1,S-adenosyl-L-methionine transmembrane transporter activity,MF,
44,GO:0000096,1,0.792561376308634,0,37,sulfur amino acid metabolic process,BP,
45,GO:0000097,1,0.901395608028489,0,16,sulfur amino acid biosynthetic process,BP,
46,GO:0000098,1,0.923104085232821,0,14,sulfur amino acid catabolic process,BP,
47,GO:0000099,1,0.955353008673212,0,6,sulfur amino acid transmembrane transporter activity,MF,
49,GO:0000103,1,0.982824295965943,0,3,sulfate assimilation,BP,
50,GO:0000104,1,0.98014761606796,0,4,succinate dehydrogenase activity,MF,
51,GO:0000105,1,0.987069932513412,0,2,histidine biosynthetic process,BP,
52,GO:0000109,1,0.92525082446791,0,12,nucleotide-excision repair complex,CC,
53,GO:0000110,1,0.979143202076113,0,3,nucleotide-excision repair factor 1 complex,CC,
54,GO:0000111,1,0.992785550449173,0,1,nucleotide-excision repair factor 2 complex,CC,
55,GO:0000112,1,0.993498118720825,0,1,nucleotide-excision repair factor 3 complex,CC,
56,GO:0000117,1,0.984651699425258,0,2,regulation of transcription involved in G2/M transition of mitotic cell cycle,BP,
57,GO:0000118,1,0.561344747993753,0,75,histone deacetylase complex,CC,
58,GO:0000120,1,0.985753416033369,0,3,RNA polymerase I transcription regulator complex,CC,
59,GO:0000121,1,0.993083004594728,0,1,glycerol-1-phosphatase activity,MF,
61,GO:0000123,1,0.603219944336199,0,75,histone acetyltransferase complex,CC,
62,GO:0000124,1,0.946663617026478,0,8,SAGA complex,CC,
63,GO:0000125,1,0.974795237989963,0,3,PCAF complex,CC,
64,GO:0000126,1,0.97474837443403,0,3,transcription factor TFIIIB complex,CC,
65,GO:0000127,1,0.959995771404901,0,6,transcription factor TFIIIC complex,CC,
66,GO:0000132,1,0.81380723719623,0,30,establishment of mitotic spindle orientation,BP,
67,GO:0000137,1,0.888961186814096,0,17,Golgi cis cisterna,CC,
68,GO:0000138,1,0.9491119953428,0,9,Golgi trans cisterna,CC,
70,GO:0000145,1,0.897556392371506,0,15,exocyst,CC,
71,GO:0000146,1,0.778368883208272,0,26,microfilament motor activity,MF,
73,GO:0000150,1,0.988761536011008,0,2,recombinase activity,MF,
76,GO:0000153,1,0.931857331052698,0,12,cytoplasmic ubiquitin ligase complex,CC,
77,GO:0000154,1,0.846478594684119,0,31,rRNA modification,BP,
78,GO:0000159,1,0.893857738799319,0,17,protein phosphatase type 2A complex,CC,
79,GO:0000160,1,0.992744505659167,0,1,phosphorelay signal transduction system,BP,
80,GO:0000164,1,0.910958647519541,0,14,protein phosphatase type 1 complex,CC,
83,GO:0000170,1,0.995946459027794,0,1,sphingosine hydroxylase activity,MF,
84,GO:0000171,1,0.982547146916876,0,3,ribonuclease MRP activity,MF,
85,GO:0000172,1,0.957433388166814,0,8,ribonuclease MRP complex,CC,
86,GO:0000173,1,0.995533397310471,0,1,inactivation of MAPK activity involved in osmosensory signaling pathway,BP,
87,GO:0000175,1,0.796280659223716,0,35,3'-5'-exoribonuclease activity,MF,
88,GO:0000176,1,0.931058497723403,0,15,nuclear exosome (RNase complex),CC,
89,GO:0000177,1,0.923997977575222,0,14,cytoplasmic exosome (RNase complex),CC,
90,GO:0000178,1,0.876651550563508,0,23,exosome (RNase complex),CC,
91,GO:0000179,1,0.978559472319525,0,4,rRNA (adenine-N6,N6-)-dimethyltransferase activity,MF,
92,GO:0000182,1,0.951979424931618,0,6,rDNA binding,MF,
93,GO:0000183,1,0.921841883589357,0,11,rDNA heterochromatin assembly,BP,
94,GO:0000184,1,0.582333537614122,0,117,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
95,GO:0000185,1,0.929178578875804,0,12,activation of MAPKKK activity,BP,
96,GO:0000186,1,0.691960092751094,0,49,activation of MAPKK activity,BP,
97,GO:0000187,1,0.391614524609709,0,141,activation of MAPK activity,BP,
100,GO:0000210,1,0.992848231990321,0,1,NAD+ diphosphatase activity,MF,
102,GO:0000213,1,0.988996190266933,0,2,tRNA-intron endonuclease activity,MF,
103,GO:0000214,1,0.979463160199463,0,4,tRNA-intron endonuclease complex,CC,
104,GO:0000215,1,0.99003451718948,0,2,tRNA 2'-phosphotransferase activity,MF,
105,GO:0000217,1,0.793935020972762,0,33,DNA secondary structure binding,MF,
106,GO:0000220,1,0.970343701127485,0,4,vacuolar proton-transporting V-type ATPase, V0 domain,CC,
107,GO:0000221,1,0.979200219204193,0,3,vacuolar proton-transporting V-type ATPase, V1 domain,CC,
108,GO:0000224,1,0.993849631313094,0,1,peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity,MF,
109,GO:0000225,1,0.996322583381171,0,1,N-acetylglucosaminylphosphatidylinositol deacetylase activity,MF,
112,GO:0000229,1,0.996393491878372,0,1,cytoplasmic chromosome,CC,
113,GO:0000235,1,0.923596507022402,0,11,astral microtubule,CC,
114,GO:0000242,1,0.852227757759342,0,20,pericentriolar material,CC,
115,GO:0000243,1,0.974548164448588,0,5,commitment complex,CC,
116,GO:0000244,1,0.916866709998098,0,13,spliceosomal tri-snRNP complex assembly,BP,
117,GO:0000245,1,0.696810660451651,0,57,spliceosomal complex assembly,BP,
118,GO:0000246,1,0.992464098604673,0,1,delta24(24-1) sterol reductase activity,MF,
119,GO:0000247,1,0.996319719131459,0,1,C-8 sterol isomerase activity,MF,
120,GO:0000248,1,0.985917575114615,0,2,C-5 sterol desaturase activity,MF,
121,GO:0000250,1,0.992482560620612,0,1,lanosterol synthase activity,MF,
122,GO:0000252,1,0.995621313891515,0,1,C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity,MF,
123,GO:0000253,1,0.988322727449689,0,3,3-keto sterol reductase activity,MF,
124,GO:0000254,1,0.983059508035584,0,3,C-4 methylsterol oxidase activity,MF,
125,GO:0000255,1,0.995872965821973,0,1,allantoin metabolic process,BP,
126,GO:0000256,1,0.995872965821973,0,1,allantoin catabolic process,BP,
127,GO:0000257,1,0.996007670282858,0,1,nitrilase activity,MF,
129,GO:0000268,1,0.969097828461068,0,5,peroxisome targeting sequence binding,MF,
130,GO:0000270,1,0.993161936937512,0,2,peptidoglycan metabolic process,BP,
131,GO:0000271,1,0.582358233784544,0,71,polysaccharide biosynthetic process,BP,
132,GO:0000272,1,0.835775750096175,0,24,polysaccharide catabolic process,BP,
136,GO:0000285,1,0.991093566580193,0,1,1-phosphatidylinositol-3-phosphate 5-kinase activity,MF,
138,GO:0000288,1,0.633779707207313,0,68,nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
139,GO:0000289,1,0.803414037295695,0,28,nuclear-transcribed mRNA poly(A) tail shortening,BP,
140,GO:0000290,1,0.950006751333,0,8,deadenylation-dependent decapping of nuclear-transcribed mRNA,BP,
141,GO:0000291,1,0.825008989124351,0,34,nuclear-transcribed mRNA catabolic process, exonucleolytic,BP,
142,GO:0000293,1,0.973330093542312,0,4,ferric-chelate reductase activity,MF,
143,GO:0000294,1,0.985266304623958,0,2,nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay,BP,
144,GO:0000295,1,0.841834987474212,0,28,adenine nucleotide transmembrane transporter activity,MF,
145,GO:0000296,1,0.986962452110584,0,2,spermine transport,BP,
146,GO:0000298,1,0.977347175921527,0,4,endopolyphosphatase activity,MF,
147,GO:0000301,1,0.98663115814396,0,2,retrograde transport, vesicle recycling within Golgi,BP,
149,GO:0000303,1,0.864325544219075,0,26,response to superoxide,BP,
150,GO:0000304,1,0.994723118729658,0,1,response to singlet oxygen,BP,
151,GO:0000305,1,0.859928639893154,0,27,response to oxygen radical,BP,
152,GO:0000306,1,0.971792311492259,0,4,extrinsic component of vacuolar membrane,CC,
153,GO:0000307,1,0.772143464667764,0,42,cyclin-dependent protein kinase holoenzyme complex,CC,
154,GO:0000308,1,0.984686548612159,0,2,cytoplasmic cyclin-dependent protein kinase holoenzyme complex,CC,
155,GO:0000309,1,0.979489020907771,0,3,nicotinamide-nucleotide adenylyltransferase activity,MF,
156,GO:0000313,1,0.703952327332613,0,84,organellar ribosome,CC,
157,GO:0000314,1,0.896196601649948,0,27,organellar small ribosomal subunit,CC,
158,GO:0000315,1,0.792311139414712,0,55,organellar large ribosomal subunit,CC,
159,GO:0000320,1,0.984980289223325,0,2,re-entry into mitotic cell cycle,BP,
160,GO:0000322,1,0.990530641241837,0,2,storage vacuole,CC,
162,GO:0000333,1,0.992614810239926,0,1,telomerase catalytic core complex,CC,
163,GO:0000334,1,0.996124168229161,0,1,3-hydroxyanthranilate 3,4-dioxygenase activity,MF,
164,GO:0000338,1,0.949953396019379,0,10,protein deneddylation,BP,
165,GO:0000339,1,0.896825590747193,0,17,RNA cap binding,MF,
166,GO:0000340,1,0.934319826485479,0,10,RNA 7-methylguanosine cap binding,MF,
167,GO:0000346,1,0.927373681496554,0,13,transcription export complex,CC,
168,GO:0000347,1,0.967979922001817,0,6,THO complex,CC,
169,GO:0000349,1,0.987863070752682,0,2,generation of catalytic spliceosome for first transesterification step,BP,
170,GO:0000350,1,0.990778690434514,0,2,generation of catalytic spliceosome for second transesterification step,BP,
171,GO:0000354,1,0.983035145250153,0,2,cis assembly of pre-catalytic spliceosome,BP,
172,GO:0000375,1,0.122321920066372,0,337,RNA splicing, via transesterification reactions,BP,
173,GO:0000377,1,0.124398081160331,0,334,RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,BP,
174,GO:0000378,1,0.993485400251684,0,1,RNA exon ligation,BP,
175,GO:0000379,1,0.984029956949343,0,3,tRNA-type intron splice site recognition and cleavage,BP,
176,GO:0000380,1,0.573547459099637,0,81,alternative mRNA splicing, via spliceosome,BP,
177,GO:0000381,1,0.615196213105586,0,70,regulation of alternative mRNA splicing, via spliceosome,BP,
178,GO:0000386,1,0.992808006426331,0,1,second spliceosomal transesterification activity,MF,
179,GO:0000387,1,0.804467991351437,0,39,spliceosomal snRNP assembly,BP,
180,GO:0000388,1,0.989992297080634,0,1,spliceosome conformational change to release U4 (or U4atac) and U1 (or U11),BP,
181,GO:0000389,1,0.962782078890648,0,6,mRNA 3'-splice site recognition,BP,
182,GO:0000390,1,0.985873806448796,0,2,spliceosomal complex disassembly,BP,
183,GO:0000393,1,0.968955413142052,0,5,spliceosomal conformational changes to generate catalytic conformation,BP,
184,GO:0000394,1,0.925222645488374,0,15,RNA splicing, via endonucleolytic cleavage and ligation,BP,
185,GO:0000395,1,0.963528608127809,0,6,mRNA 5'-splice site recognition,BP,
186,GO:0000398,1,0.124398081160331,0,334,mRNA splicing, via spliceosome,BP,
187,GO:0000400,1,0.887039448505575,0,17,four-way junction DNA binding,MF,
188,GO:0000403,1,0.961953019414247,0,5,Y-form DNA binding,MF,
189,GO:0000404,1,0.992785550449173,0,1,heteroduplex DNA loop binding,MF,
190,GO:0000405,1,0.941536067936865,0,8,bubble DNA binding,MF,
191,GO:0000406,1,0.986104085628447,0,2,double-strand/single-strand DNA junction binding,MF,
192,GO:0000407,1,0.806109840655855,0,30,phagophore assembly site,CC,
193,GO:0000408,1,0.975201846038132,0,5,EKC/KEOPS complex,CC,
194,GO:0000409,1,0.99028587089799,0,1,regulation of transcription by galactose,BP,
195,GO:0000411,1,0.99028587089799,0,1,positive regulation of transcription by galactose,BP,
196,GO:0000413,1,0.828235599321438,0,34,protein peptidyl-prolyl isomerization,BP,
197,GO:0000414,1,0.948289414012013,0,6,regulation of histone H3-K36 methylation,BP,
198,GO:0000415,1,0.990753805546624,0,1,negative regulation of histone H3-K36 methylation,BP,
199,GO:0000416,1,0.977670732353866,0,3,positive regulation of histone H3-K36 methylation,BP,
200,GO:0000417,1,0.992602043899798,0,1,HIR complex,CC,
201,GO:0000421,1,0.80709466779623,0,35,autophagosome membrane,CC,
202,GO:0000422,1,0.597053661199248,0,75,autophagy of mitochondrion,BP,
203,GO:0000423,1,0.834834541306805,0,23,mitophagy,BP,
204,GO:0000428,1,0.551478531667931,0,97,DNA-directed RNA polymerase complex,CC,
205,GO:0000429,1,0.975462480005507,0,4,carbon catabolite regulation of transcription from RNA polymerase II promoter,BP,
206,GO:0000430,1,0.98503265032302,0,3,regulation of transcription from RNA polymerase II promoter by glucose,BP,
207,GO:0000431,1,0.99028587089799,0,1,regulation of transcription from RNA polymerase II promoter by galactose,BP,
208,GO:0000432,1,0.98503265032302,0,3,positive regulation of transcription from RNA polymerase II promoter by glucose,BP,
209,GO:0000435,1,0.99028587089799,0,1,positive regulation of transcription from RNA polymerase II promoter by galactose,BP,
210,GO:0000436,1,0.975462480005507,0,4,carbon catabolite activation of transcription from RNA polymerase II promoter,BP,
211,GO:0000438,1,0.986187102482497,0,3,core TFIIH complex portion of holo TFIIH complex,CC,
212,GO:0000439,1,0.940853366679721,0,11,transcription factor TFIIH core complex,CC,
213,GO:0000444,1,0.970316096578107,0,4,MIS12/MIND type complex,CC,
214,GO:0000445,1,0.967979922001817,0,6,THO complex part of transcription export complex,CC,
215,GO:0000447,1,0.94199504142667,0,10,endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
216,GO:0000448,1,0.990451990082966,0,1,cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
217,GO:0000451,1,0.99280657630669,0,1,rRNA 2'-O-methylation,BP,
218,GO:0000453,1,0.99280657630669,0,1,enzyme-directed rRNA 2'-O-methylation,BP,
219,GO:0000454,1,0.988824412417288,0,3,snoRNA guided rRNA pseudouridine synthesis,BP,
220,GO:0000455,1,0.967885406393226,0,6,enzyme-directed rRNA pseudouridine synthesis,BP,
221,GO:0000459,1,0.954584497399513,0,9,exonucleolytic trimming involved in rRNA processing,BP,
222,GO:0000460,1,0.811032771759969,0,34,maturation of 5.8S rRNA,BP,
223,GO:0000461,1,0.997284334420131,0,1,endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
224,GO:0000462,1,0.809288365847631,0,35,maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
225,GO:0000463,1,0.919744015862564,0,13,maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
226,GO:0000466,1,0.862825947500173,0,24,maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
227,GO:0000467,1,0.954584497399513,0,9,exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
228,GO:0000469,1,0.849952338200226,0,27,cleavage involved in rRNA processing,BP,
229,GO:0000470,1,0.862396077558935,0,25,maturation of LSU-rRNA,BP,
230,GO:0000472,1,0.963860403972233,0,5,endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
231,GO:0000478,1,0.903314909777652,0,15,endonucleolytic cleavage involved in rRNA processing,BP,
232,GO:0000479,1,0.903314909777652,0,15,endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
233,GO:0000480,1,0.946010707167695,0,8,endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
234,GO:0000481,1,0.992786929074824,0,1,maturation of 5S rRNA,BP,
235,GO:0000491,1,0.956784704442379,0,8,small nucleolar ribonucleoprotein complex assembly,BP,
236,GO:0000492,1,0.967704875897871,0,6,box C/D snoRNP assembly,BP,
237,GO:0000493,1,0.988719077843043,0,2,box H/ACA snoRNP assembly,BP,
238,GO:0000494,1,0.990745305967436,0,2,box C/D snoRNA 3'-end processing,BP,
239,GO:0000495,1,0.986977603975739,0,2,box H/ACA snoRNA 3'-end processing,BP,
240,GO:0000502,1,0.744215067717711,0,59,proteasome complex,CC,
241,GO:0000506,1,0.960572354968459,0,8,glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex,CC,
242,GO:0000578,1,0.792255180911639,0,35,embryonic axis specification,BP,
243,GO:0000700,1,0.978359267968681,0,4,mismatch base pair DNA N-glycosylase activity,MF,
244,GO:0000701,1,0.991246593429522,0,2,purine-specific mismatch base pair DNA N-glycosylase activity,MF,
245,GO:0000702,1,0.982452969088867,0,4,oxidized base lesion DNA N-glycosylase activity,MF,
246,GO:0000703,1,0.992131911563082,0,2,oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity,MF,
247,GO:0000706,1,0.979381337325066,0,3,meiotic DNA double-strand break processing,BP,
248,GO:0000707,1,0.990128414188154,0,2,meiotic DNA recombinase assembly,BP,
249,GO:0000710,1,0.971639964359654,0,4,meiotic mismatch repair,BP,
250,GO:0000711,1,0.995921853638091,0,1,meiotic DNA repair synthesis,BP,
252,GO:0000715,1,0.881260689700595,0,23,nucleotide-excision repair, DNA damage recognition,BP,
253,GO:0000717,1,0.877609370013325,0,22,nucleotide-excision repair, DNA duplex unwinding,BP,
254,GO:0000718,1,0.995396421293157,0,1,nucleotide-excision repair, DNA damage removal,BP,
255,GO:0000720,1,0.974765341594044,0,4,pyrimidine dimer repair by nucleotide-excision repair,BP,
256,GO:0000721,1,0.993865211361605,0,1,(R,R)-butanediol dehydrogenase activity,MF,
257,GO:0000722,1,0.904515744864432,0,13,telomere maintenance via recombination,BP,
258,GO:0000723,1,0.383754027866955,0,139,telomere maintenance,BP,
259,GO:0000724,1,0.410346894743078,0,124,double-strand break repair via homologous recombination,BP,
260,GO:0000725,1,0.407649815886161,0,125,recombinational repair,BP,
261,GO:0000726,1,0.590284490287749,0,74,non-recombinational repair,BP,
262,GO:0000727,1,0.925894240155361,0,12,double-strand break repair via break-induced replication,BP,
263,GO:0000729,1,0.853692635894625,0,22,DNA double-strand break processing,BP,
264,GO:0000730,1,0.966410526655501,0,6,DNA recombinase assembly,BP,
265,GO:0000731,1,0.739576318795163,0,47,DNA synthesis involved in DNA repair,BP,
266,GO:0000732,1,0.992277153357096,0,1,strand displacement,BP,
267,GO:0000733,1,0.944609591610541,0,8,DNA strand renaturation,BP,
268,GO:0000735,1,0.992234960087441,0,1,removal of nonhomologous ends,BP,
269,GO:0000737,1,0.832568792430384,0,30,DNA catabolic process, endonucleolytic,BP,
270,GO:0000738,1,0.957665393794091,0,8,DNA catabolic process, exonucleolytic,BP,
271,GO:0000741,1,0.995359834508863,0,1,karyogamy,BP,
272,GO:0000768,1,0.737293006477514,0,45,syncytium formation by plasma membrane fusion,BP,
273,GO:0000773,1,0.996544990523016,0,1,phosphatidyl-N-methylethanolamine N-methyltransferase activity,MF,
274,GO:0000774,1,0.942434360751985,0,10,adenyl-nucleotide exchange factor activity,MF,
278,GO:0000778,1,0.908297760435755,0,17,condensed nuclear chromosome kinetochore,CC,
280,GO:0000780,1,0.8427680192131,0,28,condensed nuclear chromosome, centromeric region,CC,
281,GO:0000781,1,0.401559369733978,0,130,chromosome, telomeric region,CC,
282,GO:0000782,1,0.932600309076918,0,11,telomere cap complex,CC,
283,GO:0000783,1,0.932600309076918,0,11,nuclear telomere cap complex,CC,
284,GO:0000784,1,0.504306905097017,0,97,nuclear chromosome, telomeric region,CC,
286,GO:0000786,1,0.930670045183611,0,10,nucleosome,CC,
287,GO:0000788,1,0.980258319244907,0,3,nuclear nucleosome,CC,
288,GO:0000789,1,0.996393491878372,0,1,cytoplasmic chromatin,CC,
290,GO:0000791,1,0.808973173033114,0,32,euchromatin,CC,
291,GO:0000792,1,0.617585476654513,0,68,heterochromatin,CC,
294,GO:0000795,1,0.813067716638307,0,32,synaptonemal complex,CC,
296,GO:0000797,1,0.975154327444305,0,3,condensin core heterodimer,CC,
297,GO:0000798,1,0.967696474080423,0,5,nuclear cohesin complex,CC,
299,GO:0000800,1,0.908927798699836,0,13,lateral element,CC,
300,GO:0000801,1,0.965700742804226,0,6,central element,CC,
301,GO:0000803,1,0.848548091063425,0,23,sex chromosome,CC,
302,GO:0000805,1,0.950961195036968,0,6,X chromosome,CC,
303,GO:0000806,1,0.98628008277143,0,2,Y chromosome,CC,
304,GO:0000808,1,0.942885807601478,0,9,origin recognition complex,CC,
305,GO:0000811,1,0.982040869260847,0,3,GINS complex,CC,
306,GO:0000812,1,0.916347231976881,0,12,Swr1 complex,CC,
307,GO:0000813,1,0.942689915607155,0,10,ESCRT I complex,CC,
308,GO:0000814,1,0.985076712500859,0,3,ESCRT II complex,CC,
309,GO:0000815,1,0.94736919364036,0,10,ESCRT III complex,CC,
310,GO:0000818,1,0.984797287776578,0,3,nuclear MIS12/MIND complex,CC,
312,GO:0000820,1,0.94992733314074,0,7,regulation of glutamine family amino acid metabolic process,BP,
313,GO:0000821,1,0.978213953631195,0,3,regulation of arginine metabolic process,BP,
314,GO:0000822,1,0.971175284006099,0,3,inositol hexakisphosphate binding,MF,
315,GO:0000823,1,0.995272600272908,0,1,inositol-1,4,5-trisphosphate 6-kinase activity,MF,
316,GO:0000824,1,0.995272600272908,0,1,inositol tetrakisphosphate 3-kinase activity,MF,
317,GO:0000825,1,0.988293849254624,0,2,inositol tetrakisphosphate 6-kinase activity,MF,
318,GO:0000827,1,0.969416120141538,0,4,inositol-1,3,4,5,6-pentakisphosphate kinase activity,MF,
319,GO:0000828,1,0.945589562862348,0,8,inositol hexakisphosphate kinase activity,MF,
320,GO:0000829,1,0.983174063366186,0,2,inositol heptakisphosphate kinase activity,MF,
321,GO:0000831,1,0.993498118720825,0,1,inositol hexakisphosphate 6-kinase activity,MF,
322,GO:0000832,1,0.965590447762528,0,5,inositol hexakisphosphate 5-kinase activity,MF,
323,GO:0000835,1,0.951628389492483,0,8,ER ubiquitin ligase complex,CC,
324,GO:0000836,1,0.951628389492483,0,8,Hrd1p ubiquitin ligase complex,CC,
325,GO:0000839,1,0.957861001901449,0,7,Hrd1p ubiquitin ligase ERAD-L complex,CC,
326,GO:0000900,1,0.898228771019871,0,15,translation repressor activity, mRNA regulatory element binding,MF,
330,GO:0000912,1,0.9572441876825,0,6,assembly of actomyosin apparatus involved in cytokinesis,BP,
331,GO:0000915,1,0.9572441876825,0,6,actomyosin contractile ring assembly,BP,
332,GO:0000916,1,0.99451787402331,0,1,actomyosin contractile ring contraction,BP,
333,GO:0000917,1,0.995168540831618,0,1,division septum assembly,BP,
334,GO:0000921,1,0.992124562814415,0,1,septin ring assembly,BP,
336,GO:0000923,1,0.970192891435909,0,4,equatorial microtubule organizing center,CC,
337,GO:0000930,1,0.870668853115358,0,19,gamma-tubulin complex,CC,
338,GO:0000931,1,0.946914752464531,0,7,gamma-tubulin large complex,CC,
339,GO:0000932,1,0.574292620030599,0,81,P-body,CC,
340,GO:0000938,1,0.970317913160355,0,4,GARP complex,CC,
341,GO:0000939,1,0.975033608351155,0,5,condensed chromosome inner kinetochore,CC,
343,GO:0000941,1,0.989780890551503,0,2,condensed nuclear chromosome inner kinetochore,CC,
344,GO:0000942,1,0.976775310941643,0,4,condensed nuclear chromosome outer kinetochore,CC,
345,GO:0000956,1,0.339369629651068,0,196,nuclear-transcribed mRNA catabolic process,BP,
346,GO:0000957,1,0.954297080971336,0,6,mitochondrial RNA catabolic process,BP,
347,GO:0000958,1,0.978974092543594,0,3,mitochondrial mRNA catabolic process,BP,
348,GO:0000959,1,0.759904831914932,0,42,mitochondrial RNA metabolic process,BP,
349,GO:0000960,1,0.961392784337917,0,5,regulation of mitochondrial RNA catabolic process,BP,
350,GO:0000961,1,0.984055339594683,0,2,negative regulation of mitochondrial RNA catabolic process,BP,
351,GO:0000962,1,0.976973897744524,0,3,positive regulation of mitochondrial RNA catabolic process,BP,
352,GO:0000963,1,0.907913224114372,0,16,mitochondrial RNA processing,BP,
353,GO:0000964,1,0.982445699708295,0,3,mitochondrial RNA 5'-end processing,BP,
354,GO:0000965,1,0.970959787308184,0,5,mitochondrial RNA 3'-end processing,BP,
355,GO:0000966,1,0.880142367929007,0,22,RNA 5'-end processing,BP,
356,GO:0000967,1,0.963860403972233,0,5,rRNA 5'-end processing,BP,
357,GO:0000968,1,0.993485400251684,0,1,tRNA exon ligation,BP,
358,GO:0000971,1,0.993485400251684,0,1,tRNA exon ligation utilizing 2',3' cyclic phosphate of 5'-exon as source of linkage phosphate,BP,
359,GO:0000972,1,0.963696889765702,0,6,transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery,BP,
360,GO:0000973,1,0.988525425560993,0,2,posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery,BP,
361,GO:0000974,1,0.92586613321922,0,13,Prp19 complex,CC,
365,GO:0000979,1,0.882588976510925,0,20,RNA polymerase II core promoter sequence-specific DNA binding,MF,
368,GO:0000992,1,0.9561406646519,0,6,RNA polymerase III cis-regulatory region sequence-specific DNA binding,MF,
369,GO:0000993,1,0.778160333513538,0,37,RNA polymerase II complex binding,MF,
370,GO:0000994,1,0.995302486188903,0,1,RNA polymerase III core binding,MF,
371,GO:0000995,1,0.971369392189099,0,5,RNA polymerase III general transcription initiation factor activity,MF,
372,GO:0001002,1,0.974724218472902,0,3,RNA polymerase III type 1 promoter sequence-specific DNA binding,MF,
373,GO:0001003,1,0.974724218472902,0,3,RNA polymerase III type 2 promoter sequence-specific DNA binding,MF,
374,GO:0001006,1,0.9561406646519,0,6,RNA polymerase III type 3 promoter sequence-specific DNA binding,MF,
375,GO:0001010,1,0.993280454265375,0,1,RNA polymerase II sequence-specific DNA-binding transcription factor recruiting activity,MF,
376,GO:0001016,1,0.953136258680702,0,7,RNA polymerase III transcription regulatory region sequence-specific DNA binding,MF,
377,GO:0001018,1,0.980908987116608,0,3,mitochondrial promoter sequence-specific DNA binding,MF,
378,GO:0001025,1,0.966440962819055,0,3,RNA polymerase III general transcription initiation factor binding,MF,
379,GO:0001042,1,0.961448922984071,0,5,RNA polymerase I core binding,MF,
380,GO:0001046,1,0.766386930059039,0,41,core promoter sequence-specific DNA binding,MF,
381,GO:0001054,1,0.986774419287373,0,2,RNA polymerase I activity,MF,
382,GO:0001055,1,0.978171416352574,0,4,RNA polymerase II activity,MF,
383,GO:0001056,1,0.996240816312292,0,1,RNA polymerase III activity,MF,
385,GO:0001069,1,0.984046467509602,0,2,regulatory region RNA binding,MF,
386,GO:0001079,1,0.994580882739056,0,1,nitrogen catabolite regulation of transcription from RNA polymerase II promoter,BP,
387,GO:0001080,1,0.994580882739056,0,1,nitrogen catabolite activation of transcription from RNA polymerase II promoter,BP,
388,GO:0001085,1,0.694081139793012,0,53,RNA polymerase II transcription factor binding,MF,
389,GO:0001091,1,0.881446494786174,0,19,RNA polymerase II general transcription initiation factor binding,MF,
390,GO:0001093,1,0.975292786763647,0,3,TFIIB-class transcription factor binding,MF,
391,GO:0001094,1,0.939970919465283,0,10,TFIID-class transcription factor complex binding,MF,
392,GO:0001096,1,0.986617410565715,0,2,TFIIF-class transcription factor complex binding,MF,
393,GO:0001097,1,0.984716557869044,0,2,TFIIH-class transcription factor complex binding,MF,
394,GO:0001098,1,0.68977368132333,0,56,basal transcription machinery binding,MF,
395,GO:0001099,1,0.68977368132333,0,56,basal RNA polymerase II transcription machinery binding,MF,
396,GO:0001100,1,0.993485400251684,0,1,negative regulation of exit from mitosis,BP,
398,GO:0001102,1,0.74109156057285,0,44,RNA polymerase II activating transcription factor binding,MF,
399,GO:0001103,1,0.791244841383661,0,35,RNA polymerase II repressing transcription factor binding,MF,
400,GO:0001112,1,0.993174476264995,0,1,DNA-templated transcription open complex formation,BP,
401,GO:0001113,1,0.993174476264995,0,1,transcription open complex formation at RNA polymerase II promoter,BP,
402,GO:0001120,1,0.993174476264995,0,1,protein-DNA complex remodeling,BP,
403,GO:0001139,1,0.990487952420433,0,2,RNA polymerase II complex recruiting activity,MF,
404,GO:0001147,1,0.979858509712498,0,2,transcription termination site sequence-specific DNA binding,MF,
405,GO:0001156,1,0.966440962819055,0,3,TFIIIC-class transcription factor complex binding,MF,
406,GO:0001161,1,0.920419145861033,0,14,intronic transcription regulatory region sequence-specific DNA binding,MF,
407,GO:0001162,1,0.932323321028144,0,12,RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding,MF,
408,GO:0001163,1,0.945157095334059,0,8,RNA polymerase I transcription regulatory region sequence-specific DNA binding,MF,
409,GO:0001164,1,0.945157095334059,0,8,RNA polymerase I core promoter sequence-specific DNA binding,MF,
410,GO:0001165,1,0.992271898003798,0,1,RNA polymerase I cis-regulatory region sequence-specific DNA binding,MF,
411,GO:0001172,1,0.983234581950049,0,2,transcription, RNA-templated,BP,
412,GO:0001173,1,0.990487952420433,0,2,DNA-templated transcriptional start site selection,BP,
413,GO:0001174,1,0.990487952420433,0,2,transcriptional start site selection at RNA polymerase II promoter,BP,
414,GO:0001179,1,0.995145591057147,0,1,RNA polymerase I general transcription initiation factor binding,MF,
415,GO:0001181,1,0.967700886653915,0,4,RNA polymerase I general transcription initiation factor activity,MF,
416,GO:0001188,1,0.940566331688088,0,9,RNA polymerase I preinitiation complex assembly,BP,
417,GO:0001192,1,0.996705107414901,0,1,maintenance of transcriptional fidelity during DNA-templated transcription elongation,BP,
418,GO:0001193,1,0.996705107414901,0,1,maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter,BP,
421,GO:0001221,1,0.687903649224594,0,49,transcription cofactor binding,MF,
422,GO:0001222,1,0.904367693533927,0,14,transcription corepressor binding,MF,
423,GO:0001223,1,0.796294178608967,0,28,transcription coactivator binding,MF,
424,GO:0001224,1,0.933736057675463,0,8,RNA polymerase II transcription cofactor binding,MF,
425,GO:0001225,1,0.943830283337736,0,6,RNA polymerase II transcription coactivator binding,MF,
426,GO:0001226,1,0.9893111873555,0,2,RNA polymerase II transcription corepressor binding,MF,
429,GO:0001300,1,0.986186776927541,0,2,chronological cell aging,BP,
430,GO:0001302,1,0.962147558477096,0,6,replicative cell aging,BP,
431,GO:0001306,1,0.996504261929267,0,1,age-dependent response to oxidative stress,BP,
432,GO:0001315,1,0.996504261929267,0,1,age-dependent response to reactive oxygen species,BP,
433,GO:0001325,1,0.904165083853675,0,14,formation of extrachromosomal circular DNA,BP,
434,GO:0001401,1,0.939262526515798,0,11,SAM complex,CC,
435,GO:0001405,1,0.971560193084783,0,5,PAM complex, Tim23 associated import motor,CC,
437,GO:0001502,1,0.879066458331251,0,17,cartilage condensation,BP,
441,GO:0001507,1,0.98701116808666,0,2,acetylcholine catabolic process in synaptic cleft,BP,
443,GO:0001510,1,0.64618387958856,0,69,RNA methylation,BP,
444,GO:0001512,1,0.996339723294794,0,1,dihydronicotinamide riboside quinone reductase activity,MF,
445,GO:0001514,1,0.948508348526858,0,8,selenocysteine incorporation,BP,
446,GO:0001515,1,0.981290024267145,0,4,opioid peptide activity,MF,
447,GO:0001516,1,0.873826886495551,0,25,prostaglandin biosynthetic process,BP,
448,GO:0001517,1,0.955375373419027,0,6,N-acetylglucosamine 6-O-sulfotransferase activity,MF,
449,GO:0001518,1,0.846506715733422,0,17,voltage-gated sodium channel complex,CC,
450,GO:0001519,1,0.99273603595309,0,1,peptide amidation,BP,
451,GO:0001520,1,0.980197041007213,0,3,outer dense fiber,CC,
452,GO:0001522,1,0.910798418662438,0,18,pseudouridine synthesis,BP,
453,GO:0001523,1,0.593974732681868,0,82,retinoid metabolic process,BP,
455,GO:0001527,1,0.922005169936295,0,10,microfibril,CC,
456,GO:0001530,1,0.873737717004251,0,25,lipopolysaccharide binding,MF,
457,GO:0001532,1,0.992980767780948,0,1,interleukin-21 receptor activity,MF,
458,GO:0001533,1,0.8223389045003,0,28,cornified envelope,CC,
459,GO:0001534,1,0.977742108495355,0,4,radial spoke,CC,
460,GO:0001535,1,0.993480490583131,0,1,radial spoke head,CC,
461,GO:0001536,1,0.993485400251684,0,1,radial spoke stalk,CC,
466,GO:0001542,1,0.927028340855834,0,9,ovulation from ovarian follicle,BP,
467,GO:0001543,1,0.989729556844576,0,1,ovarian follicle rupture,BP,
468,GO:0001544,1,0.984505675265385,0,2,initiation of primordial ovarian follicle growth,BP,
469,GO:0001545,1,0.992591167183112,0,1,primary ovarian follicle growth,BP,
470,GO:0001546,1,0.984695801673097,0,3,preantral ovarian follicle growth,BP,
471,GO:0001547,1,0.945478838334992,0,8,antral ovarian follicle growth,BP,
472,GO:0001550,1,0.978867026347393,0,3,ovarian cumulus expansion,BP,
473,GO:0001552,1,0.99499078305067,0,1,ovarian follicle atresia,BP,
475,GO:0001554,1,0.947923053275932,0,7,luteolysis,BP,
476,GO:0001555,1,0.981739639442975,0,3,oocyte growth,BP,
477,GO:0001556,1,0.871512793859702,0,21,oocyte maturation,BP,
479,GO:0001560,1,0.973601466555066,0,3,regulation of cell growth by extracellular stimulus,BP,
480,GO:0001561,1,0.949841381953446,0,9,fatty acid alpha-oxidation,BP,
481,GO:0001562,1,0.864036221094745,0,25,response to protozoan,BP,
482,GO:0001567,1,0.995995194795129,0,1,cholesterol 25-hydroxylase activity,MF,
486,GO:0001572,1,0.992101576207316,0,1,lactosylceramide biosynthetic process,BP,
487,GO:0001573,1,0.869791515160185,0,21,ganglioside metabolic process,BP,
488,GO:0001574,1,0.916974686879816,0,13,ganglioside biosynthetic process,BP,
489,GO:0001575,1,0.994699394861936,0,1,globoside metabolic process,BP,
490,GO:0001576,1,0.994699394861936,0,1,globoside biosynthetic process,BP,
492,GO:0001579,1,0.986117540624102,0,2,medium-chain fatty acid transport,BP,
493,GO:0001580,1,0.915885507070028,0,20,detection of chemical stimulus involved in sensory perception of bitter taste,BP,
494,GO:0001581,1,0.993145878204297,0,1,detection of chemical stimulus involved in sensory perception of sour taste,BP,
495,GO:0001582,1,0.993813629352555,0,1,detection of chemical stimulus involved in sensory perception of sweet taste,BP,
496,GO:0001587,1,0.992151071097133,0,1,Gq/11-coupled serotonin receptor activity,MF,
497,GO:0001588,1,0.987107517663807,0,2,dopamine neurotransmitter receptor activity, coupled via Gs,MF,
498,GO:0001591,1,0.985371123646227,0,3,dopamine neurotransmitter receptor activity, coupled via Gi/Go,MF,
499,GO:0001595,1,0.98693094037739,0,3,angiotensin receptor activity,MF,
500,GO:0001596,1,0.994236565533486,0,1,angiotensin type I receptor activity,MF,
501,GO:0001601,1,0.981583826393312,0,3,peptide YY receptor activity,MF,
502,GO:0001602,1,0.98871905689624,0,2,pancreatic polypeptide receptor activity,MF,
503,GO:0001604,1,0.992123676117515,0,2,urotensin II receptor activity,MF,
504,GO:0001605,1,0.98488448751741,0,3,adrenomedullin receptor activity,MF,
505,GO:0001607,1,0.987765296580378,0,2,neuromedin U receptor activity,MF,
506,GO:0001609,1,0.978290952784283,0,4,G protein-coupled adenosine receptor activity,MF,
507,GO:0001614,1,0.896284706831129,0,20,purinergic nucleotide receptor activity,MF,
508,GO:0001618,1,0.64139506662304,0,65,virus receptor activity,MF,
509,GO:0001621,1,0.98434147084648,0,3,G protein-coupled ADP receptor activity,MF,
510,GO:0001626,1,0.992973222589242,0,1,nociceptin receptor activity,MF,
511,GO:0001631,1,0.98963669913248,0,2,cysteinyl leukotriene receptor activity,MF,
512,GO:0001632,1,0.988657511758573,0,2,leukotriene B4 receptor activity,MF,
513,GO:0001635,1,0.97521225603717,0,4,calcitonin gene-related peptide receptor activity,MF,
514,GO:0001637,1,0.866923486804344,0,25,G protein-coupled chemoattractant receptor activity,MF,
515,GO:0001640,1,0.944745888160209,0,7,adenylate cyclase inhibiting G protein-coupled glutamate receptor activity,MF,
516,GO:0001641,1,0.986206895095443,0,2,group II metabotropic glutamate receptor activity,MF,
517,GO:0001642,1,0.96927523613293,0,4,group III metabotropic glutamate receptor activity,MF,
519,GO:0001650,1,0.444878470720672,0,121,fibrillar center,CC,
520,GO:0001651,1,0.996301048185786,0,1,dense fibrillar component,CC,
521,GO:0001652,1,0.967247361671814,0,6,granular component,CC,
525,GO:0001656,1,0.545945486272239,0,83,metanephros development,BP,
526,GO:0001657,1,0.514432097845324,0,93,ureteric bud development,BP,
527,GO:0001658,1,0.678305291617279,0,54,branching involved in ureteric bud morphogenesis,BP,
530,GO:0001661,1,0.96482824200326,0,5,conditioned taste aversion,BP,
531,GO:0001662,1,0.774462426402613,0,39,behavioral fear response,BP,
533,GO:0001665,1,0.967860899157539,0,6,alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity,MF,
535,GO:0001667,1,0.0694676677152596,0,374,ameboidal-type cell migration,BP,
538,GO:0001672,1,0.833415240632442,0,23,regulation of chromatin assembly or disassembly,BP,
539,GO:0001673,1,0.932766706758445,0,10,male germ cell nucleus,CC,
540,GO:0001674,1,0.988584662936212,0,2,female germ cell nucleus,CC,
541,GO:0001675,1,0.932103369270456,0,10,acrosome assembly,BP,
542,GO:0001676,1,0.553753182224576,0,98,long-chain fatty acid metabolic process,BP,
544,GO:0001680,1,0.994332545728782,0,1,tRNA 3'-terminal CCA addition,BP,
545,GO:0001681,1,0.993386108402813,0,1,sialate O-acetylesterase activity,MF,
546,GO:0001682,1,0.940020312476286,0,12,tRNA 5'-leader removal,BP,
547,GO:0001691,1,0.988110185364311,0,2,pseudophosphatase activity,MF,
548,GO:0001692,1,0.970682857135623,0,5,histamine metabolic process,BP,
549,GO:0001694,1,0.994076943260129,0,1,histamine biosynthetic process,BP,
550,GO:0001695,1,0.996663383576929,0,1,histamine catabolic process,BP,
551,GO:0001696,1,0.907208949633761,0,16,gastric acid secretion,BP,
552,GO:0001697,1,0.993415275518932,0,1,histamine-induced gastric acid secretion,BP,
553,GO:0001698,1,0.993415275518932,0,1,gastrin-induced gastric acid secretion,BP,
554,GO:0001701,1,0.0803954577244336,0,355,in utero embryonic development,BP,
555,GO:0001702,1,0.823793415462118,0,24,gastrulation with mouth forming second,BP,
557,GO:0001705,1,0.979719868430784,0,3,ectoderm formation,BP,
561,GO:0001709,1,0.770006838241302,0,39,cell fate determination,BP,
563,GO:0001711,1,0.917549235592181,0,14,endodermal cell fate commitment,BP,
564,GO:0001712,1,0.979719868430784,0,3,ectodermal cell fate commitment,BP,
565,GO:0001714,1,0.964409394703571,0,7,endodermal cell fate specification,BP,
566,GO:0001715,1,0.992685567166604,0,1,ectodermal cell fate specification,BP,
567,GO:0001716,1,0.994765614437112,0,1,L-amino-acid oxidase activity,MF,
568,GO:0001725,1,0.628277616541083,0,62,stress fiber,CC,
570,GO:0001727,1,0.957506103350598,0,6,lipid kinase activity,MF,
571,GO:0001729,1,0.985688591029876,0,2,ceramide kinase activity,MF,
572,GO:0001730,1,0.979162687171919,0,3,2'-5'-oligoadenylate synthetase activity,MF,
573,GO:0001731,1,0.929930934433471,0,10,formation of translation preinitiation complex,BP,
574,GO:0001732,1,0.92277228025358,0,15,formation of cytoplasmic translation initiation complex,BP,
575,GO:0001733,1,0.978128918908366,0,4,galactosylceramide sulfotransferase activity,MF,
576,GO:0001734,1,0.988471586973023,0,2,mRNA (N6-adenosine)-methyltransferase activity,MF,
577,GO:0001735,1,0.985513891208999,0,2,prenylcysteine oxidase activity,MF,
580,GO:0001739,1,0.975230601550928,0,4,sex chromatin,CC,
581,GO:0001740,1,0.982315392935099,0,2,Barr body,CC,
582,GO:0001741,1,0.9323390794431,0,11,XY body,CC,
583,GO:0001743,1,0.983528740654196,0,2,optic placode formation,BP,
586,GO:0001755,1,0.670559519981722,0,55,neural crest cell migration,BP,
588,GO:0001757,1,0.970096740094032,0,5,somite specification,BP,
589,GO:0001758,1,0.959249739647815,0,8,retinal dehydrogenase activity,MF,
590,GO:0001759,1,0.865156401224916,0,23,organ induction,BP,
591,GO:0001760,1,0.996176625938231,0,1,aminocarboxymuconate-semialdehyde decarboxylase activity,MF,
594,GO:0001765,1,0.944619653566098,0,10,membrane raft assembly,BP,
595,GO:0001766,1,0.977078245198127,0,4,membrane raft polarization,BP,
596,GO:0001767,1,0.917391322693071,0,12,establishment of lymphocyte polarity,BP,
597,GO:0001768,1,0.926546371606883,0,11,establishment of T cell polarity,BP,
598,GO:0001770,1,0.990126656748334,0,1,establishment of natural killer cell polarity,BP,
599,GO:0001771,1,0.916186170682092,0,14,immunological synapse formation,BP,
600,GO:0001772,1,0.783454309141976,0,38,immunological synapse,CC,
601,GO:0001773,1,0.854804703118528,0,27,myeloid dendritic cell activation,BP,
602,GO:0001774,1,0.758749248327155,0,42,microglial cell activation,BP,
604,GO:0001776,1,0.582884708947499,0,82,leukocyte homeostasis,BP,
605,GO:0001777,1,0.986007682925878,0,3,T cell homeostatic proliferation,BP,
607,GO:0001779,1,0.87629567652572,0,20,natural killer cell differentiation,BP,
608,GO:0001780,1,0.890092844556509,0,16,neutrophil homeostasis,BP,
609,GO:0001781,1,0.944105293800189,0,8,neutrophil apoptotic process,BP,
610,GO:0001782,1,0.827999427044899,0,28,B cell homeostasis,BP,
611,GO:0001783,1,0.856809958062679,0,24,B cell apoptotic process,BP,
613,GO:0001785,1,0.986801392967316,0,2,prostaglandin J receptor activity,MF,
615,GO:0001787,1,0.951748376785217,0,9,natural killer cell proliferation,BP,
616,GO:0001788,1,0.991114366850749,0,2,antibody-dependent cellular cytotoxicity,BP,
617,GO:0001791,1,0.988386849932899,0,2,IgM binding,MF,
618,GO:0001792,1,0.992470592430046,0,1,polymeric immunoglobulin receptor activity,MF,
619,GO:0001794,1,0.980134687356161,0,4,type IIa hypersensitivity,BP,
620,GO:0001796,1,0.980134687356161,0,4,regulation of type IIa hypersensitivity,BP,
621,GO:0001797,1,0.995611833164541,0,1,negative regulation of type IIa hypersensitivity,BP,
622,GO:0001798,1,0.98445531849273,0,3,positive regulation of type IIa hypersensitivity,BP,
623,GO:0001802,1,0.990777348942606,0,2,type III hypersensitivity,BP,
624,GO:0001803,1,0.990777348942606,0,2,regulation of type III hypersensitivity,BP,
625,GO:0001805,1,0.990777348942606,0,2,positive regulation of type III hypersensitivity,BP,
626,GO:0001806,1,0.978152757502541,0,4,type IV hypersensitivity,BP,
627,GO:0001807,1,0.984909502794119,0,3,regulation of type IV hypersensitivity,BP,
628,GO:0001808,1,0.994792282471929,0,1,negative regulation of type IV hypersensitivity,BP,
629,GO:0001809,1,0.99596539912855,0,1,positive regulation of type IV hypersensitivity,BP,
630,GO:0001810,1,0.986429249518046,0,3,regulation of type I hypersensitivity,BP,
631,GO:0001811,1,0.995611833164541,0,1,negative regulation of type I hypersensitivity,BP,
632,GO:0001812,1,0.990777348942606,0,2,positive regulation of type I hypersensitivity,BP,
633,GO:0001813,1,0.991114366850749,0,2,regulation of antibody-dependent cellular cytotoxicity,BP,
634,GO:0001814,1,0.995611833164541,0,1,negative regulation of antibody-dependent cellular cytotoxicity,BP,
635,GO:0001815,1,0.995482909867247,0,1,positive regulation of antibody-dependent cellular cytotoxicity,BP,
636,GO:0001816,1,0.0125364729493236,0,673,cytokine production,BP,
637,GO:0001817,1,0.0190828550649187,0,611,regulation of cytokine production,BP,
638,GO:0001818,1,0.23738625862502,0,232,negative regulation of cytokine production,BP,
639,GO:0001819,1,0.0852393437654679,0,386,positive regulation of cytokine production,BP,
641,GO:0001821,1,0.947256917634573,0,10,histamine secretion,BP,
643,GO:0001823,1,0.499573498379633,0,97,mesonephros development,BP,
644,GO:0001824,1,0.552538389403934,0,92,blastocyst development,BP,
645,GO:0001825,1,0.80519519492488,0,34,blastocyst formation,BP,
646,GO:0001826,1,0.961095884721288,0,5,inner cell mass cell differentiation,BP,
647,GO:0001827,1,0.992146550965429,0,1,inner cell mass cell fate commitment,BP,
648,GO:0001828,1,0.986390228607695,0,2,inner cell mass cellular morphogenesis,BP,
649,GO:0001829,1,0.925053591132471,0,12,trophectodermal cell differentiation,BP,
650,GO:0001831,1,0.985143696676511,0,2,trophectodermal cellular morphogenesis,BP,
651,GO:0001832,1,0.866124491213653,0,19,blastocyst growth,BP,
652,GO:0001833,1,0.90996915559184,0,13,inner cell mass cell proliferation,BP,
653,GO:0001834,1,0.972482088952624,0,3,trophectodermal cell proliferation,BP,
654,GO:0001835,1,0.848447629171589,0,26,blastocyst hatching,BP,
655,GO:0001836,1,0.730393171672386,0,57,release of cytochrome c from mitochondria,BP,
658,GO:0001839,1,0.960913590411047,0,6,neural plate morphogenesis,BP,
659,GO:0001840,1,0.935361649385498,0,9,neural plate development,BP,
661,GO:0001842,1,0.956135173581526,0,7,neural fold formation,BP,
663,GO:0001844,1,0.83670225857233,0,30,protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,
664,GO:0001845,1,0.916644632888438,0,14,phagolysosome assembly,BP,
665,GO:0001846,1,0.911890874946176,0,13,opsonin binding,MF,
666,GO:0001847,1,0.971877372037938,0,4,opsonin receptor activity,MF,
667,GO:0001848,1,0.886068145694077,0,17,complement binding,MF,
668,GO:0001849,1,0.958688276352369,0,6,complement component C1q complex binding,MF,
669,GO:0001850,1,0.99520850060548,0,1,complement component C3a binding,MF,
670,GO:0001851,1,0.96477288386392,0,5,complement component C3b binding,MF,
671,GO:0001855,1,0.983953587777172,0,2,complement component C4b binding,MF,
672,GO:0001856,1,0.994213737989566,0,1,complement component C5a binding,MF,
673,GO:0001861,1,0.988255070026608,0,1,complement component C4b receptor activity,MF,
674,GO:0001865,1,0.931999674689749,0,10,NK T cell differentiation,BP,
675,GO:0001866,1,0.966985048755829,0,6,NK T cell proliferation,BP,
676,GO:0001867,1,0.954348396328751,0,9,complement activation, lectin pathway,BP,
677,GO:0001868,1,0.987324508989395,0,2,regulation of complement activation, lectin pathway,BP,
678,GO:0001869,1,0.987324508989395,0,2,negative regulation of complement activation, lectin pathway,BP,
679,GO:0001872,1,0.989084912043445,0,2,(1->3)-beta-D-glucan binding,MF,
680,GO:0001875,1,0.967917161781061,0,5,lipopolysaccharide immune receptor activity,MF,
681,GO:0001878,1,0.979087023647207,0,4,response to yeast,BP,
682,GO:0001880,1,0.977973635538845,0,3,Mullerian duct regression,BP,
683,GO:0001881,1,0.803968003978972,0,31,receptor recycling,BP,
687,GO:0001886,1,0.910834738665862,0,12,endothelial cell morphogenesis,BP,
688,GO:0001887,1,0.974184177752591,0,4,selenium compound metabolic process,BP,
689,GO:0001888,1,0.98434220948168,0,2,glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
691,GO:0001890,1,0.381425920193017,0,142,placenta development,BP,
692,GO:0001891,1,0.845477947999808,0,25,phagocytic cup,CC,
693,GO:0001892,1,0.5687937521471,0,81,embryonic placenta development,BP,
694,GO:0001893,1,0.795076239732053,0,35,maternal placenta development,BP,
697,GO:0001905,1,0.974465254582649,0,3,activation of membrane attack complex,BP,
698,GO:0001906,1,0.504680609778086,0,128,cell killing,BP,
699,GO:0001907,1,0.984584972926545,0,3,killing by symbiont of host cells,BP,
700,GO:0001909,1,0.59873034031079,0,92,leukocyte mediated cytotoxicity,BP,
701,GO:0001910,1,0.696109824158062,0,65,regulation of leukocyte mediated cytotoxicity,BP,
702,GO:0001911,1,0.903217627574814,0,19,negative regulation of leukocyte mediated cytotoxicity,BP,
703,GO:0001912,1,0.780853166848549,0,44,positive regulation of leukocyte mediated cytotoxicity,BP,
704,GO:0001913,1,0.818642550703789,0,37,T cell mediated cytotoxicity,BP,
705,GO:0001914,1,0.85694798976066,0,29,regulation of T cell mediated cytotoxicity,BP,
706,GO:0001915,1,0.958464922346696,0,7,negative regulation of T cell mediated cytotoxicity,BP,
707,GO:0001916,1,0.890988660523195,0,22,positive regulation of T cell mediated cytotoxicity,BP,
709,GO:0001918,1,0.993456252496424,0,1,farnesylated protein binding,MF,
710,GO:0001919,1,0.861489290524676,0,22,regulation of receptor recycling,BP,
711,GO:0001920,1,0.974640201035124,0,4,negative regulation of receptor recycling,BP,
712,GO:0001921,1,0.913058788674239,0,13,positive regulation of receptor recycling,BP,
713,GO:0001922,1,0.976581002716858,0,3,B-1 B cell homeostasis,BP,
714,GO:0001923,1,0.968934075556375,0,5,B-1 B cell differentiation,BP,
715,GO:0001927,1,0.994367400481405,0,1,exocyst assembly,BP,
716,GO:0001928,1,0.994367400481405,0,1,regulation of exocyst assembly,BP,
717,GO:0001931,1,0.917940631832397,0,13,uropod,CC,
721,GO:0001935,1,0.397197486094642,0,134,endothelial cell proliferation,BP,
722,GO:0001936,1,0.437274223954211,0,119,regulation of endothelial cell proliferation,BP,
723,GO:0001937,1,0.77935812274665,0,36,negative regulation of endothelial cell proliferation,BP,
724,GO:0001938,1,0.547679441733371,0,86,positive regulation of endothelial cell proliferation,BP,
725,GO:0001939,1,0.945733345579277,0,7,female pronucleus,CC,
726,GO:0001940,1,0.959520797687039,0,5,male pronucleus,CC,
727,GO:0001941,1,0.73924258240327,0,40,postsynaptic membrane organization,BP,
728,GO:0001942,1,0.56450036946901,0,80,hair follicle development,BP,
730,GO:0001945,1,0.811429172423813,0,26,lymph vessel development,BP,
731,GO:0001946,1,0.888575510763776,0,15,lymphangiogenesis,BP,
732,GO:0001947,1,0.658547495040892,0,60,heart looping,BP,
733,GO:0001949,1,0.994047495011617,0,1,sebaceous gland cell differentiation,BP,
734,GO:0001951,1,0.979464972972944,0,3,intestinal D-glucose absorption,BP,
735,GO:0001952,1,0.424005975908921,0,114,regulation of cell-matrix adhesion,BP,
736,GO:0001953,1,0.761151854711912,0,35,negative regulation of cell-matrix adhesion,BP,
737,GO:0001954,1,0.683167202249014,0,53,positive regulation of cell-matrix adhesion,BP,
738,GO:0001955,1,0.945739397251546,0,8,blood vessel maturation,BP,
740,GO:0001957,1,0.958132073474344,0,6,intramembranous ossification,BP,
741,GO:0001958,1,0.829589834980493,0,27,endochondral ossification,BP,
742,GO:0001959,1,0.391518211880817,0,145,regulation of cytokine-mediated signaling pathway,BP,
743,GO:0001960,1,0.731656915440139,0,50,negative regulation of cytokine-mediated signaling pathway,BP,
744,GO:0001961,1,0.738411705432813,0,47,positive regulation of cytokine-mediated signaling pathway,BP,
745,GO:0001963,1,0.860251426773353,0,26,synaptic transmission, dopaminergic,BP,
747,GO:0001965,1,0.85170055698751,0,24,G-protein alpha-subunit binding,MF,
748,GO:0001966,1,0.984756610960833,0,2,thigmotaxis,BP,
749,GO:0001967,1,0.925596848369795,0,11,suckling behavior,BP,
751,GO:0001969,1,0.974465254582649,0,3,regulation of activation of membrane attack complex,BP,
752,GO:0001970,1,0.984674965506873,0,2,positive regulation of activation of membrane attack complex,BP,
753,GO:0001971,1,0.989632979965608,0,1,negative regulation of activation of membrane attack complex,BP,
754,GO:0001972,1,0.917150097965015,0,14,retinoic acid binding,MF,
755,GO:0001973,1,0.934572633673561,0,11,G protein-coupled adenosine receptor signaling pathway,BP,
756,GO:0001974,1,0.756241110615638,0,38,blood vessel remodeling,BP,
757,GO:0001975,1,0.808687000297437,0,32,response to amphetamine,BP,
758,GO:0001976,1,0.936919342261085,0,10,nervous system process involved in regulation of systemic arterial blood pressure,BP,
759,GO:0001977,1,0.927083647199328,0,12,renal system process involved in regulation of blood volume,BP,
760,GO:0001978,1,0.994514925778001,0,1,regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback,BP,
761,GO:0001979,1,0.995446197891458,0,1,regulation of systemic arterial blood pressure by chemoreceptor signaling,BP,
762,GO:0001980,1,0.996743839873888,0,1,regulation of systemic arterial blood pressure by ischemic conditions,BP,
763,GO:0001983,1,0.994514925778001,0,1,baroreceptor response to increased systemic arterial blood pressure,BP,
764,GO:0001985,1,0.994514925778001,0,1,negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure,BP,
765,GO:0001990,1,0.831991442680685,0,31,regulation of systemic arterial blood pressure by hormone,BP,
766,GO:0001991,1,0.917839726491889,0,14,regulation of systemic arterial blood pressure by circulatory renin-angiotensin,BP,
767,GO:0001992,1,0.974933924454955,0,4,regulation of systemic arterial blood pressure by vasopressin,BP,
768,GO:0001993,1,0.944458206208583,0,9,regulation of systemic arterial blood pressure by norepinephrine-epinephrine,BP,
769,GO:0001994,1,0.988698120470495,0,2,norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure,BP,
770,GO:0001996,1,0.961061522277424,0,6,positive regulation of heart rate by epinephrine-norepinephrine,BP,
771,GO:0001997,1,0.987920598628125,0,2,positive regulation of the force of heart contraction by epinephrine-norepinephrine,BP,
772,GO:0001998,1,0.99503363252735,0,1,angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure,BP,
773,GO:0001999,1,0.968367743843482,0,5,renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure,BP,
774,GO:0002001,1,0.968367743843482,0,5,renin secretion into blood stream,BP,
775,GO:0002002,1,0.947837791688152,0,9,regulation of angiotensin levels in blood,BP,
776,GO:0002003,1,0.947837791688152,0,9,angiotensin maturation,BP,
777,GO:0002007,1,0.995446197891458,0,1,detection of hypoxic conditions in blood by chemoreceptor signaling,BP,
779,GO:0002011,1,0.660506667691283,0,52,morphogenesis of an epithelial sheet,BP,
780,GO:0002016,1,0.966795087467827,0,6,regulation of blood volume by renin-angiotensin,BP,
781,GO:0002017,1,0.995109094445576,0,1,regulation of blood volume by renal aldosterone,BP,
782,GO:0002018,1,0.98805187450184,0,2,renin-angiotensin regulation of aldosterone production,BP,
783,GO:0002019,1,0.983719303290826,0,3,regulation of renal output by angiotensin,BP,
786,GO:0002023,1,0.983942073068737,0,3,reduction of food intake in response to dietary excess,BP,
787,GO:0002024,1,0.93784057295054,0,9,diet induced thermogenesis,BP,
788,GO:0002025,1,0.98195790982711,0,3,norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,
789,GO:0002026,1,0.836490841855535,0,25,regulation of the force of heart contraction,BP,
790,GO:0002027,1,0.51558441641137,0,93,regulation of heart rate,BP,
793,GO:0002030,1,0.993311486956371,0,1,inhibitory G protein-coupled receptor phosphorylation,BP,
795,GO:0002032,1,0.989888372208696,0,2,desensitization of G protein-coupled receptor signaling pathway by arrestin,BP,
796,GO:0002034,1,0.977588504817047,0,4,regulation of blood vessel diameter by renin-angiotensin,BP,
797,GO:0002035,1,0.986655903402722,0,2,brain renin-angiotensin system,BP,
798,GO:0002036,1,0.955846221186213,0,6,regulation of L-glutamate import across plasma membrane,BP,
799,GO:0002037,1,0.994630224324872,0,1,negative regulation of L-glutamate import across plasma membrane,BP,
800,GO:0002038,1,0.978233444768841,0,3,positive regulation of L-glutamate import across plasma membrane,BP,
801,GO:0002039,1,0.63352636218329,0,63,p53 binding,MF,
803,GO:0002042,1,0.690490763532644,0,52,cell migration involved in sprouting angiogenesis,BP,
804,GO:0002043,1,0.875743840806826,0,19,blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
805,GO:0002046,1,0.991403786633259,0,2,opsin binding,MF,
806,GO:0002051,1,0.964914885469538,0,4,osteoblast fate commitment,BP,
808,GO:0002053,1,0.838202357426414,0,25,positive regulation of mesenchymal cell proliferation,BP,
809,GO:0002054,1,0.972393667943052,0,5,nucleobase binding,MF,
810,GO:0002055,1,0.996875419367853,0,1,adenine binding,MF,
811,GO:0002058,1,0.987749997904824,0,2,uracil binding,MF,
812,GO:0002059,1,0.994624299411827,0,1,thymine binding,MF,
813,GO:0002060,1,0.984455125130248,0,3,purine nucleobase binding,MF,
814,GO:0002061,1,0.987749997904824,0,2,pyrimidine nucleobase binding,MF,
819,GO:0002066,1,0.675813381595665,0,56,columnar/cuboidal epithelial cell development,BP,
820,GO:0002067,1,0.735142424405913,0,45,glandular epithelial cell differentiation,BP,
821,GO:0002068,1,0.836057701358233,0,25,glandular epithelial cell development,BP,
822,GO:0002069,1,0.968672321510343,0,6,columnar/cuboidal epithelial cell maturation,BP,
823,GO:0002070,1,0.905877738284701,0,15,epithelial cell maturation,BP,
824,GO:0002071,1,0.989490858899935,0,2,glandular epithelial cell maturation,BP,
825,GO:0002072,1,0.933565781148946,0,8,optic cup morphogenesis involved in camera-type eye development,BP,
826,GO:0002074,1,0.967062785547019,0,4,extraocular skeletal muscle development,BP,
827,GO:0002076,1,0.877232065470882,0,19,osteoblast development,BP,
828,GO:0002077,1,0.995999877942265,0,1,acrosome matrix dispersal,BP,
829,GO:0002079,1,0.979441505082317,0,3,inner acrosomal membrane,CC,
830,GO:0002080,1,0.89746726887633,0,18,acrosomal membrane,CC,
831,GO:0002081,1,0.980606434175797,0,3,outer acrosomal membrane,CC,
832,GO:0002082,1,0.86272169162651,0,26,regulation of oxidative phosphorylation,BP,
833,GO:0002083,1,0.995550085626571,0,1,4-hydroxybenzoate decaprenyltransferase activity,MF,
834,GO:0002084,1,0.94734594049126,0,9,protein depalmitoylation,BP,
835,GO:0002085,1,0.968272917856025,0,5,inhibition of neuroepithelial cell differentiation,BP,
836,GO:0002086,1,0.989740931167965,0,2,diaphragm contraction,BP,
837,GO:0002087,1,0.921222756642856,0,12,regulation of respiratory gaseous exchange by nervous system process,BP,
839,GO:0002089,1,0.865537450452515,0,18,lens morphogenesis in camera-type eye,BP,
841,GO:0002091,1,0.921126103418353,0,13,negative regulation of receptor internalization,BP,
842,GO:0002092,1,0.847721035856203,0,23,positive regulation of receptor internalization,BP,
843,GO:0002093,1,0.921313199790346,0,12,auditory receptor cell morphogenesis,BP,
844,GO:0002094,1,0.988539916879316,0,2,polyprenyltransferase activity,MF,
845,GO:0002095,1,0.986700722684178,0,2,caveolar macromolecular signaling complex,CC,
846,GO:0002096,1,0.985102450214249,0,2,polkadots,CC,
847,GO:0002097,1,0.893797287383266,0,19,tRNA wobble base modification,BP,
848,GO:0002098,1,0.915430684025951,0,15,tRNA wobble uridine modification,BP,
849,GO:0002100,1,0.986564208991496,0,2,tRNA wobble adenosine to inosine editing,BP,
850,GO:0002101,1,0.989687308203068,0,2,tRNA wobble cytosine modification,BP,
851,GO:0002102,1,0.802787672142571,0,29,podosome,CC,
852,GO:0002112,1,0.993670166857566,0,1,interleukin-33 receptor binding,MF,
853,GO:0002113,1,0.99431324648007,0,1,interleukin-33 binding,MF,
854,GO:0002114,1,0.987055998557199,0,2,interleukin-33 receptor activity,MF,
855,GO:0002115,1,0.885356547267122,0,18,store-operated calcium entry,BP,
856,GO:0002116,1,0.902048893221662,0,11,semaphorin receptor complex,CC,
857,GO:0002118,1,0.963366264767341,0,6,aggressive behavior,BP,
858,GO:0002121,1,0.985984593162401,0,2,inter-male aggressive behavior,BP,
859,GO:0002125,1,0.987765511715171,0,2,maternal aggressive behavior,BP,
860,GO:0002127,1,0.995893880172547,0,1,tRNA wobble base cytosine methylation,BP,
861,GO:0002128,1,0.994955596711668,0,1,tRNA nucleoside ribose methylation,BP,
862,GO:0002133,1,0.976609250792248,0,2,polycystin complex,CC,
863,GO:0002134,1,0.985309671853816,0,2,UTP binding,MF,
864,GO:0002135,1,0.993837575347301,0,1,CTP binding,MF,
865,GO:0002138,1,0.955329487785864,0,8,retinoic acid biosynthetic process,BP,
867,GO:0002140,1,0.989876487000643,0,1,stereocilia tip link,CC,
870,GO:0002143,1,0.979209434702519,0,4,tRNA wobble position uridine thiolation,BP,
871,GO:0002144,1,0.994669742655853,0,1,cytosolic tRNA wobble base thiouridylase complex,CC,
872,GO:0002148,1,0.993012904054279,0,1,hypochlorous acid metabolic process,BP,
873,GO:0002149,1,0.993012904054279,0,1,hypochlorous acid biosynthetic process,BP,
874,GO:0002151,1,0.953780846917466,0,5,G-quadruplex RNA binding,MF,
875,GO:0002152,1,0.992882358566691,0,1,bile acid conjugation,BP,
876,GO:0002153,1,0.990505659286138,0,2,steroid receptor RNA activator RNA binding,MF,
877,GO:0002154,1,0.958576196569633,0,5,thyroid hormone mediated signaling pathway,BP,
878,GO:0002155,1,0.97901078193279,0,3,regulation of thyroid hormone mediated signaling pathway,BP,
879,GO:0002158,1,0.963458754532003,0,6,osteoclast proliferation,BP,
880,GO:0002159,1,0.967831747620742,0,4,desmosome assembly,BP,
881,GO:0002161,1,0.950013952191131,0,8,aminoacyl-tRNA editing activity,MF,
882,GO:0002162,1,0.925734684771212,0,9,dystroglycan binding,MF,
883,GO:0002169,1,0.986634701249976,0,2,3-methylcrotonyl-CoA carboxylase complex, mitochondrial,CC,
884,GO:0002174,1,0.99327483731023,0,1,mammary stem cell proliferation,BP,
885,GO:0002175,1,0.962115004594006,0,5,protein localization to paranode region of axon,BP,
886,GO:0002176,1,0.970832679080745,0,6,male germ cell proliferation,BP,
887,GO:0002177,1,0.949696196786491,0,8,manchette,CC,
888,GO:0002178,1,0.933827376428667,0,11,palmitoyltransferase complex,CC,
889,GO:0002181,1,0.600292989207065,0,96,cytoplasmic translation,BP,
890,GO:0002182,1,0.941341017514674,0,9,cytoplasmic translational elongation,BP,
891,GO:0002183,1,0.821489397898578,0,33,cytoplasmic translational initiation,BP,
892,GO:0002184,1,0.976393167375759,0,3,cytoplasmic translational termination,BP,
893,GO:0002188,1,0.973027964259818,0,3,translation reinitiation,BP,
894,GO:0002189,1,0.977840743446532,0,4,ribose phosphate diphosphokinase complex,CC,
895,GO:0002190,1,0.975911608986405,0,5,cap-independent translational initiation,BP,
896,GO:0002191,1,0.981871743593874,0,3,cap-dependent translational initiation,BP,
897,GO:0002192,1,0.992286823610893,0,2,IRES-dependent translational initiation of linear mRNA,BP,
898,GO:0002193,1,0.973984219135416,0,3,MAML1-RBP-Jkappa- ICN1 complex,CC,
899,GO:0002194,1,0.993139384115289,0,1,hepatocyte cell migration,BP,
900,GO:0002196,1,0.995073384453726,0,1,Ser-tRNA(Ala) hydrolase activity,MF,
901,GO:0002199,1,0.967267574594747,0,6,zona pellucida receptor complex,CC,
902,GO:0002200,1,0.637362903569062,0,64,somatic diversification of immune receptors,BP,
903,GO:0002204,1,0.752461138214034,0,43,somatic recombination of immunoglobulin genes involved in immune response,BP,
904,GO:0002208,1,0.752461138214034,0,43,somatic diversification of immunoglobulins involved in immune response,BP,
905,GO:0002209,1,0.76568729871713,0,40,behavioral defense response,BP,
906,GO:0002215,1,0.992847714373444,0,1,defense response to nematode,BP,
907,GO:0002218,1,0.461653633218096,0,124,activation of innate immune response,BP,
908,GO:0002220,1,0.546882899865957,0,100,innate immune response activating cell surface receptor signaling pathway,BP,
909,GO:0002221,1,0.307284971478807,0,176,pattern recognition receptor signaling pathway,BP,
910,GO:0002223,1,0.554486178564545,0,97,stimulatory C-type lectin receptor signaling pathway,BP,
911,GO:0002224,1,0.409927425711138,0,135,toll-like receptor signaling pathway,BP,
912,GO:0002225,1,0.990944954802597,0,2,positive regulation of antimicrobial peptide production,BP,
913,GO:0002227,1,0.954905130607329,0,12,innate immune response in mucosa,BP,
914,GO:0002228,1,0.722856322786979,0,56,natural killer cell mediated immunity,BP,
915,GO:0002230,1,0.860932740145105,0,23,positive regulation of defense response to virus by host,BP,
916,GO:0002232,1,0.969528779398124,0,6,leukocyte chemotaxis involved in inflammatory response,BP,
918,GO:0002238,1,0.973435407632641,0,4,response to molecule of fungal origin,BP,
920,GO:0002246,1,0.962093151495014,0,7,wound healing involved in inflammatory response,BP,
921,GO:0002248,1,0.966243173999622,0,6,connective tissue replacement involved in inflammatory response wound healing,BP,
922,GO:0002249,1,0.973647546550612,0,5,lymphocyte anergy,BP,
923,GO:0002250,1,0.108534877206409,0,360,adaptive immune response,BP,
924,GO:0002251,1,0.905941373709034,0,22,organ or tissue specific immune response,BP,
927,GO:0002254,1,0.98374369186974,0,3,kinin cascade,BP,
928,GO:0002260,1,0.683644751359332,0,59,lymphocyte homeostasis,BP,
929,GO:0002262,1,0.376265133131619,0,146,myeloid cell homeostasis,BP,
931,GO:0002265,1,0.962648886155691,0,4,astrocyte activation involved in immune response,BP,
932,GO:0002266,1,0.983971907199132,0,3,follicular dendritic cell activation,BP,
933,GO:0002268,1,0.988309283098232,0,2,follicular dendritic cell differentiation,BP,
934,GO:0002269,1,0.758749248327155,0,42,leukocyte activation involved in inflammatory response,BP,
935,GO:0002270,1,0.994888873460764,0,1,plasmacytoid dendritic cell activation,BP,
938,GO:0002276,1,0.985615049688658,0,2,basophil activation involved in immune response,BP,
939,GO:0002277,1,0.982597357677381,0,3,myeloid dendritic cell activation involved in immune response,BP,
940,GO:0002278,1,0.977972329441864,0,4,eosinophil activation involved in immune response,BP,
941,GO:0002279,1,0.757006026111264,0,44,mast cell activation involved in immune response,BP,
942,GO:0002280,1,0.98270831676025,0,2,monocyte activation involved in immune response,BP,
943,GO:0002281,1,0.917101714654254,0,14,macrophage activation involved in immune response,BP,
944,GO:0002282,1,0.981619357956797,0,4,microglial cell activation involved in immune response,BP,
946,GO:0002285,1,0.372259090708663,0,150,lymphocyte activation involved in immune response,BP,
947,GO:0002286,1,0.578456451733937,0,84,T cell activation involved in immune response,BP,
948,GO:0002287,1,0.68748057893416,0,56,alpha-beta T cell activation involved in immune response,BP,
949,GO:0002290,1,0.993359695814939,0,1,gamma-delta T cell activation involved in immune response,BP,
950,GO:0002291,1,0.943334411809766,0,10,T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
951,GO:0002292,1,0.656696331707424,0,63,T cell differentiation involved in immune response,BP,
952,GO:0002293,1,0.68748057893416,0,56,alpha-beta T cell differentiation involved in immune response,BP,
953,GO:0002294,1,0.691971216972268,0,55,CD4-positive, alpha-beta T cell differentiation involved in immune response,BP,
954,GO:0002295,1,0.911769996111279,0,14,T-helper cell lineage commitment,BP,
955,GO:0002296,1,0.971895342038972,0,3,T-helper 1 cell lineage commitment,BP,
956,GO:0002298,1,0.995495369367563,0,1,CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response,BP,
957,GO:0002299,1,0.995687044980245,0,1,alpha-beta intraepithelial T cell differentiation,BP,
958,GO:0002300,1,0.995687044980245,0,1,CD8-positive, alpha-beta intraepithelial T cell differentiation,BP,
959,GO:0002302,1,0.99353414212407,0,1,CD8-positive, alpha-beta T cell differentiation involved in immune response,BP,
960,GO:0002304,1,0.995687044980245,0,1,gamma-delta intraepithelial T cell differentiation,BP,
961,GO:0002305,1,0.995687044980245,0,1,CD8-positive, gamma-delta intraepithelial T cell differentiation,BP,
962,GO:0002309,1,0.976864063901307,0,4,T cell proliferation involved in immune response,BP,
963,GO:0002312,1,0.639259238160491,0,68,B cell activation involved in immune response,BP,
964,GO:0002313,1,0.886262176480247,0,19,mature B cell differentiation involved in immune response,BP,
965,GO:0002314,1,0.97238801605548,0,5,germinal center B cell differentiation,BP,
966,GO:0002315,1,0.931496788769393,0,9,marginal zone B cell differentiation,BP,
967,GO:0002316,1,0.988121552819583,0,2,follicular B cell differentiation,BP,
968,GO:0002317,1,0.987720092577295,0,3,plasma cell differentiation,BP,
969,GO:0002318,1,0.966159034228873,0,5,myeloid progenitor cell differentiation,BP,
970,GO:0002320,1,0.866590783962518,0,20,lymphoid progenitor cell differentiation,BP,
971,GO:0002322,1,0.959077928417406,0,6,B cell proliferation involved in immune response,BP,
972,GO:0002323,1,0.94889598528964,0,9,natural killer cell activation involved in immune response,BP,
973,GO:0002325,1,0.992147544897782,0,2,natural killer cell differentiation involved in immune response,BP,
974,GO:0002326,1,0.957621256185471,0,5,B cell lineage commitment,BP,
975,GO:0002327,1,0.922766282301846,0,9,immature B cell differentiation,BP,
976,GO:0002328,1,0.911838355248966,0,11,pro-B cell differentiation,BP,
977,GO:0002329,1,0.961412256202078,0,4,pre-B cell differentiation,BP,
978,GO:0002331,1,0.977546427715142,0,2,pre-B cell allelic exclusion,BP,
979,GO:0002332,1,0.991406817090502,0,1,transitional stage B cell differentiation,BP,
980,GO:0002333,1,0.991406817090502,0,1,transitional one stage B cell differentiation,BP,
981,GO:0002335,1,0.852102125350526,0,25,mature B cell differentiation,BP,
982,GO:0002336,1,0.992959140717592,0,1,B-1 B cell lineage commitment,BP,
983,GO:0002337,1,0.988725694203299,0,2,B-1a B cell differentiation,BP,
984,GO:0002339,1,0.985054749026211,0,3,B cell selection,BP,
985,GO:0002343,1,0.993703907679917,0,1,peripheral B cell selection,BP,
986,GO:0002344,1,0.993703907679917,0,1,B cell affinity maturation,BP,
987,GO:0002347,1,0.888279158114791,0,21,response to tumor cell,BP,
988,GO:0002349,1,0.96310603854001,0,7,histamine production involved in inflammatory response,BP,
989,GO:0002351,1,0.982435229180347,0,3,serotonin production involved in inflammatory response,BP,
990,GO:0002352,1,0.991296588678177,0,2,B cell negative selection,BP,
991,GO:0002353,1,0.98374369186974,0,3,plasma kallikrein-kinin cascade,BP,
992,GO:0002355,1,0.994051164549586,0,1,detection of tumor cell,BP,
993,GO:0002357,1,0.980981395281717,0,3,defense response to tumor cell,BP,
994,GO:0002358,1,0.996784759901968,0,1,B cell homeostatic proliferation,BP,
995,GO:0002360,1,0.846389544044017,0,24,T cell lineage commitment,BP,
996,GO:0002361,1,0.970405490467706,0,5,CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation,BP,
997,GO:0002362,1,0.986812913417827,0,2,CD4-positive, CD25-positive, alpha-beta regulatory T cell lineage commitment,BP,
998,GO:0002363,1,0.882910491437981,0,19,alpha-beta T cell lineage commitment,BP,
999,GO:0002364,1,0.992550844183453,0,1,NK T cell lineage commitment,BP,
1001,GO:0002367,1,0.558559638285725,0,95,cytokine production involved in immune response,BP,
1002,GO:0002368,1,0.987995368400136,0,2,B cell cytokine production,BP,
1003,GO:0002369,1,0.7933979721558,0,39,T cell cytokine production,BP,
1004,GO:0002370,1,0.960787619062014,0,8,natural killer cell cytokine production,BP,
1005,GO:0002371,1,0.905631710470418,0,13,dendritic cell cytokine production,BP,
1006,GO:0002372,1,0.951911749669543,0,6,myeloid dendritic cell cytokine production,BP,
1007,GO:0002373,1,0.996618572272435,0,1,plasmacytoid dendritic cell cytokine production,BP,
1008,GO:0002374,1,0.971256068509549,0,4,cytokine secretion involved in immune response,BP,
1010,GO:0002377,1,0.535752984214377,0,100,immunoglobulin production,BP,
1011,GO:0002378,1,0.973549732395065,0,4,immunoglobulin biosynthetic process,BP,
1012,GO:0002379,1,0.995531636571884,0,1,immunoglobulin biosynthetic process involved in immune response,BP,
1013,GO:0002380,1,0.992331695675178,0,1,immunoglobulin secretion involved in immune response,BP,
1014,GO:0002381,1,0.720814790147077,0,51,immunoglobulin production involved in immunoglobulin mediated immune response,BP,
1015,GO:0002383,1,0.995531636571884,0,1,immune response in brain or nervous system,BP,
1016,GO:0002384,1,0.988859894471713,0,2,hepatic immune response,BP,
1017,GO:0002385,1,0.920271892614991,0,19,mucosal immune response,BP,
1018,GO:0002386,1,0.987532562604292,0,2,immune response in mucosal-associated lymphoid tissue,BP,
1019,GO:0002396,1,0.968438785029447,0,7,MHC protein complex assembly,BP,
1020,GO:0002397,1,0.990292265368787,0,2,MHC class I protein complex assembly,BP,
1021,GO:0002398,1,0.992840527149174,0,1,MHC class Ib protein complex assembly,BP,
1022,GO:0002399,1,0.984987482880765,0,4,MHC class II protein complex assembly,BP,
1023,GO:0002407,1,0.869798950717092,0,23,dendritic cell chemotaxis,BP,
1024,GO:0002408,1,0.979863170878421,0,4,myeloid dendritic cell chemotaxis,BP,
1025,GO:0002413,1,0.995723275739318,0,1,tolerance induction to tumor cell,BP,
1026,GO:0002414,1,0.982921447027178,0,3,immunoglobulin transcytosis in epithelial cells,BP,
1027,GO:0002415,1,0.987532562604292,0,2,immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor,BP,
1028,GO:0002416,1,0.995331255060361,0,1,IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor,BP,
1029,GO:0002418,1,0.906248134725386,0,17,immune response to tumor cell,BP,
1030,GO:0002419,1,0.98573457044198,0,3,T cell mediated cytotoxicity directed against tumor cell target,BP,
1031,GO:0002420,1,0.962611979670234,0,6,natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1032,GO:0002423,1,0.958461140598381,0,7,natural killer cell mediated immune response to tumor cell,BP,
1033,GO:0002424,1,0.965765302372503,0,6,T cell mediated immune response to tumor cell,BP,
1034,GO:0002426,1,0.996225422430372,0,1,immunoglobulin production in mucosal tissue,BP,
1035,GO:0002428,1,0.972891983174593,0,6,antigen processing and presentation of peptide antigen via MHC class Ib,BP,
1037,GO:0002430,1,0.936265169900505,0,10,complement receptor mediated signaling pathway,BP,
1038,GO:0002431,1,0.578635184309953,0,81,Fc receptor mediated stimulatory signaling pathway,BP,
1039,GO:0002432,1,0.992386261422583,0,1,granuloma formation,BP,
1040,GO:0002433,1,0.599680583047322,0,75,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,BP,
1041,GO:0002434,1,0.978171732971817,0,4,immune complex clearance,BP,
1042,GO:0002436,1,0.984689125298498,0,3,immune complex clearance by monocytes and macrophages,BP,
1045,GO:0002439,1,0.981424602293227,0,4,chronic inflammatory response to antigenic stimulus,BP,
1046,GO:0002440,1,0.313820407514567,0,186,production of molecular mediator of immune response,BP,
1047,GO:0002441,1,0.96310603854001,0,7,histamine secretion involved in inflammatory response,BP,
1048,GO:0002442,1,0.982435229180347,0,3,serotonin secretion involved in inflammatory response,BP,
1051,GO:0002445,1,0.980134687356161,0,4,type II hypersensitivity,BP,
1053,GO:0002447,1,0.977972329441864,0,4,eosinophil mediated immunity,BP,
1054,GO:0002448,1,0.75300565147772,0,45,mast cell mediated immunity,BP,
1055,GO:0002449,1,0.257657392732928,0,224,lymphocyte mediated immunity,BP,
1056,GO:0002450,1,0.995611833164541,0,1,B cell antigen processing and presentation,BP,
1057,GO:0002451,1,0.995653890567335,0,1,peripheral B cell tolerance induction,BP,
1058,GO:0002455,1,0.786770485714891,0,41,humoral immune response mediated by circulating immunoglobulin,BP,
1059,GO:0002456,1,0.576601061880757,0,93,T cell mediated immunity,BP,
1060,GO:0002457,1,0.972210418843631,0,5,T cell antigen processing and presentation,BP,
1061,GO:0002458,1,0.988899052524298,0,2,peripheral T cell tolerance induction,BP,
1062,GO:0002460,1,0.233296806327076,0,234,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
1063,GO:0002461,1,0.974745143393972,0,5,tolerance induction dependent upon immune response,BP,
1064,GO:0002465,1,0.980389189717252,0,4,peripheral tolerance induction,BP,
1065,GO:0002467,1,0.903516850285694,0,15,germinal center formation,BP,
1066,GO:0002468,1,0.934502573794612,0,12,dendritic cell antigen processing and presentation,BP,
1067,GO:0002470,1,0.996293842301586,0,1,plasmacytoid dendritic cell antigen processing and presentation,BP,
1068,GO:0002472,1,0.992479366854662,0,1,macrophage antigen processing and presentation,BP,
1069,GO:0002474,1,0.610412314694214,0,93,antigen processing and presentation of peptide antigen via MHC class I,BP,
1070,GO:0002475,1,0.935466458229768,0,12,antigen processing and presentation via MHC class Ib,BP,
1071,GO:0002476,1,0.976255231277879,0,5,antigen processing and presentation of endogenous peptide antigen via MHC class Ib,BP,
1072,GO:0002477,1,0.988213239182262,0,3,antigen processing and presentation of exogenous peptide antigen via MHC class Ib,BP,
1074,GO:0002479,1,0.713695498624852,0,69,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,BP,
1075,GO:0002480,1,0.963937352860239,0,8,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent,BP,
1076,GO:0002481,1,0.996555779656062,0,1,antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent,BP,
1077,GO:0002483,1,0.912373949889906,0,16,antigen processing and presentation of endogenous peptide antigen,BP,
1078,GO:0002484,1,0.970929256670791,0,7,antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway,BP,
1079,GO:0002485,1,0.995704781268359,0,1,antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent,BP,
1080,GO:0002486,1,0.970929256670791,0,7,antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent,BP,
1081,GO:0002488,1,0.992604430620992,0,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway,BP,
1082,GO:0002489,1,0.992604430620992,0,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent,BP,
1084,GO:0002501,1,0.975424041373838,0,6,peptide antigen assembly with MHC protein complex,BP,
1085,GO:0002502,1,0.990292265368787,0,2,peptide antigen assembly with MHC class I protein complex,BP,
1086,GO:0002503,1,0.984987482880765,0,4,peptide antigen assembly with MHC class II protein complex,BP,
1088,GO:0002507,1,0.866833633733791,0,24,tolerance induction,BP,
1089,GO:0002508,1,0.988368601182363,0,2,central tolerance induction,BP,
1090,GO:0002509,1,0.99464899193912,0,1,central tolerance induction to self antigen,BP,
1091,GO:0002510,1,0.993686159997233,0,1,central B cell tolerance induction,BP,
1092,GO:0002513,1,0.968378311387923,0,5,tolerance induction to self antigen,BP,
1093,GO:0002514,1,0.981663893659055,0,3,B cell tolerance induction,BP,
1094,GO:0002517,1,0.933610818753918,0,12,T cell tolerance induction,BP,
1095,GO:0002518,1,0.996253231912534,0,1,lymphocyte chemotaxis across high endothelial venule,BP,
1096,GO:0002519,1,0.985293913757079,0,3,natural killer cell tolerance induction,BP,
1098,GO:0002521,1,0.0406962494845922,0,477,leukocyte differentiation,BP,
1099,GO:0002522,1,0.988670008587182,0,2,leukocyte migration involved in immune response,BP,
1100,GO:0002523,1,0.915377862466128,0,16,leukocyte migration involved in inflammatory response,BP,
1101,GO:0002524,1,0.947475744852816,0,10,hypersensitivity,BP,
1102,GO:0002525,1,0.983428881980083,0,3,acute inflammatory response to non-antigenic stimulus,BP,
1104,GO:0002528,1,0.971420795634091,0,4,regulation of vascular permeability involved in acute inflammatory response,BP,
1105,GO:0002532,1,0.671849670569972,0,63,production of molecular mediator involved in inflammatory response,BP,
1106,GO:0002534,1,0.75295742151994,0,43,cytokine production involved in inflammatory response,BP,
1107,GO:0002536,1,0.970634087445963,0,6,respiratory burst involved in inflammatory response,BP,
1108,GO:0002537,1,0.9812026969381,0,2,nitric oxide production involved in inflammatory response,BP,
1109,GO:0002538,1,0.986915293384712,0,2,arachidonic acid metabolite production involved in inflammatory response,BP,
1110,GO:0002540,1,0.986915293384712,0,2,leukotriene production involved in inflammatory response,BP,
1111,GO:0002541,1,0.983410750363318,0,3,activation of plasma proteins involved in acute inflammatory response,BP,
1112,GO:0002542,1,0.989161153261216,0,2,Factor XII activation,BP,
1113,GO:0002543,1,0.986357862806811,0,2,activation of blood coagulation via clotting cascade,BP,
1114,GO:0002544,1,0.910287442926108,0,17,chronic inflammatory response,BP,
1115,GO:0002545,1,0.995105241891251,0,1,chronic inflammatory response to non-antigenic stimulus,BP,
1116,GO:0002548,1,0.795009316320144,0,46,monocyte chemotaxis,BP,
1117,GO:0002551,1,0.941151517231302,0,10,mast cell chemotaxis,BP,
1118,GO:0002553,1,0.96310603854001,0,7,histamine secretion by mast cell,BP,
1119,GO:0002554,1,0.982435229180347,0,3,serotonin secretion by platelet,BP,
1120,GO:0002560,1,0.992521808800393,0,1,basophil mediated immunity,BP,
1121,GO:0002561,1,0.992521808800393,0,1,basophil degranulation,BP,
1122,GO:0002562,1,0.677660534481485,0,56,somatic diversification of immune receptors via germline recombination within a single locus,BP,
1123,GO:0002566,1,0.905368166483297,0,14,somatic diversification of immune receptors via somatic mutation,BP,
1124,GO:0002568,1,0.954285043227935,0,5,somatic diversification of T cell receptor genes,BP,
1125,GO:0002572,1,0.985819954965624,0,2,pro-T cell differentiation,BP,
1126,GO:0002573,1,0.291433653785717,0,187,myeloid leukocyte differentiation,BP,
1128,GO:0002577,1,0.895361536559428,0,20,regulation of antigen processing and presentation,BP,
1129,GO:0002578,1,0.94812882228803,0,9,negative regulation of antigen processing and presentation,BP,
1130,GO:0002579,1,0.955636029265116,0,9,positive regulation of antigen processing and presentation,BP,
1131,GO:0002580,1,0.973515968303415,0,5,regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1132,GO:0002581,1,0.980227994556455,0,3,negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1133,GO:0002582,1,0.993153953134507,0,2,positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1134,GO:0002583,1,0.972510000204265,0,6,regulation of antigen processing and presentation of peptide antigen,BP,
1135,GO:0002584,1,0.979215161630429,0,4,negative regulation of antigen processing and presentation of peptide antigen,BP,
1136,GO:0002585,1,0.993153953134507,0,2,positive regulation of antigen processing and presentation of peptide antigen,BP,
1137,GO:0002586,1,0.982104763245118,0,4,regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
1138,GO:0002587,1,0.98887540801683,0,2,negative regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
1139,GO:0002588,1,0.993153953134507,0,2,positive regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
1140,GO:0002589,1,0.990232167541919,0,2,regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,
1141,GO:0002590,1,0.990232167541919,0,2,negative regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,
1142,GO:0002604,1,0.937981108280071,0,11,regulation of dendritic cell antigen processing and presentation,BP,
1143,GO:0002605,1,0.974812902935852,0,4,negative regulation of dendritic cell antigen processing and presentation,BP,
1144,GO:0002606,1,0.962226010833999,0,7,positive regulation of dendritic cell antigen processing and presentation,BP,
1145,GO:0002616,1,0.992479366854662,0,1,regulation of macrophage antigen processing and presentation,BP,
1146,GO:0002617,1,0.992479366854662,0,1,negative regulation of macrophage antigen processing and presentation,BP,
1147,GO:0002622,1,0.995611833164541,0,1,regulation of B cell antigen processing and presentation,BP,
1148,GO:0002625,1,0.990200104878853,0,2,regulation of T cell antigen processing and presentation,BP,
1149,GO:0002626,1,0.994981019878227,0,1,negative regulation of T cell antigen processing and presentation,BP,
1150,GO:0002634,1,0.940056269432926,0,9,regulation of germinal center formation,BP,
1151,GO:0002635,1,0.980692011496798,0,2,negative regulation of germinal center formation,BP,
1152,GO:0002636,1,0.988686400475704,0,3,positive regulation of germinal center formation,BP,
1153,GO:0002637,1,0.709394986712801,0,56,regulation of immunoglobulin production,BP,
1154,GO:0002638,1,0.921131445291324,0,12,negative regulation of immunoglobulin production,BP,
1155,GO:0002639,1,0.813010961711017,0,35,positive regulation of immunoglobulin production,BP,
1156,GO:0002640,1,0.993485400251684,0,1,regulation of immunoglobulin biosynthetic process,BP,
1157,GO:0002642,1,0.993485400251684,0,1,positive regulation of immunoglobulin biosynthetic process,BP,
1158,GO:0002643,1,0.90772033119647,0,16,regulation of tolerance induction,BP,
1159,GO:0002644,1,0.994655908091938,0,1,negative regulation of tolerance induction,BP,
1160,GO:0002645,1,0.946631050733432,0,9,positive regulation of tolerance induction,BP,
1161,GO:0002646,1,0.993686159997233,0,1,regulation of central tolerance induction,BP,
1162,GO:0002648,1,0.993686159997233,0,1,positive regulation of central tolerance induction,BP,
1163,GO:0002649,1,0.992214717025153,0,1,regulation of tolerance induction to self antigen,BP,
1164,GO:0002651,1,0.992214717025153,0,1,positive regulation of tolerance induction to self antigen,BP,
1165,GO:0002652,1,0.984268554787757,0,3,regulation of tolerance induction dependent upon immune response,BP,
1166,GO:0002654,1,0.989967187809642,0,2,positive regulation of tolerance induction dependent upon immune response,BP,
1167,GO:0002658,1,0.989967187809642,0,2,regulation of peripheral tolerance induction,BP,
1168,GO:0002660,1,0.989967187809642,0,2,positive regulation of peripheral tolerance induction,BP,
1169,GO:0002661,1,0.98594954415469,0,2,regulation of B cell tolerance induction,BP,
1170,GO:0002663,1,0.98594954415469,0,2,positive regulation of B cell tolerance induction,BP,
1171,GO:0002664,1,0.944611739742898,0,10,regulation of T cell tolerance induction,BP,
1172,GO:0002666,1,0.967246524946819,0,6,positive regulation of T cell tolerance induction,BP,
1173,GO:0002667,1,0.973647546550612,0,5,regulation of T cell anergy,BP,
1174,GO:0002669,1,0.990007006273175,0,2,positive regulation of T cell anergy,BP,
1176,GO:0002674,1,0.943958007464002,0,9,negative regulation of acute inflammatory response,BP,
1178,GO:0002676,1,0.95751463779979,0,8,regulation of chronic inflammatory response,BP,
1179,GO:0002677,1,0.974757891064201,0,4,negative regulation of chronic inflammatory response,BP,
1180,GO:0002678,1,0.982314708454485,0,4,positive regulation of chronic inflammatory response,BP,
1181,GO:0002679,1,0.942588254103244,0,10,respiratory burst involved in defense response,BP,
1182,GO:0002681,1,0.954285043227935,0,5,somatic recombination of T cell receptor gene segments,BP,
1186,GO:0002685,1,0.322124764243696,0,190,regulation of leukocyte migration,BP,
1187,GO:0002686,1,0.775207725460602,0,42,negative regulation of leukocyte migration,BP,
1188,GO:0002687,1,0.472501949273525,0,128,positive regulation of leukocyte migration,BP,
1189,GO:0002688,1,0.533404079430415,0,109,regulation of leukocyte chemotaxis,BP,
1190,GO:0002689,1,0.91145490829194,0,16,negative regulation of leukocyte chemotaxis,BP,
1191,GO:0002690,1,0.611555475569884,0,86,positive regulation of leukocyte chemotaxis,BP,
1192,GO:0002691,1,0.821864904794256,0,30,regulation of cellular extravasation,BP,
1193,GO:0002692,1,0.944839221450912,0,9,negative regulation of cellular extravasation,BP,
1194,GO:0002693,1,0.890812571594301,0,18,positive regulation of cellular extravasation,BP,
1198,GO:0002697,1,0.111598888180355,0,348,regulation of immune effector process,BP,
1199,GO:0002698,1,0.504879456498738,0,108,negative regulation of immune effector process,BP,
1200,GO:0002699,1,0.304663137066685,0,193,positive regulation of immune effector process,BP,
1201,GO:0002700,1,0.462335127184374,0,125,regulation of production of molecular mediator of immune response,BP,
1202,GO:0002701,1,0.820594038329808,0,32,negative regulation of production of molecular mediator of immune response,BP,
1203,GO:0002702,1,0.589534899613464,0,87,positive regulation of production of molecular mediator of immune response,BP,
1204,GO:0002703,1,0.32138468478289,0,186,regulation of leukocyte mediated immunity,BP,
1205,GO:0002704,1,0.757357597096975,0,48,negative regulation of leukocyte mediated immunity,BP,
1206,GO:0002705,1,0.486267948002221,0,119,positive regulation of leukocyte mediated immunity,BP,
1207,GO:0002706,1,0.459788797204548,0,131,regulation of lymphocyte mediated immunity,BP,
1208,GO:0002707,1,0.806310913781706,0,38,negative regulation of lymphocyte mediated immunity,BP,
1209,GO:0002708,1,0.594020827754273,0,88,positive regulation of lymphocyte mediated immunity,BP,
1210,GO:0002709,1,0.690287718466775,0,65,regulation of T cell mediated immunity,BP,
1211,GO:0002710,1,0.912453052063894,0,17,negative regulation of T cell mediated immunity,BP,
1212,GO:0002711,1,0.775717349269806,0,44,positive regulation of T cell mediated immunity,BP,
1213,GO:0002712,1,0.755003084405587,0,45,regulation of B cell mediated immunity,BP,
1214,GO:0002713,1,0.931858472769328,0,11,negative regulation of B cell mediated immunity,BP,
1215,GO:0002714,1,0.833137151639936,0,30,positive regulation of B cell mediated immunity,BP,
1216,GO:0002715,1,0.804073616068544,0,38,regulation of natural killer cell mediated immunity,BP,
1217,GO:0002716,1,0.91830610334547,0,16,negative regulation of natural killer cell mediated immunity,BP,
1218,GO:0002717,1,0.870143876248356,0,24,positive regulation of natural killer cell mediated immunity,BP,
1219,GO:0002718,1,0.625799604035062,0,77,regulation of cytokine production involved in immune response,BP,
1220,GO:0002719,1,0.885838427106169,0,21,negative regulation of cytokine production involved in immune response,BP,
1221,GO:0002720,1,0.722998312817099,0,53,positive regulation of cytokine production involved in immune response,BP,
1222,GO:0002721,1,0.993703907679917,0,1,regulation of B cell cytokine production,BP,
1223,GO:0002724,1,0.839287504297898,0,30,regulation of T cell cytokine production,BP,
1224,GO:0002725,1,0.964871316403475,0,7,negative regulation of T cell cytokine production,BP,
1225,GO:0002726,1,0.887507728052631,0,20,positive regulation of T cell cytokine production,BP,
1226,GO:0002727,1,0.960787619062014,0,8,regulation of natural killer cell cytokine production,BP,
1227,GO:0002728,1,0.988512018903625,0,2,negative regulation of natural killer cell cytokine production,BP,
1228,GO:0002729,1,0.968192787626307,0,7,positive regulation of natural killer cell cytokine production,BP,
1229,GO:0002730,1,0.913122896799219,0,12,regulation of dendritic cell cytokine production,BP,
1230,GO:0002731,1,0.988219055846674,0,2,negative regulation of dendritic cell cytokine production,BP,
1231,GO:0002732,1,0.938455824369104,0,8,positive regulation of dendritic cell cytokine production,BP,
1232,GO:0002733,1,0.951911749669543,0,6,regulation of myeloid dendritic cell cytokine production,BP,
1233,GO:0002735,1,0.951911749669543,0,6,positive regulation of myeloid dendritic cell cytokine production,BP,
1234,GO:0002736,1,0.996618572272435,0,1,regulation of plasmacytoid dendritic cell cytokine production,BP,
1235,GO:0002737,1,0.996618572272435,0,1,negative regulation of plasmacytoid dendritic cell cytokine production,BP,
1236,GO:0002752,1,0.990935594475129,0,2,cell surface pattern recognition receptor signaling pathway,BP,
1237,GO:0002753,1,0.666393468517365,0,59,cytoplasmic pattern recognition receptor signaling pathway,BP,
1238,GO:0002755,1,0.792503800697947,0,35,MyD88-dependent toll-like receptor signaling pathway,BP,
1239,GO:0002756,1,0.818942769727662,0,32,MyD88-independent toll-like receptor signaling pathway,BP,
1241,GO:0002758,1,0.543890524938649,0,101,innate immune response-activating signal transduction,BP,
1242,GO:0002759,1,0.979034429222989,0,4,regulation of antimicrobial humoral response,BP,
1243,GO:0002760,1,0.990944954802597,0,2,positive regulation of antimicrobial humoral response,BP,
1244,GO:0002761,1,0.501180255915329,0,104,regulation of myeloid leukocyte differentiation,BP,
1245,GO:0002762,1,0.739605687546746,0,44,negative regulation of myeloid leukocyte differentiation,BP,
1246,GO:0002763,1,0.728724628791895,0,49,positive regulation of myeloid leukocyte differentiation,BP,
1248,GO:0002765,1,0.957364577630413,0,8,immune response-inhibiting signal transduction,BP,
1249,GO:0002767,1,0.966108046373117,0,6,immune response-inhibiting cell surface receptor signaling pathway,BP,
1251,GO:0002769,1,0.990214160761199,0,2,natural killer cell inhibitory signaling pathway,BP,
1252,GO:0002774,1,0.979917716600217,0,3,Fc receptor mediated inhibitory signaling pathway,BP,
1253,GO:0002775,1,0.980466964865474,0,4,antimicrobial peptide production,BP,
1254,GO:0002777,1,0.996639722642843,0,1,antimicrobial peptide biosynthetic process,BP,
1255,GO:0002778,1,0.980466964865474,0,4,antibacterial peptide production,BP,
1256,GO:0002780,1,0.996639722642843,0,1,antibacterial peptide biosynthetic process,BP,
1257,GO:0002784,1,0.983773257786317,0,3,regulation of antimicrobial peptide production,BP,
1258,GO:0002785,1,0.992763426152033,0,1,negative regulation of antimicrobial peptide production,BP,
1259,GO:0002786,1,0.983773257786317,0,3,regulation of antibacterial peptide production,BP,
1260,GO:0002787,1,0.992763426152033,0,1,negative regulation of antibacterial peptide production,BP,
1265,GO:0002803,1,0.990944954802597,0,2,positive regulation of antibacterial peptide production,BP,
1266,GO:0002812,1,0.996639722642843,0,1,biosynthetic process of antibacterial peptides active against Gram-negative bacteria,BP,
1267,GO:0002819,1,0.409662333243064,0,148,regulation of adaptive immune response,BP,
1268,GO:0002820,1,0.765805135518531,0,43,negative regulation of adaptive immune response,BP,
1269,GO:0002821,1,0.578802942405307,0,93,positive regulation of adaptive immune response,BP,
1270,GO:0002822,1,0.447758444016134,0,133,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
1271,GO:0002823,1,0.786833437666233,0,38,negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
1272,GO:0002824,1,0.596865578281963,0,88,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
1273,GO:0002825,1,0.870231525103745,0,24,regulation of T-helper 1 type immune response,BP,
1274,GO:0002826,1,0.957761924111084,0,7,negative regulation of T-helper 1 type immune response,BP,
1275,GO:0002827,1,0.908417561889048,0,17,positive regulation of T-helper 1 type immune response,BP,
1276,GO:0002828,1,0.848403628468524,0,28,regulation of type 2 immune response,BP,
1277,GO:0002829,1,0.934359118305535,0,11,negative regulation of type 2 immune response,BP,
1278,GO:0002830,1,0.912675376973106,0,16,positive regulation of type 2 immune response,BP,
1279,GO:0002831,1,0.108839234546741,0,350,regulation of response to biotic stimulus,BP,
1280,GO:0002832,1,0.594210266700759,0,83,negative regulation of response to biotic stimulus,BP,
1281,GO:0002833,1,0.262354576639325,0,213,positive regulation of response to biotic stimulus,BP,
1282,GO:0002834,1,0.925652024825371,0,13,regulation of response to tumor cell,BP,
1283,GO:0002835,1,0.987141494675773,0,2,negative regulation of response to tumor cell,BP,
1284,GO:0002836,1,0.9444426210063,0,10,positive regulation of response to tumor cell,BP,
1285,GO:0002837,1,0.925652024825371,0,13,regulation of immune response to tumor cell,BP,
1286,GO:0002838,1,0.987141494675773,0,2,negative regulation of immune response to tumor cell,BP,
1287,GO:0002839,1,0.9444426210063,0,10,positive regulation of immune response to tumor cell,BP,
1288,GO:0002840,1,0.969932646940129,0,5,regulation of T cell mediated immune response to tumor cell,BP,
1289,GO:0002842,1,0.976886576974783,0,4,positive regulation of T cell mediated immune response to tumor cell,BP,
1290,GO:0002843,1,0.995723275739318,0,1,regulation of tolerance induction to tumor cell,BP,
1291,GO:0002845,1,0.995723275739318,0,1,positive regulation of tolerance induction to tumor cell,BP,
1292,GO:0002849,1,0.994219436690182,0,1,regulation of peripheral T cell tolerance induction,BP,
1293,GO:0002851,1,0.994219436690182,0,1,positive regulation of peripheral T cell tolerance induction,BP,
1294,GO:0002852,1,0.989987210179867,0,2,regulation of T cell mediated cytotoxicity directed against tumor cell target,BP,
1295,GO:0002854,1,0.989987210179867,0,2,positive regulation of T cell mediated cytotoxicity directed against tumor cell target,BP,
1296,GO:0002855,1,0.958461140598381,0,7,regulation of natural killer cell mediated immune response to tumor cell,BP,
1297,GO:0002856,1,0.987141494675773,0,2,negative regulation of natural killer cell mediated immune response to tumor cell,BP,
1298,GO:0002857,1,0.970949762223362,0,5,positive regulation of natural killer cell mediated immune response to tumor cell,BP,
1299,GO:0002858,1,0.962611979670234,0,6,regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1300,GO:0002859,1,0.987141494675773,0,2,negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1301,GO:0002860,1,0.975154139790692,0,4,positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1303,GO:0002862,1,0.948682123451219,0,11,negative regulation of inflammatory response to antigenic stimulus,BP,
1306,GO:0002865,1,0.97880907562769,0,4,negative regulation of acute inflammatory response to antigenic stimulus,BP,
1308,GO:0002870,1,0.973647546550612,0,5,T cell anergy,BP,
1309,GO:0002874,1,0.987049850574102,0,3,regulation of chronic inflammatory response to antigenic stimulus,BP,
1310,GO:0002875,1,0.995571065959689,0,1,negative regulation of chronic inflammatory response to antigenic stimulus,BP,
1311,GO:0002876,1,0.991441256313843,0,2,positive regulation of chronic inflammatory response to antigenic stimulus,BP,
1312,GO:0002877,1,0.983428881980083,0,3,regulation of acute inflammatory response to non-antigenic stimulus,BP,
1313,GO:0002878,1,0.993052350907243,0,1,negative regulation of acute inflammatory response to non-antigenic stimulus,BP,
1314,GO:0002879,1,0.99030987575804,0,2,positive regulation of acute inflammatory response to non-antigenic stimulus,BP,
1315,GO:0002880,1,0.995105241891251,0,1,regulation of chronic inflammatory response to non-antigenic stimulus,BP,
1316,GO:0002882,1,0.995105241891251,0,1,positive regulation of chronic inflammatory response to non-antigenic stimulus,BP,
1317,GO:0002883,1,0.95402267790602,0,9,regulation of hypersensitivity,BP,
1318,GO:0002884,1,0.99042674000057,0,2,negative regulation of hypersensitivity,BP,
1319,GO:0002885,1,0.968988720665988,0,6,positive regulation of hypersensitivity,BP,
1320,GO:0002886,1,0.711555806767005,0,55,regulation of myeloid leukocyte mediated immunity,BP,
1321,GO:0002887,1,0.942179451691257,0,10,negative regulation of myeloid leukocyte mediated immunity,BP,
1322,GO:0002888,1,0.819271871438517,0,32,positive regulation of myeloid leukocyte mediated immunity,BP,
1323,GO:0002889,1,0.755003084405587,0,45,regulation of immunoglobulin mediated immune response,BP,
1324,GO:0002890,1,0.931858472769328,0,11,negative regulation of immunoglobulin mediated immune response,BP,
1325,GO:0002891,1,0.833137151639936,0,30,positive regulation of immunoglobulin mediated immune response,BP,
1326,GO:0002892,1,0.980134687356161,0,4,regulation of type II hypersensitivity,BP,
1327,GO:0002893,1,0.995611833164541,0,1,negative regulation of type II hypersensitivity,BP,
1328,GO:0002894,1,0.98445531849273,0,3,positive regulation of type II hypersensitivity,BP,
1329,GO:0002895,1,0.993686159997233,0,1,regulation of central B cell tolerance induction,BP,
1330,GO:0002897,1,0.993686159997233,0,1,positive regulation of central B cell tolerance induction,BP,
1331,GO:0002901,1,0.982132214147634,0,4,mature B cell apoptotic process,BP,
1332,GO:0002902,1,0.89393140255993,0,18,regulation of B cell apoptotic process,BP,
1333,GO:0002903,1,0.935257370689625,0,11,negative regulation of B cell apoptotic process,BP,
1334,GO:0002904,1,0.98300891640832,0,3,positive regulation of B cell apoptotic process,BP,
1335,GO:0002905,1,0.982132214147634,0,4,regulation of mature B cell apoptotic process,BP,
1336,GO:0002906,1,0.982132214147634,0,4,negative regulation of mature B cell apoptotic process,BP,
1337,GO:0002911,1,0.973647546550612,0,5,regulation of lymphocyte anergy,BP,
1338,GO:0002913,1,0.990007006273175,0,2,positive regulation of lymphocyte anergy,BP,
1339,GO:0002920,1,0.713527090945332,0,57,regulation of humoral immune response,BP,
1340,GO:0002921,1,0.922391143284036,0,12,negative regulation of humoral immune response,BP,
1341,GO:0002922,1,0.929537356823278,0,14,positive regulation of humoral immune response,BP,
1342,GO:0002923,1,0.937387958484083,0,11,regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1343,GO:0002924,1,0.961676459532185,0,6,negative regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1344,GO:0002925,1,0.974753335407177,0,5,positive regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1345,GO:0002926,1,0.993009229448717,0,1,tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation,BP,
1346,GO:0002930,1,0.986794726865669,0,2,trabecular meshwork development,BP,
1348,GO:0002933,1,0.979817276199202,0,4,lipid hydroxylation,BP,
1349,GO:0002934,1,0.929668629959357,0,9,desmosome organization,BP,
1350,GO:0002939,1,0.985261049864631,0,2,tRNA N1-guanine methylation,BP,
1351,GO:0002940,1,0.988024967809154,0,2,tRNA N2-guanine methylation,BP,
1352,GO:0002941,1,0.995506018227838,0,1,synoviocyte proliferation,BP,
1353,GO:0002943,1,0.978511296206146,0,4,tRNA dihydrouridine synthesis,BP,
1354,GO:0002944,1,0.983512481509861,0,2,cyclin K-CDK12 complex,CC,
1355,GO:0002945,1,0.984691515443641,0,2,cyclin K-CDK13 complex,CC,
1356,GO:0002946,1,0.989956451213638,0,2,tRNA C5-cytosine methylation,BP,
1357,GO:0002947,1,0.977550554099133,0,4,tumor necrosis factor receptor superfamily complex,CC,
1358,GO:0002949,1,0.986864697719472,0,3,tRNA threonylcarbamoyladenosine modification,BP,
1359,GO:0002950,1,0.979595389389854,0,3,ceramide phosphoethanolamine synthase activity,MF,
1360,GO:0002951,1,0.98811293629638,0,2,leukotriene-C(4) hydrolase,MF,
1361,GO:0002953,1,0.995593670005361,0,1,5'-deoxynucleotidase activity,MF,
1367,GO:0003010,1,0.967420922468494,0,5,voluntary skeletal muscle contraction,BP,
1368,GO:0003011,1,0.98174919826028,0,3,involuntary skeletal muscle contraction,BP,
1372,GO:0003015,1,0.147724338262584,0,270,heart process,BP,
1373,GO:0003016,1,0.81418369969446,0,31,respiratory system process,BP,
1374,GO:0003017,1,0.974429103044309,0,2,lymph circulation,BP,
1376,GO:0003025,1,0.975224993565449,0,3,regulation of systemic arterial blood pressure by baroreceptor feedback,BP,
1377,GO:0003026,1,0.993485400251684,0,1,regulation of systemic arterial blood pressure by aortic arch baroreceptor feedback,BP,
1378,GO:0003027,1,0.995446197891458,0,1,regulation of systemic arterial blood pressure by carotid body chemoreceptor signaling,BP,
1379,GO:0003029,1,0.995446197891458,0,1,detection of hypoxic conditions in blood by carotid body chemoreceptor signaling,BP,
1380,GO:0003032,1,0.987451005997613,0,2,detection of oxygen,BP,
1381,GO:0003044,1,0.783019923492259,0,41,regulation of systemic arterial blood pressure mediated by a chemical signal,BP,
1382,GO:0003050,1,0.99199129610752,0,1,regulation of systemic arterial blood pressure by atrial natriuretic peptide,BP,
1383,GO:0003051,1,0.986655903402722,0,2,angiotensin-mediated drinking behavior,BP,
1385,GO:0003057,1,0.972002159003685,0,5,regulation of the force of heart contraction by chemical signal,BP,
1386,GO:0003058,1,0.996195924714731,0,1,hormonal regulation of the force of heart contraction,BP,
1387,GO:0003062,1,0.957812886275867,0,6,regulation of heart rate by chemical signal,BP,
1388,GO:0003064,1,0.988247974943382,0,2,regulation of heart rate by hormone,BP,
1389,GO:0003065,1,0.995280089214531,0,1,positive regulation of heart rate by epinephrine,BP,
1390,GO:0003068,1,0.996504261929267,0,1,regulation of systemic arterial blood pressure by acetylcholine,BP,
1391,GO:0003069,1,0.996504261929267,0,1,acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,
1392,GO:0003070,1,0.996504261929267,0,1,regulation of systemic arterial blood pressure by neurotransmitter,BP,
1393,GO:0003071,1,0.88998671161961,0,19,renal system process involved in regulation of systemic arterial blood pressure,BP,
1394,GO:0003072,1,0.977588504817047,0,4,renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure,BP,
1395,GO:0003073,1,0.61246625385733,0,78,regulation of systemic arterial blood pressure,BP,
1396,GO:0003081,1,0.890590776376929,0,20,regulation of systemic arterial blood pressure by renin-angiotensin,BP,
1397,GO:0003083,1,0.996937301888134,0,1,negative regulation of renal output by angiotensin,BP,
1398,GO:0003084,1,0.940589887766783,0,11,positive regulation of systemic arterial blood pressure,BP,
1399,GO:0003085,1,0.901631405054731,0,17,negative regulation of systemic arterial blood pressure,BP,
1401,GO:0003093,1,0.935965337808417,0,10,regulation of glomerular filtration,BP,
1402,GO:0003094,1,0.881054452921345,0,18,glomerular filtration,BP,
1403,GO:0003095,1,0.995385479573933,0,1,pressure natriuresis,BP,
1404,GO:0003096,1,0.961914424535294,0,6,renal sodium ion transport,BP,
1405,GO:0003097,1,0.969556054403913,0,5,renal water transport,BP,
1406,GO:0003099,1,0.984162017262608,0,3,positive regulation of the force of heart contraction by chemical signal,BP,
1407,GO:0003100,1,0.965972680659464,0,6,regulation of systemic arterial blood pressure by endothelin,BP,
1408,GO:0003104,1,0.973931784415182,0,4,positive regulation of glomerular filtration,BP,
1409,GO:0003105,1,0.982341530541112,0,3,negative regulation of glomerular filtration,BP,
1410,GO:0003106,1,0.996937301888134,0,1,negative regulation of glomerular filtration by angiotensin,BP,
1411,GO:0003127,1,0.980474566780548,0,2,detection of nodal flow,BP,
1412,GO:0003128,1,0.891266103971367,0,16,heart field specification,BP,
1413,GO:0003129,1,0.942427602287857,0,9,heart induction,BP,
1414,GO:0003130,1,0.988395998422978,0,2,BMP signaling pathway involved in heart induction,BP,
1415,GO:0003131,1,0.993404800891667,0,1,mesodermal-endodermal cell signaling,BP,
1416,GO:0003133,1,0.988395998422978,0,2,endodermal-mesodermal cell signaling,BP,
1417,GO:0003134,1,0.988395998422978,0,2,endodermal-mesodermal cell signaling involved in heart induction,BP,
1418,GO:0003137,1,0.97136385421617,0,4,Notch signaling pathway involved in heart induction,BP,
1419,GO:0003138,1,0.977233729514835,0,3,primary heart field specification,BP,
1420,GO:0003139,1,0.924957413383232,0,11,secondary heart field specification,BP,
1421,GO:0003140,1,0.952879627780353,0,8,determination of left/right asymmetry in lateral mesoderm,BP,
1422,GO:0003142,1,0.994198568848389,0,1,cardiogenic plate morphogenesis,BP,
1423,GO:0003143,1,0.623162378272242,0,66,embryonic heart tube morphogenesis,BP,
1424,GO:0003147,1,0.996472742840655,0,1,neural crest cell migration involved in heart formation,BP,
1425,GO:0003148,1,0.814642572843329,0,27,outflow tract septum morphogenesis,BP,
1426,GO:0003149,1,0.943435137720959,0,9,membranous septum morphogenesis,BP,
1427,GO:0003150,1,0.963868538480674,0,5,muscular septum morphogenesis,BP,
1429,GO:0003156,1,0.792760623393202,0,36,regulation of animal organ formation,BP,
1430,GO:0003157,1,0.923900781446905,0,11,endocardium development,BP,
1432,GO:0003159,1,0.893799599738141,0,18,morphogenesis of an endothelium,BP,
1433,GO:0003160,1,0.961523868481468,0,6,endocardium morphogenesis,BP,
1434,GO:0003161,1,0.919352302968313,0,12,cardiac conduction system development,BP,
1435,GO:0003162,1,0.974821825778513,0,3,atrioventricular node development,BP,
1436,GO:0003163,1,0.980143894968665,0,3,sinoatrial node development,BP,
1437,GO:0003164,1,0.967760065825124,0,5,His-Purkinje system development,BP,
1438,GO:0003165,1,0.986457094675666,0,2,Purkinje myocyte development,BP,
1439,GO:0003166,1,0.976171847615037,0,4,bundle of His development,BP,
1440,GO:0003167,1,0.99214843558072,0,1,atrioventricular bundle cell differentiation,BP,
1441,GO:0003168,1,0.995029744833407,0,1,Purkinje myocyte differentiation,BP,
1442,GO:0003169,1,0.981174644520658,0,2,coronary vein morphogenesis,BP,
1443,GO:0003170,1,0.633470846348562,0,58,heart valve development,BP,
1444,GO:0003171,1,0.825051780848248,0,24,atrioventricular valve development,BP,
1445,GO:0003172,1,0.990817241984393,0,1,sinoatrial valve development,BP,
1446,GO:0003174,1,0.920111279136319,0,10,mitral valve development,BP,
1447,GO:0003175,1,0.954220603125699,0,6,tricuspid valve development,BP,
1448,GO:0003176,1,0.792307495248319,0,32,aortic valve development,BP,
1449,GO:0003177,1,0.853799398540818,0,20,pulmonary valve development,BP,
1450,GO:0003178,1,0.988259126454876,0,1,coronary sinus valve development,BP,
1451,GO:0003179,1,0.677394515397738,0,49,heart valve morphogenesis,BP,
1452,GO:0003180,1,0.818658402025754,0,28,aortic valve morphogenesis,BP,
1453,GO:0003181,1,0.828686440296295,0,23,atrioventricular valve morphogenesis,BP,
1454,GO:0003182,1,0.988259126454876,0,1,coronary sinus valve morphogenesis,BP,
1455,GO:0003183,1,0.920111279136319,0,10,mitral valve morphogenesis,BP,
1456,GO:0003184,1,0.882173878192101,0,16,pulmonary valve morphogenesis,BP,
1457,GO:0003185,1,0.990817241984393,0,1,sinoatrial valve morphogenesis,BP,
1458,GO:0003186,1,0.958418170430874,0,5,tricuspid valve morphogenesis,BP,
1459,GO:0003188,1,0.915604347270226,0,12,heart valve formation,BP,
1460,GO:0003190,1,0.934608245109556,0,8,atrioventricular valve formation,BP,
1461,GO:0003192,1,0.968686860705697,0,3,mitral valve formation,BP,
1462,GO:0003193,1,0.995622174644115,0,1,pulmonary valve formation,BP,
1463,GO:0003195,1,0.986671172615709,0,2,tricuspid valve formation,BP,
1464,GO:0003197,1,0.718835336755319,0,45,endocardial cushion development,BP,
1465,GO:0003198,1,0.890484405385043,0,17,epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
1466,GO:0003199,1,0.984958787793694,0,3,endocardial cushion to mesenchymal transition involved in heart valve formation,BP,
1467,GO:0003203,1,0.776210892105303,0,35,endocardial cushion morphogenesis,BP,
1470,GO:0003207,1,0.92480214636518,0,11,cardiac chamber formation,BP,
1472,GO:0003209,1,0.815824939919224,0,26,cardiac atrium morphogenesis,BP,
1473,GO:0003210,1,0.996316852701051,0,1,cardiac atrium formation,BP,
1474,GO:0003211,1,0.935510155533372,0,9,cardiac ventricle formation,BP,
1475,GO:0003213,1,0.979589679281457,0,2,cardiac right atrium morphogenesis,BP,
1477,GO:0003215,1,0.876311572295235,0,18,cardiac right ventricle morphogenesis,BP,
1478,GO:0003218,1,0.992771023838117,0,1,cardiac left ventricle formation,BP,
1479,GO:0003219,1,0.978031596858062,0,3,cardiac right ventricle formation,BP,
1480,GO:0003220,1,0.971920991331486,0,2,left ventricular cardiac muscle tissue morphogenesis,BP,
1481,GO:0003221,1,0.974908473502558,0,3,right ventricular cardiac muscle tissue morphogenesis,BP,
1482,GO:0003222,1,0.878251560848627,0,16,ventricular trabecula myocardium morphogenesis,BP,
1483,GO:0003223,1,0.924069559564509,0,8,ventricular compact myocardium morphogenesis,BP,
1484,GO:0003226,1,0.987339503215136,0,1,right ventricular compact myocardium morphogenesis,BP,
1485,GO:0003228,1,0.961906687750854,0,6,atrial cardiac muscle tissue development,BP,
1486,GO:0003229,1,0.669497789459333,0,52,ventricular cardiac muscle tissue development,BP,
1487,GO:0003230,1,0.7748704055334,0,32,cardiac atrium development,BP,
1489,GO:0003235,1,0.996316852701051,0,1,sinus venosus development,BP,
1490,GO:0003236,1,0.996316852701051,0,1,sinus venosus morphogenesis,BP,
1491,GO:0003241,1,0.973535653353159,0,4,growth involved in heart morphogenesis,BP,
1492,GO:0003245,1,0.988745460158772,0,2,cardiac muscle tissue growth involved in heart morphogenesis,BP,
1493,GO:0003247,1,0.995555341111532,0,1,post-embryonic cardiac muscle cell growth involved in heart morphogenesis,BP,
1494,GO:0003249,1,0.963521729149342,0,3,cell proliferation involved in heart valve morphogenesis,BP,
1495,GO:0003250,1,0.963521729149342,0,3,regulation of cell proliferation involved in heart valve morphogenesis,BP,
1496,GO:0003251,1,0.988706352811282,0,1,positive regulation of cell proliferation involved in heart valve morphogenesis,BP,
1497,GO:0003252,1,0.974530548877666,0,2,negative regulation of cell proliferation involved in heart valve morphogenesis,BP,
1498,GO:0003253,1,0.960915531687574,0,7,cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
1500,GO:0003256,1,0.951690595635757,0,6,regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,
1501,GO:0003257,1,0.975565427442571,0,3,positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,
1502,GO:0003259,1,0.996316852701051,0,1,cardioblast anterior-lateral migration,BP,
1503,GO:0003260,1,0.996316852701051,0,1,cardioblast migration,BP,
1504,GO:0003263,1,0.933475456439324,0,10,cardioblast proliferation,BP,
1505,GO:0003264,1,0.933475456439324,0,10,regulation of cardioblast proliferation,BP,
1506,GO:0003266,1,0.939516394068113,0,9,regulation of secondary heart field cardioblast proliferation,BP,
1507,GO:0003270,1,0.988259126454876,0,1,Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation,BP,
1508,GO:0003271,1,0.994087113696333,0,1,smoothened signaling pathway involved in regulation of secondary heart field cardioblast proliferation,BP,
1509,GO:0003272,1,0.841420898816858,0,24,endocardial cushion formation,BP,
1510,GO:0003273,1,0.963618585725366,0,4,cell migration involved in endocardial cushion formation,BP,
1511,GO:0003274,1,0.971313912557516,0,4,endocardial cushion fusion,BP,
1512,GO:0003275,1,0.980280900691806,0,3,apoptotic process involved in outflow tract morphogenesis,BP,
1513,GO:0003278,1,0.969712531609853,0,5,apoptotic process involved in heart morphogenesis,BP,
1514,GO:0003279,1,0.431235761146913,0,106,cardiac septum development,BP,
1515,GO:0003281,1,0.574116240378639,0,69,ventricular septum development,BP,
1516,GO:0003283,1,0.850668088781309,0,20,atrial septum development,BP,
1517,GO:0003284,1,0.97032189730808,0,4,septum primum development,BP,
1518,GO:0003285,1,0.98795582140368,0,2,septum secundum development,BP,
1519,GO:0003289,1,0.97032189730808,0,4,atrial septum primum morphogenesis,BP,
1520,GO:0003290,1,0.992891094962401,0,1,atrial septum secundum morphogenesis,BP,
1521,GO:0003292,1,0.986404651705229,0,2,cardiac septum cell differentiation,BP,
1523,GO:0003299,1,0.850760310968212,0,21,muscle hypertrophy in response to stress,BP,
1526,GO:0003306,1,0.935657269394612,0,10,Wnt signaling pathway involved in heart development,BP,
1527,GO:0003307,1,0.950296073599907,0,8,regulation of Wnt signaling pathway involved in heart development,BP,
1528,GO:0003308,1,0.955866552262302,0,7,negative regulation of Wnt signaling pathway involved in heart development,BP,
1529,GO:0003309,1,0.845830050925057,0,24,type B pancreatic cell differentiation,BP,
1530,GO:0003310,1,0.961473764393227,0,6,pancreatic A cell differentiation,BP,
1531,GO:0003312,1,0.988466166186549,0,2,pancreatic PP cell differentiation,BP,
1532,GO:0003318,1,0.996316852701051,0,1,cell migration to the midline involved in heart development,BP,
1533,GO:0003321,1,0.955438463649947,0,7,positive regulation of blood pressure by epinephrine-norepinephrine,BP,
1534,GO:0003322,1,0.990296282249561,0,1,pancreatic A cell development,BP,
1535,GO:0003323,1,0.871364830430344,0,20,type B pancreatic cell development,BP,
1536,GO:0003326,1,0.988466166186549,0,2,pancreatic A cell fate commitment,BP,
1537,GO:0003327,1,0.994731026292765,0,1,type B pancreatic cell fate commitment,BP,
1538,GO:0003329,1,0.988466166186549,0,2,pancreatic PP cell fate commitment,BP,
1539,GO:0003330,1,0.950766099479025,0,7,regulation of extracellular matrix constituent secretion,BP,
1540,GO:0003331,1,0.987305335454078,0,2,positive regulation of extracellular matrix constituent secretion,BP,
1541,GO:0003332,1,0.969312227262309,0,4,negative regulation of extracellular matrix constituent secretion,BP,
1543,GO:0003334,1,0.931803330818614,0,9,keratinocyte development,BP,
1544,GO:0003335,1,0.989485655525831,0,2,corneocyte development,BP,
1545,GO:0003337,1,0.922824190207548,0,13,mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
1546,GO:0003338,1,0.800043982840966,0,31,metanephros morphogenesis,BP,
1547,GO:0003339,1,0.953962073331326,0,8,regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
1548,GO:0003340,1,0.982435426938962,0,3,negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
1550,GO:0003342,1,0.98825053224002,0,2,proepicardium development,BP,
1551,GO:0003343,1,0.98825053224002,0,2,septum transversum development,BP,
1552,GO:0003344,1,0.926967676347542,0,9,pericardium morphogenesis,BP,
1553,GO:0003345,1,0.992674560092666,0,1,proepicardium cell migration involved in pericardium morphogenesis,BP,
1554,GO:0003348,1,0.954831950948893,0,6,cardiac endothelial cell differentiation,BP,
1555,GO:0003350,1,0.986871885896698,0,2,pulmonary myocardium development,BP,
1556,GO:0003351,1,0.82201525901336,0,27,epithelial cilium movement involved in extracellular fluid movement,BP,
1557,GO:0003352,1,0.857523042357236,0,25,regulation of cilium movement,BP,
1558,GO:0003353,1,0.949873507120077,0,10,positive regulation of cilium movement,BP,
1559,GO:0003354,1,0.995017098870267,0,1,negative regulation of cilium movement,BP,
1560,GO:0003356,1,0.920629909513685,0,11,regulation of cilium beat frequency,BP,
1561,GO:0003357,1,0.958521576645405,0,6,noradrenergic neuron differentiation,BP,
1562,GO:0003358,1,0.987414941328659,0,2,noradrenergic neuron development,BP,
1563,GO:0003359,1,0.993962265126325,0,1,noradrenergic neuron fate commitment,BP,
1564,GO:0003360,1,0.952415266022018,0,6,brainstem development,BP,
1565,GO:0003365,1,0.971194513081476,0,3,establishment of cell polarity involved in ameboidal cell migration,BP,
1566,GO:0003366,1,0.98452407866022,0,2,cell-matrix adhesion involved in ameboidal cell migration,BP,
1569,GO:0003376,1,0.93943564078292,0,10,sphingosine-1-phosphate receptor signaling pathway,BP,
1570,GO:0003382,1,0.77547250356733,0,32,epithelial cell morphogenesis,BP,
1571,GO:0003383,1,0.963360755495087,0,4,apical constriction,BP,
1572,GO:0003400,1,0.973615156569554,0,4,regulation of COPII vesicle coating,BP,
1575,GO:0003404,1,0.986883098311891,0,2,optic vesicle morphogenesis,BP,
1576,GO:0003406,1,0.964993959048524,0,5,retinal pigment epithelium development,BP,
1578,GO:0003408,1,0.973790451433368,0,3,optic cup formation involved in camera-type eye development,BP,
1579,GO:0003409,1,0.992957821186048,0,1,optic cup structural organization,BP,
1580,GO:0003413,1,0.906815860495131,0,14,chondrocyte differentiation involved in endochondral bone morphogenesis,BP,
1581,GO:0003414,1,0.992692442912543,0,1,chondrocyte morphogenesis involved in endochondral bone morphogenesis,BP,
1582,GO:0003415,1,0.964449936196416,0,5,chondrocyte hypertrophy,BP,
1583,GO:0003416,1,0.831875153497458,0,27,endochondral bone growth,BP,
1584,GO:0003417,1,0.882804853730682,0,19,growth plate cartilage development,BP,
1585,GO:0003418,1,0.941441304159636,0,9,growth plate cartilage chondrocyte differentiation,BP,
1586,GO:0003419,1,0.980821690063098,0,4,growth plate cartilage chondrocyte proliferation,BP,
1587,GO:0003420,1,0.987170247531011,0,2,regulation of growth plate cartilage chondrocyte proliferation,BP,
1588,GO:0003421,1,0.992673043224518,0,1,growth plate cartilage axis specification,BP,
1589,GO:0003422,1,0.985418497139977,0,2,growth plate cartilage morphogenesis,BP,
1590,GO:0003429,1,0.992692442912543,0,1,growth plate cartilage chondrocyte morphogenesis,BP,
1591,GO:0003430,1,0.97841961219574,0,3,growth plate cartilage chondrocyte growth,BP,
1592,GO:0003431,1,0.964652185191915,0,5,growth plate cartilage chondrocyte development,BP,
1593,GO:0003433,1,0.944428724078073,0,8,chondrocyte development involved in endochondral bone morphogenesis,BP,
1597,GO:0003678,1,0.571749224117146,0,73,DNA helicase activity,MF,
1598,GO:0003680,1,0.953579069379329,0,7,minor groove of adenine-thymine-rich DNA binding,MF,
1599,GO:0003681,1,0.993113179433397,0,1,bent DNA binding,MF,
1601,GO:0003684,1,0.650062062705106,0,63,damaged DNA binding,MF,
1602,GO:0003688,1,0.855864089673065,0,23,DNA replication origin binding,MF,
1603,GO:0003689,1,0.948283537240456,0,9,DNA clamp loader activity,MF,
1605,GO:0003691,1,0.94349222663187,0,9,double-stranded telomeric DNA binding,MF,
1606,GO:0003692,1,0.994510995622088,0,1,left-handed Z-DNA binding,MF,
1607,GO:0003696,1,0.972045452247455,0,4,satellite DNA binding,MF,
1608,GO:0003697,1,0.499761313044664,0,104,single-stranded DNA binding,MF,
1610,GO:0003707,1,0.822125467758273,0,25,steroid hormone receptor activity,MF,
1611,GO:0003711,1,0.985412494224124,0,2,transcription elongation regulator activity,MF,
1614,GO:0003714,1,0.279146537848777,0,181,transcription corepressor activity,MF,
1615,GO:0003720,1,0.955959826371852,0,6,telomerase activity,MF,
1616,GO:0003721,1,0.992614810239926,0,1,telomerase RNA reverse transcriptase activity,MF,
1618,GO:0003724,1,0.600542926122124,0,72,RNA helicase activity,MF,
1619,GO:0003725,1,0.586141716007139,0,75,double-stranded RNA binding,MF,
1620,GO:0003726,1,0.970209973003938,0,4,double-stranded RNA adenosine deaminase activity,MF,
1621,GO:0003727,1,0.584992363726647,0,81,single-stranded RNA binding,MF,
1622,GO:0003729,1,0.155419525745622,0,274,mRNA binding,MF,
1623,GO:0003730,1,0.547004191355642,0,86,mRNA 3'-UTR binding,MF,
1624,GO:0003735,1,0.564102073108955,0,153,structural constituent of ribosome,MF,
1625,GO:0003743,1,0.746070893083837,0,49,translation initiation factor activity,MF,
1627,GO:0003747,1,0.959701560890323,0,6,translation release factor activity,MF,
1628,GO:0003755,1,0.856243634907335,0,30,peptidyl-prolyl cis-trans isomerase activity,MF,
1629,GO:0003756,1,0.903578616904312,0,16,protein disulfide isomerase activity,MF,
1633,GO:0003785,1,0.869982146504244,0,24,actin monomer binding,MF,
1634,GO:0003796,1,0.992327147974442,0,2,lysozyme activity,MF,
1635,GO:0003810,1,0.954729571934955,0,7,protein-glutamine gamma-glutamyltransferase activity,MF,
1636,GO:0003823,1,0.752417303250932,0,52,antigen binding,MF,
1638,GO:0003826,1,0.989021834520352,0,2,alpha-ketoacid dehydrogenase activity,MF,
1639,GO:0003827,1,0.993291809111469,0,1,alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,MF,
1641,GO:0003829,1,0.984386071484968,0,2,beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity,MF,
1642,GO:0003830,1,0.991937737629968,0,1,beta-1,4-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity,MF,
1643,GO:0003831,1,0.970131626903949,0,5,beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity,MF,
1644,GO:0003834,1,0.986895344770984,0,2,beta-carotene 15,15'-monooxygenase activity,MF,
1645,GO:0003835,1,0.982932932509864,0,2,beta-galactoside alpha-2,6-sialyltransferase activity,MF,
1646,GO:0003836,1,0.978190589800616,0,3,beta-galactoside (CMP) alpha-2,3-sialyltransferase activity,MF,
1647,GO:0003837,1,0.994734979912661,0,1,beta-ureidopropionase activity,MF,
1648,GO:0003839,1,0.988306370774292,0,3,gamma-glutamylcyclotransferase activity,MF,
1649,GO:0003841,1,0.902600057944647,0,14,1-acylglycerol-3-phosphate O-acyltransferase activity,MF,
1650,GO:0003842,1,0.992991956380888,0,1,1-pyrroline-5-carboxylate dehydrogenase activity,MF,
1651,GO:0003844,1,0.99310265842407,0,1,1,4-alpha-glucan branching enzyme activity,MF,
1652,GO:0003845,1,0.991063352666585,0,2,11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity,MF,
1653,GO:0003846,1,0.986781083874525,0,2,2-acylglycerol O-acyltransferase activity,MF,
1654,GO:0003847,1,0.965514439792755,0,7,1-alkyl-2-acetylglycerophosphocholine esterase activity,MF,
1655,GO:0003851,1,0.993313246129226,0,1,2-hydroxyacylsphingosine 1-beta-galactosyltransferase activity,MF,
1656,GO:0003854,1,0.983700138530608,0,3,3-beta-hydroxy-delta5-steroid dehydrogenase activity,MF,
1657,GO:0003857,1,0.958629573182024,0,8,3-hydroxyacyl-CoA dehydrogenase activity,MF,
1658,GO:0003858,1,0.986235281525569,0,2,3-hydroxybutyrate dehydrogenase activity,MF,
1659,GO:0003860,1,0.995013204505842,0,1,3-hydroxyisobutyryl-CoA hydrolase activity,MF,
1660,GO:0003863,1,0.989021834520352,0,2,3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity,MF,
1661,GO:0003865,1,0.988043120815176,0,2,3-oxo-5-alpha-steroid 4-dehydrogenase activity,MF,
1662,GO:0003867,1,0.992022490948624,0,1,4-aminobutyrate transaminase activity,MF,
1663,GO:0003868,1,0.995500697334316,0,1,4-hydroxyphenylpyruvate dioxygenase activity,MF,
1664,GO:0003870,1,0.989061442283946,0,2,5-aminolevulinate synthase activity,MF,
1665,GO:0003872,1,0.979896098692491,0,3,6-phosphofructokinase activity,MF,
1666,GO:0003873,1,0.972592091902382,0,4,6-phosphofructo-2-kinase activity,MF,
1667,GO:0003874,1,0.996625193861694,0,1,6-pyruvoyltetrahydropterin synthase activity,MF,
1668,GO:0003875,1,0.988189745351725,0,2,ADP-ribosylarginine hydrolase activity,MF,
1669,GO:0003876,1,0.985215327750068,0,2,AMP deaminase activity,MF,
1670,GO:0003878,1,0.992421935402185,0,1,ATP citrate synthase activity,MF,
1671,GO:0003880,1,0.988252374489024,0,2,protein C-terminal carboxyl O-methyltransferase activity,MF,
1672,GO:0003881,1,0.995120640013741,0,1,CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity,MF,
1673,GO:0003882,1,0.994003726829382,0,1,CDP-diacylglycerol-serine O-phosphatidyltransferase activity,MF,
1674,GO:0003883,1,0.986174206605414,0,2,CTP synthase activity,MF,
1675,GO:0003884,1,0.991227188293017,0,2,D-amino-acid oxidase activity,MF,
1676,GO:0003886,1,0.976891592287495,0,3,DNA (cytosine-5-)-methyltransferase activity,MF,
1677,GO:0003887,1,0.849341846124844,0,23,DNA-directed DNA polymerase activity,MF,
1678,GO:0003896,1,0.983724483170752,0,3,DNA primase activity,MF,
1679,GO:0003899,1,0.81056961747361,0,37,DNA-directed 5'-3' RNA polymerase activity,MF,
1680,GO:0003905,1,0.996417301251183,0,1,alkylbase DNA N-glycosylase activity,MF,
1681,GO:0003906,1,0.935633325500066,0,13,DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,
1682,GO:0003908,1,0.996158723032246,0,1,methylated-DNA-[protein]-cysteine S-methyltransferase activity,MF,
1683,GO:0003909,1,0.978748601891143,0,3,DNA ligase activity,MF,
1684,GO:0003910,1,0.978748601891143,0,3,DNA ligase (ATP) activity,MF,
1685,GO:0003912,1,0.994791295069003,0,1,DNA nucleotidylexotransferase activity,MF,
1687,GO:0003917,1,0.973677510845581,0,4,DNA topoisomerase type I (single strand cut, ATP-independent) activity,MF,
1689,GO:0003919,1,0.994929140826226,0,1,FMN adenylyltransferase activity,MF,
1690,GO:0003920,1,0.9908874434528,0,2,GMP reductase activity,MF,
1691,GO:0003921,1,0.993978431050717,0,1,GMP synthase activity,MF,
1692,GO:0003922,1,0.993978431050717,0,1,GMP synthase (glutamine-hydrolyzing) activity,MF,
1693,GO:0003923,1,0.980438637233946,0,3,GPI-anchor transamidase activity,MF,
1695,GO:0003933,1,0.99496635931707,0,1,GTP cyclohydrolase activity,MF,
1696,GO:0003934,1,0.99496635931707,0,1,GTP cyclohydrolase I activity,MF,
1697,GO:0003937,1,0.994681602725893,0,1,IMP cyclohydrolase activity,MF,
1698,GO:0003938,1,0.989374893742072,0,2,IMP dehydrogenase activity,MF,
1699,GO:0003939,1,0.993865211361605,0,1,L-iditol 2-dehydrogenase activity,MF,
1700,GO:0003940,1,0.994492341035676,0,1,L-iduronidase activity,MF,
1701,GO:0003941,1,0.985581719189374,0,3,L-serine ammonia-lyase activity,MF,
1702,GO:0003943,1,0.986751650083493,0,2,N-acetylgalactosamine-4-sulfatase activity,MF,
1703,GO:0003944,1,0.994466853180627,0,1,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase activity,MF,
1704,GO:0003945,1,0.96899779294136,0,5,N-acetyllactosamine synthase activity,MF,
1705,GO:0003947,1,0.993190248690223,0,1,(N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity,MF,
1706,GO:0003948,1,0.994699394861936,0,1,N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity,MF,
1707,GO:0003950,1,0.864918971106402,0,22,NAD+ ADP-ribosyltransferase activity,MF,
1708,GO:0003951,1,0.886746112634375,0,16,NAD+ kinase activity,MF,
1709,GO:0003952,1,0.994016440850835,0,1,NAD+ synthase (glutamine-hydrolyzing) activity,MF,
1711,GO:0003954,1,0.870275933724654,0,38,NADH dehydrogenase activity,MF,
1712,GO:0003955,1,0.983234737064676,0,3,NAD(P)H dehydrogenase (quinone) activity,MF,
1713,GO:0003956,1,0.987325118628526,0,3,NAD(P)+-protein-arginine ADP-ribosyltransferase activity,MF,
1714,GO:0003957,1,0.992206698531711,0,1,NAD(P)+ transhydrogenase (B-specific) activity,MF,
1715,GO:0003958,1,0.956301072180239,0,6,NADPH-hemoprotein reductase activity,MF,
1716,GO:0003960,1,0.98080974123967,0,4,NADPH:quinone reductase activity,MF,
1717,GO:0003963,1,0.993485400251684,0,1,RNA-3'-phosphate cyclase activity,MF,
1718,GO:0003964,1,0.955959826371852,0,6,RNA-directed DNA polymerase activity,MF,
1719,GO:0003968,1,0.983234581950049,0,2,RNA-directed 5'-3' RNA polymerase activity,MF,
1720,GO:0003972,1,0.993485400251684,0,1,RNA ligase (ATP) activity,MF,
1721,GO:0003973,1,0.982091968538487,0,3,(S)-2-hydroxy-acid oxidase activity,MF,
1722,GO:0003974,1,0.995598868018654,0,1,UDP-N-acetylglucosamine 4-epimerase activity,MF,
1723,GO:0003975,1,0.994588771784529,0,1,UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity,MF,
1724,GO:0003976,1,0.982282118812617,0,3,UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity,MF,
1725,GO:0003977,1,0.987183193872131,0,2,UDP-N-acetylglucosamine diphosphorylase activity,MF,
1726,GO:0003978,1,0.995598868018654,0,1,UDP-glucose 4-epimerase activity,MF,
1727,GO:0003979,1,0.993032448418951,0,1,UDP-glucose 6-dehydrogenase activity,MF,
1728,GO:0003980,1,0.979106992063603,0,2,UDP-glucose:glycoprotein glucosyltransferase activity,MF,
1729,GO:0003983,1,0.994590744420444,0,1,UTP:glucose-1-phosphate uridylyltransferase activity,MF,
1730,GO:0003984,1,0.994272881001173,0,1,acetolactate synthase activity,MF,
1731,GO:0003985,1,0.978624914679102,0,4,acetyl-CoA C-acetyltransferase activity,MF,
1732,GO:0003986,1,0.978303132449142,0,5,acetyl-CoA hydrolase activity,MF,
1733,GO:0003987,1,0.978870083372195,0,3,acetate-CoA ligase activity,MF,
1734,GO:0003988,1,0.964612115454677,0,7,acetyl-CoA C-acyltransferase activity,MF,
1735,GO:0003989,1,0.988282664984535,0,1,acetyl-CoA carboxylase activity,MF,
1736,GO:0003990,1,0.987832271242289,0,2,acetylcholinesterase activity,MF,
1737,GO:0003993,1,0.973063493749971,0,6,acid phosphatase activity,MF,
1738,GO:0003994,1,0.977234781390796,0,3,aconitate hydratase activity,MF,
1739,GO:0003995,1,0.931640710907707,0,11,acyl-CoA dehydrogenase activity,MF,
1740,GO:0003996,1,0.918947646676724,0,13,acyl-CoA ligase activity,MF,
1741,GO:0003997,1,0.960585538712973,0,6,acyl-CoA oxidase activity,MF,
1742,GO:0003998,1,0.993230424315789,0,2,acylphosphatase activity,MF,
1743,GO:0003999,1,0.996875419367853,0,1,adenine phosphoribosyltransferase activity,MF,
1744,GO:0004000,1,0.934902727055795,0,10,adenosine deaminase activity,MF,
1745,GO:0004001,1,0.994766602411071,0,1,adenosine kinase activity,MF,
1746,GO:0004013,1,0.994301690373698,0,1,adenosylhomocysteinase activity,MF,
1747,GO:0004014,1,0.992982499157848,0,1,adenosylmethionine decarboxylase activity,MF,
1749,GO:0004017,1,0.941809832362731,0,9,adenylate kinase activity,MF,
1750,GO:0004018,1,0.995822625406812,0,1,N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity,MF,
1751,GO:0004020,1,0.986558803582698,0,2,adenylylsulfate kinase activity,MF,
1752,GO:0004021,1,0.987776529860468,0,2,L-alanine:2-oxoglutarate aminotransferase activity,MF,
1753,GO:0004022,1,0.972757458855618,0,5,alcohol dehydrogenase (NAD+) activity,MF,
1754,GO:0004024,1,0.982297248162663,0,3,alcohol dehydrogenase activity, zinc-dependent,MF,
1755,GO:0004027,1,0.996215124615496,0,1,alcohol sulfotransferase activity,MF,
1756,GO:0004028,1,0.974648686556446,0,4,3-chloroallyl aldehyde dehydrogenase activity,MF,
1757,GO:0004029,1,0.909397669190267,0,14,aldehyde dehydrogenase (NAD+) activity,MF,
1758,GO:0004030,1,0.904766681460485,0,15,aldehyde dehydrogenase [NAD(P)+] activity,MF,
1759,GO:0004031,1,0.985950588001876,0,2,aldehyde oxidase activity,MF,
1760,GO:0004032,1,0.954699363924833,0,11,alditol:NADP+ 1-oxidoreductase activity,MF,
1761,GO:0004033,1,0.886778509210244,0,25,aldo-keto reductase (NADP) activity,MF,
1762,GO:0004034,1,0.993944393327592,0,1,aldose 1-epimerase activity,MF,
1763,GO:0004035,1,0.987165163651934,0,2,alkaline phosphatase activity,MF,
1764,GO:0004037,1,0.995872965821973,0,1,allantoicase activity,MF,
1765,GO:0004040,1,0.99068876077212,0,2,amidase activity,MF,
1766,GO:0004042,1,0.994731026292765,0,1,acetyl-CoA:L-glutamate N-acetyltransferase activity,MF,
1767,GO:0004043,1,0.992810878213112,0,1,L-aminoadipate-semialdehyde dehydrogenase activity,MF,
1768,GO:0004044,1,0.992727615987456,0,1,amidophosphoribosyltransferase activity,MF,
1769,GO:0004045,1,0.987121634826891,0,3,aminoacyl-tRNA hydrolase activity,MF,
1770,GO:0004046,1,0.982379122097346,0,4,aminoacylase activity,MF,
1771,GO:0004047,1,0.990535718837939,0,2,aminomethyltransferase activity,MF,
1772,GO:0004051,1,0.993813629352555,0,1,arachidonate 5-lipoxygenase activity,MF,
1773,GO:0004052,1,0.981773960569617,0,3,arachidonate 12(S)-lipoxygenase activity,MF,
1774,GO:0004053,1,0.990804604655692,0,2,arginase activity,MF,
1775,GO:0004055,1,0.995211344546038,0,1,argininosuccinate synthase activity,MF,
1776,GO:0004056,1,0.994888873460764,0,1,argininosuccinate lyase activity,MF,
1777,GO:0004057,1,0.994451193104267,0,1,arginyltransferase activity,MF,
1778,GO:0004058,1,0.994834712069726,0,1,aromatic-L-amino-acid decarboxylase activity,MF,
1779,GO:0004059,1,0.995840564142091,0,1,aralkylamine N-acetyltransferase activity,MF,
1780,GO:0004060,1,0.986824173830408,0,3,arylamine N-acetyltransferase activity,MF,
1781,GO:0004061,1,0.995450692884757,0,1,arylformamidase activity,MF,
1782,GO:0004062,1,0.979979910390255,0,5,aryl sulfotransferase activity,MF,
1783,GO:0004063,1,0.991629037459165,0,2,aryldialkylphosphatase activity,MF,
1784,GO:0004064,1,0.972620988360079,0,6,arylesterase activity,MF,
1785,GO:0004065,1,0.918808609505004,0,12,arylsulfatase activity,MF,
1786,GO:0004066,1,0.988234844217033,0,2,asparagine synthase (glutamine-hydrolyzing) activity,MF,
1787,GO:0004067,1,0.989318838894754,0,2,asparaginase activity,MF,
1788,GO:0004068,1,0.993577168431364,0,1,aspartate 1-decarboxylase activity,MF,
1789,GO:0004069,1,0.988652247700137,0,2,L-aspartate:2-oxoglutarate aminotransferase activity,MF,
1790,GO:0004070,1,0.990080082679038,0,1,aspartate carbamoyltransferase activity,MF,
1791,GO:0004074,1,0.993164453204105,0,2,biliverdin reductase (NAD(P)+) activity,MF,
1792,GO:0004075,1,0.993834140857347,0,1,biotin carboxylase activity,MF,
1793,GO:0004077,1,0.991069117274906,0,1,biotin-[acetyl-CoA-carboxylase] ligase activity,MF,
1794,GO:0004078,1,0.991069117274906,0,1,biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity,MF,
1795,GO:0004079,1,0.991069117274906,0,1,biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity,MF,
1796,GO:0004080,1,0.991069117274906,0,1,biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity,MF,
1797,GO:0004081,1,0.996551737234071,0,1,bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity,MF,
1798,GO:0004082,1,0.982734718822758,0,4,bisphosphoglycerate mutase activity,MF,
1800,GO:0004085,1,0.987311118206781,0,2,butyryl-CoA dehydrogenase activity,MF,
1801,GO:0004087,1,0.991302757153353,0,1,carbamoyl-phosphate synthase (ammonia) activity,MF,
1802,GO:0004088,1,0.981468262615149,0,2,carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity,MF,
1803,GO:0004089,1,0.928558768876679,0,14,carbonate dehydratase activity,MF,
1804,GO:0004090,1,0.98109126601631,0,5,carbonyl reductase (NADPH) activity,MF,
1805,GO:0004092,1,0.993411989813319,0,1,carnitine O-acetyltransferase activity,MF,
1806,GO:0004095,1,0.973096226513362,0,4,carnitine O-palmitoyltransferase activity,MF,
1807,GO:0004096,1,0.978853421067685,0,4,catalase activity,MF,
1808,GO:0004098,1,0.995062737213083,0,1,cerebroside-sulfatase activity,MF,
1809,GO:0004102,1,0.993973033967766,0,1,choline O-acetyltransferase activity,MF,
1810,GO:0004103,1,0.989183329396258,0,2,choline kinase activity,MF,
1811,GO:0004104,1,0.981504024918153,0,3,cholinesterase activity,MF,
1812,GO:0004105,1,0.987221250558265,0,2,choline-phosphate cytidylyltransferase activity,MF,
1813,GO:0004108,1,0.993225008503437,0,1,citrate (Si)-synthase activity,MF,
1814,GO:0004109,1,0.987522113649115,0,2,coproporphyrinogen oxidase activity,MF,
1815,GO:0004111,1,0.968461015723382,0,6,creatine kinase activity,MF,
1816,GO:0004112,1,0.837391880570354,0,23,cyclic-nucleotide phosphodiesterase activity,MF,
1817,GO:0004113,1,0.99177201436596,0,1,2',3'-cyclic-nucleotide 3'-phosphodiesterase activity,MF,
1818,GO:0004114,1,0.849896604181974,0,21,3',5'-cyclic-nucleotide phosphodiesterase activity,MF,
1819,GO:0004115,1,0.909163284680195,0,12,3',5'-cyclic-AMP phosphodiesterase activity,MF,
1820,GO:0004117,1,0.981085731261622,0,3,calmodulin-dependent cyclic-nucleotide phosphodiesterase activity,MF,
1821,GO:0004118,1,0.971219260756758,0,3,cGMP-stimulated cyclic-nucleotide phosphodiesterase activity,MF,
1822,GO:0004119,1,0.983612691036393,0,2,cGMP-inhibited cyclic-nucleotide phosphodiesterase activity,MF,
1823,GO:0004122,1,0.99374152799939,0,1,cystathionine beta-synthase activity,MF,
1824,GO:0004123,1,0.995364425768994,0,1,cystathionine gamma-lyase activity,MF,
1825,GO:0004126,1,0.951145678103908,0,10,cytidine deaminase activity,MF,
1826,GO:0004127,1,0.973976534986407,0,4,cytidylate kinase activity,MF,
1827,GO:0004128,1,0.960496039108577,0,7,cytochrome-b5 reductase activity, acting on NAD(P)H,MF,
1828,GO:0004129,1,0.927177894382286,0,21,cytochrome-c oxidase activity,MF,
1829,GO:0004132,1,0.994814984920004,0,1,dCMP deaminase activity,MF,
1830,GO:0004133,1,0.990024972857022,0,1,glycogen debranching enzyme activity,MF,
1831,GO:0004134,1,0.990024972857022,0,1,4-alpha-glucanotransferase activity,MF,
1832,GO:0004135,1,0.990024972857022,0,1,amylo-alpha-1,6-glucosidase activity,MF,
1833,GO:0004136,1,0.990278762745527,0,2,deoxyadenosine kinase activity,MF,
1834,GO:0004137,1,0.985700233383306,0,2,deoxycytidine kinase activity,MF,
1835,GO:0004138,1,0.990278762745527,0,2,deoxyguanosine kinase activity,MF,
1836,GO:0004139,1,0.995396421293157,0,1,deoxyribose-phosphate aldolase activity,MF,
1837,GO:0004140,1,0.989109910461436,0,2,dephospho-CoA kinase activity,MF,
1838,GO:0004142,1,0.982482578710138,0,3,diacylglycerol cholinephosphotransferase activity,MF,
1839,GO:0004143,1,0.922816522433006,0,10,diacylglycerol kinase activity,MF,
1840,GO:0004144,1,0.986781083874525,0,2,diacylglycerol O-acyltransferase activity,MF,
1841,GO:0004145,1,0.985110639721196,0,3,diamine N-acetyltransferase activity,MF,
1842,GO:0004146,1,0.992654684274114,0,1,dihydrofolate reductase activity,MF,
1843,GO:0004148,1,0.992799951621767,0,1,dihydrolipoyl dehydrogenase activity,MF,
1844,GO:0004149,1,0.993374693996666,0,1,dihydrolipoyllysine-residue succinyltransferase activity,MF,
1845,GO:0004151,1,0.990080082679038,0,1,dihydroorotase activity,MF,
1846,GO:0004152,1,0.994738933398728,0,1,dihydroorotate dehydrogenase activity,MF,
1847,GO:0004155,1,0.995532517038367,0,1,6,7-dihydropteridine reductase activity,MF,
1848,GO:0004157,1,0.994624299411827,0,1,dihydropyrimidinase activity,MF,
1849,GO:0004161,1,0.989266284362425,0,2,dimethylallyltranstransferase activity,MF,
1850,GO:0004163,1,0.995261345571075,0,1,diphosphomevalonate decarboxylase activity,MF,
1851,GO:0004164,1,0.995276346176078,0,1,diphthine synthase activity,MF,
1852,GO:0004165,1,0.979764780239334,0,3,dodecenoyl-CoA delta-isomerase activity,MF,
1853,GO:0004167,1,0.988320198891964,0,3,dopachrome isomerase activity,MF,
1854,GO:0004168,1,0.994482532380317,0,1,dolichol kinase activity,MF,
1855,GO:0004169,1,0.939918145249519,0,9,dolichyl-phosphate-mannose-protein mannosyltransferase activity,MF,
1856,GO:0004170,1,0.99512256248557,0,1,dUTP diphosphatase activity,MF,
1857,GO:0004174,1,0.987220702246134,0,2,electron-transferring-flavoprotein dehydrogenase activity,MF,
1859,GO:0004176,1,0.969036472395996,0,5,ATP-dependent peptidase activity,MF,
1860,GO:0004177,1,0.751135533119106,0,43,aminopeptidase activity,MF,
1861,GO:0004180,1,0.79241745509259,0,37,carboxypeptidase activity,MF,
1862,GO:0004181,1,0.85142593378377,0,25,metallocarboxypeptidase activity,MF,
1863,GO:0004185,1,0.968947558361127,0,5,serine-type carboxypeptidase activity,MF,
1864,GO:0004190,1,0.897874901585994,0,18,aspartic-type endopeptidase activity,MF,
1865,GO:0004197,1,0.541227037033048,0,87,cysteine-type endopeptidase activity,MF,
1866,GO:0004198,1,0.930602466623751,0,11,calcium-dependent cysteine-type endopeptidase activity,MF,
1867,GO:0004222,1,0.509544897012064,0,92,metalloendopeptidase activity,MF,
1869,GO:0004298,1,0.935422117554572,0,18,threonine-type endopeptidase activity,MF,
1870,GO:0004300,1,0.946834912851594,0,10,enoyl-CoA hydratase activity,MF,
1871,GO:0004301,1,0.970268290769252,0,6,epoxide hydrolase activity,MF,
1872,GO:0004303,1,0.949334877936119,0,11,estradiol 17-beta-dehydrogenase activity,MF,
1873,GO:0004304,1,0.995295032329313,0,1,estrone sulfotransferase activity,MF,
1874,GO:0004305,1,0.975715602515176,0,4,ethanolamine kinase activity,MF,
1875,GO:0004306,1,0.995151336053254,0,1,ethanolamine-phosphate cytidylyltransferase activity,MF,
1876,GO:0004307,1,0.990854249300368,0,2,ethanolaminephosphotransferase activity,MF,
1877,GO:0004308,1,0.98255002844889,0,3,exo-alpha-sialidase activity,MF,
1878,GO:0004309,1,0.966237019981494,0,4,exopolyphosphatase activity,MF,
1879,GO:0004310,1,0.994661836853827,0,1,farnesyl-diphosphate farnesyltransferase activity,MF,
1880,GO:0004311,1,0.981410705387046,0,3,farnesyltranstransferase activity,MF,
1881,GO:0004312,1,0.937617889116469,0,10,fatty acid synthase activity,MF,
1882,GO:0004313,1,0.988938770380431,0,1,[acyl-carrier-protein] S-acetyltransferase activity,MF,
1883,GO:0004314,1,0.983969924543204,0,2,[acyl-carrier-protein] S-malonyltransferase activity,MF,
1884,GO:0004315,1,0.985123254622089,0,2,3-oxoacyl-[acyl-carrier-protein] synthase activity,MF,
1885,GO:0004316,1,0.988938770380431,0,1,3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity,MF,
1886,GO:0004317,1,0.988938770380431,0,1,3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity,MF,
1887,GO:0004320,1,0.984329381231428,0,2,oleoyl-[acyl-carrier-protein] hydrolase activity,MF,
1888,GO:0004321,1,0.977388054481276,0,4,fatty-acyl-CoA synthase activity,MF,
1889,GO:0004322,1,0.958919849024868,0,6,ferroxidase activity,MF,
1890,GO:0004324,1,0.995074351707712,0,1,ferredoxin-NADP+ reductase activity,MF,
1891,GO:0004325,1,0.989969959568606,0,1,ferrochelatase activity,MF,
1892,GO:0004326,1,0.993931940906298,0,1,tetrahydrofolylpolyglutamate synthase activity,MF,
1893,GO:0004329,1,0.985693168234248,0,2,formate-tetrahydrofolate ligase activity,MF,
1894,GO:0004331,1,0.972592091902382,0,4,fructose-2,6-bisphosphate 2-phosphatase activity,MF,
1895,GO:0004332,1,0.985367918001048,0,3,fructose-bisphosphate aldolase activity,MF,
1896,GO:0004333,1,0.995276346176078,0,1,fumarate hydratase activity,MF,
1897,GO:0004334,1,0.995861656502991,0,1,fumarylacetoacetase activity,MF,
1898,GO:0004335,1,0.989089820543602,0,2,galactokinase activity,MF,
1899,GO:0004336,1,0.988807588787692,0,2,galactosylceramidase activity,MF,
1900,GO:0004337,1,0.989266284362425,0,2,geranyltranstransferase activity,MF,
1901,GO:0004339,1,0.990618975573862,0,1,glucan 1,4-alpha-glucosidase activity,MF,
1902,GO:0004340,1,0.963044627848834,0,5,glucokinase activity,MF,
1903,GO:0004341,1,0.995017098870267,0,1,gluconolactonase activity,MF,
1904,GO:0004342,1,0.98935759801909,0,2,glucosamine-6-phosphate deaminase activity,MF,
1905,GO:0004343,1,0.992650261608413,0,1,glucosamine 6-phosphate N-acetyltransferase activity,MF,
1906,GO:0004344,1,0.988430011882112,0,1,glucose dehydrogenase activity,MF,
1907,GO:0004345,1,0.982705343512528,0,2,glucose-6-phosphate dehydrogenase activity,MF,
1908,GO:0004346,1,0.981963345666009,0,3,glucose-6-phosphatase activity,MF,
1909,GO:0004347,1,0.994701371851211,0,1,glucose-6-phosphate isomerase activity,MF,
1910,GO:0004348,1,0.98244756983321,0,3,glucosylceramidase activity,MF,
1911,GO:0004349,1,0.992857121069063,0,1,glutamate 5-kinase activity,MF,
1912,GO:0004350,1,0.992857121069063,0,1,glutamate-5-semialdehyde dehydrogenase activity,MF,
1913,GO:0004351,1,0.987880815737928,0,2,glutamate decarboxylase activity,MF,
1914,GO:0004352,1,0.98712251406264,0,2,glutamate dehydrogenase (NAD+) activity,MF,
1915,GO:0004353,1,0.98712251406264,0,2,glutamate dehydrogenase [NAD(P)+] activity,MF,
1916,GO:0004356,1,0.992418516791467,0,1,glutamate-ammonia ligase activity,MF,
1917,GO:0004357,1,0.985919454616231,0,2,glutamate-cysteine ligase activity,MF,
1918,GO:0004359,1,0.980260708628026,0,3,glutaminase activity,MF,
1919,GO:0004360,1,0.982063112729023,0,2,glutamine-fructose-6-phosphate transaminase (isomerizing) activity,MF,
1920,GO:0004361,1,0.995423647763866,0,1,glutaryl-CoA dehydrogenase activity,MF,
1921,GO:0004362,1,0.994344147861831,0,1,glutathione-disulfide reductase activity,MF,
1922,GO:0004363,1,0.995056923966528,0,1,glutathione synthase activity,MF,
1923,GO:0004364,1,0.921431196624658,0,20,glutathione transferase activity,MF,
1924,GO:0004365,1,0.99608471895368,0,1,glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity,MF,
1925,GO:0004366,1,0.984190711702597,0,2,glycerol-3-phosphate O-acyltransferase activity,MF,
1926,GO:0004367,1,0.993343729418894,0,1,glycerol-3-phosphate dehydrogenase [NAD+] activity,MF,
1927,GO:0004368,1,0.984550374393721,0,2,glycerol-3-phosphate dehydrogenase (quinone) activity,MF,
1928,GO:0004370,1,0.980266611771767,0,2,glycerol kinase activity,MF,
1929,GO:0004372,1,0.988423017874078,0,2,glycine hydroxymethyltransferase activity,MF,
1930,GO:0004373,1,0.985996790926274,0,2,glycogen (starch) synthase activity,MF,
1931,GO:0004375,1,0.992694159277601,0,1,glycine dehydrogenase (decarboxylating) activity,MF,
1932,GO:0004376,1,0.968647908698564,0,5,glycolipid mannosyltransferase activity,MF,
1933,GO:0004377,1,0.993854814795556,0,1,GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
1934,GO:0004378,1,0.993309147199726,0,1,GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity,MF,
1935,GO:0004379,1,0.98405641985005,0,2,glycylpeptide N-tetradecanoyltransferase activity,MF,
1936,GO:0004380,1,0.995653890567335,0,1,glycoprotein-fucosylgalactoside alpha-N-acetylgalactosaminyltransferase activity,MF,
1937,GO:0004381,1,0.995653890567335,0,1,fucosylgalactoside 3-alpha-galactosyltransferase activity,MF,
1938,GO:0004382,1,0.987653147398919,0,2,guanosine-diphosphatase activity,MF,
1939,GO:0004383,1,0.971716190439683,0,4,guanylate cyclase activity,MF,
1941,GO:0004386,1,0.314873593636142,0,152,helicase activity,MF,
1942,GO:0004392,1,0.991095162891747,0,2,heme oxygenase (decyclizing) activity,MF,
1943,GO:0004394,1,0.992533254941906,0,1,heparan sulfate 2-O-sulfotransferase activity,MF,
1944,GO:0004395,1,0.996157227255456,0,1,hexaprenyldihydroxybenzoate methyltransferase activity,MF,
1945,GO:0004396,1,0.963044627848834,0,5,hexokinase activity,MF,
1946,GO:0004397,1,0.993064816825511,0,1,histidine ammonia-lyase activity,MF,
1947,GO:0004398,1,0.994076943260129,0,1,histidine decarboxylase activity,MF,
1949,GO:0004407,1,0.839165194735547,0,25,histone deacetylase activity,MF,
1950,GO:0004408,1,0.994309392451989,0,1,holocytochrome-c synthase activity,MF,
1951,GO:0004411,1,0.995016125422551,0,1,homogentisate 1,2-dioxygenase activity,MF,
1952,GO:0004415,1,0.972241178706999,0,5,hyalurononglucosaminidase activity,MF,
1953,GO:0004416,1,0.988927636408563,0,2,hydroxyacylglutathione hydrolase activity,MF,
1954,GO:0004418,1,0.995840564142091,0,1,hydroxymethylbilane synthase activity,MF,
1955,GO:0004419,1,0.989693047153587,0,2,hydroxymethylglutaryl-CoA lyase activity,MF,
1956,GO:0004420,1,0.992320893023391,0,1,hydroxymethylglutaryl-CoA reductase (NADPH) activity,MF,
1957,GO:0004421,1,0.986977439378386,0,2,hydroxymethylglutaryl-CoA synthase activity,MF,
1958,GO:0004422,1,0.995924241798657,0,1,hypoxanthine phosphoribosyltransferase activity,MF,
1959,GO:0004423,1,0.991250917792064,0,1,iduronate-2-sulfatase activity,MF,
1960,GO:0004427,1,0.987336560677429,0,3,inorganic diphosphatase activity,MF,
1961,GO:0004430,1,0.970522147650002,0,4,1-phosphatidylinositol 4-kinase activity,MF,
1963,GO:0004438,1,0.872675901540827,0,17,phosphatidylinositol-3-phosphatase activity,MF,
1964,GO:0004439,1,0.932937194161944,0,9,phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity,MF,
1965,GO:0004441,1,0.99469445244019,0,1,inositol-1,4-bisphosphate 1-phosphatase activity,MF,
1966,GO:0004445,1,0.958221366445883,0,6,inositol-polyphosphate 5-phosphatase activity,MF,
1967,GO:0004446,1,0.993381017686403,0,1,inositol-hexakisphosphate phosphatase activity,MF,
1968,GO:0004447,1,0.993249510965945,0,1,iodide peroxidase activity,MF,
1969,GO:0004448,1,0.97485538081972,0,5,isocitrate dehydrogenase activity,MF,
1970,GO:0004449,1,0.985070639712981,0,3,isocitrate dehydrogenase (NAD+) activity,MF,
1971,GO:0004450,1,0.989631476925847,0,2,isocitrate dehydrogenase (NADP+) activity,MF,
1972,GO:0004452,1,0.994610478347674,0,1,isopentenyl-diphosphate delta-isomerase activity,MF,
1973,GO:0004454,1,0.994064033971149,0,1,ketohexokinase activity,MF,
1974,GO:0004457,1,0.976105670669714,0,5,lactate dehydrogenase activity,MF,
1975,GO:0004458,1,0.994801167887543,0,1,D-lactate dehydrogenase (cytochrome) activity,MF,
1976,GO:0004459,1,0.981207772411633,0,4,L-lactate dehydrogenase activity,MF,
1977,GO:0004461,1,0.984156609744626,0,3,lactose synthase activity,MF,
1978,GO:0004462,1,0.994786357673771,0,1,lactoylglutathione lyase activity,MF,
1979,GO:0004463,1,0.994729049438732,0,1,leukotriene-A4 hydrolase activity,MF,
1980,GO:0004464,1,0.983538232327097,0,5,leukotriene-C4 synthase activity,MF,
1981,GO:0004465,1,0.975068384936176,0,4,lipoprotein lipase activity,MF,
1982,GO:0004466,1,0.975081859336347,0,4,long-chain-acyl-CoA dehydrogenase activity,MF,
1983,GO:0004467,1,0.915483196362631,0,13,long-chain fatty acid-CoA ligase activity,MF,
1984,GO:0004468,1,0.967581275908347,0,4,lysine N-acetyltransferase activity, acting on acetyl phosphate as donor,MF,
1985,GO:0004470,1,0.975967945505528,0,4,malic enzyme activity,MF,
1986,GO:0004471,1,0.979742450761912,0,3,malate dehydrogenase (decarboxylating) (NAD+) activity,MF,
1987,GO:0004473,1,0.979742450761912,0,3,malate dehydrogenase (decarboxylating) (NADP+) activity,MF,
1988,GO:0004474,1,0.99128577301311,0,1,malate synthase activity,MF,
1989,GO:0004475,1,0.995612695992936,0,1,mannose-1-phosphate guanylyltransferase activity,MF,
1990,GO:0004476,1,0.995309928040927,0,1,mannose-6-phosphate isomerase activity,MF,
1991,GO:0004477,1,0.981548792530815,0,3,methenyltetrahydrofolate cyclohydrolase activity,MF,
1992,GO:0004478,1,0.986353762059748,0,2,methionine adenosyltransferase activity,MF,
1993,GO:0004479,1,0.993513844472955,0,1,methionyl-tRNA formyltransferase activity,MF,
1994,GO:0004482,1,0.990897153807632,0,1,mRNA (guanine-N7-)-methyltransferase activity,MF,
1995,GO:0004483,1,0.98701281886265,0,2,mRNA (nucleoside-2'-O-)-methyltransferase activity,MF,
1996,GO:0004484,1,0.992348393850973,0,1,mRNA guanylyltransferase activity,MF,
1997,GO:0004485,1,0.986634701249976,0,2,methylcrotonoyl-CoA carboxylase activity,MF,
1998,GO:0004486,1,0.981548792530815,0,3,methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity,MF,
1999,GO:0004487,1,0.981548792530815,0,3,methylenetetrahydrofolate dehydrogenase (NAD+) activity,MF,
2000,GO:0004488,1,0.981548792530815,0,3,methylenetetrahydrofolate dehydrogenase (NADP+) activity,MF,
2001,GO:0004489,1,0.990070603804254,0,1,methylenetetrahydrofolate reductase (NAD(P)H) activity,MF,
2002,GO:0004490,1,0.995636778667141,0,1,methylglutaconyl-CoA hydratase activity,MF,
2003,GO:0004491,1,0.994510013234754,0,1,methylmalonate-semialdehyde dehydrogenase (acylating) activity,MF,
2004,GO:0004493,1,0.996710292900068,0,1,methylmalonyl-CoA epimerase activity,MF,
2005,GO:0004496,1,0.994730037869166,0,1,mevalonate kinase activity,MF,
2006,GO:0004497,1,0.616112157475521,0,78,monooxygenase activity,MF,
2007,GO:0004498,1,0.993931940906298,0,1,calcidiol 1-monooxygenase activity,MF,
2008,GO:0004499,1,0.970007010359221,0,5,N,N-dimethylaniline monooxygenase activity,MF,
2009,GO:0004500,1,0.986692831667053,0,2,dopamine beta-monooxygenase activity,MF,
2010,GO:0004502,1,0.99193691905189,0,1,kynurenine 3-monooxygenase activity,MF,
2011,GO:0004503,1,0.993342513253874,0,1,monophenol monooxygenase activity,MF,
2012,GO:0004504,1,0.99273603595309,0,1,peptidylglycine monooxygenase activity,MF,
2013,GO:0004505,1,0.984352885783199,0,3,phenylalanine 4-monooxygenase activity,MF,
2014,GO:0004506,1,0.99321357458309,0,1,squalene monooxygenase activity,MF,
2015,GO:0004509,1,0.994819918044891,0,1,steroid 21-monooxygenase activity,MF,
2016,GO:0004510,1,0.989412091204319,0,2,tryptophan 5-monooxygenase activity,MF,
2017,GO:0004511,1,0.995058862153243,0,1,tyrosine 3-monooxygenase activity,MF,
2018,GO:0004512,1,0.994357704239947,0,1,inositol-3-phosphate synthase activity,MF,
2019,GO:0004513,1,0.994267133521178,0,1,neolactotetraosylceramide alpha-2,3-sialyltransferase activity,MF,
2020,GO:0004514,1,0.981577957930629,0,3,nicotinate-nucleotide diphosphorylase (carboxylating) activity,MF,
2021,GO:0004515,1,0.97107035720495,0,4,nicotinate-nucleotide adenylyltransferase activity,MF,
2022,GO:0004516,1,0.993485400251684,0,1,nicotinate phosphoribosyltransferase activity,MF,
2023,GO:0004517,1,0.976732792007986,0,3,nitric-oxide synthase activity,MF,
2024,GO:0004518,1,0.292814795339878,0,189,nuclease activity,MF,
2025,GO:0004519,1,0.494994827610827,0,112,endonuclease activity,MF,
2026,GO:0004520,1,0.787415638892882,0,37,endodeoxyribonuclease activity,MF,
2027,GO:0004521,1,0.688907407452502,0,59,endoribonuclease activity,MF,
2028,GO:0004522,1,0.989288584829584,0,3,ribonuclease A activity,MF,
2029,GO:0004523,1,0.97113301739797,0,6,RNA-DNA hybrid ribonuclease activity,MF,
2030,GO:0004525,1,0.969059278735063,0,4,ribonuclease III activity,MF,
2031,GO:0004526,1,0.950424211462913,0,10,ribonuclease P activity,MF,
2032,GO:0004527,1,0.591256171592216,0,78,exonuclease activity,MF,
2033,GO:0004528,1,0.96072219766178,0,6,phosphodiesterase I activity,MF,
2034,GO:0004529,1,0.875844794298704,0,22,exodeoxyribonuclease activity,MF,
2035,GO:0004530,1,0.96628869668258,0,5,deoxyribonuclease I activity,MF,
2036,GO:0004531,1,0.991225649101839,0,2,deoxyribonuclease II activity,MF,
2037,GO:0004532,1,0.769142037876201,0,39,exoribonuclease activity,MF,
2038,GO:0004534,1,0.969362567850886,0,3,5'-3' exoribonuclease activity,MF,
2039,GO:0004535,1,0.906774504366304,0,13,poly(A)-specific ribonuclease activity,MF,
2040,GO:0004536,1,0.70160599424595,0,56,deoxyribonuclease activity,MF,
2041,GO:0004540,1,0.512843933925047,0,105,ribonuclease activity,MF,
2042,GO:0004549,1,0.933092410461715,0,13,tRNA-specific ribonuclease activity,MF,
2043,GO:0004550,1,0.915833809814407,0,17,nucleoside diphosphate kinase activity,MF,
2044,GO:0004551,1,0.913394642107792,0,16,nucleotide diphosphatase activity,MF,
2045,GO:0004553,1,0.630924510820733,0,70,hydrolase activity, hydrolyzing O-glycosyl compounds,MF,
2046,GO:0004556,1,0.990105373091556,0,2,alpha-amylase activity,MF,
2047,GO:0004557,1,0.988685061207609,0,2,alpha-galactosidase activity,MF,
2048,GO:0004558,1,0.975863320992585,0,3,alpha-1,4-glucosidase activity,MF,
2049,GO:0004559,1,0.89937024189145,0,14,alpha-mannosidase activity,MF,
2050,GO:0004560,1,0.989355823795412,0,2,alpha-L-fucosidase activity,MF,
2051,GO:0004561,1,0.993468652841837,0,1,alpha-N-acetylglucosaminidase activity,MF,
2052,GO:0004563,1,0.981979838934207,0,3,beta-N-acetylhexosaminidase activity,MF,
2053,GO:0004565,1,0.963535216080563,0,6,beta-galactosidase activity,MF,
2054,GO:0004566,1,0.981668675915545,0,3,beta-glucuronidase activity,MF,
2055,GO:0004567,1,0.992944186337183,0,1,beta-mannosidase activity,MF,
2056,GO:0004568,1,0.981868034822013,0,3,chitinase activity,MF,
2057,GO:0004569,1,0.992280297667114,0,1,glycoprotein endo-alpha-1,2-mannosidase activity,MF,
2058,GO:0004571,1,0.948377582837655,0,7,mannosyl-oligosaccharide 1,2-alpha-mannosidase activity,MF,
2059,GO:0004572,1,0.982741465488325,0,2,mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity,MF,
2060,GO:0004573,1,0.993540732699921,0,1,mannosyl-oligosaccharide glucosidase activity,MF,
2061,GO:0004576,1,0.968616344063434,0,6,oligosaccharyl transferase activity,MF,
2062,GO:0004577,1,0.993159067881704,0,1,N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity,MF,
2063,GO:0004578,1,0.992644923063749,0,1,chitobiosyldiphosphodolichol beta-mannosyltransferase activity,MF,
2064,GO:0004579,1,0.972217044729326,0,5,dolichyl-diphosphooligosaccharide-protein glycotransferase activity,MF,
2065,GO:0004581,1,0.996297446970102,0,1,dolichyl-phosphate beta-glucosyltransferase activity,MF,
2066,GO:0004582,1,0.989444110025217,0,3,dolichyl-phosphate beta-D-mannosyltransferase activity,MF,
2067,GO:0004583,1,0.988360686592606,0,2,dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity,MF,
2068,GO:0004585,1,0.995532517038367,0,1,ornithine carbamoyltransferase activity,MF,
2069,GO:0004586,1,0.98724728098565,0,2,ornithine decarboxylase activity,MF,
2070,GO:0004587,1,0.994909511305389,0,1,ornithine-oxo-acid transaminase activity,MF,
2071,GO:0004588,1,0.99365273263305,0,1,orotate phosphoribosyltransferase activity,MF,
2072,GO:0004590,1,0.99365273263305,0,1,orotidine-5'-phosphate decarboxylase activity,MF,
2073,GO:0004591,1,0.977201994932212,0,3,oxoglutarate dehydrogenase (succinyl-transferring) activity,MF,
2074,GO:0004594,1,0.981935782217274,0,3,pantothenate kinase activity,MF,
2075,GO:0004595,1,0.994290152493709,0,1,pantetheine-phosphate adenylyltransferase activity,MF,
2076,GO:0004596,1,0.940023584433033,0,10,peptide alpha-N-acetyltransferase activity,MF,
2077,GO:0004597,1,0.992778928954218,0,1,peptide-aspartate beta-dioxygenase activity,MF,
2078,GO:0004598,1,0.99273603595309,0,1,peptidylamidoglycolate lyase activity,MF,
2079,GO:0004601,1,0.804545171355091,0,45,peroxidase activity,MF,
2080,GO:0004602,1,0.934010717031825,0,17,glutathione peroxidase activity,MF,
2081,GO:0004603,1,0.996319719131459,0,1,phenylethanolamine N-methyltransferase activity,MF,
2082,GO:0004605,1,0.979496778425308,0,3,phosphatidate cytidylyltransferase activity,MF,
2083,GO:0004607,1,0.996021656013653,0,1,phosphatidylcholine-sterol O-acyltransferase activity,MF,
2084,GO:0004608,1,0.996544990523016,0,1,phosphatidylethanolamine N-methyltransferase activity,MF,
2085,GO:0004609,1,0.988264611914406,0,2,phosphatidylserine decarboxylase activity,MF,
2086,GO:0004610,1,0.994875100991796,0,1,phosphoacetylglucosamine mutase activity,MF,
2087,GO:0004611,1,0.988581622702898,0,2,phosphoenolpyruvate carboxykinase activity,MF,
2088,GO:0004613,1,0.988581622702898,0,2,phosphoenolpyruvate carboxykinase (GTP) activity,MF,
2089,GO:0004614,1,0.981936464502315,0,3,phosphoglucomutase activity,MF,
2090,GO:0004615,1,0.99038774807492,0,2,phosphomannomutase activity,MF,
2091,GO:0004616,1,0.99498492618181,0,1,phosphogluconate dehydrogenase (decarboxylating) activity,MF,
2092,GO:0004617,1,0.994833726064617,0,1,phosphoglycerate dehydrogenase activity,MF,
2093,GO:0004618,1,0.994047495011617,0,1,phosphoglycerate kinase activity,MF,
2094,GO:0004619,1,0.982734718822758,0,4,phosphoglycerate mutase activity,MF,
2096,GO:0004621,1,0.994306503233258,0,1,glycosylphosphatidylinositol phospholipase D activity,MF,
2097,GO:0004622,1,0.874903452388021,0,22,lysophospholipase activity,MF,
2098,GO:0004623,1,0.896153407124447,0,18,phospholipase A2 activity,MF,
2100,GO:0004630,1,0.969010398004413,0,5,phospholipase D activity,MF,
2101,GO:0004631,1,0.996109044487057,0,1,phosphomevalonate kinase activity,MF,
2102,GO:0004632,1,0.996160965578581,0,1,phosphopantothenate--cysteine ligase activity,MF,
2103,GO:0004633,1,0.99444337062802,0,1,phosphopantothenoylcysteine decarboxylase activity,MF,
2104,GO:0004634,1,0.978700064858602,0,4,phosphopyruvate hydratase activity,MF,
2105,GO:0004637,1,0.992870786530169,0,1,phosphoribosylamine-glycine ligase activity,MF,
2106,GO:0004638,1,0.992930320419855,0,1,phosphoribosylaminoimidazole carboxylase activity,MF,
2107,GO:0004639,1,0.992930320419855,0,1,phosphoribosylaminoimidazolesuccinocarboxamide synthase activity,MF,
2108,GO:0004641,1,0.992870786530169,0,1,phosphoribosylformylglycinamidine cyclo-ligase activity,MF,
2109,GO:0004642,1,0.991610936949817,0,1,phosphoribosylformylglycinamidine synthase activity,MF,
2110,GO:0004643,1,0.994681602725893,0,1,phosphoribosylaminoimidazolecarboxamide formyltransferase activity,MF,
2111,GO:0004644,1,0.992870786530169,0,1,phosphoribosylglycinamide formyltransferase activity,MF,
2112,GO:0004645,1,0.960496431626237,0,6,1,4-alpha-oligoglucan phosphorylase activity,MF,
2113,GO:0004647,1,0.985131185494347,0,3,phosphoserine phosphatase activity,MF,
2114,GO:0004648,1,0.99463713781154,0,1,O-phospho-L-serine:2-oxoglutarate aminotransferase activity,MF,
2115,GO:0004649,1,0.992479366854662,0,1,poly(ADP-ribose) glycohydrolase activity,MF,
2116,GO:0004651,1,0.987930449596804,0,2,polynucleotide 5'-phosphatase activity,MF,
2117,GO:0004652,1,0.957211521356449,0,6,polynucleotide adenylyltransferase activity,MF,
2118,GO:0004653,1,0.881654197302312,0,18,polypeptide N-acetylgalactosaminyltransferase activity,MF,
2119,GO:0004654,1,0.992260625091134,0,1,polyribonucleotide nucleotidyltransferase activity,MF,
2120,GO:0004655,1,0.993037838150083,0,1,porphobilinogen synthase activity,MF,
2121,GO:0004656,1,0.970711356751754,0,5,procollagen-proline 4-dioxygenase activity,MF,
2122,GO:0004657,1,0.99444337062802,0,1,proline dehydrogenase activity,MF,
2123,GO:0004658,1,0.989213190718047,0,2,propionyl-CoA carboxylase activity,MF,
2124,GO:0004659,1,0.897403053608959,0,17,prenyltransferase activity,MF,
2125,GO:0004660,1,0.989054119346575,0,2,protein farnesyltransferase activity,MF,
2126,GO:0004661,1,0.972504156415425,0,5,protein geranylgeranyltransferase activity,MF,
2127,GO:0004662,1,0.989185643592744,0,2,CAAX-protein geranylgeranyltransferase activity,MF,
2128,GO:0004663,1,0.978827294475894,0,4,Rab geranylgeranyltransferase activity,MF,
2129,GO:0004666,1,0.984315283926502,0,2,prostaglandin-endoperoxide synthase activity,MF,
2130,GO:0004667,1,0.987715435847842,0,3,prostaglandin-D synthase activity,MF,
2131,GO:0004668,1,0.972737880113778,0,4,protein-arginine deiminase activity,MF,
2132,GO:0004671,1,0.992104654937198,0,1,protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity,MF,
2134,GO:0004673,1,0.996885377699883,0,1,protein histidine kinase activity,MF,
2136,GO:0004675,1,0.866693832833367,0,17,transmembrane receptor protein serine/threonine kinase activity,MF,
2137,GO:0004676,1,0.990161200443591,0,1,3-phosphoinositide-dependent protein kinase activity,MF,
2138,GO:0004677,1,0.972077882338628,0,2,DNA-dependent protein kinase activity,MF,
2139,GO:0004679,1,0.941889768928434,0,8,AMP-activated protein kinase activity,MF,
2141,GO:0004686,1,0.989841399897807,0,1,elongation factor-2 kinase activity,MF,
2142,GO:0004687,1,0.964270488761304,0,4,myosin light chain kinase activity,MF,
2143,GO:0004689,1,0.96315986685766,0,5,phosphorylase kinase activity,MF,
2144,GO:0004690,1,0.936980328527075,0,8,cyclic nucleotide-dependent protein kinase activity,MF,
2145,GO:0004691,1,0.950599734737076,0,6,cAMP-dependent protein kinase activity,MF,
2146,GO:0004692,1,0.98568002505363,0,2,cGMP-dependent protein kinase activity,MF,
2147,GO:0004693,1,0.836885942833039,0,28,cyclin-dependent protein serine/threonine kinase activity,MF,
2148,GO:0004694,1,0.969972575626154,0,4,eukaryotic translation initiation factor 2alpha kinase activity,MF,
2149,GO:0004697,1,0.890737004156613,0,15,protein kinase C activity,MF,
2150,GO:0004698,1,0.890737004156613,0,15,calcium-dependent protein kinase C activity,MF,
2151,GO:0004699,1,0.985013952758656,0,2,calcium-independent protein kinase C activity,MF,
2152,GO:0004703,1,0.971838584150656,0,5,G protein-coupled receptor kinase activity,MF,
2153,GO:0004704,1,0.967562897435851,0,5,NF-kappaB-inducing kinase activity,MF,
2154,GO:0004705,1,0.981103396872132,0,3,JUN kinase activity,MF,
2155,GO:0004706,1,0.945110322726998,0,8,JUN kinase kinase kinase activity,MF,
2156,GO:0004707,1,0.884640049028639,0,19,MAP kinase activity,MF,
2157,GO:0004708,1,0.894716596151823,0,17,MAP kinase kinase activity,MF,
2158,GO:0004709,1,0.854399643906781,0,21,MAP kinase kinase kinase activity,MF,
2159,GO:0004711,1,0.952397641659171,0,6,ribosomal protein S6 kinase activity,MF,
2160,GO:0004712,1,0.739328654629534,0,44,protein serine/threonine/tyrosine kinase activity,MF,
2162,GO:0004714,1,0.616331821468207,0,61,transmembrane receptor protein tyrosine kinase activity,MF,
2164,GO:0004719,1,0.980700126594474,0,3,protein-L-isoaspartate (D-aspartate) O-methyltransferase activity,MF,
2165,GO:0004720,1,0.965843842345706,0,5,protein-lysine 6-oxidase activity,MF,
2168,GO:0004723,1,0.94801728825899,0,7,calcium-dependent protein serine/threonine phosphatase activity,MF,
2169,GO:0004724,1,0.928575918701924,0,11,magnesium-dependent protein serine/threonine phosphatase activity,MF,
2171,GO:0004726,1,0.943629711897695,0,9,non-membrane spanning protein tyrosine phosphatase activity,MF,
2172,GO:0004727,1,0.99090183194683,0,2,prenylated protein tyrosine phosphatase activity,MF,
2173,GO:0004729,1,0.995362589881229,0,1,oxygen-dependent protoporphyrinogen oxidase activity,MF,
2174,GO:0004731,1,0.979712372818966,0,3,purine-nucleoside phosphorylase activity,MF,
2175,GO:0004733,1,0.992860299816487,0,1,pyridoxamine-phosphate oxidase activity,MF,
2176,GO:0004735,1,0.984114216965894,0,3,pyrroline-5-carboxylate reductase activity,MF,
2177,GO:0004736,1,0.992607754396441,0,1,pyruvate carboxylase activity,MF,
2178,GO:0004738,1,0.967922618008987,0,5,pyruvate dehydrogenase activity,MF,
2179,GO:0004739,1,0.988672952531928,0,2,pyruvate dehydrogenase (acetyl-transferring) activity,MF,
2180,GO:0004740,1,0.969615206500623,0,4,pyruvate dehydrogenase (acetyl-transferring) kinase activity,MF,
2181,GO:0004741,1,0.985247323265339,0,2,[pyruvate dehydrogenase (lipoamide)] phosphatase activity,MF,
2182,GO:0004742,1,0.992425960311283,0,1,dihydrolipoyllysine-residue acetyltransferase activity,MF,
2183,GO:0004743,1,0.986698117576669,0,2,pyruvate kinase activity,MF,
2184,GO:0004744,1,0.993716915438455,0,1,retinal isomerase activity,MF,
2185,GO:0004745,1,0.928282811755214,0,14,retinol dehydrogenase activity,MF,
2186,GO:0004747,1,0.996256147268522,0,1,ribokinase activity,MF,
2188,GO:0004749,1,0.977840743446532,0,4,ribose phosphate diphosphokinase activity,MF,
2189,GO:0004750,1,0.994288231322732,0,1,ribulose-phosphate 3-epimerase activity,MF,
2190,GO:0004751,1,0.995191407578098,0,1,ribose-5-phosphate isomerase activity,MF,
2191,GO:0004753,1,0.991183072183191,0,1,saccharopine dehydrogenase activity,MF,
2192,GO:0004756,1,0.988137761316966,0,2,selenide, water dikinase activity,MF,
2193,GO:0004757,1,0.995860038144564,0,1,sepiapterin reductase activity,MF,
2194,GO:0004758,1,0.965245815211507,0,5,serine C-palmitoyltransferase activity,MF,
2195,GO:0004760,1,0.995616145417115,0,1,serine-pyruvate transaminase activity,MF,
2196,GO:0004766,1,0.996142236560983,0,1,spermidine synthase activity,MF,
2197,GO:0004767,1,0.969348399916891,0,5,sphingomyelin phosphodiesterase activity,MF,
2198,GO:0004768,1,0.978534503822289,0,3,stearoyl-CoA 9-desaturase activity,MF,
2199,GO:0004769,1,0.992499880361655,0,2,steroid delta-isomerase activity,MF,
2200,GO:0004771,1,0.94164382127051,0,9,sterol esterase activity,MF,
2201,GO:0004772,1,0.992895096867418,0,1,sterol O-acyltransferase activity,MF,
2202,GO:0004773,1,0.990747204703597,0,1,steryl-sulfatase activity,MF,
2203,GO:0004774,1,0.984652328196657,0,3,succinate-CoA ligase activity,MF,
2204,GO:0004775,1,0.984652328196657,0,3,succinate-CoA ligase (ADP-forming) activity,MF,
2205,GO:0004776,1,0.984652328196657,0,3,succinate-CoA ligase (GDP-forming) activity,MF,
2206,GO:0004777,1,0.991828016275873,0,1,succinate-semialdehyde dehydrogenase (NAD+) activity,MF,
2207,GO:0004778,1,0.991904377222391,0,2,succinyl-CoA hydrolase activity,MF,
2208,GO:0004779,1,0.986558803582698,0,2,sulfate adenylyltransferase activity,MF,
2209,GO:0004781,1,0.986558803582698,0,2,sulfate adenylyltransferase (ATP) activity,MF,
2210,GO:0004782,1,0.993577168431364,0,1,sulfinoalanine decarboxylase activity,MF,
2211,GO:0004784,1,0.979431511421267,0,5,superoxide dismutase activity,MF,
2212,GO:0004788,1,0.994172121860078,0,1,thiamine diphosphokinase activity,MF,
2213,GO:0004790,1,0.993817036477932,0,1,thioether S-methyltransferase activity,MF,
2214,GO:0004791,1,0.966819051285979,0,6,thioredoxin-disulfide reductase activity,MF,
2215,GO:0004792,1,0.986253657010854,0,3,thiosulfate sulfurtransferase activity,MF,
2216,GO:0004793,1,0.988423017874078,0,2,threonine aldolase activity,MF,
2217,GO:0004794,1,0.991579765811707,0,2,L-threonine ammonia-lyase activity,MF,
2218,GO:0004796,1,0.988391794983002,0,2,thromboxane-A synthase activity,MF,
2219,GO:0004797,1,0.987574994668126,0,2,thymidine kinase activity,MF,
2220,GO:0004798,1,0.989589739756803,0,2,thymidylate kinase activity,MF,
2221,GO:0004799,1,0.995647054770847,0,1,thymidylate synthase activity,MF,
2222,GO:0004800,1,0.9854740276823,0,2,thyroxine 5'-deiodinase activity,MF,
2223,GO:0004801,1,0.996188513865945,0,1,sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity,MF,
2224,GO:0004802,1,0.988369466792362,0,2,transketolase activity,MF,
2225,GO:0004803,1,0.985522398273702,0,2,transposase activity,MF,
2226,GO:0004806,1,0.864823746845618,0,23,triglyceride lipase activity,MF,
2227,GO:0004807,1,0.995855178946836,0,1,triose-phosphate isomerase activity,MF,
2228,GO:0004809,1,0.983044240086405,0,3,tRNA (guanine-N2-)-methyltransferase activity,MF,
2229,GO:0004810,1,0.994332545728782,0,1,tRNA adenylyltransferase activity,MF,
2230,GO:0004812,1,0.874506419677539,0,22,aminoacyl-tRNA ligase activity,MF,
2231,GO:0004813,1,0.987227239783761,0,2,alanine-tRNA ligase activity,MF,
2232,GO:0004814,1,0.989591739446053,0,2,arginine-tRNA ligase activity,MF,
2233,GO:0004815,1,0.992920493834486,0,1,aspartate-tRNA ligase activity,MF,
2234,GO:0004816,1,0.994329647803158,0,1,asparagine-tRNA ligase activity,MF,
2235,GO:0004817,1,0.99512448443958,0,1,cysteine-tRNA ligase activity,MF,
2236,GO:0004818,1,0.992654243017916,0,1,glutamate-tRNA ligase activity,MF,
2237,GO:0004821,1,0.993921306041506,0,1,histidine-tRNA ligase activity,MF,
2238,GO:0004822,1,0.992812801451679,0,1,isoleucine-tRNA ligase activity,MF,
2239,GO:0004823,1,0.992504558891871,0,1,leucine-tRNA ligase activity,MF,
2240,GO:0004825,1,0.993183302973226,0,1,methionine-tRNA ligase activity,MF,
2241,GO:0004826,1,0.978554175960936,0,4,phenylalanine-tRNA ligase activity,MF,
2242,GO:0004827,1,0.994206148392755,0,1,proline-tRNA ligase activity,MF,
2243,GO:0004828,1,0.994730037869166,0,1,serine-tRNA ligase activity,MF,
2244,GO:0004829,1,0.994127094388793,0,1,threonine-tRNA ligase activity,MF,
2245,GO:0004830,1,0.99341659294271,0,1,tryptophan-tRNA ligase activity,MF,
2246,GO:0004831,1,0.994561171467547,0,1,tyrosine-tRNA ligase activity,MF,
2247,GO:0004832,1,0.992780065780765,0,1,valine-tRNA ligase activity,MF,
2248,GO:0004833,1,0.991134054283878,0,2,tryptophan 2,3-dioxygenase activity,MF,
2249,GO:0004835,1,0.991822954314478,0,1,tubulin-tyrosine ligase activity,MF,
2250,GO:0004838,1,0.993492449495572,0,1,L-tyrosine:2-oxoglutarate aminotransferase activity,MF,
2251,GO:0004839,1,0.977611336392198,0,3,ubiquitin activating enzyme activity,MF,
2253,GO:0004843,1,0.541006733370505,0,80,thiol-dependent ubiquitin-specific protease activity,MF,
2254,GO:0004844,1,0.979403425052703,0,4,uracil DNA N-glycosylase activity,MF,
2255,GO:0004849,1,0.979516214497182,0,4,uridine kinase activity,MF,
2256,GO:0004850,1,0.989342743016558,0,2,uridine phosphorylase activity,MF,
2257,GO:0004852,1,0.996016999871114,0,1,uroporphyrinogen-III synthase activity,MF,
2258,GO:0004853,1,0.995970119365463,0,1,uroporphyrinogen decarboxylase activity,MF,
2259,GO:0004854,1,0.983365146709887,0,2,xanthine dehydrogenase activity,MF,
2260,GO:0004855,1,0.991308120580807,0,1,xanthine oxidase activity,MF,
2261,GO:0004856,1,0.992750186535513,0,1,xylulokinase activity,MF,
2263,GO:0004859,1,0.964515908829455,0,8,phospholipase inhibitor activity,MF,
2264,GO:0004860,1,0.692984085728845,0,59,protein kinase inhibitor activity,MF,
2265,GO:0004861,1,0.936502190354688,0,12,cyclin-dependent protein serine/threonine kinase inhibitor activity,MF,
2266,GO:0004862,1,0.953414919406535,0,8,cAMP-dependent protein kinase inhibitor activity,MF,
2270,GO:0004867,1,0.68468170506283,0,64,serine-type endopeptidase inhibitor activity,MF,
2272,GO:0004873,1,0.9917132250533,0,2,asialoglycoprotein receptor activity,MF,
2273,GO:0004875,1,0.94162955213784,0,9,complement receptor activity,MF,
2274,GO:0004876,1,0.994969292905976,0,1,complement component C3a receptor activity,MF,
2275,GO:0004877,1,0.988255070026608,0,1,complement component C3b receptor activity,MF,
2276,GO:0004878,1,0.987736458624979,0,2,complement component C5a receptor activity,MF,
2277,GO:0004879,1,0.692928784042853,0,49,nuclear receptor activity,MF,
2278,GO:0004883,1,0.990539308833184,0,1,glucocorticoid receptor activity,MF,
2281,GO:0004896,1,0.572722481708826,0,87,cytokine receptor activity,MF,
2282,GO:0004897,1,0.941248005975056,0,7,ciliary neurotrophic factor receptor activity,MF,
2283,GO:0004900,1,0.995164721520779,0,1,erythropoietin receptor activity,MF,
2284,GO:0004903,1,0.992419139235533,0,1,growth hormone receptor activity,MF,
2285,GO:0004904,1,0.96980069638266,0,5,interferon receptor activity,MF,
2286,GO:0004905,1,0.986961624551999,0,2,type I interferon receptor activity,MF,
2287,GO:0004906,1,0.989101232104662,0,2,interferon-gamma receptor activity,MF,
2288,GO:0004908,1,0.956732991376361,0,7,interleukin-1 receptor activity,MF,
2289,GO:0004909,1,0.987001291026769,0,2,interleukin-1, type I, activating receptor activity,MF,
2290,GO:0004910,1,0.98914346902253,0,2,interleukin-1, type II, blocking receptor activity,MF,
2291,GO:0004911,1,0.981450098904205,0,3,interleukin-2 receptor activity,MF,
2292,GO:0004912,1,0.992073680321259,0,1,interleukin-3 receptor activity,MF,
2293,GO:0004913,1,0.989870946550295,0,2,interleukin-4 receptor activity,MF,
2294,GO:0004914,1,0.986945992337843,0,2,interleukin-5 receptor activity,MF,
2295,GO:0004915,1,0.985634702558487,0,2,interleukin-6 receptor activity,MF,
2296,GO:0004917,1,0.991000331637924,0,2,interleukin-7 receptor activity,MF,
2297,GO:0004918,1,0.987481878191002,0,2,interleukin-8 receptor activity,MF,
2298,GO:0004920,1,0.987774042778535,0,2,interleukin-10 receptor activity,MF,
2299,GO:0004921,1,0.981119870888854,0,3,interleukin-11 receptor activity,MF,
2300,GO:0004923,1,0.953178031635698,0,5,leukemia inhibitory factor receptor activity,MF,
2301,GO:0004924,1,0.953178031635698,0,5,oncostatin-M receptor activity,MF,
2302,GO:0004925,1,0.986323792207273,0,1,prolactin receptor activity,MF,
2304,GO:0004931,1,0.961565753691147,0,7,extracellularly ATP-gated cation channel activity,MF,
2305,GO:0004935,1,0.953018201336028,0,8,adrenergic receptor activity,MF,
2306,GO:0004936,1,0.970533854248686,0,5,alpha-adrenergic receptor activity,MF,
2307,GO:0004937,1,0.982639419726042,0,3,alpha1-adrenergic receptor activity,MF,
2308,GO:0004938,1,0.987682707184241,0,2,alpha2-adrenergic receptor activity,MF,
2309,GO:0004939,1,0.98195790982711,0,3,beta-adrenergic receptor activity,MF,
2310,GO:0004940,1,0.993369666664661,0,1,beta1-adrenergic receptor activity,MF,
2311,GO:0004941,1,0.994802155015821,0,1,beta2-adrenergic receptor activity,MF,
2312,GO:0004945,1,0.98693094037739,0,3,angiotensin type II receptor activity,MF,
2313,GO:0004946,1,0.995933779426078,0,1,bombesin receptor activity,MF,
2314,GO:0004947,1,0.988675870931292,0,2,bradykinin receptor activity,MF,
2315,GO:0004948,1,0.984796278976506,0,2,calcitonin receptor activity,MF,
2317,GO:0004950,1,0.866923486804344,0,25,chemokine receptor activity,MF,
2318,GO:0004951,1,0.990141657417038,0,2,cholecystokinin receptor activity,MF,
2319,GO:0004952,1,0.972665381574716,0,5,dopamine neurotransmitter receptor activity,MF,
2320,GO:0004953,1,0.915465217258578,0,15,icosanoid receptor activity,MF,
2321,GO:0004954,1,0.935679280077458,0,11,prostanoid receptor activity,MF,
2322,GO:0004955,1,0.941003777740849,0,10,prostaglandin receptor activity,MF,
2323,GO:0004956,1,0.986801392967316,0,2,prostaglandin D receptor activity,MF,
2324,GO:0004957,1,0.97148011483672,0,5,prostaglandin E receptor activity,MF,
2325,GO:0004958,1,0.985162631949657,0,2,prostaglandin F receptor activity,MF,
2326,GO:0004960,1,0.994345115448986,0,1,thromboxane receptor activity,MF,
2327,GO:0004961,1,0.994345115448986,0,1,thromboxane A2 receptor activity,MF,
2328,GO:0004962,1,0.985216981583427,0,2,endothelin receptor activity,MF,
2329,GO:0004965,1,0.976385603614195,0,3,G protein-coupled GABA receptor activity,MF,
2330,GO:0004966,1,0.98283577150678,0,4,galanin receptor activity,MF,
2331,GO:0004967,1,0.988615265462747,0,2,glucagon receptor activity,MF,
2332,GO:0004968,1,0.992489771890766,0,1,gonadotropin-releasing hormone receptor activity,MF,
2333,GO:0004969,1,0.968041268954461,0,5,histamine receptor activity,MF,
2335,GO:0004971,1,0.967191632366839,0,4,AMPA glutamate receptor activity,MF,
2337,GO:0004974,1,0.978410592231889,0,4,leukotriene receptor activity,MF,
2338,GO:0004977,1,0.980859192165973,0,4,melanocortin receptor activity,MF,
2339,GO:0004979,1,0.995137923412935,0,1,beta-endorphin receptor activity,MF,
2340,GO:0004980,1,0.989041775563502,0,2,melanocyte-stimulating hormone receptor activity,MF,
2341,GO:0004982,1,0.985010694264898,0,3,N-formyl peptide receptor activity,MF,
2343,GO:0004984,1,0.932061045763869,0,16,olfactory receptor activity,MF,
2344,GO:0004985,1,0.954483969902468,0,9,opioid receptor activity,MF,
2345,GO:0004990,1,0.992423485405219,0,1,oxytocin receptor activity,MF,
2346,GO:0004991,1,0.988206060624149,0,2,parathyroid hormone receptor activity,MF,
2347,GO:0004992,1,0.979786647774147,0,3,platelet activating factor receptor activity,MF,
2349,GO:0004994,1,0.977187061934357,0,4,somatostatin receptor activity,MF,
2350,GO:0004995,1,0.9825069356659,0,3,tachykinin receptor activity,MF,
2351,GO:0004996,1,0.988889890537701,0,2,thyroid-stimulating hormone receptor activity,MF,
2352,GO:0004998,1,0.985187469975558,0,2,transferrin receptor activity,MF,
2353,GO:0004999,1,0.981721746381808,0,3,vasoactive intestinal polypeptide receptor activity,MF,
2354,GO:0005000,1,0.963536249258997,0,6,vasopressin receptor activity,MF,
2355,GO:0005001,1,0.8568516748817,0,17,transmembrane receptor protein tyrosine phosphatase activity,MF,
2356,GO:0005003,1,0.87017147204722,0,19,ephrin receptor activity,MF,
2357,GO:0005004,1,0.944493534925565,0,7,GPI-linked ephrin receptor activity,MF,
2358,GO:0005005,1,0.881597080793613,0,17,transmembrane-ephrin receptor activity,MF,
2359,GO:0005006,1,0.987391045386709,0,2,epidermal growth factor-activated receptor activity,MF,
2360,GO:0005007,1,0.963259415028361,0,5,fibroblast growth factor-activated receptor activity,MF,
2361,GO:0005008,1,0.990498239420871,0,1,hepatocyte growth factor-activated receptor activity,MF,
2362,GO:0005009,1,0.968077026785472,0,3,insulin-activated receptor activity,MF,
2363,GO:0005010,1,0.966952866108348,0,3,insulin-like growth factor-activated receptor activity,MF,
2364,GO:0005011,1,0.984799690253486,0,2,macrophage colony-stimulating factor receptor activity,MF,
2365,GO:0005017,1,0.97782655247117,0,3,platelet-derived growth factor-activated receptor activity,MF,
2366,GO:0005018,1,0.990562050650331,0,1,platelet-derived growth factor alpha-receptor activity,MF,
2367,GO:0005019,1,0.987144369750802,0,2,platelet-derived growth factor beta-receptor activity,MF,
2368,GO:0005020,1,0.991803495022634,0,1,stem cell factor receptor activity,MF,
2369,GO:0005021,1,0.945097794506884,0,7,vascular endothelial growth factor-activated receptor activity,MF,
2370,GO:0005024,1,0.904480329126672,0,12,transforming growth factor beta-activated receptor activity,MF,
2371,GO:0005025,1,0.961391744152933,0,5,transforming growth factor beta receptor activity, type I,MF,
2372,GO:0005026,1,0.992214717025153,0,1,transforming growth factor beta receptor activity, type II,MF,
2373,GO:0005030,1,0.967684815646607,0,4,neurotrophin receptor activity,MF,
2374,GO:0005031,1,0.945650079094226,0,10,tumor necrosis factor-activated receptor activity,MF,
2375,GO:0005034,1,0.970358978246271,0,4,osmosensor activity,MF,
2376,GO:0005035,1,0.934555415275705,0,12,death receptor activity,MF,
2377,GO:0005041,1,0.899330971303238,0,12,low-density lipoprotein particle receptor activity,MF,
2378,GO:0005042,1,0.949225581709961,0,6,netrin receptor activity,MF,
2379,GO:0005043,1,0.992767886172341,0,1,netrin receptor activity involved in chemorepulsion,MF,
2380,GO:0005044,1,0.735978762110829,0,43,scavenger receptor activity,MF,
2381,GO:0005046,1,0.98538632313689,0,3,KDEL sequence binding,MF,
2382,GO:0005047,1,0.982339998619791,0,3,signal recognition particle binding,MF,
2383,GO:0005048,1,0.755841240381452,0,41,signal sequence binding,MF,
2384,GO:0005049,1,0.923512054011401,0,10,nuclear export signal receptor activity,MF,
2385,GO:0005052,1,0.985893603376691,0,2,peroxisome matrix targeting signal-1 binding,MF,
2386,GO:0005053,1,0.995812805107891,0,1,peroxisome matrix targeting signal-2 binding,MF,
2387,GO:0005055,1,0.99041292160774,0,2,laminin receptor activity,MF,
2388,GO:0005068,1,0.915142489461381,0,13,transmembrane receptor protein tyrosine kinase adaptor activity,MF,
2389,GO:0005078,1,0.910551440803677,0,11,MAP-kinase scaffold activity,MF,
2391,GO:0005085,1,0.186777941312023,0,209,guanyl-nucleotide exchange factor activity,MF,
2392,GO:0005086,1,0.853081531401653,0,19,ARF guanyl-nucleotide exchange factor activity,MF,
2393,GO:0005087,1,0.979674643196786,0,4,Ran guanyl-nucleotide exchange factor activity,MF,
2394,GO:0005088,1,0.398192008419677,0,113,Ras guanyl-nucleotide exchange factor activity,MF,
2395,GO:0005089,1,0.605026768275319,0,59,Rho guanyl-nucleotide exchange factor activity,MF,
2396,GO:0005090,1,0.994543446778112,0,1,Sar guanyl-nucleotide exchange factor activity,MF,
2397,GO:0005092,1,0.900900246899547,0,16,GDP-dissociation inhibitor activity,MF,
2398,GO:0005093,1,0.988170328359349,0,2,Rab GDP-dissociation inhibitor activity,MF,
2399,GO:0005094,1,0.988032442383408,0,3,Rho GDP-dissociation inhibitor activity,MF,
2400,GO:0005095,1,0.910509351951135,0,14,GTPase inhibitor activity,MF,
2401,GO:0005096,1,0.143760786698891,0,252,GTPase activator activity,MF,
2403,GO:0005104,1,0.891104115823814,0,19,fibroblast growth factor receptor binding,MF,
2404,GO:0005105,1,0.982906641482924,0,4,type 1 fibroblast growth factor receptor binding,MF,
2405,GO:0005109,1,0.800804340255029,0,34,frizzled binding,MF,
2406,GO:0005111,1,0.978311390622417,0,5,type 2 fibroblast growth factor receptor binding,MF,
2407,GO:0005112,1,0.830553719753593,0,22,Notch binding,MF,
2408,GO:0005113,1,0.949978438073404,0,8,patched binding,MF,
2409,GO:0005114,1,0.944142855996797,0,8,type II transforming growth factor beta receptor binding,MF,
2410,GO:0005115,1,0.991228585807255,0,1,receptor tyrosine kinase-like orphan receptor binding,MF,
2411,GO:0005119,1,0.975194738788909,0,3,smoothened binding,MF,
2412,GO:0005123,1,0.892630991377711,0,19,death receptor binding,MF,
2413,GO:0005124,1,0.979939686936925,0,4,scavenger receptor binding,MF,
2414,GO:0005125,1,0.438790351953559,0,162,cytokine activity,MF,
2415,GO:0005126,1,0.318936326462522,0,196,cytokine receptor binding,MF,
2416,GO:0005127,1,0.93952011195102,0,8,ciliary neurotrophic factor receptor binding,MF,
2417,GO:0005128,1,0.989069367608075,0,2,erythropoietin receptor binding,MF,
2418,GO:0005130,1,0.995761663016173,0,1,granulocyte colony-stimulating factor receptor binding,MF,
2419,GO:0005131,1,0.970858099169505,0,4,growth hormone receptor binding,MF,
2420,GO:0005134,1,0.981983263996188,0,3,interleukin-2 receptor binding,MF,
2421,GO:0005135,1,0.992978698265695,0,1,interleukin-3 receptor binding,MF,
2422,GO:0005136,1,0.988458399338786,0,2,interleukin-4 receptor binding,MF,
2423,GO:0005137,1,0.994545415406379,0,1,interleukin-5 receptor binding,MF,
2424,GO:0005138,1,0.958833747239116,0,7,interleukin-6 receptor binding,MF,
2425,GO:0005139,1,0.988649673052252,0,2,interleukin-7 receptor binding,MF,
2426,GO:0005141,1,0.995571065959689,0,1,interleukin-10 receptor binding,MF,
2427,GO:0005142,1,0.994183440541481,0,1,interleukin-11 receptor binding,MF,
2428,GO:0005143,1,0.975691673509592,0,4,interleukin-12 receptor binding,MF,
2429,GO:0005144,1,0.996134718669981,0,1,interleukin-13 receptor binding,MF,
2430,GO:0005146,1,0.988205243519531,0,2,leukemia inhibitory factor receptor binding,MF,
2431,GO:0005147,1,0.99514750660631,0,1,oncostatin-M receptor binding,MF,
2432,GO:0005148,1,0.996267059726509,0,1,prolactin receptor binding,MF,
2433,GO:0005149,1,0.93031090460567,0,11,interleukin-1 receptor binding,MF,
2434,GO:0005150,1,0.988120619044003,0,2,interleukin-1, type I receptor binding,MF,
2435,GO:0005151,1,0.986996787451653,0,2,interleukin-1, type II receptor binding,MF,
2436,GO:0005152,1,0.985686651857684,0,2,interleukin-1 receptor antagonist activity,MF,
2437,GO:0005153,1,0.986510069673359,0,2,interleukin-8 receptor binding,MF,
2438,GO:0005154,1,0.800199301499705,0,30,epidermal growth factor receptor binding,MF,
2439,GO:0005157,1,0.985181909778778,0,3,macrophage colony-stimulating factor receptor binding,MF,
2440,GO:0005158,1,0.823564605297053,0,22,insulin receptor binding,MF,
2441,GO:0005159,1,0.909694383104315,0,13,insulin-like growth factor receptor binding,MF,
2442,GO:0005160,1,0.849415415406901,0,24,transforming growth factor beta receptor binding,MF,
2443,GO:0005161,1,0.897781717734078,0,14,platelet-derived growth factor receptor binding,MF,
2444,GO:0005163,1,0.981928803989521,0,4,nerve growth factor receptor binding,MF,
2445,GO:0005164,1,0.85724467764311,0,29,tumor necrosis factor receptor binding,MF,
2446,GO:0005165,1,0.928797537701331,0,11,neurotrophin receptor binding,MF,
2447,GO:0005166,1,0.993666984581349,0,1,neurotrophin p75 receptor binding,MF,
2448,GO:0005167,1,0.951932083046898,0,6,neurotrophin TRK receptor binding,MF,
2449,GO:0005168,1,0.951932083046898,0,6,neurotrophin TRKA receptor binding,MF,
2450,GO:0005169,1,0.991674659298037,0,1,neurotrophin TRKB receptor binding,MF,
2451,GO:0005170,1,0.991674659298037,0,1,neurotrophin TRKC receptor binding,MF,
2452,GO:0005171,1,0.98966930603566,0,2,hepatocyte growth factor receptor binding,MF,
2453,GO:0005172,1,0.915137003158487,0,13,vascular endothelial growth factor receptor binding,MF,
2454,GO:0005173,1,0.966128757700224,0,4,stem cell factor receptor binding,MF,
2455,GO:0005174,1,0.989548852956832,0,2,CD40 receptor binding,MF,
2456,GO:0005175,1,0.996958153558103,0,1,CD27 receptor binding,MF,
2457,GO:0005176,1,0.982938999667221,0,3,ErbB-2 class receptor binding,MF,
2460,GO:0005183,1,0.992714537688978,0,2,gonadotropin hormone-releasing hormone activity,MF,
2468,GO:0005217,1,0.79138221931558,0,26,intracellular ligand-gated ion channel activity,MF,
2469,GO:0005219,1,0.947820678963595,0,4,ryanodine-sensitive calcium-release channel activity,MF,
2470,GO:0005220,1,0.962241387894571,0,3,inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,MF,
2471,GO:0005221,1,0.936776976075879,0,9,intracellular cyclic nucleotide activated cation channel activity,MF,
2472,GO:0005222,1,0.942901784176448,0,8,intracellular cAMP-activated cation channel activity,MF,
2473,GO:0005223,1,0.961050000441355,0,6,intracellular cGMP-activated cation channel activity,MF,
2474,GO:0005225,1,0.932106103301043,0,9,volume-sensitive anion channel activity,MF,
2475,GO:0005227,1,0.864418098752659,0,22,calcium activated cation channel activity,MF,
2476,GO:0005228,1,0.983332936044792,0,2,intracellular sodium activated potassium channel activity,MF,
2477,GO:0005229,1,0.892766365203977,0,16,intracellular calcium activated chloride channel activity,MF,
2482,GO:0005242,1,0.868624987670964,0,21,inward rectifier potassium channel activity,MF,
2483,GO:0005243,1,0.922853259874113,0,14,gap junction channel activity,MF,
2486,GO:0005246,1,0.779604787476308,0,42,calcium channel regulator activity,MF,
2487,GO:0005247,1,0.93351302305462,0,9,voltage-gated chloride channel activity,MF,
2488,GO:0005248,1,0.805682246198074,0,23,voltage-gated sodium channel activity,MF,
2490,GO:0005250,1,0.971848990097324,0,4,A-type (transient outward) potassium channel activity,MF,
2492,GO:0005252,1,0.992629128099668,0,1,open rectifier potassium channel activity,MF,
2495,GO:0005260,1,0.99094935654551,0,1,intracellularly ATP-gated chloride channel activity,MF,
2499,GO:0005272,1,0.693782814535829,0,43,sodium channel activity,MF,
2500,GO:0005275,1,0.982108006158698,0,3,amine transmembrane transporter activity,MF,
2501,GO:0005277,1,0.989258873748319,0,2,acetylcholine transmembrane transporter activity,MF,
2502,GO:0005280,1,0.985126492680312,0,2,amino acid:proton symporter activity,MF,
2503,GO:0005283,1,0.891800125143357,0,15,amino acid:sodium symporter activity,MF,
2504,GO:0005287,1,0.994158947353131,0,1,high-affinity basic amino acid transmembrane transporter activity,MF,
2505,GO:0005289,1,0.994158947353131,0,1,high-affinity arginine transmembrane transporter activity,MF,
2506,GO:0005290,1,0.966141648512299,0,5,L-histidine transmembrane transporter activity,MF,
2507,GO:0005292,1,0.994158947353131,0,1,high-affinity lysine transmembrane transporter activity,MF,
2508,GO:0005294,1,0.987991015504381,0,1,neutral L-amino acid secondary active transmembrane transporter activity,MF,
2509,GO:0005295,1,0.967871312345914,0,4,neutral amino acid:sodium symporter activity,MF,
2510,GO:0005298,1,0.976962752282488,0,3,proline:sodium symporter activity,MF,
2511,GO:0005302,1,0.993064816825511,0,1,L-tyrosine transmembrane transporter activity,MF,
2512,GO:0005308,1,0.979692004973333,0,3,creatine transmembrane transporter activity,MF,
2513,GO:0005309,1,0.9928210559604,0,1,creatine:sodium symporter activity,MF,
2516,GO:0005314,1,0.967445973625178,0,4,high-affinity glutamate transmembrane transporter activity,MF,
2518,GO:0005316,1,0.992966464844816,0,1,high-affinity inorganic phosphate:sodium symporter activity,MF,
2519,GO:0005319,1,0.454384693258614,0,115,lipid transporter activity,MF,
2520,GO:0005324,1,0.907425800857863,0,17,long-chain fatty acid transporter activity,MF,
2522,GO:0005328,1,0.992920493834486,0,1,neurotransmitter:sodium symporter activity,MF,
2523,GO:0005330,1,0.972422248265779,0,4,dopamine:sodium symporter activity,MF,
2524,GO:0005332,1,0.974914105143117,0,4,gamma-aminobutyric acid:sodium symporter activity,MF,
2525,GO:0005334,1,0.980845014912486,0,3,norepinephrine:sodium symporter activity,MF,
2526,GO:0005335,1,0.980858923137833,0,3,serotonin:sodium symporter activity,MF,
2527,GO:0005337,1,0.965588784684936,0,6,nucleoside transmembrane transporter activity,MF,
2528,GO:0005338,1,0.928804140418513,0,12,nucleotide-sugar transmembrane transporter activity,MF,
2530,GO:0005343,1,0.827811843885007,0,26,organic acid:sodium symporter activity,MF,
2531,GO:0005344,1,0.951178126883762,0,13,oxygen carrier activity,MF,
2532,GO:0005345,1,0.971159760697554,0,5,purine nucleobase transmembrane transporter activity,MF,
2533,GO:0005346,1,0.841834987474212,0,28,purine ribonucleotide transmembrane transporter activity,MF,
2534,GO:0005347,1,0.862423385685581,0,24,ATP transmembrane transporter activity,MF,
2535,GO:0005350,1,0.982512339031232,0,3,pyrimidine nucleobase transmembrane transporter activity,MF,
2536,GO:0005351,1,0.955744354066509,0,7,carbohydrate:proton symporter activity,MF,
2537,GO:0005353,1,0.975972045563522,0,4,fructose transmembrane transporter activity,MF,
2538,GO:0005354,1,0.992018909459589,0,1,galactose transmembrane transporter activity,MF,
2539,GO:0005355,1,0.883737122686018,0,19,glucose transmembrane transporter activity,MF,
2540,GO:0005362,1,0.98735393382061,0,2,low-affinity glucose:sodium symporter activity,MF,
2541,GO:0005365,1,0.969025528851209,0,3,myo-inositol transmembrane transporter activity,MF,
2542,GO:0005366,1,0.990200972424931,0,1,myo-inositol:proton symporter activity,MF,
2543,GO:0005367,1,0.978617082630758,0,2,myo-inositol:sodium symporter activity,MF,
2544,GO:0005368,1,0.9765820363949,0,3,taurine transmembrane transporter activity,MF,
2545,GO:0005369,1,0.990631249493595,0,1,taurine:sodium symporter activity,MF,
2546,GO:0005371,1,0.995616145417115,0,1,tricarboxylate secondary active transmembrane transporter activity,MF,
2548,GO:0005375,1,0.960313180149247,0,5,copper ion transmembrane transporter activity,MF,
2549,GO:0005381,1,0.93822504929422,0,10,iron ion transmembrane transporter activity,MF,
2550,GO:0005384,1,0.938839994462048,0,9,manganese ion transmembrane transporter activity,MF,
2552,GO:0005388,1,0.920911358028794,0,9,calcium transmembrane transporter activity, phosphorylative mechanism,MF,
2553,GO:0005391,1,0.934901273985335,0,11,sodium:potassium-exchanging ATPase activity,MF,
2554,GO:0005402,1,0.894282554559677,0,16,carbohydrate:cation symporter activity,MF,
2555,GO:0005412,1,0.95049199073221,0,7,glucose:sodium symporter activity,MF,
2556,GO:0005415,1,0.989255543358429,0,2,nucleoside:sodium symporter activity,MF,
2557,GO:0005416,1,0.878520857580101,0,17,amino acid:cation symporter activity,MF,
2558,GO:0005427,1,0.992743852065289,0,1,proton-dependent oligopeptide secondary active transmembrane transporter activity,MF,
2559,GO:0005432,1,0.935173932956048,0,9,calcium:sodium antiporter activity,MF,
2561,GO:0005451,1,0.914878161699155,0,12,monovalent cation:proton antiporter activity,MF,
2563,GO:0005456,1,0.995234987992997,0,1,CMP-N-acetylneuraminate transmembrane transporter activity,MF,
2564,GO:0005457,1,0.9930210826683,0,1,GDP-fucose transmembrane transporter activity,MF,
2565,GO:0005459,1,0.981607297380756,0,4,UDP-galactose transmembrane transporter activity,MF,
2566,GO:0005460,1,0.996269238416192,0,1,UDP-glucose transmembrane transporter activity,MF,
2567,GO:0005461,1,0.980541851418073,0,3,UDP-glucuronic acid transmembrane transporter activity,MF,
2568,GO:0005462,1,0.965820949401527,0,5,UDP-N-acetylglucosamine transmembrane transporter activity,MF,
2569,GO:0005463,1,0.980541851418073,0,3,UDP-N-acetylgalactosamine transmembrane transporter activity,MF,
2570,GO:0005464,1,0.990363169594414,0,1,UDP-xylose transmembrane transporter activity,MF,
2571,GO:0005477,1,0.992822526652983,0,1,pyruvate secondary active transmembrane transporter activity,MF,
2572,GO:0005483,1,0.980706668926755,0,3,soluble NSF attachment protein activity,MF,
2575,GO:0005496,1,0.551826218301574,0,91,steroid binding,MF,
2576,GO:0005497,1,0.981069391565595,0,4,androgen binding,MF,
2577,GO:0005499,1,0.968724720123577,0,5,vitamin D binding,MF,
2578,GO:0005501,1,0.870417615680536,0,25,retinoid binding,MF,
2579,GO:0005502,1,0.975370074323722,0,4,11-cis retinal binding,MF,
2580,GO:0005503,1,0.987150396071007,0,2,all-trans retinal binding,MF,
2581,GO:0005504,1,0.853372699877901,0,32,fatty acid binding,MF,
2583,GO:0005507,1,0.739911304976174,0,52,copper ion binding,MF,
2589,GO:0005519,1,0.992627756951482,0,1,cytoskeletal regulatory protein binding,MF,
2591,GO:0005521,1,0.887775741016351,0,16,lamin binding,MF,
2592,GO:0005522,1,0.904136114822754,0,11,profilin binding,MF,
2593,GO:0005523,1,0.915330058484141,0,15,tropomyosin binding,MF,
2596,GO:0005527,1,0.949251959821825,0,10,macrolide binding,MF,
2597,GO:0005528,1,0.957723668899999,0,8,FK506 binding,MF,
2598,GO:0005534,1,0.977844482262751,0,4,galactose binding,MF,
2599,GO:0005536,1,0.927367527410013,0,11,glucose binding,MF,
2600,GO:0005537,1,0.914551250092369,0,15,mannose binding,MF,
2606,GO:0005545,1,0.896395373234313,0,14,1-phosphatidylinositol binding,MF,
2609,GO:0005548,1,0.750346162178095,0,41,phospholipid transporter activity,MF,
2610,GO:0005549,1,0.966353954324219,0,10,odorant binding,MF,
2613,GO:0005577,1,0.959227360444771,0,6,fibrinogen complex,CC,
2614,GO:0005579,1,0.970821452494286,0,4,membrane attack complex,CC,
2615,GO:0005581,1,0.561997403087019,0,78,collagen trimer,CC,
2616,GO:0005582,1,0.991695476593035,0,1,collagen type XV trimer,CC,
2617,GO:0005583,1,0.899387678403549,0,12,fibrillar collagen trimer,CC,
2618,GO:0005584,1,0.982749479364559,0,2,collagen type I trimer,CC,
2619,GO:0005585,1,0.991931183276185,0,1,collagen type II trimer,CC,
2620,GO:0005586,1,0.99149712289247,0,1,collagen type III trimer,CC,
2621,GO:0005587,1,0.940947034226672,0,6,collagen type IV trimer,CC,
2622,GO:0005588,1,0.961979334784409,0,4,collagen type V trimer,CC,
2623,GO:0005589,1,0.977135432263037,0,3,collagen type VI trimer,CC,
2624,GO:0005590,1,0.988292410678583,0,1,collagen type VII trimer,CC,
2625,GO:0005591,1,0.993701478078327,0,1,collagen type VIII trimer,CC,
2626,GO:0005592,1,0.980983387621744,0,2,collagen type XI trimer,CC,
2627,GO:0005593,1,0.950992277007097,0,6,FACIT collagen trimer,CC,
2628,GO:0005594,1,0.980265087338823,0,3,collagen type IX trimer,CC,
2629,GO:0005595,1,0.987806343916041,0,1,collagen type XII trimer,CC,
2630,GO:0005596,1,0.990646159816037,0,1,collagen type XIV trimer,CC,
2631,GO:0005597,1,0.991395665866644,0,1,collagen type XVI trimer,CC,
2632,GO:0005598,1,0.993701478078327,0,1,short-chain collagen trimer,CC,
2633,GO:0005600,1,0.993147745928254,0,1,collagen type XIII trimer,CC,
2634,GO:0005602,1,0.992896861733,0,2,complement component C1 complex,CC,
2636,GO:0005606,1,0.969001926039928,0,3,laminin-1 complex,CC,
2637,GO:0005607,1,0.983151186367766,0,2,laminin-2 complex,CC,
2638,GO:0005608,1,0.979394354552226,0,2,laminin-3 complex,CC,
2639,GO:0005610,1,0.968776627221721,0,3,laminin-5 complex,CC,
2645,GO:0005637,1,0.700899177590158,0,53,nuclear inner membrane,CC,
2646,GO:0005638,1,0.97084842865762,0,5,lamin filament,CC,
2647,GO:0005639,1,0.913988435780824,0,14,integral component of nuclear inner membrane,CC,
2648,GO:0005640,1,0.822360950570503,0,25,nuclear outer membrane,CC,
2649,GO:0005641,1,0.93322775215426,0,9,nuclear envelope lumen,CC,
2650,GO:0005642,1,0.9526707211525,0,6,annulate lamellae,CC,
2651,GO:0005643,1,0.584575274500638,0,75,nuclear pore,CC,
2652,GO:0005652,1,0.932619139995335,0,11,nuclear lamina,CC,
2654,GO:0005655,1,0.975708538822473,0,5,nucleolar ribonuclease P complex,CC,
2655,GO:0005656,1,0.984288498641211,0,3,nuclear pre-replicative complex,CC,
2656,GO:0005657,1,0.654904620687453,0,65,replication fork,CC,
2657,GO:0005658,1,0.969115546055198,0,5,alpha DNA polymerase:primase complex,CC,
2658,GO:0005662,1,0.915517495486681,0,14,DNA replication factor A complex,CC,
2659,GO:0005663,1,0.97325909831629,0,5,DNA replication factor C complex,CC,
2660,GO:0005664,1,0.942885807601478,0,9,nuclear origin of replication recognition complex,CC,
2661,GO:0005665,1,0.927741645992671,0,15,RNA polymerase II, core complex,CC,
2662,GO:0005666,1,0.908934831441309,0,18,RNA polymerase III complex,CC,
2663,GO:0005667,1,0.0731871794631927,0,381,transcription regulator complex,CC,
2664,GO:0005668,1,0.990444451262501,0,2,RNA polymerase transcription factor SL1 complex,CC,
2665,GO:0005669,1,0.825018016058777,0,32,transcription factor TFIID complex,CC,
2666,GO:0005671,1,0.913782041368889,0,13,Ada2/Gcn5/Ada3 transcription activator complex,CC,
2667,GO:0005672,1,0.978390612499954,0,5,transcription factor TFIIA complex,CC,
2668,GO:0005673,1,0.988929982664503,0,2,transcription factor TFIIE complex,CC,
2669,GO:0005674,1,0.9897038468169,0,2,transcription factor TFIIF complex,CC,
2670,GO:0005675,1,0.934022861318157,0,12,transcription factor TFIIH holo complex,CC,
2671,GO:0005677,1,0.951270775670349,0,7,chromatin silencing complex,CC,
2673,GO:0005681,1,0.346739979615923,0,178,spliceosomal complex,CC,
2674,GO:0005682,1,0.916342854683085,0,16,U5 snRNP,CC,
2675,GO:0005683,1,0.972863184881859,0,7,U7 snRNP,CC,
2676,GO:0005684,1,0.609817603923157,0,87,U2-type spliceosomal complex,CC,
2677,GO:0005685,1,0.915049088852063,0,18,U1 snRNP,CC,
2678,GO:0005686,1,0.913538321871571,0,19,U2 snRNP,CC,
2679,GO:0005687,1,0.958746194094356,0,10,U4 snRNP,CC,
2680,GO:0005688,1,0.965645603873175,0,8,U6 snRNP,CC,
2681,GO:0005689,1,0.874910037107961,0,27,U12-type spliceosomal complex,CC,
2682,GO:0005690,1,0.994496266384301,0,1,U4atac snRNP,CC,
2683,GO:0005691,1,0.992406616605623,0,1,U6atac snRNP,CC,
2685,GO:0005697,1,0.877603769560381,0,20,telomerase holoenzyme complex,CC,
2686,GO:0005712,1,0.983498502919372,0,2,chiasma,CC,
2687,GO:0005713,1,0.993971236807866,0,1,recombination nodule,CC,
2688,GO:0005715,1,0.993971236807866,0,1,late recombination nodule,CC,
2689,GO:0005719,1,0.845333014924999,0,25,nuclear euchromatin,CC,
2690,GO:0005720,1,0.820746994557704,0,27,nuclear heterochromatin,CC,
2691,GO:0005721,1,0.872924679696609,0,18,pericentric heterochromatin,CC,
2692,GO:0005726,1,0.961370101504719,0,5,perichromatin fibrils,CC,
2694,GO:0005731,1,0.995412779025815,0,1,nucleolus organizer region,CC,
2695,GO:0005732,1,0.898690197754258,0,22,small nucleolar ribonucleoprotein complex,CC,
2696,GO:0005736,1,0.948907103965387,0,10,RNA polymerase I complex,CC,
2701,GO:0005742,1,0.968732233112585,0,7,mitochondrial outer membrane translocase complex,CC,
2702,GO:0005743,1,0.123116914171114,0,407,mitochondrial inner membrane,CC,
2703,GO:0005744,1,0.939871811057532,0,12,TIM23 mitochondrial import inner membrane translocase complex,CC,
2704,GO:0005745,1,0.986862338780511,0,2,m-AAA complex,CC,
2705,GO:0005746,1,0.755152392179769,0,71,mitochondrial respirasome,CC,
2706,GO:0005747,1,0.859390433798105,0,41,mitochondrial respiratory chain complex I,CC,
2707,GO:0005749,1,0.98014761606796,0,4,mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone),CC,
2708,GO:0005750,1,0.955384418711893,0,10,mitochondrial respiratory chain complex III,CC,
2709,GO:0005751,1,0.964297484806896,0,11,mitochondrial respiratory chain complex IV,CC,
2710,GO:0005753,1,0.994488416755265,0,1,mitochondrial proton-transporting ATP synthase complex,CC,
2711,GO:0005757,1,0.980246509005829,0,4,mitochondrial permeability transition pore complex,CC,
2712,GO:0005758,1,0.685325804399101,0,71,mitochondrial intermembrane space,CC,
2714,GO:0005760,1,0.980488282358029,0,3,gamma DNA polymerase complex,CC,
2715,GO:0005761,1,0.703952327332613,0,84,mitochondrial ribosome,CC,
2716,GO:0005762,1,0.792311139414712,0,55,mitochondrial large ribosomal subunit,CC,
2717,GO:0005763,1,0.896196601649948,0,27,mitochondrial small ribosomal subunit,CC,
2720,GO:0005766,1,0.416593931927532,0,145,primary lysosome,CC,
2721,GO:0005767,1,0.918240553120919,0,15,secondary lysosome,CC,
2725,GO:0005771,1,0.725736960153701,0,54,multivesicular body,CC,
2728,GO:0005775,1,0.366162842116339,0,160,vacuolar lumen,CC,
2729,GO:0005776,1,0.547868763833944,0,90,autophagosome,CC,
2730,GO:0005777,1,0.464109645782438,0,126,peroxisome,CC,
2731,GO:0005778,1,0.688956393468707,0,58,peroxisomal membrane,CC,
2732,GO:0005779,1,0.917088520329589,0,15,integral component of peroxisomal membrane,CC,
2733,GO:0005782,1,0.753475913101249,0,51,peroxisomal matrix,CC,
2735,GO:0005784,1,0.97559810475093,0,5,Sec61 translocon complex,CC,
2736,GO:0005785,1,0.968442493001582,0,6,signal recognition particle receptor complex,CC,
2737,GO:0005786,1,0.970053910016469,0,6,signal recognition particle, endoplasmic reticulum targeting,CC,
2738,GO:0005787,1,0.975301204633466,0,5,signal peptidase complex,CC,
2741,GO:0005790,1,0.777741244789382,0,32,smooth endoplasmic reticulum,CC,
2742,GO:0005791,1,0.630645186994611,0,78,rough endoplasmic reticulum,CC,
2743,GO:0005793,1,0.449598958020048,0,119,endoplasmic reticulum-Golgi intermediate compartment,CC,
2745,GO:0005795,1,0.407453306821663,0,131,Golgi stack,CC,
2746,GO:0005796,1,0.597466670098819,0,76,Golgi lumen,CC,
2747,GO:0005797,1,0.943888395517628,0,10,Golgi medial cisterna,CC,
2749,GO:0005801,1,0.680252188653404,0,56,cis-Golgi network,CC,
2751,GO:0005811,1,0.566583526574509,0,88,lipid droplet,CC,
2755,GO:0005818,1,0.923596507022402,0,11,aster,CC,
2757,GO:0005826,1,0.971269577748665,0,4,actomyosin contractile ring,CC,
2758,GO:0005827,1,0.964642974323915,0,5,polar microtubule,CC,
2759,GO:0005828,1,0.940199492134954,0,7,kinetochore microtubule,CC,
2761,GO:0005832,1,0.951075629991943,0,9,chaperonin-containing T-complex,CC,
2762,GO:0005833,1,0.964259231748316,0,11,hemoglobin complex,CC,
2763,GO:0005834,1,0.8295989846533,0,32,heterotrimeric G-protein complex,CC,
2764,GO:0005838,1,0.904019075548365,0,21,proteasome regulatory particle,CC,
2765,GO:0005839,1,0.937807250840075,0,17,proteasome core complex,CC,
2766,GO:0005840,1,0.387394099332138,0,216,ribosome,CC,
2767,GO:0005844,1,0.697735318591479,0,65,polysome,CC,
2768,GO:0005845,1,0.934990413615116,0,10,mRNA cap binding complex,CC,
2769,GO:0005846,1,0.979936325198303,0,3,nuclear cap binding complex,CC,
2770,GO:0005847,1,0.890730761160039,0,17,mRNA cleavage and polyadenylation specificity factor complex,CC,
2771,GO:0005848,1,0.994293996396013,0,1,mRNA cleavage stimulating factor complex,CC,
2772,GO:0005849,1,0.868020178831478,0,21,mRNA cleavage factor complex,CC,
2773,GO:0005850,1,0.972108150900095,0,4,eukaryotic translation initiation factor 2 complex,CC,
2774,GO:0005851,1,0.96772961381474,0,6,eukaryotic translation initiation factor 2B complex,CC,
2775,GO:0005852,1,0.91806060241821,0,16,eukaryotic translation initiation factor 3 complex,CC,
2777,GO:0005854,1,0.984968593917686,0,3,nascent polypeptide-associated complex,CC,
2779,GO:0005858,1,0.830584379667519,0,18,axonemal dynein complex,CC,
2780,GO:0005859,1,0.922968803439219,0,12,muscle myosin complex,CC,
2781,GO:0005861,1,0.968019813074661,0,8,troponin complex,CC,
2782,GO:0005862,1,0.977717901225896,0,4,muscle thin filament tropomyosin,CC,
2783,GO:0005863,1,0.976733486753937,0,3,striated muscle myosin thick filament,CC,
2784,GO:0005865,1,0.890774369363587,0,21,striated muscle thin filament,CC,
2785,GO:0005868,1,0.88251626757032,0,18,cytoplasmic dynein complex,CC,
2786,GO:0005869,1,0.938475738404041,0,12,dynactin complex,CC,
2788,GO:0005873,1,0.983127853736772,0,2,plus-end kinesin complex,CC,
2792,GO:0005879,1,0.95570310421304,0,6,axonemal microtubule,CC,
2794,GO:0005881,1,0.614901393395203,0,69,cytoplasmic microtubule,CC,
2797,GO:0005884,1,0.460713137287712,0,110,actin filament,CC,
2798,GO:0005885,1,0.949355499639697,0,11,Arp2/3 protein complex,CC,
2801,GO:0005889,1,0.992802308443374,0,1,potassium:proton exchanging ATPase complex,CC,
2802,GO:0005890,1,0.9353655553187,0,12,sodium:potassium-exchanging ATPase complex,CC,
2803,GO:0005891,1,0.725417132960902,0,40,voltage-gated calcium channel complex,CC,
2804,GO:0005892,1,0.907981333395982,0,15,acetylcholine-gated channel complex,CC,
2805,GO:0005893,1,0.985661150963888,0,2,interleukin-2 receptor complex,CC,
2806,GO:0005895,1,0.994545415406379,0,1,interleukin-5 receptor complex,CC,
2807,GO:0005896,1,0.981968435661144,0,3,interleukin-6 receptor complex,CC,
2808,GO:0005898,1,0.99261246811091,0,1,interleukin-13 receptor complex,CC,
2809,GO:0005899,1,0.95717551392071,0,4,insulin receptor complex,CC,
2810,GO:0005900,1,0.985854367272596,0,2,oncostatin-M receptor complex,CC,
2811,GO:0005901,1,0.57269409376788,0,75,caveola,CC,
2814,GO:0005905,1,0.588474623524944,0,69,clathrin-coated pit,CC,
2817,GO:0005914,1,0.992930941677227,0,1,spot adherens junction,CC,
2818,GO:0005915,1,0.947614626164,0,7,zonula adherens,CC,
2819,GO:0005916,1,0.925787328927668,0,10,fascia adherens,CC,
2820,GO:0005921,1,0.868863190364791,0,23,gap junction,CC,
2821,GO:0005922,1,0.922853259874113,0,14,connexin complex,CC,
2824,GO:0005927,1,0.984012660414623,0,3,muscle tendon junction,CC,
2828,GO:0005942,1,0.830750828788155,0,25,phosphatidylinositol 3-kinase complex,CC,
2829,GO:0005943,1,0.975822811451317,0,3,phosphatidylinositol 3-kinase complex, class IA,CC,
2830,GO:0005944,1,0.976900960201829,0,3,phosphatidylinositol 3-kinase complex, class IB,CC,
2831,GO:0005945,1,0.979896098692491,0,3,6-phosphofructokinase complex,CC,
2832,GO:0005947,1,0.967152879291293,0,5,mitochondrial alpha-ketoglutarate dehydrogenase complex,CC,
2833,GO:0005948,1,0.994272881001173,0,1,acetolactate synthase complex,CC,
2834,GO:0005952,1,0.948819225419612,0,8,cAMP-dependent protein kinase complex,CC,
2835,GO:0005953,1,0.989185643592744,0,2,CAAX-protein geranylgeranyltransferase complex,CC,
2837,GO:0005955,1,0.961166168827614,0,5,calcineurin complex,CC,
2838,GO:0005956,1,0.985484146507917,0,3,protein kinase CK2 complex,CC,
2839,GO:0005958,1,0.973355456136238,0,3,DNA-dependent protein kinase-DNA ligase 4 complex,CC,
2840,GO:0005960,1,0.988505392280962,0,2,glycine cleavage complex,CC,
2841,GO:0005964,1,0.96315986685766,0,5,phosphorylase kinase complex,CC,
2842,GO:0005965,1,0.989054119346575,0,2,protein farnesyltransferase complex,CC,
2843,GO:0005967,1,0.96804886132212,0,5,mitochondrial pyruvate dehydrogenase complex,CC,
2844,GO:0005968,1,0.973456631491591,0,4,Rab-protein geranylgeranyltransferase complex,CC,
2845,GO:0005969,1,0.989330751832868,0,1,serine-pyruvate aminotransferase complex,CC,
2848,GO:0005976,1,0.477739494156768,0,100,polysaccharide metabolic process,BP,
2849,GO:0005977,1,0.621928357714092,0,64,glycogen metabolic process,BP,
2850,GO:0005978,1,0.727663292898435,0,41,glycogen biosynthetic process,BP,
2851,GO:0005979,1,0.808660211589737,0,26,regulation of glycogen biosynthetic process,BP,
2852,GO:0005980,1,0.853615469991423,0,21,glycogen catabolic process,BP,
2853,GO:0005981,1,0.965361531820934,0,5,regulation of glycogen catabolic process,BP,
2854,GO:0005982,1,0.990618975573862,0,1,starch metabolic process,BP,
2855,GO:0005983,1,0.990618975573862,0,1,starch catabolic process,BP,
2856,GO:0005984,1,0.942782767526159,0,9,disaccharide metabolic process,BP,
2857,GO:0005985,1,0.988545344402937,0,2,sucrose metabolic process,BP,
2858,GO:0005986,1,0.995723275739318,0,1,sucrose biosynthetic process,BP,
2859,GO:0005988,1,0.982264777054666,0,3,lactose metabolic process,BP,
2860,GO:0005989,1,0.982264777054666,0,3,lactose biosynthetic process,BP,
2861,GO:0005991,1,0.993251680226007,0,1,trehalose metabolic process,BP,
2862,GO:0005996,1,0.187496301620511,0,252,monosaccharide metabolic process,BP,
2863,GO:0005997,1,0.980492629324438,0,4,xylulose metabolic process,BP,
2864,GO:0005998,1,0.992750186535513,0,1,xylulose catabolic process,BP,
2865,GO:0005999,1,0.990866556259973,0,2,xylulose biosynthetic process,BP,
2866,GO:0006000,1,0.927396438178165,0,13,fructose metabolic process,BP,
2867,GO:0006001,1,0.975995231070314,0,4,fructose catabolic process,BP,
2868,GO:0006002,1,0.924343911400679,0,11,fructose 6-phosphate metabolic process,BP,
2869,GO:0006003,1,0.972592091902382,0,4,fructose 2,6-bisphosphate metabolic process,BP,
2870,GO:0006004,1,0.903314383702692,0,14,fucose metabolic process,BP,
2871,GO:0006006,1,0.279480937123085,0,189,glucose metabolic process,BP,
2872,GO:0006007,1,0.814357005526808,0,32,glucose catabolic process,BP,
2873,GO:0006011,1,0.964633367209282,0,5,UDP-glucose metabolic process,BP,
2874,GO:0006012,1,0.919778974667401,0,13,galactose metabolic process,BP,
2875,GO:0006013,1,0.941070964343481,0,9,mannose metabolic process,BP,
2876,GO:0006014,1,0.987740132423636,0,3,D-ribose metabolic process,BP,
2877,GO:0006015,1,0.971416069917617,0,5,5-phosphoribose 1-diphosphate biosynthetic process,BP,
2878,GO:0006020,1,0.926904244968214,0,10,inositol metabolic process,BP,
2879,GO:0006021,1,0.983132075636831,0,3,inositol biosynthetic process,BP,
2883,GO:0006026,1,0.665034921851074,0,59,aminoglycan catabolic process,BP,
2884,GO:0006027,1,0.683515932557967,0,54,glycosaminoglycan catabolic process,BP,
2886,GO:0006030,1,0.97306318619439,0,5,chitin metabolic process,BP,
2887,GO:0006032,1,0.97306318619439,0,5,chitin catabolic process,BP,
2888,GO:0006040,1,0.794865934445516,0,36,amino sugar metabolic process,BP,
2889,GO:0006041,1,0.977051306418257,0,4,glucosamine metabolic process,BP,
2890,GO:0006043,1,0.98935759801909,0,2,glucosamine catabolic process,BP,
2891,GO:0006044,1,0.898048396481514,0,16,N-acetylglucosamine metabolic process,BP,
2892,GO:0006045,1,0.984471462329873,0,2,N-acetylglucosamine biosynthetic process,BP,
2893,GO:0006046,1,0.984602494052414,0,3,N-acetylglucosamine catabolic process,BP,
2894,GO:0006047,1,0.910714022431415,0,15,UDP-N-acetylglucosamine metabolic process,BP,
2895,GO:0006048,1,0.934654385873351,0,11,UDP-N-acetylglucosamine biosynthetic process,BP,
2896,GO:0006049,1,0.993291809111469,0,1,UDP-N-acetylglucosamine catabolic process,BP,
2897,GO:0006050,1,0.991507790402935,0,2,mannosamine metabolic process,BP,
2898,GO:0006051,1,0.991507790402935,0,2,N-acetylmannosamine metabolic process,BP,
2899,GO:0006054,1,0.93616207722237,0,11,N-acetylneuraminate metabolic process,BP,
2900,GO:0006055,1,0.996195924714731,0,1,CMP-N-acetylneuraminate biosynthetic process,BP,
2901,GO:0006056,1,0.995309928040927,0,1,mannoprotein metabolic process,BP,
2902,GO:0006057,1,0.995309928040927,0,1,mannoprotein biosynthetic process,BP,
2903,GO:0006059,1,0.985885674006106,0,3,hexitol metabolic process,BP,
2904,GO:0006060,1,0.989836290059458,0,2,sorbitol metabolic process,BP,
2905,GO:0006061,1,0.995946459027794,0,1,sorbitol biosynthetic process,BP,
2906,GO:0006062,1,0.993865211361605,0,1,sorbitol catabolic process,BP,
2907,GO:0006063,1,0.955762979249496,0,8,uronic acid metabolic process,BP,
2908,GO:0006064,1,0.975234285249958,0,5,glucuronate catabolic process,BP,
2909,GO:0006065,1,0.978445220911972,0,3,UDP-glucuronate biosynthetic process,BP,
2910,GO:0006066,1,0.116779697982415,0,330,alcohol metabolic process,BP,
2911,GO:0006067,1,0.916534893400969,0,16,ethanol metabolic process,BP,
2912,GO:0006068,1,0.951768404907922,0,10,ethanol catabolic process,BP,
2913,GO:0006069,1,0.950777160304157,0,8,ethanol oxidation,BP,
2914,GO:0006071,1,0.896138798376317,0,16,glycerol metabolic process,BP,
2915,GO:0006072,1,0.942877189759959,0,7,glycerol-3-phosphate metabolic process,BP,
2916,GO:0006073,1,0.616066426129562,0,65,cellular glucan metabolic process,BP,
2917,GO:0006081,1,0.706107763003668,0,58,cellular aldehyde metabolic process,BP,
2919,GO:0006083,1,0.985609782595801,0,2,acetate metabolic process,BP,
2920,GO:0006084,1,0.788532308978483,0,36,acetyl-CoA metabolic process,BP,
2921,GO:0006085,1,0.866719199190813,0,21,acetyl-CoA biosynthetic process,BP,
2922,GO:0006086,1,0.89932307815644,0,15,acetyl-CoA biosynthetic process from pyruvate,BP,
2923,GO:0006089,1,0.928020293588444,0,12,lactate metabolic process,BP,
2924,GO:0006090,1,0.383601519195038,0,139,pyruvate metabolic process,BP,
2926,GO:0006094,1,0.616395997179496,0,76,gluconeogenesis,BP,
2927,GO:0006096,1,0.478667977460962,0,104,glycolytic process,BP,
2928,GO:0006097,1,0.989631476925847,0,2,glyoxylate cycle,BP,
2929,GO:0006098,1,0.923737700130698,0,14,pentose-phosphate shunt,BP,
2930,GO:0006099,1,0.823088137229561,0,33,tricarboxylic acid cycle,BP,
2931,GO:0006101,1,0.963254956919849,0,5,citrate metabolic process,BP,
2932,GO:0006102,1,0.96852511214647,0,6,isocitrate metabolic process,BP,
2933,GO:0006103,1,0.912560175063618,0,15,2-oxoglutarate metabolic process,BP,
2934,GO:0006104,1,0.970471346644644,0,5,succinyl-CoA metabolic process,BP,
2935,GO:0006105,1,0.971311130664665,0,5,succinate metabolic process,BP,
2936,GO:0006106,1,0.983981664089846,0,3,fumarate metabolic process,BP,
2937,GO:0006107,1,0.958034516095583,0,8,oxaloacetate metabolic process,BP,
2938,GO:0006108,1,0.961966070831667,0,7,malate metabolic process,BP,
2939,GO:0006109,1,0.272413247999228,0,180,regulation of carbohydrate metabolic process,BP,
2940,GO:0006110,1,0.591873994582188,0,71,regulation of glycolytic process,BP,
2941,GO:0006111,1,0.764313345432362,0,37,regulation of gluconeogenesis,BP,
2943,GO:0006113,1,0.986422572574789,0,2,fermentation,BP,
2944,GO:0006114,1,0.964533043276981,0,6,glycerol biosynthetic process,BP,
2945,GO:0006116,1,0.978683509791892,0,3,NADH oxidation,BP,
2946,GO:0006117,1,0.993780655446095,0,1,acetaldehyde metabolic process,BP,
2947,GO:0006119,1,0.61405075326886,0,106,oxidative phosphorylation,BP,
2948,GO:0006120,1,0.835998699683354,0,46,mitochondrial electron transport, NADH to ubiquinone,BP,
2949,GO:0006121,1,0.980062352313979,0,4,mitochondrial electron transport, succinate to ubiquinone,BP,
2950,GO:0006122,1,0.93920917642379,0,12,mitochondrial electron transport, ubiquinol to cytochrome c,BP,
2951,GO:0006123,1,0.937940471118693,0,16,mitochondrial electron transport, cytochrome c to oxygen,BP,
2952,GO:0006127,1,0.984550374393721,0,2,glycerophosphate shuttle,BP,
2955,GO:0006144,1,0.897791128866858,0,18,purine nucleobase metabolic process,BP,
2956,GO:0006145,1,0.968346877875627,0,4,purine nucleobase catabolic process,BP,
2957,GO:0006147,1,0.991583712489953,0,1,guanine catabolic process,BP,
2958,GO:0006148,1,0.99407140587962,0,1,inosine catabolic process,BP,
2959,GO:0006152,1,0.966493042731489,0,6,purine nucleoside catabolic process,BP,
2960,GO:0006154,1,0.989547854460898,0,2,adenosine catabolic process,BP,
2961,GO:0006157,1,0.995726628919274,0,1,deoxyadenosine catabolic process,BP,
2964,GO:0006165,1,0.438095106449403,0,121,nucleoside diphosphate phosphorylation,BP,
2965,GO:0006166,1,0.974845588704163,0,5,purine ribonucleoside salvage,BP,
2966,GO:0006167,1,0.984109693620292,0,4,AMP biosynthetic process,BP,
2967,GO:0006168,1,0.992812268622064,0,2,adenine salvage,BP,
2968,GO:0006170,1,0.990278762745527,0,2,dAMP biosynthetic process,BP,
2970,GO:0006172,1,0.969010713964277,0,5,ADP biosynthetic process,BP,
2971,GO:0006173,1,0.992795034113585,0,1,dADP biosynthetic process,BP,
2972,GO:0006174,1,0.993485400251684,0,1,dADP phosphorylation,BP,
2973,GO:0006175,1,0.994766602411071,0,1,dATP biosynthetic process,BP,
2974,GO:0006177,1,0.979407830318689,0,4,GMP biosynthetic process,BP,
2975,GO:0006178,1,0.995924241798657,0,1,guanine salvage,BP,
2976,GO:0006182,1,0.962962533255593,0,7,cGMP biosynthetic process,BP,
2977,GO:0006183,1,0.958313608918465,0,10,GTP biosynthetic process,BP,
2978,GO:0006185,1,0.99654903995315,0,1,dGDP biosynthetic process,BP,
2979,GO:0006186,1,0.993485400251684,0,1,dGDP phosphorylation,BP,
2980,GO:0006188,1,0.943192060583004,0,9,IMP biosynthetic process,BP,
2981,GO:0006189,1,0.961271783130641,0,6,'de novo' IMP biosynthetic process,BP,
2982,GO:0006193,1,0.996397002640242,0,1,ITP catabolic process,BP,
2983,GO:0006195,1,0.76672341175429,0,42,purine nucleotide catabolic process,BP,
2984,GO:0006196,1,0.98507649057716,0,2,AMP catabolic process,BP,
2985,GO:0006198,1,0.927715814365917,0,9,cAMP catabolic process,BP,
2986,GO:0006203,1,0.984844254215666,0,3,dGTP catabolic process,BP,
2987,GO:0006206,1,0.898784927030514,0,16,pyrimidine nucleobase metabolic process,BP,
2988,GO:0006207,1,0.952783164142478,0,6,'de novo' pyrimidine nucleobase biosynthetic process,BP,
2989,GO:0006208,1,0.982326596368101,0,3,pyrimidine nucleobase catabolic process,BP,
2990,GO:0006210,1,0.982326596368101,0,3,thymine catabolic process,BP,
2991,GO:0006211,1,0.963589965592405,0,3,5-methylcytosine catabolic process,BP,
2992,GO:0006212,1,0.987749997904824,0,2,uracil catabolic process,BP,
2993,GO:0006213,1,0.843929193581208,0,32,pyrimidine nucleoside metabolic process,BP,
2994,GO:0006214,1,0.99308891600688,0,1,thymidine catabolic process,BP,
2995,GO:0006216,1,0.951145678103908,0,10,cytidine catabolic process,BP,
2996,GO:0006218,1,0.989342743016558,0,2,uridine catabolic process,BP,
2997,GO:0006220,1,0.792874903721774,0,44,pyrimidine nucleotide metabolic process,BP,
2998,GO:0006221,1,0.858407754387212,0,29,pyrimidine nucleotide biosynthetic process,BP,
2999,GO:0006222,1,0.942506878814426,0,10,UMP biosynthetic process,BP,
3000,GO:0006225,1,0.993369666664661,0,1,UDP biosynthetic process,BP,
3001,GO:0006226,1,0.989962584884548,0,2,dUMP biosynthetic process,BP,
3002,GO:0006227,1,0.989589739756803,0,2,dUDP biosynthetic process,BP,
3003,GO:0006228,1,0.958996882694853,0,9,UTP biosynthetic process,BP,
3004,GO:0006231,1,0.984530262433991,0,3,dTMP biosynthetic process,BP,
3005,GO:0006233,1,0.989589739756803,0,2,dTDP biosynthetic process,BP,
3006,GO:0006235,1,0.981415908662102,0,4,dTTP biosynthetic process,BP,
3007,GO:0006241,1,0.941885908799881,0,13,CTP biosynthetic process,BP,
3008,GO:0006244,1,0.937477581878759,0,13,pyrimidine nucleotide catabolic process,BP,
3009,GO:0006253,1,0.996375183284148,0,1,dCTP catabolic process,BP,
3010,GO:0006256,1,0.993279327662994,0,1,UDP catabolic process,BP,
3011,GO:0006258,1,0.990579426071238,0,2,UDP-glucose catabolic process,BP,
3014,GO:0006261,1,0.386455534255728,0,143,DNA-dependent DNA replication,BP,
3015,GO:0006264,1,0.926362325993487,0,12,mitochondrial DNA replication,BP,
3018,GO:0006267,1,0.946940681308538,0,8,pre-replicative complex assembly involved in nuclear cell cycle DNA replication,BP,
3019,GO:0006268,1,0.904071064464162,0,15,DNA unwinding involved in DNA replication,BP,
3020,GO:0006269,1,0.968501547145308,0,5,DNA replication, synthesis of RNA primer,BP,
3021,GO:0006270,1,0.785621511188108,0,38,DNA replication initiation,BP,
3022,GO:0006271,1,0.884698047223552,0,19,DNA strand elongation involved in DNA replication,BP,
3023,GO:0006272,1,0.971574039340429,0,4,leading strand elongation,BP,
3024,GO:0006273,1,0.970272589638745,0,4,lagging strand elongation,BP,
3025,GO:0006275,1,0.487773171442289,0,104,regulation of DNA replication,BP,
3026,GO:0006278,1,0.631893856673804,0,67,RNA-dependent DNA biosynthetic process,BP,
3029,GO:0006283,1,0.65833799987638,0,73,transcription-coupled nucleotide-excision repair,BP,
3030,GO:0006284,1,0.778411302216557,0,40,base-excision repair,BP,
3031,GO:0006285,1,0.951269295890582,0,10,base-excision repair, AP site formation,BP,
3032,GO:0006286,1,0.991974809355823,0,2,base-excision repair, base-free sugar-phosphate removal,BP,
3033,GO:0006287,1,0.961239678590429,0,6,base-excision repair, gap-filling,BP,
3034,GO:0006288,1,0.983789374405583,0,3,base-excision repair, DNA ligation,BP,
3035,GO:0006289,1,0.527643198319283,0,106,nucleotide-excision repair,BP,
3036,GO:0006290,1,0.939149369803875,0,9,pyrimidine dimer repair,BP,
3037,GO:0006293,1,0.874851934558359,0,21,nucleotide-excision repair, preincision complex stabilization,BP,
3038,GO:0006294,1,0.846231530813585,0,29,nucleotide-excision repair, preincision complex assembly,BP,
3039,GO:0006295,1,0.874851934558359,0,21,nucleotide-excision repair, DNA incision, 3'-to lesion,BP,
3040,GO:0006296,1,0.804296175044124,0,37,nucleotide-excision repair, DNA incision, 5'-to lesion,BP,
3041,GO:0006297,1,0.874147174534223,0,23,nucleotide-excision repair, DNA gap filling,BP,
3042,GO:0006298,1,0.810024620691035,0,32,mismatch repair,BP,
3043,GO:0006301,1,0.732342896822365,0,49,postreplication repair,BP,
3045,GO:0006303,1,0.617189156468738,0,67,double-strand break repair via nonhomologous end joining,BP,
3046,GO:0006304,1,0.50112319826615,0,104,DNA modification,BP,
3047,GO:0006305,1,0.651883434302628,0,60,DNA alkylation,BP,
3048,GO:0006306,1,0.651883434302628,0,60,DNA methylation,BP,
3049,GO:0006307,1,0.944998359686918,0,10,DNA dealkylation involved in DNA repair,BP,
3050,GO:0006308,1,0.787421310304291,0,39,DNA catabolic process,BP,
3051,GO:0006309,1,0.862076288842912,0,24,apoptotic DNA fragmentation,BP,
3053,GO:0006311,1,0.979748307187946,0,3,meiotic gene conversion,BP,
3054,GO:0006312,1,0.857670467763089,0,21,mitotic recombination,BP,
3055,GO:0006313,1,0.985522398273702,0,2,transposition, DNA-mediated,BP,
3058,GO:0006333,1,0.403107273892258,0,131,chromatin assembly or disassembly,BP,
3059,GO:0006334,1,0.669793945337834,0,62,nucleosome assembly,BP,
3060,GO:0006335,1,0.948456615270821,0,8,DNA replication-dependent nucleosome assembly,BP,
3061,GO:0006336,1,0.808643122221593,0,34,DNA replication-independent nucleosome assembly,BP,
3062,GO:0006337,1,0.89899050538355,0,15,nucleosome disassembly,BP,
3063,GO:0006338,1,0.285671192170941,0,173,chromatin remodeling,BP,
3064,GO:0006342,1,0.786451661948412,0,34,chromatin silencing,BP,
3065,GO:0006346,1,0.8834772803979,0,17,DNA methylation-dependent heterochromatin assembly,BP,
3066,GO:0006348,1,0.939491008639307,0,10,chromatin silencing at telomere,BP,
3067,GO:0006349,1,0.881824606051164,0,17,regulation of gene expression by genetic imprinting,BP,
3069,GO:0006352,1,0.227816533852362,0,220,DNA-templated transcription, initiation,BP,
3070,GO:0006353,1,0.655230468220576,0,71,DNA-templated transcription, termination,BP,
3071,GO:0006354,1,0.518251714468104,0,104,DNA-templated transcription, elongation,BP,
3073,GO:0006356,1,0.834006736808128,0,27,regulation of transcription by RNA polymerase I,BP,
3075,GO:0006359,1,0.854343640027198,0,23,regulation of transcription by RNA polymerase III,BP,
3076,GO:0006360,1,0.694336545894449,0,56,transcription by RNA polymerase I,BP,
3077,GO:0006361,1,0.827484797928257,0,32,transcription initiation from RNA polymerase I promoter,BP,
3078,GO:0006362,1,0.8559121136852,0,27,transcription elongation from RNA polymerase I promoter,BP,
3079,GO:0006363,1,0.858726030816169,0,27,termination of RNA polymerase I transcription,BP,
3080,GO:0006364,1,0.306558145961176,0,205,rRNA processing,BP,
3082,GO:0006367,1,0.300475035956167,0,180,transcription initiation from RNA polymerase II promoter,BP,
3083,GO:0006368,1,0.61127149651714,0,78,transcription elongation from RNA polymerase II promoter,BP,
3084,GO:0006369,1,0.806905332058574,0,35,termination of RNA polymerase II transcription,BP,
3085,GO:0006370,1,0.838361268787414,0,31,7-methylguanosine mRNA capping,BP,
3086,GO:0006376,1,0.811496541464906,0,31,mRNA splice site selection,BP,
3087,GO:0006378,1,0.748580852892667,0,42,mRNA polyadenylation,BP,
3088,GO:0006379,1,0.877759161436896,0,20,mRNA cleavage,BP,
3089,GO:0006382,1,0.943819092663671,0,8,adenosine to inosine editing,BP,
3090,GO:0006383,1,0.745952625513868,0,46,transcription by RNA polymerase III,BP,
3091,GO:0006384,1,0.940783356776087,0,8,transcription initiation from RNA polymerase III promoter,BP,
3092,GO:0006386,1,0.996805071866537,0,1,termination of RNA polymerase III transcription,BP,
3093,GO:0006388,1,0.932118365424173,0,14,tRNA splicing, via endonucleolytic cleavage and ligation,BP,
3094,GO:0006390,1,0.911842201640423,0,14,mitochondrial transcription,BP,
3095,GO:0006391,1,0.983082101750055,0,3,transcription initiation from mitochondrial promoter,BP,
3096,GO:0006392,1,0.993485400251684,0,1,transcription elongation from mitochondrial promoter,BP,
3097,GO:0006393,1,0.98701281886265,0,2,termination of mitochondrial transcription,BP,
3098,GO:0006396,1,0.00403643922976002,0,859,RNA processing,BP,
3099,GO:0006397,1,0.0472266097968146,0,475,mRNA processing,BP,
3100,GO:0006398,1,0.968277135790394,0,5,mRNA 3'-end processing by stem-loop binding and cleavage,BP,
3101,GO:0006399,1,0.399455831320513,0,157,tRNA metabolic process,BP,
3102,GO:0006400,1,0.611250159122097,0,81,tRNA modification,BP,
3103,GO:0006401,1,0.102604193241602,0,382,RNA catabolic process,BP,
3104,GO:0006402,1,0.128713146808005,0,347,mRNA catabolic process,BP,
3105,GO:0006403,1,0.226939194075785,0,219,RNA localization,BP,
3106,GO:0006404,1,0.979911229589481,0,3,RNA import into nucleus,BP,
3107,GO:0006405,1,0.408370524367124,0,133,RNA export from nucleus,BP,
3108,GO:0006406,1,0.489378854869266,0,105,mRNA export from nucleus,BP,
3109,GO:0006407,1,0.984874813039264,0,2,rRNA export from nucleus,BP,
3110,GO:0006408,1,0.990075277783532,0,2,snRNA export from nucleus,BP,
3111,GO:0006409,1,0.798987105798413,0,31,tRNA export from nucleus,BP,
3113,GO:0006413,1,0.387121511771613,0,186,translational initiation,BP,
3115,GO:0006415,1,0.626574692761112,0,101,translational termination,BP,
3117,GO:0006418,1,0.861277498673563,0,26,tRNA aminoacylation for protein translation,BP,
3118,GO:0006419,1,0.987227239783761,0,2,alanyl-tRNA aminoacylation,BP,
3119,GO:0006420,1,0.989591739446053,0,2,arginyl-tRNA aminoacylation,BP,
3120,GO:0006421,1,0.987289885954722,0,2,asparaginyl-tRNA aminoacylation,BP,
3121,GO:0006423,1,0.99512448443958,0,1,cysteinyl-tRNA aminoacylation,BP,
3122,GO:0006424,1,0.992654243017916,0,1,glutamyl-tRNA aminoacylation,BP,
3123,GO:0006427,1,0.993921306041506,0,1,histidyl-tRNA aminoacylation,BP,
3124,GO:0006428,1,0.992812801451679,0,1,isoleucyl-tRNA aminoacylation,BP,
3125,GO:0006429,1,0.992504558891871,0,1,leucyl-tRNA aminoacylation,BP,
3126,GO:0006431,1,0.993183302973226,0,1,methionyl-tRNA aminoacylation,BP,
3127,GO:0006432,1,0.984794980274027,0,3,phenylalanyl-tRNA aminoacylation,BP,
3128,GO:0006433,1,0.994206148392755,0,1,prolyl-tRNA aminoacylation,BP,
3129,GO:0006434,1,0.994730037869166,0,1,seryl-tRNA aminoacylation,BP,
3130,GO:0006435,1,0.994127094388793,0,1,threonyl-tRNA aminoacylation,BP,
3131,GO:0006436,1,0.99341659294271,0,1,tryptophanyl-tRNA aminoacylation,BP,
3132,GO:0006437,1,0.994561171467547,0,1,tyrosyl-tRNA aminoacylation,BP,
3133,GO:0006438,1,0.992780065780765,0,1,valyl-tRNA aminoacylation,BP,
3134,GO:0006446,1,0.611860155856044,0,76,regulation of translational initiation,BP,
3135,GO:0006447,1,0.979497064723939,0,3,regulation of translational initiation by iron,BP,
3136,GO:0006448,1,0.890701288877522,0,18,regulation of translational elongation,BP,
3137,GO:0006449,1,0.931828307222443,0,10,regulation of translational termination,BP,
3138,GO:0006450,1,0.925490289633152,0,14,regulation of translational fidelity,BP,
3139,GO:0006451,1,0.948508348526858,0,8,translational readthrough,BP,
3141,GO:0006458,1,0.805965707418478,0,36,'de novo' protein folding,BP,
3142,GO:0006463,1,0.992729770970946,0,1,steroid hormone receptor complex assembly,BP,
3144,GO:0006465,1,0.939593264088968,0,11,signal peptide processing,BP,
3148,GO:0006471,1,0.82629725636186,0,29,protein ADP-ribosylation,BP,
3149,GO:0006473,1,0.275718872387847,0,186,protein acetylation,BP,
3150,GO:0006474,1,0.893839767510167,0,16,N-terminal protein amino acid acetylation,BP,
3151,GO:0006475,1,0.34086716042248,0,154,internal protein amino acid acetylation,BP,
3152,GO:0006476,1,0.510847863699876,0,92,protein deacetylation,BP,
3153,GO:0006477,1,0.953735595970108,0,7,protein sulfation,BP,
3154,GO:0006478,1,0.989777603226024,0,2,peptidyl-tyrosine sulfation,BP,
3155,GO:0006479,1,0.327024049580264,0,154,protein methylation,BP,
3156,GO:0006480,1,0.990127097973297,0,2,N-terminal protein amino acid methylation,BP,
3157,GO:0006481,1,0.988252374489024,0,2,C-terminal protein methylation,BP,
3158,GO:0006482,1,0.788415976716106,0,29,protein demethylation,BP,
3160,GO:0006487,1,0.642974215291286,0,71,protein N-linked glycosylation,BP,
3161,GO:0006488,1,0.878096880766184,0,20,dolichol-linked oligosaccharide biosynthetic process,BP,
3162,GO:0006489,1,0.95845036890053,0,7,dolichyl diphosphate biosynthetic process,BP,
3163,GO:0006490,1,0.87269381355501,0,21,oligosaccharide-lipid intermediate biosynthetic process,BP,
3165,GO:0006493,1,0.548531460335253,0,84,protein O-linked glycosylation,BP,
3166,GO:0006497,1,0.567905379703754,0,89,protein lipidation,BP,
3167,GO:0006498,1,0.957588693369194,0,6,N-terminal protein lipidation,BP,
3168,GO:0006499,1,0.967394573368551,0,4,N-terminal protein myristoylation,BP,
3169,GO:0006500,1,0.989866962287227,0,2,N-terminal protein palmitoylation,BP,
3170,GO:0006501,1,0.960208813304621,0,6,C-terminal protein lipidation,BP,
3171,GO:0006505,1,0.834187374945226,0,31,GPI anchor metabolic process,BP,
3172,GO:0006506,1,0.838972439063841,0,30,GPI anchor biosynthetic process,BP,
3173,GO:0006507,1,0.994306503233258,0,1,GPI anchor release,BP,
3178,GO:0006515,1,0.82241578648564,0,28,protein quality control for misfolded or incompletely synthesized proteins,BP,
3179,GO:0006516,1,0.879531999224574,0,20,glycoprotein catabolic process,BP,
3180,GO:0006517,1,0.82729190669816,0,26,protein deglycosylation,BP,
3183,GO:0006521,1,0.750972131945932,0,58,regulation of cellular amino acid metabolic process,BP,
3184,GO:0006522,1,0.979137115994759,0,4,alanine metabolic process,BP,
3185,GO:0006524,1,0.979137115994759,0,4,alanine catabolic process,BP,
3186,GO:0006525,1,0.8942957374622,0,19,arginine metabolic process,BP,
3187,GO:0006526,1,0.975663348091973,0,5,arginine biosynthetic process,BP,
3188,GO:0006527,1,0.937242119422761,0,10,arginine catabolic process,BP,
3189,GO:0006528,1,0.974158254626988,0,5,asparagine metabolic process,BP,
3190,GO:0006529,1,0.988234844217033,0,2,asparagine biosynthetic process,BP,
3191,GO:0006530,1,0.994133635482561,0,1,asparagine catabolic process,BP,
3192,GO:0006531,1,0.975632332027083,0,5,aspartate metabolic process,BP,
3193,GO:0006532,1,0.988652247700137,0,2,aspartate biosynthetic process,BP,
3194,GO:0006533,1,0.980327716277225,0,4,aspartate catabolic process,BP,
3195,GO:0006534,1,0.936010431881776,0,11,cysteine metabolic process,BP,
3196,GO:0006535,1,0.99374152799939,0,1,cysteine biosynthetic process from serine,BP,
3197,GO:0006536,1,0.818218116310457,0,31,glutamate metabolic process,BP,
3198,GO:0006537,1,0.966269206891305,0,5,glutamate biosynthetic process,BP,
3199,GO:0006538,1,0.95205510529831,0,8,glutamate catabolic process,BP,
3200,GO:0006539,1,0.995066610505164,0,1,glutamate catabolic process via 2-oxoglutarate,BP,
3201,GO:0006540,1,0.987880815737928,0,2,glutamate decarboxylation to succinate,BP,
3202,GO:0006541,1,0.864564120811243,0,21,glutamine metabolic process,BP,
3203,GO:0006542,1,0.992418516791467,0,1,glutamine biosynthetic process,BP,
3204,GO:0006543,1,0.978989542807183,0,3,glutamine catabolic process,BP,
3205,GO:0006544,1,0.936886798750083,0,12,glycine metabolic process,BP,
3206,GO:0006545,1,0.98408941062417,0,3,glycine biosynthetic process,BP,
3207,GO:0006546,1,0.983298336378784,0,3,glycine catabolic process,BP,
3208,GO:0006547,1,0.947314275729455,0,9,histidine metabolic process,BP,
3209,GO:0006548,1,0.959728703477385,0,7,histidine catabolic process,BP,
3210,GO:0006549,1,0.97624712361897,0,5,isoleucine metabolic process,BP,
3211,GO:0006550,1,0.990210065833595,0,2,isoleucine catabolic process,BP,
3213,GO:0006552,1,0.964659301995142,0,6,leucine catabolic process,BP,
3214,GO:0006553,1,0.91935858512681,0,13,lysine metabolic process,BP,
3215,GO:0006554,1,0.925506675388316,0,12,lysine catabolic process,BP,
3216,GO:0006555,1,0.902974955798248,0,16,methionine metabolic process,BP,
3217,GO:0006556,1,0.974738705840014,0,4,S-adenosylmethionine biosynthetic process,BP,
3218,GO:0006557,1,0.992982499157848,0,1,S-adenosylmethioninamine biosynthetic process,BP,
3219,GO:0006558,1,0.951556116547658,0,10,L-phenylalanine metabolic process,BP,
3220,GO:0006559,1,0.951556116547658,0,10,L-phenylalanine catabolic process,BP,
3221,GO:0006560,1,0.955721927658397,0,8,proline metabolic process,BP,
3222,GO:0006561,1,0.97210870081874,0,5,proline biosynthetic process,BP,
3223,GO:0006562,1,0.983147797343285,0,3,proline catabolic process,BP,
3224,GO:0006563,1,0.946654609271729,0,10,L-serine metabolic process,BP,
3225,GO:0006564,1,0.962609010910407,0,7,L-serine biosynthetic process,BP,
3226,GO:0006565,1,0.977924444744348,0,4,L-serine catabolic process,BP,
3227,GO:0006566,1,0.982163669639003,0,4,threonine metabolic process,BP,
3228,GO:0006567,1,0.987264803794523,0,3,threonine catabolic process,BP,
3229,GO:0006568,1,0.946687788676749,0,10,tryptophan metabolic process,BP,
3230,GO:0006569,1,0.961691891780708,0,8,tryptophan catabolic process,BP,
3231,GO:0006570,1,0.955447348147926,0,9,tyrosine metabolic process,BP,
3232,GO:0006571,1,0.99360298701045,0,1,tyrosine biosynthetic process,BP,
3233,GO:0006572,1,0.976145378019111,0,5,tyrosine catabolic process,BP,
3235,GO:0006574,1,0.979074820503202,0,4,valine catabolic process,BP,
3237,GO:0006576,1,0.744694063091314,0,52,cellular biogenic amine metabolic process,BP,
3238,GO:0006577,1,0.89646448710265,0,17,amino-acid betaine metabolic process,BP,
3239,GO:0006578,1,0.956481508655909,0,7,amino-acid betaine biosynthetic process,BP,
3240,GO:0006579,1,0.981075930243236,0,3,amino-acid betaine catabolic process,BP,
3241,GO:0006580,1,0.986912073567168,0,2,ethanolamine metabolic process,BP,
3242,GO:0006581,1,0.98701116808666,0,2,acetylcholine catabolic process,BP,
3243,GO:0006582,1,0.856998292001583,0,21,melanin metabolic process,BP,
3244,GO:0006583,1,0.994191945115951,0,1,melanin biosynthetic process from tyrosine,BP,
3245,GO:0006584,1,0.731866971634369,0,49,catecholamine metabolic process,BP,
3246,GO:0006585,1,0.995058862153243,0,1,dopamine biosynthetic process from tyrosine,BP,
3247,GO:0006586,1,0.927939022696071,0,14,indolalkylamine metabolic process,BP,
3248,GO:0006589,1,0.986692831667053,0,2,octopamine biosynthetic process,BP,
3249,GO:0006590,1,0.869347472643155,0,19,thyroid hormone generation,BP,
3250,GO:0006591,1,0.951621069885544,0,9,ornithine metabolic process,BP,
3251,GO:0006592,1,0.992857121069063,0,1,ornithine biosynthetic process,BP,
3252,GO:0006593,1,0.995532517038367,0,1,ornithine catabolic process,BP,
3253,GO:0006595,1,0.923686670548179,0,16,polyamine metabolic process,BP,
3254,GO:0006596,1,0.936317383734387,0,13,polyamine biosynthetic process,BP,
3255,GO:0006597,1,0.988471930737706,0,2,spermine biosynthetic process,BP,
3256,GO:0006598,1,0.983240546705433,0,4,polyamine catabolic process,BP,
3257,GO:0006599,1,0.978178398879015,0,5,phosphagen metabolic process,BP,
3258,GO:0006600,1,0.961744813891612,0,8,creatine metabolic process,BP,
3259,GO:0006601,1,0.990313586543384,0,2,creatine biosynthetic process,BP,
3260,GO:0006603,1,0.978178398879015,0,5,phosphocreatine metabolic process,BP,
3262,GO:0006606,1,0.371603272395457,0,135,protein import into nucleus,BP,
3263,GO:0006607,1,0.877147873195653,0,16,NLS-bearing protein import into nucleus,BP,
3264,GO:0006610,1,0.973266657608147,0,4,ribosomal protein import into nucleus,BP,
3265,GO:0006611,1,0.305059355688328,0,176,protein export from nucleus,BP,
3267,GO:0006613,1,0.678717517672053,0,98,cotranslational protein targeting to membrane,BP,
3268,GO:0006614,1,0.70016137840568,0,94,SRP-dependent cotranslational protein targeting to membrane,BP,
3269,GO:0006616,1,0.953577000518217,0,8,SRP-dependent cotranslational protein targeting to membrane, translocation,BP,
3270,GO:0006617,1,0.991102162438874,0,2,SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition,BP,
3271,GO:0006620,1,0.934224517412088,0,11,posttranslational protein targeting to endoplasmic reticulum membrane,BP,
3272,GO:0006621,1,0.947482431606447,0,9,protein retention in ER lumen,BP,
3273,GO:0006622,1,0.856422772624835,0,20,protein targeting to lysosome,BP,
3274,GO:0006623,1,0.747133331962521,0,37,protein targeting to vacuole,BP,
3275,GO:0006624,1,0.991526870042138,0,2,vacuolar protein processing,BP,
3276,GO:0006625,1,0.668410816567974,0,68,protein targeting to peroxisome,BP,
3277,GO:0006626,1,0.581493082419408,0,92,protein targeting to mitochondrion,BP,
3278,GO:0006627,1,0.959283408433202,0,7,protein processing involved in protein targeting to mitochondrion,BP,
3281,GO:0006633,1,0.422019781160443,0,142,fatty acid biosynthetic process,BP,
3283,GO:0006636,1,0.743991422053642,0,52,unsaturated fatty acid biosynthetic process,BP,
3284,GO:0006637,1,0.562964852652021,0,93,acyl-CoA metabolic process,BP,
3287,GO:0006640,1,0.980147261812473,0,3,monoacylglycerol biosynthetic process,BP,
3289,GO:0006642,1,0.963567166810806,0,4,triglyceride mobilization,BP,
3293,GO:0006649,1,0.983033324552531,0,2,phospholipid transfer to membrane,BP,
3295,GO:0006651,1,0.954029797763962,0,7,diacylglycerol biosynthetic process,BP,
3296,GO:0006654,1,0.741902091622292,0,41,phosphatidic acid biosynthetic process,BP,
3297,GO:0006655,1,0.936974455976058,0,10,phosphatidylglycerol biosynthetic process,BP,
3298,GO:0006656,1,0.803984252856773,0,37,phosphatidylcholine biosynthetic process,BP,
3299,GO:0006657,1,0.95943092031077,0,7,CDP-choline pathway,BP,
3300,GO:0006658,1,0.85215864196144,0,26,phosphatidylserine metabolic process,BP,
3301,GO:0006659,1,0.975396686519869,0,4,phosphatidylserine biosynthetic process,BP,
3302,GO:0006660,1,0.984591370943016,0,3,phosphatidylserine catabolic process,BP,
3303,GO:0006661,1,0.441698966879949,0,114,phosphatidylinositol biosynthetic process,BP,
3304,GO:0006662,1,0.88307526991871,0,19,glycerol ether metabolic process,BP,
3305,GO:0006663,1,0.96987127134489,0,5,platelet activating factor biosynthetic process,BP,
3308,GO:0006666,1,0.99178820665718,0,1,3-keto-sphinganine metabolic process,BP,
3309,GO:0006667,1,0.981164526964519,0,3,sphinganine metabolic process,BP,
3310,GO:0006668,1,0.98624708086364,0,2,sphinganine-1-phosphate metabolic process,BP,
3311,GO:0006669,1,0.993244115038388,0,1,sphinganine-1-phosphate biosynthetic process,BP,
3312,GO:0006670,1,0.906901662990269,0,15,sphingosine metabolic process,BP,
3313,GO:0006671,1,0.992400931110111,0,1,phytosphingosine metabolic process,BP,
3314,GO:0006672,1,0.567123028211823,0,89,ceramide metabolic process,BP,
3315,GO:0006677,1,0.897402979489129,0,18,glycosylceramide metabolic process,BP,
3316,GO:0006678,1,0.951709822997644,0,8,glucosylceramide metabolic process,BP,
3317,GO:0006679,1,0.981586131861597,0,3,glucosylceramide biosynthetic process,BP,
3318,GO:0006680,1,0.9760168728668,0,4,glucosylceramide catabolic process,BP,
3319,GO:0006681,1,0.948361639095648,0,9,galactosylceramide metabolic process,BP,
3320,GO:0006682,1,0.965479897483713,0,6,galactosylceramide biosynthetic process,BP,
3321,GO:0006683,1,0.982275866128831,0,3,galactosylceramide catabolic process,BP,
3322,GO:0006684,1,0.926123581969354,0,12,sphingomyelin metabolic process,BP,
3323,GO:0006685,1,0.96300259585649,0,6,sphingomyelin catabolic process,BP,
3324,GO:0006686,1,0.961718297726826,0,6,sphingomyelin biosynthetic process,BP,
3327,GO:0006689,1,0.964841227646155,0,6,ganglioside catabolic process,BP,
3328,GO:0006690,1,0.594168237250323,0,93,icosanoid metabolic process,BP,
3329,GO:0006691,1,0.878583522979881,0,23,leukotriene metabolic process,BP,
3330,GO:0006692,1,0.789320134818703,0,43,prostanoid metabolic process,BP,
3331,GO:0006693,1,0.789320134818703,0,43,prostaglandin metabolic process,BP,
3332,GO:0006694,1,0.354436472081458,0,163,steroid biosynthetic process,BP,
3333,GO:0006695,1,0.653630613251219,0,63,cholesterol biosynthetic process,BP,
3334,GO:0006699,1,0.814194648866711,0,33,bile acid biosynthetic process,BP,
3335,GO:0006700,1,0.879715297742453,0,20,C21-steroid hormone biosynthetic process,BP,
3336,GO:0006701,1,0.965827420400307,0,5,progesterone biosynthetic process,BP,
3337,GO:0006702,1,0.956422298136319,0,7,androgen biosynthetic process,BP,
3338,GO:0006703,1,0.946107769789364,0,11,estrogen biosynthetic process,BP,
3339,GO:0006704,1,0.910046696916854,0,14,glucocorticoid biosynthetic process,BP,
3340,GO:0006705,1,0.938502657687617,0,9,mineralocorticoid biosynthetic process,BP,
3341,GO:0006706,1,0.88713453079083,0,22,steroid catabolic process,BP,
3342,GO:0006707,1,0.953061584801484,0,9,cholesterol catabolic process,BP,
3343,GO:0006710,1,0.973531797907361,0,5,androgen catabolic process,BP,
3344,GO:0006711,1,0.995295032329313,0,1,estrogen catabolic process,BP,
3345,GO:0006713,1,0.995281959653371,0,1,glucocorticoid catabolic process,BP,
3346,GO:0006714,1,0.991854312057638,0,2,sesquiterpenoid metabolic process,BP,
3347,GO:0006720,1,0.496139605044259,0,114,isoprenoid metabolic process,BP,
3348,GO:0006721,1,0.547198432220651,0,96,terpenoid metabolic process,BP,
3349,GO:0006722,1,0.986611845429653,0,2,triterpenoid metabolic process,BP,
3351,GO:0006726,1,0.988543175008776,0,2,eye pigment biosynthetic process,BP,
3352,GO:0006729,1,0.966781626497637,0,7,tetrahydrobiopterin biosynthetic process,BP,
3353,GO:0006730,1,0.796721556493028,0,38,one-carbon metabolic process,BP,
3354,GO:0006734,1,0.79329891119405,0,37,NADH metabolic process,BP,
3355,GO:0006735,1,0.847777778292187,0,26,NADH regeneration,BP,
3356,GO:0006738,1,0.99407140587962,0,1,nicotinamide riboside catabolic process,BP,
3357,GO:0006739,1,0.833185114520827,0,31,NADP metabolic process,BP,
3358,GO:0006740,1,0.911233843748846,0,16,NADPH regeneration,BP,
3359,GO:0006741,1,0.981977330190175,0,3,NADP biosynthetic process,BP,
3360,GO:0006742,1,0.984001626559189,0,3,NADP catabolic process,BP,
3361,GO:0006743,1,0.912999533319687,0,17,ubiquinone metabolic process,BP,
3362,GO:0006744,1,0.926564452613002,0,15,ubiquinone biosynthetic process,BP,
3363,GO:0006747,1,0.994929140826226,0,1,FAD biosynthetic process,BP,
3364,GO:0006749,1,0.806914201128558,0,42,glutathione metabolic process,BP,
3365,GO:0006750,1,0.913137985447417,0,15,glutathione biosynthetic process,BP,
3366,GO:0006751,1,0.969532526612521,0,6,glutathione catabolic process,BP,
3368,GO:0006754,1,0.844422185225362,0,29,ATP biosynthetic process,BP,
3369,GO:0006756,1,0.993485400251684,0,1,AMP phosphorylation,BP,
3370,GO:0006757,1,0.475526669284247,0,105,ATP generation from ADP,BP,
3374,GO:0006768,1,0.944725616755671,0,9,biotin metabolic process,BP,
3375,GO:0006771,1,0.955287586014606,0,7,riboflavin metabolic process,BP,
3376,GO:0006772,1,0.983214189199916,0,3,thiamine metabolic process,BP,
3377,GO:0006775,1,0.790123215731816,0,38,fat-soluble vitamin metabolic process,BP,
3378,GO:0006776,1,0.95784406558695,0,7,vitamin A metabolic process,BP,
3379,GO:0006777,1,0.963161630110255,0,6,Mo-molybdopterin cofactor biosynthetic process,BP,
3380,GO:0006778,1,0.814497322548297,0,34,porphyrin-containing compound metabolic process,BP,
3381,GO:0006779,1,0.848601359569091,0,26,porphyrin-containing compound biosynthetic process,BP,
3382,GO:0006780,1,0.990580002549481,0,2,uroporphyrinogen III biosynthetic process,BP,
3383,GO:0006781,1,0.994541478353388,0,1,succinyl-CoA pathway,BP,
3384,GO:0006782,1,0.950669233672999,0,9,protoporphyrinogen IX biosynthetic process,BP,
3385,GO:0006783,1,0.873732709061984,0,22,heme biosynthetic process,BP,
3386,GO:0006784,1,0.983417040598346,0,2,heme A biosynthetic process,BP,
3387,GO:0006787,1,0.984319878948359,0,4,porphyrin-containing compound catabolic process,BP,
3388,GO:0006788,1,0.991095162891747,0,2,heme oxidation,BP,
3392,GO:0006797,1,0.959839326309187,0,5,polyphosphate metabolic process,BP,
3393,GO:0006798,1,0.966237019981494,0,4,polyphosphate catabolic process,BP,
3394,GO:0006801,1,0.685579725137289,0,63,superoxide metabolic process,BP,
3395,GO:0006805,1,0.619430384284462,0,86,xenobiotic metabolic process,BP,
3397,GO:0006808,1,0.98413107587557,0,3,regulation of nitrogen utilization,BP,
3398,GO:0006809,1,0.649531093216101,0,64,nitric oxide biosynthetic process,BP,
3408,GO:0006824,1,0.964042604541687,0,6,cobalt ion transport,BP,
3409,GO:0006825,1,0.885264661984584,0,18,copper ion transport,BP,
3410,GO:0006826,1,0.648105515765874,0,70,iron ion transport,BP,
3411,GO:0006828,1,0.897824059801384,0,15,manganese ion transport,BP,
3418,GO:0006842,1,0.974014681170834,0,4,tricarboxylic acid transport,BP,
3419,GO:0006843,1,0.995616145417115,0,1,mitochondrial citrate transmembrane transport,BP,
3420,GO:0006844,1,0.970958643747749,0,5,acyl carnitine transport,BP,
3421,GO:0006848,1,0.975279476750846,0,4,pyruvate transport,BP,
3422,GO:0006850,1,0.98701281886265,0,2,mitochondrial pyruvate transmembrane transport,BP,
3423,GO:0006851,1,0.866999681368227,0,23,mitochondrial calcium ion transmembrane transport,BP,
3424,GO:0006853,1,0.93259106354925,0,9,carnitine shuttle,BP,
3425,GO:0006855,1,0.942348424980793,0,8,drug transmembrane transport,BP,
3426,GO:0006857,1,0.928510379766409,0,10,oligopeptide transport,BP,
3427,GO:0006858,1,0.80899379870853,0,30,extracellular transport,BP,
3428,GO:0006862,1,0.800307552254176,0,36,nucleotide transport,BP,
3429,GO:0006863,1,0.961251322676667,0,7,purine nucleobase transport,BP,
3430,GO:0006864,1,0.988101881709564,0,2,pyrimidine nucleotide transport,BP,
3432,GO:0006867,1,0.982429551768835,0,3,asparagine transport,BP,
3433,GO:0006868,1,0.940728400925225,0,9,glutamine transport,BP,
3438,GO:0006876,1,0.985734007648007,0,2,cellular cadmium ion homeostasis,BP,
3439,GO:0006878,1,0.916363716937222,0,14,cellular copper ion homeostasis,BP,
3440,GO:0006879,1,0.679761400752987,0,61,cellular iron ion homeostasis,BP,
3441,GO:0006880,1,0.987841033932377,0,3,intracellular sequestering of iron ion,BP,
3443,GO:0006883,1,0.886000790458319,0,17,cellular sodium ion homeostasis,BP,
3444,GO:0006884,1,0.823411458910266,0,27,cell volume homeostasis,BP,
3448,GO:0006888,1,0.27566042288776,0,188,endoplasmic reticulum to Golgi vesicle-mediated transport,BP,
3450,GO:0006891,1,0.811218918073933,0,32,intra-Golgi vesicle-mediated transport,BP,
3451,GO:0006892,1,0.481153369766928,0,98,post-Golgi vesicle-mediated transport,BP,
3452,GO:0006893,1,0.6620909170064,0,56,Golgi to plasma membrane transport,BP,
3453,GO:0006895,1,0.880218155273936,0,15,Golgi to endosome transport,BP,
3454,GO:0006896,1,0.893835044305343,0,17,Golgi to vacuole transport,BP,
3458,GO:0006901,1,0.634943545808547,0,68,vesicle coating,BP,
3459,GO:0006903,1,0.5404874286522,0,90,vesicle targeting,BP,
3462,GO:0006907,1,0.866749906012374,0,22,pinocytosis,BP,
3463,GO:0006909,1,0.193224132378066,0,249,phagocytosis,BP,
3464,GO:0006910,1,0.916682788418181,0,14,phagocytosis, recognition,BP,
3465,GO:0006911,1,0.715521291067604,0,51,phagocytosis, engulfment,BP,
3466,GO:0006913,1,0.100030985412931,0,332,nucleocytoplasmic transport,BP,
3469,GO:0006919,1,0.603092340792796,0,83,activation of cysteine-type endopeptidase activity involved in apoptotic process,BP,
3471,GO:0006924,1,0.950794790472398,0,8,activation-induced cell death of T cells,BP,
3472,GO:0006925,1,0.881139355805438,0,19,inflammatory cell apoptotic process,BP,
3474,GO:0006929,1,0.817457013877459,0,26,substrate-dependent cell migration,BP,
3475,GO:0006930,1,0.936305115377751,0,9,substrate-dependent cell migration, cell extension,BP,
3476,GO:0006931,1,0.967283152243106,0,4,substrate-dependent cell migration, cell attachment to substrate,BP,
3477,GO:0006933,1,0.98188690974751,0,3,negative regulation of cell adhesion involved in substrate-bound cell migration,BP,
3478,GO:0006935,1,0.0176610561520537,0,584,chemotaxis,BP,
3484,GO:0006942,1,0.544388713936916,0,85,regulation of striated muscle contraction,BP,
3485,GO:0006948,1,0.99310439906465,0,1,induction by virus of host cell-cell fusion,BP,
3486,GO:0006949,1,0.732078793785208,0,46,syncytium formation,BP,
3492,GO:0006956,1,0.730111879496385,0,53,complement activation,BP,
3493,GO:0006957,1,0.929082294311258,0,11,complement activation, alternative pathway,BP,
3494,GO:0006958,1,0.843543341341651,0,27,complement activation, classical pathway,BP,
3495,GO:0006959,1,0.391598393497539,0,179,humoral immune response,BP,
3496,GO:0006968,1,0.757571751346099,0,48,cellular defense response,BP,
3497,GO:0006970,1,0.570891986423085,0,81,response to osmotic stress,BP,
3498,GO:0006971,1,0.925615844604457,0,10,hypotonic response,BP,
3499,GO:0006972,1,0.850416540209335,0,25,hyperosmotic response,BP,
3501,GO:0006975,1,0.946793780592925,0,8,DNA damage induced protein phosphorylation,BP,
3502,GO:0006977,1,0.70300705439833,0,54,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,BP,
3505,GO:0006982,1,0.992000291847301,0,2,response to lipid hydroperoxide,BP,
3506,GO:0006983,1,0.924058982654727,0,11,ER overload response,BP,
3507,GO:0006984,1,0.727078821553383,0,48,ER-nucleus signaling pathway,BP,
3509,GO:0006990,1,0.979236076840146,0,3,positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response,BP,
3510,GO:0006991,1,0.900190339009293,0,15,response to sterol depletion,BP,
3511,GO:0006995,1,0.9466537926883,0,11,cellular response to nitrogen starvation,BP,
3513,GO:0006997,1,0.445720950875806,0,116,nucleus organization,BP,
3514,GO:0006998,1,0.725988689388437,0,50,nuclear envelope organization,BP,
3515,GO:0006999,1,0.901737391022413,0,14,nuclear pore organization,BP,
3516,GO:0007000,1,0.957122688608912,0,7,nucleolus organization,BP,
3517,GO:0007004,1,0.643833175241405,0,65,telomere maintenance via telomerase,BP,
3520,GO:0007007,1,0.853955319710862,0,29,inner mitochondrial membrane organization,BP,
3521,GO:0007008,1,0.967433270956736,0,6,outer mitochondrial membrane organization,BP,
3524,GO:0007014,1,0.992742545978975,0,1,actin ubiquitination,BP,
3531,GO:0007023,1,0.972751161126375,0,5,post-chaperonin tubulin folding pathway,BP,
3533,GO:0007028,1,0.921149864406291,0,10,cytoplasm organization,BP,
3534,GO:0007029,1,0.648990890726639,0,62,endoplasmic reticulum organization,BP,
3535,GO:0007030,1,0.363509383109341,0,135,Golgi organization,BP,
3536,GO:0007031,1,0.611418415199621,0,81,peroxisome organization,BP,
3538,GO:0007033,1,0.336119437017685,0,161,vacuole organization,BP,
3539,GO:0007034,1,0.362838144716816,0,141,vacuolar transport,BP,
3540,GO:0007035,1,0.863287717697773,0,23,vacuolar acidification,BP,
3541,GO:0007039,1,0.865433780783894,0,19,protein catabolic process in the vacuole,BP,
3542,GO:0007040,1,0.65593327961811,0,62,lysosome organization,BP,
3543,GO:0007041,1,0.469446766131656,0,102,lysosomal transport,BP,
3544,GO:0007042,1,0.954975240604493,0,9,lysosomal lumen acidification,BP,
3545,GO:0007043,1,0.391047422471364,0,132,cell-cell junction assembly,BP,
3546,GO:0007044,1,0.454769032610224,0,97,cell-substrate junction assembly,BP,
3551,GO:0007056,1,0.988977957797366,0,2,spindle assembly involved in female meiosis,BP,
3552,GO:0007057,1,0.988977957797366,0,2,spindle assembly involved in female meiosis I,BP,
3554,GO:0007060,1,0.974299139810447,0,4,male meiosis chromosome segregation,BP,
3555,GO:0007062,1,0.713009054635891,0,47,sister chromatid cohesion,BP,
3556,GO:0007063,1,0.870305295015898,0,18,regulation of sister chromatid cohesion,BP,
3557,GO:0007064,1,0.849756787791091,0,21,mitotic sister chromatid cohesion,BP,
3558,GO:0007066,1,0.996621222234565,0,1,female meiosis sister chromatid cohesion,BP,
3559,GO:0007072,1,0.995412779025815,0,1,positive regulation of transcription involved in exit from mitosis,BP,
3561,GO:0007077,1,0.922799022643532,0,12,mitotic nuclear envelope disassembly,BP,
3562,GO:0007079,1,0.968482178311453,0,4,mitotic chromosome movement towards spindle pole,BP,
3564,GO:0007084,1,0.946316473503139,0,10,mitotic nuclear envelope reassembly,BP,
3566,GO:0007089,1,0.971833675748206,0,4,traversing start control point of mitotic cell cycle,BP,
3570,GO:0007095,1,0.864943482168621,0,20,mitotic G2 DNA damage checkpoint,BP,
3572,GO:0007097,1,0.804748090023614,0,23,nuclear migration,BP,
3573,GO:0007098,1,0.421419077822175,0,120,centrosome cycle,BP,
3574,GO:0007099,1,0.775866865693121,0,34,centriole replication,BP,
3575,GO:0007100,1,0.910005590558536,0,14,mitotic centrosome separation,BP,
3576,GO:0007113,1,0.985451823664798,0,3,endomitotic cell cycle,BP,
3578,GO:0007129,1,0.793306840394284,0,36,homologous chromosome pairing at meiosis,BP,
3579,GO:0007130,1,0.904979231551753,0,16,synaptonemal complex assembly,BP,
3581,GO:0007135,1,0.941489928421275,0,10,meiosis II,BP,
3582,GO:0007140,1,0.773155521547479,0,37,male meiotic nuclear division,BP,
3583,GO:0007141,1,0.89318572550381,0,18,male meiosis I,BP,
3585,GO:0007144,1,0.957031186157607,0,7,female meiosis I,BP,
3586,GO:0007146,1,0.993485400251684,0,1,meiotic recombination nodule assembly,BP,
3587,GO:0007147,1,0.992780065780765,0,1,female meiosis II,BP,
3592,GO:0007158,1,0.875505053667641,0,17,neuron cell-cell adhesion,BP,
3594,GO:0007160,1,0.204145883713019,0,210,cell-matrix adhesion,BP,
3595,GO:0007161,1,0.960158675842231,0,4,calcium-independent cell-matrix adhesion,BP,
3596,GO:0007162,1,0.173510870496109,0,254,negative regulation of cell adhesion,BP,
3597,GO:0007163,1,0.215517563251118,0,210,establishment or maintenance of cell polarity,BP,
3602,GO:0007168,1,0.958528584986642,0,8,receptor guanylyl cyclase signaling pathway,BP,
3604,GO:0007171,1,0.908102012563494,0,13,activation of transmembrane receptor protein tyrosine kinase activity,BP,
3605,GO:0007172,1,0.949299598199203,0,8,signal complex assembly,BP,
3607,GO:0007174,1,0.989100503877857,0,2,epidermal growth factor catabolic process,BP,
3608,GO:0007175,1,0.908403061750182,0,14,negative regulation of epidermal growth factor-activated receptor activity,BP,
3611,GO:0007179,1,0.265634595375923,0,181,transforming growth factor beta receptor signaling pathway,BP,
3612,GO:0007181,1,0.98002839844619,0,3,transforming growth factor beta receptor complex assembly,BP,
3613,GO:0007182,1,0.951572285894921,0,6,common-partner SMAD protein phosphorylation,BP,
3614,GO:0007183,1,0.907833984599394,0,13,SMAD protein complex assembly,BP,
3615,GO:0007185,1,0.944937196437517,0,6,transmembrane receptor protein tyrosine phosphatase signaling pathway,BP,
3621,GO:0007191,1,0.936723199676394,0,11,adenylate cyclase-activating dopamine receptor signaling pathway,BP,
3623,GO:0007194,1,0.881380068807955,0,19,negative regulation of adenylate cyclase activity,BP,
3624,GO:0007195,1,0.961517138295743,0,6,adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
3625,GO:0007196,1,0.944745888160209,0,7,adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway,BP,
3627,GO:0007198,1,0.964059447926401,0,7,adenylate cyclase-inhibiting serotonin receptor signaling pathway,BP,
3628,GO:0007199,1,0.993779815907898,0,1,G protein-coupled receptor signaling pathway coupled to cGMP nucleotide second messenger,BP,
3629,GO:0007200,1,0.57484881421519,0,92,phospholipase C-activating G protein-coupled receptor signaling pathway,BP,
3630,GO:0007202,1,0.82069501117442,0,32,activation of phospholipase C activity,BP,
3632,GO:0007205,1,0.845712694868322,0,24,protein kinase C-activating G protein-coupled receptor signaling pathway,BP,
3633,GO:0007206,1,0.982026579240311,0,2,phospholipase C-activating G protein-coupled glutamate receptor signaling pathway,BP,
3634,GO:0007207,1,0.982049018182755,0,3,phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway,BP,
3635,GO:0007208,1,0.98524033198002,0,2,phospholipase C-activating serotonin receptor signaling pathway,BP,
3637,GO:0007212,1,0.783116403700036,0,38,dopamine receptor signaling pathway,BP,
3641,GO:0007216,1,0.888947478329836,0,15,G protein-coupled glutamate receptor signaling pathway,BP,
3642,GO:0007217,1,0.96681258131262,0,7,tachykinin receptor signaling pathway,BP,
3645,GO:0007220,1,0.936716208546583,0,10,Notch receptor processing,BP,
3646,GO:0007221,1,0.851966003422741,0,18,positive regulation of transcription of Notch receptor target,BP,
3648,GO:0007224,1,0.38067187013514,0,134,smoothened signaling pathway,BP,
3649,GO:0007225,1,0.992155581099823,0,1,patched ligand maturation,BP,
3650,GO:0007227,1,0.973304201630018,0,4,signal transduction downstream of smoothened,BP,
3651,GO:0007228,1,0.980521818754172,0,3,positive regulation of hh target transcription factor activity,BP,
3652,GO:0007229,1,0.480448961666153,0,101,integrin-mediated signaling pathway,BP,
3653,GO:0007231,1,0.97084146688098,0,4,osmosensory signaling pathway,BP,
3654,GO:0007249,1,0.177113810615039,0,268,I-kappaB kinase/NF-kappaB signaling,BP,
3655,GO:0007250,1,0.894984480042743,0,17,activation of NF-kappaB-inducing kinase activity,BP,
3656,GO:0007252,1,0.883023065614697,0,18,I-kappaB phosphorylation,BP,
3657,GO:0007253,1,0.959939577139364,0,8,cytoplasmic sequestering of NF-kappaB,BP,
3659,GO:0007256,1,0.917811117984185,0,11,activation of JNKK activity,BP,
3660,GO:0007257,1,0.772888528650386,0,36,activation of JUN kinase activity,BP,
3661,GO:0007258,1,0.974383030655924,0,4,JUN phosphorylation,BP,
3662,GO:0007259,1,0.488702125169078,0,110,receptor signaling pathway via JAK-STAT,BP,
3663,GO:0007260,1,0.695765772176806,0,59,tyrosine phosphorylation of STAT protein,BP,
3667,GO:0007266,1,0.400239691430511,0,127,Rho protein signal transduction,BP,
3671,GO:0007270,1,0.93203058526711,0,8,neuron-neuron synaptic transmission,BP,
3673,GO:0007272,1,0.375754057220098,0,134,ensheathment of neurons,BP,
3674,GO:0007274,1,0.862753607339852,0,22,neuromuscular synaptic transmission,BP,
3679,GO:0007284,1,0.984924104052982,0,2,spermatogonial cell division,BP,
3682,GO:0007289,1,0.903380216893619,0,14,spermatid nucleus differentiation,BP,
3683,GO:0007290,1,0.992133309959483,0,1,spermatid nucleus elongation,BP,
3684,GO:0007291,1,0.996563851948876,0,1,sperm individualization,BP,
3686,GO:0007296,1,0.965821497229938,0,4,vitellogenesis,BP,
3687,GO:0007308,1,0.980817459262998,0,3,oocyte construction,BP,
3688,GO:0007309,1,0.980817459262998,0,3,oocyte axis specification,BP,
3689,GO:0007314,1,0.980817459262998,0,3,oocyte anterior/posterior axis specification,BP,
3690,GO:0007315,1,0.980817459262998,0,3,pole plasm assembly,BP,
3691,GO:0007320,1,0.946314438155797,0,9,insemination,BP,
3693,GO:0007339,1,0.846698814548548,0,29,binding of sperm to zona pellucida,BP,
3694,GO:0007340,1,0.817653803025638,0,31,acrosome reaction,BP,
3695,GO:0007341,1,0.972224254434494,0,6,penetration of zona pellucida,BP,
3697,GO:0007343,1,0.984701042054663,0,2,egg activation,BP,
3698,GO:0007344,1,0.995359834508863,0,1,pronuclear fusion,BP,
3700,GO:0007349,1,0.996563851948876,0,1,cellularization,BP,
3701,GO:0007350,1,0.882845105041738,0,18,blastoderm segmentation,BP,
3702,GO:0007351,1,0.910059768750306,0,14,tripartite regional subdivision,BP,
3703,GO:0007352,1,0.977718879996173,0,3,zygotic specification of dorsal/ventral axis,BP,
3704,GO:0007354,1,0.971411815768228,0,5,zygotic determination of anterior/posterior axis, embryo,BP,
3705,GO:0007356,1,0.978304001635214,0,4,thorax and anterior abdomen determination,BP,
3708,GO:0007371,1,0.992730633679347,0,1,ventral midline determination,BP,
3709,GO:0007379,1,0.913696757768032,0,15,segment specification,BP,
3710,GO:0007386,1,0.964273134595876,0,5,compartment pattern specification,BP,
3711,GO:0007387,1,0.99356890853884,0,1,anterior compartment pattern formation,BP,
3712,GO:0007388,1,0.99356890853884,0,1,posterior compartment specification,BP,
3714,GO:0007398,1,0.874208243435258,0,19,ectoderm development,BP,
3716,GO:0007400,1,0.993962265126325,0,1,neuroblast fate determination,BP,
3717,GO:0007402,1,0.990895578622009,0,2,ganglion mother cell fate determination,BP,
3718,GO:0007403,1,0.992882079557312,0,1,glial cell fate determination,BP,
3720,GO:0007406,1,0.954521456629695,0,6,negative regulation of neuroblast proliferation,BP,
3722,GO:0007411,1,0.118089427943688,0,271,axon guidance,BP,
3723,GO:0007412,1,0.981730395678946,0,3,axon target recognition,BP,
3727,GO:0007418,1,0.971938653435779,0,4,ventral midline development,BP,
3729,GO:0007422,1,0.578573801397477,0,74,peripheral nervous system development,BP,
3731,GO:0007431,1,0.754693826472827,0,39,salivary gland development,BP,
3732,GO:0007435,1,0.775176075952008,0,35,salivary gland morphogenesis,BP,
3733,GO:0007439,1,0.987099747161919,0,2,ectodermal digestive tract development,BP,
3734,GO:0007440,1,0.916689957774195,0,10,foregut morphogenesis,BP,
3735,GO:0007442,1,0.947966612976883,0,7,hindgut morphogenesis,BP,
3736,GO:0007468,1,0.983243324060795,0,3,regulation of rhodopsin gene expression,BP,
3738,GO:0007493,1,0.987084288463088,0,2,endodermal cell fate determination,BP,
3739,GO:0007494,1,0.917924382480165,0,13,midgut development,BP,
3740,GO:0007495,1,0.993040942839371,0,1,visceral mesoderm-endoderm interaction involved in midgut development,BP,
3741,GO:0007497,1,0.98456282492583,0,2,posterior midgut development,BP,
3743,GO:0007499,1,0.992234600739859,0,1,ectoderm and mesoderm interaction,BP,
3744,GO:0007500,1,0.988604934214374,0,2,mesodermal cell fate determination,BP,
3746,GO:0007506,1,0.987222498635549,0,2,gonadal mesoderm development,BP,
3748,GO:0007509,1,0.990590062659351,0,1,mesoderm migration involved in gastrulation,BP,
3749,GO:0007512,1,0.9159446571631,0,12,adult heart development,BP,
3751,GO:0007518,1,0.989437416725582,0,2,myoblast fate determination,BP,
3753,GO:0007520,1,0.798610730810495,0,34,myoblast fusion,BP,
3754,GO:0007521,1,0.983790219241387,0,2,muscle cell fate determination,BP,
3755,GO:0007522,1,0.991105575611404,0,1,visceral muscle development,BP,
3756,GO:0007525,1,0.971351403636857,0,2,somatic muscle development,BP,
3757,GO:0007528,1,0.672272624762274,0,49,neuromuscular junction development,BP,
3758,GO:0007529,1,0.985234545512262,0,2,establishment of synaptic specificity at neuromuscular junction,BP,
3759,GO:0007530,1,0.861196171722309,0,22,sex determination,BP,
3760,GO:0007531,1,0.987515183603508,0,1,mating type determination,BP,
3761,GO:0007533,1,0.987515183603508,0,1,mating type switching,BP,
3762,GO:0007538,1,0.984304394873449,0,2,primary sex determination,BP,
3763,GO:0007542,1,0.984304394873449,0,2,primary sex determination, germ-line,BP,
3765,GO:0007549,1,0.890151705675312,0,14,dosage compensation,BP,
3767,GO:0007566,1,0.744557282521259,0,46,embryo implantation,BP,
3768,GO:0007567,1,0.899305874033848,0,16,parturition,BP,
3771,GO:0007571,1,0.996504261929267,0,1,age-dependent general metabolic decline,BP,
3773,GO:0007585,1,0.667107457432679,0,61,respiratory gaseous exchange by respiratory system,BP,
3775,GO:0007588,1,0.715882714141812,0,52,excretion,BP,
3778,GO:0007596,1,0.141550113789024,0,290,blood coagulation,BP,
3779,GO:0007597,1,0.92102111205625,0,14,blood coagulation, intrinsic pathway,BP,
3780,GO:0007598,1,0.977084992801672,0,4,blood coagulation, extrinsic pathway,BP,
3781,GO:0007599,1,0.137505101797751,0,295,hemostasis,BP,
3784,GO:0007602,1,0.760597100790359,0,45,phototransduction,BP,
3785,GO:0007603,1,0.839486607339074,0,27,phototransduction, visible light,BP,
3787,GO:0007606,1,0.618384770980394,0,85,sensory perception of chemical stimulus,BP,
3793,GO:0007614,1,0.931154263199335,0,11,short-term memory,BP,
3795,GO:0007617,1,0.861745263477529,0,21,mating behavior,BP,
3797,GO:0007619,1,0.979056046744758,0,3,courtship behavior,BP,
3799,GO:0007621,1,0.977996998486474,0,3,negative regulation of female receptivity,BP,
3800,GO:0007622,1,0.739610505696896,0,46,rhythmic behavior,BP,
3802,GO:0007624,1,0.98597113632575,0,2,ultradian rhythm,BP,
3803,GO:0007625,1,0.906612385333842,0,16,grooming behavior,BP,
3805,GO:0007628,1,0.816016046586137,0,27,adult walking behavior,BP,
3807,GO:0007632,1,0.689209677662686,0,49,visual behavior,BP,
3808,GO:0007634,1,0.988168927873414,0,2,optokinetic behavior,BP,
3809,GO:0007635,1,0.895486317349252,0,15,chemosensory behavior,BP,
3810,GO:0007638,1,0.884682432034418,0,14,mechanosensory behavior,BP,
3811,GO:0008009,1,0.869229843745341,0,34,chemokine activity,MF,
3812,GO:0008013,1,0.521033559152669,0,82,beta-catenin binding,MF,
3814,GO:0008016,1,0.1987873719458,0,230,regulation of heart contraction,BP,
3816,GO:0008020,1,0.94832594807479,0,10,G protein-coupled photoreceptor activity,MF,
3819,GO:0008023,1,0.715831614839587,0,47,transcription elongation factor complex,CC,
3820,GO:0008024,1,0.942036607963882,0,8,cyclin/CDK positive transcription elongation factor complex,CC,
3821,GO:0008028,1,0.715308018013084,0,52,monocarboxylic acid transmembrane transporter activity,MF,
3822,GO:0008033,1,0.500750341804337,0,118,tRNA processing,BP,
3823,GO:0008035,1,0.942208391093924,0,10,high-density lipoprotein particle binding,MF,
3826,GO:0008039,1,0.993193748184085,0,1,synaptic target recognition,BP,
3827,GO:0008043,1,0.99293792104797,0,2,intracellular ferritin complex,CC,
3828,GO:0008045,1,0.811119616808416,0,30,motor neuron axon guidance,BP,
3829,GO:0008046,1,0.932111677606192,0,9,axon guidance receptor activity,MF,
3831,GO:0008048,1,0.985772897805684,0,3,calcium sensitive guanylate cyclase activator activity,MF,
3832,GO:0008049,1,0.995054985345219,0,1,male courtship behavior,BP,
3833,GO:0008050,1,0.983922344197507,0,2,female courtship behavior,BP,
3834,GO:0008052,1,0.996543639775421,0,1,sensory organ boundary specification,BP,
3835,GO:0008053,1,0.856583484648177,0,24,mitochondrial fusion,BP,
3836,GO:0008057,1,0.989819170001524,0,1,eye pigment granule organization,BP,
3837,GO:0008061,1,0.959416409303276,0,7,chitin binding,MF,
3838,GO:0008063,1,0.953441796641972,0,7,Toll signaling pathway,BP,
3839,GO:0008064,1,0.314682347189879,0,170,regulation of actin polymerization or depolymerization,BP,
3840,GO:0008065,1,0.980890678036309,0,3,establishment of blood-nerve barrier,BP,
3843,GO:0008073,1,0.988129170436588,0,3,ornithine decarboxylase inhibitor activity,MF,
3845,GO:0008078,1,0.983461611962841,0,3,mesodermal cell migration,BP,
3846,GO:0008079,1,0.959701560890323,0,6,translation termination factor activity,MF,
3847,GO:0008080,1,0.600684860351481,0,74,N-acetyltransferase activity,MF,
3852,GO:0008090,1,0.8438579428628,0,19,retrograde axonal transport,BP,
3853,GO:0008091,1,0.91109962632992,0,9,spectrin,CC,
3855,GO:0008093,1,0.848756466620599,0,21,cytoskeletal anchor activity,MF,
3857,GO:0008097,1,0.954465509161016,0,10,5S rRNA binding,MF,
3859,GO:0008106,1,0.910786984361619,0,20,alcohol dehydrogenase (NADP+) activity,MF,
3860,GO:0008107,1,0.992491492776948,0,1,galactoside 2-alpha-L-fucosyltransferase activity,MF,
3861,GO:0008108,1,0.996047932566051,0,1,UDP-glucose:hexose-1-phosphate uridylyltransferase activity,MF,
3862,GO:0008109,1,0.985250960011242,0,2,N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity,MF,
3863,GO:0008111,1,0.994925217038383,0,1,alpha-methylacyl-CoA racemase activity,MF,
3864,GO:0008112,1,0.995662418558811,0,1,nicotinamide N-methyltransferase activity,MF,
3865,GO:0008113,1,0.991886613293081,0,2,peptide-methionine (S)-S-oxide reductase activity,MF,
3866,GO:0008115,1,0.994069561690604,0,1,sarcosine oxidase activity,MF,
3867,GO:0008116,1,0.991434893690055,0,1,prostaglandin-I synthase activity,MF,
3868,GO:0008117,1,0.983950934431879,0,2,sphinganine-1-phosphate aldolase activity,MF,
3869,GO:0008118,1,0.994432623326744,0,1,N-acetyllactosaminide alpha-2,3-sialyltransferase activity,MF,
3870,GO:0008119,1,0.992992664227769,0,1,thiopurine S-methyltransferase activity,MF,
3871,GO:0008120,1,0.995564084830786,0,1,ceramide glucosyltransferase activity,MF,
3872,GO:0008121,1,0.977468206319498,0,6,ubiquinol-cytochrome-c reductase activity,MF,
3873,GO:0008124,1,0.990690940237195,0,2,4-alpha-hydroxytetrahydrobiopterin dehydratase activity,MF,
3874,GO:0008126,1,0.967108592543713,0,5,acetylesterase activity,MF,
3875,GO:0008127,1,0.996107528753137,0,1,quercetin 2,3-dioxygenase activity,MF,
3876,GO:0008131,1,0.966333121328575,0,5,primary amine oxidase activity,MF,
3879,GO:0008137,1,0.870275933724654,0,38,NADH dehydrogenase (ubiquinone) activity,MF,
3881,GO:0008139,1,0.851515635483756,0,21,nuclear localization sequence binding,MF,
3882,GO:0008140,1,0.945588573130649,0,9,cAMP response element binding protein binding,MF,
3883,GO:0008142,1,0.948559985047106,0,7,oxysterol binding,MF,
3884,GO:0008143,1,0.849347227811992,0,23,poly(A) binding,MF,
3887,GO:0008147,1,0.994104444624313,0,2,structural constituent of bone,MF,
3890,GO:0008154,1,0.255203460405273,0,199,actin polymerization or depolymerization,BP,
3891,GO:0008156,1,0.818722726281034,0,29,negative regulation of DNA replication,BP,
3892,GO:0008157,1,0.823749799821074,0,28,protein phosphatase 1 binding,MF,
3893,GO:0008158,1,0.978852139713037,0,3,hedgehog receptor activity,MF,
3894,GO:0008160,1,0.99371854727717,0,1,protein tyrosine phosphatase activator activity,MF,
3895,GO:0008168,1,0.305462452012711,0,181,methyltransferase activity,MF,
3896,GO:0008169,1,0.972321340067842,0,5,C-methyltransferase activity,MF,
3897,GO:0008170,1,0.575970094587538,0,81,N-methyltransferase activity,MF,
3898,GO:0008171,1,0.902005676405696,0,17,O-methyltransferase activity,MF,
3899,GO:0008172,1,0.95968452455609,0,6,S-methyltransferase activity,MF,
3900,GO:0008173,1,0.690751675082708,0,59,RNA methyltransferase activity,MF,
3901,GO:0008174,1,0.927880845449094,0,11,mRNA methyltransferase activity,MF,
3902,GO:0008175,1,0.812806956161678,0,32,tRNA methyltransferase activity,MF,
3903,GO:0008176,1,0.991462479728688,0,2,tRNA (guanine-N7-)-methyltransferase activity,MF,
3904,GO:0008177,1,0.99045688053747,0,2,succinate dehydrogenase (ubiquinone) activity,MF,
3905,GO:0008179,1,0.907428057165132,0,13,adenylate cyclase binding,MF,
3906,GO:0008180,1,0.815043607085889,0,32,COP9 signalosome,CC,
3907,GO:0008184,1,0.978968368666867,0,3,glycogen phosphorylase activity,MF,
3908,GO:0008186,1,0.962616612354492,0,5,RNA-dependent ATPase activity,MF,
3909,GO:0008187,1,0.819417459762226,0,29,poly-pyrimidine tract binding,MF,
3911,GO:0008190,1,0.935267820735967,0,10,eukaryotic initiation factor 4E binding,MF,
3912,GO:0008191,1,0.909972474358524,0,16,metalloendopeptidase inhibitor activity,MF,
3913,GO:0008192,1,0.988476371344805,0,2,RNA guanylyltransferase activity,MF,
3914,GO:0008193,1,0.996098421465762,0,1,tRNA guanylyltransferase activity,MF,
3915,GO:0008194,1,0.474660594604931,0,113,UDP-glycosyltransferase activity,MF,
3916,GO:0008195,1,0.975129577053895,0,3,phosphatidate phosphatase activity,MF,
3917,GO:0008198,1,0.864126441628331,0,23,ferrous iron binding,MF,
3919,GO:0008200,1,0.796341152513995,0,35,ion channel inhibitor activity,MF,
3922,GO:0008203,1,0.432326055119143,0,127,cholesterol metabolic process,BP,
3923,GO:0008206,1,0.758898765696271,0,44,bile acid metabolic process,BP,
3924,GO:0008207,1,0.837189700065932,0,30,C21-steroid hormone metabolic process,BP,
3925,GO:0008209,1,0.874043853588082,0,22,androgen metabolic process,BP,
3926,GO:0008210,1,0.871603375408383,0,24,estrogen metabolic process,BP,
3927,GO:0008211,1,0.878577992265515,0,21,glucocorticoid metabolic process,BP,
3928,GO:0008212,1,0.938502657687617,0,9,mineralocorticoid metabolic process,BP,
3929,GO:0008213,1,0.327024049580264,0,154,protein alkylation,BP,
3930,GO:0008214,1,0.788415976716106,0,29,protein dealkylation,BP,
3931,GO:0008215,1,0.975443903874239,0,5,spermine metabolic process,BP,
3932,GO:0008216,1,0.962509588070567,0,8,spermidine metabolic process,BP,
3936,GO:0008228,1,0.949005295914655,0,8,opsonization,BP,
3938,GO:0008234,1,0.477710571277008,0,107,cysteine-type peptidase activity,MF,
3939,GO:0008235,1,0.68058574676633,0,58,metalloexopeptidase activity,MF,
3941,GO:0008237,1,0.312974356812201,0,167,metallopeptidase activity,MF,
3942,GO:0008238,1,0.572682860192471,0,86,exopeptidase activity,MF,
3943,GO:0008239,1,0.949859712654611,0,8,dipeptidyl-peptidase activity,MF,
3944,GO:0008240,1,0.978067014620361,0,3,tripeptidyl-peptidase activity,MF,
3945,GO:0008241,1,0.985800573789646,0,2,peptidyl-dipeptidase activity,MF,
3946,GO:0008242,1,0.512608641040085,0,88,omega peptidase activity,MF,
3947,GO:0008250,1,0.936941618996921,0,13,oligosaccharyltransferase complex,CC,
3948,GO:0008251,1,0.950981692697521,0,7,tRNA-specific adenosine deaminase activity,MF,
3949,GO:0008252,1,0.927854102640017,0,12,nucleotidase activity,MF,
3950,GO:0008253,1,0.933475585662979,0,11,5'-nucleotidase activity,MF,
3951,GO:0008260,1,0.988066143182668,0,2,3-oxoacid CoA-transferase activity,MF,
3952,GO:0008263,1,0.987000007718386,0,2,pyrimidine-specific mismatch base pair DNA N-glycosylase activity,MF,
3953,GO:0008265,1,0.993532681904863,0,1,Mo-molybdopterin cofactor sulfurase activity,MF,
3954,GO:0008266,1,0.839068257511734,0,26,poly(U) RNA binding,MF,
3955,GO:0008269,1,0.994464894599637,0,1,JAK pathway signal transduction adaptor activity,MF,
3957,GO:0008271,1,0.928745765751354,0,10,secondary active sulfate transmembrane transporter activity,MF,
3958,GO:0008272,1,0.902750080292213,0,15,sulfate transport,BP,
3959,GO:0008273,1,0.97107097312017,0,4,calcium, potassium:sodium antiporter activity,MF,
3960,GO:0008274,1,0.946914752464531,0,7,gamma-tubulin ring complex,CC,
3961,GO:0008275,1,0.968898220608844,0,4,gamma-tubulin small complex,CC,
3962,GO:0008276,1,0.593243502645406,0,75,protein methyltransferase activity,MF,
3964,GO:0008278,1,0.93251549684584,0,9,cohesin complex,CC,
3965,GO:0008281,1,0.984197431002712,0,2,sulfonylurea receptor activity,MF,
3966,GO:0008282,1,0.977436036266542,0,3,inward rectifying potassium channel,CC,
3970,GO:0008286,1,0.385433301256761,0,135,insulin receptor signaling pathway,BP,
3971,GO:0008287,1,0.732330693527853,0,46,protein serine/threonine phosphatase complex,CC,
3973,GO:0008290,1,0.957760376088519,0,7,F-actin capping protein complex,CC,
3974,GO:0008291,1,0.974849006870859,0,4,acetylcholine metabolic process,BP,
3975,GO:0008292,1,0.987679388903247,0,2,acetylcholine biosynthetic process,BP,
3977,GO:0008295,1,0.979219404486094,0,4,spermidine biosynthetic process,BP,
3978,GO:0008296,1,0.93985832397779,0,11,3'-5'-exodeoxyribonuclease activity,MF,
3979,GO:0008297,1,0.943643719903081,0,9,single-stranded DNA exodeoxyribonuclease activity,MF,
3980,GO:0008298,1,0.931791801638859,0,12,intracellular mRNA localization,BP,
3981,GO:0008299,1,0.856765292376168,0,26,isoprenoid biosynthetic process,BP,
3982,GO:0008300,1,0.952676588829939,0,9,isoprenoid catabolic process,BP,
3984,GO:0008303,1,0.970267775101697,0,5,caspase complex,CC,
3985,GO:0008305,1,0.786695448779729,0,31,integrin complex,CC,
3987,GO:0008307,1,0.731568197867274,0,40,structural constituent of muscle,MF,
3988,GO:0008308,1,0.907579049694986,0,15,voltage-gated anion channel activity,MF,
3989,GO:0008309,1,0.978324730876865,0,4,double-stranded DNA exodeoxyribonuclease activity,MF,
3990,GO:0008310,1,0.966847407744063,0,5,single-stranded DNA 3'-5' exodeoxyribonuclease activity,MF,
3991,GO:0008311,1,0.99074601167897,0,2,double-stranded DNA 3'-5' exodeoxyribonuclease activity,MF,
3992,GO:0008312,1,0.964701946526075,0,7,7S RNA binding,MF,
3993,GO:0008315,1,0.980518317012783,0,3,G2/MI transition of meiotic cell cycle,BP,
3994,GO:0008318,1,0.954179755185323,0,7,protein prenyltransferase activity,MF,
3995,GO:0008320,1,0.90498320714094,0,17,protein transmembrane transporter activity,MF,
3996,GO:0008321,1,0.976608349901563,0,3,Ral guanyl-nucleotide exchange factor activity,MF,
3998,GO:0008327,1,0.864305682917876,0,21,methyl-CpG binding,MF,
4001,GO:0008331,1,0.907758576633355,0,10,high voltage-gated calcium channel activity,MF,
4002,GO:0008332,1,0.967068354923507,0,3,low voltage-gated calcium channel activity,MF,
4003,GO:0008333,1,0.705857890044401,0,48,endosome to lysosome transport,BP,
4004,GO:0008334,1,0.870001245744958,0,22,histone mRNA metabolic process,BP,
4005,GO:0008336,1,0.995089812038132,0,1,gamma-butyrobetaine dioxygenase activity,MF,
4006,GO:0008340,1,0.887758060415292,0,15,determination of adult lifespan,BP,
4008,GO:0008344,1,0.597859050829988,0,73,adult locomotory behavior,BP,
4009,GO:0008347,1,0.711684756893857,0,48,glial cell migration,BP,
4010,GO:0008348,1,0.992763426152033,0,1,negative regulation of antimicrobial humoral response,BP,
4011,GO:0008349,1,0.971968205692385,0,4,MAP kinase kinase kinase kinase activity,MF,
4012,GO:0008352,1,0.993646434622282,0,1,katanin complex,CC,
4013,GO:0008353,1,0.915519519243254,0,12,RNA polymerase II CTD heptapeptide repeat kinase activity,MF,
4014,GO:0008354,1,0.957335397338564,0,6,germ cell migration,BP,
4015,GO:0008355,1,0.984918013280684,0,2,olfactory learning,BP,
4017,GO:0008358,1,0.980817459262998,0,3,maternal determination of anterior/posterior axis, embryo,BP,
4018,GO:0008360,1,0.352723257867859,0,144,regulation of cell shape,BP,
4019,GO:0008361,1,0.275065319223931,0,172,regulation of cell size,BP,
4020,GO:0008366,1,0.375754057220098,0,134,axon ensheathment,BP,
4022,GO:0008374,1,0.779500953054214,0,36,O-acyltransferase activity,MF,
4023,GO:0008375,1,0.759463649616886,0,43,acetylglucosaminyltransferase activity,MF,
4024,GO:0008376,1,0.753751403528383,0,42,acetylgalactosaminyltransferase activity,MF,
4025,GO:0008378,1,0.858794009934708,0,25,galactosyltransferase activity,MF,
4026,GO:0008379,1,0.982271603470988,0,5,thioredoxin peroxidase activity,MF,
4027,GO:0008380,1,0.0696337029910192,0,421,RNA splicing,BP,
4028,GO:0008381,1,0.890266568652145,0,17,mechanosensitive ion channel activity,MF,
4029,GO:0008384,1,0.985523300760069,0,2,IkappaB kinase activity,MF,
4030,GO:0008385,1,0.95438484992292,0,7,IkappaB kinase complex,CC,
4031,GO:0008386,1,0.994931102309887,0,1,cholesterol monooxygenase (side-chain-cleaving) activity,MF,
4032,GO:0008387,1,0.994326750937077,0,1,steroid 7-alpha-hydroxylase activity,MF,
4033,GO:0008389,1,0.995322921917165,0,1,coumarin 7-hydroxylase activity,MF,
4034,GO:0008391,1,0.941472006291556,0,11,arachidonic acid monooxygenase activity,MF,
4035,GO:0008392,1,0.960586337680324,0,8,arachidonic acid epoxygenase activity,MF,
4036,GO:0008395,1,0.873364988784515,0,24,steroid hydroxylase activity,MF,
4037,GO:0008396,1,0.988464599817536,0,2,oxysterol 7-alpha-hydroxylase activity,MF,
4038,GO:0008397,1,0.992642687870581,0,1,sterol 12-alpha-hydroxylase activity,MF,
4039,GO:0008398,1,0.993133870561633,0,1,sterol 14-demethylase activity,MF,
4040,GO:0008401,1,0.967093206731866,0,6,retinoic acid 4-hydroxylase activity,MF,
4041,GO:0008403,1,0.993049970701491,0,1,25-hydroxycholecalciferol-24-hydroxylase activity,MF,
4042,GO:0008404,1,0.99514750660631,0,1,arachidonic acid 14,15-epoxygenase activity,MF,
4043,GO:0008405,1,0.99514750660631,0,1,arachidonic acid 11,12-epoxygenase activity,MF,
4045,GO:0008408,1,0.709404358869193,0,53,3'-5' exonuclease activity,MF,
4046,GO:0008409,1,0.882193782936639,0,17,5'-3' exonuclease activity,MF,
4047,GO:0008410,1,0.967256795065048,0,6,CoA-transferase activity,MF,
4048,GO:0008413,1,0.991757980238503,0,2,8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity,MF,
4049,GO:0008417,1,0.915676575685097,0,12,fucosyltransferase activity,MF,
4050,GO:0008418,1,0.996378005760676,0,1,protein-N-terminal asparagine amidohydrolase activity,MF,
4051,GO:0008419,1,0.993660636536508,0,1,RNA lariat debranching enzyme activity,MF,
4052,GO:0008420,1,0.954632834588584,0,7,RNA polymerase II CTD heptapeptide repeat phosphatase activity,MF,
4053,GO:0008422,1,0.969288135133467,0,5,beta-glucosidase activity,MF,
4054,GO:0008424,1,0.992965124727951,0,1,glycoprotein 6-alpha-L-fucosyltransferase activity,MF,
4055,GO:0008425,1,0.991946577981475,0,2,2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity,MF,
4056,GO:0008426,1,0.985560377352644,0,3,protein kinase C inhibitor activity,MF,
4057,GO:0008427,1,0.986836494748853,0,3,calcium-dependent protein kinase inhibitor activity,MF,
4058,GO:0008428,1,0.980844912838534,0,3,ribonuclease inhibitor activity,MF,
4059,GO:0008429,1,0.932361611680048,0,11,phosphatidylethanolamine binding,MF,
4061,GO:0008431,1,0.986891080756356,0,2,vitamin E binding,MF,
4062,GO:0008432,1,0.93947288036233,0,9,JUN kinase binding,MF,
4063,GO:0008437,1,0.994865257253236,0,1,thyrotropin-releasing hormone activity,MF,
4064,GO:0008440,1,0.974663062530454,0,4,inositol-1,4,5-trisphosphate 3-kinase activity,MF,
4065,GO:0008441,1,0.993982033751052,0,1,3'(2'),5'-bisphosphate nucleotidase activity,MF,
4066,GO:0008442,1,0.994916384605099,0,1,3-hydroxyisobutyrate dehydrogenase activity,MF,
4067,GO:0008443,1,0.953033818086841,0,7,phosphofructokinase activity,MF,
4068,GO:0008444,1,0.994492341035676,0,1,CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity,MF,
4069,GO:0008445,1,0.995588465141736,0,1,D-aspartate oxidase activity,MF,
4070,GO:0008446,1,0.995486473670405,0,1,GDP-mannose 4,6-dehydratase activity,MF,
4071,GO:0008448,1,0.995194259872767,0,1,N-acetylglucosamine-6-phosphate deacetylase activity,MF,
4072,GO:0008449,1,0.969566127619102,0,4,N-acetylglucosamine-6-sulfatase activity,MF,
4073,GO:0008452,1,0.993485400251684,0,1,RNA ligase activity,MF,
4074,GO:0008453,1,0.995616145417115,0,1,alanine-glyoxylate transaminase activity,MF,
4075,GO:0008454,1,0.979773000057929,0,3,alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity,MF,
4076,GO:0008455,1,0.993577168431364,0,1,alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,MF,
4077,GO:0008456,1,0.992736252445123,0,1,alpha-N-acetylgalactosaminidase activity,MF,
4078,GO:0008457,1,0.981973973214762,0,3,beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity,MF,
4079,GO:0008458,1,0.986448954587384,0,2,carnitine O-octanoyltransferase activity,MF,
4080,GO:0008459,1,0.984560401194257,0,2,chondroitin 6-sulfotransferase activity,MF,
4081,GO:0008460,1,0.995054985345219,0,1,dTDP-glucose 4,6-dehydratase activity,MF,
4082,GO:0008465,1,0.996197405127411,0,1,glycerate dehydrogenase activity,MF,
4083,GO:0008466,1,0.988205016753309,0,2,glycogenin glucosyltransferase activity,MF,
4084,GO:0008467,1,0.965674312062213,0,6,[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity,MF,
4085,GO:0008469,1,0.960320399401902,0,7,histone-arginine N-methyltransferase activity,MF,
4086,GO:0008470,1,0.992243203392524,0,1,isovaleryl-CoA dehydrogenase activity,MF,
4087,GO:0008474,1,0.932782559931559,0,12,palmitoyl-(protein) hydrolase activity,MF,
4088,GO:0008475,1,0.979148684908135,0,3,procollagen-lysine 5-dioxygenase activity,MF,
4089,GO:0008476,1,0.989777603226024,0,2,protein-tyrosine sulfotransferase activity,MF,
4090,GO:0008478,1,0.989873918312169,0,1,pyridoxal kinase activity,MF,
4091,GO:0008479,1,0.996047932566051,0,1,queuine tRNA-ribosyltransferase activity,MF,
4092,GO:0008480,1,0.992950953916412,0,1,sarcosine dehydrogenase activity,MF,
4093,GO:0008481,1,0.988414559184358,0,2,sphinganine kinase activity,MF,
4094,GO:0008482,1,0.99422133748271,0,1,sulfite oxidase activity,MF,
4096,GO:0008484,1,0.897437989418186,0,15,sulfuric ester hydrolase activity,MF,
4097,GO:0008486,1,0.977347175921527,0,4,diphosphoinositol-polyphosphate diphosphatase activity,MF,
4098,GO:0008488,1,0.993051953479284,0,1,gamma-glutamyl carboxylase activity,MF,
4099,GO:0008489,1,0.977748109702185,0,3,UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity,MF,
4100,GO:0008493,1,0.99514079979557,0,1,tetracycline transmembrane transporter activity,MF,
4101,GO:0008494,1,0.925756168665322,0,12,translation activator activity,MF,
4102,GO:0008495,1,0.99320639275261,0,1,protoheme IX farnesyltransferase activity,MF,
4103,GO:0008499,1,0.956380790872281,0,7,UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity,MF,
4104,GO:0008502,1,0.979696882598934,0,4,melatonin receptor activity,MF,
4106,GO:0008504,1,0.941640879251696,0,9,monoamine transmembrane transporter activity,MF,
4107,GO:0008506,1,0.97456033172572,0,4,sucrose:proton symporter activity,MF,
4108,GO:0008507,1,0.992800893154305,0,1,sodium:iodide symporter activity,MF,
4109,GO:0008508,1,0.981734523900754,0,4,bile acid:sodium symporter activity,MF,
4112,GO:0008511,1,0.982552748608069,0,2,sodium:potassium:chloride symporter activity,MF,
4113,GO:0008513,1,0.989677674598877,0,2,secondary active organic cation transmembrane transporter activity,MF,
4115,GO:0008515,1,0.97456033172572,0,4,sucrose transmembrane transporter activity,MF,
4116,GO:0008517,1,0.970332795686062,0,4,folic acid transmembrane transporter activity,MF,
4117,GO:0008518,1,0.993391227483216,0,1,folate:anion antiporter activity,MF,
4118,GO:0008519,1,0.943503674373163,0,8,ammonium transmembrane transporter activity,MF,
4119,GO:0008520,1,0.984466788442784,0,2,L-ascorbate:sodium symporter activity,MF,
4120,GO:0008521,1,0.993648007022561,0,1,acetyl-CoA transmembrane transporter activity,MF,
4121,GO:0008523,1,0.992955520887157,0,1,sodium-dependent multivitamin transmembrane transporter activity,MF,
4122,GO:0008525,1,0.917767791885956,0,11,phosphatidylcholine transporter activity,MF,
4123,GO:0008526,1,0.940754182066443,0,9,phosphatidylinositol transfer activity,MF,
4124,GO:0008527,1,0.946899680338619,0,12,taste receptor activity,MF,
4126,GO:0008531,1,0.993577168431364,0,1,riboflavin kinase activity,MF,
4127,GO:0008532,1,0.945947345312324,0,9,N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity,MF,
4128,GO:0008534,1,0.986721776372829,0,3,oxidized purine nucleobase lesion DNA N-glycosylase activity,MF,
4129,GO:0008535,1,0.869721644572422,0,24,respiratory chain complex IV assembly,BP,
4131,GO:0008537,1,0.986260632359356,0,3,proteasome activator complex,CC,
4132,GO:0008540,1,0.941479706020632,0,12,proteasome regulatory particle, base subcomplex,CC,
4133,GO:0008541,1,0.968352088761754,0,7,proteasome regulatory particle, lid subcomplex,CC,
4134,GO:0008542,1,0.719886479081521,0,43,visual learning,BP,
4137,GO:0008545,1,0.985689372677808,0,2,JUN kinase kinase activity,MF,
4138,GO:0008553,1,0.902318638298493,0,16,proton-exporting ATPase activity, phosphorylative mechanism,MF,
4139,GO:0008554,1,0.927525722228311,0,12,sodium transmembrane transporter activity, phosphorylative mechanism,MF,
4140,GO:0008555,1,0.991637193618431,0,1,ATPase-coupled chloride transmembrane transporter activity,MF,
4141,GO:0008556,1,0.934901273985335,0,11,potassium transmembrane transporter activity, phosphorylative mechanism,MF,
4142,GO:0008559,1,0.952903459291171,0,6,ATPase-coupled xenobiotic transmembrane transporter activity,MF,
4143,GO:0008568,1,0.943817354423743,0,8,microtubule-severing ATPase activity,MF,
4144,GO:0008569,1,0.79787126092766,0,18,ATP-dependent microtubule motor activity, minus-end-directed,MF,
4145,GO:0008574,1,0.867531818676571,0,16,ATP-dependent microtubule motor activity, plus-end-directed,MF,
4146,GO:0008579,1,0.991717084576294,0,1,JUN kinase phosphatase activity,MF,
4147,GO:0008582,1,0.962086736533581,0,5,regulation of synaptic growth at neuromuscular junction,BP,
4150,GO:0008589,1,0.546333709775935,0,81,regulation of smoothened signaling pathway,BP,
4151,GO:0008591,1,0.995255708783232,0,1,regulation of Wnt signaling pathway, calcium modulating pathway,BP,
4152,GO:0008592,1,0.970963963588997,0,4,regulation of Toll signaling pathway,BP,
4154,GO:0008594,1,0.97431507377241,0,4,photoreceptor cell morphogenesis,BP,
4155,GO:0008595,1,0.910059768750306,0,14,anterior/posterior axis specification, embryo,BP,
4156,GO:0008597,1,0.982589280389773,0,3,calcium-dependent protein serine/threonine phosphatase regulator activity,MF,
4157,GO:0008603,1,0.945513781999008,0,10,cAMP-dependent protein kinase regulator activity,MF,
4158,GO:0008607,1,0.981860606714765,0,3,phosphorylase kinase regulator activity,MF,
4159,GO:0008608,1,0.820319004483847,0,30,attachment of spindle microtubules to kinetochore,BP,
4160,GO:0008609,1,0.989623211472015,0,1,alkylglycerone-phosphate synthase activity,MF,
4162,GO:0008611,1,0.931375540592807,0,10,ether lipid biosynthetic process,BP,
4163,GO:0008612,1,0.984302102141184,0,3,peptidyl-lysine modification to peptidyl-hypusine,BP,
4164,GO:0008613,1,0.99692868868657,0,1,diuretic hormone activity,MF,
4165,GO:0008614,1,0.987535346189158,0,2,pyridoxine metabolic process,BP,
4166,GO:0008615,1,0.987535346189158,0,2,pyridoxine biosynthetic process,BP,
4167,GO:0008617,1,0.996520604840365,0,1,guanosine metabolic process,BP,
4168,GO:0008622,1,0.97042891354492,0,5,epsilon DNA polymerase complex,CC,
4169,GO:0008623,1,0.979505167364623,0,3,CHRAC,CC,
4171,GO:0008626,1,0.973972771193132,0,5,granzyme-mediated apoptotic signaling pathway,BP,
4172,GO:0008627,1,0.946998111704461,0,8,intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
4173,GO:0008628,1,0.986694832845218,0,3,hormone-mediated apoptotic signaling pathway,BP,
4176,GO:0008635,1,0.957348682064264,0,7,activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,BP,
4178,GO:0008641,1,0.935064634145829,0,10,ubiquitin-like modifier activating enzyme activity,MF,
4179,GO:0008643,1,0.408076608564898,0,130,carbohydrate transport,BP,
4180,GO:0008645,1,0.513494537834418,0,94,hexose transmembrane transport,BP,
4181,GO:0008649,1,0.91044988569222,0,17,rRNA methyltransferase activity,MF,
4182,GO:0008650,1,0.99280657630669,0,1,rRNA (uridine-2'-O-)-methyltransferase activity,MF,
4184,GO:0008653,1,0.994112177098516,0,1,lipopolysaccharide metabolic process,BP,
4186,GO:0008655,1,0.949841172830489,0,10,pyrimidine-containing compound salvage,BP,
4187,GO:0008656,1,0.909720804612944,0,15,cysteine-type endopeptidase activator activity involved in apoptotic process,MF,
4188,GO:0008659,1,0.988938770380431,0,1,(3R)-hydroxymyristoyl-[acyl-carrier-protein] dehydratase activity,MF,
4189,GO:0008663,1,0.993485400251684,0,1,2',3'-cyclic-nucleotide 2'-phosphodiesterase activity,MF,
4190,GO:0008670,1,0.991834004465769,0,2,2,4-dienoyl-CoA reductase (NADPH) activity,MF,
4191,GO:0008682,1,0.993769765052935,0,1,2-octoprenyl-3-methyl-6-methoxy-1,4-benzoquinone hydroxylase activity,MF,
4192,GO:0008689,1,0.996157227255456,0,1,3-demethylubiquinone-9 3-O-methyltransferase activity,MF,
4193,GO:0008693,1,0.988938770380431,0,1,3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase activity,MF,
4194,GO:0008700,1,0.993485400251684,0,1,4-hydroxy-2-oxoglutarate aldolase activity,MF,
4195,GO:0008705,1,0.987253255200936,0,1,methionine synthase activity,MF,
4196,GO:0008709,1,0.996601969691748,0,1,cholate 7-alpha-dehydrogenase activity,MF,
4197,GO:0008720,1,0.994801167887543,0,1,D-lactate dehydrogenase activity,MF,
4198,GO:0008721,1,0.993951530489555,0,1,D-serine ammonia-lyase activity,MF,
4199,GO:0008725,1,0.996417301251183,0,1,DNA-3-methyladenine glycosylase activity,MF,
4200,GO:0008732,1,0.988423017874078,0,2,L-allo-threonine aldolase activity,MF,
4201,GO:0008745,1,0.996602635136203,0,1,N-acetylmuramoyl-L-alanine amidase activity,MF,
4202,GO:0008746,1,0.988655796523995,0,2,NAD(P)+ transhydrogenase activity,MF,
4203,GO:0008747,1,0.995691275242356,0,1,N-acetylneuraminate lyase activity,MF,
4204,GO:0008753,1,0.992867263990588,0,1,NADPH dehydrogenase (quinone) activity,MF,
4205,GO:0008757,1,0.418940923877485,0,133,S-adenosylmethionine-dependent methyltransferase activity,MF,
4206,GO:0008761,1,0.991703264704624,0,1,UDP-N-acetylglucosamine 2-epimerase activity,MF,
4207,GO:0008768,1,0.993237896274628,0,2,UDP-sugar diphosphatase activity,MF,
4208,GO:0008775,1,0.995214187065311,0,1,acetate CoA-transferase activity,MF,
4209,GO:0008781,1,0.991580550252974,0,2,N-acylneuraminate cytidylyltransferase activity,MF,
4210,GO:0008783,1,0.99448449356263,0,1,agmatinase activity,MF,
4211,GO:0008785,1,0.995681114887179,0,1,alkyl hydroperoxide reductase activity,MF,
4212,GO:0008792,1,0.993485400251684,0,1,arginine decarboxylase activity,MF,
4213,GO:0008794,1,0.99665551211534,0,1,arsenate reductase (glutaredoxin) activity,MF,
4214,GO:0008796,1,0.996551737234071,0,1,bis(5'-nucleosyl)-tetraphosphatase activity,MF,
4215,GO:0008798,1,0.985506014265698,0,2,beta-aspartyl-peptidase activity,MF,
4216,GO:0008800,1,0.995450692884757,0,1,beta-lactamase activity,MF,
4217,GO:0008802,1,0.992810878213112,0,1,betaine-aldehyde dehydrogenase activity,MF,
4218,GO:0008803,1,0.996551737234071,0,1,bis(5'-nucleosyl)-tetraphosphatase (symmetrical) activity,MF,
4219,GO:0008808,1,0.992705087473751,0,1,cardiolipin synthase activity,MF,
4220,GO:0008812,1,0.992773273326414,0,1,choline dehydrogenase activity,MF,
4221,GO:0008817,1,0.992548210700491,0,1,cob(I)yrinic acid a,c-diamide adenosyltransferase activity,MF,
4222,GO:0008821,1,0.968531057570249,0,5,crossover junction endodeoxyribonuclease activity,MF,
4223,GO:0008823,1,0.975679012882765,0,3,cupric reductase activity,MF,
4224,GO:0008828,1,0.996906466060705,0,1,dATP pyrophosphohydrolase activity,MF,
4225,GO:0008832,1,0.993029393211783,0,1,dGTPase activity,MF,
4226,GO:0008843,1,0.994261390993069,0,1,endochitinase activity,MF,
4227,GO:0008852,1,0.993398959546306,0,1,exodeoxyribonuclease I activity,MF,
4228,GO:0008853,1,0.978760978559474,0,4,exodeoxyribonuclease III activity,MF,
4229,GO:0008859,1,0.996595975632083,0,1,exoribonuclease II activity,MF,
4230,GO:0008865,1,0.963044627848834,0,5,fructokinase activity,MF,
4231,GO:0008887,1,0.993001238331393,0,1,glycerate kinase activity,MF,
4232,GO:0008889,1,0.985969619828138,0,2,glycerophosphodiester phosphodiesterase activity,MF,
4233,GO:0008890,1,0.995648764838784,0,1,glycine C-acetyltransferase activity,MF,
4234,GO:0008891,1,0.995356157800689,0,1,glycolate oxidase activity,MF,
4235,GO:0008892,1,0.991583712489953,0,1,guanine deaminase activity,MF,
4236,GO:0008893,1,0.996478243032291,0,1,guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity,MF,
4237,GO:0008894,1,0.993531223273919,0,1,guanosine-5'-triphosphate,3'-diphosphate diphosphatase activity,MF,
4238,GO:0008897,1,0.993362178087714,0,1,holo-[acyl-carrier-protein] synthase activity,MF,
4239,GO:0008900,1,0.981530989833603,0,3,potassium:proton exchanging ATPase activity,MF,
4240,GO:0008903,1,0.996385052756459,0,1,hydroxypyruvate isomerase activity,MF,
4241,GO:0008905,1,0.995612695992936,0,1,mannose-phosphate guanylyltransferase activity,MF,
4242,GO:0008929,1,0.995855178946836,0,1,methylglyoxal synthase activity,MF,
4243,GO:0008934,1,0.981860926507983,0,3,inositol monophosphate 1-phosphatase activity,MF,
4244,GO:0008937,1,0.995074351707712,0,1,ferredoxin-NAD(P) reductase activity,MF,
4245,GO:0008940,1,0.9924770361683,0,1,nitrate reductase activity,MF,
4246,GO:0008941,1,0.99390014550595,0,1,nitric oxide dioxygenase activity,MF,
4247,GO:0008946,1,0.992622242279326,0,1,oligonucleotidase activity,MF,
4248,GO:0008948,1,0.975314213559367,0,4,oxaloacetate decarboxylase activity,MF,
4249,GO:0008955,1,0.992638197178312,0,1,peptidoglycan glycosyltransferase activity,MF,
4250,GO:0008962,1,0.993767259184394,0,1,phosphatidylglycerophosphatase activity,MF,
4251,GO:0008963,1,0.994588771784529,0,1,phospho-N-acetylmuramoyl-pentapeptide-transferase activity,MF,
4252,GO:0008967,1,0.987952110317708,0,2,phosphoglycolate phosphatase activity,MF,
4253,GO:0008970,1,0.959096401242776,0,7,phospholipase A1 activity,MF,
4254,GO:0008973,1,0.992994793884361,0,1,phosphopentomutase activity,MF,
4255,GO:0008988,1,0.977219513071246,0,4,rRNA (adenine-N6-)-methyltransferase activity,MF,
4256,GO:0008995,1,0.993759758138751,0,1,ribonuclease E activity,MF,
4257,GO:0009000,1,0.99397663109162,0,1,selenocysteine lyase activity,MF,
4258,GO:0009007,1,0.984912216445267,0,2,site-specific DNA-methyltransferase (adenine-specific) activity,MF,
4259,GO:0009008,1,0.958451739232566,0,6,DNA-methyltransferase activity,MF,
4260,GO:0009013,1,0.991828016275873,0,1,succinate-semialdehyde dehydrogenase [NAD(P)+] activity,MF,
4261,GO:0009019,1,0.972463399045869,0,4,tRNA (guanine-N1-)-methyltransferase activity,MF,
4262,GO:0009020,1,0.994955596711668,0,1,tRNA (guanosine-2'-O-)-methyltransferase activity,MF,
4263,GO:0009032,1,0.99551487069965,0,1,thymidine phosphorylase activity,MF,
4264,GO:0009041,1,0.98302774501973,0,3,uridylate kinase activity,MF,
4265,GO:0009048,1,0.890151705675312,0,14,dosage compensation by inactivation of X chromosome,BP,
4266,GO:0009051,1,0.974345295719222,0,4,pentose-phosphate shunt, oxidative branch,BP,
4267,GO:0009052,1,0.973298247102382,0,5,pentose-phosphate shunt, non-oxidative branch,BP,
4268,GO:0009055,1,0.626729221839912,0,96,electron transfer activity,MF,
4273,GO:0009060,1,0.671785312988482,0,75,aerobic respiration,BP,
4276,GO:0009064,1,0.643894243301979,0,69,glutamine family amino acid metabolic process,BP,
4277,GO:0009065,1,0.853723562518148,0,25,glutamine family amino acid catabolic process,BP,
4278,GO:0009066,1,0.763768127405711,0,45,aspartate family amino acid metabolic process,BP,
4279,GO:0009067,1,0.8731411465137,0,20,aspartate family amino acid biosynthetic process,BP,
4280,GO:0009068,1,0.884123816921117,0,21,aspartate family amino acid catabolic process,BP,
4281,GO:0009069,1,0.825411156518622,0,33,serine family amino acid metabolic process,BP,
4282,GO:0009070,1,0.919027665977062,0,15,serine family amino acid biosynthetic process,BP,
4283,GO:0009071,1,0.937832247567528,0,12,serine family amino acid catabolic process,BP,
4284,GO:0009072,1,0.828836372627117,0,35,aromatic amino acid family metabolic process,BP,
4285,GO:0009073,1,0.977444312608049,0,4,aromatic amino acid family biosynthetic process,BP,
4286,GO:0009074,1,0.87820220920166,0,25,aromatic amino acid family catabolic process,BP,
4287,GO:0009078,1,0.979137115994759,0,4,pyruvate family amino acid metabolic process,BP,
4288,GO:0009080,1,0.979137115994759,0,4,pyruvate family amino acid catabolic process,BP,
4292,GO:0009084,1,0.909481785910822,0,16,glutamine family amino acid biosynthetic process,BP,
4293,GO:0009085,1,0.984603195233279,0,2,lysine biosynthetic process,BP,
4294,GO:0009086,1,0.920716685854335,0,12,methionine biosynthetic process,BP,
4295,GO:0009087,1,0.99289280569619,0,1,methionine catabolic process,BP,
4296,GO:0009092,1,0.981427558693829,0,4,homoserine metabolic process,BP,
4297,GO:0009093,1,0.978704026600772,0,4,cysteine catabolic process,BP,
4298,GO:0009095,1,0.99360298701045,0,1,aromatic amino acid family biosynthetic process, prephenate pathway,BP,
4299,GO:0009097,1,0.985900390602043,0,3,isoleucine biosynthetic process,BP,
4304,GO:0009104,1,0.994112177098516,0,1,lipopolysaccharide catabolic process,BP,
4305,GO:0009106,1,0.988321251196018,0,2,lipoate metabolic process,BP,
4306,GO:0009107,1,0.99548914444974,0,1,lipoate biosynthetic process,BP,
4307,GO:0009110,1,0.89289716686478,0,19,vitamin biosynthetic process,BP,
4308,GO:0009111,1,0.94111906276878,0,11,vitamin catabolic process,BP,
4309,GO:0009112,1,0.812454757237764,0,33,nucleobase metabolic process,BP,
4310,GO:0009113,1,0.945357258275411,0,10,purine nucleobase biosynthetic process,BP,
4311,GO:0009115,1,0.983365146709887,0,2,xanthine catabolic process,BP,
4315,GO:0009120,1,0.965135909942093,0,7,deoxyribonucleoside metabolic process,BP,
4317,GO:0009124,1,0.80132813373304,0,39,nucleoside monophosphate biosynthetic process,BP,
4318,GO:0009125,1,0.966915365036436,0,6,nucleoside monophosphate catabolic process,BP,
4320,GO:0009127,1,0.899799382310843,0,19,purine nucleoside monophosphate biosynthetic process,BP,
4321,GO:0009128,1,0.977515172680799,0,4,purine nucleoside monophosphate catabolic process,BP,
4322,GO:0009129,1,0.919364473635484,0,15,pyrimidine nucleoside monophosphate metabolic process,BP,
4323,GO:0009130,1,0.92338871977271,0,14,pyrimidine nucleoside monophosphate biosynthetic process,BP,
4324,GO:0009131,1,0.995645343956262,0,1,pyrimidine nucleoside monophosphate catabolic process,BP,
4326,GO:0009133,1,0.944084259295153,0,10,nucleoside diphosphate biosynthetic process,BP,
4327,GO:0009134,1,0.965004268045563,0,6,nucleoside diphosphate catabolic process,BP,
4329,GO:0009136,1,0.965665642555419,0,6,purine nucleoside diphosphate biosynthetic process,BP,
4330,GO:0009137,1,0.98163572878734,0,3,purine nucleoside diphosphate catabolic process,BP,
4331,GO:0009138,1,0.976420010021566,0,4,pyrimidine nucleoside diphosphate metabolic process,BP,
4332,GO:0009139,1,0.98302774501973,0,3,pyrimidine nucleoside diphosphate biosynthetic process,BP,
4333,GO:0009140,1,0.993279327662994,0,1,pyrimidine nucleoside diphosphate catabolic process,BP,
4334,GO:0009141,1,0.620757813068833,0,82,nucleoside triphosphate metabolic process,BP,
4335,GO:0009142,1,0.731428317015439,0,56,nucleoside triphosphate biosynthetic process,BP,
4336,GO:0009143,1,0.932381993103828,0,12,nucleoside triphosphate catabolic process,BP,
4337,GO:0009144,1,0.710872915484715,0,60,purine nucleoside triphosphate metabolic process,BP,
4338,GO:0009145,1,0.804919186292031,0,40,purine nucleoside triphosphate biosynthetic process,BP,
4339,GO:0009146,1,0.968362712597881,0,6,purine nucleoside triphosphate catabolic process,BP,
4340,GO:0009147,1,0.901678853804844,0,21,pyrimidine nucleoside triphosphate metabolic process,BP,
4341,GO:0009148,1,0.915194534544365,0,18,pyrimidine nucleoside triphosphate biosynthetic process,BP,
4342,GO:0009149,1,0.991515248896441,0,2,pyrimidine nucleoside triphosphate catabolic process,BP,
4344,GO:0009151,1,0.941019784190143,0,11,purine deoxyribonucleotide metabolic process,BP,
4346,GO:0009153,1,0.974621309301336,0,5,purine deoxyribonucleotide biosynthetic process,BP,
4347,GO:0009154,1,0.82628688303891,0,29,purine ribonucleotide catabolic process,BP,
4348,GO:0009155,1,0.971865341541392,0,5,purine deoxyribonucleotide catabolic process,BP,
4349,GO:0009156,1,0.840998803002338,0,30,ribonucleoside monophosphate biosynthetic process,BP,
4350,GO:0009157,1,0.958143033875812,0,8,deoxyribonucleoside monophosphate biosynthetic process,BP,
4351,GO:0009158,1,0.981060953590036,0,3,ribonucleoside monophosphate catabolic process,BP,
4352,GO:0009159,1,0.989158830445338,0,2,deoxyribonucleoside monophosphate catabolic process,BP,
4354,GO:0009162,1,0.944478808062826,0,11,deoxyribonucleoside monophosphate metabolic process,BP,
4355,GO:0009163,1,0.835765191046198,0,35,nucleoside biosynthetic process,BP,
4356,GO:0009164,1,0.863265282053951,0,28,nucleoside catabolic process,BP,
4358,GO:0009166,1,0.678627335175095,0,64,nucleotide catabolic process,BP,
4360,GO:0009168,1,0.908640935412982,0,17,purine ribonucleoside monophosphate biosynthetic process,BP,
4361,GO:0009169,1,0.981060953590036,0,3,purine ribonucleoside monophosphate catabolic process,BP,
4362,GO:0009170,1,0.986861015711031,0,3,purine deoxyribonucleoside monophosphate metabolic process,BP,
4363,GO:0009171,1,0.990278762745527,0,2,purine deoxyribonucleoside monophosphate biosynthetic process,BP,
4364,GO:0009173,1,0.942506878814426,0,10,pyrimidine ribonucleoside monophosphate metabolic process,BP,
4365,GO:0009174,1,0.942506878814426,0,10,pyrimidine ribonucleoside monophosphate biosynthetic process,BP,
4366,GO:0009176,1,0.975460278748818,0,5,pyrimidine deoxyribonucleoside monophosphate metabolic process,BP,
4367,GO:0009177,1,0.979727529286381,0,4,pyrimidine deoxyribonucleoside monophosphate biosynthetic process,BP,
4368,GO:0009178,1,0.995645343956262,0,1,pyrimidine deoxyribonucleoside monophosphate catabolic process,BP,
4370,GO:0009180,1,0.965665642555419,0,6,purine ribonucleoside diphosphate biosynthetic process,BP,
4371,GO:0009181,1,0.98163572878734,0,3,purine ribonucleoside diphosphate catabolic process,BP,
4372,GO:0009182,1,0.98292266196913,0,3,purine deoxyribonucleoside diphosphate metabolic process,BP,
4373,GO:0009183,1,0.989368690165085,0,2,purine deoxyribonucleoside diphosphate biosynthetic process,BP,
4375,GO:0009186,1,0.97268842556259,0,5,deoxyribonucleoside diphosphate metabolic process,BP,
4377,GO:0009188,1,0.959260726784737,0,7,ribonucleoside diphosphate biosynthetic process,BP,
4378,GO:0009189,1,0.979068007786534,0,4,deoxyribonucleoside diphosphate biosynthetic process,BP,
4380,GO:0009191,1,0.971373126149376,0,5,ribonucleoside diphosphate catabolic process,BP,
4381,GO:0009193,1,0.986693112048907,0,2,pyrimidine ribonucleoside diphosphate metabolic process,BP,
4382,GO:0009194,1,0.993369666664661,0,1,pyrimidine ribonucleoside diphosphate biosynthetic process,BP,
4383,GO:0009195,1,0.993279327662994,0,1,pyrimidine ribonucleoside diphosphate catabolic process,BP,
4384,GO:0009196,1,0.989589739756803,0,2,pyrimidine deoxyribonucleoside diphosphate metabolic process,BP,
4385,GO:0009197,1,0.989589739756803,0,2,pyrimidine deoxyribonucleoside diphosphate biosynthetic process,BP,
4386,GO:0009199,1,0.712866462551347,0,58,ribonucleoside triphosphate metabolic process,BP,
4387,GO:0009200,1,0.917418341983102,0,17,deoxyribonucleoside triphosphate metabolic process,BP,
4388,GO:0009201,1,0.778975869769615,0,45,ribonucleoside triphosphate biosynthetic process,BP,
4389,GO:0009202,1,0.969917216491669,0,6,deoxyribonucleoside triphosphate biosynthetic process,BP,
4390,GO:0009203,1,0.996397002640242,0,1,ribonucleoside triphosphate catabolic process,BP,
4391,GO:0009204,1,0.960143758990651,0,8,deoxyribonucleoside triphosphate catabolic process,BP,
4392,GO:0009205,1,0.740516511295908,0,52,purine ribonucleoside triphosphate metabolic process,BP,
4393,GO:0009206,1,0.809162823091504,0,39,purine ribonucleoside triphosphate biosynthetic process,BP,
4394,GO:0009207,1,0.996397002640242,0,1,purine ribonucleoside triphosphate catabolic process,BP,
4395,GO:0009208,1,0.926635944958923,0,15,pyrimidine ribonucleoside triphosphate metabolic process,BP,
4396,GO:0009209,1,0.932536909149878,0,14,pyrimidine ribonucleoside triphosphate biosynthetic process,BP,
4397,GO:0009211,1,0.973087278725958,0,6,pyrimidine deoxyribonucleoside triphosphate metabolic process,BP,
4398,GO:0009212,1,0.981415908662102,0,4,pyrimidine deoxyribonucleoside triphosphate biosynthetic process,BP,
4399,GO:0009213,1,0.991515248896441,0,2,pyrimidine deoxyribonucleoside triphosphate catabolic process,BP,
4400,GO:0009214,1,0.895038983307667,0,14,cyclic nucleotide catabolic process,BP,
4401,GO:0009215,1,0.953829729361167,0,9,purine deoxyribonucleoside triphosphate metabolic process,BP,
4402,GO:0009216,1,0.988285756944155,0,2,purine deoxyribonucleoside triphosphate biosynthetic process,BP,
4403,GO:0009217,1,0.971865341541392,0,5,purine deoxyribonucleoside triphosphate catabolic process,BP,
4404,GO:0009218,1,0.88214267799985,0,23,pyrimidine ribonucleotide metabolic process,BP,
4405,GO:0009219,1,0.91592452417483,0,18,pyrimidine deoxyribonucleotide metabolic process,BP,
4406,GO:0009220,1,0.893776586847457,0,21,pyrimidine ribonucleotide biosynthetic process,BP,
4407,GO:0009221,1,0.965721681377126,0,7,pyrimidine deoxyribonucleotide biosynthetic process,BP,
4408,GO:0009222,1,0.993279327662994,0,1,pyrimidine ribonucleotide catabolic process,BP,
4409,GO:0009223,1,0.943824376102658,0,12,pyrimidine deoxyribonucleotide catabolic process,BP,
4410,GO:0009225,1,0.806079473882226,0,35,nucleotide-sugar metabolic process,BP,
4411,GO:0009226,1,0.885297519778379,0,21,nucleotide-sugar biosynthetic process,BP,
4412,GO:0009227,1,0.983933802599311,0,3,nucleotide-sugar catabolic process,BP,
4413,GO:0009229,1,0.994172121860078,0,1,thiamine diphosphate biosynthetic process,BP,
4414,GO:0009231,1,0.993577168431364,0,1,riboflavin biosynthetic process,BP,
4415,GO:0009233,1,0.974644031258331,0,4,menaquinone metabolic process,BP,
4416,GO:0009234,1,0.992771023838117,0,1,menaquinone biosynthetic process,BP,
4417,GO:0009235,1,0.887588758906596,0,18,cobalamin metabolic process,BP,
4418,GO:0009237,1,0.993288385648692,0,1,siderophore metabolic process,BP,
4419,GO:0009240,1,0.980847921192071,0,4,isopentenyl diphosphate biosynthetic process,BP,
4421,GO:0009249,1,0.973534885509564,0,7,protein lipoylation,BP,
4422,GO:0009250,1,0.727663292898435,0,41,glucan biosynthetic process,BP,
4423,GO:0009251,1,0.845595075372656,0,22,glucan catabolic process,BP,
4424,GO:0009253,1,0.993161936937512,0,2,peptidoglycan catabolic process,BP,
4425,GO:0009256,1,0.963182435573622,0,5,10-formyltetrahydrofolate metabolic process,BP,
4426,GO:0009257,1,0.985693168234248,0,2,10-formyltetrahydrofolate biosynthetic process,BP,
4427,GO:0009258,1,0.982894963315504,0,2,10-formyltetrahydrofolate catabolic process,BP,
4430,GO:0009261,1,0.820723110217161,0,30,ribonucleotide catabolic process,BP,
4433,GO:0009264,1,0.913028730683313,0,18,deoxyribonucleotide catabolic process,BP,
4434,GO:0009265,1,0.941204472280075,0,12,2'-deoxyribonucleotide biosynthetic process,BP,
4436,GO:0009267,1,0.367557937375899,0,147,cellular response to starvation,BP,
4437,GO:0009268,1,0.804258429080712,0,36,response to pH,BP,
4438,GO:0009295,1,0.772972885273056,0,40,nucleoid,CC,
4439,GO:0009298,1,0.981416936985774,0,4,GDP-mannose biosynthetic process,BP,
4440,GO:0009299,1,0.881033574561162,0,17,mRNA transcription,BP,
4441,GO:0009301,1,0.648375156444006,0,70,snRNA transcription,BP,
4442,GO:0009303,1,0.842272581292509,0,27,rRNA transcription,BP,
4443,GO:0009304,1,0.949922061359465,0,8,tRNA transcription,BP,
4444,GO:0009305,1,0.991069117274906,0,1,protein biotinylation,BP,
4446,GO:0009308,1,0.493094719950641,0,128,amine metabolic process,BP,
4447,GO:0009309,1,0.896819738647618,0,21,amine biosynthetic process,BP,
4448,GO:0009310,1,0.893106907402513,0,20,amine catabolic process,BP,
4450,GO:0009312,1,0.909312532415319,0,16,oligosaccharide biosynthetic process,BP,
4451,GO:0009313,1,0.932434156120154,0,11,oligosaccharide catabolic process,BP,
4453,GO:0009328,1,0.989565199631513,0,2,phenylalanine-tRNA ligase complex,CC,
4455,GO:0009331,1,0.977319589413715,0,3,glycerol-3-phosphate dehydrogenase complex,CC,
4456,GO:0009353,1,0.99606637078802,0,1,mitochondrial oxoglutarate dehydrogenase complex,CC,
4457,GO:0009360,1,0.993586231484525,0,1,DNA polymerase III complex,CC,
4458,GO:0009361,1,0.995853557838558,0,1,succinate-CoA ligase complex (ADP-forming),CC,
4459,GO:0009368,1,0.99051922383684,0,2,endopeptidase Clp complex,CC,
4460,GO:0009374,1,0.96038761598633,0,5,biotin binding,MF,
4461,GO:0009378,1,0.952804492785823,0,6,four-way junction helicase activity,MF,
4462,GO:0009383,1,0.980217015528017,0,3,rRNA (cytosine-C5-)-methyltransferase activity,MF,
4463,GO:0009384,1,0.991703264704624,0,1,N-acylmannosamine kinase activity,MF,
4464,GO:0009386,1,0.98993930597724,0,2,translational attenuation,BP,
4465,GO:0009394,1,0.861856973978444,0,29,2'-deoxyribonucleotide metabolic process,BP,
4466,GO:0009395,1,0.774620470753563,0,41,phospholipid catabolic process,BP,
4467,GO:0009396,1,0.952442073773182,0,8,folic acid-containing compound biosynthetic process,BP,
4468,GO:0009397,1,0.979643098222895,0,3,folic acid-containing compound catabolic process,BP,
4469,GO:0009398,1,0.993577168431364,0,1,FMN biosynthetic process,BP,
4470,GO:0009404,1,0.920130749795507,0,13,toxin metabolic process,BP,
4471,GO:0009405,1,0.982797904000116,0,2,pathogenesis,BP,
4472,GO:0009407,1,0.989744192529501,0,2,toxin catabolic process,BP,
4475,GO:0009410,1,0.584843041391085,0,96,response to xenobiotic stimulus,BP,
4476,GO:0009411,1,0.420209808001018,0,131,response to UV,BP,
4477,GO:0009414,1,0.953571116935109,0,8,response to water deprivation,BP,
4478,GO:0009415,1,0.910301330759883,0,14,response to water,BP,
4480,GO:0009435,1,0.859888569552055,0,25,NAD biosynthetic process,BP,
4481,GO:0009436,1,0.989129820241326,0,2,glyoxylate catabolic process,BP,
4482,GO:0009437,1,0.921464597669854,0,13,carnitine metabolic process,BP,
4483,GO:0009438,1,0.976385971645189,0,5,methylglyoxal metabolic process,BP,
4484,GO:0009439,1,0.992209072315951,0,2,cyanate metabolic process,BP,
4485,GO:0009440,1,0.992209072315951,0,2,cyanate catabolic process,BP,
4486,GO:0009441,1,0.98205695417273,0,3,glycolate metabolic process,BP,
4487,GO:0009443,1,0.989873918312169,0,1,pyridoxal 5'-phosphate salvage,BP,
4488,GO:0009444,1,0.991695043621099,0,1,pyruvate oxidation,BP,
4489,GO:0009445,1,0.96413572686934,0,7,putrescine metabolic process,BP,
4490,GO:0009446,1,0.970965682664698,0,5,putrescine biosynthetic process,BP,
4491,GO:0009447,1,0.988450247443538,0,3,putrescine catabolic process,BP,
4492,GO:0009448,1,0.966068255118479,0,5,gamma-aminobutyric acid metabolic process,BP,
4493,GO:0009449,1,0.979089409017551,0,3,gamma-aminobutyric acid biosynthetic process,BP,
4494,GO:0009450,1,0.983915053412378,0,2,gamma-aminobutyric acid catabolic process,BP,
4495,GO:0009451,1,0.417535873801241,0,144,RNA modification,BP,
4496,GO:0009452,1,0.832272250036608,0,32,7-methylguanosine RNA capping,BP,
4498,GO:0009581,1,0.444367271402219,0,117,detection of external stimulus,BP,
4499,GO:0009582,1,0.436399692517344,0,120,detection of abiotic stimulus,BP,
4500,GO:0009583,1,0.679294133396883,0,60,detection of light stimulus,BP,
4501,GO:0009584,1,0.720604269732829,0,50,detection of visible light,BP,
4502,GO:0009590,1,0.994772529863122,0,1,detection of gravity,BP,
4504,GO:0009595,1,0.812102775015991,0,32,detection of biotic stimulus,BP,
4505,GO:0009597,1,0.96813233081105,0,5,detection of virus,BP,
4508,GO:0009608,1,0.976604097163574,0,4,response to symbiont,BP,
4509,GO:0009609,1,0.976604097163574,0,4,response to symbiotic bacterium,BP,
4512,GO:0009615,1,0.160277679324809,0,290,response to virus,BP,
4514,GO:0009620,1,0.827091019253917,0,39,response to fungus,BP,
4515,GO:0009624,1,0.990032490751269,0,2,response to nematode,BP,
4517,GO:0009629,1,0.945884538562126,0,10,response to gravity,BP,
4518,GO:0009631,1,0.984916870770151,0,2,cold acclimation,BP,
4519,GO:0009635,1,0.962778051500121,0,7,response to herbicide,BP,
4521,GO:0009637,1,0.985581877608286,0,2,response to blue light,BP,
4523,GO:0009644,1,0.986477831582575,0,2,response to high light intensity,BP,
4524,GO:0009645,1,0.992850308233352,0,1,response to low light intensity stimulus,BP,
4525,GO:0009648,1,0.827564085566568,0,30,photoperiodism,BP,
4526,GO:0009649,1,0.820952000789582,0,31,entrainment of circadian clock,BP,
4527,GO:0009650,1,0.924218292728569,0,13,UV protection,BP,
4528,GO:0009651,1,0.859094955920519,0,24,response to salt stress,BP,
4530,GO:0009669,1,0.97456033172572,0,4,sucrose:cation symporter activity,MF,
4531,GO:0009673,1,0.992764316125675,0,1,low-affinity phosphate transmembrane transporter activity,MF,
4532,GO:0009674,1,0.982552748608069,0,2,potassium:sodium symporter activity,MF,
4533,GO:0009678,1,0.837570837584351,0,29,pyrophosphate hydrolysis-driven proton transmembrane transporter activity,MF,
4534,GO:0009692,1,0.99373000630199,0,1,ethylene metabolic process,BP,
4535,GO:0009698,1,0.971133898716362,0,6,phenylpropanoid metabolic process,BP,
4536,GO:0009712,1,0.731866971634369,0,49,catechol-containing compound metabolic process,BP,
4537,GO:0009713,1,0.890987850241059,0,19,catechol-containing compound biosynthetic process,BP,
4540,GO:0009726,1,0.976092587703601,0,3,detection of endogenous stimulus,BP,
4541,GO:0009730,1,0.978227282232147,0,4,detection of carbohydrate stimulus,BP,
4542,GO:0009732,1,0.978227282232147,0,4,detection of hexose stimulus,BP,
4543,GO:0009737,1,0.992424723643522,0,1,response to abscisic acid,BP,
4544,GO:0009738,1,0.992424723643522,0,1,abscisic acid-activated signaling pathway,BP,
4546,GO:0009744,1,0.971598194978341,0,4,response to sucrose,BP,
4549,GO:0009750,1,0.949565123871449,0,8,response to fructose,BP,
4550,GO:0009753,1,0.984348042181253,0,4,response to jasmonic acid,BP,
4551,GO:0009755,1,0.304658902399436,0,169,hormone-mediated signaling pathway,BP,
4552,GO:0009756,1,0.953001076778173,0,8,carbohydrate mediated signaling,BP,
4553,GO:0009757,1,0.965388870488985,0,6,hexose mediated signaling,BP,
4554,GO:0009758,1,0.988705528950714,0,1,carbohydrate utilization,BP,
4555,GO:0009785,1,0.985581877608286,0,2,blue light signaling pathway,BP,
4557,GO:0009787,1,0.992424723643522,0,1,regulation of abscisic acid-activated signaling pathway,BP,
4558,GO:0009789,1,0.992424723643522,0,1,positive regulation of abscisic acid-activated signaling pathway,BP,
4562,GO:0009794,1,0.975408134756125,0,4,regulation of mitotic cell cycle, embryonic,BP,
4563,GO:0009798,1,0.582445669477015,0,80,axis specification,BP,
4565,GO:0009804,1,0.971133898716362,0,6,coumarin metabolic process,BP,
4566,GO:0009810,1,0.994464894599637,0,1,stilbene metabolic process,BP,
4567,GO:0009812,1,0.966917828562708,0,6,flavonoid metabolic process,BP,
4568,GO:0009820,1,0.975223068754077,0,5,alkaloid metabolic process,BP,
4569,GO:0009822,1,0.991086820154952,0,2,alkaloid catabolic process,BP,
4570,GO:0009826,1,0.98580361574266,0,2,unidimensional cell growth,BP,
4571,GO:0009838,1,0.973977769367062,0,5,abscission,BP,
4572,GO:0009841,1,0.994174006640747,0,1,mitochondrial endopeptidase Clp complex,CC,
4574,GO:0009880,1,0.642517833443663,0,63,embryonic pattern specification,BP,
4575,GO:0009881,1,0.934645661232137,0,12,photoreceptor activity,MF,
4576,GO:0009882,1,0.985581877608286,0,2,blue light photoreceptor activity,MF,
4577,GO:0009886,1,0.913134091665177,0,12,post-embryonic animal morphogenesis,BP,
4590,GO:0009912,1,0.967500818619679,0,4,auditory receptor cell fate commitment,BP,
4593,GO:0009918,1,0.993655100153634,0,1,sterol delta7 reductase activity,MF,
4594,GO:0009922,1,0.961072995080493,0,6,fatty acid elongase activity,MF,
4597,GO:0009946,1,0.985671699424751,0,3,proximal/distal axis specification,BP,
4598,GO:0009948,1,0.749100305513563,0,45,anterior/posterior axis specification,BP,
4599,GO:0009949,1,0.995665824555013,0,1,polarity specification of anterior/posterior axis,BP,
4600,GO:0009950,1,0.928984386140342,0,11,dorsal/ventral axis specification,BP,
4602,GO:0009953,1,0.567783341162013,0,87,dorsal/ventral pattern formation,BP,
4603,GO:0009954,1,0.806854134399025,0,33,proximal/distal pattern formation,BP,
4604,GO:0009955,1,0.994472730706653,0,1,adaxial/abaxial pattern specification,BP,
4605,GO:0009956,1,0.992657547214409,0,1,radial pattern formation,BP,
4606,GO:0009957,1,0.976439976893373,0,3,epidermal cell fate specification,BP,
4610,GO:0009972,1,0.951145678103908,0,10,cytidine deamination,BP,
4612,GO:0009982,1,0.930125572339194,0,13,pseudouridine synthase activity,MF,
4617,GO:0009992,1,0.971131711128316,0,5,cellular water homeostasis,BP,
4618,GO:0009994,1,0.747651964419908,0,44,oocyte differentiation,BP,
4621,GO:0010002,1,0.882286349295666,0,17,cardioblast differentiation,BP,
4623,GO:0010009,1,0.975119575438392,0,4,cytoplasmic side of endosome membrane,CC,
4624,GO:0010021,1,0.993065630855463,0,1,amylopectin biosynthetic process,BP,
4625,GO:0010025,1,0.986440709098555,0,2,wax biosynthetic process,BP,
4628,GO:0010034,1,0.992823017844057,0,1,response to acetate,BP,
4630,GO:0010037,1,0.993116283172753,0,1,response to carbon dioxide,BP,
4632,GO:0010039,1,0.807148216969217,0,32,response to iron ion,BP,
4633,GO:0010040,1,0.976471875812149,0,4,response to iron(II) ion,BP,
4634,GO:0010041,1,0.96850502715419,0,5,response to iron(III) ion,BP,
4635,GO:0010042,1,0.874709502083329,0,19,response to manganese ion,BP,
4637,GO:0010044,1,0.975621835992068,0,4,response to aluminum ion,BP,
4638,GO:0010045,1,0.98971081351825,0,1,response to nickel cation,BP,
4639,GO:0010046,1,0.980103795953093,0,4,response to mycotoxin,BP,
4640,GO:0010070,1,0.994069561690604,0,1,zygote asymmetric cell division,BP,
4641,GO:0010085,1,0.994709279864805,0,1,polarity specification of proximal/distal axis,BP,
4642,GO:0010092,1,0.785882431281742,0,35,specification of animal organ identity,BP,
4643,GO:0010106,1,0.994981019878227,0,1,cellular response to iron ion starvation,BP,
4644,GO:0010121,1,0.994909511305389,0,1,arginine catabolic process to proline via ornithine,BP,
4645,GO:0010124,1,0.991496763794215,0,2,phenylacetate catabolic process,BP,
4646,GO:0010133,1,0.987473881005353,0,2,proline catabolic process to glutamate,BP,
4647,GO:0010138,1,0.975544891642433,0,5,pyrimidine ribonucleotide salvage,BP,
4648,GO:0010142,1,0.986977439378386,0,2,farnesyl diphosphate biosynthetic process, mevalonate pathway,BP,
4649,GO:0010155,1,0.901692971802046,0,20,regulation of proton transport,BP,
4650,GO:0010157,1,0.983352222198289,0,2,response to chlorate,BP,
4651,GO:0010159,1,0.980554940728525,0,3,specification of animal organ position,BP,
4652,GO:0010160,1,0.996543639775421,0,1,formation of animal organ boundary,BP,
4653,GO:0010164,1,0.995593670005361,0,1,response to cesium ion,BP,
4655,GO:0010166,1,0.986440709098555,0,2,wax metabolic process,BP,
4656,GO:0010171,1,0.697439441788167,0,48,body morphogenesis,BP,
4657,GO:0010172,1,0.91322585631926,0,11,embryonic body morphogenesis,BP,
4658,GO:0010181,1,0.914110599526322,0,14,FMN binding,MF,
4659,GO:0010182,1,0.965388870488985,0,6,sugar mediated signaling pathway,BP,
4660,GO:0010185,1,0.993670166857566,0,1,regulation of cellular defense response,BP,
4661,GO:0010186,1,0.993670166857566,0,1,positive regulation of cellular defense response,BP,
4662,GO:0010189,1,0.995485583015882,0,1,vitamin E biosynthetic process,BP,
4663,GO:0010193,1,0.984531871497419,0,3,response to ozone,BP,
4665,GO:0010216,1,0.95033260348891,0,6,maintenance of DNA methylation,BP,
4666,GO:0010224,1,0.908804375656488,0,16,response to UV-B,BP,
4667,GO:0010225,1,0.896185454155787,0,16,response to UV-C,BP,
4669,GO:0010232,1,0.929361559318052,0,12,vascular transport,BP,
4671,GO:0010248,1,0.922270889860025,0,14,establishment or maintenance of transmembrane electrochemical gradient,BP,
4672,GO:0010255,1,0.965388870488985,0,6,glucose mediated signaling pathway,BP,
4674,GO:0010257,1,0.792718638613834,0,56,NADH dehydrogenase complex assembly,BP,
4676,GO:0010260,1,0.987810396949265,0,2,animal organ senescence,BP,
4677,GO:0010265,1,0.96079829978185,0,6,SCF complex assembly,BP,
4678,GO:0010266,1,0.979899465127547,0,3,response to vitamin B1,BP,
4679,GO:0010269,1,0.957926337983404,0,6,response to selenium ion,BP,
4680,GO:0010272,1,0.993773947599345,0,1,response to silver ion,BP,
4681,GO:0010273,1,0.96131969105366,0,11,detoxification of copper ion,BP,
4682,GO:0010286,1,0.974971801786733,0,5,heat acclimation,BP,
4683,GO:0010288,1,0.868420354561405,0,21,response to lead ion,BP,
4684,GO:0010309,1,0.995491813453926,0,1,acireductone dioxygenase [iron(II)-requiring] activity,MF,
4685,GO:0010310,1,0.906188569961657,0,18,regulation of hydrogen peroxide metabolic process,BP,
4686,GO:0010314,1,0.881648410904995,0,15,phosphatidylinositol-5-phosphate binding,MF,
4687,GO:0010324,1,0.641800816620172,0,68,membrane invagination,BP,
4689,GO:0010335,1,0.992333039689406,0,1,response to non-ionic osmotic stress,BP,
4690,GO:0010340,1,0.969176995658934,0,5,carboxyl-O-methyltransferase activity,MF,
4691,GO:0010348,1,0.993485400251684,0,1,lithium:proton antiporter activity,MF,
4692,GO:0010359,1,0.933127908767873,0,9,regulation of anion channel activity,BP,
4693,GO:0010360,1,0.979220916181309,0,3,negative regulation of anion channel activity,BP,
4694,GO:0010369,1,0.899377057925357,0,15,chromocenter,CC,
4695,GO:0010370,1,0.987575752091345,0,2,perinucleolar chromocenter,CC,
4696,GO:0010385,1,0.958705179377081,0,5,double-stranded methylated DNA binding,MF,
4697,GO:0010387,1,0.977971139759491,0,4,COP9 signalosome assembly,BP,
4699,GO:0010390,1,0.826433420928775,0,27,histone monoubiquitination,BP,
4700,GO:0010420,1,0.996157227255456,0,1,3,4-dihydroxy-5-polyprenylbenzoic acid O-methyltransferase activity,MF,
4701,GO:0010421,1,0.936275893121832,0,11,hydrogen peroxide-mediated programmed cell death,BP,
4702,GO:0010428,1,0.991170589187622,0,1,methyl-CpNpG binding,MF,
4703,GO:0010430,1,0.974068855504276,0,4,fatty acid omega-oxidation,BP,
4704,GO:0010436,1,0.986895344770984,0,2,carotenoid dioxygenase activity,MF,
4705,GO:0010446,1,0.98781176927002,0,2,response to alkaline pH,BP,
4706,GO:0010447,1,0.880134232939597,0,21,response to acidic pH,BP,
4707,GO:0010452,1,0.88933302737292,0,14,histone H3-K36 methylation,BP,
4710,GO:0010455,1,0.967973183813886,0,6,positive regulation of cell fate commitment,BP,
4711,GO:0010457,1,0.902994977529746,0,12,centriole-centriole cohesion,BP,
4713,GO:0010459,1,0.947815939130781,0,10,negative regulation of heart rate,BP,
4714,GO:0010460,1,0.847728318235089,0,25,positive regulation of heart rate,BP,
4715,GO:0010463,1,0.733262321019695,0,43,mesenchymal cell proliferation,BP,
4716,GO:0010464,1,0.793355779897328,0,33,regulation of mesenchymal cell proliferation,BP,
4717,GO:0010465,1,0.98390619534564,0,2,nerve growth factor receptor activity,MF,
4723,GO:0010477,1,0.992994082977645,0,1,response to sulfur dioxide,BP,
4724,GO:0010481,1,0.988353958560023,0,2,epidermal cell division,BP,
4725,GO:0010482,1,0.988353958560023,0,2,regulation of epidermal cell division,BP,
4726,GO:0010484,1,0.935284951738199,0,8,H3 histone acetyltransferase activity,MF,
4727,GO:0010485,1,0.885468096078315,0,17,H4 histone acetyltransferase activity,MF,
4728,GO:0010494,1,0.592680133729561,0,71,cytoplasmic stress granule,CC,
4729,GO:0010496,1,0.969319181719682,0,5,intercellular transport,BP,
4732,GO:0010501,1,0.945406779473607,0,8,RNA secondary structure unwinding,BP,
4736,GO:0010509,1,0.99149712289247,0,1,polyamine homeostasis,BP,
4737,GO:0010510,1,0.941382547616578,0,8,regulation of acetyl-CoA biosynthetic process from pyruvate,BP,
4738,GO:0010511,1,0.950803401997461,0,8,regulation of phosphatidylinositol biosynthetic process,BP,
4739,GO:0010512,1,0.986866068213045,0,2,negative regulation of phosphatidylinositol biosynthetic process,BP,
4740,GO:0010513,1,0.963462128595326,0,6,positive regulation of phosphatidylinositol biosynthetic process,BP,
4743,GO:0010519,1,0.968564057225339,0,5,negative regulation of phospholipase activity,BP,
4744,GO:0010520,1,0.972660435154754,0,4,regulation of reciprocal meiotic recombination,BP,
4745,GO:0010521,1,0.97637313542813,0,4,telomerase inhibitor activity,MF,
4746,GO:0010522,1,0.532935457640422,0,92,regulation of calcium ion transport into cytosol,BP,
4747,GO:0010523,1,0.907397711868515,0,16,negative regulation of calcium ion transport into cytosol,BP,
4748,GO:0010524,1,0.725737354654238,0,51,positive regulation of calcium ion transport into cytosol,BP,
4749,GO:0010525,1,0.992796902459295,0,1,regulation of transposition, RNA-mediated,BP,
4750,GO:0010526,1,0.992796902459295,0,1,negative regulation of transposition, RNA-mediated,BP,
4751,GO:0010528,1,0.88797975148291,0,19,regulation of transposition,BP,
4752,GO:0010529,1,0.88797975148291,0,19,negative regulation of transposition,BP,
4753,GO:0010533,1,0.974397970906087,0,5,regulation of activation of Janus kinase activity,BP,
4754,GO:0010536,1,0.98290577010734,0,3,positive regulation of activation of Janus kinase activity,BP,
4756,GO:0010544,1,0.884727622371014,0,18,negative regulation of platelet activation,BP,
4760,GO:0010559,1,0.766881720079655,0,40,regulation of glycoprotein biosynthetic process,BP,
4761,GO:0010560,1,0.855542613635988,0,22,positive regulation of glycoprotein biosynthetic process,BP,
4762,GO:0010561,1,0.928359019695048,0,12,negative regulation of glycoprotein biosynthetic process,BP,
4767,GO:0010566,1,0.893424577516644,0,17,regulation of ketone biosynthetic process,BP,
4768,GO:0010569,1,0.751605037037485,0,39,regulation of double-strand break repair via homologous recombination,BP,
4769,GO:0010571,1,0.942155612824474,0,7,positive regulation of nuclear cell cycle DNA replication,BP,
4770,GO:0010572,1,0.951258947769024,0,7,positive regulation of platelet activation,BP,
4771,GO:0010573,1,0.803131126661756,0,32,vascular endothelial growth factor production,BP,
4772,GO:0010574,1,0.820039114099784,0,29,regulation of vascular endothelial growth factor production,BP,
4773,GO:0010575,1,0.832196534809236,0,26,positive regulation of vascular endothelial growth factor production,BP,
4774,GO:0010578,1,0.993806829008205,0,1,regulation of adenylate cyclase activity involved in G protein-coupled receptor signaling pathway,BP,
4775,GO:0010585,1,0.99501807222187,0,1,glutamine secretion,BP,
4776,GO:0010586,1,0.837070792203085,0,25,miRNA metabolic process,BP,
4777,GO:0010587,1,0.956952647116282,0,6,miRNA catabolic process,BP,
4778,GO:0010591,1,0.80354653574399,0,31,regulation of lamellipodium assembly,BP,
4779,GO:0010592,1,0.852585380549888,0,22,positive regulation of lamellipodium assembly,BP,
4780,GO:0010593,1,0.982839493278581,0,2,negative regulation of lamellipodium assembly,BP,
4781,GO:0010594,1,0.35651112430454,0,147,regulation of endothelial cell migration,BP,
4782,GO:0010595,1,0.523802790384873,0,93,positive regulation of endothelial cell migration,BP,
4783,GO:0010596,1,0.724797117859016,0,46,negative regulation of endothelial cell migration,BP,
4784,GO:0010603,1,0.928273735384471,0,9,regulation of cytoplasmic mRNA processing body assembly,BP,
4787,GO:0010606,1,0.947265411141852,0,6,positive regulation of cytoplasmic mRNA processing body assembly,BP,
4788,GO:0010607,1,0.994951680710427,0,1,negative regulation of cytoplasmic mRNA processing body assembly,BP,
4790,GO:0010609,1,0.9877571453435,0,2,mRNA localization resulting in posttranscriptional regulation of gene expression,BP,
4791,GO:0010610,1,0.974641089926468,0,3,regulation of mRNA stability involved in response to stress,BP,
4793,GO:0010612,1,0.937634123867378,0,8,regulation of cardiac muscle adaptation,BP,
4794,GO:0010613,1,0.816995805394164,0,27,positive regulation of cardiac muscle hypertrophy,BP,
4796,GO:0010615,1,0.985149640035517,0,2,positive regulation of cardiac muscle adaptation,BP,
4797,GO:0010616,1,0.951775257571991,0,6,negative regulation of cardiac muscle adaptation,BP,
4798,GO:0010621,1,0.985441726982755,0,3,negative regulation of transcription by transcription factor localization,BP,
4799,GO:0010623,1,0.91538513809016,0,13,programmed cell death involved in cell development,BP,
4800,GO:0010624,1,0.954413845298288,0,6,regulation of Schwann cell proliferation,BP,
4801,GO:0010626,1,0.954413845298288,0,6,negative regulation of Schwann cell proliferation,BP,
4804,GO:0010631,1,0.150236528516426,0,265,epithelial cell migration,BP,
4805,GO:0010632,1,0.230467809304698,0,205,regulation of epithelial cell migration,BP,
4806,GO:0010633,1,0.654492050131713,0,61,negative regulation of epithelial cell migration,BP,
4807,GO:0010634,1,0.385861947579997,0,134,positive regulation of epithelial cell migration,BP,
4808,GO:0010635,1,0.917025343901875,0,12,regulation of mitochondrial fusion,BP,
4809,GO:0010636,1,0.979210718996341,0,3,positive regulation of mitochondrial fusion,BP,
4810,GO:0010637,1,0.942576186606675,0,8,negative regulation of mitochondrial fusion,BP,
4813,GO:0010640,1,0.847783792400995,0,22,regulation of platelet-derived growth factor receptor signaling pathway,BP,
4814,GO:0010641,1,0.962760319397504,0,5,positive regulation of platelet-derived growth factor receptor signaling pathway,BP,
4815,GO:0010642,1,0.915652868956074,0,12,negative regulation of platelet-derived growth factor receptor signaling pathway,BP,
4816,GO:0010643,1,0.986332228899045,0,2,cell communication by chemical coupling,BP,
4817,GO:0010644,1,0.7930078380779,0,30,cell communication by electrical coupling,BP,
4818,GO:0010645,1,0.99308891600688,0,1,regulation of cell communication by chemical coupling,BP,
4822,GO:0010649,1,0.909149719140203,0,13,regulation of cell communication by electrical coupling,BP,
4823,GO:0010650,1,0.980173136980363,0,2,positive regulation of cell communication by electrical coupling,BP,
4824,GO:0010652,1,0.99308891600688,0,1,positive regulation of cell communication by chemical coupling,BP,
4837,GO:0010668,1,0.950254955529588,0,7,ectodermal cell differentiation,BP,
4838,GO:0010669,1,0.87111772376557,0,21,epithelial structure maintenance,BP,
4839,GO:0010675,1,0.409979967859405,0,124,regulation of cellular carbohydrate metabolic process,BP,
4840,GO:0010676,1,0.6960029971203,0,49,positive regulation of cellular carbohydrate metabolic process,BP,
4841,GO:0010677,1,0.776092211560368,0,36,negative regulation of cellular carbohydrate metabolic process,BP,
4842,GO:0010692,1,0.927307212947395,0,9,regulation of alkaline phosphatase activity,BP,
4843,GO:0010693,1,0.979742692365363,0,3,negative regulation of alkaline phosphatase activity,BP,
4844,GO:0010694,1,0.946491001591917,0,6,positive regulation of alkaline phosphatase activity,BP,
4845,GO:0010698,1,0.986629517119559,0,3,acetyltransferase activator activity,MF,
4846,GO:0010700,1,0.973000247939331,0,5,negative regulation of norepinephrine secretion,BP,
4847,GO:0010701,1,0.979945930721773,0,3,positive regulation of norepinephrine secretion,BP,
4848,GO:0010705,1,0.985804373263158,0,2,meiotic DNA double-strand break processing involved in reciprocal meiotic recombination,BP,
4849,GO:0010706,1,0.984331125099534,0,2,ganglioside biosynthetic process via lactosylceramide,BP,
4850,GO:0010710,1,0.983085473073204,0,3,regulation of collagen catabolic process,BP,
4851,GO:0010711,1,0.996831585739888,0,1,negative regulation of collagen catabolic process,BP,
4853,GO:0010713,1,0.94261272884581,0,11,negative regulation of collagen metabolic process,BP,
4855,GO:0010715,1,0.899702094451872,0,14,regulation of extracellular matrix disassembly,BP,
4856,GO:0010716,1,0.97759105834382,0,4,negative regulation of extracellular matrix disassembly,BP,
4858,GO:0010718,1,0.717737392235775,0,46,positive regulation of epithelial to mesenchymal transition,BP,
4862,GO:0010722,1,0.990061127783499,0,1,regulation of ferrochelatase activity,BP,
4863,GO:0010723,1,0.99092457197378,0,1,positive regulation of transcription from RNA polymerase II promoter in response to iron,BP,
4864,GO:0010724,1,0.974706474247784,0,4,regulation of definitive erythrocyte differentiation,BP,
4865,GO:0010725,1,0.98876665776415,0,2,regulation of primitive erythrocyte differentiation,BP,
4866,GO:0010726,1,0.975412610097859,0,4,positive regulation of hydrogen peroxide metabolic process,BP,
4867,GO:0010727,1,0.955279584385172,0,8,negative regulation of hydrogen peroxide metabolic process,BP,
4868,GO:0010728,1,0.964007308917429,0,6,regulation of hydrogen peroxide biosynthetic process,BP,
4869,GO:0010729,1,0.989952272034984,0,2,positive regulation of hydrogen peroxide biosynthetic process,BP,
4870,GO:0010730,1,0.973794317199851,0,4,negative regulation of hydrogen peroxide biosynthetic process,BP,
4871,GO:0010731,1,0.991350884343908,0,2,protein glutathionylation,BP,
4872,GO:0010732,1,0.991350884343908,0,2,regulation of protein glutathionylation,BP,
4873,GO:0010734,1,0.991350884343908,0,2,negative regulation of protein glutathionylation,BP,
4874,GO:0010735,1,0.980255654302525,0,3,positive regulation of transcription via serum response element binding,BP,
4875,GO:0010736,1,0.992446741197036,0,1,serum response element binding,MF,
4876,GO:0010737,1,0.789437868703646,0,30,protein kinase A signaling,BP,
4877,GO:0010738,1,0.862573854357668,0,20,regulation of protein kinase A signaling,BP,
4878,GO:0010739,1,0.957180654548976,0,7,positive regulation of protein kinase A signaling,BP,
4879,GO:0010742,1,0.803461513140472,0,31,macrophage derived foam cell differentiation,BP,
4880,GO:0010743,1,0.829019444390307,0,27,regulation of macrophage derived foam cell differentiation,BP,
4881,GO:0010744,1,0.902158856033417,0,16,positive regulation of macrophage derived foam cell differentiation,BP,
4882,GO:0010745,1,0.919008411801349,0,11,negative regulation of macrophage derived foam cell differentiation,BP,
4883,GO:0010746,1,0.960113425701186,0,5,regulation of long-chain fatty acid import across plasma membrane,BP,
4884,GO:0010747,1,0.992915058490255,0,1,positive regulation of long-chain fatty acid import across plasma membrane,BP,
4885,GO:0010748,1,0.966966618957471,0,4,negative regulation of long-chain fatty acid import across plasma membrane,BP,
4886,GO:0010749,1,0.94127180628669,0,8,regulation of nitric oxide mediated signal transduction,BP,
4887,GO:0010750,1,0.979550956086327,0,3,positive regulation of nitric oxide mediated signal transduction,BP,
4888,GO:0010751,1,0.977302396131332,0,3,negative regulation of nitric oxide mediated signal transduction,BP,
4889,GO:0010752,1,0.917373871587128,0,13,regulation of cGMP-mediated signaling,BP,
4890,GO:0010753,1,0.970039560360321,0,6,positive regulation of cGMP-mediated signaling,BP,
4891,GO:0010754,1,0.952943081266067,0,6,negative regulation of cGMP-mediated signaling,BP,
4892,GO:0010755,1,0.945114835156939,0,10,regulation of plasminogen activation,BP,
4893,GO:0010756,1,0.975165855921407,0,5,positive regulation of plasminogen activation,BP,
4894,GO:0010757,1,0.969191319794248,0,5,negative regulation of plasminogen activation,BP,
4895,GO:0010758,1,0.857022819645714,0,25,regulation of macrophage chemotaxis,BP,
4896,GO:0010759,1,0.904855271432823,0,16,positive regulation of macrophage chemotaxis,BP,
4897,GO:0010760,1,0.967133520807217,0,6,negative regulation of macrophage chemotaxis,BP,
4898,GO:0010761,1,0.729910085401138,0,43,fibroblast migration,BP,
4899,GO:0010762,1,0.7966316556066,0,32,regulation of fibroblast migration,BP,
4900,GO:0010763,1,0.900281341026423,0,14,positive regulation of fibroblast migration,BP,
4901,GO:0010764,1,0.963219737937068,0,6,negative regulation of fibroblast migration,BP,
4902,GO:0010765,1,0.787487177713506,0,33,positive regulation of sodium ion transport,BP,
4903,GO:0010766,1,0.867388822981956,0,18,negative regulation of sodium ion transport,BP,
4904,GO:0010767,1,0.984398265919614,0,2,regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,
4905,GO:0010768,1,0.990730488576734,0,1,negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,
4907,GO:0010770,1,0.322798941388704,0,148,positive regulation of cell morphogenesis involved in differentiation,BP,
4908,GO:0010771,1,0.495788847031884,0,95,negative regulation of cell morphogenesis involved in differentiation,BP,
4909,GO:0010780,1,0.991034474838015,0,1,meiotic DNA double-strand break formation involved in reciprocal meiotic recombination,BP,
4910,GO:0010789,1,0.993485400251684,0,1,meiotic sister chromatid cohesion involved in meiosis I,BP,
4911,GO:0010792,1,0.967020415836119,0,5,DNA double-strand break processing involved in repair via single-strand annealing,BP,
4912,GO:0010793,1,0.953427575636393,0,6,regulation of mRNA export from nucleus,BP,
4913,GO:0010795,1,0.988912510918753,0,2,regulation of ubiquinone biosynthetic process,BP,
4914,GO:0010796,1,0.985689744685281,0,3,regulation of multivesicular body size,BP,
4915,GO:0010797,1,0.996234226671177,0,1,regulation of multivesicular body size involved in endosome transport,BP,
4916,GO:0010799,1,0.7472345436906,0,43,regulation of peptidyl-threonine phosphorylation,BP,
4917,GO:0010800,1,0.819560345792744,0,29,positive regulation of peptidyl-threonine phosphorylation,BP,
4918,GO:0010801,1,0.896447634445141,0,17,negative regulation of peptidyl-threonine phosphorylation,BP,
4919,GO:0010803,1,0.729781319125914,0,51,regulation of tumor necrosis factor-mediated signaling pathway,BP,
4920,GO:0010804,1,0.92003676452963,0,16,negative regulation of tumor necrosis factor-mediated signaling pathway,BP,
4921,GO:0010807,1,0.954854253713729,0,7,regulation of synaptic vesicle priming,BP,
4922,GO:0010808,1,0.990726970489902,0,1,positive regulation of synaptic vesicle priming,BP,
4925,GO:0010812,1,0.647789783424088,0,57,negative regulation of cell-substrate adhesion,BP,
4926,GO:0010813,1,0.987714285422301,0,2,neuropeptide catabolic process,BP,
4927,GO:0010814,1,0.991849041800206,0,1,substance P catabolic process,BP,
4928,GO:0010815,1,0.973671735087947,0,4,bradykinin catabolic process,BP,
4929,GO:0010816,1,0.991849041800206,0,1,calcitonin catabolic process,BP,
4931,GO:0010818,1,0.867118559699104,0,25,T cell chemotaxis,BP,
4932,GO:0010819,1,0.914928858286073,0,15,regulation of T cell chemotaxis,BP,
4933,GO:0010820,1,0.91833392617384,0,14,positive regulation of T cell chemotaxis,BP,
4934,GO:0010821,1,0.301156089767146,0,182,regulation of mitochondrion organization,BP,
4935,GO:0010822,1,0.465799323294775,0,115,positive regulation of mitochondrion organization,BP,
4936,GO:0010823,1,0.692274232414633,0,56,negative regulation of mitochondrion organization,BP,
4937,GO:0010824,1,0.732711642854899,0,43,regulation of centrosome duplication,BP,
4938,GO:0010825,1,0.942693814013403,0,8,positive regulation of centrosome duplication,BP,
4939,GO:0010826,1,0.914633505429665,0,13,negative regulation of centrosome duplication,BP,
4940,GO:0010827,1,0.630878863052211,0,64,regulation of glucose transmembrane transport,BP,
4941,GO:0010828,1,0.754809484764625,0,36,positive regulation of glucose transmembrane transport,BP,
4942,GO:0010829,1,0.908794096775521,0,16,negative regulation of glucose transmembrane transport,BP,
4943,GO:0010830,1,0.740046634357983,0,47,regulation of myotube differentiation,BP,
4944,GO:0010831,1,0.846424112933273,0,27,positive regulation of myotube differentiation,BP,
4945,GO:0010832,1,0.910549757495547,0,14,negative regulation of myotube differentiation,BP,
4946,GO:0010833,1,0.596087521396011,0,76,telomere maintenance via telomere lengthening,BP,
4947,GO:0010835,1,0.969593948559841,0,5,regulation of protein ADP-ribosylation,BP,
4948,GO:0010836,1,0.984968962643726,0,3,negative regulation of protein ADP-ribosylation,BP,
4949,GO:0010837,1,0.805427499916936,0,29,regulation of keratinocyte proliferation,BP,
4950,GO:0010838,1,0.925282865925037,0,11,positive regulation of keratinocyte proliferation,BP,
4951,GO:0010839,1,0.913757411884112,0,11,negative regulation of keratinocyte proliferation,BP,
4952,GO:0010840,1,0.983480566124891,0,3,regulation of circadian sleep/wake cycle, wakefulness,BP,
4953,GO:0010841,1,0.988193611304981,0,2,positive regulation of circadian sleep/wake cycle, wakefulness,BP,
4955,GO:0010844,1,0.992751063278533,0,1,recombination hotspot binding,MF,
4956,GO:0010845,1,0.972660435154754,0,4,positive regulation of reciprocal meiotic recombination,BP,
4957,GO:0010847,1,0.867049752203072,0,18,regulation of chromatin assembly,BP,
4958,GO:0010848,1,0.985439525452949,0,2,regulation of chromatin disassembly,BP,
4959,GO:0010849,1,0.994488416755265,0,1,regulation of proton-transporting ATPase activity, rotational mechanism,BP,
4960,GO:0010851,1,0.97281658261656,0,5,cyclase regulator activity,MF,
4961,GO:0010852,1,0.994299766113736,0,1,cyclase inhibitor activity,MF,
4962,GO:0010853,1,0.985772897805684,0,3,cyclase activator activity,MF,
4963,GO:0010854,1,0.992516567002504,0,1,adenylate cyclase regulator activity,MF,
4964,GO:0010855,1,0.992516567002504,0,1,adenylate cyclase inhibitor activity,MF,
4965,GO:0010856,1,0.971338461448449,0,5,adenylate cyclase activator activity,MF,
4967,GO:0010858,1,0.986836494748853,0,3,calcium-dependent protein kinase regulator activity,MF,
4968,GO:0010859,1,0.992410389645857,0,1,calcium-dependent cysteine-type endopeptidase inhibitor activity,MF,
4969,GO:0010862,1,0.747956631804394,0,44,positive regulation of pathway-restricted SMAD protein phosphorylation,BP,
4970,GO:0010863,1,0.744394437258306,0,44,positive regulation of phospholipase C activity,BP,
4971,GO:0010866,1,0.897908891402122,0,17,regulation of triglyceride biosynthetic process,BP,
4972,GO:0010867,1,0.922269031122653,0,13,positive regulation of triglyceride biosynthetic process,BP,
4973,GO:0010868,1,0.984968709613439,0,2,negative regulation of triglyceride biosynthetic process,BP,
4974,GO:0010869,1,0.869158337252001,0,20,regulation of receptor biosynthetic process,BP,
4975,GO:0010870,1,0.929492622526358,0,12,positive regulation of receptor biosynthetic process,BP,
4976,GO:0010871,1,0.959287921960877,0,5,negative regulation of receptor biosynthetic process,BP,
4977,GO:0010872,1,0.949566685638095,0,9,regulation of cholesterol esterification,BP,
4978,GO:0010873,1,0.972844693559286,0,6,positive regulation of cholesterol esterification,BP,
4979,GO:0010874,1,0.829044886151577,0,27,regulation of cholesterol efflux,BP,
4980,GO:0010875,1,0.873726505802998,0,19,positive regulation of cholesterol efflux,BP,
4982,GO:0010877,1,0.99066120842078,0,2,lipid transport involved in lipid storage,BP,
4983,GO:0010878,1,0.873644990901109,0,18,cholesterol storage,BP,
4984,GO:0010879,1,0.994353828774869,0,1,cholesterol transport involved in cholesterol storage,BP,
4985,GO:0010880,1,0.81382932406645,0,27,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,
4986,GO:0010881,1,0.864835269156472,0,20,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,BP,
4987,GO:0010882,1,0.832229347806917,0,25,regulation of cardiac muscle contraction by calcium ion signaling,BP,
4988,GO:0010883,1,0.725967385022884,0,47,regulation of lipid storage,BP,
4989,GO:0010884,1,0.856913416209874,0,23,positive regulation of lipid storage,BP,
4990,GO:0010885,1,0.884907029867345,0,16,regulation of cholesterol storage,BP,
4991,GO:0010886,1,0.945085683306703,0,7,positive regulation of cholesterol storage,BP,
4992,GO:0010887,1,0.936359420709118,0,9,negative regulation of cholesterol storage,BP,
4993,GO:0010888,1,0.870185417493724,0,20,negative regulation of lipid storage,BP,
4994,GO:0010889,1,0.917107511438032,0,14,regulation of sequestering of triglyceride,BP,
4995,GO:0010890,1,0.955460662151107,0,9,positive regulation of sequestering of triglyceride,BP,
4996,GO:0010891,1,0.959876916803595,0,5,negative regulation of sequestering of triglyceride,BP,
4997,GO:0010893,1,0.905704748116946,0,15,positive regulation of steroid biosynthetic process,BP,
4998,GO:0010894,1,0.877021436101117,0,22,negative regulation of steroid biosynthetic process,BP,
4999,GO:0010896,1,0.938808212028857,0,10,regulation of triglyceride catabolic process,BP,
5000,GO:0010897,1,0.967305957469524,0,4,negative regulation of triglyceride catabolic process,BP,
5001,GO:0010898,1,0.970548707185912,0,6,positive regulation of triglyceride catabolic process,BP,
5002,GO:0010899,1,0.982639121436419,0,3,regulation of phosphatidylcholine catabolic process,BP,
5003,GO:0010900,1,0.997210052435373,0,1,negative regulation of phosphatidylcholine catabolic process,BP,
5004,GO:0010901,1,0.993583100082401,0,2,regulation of very-low-density lipoprotein particle remodeling,BP,
5005,GO:0010902,1,0.996899034362622,0,1,positive regulation of very-low-density lipoprotein particle remodeling,BP,
5006,GO:0010903,1,0.996673854950561,0,1,negative regulation of very-low-density lipoprotein particle remodeling,BP,
5007,GO:0010904,1,0.994510013234754,0,1,regulation of UDP-glucose catabolic process,BP,
5008,GO:0010905,1,0.994510013234754,0,1,negative regulation of UDP-glucose catabolic process,BP,
5009,GO:0010906,1,0.482612696578942,0,100,regulation of glucose metabolic process,BP,
5010,GO:0010907,1,0.7743451808785,0,33,positive regulation of glucose metabolic process,BP,
5011,GO:0010908,1,0.97913760561864,0,3,regulation of heparan sulfate proteoglycan biosynthetic process,BP,
5012,GO:0010909,1,0.97913760561864,0,3,positive regulation of heparan sulfate proteoglycan biosynthetic process,BP,
5015,GO:0010915,1,0.989810408000294,0,3,regulation of very-low-density lipoprotein particle clearance,BP,
5016,GO:0010916,1,0.989810408000294,0,3,negative regulation of very-low-density lipoprotein particle clearance,BP,
5017,GO:0010917,1,0.937509750245977,0,12,negative regulation of mitochondrial membrane potential,BP,
5018,GO:0010918,1,0.939939791100871,0,10,positive regulation of mitochondrial membrane potential,BP,
5019,GO:0010919,1,0.925007274551203,0,12,regulation of inositol phosphate biosynthetic process,BP,
5020,GO:0010920,1,0.993370920870107,0,1,negative regulation of inositol phosphate biosynthetic process,BP,
5022,GO:0010922,1,0.799039192851548,0,30,positive regulation of phosphatase activity,BP,
5024,GO:0010924,1,0.993370920870107,0,1,regulation of inositol-polyphosphate 5-phosphatase activity,BP,
5025,GO:0010925,1,0.993370920870107,0,1,positive regulation of inositol-polyphosphate 5-phosphatase activity,BP,
5026,GO:0010927,1,0.458799652238252,0,100,cellular component assembly involved in morphogenesis,BP,
5027,GO:0010931,1,0.989143736515247,0,1,macrophage tolerance induction,BP,
5028,GO:0010932,1,0.989143736515247,0,1,regulation of macrophage tolerance induction,BP,
5029,GO:0010933,1,0.989143736515247,0,1,positive regulation of macrophage tolerance induction,BP,
5030,GO:0010934,1,0.900219201885561,0,16,macrophage cytokine production,BP,
5031,GO:0010935,1,0.91242498234076,0,14,regulation of macrophage cytokine production,BP,
5032,GO:0010936,1,0.965185713556609,0,5,negative regulation of macrophage cytokine production,BP,
5033,GO:0010938,1,0.992767886172341,0,1,cytoplasmic microtubule depolymerization,BP,
5034,GO:0010939,1,0.852728908001661,0,26,regulation of necrotic cell death,BP,
5035,GO:0010940,1,0.954057177838953,0,9,positive regulation of necrotic cell death,BP,
5038,GO:0010944,1,0.941736114264389,0,9,negative regulation of transcription by competitive promoter binding,BP,
5040,GO:0010949,1,0.993629231528571,0,1,negative regulation of intestinal phytosterol absorption,BP,
5044,GO:0010954,1,0.883145042086136,0,19,positive regulation of protein processing,BP,
5045,GO:0010955,1,0.846040003610998,0,27,negative regulation of protein processing,BP,
5046,GO:0010956,1,0.980213472501995,0,3,negative regulation of calcidiol 1-monooxygenase activity,BP,
5047,GO:0010957,1,0.970582174481768,0,5,negative regulation of vitamin D biosynthetic process,BP,
5048,GO:0010958,1,0.920777891633236,0,12,regulation of amino acid import across plasma membrane,BP,
5050,GO:0010960,1,0.91211110921757,0,11,magnesium ion homeostasis,BP,
5051,GO:0010961,1,0.962064522216964,0,5,cellular magnesium ion homeostasis,BP,
5052,GO:0010962,1,0.808660211589737,0,26,regulation of glucan biosynthetic process,BP,
5053,GO:0010963,1,0.989676593114611,0,2,regulation of L-arginine import,BP,
5055,GO:0010966,1,0.958376442725398,0,6,regulation of phosphate transport,BP,
5056,GO:0010967,1,0.995450692884757,0,1,regulation of polyamine biosynthetic process,BP,
5057,GO:0010968,1,0.954053146793128,0,7,regulation of microtubule nucleation,BP,
5059,GO:0010971,1,0.843355687407024,0,26,positive regulation of G2/M transition of mitotic cell cycle,BP,
5060,GO:0010972,1,0.62374983419337,0,85,negative regulation of G2/M transition of mitotic cell cycle,BP,
5064,GO:0010979,1,0.986155804297656,0,2,regulation of vitamin D 24-hydroxylase activity,BP,
5065,GO:0010980,1,0.986155804297656,0,2,positive regulation of vitamin D 24-hydroxylase activity,BP,
5066,GO:0010982,1,0.986894616134911,0,2,regulation of high-density lipoprotein particle clearance,BP,
5067,GO:0010983,1,0.986894616134911,0,2,positive regulation of high-density lipoprotein particle clearance,BP,
5068,GO:0010984,1,0.921998035077567,0,15,regulation of lipoprotein particle clearance,BP,
5069,GO:0010985,1,0.963185000920789,0,7,negative regulation of lipoprotein particle clearance,BP,
5070,GO:0010986,1,0.975898700712502,0,4,positive regulation of lipoprotein particle clearance,BP,
5071,GO:0010988,1,0.94387325274428,0,10,regulation of low-density lipoprotein particle clearance,BP,
5072,GO:0010989,1,0.973103223361815,0,4,negative regulation of low-density lipoprotein particle clearance,BP,
5073,GO:0010990,1,0.957423394262287,0,6,regulation of SMAD protein complex assembly,BP,
5074,GO:0010991,1,0.964547519913115,0,5,negative regulation of SMAD protein complex assembly,BP,
5077,GO:0010996,1,0.832149871788094,0,25,response to auditory stimulus,BP,
5078,GO:0010997,1,0.958320508360137,0,7,anaphase-promoting complex binding,MF,
5079,GO:0010998,1,0.932953430805804,0,10,regulation of translational initiation by eIF2 alpha phosphorylation,BP,
5080,GO:0010999,1,0.992350051390767,0,1,regulation of eIF2 alpha phosphorylation by heme,BP,
5084,GO:0012507,1,0.70509209533057,0,57,ER to Golgi transport vesicle membrane,CC,
5086,GO:0014002,1,0.758696873999687,0,40,astrocyte development,BP,
5088,GO:0014004,1,0.967171028568593,0,5,microglia differentiation,BP,
5089,GO:0014005,1,0.972542304778042,0,4,microglia development,BP,
5090,GO:0014006,1,0.994478610855959,0,1,regulation of microglia differentiation,BP,
5091,GO:0014008,1,0.994478610855959,0,1,positive regulation of microglia differentiation,BP,
5092,GO:0014009,1,0.734748015935906,0,45,glial cell proliferation,BP,
5093,GO:0014010,1,0.945939640533196,0,7,Schwann cell proliferation,BP,
5094,GO:0014011,1,0.993485400251684,0,1,Schwann cell proliferation involved in axon regeneration,BP,
5095,GO:0014012,1,0.959854250908542,0,6,peripheral nervous system axon regeneration,BP,
5098,GO:0014015,1,0.629457134681602,0,70,positive regulation of gliogenesis,BP,
5099,GO:0014016,1,0.981969692263908,0,3,neuroblast differentiation,BP,
5100,GO:0014017,1,0.993962265126325,0,1,neuroblast fate commitment,BP,
5102,GO:0014022,1,0.97827783130399,0,3,neural plate elongation,BP,
5103,GO:0014028,1,0.979902392938432,0,3,notochord formation,BP,
5104,GO:0014029,1,0.928534589117772,0,11,neural crest formation,BP,
5105,GO:0014031,1,0.552768086933199,0,83,mesenchymal cell development,BP,
5106,GO:0014032,1,0.571425528406062,0,79,neural crest cell development,BP,
5107,GO:0014033,1,0.535930890691341,0,87,neural crest cell differentiation,BP,
5108,GO:0014034,1,0.981392139811472,0,3,neural crest cell fate commitment,BP,
5109,GO:0014036,1,0.988954173598135,0,2,neural crest cell fate specification,BP,
5110,GO:0014037,1,0.741975679241732,0,38,Schwann cell differentiation,BP,
5111,GO:0014038,1,0.970320571789518,0,4,regulation of Schwann cell differentiation,BP,
5112,GO:0014040,1,0.9748451652149,0,3,positive regulation of Schwann cell differentiation,BP,
5113,GO:0014041,1,0.924724462843474,0,10,regulation of neuron maturation,BP,
5114,GO:0014042,1,0.957707637825893,0,5,positive regulation of neuron maturation,BP,
5115,GO:0014043,1,0.980482832039281,0,3,negative regulation of neuron maturation,BP,
5116,GO:0014044,1,0.786534358491996,0,30,Schwann cell development,BP,
5117,GO:0014045,1,0.970539129483579,0,5,establishment of endothelial blood-brain barrier,BP,
5122,GO:0014050,1,0.96993939127864,0,5,negative regulation of glutamate secretion,BP,
5123,GO:0014051,1,0.925611273328371,0,10,gamma-aminobutyric acid secretion,BP,
5124,GO:0014052,1,0.954427867895629,0,7,regulation of gamma-aminobutyric acid secretion,BP,
5125,GO:0014053,1,0.988351324943882,0,2,negative regulation of gamma-aminobutyric acid secretion,BP,
5126,GO:0014054,1,0.973092812439015,0,4,positive regulation of gamma-aminobutyric acid secretion,BP,
5127,GO:0014055,1,0.981614101904302,0,3,acetylcholine secretion, neurotransmission,BP,
5128,GO:0014056,1,0.981614101904302,0,3,regulation of acetylcholine secretion, neurotransmission,BP,
5129,GO:0014057,1,0.987910921594166,0,2,positive regulation of acetylcholine secretion, neurotransmission,BP,
5131,GO:0014060,1,0.976311981596237,0,5,regulation of epinephrine secretion,BP,
5132,GO:0014061,1,0.931456307672822,0,12,regulation of norepinephrine secretion,BP,
5135,GO:0014064,1,0.992303149335604,0,1,positive regulation of serotonin secretion,BP,
5136,GO:0014065,1,0.370084246302149,0,137,phosphatidylinositol 3-kinase signaling,BP,
5137,GO:0014066,1,0.449794153279539,0,111,regulation of phosphatidylinositol 3-kinase signaling,BP,
5138,GO:0014067,1,0.921481822784249,0,12,negative regulation of phosphatidylinositol 3-kinase signaling,BP,
5139,GO:0014068,1,0.55661858599404,0,80,positive regulation of phosphatidylinositol 3-kinase signaling,BP,
5145,GO:0014701,1,0.913672706880229,0,9,junctional sarcoplasmic reticulum membrane,CC,
5146,GO:0014704,1,0.686054620827849,0,50,intercalated disc,CC,
5147,GO:0014705,1,0.992490345943061,0,1,C zone,CC,
5149,GO:0014707,1,0.988931563569064,0,2,branchiomeric skeletal muscle development,BP,
5150,GO:0014717,1,0.988989593846571,0,2,regulation of satellite cell activation involved in skeletal muscle regeneration,BP,
5151,GO:0014718,1,0.988989593846571,0,2,positive regulation of satellite cell activation involved in skeletal muscle regeneration,BP,
5152,GO:0014719,1,0.959786316710569,0,6,skeletal muscle satellite cell activation,BP,
5153,GO:0014721,1,0.967420922468494,0,5,twitch skeletal muscle contraction,BP,
5154,GO:0014722,1,0.971354831629744,0,5,regulation of skeletal muscle contraction by calcium ion signaling,BP,
5155,GO:0014724,1,0.983916444230949,0,2,regulation of twitch skeletal muscle contraction,BP,
5156,GO:0014728,1,0.99102648561174,0,1,regulation of the force of skeletal muscle contraction,BP,
5157,GO:0014731,1,0.920441678730911,0,8,spectrin-associated cytoskeleton,CC,
5158,GO:0014732,1,0.965778287807133,0,6,skeletal muscle atrophy,BP,
5159,GO:0014733,1,0.91783237309666,0,11,regulation of skeletal muscle adaptation,BP,
5160,GO:0014734,1,0.974579873806873,0,3,skeletal muscle hypertrophy,BP,
5161,GO:0014735,1,0.97421359298454,0,3,regulation of muscle atrophy,BP,
5162,GO:0014736,1,0.988705528950714,0,1,negative regulation of muscle atrophy,BP,
5163,GO:0014737,1,0.98534416527613,0,2,positive regulation of muscle atrophy,BP,
5164,GO:0014738,1,0.98433505992497,0,3,regulation of muscle hyperplasia,BP,
5165,GO:0014739,1,0.996998370372723,0,1,positive regulation of muscle hyperplasia,BP,
5166,GO:0014740,1,0.987298945399191,0,2,negative regulation of muscle hyperplasia,BP,
5168,GO:0014742,1,0.816995805394164,0,27,positive regulation of muscle hypertrophy,BP,
5170,GO:0014744,1,0.95686044578539,0,6,positive regulation of muscle adaptation,BP,
5171,GO:0014745,1,0.920575548561589,0,10,negative regulation of muscle adaptation,BP,
5172,GO:0014802,1,0.969823578084645,0,4,terminal cisterna,CC,
5173,GO:0014804,1,0.994949722254885,0,1,terminal cisterna lumen,CC,
5174,GO:0014805,1,0.982524313778416,0,4,smooth muscle adaptation,BP,
5175,GO:0014806,1,0.989710493382592,0,2,smooth muscle hyperplasia,BP,
5176,GO:0014807,1,0.958347552543091,0,6,regulation of somitogenesis,BP,
5177,GO:0014808,1,0.791563021127852,0,30,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,
5178,GO:0014809,1,0.977853760649444,0,4,regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,
5179,GO:0014810,1,0.996820242649224,0,1,positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,
5180,GO:0014812,1,0.565118970928544,0,77,muscle cell migration,BP,
5181,GO:0014813,1,0.994359642626978,0,1,skeletal muscle satellite cell commitment,BP,
5182,GO:0014816,1,0.931922578850703,0,9,skeletal muscle satellite cell differentiation,BP,
5183,GO:0014819,1,0.923626387931225,0,12,regulation of skeletal muscle contraction,BP,
5185,GO:0014821,1,0.897635815553909,0,19,phasic smooth muscle contraction,BP,
5186,GO:0014822,1,0.99381533233784,0,1,detection of wounding,BP,
5187,GO:0014823,1,0.641507266807323,0,64,response to activity,BP,
5189,GO:0014825,1,0.996779666664659,0,1,stomach fundus smooth muscle contraction,BP,
5190,GO:0014826,1,0.977286608752646,0,4,vein smooth muscle contraction,BP,
5191,GO:0014827,1,0.965964320466002,0,6,intestine smooth muscle contraction,BP,
5192,GO:0014828,1,0.991803495022634,0,1,distal stomach smooth muscle contraction,BP,
5194,GO:0014831,1,0.934199926979836,0,11,gastro-intestinal system smooth muscle contraction,BP,
5195,GO:0014832,1,0.950665469949549,0,7,urinary bladder smooth muscle contraction,BP,
5196,GO:0014834,1,0.972065039101472,0,4,skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration,BP,
5197,GO:0014835,1,0.994344147861831,0,1,myoblast differentiation involved in skeletal muscle regeneration,BP,
5198,GO:0014839,1,0.978358111126938,0,4,myoblast migration involved in skeletal muscle regeneration,BP,
5199,GO:0014841,1,0.903180290135787,0,14,skeletal muscle satellite cell proliferation,BP,
5200,GO:0014842,1,0.912678172808739,0,13,regulation of skeletal muscle satellite cell proliferation,BP,
5201,GO:0014843,1,0.990404066014189,0,1,growth factor dependent regulation of skeletal muscle satellite cell proliferation,BP,
5202,GO:0014846,1,0.983950998741642,0,2,esophagus smooth muscle contraction,BP,
5203,GO:0014847,1,0.996779666664659,0,1,proximal stomach smooth muscle contraction,BP,
5204,GO:0014848,1,0.950665469949549,0,7,urinary tract smooth muscle contraction,BP,
5205,GO:0014850,1,0.85787224923958,0,21,response to muscle activity,BP,
5206,GO:0014852,1,0.993355368516005,0,1,regulation of skeletal muscle contraction by neural stimulation via neuromuscular junction,BP,
5207,GO:0014853,1,0.993355368516005,0,1,regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction,BP,
5208,GO:0014854,1,0.909265477577981,0,13,response to inactivity,BP,
5209,GO:0014855,1,0.630539656659593,0,64,striated muscle cell proliferation,BP,
5210,GO:0014856,1,0.899261763500264,0,15,skeletal muscle cell proliferation,BP,
5211,GO:0014857,1,0.908718852260838,0,14,regulation of skeletal muscle cell proliferation,BP,
5212,GO:0014858,1,0.979485344401108,0,3,positive regulation of skeletal muscle cell proliferation,BP,
5213,GO:0014859,1,0.972502144575631,0,4,negative regulation of skeletal muscle cell proliferation,BP,
5214,GO:0014861,1,0.991633698096644,0,1,regulation of skeletal muscle contraction via regulation of action potential,BP,
5215,GO:0014862,1,0.99102648561174,0,1,regulation of skeletal muscle contraction by chemo-mechanical energy conversion,BP,
5216,GO:0014866,1,0.926837682924539,0,8,skeletal myofibril assembly,BP,
5217,GO:0014870,1,0.924451758297879,0,10,response to muscle inactivity,BP,
5218,GO:0014873,1,0.98918098912362,0,2,response to muscle activity involved in regulation of muscle adaptation,BP,
5219,GO:0014874,1,0.911917160411245,0,12,response to stimulus involved in regulation of muscle adaptation,BP,
5220,GO:0014877,1,0.930518061252527,0,9,response to muscle inactivity involved in regulation of muscle adaptation,BP,
5221,GO:0014878,1,0.981595435770079,0,3,response to electrical stimulus involved in regulation of muscle adaptation,BP,
5222,GO:0014883,1,0.957540902354614,0,6,transition between fast and slow fiber,BP,
5223,GO:0014886,1,0.992982846175729,0,1,transition between slow and fast fiber,BP,
5224,GO:0014887,1,0.850760310968212,0,21,cardiac muscle adaptation,BP,
5225,GO:0014888,1,0.751339591110653,0,41,striated muscle adaptation,BP,
5226,GO:0014889,1,0.933266907688494,0,10,muscle atrophy,BP,
5227,GO:0014891,1,0.959530828397324,0,7,striated muscle atrophy,BP,
5228,GO:0014894,1,0.930518061252527,0,9,response to denervation involved in regulation of muscle adaptation,BP,
5229,GO:0014895,1,0.996937301888134,0,1,smooth muscle hypertrophy,BP,
5232,GO:0014898,1,0.850760310968212,0,21,cardiac muscle hypertrophy in response to stress,BP,
5233,GO:0014900,1,0.980108116579925,0,4,muscle hyperplasia,BP,
5234,GO:0014901,1,0.981994533043625,0,3,satellite cell activation involved in skeletal muscle regeneration,BP,
5235,GO:0014902,1,0.525374035759414,0,93,myotube differentiation,BP,
5236,GO:0014904,1,0.818338251069618,0,29,myotube cell development,BP,
5237,GO:0014905,1,0.983019941356122,0,3,myoblast fusion involved in skeletal muscle regeneration,BP,
5238,GO:0014908,1,0.962530225636161,0,6,myotube differentiation involved in skeletal muscle regeneration,BP,
5239,GO:0014909,1,0.617444361334026,0,64,smooth muscle cell migration,BP,
5240,GO:0014910,1,0.642132973271771,0,58,regulation of smooth muscle cell migration,BP,
5241,GO:0014911,1,0.753019484151054,0,36,positive regulation of smooth muscle cell migration,BP,
5242,GO:0014912,1,0.859458252281721,0,21,negative regulation of smooth muscle cell migration,BP,
5243,GO:0014916,1,0.964958477042585,0,4,regulation of lung blood pressure,BP,
5244,GO:0015002,1,0.927177894382286,0,21,heme-copper terminal oxidase activity,MF,
5245,GO:0015012,1,0.820021561782113,0,26,heparan sulfate proteoglycan biosynthetic process,BP,
5246,GO:0015014,1,0.938512068808761,0,8,heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
5247,GO:0015015,1,0.956176929444113,0,6,heparan sulfate proteoglycan biosynthetic process, enzymatic modification,BP,
5248,GO:0015016,1,0.966410784595299,0,4,[heparan sulfate]-glucosamine N-sulfotransferase activity,MF,
5249,GO:0015018,1,0.983795394828412,0,3,galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity,MF,
5250,GO:0015019,1,0.991767744156464,0,1,heparan-alpha-glucosaminide N-acetyltransferase activity,MF,
5251,GO:0015020,1,0.911918630836371,0,14,glucuronosyltransferase activity,MF,
5252,GO:0015026,1,0.743857003734933,0,42,coreceptor activity,MF,
5253,GO:0015030,1,0.712604080792106,0,55,Cajal body,CC,
5255,GO:0015035,1,0.913833522334451,0,18,protein disulfide oxidoreductase activity,MF,
5256,GO:0015036,1,0.829539225868851,0,36,disulfide oxidoreductase activity,MF,
5257,GO:0015037,1,0.939205300276131,0,13,peptide disulfide oxidoreductase activity,MF,
5258,GO:0015038,1,0.97979356604185,0,5,glutathione disulfide oxidoreductase activity,MF,
5259,GO:0015039,1,0.995074351707712,0,1,NADPH-adrenodoxin reductase activity,MF,
5260,GO:0015052,1,0.993678146465378,0,1,beta3-adrenergic receptor activity,MF,
5261,GO:0015054,1,0.994640101068689,0,1,gastrin receptor activity,MF,
5262,GO:0015056,1,0.989280054341,0,2,corticotrophin-releasing factor receptor activity,MF,
5263,GO:0015057,1,0.966850020059127,0,5,thrombin-activated receptor activity,MF,
5264,GO:0015067,1,0.993764756070365,0,1,amidinotransferase activity,MF,
5265,GO:0015068,1,0.993764756070365,0,1,glycine amidinotransferase activity,MF,
5266,GO:0015074,1,0.931459640033421,0,10,DNA integration,BP,
5269,GO:0015078,1,0.581950663062313,0,90,proton transmembrane transporter activity,MF,
5273,GO:0015086,1,0.97073147132645,0,4,cadmium ion transmembrane transporter activity,MF,
5274,GO:0015087,1,0.978461575485195,0,3,cobalt ion transmembrane transporter activity,MF,
5275,GO:0015093,1,0.970743229939362,0,4,ferrous iron transmembrane transporter activity,MF,
5276,GO:0015094,1,0.992530547375531,0,1,lead ion transmembrane transporter activity,MF,
5277,GO:0015095,1,0.900231986912014,0,15,magnesium ion transmembrane transporter activity,MF,
5278,GO:0015098,1,0.995073384453726,0,1,molybdate ion transmembrane transporter activity,MF,
5279,GO:0015099,1,0.992530547375531,0,1,nickel cation transmembrane transporter activity,MF,
5280,GO:0015101,1,0.863369952001693,0,23,organic cation transmembrane transporter activity,MF,
5284,GO:0015111,1,0.977478690733546,0,3,iodide transmembrane transporter activity,MF,
5285,GO:0015112,1,0.993659052978588,0,1,nitrate transmembrane transporter activity,MF,
5286,GO:0015114,1,0.952202816464175,0,6,phosphate ion transmembrane transporter activity,MF,
5287,GO:0015116,1,0.909175194681615,0,14,sulfate transmembrane transporter activity,MF,
5288,GO:0015117,1,0.978943369093154,0,4,thiosulfate transmembrane transporter activity,MF,
5289,GO:0015119,1,0.980420757594002,0,3,hexose phosphate transmembrane transporter activity,MF,
5290,GO:0015125,1,0.915019480064836,0,14,bile acid transmembrane transporter activity,MF,
5291,GO:0015126,1,0.992116162369238,0,1,canalicular bile acid transmembrane transporter activity,MF,
5292,GO:0015127,1,0.991892418496674,0,1,bilirubin transmembrane transporter activity,MF,
5293,GO:0015129,1,0.966554460791894,0,5,lactate transmembrane transporter activity,MF,
5294,GO:0015130,1,0.992547418446041,0,1,mevalonate transmembrane transporter activity,MF,
5295,GO:0015131,1,0.978943369093154,0,4,oxaloacetate transmembrane transporter activity,MF,
5296,GO:0015132,1,0.992498905753414,0,1,prostaglandin transmembrane transporter activity,MF,
5297,GO:0015136,1,0.988429465790395,0,2,sialic acid transmembrane transporter activity,MF,
5298,GO:0015137,1,0.974014681170834,0,4,citrate transmembrane transporter activity,MF,
5299,GO:0015139,1,0.981359375742533,0,3,alpha-ketoglutarate transmembrane transporter activity,MF,
5300,GO:0015140,1,0.978943369093154,0,4,malate transmembrane transporter activity,MF,
5301,GO:0015141,1,0.96489695670597,0,6,succinate transmembrane transporter activity,MF,
5302,GO:0015142,1,0.974014681170834,0,4,tricarboxylic acid transmembrane transporter activity,MF,
5303,GO:0015143,1,0.983046735754748,0,3,urate transmembrane transporter activity,MF,
5304,GO:0015144,1,0.805167492431587,0,34,carbohydrate transmembrane transporter activity,MF,
5305,GO:0015145,1,0.869993010632226,0,21,monosaccharide transmembrane transporter activity,MF,
5306,GO:0015146,1,0.978617082630758,0,2,pentose transmembrane transporter activity,MF,
5307,GO:0015149,1,0.883737122686018,0,19,hexose transmembrane transporter activity,MF,
5308,GO:0015150,1,0.978617082630758,0,2,fucose transmembrane transporter activity,MF,
5309,GO:0015151,1,0.986382830719601,0,2,alpha-glucoside transmembrane transporter activity,MF,
5310,GO:0015152,1,0.994663813224979,0,1,glucose-6-phosphate transmembrane transporter activity,MF,
5311,GO:0015154,1,0.97456033172572,0,4,disaccharide transmembrane transporter activity,MF,
5312,GO:0015157,1,0.97456033172572,0,4,oligosaccharide transmembrane transporter activity,MF,
5313,GO:0015165,1,0.940795626474645,0,10,pyrimidine nucleotide-sugar transmembrane transporter activity,MF,
5314,GO:0015166,1,0.934109040200075,0,10,polyol transmembrane transporter activity,MF,
5315,GO:0015168,1,0.969631179803068,0,6,glycerol transmembrane transporter activity,MF,
5318,GO:0015173,1,0.934678878060274,0,10,aromatic amino acid transmembrane transporter activity,MF,
5319,GO:0015174,1,0.908173416926512,0,14,basic amino acid transmembrane transporter activity,MF,
5320,GO:0015175,1,0.812096708613548,0,30,neutral amino acid transmembrane transporter activity,MF,
5322,GO:0015180,1,0.953228717521691,0,7,L-alanine transmembrane transporter activity,MF,
5323,GO:0015181,1,0.949958543432516,0,7,arginine transmembrane transporter activity,MF,
5324,GO:0015182,1,0.982429551768835,0,3,L-asparagine transmembrane transporter activity,MF,
5325,GO:0015183,1,0.944326251247893,0,9,L-aspartate transmembrane transporter activity,MF,
5326,GO:0015184,1,0.980449837115479,0,3,L-cystine transmembrane transporter activity,MF,
5327,GO:0015185,1,0.954851696169261,0,7,gamma-aminobutyric acid transmembrane transporter activity,MF,
5328,GO:0015186,1,0.947475552756005,0,8,L-glutamine transmembrane transporter activity,MF,
5329,GO:0015187,1,0.954594648278872,0,7,glycine transmembrane transporter activity,MF,
5330,GO:0015188,1,0.991633698096644,0,1,L-isoleucine transmembrane transporter activity,MF,
5331,GO:0015189,1,0.968545127706012,0,4,L-lysine transmembrane transporter activity,MF,
5332,GO:0015190,1,0.967158992231073,0,5,L-leucine transmembrane transporter activity,MF,
5333,GO:0015191,1,0.993470039179441,0,1,L-methionine transmembrane transporter activity,MF,
5334,GO:0015193,1,0.962633583021259,0,5,L-proline transmembrane transporter activity,MF,
5335,GO:0015194,1,0.95684612086894,0,7,L-serine transmembrane transporter activity,MF,
5336,GO:0015195,1,0.992455462665037,0,1,L-threonine transmembrane transporter activity,MF,
5337,GO:0015196,1,0.98631622495794,0,2,L-tryptophan transmembrane transporter activity,MF,
5338,GO:0015199,1,0.991633698096644,0,1,amino-acid betaine transmembrane transporter activity,MF,
5340,GO:0015205,1,0.956070150371128,0,7,nucleobase transmembrane transporter activity,MF,
5341,GO:0015207,1,0.988447386120217,0,2,adenine transmembrane transporter activity,MF,
5342,GO:0015211,1,0.988141161585106,0,2,purine nucleoside transmembrane transporter activity,MF,
5343,GO:0015212,1,0.994791295069003,0,1,cytidine transmembrane transporter activity,MF,
5344,GO:0015213,1,0.977522860619714,0,4,uridine transmembrane transporter activity,MF,
5345,GO:0015214,1,0.977522860619714,0,4,pyrimidine nucleoside transmembrane transporter activity,MF,
5346,GO:0015215,1,0.826155525584917,0,31,nucleotide transmembrane transporter activity,MF,
5347,GO:0015216,1,0.835309126872362,0,29,purine nucleotide transmembrane transporter activity,MF,
5348,GO:0015217,1,0.98747383123151,0,2,ADP transmembrane transporter activity,MF,
5349,GO:0015218,1,0.988101881709564,0,2,pyrimidine nucleotide transmembrane transporter activity,MF,
5350,GO:0015220,1,0.973014863822775,0,4,choline transmembrane transporter activity,MF,
5351,GO:0015225,1,0.978298531550335,0,3,biotin transmembrane transporter activity,MF,
5352,GO:0015226,1,0.98249083445578,0,3,carnitine transmembrane transporter activity,MF,
5353,GO:0015227,1,0.976664738078989,0,4,acyl carnitine transmembrane transporter activity,MF,
5354,GO:0015228,1,0.98747383123151,0,2,coenzyme A transmembrane transporter activity,MF,
5355,GO:0015229,1,0.984466788442784,0,2,L-ascorbic acid transmembrane transporter activity,MF,
5356,GO:0015230,1,0.987573276862597,0,2,FAD transmembrane transporter activity,MF,
5357,GO:0015232,1,0.943414383222522,0,9,heme transmembrane transporter activity,MF,
5358,GO:0015233,1,0.992955520887157,0,1,pantothenate transmembrane transporter activity,MF,
5359,GO:0015234,1,0.981158290205886,0,3,thiamine transmembrane transporter activity,MF,
5360,GO:0015245,1,0.957991368326794,0,7,fatty acid transmembrane transporter activity,MF,
5361,GO:0015247,1,0.968245906242229,0,4,aminophospholipid flippase activity,MF,
5362,GO:0015248,1,0.810842583975243,0,30,sterol transporter activity,MF,
5363,GO:0015250,1,0.946154280657825,0,10,water channel activity,MF,
5364,GO:0015252,1,0.978826379813405,0,4,proton channel activity,MF,
5365,GO:0015254,1,0.975968605388145,0,5,glycerol channel activity,MF,
5368,GO:0015269,1,0.943055551271919,0,10,calcium-activated potassium channel activity,MF,
5369,GO:0015271,1,0.916927841071079,0,12,outward rectifier potassium channel activity,MF,
5370,GO:0015272,1,0.958294691699716,0,6,ATP-activated inward rectifier potassium channel activity,MF,
5371,GO:0015275,1,0.978509260326414,0,3,stretch-activated, cation-selective, calcium channel activity,MF,
5373,GO:0015277,1,0.960237660998406,0,5,kainate selective glutamate receptor activity,MF,
5374,GO:0015278,1,0.852614480139493,0,16,calcium-release channel activity,MF,
5375,GO:0015279,1,0.931161995216056,0,9,store-operated calcium channel activity,MF,
5376,GO:0015280,1,0.930914156279571,0,10,ligand-gated sodium channel activity,MF,
5377,GO:0015288,1,0.976197988271106,0,5,porin activity,MF,
5379,GO:0015292,1,0.993485400251684,0,1,uniporter activity,MF,
5382,GO:0015295,1,0.89744865974415,0,16,solute:proton symporter activity,MF,
5383,GO:0015296,1,0.859658364484137,0,20,anion:cation symporter activity,MF,
5385,GO:0015298,1,0.802704470298007,0,29,solute:cation antiporter activity,MF,
5386,GO:0015299,1,0.870109579428117,0,18,solute:proton antiporter activity,MF,
5388,GO:0015315,1,0.980420757594002,0,3,organophosphate:inorganic phosphate antiporter activity,MF,
5389,GO:0015317,1,0.995475772770149,0,1,phosphate:proton symporter activity,MF,
5392,GO:0015322,1,0.992743852065289,0,1,secondary active oligopeptide transmembrane transporter activity,MF,
5393,GO:0015327,1,0.987991015504381,0,1,cystine:glutamate antiporter activity,MF,
5394,GO:0015328,1,0.987991015504381,0,1,cystine secondary active transmembrane transporter activity,MF,
5395,GO:0015333,1,0.991535205056401,0,1,peptide:proton symporter activity,MF,
5396,GO:0015343,1,0.993485400251684,0,1,siderophore transmembrane transporter activity,MF,
5397,GO:0015347,1,0.917870442956439,0,12,sodium-independent organic anion transmembrane transporter activity,MF,
5398,GO:0015349,1,0.957977239983338,0,6,thyroid hormone transmembrane transporter activity,MF,
5399,GO:0015350,1,0.984104693415259,0,2,methotrexate transmembrane transporter activity,MF,
5400,GO:0015355,1,0.937544206716304,0,11,secondary active monocarboxylate transmembrane transporter activity,MF,
5401,GO:0015362,1,0.992586997250308,0,1,high-affinity sodium:dicarboxylate symporter activity,MF,
5402,GO:0015367,1,0.995298760750246,0,1,oxoglutarate:malate antiporter activity,MF,
5403,GO:0015368,1,0.927272434608547,0,10,calcium:cation antiporter activity,MF,
5404,GO:0015369,1,0.991556402184993,0,1,calcium:proton antiporter activity,MF,
5406,GO:0015373,1,0.917086187792031,0,12,anion:sodium symporter activity,MF,
5407,GO:0015375,1,0.986410211533028,0,2,glycine:sodium symporter activity,MF,
5408,GO:0015377,1,0.884799282253498,0,16,cation:chloride symporter activity,MF,
5409,GO:0015378,1,0.929960641420634,0,10,sodium:chloride symporter activity,MF,
5410,GO:0015379,1,0.934862955768653,0,8,potassium:chloride symporter activity,MF,
5411,GO:0015382,1,0.993317365421639,0,1,sodium:sulfate symporter activity,MF,
5412,GO:0015385,1,0.922675098283799,0,11,sodium:proton antiporter activity,MF,
5413,GO:0015386,1,0.928729860446002,0,10,potassium:proton antiporter activity,MF,
5414,GO:0015389,1,0.989255543358429,0,2,pyrimidine- and adenine-specific:sodium symporter activity,MF,
5415,GO:0015390,1,0.994435553401407,0,1,purine-specific nucleoside:sodium symporter activity,MF,
5416,GO:0015391,1,0.989255543358429,0,2,nucleobase:cation symporter activity,MF,
5418,GO:0015410,1,0.978559467763031,0,3,manganese transmembrane transporter activity, phosphorylative mechanism,MF,
5419,GO:0015420,1,0.981354451207694,0,3,ATPase-coupled vitamin B12 transmembrane transporter activity,MF,
5420,GO:0015431,1,0.990721694075468,0,1,ATPase-coupled glutathione S-conjugate transmembrane transporter activity,MF,
5421,GO:0015432,1,0.98499447041333,0,2,ATPase-coupled bile acid transmembrane transporter activity,MF,
5422,GO:0015433,1,0.971820751049517,0,4,ATPase-coupled peptide antigen transmembrane transporter activity,MF,
5423,GO:0015439,1,0.993220829637341,0,1,ATPase-coupled heme transmembrane transporter activity,MF,
5424,GO:0015440,1,0.971820751049517,0,4,ATPase-coupled peptide transmembrane transporter activity,MF,
5425,GO:0015450,1,0.975846945863335,0,5,P-P-bond-hydrolysis-driven protein transmembrane transporter activity,MF,
5426,GO:0015459,1,0.705820702487962,0,51,potassium channel regulator activity,MF,
5428,GO:0015467,1,0.974032106803933,0,4,G-protein activated inward rectifier potassium channel activity,MF,
5429,GO:0015485,1,0.759528416689367,0,42,cholesterol binding,MF,
5430,GO:0015491,1,0.837849861707096,0,24,cation:cation antiporter activity,MF,
5431,GO:0015495,1,0.993791596739718,0,1,gamma-aminobutyric acid:proton symporter activity,MF,
5432,GO:0015499,1,0.993655100153634,0,1,formate transmembrane transporter activity,MF,
5433,GO:0015501,1,0.967445973625178,0,4,glutamate:sodium symporter activity,MF,
5434,GO:0015526,1,0.980420757594002,0,3,hexose-phosphate:inorganic phosphate antiporter activity,MF,
5435,GO:0015538,1,0.992946109883731,0,1,sialic acid:proton symporter activity,MF,
5436,GO:0015556,1,0.91115885896589,0,15,C4-dicarboxylate transmembrane transporter activity,MF,
5437,GO:0015562,1,0.908631164244359,0,13,efflux transmembrane transporter activity,MF,
5438,GO:0015605,1,0.800375367067906,0,36,organophosphate ester transmembrane transporter activity,MF,
5439,GO:0015607,1,0.992762537164016,0,1,ATPase-coupled fatty-acyl-CoA transmembrane transporter activity,MF,
5440,GO:0015616,1,0.956335035148096,0,5,DNA translocase activity,MF,
5445,GO:0015636,1,0.989028126227307,0,2,short-chain fatty acid transmembrane transporter activity,MF,
5446,GO:0015643,1,0.944460526177082,0,10,toxic substance binding,MF,
5447,GO:0015645,1,0.884661986223122,0,19,fatty acid ligase activity,MF,
5448,GO:0015651,1,0.938787738488185,0,10,quaternary ammonium group transmembrane transporter activity,MF,
5449,GO:0015658,1,0.952137491779439,0,7,branched-chain amino acid transmembrane transporter activity,MF,
5450,GO:0015660,1,0.993655100153634,0,1,formate efflux transmembrane transporter activity,MF,
5451,GO:0015662,1,0.794809474040607,0,32,ion transmembrane transporter activity, phosphorylative mechanism,MF,
5452,GO:0015665,1,0.985221070037834,0,3,alcohol transmembrane transporter activity,MF,
5453,GO:0015669,1,0.924881642589207,0,18,gas transport,BP,
5454,GO:0015670,1,0.978072490714959,0,4,carbon dioxide transport,BP,
5455,GO:0015671,1,0.945628416778515,0,14,oxygen transport,BP,
5457,GO:0015675,1,0.992530547375531,0,1,nickel cation transport,BP,
5458,GO:0015677,1,0.948450440159991,0,6,copper ion import,BP,
5459,GO:0015679,1,0.992132171079246,0,1,plasma membrane copper ion transport,BP,
5460,GO:0015680,1,0.987299732903991,0,2,protein maturation by copper ion transfer,BP,
5461,GO:0015689,1,0.995073384453726,0,1,molybdate ion transport,BP,
5462,GO:0015691,1,0.965726406398626,0,5,cadmium ion transport,BP,
5463,GO:0015692,1,0.992530547375531,0,1,lead ion transport,BP,
5464,GO:0015693,1,0.892692494662254,0,16,magnesium ion transport,BP,
5465,GO:0015694,1,0.991892418496674,0,1,mercury ion transport,BP,
5467,GO:0015696,1,0.943503674373163,0,8,ammonium transport,BP,
5468,GO:0015697,1,0.920914443670421,0,13,quaternary ammonium group transport,BP,
5471,GO:0015705,1,0.955743298321179,0,5,iodide transport,BP,
5472,GO:0015706,1,0.993659052978588,0,1,nitrate transport,BP,
5473,GO:0015707,1,0.992679532988169,0,1,nitrite transport,BP,
5474,GO:0015709,1,0.978943369093154,0,4,thiosulfate transport,BP,
5476,GO:0015712,1,0.96493176977791,0,6,hexose phosphate transport,BP,
5478,GO:0015721,1,0.852711811907829,0,24,bile acid and bile salt transport,BP,
5479,GO:0015722,1,0.970346805398522,0,4,canalicular bile acid transport,BP,
5480,GO:0015723,1,0.991892418496674,0,1,bilirubin transport,BP,
5481,GO:0015724,1,0.993655100153634,0,1,formate transport,BP,
5482,GO:0015727,1,0.959256014309687,0,6,lactate transport,BP,
5483,GO:0015728,1,0.992547418446041,0,1,mevalonate transport,BP,
5484,GO:0015729,1,0.978943369093154,0,4,oxaloacetate transport,BP,
5485,GO:0015732,1,0.921376468894632,0,13,prostaglandin transport,BP,
5486,GO:0015734,1,0.952526975444595,0,6,taurine transport,BP,
5487,GO:0015739,1,0.979195040464793,0,4,sialic acid transport,BP,
5488,GO:0015740,1,0.842214574626615,0,24,C4-dicarboxylate transport,BP,
5489,GO:0015742,1,0.976107127438767,0,4,alpha-ketoglutarate transport,BP,
5490,GO:0015743,1,0.978943369093154,0,4,malate transport,BP,
5491,GO:0015744,1,0.96489695670597,0,6,succinate transport,BP,
5492,GO:0015746,1,0.974014681170834,0,4,citrate transport,BP,
5493,GO:0015747,1,0.976954184488206,0,4,urate transport,BP,
5494,GO:0015748,1,0.452350765581356,0,117,organophosphate ester transport,BP,
5495,GO:0015749,1,0.505465435638421,0,96,monosaccharide transmembrane transport,BP,
5496,GO:0015750,1,0.978617082630758,0,2,pentose transmembrane transport,BP,
5497,GO:0015755,1,0.975972045563522,0,4,fructose transmembrane transport,BP,
5498,GO:0015756,1,0.978617082630758,0,2,fucose transmembrane transport,BP,
5499,GO:0015757,1,0.984575397838648,0,2,galactose transmembrane transport,BP,
5500,GO:0015760,1,0.96493176977791,0,6,glucose-6-phosphate transport,BP,
5501,GO:0015766,1,0.97456033172572,0,4,disaccharide transport,BP,
5502,GO:0015770,1,0.97456033172572,0,4,sucrose transport,BP,
5503,GO:0015772,1,0.97456033172572,0,4,oligosaccharide transport,BP,
5504,GO:0015774,1,0.991729149257186,0,1,polysaccharide transport,BP,
5505,GO:0015780,1,0.928938465301116,0,12,nucleotide-sugar transmembrane transport,BP,
5506,GO:0015782,1,0.995234987992997,0,1,CMP-N-acetylneuraminate transmembrane transport,BP,
5507,GO:0015783,1,0.9930210826683,0,1,GDP-fucose transmembrane transport,BP,
5508,GO:0015786,1,0.990634276287645,0,2,UDP-glucose transmembrane transport,BP,
5509,GO:0015787,1,0.980541851418073,0,3,UDP-glucuronic acid transmembrane transport,BP,
5510,GO:0015789,1,0.980541851418073,0,3,UDP-N-acetylgalactosamine transmembrane transport,BP,
5511,GO:0015790,1,0.990363169594414,0,1,UDP-xylose transmembrane transport,BP,
5512,GO:0015791,1,0.915942098266835,0,12,polyol transport,BP,
5513,GO:0015793,1,0.969631179803068,0,6,glycerol transport,BP,
5514,GO:0015797,1,0.993655100153634,0,1,mannitol transport,BP,
5515,GO:0015798,1,0.950680986400193,0,5,myo-inositol transport,BP,
5517,GO:0015801,1,0.915866018349886,0,13,aromatic amino acid transport,BP,
5518,GO:0015802,1,0.898241773481886,0,16,basic amino acid transport,BP,
5521,GO:0015805,1,0.994425789488496,0,1,S-adenosyl-L-methionine transport,BP,
5523,GO:0015808,1,0.948341180329889,0,8,L-alanine transport,BP,
5524,GO:0015809,1,0.928648344288697,0,11,arginine transport,BP,
5525,GO:0015810,1,0.938903119632647,0,9,aspartate transmembrane transport,BP,
5526,GO:0015811,1,0.980449837115479,0,3,L-cystine transport,BP,
5527,GO:0015812,1,0.890630434467788,0,16,gamma-aminobutyric acid transport,BP,
5530,GO:0015817,1,0.987474554389584,0,2,histidine transport,BP,
5531,GO:0015818,1,0.991633698096644,0,1,isoleucine transport,BP,
5532,GO:0015819,1,0.989904756538075,0,1,lysine transport,BP,
5534,GO:0015821,1,0.993470039179441,0,1,methionine transport,BP,
5535,GO:0015822,1,0.94866551975401,0,7,ornithine transport,BP,
5536,GO:0015823,1,0.986697822403913,0,2,phenylalanine transport,BP,
5538,GO:0015825,1,0.95684612086894,0,7,L-serine transport,BP,
5539,GO:0015826,1,0.992455462665037,0,1,threonine transport,BP,
5540,GO:0015827,1,0.966665983489274,0,5,tryptophan transport,BP,
5541,GO:0015828,1,0.993064816825511,0,1,tyrosine transport,BP,
5542,GO:0015829,1,0.992760540468,0,1,valine transport,BP,
5545,GO:0015838,1,0.961345043076157,0,6,amino-acid betaine transport,BP,
5547,GO:0015842,1,0.978501839524222,0,4,aminergic neurotransmitter loading into synaptic vesicle,BP,
5549,GO:0015846,1,0.961591046940669,0,7,polyamine transport,BP,
5552,GO:0015851,1,0.946314146507936,0,9,nucleobase transport,BP,
5553,GO:0015853,1,0.978364340271001,0,4,adenine transport,BP,
5554,GO:0015854,1,0.993879134071437,0,1,guanine transport,BP,
5555,GO:0015855,1,0.976497454307686,0,4,pyrimidine nucleobase transport,BP,
5556,GO:0015858,1,0.954567677448279,0,8,nucleoside transport,BP,
5557,GO:0015860,1,0.98264204813725,0,3,purine nucleoside transmembrane transport,BP,
5558,GO:0015861,1,0.994791295069003,0,1,cytidine transport,BP,
5559,GO:0015862,1,0.977522860619714,0,4,uridine transport,BP,
5560,GO:0015864,1,0.977522860619714,0,4,pyrimidine nucleoside transport,BP,
5561,GO:0015865,1,0.820185865233289,0,32,purine nucleotide transport,BP,
5562,GO:0015866,1,0.97995325066505,0,3,ADP transport,BP,
5563,GO:0015867,1,0.850582239539283,0,26,ATP transport,BP,
5564,GO:0015868,1,0.826594750232984,0,31,purine ribonucleotide transport,BP,
5565,GO:0015870,1,0.975397935780096,0,4,acetylcholine transport,BP,
5566,GO:0015871,1,0.956086640192526,0,6,choline transport,BP,
5568,GO:0015874,1,0.876443341941364,0,21,norepinephrine transport,BP,
5569,GO:0015876,1,0.993648007022561,0,1,acetyl-CoA transport,BP,
5570,GO:0015878,1,0.978298531550335,0,3,biotin transport,BP,
5571,GO:0015879,1,0.977237445225625,0,4,carnitine transport,BP,
5572,GO:0015880,1,0.98747383123151,0,2,coenzyme A transport,BP,
5573,GO:0015881,1,0.979692004973333,0,3,creatine transmembrane transport,BP,
5574,GO:0015882,1,0.984466788442784,0,2,L-ascorbic acid transmembrane transport,BP,
5575,GO:0015883,1,0.987573276862597,0,2,FAD transport,BP,
5577,GO:0015886,1,0.943414383222522,0,9,heme transport,BP,
5578,GO:0015887,1,0.992955520887157,0,1,pantothenate transmembrane transport,BP,
5579,GO:0015888,1,0.974606134462283,0,4,thiamine transport,BP,
5580,GO:0015889,1,0.954540415959286,0,7,cobalamin transport,BP,
5581,GO:0015891,1,0.984850641543743,0,3,siderophore transport,BP,
5582,GO:0015893,1,0.927360689936122,0,10,drug transport,BP,
5583,GO:0015904,1,0.99514079979557,0,1,tetracycline transmembrane transport,BP,
5586,GO:0015910,1,0.972107763398461,0,4,long-chain fatty acid import into peroxisome,BP,
5587,GO:0015911,1,0.940772400522148,0,8,long-chain fatty acid import across plasma membrane,BP,
5588,GO:0015912,1,0.989028126227307,0,2,short-chain fatty acid transport,BP,
5589,GO:0015913,1,0.994265218791685,0,1,short-chain fatty acid import,BP,
5590,GO:0015914,1,0.586268554556501,0,75,phospholipid transport,BP,
5591,GO:0015916,1,0.986456059991618,0,2,fatty-acyl-CoA transport,BP,
5592,GO:0015917,1,0.967175337915194,0,4,aminophospholipid transport,BP,
5593,GO:0015918,1,0.551531095780499,0,87,sterol transport,BP,
5594,GO:0015919,1,0.874559945433571,0,20,peroxisomal membrane transport,BP,
5595,GO:0015920,1,0.988840042681374,0,2,lipopolysaccharide transport,BP,
5596,GO:0015922,1,0.995588465141736,0,1,aspartate oxidase activity,MF,
5597,GO:0015923,1,0.893017747478002,0,15,mannosidase activity,MF,
5598,GO:0015924,1,0.932001383504152,0,9,mannosyl-oligosaccharide mannosidase activity,MF,
5599,GO:0015925,1,0.952628843766214,0,8,galactosidase activity,MF,
5600,GO:0015926,1,0.923558349400112,0,11,glucosidase activity,MF,
5601,GO:0015928,1,0.989355823795412,0,2,fucosidase activity,MF,
5602,GO:0015929,1,0.936371684576317,0,11,hexosaminidase activity,MF,
5603,GO:0015931,1,0.196498183526536,0,242,nucleobase-containing compound transport,BP,
5604,GO:0015932,1,0.729348390887503,0,51,nucleobase-containing compound transmembrane transporter activity,MF,
5605,GO:0015934,1,0.649892926932438,0,110,large ribosomal subunit,CC,
5606,GO:0015935,1,0.754006196527317,0,70,small ribosomal subunit,CC,
5607,GO:0015936,1,0.915956296881934,0,15,coenzyme A metabolic process,BP,
5608,GO:0015937,1,0.946807376190286,0,10,coenzyme A biosynthetic process,BP,
5609,GO:0015938,1,0.996520604840365,0,1,coenzyme A catabolic process,BP,
5610,GO:0015939,1,0.961452656772278,0,7,pantothenate metabolic process,BP,
5611,GO:0015942,1,0.965621637287611,0,6,formate metabolic process,BP,
5613,GO:0015959,1,0.966776055751947,0,6,diadenosine polyphosphate metabolic process,BP,
5614,GO:0015960,1,0.992745377702806,0,1,diadenosine polyphosphate biosynthetic process,BP,
5615,GO:0015961,1,0.973842784136824,0,5,diadenosine polyphosphate catabolic process,BP,
5616,GO:0015962,1,0.996415206418902,0,1,diadenosine triphosphate metabolic process,BP,
5617,GO:0015964,1,0.996415206418902,0,1,diadenosine triphosphate catabolic process,BP,
5618,GO:0015965,1,0.992745377702806,0,1,diadenosine tetraphosphate metabolic process,BP,
5619,GO:0015966,1,0.992745377702806,0,1,diadenosine tetraphosphate biosynthetic process,BP,
5621,GO:0015985,1,0.977091920260217,0,5,energy coupled proton transport, down electrochemical gradient,BP,
5622,GO:0015986,1,0.977091920260217,0,5,ATP synthesis coupled proton transport,BP,
5623,GO:0015988,1,0.996812663966201,0,1,energy coupled proton transmembrane transport, against electrochemical gradient,BP,
5624,GO:0015990,1,0.996812663966201,0,1,electron transport coupled proton transport,BP,
5625,GO:0016004,1,0.939791151772239,0,10,phospholipase activator activity,MF,
5626,GO:0016005,1,0.98579818658259,0,2,phospholipase A2 activator activity,MF,
5627,GO:0016010,1,0.873734664468442,0,19,dystrophin-associated glycoprotein complex,CC,
5628,GO:0016011,1,0.954268650473371,0,7,dystroglycan complex,CC,
5629,GO:0016012,1,0.962597294112304,0,6,sarcoglycan complex,CC,
5630,GO:0016013,1,0.97445408758974,0,4,syntrophin complex,CC,
5631,GO:0016015,1,0.96975889656129,0,6,morphogen activity,MF,
5632,GO:0016018,1,0.930871430515435,0,13,cyclosporin A binding,MF,
5633,GO:0016019,1,0.992257505756694,0,2,peptidoglycan immune receptor activity,MF,
5636,GO:0016024,1,0.920502871552482,0,11,CDP-diacylglycerol biosynthetic process,BP,
5637,GO:0016028,1,0.992775529992152,0,1,rhabdomere,CC,
5638,GO:0016031,1,0.992906731455803,0,1,tRNA import into mitochondrion,BP,
5640,GO:0016034,1,0.996047932566051,0,1,maleylacetoacetate isomerase activity,MF,
5641,GO:0016035,1,0.972086870604264,0,4,zeta DNA polymerase complex,CC,
5642,GO:0016036,1,0.983419394431964,0,2,cellular response to phosphate starvation,BP,
5643,GO:0016037,1,0.993488214960511,0,1,light absorption,BP,
5644,GO:0016038,1,0.993488214960511,0,1,absorption of visible light,BP,
5647,GO:0016045,1,0.908639137658319,0,14,detection of bacterium,BP,
5648,GO:0016046,1,0.985501989626426,0,2,detection of fungus,BP,
5649,GO:0016048,1,0.8642474770105,0,22,detection of temperature stimulus,BP,
5653,GO:0016052,1,0.290388722809635,0,179,carbohydrate catabolic process,BP,
5657,GO:0016056,1,0.856480116222594,0,24,rhodopsin mediated signaling pathway,BP,
5658,GO:0016064,1,0.536505709321549,0,102,immunoglobulin mediated immune response,BP,
5659,GO:0016068,1,0.986429249518046,0,3,type I hypersensitivity,BP,
5661,GO:0016071,1,0.00699829601204442,0,789,mRNA metabolic process,BP,
5662,GO:0016072,1,0.284831450063472,0,214,rRNA metabolic process,BP,
5663,GO:0016073,1,0.821170141824465,0,33,snRNA metabolic process,BP,
5664,GO:0016074,1,0.932592354791484,0,13,snoRNA metabolic process,BP,
5665,GO:0016075,1,0.888334525595607,0,19,rRNA catabolic process,BP,
5666,GO:0016076,1,0.981961126147657,0,3,snRNA catabolic process,BP,
5667,GO:0016077,1,0.984577160746814,0,2,snoRNA catabolic process,BP,
5668,GO:0016078,1,0.930540472258412,0,11,tRNA catabolic process,BP,
5670,GO:0016080,1,0.975012672260687,0,3,synaptic vesicle targeting,BP,
5673,GO:0016093,1,0.95809695556124,0,8,polyprenol metabolic process,BP,
5674,GO:0016094,1,0.978866169404257,0,3,polyprenol biosynthetic process,BP,
5675,GO:0016095,1,0.985553545721374,0,3,polyprenol catabolic process,BP,
5676,GO:0016098,1,0.991163605856318,0,2,monoterpenoid metabolic process,BP,
5677,GO:0016101,1,0.573826646562236,0,88,diterpenoid metabolic process,BP,
5678,GO:0016102,1,0.949103061735156,0,9,diterpenoid biosynthetic process,BP,
5679,GO:0016103,1,0.979484356691164,0,4,diterpenoid catabolic process,BP,
5680,GO:0016104,1,0.992482560620612,0,1,triterpenoid biosynthetic process,BP,
5681,GO:0016107,1,0.991854312057638,0,2,sesquiterpenoid catabolic process,BP,
5682,GO:0016108,1,0.980693782352117,0,3,tetraterpenoid metabolic process,BP,
5683,GO:0016109,1,0.993716915438455,0,1,tetraterpenoid biosynthetic process,BP,
5684,GO:0016114,1,0.913920759371913,0,15,terpenoid biosynthetic process,BP,
5685,GO:0016115,1,0.971504130919163,0,6,terpenoid catabolic process,BP,
5686,GO:0016116,1,0.980693782352117,0,3,carotenoid metabolic process,BP,
5687,GO:0016117,1,0.993716915438455,0,1,carotenoid biosynthetic process,BP,
5688,GO:0016119,1,0.986895344770984,0,2,carotene metabolic process,BP,
5689,GO:0016121,1,0.986895344770984,0,2,carotene catabolic process,BP,
5690,GO:0016122,1,0.987125339513298,0,2,xanthophyll metabolic process,BP,
5691,GO:0016123,1,0.993716915438455,0,1,xanthophyll biosynthetic process,BP,
5692,GO:0016125,1,0.396565890481664,0,141,sterol metabolic process,BP,
5693,GO:0016126,1,0.636813633369885,0,68,sterol biosynthetic process,BP,
5694,GO:0016127,1,0.953061584801484,0,9,sterol catabolic process,BP,
5695,GO:0016128,1,0.993655100153634,0,1,phytosteroid metabolic process,BP,
5696,GO:0016129,1,0.993655100153634,0,1,phytosteroid biosynthetic process,BP,
5697,GO:0016131,1,0.993655100153634,0,1,brassinosteroid metabolic process,BP,
5698,GO:0016132,1,0.993655100153634,0,1,brassinosteroid biosynthetic process,BP,
5699,GO:0016137,1,0.908078250537716,0,19,glycoside metabolic process,BP,
5700,GO:0016139,1,0.949444048765664,0,9,glycoside catabolic process,BP,
5701,GO:0016149,1,0.992752819114746,0,1,translation release factor activity, codon specific,MF,
5702,GO:0016151,1,0.995352477807763,0,1,nickel cation binding,MF,
5703,GO:0016153,1,0.992914158918487,0,1,urocanate hydratase activity,MF,
5704,GO:0016154,1,0.99551487069965,0,1,pyrimidine-nucleoside phosphorylase activity,MF,
5705,GO:0016155,1,0.982894963315504,0,2,formyltetrahydrofolate dehydrogenase activity,MF,
5706,GO:0016160,1,0.980816251049044,0,3,amylase activity,MF,
5707,GO:0016165,1,0.981582095927638,0,3,linoleate 13S-lipoxygenase activity,MF,
5708,GO:0016167,1,0.976708114120583,0,3,glial cell-derived neurotrophic factor receptor activity,MF,
5709,GO:0016170,1,0.991928311648251,0,1,interleukin-15 receptor binding,MF,
5710,GO:0016174,1,0.936583511515361,0,9,NAD(P)H oxidase H2O2-forming activity,MF,
5711,GO:0016175,1,0.940056220962439,0,10,superoxide-generating NAD(P)H oxidase activity,MF,
5712,GO:0016176,1,0.948545897332505,0,8,superoxide-generating NADPH oxidase activator activity,MF,
5713,GO:0016180,1,0.868916909640663,0,23,snRNA processing,BP,
5714,GO:0016182,1,0.984766016682722,0,2,synaptic vesicle budding from endosome,BP,
5717,GO:0016189,1,0.976437002572217,0,3,synaptic vesicle to endosome fusion,BP,
5718,GO:0016191,1,0.961850831128101,0,5,synaptic vesicle uncoating,BP,
5720,GO:0016197,1,0.214480368063496,0,215,endosomal transport,BP,
5721,GO:0016198,1,0.949115291512067,0,7,axon choice point recognition,BP,
5722,GO:0016199,1,0.960538243432268,0,5,axon midline choice point recognition,BP,
5724,GO:0016203,1,0.991351019446412,0,1,muscle attachment,BP,
5725,GO:0016206,1,0.987535891920397,0,2,catechol O-methyltransferase activity,MF,
5726,GO:0016208,1,0.928088791686774,0,12,AMP binding,MF,
5727,GO:0016209,1,0.702596422444179,0,72,antioxidant activity,MF,
5728,GO:0016211,1,0.992418516791467,0,1,ammonia ligase activity,MF,
5729,GO:0016212,1,0.98846759873938,0,2,kynurenine-oxoglutarate transaminase activity,MF,
5730,GO:0016213,1,0.985499356963932,0,2,linoleoyl-CoA desaturase activity,MF,
5731,GO:0016215,1,0.971079441361318,0,4,acyl-CoA desaturase activity,MF,
5732,GO:0016222,1,0.987184485580325,0,2,procollagen-proline 4-dioxygenase complex,CC,
5733,GO:0016226,1,0.89915672287602,0,20,iron-sulfur cluster assembly,BP,
5734,GO:0016229,1,0.876753853870523,0,28,steroid dehydrogenase activity,MF,
5735,GO:0016230,1,0.988805471895094,0,2,sphingomyelin phosphodiesterase activator activity,MF,
5736,GO:0016232,1,0.993421218018077,0,1,HNK-1 sulfotransferase activity,MF,
5737,GO:0016233,1,0.758954870233357,0,38,telomere capping,BP,
5739,GO:0016235,1,0.763441310870988,0,38,aggresome,CC,
5741,GO:0016237,1,0.954330865397875,0,5,lysosomal microautophagy,BP,
5743,GO:0016240,1,0.97338192485962,0,4,autophagosome membrane docking,BP,
5746,GO:0016243,1,0.992615277517046,0,1,regulation of autophagosome size,BP,
5747,GO:0016246,1,0.894580922124226,0,16,RNA interference,BP,
5749,GO:0016248,1,0.790503313681663,0,36,channel inhibitor activity,MF,
5750,GO:0016250,1,0.993485400251684,0,1,N-sulfoglucosamine sulfohydrolase activity,MF,
5751,GO:0016251,1,0.81852390486933,0,36,RNA polymerase II general transcription initiation factor activity,MF,
5752,GO:0016254,1,0.915520534280098,0,16,preassembly of GPI anchor in ER membrane,BP,
5753,GO:0016255,1,0.957482449361722,0,6,attachment of GPI anchor to protein,BP,
5754,GO:0016256,1,0.99141350534263,0,1,N-glycan processing to lysosome,BP,
5755,GO:0016259,1,0.979634484039335,0,3,selenocysteine metabolic process,BP,
5756,GO:0016260,1,0.988137761316966,0,2,selenocysteine biosynthetic process,BP,
5757,GO:0016262,1,0.980281490388147,0,3,protein N-acetylglucosaminyltransferase activity,MF,
5758,GO:0016263,1,0.990271370252498,0,2,glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity,MF,
5759,GO:0016264,1,0.924323155349917,0,12,gap junction assembly,BP,
5760,GO:0016266,1,0.712915833419697,0,47,O-glycan processing,BP,
5761,GO:0016267,1,0.990271370252498,0,2,O-glycan processing, core 1,BP,
5762,GO:0016272,1,0.975017827013291,0,7,prefoldin complex,CC,
5763,GO:0016273,1,0.936042882898588,0,11,arginine N-methyltransferase activity,MF,
5764,GO:0016274,1,0.936042882898588,0,11,protein-arginine N-methyltransferase activity,MF,
5765,GO:0016277,1,0.994089891580228,0,1,[myelin basic protein]-arginine N-methyltransferase activity,MF,
5766,GO:0016278,1,0.695392487009445,0,48,lysine N-methyltransferase activity,MF,
5767,GO:0016279,1,0.699968738236331,0,47,protein-lysine N-methyltransferase activity,MF,
5768,GO:0016281,1,0.919595815325215,0,13,eukaryotic translation initiation factor 4F complex,CC,
5769,GO:0016282,1,0.922688025093743,0,16,eukaryotic 43S preinitiation complex,CC,
5770,GO:0016286,1,0.97704290618482,0,4,small conductance calcium-activated potassium channel activity,MF,
5771,GO:0016287,1,0.993601456362932,0,1,glycerone-phosphate O-acyltransferase activity,MF,
5772,GO:0016289,1,0.898487332722298,0,20,CoA hydrolase activity,MF,
5773,GO:0016290,1,0.937509782182538,0,12,palmitoyl-CoA hydrolase activity,MF,
5774,GO:0016295,1,0.984329381231428,0,2,myristoyl-[acyl-carrier-protein] hydrolase activity,MF,
5775,GO:0016296,1,0.984329381231428,0,2,palmitoyl-[acyl-carrier-protein] hydrolase activity,MF,
5776,GO:0016297,1,0.984329381231428,0,2,acyl-[acyl-carrier-protein] hydrolase activity,MF,
5778,GO:0016300,1,0.979269956969257,0,3,tRNA (uracil) methyltransferase activity,MF,
5780,GO:0016303,1,0.914756125312994,0,10,1-phosphatidylinositol-3-kinase activity,MF,
5781,GO:0016307,1,0.896289543664212,0,14,phosphatidylinositol phosphate kinase activity,MF,
5782,GO:0016308,1,0.958839305328846,0,6,1-phosphatidylinositol-4-phosphate 5-kinase activity,MF,
5783,GO:0016309,1,0.985830912819063,0,2,1-phosphatidylinositol-5-phosphate 4-kinase activity,MF,
5786,GO:0016312,1,0.987745527795689,0,2,inositol bisphosphate phosphatase activity,MF,
5787,GO:0016314,1,0.9719597280661,0,4,phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity,MF,
5788,GO:0016316,1,0.983104675016502,0,2,phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity,MF,
5789,GO:0016320,1,0.985399800034917,0,2,endoplasmic reticulum membrane fusion,BP,
5791,GO:0016322,1,0.922808728929085,0,12,neuron remodeling,BP,
5794,GO:0016327,1,0.906680464941525,0,16,apicolateral plasma membrane,CC,
5795,GO:0016328,1,0.632504399442396,0,63,lateral plasma membrane,CC,
5797,GO:0016332,1,0.99265776707409,0,1,establishment or maintenance of polarity of embryonic epithelium,BP,
5798,GO:0016333,1,0.993269816259471,0,1,morphogenesis of follicular epithelium,BP,
5799,GO:0016334,1,0.993269816259471,0,1,establishment or maintenance of polarity of follicular epithelium,BP,
5800,GO:0016338,1,0.903630018375334,0,18,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules,BP,
5802,GO:0016340,1,0.981401762420102,0,2,calcium-dependent cell-matrix adhesion,BP,
5803,GO:0016342,1,0.785154824369699,0,31,catenin complex,CC,
5804,GO:0016344,1,0.977078979764402,0,3,meiotic chromosome movement towards spindle pole,BP,
5806,GO:0016361,1,0.961185767367168,0,5,activin receptor activity, type I,MF,
5807,GO:0016362,1,0.972933917079663,0,2,activin receptor activity, type II,MF,
5809,GO:0016401,1,0.973408247445283,0,4,palmitoyl-CoA oxidase activity,MF,
5810,GO:0016402,1,0.993375324386272,0,1,pristanoyl-CoA oxidase activity,MF,
5811,GO:0016403,1,0.988702429221943,0,2,dimethylargininase activity,MF,
5812,GO:0016404,1,0.985897508854441,0,2,15-hydroxyprostaglandin dehydrogenase (NAD+) activity,MF,
5813,GO:0016405,1,0.859820604151615,0,23,CoA-ligase activity,MF,
5814,GO:0016406,1,0.959906183898145,0,6,carnitine O-acyltransferase activity,MF,
5815,GO:0016407,1,0.531812046029247,0,93,acetyltransferase activity,MF,
5816,GO:0016408,1,0.906044218119597,0,17,C-acyltransferase activity,MF,
5817,GO:0016409,1,0.771034680280494,0,39,palmitoyltransferase activity,MF,
5818,GO:0016410,1,0.552741123709345,0,87,N-acyltransferase activity,MF,
5819,GO:0016411,1,0.884908063184769,0,17,acylglycerol O-acyltransferase activity,MF,
5820,GO:0016413,1,0.953878066807772,0,7,O-acetyltransferase activity,MF,
5821,GO:0016414,1,0.986448954587384,0,2,O-octanoyltransferase activity,MF,
5822,GO:0016415,1,0.983089284274444,0,3,octanoyltransferase activity,MF,
5823,GO:0016416,1,0.965355890006062,0,5,O-palmitoyltransferase activity,MF,
5824,GO:0016417,1,0.808566067136599,0,32,S-acyltransferase activity,MF,
5825,GO:0016418,1,0.981447680329024,0,2,S-acetyltransferase activity,MF,
5826,GO:0016419,1,0.983969924543204,0,2,S-malonyltransferase activity,MF,
5827,GO:0016420,1,0.983969924543204,0,2,malonyltransferase activity,MF,
5828,GO:0016421,1,0.96455186642541,0,5,CoA carboxylase activity,MF,
5829,GO:0016422,1,0.983277829084815,0,3,mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity,MF,
5830,GO:0016423,1,0.923160641624193,0,13,tRNA (guanine) methyltransferase activity,MF,
5831,GO:0016426,1,0.97613346421243,0,4,tRNA (adenine) methyltransferase activity,MF,
5832,GO:0016427,1,0.941153340538328,0,9,tRNA (cytosine) methyltransferase activity,MF,
5833,GO:0016428,1,0.973354586633483,0,4,tRNA (cytosine-5-)-methyltransferase activity,MF,
5834,GO:0016429,1,0.97613346421243,0,4,tRNA (adenine-N1-)-methyltransferase activity,MF,
5835,GO:0016432,1,0.98563751707215,0,2,tRNA-uridine aminocarboxypropyltransferase activity,MF,
5836,GO:0016433,1,0.957894344566175,0,8,rRNA (adenine) methyltransferase activity,MF,
5837,GO:0016434,1,0.973830022161517,0,4,rRNA (cytosine) methyltransferase activity,MF,
5838,GO:0016435,1,0.989899286460228,0,2,rRNA (guanine) methyltransferase activity,MF,
5839,GO:0016436,1,0.986025805857401,0,2,rRNA (uridine) methyltransferase activity,MF,
5840,GO:0016441,1,0.420735975868668,0,121,posttranscriptional gene silencing,BP,
5841,GO:0016442,1,0.891231615625002,0,14,RISC complex,CC,
5842,GO:0016444,1,0.677660534481485,0,56,somatic cell DNA recombination,BP,
5843,GO:0016445,1,0.687232196343988,0,55,somatic diversification of immunoglobulins,BP,
5844,GO:0016446,1,0.913964188263721,0,13,somatic hypermutation of immunoglobulin genes,BP,
5845,GO:0016447,1,0.723761940134822,0,48,somatic recombination of immunoglobulin gene segments,BP,
5846,GO:0016453,1,0.974365767295793,0,5,C-acetyltransferase activity,MF,
5847,GO:0016454,1,0.965245815211507,0,5,C-palmitoyltransferase activity,MF,
5848,GO:0016458,1,0.267671826184203,0,183,gene silencing,BP,
5849,GO:0016459,1,0.657588305345052,0,51,myosin complex,CC,
5850,GO:0016460,1,0.884159076165242,0,17,myosin II complex,CC,
5851,GO:0016461,1,0.919423119278948,0,10,unconventional myosin complex,CC,
5853,GO:0016469,1,0.859768069242179,0,28,proton-transporting two-sector ATPase complex,CC,
5854,GO:0016471,1,0.912010597072564,0,16,vacuolar proton-transporting V-type ATPase complex,CC,
5855,GO:0016476,1,0.984892205588471,0,2,regulation of embryonic cell shape,BP,
5857,GO:0016479,1,0.977070767999809,0,3,negative regulation of transcription by RNA polymerase I,BP,
5858,GO:0016480,1,0.985794261951948,0,3,negative regulation of transcription by RNA polymerase III,BP,
5862,GO:0016487,1,0.991854312057638,0,2,farnesol metabolic process,BP,
5863,GO:0016488,1,0.991854312057638,0,2,farnesol catabolic process,BP,
5865,GO:0016492,1,0.988196794233126,0,2,G protein-coupled neurotensin receptor activity,MF,
5866,GO:0016493,1,0.883812422198642,0,22,C-C chemokine receptor activity,MF,
5867,GO:0016494,1,0.955941088854052,0,8,C-X-C chemokine receptor activity,MF,
5868,GO:0016495,1,0.993044849330838,0,1,C-X3-C chemokine receptor activity,MF,
5869,GO:0016496,1,0.992989838930325,0,1,substance P receptor activity,MF,
5870,GO:0016497,1,0.994067718307896,0,1,substance K receptor activity,MF,
5871,GO:0016499,1,0.990120711469736,0,2,orexin receptor activity,MF,
5872,GO:0016500,1,0.912076462154379,0,12,protein-hormone receptor activity,MF,
5873,GO:0016501,1,0.994711256870096,0,1,prostacyclin receptor activity,MF,
5874,GO:0016502,1,0.896284706831129,0,20,nucleotide receptor activity,MF,
5875,GO:0016503,1,0.996092337636168,0,1,pheromone receptor activity,MF,
5877,GO:0016505,1,0.894636914877049,0,18,peptidase activator activity involved in apoptotic process,MF,
5878,GO:0016507,1,0.993156218721447,0,1,mitochondrial fatty acid beta-oxidation multienzyme complex,CC,
5879,GO:0016508,1,0.979553023761504,0,3,long-chain-enoyl-CoA hydratase activity,MF,
5880,GO:0016509,1,0.985863517376971,0,2,long-chain-3-hydroxyacyl-CoA dehydrogenase activity,MF,
5881,GO:0016513,1,0.97684080269111,0,3,core-binding factor complex,CC,
5882,GO:0016514,1,0.88776824308441,0,17,SWI/SNF complex,CC,
5883,GO:0016517,1,0.994901652363875,0,1,interleukin-12 receptor activity,MF,
5884,GO:0016519,1,0.994810050967163,0,1,gastric inhibitory peptide receptor activity,MF,
5885,GO:0016520,1,0.988291573437969,0,2,growth hormone-releasing hormone receptor activity,MF,
5886,GO:0016521,1,0.993052350907243,0,1,pituitary adenylate cyclase activating polypeptide activity,MF,
5888,GO:0016528,1,0.559802812845183,0,74,sarcoplasm,CC,
5889,GO:0016529,1,0.602856460689133,0,65,sarcoplasmic reticulum,CC,
5890,GO:0016530,1,0.964002700815383,0,6,metallochaperone activity,MF,
5891,GO:0016531,1,0.980113471000595,0,4,copper chaperone activity,MF,
5892,GO:0016532,1,0.98559264791132,0,2,superoxide dismutase copper chaperone activity,MF,
5893,GO:0016533,1,0.983064484004102,0,3,protein kinase 5 complex,CC,
5894,GO:0016538,1,0.764590596355383,0,46,cyclin-dependent protein serine/threonine kinase regulator activity,MF,
5895,GO:0016539,1,0.990427332864135,0,2,intein-mediated protein splicing,BP,
5896,GO:0016540,1,0.884270218819382,0,20,protein autoprocessing,BP,
5897,GO:0016553,1,0.9000360607136,0,17,base conversion or substitution editing,BP,
5898,GO:0016554,1,0.953636980591151,0,9,cytidine to uridine editing,BP,
5899,GO:0016556,1,0.878257512556836,0,20,mRNA modification,BP,
5900,GO:0016557,1,0.985040145631705,0,3,peroxisome membrane biogenesis,BP,
5901,GO:0016558,1,0.919492913169145,0,13,protein import into peroxisome matrix,BP,
5902,GO:0016559,1,0.95499669914003,0,9,peroxisome fission,BP,
5903,GO:0016560,1,0.973446180245209,0,4,protein import into peroxisome matrix, docking,BP,
5904,GO:0016561,1,0.987889956065292,0,2,protein import into peroxisome matrix, translocation,BP,
5906,GO:0016569,1,0.0412119238087853,0,436,covalent chromatin modification,BP,
5907,GO:0016570,1,0.0442838077943354,0,426,histone modification,BP,
5908,GO:0016571,1,0.393951404975958,0,124,histone methylation,BP,
5909,GO:0016572,1,0.785282900701385,0,36,histone phosphorylation,BP,
5910,GO:0016573,1,0.351806065104278,0,149,histone acetylation,BP,
5911,GO:0016574,1,0.721934632706417,0,45,histone ubiquitination,BP,
5912,GO:0016575,1,0.584414966814116,0,75,histone deacetylation,BP,
5913,GO:0016576,1,0.95976284699109,0,6,histone dephosphorylation,BP,
5914,GO:0016577,1,0.797381609360022,0,27,histone demethylation,BP,
5915,GO:0016578,1,0.85486601488686,0,22,histone deubiquitination,BP,
5916,GO:0016579,1,0.196394033315241,0,239,protein deubiquitination,BP,
5917,GO:0016580,1,0.91340869418411,0,12,Sin3 complex,CC,
5918,GO:0016581,1,0.886794617438606,0,15,NuRD complex,CC,
5919,GO:0016584,1,0.96506534256102,0,5,nucleosome positioning,BP,
5920,GO:0016586,1,0.989729556844576,0,1,RSC-type complex,CC,
5921,GO:0016589,1,0.951823011861096,0,6,NURF complex,CC,
5922,GO:0016590,1,0.991094455987964,0,1,ACF complex,CC,
5923,GO:0016591,1,0.631597622437649,0,75,RNA polymerase II, holoenzyme,CC,
5924,GO:0016592,1,0.763425838475641,0,40,mediator complex,CC,
5925,GO:0016593,1,0.945042387664075,0,8,Cdc73/Paf1 complex,CC,
5928,GO:0016596,1,0.993485400251684,0,1,thienylcyclohexylpiperidine binding,MF,
5930,GO:0016598,1,0.989674688622677,0,2,protein arginylation,BP,
5931,GO:0016600,1,0.940246646934794,0,8,flotillin complex,CC,
5932,GO:0016601,1,0.769216595221492,0,37,Rac protein signal transduction,BP,
5933,GO:0016602,1,0.975073564676098,0,4,CCAAT-binding factor complex,CC,
5934,GO:0016603,1,0.99001500555391,0,2,glutaminyl-peptide cyclotransferase activity,MF,
5937,GO:0016607,1,0.0799370284077346,0,372,nuclear speck,CC,
5938,GO:0016608,1,0.994136689179906,0,2,growth hormone-releasing hormone activity,MF,
5939,GO:0016614,1,0.546412134703211,0,111,oxidoreductase activity, acting on CH-OH group of donors,MF,
5940,GO:0016615,1,0.961538119269074,0,7,malate dehydrogenase activity,MF,
5941,GO:0016616,1,0.577395972996613,0,102,oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,
5942,GO:0016618,1,0.996197405127411,0,1,hydroxypyruvate reductase activity,MF,
5943,GO:0016620,1,0.818603702464734,0,32,oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor,MF,
5944,GO:0016623,1,0.985950588001876,0,2,oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor,MF,
5945,GO:0016624,1,0.955520664273159,0,7,oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor,MF,
5946,GO:0016627,1,0.722727387661218,0,55,oxidoreductase activity, acting on the CH-CH group of donors,MF,
5947,GO:0016628,1,0.876725646476783,0,24,oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor,MF,
5948,GO:0016634,1,0.944193328262818,0,9,oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor,MF,
5949,GO:0016635,1,0.985245521587417,0,3,oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor,MF,
5950,GO:0016638,1,0.887184704690854,0,19,oxidoreductase activity, acting on the CH-NH2 group of donors,MF,
5951,GO:0016639,1,0.98712251406264,0,2,oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor,MF,
5952,GO:0016641,1,0.908476655680568,0,15,oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor,MF,
5953,GO:0016642,1,0.992694159277601,0,1,oxidoreductase activity, acting on the CH-NH2 group of donors, disulfide as acceptor,MF,
5954,GO:0016645,1,0.860311204899278,0,24,oxidoreductase activity, acting on the CH-NH group of donors,MF,
5955,GO:0016646,1,0.907607594391121,0,15,oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor,MF,
5956,GO:0016647,1,0.979178358974401,0,4,oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor,MF,
5957,GO:0016649,1,0.987220702246134,0,2,oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor,MF,
5958,GO:0016651,1,0.620448861434339,0,96,oxidoreductase activity, acting on NAD(P)H,MF,
5959,GO:0016652,1,0.988655796523995,0,2,oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor,MF,
5960,GO:0016653,1,0.915033227000125,0,13,oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor,MF,
5961,GO:0016655,1,0.811328060775409,0,53,oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor,MF,
5962,GO:0016657,1,0.9908874434528,0,2,oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor,MF,
5963,GO:0016661,1,0.982654675967962,0,3,oxidoreductase activity, acting on other nitrogenous compounds as donors,MF,
5964,GO:0016662,1,0.99374152799939,0,1,oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor,MF,
5965,GO:0016667,1,0.747267546186502,0,53,oxidoreductase activity, acting on a sulfur group of donors,MF,
5966,GO:0016668,1,0.93966090443675,0,11,oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor,MF,
5967,GO:0016670,1,0.943052398605664,0,9,oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor,MF,
5968,GO:0016671,1,0.961825987900013,0,7,oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor,MF,
5969,GO:0016672,1,0.992631497452783,0,2,oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor,MF,
5970,GO:0016675,1,0.921517967249261,0,22,oxidoreductase activity, acting on a heme group of donors,MF,
5971,GO:0016676,1,0.927177894382286,0,21,oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor,MF,
5972,GO:0016679,1,0.971338090949915,0,7,oxidoreductase activity, acting on diphenols and related substances as donors,MF,
5973,GO:0016681,1,0.977468206319498,0,6,oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor,MF,
5974,GO:0016684,1,0.786836649167627,0,49,oxidoreductase activity, acting on peroxide as acceptor,MF,
5975,GO:0016701,1,0.873088491864295,0,24,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen,MF,
5976,GO:0016702,1,0.873088491864295,0,24,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,MF,
5977,GO:0016705,1,0.416629067373321,0,134,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,MF,
5978,GO:0016706,1,0.737565903409758,0,43,2-oxoglutarate-dependent dioxygenase activity,MF,
5979,GO:0016708,1,0.99390014550595,0,1,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor,MF,
5980,GO:0016709,1,0.793370963693621,0,37,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen,MF,
5981,GO:0016711,1,0.99373000630199,0,1,flavonoid 3'-monooxygenase activity,MF,
5982,GO:0016712,1,0.887539878635853,0,21,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen,MF,
5983,GO:0016713,1,0.982567370932304,0,3,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen,MF,
5984,GO:0016714,1,0.962800046452903,0,7,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen,MF,
5985,GO:0016715,1,0.972272837975495,0,4,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen,MF,
5986,GO:0016716,1,0.993342513253874,0,1,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen,MF,
5987,GO:0016717,1,0.96475139735286,0,5,oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water,MF,
5988,GO:0016721,1,0.979431511421267,0,5,oxidoreductase activity, acting on superoxide radicals as acceptor,MF,
5989,GO:0016722,1,0.892984925166954,0,16,oxidoreductase activity, oxidizing metal ions,MF,
5990,GO:0016723,1,0.93672028289821,0,9,oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor,MF,
5991,GO:0016724,1,0.958919849024868,0,6,oxidoreductase activity, oxidizing metal ions, oxygen as acceptor,MF,
5993,GO:0016726,1,0.983365146709887,0,2,oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor,MF,
5994,GO:0016727,1,0.991308120580807,0,1,oxidoreductase activity, acting on CH or CH2 groups, oxygen as acceptor,MF,
5996,GO:0016730,1,0.995074351707712,0,1,oxidoreductase activity, acting on iron-sulfur proteins as donors,MF,
5997,GO:0016731,1,0.995074351707712,0,1,oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor,MF,
5999,GO:0016741,1,0.283551031456351,0,192,transferase activity, transferring one-carbon groups,MF,
6000,GO:0016742,1,0.948528938740076,0,8,hydroxymethyl-, formyl- and related transferase activity,MF,
6001,GO:0016743,1,0.985656476617247,0,2,carboxyl- or carbamoyltransferase activity,MF,
6002,GO:0016744,1,0.978962063417373,0,4,transferase activity, transferring aldehyde or ketonic groups,MF,
6003,GO:0016746,1,0.237302016431458,0,217,transferase activity, transferring acyl groups,MF,
6004,GO:0016747,1,0.280598719402627,0,192,transferase activity, transferring acyl groups other than amino-acyl groups,MF,
6005,GO:0016748,1,0.9825078887906,0,3,succinyltransferase activity,MF,
6006,GO:0016749,1,0.989061442283946,0,2,N-succinyltransferase activity,MF,
6007,GO:0016751,1,0.993374693996666,0,1,S-succinyltransferase activity,MF,
6008,GO:0016755,1,0.922876805141944,0,13,transferase activity, transferring amino-acyl groups,MF,
6010,GO:0016758,1,0.329509603478364,0,168,transferase activity, transferring hexosyl groups,MF,
6011,GO:0016763,1,0.762503166416372,0,42,transferase activity, transferring pentosyl groups,MF,
6012,GO:0016765,1,0.761083987137225,0,51,transferase activity, transferring alkyl or aryl (other than methyl) groups,MF,
6013,GO:0016768,1,0.995457874490136,0,1,spermine synthase activity,MF,
6017,GO:0016774,1,0.986946711682724,0,2,phosphotransferase activity, carboxyl group as acceptor,MF,
6018,GO:0016775,1,0.965443656064461,0,7,phosphotransferase activity, nitrogenous group as acceptor,MF,
6020,GO:0016778,1,0.97214073217279,0,5,diphosphotransferase activity,MF,
6021,GO:0016779,1,0.501197646503329,0,110,nucleotidyltransferase activity,MF,
6022,GO:0016780,1,0.893826372759039,0,18,phosphotransferase activity, for other substituted phosphate groups,MF,
6023,GO:0016781,1,0.988137761316966,0,2,phosphotransferase activity, paired acceptors,MF,
6025,GO:0016783,1,0.953686704335964,0,10,sulfurtransferase activity,MF,
6026,GO:0016784,1,0.995831605285646,0,1,3-mercaptopyruvate sulfurtransferase activity,MF,
6027,GO:0016785,1,0.991395665866644,0,1,transferase activity, transferring selenium-containing groups,MF,
6030,GO:0016790,1,0.8126346575314,0,37,thiolester hydrolase activity,MF,
6032,GO:0016793,1,0.993029393211783,0,1,triphosphoric monoester hydrolase activity,MF,
6033,GO:0016794,1,0.996478243032291,0,1,diphosphoric monoester hydrolase activity,MF,
6034,GO:0016796,1,0.68753599291301,0,57,exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,MF,
6037,GO:0016801,1,0.941713077237731,0,11,hydrolase activity, acting on ether bonds,MF,
6038,GO:0016802,1,0.994301690373698,0,1,trialkylsulfonium hydrolase activity,MF,
6039,GO:0016803,1,0.9471129482824,0,10,ether hydrolase activity,MF,
6040,GO:0016805,1,0.912885052922241,0,15,dipeptidase activity,MF,
6041,GO:0016810,1,0.523301643384593,0,108,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds,MF,
6042,GO:0016811,1,0.692903779727987,0,62,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides,MF,
6043,GO:0016812,1,0.960814287214491,0,6,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides,MF,
6044,GO:0016813,1,0.943726921834621,0,10,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines,MF,
6045,GO:0016814,1,0.833927215713385,0,30,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines,MF,
6046,GO:0016815,1,0.996007670282858,0,1,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in nitriles,MF,
6049,GO:0016822,1,0.987209101042578,0,3,hydrolase activity, acting on acid carbon-carbon bonds,MF,
6050,GO:0016823,1,0.987209101042578,0,3,hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances,MF,
6051,GO:0016826,1,0.993485400251684,0,1,hydrolase activity, acting on acid sulfur-nitrogen bonds,MF,
6053,GO:0016830,1,0.767753338034116,0,45,carbon-carbon lyase activity,MF,
6054,GO:0016831,1,0.832481628503582,0,31,carboxy-lyase activity,MF,
6055,GO:0016832,1,0.947692578224678,0,9,aldehyde-lyase activity,MF,
6056,GO:0016833,1,0.963614611718586,0,6,oxo-acid-lyase activity,MF,
6058,GO:0016836,1,0.738444323863843,0,54,hydro-lyase activity,MF,
6060,GO:0016840,1,0.93437485674762,0,13,carbon-nitrogen lyase activity,MF,
6061,GO:0016841,1,0.973921653935708,0,5,ammonia-lyase activity,MF,
6062,GO:0016842,1,0.965698127000362,0,7,amidine-lyase activity,MF,
6063,GO:0016843,1,0.993485400251684,0,1,amine-lyase activity,MF,
6064,GO:0016844,1,0.993485400251684,0,1,strictosidine synthase activity,MF,
6065,GO:0016846,1,0.958940539297201,0,10,carbon-sulfur lyase activity,MF,
6068,GO:0016854,1,0.918229493617928,0,14,racemase and epimerase activity,MF,
6069,GO:0016855,1,0.993951530489555,0,1,racemase and epimerase activity, acting on amino acids and derivatives,MF,
6070,GO:0016857,1,0.939336439957416,0,9,racemase and epimerase activity, acting on carbohydrates and derivatives,MF,
6071,GO:0016859,1,0.843379502302956,0,33,cis-trans isomerase activity,MF,
6072,GO:0016860,1,0.785518760014887,0,44,intramolecular oxidoreductase activity,MF,
6073,GO:0016861,1,0.96056529163932,0,8,intramolecular oxidoreductase activity, interconverting aldoses and ketoses,MF,
6074,GO:0016862,1,0.988971946978189,0,3,intramolecular oxidoreductase activity, interconverting keto- and enol-groups,MF,
6075,GO:0016863,1,0.948927948374031,0,11,intramolecular oxidoreductase activity, transposing C=C bonds,MF,
6076,GO:0016864,1,0.903578616904312,0,16,intramolecular oxidoreductase activity, transposing S-S bonds,MF,
6077,GO:0016866,1,0.866255609260574,0,25,intramolecular transferase activity,MF,
6078,GO:0016868,1,0.94511315904266,0,10,intramolecular transferase activity, phosphotransferases,MF,
6079,GO:0016872,1,0.994357704239947,0,1,intramolecular lyase activity,MF,
6080,GO:0016874,1,0.459231599213278,0,118,ligase activity,MF,
6081,GO:0016875,1,0.874506419677539,0,22,ligase activity, forming carbon-oxygen bonds,MF,
6082,GO:0016877,1,0.785835719927777,0,37,ligase activity, forming carbon-sulfur bonds,MF,
6083,GO:0016878,1,0.840506072270546,0,27,acid-thiol ligase activity,MF,
6084,GO:0016879,1,0.747932411095055,0,43,ligase activity, forming carbon-nitrogen bonds,MF,
6085,GO:0016880,1,0.985952817151318,0,2,acid-ammonia (or amide) ligase activity,MF,
6086,GO:0016881,1,0.889394979407139,0,18,acid-amino acid ligase activity,MF,
6087,GO:0016882,1,0.989586248665296,0,2,cyclo-ligase activity,MF,
6088,GO:0016884,1,0.934479065728192,0,10,carbon-nitrogen ligase activity, with glutamine as amido-N-donor,MF,
6089,GO:0016885,1,0.957419099521823,0,6,ligase activity, forming carbon-carbon bonds,MF,
6090,GO:0016886,1,0.966034704258036,0,5,ligase activity, forming phosphoric ester bonds,MF,
6092,GO:0016888,1,0.897581846211074,0,16,endodeoxyribonuclease activity, producing 5'-phosphomonoesters,MF,
6093,GO:0016889,1,0.954345037745796,0,8,endodeoxyribonuclease activity, producing 3'-phosphomonoesters,MF,
6094,GO:0016890,1,0.98821285414692,0,2,site-specific endodeoxyribonuclease activity, specific for altered base,MF,
6095,GO:0016891,1,0.846282497370049,0,28,endoribonuclease activity, producing 5'-phosphomonoesters,MF,
6096,GO:0016892,1,0.974664225453309,0,6,endoribonuclease activity, producing 3'-phosphomonoesters,MF,
6097,GO:0016893,1,0.784018378117237,0,40,endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,MF,
6098,GO:0016894,1,0.930154785649629,0,14,endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters,MF,
6099,GO:0016895,1,0.875844794298704,0,22,exodeoxyribonuclease activity, producing 5'-phosphomonoesters,MF,
6100,GO:0016896,1,0.777391733861029,0,37,exoribonuclease activity, producing 5'-phosphomonoesters,MF,
6101,GO:0016898,1,0.994801167887543,0,1,oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor,MF,
6102,GO:0016899,1,0.97494071905516,0,4,oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor,MF,
6103,GO:0016900,1,0.99296572539545,0,2,oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor,MF,
6104,GO:0016901,1,0.984550374393721,0,2,oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor,MF,
6105,GO:0016903,1,0.779962782134092,0,39,oxidoreductase activity, acting on the aldehyde or oxo group of donors,MF,
6108,GO:0016918,1,0.938516022965996,0,13,retinal binding,MF,
6109,GO:0016920,1,0.990133562464487,0,1,pyroglutamyl-peptidase activity,MF,
6110,GO:0016922,1,0.497190645902855,0,96,nuclear receptor binding,MF,
6111,GO:0016925,1,0.59914948990296,0,74,protein sumoylation,BP,
6112,GO:0016926,1,0.946432163816937,0,7,protein desumoylation,BP,
6113,GO:0016929,1,0.946432163816937,0,7,SUMO-specific protease activity,MF,
6114,GO:0016933,1,0.974377365438157,0,4,extracellularly glycine-gated ion channel activity,MF,
6115,GO:0016934,1,0.974377365438157,0,4,extracellularly glycine-gated chloride channel activity,MF,
6116,GO:0016935,1,0.985994919054154,0,2,glycine-gated chloride channel complex,CC,
6117,GO:0016936,1,0.967793233931837,0,8,galactoside binding,MF,
6118,GO:0016938,1,0.993256583915454,0,1,kinesin I complex,CC,
6119,GO:0016939,1,0.97523925258104,0,3,kinesin II complex,CC,
6120,GO:0016941,1,0.979202062613719,0,3,natriuretic peptide receptor activity,MF,
6121,GO:0016942,1,0.966314153073627,0,5,insulin-like growth factor binding protein complex,CC,
6122,GO:0016964,1,0.9840305255831,0,1,alpha-2 macroglobulin receptor activity,MF,
6123,GO:0016971,1,0.979785433655261,0,3,flavin-linked sulfhydryl oxidase activity,MF,
6124,GO:0016972,1,0.972092128567302,0,4,thiol oxidase activity,MF,
6125,GO:0016973,1,0.899229050092491,0,18,poly(A)+ mRNA export from nucleus,BP,
6126,GO:0016979,1,0.995930602882816,0,1,lipoate-protein ligase activity,MF,
6127,GO:0016992,1,0.99548914444974,0,1,lipoate synthase activity,MF,
6128,GO:0016997,1,0.98255002844889,0,3,alpha-sialidase activity,MF,
6129,GO:0016998,1,0.996547690611412,0,1,cell wall macromolecule catabolic process,BP,
6130,GO:0016999,1,0.987379628465621,0,2,antibiotic metabolic process,BP,
6131,GO:0017002,1,0.920212279954764,0,9,activin-activated receptor activity,MF,
6132,GO:0017003,1,0.994309392451989,0,1,protein-heme linkage,BP,
6133,GO:0017004,1,0.815852425794547,0,35,cytochrome complex assembly,BP,
6134,GO:0017005,1,0.992773273326414,0,1,3'-tyrosyl-DNA phosphodiesterase activity,MF,
6135,GO:0017006,1,0.994309392451989,0,1,protein-tetrapyrrole linkage,BP,
6136,GO:0017014,1,0.909673246113459,0,14,protein nitrosylation,BP,
6137,GO:0017015,1,0.429289182444466,0,115,regulation of transforming growth factor beta receptor signaling pathway,BP,
6140,GO:0017018,1,0.965655533170479,0,4,myosin phosphatase activity,MF,
6141,GO:0017020,1,0.978745776737411,0,3,myosin phosphatase regulator activity,MF,
6142,GO:0017022,1,0.624631493506193,0,67,myosin binding,MF,
6143,GO:0017024,1,0.996676468549678,0,1,myosin I binding,MF,
6144,GO:0017025,1,0.856099000436658,0,26,TBP-class protein binding,MF,
6145,GO:0017034,1,0.958726511067185,0,5,Rap guanyl-nucleotide exchange factor activity,MF,
6146,GO:0017038,1,0.281620733718396,0,182,protein import,BP,
6147,GO:0017040,1,0.971062971267595,0,5,N-acylsphingosine amidohydrolase activity,MF,
6148,GO:0017041,1,0.995919463972863,0,1,galactosylgalactosylglucosylceramidase activity,MF,
6149,GO:0017042,1,0.995473093091466,0,1,glycosylceramidase activity,MF,
6150,GO:0017045,1,0.996142236560983,0,1,corticotropin-releasing hormone activity,MF,
6151,GO:0017046,1,0.751616963764692,0,44,peptide hormone binding,MF,
6153,GO:0017049,1,0.872298392875112,0,20,GTP-Rho binding,MF,
6154,GO:0017050,1,0.981766538195843,0,3,D-erythro-sphingosine kinase activity,MF,
6155,GO:0017053,1,0.576395851092696,0,73,transcription repressor complex,CC,
6156,GO:0017054,1,0.989577725003482,0,2,negative cofactor 2 complex,CC,
6157,GO:0017055,1,0.986984487561288,0,2,negative regulation of RNA polymerase II transcription preinitiation complex assembly,BP,
6158,GO:0017056,1,0.84844931775852,0,23,structural constituent of nuclear pore,MF,
6159,GO:0017057,1,0.984962155624382,0,2,6-phosphogluconolactonase activity,MF,
6160,GO:0017059,1,0.951162598145237,0,8,serine C-palmitoyltransferase complex,CC,
6161,GO:0017060,1,0.989389632141995,0,2,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity,MF,
6162,GO:0017061,1,0.985556183045848,0,2,S-methyl-5-thioadenosine phosphorylase activity,MF,
6163,GO:0017062,1,0.942334491795444,0,10,respiratory chain complex III assembly,BP,
6164,GO:0017064,1,0.984846208989022,0,3,fatty acid amide hydrolase activity,MF,
6165,GO:0017065,1,0.99567432657727,0,1,single-strand selective uracil DNA N-glycosylase activity,MF,
6166,GO:0017069,1,0.785231668726106,0,42,snRNA binding,MF,
6167,GO:0017070,1,0.924286419847895,0,14,U6 snRNA binding,MF,
6168,GO:0017071,1,0.99276810985334,0,1,intracellular cyclic nucleotide activated cation channel complex,CC,
6171,GO:0017077,1,0.989787646678406,0,2,oxidative phosphorylation uncoupler activity,MF,
6173,GO:0017081,1,0.900692118034392,0,15,chloride channel regulator activity,MF,
6174,GO:0017083,1,0.95406433901542,0,6,4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activity,MF,
6175,GO:0017085,1,0.925836689891372,0,11,response to insecticide,BP,
6176,GO:0017089,1,0.989121363957628,0,2,glycolipid transfer activity,MF,
6177,GO:0017090,1,0.993272601741903,0,1,meprin A complex,CC,
6178,GO:0017091,1,0.843275881843853,0,26,AU-rich element binding,MF,
6179,GO:0017095,1,0.974703741298118,0,3,heparan sulfate 6-O-sulfotransferase activity,MF,
6180,GO:0017098,1,0.993837575347301,0,1,sulfonylurea receptor binding,MF,
6181,GO:0017099,1,0.981041233999743,0,3,very-long-chain-acyl-CoA dehydrogenase activity,MF,
6182,GO:0017101,1,0.986796054803132,0,3,aminoacyl-tRNA synthetase multienzyme complex,CC,
6183,GO:0017108,1,0.94586598003967,0,8,5'-flap endonuclease activity,MF,
6184,GO:0017109,1,0.985919454616231,0,2,glutamate-cysteine ligase complex,CC,
6185,GO:0017110,1,0.942816001462107,0,10,nucleoside-diphosphatase activity,MF,
6187,GO:0017112,1,0.776224509912093,0,32,Rab guanyl-nucleotide exchange factor activity,MF,
6188,GO:0017113,1,0.99308891600688,0,1,dihydropyrimidine dehydrogenase (NADP+) activity,MF,
6189,GO:0017116,1,0.888690925482637,0,18,single-stranded DNA helicase activity,MF,
6190,GO:0017118,1,0.995930602882816,0,1,lipoyltransferase activity,MF,
6191,GO:0017119,1,0.917604607895368,0,13,Golgi transport complex,CC,
6192,GO:0017121,1,0.901850331817895,0,15,plasma membrane phospholipid scrambling,BP,
6193,GO:0017122,1,0.991543159178868,0,1,protein N-acetylglucosaminyltransferase complex,CC,
6195,GO:0017125,1,0.992152951499353,0,1,deoxycytidyl transferase activity,MF,
6196,GO:0017126,1,0.988170579637,0,2,nucleologenesis,BP,
6197,GO:0017128,1,0.946990101889083,0,8,phospholipid scramblase activity,MF,
6198,GO:0017129,1,0.988154517270257,0,2,triglyceride binding,MF,
6199,GO:0017130,1,0.990356648416623,0,1,poly(C) RNA binding,MF,
6200,GO:0017134,1,0.861645963285735,0,21,fibroblast growth factor binding,MF,
6201,GO:0017136,1,0.902977476932131,0,15,NAD-dependent histone deacetylase activity,MF,
6203,GO:0017143,1,0.987401106736364,0,2,insecticide metabolic process,BP,
6204,GO:0017144,1,0.817703543000969,0,33,drug metabolic process,BP,
6209,GO:0017150,1,0.978511296206146,0,4,tRNA dihydrouridine synthase activity,MF,
6210,GO:0017151,1,0.945289935863859,0,8,DEAD/H-box RNA helicase binding,MF,
6211,GO:0017153,1,0.953562909510278,0,6,sodium:dicarboxylate symporter activity,MF,
6212,GO:0017154,1,0.893469059852629,0,12,semaphorin receptor activity,MF,
6216,GO:0017159,1,0.983075585269142,0,3,pantetheine hydrolase activity,MF,
6217,GO:0017160,1,0.896028517224529,0,15,Ral GTPase binding,MF,
6218,GO:0017162,1,0.936652435333922,0,9,aryl hydrocarbon receptor binding,MF,
6219,GO:0017166,1,0.908596638873911,0,11,vinculin binding,MF,
6220,GO:0017168,1,0.992602043899798,0,1,5-oxoprolinase (ATP-hydrolyzing) activity,MF,
6221,GO:0017169,1,0.963013029095975,0,7,CDP-alcohol phosphatidyltransferase activity,MF,
6223,GO:0017172,1,0.995600599169637,0,1,cysteine dioxygenase activity,MF,
6224,GO:0017174,1,0.996442349698947,0,1,glycine N-methyltransferase activity,MF,
6225,GO:0017176,1,0.971035492539962,0,6,phosphatidylinositol N-acetylglucosaminyltransferase activity,MF,
6226,GO:0017177,1,0.987050016301257,0,2,glucosidase II complex,CC,
6227,GO:0017178,1,0.993485400251684,0,1,diphthine-ammonia ligase activity,MF,
6228,GO:0017182,1,0.95787416544366,0,7,peptidyl-diphthamide metabolic process,BP,
6229,GO:0017183,1,0.95787416544366,0,7,peptidyl-diphthamide biosynthetic process from peptidyl-histidine,BP,
6230,GO:0017185,1,0.947146662590008,0,8,peptidyl-lysine hydroxylation,BP,
6231,GO:0017186,1,0.99001500555391,0,2,peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase,BP,
6232,GO:0017187,1,0.986066066767333,0,3,peptidyl-glutamic acid carboxylation,BP,
6233,GO:0017188,1,0.991200913211015,0,1,aspartate N-acetyltransferase activity,MF,
6234,GO:0017196,1,0.954689508941907,0,7,N-terminal peptidyl-methionine acetylation,BP,
6235,GO:0017198,1,0.992472035501039,0,2,N-terminal peptidyl-serine acetylation,BP,
6236,GO:0018002,1,0.992472035501039,0,2,N-terminal peptidyl-glutamic acid acetylation,BP,
6237,GO:0018008,1,0.98405641985005,0,2,N-terminal peptidyl-glycine N-myristoylation,BP,
6238,GO:0018009,1,0.994606530520041,0,1,N-terminal peptidyl-L-cysteine N-palmitoylation,BP,
6239,GO:0018011,1,0.993485400251684,0,1,N-terminal peptidyl-alanine methylation,BP,
6240,GO:0018012,1,0.993485400251684,0,1,N-terminal peptidyl-alanine trimethylation,BP,
6241,GO:0018013,1,0.993485400251684,0,1,N-terminal peptidyl-glycine methylation,BP,
6242,GO:0018016,1,0.993485400251684,0,1,N-terminal peptidyl-proline dimethylation,BP,
6243,GO:0018021,1,0.988070887338356,0,2,peptidyl-histidine methylation,BP,
6244,GO:0018022,1,0.446023912839006,0,106,peptidyl-lysine methylation,BP,
6245,GO:0018023,1,0.730825975103696,0,41,peptidyl-lysine trimethylation,BP,
6246,GO:0018024,1,0.736876220279332,0,39,histone-lysine N-methyltransferase activity,MF,
6247,GO:0018025,1,0.993485400251684,0,1,calmodulin-lysine N-methyltransferase activity,MF,
6248,GO:0018026,1,0.950908273633899,0,7,peptidyl-lysine monomethylation,BP,
6249,GO:0018027,1,0.862546731511977,0,20,peptidyl-lysine dimethylation,BP,
6250,GO:0018032,1,0.99273603595309,0,1,protein amidation,BP,
6251,GO:0018057,1,0.965843842345706,0,5,peptidyl-lysine oxidation,BP,
6252,GO:0018063,1,0.994309392451989,0,1,cytochrome c-heme linkage,BP,
6253,GO:0018064,1,0.988070887338356,0,2,protein-histidine N-methyltransferase activity,MF,
6254,GO:0018076,1,0.961000413349335,0,4,N-terminal peptidyl-lysine acetylation,BP,
6255,GO:0018094,1,0.987425689828189,0,2,protein polyglycylation,BP,
6256,GO:0018095,1,0.930726840069926,0,11,protein polyglutamylation,BP,
6257,GO:0018101,1,0.972737880113778,0,4,protein citrullination,BP,
6258,GO:0018103,1,0.964286402162829,0,5,protein C-linked glycosylation,BP,
6260,GO:0018106,1,0.996885377699883,0,1,peptidyl-histidine phosphorylation,BP,
6263,GO:0018114,1,0.993951530489555,0,1,threonine racemase activity,MF,
6264,GO:0018117,1,0.995536036961095,0,1,protein adenylylation,BP,
6265,GO:0018119,1,0.909673246113459,0,14,peptidyl-cysteine S-nitrosylation,BP,
6266,GO:0018120,1,0.99173340162477,0,2,peptidyl-arginine ADP-ribosylation,BP,
6267,GO:0018125,1,0.983804136774016,0,3,peptidyl-cysteine methylation,BP,
6268,GO:0018126,1,0.846996576862027,0,25,protein hydroxylation,BP,
6270,GO:0018142,1,0.993485400251684,0,1,protein-DNA covalent cross-linking,BP,
6271,GO:0018143,1,0.993485400251684,0,1,nucleic acid-protein covalent cross-linking,BP,
6272,GO:0018146,1,0.838022271954773,0,26,keratan sulfate biosynthetic process,BP,
6273,GO:0018149,1,0.827963936014385,0,27,peptide cross-linking,BP,
6274,GO:0018153,1,0.987962955643361,0,2,isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine,BP,
6275,GO:0018158,1,0.923222578654523,0,14,protein oxidation,BP,
6276,GO:0018160,1,0.995840564142091,0,1,peptidyl-pyrromethane cofactor linkage,BP,
6277,GO:0018166,1,0.991822954314478,0,1,C-terminal protein-tyrosinylation,BP,
6278,GO:0018171,1,0.980357386925441,0,4,peptidyl-cysteine oxidation,BP,
6279,GO:0018175,1,0.995536036961095,0,1,protein nucleotidylation,BP,
6280,GO:0018192,1,0.993998291325329,0,1,enzyme active site formation via cysteine modification to L-cysteine persulfide,BP,
6282,GO:0018194,1,0.993485400251684,0,1,peptidyl-alanine modification,BP,
6283,GO:0018195,1,0.874249901554189,0,23,peptidyl-arginine modification,BP,
6284,GO:0018196,1,0.838213370755474,0,30,peptidyl-asparagine modification,BP,
6285,GO:0018197,1,0.975867719556359,0,3,peptidyl-aspartic acid modification,BP,
6286,GO:0018198,1,0.744186889676741,0,47,peptidyl-cysteine modification,BP,
6287,GO:0018199,1,0.978096960810979,0,4,peptidyl-glutamine modification,BP,
6288,GO:0018200,1,0.851835374403024,0,26,peptidyl-glutamic acid modification,BP,
6289,GO:0018201,1,0.973850186400239,0,4,peptidyl-glycine modification,BP,
6290,GO:0018202,1,0.934317814982026,0,11,peptidyl-histidine modification,BP,
6291,GO:0018205,1,0.0787796093079982,0,359,peptidyl-lysine modification,BP,
6292,GO:0018206,1,0.928977265953782,0,12,peptidyl-methionine modification,BP,
6293,GO:0018208,1,0.751217392697214,0,49,peptidyl-proline modification,BP,
6296,GO:0018211,1,0.964286402162829,0,5,peptidyl-tryptophan modification,BP,
6298,GO:0018214,1,0.986066066767333,0,3,protein carboxylation,BP,
6299,GO:0018216,1,0.917973822339797,0,14,peptidyl-arginine methylation,BP,
6300,GO:0018217,1,0.992615277517046,0,1,peptidyl-aspartic acid phosphorylation,BP,
6301,GO:0018230,1,0.861781358844125,0,23,peptidyl-L-cysteine S-palmitoylation,BP,
6302,GO:0018231,1,0.861781358844125,0,23,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine,BP,
6303,GO:0018242,1,0.94207582140067,0,8,protein O-linked glycosylation via serine,BP,
6304,GO:0018243,1,0.93677524431255,0,9,protein O-linked glycosylation via threonine,BP,
6305,GO:0018262,1,0.984128836735374,0,3,isopeptide cross-linking,BP,
6306,GO:0018271,1,0.991069117274906,0,1,biotin-protein ligase activity,MF,
6307,GO:0018272,1,0.995364425768994,0,1,protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine,BP,
6308,GO:0018276,1,0.996119637507407,0,1,isopeptide cross-linking via N6-glycyl-L-lysine,BP,
6309,GO:0018277,1,0.994166471560936,0,1,protein deamination,BP,
6310,GO:0018279,1,0.846453989964429,0,29,protein N-linked glycosylation via asparagine,BP,
6311,GO:0018282,1,0.984255268705037,0,2,metal incorporation into metallo-sulfur cluster,BP,
6312,GO:0018283,1,0.984255268705037,0,2,iron incorporation into metallo-sulfur cluster,BP,
6313,GO:0018293,1,0.996245933595951,0,1,protein-FAD linkage,BP,
6314,GO:0018298,1,0.955642281588243,0,8,protein-chromophore linkage,BP,
6315,GO:0018307,1,0.990643537531887,0,2,enzyme active site formation,BP,
6316,GO:0018312,1,0.987766301201381,0,2,peptidyl-serine ADP-ribosylation,BP,
6317,GO:0018315,1,0.9924770361683,0,1,molybdenum incorporation into molybdenum-molybdopterin complex,BP,
6318,GO:0018317,1,0.964286402162829,0,5,protein C-linked glycosylation via tryptophan,BP,
6319,GO:0018322,1,0.991822954314478,0,1,protein tyrosinylation,BP,
6320,GO:0018323,1,0.996625193861694,0,1,enzyme active site formation via L-cysteine sulfinic acid,BP,
6321,GO:0018335,1,0.972013745602573,0,4,protein succinylation,BP,
6322,GO:0018342,1,0.932874242294015,0,10,protein prenylation,BP,
6323,GO:0018343,1,0.982581288460664,0,3,protein farnesylation,BP,
6324,GO:0018344,1,0.957059056832963,0,7,protein geranylgeranylation,BP,
6325,GO:0018345,1,0.798993496769368,0,35,protein palmitoylation,BP,
6326,GO:0018350,1,0.994115901968501,0,1,protein esterification,BP,
6327,GO:0018352,1,0.989544569889857,0,2,protein-pyridoxal-5-phosphate linkage,BP,
6328,GO:0018364,1,0.968829874326259,0,5,peptidyl-glutamine methylation,BP,
6329,GO:0018377,1,0.967394573368551,0,4,protein myristoylation,BP,
6330,GO:0018393,1,0.345049180158721,0,152,internal peptidyl-lysine acetylation,BP,
6331,GO:0018394,1,0.325627067409818,0,160,peptidyl-lysine acetylation,BP,
6332,GO:0018395,1,0.992783259455901,0,1,peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine,BP,
6333,GO:0018400,1,0.990508720235897,0,1,peptidyl-proline hydroxylation to 3-hydroxy-L-proline,BP,
6334,GO:0018401,1,0.946614341819506,0,9,peptidyl-proline hydroxylation to 4-hydroxy-L-proline,BP,
6335,GO:0018406,1,0.964286402162829,0,5,protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan,BP,
6336,GO:0018410,1,0.917126242627648,0,13,C-terminal protein amino acid modification,BP,
6337,GO:0018423,1,0.996117370092005,0,1,protein C-terminal leucine carboxyl O-methyltransferase activity,MF,
6338,GO:0018424,1,0.992616677084315,0,1,peptidyl-glutamic acid poly-ADP-ribosylation,BP,
6339,GO:0018444,1,0.976393167375759,0,3,translation release factor complex,CC,
6340,GO:0018455,1,0.968999365863015,0,6,alcohol dehydrogenase [NAD(P)+] activity,MF,
6341,GO:0018467,1,0.993671760050592,0,1,formaldehyde dehydrogenase activity,MF,
6342,GO:0018477,1,0.993418572436684,0,1,benzaldehyde dehydrogenase (NADP+) activity,MF,
6343,GO:0018478,1,0.994510013234754,0,1,malonate-semialdehyde dehydrogenase (acetylating) activity,MF,
6344,GO:0018479,1,0.983475359334732,0,3,benzaldehyde dehydrogenase (NAD+) activity,MF,
6345,GO:0018549,1,0.995425456396488,0,1,methanethiol oxidase activity,MF,
6346,GO:0018585,1,0.994554276687147,0,1,fluorene oxygenase activity,MF,
6347,GO:0018601,1,0.995497146143176,0,1,4-nitrophenol 2-monooxygenase activity,MF,
6348,GO:0018636,1,0.98804325966514,0,3,phenanthrene 9,10-monooxygenase activity,MF,
6349,GO:0018685,1,0.995385479573933,0,1,alkane 1-monooxygenase activity,MF,
6350,GO:0018729,1,0.995151336053254,0,1,propionate CoA-transferase activity,MF,
6351,GO:0018733,1,0.996264879771627,0,1,3,4-dihydrocoumarin hydrolase activity,MF,
6352,GO:0018738,1,0.996260516059963,0,1,S-formylglutathione hydrolase activity,MF,
6353,GO:0018773,1,0.995481126780028,0,1,acetylpyruvate hydrolase activity,MF,
6354,GO:0018812,1,0.974192639685168,0,4,3-hydroxyacyl-CoA dehydratase activity,MF,
6355,GO:0018858,1,0.988029361899968,0,2,benzoate-CoA ligase activity,MF,
6356,GO:0018871,1,0.994806103234431,0,1,1-aminocyclopropane-1-carboxylate metabolic process,BP,
6357,GO:0018872,1,0.986113193849322,0,2,arsonoacetate metabolic process,BP,
6358,GO:0018874,1,0.99475869813706,0,1,benzoate metabolic process,BP,
6359,GO:0018879,1,0.988220179668693,0,2,biphenyl metabolic process,BP,
6360,GO:0018885,1,0.995497146143176,0,1,carbon tetrachloride metabolic process,BP,
6361,GO:0018894,1,0.987401106736364,0,2,dibenzo-p-dioxin metabolic process,BP,
6362,GO:0018904,1,0.859518224632213,0,24,ether metabolic process,BP,
6363,GO:0018910,1,0.995497146143176,0,1,benzene metabolic process,BP,
6364,GO:0018916,1,0.981088477467176,0,4,nitrobenzene metabolic process,BP,
6365,GO:0018917,1,0.994554276687147,0,1,fluorene metabolic process,BP,
6366,GO:0018931,1,0.995946459027794,0,1,naphthalene metabolic process,BP,
6367,GO:0018958,1,0.517483075120444,0,98,phenol-containing compound metabolic process,BP,
6368,GO:0018960,1,0.995497146143176,0,1,4-nitrophenol metabolic process,BP,
6369,GO:0018963,1,0.988721583482505,0,2,phthalate metabolic process,BP,
6370,GO:0018964,1,0.992471180299752,0,1,propylene metabolic process,BP,
6371,GO:0018969,1,0.99331972847616,0,1,thiocyanate metabolic process,BP,
6372,GO:0018992,1,0.984304394873449,0,2,germ-line sex determination,BP,
6373,GO:0018993,1,0.986511821093867,0,2,somatic sex determination,BP,
6376,GO:0019002,1,0.979951553130876,0,3,GMP binding,MF,
6377,GO:0019003,1,0.651898303515703,0,72,GDP binding,MF,
6378,GO:0019005,1,0.688772080264078,0,59,SCF ubiquitin ligase complex,CC,
6379,GO:0019008,1,0.988478700515722,0,2,molybdopterin synthase complex,CC,
6380,GO:0019034,1,0.97740687678143,0,3,viral replication complex,CC,
6382,GO:0019042,1,0.930916230198531,0,11,viral latency,BP,
6383,GO:0019043,1,0.950153975136596,0,9,establishment of viral latency,BP,
6384,GO:0019045,1,0.97976326212372,0,2,latent virus replication,BP,
6385,GO:0019046,1,0.97976326212372,0,2,release from viral latency,BP,
6386,GO:0019048,1,0.820549586641837,0,27,modulation by virus of host process,BP,
6387,GO:0019049,1,0.985406149117982,0,2,mitigation of host defenses by virus,BP,
6388,GO:0019050,1,0.983971782276571,0,3,suppression by virus of host apoptotic process,BP,
6389,GO:0019054,1,0.885729214984118,0,18,modulation by virus of host cellular process,BP,
6390,GO:0019056,1,0.993347388179072,0,1,modulation by virus of host transcription,BP,
6392,GO:0019060,1,0.992100490019366,0,2,intracellular transport of viral protein in host cell,BP,
6393,GO:0019061,1,0.994334478263746,0,1,uncoating of virus,BP,
6394,GO:0019062,1,0.953944546615563,0,7,virion attachment to host cell,BP,
6395,GO:0019064,1,0.964460916660393,0,6,fusion of virus membrane with host plasma membrane,BP,
6396,GO:0019065,1,0.946937639822054,0,7,receptor-mediated endocytosis of virus by host cell,BP,
6397,GO:0019068,1,0.789799210783457,0,40,virion assembly,BP,
6398,GO:0019072,1,0.983549599205235,0,2,viral genome packaging,BP,
6399,GO:0019074,1,0.983549599205235,0,2,viral RNA genome packaging,BP,
6400,GO:0019075,1,0.98701281886265,0,2,virus maturation,BP,
6401,GO:0019076,1,0.807470085696356,0,32,viral release from host cell,BP,
6403,GO:0019080,1,0.371572929088055,0,187,viral gene expression,BP,
6404,GO:0019081,1,0.911031493757185,0,14,viral translation,BP,
6405,GO:0019082,1,0.98132218023881,0,3,viral protein processing,BP,
6406,GO:0019083,1,0.412785489738508,0,171,viral transcription,BP,
6407,GO:0019085,1,0.98530541163113,0,2,early viral transcription,BP,
6408,GO:0019086,1,0.97634375948635,0,4,late viral transcription,BP,
6409,GO:0019087,1,0.983002427736553,0,2,transformation of host cell by virus,BP,
6410,GO:0019098,1,0.822427934182219,0,28,reproductive behavior,BP,
6411,GO:0019100,1,0.984304394873449,0,2,male germ-line sex determination,BP,
6412,GO:0019101,1,0.99330216760911,0,1,female somatic sex determination,BP,
6413,GO:0019102,1,0.993164323925024,0,1,male somatic sex determination,BP,
6414,GO:0019103,1,0.964902164255842,0,6,pyrimidine nucleotide binding,MF,
6415,GO:0019104,1,0.937946493167275,0,13,DNA N-glycosylase activity,MF,
6416,GO:0019107,1,0.96996662619179,0,5,myristoyltransferase activity,MF,
6417,GO:0019115,1,0.978471053655259,0,4,benzaldehyde dehydrogenase [NAD(P)+] activity,MF,
6418,GO:0019118,1,0.996007670282858,0,1,phenanthrene-epoxide hydrolase activity,MF,
6419,GO:0019119,1,0.996007670282858,0,1,phenanthrene-9,10-epoxide hydrolase activity,MF,
6420,GO:0019135,1,0.98798417972145,0,2,deoxyhypusine monooxygenase activity,MF,
6421,GO:0019136,1,0.977973347791923,0,4,deoxynucleoside kinase activity,MF,
6422,GO:0019144,1,0.991991372955657,0,2,ADP-sugar diphosphatase activity,MF,
6423,GO:0019145,1,0.993905421826104,0,1,aminobutyraldehyde dehydrogenase activity,MF,
6424,GO:0019150,1,0.994757710028952,0,1,D-ribulokinase activity,MF,
6425,GO:0019153,1,0.995624755771993,0,1,protein-disulfide reductase (glutathione) activity,MF,
6426,GO:0019158,1,0.963044627848834,0,5,mannokinase activity,MF,
6427,GO:0019166,1,0.984977726767777,0,3,trans-2-enoyl-CoA reductase (NADPH) activity,MF,
6428,GO:0019171,1,0.988938770380431,0,1,3-hydroxyacyl-[acyl-carrier-protein] dehydratase activity,MF,
6429,GO:0019184,1,0.900474722892591,0,17,nonribosomal peptide biosynthetic process,BP,
6430,GO:0019185,1,0.97912021077087,0,3,snRNA-activating protein complex,CC,
6431,GO:0019187,1,0.992644923063749,0,1,beta-1,4-mannosyltransferase activity,MF,
6432,GO:0019198,1,0.8568516748817,0,17,transmembrane receptor protein phosphatase activity,MF,
6433,GO:0019199,1,0.533800571864451,0,78,transmembrane receptor protein kinase activity,MF,
6434,GO:0019200,1,0.870873684988353,0,21,carbohydrate kinase activity,MF,
6435,GO:0019202,1,0.986388592278304,0,2,amino acid kinase activity,MF,
6436,GO:0019203,1,0.950958610243454,0,8,carbohydrate phosphatase activity,MF,
6438,GO:0019206,1,0.952920914601501,0,9,nucleoside kinase activity,MF,
6442,GO:0019210,1,0.677907186224597,0,62,kinase inhibitor activity,MF,
6443,GO:0019211,1,0.904554917991279,0,15,phosphatase activator activity,MF,
6445,GO:0019213,1,0.768287041718871,0,39,deacetylase activity,MF,
6446,GO:0019215,1,0.909349632096077,0,14,intermediate filament binding,MF,
6449,GO:0019218,1,0.488497564912125,0,109,regulation of steroid metabolic process,BP,
6454,GO:0019226,1,0.604205193918811,0,68,transmission of nerve impulse,BP,
6455,GO:0019227,1,0.94225224883136,0,8,neuronal action potential propagation,BP,
6456,GO:0019228,1,0.756015542794421,0,34,neuronal action potential,BP,
6458,GO:0019230,1,0.965508524830398,0,5,proprioception,BP,
6460,GO:0019236,1,0.981643996891234,0,4,response to pheromone,BP,
6461,GO:0019237,1,0.956842131567673,0,6,centromeric DNA binding,MF,
6462,GO:0019238,1,0.971411897443111,0,5,cyclohydrolase activity,MF,
6463,GO:0019239,1,0.854933857216669,0,26,deaminase activity,MF,
6464,GO:0019240,1,0.959097530490756,0,5,citrulline biosynthetic process,BP,
6465,GO:0019242,1,0.995855178946836,0,1,methylglyoxal biosynthetic process,BP,
6466,GO:0019243,1,0.988927636408563,0,2,methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione,BP,
6467,GO:0019244,1,0.99616768517679,0,1,lactate biosynthetic process from pyruvate,BP,
6468,GO:0019249,1,0.983637147805709,0,3,lactate biosynthetic process,BP,
6469,GO:0019254,1,0.981178494167589,0,3,carnitine metabolic process, CoA-linked,BP,
6470,GO:0019255,1,0.989493291113682,0,2,glucose 1-phosphate metabolic process,BP,
6471,GO:0019262,1,0.972032387305661,0,6,N-acetylneuraminate catabolic process,BP,
6472,GO:0019264,1,0.988423017874078,0,2,glycine biosynthetic process from serine,BP,
6473,GO:0019265,1,0.995616145417115,0,1,glycine biosynthetic process, by transamination of glyoxylate,BP,
6474,GO:0019276,1,0.986040162008856,0,2,UDP-N-acetylgalactosamine metabolic process,BP,
6475,GO:0019284,1,0.984200188783053,0,3,L-methionine salvage from S-adenosylmethionine,BP,
6476,GO:0019285,1,0.98563558986136,0,2,glycine betaine biosynthetic process from choline,BP,
6477,GO:0019287,1,0.986163611373472,0,3,isopentenyl diphosphate biosynthetic process, mevalonate pathway,BP,
6478,GO:0019290,1,0.993288385648692,0,1,siderophore biosynthetic process,BP,
6479,GO:0019303,1,0.992513082379438,0,2,D-ribose catabolic process,BP,
6480,GO:0019317,1,0.938685719831507,0,8,fucose catabolic process,BP,
6481,GO:0019318,1,0.217909486462934,0,226,hexose metabolic process,BP,
6482,GO:0019319,1,0.605321369684655,0,79,hexose biosynthetic process,BP,
6483,GO:0019320,1,0.722599246676606,0,50,hexose catabolic process,BP,
6484,GO:0019321,1,0.931896597705976,0,14,pentose metabolic process,BP,
6485,GO:0019322,1,0.980186686371916,0,4,pentose biosynthetic process,BP,
6486,GO:0019323,1,0.976181726036265,0,5,pentose catabolic process,BP,
6487,GO:0019336,1,0.932315249634369,0,11,phenol-containing compound catabolic process,BP,
6488,GO:0019341,1,0.99373000630199,0,1,dibenzo-p-dioxin catabolic process,BP,
6489,GO:0019343,1,0.989134676422618,0,2,cysteine biosynthetic process via cystathionine,BP,
6490,GO:0019344,1,0.98335924864736,0,3,cysteine biosynthetic process,BP,
6491,GO:0019346,1,0.981427558693829,0,4,transsulfuration,BP,
6492,GO:0019348,1,0.97281984154312,0,5,dolichol metabolic process,BP,
6493,GO:0019359,1,0.844367869298944,0,28,nicotinamide nucleotide biosynthetic process,BP,
6494,GO:0019362,1,0.828618880636905,0,31,pyridine nucleotide metabolic process,BP,
6495,GO:0019363,1,0.844367869298944,0,28,pyridine nucleotide biosynthetic process,BP,
6496,GO:0019364,1,0.974359523429541,0,4,pyridine nucleotide catabolic process,BP,
6497,GO:0019365,1,0.993485400251684,0,1,pyridine nucleotide salvage,BP,
6498,GO:0019367,1,0.961072995080493,0,6,fatty acid elongation, saturated fatty acid,BP,
6499,GO:0019368,1,0.961072995080493,0,6,fatty acid elongation, unsaturated fatty acid,BP,
6500,GO:0019369,1,0.765898975981522,0,46,arachidonic acid metabolic process,BP,
6501,GO:0019370,1,0.939715708776051,0,12,leukotriene biosynthetic process,BP,
6502,GO:0019371,1,0.942615836767321,0,11,cyclooxygenase pathway,BP,
6503,GO:0019372,1,0.918876644346213,0,16,lipoxygenase pathway,BP,
6504,GO:0019373,1,0.941516718224295,0,11,epoxygenase P450 pathway,BP,
6505,GO:0019374,1,0.948361639095648,0,9,galactolipid metabolic process,BP,
6506,GO:0019375,1,0.965479897483713,0,6,galactolipid biosynthetic process,BP,
6507,GO:0019376,1,0.982275866128831,0,3,galactolipid catabolic process,BP,
6508,GO:0019377,1,0.913754048462168,0,15,glycolipid catabolic process,BP,
6509,GO:0019388,1,0.952370853805845,0,8,galactose catabolic process,BP,
6510,GO:0019389,1,0.987992906677829,0,2,glucuronoside metabolic process,BP,
6511,GO:0019391,1,0.987992906677829,0,2,glucuronoside catabolic process,BP,
6513,GO:0019400,1,0.883476608545339,0,19,alditol metabolic process,BP,
6514,GO:0019401,1,0.960621856680217,0,7,alditol biosynthetic process,BP,
6515,GO:0019402,1,0.996009226819508,0,1,galactitol metabolic process,BP,
6516,GO:0019405,1,0.961621934652444,0,5,alditol catabolic process,BP,
6517,GO:0019406,1,0.995946459027794,0,1,hexitol biosynthetic process,BP,
6518,GO:0019407,1,0.993865211361605,0,1,hexitol catabolic process,BP,
6519,GO:0019408,1,0.985808421525535,0,2,dolichol biosynthetic process,BP,
6520,GO:0019413,1,0.985609782595801,0,2,acetate biosynthetic process,BP,
6521,GO:0019417,1,0.985529566409249,0,2,sulfur oxidation,BP,
6522,GO:0019418,1,0.983064735014131,0,4,sulfide oxidation,BP,
6523,GO:0019427,1,0.985609782595801,0,2,acetyl-CoA biosynthetic process from acetate,BP,
6524,GO:0019430,1,0.880928000574643,0,23,removal of superoxide radicals,BP,
6525,GO:0019432,1,0.809788130709358,0,31,triglyceride biosynthetic process,BP,
6528,GO:0019439,1,0.032569986947771,0,569,aromatic compound catabolic process,BP,
6529,GO:0019441,1,0.982492123853737,0,4,tryptophan catabolic process to kynurenine,BP,
6530,GO:0019442,1,0.991276168539519,0,2,tryptophan catabolic process to acetyl-CoA,BP,
6531,GO:0019448,1,0.978704026600772,0,4,L-cysteine catabolic process,BP,
6532,GO:0019449,1,0.993577168431364,0,1,L-cysteine catabolic process to hypotaurine,BP,
6533,GO:0019452,1,0.993577168431364,0,1,L-cysteine catabolic process to taurine,BP,
6534,GO:0019464,1,0.983298336378784,0,3,glycine decarboxylation via glycine cleavage system,BP,
6535,GO:0019470,1,0.975154589353326,0,4,4-hydroxyproline catabolic process,BP,
6536,GO:0019471,1,0.975154589353326,0,4,4-hydroxyproline metabolic process,BP,
6537,GO:0019474,1,0.973325119194182,0,4,L-lysine catabolic process to acetyl-CoA,BP,
6538,GO:0019477,1,0.973325119194182,0,4,L-lysine catabolic process,BP,
6539,GO:0019478,1,0.991227188293017,0,2,D-amino acid catabolic process,BP,
6540,GO:0019482,1,0.975481578980834,0,4,beta-alanine metabolic process,BP,
6541,GO:0019483,1,0.987859921040106,0,2,beta-alanine biosynthetic process,BP,
6542,GO:0019493,1,0.994909511305389,0,1,arginine catabolic process to proline,BP,
6543,GO:0019509,1,0.971941747913543,0,5,L-methionine salvage from methylthioadenosine,BP,
6544,GO:0019510,1,0.994301690373698,0,1,S-adenosylhomocysteine catabolic process,BP,
6545,GO:0019511,1,0.913130241071248,0,14,peptidyl-proline hydroxylation,BP,
6546,GO:0019516,1,0.99616768517679,0,1,lactate oxidation,BP,
6547,GO:0019518,1,0.987264803794523,0,3,L-threonine catabolic process to glycine,BP,
6548,GO:0019519,1,0.993865211361605,0,1,pentitol metabolic process,BP,
6549,GO:0019520,1,0.988502672481922,0,2,aldonic acid metabolic process,BP,
6550,GO:0019521,1,0.988502672481922,0,2,D-gluconate metabolic process,BP,
6551,GO:0019527,1,0.993865211361605,0,1,pentitol catabolic process,BP,
6552,GO:0019530,1,0.954528658540324,0,7,taurine metabolic process,BP,
6553,GO:0019531,1,0.941290066155387,0,8,oxalate transmembrane transporter activity,MF,
6554,GO:0019532,1,0.937161092630692,0,9,oxalate transport,BP,
6555,GO:0019534,1,0.950582397232165,0,7,toxin transmembrane transporter activity,MF,
6557,GO:0019541,1,0.974354095952518,0,4,propionate metabolic process,BP,
6558,GO:0019542,1,0.985609782595801,0,2,propionate biosynthetic process,BP,
6559,GO:0019543,1,0.988581622702898,0,2,propionate catabolic process,BP,
6560,GO:0019544,1,0.994909511305389,0,1,arginine catabolic process to glutamate,BP,
6561,GO:0019547,1,0.990804604655692,0,2,arginine catabolic process to ornithine,BP,
6562,GO:0019550,1,0.988652247700137,0,2,glutamate catabolic process to aspartate,BP,
6563,GO:0019551,1,0.988652247700137,0,2,glutamate catabolic process to 2-oxoglutarate,BP,
6564,GO:0019556,1,0.975869498680549,0,4,histidine catabolic process to glutamate and formamide,BP,
6565,GO:0019557,1,0.975869498680549,0,4,histidine catabolic process to glutamate and formate,BP,
6566,GO:0019563,1,0.967559659576276,0,4,glycerol catabolic process,BP,
6567,GO:0019566,1,0.98701281886265,0,2,arabinose metabolic process,BP,
6568,GO:0019585,1,0.955762979249496,0,8,glucuronate metabolic process,BP,
6569,GO:0019605,1,0.989814233934827,0,2,butyrate metabolic process,BP,
6570,GO:0019606,1,0.99550779028936,0,1,2-oxobutyrate catabolic process,BP,
6571,GO:0019614,1,0.949998771566984,0,8,catechol-containing compound catabolic process,BP,
6572,GO:0019626,1,0.956931244335929,0,8,short-chain fatty acid catabolic process,BP,
6573,GO:0019627,1,0.93720424845033,0,12,urea metabolic process,BP,
6575,GO:0019640,1,0.975234285249958,0,5,glucuronate catabolic process to xylulose 5-phosphate,BP,
6576,GO:0019646,1,0.937940471118693,0,16,aerobic electron transport chain,BP,
6577,GO:0019659,1,0.986422572574789,0,2,glucose catabolic process to lactate,BP,
6578,GO:0019660,1,0.986422572574789,0,2,glycolytic fermentation,BP,
6579,GO:0019661,1,0.986422572574789,0,2,glucose catabolic process to lactate via pyruvate,BP,
6580,GO:0019673,1,0.973614126286571,0,6,GDP-mannose metabolic process,BP,
6582,GO:0019676,1,0.987040076203154,0,2,ammonia assimilation cycle,BP,
6583,GO:0019677,1,0.979587863090325,0,3,NAD catabolic process,BP,
6584,GO:0019682,1,0.963069162442214,0,7,glyceraldehyde-3-phosphate metabolic process,BP,
6585,GO:0019692,1,0.851864601905724,0,31,deoxyribose phosphate metabolic process,BP,
6587,GO:0019694,1,0.954528658540324,0,7,alkanesulfonate metabolic process,BP,
6588,GO:0019695,1,0.939777085691115,0,9,choline metabolic process,BP,
6589,GO:0019706,1,0.833580898628453,0,28,protein-cysteine S-palmitoyltransferase activity,MF,
6590,GO:0019707,1,0.833580898628453,0,28,protein-cysteine S-acyltransferase activity,MF,
6591,GO:0019720,1,0.963161630110255,0,6,Mo-molybdopterin cofactor metabolic process,BP,
6593,GO:0019724,1,0.529130038797839,0,105,B cell mediated immunity,BP,
6595,GO:0019730,1,0.716842154489742,0,78,antimicrobial humoral response,BP,
6596,GO:0019731,1,0.889556891048651,0,28,antibacterial humoral response,BP,
6597,GO:0019732,1,0.981543304313665,0,4,antifungal humoral response,BP,
6598,GO:0019740,1,0.976668713249481,0,4,nitrogen utilization,BP,
6599,GO:0019742,1,0.99408526275215,0,1,pentacyclic triterpenoid metabolic process,BP,
6600,GO:0019747,1,0.979129598984026,0,4,regulation of isoprenoid metabolic process,BP,
6601,GO:0019748,1,0.726747652403074,0,51,secondary metabolic process,BP,
6602,GO:0019751,1,0.469972267429592,0,111,polyol metabolic process,BP,
6605,GO:0019763,1,0.97749063995455,0,5,immunoglobulin receptor activity,MF,
6606,GO:0019767,1,0.997055085107326,0,1,IgE receptor activity,MF,
6607,GO:0019770,1,0.995611833164541,0,1,IgG receptor activity,MF,
6608,GO:0019772,1,0.995611833164541,0,1,low-affinity IgG receptor activity,MF,
6609,GO:0019773,1,0.974904626312812,0,7,proteasome core complex, alpha-subunit complex,CC,
6610,GO:0019774,1,0.96898181496523,0,9,proteasome core complex, beta-subunit complex,CC,
6611,GO:0019776,1,0.996184060311513,0,1,Atg8 ligase activity,MF,
6612,GO:0019777,1,0.990383834074222,0,2,Atg12 transferase activity,MF,
6613,GO:0019778,1,0.99197597420295,0,1,Atg12 activating enzyme activity,MF,
6614,GO:0019779,1,0.99197597420295,0,1,Atg8 activating enzyme activity,MF,
6615,GO:0019780,1,0.990664587957033,0,1,FAT10 activating enzyme activity,MF,
6616,GO:0019781,1,0.989894596006989,0,2,NEDD8 activating enzyme activity,MF,
6617,GO:0019782,1,0.992938463275816,0,1,ISG15 activating enzyme activity,MF,
6618,GO:0019783,1,0.893939756597206,0,17,ubiquitin-like protein-specific protease activity,MF,
6619,GO:0019784,1,0.964989623109243,0,7,NEDD8-specific protease activity,MF,
6620,GO:0019785,1,0.992581052002283,0,1,ISG15-specific protease activity,MF,
6622,GO:0019788,1,0.969475539901629,0,6,NEDD8 transferase activity,MF,
6623,GO:0019789,1,0.886925518551699,0,17,SUMO transferase activity,MF,
6624,GO:0019797,1,0.980581987539661,0,3,procollagen-proline 3-dioxygenase activity,MF,
6625,GO:0019798,1,0.95185652014464,0,8,procollagen-proline dioxygenase activity,MF,
6626,GO:0019799,1,0.993485400251684,0,1,tubulin N-acetyltransferase activity,MF,
6627,GO:0019800,1,0.962824112143419,0,6,peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan,BP,
6628,GO:0019805,1,0.980190756813201,0,4,quinolinate biosynthetic process,BP,
6629,GO:0019806,1,0.990346651867284,0,1,bromide peroxidase activity,MF,
6630,GO:0019807,1,0.995974833712362,0,1,aspartoacylase activity,MF,
6631,GO:0019808,1,0.985999238466469,0,3,polyamine binding,MF,
6632,GO:0019809,1,0.992967882676955,0,2,spermidine binding,MF,
6633,GO:0019810,1,0.992982499157848,0,1,putrescine binding,MF,
6634,GO:0019811,1,0.992303149335604,0,1,cocaine binding,MF,
6635,GO:0019814,1,0.971176655014034,0,6,immunoglobulin complex,CC,
6636,GO:0019815,1,0.980734806476695,0,4,B cell receptor complex,CC,
6637,GO:0019825,1,0.863845152035419,0,29,oxygen binding,MF,
6638,GO:0019826,1,0.977493965722004,0,3,oxygen sensor activity,MF,
6640,GO:0019828,1,0.963393235921184,0,6,aspartic-type endopeptidase inhibitor activity,MF,
6642,GO:0019834,1,0.987132837104621,0,3,phospholipase A2 inhibitor activity,MF,
6643,GO:0019835,1,0.907431774288974,0,19,cytolysis,BP,
6645,GO:0019840,1,0.864788208100864,0,26,isoprenoid binding,MF,
6646,GO:0019841,1,0.949380929349708,0,11,retinol binding,MF,
6648,GO:0019843,1,0.764928042888233,0,57,rRNA binding,MF,
6649,GO:0019852,1,0.937802349081674,0,11,L-ascorbic acid metabolic process,BP,
6650,GO:0019853,1,0.990869267515888,0,2,L-ascorbic acid biosynthetic process,BP,
6651,GO:0019855,1,0.951464103026142,0,9,calcium channel inhibitor activity,MF,
6652,GO:0019856,1,0.93960385700077,0,8,pyrimidine nucleobase biosynthetic process,BP,
6653,GO:0019857,1,0.963589965592405,0,3,5-methylcytosine metabolic process,BP,
6654,GO:0019858,1,0.989364478290208,0,2,cytosine metabolic process,BP,
6655,GO:0019859,1,0.982326596368101,0,3,thymine metabolic process,BP,
6656,GO:0019860,1,0.98344984648523,0,3,uracil metabolic process,BP,
6657,GO:0019862,1,0.995676024762336,0,1,IgA binding,MF,
6658,GO:0019863,1,0.984971151442686,0,4,IgE binding,MF,
6659,GO:0019864,1,0.958518245707737,0,9,IgG binding,MF,
6660,GO:0019865,1,0.908339376409448,0,18,immunoglobulin binding,MF,
6661,GO:0019866,1,0.0856366313994711,0,460,organelle inner membrane,CC,
6663,GO:0019869,1,0.929776939081967,0,10,chloride channel inhibitor activity,MF,
6664,GO:0019870,1,0.929576825166038,0,9,potassium channel inhibitor activity,MF,
6665,GO:0019871,1,0.945767602040615,0,8,sodium channel inhibitor activity,MF,
6666,GO:0019878,1,0.984603195233279,0,2,lysine biosynthetic process via aminoadipic acid,BP,
6668,GO:0019883,1,0.881128185778581,0,22,antigen processing and presentation of endogenous antigen,BP,
6670,GO:0019885,1,0.912373949889906,0,16,antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
6674,GO:0019894,1,0.739944207012195,0,40,kinesin binding,MF,
6675,GO:0019896,1,0.911563155567167,0,13,axonal transport of mitochondrion,BP,
6681,GO:0019902,1,0.25698653500793,0,188,phosphatase binding,MF,
6682,GO:0019903,1,0.361647866732452,0,143,protein phosphatase binding,MF,
6685,GO:0019907,1,0.987776055244066,0,3,cyclin-dependent protein kinase activating kinase holoenzyme complex,CC,
6686,GO:0019908,1,0.926675831286864,0,12,nuclear cyclin-dependent protein kinase holoenzyme complex,CC,
6687,GO:0019911,1,0.944134535111518,0,10,structural constituent of myelin sheath,MF,
6688,GO:0019912,1,0.99447567045752,0,1,cyclin-dependent protein kinase activating kinase activity,MF,
6689,GO:0019915,1,0.609800370532999,0,73,lipid storage,BP,
6690,GO:0019918,1,0.97531469525887,0,4,peptidyl-arginine methylation, to symmetrical-dimethyl arginine,BP,
6691,GO:0019919,1,0.971840475643314,0,5,peptidyl-arginine methylation, to asymmetrical-dimethyl arginine,BP,
6697,GO:0019948,1,0.98764125690761,0,2,SUMO activating enzyme activity,MF,
6699,GO:0019955,1,0.447586796421218,0,123,cytokine binding,MF,
6700,GO:0019956,1,0.820207257865174,0,32,chemokine binding,MF,
6701,GO:0019957,1,0.878679676422547,0,23,C-C chemokine binding,MF,
6702,GO:0019958,1,0.961606721701746,0,6,C-X-C chemokine binding,MF,
6703,GO:0019959,1,0.979780110616497,0,3,interleukin-8 binding,MF,
6704,GO:0019960,1,0.959706261607523,0,5,C-X3-C chemokine binding,MF,
6705,GO:0019961,1,0.983918690132299,0,2,interferon binding,MF,
6706,GO:0019962,1,0.99099632162095,0,1,type I interferon binding,MF,
6707,GO:0019964,1,0.992858707685603,0,1,interferon-gamma binding,MF,
6708,GO:0019966,1,0.956293366152922,0,7,interleukin-1 binding,MF,
6709,GO:0019969,1,0.992739503907205,0,1,interleukin-10 binding,MF,
6710,GO:0019970,1,0.981119870888854,0,3,interleukin-11 binding,MF,
6711,GO:0019972,1,0.995890670052125,0,1,interleukin-12 binding,MF,
6712,GO:0019975,1,0.995890670052125,0,1,interleukin-17 binding,MF,
6713,GO:0019976,1,0.981450098904205,0,3,interleukin-2 binding,MF,
6714,GO:0019981,1,0.985634702558487,0,2,interleukin-6 binding,MF,
6715,GO:0019985,1,0.780646153142385,0,39,translesion synthesis,BP,
6716,GO:0019988,1,0.993513844472955,0,1,charged-tRNA amino acid modification,BP,
6717,GO:0019992,1,0.910653485802233,0,12,diacylglycerol binding,MF,
6718,GO:0020003,1,0.984265084013801,0,3,symbiont-containing vacuole,CC,
6719,GO:0020005,1,0.990719827746905,0,2,symbiont-containing vacuole membrane,CC,
6720,GO:0020016,1,0.978166551369693,0,3,ciliary pocket,CC,
6721,GO:0020018,1,0.978166551369693,0,3,ciliary pocket membrane,CC,
6722,GO:0020027,1,0.920755048691946,0,15,hemoglobin metabolic process,BP,
6723,GO:0020037,1,0.520506868537092,0,108,heme binding,MF,
6724,GO:0021501,1,0.994705325851602,0,1,prechordal plate formation,BP,
6725,GO:0021502,1,0.979890550453956,0,3,neural fold elevation formation,BP,
6726,GO:0021503,1,0.988973249814488,0,1,neural fold bending,BP,
6727,GO:0021508,1,0.990400583427858,0,1,floor plate formation,BP,
6728,GO:0021509,1,0.994892806470944,0,1,roof plate formation,BP,
6730,GO:0021511,1,0.846829714050604,0,24,spinal cord patterning,BP,
6731,GO:0021512,1,0.992483429446274,0,1,spinal cord anterior/posterior patterning,BP,
6732,GO:0021513,1,0.864990235236716,0,22,spinal cord dorsal/ventral patterning,BP,
6733,GO:0021514,1,0.892302821450932,0,17,ventral spinal cord interneuron differentiation,BP,
6734,GO:0021515,1,0.698886123943568,0,53,cell differentiation in spinal cord,BP,
6736,GO:0021517,1,0.726562851601598,0,47,ventral spinal cord development,BP,
6737,GO:0021519,1,0.996134718669981,0,1,spinal cord association neuron specification,BP,
6738,GO:0021520,1,0.925649967465916,0,12,spinal cord motor neuron cell fate specification,BP,
6739,GO:0021521,1,0.929772167196724,0,11,ventral spinal cord interneuron specification,BP,
6740,GO:0021522,1,0.795290511486192,0,34,spinal cord motor neuron differentiation,BP,
6741,GO:0021523,1,0.970230641817925,0,5,somatic motor neuron differentiation,BP,
6742,GO:0021524,1,0.98453199785556,0,3,visceral motor neuron differentiation,BP,
6743,GO:0021526,1,0.989282766711304,0,2,medial motor column neuron differentiation,BP,
6744,GO:0021527,1,0.935267389233357,0,11,spinal cord association neuron differentiation,BP,
6745,GO:0021528,1,0.993485400251684,0,1,commissural neuron differentiation in spinal cord,BP,
6746,GO:0021529,1,0.964284397088582,0,5,spinal cord oligodendrocyte cell differentiation,BP,
6747,GO:0021530,1,0.982735019643268,0,3,spinal cord oligodendrocyte cell fate specification,BP,
6748,GO:0021532,1,0.771250986040385,0,38,neural tube patterning,BP,
6749,GO:0021533,1,0.857083660023523,0,20,cell differentiation in hindbrain,BP,
6750,GO:0021534,1,0.902286920459614,0,15,cell proliferation in hindbrain,BP,
6751,GO:0021535,1,0.894089090380731,0,14,cell migration in hindbrain,BP,
6754,GO:0021538,1,0.976015006069518,0,3,epithalamus development,BP,
6755,GO:0021539,1,0.995650474160525,0,1,subthalamus development,BP,
6756,GO:0021540,1,0.955296870108713,0,6,corpus callosum morphogenesis,BP,
6757,GO:0021541,1,0.992501454975043,0,1,ammon gyrus development,BP,
6758,GO:0021542,1,0.894081390938536,0,16,dentate gyrus development,BP,
6760,GO:0021544,1,0.836166850761753,0,24,subpallium development,BP,
6761,GO:0021545,1,0.725571574854619,0,46,cranial nerve development,BP,
6762,GO:0021546,1,0.966535628414155,0,6,rhombomere development,BP,
6763,GO:0021547,1,0.994705325851602,0,1,midbrain-hindbrain boundary initiation,BP,
6764,GO:0021548,1,0.942407479587684,0,9,pons development,BP,
6765,GO:0021549,1,0.502592856440236,0,94,cerebellum development,BP,
6766,GO:0021550,1,0.993962265126325,0,1,medulla oblongata development,BP,
6767,GO:0021551,1,0.986226815696577,0,1,central nervous system morphogenesis,BP,
6768,GO:0021553,1,0.973032875981631,0,3,olfactory nerve development,BP,
6769,GO:0021554,1,0.911219726563144,0,13,optic nerve development,BP,
6770,GO:0021555,1,0.983728006925544,0,3,midbrain-hindbrain boundary morphogenesis,BP,
6771,GO:0021557,1,0.984357420631667,0,3,oculomotor nerve development,BP,
6772,GO:0021558,1,0.99133921462357,0,2,trochlear nerve development,BP,
6773,GO:0021559,1,0.929434515162993,0,11,trigeminal nerve development,BP,
6774,GO:0021560,1,0.986987936709867,0,2,abducens nerve development,BP,
6775,GO:0021561,1,0.929965980277521,0,10,facial nerve development,BP,
6776,GO:0021562,1,0.944257699349549,0,8,vestibulocochlear nerve development,BP,
6777,GO:0021563,1,0.96061005979008,0,5,glossopharyngeal nerve development,BP,
6778,GO:0021564,1,0.975832556388619,0,3,vagus nerve development,BP,
6779,GO:0021566,1,0.992000931569184,0,1,hypoglossal nerve development,BP,
6780,GO:0021568,1,0.991385398472059,0,2,rhombomere 2 development,BP,
6781,GO:0021569,1,0.984381405169976,0,3,rhombomere 3 development,BP,
6782,GO:0021570,1,0.995626475582901,0,1,rhombomere 4 development,BP,
6783,GO:0021571,1,0.986335924732979,0,2,rhombomere 5 development,BP,
6784,GO:0021572,1,0.992924153963669,0,1,rhombomere 6 development,BP,
6785,GO:0021575,1,0.744955516967053,0,39,hindbrain morphogenesis,BP,
6786,GO:0021577,1,0.986435942569728,0,2,hindbrain structural organization,BP,
6787,GO:0021578,1,0.957420383039598,0,6,hindbrain maturation,BP,
6788,GO:0021586,1,0.979258902925911,0,3,pons maturation,BP,
6789,GO:0021587,1,0.757608250239696,0,36,cerebellum morphogenesis,BP,
6790,GO:0021589,1,0.986435942569728,0,2,cerebellum structural organization,BP,
6791,GO:0021590,1,0.977703550151173,0,3,cerebellum maturation,BP,
6793,GO:0021592,1,0.981451562020382,0,2,fourth ventricle development,BP,
6794,GO:0021593,1,0.988706026220421,0,2,rhombomere morphogenesis,BP,
6795,GO:0021594,1,0.993365290703681,0,1,rhombomere formation,BP,
6796,GO:0021595,1,0.993365290703681,0,1,rhombomere structural organization,BP,
6797,GO:0021598,1,0.986987936709867,0,2,abducens nerve morphogenesis,BP,
6798,GO:0021599,1,0.986987936709867,0,2,abducens nerve formation,BP,
6799,GO:0021602,1,0.827620514060396,0,27,cranial nerve morphogenesis,BP,
6800,GO:0021603,1,0.949900855812333,0,8,cranial nerve formation,BP,
6801,GO:0021604,1,0.931452591723799,0,10,cranial nerve structural organization,BP,
6802,GO:0021610,1,0.929965980277521,0,10,facial nerve morphogenesis,BP,
6803,GO:0021612,1,0.943500066616735,0,8,facial nerve structural organization,BP,
6804,GO:0021615,1,0.973230699744167,0,4,glossopharyngeal nerve morphogenesis,BP,
6805,GO:0021618,1,0.992000931569184,0,1,hypoglossal nerve morphogenesis,BP,
6806,GO:0021622,1,0.988442016288435,0,2,oculomotor nerve morphogenesis,BP,
6807,GO:0021623,1,0.988442016288435,0,2,oculomotor nerve formation,BP,
6808,GO:0021626,1,0.95075849345814,0,7,central nervous system maturation,BP,
6809,GO:0021631,1,0.952891901209984,0,6,optic nerve morphogenesis,BP,
6810,GO:0021633,1,0.987238456943737,0,2,optic nerve structural organization,BP,
6811,GO:0021634,1,0.992562811373111,0,1,optic nerve formation,BP,
6812,GO:0021636,1,0.96202924002393,0,5,trigeminal nerve morphogenesis,BP,
6813,GO:0021637,1,0.96202924002393,0,5,trigeminal nerve structural organization,BP,
6814,GO:0021639,1,0.995452489483422,0,1,trochlear nerve morphogenesis,BP,
6815,GO:0021642,1,0.995452489483422,0,1,trochlear nerve formation,BP,
6816,GO:0021644,1,0.988651167581381,0,2,vagus nerve morphogenesis,BP,
6817,GO:0021648,1,0.959688336375771,0,6,vestibulocochlear nerve morphogenesis,BP,
6818,GO:0021649,1,0.985628222084199,0,2,vestibulocochlear nerve structural organization,BP,
6819,GO:0021650,1,0.973685634043099,0,4,vestibulocochlear nerve formation,BP,
6820,GO:0021658,1,0.988706026220421,0,2,rhombomere 3 morphogenesis,BP,
6821,GO:0021659,1,0.993365290703681,0,1,rhombomere 3 structural organization,BP,
6822,GO:0021660,1,0.993365290703681,0,1,rhombomere 3 formation,BP,
6823,GO:0021664,1,0.993365290703681,0,1,rhombomere 5 morphogenesis,BP,
6824,GO:0021665,1,0.993365290703681,0,1,rhombomere 5 structural organization,BP,
6825,GO:0021666,1,0.993365290703681,0,1,rhombomere 5 formation,BP,
6826,GO:0021670,1,0.902151004333763,0,12,lateral ventricle development,BP,
6828,GO:0021678,1,0.968594966469704,0,5,third ventricle development,BP,
6829,GO:0021679,1,0.986147705151045,0,2,cerebellar molecular layer development,BP,
6830,GO:0021680,1,0.824249483142977,0,24,cerebellar Purkinje cell layer development,BP,
6831,GO:0021681,1,0.912901780151137,0,13,cerebellar granular layer development,BP,
6832,GO:0021682,1,0.991351019446412,0,1,nerve maturation,BP,
6833,GO:0021683,1,0.935347439950868,0,9,cerebellar granular layer morphogenesis,BP,
6834,GO:0021684,1,0.9502137702147,0,7,cerebellar granular layer formation,BP,
6835,GO:0021685,1,0.989945921585943,0,1,cerebellar granular layer structural organization,BP,
6836,GO:0021686,1,0.995546578106542,0,1,cerebellar granular layer maturation,BP,
6837,GO:0021687,1,0.986147705151045,0,2,cerebellar molecular layer morphogenesis,BP,
6838,GO:0021688,1,0.992949333626043,0,1,cerebellar molecular layer formation,BP,
6839,GO:0021691,1,0.98207794731012,0,2,cerebellar Purkinje cell layer maturation,BP,
6840,GO:0021692,1,0.887913195706149,0,14,cerebellar Purkinje cell layer morphogenesis,BP,
6841,GO:0021693,1,0.982965441277616,0,2,cerebellar Purkinje cell layer structural organization,BP,
6842,GO:0021694,1,0.912967202691123,0,11,cerebellar Purkinje cell layer formation,BP,
6843,GO:0021695,1,0.715105030962943,0,45,cerebellar cortex development,BP,
6844,GO:0021696,1,0.79376995514461,0,30,cerebellar cortex morphogenesis,BP,
6845,GO:0021697,1,0.844979406815231,0,22,cerebellar cortex formation,BP,
6846,GO:0021698,1,0.982965441277616,0,2,cerebellar cortex structural organization,BP,
6847,GO:0021699,1,0.977703550151173,0,3,cerebellar cortex maturation,BP,
6849,GO:0021702,1,0.912967202691123,0,11,cerebellar Purkinje cell differentiation,BP,
6850,GO:0021703,1,0.995452489483422,0,1,locus ceruleus development,BP,
6851,GO:0021707,1,0.9502137702147,0,7,cerebellar granule cell differentiation,BP,
6852,GO:0021718,1,0.986688494010762,0,2,superior olivary nucleus development,BP,
6853,GO:0021722,1,0.986688494010762,0,2,superior olivary nucleus maturation,BP,
6854,GO:0021730,1,0.982347036917411,0,2,trigeminal sensory nucleus development,BP,
6855,GO:0021740,1,0.982347036917411,0,2,principal sensory nucleus of trigeminal nerve development,BP,
6856,GO:0021747,1,0.976897932239279,0,3,cochlear nucleus development,BP,
6857,GO:0021750,1,0.993962265126325,0,1,vestibular nucleus development,BP,
6858,GO:0021756,1,0.866575031507885,0,18,striatum development,BP,
6859,GO:0021757,1,0.992773273326414,0,1,caudate nucleus development,BP,
6860,GO:0021758,1,0.992773273326414,0,1,putamen development,BP,
6862,GO:0021761,1,0.482734700665655,0,100,limbic system development,BP,
6863,GO:0021762,1,0.782200157384001,0,39,substantia nigra development,BP,
6864,GO:0021764,1,0.954911091868522,0,5,amygdala development,BP,
6865,GO:0021766,1,0.576037248272432,0,75,hippocampus development,BP,
6866,GO:0021767,1,0.988379455155735,0,1,mammillary body development,BP,
6867,GO:0021768,1,0.992842058054592,0,1,nucleus accumbens development,BP,
6868,GO:0021769,1,0.972815344769046,0,4,orbitofrontal cortex development,BP,
6869,GO:0021771,1,0.991335828745202,0,1,lateral geniculate nucleus development,BP,
6870,GO:0021772,1,0.792013467581026,0,31,olfactory bulb development,BP,
6871,GO:0021773,1,0.966150774080353,0,4,striatal medium spiny neuron differentiation,BP,
6872,GO:0021775,1,0.971863062098098,0,3,smoothened signaling pathway involved in ventral spinal cord interneuron specification,BP,
6873,GO:0021776,1,0.971863062098098,0,3,smoothened signaling pathway involved in spinal cord motor neuron cell fate specification,BP,
6874,GO:0021778,1,0.962066058896859,0,5,oligodendrocyte cell fate specification,BP,
6875,GO:0021779,1,0.962066058896859,0,5,oligodendrocyte cell fate commitment,BP,
6876,GO:0021780,1,0.962066058896859,0,5,glial cell fate specification,BP,
6877,GO:0021781,1,0.912083585058432,0,13,glial cell fate commitment,BP,
6878,GO:0021782,1,0.460383175203311,0,113,glial cell development,BP,
6879,GO:0021783,1,0.899666876979085,0,15,preganglionic parasympathetic fiber development,BP,
6880,GO:0021784,1,0.98986384802448,0,2,postganglionic parasympathetic fiber development,BP,
6881,GO:0021785,1,0.94657300508961,0,6,branchiomotor neuron axon guidance,BP,
6882,GO:0021793,1,0.99289280569619,0,1,chemorepulsion of branchiomotor axon,BP,
6883,GO:0021794,1,0.922409314946812,0,12,thalamus development,BP,
6884,GO:0021795,1,0.75382539074672,0,38,cerebral cortex cell migration,BP,
6885,GO:0021796,1,0.958097461516449,0,6,cerebral cortex regionalization,BP,
6886,GO:0021797,1,0.983497324891505,0,3,forebrain anterior/posterior pattern specification,BP,
6887,GO:0021798,1,0.953383967226728,0,7,forebrain dorsal/ventral pattern formation,BP,
6888,GO:0021799,1,0.814968829178673,0,27,cerebral cortex radially oriented cell migration,BP,
6889,GO:0021800,1,0.947058639694655,0,6,cerebral cortex tangential migration,BP,
6890,GO:0021801,1,0.856155564686385,0,20,cerebral cortex radial glia guided migration,BP,
6891,GO:0021806,1,0.995813624427712,0,1,initiation of movement involved in cerebral cortex radial glia guided migration,BP,
6892,GO:0021808,1,0.995813624427712,0,1,cytosolic calcium signaling involved in initiation of cell movement in glial-mediated radial cell migration,BP,
6893,GO:0021812,1,0.985007179306204,0,2,neuronal-glial interaction involved in cerebral cortex radial glia guided migration,BP,
6894,GO:0021813,1,0.993758094628683,0,1,cell-cell adhesion involved in neuronal-glial interactions involved in cerebral cortex radial glia guided migration,BP,
6895,GO:0021814,1,0.960102453676585,0,5,cell motility involved in cerebral cortex radial glia guided migration,BP,
6896,GO:0021815,1,0.97158392673708,0,3,modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration,BP,
6897,GO:0021817,1,0.97158392673708,0,3,nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration,BP,
6898,GO:0021819,1,0.924864251892453,0,10,layer formation in cerebral cortex,BP,
6899,GO:0021823,1,0.981883518248155,0,2,cerebral cortex tangential migration using cell-cell interactions,BP,
6900,GO:0021825,1,0.981883518248155,0,2,substrate-dependent cerebral cortex tangential migration,BP,
6901,GO:0021826,1,0.938739714699194,0,9,substrate-independent telencephalic tangential migration,BP,
6902,GO:0021827,1,0.981883518248155,0,2,postnatal olfactory bulb interneuron migration,BP,
6903,GO:0021828,1,0.977133129279142,0,3,gonadotrophin-releasing hormone neuronal migration to the hypothalamus,BP,
6904,GO:0021830,1,0.938739714699194,0,9,interneuron migration from the subpallium to the cortex,BP,
6905,GO:0021831,1,0.993349835925358,0,1,embryonic olfactory bulb interneuron precursor migration,BP,
6906,GO:0021836,1,0.981883518248155,0,2,chemorepulsion involved in postnatal olfactory bulb interneuron migration,BP,
6907,GO:0021840,1,0.986926745326322,0,2,directional guidance of interneurons involved in migration from the subpallium to the cortex,BP,
6908,GO:0021842,1,0.986926745326322,0,2,chemorepulsion involved in interneuron migration from the subpallium to the cortex,BP,
6909,GO:0021843,1,0.938739714699194,0,9,substrate-independent telencephalic tangential interneuron migration,BP,
6911,GO:0021847,1,0.978319772084951,0,3,ventricular zone neuroblast division,BP,
6912,GO:0021849,1,0.975680329422855,0,3,neuroblast division in subventricular zone,BP,
6913,GO:0021852,1,0.977277838610207,0,3,pyramidal neuron migration,BP,
6914,GO:0021853,1,0.957961629700173,0,6,cerebral cortex GABAergic interneuron migration,BP,
6915,GO:0021854,1,0.89511916491272,0,18,hypothalamus development,BP,
6916,GO:0021855,1,0.977133129279142,0,3,hypothalamus cell migration,BP,
6917,GO:0021856,1,0.977133129279142,0,3,hypothalamic tangential migration using cell-axon interactions,BP,
6920,GO:0021861,1,0.959322838417125,0,7,forebrain radial glial cell differentiation,BP,
6921,GO:0021869,1,0.95862802146615,0,6,forebrain ventricular zone progenitor cell division,BP,
6922,GO:0021870,1,0.991003416536882,0,1,Cajal-Retzius cell differentiation,BP,
6923,GO:0021871,1,0.869720053499883,0,21,forebrain regionalization,BP,
6926,GO:0021877,1,0.931361962162014,0,10,forebrain neuron fate commitment,BP,
6928,GO:0021882,1,0.988646125316627,0,2,regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment,BP,
6930,GO:0021885,1,0.676000764860262,0,53,forebrain cell migration,BP,
6931,GO:0021886,1,0.973790508205412,0,4,hypothalamus gonadotrophin-releasing hormone neuron differentiation,BP,
6932,GO:0021888,1,0.973790508205412,0,4,hypothalamus gonadotrophin-releasing hormone neuron development,BP,
6933,GO:0021889,1,0.913424621726711,0,12,olfactory bulb interneuron differentiation,BP,
6934,GO:0021891,1,0.945358851966816,0,7,olfactory bulb interneuron development,BP,
6935,GO:0021892,1,0.932738900993053,0,11,cerebral cortex GABAergic interneuron differentiation,BP,
6936,GO:0021893,1,0.988646125316627,0,2,cerebral cortex GABAergic interneuron fate commitment,BP,
6937,GO:0021894,1,0.954562691105721,0,7,cerebral cortex GABAergic interneuron development,BP,
6938,GO:0021895,1,0.836171645639881,0,25,cerebral cortex neuron differentiation,BP,
6939,GO:0021896,1,0.977628561199698,0,2,forebrain astrocyte differentiation,BP,
6940,GO:0021897,1,0.977628561199698,0,2,forebrain astrocyte development,BP,
6941,GO:0021898,1,0.988646125316627,0,2,commitment of multipotent stem cells to neuronal lineage in forebrain,BP,
6942,GO:0021902,1,0.94739621258575,0,7,commitment of neuronal cell to specific neuron type in forebrain,BP,
6943,GO:0021903,1,0.936824083584865,0,10,rostrocaudal neural tube patterning,BP,
6944,GO:0021904,1,0.853368912084967,0,23,dorsal/ventral neural tube patterning,BP,
6945,GO:0021905,1,0.990296282249561,0,1,forebrain-midbrain boundary formation,BP,
6946,GO:0021910,1,0.945015032919713,0,7,smoothened signaling pathway involved in ventral spinal cord patterning,BP,
6947,GO:0021912,1,0.98326741911664,0,3,regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification,BP,
6948,GO:0021913,1,0.978502845754055,0,4,regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification,BP,
6949,GO:0021914,1,0.979504287757546,0,3,negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning,BP,
6951,GO:0021917,1,0.990296282249561,0,1,somatic motor neuron fate commitment,BP,
6952,GO:0021918,1,0.990296282249561,0,1,regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment,BP,
6953,GO:0021919,1,0.992822035943251,0,1,BMP signaling pathway involved in spinal cord dorsal/ventral patterning,BP,
6954,GO:0021920,1,0.996134718669981,0,1,regulation of transcription from RNA polymerase II promoter involved in spinal cord association neuron specification,BP,
6955,GO:0021924,1,0.907543287024729,0,14,cell proliferation in external granule layer,BP,
6956,GO:0021930,1,0.907543287024729,0,14,cerebellar granule cell precursor proliferation,BP,
6957,GO:0021932,1,0.927529695322003,0,10,hindbrain radial glia guided cell migration,BP,
6958,GO:0021933,1,0.995546578106542,0,1,radial glia guided migration of cerebellar granule cell,BP,
6959,GO:0021934,1,0.978093960698349,0,2,hindbrain tangential cell migration,BP,
6960,GO:0021935,1,0.978093960698349,0,2,cerebellar granule cell precursor tangential migration,BP,
6961,GO:0021936,1,0.94178056331928,0,9,regulation of cerebellar granule cell precursor proliferation,BP,
6962,GO:0021937,1,0.966794937378114,0,5,cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation,BP,
6963,GO:0021938,1,0.971938653435779,0,4,smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation,BP,
6964,GO:0021940,1,0.953337003307333,0,7,positive regulation of cerebellar granule cell precursor proliferation,BP,
6965,GO:0021941,1,0.987883663725474,0,2,negative regulation of cerebellar granule cell precursor proliferation,BP,
6966,GO:0021942,1,0.969567833637649,0,4,radial glia guided migration of Purkinje cell,BP,
6967,GO:0021943,1,0.967774686757148,0,4,formation of radial glial scaffolds,BP,
6968,GO:0021944,1,0.992936571281498,0,1,neuronal-glial interaction involved in hindbrain glial-mediated radial cell migration,BP,
6969,GO:0021952,1,0.802043829795662,0,26,central nervous system projection neuron axonogenesis,BP,
6972,GO:0021955,1,0.752942406319055,0,35,central nervous system neuron axonogenesis,BP,
6973,GO:0021956,1,0.994879037054919,0,1,central nervous system interneuron axonogenesis,BP,
6974,GO:0021957,1,0.943238850632728,0,7,corticospinal tract morphogenesis,BP,
6975,GO:0021960,1,0.960619360715443,0,5,anterior commissure morphogenesis,BP,
6976,GO:0021965,1,0.970223322107566,0,3,spinal cord ventral commissure morphogenesis,BP,
6977,GO:0021966,1,0.988139547824038,0,2,corticospinal neuron axon guidance,BP,
6978,GO:0021972,1,0.991971119219569,0,1,corticospinal neuron axon guidance through spinal cord,BP,
6979,GO:0021978,1,0.928030769648344,0,12,telencephalon regionalization,BP,
6980,GO:0021979,1,0.953352214751915,0,7,hypothalamus cell differentiation,BP,
6981,GO:0021983,1,0.777995705311374,0,40,pituitary gland development,BP,
6982,GO:0021984,1,0.944108513485509,0,11,adenohypophysis development,BP,
6983,GO:0021985,1,0.986249471958507,0,2,neurohypophysis development,BP,
6984,GO:0021986,1,0.976015006069518,0,3,habenula development,BP,
6986,GO:0021988,1,0.77974391261443,0,33,olfactory lobe development,BP,
6987,GO:0021989,1,0.991552872452267,0,1,olfactory cortex development,BP,
6988,GO:0021993,1,0.991720534304018,0,1,initiation of neural tube closure,BP,
6989,GO:0021997,1,0.980398926267549,0,2,neural plate axis specification,BP,
6990,GO:0021998,1,0.992783259455901,0,1,neural plate mediolateral regionalization,BP,
6991,GO:0021999,1,0.96561422764816,0,5,neural plate anterior/posterior regionalization,BP,
6992,GO:0022007,1,0.97827783130399,0,3,convergent extension involved in neural plate elongation,BP,
6994,GO:0022009,1,0.974288450822829,0,4,central nervous system vasculogenesis,BP,
6995,GO:0022010,1,0.86625999702383,0,21,central nervous system myelination,BP,
6996,GO:0022011,1,0.804340173925328,0,27,myelination in peripheral nervous system,BP,
6997,GO:0022012,1,0.989166318178273,0,1,subpallium cell proliferation in forebrain,BP,
6998,GO:0022013,1,0.988878630687743,0,1,pallium cell proliferation in forebrain,BP,
6999,GO:0022018,1,0.989166318178273,0,1,lateral ganglionic eminence cell proliferation,BP,
7000,GO:0022027,1,0.945237449262421,0,5,interkinetic nuclear migration,BP,
7001,GO:0022028,1,0.956658320702259,0,5,tangential migration from the subventricular zone to the olfactory bulb,BP,
7002,GO:0022029,1,0.69098409588083,0,50,telencephalon cell migration,BP,
7003,GO:0022030,1,0.856155564686385,0,20,telencephalon glial cell migration,BP,
7004,GO:0022037,1,0.476016751715339,0,102,metencephalon development,BP,
7005,GO:0022038,1,0.861142079024011,0,20,corpus callosum development,BP,
7006,GO:0022400,1,0.862455242481629,0,23,regulation of rhodopsin mediated signaling pathway,BP,
7009,GO:0022403,1,0.984638596256118,0,2,cell cycle phase,BP,
7010,GO:0022404,1,0.555871145757534,0,82,molting cycle process,BP,
7011,GO:0022405,1,0.555871145757534,0,82,hair cycle process,BP,
7014,GO:0022408,1,0.353410356489097,0,161,negative regulation of cell-cell adhesion,BP,
7016,GO:0022410,1,0.878911931104048,0,23,circadian sleep/wake cycle process,BP,
7019,GO:0022413,1,0.987515183603508,0,1,reproductive process in single-celled organism,BP,
7021,GO:0022417,1,0.969557639195924,0,7,protein maturation by protein folding,BP,
7026,GO:0022605,1,0.963883073610526,0,6,mammalian oogenesis stage,BP,
7029,GO:0022612,1,0.427895069324161,0,117,gland morphogenesis,BP,
7030,GO:0022613,1,0.0888349731766194,0,404,ribonucleoprotein complex biogenesis,BP,
7031,GO:0022614,1,0.962984211160322,0,5,membrane to membrane docking,BP,
7032,GO:0022615,1,0.979578479484913,0,4,protein to membrane docking,BP,
7033,GO:0022616,1,0.843094444371389,0,25,DNA strand elongation,BP,
7034,GO:0022617,1,0.62827515837237,0,69,extracellular matrix disassembly,BP,
7035,GO:0022618,1,0.341777033987849,0,178,ribonucleoprotein complex assembly,BP,
7036,GO:0022624,1,0.89158594072061,0,24,proteasome accessory complex,CC,
7037,GO:0022625,1,0.824231553674937,0,54,cytosolic large ribosomal subunit,CC,
7038,GO:0022626,1,0.666142401428106,0,103,cytosolic ribosome,CC,
7039,GO:0022627,1,0.838483036659111,0,44,cytosolic small ribosomal subunit,CC,
7042,GO:0022821,1,0.901843039288692,0,14,potassium ion antiporter activity,MF,
7044,GO:0022829,1,0.883454015100561,0,22,wide pore channel activity,MF,
7049,GO:0022839,1,0.765466996212342,0,39,ion gated channel activity,MF,
7054,GO:0022848,1,0.917947047504115,0,14,acetylcholine-gated cation-selective channel activity,MF,
7056,GO:0022850,1,0.989654452355412,0,2,serotonin-gated cation-selective channel activity,MF,
7058,GO:0022852,1,0.985782547481548,0,2,glycine-gated chloride ion channel activity,MF,
7061,GO:0022858,1,0.939451721465865,0,9,alanine transmembrane transporter activity,MF,
7062,GO:0022884,1,0.891071602433399,0,19,macromolecule transmembrane transporter activity,MF,
7063,GO:0022889,1,0.944357538672884,0,9,serine transmembrane transporter activity,MF,
7065,GO:0022894,1,0.994398498066526,0,1,Intermediate conductance calcium-activated potassium channel activity,MF,
7067,GO:0022900,1,0.466929121283747,0,158,electron transport chain,BP,
7068,GO:0022904,1,0.644097297531711,0,98,respiratory electron transport chain,BP,
7070,GO:0023016,1,0.97295828577,0,3,signal transduction by trans-phosphorylation,BP,
7071,GO:0023019,1,0.8876800810296,0,19,signal transduction involved in regulation of gene expression,BP,
7072,GO:0023021,1,0.981891169255511,0,3,termination of signal transduction,BP,
7073,GO:0023023,1,0.880817628655192,0,24,MHC protein complex binding,MF,
7074,GO:0023024,1,0.969741462239753,0,6,MHC class I protein complex binding,MF,
7075,GO:0023025,1,0.979808078709216,0,3,MHC class Ib protein complex binding,MF,
7076,GO:0023026,1,0.920597373228713,0,16,MHC class II protein complex binding,MF,
7077,GO:0023029,1,0.957112662502429,0,7,MHC class Ib protein binding,MF,
7078,GO:0023030,1,0.993032448418951,0,1,MHC class Ib protein binding, via antigen binding groove,MF,
7079,GO:0023035,1,0.915711857185196,0,15,CD40 signaling pathway,BP,
7080,GO:0023041,1,0.960229810614761,0,6,neuronal signal transduction,BP,
7088,GO:0030002,1,0.927542565703833,0,10,cellular anion homeostasis,BP,
7091,GO:0030007,1,0.905462280365589,0,14,cellular potassium ion homeostasis,BP,
7092,GO:0030008,1,0.92546502393447,0,14,TRAPP complex,CC,
7093,GO:0030010,1,0.361225191861387,0,136,establishment of cell polarity,BP,
7094,GO:0030011,1,0.876236513609647,0,18,maintenance of cell polarity,BP,
7095,GO:0030014,1,0.895691809859243,0,15,CCR4-NOT complex,CC,
7096,GO:0030015,1,0.96546149890741,0,5,CCR4-NOT core complex,CC,
7100,GO:0030020,1,0.704219091402549,0,40,extracellular matrix structural constituent conferring tensile strength,MF,
7101,GO:0030021,1,0.886110571817831,0,16,extracellular matrix structural constituent conferring compression resistance,MF,
7102,GO:0030023,1,0.922571623915516,0,9,extracellular matrix constituent conferring elasticity,MF,
7103,GO:0030026,1,0.993003767187949,0,1,cellular manganese ion homeostasis,BP,
7108,GO:0030032,1,0.655314011726007,0,59,lamellipodium assembly,BP,
7109,GO:0030033,1,0.879895591254025,0,17,microvillus assembly,BP,
7110,GO:0030034,1,0.992823509518303,0,1,microvillar actin bundle assembly,BP,
7111,GO:0030035,1,0.969477948073145,0,4,microspike assembly,BP,
7113,GO:0030037,1,0.991976782603323,0,1,actin filament reorganization involved in cell cycle,BP,
7114,GO:0030038,1,0.482187130420957,0,99,contractile actin filament bundle assembly,BP,
7115,GO:0030041,1,0.309516459333484,0,173,actin filament polymerization,BP,
7116,GO:0030042,1,0.673709333108533,0,52,actin filament depolymerization,BP,
7117,GO:0030043,1,0.978195381971485,0,4,actin filament fragmentation,BP,
7119,GO:0030047,1,0.972883550283902,0,4,actin modification,BP,
7120,GO:0030048,1,0.325572579371625,0,140,actin filament-based movement,BP,
7121,GO:0030049,1,0.780576419944083,0,35,muscle filament sliding,BP,
7122,GO:0030050,1,0.848056299399415,0,18,vesicle transport along actin filament,BP,
7125,GO:0030056,1,0.94173116452995,0,5,hemidesmosome,CC,
7126,GO:0030057,1,0.836704005429543,0,22,desmosome,CC,
7127,GO:0030060,1,0.981423039655712,0,4,L-malate dehydrogenase activity,MF,
7128,GO:0030061,1,0.954624003094311,0,7,mitochondrial crista,CC,
7129,GO:0030062,1,0.961521850038258,0,6,mitochondrial tricarboxylic acid cycle enzyme complex,CC,
7130,GO:0030070,1,0.986239793892677,0,2,insulin processing,BP,
7134,GO:0030091,1,0.965427879055401,0,7,protein repair,BP,
7136,GO:0030098,1,0.111728405330257,0,325,lymphocyte differentiation,BP,
7137,GO:0030099,1,0.080695517894527,0,370,myeloid cell differentiation,BP,
7139,GO:0030101,1,0.703608427108969,0,59,natural killer cell activation,BP,
7140,GO:0030103,1,0.990139289102031,0,2,vasopressin secretion,BP,
7142,GO:0030107,1,0.993359695814939,0,1,HLA-A specific inhibitory MHC class I receptor activity,MF,
7143,GO:0030108,1,0.995831605285646,0,1,HLA-A specific activating MHC class I receptor activity,MF,
7144,GO:0030109,1,0.988454891678919,0,2,HLA-B specific inhibitory MHC class I receptor activity,MF,
7146,GO:0030116,1,0.985896987034226,0,4,glial cell-derived neurotrophic factor receptor binding,MF,
7148,GO:0030118,1,0.737656655447537,0,43,clathrin coat,CC,
7149,GO:0030119,1,0.775863911656234,0,37,AP-type membrane coat adaptor complex,CC,
7150,GO:0030120,1,0.706132669225625,0,52,vesicle coat,CC,
7151,GO:0030121,1,0.966880879326636,0,5,AP-1 adaptor complex,CC,
7152,GO:0030122,1,0.931878573853866,0,10,AP-2 adaptor complex,CC,
7153,GO:0030123,1,0.936993638484115,0,9,AP-3 adaptor complex,CC,
7154,GO:0030124,1,0.975529835802879,0,4,AP-4 adaptor complex,CC,
7155,GO:0030125,1,0.836134929236534,0,26,clathrin vesicle coat,CC,
7156,GO:0030126,1,0.931553401690034,0,12,COPI vesicle coat,CC,
7157,GO:0030127,1,0.900180674640555,0,15,COPII vesicle coat,CC,
7158,GO:0030128,1,0.924617181909199,0,11,clathrin coat of endocytic vesicle,CC,
7159,GO:0030130,1,0.927551596997289,0,11,clathrin coat of trans-Golgi network vesicle,CC,
7160,GO:0030131,1,0.860452596224802,0,22,clathrin adaptor complex,CC,
7161,GO:0030132,1,0.899722423084319,0,15,clathrin coat of coated pit,CC,
7163,GO:0030134,1,0.577862322270784,0,88,COPII-coated ER to Golgi transport vesicle,CC,
7166,GO:0030137,1,0.857685190167421,0,26,COPI-coated vesicle,CC,
7170,GO:0030142,1,0.987874704285897,0,1,COPI-coated Golgi to ER transport vesicle,CC,
7171,GO:0030144,1,0.986620213168677,0,2,alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity,MF,
7172,GO:0030145,1,0.665493090902347,0,60,manganese ion binding,MF,
7174,GO:0030149,1,0.835842433899819,0,29,sphingolipid catabolic process,BP,
7175,GO:0030150,1,0.915346344304541,0,17,protein import into mitochondrial matrix,BP,
7176,GO:0030151,1,0.987791020227138,0,2,molybdenum ion binding,MF,
7179,GO:0030156,1,0.996876665376451,0,1,benzodiazepine receptor binding,MF,
7180,GO:0030157,1,0.932575984416362,0,11,pancreatic juice secretion,BP,
7181,GO:0030158,1,0.981135298929048,0,2,protein xylosyltransferase activity,MF,
7182,GO:0030159,1,0.741964952390283,0,41,signaling receptor complex adaptor activity,MF,
7183,GO:0030160,1,0.964126479377739,0,4,synaptic receptor adaptor activity,MF,
7188,GO:0030167,1,0.973799856875167,0,4,proteoglycan catabolic process,BP,
7189,GO:0030168,1,0.360303988808817,0,148,platelet activation,BP,
7190,GO:0030169,1,0.903927052018862,0,14,low-density lipoprotein particle binding,MF,
7192,GO:0030171,1,0.995397331780574,0,1,voltage-gated proton channel activity,MF,
7193,GO:0030172,1,0.989384927634272,0,3,troponin C binding,MF,
7195,GO:0030174,1,0.957428152453846,0,7,regulation of DNA-dependent DNA replication initiation,BP,
7197,GO:0030176,1,0.412654393897779,0,146,integral component of endoplasmic reticulum membrane,CC,
7201,GO:0030183,1,0.466084924192641,0,111,B cell differentiation,BP,
7202,GO:0030184,1,0.993508103168564,0,1,nitric oxide transmembrane transporter activity,MF,
7203,GO:0030185,1,0.985274997174162,0,3,nitric oxide transport,BP,
7204,GO:0030186,1,0.995840564142091,0,1,melatonin metabolic process,BP,
7205,GO:0030187,1,0.995840564142091,0,1,melatonin biosynthetic process,BP,
7206,GO:0030193,1,0.625747996700496,0,74,regulation of blood coagulation,BP,
7207,GO:0030194,1,0.85238030030237,0,25,positive regulation of blood coagulation,BP,
7208,GO:0030195,1,0.763421519228392,0,44,negative regulation of blood coagulation,BP,
7209,GO:0030197,1,0.985920131641073,0,2,extracellular matrix constituent, lubricant activity,MF,
7212,GO:0030200,1,0.981675919699231,0,3,heparan sulfate proteoglycan catabolic process,BP,
7213,GO:0030201,1,0.786486070193083,0,32,heparan sulfate proteoglycan metabolic process,BP,
7214,GO:0030202,1,0.926260738770895,0,10,heparin metabolic process,BP,
7217,GO:0030205,1,0.907504516137373,0,13,dermatan sulfate metabolic process,BP,
7219,GO:0030207,1,0.906911402365617,0,14,chondroitin sulfate catabolic process,BP,
7220,GO:0030208,1,0.912535038099107,0,12,dermatan sulfate biosynthetic process,BP,
7221,GO:0030209,1,0.994492341035676,0,1,dermatan sulfate catabolic process,BP,
7222,GO:0030210,1,0.931394177515915,0,9,heparin biosynthetic process,BP,
7223,GO:0030211,1,0.994492341035676,0,1,heparin catabolic process,BP,
7224,GO:0030212,1,0.791198886682272,0,35,hyaluronan metabolic process,BP,
7225,GO:0030213,1,0.908086603492952,0,14,hyaluronan biosynthetic process,BP,
7226,GO:0030214,1,0.914362701891266,0,14,hyaluronan catabolic process,BP,
7227,GO:0030215,1,0.832064188192311,0,23,semaphorin receptor binding,MF,
7228,GO:0030216,1,0.39443260389125,0,140,keratinocyte differentiation,BP,
7229,GO:0030217,1,0.208770637472235,0,233,T cell differentiation,BP,
7230,GO:0030218,1,0.464849101198687,0,113,erythrocyte differentiation,BP,
7231,GO:0030219,1,0.613141045728968,0,69,megakaryocyte differentiation,BP,
7232,GO:0030220,1,0.860360181931726,0,20,platelet formation,BP,
7233,GO:0030221,1,0.987814830784317,0,2,basophil differentiation,BP,
7234,GO:0030222,1,0.981627924526955,0,3,eosinophil differentiation,BP,
7235,GO:0030223,1,0.946994459564417,0,8,neutrophil differentiation,BP,
7236,GO:0030224,1,0.792009623482069,0,34,monocyte differentiation,BP,
7237,GO:0030225,1,0.776767744618398,0,41,macrophage differentiation,BP,
7238,GO:0030226,1,0.96218705908312,0,3,apolipoprotein receptor activity,MF,
7239,GO:0030228,1,0.88210525083726,0,15,lipoprotein particle receptor activity,MF,
7240,GO:0030229,1,0.970823661046334,0,4,very-low-density lipoprotein particle receptor activity,MF,
7241,GO:0030233,1,0.995544823186114,0,1,deoxynucleotide transmembrane transporter activity,MF,
7243,GO:0030235,1,0.948728509147685,0,7,nitric-oxide synthase regulator activity,MF,
7244,GO:0030237,1,0.986012111275205,0,2,female sex determination,BP,
7245,GO:0030238,1,0.909316107619822,0,14,male sex determination,BP,
7246,GO:0030239,1,0.611648792648642,0,63,myofibril assembly,BP,
7247,GO:0030240,1,0.940717531935307,0,6,skeletal muscle thin filament assembly,BP,
7248,GO:0030241,1,0.95592359410678,0,3,skeletal muscle myosin thick filament assembly,BP,
7249,GO:0030242,1,0.962258382316782,0,5,autophagy of peroxisome,BP,
7251,GO:0030247,1,0.867049314519175,0,23,polysaccharide binding,MF,
7252,GO:0030249,1,0.980152957470587,0,4,guanylate cyclase regulator activity,MF,
7253,GO:0030250,1,0.985772897805684,0,3,guanylate cyclase activator activity,MF,
7254,GO:0030251,1,0.994299766113736,0,1,guanylate cyclase inhibitor activity,MF,
7255,GO:0030252,1,0.909767119253934,0,14,growth hormone secretion,BP,
7257,GO:0030259,1,0.941072597734605,0,10,lipid glycosylation,BP,
7261,GO:0030264,1,0.993485400251684,0,1,nuclear fragmentation involved in apoptotic nuclear change,BP,
7262,GO:0030267,1,0.996197405127411,0,1,glyoxylate reductase (NADP) activity,MF,
7263,GO:0030272,1,0.996692114781991,0,1,5-formyltetrahydrofolate cyclo-ligase activity,MF,
7264,GO:0030273,1,0.994062193021985,0,1,melanin-concentrating hormone receptor activity,MF,
7265,GO:0030274,1,0.957717122710892,0,6,LIM domain binding,MF,
7266,GO:0030275,1,0.911912598773891,0,14,LRR domain binding,MF,
7268,GO:0030277,1,0.908920689988795,0,15,maintenance of gastrointestinal epithelium,BP,
7270,GO:0030279,1,0.647323444077505,0,64,negative regulation of ossification,BP,
7271,GO:0030280,1,0.963412357579593,0,5,structural constituent of skin epidermis,MF,
7272,GO:0030282,1,0.484658085953538,0,106,bone mineralization,BP,
7273,GO:0030283,1,0.976463305741707,0,6,testosterone dehydrogenase [NAD(P)] activity,MF,
7274,GO:0030284,1,0.964575052039851,0,5,estrogen receptor activity,MF,
7276,GO:0030286,1,0.665553233918489,0,47,dynein complex,CC,
7277,GO:0030289,1,0.984621767561073,0,3,protein phosphatase 4 complex,CC,
7278,GO:0030290,1,0.992803253984512,0,1,sphingolipid activator protein activity,MF,
7279,GO:0030291,1,0.848838943319377,0,28,protein serine/threonine kinase inhibitor activity,MF,
7280,GO:0030292,1,0.985774341060296,0,2,protein tyrosine kinase inhibitor activity,MF,
7281,GO:0030294,1,0.994463915421955,0,1,receptor signaling protein tyrosine kinase inhibitor activity,MF,
7283,GO:0030296,1,0.895568537482557,0,15,protein tyrosine kinase activator activity,MF,
7284,GO:0030297,1,0.951430493833868,0,7,transmembrane receptor protein tyrosine kinase activator activity,MF,
7285,GO:0030299,1,0.94032622352253,0,10,intestinal cholesterol absorption,BP,
7286,GO:0030300,1,0.977648263166429,0,4,regulation of intestinal cholesterol absorption,BP,
7287,GO:0030301,1,0.602934007667107,0,75,cholesterol transport,BP,
7288,GO:0030302,1,0.995544823186114,0,1,deoxynucleotide transport,BP,
7289,GO:0030305,1,0.987838761890084,0,2,heparanase activity,MF,
7290,GO:0030306,1,0.942305989313331,0,7,ADP-ribosylation factor binding,MF,
7293,GO:0030309,1,0.931911573988845,0,11,poly-N-acetyllactosamine metabolic process,BP,
7294,GO:0030311,1,0.938534872889337,0,10,poly-N-acetyllactosamine biosynthetic process,BP,
7295,GO:0030312,1,0.985343345629228,0,3,external encapsulating structure,CC,
7296,GO:0030314,1,0.941327491880024,0,7,junctional membrane complex,CC,
7297,GO:0030315,1,0.654677997542709,0,54,T-tubule,CC,
7298,GO:0030316,1,0.554181669782584,0,85,osteoclast differentiation,BP,
7300,GO:0030318,1,0.824027306496412,0,24,melanocyte differentiation,BP,
7301,GO:0030320,1,0.927542565703833,0,10,cellular monovalent inorganic anion homeostasis,BP,
7302,GO:0030321,1,0.968743661478791,0,5,transepithelial chloride transport,BP,
7304,GO:0030323,1,0.282579921473169,0,173,respiratory tube development,BP,
7305,GO:0030324,1,0.290894101408697,0,169,lung development,BP,
7306,GO:0030325,1,0.845579952622585,0,23,adrenal gland development,BP,
7308,GO:0030327,1,0.978675778429948,0,3,prenylated protein catabolic process,BP,
7309,GO:0030328,1,0.985513891208999,0,2,prenylcysteine catabolic process,BP,
7310,GO:0030329,1,0.985513891208999,0,2,prenylcysteine metabolic process,BP,
7312,GO:0030331,1,0.755550060139846,0,38,estrogen receptor binding,MF,
7313,GO:0030332,1,0.827904708883608,0,29,cyclin binding,MF,
7315,GO:0030335,1,0.036686082156434,0,471,positive regulation of cell migration,BP,
7317,GO:0030337,1,0.985234671897864,0,3,DNA polymerase processivity factor activity,MF,
7318,GO:0030342,1,0.993049970701491,0,1,1-alpha,25-dihydroxyvitamin D3 24-hydroxylase activity,MF,
7319,GO:0030343,1,0.989912558277753,0,2,vitamin D3 25-hydroxylase activity,MF,
7320,GO:0030345,1,0.993129312864384,0,1,structural constituent of tooth enamel,MF,
7321,GO:0030346,1,0.952379212376859,0,7,protein phosphatase 2B binding,MF,
7323,GO:0030350,1,0.983621400543981,0,2,iron-responsive element binding,MF,
7324,GO:0030351,1,0.993381017686403,0,1,inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity,MF,
7325,GO:0030354,1,0.996856687076956,0,1,melanin-concentrating hormone activity,MF,
7326,GO:0030366,1,0.995913084164183,0,1,molybdopterin synthase activity,MF,
7327,GO:0030368,1,0.944171012931871,0,8,interleukin-17 receptor activity,MF,
7328,GO:0030369,1,0.985185698725017,0,2,ICAM-3 receptor activity,MF,
7329,GO:0030371,1,0.835666403667011,0,25,translation repressor activity,MF,
7331,GO:0030375,1,0.966154280399901,0,4,thyroid hormone receptor coactivator activity,MF,
7332,GO:0030377,1,0.995889063975349,0,1,urokinase plasminogen activator receptor activity,MF,
7333,GO:0030378,1,0.993951530489555,0,1,serine racemase activity,MF,
7334,GO:0030379,1,0.990177621939258,0,1,neurotensin receptor activity, non-G protein-coupled,MF,
7335,GO:0030382,1,0.987146995272708,0,1,sperm mitochondrion organization,BP,
7336,GO:0030387,1,0.995897087585259,0,1,fructosamine-3-kinase activity,MF,
7337,GO:0030388,1,0.96142442373476,0,7,fructose 1,6-bisphosphate metabolic process,BP,
7338,GO:0030389,1,0.992854169655527,0,2,fructosamine metabolic process,BP,
7339,GO:0030393,1,0.995897087585259,0,1,fructoselysine metabolic process,BP,
7340,GO:0030395,1,0.99248407600766,0,2,lactose binding,MF,
7341,GO:0030397,1,0.897772886509515,0,16,membrane disassembly,BP,
7342,GO:0030407,1,0.9950724170859,0,1,formimidoyltransferase activity,MF,
7343,GO:0030409,1,0.9950724170859,0,1,glutamate formimidoyltransferase activity,MF,
7344,GO:0030412,1,0.9950724170859,0,1,formimidoyltetrahydrofolate cyclodeaminase activity,MF,
7346,GO:0030421,1,0.996673854950561,0,1,defecation,BP,
7347,GO:0030422,1,0.935485051392176,0,10,production of siRNA involved in RNA interference,BP,
7348,GO:0030423,1,0.9712657275491,0,4,targeting of mRNA for destruction involved in RNA interference,BP,
7353,GO:0030429,1,0.995811985613003,0,1,kynureninase activity,MF,
7354,GO:0030430,1,0.965001479202509,0,6,host cell cytoplasm,CC,
7355,GO:0030431,1,0.828361622687993,0,30,sleep,BP,
7356,GO:0030432,1,0.950896425953903,0,9,peristalsis,BP,
7357,GO:0030433,1,0.629828390181441,0,71,ubiquitin-dependent ERAD pathway,BP,
7358,GO:0030449,1,0.776250726217763,0,41,regulation of complement activation,BP,
7359,GO:0030450,1,0.977561229052772,0,3,regulation of complement activation, classical pathway,BP,
7360,GO:0030451,1,0.978564607090293,0,3,regulation of complement activation, alternative pathway,BP,
7361,GO:0030473,1,0.956575997772556,0,5,nuclear migration along microtubule,BP,
7362,GO:0030478,1,0.971224275984298,0,4,actin cap,CC,
7363,GO:0030485,1,0.983676267609822,0,3,smooth muscle contractile fiber,CC,
7364,GO:0030488,1,0.789861949989022,0,37,tRNA methylation,BP,
7365,GO:0030490,1,0.758844113968884,0,46,maturation of SSU-rRNA,BP,
7366,GO:0030492,1,0.969748211207147,0,8,hemoglobin binding,MF,
7368,GO:0030497,1,0.926036620941331,0,12,fatty acid elongation,BP,
7369,GO:0030500,1,0.631282861006587,0,66,regulation of bone mineralization,BP,
7370,GO:0030501,1,0.765413427012627,0,37,positive regulation of bone mineralization,BP,
7371,GO:0030502,1,0.915364404168426,0,13,negative regulation of bone mineralization,BP,
7372,GO:0030504,1,0.989173849157718,0,1,inorganic diphosphate transmembrane transporter activity,MF,
7373,GO:0030505,1,0.979093696204519,0,2,inorganic diphosphate transport,BP,
7374,GO:0030506,1,0.839576541627328,0,18,ankyrin binding,MF,
7378,GO:0030511,1,0.807442683438512,0,29,positive regulation of transforming growth factor beta receptor signaling pathway,BP,
7379,GO:0030512,1,0.568629644399223,0,77,negative regulation of transforming growth factor beta receptor signaling pathway,BP,
7380,GO:0030513,1,0.785356080377894,0,31,positive regulation of BMP signaling pathway,BP,
7382,GO:0030515,1,0.8319768429339,0,30,snoRNA binding,MF,
7383,GO:0030516,1,0.483841903683809,0,94,regulation of axon extension,BP,
7385,GO:0030518,1,0.469706148136009,0,106,intracellular steroid hormone receptor signaling pathway,BP,
7386,GO:0030519,1,0.992643135437148,0,1,snoRNP binding,MF,
7387,GO:0030520,1,0.699375662982473,0,52,intracellular estrogen receptor signaling pathway,BP,
7388,GO:0030521,1,0.75823516253218,0,38,androgen receptor signaling pathway,BP,
7389,GO:0030522,1,0.185595905787101,0,240,intracellular receptor signaling pathway,BP,
7390,GO:0030523,1,0.992425960311283,0,1,dihydrolipoamide S-acyltransferase activity,MF,
7391,GO:0030526,1,0.992073680321259,0,1,granulocyte macrophage colony-stimulating factor receptor complex,CC,
7392,GO:0030527,1,0.994921292172814,0,1,structural constituent of chromatin,MF,
7393,GO:0030532,1,0.712350842845268,0,61,small nuclear ribonucleoprotein complex,CC,
7395,GO:0030538,1,0.983064271875414,0,3,embryonic genitalia morphogenesis,BP,
7396,GO:0030539,1,0.872403903491225,0,21,male genitalia development,BP,
7397,GO:0030540,1,0.886184656529879,0,16,female genitalia development,BP,
7398,GO:0030544,1,0.775553202771538,0,39,Hsp70 protein binding,MF,
7401,GO:0030547,1,0.87705674545508,0,23,receptor inhibitor activity,MF,
7402,GO:0030548,1,0.957918553653623,0,9,acetylcholine receptor regulator activity,MF,
7403,GO:0030549,1,0.996327590582107,0,1,acetylcholine receptor activator activity,MF,
7404,GO:0030550,1,0.969892310856123,0,6,acetylcholine receptor inhibitor activity,MF,
7405,GO:0030551,1,0.783426944143805,0,33,cyclic nucleotide binding,MF,
7406,GO:0030552,1,0.840774308364835,0,23,cAMP binding,MF,
7407,GO:0030553,1,0.913997085265602,0,12,cGMP binding,MF,
7409,GO:0030572,1,0.992705087473751,0,1,phosphatidyltransferase activity,MF,
7410,GO:0030573,1,0.99489870426208,0,1,bile acid catabolic process,BP,
7411,GO:0030574,1,0.777067641995561,0,39,collagen catabolic process,BP,
7412,GO:0030575,1,0.888085984269378,0,15,nuclear body organization,BP,
7413,GO:0030576,1,0.97619765470355,0,4,Cajal body organization,BP,
7414,GO:0030578,1,0.949925508151477,0,6,PML body organization,BP,
7415,GO:0030579,1,0.966799709636073,0,5,ubiquitin-dependent SMAD protein catabolic process,BP,
7416,GO:0030580,1,0.991946577981475,0,2,quinone cofactor methyltransferase activity,MF,
7417,GO:0030581,1,0.992100490019366,0,2,symbiont intracellular protein transport in host,BP,
7418,GO:0030586,1,0.992963121628234,0,1,[methionine synthase] reductase activity,MF,
7419,GO:0030592,1,0.982006220916906,0,3,DNA ADP-ribosylation,BP,
7420,GO:0030593,1,0.638064937409239,0,84,neutrophil chemotaxis,BP,
7422,GO:0030595,1,0.320524492921514,0,197,leukocyte chemotaxis,BP,
7423,GO:0030611,1,0.99665551211534,0,1,arsenate reductase activity,MF,
7424,GO:0030613,1,0.989311406961651,0,3,oxidoreductase activity, acting on phosphorus or arsenic in donors,MF,
7425,GO:0030614,1,0.989311406961651,0,3,oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor,MF,
7426,GO:0030619,1,0.959338382862333,0,7,U1 snRNA binding,MF,
7427,GO:0030620,1,0.976846292883871,0,4,U2 snRNA binding,MF,
7428,GO:0030621,1,0.965971225347063,0,5,U4 snRNA binding,MF,
7429,GO:0030622,1,0.986135457787102,0,2,U4atac snRNA binding,MF,
7430,GO:0030623,1,0.982545374185161,0,2,U5 snRNA binding,MF,
7431,GO:0030624,1,0.992406616605623,0,1,U6atac snRNA binding,MF,
7432,GO:0030626,1,0.987812454431104,0,2,U12 snRNA binding,MF,
7433,GO:0030627,1,0.99626197119431,0,1,pre-mRNA 5'-splice site binding,MF,
7434,GO:0030628,1,0.975347048884789,0,5,pre-mRNA 3'-splice site binding,MF,
7435,GO:0030629,1,0.990435120953699,0,2,U6 snRNA 3'-end binding,MF,
7436,GO:0030638,1,0.961205028700096,0,9,polyketide metabolic process,BP,
7438,GO:0030643,1,0.961432770787388,0,5,cellular phosphate ion homeostasis,BP,
7439,GO:0030644,1,0.964763917043732,0,5,cellular chloride ion homeostasis,BP,
7440,GO:0030647,1,0.961205028700096,0,9,aminoglycoside antibiotic metabolic process,BP,
7441,GO:0030653,1,0.991892418496674,0,1,beta-lactam antibiotic metabolic process,BP,
7442,GO:0030656,1,0.932458614390923,0,12,regulation of vitamin metabolic process,BP,
7447,GO:0030663,1,0.909236528230464,0,17,COPI-coated vesicle membrane,CC,
7451,GO:0030669,1,0.791136155353205,0,37,clathrin-coated endocytic vesicle membrane,CC,
7452,GO:0030670,1,0.644895013944629,0,71,phagocytic vesicle membrane,CC,
7456,GO:0030676,1,0.855836738116267,0,19,Rac guanyl-nucleotide exchange factor activity,MF,
7457,GO:0030677,1,0.94101907068569,0,12,ribonuclease P complex,CC,
7458,GO:0030678,1,0.990109285826032,0,2,mitochondrial ribonuclease P complex,CC,
7459,GO:0030681,1,0.950424211462913,0,10,multimeric ribonuclease P complex,CC,
7460,GO:0030682,1,0.975432295825066,0,3,mitigation of host defenses by symbiont,BP,
7461,GO:0030683,1,0.985406149117982,0,2,mitigation of host immune response by virus,BP,
7462,GO:0030684,1,0.637487320458372,0,70,preribosome,CC,
7463,GO:0030686,1,0.845557842171991,0,25,90S preribosome,CC,
7464,GO:0030687,1,0.871589922689534,0,22,preribosome, large subunit precursor,CC,
7465,GO:0030688,1,0.906370265308347,0,15,preribosome, small subunit precursor,CC,
7466,GO:0030689,1,0.982356128905223,0,3,Noc complex,CC,
7467,GO:0030690,1,0.993425199756488,0,1,Noc1p-Noc2p complex,CC,
7468,GO:0030691,1,0.993425199756488,0,1,Noc2p-Noc3p complex,CC,
7469,GO:0030692,1,0.988858401820611,0,2,Noc4p-Nop14p complex,CC,
7470,GO:0030695,1,0.11570264193335,0,284,GTPase regulator activity,MF,
7471,GO:0030696,1,0.993058749533747,0,1,tRNA (m5U54) methyltransferase activity,MF,
7472,GO:0030697,1,0.993058749533747,0,1,S-adenosylmethionine-dependent tRNA (m5U54) methyltransferase activity,MF,
7473,GO:0030704,1,0.994738933398728,0,1,vitelline membrane formation,BP,
7475,GO:0030718,1,0.988415073389401,0,2,germ-line stem cell population maintenance,BP,
7476,GO:0030719,1,0.986664131620679,0,2,P granule organization,BP,
7477,GO:0030728,1,0.863860166613505,0,21,ovulation,BP,
7478,GO:0030729,1,0.992935942344337,0,1,acetoacetate-CoA ligase activity,MF,
7479,GO:0030730,1,0.899862839516076,0,17,sequestering of triglyceride,BP,
7480,GO:0030731,1,0.996527394044305,0,1,guanidinoacetate N-methyltransferase activity,MF,
7481,GO:0030742,1,0.86460007270759,0,23,GTP-dependent protein binding,MF,
7482,GO:0030748,1,0.993817036477932,0,1,amine N-methyltransferase activity,MF,
7483,GO:0030760,1,0.995662418558811,0,1,pyridine N-methyltransferase activity,MF,
7484,GO:0030791,1,0.993969440585929,0,1,arsenite methyltransferase activity,MF,
7485,GO:0030792,1,0.986113193849322,0,2,methylarsonite methyltransferase activity,MF,
7488,GO:0030810,1,0.901307788856432,0,17,positive regulation of nucleotide biosynthetic process,BP,
7489,GO:0030832,1,0.307505618543323,0,171,regulation of actin filament length,BP,
7490,GO:0030833,1,0.349894804142273,0,155,regulation of actin filament polymerization,BP,
7491,GO:0030834,1,0.696253413066881,0,48,regulation of actin filament depolymerization,BP,
7492,GO:0030835,1,0.74563236571527,0,38,negative regulation of actin filament depolymerization,BP,
7493,GO:0030836,1,0.93372456228961,0,10,positive regulation of actin filament depolymerization,BP,
7494,GO:0030837,1,0.667650150081817,0,57,negative regulation of actin filament polymerization,BP,
7495,GO:0030838,1,0.567389110615033,0,88,positive regulation of actin filament polymerization,BP,
7496,GO:0030842,1,0.991480258096105,0,1,regulation of intermediate filament depolymerization,BP,
7497,GO:0030844,1,0.991480258096105,0,1,positive regulation of intermediate filament depolymerization,BP,
7498,GO:0030845,1,0.993370920870107,0,1,phospholipase C-inhibiting G protein-coupled receptor signaling pathway,BP,
7499,GO:0030846,1,0.974083704580955,0,3,termination of RNA polymerase II transcription, poly(A)-coupled,BP,
7500,GO:0030849,1,0.987250986164813,0,2,autosome,CC,
7501,GO:0030850,1,0.709431107028718,0,47,prostate gland development,BP,
7502,GO:0030851,1,0.828850093318515,0,30,granulocyte differentiation,BP,
7503,GO:0030852,1,0.921556620379009,0,13,regulation of granulocyte differentiation,BP,
7504,GO:0030853,1,0.953035151235366,0,7,negative regulation of granulocyte differentiation,BP,
7505,GO:0030854,1,0.960002829294653,0,7,positive regulation of granulocyte differentiation,BP,
7507,GO:0030856,1,0.397546816131121,0,132,regulation of epithelial cell differentiation,BP,
7508,GO:0030857,1,0.7606879500291,0,41,negative regulation of epithelial cell differentiation,BP,
7509,GO:0030858,1,0.699867514253445,0,52,positive regulation of epithelial cell differentiation,BP,
7510,GO:0030859,1,0.851217056143973,0,22,polarized epithelial cell differentiation,BP,
7511,GO:0030860,1,0.985455046078997,0,2,regulation of polarized epithelial cell differentiation,BP,
7512,GO:0030862,1,0.991482478357323,0,1,positive regulation of polarized epithelial cell differentiation,BP,
7513,GO:0030863,1,0.45218634082359,0,102,cortical cytoskeleton,CC,
7514,GO:0030864,1,0.556522306604228,0,77,cortical actin cytoskeleton,CC,
7515,GO:0030865,1,0.661502636667262,0,59,cortical cytoskeleton organization,BP,
7516,GO:0030866,1,0.749988687251636,0,38,cortical actin cytoskeleton organization,BP,
7517,GO:0030867,1,0.861622285511386,0,27,rough endoplasmic reticulum membrane,CC,
7518,GO:0030868,1,0.971541701653052,0,5,smooth endoplasmic reticulum membrane,CC,
7519,GO:0030870,1,0.964212435199677,0,5,Mre11 complex,CC,
7520,GO:0030874,1,0.995412779025815,0,1,nucleolar chromatin,CC,
7521,GO:0030877,1,0.908327995564768,0,12,beta-catenin destruction complex,CC,
7522,GO:0030878,1,0.878320637453074,0,21,thyroid gland development,BP,
7524,GO:0030880,1,0.541810124993471,0,99,RNA polymerase complex,CC,
7525,GO:0030881,1,0.966970249214747,0,7,beta-2-microglobulin binding,MF,
7526,GO:0030882,1,0.969969641814025,0,5,lipid antigen binding,MF,
7527,GO:0030883,1,0.976420349168539,0,4,endogenous lipid antigen binding,MF,
7528,GO:0030884,1,0.976420349168539,0,4,exogenous lipid antigen binding,MF,
7529,GO:0030885,1,0.973322033739861,0,6,regulation of myeloid dendritic cell activation,BP,
7530,GO:0030886,1,0.985862031398652,0,3,negative regulation of myeloid dendritic cell activation,BP,
7531,GO:0030887,1,0.990767458835346,0,2,positive regulation of myeloid dendritic cell activation,BP,
7533,GO:0030889,1,0.896355726764494,0,17,negative regulation of B cell proliferation,BP,
7535,GO:0030891,1,0.982985831827347,0,3,VCB complex,CC,
7536,GO:0030892,1,0.982353093473865,0,3,mitotic cohesin complex,CC,
7537,GO:0030893,1,0.948826791163587,0,7,meiotic cohesin complex,CC,
7538,GO:0030894,1,0.859484913719693,0,25,replisome,CC,
7539,GO:0030895,1,0.98877059097788,0,2,apolipoprotein B mRNA editing enzyme complex,CC,
7540,GO:0030896,1,0.976761984852584,0,4,checkpoint clamp complex,CC,
7541,GO:0030897,1,0.909030773580134,0,12,HOPS complex,CC,
7542,GO:0030898,1,0.805599499259825,0,23,actin-dependent ATPase activity,MF,
7543,GO:0030899,1,0.981308499211205,0,3,calcium-dependent ATPase activity,MF,
7546,GO:0030902,1,0.36226592348372,0,141,hindbrain development,BP,
7547,GO:0030903,1,0.882551531199833,0,18,notochord development,BP,
7548,GO:0030904,1,0.872091435515314,0,20,retromer complex,CC,
7549,GO:0030905,1,0.972116263642662,0,4,retromer, tubulation complex,CC,
7550,GO:0030906,1,0.976037759859541,0,4,retromer, cargo-selective complex,CC,
7551,GO:0030908,1,0.990427332864135,0,2,protein splicing,BP,
7552,GO:0030910,1,0.977808526879279,0,3,olfactory placode formation,BP,
7553,GO:0030911,1,0.943560027329871,0,8,TPR domain binding,MF,
7554,GO:0030913,1,0.945243848290556,0,7,paranodal junction assembly,BP,
7555,GO:0030914,1,0.930364981908146,0,11,STAGA complex,CC,
7556,GO:0030915,1,0.96780779055377,0,6,Smc5-Smc6 complex,CC,
7557,GO:0030916,1,0.954968079828553,0,8,otic vesicle formation,BP,
7558,GO:0030917,1,0.956507814852921,0,7,midbrain-hindbrain boundary development,BP,
7559,GO:0030920,1,0.992472035501039,0,2,peptidyl-serine acetylation,BP,
7560,GO:0030934,1,0.967106331935038,0,3,anchoring collagen complex,CC,
7561,GO:0030935,1,0.993701478078327,0,1,sheet-forming collagen trimer,CC,
7562,GO:0030936,1,0.993147745928254,0,1,transmembrane collagen trimer,CC,
7563,GO:0030942,1,0.98470320488005,0,3,endoplasmic reticulum signal peptide binding,MF,
7564,GO:0030943,1,0.982125640959197,0,3,mitochondrion targeting sequence binding,MF,
7565,GO:0030947,1,0.834530251327022,0,28,regulation of vascular endothelial growth factor receptor signaling pathway,BP,
7566,GO:0030948,1,0.931150917384377,0,11,negative regulation of vascular endothelial growth factor receptor signaling pathway,BP,
7567,GO:0030949,1,0.922325214916077,0,13,positive regulation of vascular endothelial growth factor receptor signaling pathway,BP,
7568,GO:0030950,1,0.964476406170963,0,5,establishment or maintenance of actin cytoskeleton polarity,BP,
7569,GO:0030951,1,0.97071942196436,0,4,establishment or maintenance of microtubule cytoskeleton polarity,BP,
7570,GO:0030952,1,0.936225919965358,0,9,establishment or maintenance of cytoskeleton polarity,BP,
7571,GO:0030953,1,0.921739886505638,0,10,astral microtubule organization,BP,
7572,GO:0030954,1,0.991804342867668,0,1,astral microtubule nucleation,BP,
7573,GO:0030955,1,0.916982794536373,0,12,potassium ion binding,MF,
7574,GO:0030956,1,0.983397955973177,0,3,glutamyl-tRNA(Gln) amidotransferase complex,CC,
7575,GO:0030957,1,0.940973312375359,0,10,Tat protein binding,MF,
7576,GO:0030961,1,0.993485400251684,0,1,peptidyl-arginine hydroxylation,BP,
7577,GO:0030964,1,0.859390433798105,0,41,NADH dehydrogenase complex,CC,
7579,GO:0030970,1,0.845089728905266,0,26,retrograde protein transport, ER to cytosol,BP,
7580,GO:0030971,1,0.637004371269871,0,67,receptor tyrosine kinase binding,MF,
7581,GO:0030974,1,0.989241324832522,0,2,thiamine pyrophosphate transmembrane transport,BP,
7582,GO:0030975,1,0.994172121860078,0,1,thiamine binding,MF,
7583,GO:0030976,1,0.955303338365607,0,7,thiamine pyrophosphate binding,MF,
7584,GO:0030977,1,0.995238761465561,0,1,taurine binding,MF,
7585,GO:0030981,1,0.973365174425038,0,3,cortical microtubule cytoskeleton,CC,
7586,GO:0030983,1,0.916368197203119,0,13,mismatched DNA binding,MF,
7587,GO:0030984,1,0.989816022957328,0,2,kininogen binding,MF,
7588,GO:0030990,1,0.837050813335088,0,27,intraciliary transport particle,CC,
7589,GO:0030991,1,0.946185463271144,0,7,intraciliary transport particle A,CC,
7590,GO:0030992,1,0.888320560713183,0,19,intraciliary transport particle B,CC,
7591,GO:0030997,1,0.976724498159555,0,3,regulation of centriole-centriole cohesion,BP,
7592,GO:0031000,1,0.86127642480368,0,17,response to caffeine,BP,
7593,GO:0031004,1,0.978427457710382,0,3,potassium ion-transporting ATPase complex,CC,
7594,GO:0031005,1,0.927969624777506,0,10,filamin binding,MF,
7595,GO:0031010,1,0.916728852223818,0,11,ISWI-type complex,CC,
7596,GO:0031011,1,0.921936715216354,0,15,Ino80 complex,CC,
7598,GO:0031013,1,0.978231451407101,0,5,troponin I binding,MF,
7599,GO:0031014,1,0.987139435686381,0,4,troponin T binding,MF,
7600,GO:0031016,1,0.603056646436259,0,73,pancreas development,BP,
7601,GO:0031017,1,0.958525848339046,0,6,exocrine pancreas development,BP,
7602,GO:0031018,1,0.749906912220765,0,43,endocrine pancreas development,BP,
7603,GO:0031021,1,0.993485400251684,0,1,interphase microtubule organizing center,CC,
7604,GO:0031022,1,0.978694439234305,0,2,nuclear migration along microfilament,BP,
7605,GO:0031023,1,0.386084035210252,0,131,microtubule organizing center organization,BP,
7606,GO:0031032,1,0.237249355781274,0,188,actomyosin structure organization,BP,
7607,GO:0031033,1,0.943923171542619,0,5,myosin filament organization,BP,
7608,GO:0031034,1,0.948991687473811,0,4,myosin filament assembly,BP,
7609,GO:0031038,1,0.994661836853827,0,1,myosin II filament organization,BP,
7611,GO:0031047,1,0.368197495130225,0,140,gene silencing by RNA,BP,
7612,GO:0031048,1,0.975879996691043,0,3,heterochromatin assembly by small RNA,BP,
7613,GO:0031049,1,0.985446793424303,0,2,programmed DNA elimination,BP,
7614,GO:0031050,1,0.704919750766777,0,49,dsRNA processing,BP,
7615,GO:0031052,1,0.985446793424303,0,2,chromosome breakage,BP,
7616,GO:0031053,1,0.910240702936503,0,13,primary miRNA processing,BP,
7617,GO:0031054,1,0.919563900616081,0,12,pre-miRNA processing,BP,
7618,GO:0031055,1,0.851654999106073,0,28,chromatin remodeling at centromere,BP,
7619,GO:0031056,1,0.36853686133868,0,138,regulation of histone modification,BP,
7620,GO:0031057,1,0.751457199067925,0,40,negative regulation of histone modification,BP,
7621,GO:0031058,1,0.542169814626123,0,86,positive regulation of histone modification,BP,
7622,GO:0031060,1,0.63874598672166,0,59,regulation of histone methylation,BP,
7623,GO:0031061,1,0.876851163092214,0,18,negative regulation of histone methylation,BP,
7624,GO:0031062,1,0.764488010136616,0,36,positive regulation of histone methylation,BP,
7625,GO:0031063,1,0.825408520379786,0,27,regulation of histone deacetylation,BP,
7626,GO:0031064,1,0.957269278670873,0,6,negative regulation of histone deacetylation,BP,
7627,GO:0031065,1,0.880824407812661,0,17,positive regulation of histone deacetylation,BP,
7628,GO:0031069,1,0.843147428823271,0,25,hair follicle morphogenesis,BP,
7629,GO:0031071,1,0.994136441522747,0,1,cysteine desulfurase activity,MF,
7630,GO:0031072,1,0.46243442694549,0,115,heat shock protein binding,MF,
7631,GO:0031073,1,0.994293996396013,0,1,cholesterol 26-hydroxylase activity,MF,
7632,GO:0031074,1,0.980606345210391,0,3,nucleocytoplasmic transport complex,CC,
7633,GO:0031076,1,0.733819360257419,0,39,embryonic camera-type eye development,BP,
7634,GO:0031077,1,0.954571027343517,0,7,post-embryonic camera-type eye development,BP,
7635,GO:0031078,1,0.928681853975168,0,10,histone deacetylase activity (H3-K14 specific),MF,
7636,GO:0031080,1,0.932466252532849,0,10,nuclear pore outer ring,CC,
7639,GO:0031084,1,0.978348209992036,0,3,BLOC-2 complex,CC,
7640,GO:0031085,1,0.986123010168503,0,2,BLOC-3 complex,CC,
7641,GO:0031086,1,0.962737214149439,0,6,nuclear-transcribed mRNA catabolic process, deadenylation-independent decay,BP,
7642,GO:0031087,1,0.969343143352309,0,5,deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
7643,GO:0031088,1,0.958831693818338,0,6,platelet dense granule membrane,CC,
7644,GO:0031089,1,0.943744649942551,0,11,platelet dense granule lumen,CC,
7648,GO:0031093,1,0.67887701513693,0,62,platelet alpha granule lumen,CC,
7649,GO:0031094,1,0.912718271826771,0,10,platelet dense tubular network,CC,
7650,GO:0031095,1,0.924743717671981,0,8,platelet dense tubular network membrane,CC,
7654,GO:0031102,1,0.6867085296169,0,53,neuron projection regeneration,BP,
7655,GO:0031103,1,0.717195861388181,0,46,axon regeneration,BP,
7656,GO:0031104,1,0.988319660148692,0,2,dendrite regeneration,BP,
7657,GO:0031106,1,0.986648170410017,0,2,septin ring organization,BP,
7665,GO:0031116,1,0.799313172123488,0,29,positive regulation of microtubule polymerization,BP,
7667,GO:0031118,1,0.953999420647921,0,10,rRNA pseudouridine synthesis,BP,
7668,GO:0031119,1,0.972715680099789,0,5,tRNA pseudouridine synthesis,BP,
7669,GO:0031120,1,0.987750637092529,0,3,snRNA pseudouridine synthesis,BP,
7670,GO:0031122,1,0.622545813487831,0,60,cytoplasmic microtubule organization,BP,
7671,GO:0031123,1,0.43479327668578,0,131,RNA 3'-end processing,BP,
7672,GO:0031124,1,0.539646489584668,0,94,mRNA 3'-end processing,BP,
7673,GO:0031125,1,0.951990955176129,0,10,rRNA 3'-end processing,BP,
7674,GO:0031126,1,0.951683777309675,0,10,snoRNA 3'-end processing,BP,
7675,GO:0031127,1,0.992491492776948,0,1,alpha-(1,2)-fucosyltransferase activity,MF,
7676,GO:0031128,1,0.793511032118443,0,34,developmental induction,BP,
7677,GO:0031129,1,0.991793308452133,0,1,inductive cell-cell signaling,BP,
7678,GO:0031133,1,0.971077316333554,0,4,regulation of axon diameter,BP,
7679,GO:0031134,1,0.980922285446874,0,3,sister chromatid biorientation,BP,
7680,GO:0031143,1,0.903380288015194,0,15,pseudopodium,CC,
7682,GO:0031146,1,0.614185938598227,0,87,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,BP,
7683,GO:0031151,1,0.989812333227128,0,1,histone methyltransferase activity (H3-K79 specific),MF,
7684,GO:0031161,1,0.993072186303729,0,1,phosphatidylinositol catabolic process,BP,
7685,GO:0031163,1,0.89915672287602,0,20,metallo-sulfur cluster assembly,BP,
7686,GO:0031166,1,0.964901088760401,0,5,integral component of vacuolar membrane,CC,
7687,GO:0031167,1,0.90079534702215,0,19,rRNA methylation,BP,
7689,GO:0031177,1,0.988938770380431,0,1,phosphopantetheine binding,MF,
7690,GO:0031179,1,0.986939790968743,0,2,peptide modification,BP,
7692,GO:0031204,1,0.955912535843641,0,7,posttranslational protein targeting to membrane, translocation,BP,
7693,GO:0031205,1,0.987748623394397,0,2,endoplasmic reticulum Sec complex,CC,
7694,GO:0031207,1,0.990629495790667,0,1,Sec62/Sec63 complex,CC,
7695,GO:0031208,1,0.977830156594049,0,3,POZ domain binding,MF,
7696,GO:0031209,1,0.936325421153021,0,9,SCAR complex,CC,
7698,GO:0031211,1,0.951162598145237,0,8,endoplasmic reticulum palmitoyltransferase complex,CC,
7699,GO:0031213,1,0.984572546570377,0,2,RSF complex,CC,
7700,GO:0031214,1,0.388635405160107,0,138,biomineral tissue development,BP,
7701,GO:0031223,1,0.901254861431951,0,12,auditory behavior,BP,
7705,GO:0031227,1,0.393514091714899,0,153,intrinsic component of endoplasmic reticulum membrane,CC,
7707,GO:0031229,1,0.913988435780824,0,14,intrinsic component of nuclear inner membrane,CC,
7708,GO:0031231,1,0.917088520329589,0,15,intrinsic component of peroxisomal membrane,CC,
7709,GO:0031232,1,0.947517389559914,0,8,extrinsic component of external side of plasma membrane,CC,
7712,GO:0031235,1,0.952848536101234,0,6,intrinsic component of the cytoplasmic side of the plasma membrane,CC,
7713,GO:0031247,1,0.988356562701765,0,2,actin rod assembly,BP,
7714,GO:0031248,1,0.56283719385438,0,85,protein acetyltransferase complex,CC,
7715,GO:0031249,1,0.994054837410308,0,1,denatured protein binding,MF,
7716,GO:0031251,1,0.983157697598574,0,2,PAN complex,CC,
7719,GO:0031254,1,0.917940631832397,0,13,cell trailing edge,CC,
7721,GO:0031257,1,0.993485400251684,0,1,cell trailing edge membrane,CC,
7722,GO:0031258,1,0.844190353107507,0,22,lamellipodium membrane,CC,
7723,GO:0031259,1,0.993485400251684,0,1,uropod membrane,CC,
7724,GO:0031261,1,0.970787929931528,0,5,DNA replication preinitiation complex,CC,
7725,GO:0031262,1,0.982659840708783,0,4,Ndc80 complex,CC,
7726,GO:0031264,1,0.945999592686712,0,9,death-inducing signaling complex,CC,
7727,GO:0031265,1,0.962994227382285,0,6,CD95 death-inducing signaling complex,CC,
7729,GO:0031268,1,0.920358013715677,0,13,pseudopodium organization,BP,
7730,GO:0031269,1,0.920358013715677,0,13,pseudopodium assembly,BP,
7731,GO:0031271,1,0.993485400251684,0,1,lateral pseudopodium assembly,BP,
7732,GO:0031272,1,0.920358013715677,0,13,regulation of pseudopodium assembly,BP,
7733,GO:0031274,1,0.926397725149403,0,12,positive regulation of pseudopodium assembly,BP,
7734,GO:0031275,1,0.993485400251684,0,1,regulation of lateral pseudopodium assembly,BP,
7740,GO:0031284,1,0.958118844141193,0,7,positive regulation of guanylate cyclase activity,BP,
7741,GO:0031289,1,0.993160020384076,0,1,actin phosphorylation,BP,
7742,GO:0031290,1,0.861032614819777,0,19,retinal ganglion cell axon guidance,BP,
7743,GO:0031291,1,0.976556972090575,0,4,Ran protein signal transduction,BP,
7744,GO:0031293,1,0.886652765318467,0,18,membrane protein intracellular domain proteolysis,BP,
7745,GO:0031294,1,0.716962185386139,0,55,lymphocyte costimulation,BP,
7746,GO:0031295,1,0.71965327455734,0,54,T cell costimulation,BP,
7747,GO:0031296,1,0.989228814647265,0,3,B cell costimulation,BP,
7748,GO:0031297,1,0.799705964268457,0,31,replication fork processing,BP,
7749,GO:0031298,1,0.950267593610092,0,8,replication fork protection complex,CC,
7752,GO:0031302,1,0.978966671847122,0,3,intrinsic component of endosome membrane,CC,
7753,GO:0031304,1,0.785916074390444,0,43,intrinsic component of mitochondrial inner membrane,CC,
7754,GO:0031305,1,0.785916074390444,0,43,integral component of mitochondrial inner membrane,CC,
7755,GO:0031306,1,0.868483489414591,0,22,intrinsic component of mitochondrial outer membrane,CC,
7756,GO:0031307,1,0.875275897622585,0,21,integral component of mitochondrial outer membrane,CC,
7757,GO:0031308,1,0.993485400251684,0,1,intrinsic component of nuclear outer membrane,CC,
7758,GO:0031309,1,0.993485400251684,0,1,integral component of nuclear outer membrane,CC,
7759,GO:0031310,1,0.964901088760401,0,5,intrinsic component of vacuolar membrane,CC,
7760,GO:0031312,1,0.764396737733562,0,41,extrinsic component of organelle membrane,CC,
7761,GO:0031313,1,0.94097941372618,0,9,extrinsic component of endosome membrane,CC,
7762,GO:0031314,1,0.943205849890933,0,10,extrinsic component of mitochondrial inner membrane,CC,
7763,GO:0031315,1,0.983630500972272,0,2,extrinsic component of mitochondrial outer membrane,CC,
7764,GO:0031320,1,0.993865211361605,0,1,hexitol dehydrogenase activity,MF,
7774,GO:0031332,1,0.891231615625002,0,14,RNAi effector complex,CC,
7776,GO:0031334,1,0.212609822040879,0,230,positive regulation of protein-containing complex assembly,BP,
7777,GO:0031335,1,0.976421901284873,0,3,regulation of sulfur amino acid metabolic process,BP,
7778,GO:0031337,1,0.994345115448986,0,1,positive regulation of sulfur amino acid metabolic process,BP,
7782,GO:0031341,1,0.642578727776388,0,78,regulation of cell killing,BP,
7783,GO:0031342,1,0.894172554603386,0,21,negative regulation of cell killing,BP,
7784,GO:0031343,1,0.745828986339089,0,52,positive regulation of cell killing,BP,
7789,GO:0031348,1,0.309937954522505,0,187,negative regulation of defense response,BP,
7792,GO:0031365,1,0.827332835718472,0,28,N-terminal protein amino acid modification,BP,
7793,GO:0031369,1,0.82857593159923,0,30,translation initiation factor binding,MF,
7794,GO:0031370,1,0.992151823469286,0,1,eukaryotic initiation factor 4G binding,MF,
7795,GO:0031371,1,0.954466302966368,0,8,ubiquitin conjugating enzyme complex,CC,
7796,GO:0031372,1,0.989611652693199,0,2,UBC13-MMS2 complex,CC,
7797,GO:0031379,1,0.982571271893216,0,2,RNA-directed RNA polymerase complex,CC,
7798,GO:0031380,1,0.989882481429786,0,1,nuclear RNA-directed RNA polymerase complex,CC,
7799,GO:0031386,1,0.953185140025341,0,12,protein tag,MF,
7800,GO:0031389,1,0.993318546113577,0,1,Rad17 RFC-like complex,CC,
7801,GO:0031390,1,0.955251072983393,0,8,Ctf18 RFC-like complex,CC,
7802,GO:0031391,1,0.978940766935748,0,3,Elg1 RFC-like complex,CC,
7803,GO:0031392,1,0.950334145366283,0,9,regulation of prostaglandin biosynthetic process,BP,
7804,GO:0031393,1,0.985827715431558,0,2,negative regulation of prostaglandin biosynthetic process,BP,
7805,GO:0031394,1,0.966929281083553,0,6,positive regulation of prostaglandin biosynthetic process,BP,
7807,GO:0031397,1,0.628887441317723,0,72,negative regulation of protein ubiquitination,BP,
7812,GO:0031402,1,0.93743292429574,0,8,sodium ion binding,MF,
7813,GO:0031403,1,0.982841956510571,0,2,lithium ion binding,MF,
7814,GO:0031404,1,0.911020319591569,0,13,chloride ion binding,MF,
7815,GO:0031405,1,0.987069903885068,0,1,lipoic acid binding,MF,
7817,GO:0031407,1,0.981128798439743,0,3,oxylipin metabolic process,BP,
7818,GO:0031408,1,0.986892190738627,0,2,oxylipin biosynthetic process,BP,
7820,GO:0031414,1,0.933380738493098,0,10,N-terminal protein acetyltransferase complex,CC,
7821,GO:0031415,1,0.972234972251788,0,5,NatA complex,CC,
7822,GO:0031416,1,0.987705953080056,0,2,NatB complex,CC,
7823,GO:0031417,1,0.972000382394605,0,3,NatC complex,CC,
7824,GO:0031418,1,0.880430075297637,0,20,L-ascorbic acid binding,MF,
7825,GO:0031419,1,0.941920435460088,0,8,cobalamin binding,MF,
7826,GO:0031420,1,0.880237076819334,0,17,alkali metal ion binding,MF,
7827,GO:0031422,1,0.992849268953041,0,1,RecQ family helicase-topoisomerase III complex,CC,
7828,GO:0031424,1,0.638414478771784,0,74,keratinization,BP,
7829,GO:0031427,1,0.973687364223052,0,4,response to methotrexate,BP,
7830,GO:0031428,1,0.974638602983301,0,5,box C/D snoRNP complex,CC,
7831,GO:0031429,1,0.976898336148395,0,5,box H/ACA snoRNP complex,CC,
7833,GO:0031431,1,0.986131432341267,0,2,Dbf4-dependent protein kinase complex,CC,
7834,GO:0031432,1,0.906218358447195,0,14,titin binding,MF,
7835,GO:0031433,1,0.94117539811082,0,6,telethonin binding,MF,
7836,GO:0031434,1,0.914680843723195,0,13,mitogen-activated protein kinase kinase binding,MF,
7837,GO:0031435,1,0.887068118496655,0,17,mitogen-activated protein kinase kinase kinase binding,MF,
7838,GO:0031436,1,0.980635068865881,0,3,BRCA1-BARD1 complex,CC,
7839,GO:0031437,1,0.992391386628437,0,1,regulation of mRNA cleavage,BP,
7840,GO:0031439,1,0.992391386628437,0,1,positive regulation of mRNA cleavage,BP,
7841,GO:0031440,1,0.828994190491931,0,27,regulation of mRNA 3'-end processing,BP,
7842,GO:0031441,1,0.939593573921968,0,9,negative regulation of mRNA 3'-end processing,BP,
7843,GO:0031442,1,0.927807675321051,0,11,positive regulation of mRNA 3'-end processing,BP,
7844,GO:0031443,1,0.98320133750643,0,2,fast-twitch skeletal muscle fiber contraction,BP,
7845,GO:0031444,1,0.98395266279549,0,3,slow-twitch skeletal muscle fiber contraction,BP,
7846,GO:0031445,1,0.880975018967647,0,16,regulation of heterochromatin assembly,BP,
7847,GO:0031446,1,0.992826222446352,0,1,regulation of fast-twitch skeletal muscle fiber contraction,BP,
7848,GO:0031448,1,0.992826222446352,0,1,positive regulation of fast-twitch skeletal muscle fiber contraction,BP,
7849,GO:0031449,1,0.99102648561174,0,1,regulation of slow-twitch skeletal muscle fiber contraction,BP,
7850,GO:0031452,1,0.964627001578888,0,4,negative regulation of heterochromatin assembly,BP,
7851,GO:0031453,1,0.919814481230018,0,11,positive regulation of heterochromatin assembly,BP,
7852,GO:0031455,1,0.98563558986136,0,2,glycine betaine metabolic process,BP,
7853,GO:0031456,1,0.98563558986136,0,2,glycine betaine biosynthetic process,BP,
7854,GO:0031460,1,0.992041511279008,0,1,glycine betaine transport,BP,
7856,GO:0031462,1,0.916073981188725,0,13,Cul2-RING ubiquitin ligase complex,CC,
7858,GO:0031464,1,0.933274698063049,0,11,Cul4A-RING E3 ubiquitin ligase complex,CC,
7859,GO:0031465,1,0.969200944776822,0,5,Cul4B-RING E3 ubiquitin ligase complex,CC,
7860,GO:0031466,1,0.972372950787061,0,5,Cul5-RING ubiquitin ligase complex,CC,
7861,GO:0031467,1,0.975197155119801,0,4,Cul7-RING ubiquitin ligase complex,CC,
7862,GO:0031468,1,0.901083349676534,0,18,nuclear envelope reassembly,BP,
7863,GO:0031475,1,0.995756677547092,0,1,myosin V complex,CC,
7864,GO:0031477,1,0.989876487000643,0,1,myosin VII complex,CC,
7865,GO:0031489,1,0.907226052281962,0,16,myosin V binding,MF,
7866,GO:0031490,1,0.532512685543218,0,86,chromatin DNA binding,MF,
7867,GO:0031491,1,0.704007775242049,0,51,nucleosome binding,MF,
7868,GO:0031492,1,0.853643632795688,0,24,nucleosomal DNA binding,MF,
7869,GO:0031493,1,0.971028186059946,0,5,nucleosomal histone binding,MF,
7870,GO:0031494,1,0.987515183603508,0,1,regulation of mating type switching,BP,
7871,GO:0031497,1,0.479368250759127,0,108,chromatin assembly,BP,
7872,GO:0031498,1,0.88588694107727,0,17,chromatin disassembly,BP,
7873,GO:0031499,1,0.993349835925358,0,1,TRAMP complex,CC,
7874,GO:0031501,1,0.976240995239196,0,5,mannosyltransferase complex,CC,
7876,GO:0031506,1,0.995309928040927,0,1,cell wall glycoprotein biosynthetic process,BP,
7877,GO:0031507,1,0.751339622871173,0,39,heterochromatin assembly,BP,
7878,GO:0031508,1,0.989431794717242,0,2,pericentric heterochromatin assembly,BP,
7879,GO:0031509,1,0.995555341111532,0,1,subtelomeric heterochromatin assembly,BP,
7880,GO:0031510,1,0.98764125690761,0,2,SUMO activating enzyme complex,CC,
7881,GO:0031511,1,0.995572809322688,0,1,Mis6-Sim4 complex,CC,
7882,GO:0031514,1,0.370272382020022,0,149,motile cilium,CC,
7883,GO:0031515,1,0.982535413758095,0,3,tRNA (m1A) methyltransferase complex,CC,
7884,GO:0031519,1,0.734674612276634,0,43,PcG protein complex,CC,
7886,GO:0031526,1,0.696470967202444,0,50,brush border membrane,CC,
7887,GO:0031527,1,0.866003569178777,0,18,filopodium membrane,CC,
7888,GO:0031528,1,0.844104917400277,0,24,microvillus membrane,CC,
7889,GO:0031529,1,0.725487146926368,0,50,ruffle organization,BP,
7890,GO:0031530,1,0.992714537688978,0,2,gonadotropin-releasing hormone receptor binding,MF,
7891,GO:0031531,1,0.99606637078802,0,1,thyrotropin-releasing hormone receptor binding,MF,
7892,GO:0031532,1,0.482090498020938,0,104,actin cytoskeleton reorganization,BP,
7893,GO:0031533,1,0.990897153807632,0,1,mRNA cap methyltransferase complex,CC,
7895,GO:0031543,1,0.924997886960498,0,12,peptidyl-proline dioxygenase activity,MF,
7896,GO:0031544,1,0.973892489430393,0,4,peptidyl-proline 3-dioxygenase activity,MF,
7897,GO:0031545,1,0.949807605036681,0,8,peptidyl-proline 4-dioxygenase activity,MF,
7898,GO:0031547,1,0.943070873588082,0,7,brain-derived neurotrophic factor receptor signaling pathway,BP,
7899,GO:0031548,1,0.977467605191321,0,3,regulation of brain-derived neurotrophic factor receptor signaling pathway,BP,
7900,GO:0031549,1,0.991623201497004,0,1,negative regulation of brain-derived neurotrophic factor receptor signaling pathway,BP,
7901,GO:0031550,1,0.985726014451418,0,2,positive regulation of brain-derived neurotrophic factor receptor signaling pathway,BP,
7902,GO:0031554,1,0.967324117066539,0,4,regulation of DNA-templated transcription, termination,BP,
7903,GO:0031559,1,0.992482560620612,0,1,oxidosqualene cyclase activity,MF,
7905,GO:0031571,1,0.664128869379276,0,61,mitotic G1 DNA damage checkpoint,BP,
7906,GO:0031572,1,0.810694283247173,0,29,G2 DNA damage checkpoint,BP,
7907,GO:0031573,1,0.918717069355461,0,14,intra-S DNA damage checkpoint,BP,
7909,GO:0031579,1,0.868294717371624,0,23,membrane raft organization,BP,
7910,GO:0031580,1,0.965845507193676,0,6,membrane raft distribution,BP,
7911,GO:0031581,1,0.894518788365958,0,12,hemidesmosome assembly,BP,
7912,GO:0031583,1,0.994682591125216,0,1,phospholipase D-activating G protein-coupled receptor signaling pathway,BP,
7914,GO:0031585,1,0.951856899985041,0,5,regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,BP,
7915,GO:0031587,1,0.965374018048269,0,4,positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,BP,
7916,GO:0031588,1,0.947022986606656,0,8,nucleotide-activated protein kinase complex,CC,
7918,GO:0031590,1,0.979856343559491,0,3,wybutosine metabolic process,BP,
7919,GO:0031591,1,0.979856343559491,0,3,wybutosine biosynthetic process,BP,
7920,GO:0031592,1,0.989397281312903,0,1,centrosomal corona,CC,
7921,GO:0031593,1,0.762538198171938,0,40,polyubiquitin modification-dependent protein binding,MF,
7922,GO:0031594,1,0.5723243799377,0,74,neuromuscular junction,CC,
7923,GO:0031595,1,0.984296659173463,0,3,nuclear proteasome complex,CC,
7924,GO:0031597,1,0.954844555973915,0,8,cytosolic proteasome complex,CC,
7925,GO:0031616,1,0.925196597347043,0,13,spindle pole centrosome,CC,
7926,GO:0031617,1,0.982659840708783,0,4,NMS complex,CC,
7927,GO:0031618,1,0.928907904074025,0,9,nuclear pericentric heterochromatin,CC,
7931,GO:0031624,1,0.79948468189163,0,30,ubiquitin conjugating enzyme binding,MF,
7932,GO:0031625,1,0.153483460724017,0,283,ubiquitin protein ligase binding,MF,
7933,GO:0031626,1,0.991787355812672,0,1,beta-endorphin binding,MF,
7934,GO:0031627,1,0.986137111312619,0,2,telomeric loop formation,BP,
7935,GO:0031628,1,0.952189177145035,0,8,opioid receptor binding,MF,
7939,GO:0031635,1,0.987166970819965,0,2,adenylate cyclase-inhibiting opioid receptor signaling pathway,BP,
7940,GO:0031638,1,0.755118225447171,0,47,zymogen activation,BP,
7941,GO:0031639,1,0.907489846837448,0,17,plasminogen activation,BP,
7942,GO:0031640,1,0.846724074369077,0,38,killing of cells of other organism,BP,
7943,GO:0031641,1,0.733605500841428,0,44,regulation of myelination,BP,
7944,GO:0031642,1,0.944884187745741,0,8,negative regulation of myelination,BP,
7945,GO:0031643,1,0.881079956386004,0,18,positive regulation of myelination,BP,
7947,GO:0031645,1,0.856882218696619,0,23,negative regulation of nervous system process,BP,
7948,GO:0031646,1,0.634054588655445,0,62,positive regulation of nervous system process,BP,
7950,GO:0031648,1,0.713863264474993,0,48,protein destabilization,BP,
7953,GO:0031651,1,0.992535412985527,0,1,negative regulation of heat generation,BP,
7955,GO:0031663,1,0.71738552003351,0,54,lipopolysaccharide-mediated signaling pathway,BP,
7956,GO:0031664,1,0.870674416871454,0,23,regulation of lipopolysaccharide-mediated signaling pathway,BP,
7957,GO:0031665,1,0.946262918413746,0,10,negative regulation of lipopolysaccharide-mediated signaling pathway,BP,
7958,GO:0031666,1,0.944521016743255,0,9,positive regulation of lipopolysaccharide-mediated signaling pathway,BP,
7964,GO:0031673,1,0.98221123546182,0,1,H zone,CC,
7966,GO:0031680,1,0.950873647650921,0,10,G-protein beta/gamma-subunit complex,CC,
7967,GO:0031681,1,0.906149769115436,0,18,G-protein beta-subunit binding,MF,
7968,GO:0031682,1,0.956140172225225,0,6,G-protein gamma-subunit binding,MF,
7969,GO:0031683,1,0.888559419740541,0,19,G-protein beta/gamma-subunit complex binding,MF,
7970,GO:0031685,1,0.975192485146672,0,4,adenosine receptor binding,MF,
7971,GO:0031686,1,0.993109651793413,0,1,A1 adenosine receptor binding,MF,
7972,GO:0031687,1,0.989295167643845,0,2,A2A adenosine receptor binding,MF,
7973,GO:0031690,1,0.87832167168936,0,19,adrenergic receptor binding,MF,
7974,GO:0031691,1,0.989563484257934,0,2,alpha-1A adrenergic receptor binding,MF,
7975,GO:0031692,1,0.982316094094049,0,3,alpha-1B adrenergic receptor binding,MF,
7976,GO:0031694,1,0.978852490830925,0,4,alpha-2A adrenergic receptor binding,MF,
7977,GO:0031695,1,0.993988347351852,0,1,alpha-2B adrenergic receptor binding,MF,
7978,GO:0031696,1,0.98670887422754,0,2,alpha-2C adrenergic receptor binding,MF,
7979,GO:0031697,1,0.961101724501019,0,5,beta-1 adrenergic receptor binding,MF,
7980,GO:0031698,1,0.961179503507339,0,5,beta-2 adrenergic receptor binding,MF,
7981,GO:0031699,1,0.992535412985527,0,1,beta-3 adrenergic receptor binding,MF,
7982,GO:0031700,1,0.995874578703165,0,1,adrenomedullin receptor binding,MF,
7983,GO:0031701,1,0.945770186792083,0,8,angiotensin receptor binding,MF,
7984,GO:0031702,1,0.951026603379787,0,7,type 1 angiotensin receptor binding,MF,
7985,GO:0031703,1,0.993779815907898,0,1,type 2 angiotensin receptor binding,MF,
7986,GO:0031704,1,0.993014381373215,0,1,apelin receptor binding,MF,
7988,GO:0031707,1,0.994682591125216,0,1,endothelin A receptor binding,MF,
7989,GO:0031708,1,0.984705479016641,0,3,endothelin B receptor binding,MF,
7991,GO:0031711,1,0.987195346751868,0,2,bradykinin receptor binding,MF,
7992,GO:0031714,1,0.991844005512988,0,1,C5a anaphylatoxin chemotactic receptor binding,MF,
7993,GO:0031715,1,0.991844005512988,0,1,C5L2 anaphylatoxin chemotactic receptor binding,MF,
7994,GO:0031716,1,0.996493328050457,0,1,calcitonin receptor binding,MF,
7995,GO:0031717,1,0.995546578106542,0,1,cannabinoid receptor binding,MF,
7996,GO:0031718,1,0.995546578106542,0,1,type 1 cannabinoid receptor binding,MF,
7997,GO:0031720,1,0.973609843351886,0,9,haptoglobin binding,MF,
7998,GO:0031721,1,0.988034622469134,0,4,hemoglobin alpha binding,MF,
7999,GO:0031724,1,0.996253231912534,0,1,CXCR5 chemokine receptor binding,MF,
8000,GO:0031726,1,0.996794928020969,0,1,CCR1 chemokine receptor binding,MF,
8001,GO:0031727,1,0.984624771268645,0,4,CCR2 chemokine receptor binding,MF,
8002,GO:0031728,1,0.994327642249785,0,2,CCR3 chemokine receptor binding,MF,
8003,GO:0031729,1,0.997027411383031,0,1,CCR4 chemokine receptor binding,MF,
8004,GO:0031730,1,0.973546278330127,0,4,CCR5 chemokine receptor binding,MF,
8005,GO:0031731,1,0.993966088061504,0,2,CCR6 chemokine receptor binding,MF,
8006,GO:0031732,1,0.993657086825178,0,2,CCR7 chemokine receptor binding,MF,
8007,GO:0031735,1,0.989914454286013,0,3,CCR10 chemokine receptor binding,MF,
8008,GO:0031737,1,0.992979387120577,0,1,CX3C chemokine receptor binding,MF,
8009,GO:0031739,1,0.994640101068689,0,1,cholecystokinin receptor binding,MF,
8010,GO:0031741,1,0.994640101068689,0,1,type B gastrin/cholecystokinin receptor binding,MF,
8011,GO:0031748,1,0.949453407601877,0,9,D1 dopamine receptor binding,MF,
8013,GO:0031750,1,0.981739603168739,0,3,D3 dopamine receptor binding,MF,
8014,GO:0031751,1,0.988235849520587,0,2,D4 dopamine receptor binding,MF,
8015,GO:0031752,1,0.978860728565578,0,3,D5 dopamine receptor binding,MF,
8016,GO:0031753,1,0.993453515718405,0,1,endothelial differentiation G protein-coupled receptor binding,MF,
8017,GO:0031755,1,0.993453515718405,0,1,Edg-2 lysophosphatidic acid receptor binding,MF,
8018,GO:0031762,1,0.989563484257934,0,2,follicle-stimulating hormone receptor binding,MF,
8019,GO:0031763,1,0.996825287701079,0,1,galanin receptor binding,MF,
8020,GO:0031764,1,0.996825287701079,0,1,type 1 galanin receptor binding,MF,
8021,GO:0031765,1,0.996825287701079,0,1,type 2 galanin receptor binding,MF,
8022,GO:0031766,1,0.996825287701079,0,1,type 3 galanin receptor binding,MF,
8023,GO:0031768,1,0.996906466060705,0,1,ghrelin receptor binding,MF,
8024,GO:0031770,1,0.997221714769688,0,1,growth hormone-releasing hormone receptor binding,MF,
8025,GO:0031773,1,0.996908940589292,0,1,kisspeptin receptor binding,MF,
8026,GO:0031775,1,0.989147080879768,0,1,lutropin-choriogonadotropic hormone receptor binding,MF,
8027,GO:0031776,1,0.996856687076956,0,1,melanin-concentrating hormone receptor binding,MF,
8028,GO:0031777,1,0.996856687076956,0,1,type 1 melanin-concentrating hormone receptor binding,MF,
8034,GO:0031798,1,0.98964657606176,0,1,type 1 metabotropic glutamate receptor binding,MF,
8035,GO:0031799,1,0.989455055931512,0,2,type 2 metabotropic glutamate receptor binding,MF,
8036,GO:0031800,1,0.983879342097422,0,3,type 3 metabotropic glutamate receptor binding,MF,
8037,GO:0031802,1,0.967727308168018,0,5,type 5 metabotropic glutamate receptor binding,MF,
8038,GO:0031811,1,0.992663684688279,0,1,G protein-coupled nucleotide receptor binding,MF,
8039,GO:0031812,1,0.992663684688279,0,1,P2Y1 nucleotide receptor binding,MF,
8040,GO:0031821,1,0.945400423966516,0,9,G protein-coupled serotonin receptor binding,MF,
8041,GO:0031826,1,0.974049832049973,0,5,type 2A serotonin receptor binding,MF,
8042,GO:0031834,1,0.993372044805998,0,2,neurokinin receptor binding,MF,
8043,GO:0031835,1,0.993372044805998,0,2,substance P receptor binding,MF,
8044,GO:0031838,1,0.969749770686608,0,10,haptoglobin-hemoglobin complex,CC,
8045,GO:0031839,1,0.996779666664659,0,1,type 1 neuromedin U receptor binding,MF,
8046,GO:0031840,1,0.996779666664659,0,1,type 2 neuromedin U receptor binding,MF,
8047,GO:0031848,1,0.933916161977364,0,10,protection from non-homologous end joining at telomere,BP,
8048,GO:0031849,1,0.977382010906415,0,4,olfactory receptor binding,MF,
8049,GO:0031852,1,0.970494005723782,0,4,mu-type opioid receptor binding,MF,
8050,GO:0031858,1,0.993052350907243,0,1,pituitary adenylate cyclase-activating polypeptide receptor binding,MF,
8051,GO:0031859,1,0.995060799902909,0,1,platelet activating factor receptor binding,MF,
8052,GO:0031860,1,0.97641313114033,0,3,telomeric 3' overhang formation,BP,
8053,GO:0031862,1,0.983768540268839,0,2,prostanoid receptor binding,MF,
8054,GO:0031867,1,0.992689437012252,0,1,EP4 subtype prostaglandin E2 receptor binding,MF,
8055,GO:0031870,1,0.991014061787873,0,1,thromboxane A2 receptor binding,MF,
8056,GO:0031871,1,0.979639271247153,0,3,proteinase activated receptor binding,MF,
8057,GO:0031877,1,0.990500859303761,0,1,somatostatin receptor binding,MF,
8058,GO:0031883,1,0.994675672511488,0,1,taste receptor binding,MF,
8059,GO:0031893,1,0.987058836660536,0,2,vasopressin receptor binding,MF,
8060,GO:0031894,1,0.992542377230726,0,1,V1A vasopressin receptor binding,MF,
8061,GO:0031896,1,0.99447567045752,0,1,V2 vasopressin receptor binding,MF,
8062,GO:0031901,1,0.362840001039176,0,146,early endosome membrane,CC,
8064,GO:0031903,1,0.688956393468707,0,58,microbody membrane,CC,
8065,GO:0031904,1,0.83578979336717,0,28,endosome lumen,CC,
8066,GO:0031905,1,0.98346349770696,0,3,early endosome lumen,CC,
8067,GO:0031906,1,0.976440013884213,0,6,late endosome lumen,CC,
8068,GO:0031907,1,0.753475913101249,0,51,microbody lumen,CC,
8069,GO:0031914,1,0.964437026458525,0,5,negative regulation of synaptic plasticity,BP,
8070,GO:0031915,1,0.915910397829383,0,11,positive regulation of synaptic plasticity,BP,
8071,GO:0031929,1,0.465793129675472,0,107,TOR signaling,BP,
8072,GO:0031930,1,0.995851936041635,0,1,mitochondria-nucleus signaling pathway,BP,
8073,GO:0031931,1,0.93187355460823,0,8,TORC1 complex,CC,
8074,GO:0031932,1,0.908111875038111,0,12,TORC2 complex,CC,
8075,GO:0031935,1,0.937242399379274,0,9,regulation of chromatin silencing,BP,
8076,GO:0031936,1,0.9699092595908,0,4,negative regulation of chromatin silencing,BP,
8077,GO:0031937,1,0.978401639430461,0,3,positive regulation of chromatin silencing,BP,
8078,GO:0031938,1,0.990603084429704,0,2,regulation of chromatin silencing at telomere,BP,
8079,GO:0031940,1,0.995555341111532,0,1,positive regulation of chromatin silencing at telomere,BP,
8080,GO:0031941,1,0.806726532097747,0,31,filamentous actin,CC,
8081,GO:0031943,1,0.934354591753647,0,10,regulation of glucocorticoid metabolic process,BP,
8082,GO:0031944,1,0.967054418134866,0,5,negative regulation of glucocorticoid metabolic process,BP,
8083,GO:0031945,1,0.992661278022655,0,1,positive regulation of glucocorticoid metabolic process,BP,
8084,GO:0031946,1,0.941462001606109,0,8,regulation of glucocorticoid biosynthetic process,BP,
8085,GO:0031947,1,0.967054418134866,0,5,negative regulation of glucocorticoid biosynthetic process,BP,
8086,GO:0031948,1,0.992661278022655,0,1,positive regulation of glucocorticoid biosynthetic process,BP,
8087,GO:0031952,1,0.719008166685246,0,45,regulation of protein autophosphorylation,BP,
8088,GO:0031953,1,0.917425530936871,0,12,negative regulation of protein autophosphorylation,BP,
8089,GO:0031954,1,0.833401620632143,0,25,positive regulation of protein autophosphorylation,BP,
8090,GO:0031956,1,0.935289819952107,0,10,medium-chain fatty acid-CoA ligase activity,MF,
8091,GO:0031957,1,0.943061701026455,0,9,very long-chain fatty acid-CoA ligase activity,MF,
8092,GO:0031958,1,0.90221049184441,0,14,corticosteroid receptor signaling pathway,BP,
8093,GO:0031959,1,0.991700669806181,0,1,mineralocorticoid receptor signaling pathway,BP,
8095,GO:0031962,1,0.991164795113101,0,1,mineralocorticoid receptor binding,MF,
8096,GO:0031965,1,0.144670623362135,0,276,nuclear membrane,CC,
8100,GO:0031970,1,0.639397661545614,0,80,organelle envelope lumen,CC,
8107,GO:0031985,1,0.508273161007631,0,101,Golgi cisterna,CC,
8108,GO:0031987,1,0.928004112342007,0,10,locomotion involved in locomotory behavior,BP,
8109,GO:0031989,1,0.995933779426078,0,1,bombesin receptor signaling pathway,BP,
8110,GO:0031990,1,0.982225938063975,0,2,mRNA export from nucleus in response to heat stress,BP,
8113,GO:0031996,1,0.931721627276805,0,11,thioesterase binding,MF,
8114,GO:0031997,1,0.983050867373093,0,3,N-terminal myristoylation domain binding,MF,
8117,GO:0032000,1,0.924776629369443,0,10,positive regulation of fatty acid beta-oxidation,BP,
8118,GO:0032002,1,0.988516245461563,0,2,interleukin-28 receptor complex,CC,
8119,GO:0032006,1,0.545347794118798,0,86,regulation of TOR signaling,BP,
8120,GO:0032007,1,0.774533271602443,0,36,negative regulation of TOR signaling,BP,
8121,GO:0032008,1,0.7718081284345,0,38,positive regulation of TOR signaling,BP,
8122,GO:0032009,1,0.910946162254764,0,13,early phagosome,CC,
8123,GO:0032010,1,0.968326902344288,0,6,phagolysosome,CC,
8124,GO:0032011,1,0.852960484565676,0,19,ARF protein signal transduction,BP,
8125,GO:0032012,1,0.852960484565676,0,19,regulation of ARF protein signal transduction,BP,
8126,GO:0032014,1,0.983191849180449,0,2,positive regulation of ARF protein signal transduction,BP,
8127,GO:0032020,1,0.970489892332174,0,6,ISG15-protein conjugation,BP,
8128,GO:0032021,1,0.974192639685168,0,4,NELF complex,CC,
8129,GO:0032023,1,0.994326750937077,0,1,trypsinogen activation,BP,
8131,GO:0032025,1,0.94514115995498,0,9,response to cobalt ion,BP,
8133,GO:0032027,1,0.955269544391497,0,7,myosin light chain binding,MF,
8134,GO:0032028,1,0.98570329309494,0,2,myosin head/neck binding,MF,
8135,GO:0032029,1,0.986329841623739,0,1,myosin tail binding,MF,
8136,GO:0032034,1,0.990991888077606,0,1,myosin II head/neck binding,MF,
8137,GO:0032036,1,0.9356407213595,0,11,myosin heavy chain binding,MF,
8138,GO:0032038,1,0.984381077264059,0,3,myosin II heavy chain binding,MF,
8139,GO:0032039,1,0.887599016488501,0,15,integrator complex,CC,
8140,GO:0032040,1,0.807279925936807,0,33,small-subunit processome,CC,
8141,GO:0032041,1,0.928681853975168,0,10,NAD-dependent histone deacetylase activity (H3-K14 specific),MF,
8142,GO:0032042,1,0.91061740858707,0,14,mitochondrial DNA metabolic process,BP,
8143,GO:0032044,1,0.988574500835349,0,2,DSIF complex,CC,
8144,GO:0032045,1,0.903685444748937,0,14,guanyl-nucleotide exchange factor complex,CC,
8145,GO:0032048,1,0.90259986908783,0,17,cardiolipin metabolic process,BP,
8146,GO:0032049,1,0.951859045743564,0,8,cardiolipin biosynthetic process,BP,
8147,GO:0032050,1,0.938675209473508,0,8,clathrin heavy chain binding,MF,
8148,GO:0032051,1,0.959919925671859,0,5,clathrin light chain binding,MF,
8149,GO:0032052,1,0.958482005324819,0,9,bile acid binding,MF,
8150,GO:0032053,1,0.968115770897602,0,4,ciliary basal body organization,BP,
8151,GO:0032055,1,0.960696621309962,0,6,negative regulation of translation in response to stress,BP,
8152,GO:0032056,1,0.943905923008005,0,8,positive regulation of translation in response to stress,BP,
8153,GO:0032057,1,0.97194880648605,0,4,negative regulation of translational initiation in response to stress,BP,
8154,GO:0032058,1,0.970131326919441,0,4,positive regulation of translational initiation in response to stress,BP,
8155,GO:0032059,1,0.938141491817022,0,9,bleb,CC,
8156,GO:0032060,1,0.925867776757544,0,11,bleb assembly,BP,
8157,GO:0032069,1,0.877018237411616,0,22,regulation of nuclease activity,BP,
8158,GO:0032070,1,0.945428268699085,0,10,regulation of deoxyribonuclease activity,BP,
8159,GO:0032071,1,0.955330916514282,0,8,regulation of endodeoxyribonuclease activity,BP,
8160,GO:0032072,1,0.992883196635576,0,1,regulation of restriction endodeoxyribonuclease activity,BP,
8161,GO:0032074,1,0.958313060183368,0,7,negative regulation of nuclease activity,BP,
8162,GO:0032075,1,0.95649919758694,0,8,positive regulation of nuclease activity,BP,
8163,GO:0032076,1,0.99026151246265,0,2,negative regulation of deoxyribonuclease activity,BP,
8164,GO:0032077,1,0.972549065315506,0,5,positive regulation of deoxyribonuclease activity,BP,
8165,GO:0032078,1,0.996675161961626,0,1,negative regulation of endodeoxyribonuclease activity,BP,
8166,GO:0032079,1,0.976408065516672,0,4,positive regulation of endodeoxyribonuclease activity,BP,
8167,GO:0032088,1,0.603992956968074,0,79,negative regulation of NF-kappaB transcription factor activity,BP,
8168,GO:0032089,1,0.985124401354647,0,2,NACHT domain binding,MF,
8169,GO:0032090,1,0.989526541986794,0,2,Pyrin domain binding,MF,
8170,GO:0032091,1,0.53549772877019,0,95,negative regulation of protein binding,BP,
8171,GO:0032092,1,0.569340400598455,0,80,positive regulation of protein binding,BP,
8172,GO:0032093,1,0.993485400251684,0,1,SAM domain binding,MF,
8173,GO:0032094,1,0.820755777271662,0,33,response to food,BP,
8174,GO:0032095,1,0.906739919510642,0,18,regulation of response to food,BP,
8175,GO:0032096,1,0.936364983253501,0,12,negative regulation of response to food,BP,
8176,GO:0032097,1,0.989175472550212,0,3,positive regulation of response to food,BP,
8177,GO:0032098,1,0.900597532259758,0,20,regulation of appetite,BP,
8178,GO:0032099,1,0.936364983253501,0,12,negative regulation of appetite,BP,
8179,GO:0032100,1,0.989175472550212,0,3,positive regulation of appetite,BP,
8183,GO:0032104,1,0.868364614112912,0,24,regulation of response to extracellular stimulus,BP,
8184,GO:0032105,1,0.923823409207075,0,14,negative regulation of response to extracellular stimulus,BP,
8185,GO:0032106,1,0.977876598469718,0,5,positive regulation of response to extracellular stimulus,BP,
8186,GO:0032107,1,0.868364614112912,0,24,regulation of response to nutrient levels,BP,
8187,GO:0032108,1,0.923823409207075,0,14,negative regulation of response to nutrient levels,BP,
8188,GO:0032109,1,0.977876598469718,0,5,positive regulation of response to nutrient levels,BP,
8189,GO:0032116,1,0.981156989793675,0,2,SMC loading complex,CC,
8192,GO:0032129,1,0.988274593939241,0,2,histone deacetylase activity (H3-K9 specific),MF,
8194,GO:0032135,1,0.960613903888367,0,6,DNA insertion or deletion binding,MF,
8195,GO:0032137,1,0.979616442470265,0,3,guanine/thymine mispair binding,MF,
8196,GO:0032138,1,0.971436419893408,0,4,single base insertion or deletion binding,MF,
8197,GO:0032139,1,0.981458293792722,0,3,dinucleotide insertion or deletion binding,MF,
8198,GO:0032142,1,0.977904992966658,0,3,single guanine insertion binding,MF,
8199,GO:0032143,1,0.985559006025462,0,2,single thymine insertion binding,MF,
8200,GO:0032144,1,0.992022490948624,0,1,4-aminobutyrate transaminase complex,CC,
8201,GO:0032145,1,0.992022490948624,0,1,succinate-semialdehyde dehydrogenase binding,MF,
8203,GO:0032148,1,0.820074657876788,0,29,activation of protein kinase B activity,BP,
8204,GO:0032153,1,0.671570201421766,0,56,cell division site,CC,
8205,GO:0032154,1,0.705491580464106,0,49,cleavage furrow,CC,
8206,GO:0032156,1,0.992501737686181,0,1,septin cytoskeleton,CC,
8207,GO:0032181,1,0.985352288096756,0,2,dinucleotide repeat insertion binding,MF,
8209,GO:0032183,1,0.884879739379392,0,15,SUMO binding,MF,
8210,GO:0032184,1,0.960199620465896,0,5,SUMO polymer binding,MF,
8211,GO:0032185,1,0.97467081521103,0,4,septin cytoskeleton organization,BP,
8212,GO:0032190,1,0.986181640178728,0,3,acrosin binding,MF,
8213,GO:0032194,1,0.992771023838117,0,1,ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate,BP,
8214,GO:0032196,1,0.871193244517651,0,22,transposition,BP,
8215,GO:0032197,1,0.988360404724548,0,2,transposition, RNA-mediated,BP,
8216,GO:0032200,1,0.379807088543096,0,140,telomere organization,BP,
8217,GO:0032201,1,0.850958180927683,0,27,telomere maintenance via semi-conservative replication,BP,
8218,GO:0032202,1,0.973164592262252,0,5,telomere assembly,BP,
8219,GO:0032203,1,0.995152293069162,0,1,telomere formation via telomerase,BP,
8220,GO:0032204,1,0.579112251633057,0,76,regulation of telomere maintenance,BP,
8221,GO:0032205,1,0.775474118993834,0,33,negative regulation of telomere maintenance,BP,
8222,GO:0032206,1,0.717459476891712,0,49,positive regulation of telomere maintenance,BP,
8223,GO:0032207,1,0.993317365421639,0,1,regulation of telomere maintenance via recombination,BP,
8224,GO:0032208,1,0.993317365421639,0,1,negative regulation of telomere maintenance via recombination,BP,
8225,GO:0032210,1,0.70196605435956,0,51,regulation of telomere maintenance via telomerase,BP,
8226,GO:0032211,1,0.877227719620701,0,18,negative regulation of telomere maintenance via telomerase,BP,
8227,GO:0032212,1,0.799873856936561,0,34,positive regulation of telomere maintenance via telomerase,BP,
8228,GO:0032213,1,0.986638367949322,0,2,regulation of telomere maintenance via semi-conservative replication,BP,
8229,GO:0032214,1,0.986638367949322,0,2,negative regulation of telomere maintenance via semi-conservative replication,BP,
8230,GO:0032217,1,0.96947232851846,0,5,riboflavin transmembrane transporter activity,MF,
8231,GO:0032218,1,0.96947232851846,0,5,riboflavin transport,BP,
8232,GO:0032222,1,0.96019530146296,0,6,regulation of synaptic transmission, cholinergic,BP,
8233,GO:0032223,1,0.993778976671205,0,1,negative regulation of synaptic transmission, cholinergic,BP,
8234,GO:0032224,1,0.972407142614359,0,4,positive regulation of synaptic transmission, cholinergic,BP,
8235,GO:0032225,1,0.908088945226236,0,16,regulation of synaptic transmission, dopaminergic,BP,
8236,GO:0032226,1,0.9612590056232,0,7,positive regulation of synaptic transmission, dopaminergic,BP,
8237,GO:0032227,1,0.977853820399326,0,3,negative regulation of synaptic transmission, dopaminergic,BP,
8239,GO:0032229,1,0.958524651555433,0,7,negative regulation of synaptic transmission, GABAergic,BP,
8240,GO:0032230,1,0.91675345137606,0,12,positive regulation of synaptic transmission, GABAergic,BP,
8241,GO:0032231,1,0.488909719020605,0,96,regulation of actin filament bundle assembly,BP,
8242,GO:0032232,1,0.80289157333994,0,28,negative regulation of actin filament bundle assembly,BP,
8243,GO:0032233,1,0.655303329006035,0,60,positive regulation of actin filament bundle assembly,BP,
8244,GO:0032237,1,0.970684399674059,0,4,activation of store-operated calcium channel activity,BP,
8245,GO:0032238,1,0.988141161585106,0,2,adenosine transport,BP,
8246,GO:0032239,1,0.863615181291739,0,19,regulation of nucleobase-containing compound transport,BP,
8247,GO:0032240,1,0.974632989178906,0,3,negative regulation of nucleobase-containing compound transport,BP,
8248,GO:0032241,1,0.936298343934012,0,9,positive regulation of nucleobase-containing compound transport,BP,
8249,GO:0032242,1,0.988590104204679,0,2,regulation of nucleoside transport,BP,
8250,GO:0032243,1,0.995168540831618,0,1,negative regulation of nucleoside transport,BP,
8251,GO:0032244,1,0.993389945047484,0,1,positive regulation of nucleoside transport,BP,
8254,GO:0032259,1,0.123021538080109,0,306,methylation,BP,
8255,GO:0032261,1,0.968853540497113,0,6,purine nucleotide salvage,BP,
8256,GO:0032262,1,0.975544891642433,0,5,pyrimidine nucleotide salvage,BP,
8257,GO:0032263,1,0.995924241798657,0,1,GMP salvage,BP,
8258,GO:0032264,1,0.981199230452247,0,3,IMP salvage,BP,
8259,GO:0032266,1,0.726341990940316,0,42,phosphatidylinositol-3-phosphate binding,MF,
8265,GO:0032273,1,0.435330400104191,0,123,positive regulation of protein polymerization,BP,
8266,GO:0032274,1,0.918562500536698,0,13,gonadotropin secretion,BP,
8267,GO:0032275,1,0.940416482671877,0,9,luteinizing hormone secretion,BP,
8268,GO:0032276,1,0.940216261294985,0,10,regulation of gonadotropin secretion,BP,
8269,GO:0032277,1,0.96723270854714,0,6,negative regulation of gonadotropin secretion,BP,
8270,GO:0032278,1,0.956105821800523,0,7,positive regulation of gonadotropin secretion,BP,
8272,GO:0032280,1,0.91665691876442,0,11,symmetric synapse,CC,
8273,GO:0032281,1,0.848151038218196,0,26,AMPA glutamate receptor complex,CC,
8274,GO:0032286,1,0.972679609605861,0,4,central nervous system myelin maintenance,BP,
8275,GO:0032287,1,0.931493746718987,0,8,peripheral nervous system myelin maintenance,BP,
8276,GO:0032288,1,0.84923241196107,0,21,myelin assembly,BP,
8277,GO:0032289,1,0.970444906214636,0,4,central nervous system myelin formation,BP,
8278,GO:0032290,1,0.981065805676167,0,2,peripheral nervous system myelin formation,BP,
8279,GO:0032291,1,0.86625999702383,0,21,axon ensheathment in central nervous system,BP,
8280,GO:0032292,1,0.804340173925328,0,27,peripheral nervous system axon ensheathment,BP,
8281,GO:0032296,1,0.969059278735063,0,4,double-stranded RNA-specific ribonuclease activity,MF,
8282,GO:0032298,1,0.99439752472598,0,1,positive regulation of DNA-dependent DNA replication initiation,BP,
8283,GO:0032299,1,0.985532797268961,0,3,ribonuclease H2 complex,CC,
8284,GO:0032300,1,0.94860671558537,0,7,mismatch repair complex,CC,
8285,GO:0032301,1,0.985559006025462,0,2,MutSalpha complex,CC,
8286,GO:0032302,1,0.985352288096756,0,2,MutSbeta complex,CC,
8287,GO:0032303,1,0.931523646360432,0,12,regulation of icosanoid secretion,BP,
8288,GO:0032304,1,0.991922972061398,0,1,negative regulation of icosanoid secretion,BP,
8289,GO:0032305,1,0.939108581891723,0,11,positive regulation of icosanoid secretion,BP,
8290,GO:0032306,1,0.964218390898206,0,7,regulation of prostaglandin secretion,BP,
8291,GO:0032308,1,0.964218390898206,0,7,positive regulation of prostaglandin secretion,BP,
8293,GO:0032310,1,0.942896800252452,0,10,prostaglandin secretion,BP,
8294,GO:0032311,1,0.991659561251107,0,2,angiogenin-PRI complex,CC,
8295,GO:0032324,1,0.963161630110255,0,6,molybdopterin cofactor biosynthetic process,BP,
8297,GO:0032329,1,0.950886927360429,0,8,serine transport,BP,
8298,GO:0032330,1,0.722241767746828,0,45,regulation of chondrocyte differentiation,BP,
8299,GO:0032331,1,0.877880586497754,0,19,negative regulation of chondrocyte differentiation,BP,
8300,GO:0032332,1,0.863411468077475,0,20,positive regulation of chondrocyte differentiation,BP,
8301,GO:0032341,1,0.943392349947414,0,8,aldosterone metabolic process,BP,
8302,GO:0032342,1,0.943392349947414,0,8,aldosterone biosynthetic process,BP,
8303,GO:0032344,1,0.953637077668725,0,7,regulation of aldosterone metabolic process,BP,
8304,GO:0032345,1,0.974143970854964,0,4,negative regulation of aldosterone metabolic process,BP,
8305,GO:0032346,1,0.985817512867605,0,2,positive regulation of aldosterone metabolic process,BP,
8306,GO:0032347,1,0.953637077668725,0,7,regulation of aldosterone biosynthetic process,BP,
8307,GO:0032348,1,0.974143970854964,0,4,negative regulation of aldosterone biosynthetic process,BP,
8308,GO:0032349,1,0.985817512867605,0,2,positive regulation of aldosterone biosynthetic process,BP,
8309,GO:0032350,1,0.814446241189844,0,31,regulation of hormone metabolic process,BP,
8310,GO:0032351,1,0.949867368408231,0,8,negative regulation of hormone metabolic process,BP,
8311,GO:0032352,1,0.914040298135977,0,13,positive regulation of hormone metabolic process,BP,
8312,GO:0032353,1,0.959955106475548,0,6,negative regulation of hormone biosynthetic process,BP,
8313,GO:0032354,1,0.895941288247491,0,14,response to follicle-stimulating hormone,BP,
8315,GO:0032356,1,0.937757608905872,0,10,oxidized DNA binding,MF,
8316,GO:0032357,1,0.942804598164591,0,9,oxidized purine DNA binding,MF,
8317,GO:0032358,1,0.99674640915843,0,1,oxidized pyrimidine DNA binding,MF,
8318,GO:0032361,1,0.994871164100436,0,1,pyridoxal phosphate catabolic process,BP,
8319,GO:0032364,1,0.955654585574208,0,7,oxygen homeostasis,BP,
8320,GO:0032365,1,0.767545489952896,0,37,intracellular lipid transport,BP,
8321,GO:0032366,1,0.860279334067111,0,21,intracellular sterol transport,BP,
8322,GO:0032367,1,0.860279334067111,0,21,intracellular cholesterol transport,BP,
8323,GO:0032368,1,0.550549566016836,0,93,regulation of lipid transport,BP,
8324,GO:0032369,1,0.866548776263001,0,20,negative regulation of lipid transport,BP,
8325,GO:0032370,1,0.687843805525899,0,60,positive regulation of lipid transport,BP,
8326,GO:0032371,1,0.751949236894399,0,44,regulation of sterol transport,BP,
8327,GO:0032372,1,0.94383350184812,0,9,negative regulation of sterol transport,BP,
8328,GO:0032373,1,0.838967270177788,0,26,positive regulation of sterol transport,BP,
8329,GO:0032374,1,0.755622538693909,0,43,regulation of cholesterol transport,BP,
8330,GO:0032375,1,0.94383350184812,0,9,negative regulation of cholesterol transport,BP,
8331,GO:0032376,1,0.838967270177788,0,26,positive regulation of cholesterol transport,BP,
8332,GO:0032377,1,0.955553358366792,0,7,regulation of intracellular lipid transport,BP,
8333,GO:0032378,1,0.982037944097064,0,2,negative regulation of intracellular lipid transport,BP,
8334,GO:0032379,1,0.984822422012981,0,3,positive regulation of intracellular lipid transport,BP,
8335,GO:0032380,1,0.955553358366792,0,7,regulation of intracellular sterol transport,BP,
8336,GO:0032381,1,0.982037944097064,0,2,negative regulation of intracellular sterol transport,BP,
8337,GO:0032382,1,0.984822422012981,0,3,positive regulation of intracellular sterol transport,BP,
8338,GO:0032383,1,0.955553358366792,0,7,regulation of intracellular cholesterol transport,BP,
8339,GO:0032384,1,0.982037944097064,0,2,negative regulation of intracellular cholesterol transport,BP,
8340,GO:0032385,1,0.984822422012981,0,3,positive regulation of intracellular cholesterol transport,BP,
8344,GO:0032389,1,0.987397457005509,0,2,MutLalpha complex,CC,
8347,GO:0032393,1,0.966073712768585,0,7,MHC class I receptor activity,MF,
8348,GO:0032394,1,0.980502935154744,0,4,MHC class Ib receptor activity,MF,
8349,GO:0032395,1,0.962071168238616,0,9,MHC class II receptor activity,MF,
8350,GO:0032396,1,0.981811597795858,0,3,inhibitory MHC class I receptor activity,MF,
8351,GO:0032397,1,0.991538976957046,0,2,activating MHC class I receptor activity,MF,
8352,GO:0032398,1,0.991628915621202,0,2,MHC class Ib protein complex,CC,
8353,GO:0032400,1,0.852680643893422,0,25,melanosome localization,BP,
8354,GO:0032401,1,0.863558205384717,0,23,establishment of melanosome localization,BP,
8355,GO:0032402,1,0.872452550786378,0,22,melanosome transport,BP,
8356,GO:0032404,1,0.929088071424134,0,11,mismatch repair complex binding,MF,
8357,GO:0032405,1,0.958201834534616,0,6,MutLalpha complex binding,MF,
8358,GO:0032406,1,0.986764838496335,0,2,MutLbeta complex binding,MF,
8359,GO:0032407,1,0.954777163739783,0,7,MutSalpha complex binding,MF,
8360,GO:0032408,1,0.986764838496335,0,2,MutSbeta complex binding,MF,
8362,GO:0032410,1,0.619669072201924,0,73,negative regulation of transporter activity,BP,
8365,GO:0032413,1,0.650371045828154,0,66,negative regulation of ion transmembrane transporter activity,BP,
8367,GO:0032415,1,0.969552402749655,0,6,regulation of sodium:proton antiporter activity,BP,
8368,GO:0032416,1,0.990522763132565,0,2,negative regulation of sodium:proton antiporter activity,BP,
8369,GO:0032417,1,0.978830995380077,0,4,positive regulation of sodium:proton antiporter activity,BP,
8371,GO:0032419,1,0.99441603432747,0,1,extrinsic component of lysosome membrane,CC,
8374,GO:0032422,1,0.971321073710036,0,4,purine-rich negative regulatory element binding,MF,
8375,GO:0032423,1,0.972346994620558,0,4,regulation of mismatch repair,BP,
8376,GO:0032425,1,0.979700666260381,0,3,positive regulation of mismatch repair,BP,
8378,GO:0032427,1,0.986888860126263,0,2,GBD domain binding,MF,
8379,GO:0032428,1,0.992803253984512,0,1,beta-N-acetylgalactosaminidase activity,MF,
8380,GO:0032429,1,0.93907372690832,0,9,regulation of phospholipase A2 activity,BP,
8381,GO:0032430,1,0.971667625025808,0,5,positive regulation of phospholipase A2 activity,BP,
8382,GO:0032431,1,0.985196816622225,0,3,activation of phospholipase A2 activity,BP,
8384,GO:0032433,1,0.878301524129076,0,16,filopodium tip,CC,
8385,GO:0032434,1,0.440311322446102,0,124,regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,
8386,GO:0032435,1,0.806925360681981,0,33,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,
8387,GO:0032436,1,0.580899470349112,0,82,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,
8388,GO:0032437,1,0.940474988088002,0,9,cuticular plate,CC,
8389,GO:0032438,1,0.835522268826446,0,27,melanosome organization,BP,
8390,GO:0032440,1,0.996178113993336,0,1,2-alkenal reductase [NAD(P)+] activity,MF,
8391,GO:0032444,1,0.970859262250329,0,3,activin responsive factor complex,CC,
8392,GO:0032445,1,0.994246102295014,0,1,fructose import,BP,
8394,GO:0032447,1,0.97997198164395,0,4,protein urmylation,BP,
8395,GO:0032448,1,0.995653890567335,0,1,DNA hairpin binding,MF,
8396,GO:0032449,1,0.970435731091163,0,4,CBM complex,CC,
8397,GO:0032450,1,0.975863320992585,0,3,maltose alpha-glucosidase activity,MF,
8398,GO:0032451,1,0.765102349245685,0,34,demethylase activity,MF,
8399,GO:0032452,1,0.807472524202449,0,25,histone demethylase activity,MF,
8400,GO:0032453,1,0.94687698505508,0,6,histone demethylase activity (H3-K4 specific),MF,
8401,GO:0032454,1,0.905940450043029,0,12,histone demethylase activity (H3-K9 specific),MF,
8402,GO:0032455,1,0.975094033107373,0,4,nerve growth factor processing,BP,
8403,GO:0032456,1,0.720013525829518,0,45,endocytic recycling,BP,
8404,GO:0032458,1,0.992673476787072,0,1,slow endocytic recycling,BP,
8405,GO:0032459,1,0.987845220901783,0,2,regulation of protein oligomerization,BP,
8406,GO:0032460,1,0.992961790923873,0,1,negative regulation of protein oligomerization,BP,
8407,GO:0032461,1,0.994847526454866,0,1,positive regulation of protein oligomerization,BP,
8408,GO:0032462,1,0.992961790923873,0,1,regulation of protein homooligomerization,BP,
8409,GO:0032463,1,0.992961790923873,0,1,negative regulation of protein homooligomerization,BP,
8410,GO:0032465,1,0.563342762311536,0,79,regulation of cytokinesis,BP,
8411,GO:0032466,1,0.957103608562739,0,7,negative regulation of cytokinesis,BP,
8412,GO:0032467,1,0.803823213392418,0,31,positive regulation of cytokinesis,BP,
8413,GO:0032468,1,0.987820297961017,0,2,Golgi calcium ion homeostasis,BP,
8414,GO:0032469,1,0.851279793686527,0,23,endoplasmic reticulum calcium ion homeostasis,BP,
8415,GO:0032470,1,0.982050389382901,0,2,positive regulation of endoplasmic reticulum calcium ion concentration,BP,
8416,GO:0032471,1,0.954547867352479,0,8,negative regulation of endoplasmic reticulum calcium ion concentration,BP,
8417,GO:0032472,1,0.987820297961017,0,2,Golgi calcium ion transport,BP,
8418,GO:0032473,1,0.983097781417425,0,2,cytoplasmic side of mitochondrial outer membrane,CC,
8419,GO:0032474,1,0.970845297110041,0,4,otolith morphogenesis,BP,
8420,GO:0032475,1,0.993668575033675,0,1,otolith formation,BP,
8421,GO:0032479,1,0.460561826058283,0,114,regulation of type I interferon production,BP,
8422,GO:0032480,1,0.755302545931251,0,41,negative regulation of type I interferon production,BP,
8423,GO:0032481,1,0.623824327357859,0,69,positive regulation of type I interferon production,BP,
8424,GO:0032482,1,0.869189133317216,0,21,Rab protein signal transduction,BP,
8425,GO:0032483,1,0.941730912596441,0,7,regulation of Rab protein signal transduction,BP,
8426,GO:0032484,1,0.975180057177949,0,3,Ral protein signal transduction,BP,
8427,GO:0032485,1,0.975180057177949,0,3,regulation of Ral protein signal transduction,BP,
8428,GO:0032486,1,0.892293405156452,0,14,Rap protein signal transduction,BP,
8429,GO:0032487,1,0.962324497065033,0,4,regulation of Rap protein signal transduction,BP,
8430,GO:0032488,1,0.928291189703698,0,12,Cdc42 protein signal transduction,BP,
8431,GO:0032489,1,0.962629415817695,0,6,regulation of Cdc42 protein signal transduction,BP,
8432,GO:0032490,1,0.919778041157627,0,12,detection of molecule of bacterial origin,BP,
8433,GO:0032491,1,0.994053000565831,0,1,detection of molecule of fungal origin,BP,
8434,GO:0032493,1,0.946051340587252,0,8,response to bacterial lipoprotein,BP,
8435,GO:0032494,1,0.936143887861288,0,11,response to peptidoglycan,BP,
8436,GO:0032495,1,0.883831976029656,0,18,response to muramyl dipeptide,BP,
8438,GO:0032497,1,0.978691504000533,0,4,detection of lipopolysaccharide,BP,
8439,GO:0032498,1,0.992336393545571,0,1,detection of muramyl dipeptide,BP,
8440,GO:0032499,1,0.988829064379885,0,2,detection of peptidoglycan,BP,
8441,GO:0032500,1,0.992336393545571,0,1,muramyl dipeptide binding,MF,
8445,GO:0032505,1,0.987515183603508,0,1,reproduction of a single-celled organism,BP,
8446,GO:0032506,1,0.780931404429913,0,39,cytokinetic process,BP,
8447,GO:0032507,1,0.651131795658122,0,63,maintenance of protein location in cell,BP,
8449,GO:0032509,1,0.817893874355541,0,33,endosome transport via multivesicular body sorting pathway,BP,
8450,GO:0032510,1,0.947601259601663,0,7,endosome to lysosome transport via multivesicular body sorting pathway,BP,
8451,GO:0032511,1,0.917816460932416,0,16,late endosome to vacuole transport via multivesicular body sorting pathway,BP,
8453,GO:0032516,1,0.878487860015751,0,18,positive regulation of phosphoprotein phosphatase activity,BP,
8454,GO:0032525,1,0.937477208212222,0,11,somite rostral/caudal axis specification,BP,
8456,GO:0032527,1,0.734317009870601,0,45,protein exit from endoplasmic reticulum,BP,
8460,GO:0032534,1,0.954070074756074,0,6,regulation of microvillus assembly,BP,
8463,GO:0032541,1,0.970581886314032,0,5,cortical endoplasmic reticulum,CC,
8464,GO:0032542,1,0.986703975603667,0,2,sulfiredoxin activity,MF,
8465,GO:0032543,1,0.538480745404712,0,129,mitochondrial translation,BP,
8466,GO:0032545,1,0.988796662089168,0,2,CURI complex,CC,
8469,GO:0032552,1,0.972112550768645,0,5,deoxyribonucleotide binding,MF,
8471,GO:0032554,1,0.975649975837363,0,4,purine deoxyribonucleotide binding,MF,
8473,GO:0032556,1,0.996375183284148,0,1,pyrimidine deoxyribonucleotide binding,MF,
8474,GO:0032557,1,0.979979093097208,0,3,pyrimidine ribonucleotide binding,MF,
8475,GO:0032558,1,0.98249980081879,0,3,adenyl deoxyribonucleotide binding,MF,
8477,GO:0032560,1,0.993029393211783,0,1,guanyl deoxyribonucleotide binding,MF,
8479,GO:0032564,1,0.986910255137114,0,2,dATP binding,MF,
8480,GO:0032567,1,0.993029393211783,0,1,dGTP binding,MF,
8482,GO:0032571,1,0.977340992492947,0,4,response to vitamin K,BP,
8483,GO:0032574,1,0.985483564302145,0,2,5'-3' RNA helicase activity,MF,
8484,GO:0032580,1,0.596619636761055,0,77,Golgi cisterna membrane,CC,
8485,GO:0032581,1,0.995175219064203,0,1,ER-dependent peroxisome organization,BP,
8486,GO:0032584,1,0.954360310111699,0,7,growth cone membrane,CC,
8487,GO:0032585,1,0.932306498877052,0,11,multivesicular body membrane,CC,
8489,GO:0032588,1,0.573105820112077,0,85,trans-Golgi network membrane,CC,
8494,GO:0032593,1,0.923941589018794,0,10,insulin-responsive compartment,CC,
8495,GO:0032594,1,0.960468214752509,0,7,protein transport within lipid bilayer,BP,
8496,GO:0032596,1,0.974447142446925,0,4,protein transport into membrane raft,BP,
8497,GO:0032601,1,0.979469110629194,0,3,connective tissue growth factor production,BP,
8498,GO:0032602,1,0.677400240031224,0,66,chemokine production,BP,
8499,GO:0032603,1,0.992173794458403,0,2,fractalkine production,BP,
8500,GO:0032604,1,0.930210008122595,0,12,granulocyte macrophage colony-stimulating factor production,BP,
8501,GO:0032605,1,0.993029393211783,0,1,hepatocyte growth factor production,BP,
8502,GO:0032606,1,0.45560173188148,0,116,type I interferon production,BP,
8503,GO:0032607,1,0.824005013929877,0,27,interferon-alpha production,BP,
8504,GO:0032608,1,0.717955116213829,0,48,interferon-beta production,BP,
8505,GO:0032609,1,0.556904236097217,0,99,interferon-gamma production,BP,
8506,GO:0032610,1,0.973129737428243,0,4,interleukin-1 alpha production,BP,
8507,GO:0032611,1,0.618036423128884,0,81,interleukin-1 beta production,BP,
8508,GO:0032612,1,0.578120426476165,0,92,interleukin-1 production,BP,
8509,GO:0032613,1,0.743569897504548,0,51,interleukin-10 production,BP,
8510,GO:0032615,1,0.721838607431715,0,52,interleukin-12 production,BP,
8511,GO:0032616,1,0.905068900020325,0,16,interleukin-13 production,BP,
8512,GO:0032618,1,0.990793493375569,0,2,interleukin-15 production,BP,
8513,GO:0032620,1,0.863372866515687,0,26,interleukin-17 production,BP,
8514,GO:0032621,1,0.945769868736817,0,8,interleukin-18 production,BP,
8515,GO:0032623,1,0.717577539904251,0,52,interleukin-2 production,BP,
8516,GO:0032625,1,0.98911794700941,0,2,interleukin-21 production,BP,
8517,GO:0032627,1,0.972294847298579,0,4,interleukin-23 production,BP,
8518,GO:0032632,1,0.986965443315165,0,2,interleukin-3 production,BP,
8519,GO:0032633,1,0.832058486958981,0,31,interleukin-4 production,BP,
8520,GO:0032634,1,0.915149557901877,0,13,interleukin-5 production,BP,
8521,GO:0032635,1,0.452479027159648,0,126,interleukin-6 production,BP,
8522,GO:0032637,1,0.645299986338609,0,72,interleukin-8 production,BP,
8523,GO:0032639,1,0.995482909867247,0,1,TRAIL production,BP,
8524,GO:0032640,1,0.536322884766018,0,101,tumor necrosis factor production,BP,
8525,GO:0032642,1,0.697938825849291,0,59,regulation of chemokine production,BP,
8526,GO:0032643,1,0.979469110629194,0,3,regulation of connective tissue growth factor production,BP,
8527,GO:0032645,1,0.934520170130621,0,11,regulation of granulocyte macrophage colony-stimulating factor production,BP,
8528,GO:0032646,1,0.993029393211783,0,1,regulation of hepatocyte growth factor production,BP,
8529,GO:0032647,1,0.831144339806764,0,25,regulation of interferon-alpha production,BP,
8530,GO:0032648,1,0.72315622690941,0,47,regulation of interferon-beta production,BP,
8531,GO:0032649,1,0.595603847503179,0,89,regulation of interferon-gamma production,BP,
8532,GO:0032650,1,0.976022341910708,0,3,regulation of interleukin-1 alpha production,BP,
8533,GO:0032651,1,0.656469149382533,0,72,regulation of interleukin-1 beta production,BP,
8534,GO:0032652,1,0.615929563099122,0,82,regulation of interleukin-1 production,BP,
8535,GO:0032653,1,0.755808465023189,0,48,regulation of interleukin-10 production,BP,
8536,GO:0032655,1,0.73183396856338,0,50,regulation of interleukin-12 production,BP,
8537,GO:0032656,1,0.91458794280913,0,14,regulation of interleukin-13 production,BP,
8538,GO:0032658,1,0.995291300945664,0,1,regulation of interleukin-15 production,BP,
8539,GO:0032660,1,0.888050832696071,0,21,regulation of interleukin-17 production,BP,
8540,GO:0032661,1,0.960043951224829,0,6,regulation of interleukin-18 production,BP,
8541,GO:0032663,1,0.735538013318097,0,47,regulation of interleukin-2 production,BP,
8542,GO:0032667,1,0.972294847298579,0,4,regulation of interleukin-23 production,BP,
8543,GO:0032672,1,0.994244193778852,0,1,regulation of interleukin-3 production,BP,
8544,GO:0032673,1,0.840954517989574,0,29,regulation of interleukin-4 production,BP,
8545,GO:0032674,1,0.915149557901877,0,13,regulation of interleukin-5 production,BP,
8546,GO:0032675,1,0.484095898481362,0,116,regulation of interleukin-6 production,BP,
8547,GO:0032677,1,0.670381291876103,0,66,regulation of interleukin-8 production,BP,
8548,GO:0032679,1,0.995482909867247,0,1,regulation of TRAIL production,BP,
8549,GO:0032680,1,0.552080184212807,0,96,regulation of tumor necrosis factor production,BP,
8550,GO:0032682,1,0.921108967659175,0,14,negative regulation of chemokine production,BP,
8551,GO:0032683,1,0.992497201459322,0,1,negative regulation of connective tissue growth factor production,BP,
8552,GO:0032685,1,0.992981459590117,0,1,negative regulation of granulocyte macrophage colony-stimulating factor production,BP,
8553,GO:0032686,1,0.993029393211783,0,1,negative regulation of hepatocyte growth factor production,BP,
8554,GO:0032687,1,0.966901316639206,0,5,negative regulation of interferon-alpha production,BP,
8555,GO:0032688,1,0.916503252215282,0,13,negative regulation of interferon-beta production,BP,
8556,GO:0032689,1,0.84322984694276,0,31,negative regulation of interferon-gamma production,BP,
8557,GO:0032690,1,0.992979387120577,0,1,negative regulation of interleukin-1 alpha production,BP,
8558,GO:0032691,1,0.886006109786499,0,22,negative regulation of interleukin-1 beta production,BP,
8559,GO:0032692,1,0.859630699428408,0,27,negative regulation of interleukin-1 production,BP,
8560,GO:0032693,1,0.924255109889266,0,14,negative regulation of interleukin-10 production,BP,
8561,GO:0032695,1,0.901881627654974,0,16,negative regulation of interleukin-12 production,BP,
8562,GO:0032696,1,0.982182388852378,0,3,negative regulation of interleukin-13 production,BP,
8563,GO:0032700,1,0.953637472522971,0,8,negative regulation of interleukin-17 production,BP,
8564,GO:0032701,1,0.988583300729842,0,2,negative regulation of interleukin-18 production,BP,
8565,GO:0032703,1,0.872661062610397,0,22,negative regulation of interleukin-2 production,BP,
8566,GO:0032707,1,0.985601446153724,0,2,negative regulation of interleukin-23 production,BP,
8567,GO:0032712,1,0.994244193778852,0,1,negative regulation of interleukin-3 production,BP,
8568,GO:0032713,1,0.964013588456769,0,6,negative regulation of interleukin-4 production,BP,
8569,GO:0032714,1,0.979971921254934,0,3,negative regulation of interleukin-5 production,BP,
8570,GO:0032715,1,0.797905282175774,0,36,negative regulation of interleukin-6 production,BP,
8571,GO:0032717,1,0.905095475037592,0,17,negative regulation of interleukin-8 production,BP,
8572,GO:0032720,1,0.765195412169747,0,45,negative regulation of tumor necrosis factor production,BP,
8573,GO:0032722,1,0.785981097466268,0,39,positive regulation of chemokine production,BP,
8574,GO:0032723,1,0.986874404719267,0,2,positive regulation of connective tissue growth factor production,BP,
8575,GO:0032725,1,0.941129520685415,0,10,positive regulation of granulocyte macrophage colony-stimulating factor production,BP,
8576,GO:0032727,1,0.859639606273394,0,20,positive regulation of interferon-alpha production,BP,
8577,GO:0032728,1,0.810485647230439,0,30,positive regulation of interferon-beta production,BP,
8578,GO:0032729,1,0.709030599566973,0,57,positive regulation of interferon-gamma production,BP,
8579,GO:0032730,1,0.982924255870819,0,2,positive regulation of interleukin-1 alpha production,BP,
8580,GO:0032731,1,0.759275745993687,0,46,positive regulation of interleukin-1 beta production,BP,
8581,GO:0032732,1,0.732180828805795,0,51,positive regulation of interleukin-1 production,BP,
8582,GO:0032733,1,0.821326846504323,0,34,positive regulation of interleukin-10 production,BP,
8583,GO:0032735,1,0.830692509056111,0,31,positive regulation of interleukin-12 production,BP,
8584,GO:0032736,1,0.93119127774578,0,11,positive regulation of interleukin-13 production,BP,
8585,GO:0032738,1,0.995291300945664,0,1,positive regulation of interleukin-15 production,BP,
8586,GO:0032740,1,0.931256299207435,0,13,positive regulation of interleukin-17 production,BP,
8587,GO:0032741,1,0.977981209334089,0,3,positive regulation of interleukin-18 production,BP,
8588,GO:0032743,1,0.836242159604663,0,26,positive regulation of interleukin-2 production,BP,
8589,GO:0032747,1,0.986500950253062,0,2,positive regulation of interleukin-23 production,BP,
8590,GO:0032753,1,0.870529405751211,0,23,positive regulation of interleukin-4 production,BP,
8591,GO:0032754,1,0.938720366304466,0,9,positive regulation of interleukin-5 production,BP,
8592,GO:0032755,1,0.618073684050864,0,77,positive regulation of interleukin-6 production,BP,
8593,GO:0032757,1,0.74382417642397,0,49,positive regulation of interleukin-8 production,BP,
8594,GO:0032759,1,0.995482909867247,0,1,positive regulation of TRAIL production,BP,
8595,GO:0032760,1,0.747626877567936,0,46,positive regulation of tumor necrosis factor production,BP,
8596,GO:0032762,1,0.957749707453176,0,7,mast cell cytokine production,BP,
8597,GO:0032763,1,0.970728173287548,0,5,regulation of mast cell cytokine production,BP,
8598,GO:0032764,1,0.988562444650412,0,2,negative regulation of mast cell cytokine production,BP,
8599,GO:0032765,1,0.981961446029318,0,3,positive regulation of mast cell cytokine production,BP,
8600,GO:0032767,1,0.978969384902394,0,3,copper-dependent protein binding,MF,
8603,GO:0032770,1,0.853942728218548,0,26,positive regulation of monooxygenase activity,BP,
8604,GO:0032771,1,0.992465874593964,0,1,regulation of monophenol monooxygenase activity,BP,
8605,GO:0032773,1,0.992465874593964,0,1,positive regulation of monophenol monooxygenase activity,BP,
8607,GO:0032775,1,0.984912216445267,0,2,DNA methylation on adenine,BP,
8608,GO:0032776,1,0.976891592287495,0,3,DNA methylation on cytosine,BP,
8609,GO:0032777,1,0.976132561886371,0,4,Piccolo NuA4 histone acetyltransferase complex,CC,
8610,GO:0032780,1,0.907591779734221,0,17,negative regulation of ATPase activity,BP,
8612,GO:0032782,1,0.955706124328707,0,7,bile acid secretion,BP,
8613,GO:0032783,1,0.955150473513078,0,5,super elongation complex,CC,
8614,GO:0032784,1,0.735569237495981,0,45,regulation of DNA-templated transcription, elongation,BP,
8615,GO:0032785,1,0.906267699312774,0,15,negative regulation of DNA-templated transcription, elongation,BP,
8616,GO:0032786,1,0.841084132662004,0,25,positive regulation of DNA-templated transcription, elongation,BP,
8618,GO:0032788,1,0.995572809322688,0,1,saturated monocarboxylic acid metabolic process,BP,
8619,GO:0032789,1,0.995572809322688,0,1,unsaturated monocarboxylic acid metabolic process,BP,
8620,GO:0032790,1,0.947502718819276,0,8,ribosome disassembly,BP,
8621,GO:0032791,1,0.995356157800689,0,1,lead ion binding,MF,
8622,GO:0032792,1,0.9693891517805,0,5,negative regulation of CREB transcription factor activity,BP,
8624,GO:0032794,1,0.894979479359754,0,14,GTPase activating protein binding,MF,
8625,GO:0032795,1,0.982592363851814,0,3,heterotrimeric G-protein binding,MF,
8626,GO:0032796,1,0.985365286271229,0,2,uropod organization,BP,
8627,GO:0032797,1,0.937007361150801,0,11,SMN complex,CC,
8628,GO:0032798,1,0.98701281886265,0,2,Swi5-Sfr1 complex,CC,
8629,GO:0032799,1,0.862185646958563,0,22,low-density lipoprotein receptor particle metabolic process,BP,
8630,GO:0032800,1,0.849896722834342,0,24,receptor biosynthetic process,BP,
8631,GO:0032801,1,0.781579955827644,0,34,receptor catabolic process,BP,
8632,GO:0032802,1,0.909510485378637,0,14,low-density lipoprotein particle receptor catabolic process,BP,
8633,GO:0032803,1,0.960118298274817,0,6,regulation of low-density lipoprotein particle receptor catabolic process,BP,
8634,GO:0032804,1,0.988109830503278,0,2,negative regulation of low-density lipoprotein particle receptor catabolic process,BP,
8635,GO:0032805,1,0.97839060575754,0,3,positive regulation of low-density lipoprotein particle receptor catabolic process,BP,
8636,GO:0032806,1,0.879847843732584,0,20,carboxy-terminal domain protein kinase complex,CC,
8637,GO:0032807,1,0.982882612012506,0,3,DNA ligase IV complex,CC,
8638,GO:0032808,1,0.94986153812121,0,7,lacrimal gland development,BP,
8640,GO:0032810,1,0.987705832481487,0,2,sterol response element binding,MF,
8641,GO:0032811,1,0.983871988473327,0,3,negative regulation of epinephrine secretion,BP,
8642,GO:0032812,1,0.992317314619541,0,2,positive regulation of epinephrine secretion,BP,
8643,GO:0032813,1,0.778076060990585,0,45,tumor necrosis factor receptor superfamily binding,MF,
8644,GO:0032814,1,0.841985587648927,0,30,regulation of natural killer cell activation,BP,
8645,GO:0032815,1,0.961560166109842,0,8,negative regulation of natural killer cell activation,BP,
8646,GO:0032816,1,0.900801047477754,0,18,positive regulation of natural killer cell activation,BP,
8647,GO:0032817,1,0.958896863870201,0,8,regulation of natural killer cell proliferation,BP,
8648,GO:0032819,1,0.972388283733517,0,6,positive regulation of natural killer cell proliferation,BP,
8649,GO:0032823,1,0.933227959585575,0,11,regulation of natural killer cell differentiation,BP,
8650,GO:0032824,1,0.996602635136203,0,1,negative regulation of natural killer cell differentiation,BP,
8651,GO:0032825,1,0.948187195486677,0,8,positive regulation of natural killer cell differentiation,BP,
8652,GO:0032826,1,0.992147544897782,0,2,regulation of natural killer cell differentiation involved in immune response,BP,
8653,GO:0032827,1,0.996602635136203,0,1,negative regulation of natural killer cell differentiation involved in immune response,BP,
8654,GO:0032829,1,0.989740585822995,0,2,regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation,BP,
8655,GO:0032831,1,0.989740585822995,0,2,positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation,BP,
8656,GO:0032832,1,0.995495369367563,0,1,regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response,BP,
8657,GO:0032834,1,0.995495369367563,0,1,positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response,BP,
8658,GO:0032835,1,0.649663433858654,0,56,glomerulus development,BP,
8659,GO:0032836,1,0.920008239941291,0,10,glomerular basement membrane development,BP,
8662,GO:0032841,1,0.992785550449173,0,1,calcitonin binding,MF,
8663,GO:0032847,1,0.963633034859399,0,6,regulation of cellular pH reduction,BP,
8664,GO:0032848,1,0.992685782329349,0,1,negative regulation of cellular pH reduction,BP,
8665,GO:0032849,1,0.976147332295354,0,4,positive regulation of cellular pH reduction,BP,
8667,GO:0032869,1,0.229808518396533,0,208,cellular response to insulin stimulus,BP,
8671,GO:0032874,1,0.345120296032144,0,153,positive regulation of stress-activated MAPK cascade,BP,
8672,GO:0032875,1,0.97190699892008,0,4,regulation of DNA endoreduplication,BP,
8673,GO:0032876,1,0.994537542124391,0,1,negative regulation of DNA endoreduplication,BP,
8674,GO:0032877,1,0.984110321663544,0,2,positive regulation of DNA endoreduplication,BP,
8675,GO:0032878,1,0.845465623707137,0,21,regulation of establishment or maintenance of cell polarity,BP,
8678,GO:0032881,1,0.744877004680323,0,38,regulation of polysaccharide metabolic process,BP,
8679,GO:0032885,1,0.760383952569175,0,34,regulation of polysaccharide biosynthetic process,BP,
8681,GO:0032887,1,0.990030135300583,0,1,regulation of spindle elongation,BP,
8682,GO:0032888,1,0.990030135300583,0,1,regulation of mitotic spindle elongation,BP,
8683,GO:0032889,1,0.972699759822508,0,5,regulation of vacuole fusion, non-autophagic,BP,
8685,GO:0032891,1,0.875951036932466,0,20,negative regulation of organic acid transport,BP,
8687,GO:0032896,1,0.991557284417218,0,1,palmitoyl-CoA 9-desaturase activity,MF,
8688,GO:0032897,1,0.856849252374549,0,23,negative regulation of viral transcription,BP,
8689,GO:0032898,1,0.9718342078075,0,4,neurotrophin production,BP,
8690,GO:0032899,1,0.986105759011875,0,2,regulation of neurotrophin production,BP,
8691,GO:0032900,1,0.993389945047484,0,1,negative regulation of neurotrophin production,BP,
8692,GO:0032901,1,0.992667829017724,0,1,positive regulation of neurotrophin production,BP,
8693,GO:0032902,1,0.985529371590688,0,2,nerve growth factor production,BP,
8694,GO:0032905,1,0.927045192649046,0,12,transforming growth factor beta1 production,BP,
8695,GO:0032906,1,0.940812924312726,0,8,transforming growth factor beta2 production,BP,
8696,GO:0032907,1,0.971816410823387,0,3,transforming growth factor beta3 production,BP,
8697,GO:0032908,1,0.933128346001497,0,11,regulation of transforming growth factor beta1 production,BP,
8698,GO:0032909,1,0.940812924312726,0,8,regulation of transforming growth factor beta2 production,BP,
8699,GO:0032910,1,0.971816410823387,0,3,regulation of transforming growth factor beta3 production,BP,
8700,GO:0032911,1,0.96885079072688,0,5,negative regulation of transforming growth factor beta1 production,BP,
8701,GO:0032912,1,0.985363870005149,0,2,negative regulation of transforming growth factor beta2 production,BP,
8702,GO:0032914,1,0.955934203713928,0,7,positive regulation of transforming growth factor beta1 production,BP,
8703,GO:0032915,1,0.989688511774712,0,2,positive regulation of transforming growth factor beta2 production,BP,
8704,GO:0032916,1,0.979177726380162,0,2,positive regulation of transforming growth factor beta3 production,BP,
8705,GO:0032917,1,0.992967882676955,0,2,polyamine acetylation,BP,
8706,GO:0032918,1,0.992967882676955,0,2,spermidine acetylation,BP,
8707,GO:0032919,1,0.9965839600578,0,1,spermine acetylation,BP,
8708,GO:0032920,1,0.9965839600578,0,1,putrescine acetylation,BP,
8709,GO:0032922,1,0.62421338974507,0,61,circadian regulation of gene expression,BP,
8710,GO:0032924,1,0.764203624741716,0,39,activin receptor signaling pathway,BP,
8711,GO:0032925,1,0.852867159937419,0,24,regulation of activin receptor signaling pathway,BP,
8712,GO:0032926,1,0.936178373025021,0,10,negative regulation of activin receptor signaling pathway,BP,
8713,GO:0032927,1,0.939015045454485,0,8,positive regulation of activin receptor signaling pathway,BP,
8714,GO:0032928,1,0.892316829929399,0,20,regulation of superoxide anion generation,BP,
8715,GO:0032929,1,0.991933139740391,0,2,negative regulation of superoxide anion generation,BP,
8716,GO:0032930,1,0.899581297012771,0,18,positive regulation of superoxide anion generation,BP,
8717,GO:0032933,1,0.913782711780271,0,13,SREBP signaling pathway,BP,
8718,GO:0032934,1,0.709795488153141,0,51,sterol binding,MF,
8719,GO:0032937,1,0.979919682495022,0,3,SREBP-SCAP-Insig complex,CC,
8724,GO:0032945,1,0.64622992425602,0,72,negative regulation of mononuclear cell proliferation,BP,
8726,GO:0032954,1,0.976562730287868,0,3,regulation of cytokinetic process,BP,
8727,GO:0032956,1,0.0969607880372589,0,326,regulation of actin cytoskeleton organization,BP,
8728,GO:0032957,1,0.933079540600455,0,10,inositol trisphosphate metabolic process,BP,
8729,GO:0032958,1,0.849117709181108,0,24,inositol phosphate biosynthetic process,BP,
8730,GO:0032959,1,0.952776441738926,0,7,inositol trisphosphate biosynthetic process,BP,
8731,GO:0032960,1,0.967212053846881,0,5,regulation of inositol trisphosphate biosynthetic process,BP,
8732,GO:0032962,1,0.974593752072364,0,4,positive regulation of inositol trisphosphate biosynthetic process,BP,
8736,GO:0032966,1,0.945610494552132,0,10,negative regulation of collagen biosynthetic process,BP,
8738,GO:0032968,1,0.918583452395504,0,11,positive regulation of transcription elongation from RNA polymerase II promoter,BP,
8739,GO:0032970,1,0.0690716519776747,0,367,regulation of actin filament-based process,BP,
8740,GO:0032971,1,0.982950500832595,0,3,regulation of muscle filament sliding,BP,
8741,GO:0032972,1,0.996927456917331,0,1,regulation of muscle filament sliding speed,BP,
8742,GO:0032976,1,0.996784759901968,0,1,release of matrix enzymes from mitochondria,BP,
8743,GO:0032977,1,0.987751644555762,0,2,membrane insertase activity,MF,
8744,GO:0032978,1,0.983491827421652,0,3,protein insertion into membrane from inner side,BP,
8745,GO:0032979,1,0.983491827421652,0,3,protein insertion into mitochondrial inner membrane from matrix,BP,
8746,GO:0032981,1,0.792718638613834,0,56,mitochondrial respiratory chain complex I assembly,BP,
8747,GO:0032982,1,0.84475490519517,0,20,myosin filament,CC,
8748,GO:0032983,1,0.967089680410714,0,4,kainate selective glutamate receptor complex,CC,
8750,GO:0032986,1,0.891122388080618,0,17,protein-DNA complex disassembly,BP,
8751,GO:0032988,1,0.953509238549423,0,7,ribonucleoprotein complex disassembly,BP,
8755,GO:0032993,1,0.511056621535578,0,103,protein-DNA complex,CC,
8756,GO:0032994,1,0.835057132171025,0,33,protein-lipid complex,CC,
8757,GO:0032996,1,0.99513408635658,0,1,Bcl3-Bcl10 complex,CC,
8758,GO:0032997,1,0.992495680784366,0,2,Fc receptor complex,CC,
8759,GO:0032998,1,0.992495680784366,0,2,Fc-epsilon receptor I complex,CC,
8760,GO:0033002,1,0.289061342213756,0,183,muscle cell proliferation,BP,
8763,GO:0033005,1,0.899510002536439,0,18,positive regulation of mast cell activation,BP,
8764,GO:0033006,1,0.836114628072261,0,30,regulation of mast cell activation involved in immune response,BP,
8765,GO:0033007,1,0.956210698452917,0,8,negative regulation of mast cell activation involved in immune response,BP,
8766,GO:0033008,1,0.922312437181576,0,14,positive regulation of mast cell activation involved in immune response,BP,
8767,GO:0033010,1,0.941404781381763,0,8,paranodal junction,CC,
8768,GO:0033011,1,0.984192624850448,0,3,perinuclear theca,CC,
8769,GO:0033013,1,0.722761480472641,0,52,tetrapyrrole metabolic process,BP,
8770,GO:0033014,1,0.848601359569091,0,26,tetrapyrrole biosynthetic process,BP,
8771,GO:0033015,1,0.984319878948359,0,4,tetrapyrrole catabolic process,BP,
8772,GO:0033017,1,0.750217922055652,0,36,sarcoplasmic reticulum membrane,CC,
8773,GO:0033018,1,0.946790653182202,0,9,sarcoplasmic reticulum lumen,CC,
8774,GO:0033023,1,0.981592226119714,0,3,mast cell homeostasis,BP,
8775,GO:0033024,1,0.981592226119714,0,3,mast cell apoptotic process,BP,
8776,GO:0033025,1,0.981592226119714,0,3,regulation of mast cell apoptotic process,BP,
8777,GO:0033026,1,0.988701400195537,0,2,negative regulation of mast cell apoptotic process,BP,
8778,GO:0033028,1,0.830423801817364,0,29,myeloid cell apoptotic process,BP,
8779,GO:0033029,1,0.947631586719153,0,7,regulation of neutrophil apoptotic process,BP,
8780,GO:0033030,1,0.984489385228814,0,2,negative regulation of neutrophil apoptotic process,BP,
8781,GO:0033031,1,0.974270267827617,0,4,positive regulation of neutrophil apoptotic process,BP,
8782,GO:0033032,1,0.848977103995075,0,25,regulation of myeloid cell apoptotic process,BP,
8783,GO:0033033,1,0.925383262888915,0,13,negative regulation of myeloid cell apoptotic process,BP,
8784,GO:0033034,1,0.954728736184455,0,7,positive regulation of myeloid cell apoptotic process,BP,
8786,GO:0033037,1,0.983107117433234,0,2,polysaccharide localization,BP,
8787,GO:0033038,1,0.970932526594674,0,8,bitter taste receptor activity,MF,
8788,GO:0033040,1,0.993145878204297,0,1,sour taste receptor activity,MF,
8789,GO:0033041,1,0.993813629352555,0,1,sweet taste receptor activity,MF,
8796,GO:0033058,1,0.970614004609239,0,3,directional locomotion,BP,
8797,GO:0033059,1,0.706078513031681,0,52,cellular pigmentation,BP,
8798,GO:0033061,1,0.958197634878684,0,7,DNA recombinase mediator complex,CC,
8799,GO:0033063,1,0.976931387467506,0,4,Rad51B-Rad51C-Rad51D-XRCC2 complex,CC,
8800,GO:0033065,1,0.990377115717114,0,2,Rad51C-XRCC3 complex,CC,
8801,GO:0033076,1,0.985609342930839,0,3,isoquinoline alkaloid metabolic process,BP,
8802,GO:0033077,1,0.61403246574187,0,72,T cell differentiation in thymus,BP,
8803,GO:0033078,1,0.983072521296126,0,3,extrathymic T cell differentiation,BP,
8804,GO:0033079,1,0.944413680995462,0,10,immature T cell proliferation,BP,
8805,GO:0033080,1,0.954716641179536,0,8,immature T cell proliferation in thymus,BP,
8806,GO:0033081,1,0.85501082213293,0,25,regulation of T cell differentiation in thymus,BP,
8807,GO:0033082,1,0.987587275809271,0,2,regulation of extrathymic T cell differentiation,BP,
8808,GO:0033083,1,0.951399202660673,0,9,regulation of immature T cell proliferation,BP,
8809,GO:0033084,1,0.961777601315327,0,7,regulation of immature T cell proliferation in thymus,BP,
8810,GO:0033085,1,0.962705285723448,0,7,negative regulation of T cell differentiation in thymus,BP,
8811,GO:0033087,1,0.97779590743333,0,4,negative regulation of immature T cell proliferation,BP,
8812,GO:0033088,1,0.98229202446778,0,3,negative regulation of immature T cell proliferation in thymus,BP,
8813,GO:0033089,1,0.921662554326955,0,13,positive regulation of T cell differentiation in thymus,BP,
8814,GO:0033091,1,0.973009856791476,0,5,positive regulation of immature T cell proliferation,BP,
8815,GO:0033092,1,0.979119455252652,0,4,positive regulation of immature T cell proliferation in thymus,BP,
8816,GO:0033093,1,0.961566399642884,0,5,Weibel-Palade body,CC,
8817,GO:0033100,1,0.994578910864439,0,1,NuA3 histone acetyltransferase complex,CC,
8818,GO:0033106,1,0.97553630226492,0,5,cis-Golgi network membrane,CC,
8819,GO:0033108,1,0.658163024152208,0,90,mitochondrial respiratory chain complex assembly,BP,
8820,GO:0033116,1,0.644523414986314,0,68,endoplasmic reticulum-Golgi intermediate compartment membrane,CC,
8821,GO:0033119,1,0.854077987783289,0,26,negative regulation of RNA splicing,BP,
8822,GO:0033120,1,0.789030262049676,0,35,positive regulation of RNA splicing,BP,
8823,GO:0033127,1,0.924375652696201,0,12,regulation of histone phosphorylation,BP,
8824,GO:0033128,1,0.989237078401403,0,2,negative regulation of histone phosphorylation,BP,
8825,GO:0033129,1,0.946278687157421,0,8,positive regulation of histone phosphorylation,BP,
8826,GO:0033130,1,0.929733336186897,0,11,acetylcholine receptor binding,MF,
8827,GO:0033131,1,0.944998901492222,0,9,regulation of glucokinase activity,BP,
8828,GO:0033132,1,0.977822122017368,0,4,negative regulation of glucokinase activity,BP,
8829,GO:0033133,1,0.966439723350853,0,5,positive regulation of glucokinase activity,BP,
8831,GO:0033137,1,0.848093922694674,0,25,negative regulation of peptidyl-serine phosphorylation,BP,
8833,GO:0033139,1,0.976066621112075,0,4,regulation of peptidyl-serine phosphorylation of STAT protein,BP,
8834,GO:0033140,1,0.991184092367446,0,2,negative regulation of peptidyl-serine phosphorylation of STAT protein,BP,
8835,GO:0033141,1,0.984749410750875,0,2,positive regulation of peptidyl-serine phosphorylation of STAT protein,BP,
8836,GO:0033142,1,0.974688885684094,0,3,progesterone receptor binding,MF,
8837,GO:0033143,1,0.613402036691086,0,70,regulation of intracellular steroid hormone receptor signaling pathway,BP,
8838,GO:0033144,1,0.79143100635251,0,33,negative regulation of intracellular steroid hormone receptor signaling pathway,BP,
8839,GO:0033145,1,0.926940507219617,0,11,positive regulation of intracellular steroid hormone receptor signaling pathway,BP,
8840,GO:0033146,1,0.781595092626501,0,35,regulation of intracellular estrogen receptor signaling pathway,BP,
8841,GO:0033147,1,0.918211574432093,0,12,negative regulation of intracellular estrogen receptor signaling pathway,BP,
8842,GO:0033148,1,0.938607118019877,0,9,positive regulation of intracellular estrogen receptor signaling pathway,BP,
8843,GO:0033149,1,0.979506032375882,0,3,FFAT motif binding,MF,
8844,GO:0033150,1,0.989877509152943,0,2,cytoskeletal calyx,CC,
8845,GO:0033151,1,0.901183810390996,0,13,V(D)J recombination,BP,
8846,GO:0033152,1,0.962311438983408,0,5,immunoglobulin V(D)J recombination,BP,
8847,GO:0033153,1,0.954285043227935,0,5,T cell receptor V(D)J recombination,BP,
8849,GO:0033162,1,0.930293597096598,0,13,melanosome membrane,CC,
8850,GO:0033165,1,0.962807525438261,0,5,interphotoreceptor matrix,CC,
8851,GO:0033167,1,0.987499776875702,0,1,ARC complex,CC,
8852,GO:0033168,1,0.987499776875702,0,1,conversion of ds siRNA to ss siRNA involved in RNA interference,BP,
8853,GO:0033169,1,0.900315062506222,0,13,histone H3-K9 demethylation,BP,
8854,GO:0033170,1,0.948283537240456,0,9,protein-DNA loading ATPase activity,MF,
8856,GO:0033176,1,0.872413015648165,0,25,proton-transporting V-type ATPase complex,CC,
8857,GO:0033177,1,0.944381633561858,0,10,proton-transporting two-sector ATPase complex, proton-transporting domain,CC,
8858,GO:0033178,1,0.940550436388853,0,11,proton-transporting two-sector ATPase complex, catalytic domain,CC,
8859,GO:0033179,1,0.944381633561858,0,10,proton-transporting V-type ATPase, V0 domain,CC,
8860,GO:0033180,1,0.949108403223207,0,9,proton-transporting V-type ATPase, V1 domain,CC,
8861,GO:0033181,1,0.981293217432872,0,4,plasma membrane proton-transporting V-type ATPase complex,CC,
8862,GO:0033182,1,0.918485060684162,0,12,regulation of histone ubiquitination,BP,
8863,GO:0033183,1,0.966031350252639,0,4,negative regulation of histone ubiquitination,BP,
8864,GO:0033184,1,0.965145754890278,0,5,positive regulation of histone ubiquitination,BP,
8865,GO:0033185,1,0.989444110025217,0,3,dolichol-phosphate-mannose synthase complex,CC,
8866,GO:0033186,1,0.976809062698127,0,3,CAF-1 complex,CC,
8867,GO:0033188,1,0.979595389389854,0,3,sphingomyelin synthase activity,MF,
8868,GO:0033189,1,0.895236658895137,0,17,response to vitamin A,BP,
8869,GO:0033192,1,0.961496619466616,0,5,calmodulin-dependent protein phosphatase activity,MF,
8870,GO:0033193,1,0.991955693871497,0,1,Lsd1/2 complex,CC,
8872,GO:0033197,1,0.935374734036775,0,11,response to vitamin E,BP,
8874,GO:0033202,1,0.921936715216354,0,15,DNA helicase complex,CC,
8875,GO:0033204,1,0.950424211462913,0,10,ribonuclease P RNA binding,MF,
8876,GO:0033206,1,0.962081910951038,0,5,meiotic cytokinesis,BP,
8877,GO:0033209,1,0.428185614474355,0,155,tumor necrosis factor-mediated signaling pathway,BP,
8878,GO:0033210,1,0.936575063357013,0,11,leptin-mediated signaling pathway,BP,
8879,GO:0033211,1,0.954040058389203,0,7,adiponectin-activated signaling pathway,BP,
8880,GO:0033212,1,0.957749784767081,0,7,iron import into cell,BP,
8881,GO:0033214,1,0.994149557619953,0,1,siderophore-dependent iron import into cell,BP,
8882,GO:0033215,1,0.993754771323867,0,1,reductive iron assimilation,BP,
8884,GO:0033220,1,0.964785232204309,0,5,ATPase-coupled amide-transporter activity,MF,
8885,GO:0033227,1,0.981602528295198,0,3,dsRNA transport,BP,
8886,GO:0033229,1,0.992736252445123,0,1,cysteine transmembrane transporter activity,MF,
8887,GO:0033233,1,0.856002915711879,0,24,regulation of protein sumoylation,BP,
8888,GO:0033234,1,0.938830365056991,0,10,negative regulation of protein sumoylation,BP,
8889,GO:0033235,1,0.921519369599681,0,13,positive regulation of protein sumoylation,BP,
8890,GO:0033238,1,0.673712996431612,0,75,regulation of cellular amine metabolic process,BP,
8891,GO:0033239,1,0.960939977673704,0,5,negative regulation of cellular amine metabolic process,BP,
8892,GO:0033240,1,0.950030176311208,0,9,positive regulation of cellular amine metabolic process,BP,
8893,GO:0033241,1,0.988659840744814,0,1,regulation of cellular amine catabolic process,BP,
8894,GO:0033242,1,0.988659840744814,0,1,negative regulation of cellular amine catabolic process,BP,
8895,GO:0033256,1,0.976722688155207,0,4,I-kappaB/NF-kappaB complex,CC,
8896,GO:0033257,1,0.988309283098232,0,2,Bcl3/NF-kappaB2 complex,CC,
8897,GO:0033260,1,0.68423628125336,0,58,nuclear DNA replication,BP,
8898,GO:0033262,1,0.890911979650116,0,16,regulation of nuclear cell cycle DNA replication,BP,
8899,GO:0033263,1,0.96564688319684,0,5,CORVET complex,CC,
8900,GO:0033265,1,0.987648973733266,0,2,choline binding,MF,
8901,GO:0033268,1,0.878543791477698,0,15,node of Ranvier,CC,
8902,GO:0033269,1,0.973414804664269,0,4,internode region of axon,CC,
8903,GO:0033270,1,0.903897171005486,0,12,paranode region of axon,CC,
8905,GO:0033274,1,0.990070603804254,0,1,response to vitamin B2,BP,
8906,GO:0033275,1,0.780576419944083,0,35,actin-myosin filament sliding,BP,
8907,GO:0033276,1,0.916149186506643,0,13,transcription factor TFTC complex,CC,
8908,GO:0033277,1,0.985244353155678,0,2,abortive mitotic cell cycle,BP,
8909,GO:0033278,1,0.96374954814517,0,5,cell proliferation in midbrain,BP,
8910,GO:0033280,1,0.814129301337782,0,31,response to vitamin D,BP,
8911,GO:0033283,1,0.98499447041333,0,2,ATPase-coupled organic acid transmembrane transporter activity,MF,
8912,GO:0033284,1,0.98499447041333,0,2,ATPase-coupled carboxylic acid transmembrane transporter activity,MF,
8913,GO:0033285,1,0.98499447041333,0,2,ATPase-coupled monocarboxylic acid transmembrane transporter activity,MF,
8914,GO:0033290,1,0.929752282293369,0,14,eukaryotic 48S preinitiation complex,CC,
8915,GO:0033291,1,0.997311409978168,0,1,eukaryotic 80S initiation complex,CC,
8916,GO:0033292,1,0.932463594209235,0,9,T-tubule organization,BP,
8917,GO:0033293,1,0.719646785104929,0,59,monocarboxylic acid binding,MF,
8918,GO:0033299,1,0.964576747291162,0,6,secretion of lysosomal enzymes,BP,
8919,GO:0033300,1,0.956251401941651,0,7,dehydroascorbic acid transmembrane transporter activity,MF,
8920,GO:0033301,1,0.992739720953922,0,1,cell cycle comprising mitosis without cytokinesis,BP,
8921,GO:0033306,1,0.987869742493981,0,2,phytol metabolic process,BP,
8922,GO:0033313,1,0.968548812412279,0,5,meiotic cell cycle checkpoint,BP,
8923,GO:0033314,1,0.944222622673014,0,9,mitotic DNA replication checkpoint,BP,
8924,GO:0033316,1,0.993174963603365,0,1,meiotic spindle assembly checkpoint,BP,
8925,GO:0033319,1,0.994691487034644,0,1,UDP-D-xylose metabolic process,BP,
8926,GO:0033320,1,0.994691487034644,0,1,UDP-D-xylose biosynthetic process,BP,
8927,GO:0033326,1,0.973027488326015,0,3,cerebrospinal fluid secretion,BP,
8928,GO:0033327,1,0.927860589025972,0,11,Leydig cell differentiation,BP,
8929,GO:0033328,1,0.985879985575619,0,2,peroxisome membrane targeting sequence binding,MF,
8930,GO:0033341,1,0.983379056584005,0,2,regulation of collagen binding,BP,
8931,GO:0033342,1,0.993872164121236,0,1,negative regulation of collagen binding,BP,
8932,GO:0033343,1,0.989442840824624,0,1,positive regulation of collagen binding,BP,
8933,GO:0033344,1,0.764173388975084,0,39,cholesterol efflux,BP,
8934,GO:0033345,1,0.994133635482561,0,1,asparagine catabolic process via L-aspartate,BP,
8935,GO:0033353,1,0.95670233577351,0,7,S-adenosylmethionine cycle,BP,
8937,GO:0033364,1,0.981285184914978,0,2,mast cell secretory granule organization,BP,
8939,GO:0033366,1,0.978152149245768,0,4,protein localization to secretory granule,BP,
8940,GO:0033367,1,0.996181088331928,0,1,protein localization to mast cell secretory granule,BP,
8941,GO:0033368,1,0.996181088331928,0,1,protease localization to mast cell secretory granule,BP,
8942,GO:0033370,1,0.996181088331928,0,1,maintenance of protein location in mast cell secretory granule,BP,
8943,GO:0033371,1,0.996181088331928,0,1,T cell secretory granule organization,BP,
8944,GO:0033373,1,0.996181088331928,0,1,maintenance of protease location in mast cell secretory granule,BP,
8945,GO:0033374,1,0.996181088331928,0,1,protein localization to T cell secretory granule,BP,
8946,GO:0033375,1,0.996181088331928,0,1,protease localization to T cell secretory granule,BP,
8947,GO:0033377,1,0.996181088331928,0,1,maintenance of protein location in T cell secretory granule,BP,
8948,GO:0033379,1,0.996181088331928,0,1,maintenance of protease location in T cell secretory granule,BP,
8949,GO:0033380,1,0.996181088331928,0,1,granzyme B localization to T cell secretory granule,BP,
8950,GO:0033382,1,0.996181088331928,0,1,maintenance of granzyme B location in T cell secretory granule,BP,
8951,GO:0033383,1,0.989266284362425,0,2,geranyl diphosphate metabolic process,BP,
8952,GO:0033384,1,0.989266284362425,0,2,geranyl diphosphate biosynthetic process,BP,
8953,GO:0033385,1,0.99342786313125,0,1,geranylgeranyl diphosphate metabolic process,BP,
8954,GO:0033386,1,0.99342786313125,0,1,geranylgeranyl diphosphate biosynthetic process,BP,
8955,GO:0033387,1,0.980814937216234,0,3,putrescine biosynthetic process from ornithine,BP,
8956,GO:0033388,1,0.99448449356263,0,1,putrescine biosynthetic process from arginine,BP,
8957,GO:0033389,1,0.99448449356263,0,1,putrescine biosynthetic process from arginine, using agmatinase,BP,
8958,GO:0033391,1,0.914085710690722,0,12,chromatoid body,CC,
8959,GO:0033396,1,0.994734979912661,0,1,beta-alanine biosynthetic process via 3-ureidopropionate,BP,
8960,GO:0033477,1,0.994886906618171,0,1,S-methylmethionine metabolic process,BP,
8961,GO:0033483,1,0.93898176612863,0,10,gas homeostasis,BP,
8962,GO:0033484,1,0.982561354585369,0,3,nitric oxide homeostasis,BP,
8963,GO:0033489,1,0.976134705346399,0,4,cholesterol biosynthetic process via desmosterol,BP,
8964,GO:0033490,1,0.976134705346399,0,4,cholesterol biosynthetic process via lathosterol,BP,
8965,GO:0033499,1,0.985658390850277,0,3,galactose catabolic process via UDP-galactose,BP,
8967,GO:0033503,1,0.974339635743983,0,4,HULC complex,CC,
8968,GO:0033504,1,0.955802180475119,0,6,floor plate development,BP,
8969,GO:0033505,1,0.985160147146965,0,2,floor plate morphogenesis,BP,
8970,GO:0033512,1,0.979133028323518,0,3,L-lysine catabolic process to acetyl-CoA via saccharopine,BP,
8971,GO:0033514,1,0.994069561690604,0,1,L-lysine catabolic process to acetyl-CoA via L-pipecolate,BP,
8972,GO:0033522,1,0.832875141068607,0,25,histone H2A ubiquitination,BP,
8973,GO:0033523,1,0.920991146375046,0,12,histone H2B ubiquitination,BP,
8974,GO:0033539,1,0.945555768407354,0,10,fatty acid beta-oxidation using acyl-CoA dehydrogenase,BP,
8975,GO:0033540,1,0.917589736662763,0,14,fatty acid beta-oxidation using acyl-CoA oxidase,BP,
8977,GO:0033553,1,0.970593932464386,0,4,rDNA heterochromatin,CC,
8979,GO:0033555,1,0.604866750647377,0,74,multicellular organismal response to stress,BP,
8980,GO:0033557,1,0.98701281886265,0,2,Slx1-Slx4 complex,CC,
8981,GO:0033558,1,0.833337999483177,0,26,protein deacetylase activity,MF,
8982,GO:0033559,1,0.57254512122414,0,98,unsaturated fatty acid metabolic process,BP,
8983,GO:0033561,1,0.851355337112752,0,24,regulation of water loss via skin,BP,
8984,GO:0033563,1,0.973599223295641,0,3,dorsal/ventral axon guidance,BP,
8985,GO:0033564,1,0.951383692934006,0,6,anterior/posterior axon guidance,BP,
8986,GO:0033565,1,0.978022744863485,0,3,ESCRT-0 complex,CC,
8987,GO:0033566,1,0.98758589116065,0,2,gamma-tubulin complex localization,BP,
8988,GO:0033567,1,0.98553476511138,0,2,DNA replication, Okazaki fragment processing,BP,
8989,GO:0033572,1,0.808047984361821,0,35,transferrin transport,BP,
8990,GO:0033574,1,0.786723023653869,0,39,response to testosterone,BP,
8991,GO:0033577,1,0.989222249877785,0,2,protein glycosylation in endoplasmic reticulum,BP,
8992,GO:0033578,1,0.965970320112736,0,5,protein glycosylation in Golgi,BP,
8993,GO:0033588,1,0.96550716834476,0,6,Elongator holoenzyme complex,CC,
8994,GO:0033590,1,0.983321766549841,0,3,response to cobalamin,BP,
8995,GO:0033591,1,0.966704873814269,0,5,response to L-ascorbic acid,BP,
8996,GO:0033592,1,0.964504441508326,0,5,RNA strand annealing activity,MF,
8997,GO:0033593,1,0.986616515524639,0,1,BRCA2-MAGE-D1 complex,CC,
8998,GO:0033594,1,0.978538543842379,0,4,response to hydroxyisoflavone,BP,
8999,GO:0033595,1,0.987475947886162,0,2,response to genistein,BP,
9000,GO:0033596,1,0.980362755691751,0,2,TSC1-TSC2 complex,CC,
9001,GO:0033597,1,0.994572010576078,0,1,mitotic checkpoint complex,CC,
9002,GO:0033598,1,0.830283492230719,0,26,mammary gland epithelial cell proliferation,BP,
9003,GO:0033599,1,0.892921364171638,0,16,regulation of mammary gland epithelial cell proliferation,BP,
9004,GO:0033600,1,0.965904416348444,0,4,negative regulation of mammary gland epithelial cell proliferation,BP,
9005,GO:0033601,1,0.947063954966545,0,7,positive regulation of mammary gland epithelial cell proliferation,BP,
9010,GO:0033609,1,0.993485400251684,0,1,oxalate metabolic process,BP,
9011,GO:0033612,1,0.85921583312999,0,24,receptor serine/threonine kinase binding,MF,
9012,GO:0033613,1,0.595860929417835,0,74,activating transcription factor binding,MF,
9013,GO:0033615,1,0.982800186640668,0,3,mitochondrial proton-transporting ATP synthase complex assembly,BP,
9014,GO:0033617,1,0.890211684152571,0,21,mitochondrial cytochrome c oxidase assembly,BP,
9016,GO:0033622,1,0.847270665935702,0,24,integrin activation,BP,
9017,GO:0033623,1,0.906525362988384,0,15,regulation of integrin activation,BP,
9018,GO:0033624,1,0.975791685611282,0,3,negative regulation of integrin activation,BP,
9019,GO:0033625,1,0.948711421318858,0,9,positive regulation of integrin activation,BP,
9020,GO:0033626,1,0.988587550972749,0,2,positive regulation of integrin activation by cell surface receptor linked signal transduction,BP,
9023,GO:0033629,1,0.926127729757848,0,10,negative regulation of cell adhesion mediated by integrin,BP,
9025,GO:0033631,1,0.900000908402062,0,15,cell-cell adhesion mediated by integrin,BP,
9026,GO:0033632,1,0.935888813298713,0,10,regulation of cell-cell adhesion mediated by integrin,BP,
9027,GO:0033633,1,0.979620264185516,0,2,negative regulation of cell-cell adhesion mediated by integrin,BP,
9028,GO:0033634,1,0.97258569836627,0,5,positive regulation of cell-cell adhesion mediated by integrin,BP,
9033,GO:0033650,1,0.995348794548339,0,1,host cell mitochondrion,CC,
9034,GO:0033655,1,0.965001479202509,0,6,host cell cytoplasm part,CC,
9035,GO:0033668,1,0.976635648268054,0,4,negative regulation by symbiont of host apoptotic process,BP,
9038,GO:0033677,1,0.97957133393937,0,3,DNA/RNA helicase activity,MF,
9039,GO:0033678,1,0.993641725865143,0,1,5'-3' DNA/RNA helicase activity,MF,
9040,GO:0033679,1,0.992243560850596,0,1,3'-5' DNA/RNA helicase activity,MF,
9041,GO:0033683,1,0.795074863106043,0,39,nucleotide-excision repair, DNA incision,BP,
9042,GO:0033684,1,0.962580147561083,0,6,regulation of luteinizing hormone secretion,BP,
9043,GO:0033685,1,0.990232611894415,0,2,negative regulation of luteinizing hormone secretion,BP,
9044,GO:0033686,1,0.972077483931194,0,4,positive regulation of luteinizing hormone secretion,BP,
9045,GO:0033687,1,0.826588457339902,0,28,osteoblast proliferation,BP,
9046,GO:0033688,1,0.85204399742686,0,23,regulation of osteoblast proliferation,BP,
9047,GO:0033689,1,0.932843223841203,0,9,negative regulation of osteoblast proliferation,BP,
9048,GO:0033690,1,0.930776095443724,0,11,positive regulation of osteoblast proliferation,BP,
9049,GO:0033691,1,0.883314835744156,0,19,sialic acid binding,MF,
9050,GO:0033692,1,0.615061750828779,0,64,cellular polysaccharide biosynthetic process,BP,
9052,GO:0033695,1,0.99501807222187,0,1,oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor,MF,
9053,GO:0033699,1,0.994833726064617,0,1,DNA 5'-adenosine monophosphate hydrolase activity,MF,
9054,GO:0033700,1,0.947954217202762,0,8,phospholipid efflux,BP,
9055,GO:0033721,1,0.993418572436684,0,1,aldehyde dehydrogenase (NADP+) activity,MF,
9056,GO:0033735,1,0.99660795465688,0,1,aspartate dehydrogenase activity,MF,
9057,GO:0033737,1,0.993905421826104,0,1,1-pyrroline dehydrogenase activity,MF,
9058,GO:0033743,1,0.977436277071527,0,4,peptide-methionine (R)-S-oxide reductase activity,MF,
9059,GO:0033744,1,0.995817718402562,0,1,L-methionine:thioredoxin-disulfide S-oxidoreductase activity,MF,
9060,GO:0033745,1,0.981310682378421,0,3,L-methionine-(R)-S-oxide reductase activity,MF,
9061,GO:0033746,1,0.992783259455901,0,1,histone demethylase activity (H3-R2 specific),MF,
9062,GO:0033749,1,0.992783259455901,0,1,histone demethylase activity (H4-R3 specific),MF,
9063,GO:0033750,1,0.924259685977105,0,14,ribosome localization,BP,
9064,GO:0033754,1,0.995669227585166,0,1,indoleamine 2,3-dioxygenase activity,MF,
9066,GO:0033764,1,0.892554792620553,0,25,steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,
9067,GO:0033765,1,0.988043120815176,0,2,steroid dehydrogenase activity, acting on the CH-CH group of donors,MF,
9068,GO:0033781,1,0.994705325851602,0,1,cholesterol 24-hydroxylase activity,MF,
9069,GO:0033783,1,0.994104736380736,0,1,25-hydroxycholesterol 7alpha-hydroxylase activity,MF,
9070,GO:0033787,1,0.993381017686403,0,1,cyanocobalamin reductase (cyanide-eliminating) activity,MF,
9071,GO:0033791,1,0.994251831296018,0,1,3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity,MF,
9072,GO:0033798,1,0.9854740276823,0,2,thyroxine 5-deiodinase activity,MF,
9073,GO:0033814,1,0.995917870026012,0,1,propanoyl-CoA C-acyltransferase activity,MF,
9074,GO:0033819,1,0.996594642379455,0,1,lipoyl(octanoyl) transferase activity,MF,
9075,GO:0033823,1,0.99321667488879,0,1,procollagen glucosyltransferase activity,MF,
9076,GO:0033829,1,0.984544715219732,0,3,O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity,MF,
9077,GO:0033842,1,0.985776929508636,0,2,N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity,MF,
9078,GO:0033857,1,0.983174063366186,0,2,diphosphoinositol-pentakisphosphate kinase activity,MF,
9079,GO:0033858,1,0.993053146637377,0,1,N-acetylgalactosamine kinase activity,MF,
9080,GO:0033860,1,0.946407898721716,0,10,regulation of NAD(P)H oxidase activity,BP,
9081,GO:0033861,1,0.990308533647588,0,2,negative regulation of NAD(P)H oxidase activity,BP,
9082,GO:0033862,1,0.986633963947602,0,2,UMP kinase activity,MF,
9083,GO:0033864,1,0.96245304949769,0,7,positive regulation of NAD(P)H oxidase activity,BP,
9085,GO:0033866,1,0.658731396348789,0,63,nucleoside bisphosphate biosynthetic process,BP,
9086,GO:0033867,1,0.995543067491439,0,1,Fas-activated serine/threonine kinase activity,MF,
9087,GO:0033869,1,0.974377225590171,0,5,nucleoside bisphosphate catabolic process,BP,
9088,GO:0033871,1,0.994979066216479,0,1,[heparan sulfate]-glucosamine 3-sulfotransferase 2 activity,MF,
9089,GO:0033872,1,0.988723279664938,0,2,[heparan sulfate]-glucosamine 3-sulfotransferase 3 activity,MF,
9091,GO:0033878,1,0.981353951249475,0,2,hormone-sensitive lipase activity,MF,
9092,GO:0033882,1,0.989223741344258,0,2,choloyl-CoA hydrolase activity,MF,
9093,GO:0033883,1,0.991256315711728,0,2,pyridoxal phosphatase activity,MF,
9094,GO:0033885,1,0.994464894599637,0,1,10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity,MF,
9095,GO:0033897,1,0.996181088331928,0,1,ribonuclease T2 activity,MF,
9096,GO:0033906,1,0.989482153638953,0,2,hyaluronoglucuronidase activity,MF,
9097,GO:0033919,1,0.992659962892898,0,1,glucan 1,3-alpha-glucosidase activity,MF,
9098,GO:0033925,1,0.992333039689406,0,1,mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity,MF,
9099,GO:0033961,1,0.995357077286239,0,1,cis-stilbene-oxide hydrolase activity,MF,
9100,GO:0033962,1,0.855250846503522,0,19,P-body assembly,BP,
9101,GO:0033967,1,0.990745305967436,0,2,box C/D snoRNA metabolic process,BP,
9102,GO:0033979,1,0.979715595436129,0,3,box H/ACA snoRNA metabolic process,BP,
9103,GO:0033981,1,0.996992298478431,0,1,D-dopachrome decarboxylase activity,MF,
9104,GO:0033989,1,0.993599927191694,0,1,3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity,MF,
9106,GO:0034014,1,0.994306503233258,0,1,response to triglyceride,BP,
9107,GO:0034030,1,0.658731396348789,0,63,ribonucleoside bisphosphate biosynthetic process,BP,
9108,GO:0034031,1,0.974377225590171,0,5,ribonucleoside bisphosphate catabolic process,BP,
9110,GO:0034033,1,0.658731396348789,0,63,purine nucleoside bisphosphate biosynthetic process,BP,
9111,GO:0034034,1,0.974377225590171,0,5,purine nucleoside bisphosphate catabolic process,BP,
9113,GO:0034036,1,0.958947370877971,0,6,purine ribonucleoside bisphosphate biosynthetic process,BP,
9114,GO:0034038,1,0.996273592006305,0,1,deoxyhypusine synthase activity,MF,
9115,GO:0034039,1,0.990245068074104,0,2,8-oxo-7,8-dihydroguanine DNA N-glycosylase activity,MF,
9116,GO:0034040,1,0.958400261594912,0,5,ATPase-coupled lipid transmembrane transporter activity,MF,
9117,GO:0034041,1,0.993221350674242,0,1,ATPase-coupled sterol transmembrane transporter activity,MF,
9118,GO:0034045,1,0.887969188599959,0,16,phagophore assembly site membrane,CC,
9119,GO:0034046,1,0.939494592369684,0,8,poly(G) binding,MF,
9120,GO:0034056,1,0.970812832944483,0,4,estrogen response element binding,MF,
9121,GO:0034057,1,0.98653017257825,0,2,RNA strand-exchange activity,MF,
9122,GO:0034058,1,0.936127466075795,0,9,endosomal vesicle fusion,BP,
9123,GO:0034059,1,0.982341090422889,0,2,response to anoxia,BP,
9124,GO:0034061,1,0.811876950073457,0,29,DNA polymerase activity,MF,
9125,GO:0034062,1,0.800001091074571,0,39,5'-3' RNA polymerase activity,MF,
9126,GO:0034063,1,0.834884041139107,0,23,stress granule assembly,BP,
9127,GO:0034066,1,0.989616527519495,0,2,RIC1-RGP1 guanyl-nucleotide exchange factor complex,CC,
9128,GO:0034067,1,0.809536738713685,0,25,protein localization to Golgi apparatus,BP,
9129,GO:0034080,1,0.860765336958018,0,26,CENP-A containing nucleosome assembly,BP,
9130,GO:0034085,1,0.948672998004129,0,7,establishment of sister chromatid cohesion,BP,
9131,GO:0034086,1,0.928675477112658,0,9,maintenance of sister chromatid cohesion,BP,
9132,GO:0034087,1,0.980485097442565,0,2,establishment of mitotic sister chromatid cohesion,BP,
9133,GO:0034088,1,0.928675477112658,0,9,maintenance of mitotic sister chromatid cohesion,BP,
9134,GO:0034091,1,0.959473713954028,0,5,regulation of maintenance of sister chromatid cohesion,BP,
9135,GO:0034092,1,0.971757651226627,0,3,negative regulation of maintenance of sister chromatid cohesion,BP,
9136,GO:0034093,1,0.987362647494748,0,2,positive regulation of maintenance of sister chromatid cohesion,BP,
9138,GO:0034098,1,0.951625571087113,0,7,VCP-NPL4-UFD1 AAA ATPase complex,CC,
9139,GO:0034101,1,0.445037112603467,0,121,erythrocyte homeostasis,BP,
9142,GO:0034105,1,0.837712041939142,0,26,positive regulation of tissue remodeling,BP,
9144,GO:0034110,1,0.826551711399789,0,27,regulation of homotypic cell-cell adhesion,BP,
9145,GO:0034111,1,0.902779029222883,0,15,negative regulation of homotypic cell-cell adhesion,BP,
9146,GO:0034112,1,0.952719854974364,0,7,positive regulation of homotypic cell-cell adhesion,BP,
9147,GO:0034113,1,0.676295302148134,0,58,heterotypic cell-cell adhesion,BP,
9148,GO:0034114,1,0.877433238318135,0,22,regulation of heterotypic cell-cell adhesion,BP,
9149,GO:0034115,1,0.944585900455041,0,9,negative regulation of heterotypic cell-cell adhesion,BP,
9150,GO:0034116,1,0.924829630805503,0,14,positive regulation of heterotypic cell-cell adhesion,BP,
9151,GO:0034117,1,0.997098105382199,0,1,erythrocyte aggregation,BP,
9152,GO:0034118,1,0.997098105382199,0,1,regulation of erythrocyte aggregation,BP,
9153,GO:0034120,1,0.997098105382199,0,1,positive regulation of erythrocyte aggregation,BP,
9154,GO:0034121,1,0.643892212663655,0,65,regulation of toll-like receptor signaling pathway,BP,
9155,GO:0034122,1,0.779210440044385,0,36,negative regulation of toll-like receptor signaling pathway,BP,
9156,GO:0034123,1,0.856137413580243,0,24,positive regulation of toll-like receptor signaling pathway,BP,
9157,GO:0034124,1,0.978335660534405,0,4,regulation of MyD88-dependent toll-like receptor signaling pathway,BP,
9158,GO:0034125,1,0.990450284509057,0,2,negative regulation of MyD88-dependent toll-like receptor signaling pathway,BP,
9159,GO:0034127,1,0.950281900897225,0,8,regulation of MyD88-independent toll-like receptor signaling pathway,BP,
9160,GO:0034128,1,0.955135918405649,0,7,negative regulation of MyD88-independent toll-like receptor signaling pathway,BP,
9161,GO:0034130,1,0.993379749425239,0,1,toll-like receptor 1 signaling pathway,BP,
9162,GO:0034134,1,0.910191512064681,0,14,toll-like receptor 2 signaling pathway,BP,
9163,GO:0034135,1,0.941040978250552,0,9,regulation of toll-like receptor 2 signaling pathway,BP,
9164,GO:0034136,1,0.968824350517313,0,4,negative regulation of toll-like receptor 2 signaling pathway,BP,
9165,GO:0034137,1,0.963310508499527,0,6,positive regulation of toll-like receptor 2 signaling pathway,BP,
9166,GO:0034138,1,0.87951024653056,0,20,toll-like receptor 3 signaling pathway,BP,
9167,GO:0034139,1,0.942083206528632,0,9,regulation of toll-like receptor 3 signaling pathway,BP,
9168,GO:0034140,1,0.978425643796071,0,3,negative regulation of toll-like receptor 3 signaling pathway,BP,
9169,GO:0034141,1,0.956450313590244,0,7,positive regulation of toll-like receptor 3 signaling pathway,BP,
9170,GO:0034142,1,0.806633045031799,0,33,toll-like receptor 4 signaling pathway,BP,
9171,GO:0034143,1,0.887421746927554,0,18,regulation of toll-like receptor 4 signaling pathway,BP,
9172,GO:0034144,1,0.952930638824625,0,7,negative regulation of toll-like receptor 4 signaling pathway,BP,
9173,GO:0034145,1,0.946366897350985,0,9,positive regulation of toll-like receptor 4 signaling pathway,BP,
9174,GO:0034146,1,0.984909762028944,0,2,toll-like receptor 5 signaling pathway,BP,
9175,GO:0034147,1,0.992375939051885,0,1,regulation of toll-like receptor 5 signaling pathway,BP,
9176,GO:0034148,1,0.992375939051885,0,1,negative regulation of toll-like receptor 5 signaling pathway,BP,
9177,GO:0034150,1,0.99119377564533,0,1,toll-like receptor 6 signaling pathway,BP,
9178,GO:0034154,1,0.935759741565412,0,10,toll-like receptor 7 signaling pathway,BP,
9179,GO:0034155,1,0.968214008561527,0,5,regulation of toll-like receptor 7 signaling pathway,BP,
9180,GO:0034156,1,0.995427264223568,0,1,negative regulation of toll-like receptor 7 signaling pathway,BP,
9181,GO:0034157,1,0.9726629709326,0,4,positive regulation of toll-like receptor 7 signaling pathway,BP,
9182,GO:0034158,1,0.984183631699505,0,2,toll-like receptor 8 signaling pathway,BP,
9183,GO:0034159,1,0.991611813634978,0,1,regulation of toll-like receptor 8 signaling pathway,BP,
9184,GO:0034161,1,0.991611813634978,0,1,positive regulation of toll-like receptor 8 signaling pathway,BP,
9185,GO:0034162,1,0.848304220790437,0,24,toll-like receptor 9 signaling pathway,BP,
9186,GO:0034163,1,0.938873687188058,0,9,regulation of toll-like receptor 9 signaling pathway,BP,
9187,GO:0034164,1,0.978526036119517,0,3,negative regulation of toll-like receptor 9 signaling pathway,BP,
9188,GO:0034165,1,0.973206501821113,0,4,positive regulation of toll-like receptor 9 signaling pathway,BP,
9189,GO:0034166,1,0.992951928801455,0,1,toll-like receptor 10 signaling pathway,BP,
9190,GO:0034182,1,0.959473713954028,0,5,regulation of maintenance of mitotic sister chromatid cohesion,BP,
9191,GO:0034183,1,0.971757651226627,0,3,negative regulation of maintenance of mitotic sister chromatid cohesion,BP,
9192,GO:0034184,1,0.987362647494748,0,2,positive regulation of maintenance of mitotic sister chromatid cohesion,BP,
9193,GO:0034185,1,0.871500064420173,0,17,apolipoprotein binding,MF,
9194,GO:0034186,1,0.968093335712571,0,5,apolipoprotein A-I binding,MF,
9195,GO:0034188,1,0.977805565933432,0,2,apolipoprotein A-I receptor activity,MF,
9196,GO:0034189,1,0.977697775067043,0,4,very-low-density lipoprotein particle binding,MF,
9197,GO:0034190,1,0.967946130022166,0,5,apolipoprotein receptor binding,MF,
9198,GO:0034191,1,0.974993036543811,0,4,apolipoprotein A-I receptor binding,MF,
9199,GO:0034196,1,0.973502714816263,0,5,acylglycerol transport,BP,
9200,GO:0034197,1,0.973502714816263,0,5,triglyceride transport,BP,
9201,GO:0034198,1,0.765558744662382,0,42,cellular response to amino acid starvation,BP,
9203,GO:0034201,1,0.963114370330441,0,6,response to oleic acid,BP,
9204,GO:0034203,1,0.991870791927317,0,1,glycolipid translocation,BP,
9205,GO:0034204,1,0.709530051663563,0,42,lipid translocation,BP,
9206,GO:0034205,1,0.767625324713552,0,36,amyloid-beta formation,BP,
9207,GO:0034211,1,0.988303784808711,0,1,GTP-dependent protein kinase activity,MF,
9208,GO:0034212,1,0.663062415202627,0,57,peptide N-acetyltransferase activity,MF,
9209,GO:0034213,1,0.995709833957817,0,1,quinolinate catabolic process,BP,
9210,GO:0034214,1,0.946177844712643,0,7,protein hexamerization,BP,
9211,GO:0034219,1,0.498309120252227,0,98,carbohydrate transmembrane transport,BP,
9213,GO:0034224,1,0.994385852243475,0,1,cellular response to zinc ion starvation,BP,
9214,GO:0034227,1,0.975008404827425,0,5,tRNA thio-modification,BP,
9215,GO:0034230,1,0.985689338298558,0,2,enkephalin processing,BP,
9216,GO:0034231,1,0.992153327368389,0,1,islet amyloid polypeptide processing,BP,
9217,GO:0034235,1,0.965644790273153,0,6,GPI anchor binding,MF,
9218,GO:0034236,1,0.904990772561908,0,13,protein kinase A catalytic subunit binding,MF,
9220,GO:0034238,1,0.975693420443127,0,5,macrophage fusion,BP,
9221,GO:0034239,1,0.979819505078846,0,4,regulation of macrophage fusion,BP,
9222,GO:0034241,1,0.979819505078846,0,4,positive regulation of macrophage fusion,BP,
9223,GO:0034242,1,0.982425220909907,0,3,negative regulation of syncytium formation by plasma membrane fusion,BP,
9224,GO:0034243,1,0.837252964067173,0,25,regulation of transcription elongation from RNA polymerase II promoter,BP,
9225,GO:0034244,1,0.919621750215569,0,13,negative regulation of transcription elongation from RNA polymerase II promoter,BP,
9226,GO:0034245,1,0.992698875554292,0,1,mitochondrial DNA-directed RNA polymerase complex,CC,
9227,GO:0034246,1,0.985263600866983,0,2,mitochondrial transcription factor activity,MF,
9228,GO:0034247,1,0.996119637507407,0,1,snoRNA splicing,BP,
9231,GO:0034250,1,0.375836007777529,0,150,positive regulation of cellular amide metabolic process,BP,
9232,GO:0034255,1,0.994580882739056,0,1,regulation of urea metabolic process,BP,
9233,GO:0034260,1,0.724699831125936,0,45,negative regulation of GTPase activity,BP,
9234,GO:0034263,1,0.992021695472284,0,1,positive regulation of autophagy in response to ER overload,BP,
9235,GO:0034271,1,0.979751851735678,0,3,phosphatidylinositol 3-kinase complex, class III, type I,CC,
9236,GO:0034272,1,0.979751851735678,0,3,phosphatidylinositol 3-kinase complex, class III, type II,CC,
9237,GO:0034274,1,0.977750840034734,0,3,Atg12-Atg5-Atg16 complex,CC,
9238,GO:0034275,1,0.987640718616735,0,2,kynurenic acid metabolic process,BP,
9239,GO:0034276,1,0.987640718616735,0,2,kynurenic acid biosynthetic process,BP,
9241,GO:0034285,1,0.971598194978341,0,4,response to disaccharide,BP,
9242,GO:0034287,1,0.978227282232147,0,4,detection of monosaccharide stimulus,BP,
9243,GO:0034308,1,0.616419338797657,0,82,primary alcohol metabolic process,BP,
9244,GO:0034309,1,0.922090340294276,0,11,primary alcohol biosynthetic process,BP,
9245,GO:0034310,1,0.939625398846597,0,13,primary alcohol catabolic process,BP,
9246,GO:0034311,1,0.873188260700761,0,23,diol metabolic process,BP,
9247,GO:0034312,1,0.886296567753925,0,20,diol biosynthetic process,BP,
9248,GO:0034314,1,0.801268406101986,0,35,Arp2/3 complex-mediated actin nucleation,BP,
9249,GO:0034315,1,0.88063835781422,0,19,regulation of Arp2/3 complex-mediated actin nucleation,BP,
9250,GO:0034316,1,0.964716692485789,0,6,negative regulation of Arp2/3 complex-mediated actin nucleation,BP,
9253,GO:0034331,1,0.795048335832484,0,30,cell junction maintenance,BP,
9254,GO:0034332,1,0.628809219301927,0,61,adherens junction organization,BP,
9255,GO:0034333,1,0.915655330227634,0,12,adherens junction assembly,BP,
9256,GO:0034334,1,0.960729012050893,0,5,adherens junction maintenance,BP,
9257,GO:0034337,1,0.995152293069162,0,1,RNA folding,BP,
9258,GO:0034338,1,0.960265577419424,0,6,short-chain carboxylesterase activity,MF,
9259,GO:0034340,1,0.614163313479827,0,79,response to type I interferon,BP,
9261,GO:0034342,1,0.993485400251684,0,1,response to type III interferon,BP,
9262,GO:0034343,1,0.978342378287136,0,3,type III interferon production,BP,
9263,GO:0034344,1,0.978342378287136,0,3,regulation of type III interferon production,BP,
9264,GO:0034346,1,0.99316769075087,0,1,positive regulation of type III interferon production,BP,
9265,GO:0034349,1,0.902850230007351,0,15,glial cell apoptotic process,BP,
9266,GO:0034350,1,0.932565022774169,0,10,regulation of glial cell apoptotic process,BP,
9267,GO:0034351,1,0.946347373835139,0,8,negative regulation of glial cell apoptotic process,BP,
9268,GO:0034352,1,0.985444232998811,0,2,positive regulation of glial cell apoptotic process,BP,
9269,GO:0034353,1,0.993485400251684,0,1,RNA pyrophosphohydrolase activity,MF,
9270,GO:0034354,1,0.971503969332525,0,6,'de novo' NAD biosynthetic process from tryptophan,BP,
9271,GO:0034355,1,0.993485400251684,0,1,NAD salvage,BP,
9272,GO:0034356,1,0.928236617600795,0,11,NAD biosynthesis via nicotinamide riboside salvage pathway,BP,
9273,GO:0034358,1,0.848077766852947,0,30,plasma lipoprotein particle,CC,
9274,GO:0034359,1,0.98460608656811,0,1,mature chylomicron,CC,
9275,GO:0034360,1,0.98460608656811,0,1,chylomicron remnant,CC,
9276,GO:0034361,1,0.919740776122314,0,15,very-low-density lipoprotein particle,CC,
9277,GO:0034362,1,0.937268700055968,0,11,low-density lipoprotein particle,CC,
9278,GO:0034363,1,0.974653442792913,0,4,intermediate-density lipoprotein particle,CC,
9279,GO:0034364,1,0.900591828852297,0,22,high-density lipoprotein particle,CC,
9280,GO:0034365,1,0.989841306448194,0,3,discoidal high-density lipoprotein particle,CC,
9281,GO:0034366,1,0.975588179529564,0,6,spherical high-density lipoprotein particle,CC,
9282,GO:0034367,1,0.861709415293358,0,25,protein-containing complex remodeling,BP,
9283,GO:0034368,1,0.867639898961541,0,24,protein-lipid complex remodeling,BP,
9284,GO:0034369,1,0.867639898961541,0,24,plasma lipoprotein particle remodeling,BP,
9285,GO:0034370,1,0.955058567419689,0,8,triglyceride-rich lipoprotein particle remodeling,BP,
9286,GO:0034371,1,0.967562736122309,0,5,chylomicron remodeling,BP,
9287,GO:0034372,1,0.969995101580292,0,7,very-low-density lipoprotein particle remodeling,BP,
9288,GO:0034373,1,0.995609243544747,0,1,intermediate-density lipoprotein particle remodeling,BP,
9289,GO:0034374,1,0.92049295870764,0,13,low-density lipoprotein particle remodeling,BP,
9290,GO:0034375,1,0.92536319317501,0,15,high-density lipoprotein particle remodeling,BP,
9291,GO:0034377,1,0.856329034530494,0,24,plasma lipoprotein particle assembly,BP,
9292,GO:0034378,1,0.947645496814393,0,8,chylomicron assembly,BP,
9293,GO:0034379,1,0.929269838460098,0,11,very-low-density lipoprotein particle assembly,BP,
9294,GO:0034380,1,0.932463698398618,0,11,high-density lipoprotein particle assembly,BP,
9295,GO:0034381,1,0.74554064501838,0,47,plasma lipoprotein particle clearance,BP,
9296,GO:0034382,1,0.956816671131806,0,7,chylomicron remnant clearance,BP,
9297,GO:0034383,1,0.820789463088291,0,30,low-density lipoprotein particle clearance,BP,
9298,GO:0034384,1,0.933448628781724,0,11,high-density lipoprotein particle clearance,BP,
9299,GO:0034385,1,0.919740776122314,0,15,triglyceride-rich plasma lipoprotein particle,CC,
9300,GO:0034386,1,0.992022490948624,0,1,4-aminobutyrate:2-oxoglutarate transaminase activity,MF,
9301,GO:0034388,1,0.966440420357176,0,5,Pwp2p-containing subcomplex of 90S preribosome,CC,
9302,GO:0034389,1,0.863209587228921,0,24,lipid droplet organization,BP,
9303,GO:0034390,1,0.877224419544502,0,20,smooth muscle cell apoptotic process,BP,
9304,GO:0034391,1,0.877224419544502,0,20,regulation of smooth muscle cell apoptotic process,BP,
9305,GO:0034392,1,0.956010876153097,0,6,negative regulation of smooth muscle cell apoptotic process,BP,
9306,GO:0034393,1,0.929557177720003,0,12,positive regulation of smooth muscle cell apoptotic process,BP,
9307,GO:0034394,1,0.644477811673299,0,62,protein localization to cell surface,BP,
9308,GO:0034395,1,0.979685953671596,0,3,regulation of transcription from RNA polymerase II promoter in response to iron,BP,
9309,GO:0034397,1,0.949454958878959,0,7,telomere localization,BP,
9310,GO:0034398,1,0.987999883516934,0,2,telomere tethering at nuclear periphery,BP,
9312,GO:0034401,1,0.55917165637446,0,80,chromatin organization involved in regulation of transcription,BP,
9313,GO:0034402,1,0.985421573757186,0,2,recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex,BP,
9314,GO:0034404,1,0.560064723117083,0,100,nucleobase-containing small molecule biosynthetic process,BP,
9315,GO:0034405,1,0.795554036082092,0,32,response to fluid shear stress,BP,
9316,GO:0034414,1,0.987157868047686,0,2,tRNA 3'-trailer cleavage, endonucleolytic,BP,
9317,GO:0034416,1,0.993381017686403,0,1,bisphosphoglycerate phosphatase activity,MF,
9318,GO:0034417,1,0.993381017686403,0,1,bisphosphoglycerate 3-phosphatase activity,MF,
9319,GO:0034418,1,0.988668418772748,0,2,urate biosynthetic process,BP,
9320,GO:0034421,1,0.979722705061485,0,3,post-translational protein acetylation,BP,
9321,GO:0034423,1,0.993689374840525,0,1,autophagosome lumen,CC,
9322,GO:0034427,1,0.953668694739949,0,10,nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5',BP,
9323,GO:0034431,1,0.977347175921527,0,4,bis(5'-adenosyl)-hexaphosphatase activity,MF,
9324,GO:0034432,1,0.977347175921527,0,4,bis(5'-adenosyl)-pentaphosphatase activity,MF,
9325,GO:0034433,1,0.933990012383288,0,12,steroid esterification,BP,
9326,GO:0034434,1,0.933990012383288,0,12,sterol esterification,BP,
9327,GO:0034435,1,0.933990012383288,0,12,cholesterol esterification,BP,
9328,GO:0034436,1,0.976217365225473,0,4,glycoprotein transport,BP,
9329,GO:0034439,1,0.98926368605863,0,2,lipoprotein lipid oxidation,BP,
9331,GO:0034441,1,0.99212373839129,0,2,plasma lipoprotein particle oxidation,BP,
9332,GO:0034442,1,0.98926368605863,0,2,regulation of lipoprotein oxidation,BP,
9333,GO:0034443,1,0.996355366728928,0,1,negative regulation of lipoprotein oxidation,BP,
9334,GO:0034444,1,0.996846663851221,0,1,regulation of plasma lipoprotein oxidation,BP,
9335,GO:0034445,1,0.996846663851221,0,1,negative regulation of plasma lipoprotein oxidation,BP,
9336,GO:0034446,1,0.490795512818328,0,99,substrate adhesion-dependent cell spreading,BP,
9337,GO:0034447,1,0.954823108878874,0,8,very-low-density lipoprotein particle clearance,BP,
9338,GO:0034448,1,0.97817308137824,0,4,EGO complex,CC,
9339,GO:0034450,1,0.912360174964758,0,13,ubiquitin-ubiquitin ligase activity,MF,
9340,GO:0034451,1,0.523083657604634,0,91,centriolar satellite,CC,
9341,GO:0034452,1,0.899500633647674,0,11,dynactin binding,MF,
9342,GO:0034453,1,0.833871906968212,0,21,microtubule anchoring,BP,
9343,GO:0034454,1,0.914875642610043,0,10,microtubule anchoring at centrosome,BP,
9344,GO:0034455,1,0.984385118512747,0,2,t-UTP complex,CC,
9345,GO:0034456,1,0.988796662089168,0,2,UTP-C complex,CC,
9346,GO:0034457,1,0.986659158973838,0,3,Mpp10 complex,CC,
9347,GO:0034458,1,0.977148597829326,0,3,3'-5' RNA helicase activity,MF,
9348,GO:0034462,1,0.97251832943422,0,3,small-subunit processome assembly,BP,
9349,GO:0034463,1,0.997311409978168,0,1,90S preribosome assembly,BP,
9350,GO:0034464,1,0.948175462856223,0,8,BBSome,CC,
9351,GO:0034465,1,0.975978813647686,0,4,response to carbon monoxide,BP,
9352,GO:0034466,1,0.993486806773018,0,1,chromaffin granule lumen,CC,
9353,GO:0034470,1,0.123476953188392,0,348,ncRNA processing,BP,
9354,GO:0034471,1,0.89355388458454,0,20,ncRNA 5'-end processing,BP,
9355,GO:0034472,1,0.892908179819368,0,19,snRNA 3'-end processing,BP,
9356,GO:0034473,1,0.98789019356638,0,3,U1 snRNA 3'-end processing,BP,
9357,GO:0034474,1,0.99019145718403,0,1,U2 snRNA 3'-end processing,BP,
9358,GO:0034475,1,0.967796708217716,0,8,U4 snRNA 3'-end processing,BP,
9359,GO:0034476,1,0.98789019356638,0,3,U5 snRNA 3'-end processing,BP,
9360,GO:0034477,1,0.98693080082192,0,2,U6 snRNA 3'-end processing,BP,
9361,GO:0034478,1,0.993278202668155,0,1,phosphatidylglycerol catabolic process,BP,
9362,GO:0034481,1,0.966386915855484,0,5,chondroitin sulfotransferase activity,MF,
9363,GO:0034483,1,0.902805496785642,0,14,heparan sulfate sulfotransferase activity,MF,
9364,GO:0034485,1,0.987451620426393,0,2,phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,MF,
9365,GO:0034497,1,0.917820997715029,0,12,protein localization to phagophore assembly site,BP,
9366,GO:0034498,1,0.945630653502957,0,8,early endosome to Golgi transport,BP,
9367,GO:0034499,1,0.96575885908739,0,5,late endosome to Golgi transport,BP,
9368,GO:0034501,1,0.909459603161558,0,16,protein localization to kinetochore,BP,
9369,GO:0034502,1,0.61126108210319,0,73,protein localization to chromosome,BP,
9370,GO:0034504,1,0.1706905539226,0,252,protein localization to nucleus,BP,
9371,GO:0034505,1,0.876613263087435,0,18,tooth mineralization,BP,
9372,GO:0034506,1,0.992604430620992,0,1,chromosome, centromeric core domain,CC,
9374,GO:0034511,1,0.939184350091253,0,8,U3 snoRNA binding,MF,
9375,GO:0034512,1,0.992643135437148,0,1,box C/D snoRNA binding,MF,
9376,GO:0034513,1,0.976898336148395,0,5,box H/ACA snoRNA binding,MF,
9377,GO:0034514,1,0.994255653482727,0,1,mitochondrial unfolded protein response,BP,
9378,GO:0034515,1,0.986314054539944,0,2,proteasome storage granule,CC,
9379,GO:0034516,1,0.995811985613003,0,1,response to vitamin B6,BP,
9380,GO:0034518,1,0.928895243264148,0,11,RNA cap binding complex,CC,
9381,GO:0034545,1,0.995481126780028,0,1,fumarylpyruvate hydrolase activity,MF,
9382,GO:0034551,1,0.942334491795444,0,10,mitochondrial respiratory chain complex III assembly,BP,
9383,GO:0034552,1,0.992617672297874,0,2,respiratory chain complex II assembly,BP,
9384,GO:0034553,1,0.992617672297874,0,2,mitochondrial respiratory chain complex II assembly,BP,
9385,GO:0034584,1,0.985761040227409,0,2,piRNA binding,MF,
9386,GO:0034587,1,0.910640897957034,0,14,piRNA metabolic process,BP,
9387,GO:0034589,1,0.992455462665037,0,1,hydroxyproline transport,BP,
9388,GO:0034590,1,0.992455462665037,0,1,L-hydroxyproline transmembrane transporter activity,MF,
9389,GO:0034592,1,0.996154982470263,0,1,synaptic vesicle lumen,CC,
9390,GO:0034593,1,0.845810218963725,0,21,phosphatidylinositol bisphosphate phosphatase activity,MF,
9391,GO:0034594,1,0.959759761410867,0,6,phosphatidylinositol trisphosphate phosphatase activity,MF,
9392,GO:0034595,1,0.911862815043631,0,12,phosphatidylinositol phosphate 5-phosphatase activity,MF,
9393,GO:0034596,1,0.952996216721811,0,6,phosphatidylinositol phosphate 4-phosphatase activity,MF,
9394,GO:0034597,1,0.983104675016502,0,2,phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity,MF,
9396,GO:0034603,1,0.967922618008987,0,5,pyruvate dehydrogenase [NAD(P)+] activity,MF,
9397,GO:0034604,1,0.967922618008987,0,5,pyruvate dehydrogenase (NAD+) activity,MF,
9399,GO:0034611,1,0.992622242279326,0,1,oligoribonucleotidase activity,MF,
9400,GO:0034612,1,0.201159822373844,0,273,response to tumor necrosis factor,BP,
9403,GO:0034616,1,0.912502642830459,0,13,response to laminar fluid shear stress,BP,
9404,GO:0034617,1,0.971905486584226,0,4,tetrahydrobiopterin binding,MF,
9405,GO:0034618,1,0.966077205798428,0,5,arginine binding,MF,
9408,GO:0034625,1,0.961072995080493,0,6,fatty acid elongation, monounsaturated fatty acid,BP,
9409,GO:0034626,1,0.961072995080493,0,6,fatty acid elongation, polyunsaturated fatty acid,BP,
9410,GO:0034627,1,0.971503969332525,0,6,'de novo' NAD biosynthetic process,BP,
9411,GO:0034629,1,0.8722230127778,0,20,cellular protein-containing complex localization,BP,
9412,GO:0034632,1,0.990032317049768,0,2,retinol transmembrane transporter activity,MF,
9413,GO:0034633,1,0.990032317049768,0,2,retinol transport,BP,
9414,GO:0034634,1,0.976579456270282,0,3,glutathione transmembrane transporter activity,MF,
9415,GO:0034635,1,0.959894852049684,0,5,glutathione transport,BP,
9416,GO:0034637,1,0.567902012274003,0,78,cellular carbohydrate biosynthetic process,BP,
9417,GO:0034638,1,0.925406067364128,0,13,phosphatidylcholine catabolic process,BP,
9418,GO:0034640,1,0.993009229448717,0,1,establishment of mitochondrion localization by microtubule attachment,BP,
9420,GO:0034643,1,0.851016758188827,0,22,establishment of mitochondrion localization, microtubule-mediated,BP,
9421,GO:0034644,1,0.596484620600072,0,77,cellular response to UV,BP,
9423,GO:0034647,1,0.960481269167229,0,4,histone demethylase activity (H3-trimethyl-K4 specific),MF,
9424,GO:0034648,1,0.963999975825077,0,4,histone demethylase activity (H3-dimethyl-K4 specific),MF,
9425,GO:0034649,1,0.992667829017724,0,1,histone demethylase activity (H3-monomethyl-K4 specific),MF,
9426,GO:0034650,1,0.933418578583006,0,9,cortisol metabolic process,BP,
9427,GO:0034651,1,0.938177131568854,0,8,cortisol biosynthetic process,BP,
9428,GO:0034653,1,0.979484356691164,0,4,retinoic acid catabolic process,BP,
9430,GO:0034655,1,0.0456700735026676,0,513,nucleobase-containing compound catabolic process,BP,
9431,GO:0034656,1,0.773641156265752,0,45,nucleobase-containing small molecule catabolic process,BP,
9432,GO:0034657,1,0.974032792054873,0,4,GID complex,CC,
9433,GO:0034660,1,0.0780810095033046,0,417,ncRNA metabolic process,BP,
9434,GO:0034661,1,0.812278057523183,0,31,ncRNA catabolic process,BP,
9435,GO:0034663,1,0.94684209951995,0,9,endoplasmic reticulum chaperone complex,CC,
9436,GO:0034665,1,0.984877705812557,0,2,integrin alpha1-beta1 complex,CC,
9437,GO:0034666,1,0.975503786011355,0,3,integrin alpha2-beta1 complex,CC,
9438,GO:0034667,1,0.984754940245673,0,2,integrin alpha3-beta1 complex,CC,
9439,GO:0034668,1,0.976548920076783,0,3,integrin alpha4-beta1 complex,CC,
9440,GO:0034669,1,0.98452407866022,0,2,integrin alpha4-beta7 complex,CC,
9441,GO:0034670,1,0.987907143261014,0,1,chemotaxis to arachidonic acid,BP,
9442,GO:0034673,1,0.978519036833592,0,3,inhibin-betaglycan-ActRII complex,CC,
9443,GO:0034674,1,0.985249087792578,0,2,integrin alpha5-beta1 complex,CC,
9444,GO:0034676,1,0.99129247720025,0,1,integrin alpha6-beta4 complex,CC,
9445,GO:0034677,1,0.992720734818585,0,1,integrin alpha7-beta1 complex,CC,
9446,GO:0034678,1,0.978117471627351,0,3,integrin alpha8-beta1 complex,CC,
9447,GO:0034679,1,0.992625465106464,0,1,integrin alpha9-beta1 complex,CC,
9448,GO:0034680,1,0.984574876855514,0,2,integrin alpha10-beta1 complex,CC,
9449,GO:0034681,1,0.984714139306437,0,2,integrin alpha11-beta1 complex,CC,
9450,GO:0034683,1,0.982364191911462,0,2,integrin alphav-beta3 complex,CC,
9451,GO:0034684,1,0.983229278306668,0,2,integrin alphav-beta5 complex,CC,
9452,GO:0034685,1,0.984394350402638,0,2,integrin alphav-beta6 complex,CC,
9453,GO:0034686,1,0.979063375190207,0,2,integrin alphav-beta8 complex,CC,
9454,GO:0034687,1,0.985185698725017,0,2,integrin alphaL-beta2 complex,CC,
9455,GO:0034688,1,0.985455727135341,0,2,integrin alphaM-beta2 complex,CC,
9456,GO:0034689,1,0.985524027297613,0,2,integrin alphaX-beta2 complex,CC,
9457,GO:0034693,1,0.993982033751052,0,1,U11/U12 snRNP,CC,
9458,GO:0034694,1,0.813752444774875,0,30,response to prostaglandin,BP,
9459,GO:0034695,1,0.864722777234369,0,22,response to prostaglandin E,BP,
9460,GO:0034696,1,0.988473546232705,0,2,response to prostaglandin F,BP,
9461,GO:0034698,1,0.836042725491087,0,24,response to gonadotropin,BP,
9462,GO:0034699,1,0.977939119099247,0,3,response to luteinizing hormone,BP,
9465,GO:0034704,1,0.604311062693541,0,61,calcium channel complex,CC,
9467,GO:0034706,1,0.790956365060374,0,26,sodium channel complex,CC,
9469,GO:0034708,1,0.514677072890953,0,96,methyltransferase complex,CC,
9470,GO:0034709,1,0.952270708622346,0,12,methylosome,CC,
9471,GO:0034711,1,0.970131894424708,0,5,inhibin binding,MF,
9472,GO:0034713,1,0.937585619054731,0,9,type I transforming growth factor beta receptor binding,MF,
9473,GO:0034714,1,0.979450745471859,0,3,type III transforming growth factor beta receptor binding,MF,
9474,GO:0034715,1,0.977122098867392,0,6,pICln-Sm protein complex,CC,
9475,GO:0034718,1,0.991593383038989,0,1,SMN-Gemin2 complex,CC,
9476,GO:0034719,1,0.913272008127522,0,18,SMN-Sm protein complex,CC,
9477,GO:0034720,1,0.938625440378191,0,7,histone H3-K4 demethylation,BP,
9478,GO:0034721,1,0.952112357627549,0,5,histone H3-K4 demethylation, trimethyl-H3-K4-specific,BP,
9479,GO:0034722,1,0.995802959596816,0,1,gamma-glutamyl-peptidase activity,MF,
9480,GO:0034723,1,0.948456615270821,0,8,DNA replication-dependent nucleosome organization,BP,
9481,GO:0034724,1,0.802311107590591,0,35,DNA replication-independent nucleosome organization,BP,
9482,GO:0034727,1,0.954330865397875,0,5,piecemeal microautophagy of the nucleus,BP,
9483,GO:0034728,1,0.52337258556954,0,95,nucleosome organization,BP,
9484,GO:0034729,1,0.978657459290588,0,3,histone H3-K79 methylation,BP,
9485,GO:0034736,1,0.992895096867418,0,1,cholesterol O-acyltransferase activity,MF,
9486,GO:0034739,1,0.982976262025118,0,3,histone deacetylase activity (H4-K16 specific),MF,
9487,GO:0034750,1,0.984719702219304,0,2,Scrib-APC-beta-catenin complex,CC,
9488,GO:0034751,1,0.981016052837841,0,3,aryl hydrocarbon receptor complex,CC,
9489,GO:0034752,1,0.990859160230564,0,1,cytosolic aryl hydrocarbon receptor complex,CC,
9490,GO:0034754,1,0.548473691075743,0,103,cellular hormone metabolic process,BP,
9491,GO:0034755,1,0.904478296981352,0,16,iron ion transmembrane transport,BP,
9492,GO:0034756,1,0.967934878418403,0,6,regulation of iron ion transport,BP,
9493,GO:0034757,1,0.98262901372387,0,3,negative regulation of iron ion transport,BP,
9494,GO:0034759,1,0.98262901372387,0,3,regulation of iron ion transmembrane transport,BP,
9495,GO:0034760,1,0.98262901372387,0,3,negative regulation of iron ion transmembrane transport,BP,
9497,GO:0034763,1,0.492061989703442,0,110,negative regulation of transmembrane transport,BP,
9500,GO:0034766,1,0.553224158816318,0,90,negative regulation of ion transmembrane transport,BP,
9502,GO:0034769,1,0.987322069340163,0,2,basement membrane disassembly,BP,
9503,GO:0034770,1,0.945249239845279,0,6,histone H4-K20 methylation,BP,
9504,GO:0034773,1,0.968550957534139,0,4,histone H4-K20 trimethylation,BP,
9506,GO:0034775,1,0.964848971274922,0,4,glutathione transmembrane transport,BP,
9508,GO:0034777,1,0.994411160124299,0,1,recycling endosome lumen,CC,
9509,GO:0034875,1,0.99501807222187,0,1,caffeine oxidase activity,MF,
9510,GO:0034899,1,0.994716199359941,0,1,trimethylamine monooxygenase activity,MF,
9511,GO:0034959,1,0.991849041800206,0,1,endothelin maturation,BP,
9512,GO:0034963,1,0.990745305967436,0,2,box C/D snoRNA processing,BP,
9513,GO:0034964,1,0.986977603975739,0,2,box H/ACA snoRNA processing,BP,
9514,GO:0034968,1,0.46646313947654,0,99,histone lysine methylation,BP,
9515,GO:0034969,1,0.941787394507112,0,10,histone arginine methylation,BP,
9516,GO:0034970,1,0.986956101927331,0,2,histone H3-R2 methylation,BP,
9517,GO:0034971,1,0.987846421156099,0,2,histone H3-R17 methylation,BP,
9518,GO:0034975,1,0.946889570359448,0,8,protein folding in endoplasmic reticulum,BP,
9520,GO:0034979,1,0.896711742185776,0,16,NAD-dependent protein deacetylase activity,MF,
9521,GO:0034982,1,0.931433394854376,0,12,mitochondrial protein processing,BP,
9522,GO:0034983,1,0.945841729541917,0,8,peptidyl-lysine deacetylation,BP,
9523,GO:0034986,1,0.983565617197023,0,2,iron chaperone activity,MF,
9524,GO:0034987,1,0.962631186682825,0,6,immunoglobulin receptor binding,MF,
9525,GO:0034988,1,0.982976017290903,0,2,Fc-gamma receptor I complex binding,MF,
9526,GO:0034990,1,0.982353093473865,0,3,nuclear mitotic cohesin complex,CC,
9527,GO:0034991,1,0.967696474080423,0,5,nuclear meiotic cohesin complex,CC,
9528,GO:0034992,1,0.923604611743795,0,8,microtubule organizing center attachment site,CC,
9529,GO:0034993,1,0.923604611743795,0,8,meiotic nuclear membrane microtubule tethering complex,CC,
9530,GO:0034998,1,0.987458243711833,0,2,oligosaccharyltransferase I complex,CC,
9531,GO:0035000,1,0.993421218018077,0,1,oligosaccharyltransferase III complex,CC,
9532,GO:0035004,1,0.910427860527861,0,11,phosphatidylinositol 3-kinase activity,MF,
9533,GO:0035005,1,0.941298921545554,0,7,1-phosphatidylinositol-4-phosphate 3-kinase activity,MF,
9534,GO:0035014,1,0.886214639139752,0,17,phosphatidylinositol 3-kinase regulator activity,MF,
9535,GO:0035019,1,0.626876220972714,0,70,somatic stem cell population maintenance,BP,
9536,GO:0035020,1,0.879441493843181,0,17,regulation of Rac protein signal transduction,BP,
9537,GO:0035021,1,0.966402565232666,0,4,negative regulation of Rac protein signal transduction,BP,
9538,GO:0035022,1,0.972019234347959,0,4,positive regulation of Rac protein signal transduction,BP,
9539,GO:0035023,1,0.569609915857455,0,77,regulation of Rho protein signal transduction,BP,
9540,GO:0035024,1,0.846286441122223,0,21,negative regulation of Rho protein signal transduction,BP,
9541,GO:0035025,1,0.830325220366275,0,28,positive regulation of Rho protein signal transduction,BP,
9542,GO:0035026,1,0.985257909108037,0,2,leading edge cell differentiation,BP,
9543,GO:0035032,1,0.961898565468739,0,6,phosphatidylinositol 3-kinase complex, class III,CC,
9544,GO:0035033,1,0.978225897209622,0,4,histone deacetylase regulator activity,MF,
9545,GO:0035034,1,0.987787016133714,0,2,histone acetyltransferase regulator activity,MF,
9546,GO:0035035,1,0.813899470408126,0,28,histone acetyltransferase binding,MF,
9548,GO:0035037,1,0.992316819013709,0,1,sperm entry,BP,
9549,GO:0035038,1,0.987436872975043,0,2,female pronucleus assembly,BP,
9550,GO:0035039,1,0.994257565424587,0,1,male pronucleus assembly,BP,
9551,GO:0035050,1,0.5930869048171,0,73,embryonic heart tube development,BP,
9553,GO:0035054,1,0.980608091404295,0,3,embryonic heart tube anterior/posterior pattern specification,BP,
9554,GO:0035060,1,0.974046280553131,0,3,brahma complex,CC,
9555,GO:0035061,1,0.960028904754522,0,5,interchromatin granule,CC,
9556,GO:0035063,1,0.972393524590967,0,3,nuclear speck organization,BP,
9557,GO:0035064,1,0.641230156229391,0,62,methylated histone binding,MF,
9558,GO:0035065,1,0.698520145527501,0,54,regulation of histone acetylation,BP,
9559,GO:0035066,1,0.824878466191091,0,29,positive regulation of histone acetylation,BP,
9560,GO:0035067,1,0.902336712739462,0,16,negative regulation of histone acetylation,BP,
9562,GO:0035087,1,0.972481571240026,0,4,siRNA loading onto RISC involved in RNA interference,BP,
9563,GO:0035088,1,0.716142708609802,0,45,establishment or maintenance of apical/basal cell polarity,BP,
9564,GO:0035089,1,0.873828678099946,0,19,establishment of apical/basal cell polarity,BP,
9565,GO:0035090,1,0.932825718171913,0,11,maintenance of apical/basal cell polarity,BP,
9567,GO:0035092,1,0.955054914134148,0,6,sperm chromatin condensation,BP,
9568,GO:0035093,1,0.966328169226117,0,4,spermatogenesis, exchange of chromosomal proteins,BP,
9570,GO:0035095,1,0.947477202966763,0,7,behavioral response to nicotine,BP,
9571,GO:0035097,1,0.586977217612877,0,71,histone methyltransferase complex,CC,
9572,GO:0035098,1,0.901024554288213,0,14,ESC/E(Z) complex,CC,
9573,GO:0035101,1,0.972837486710044,0,4,FACT complex,CC,
9574,GO:0035102,1,0.904373306322375,0,14,PRC1 complex,CC,
9575,GO:0035103,1,0.994278633367177,0,1,sterol regulatory element binding protein cleavage,BP,
9576,GO:0035106,1,0.980884116132476,0,3,operant conditioning,BP,
9579,GO:0035112,1,0.912760152090598,0,13,genitalia morphogenesis,BP,
9581,GO:0035115,1,0.809098075851625,0,32,embryonic forelimb morphogenesis,BP,
9582,GO:0035116,1,0.830510159171747,0,28,embryonic hindlimb morphogenesis,BP,
9583,GO:0035120,1,0.986811811721545,0,1,post-embryonic appendage morphogenesis,BP,
9584,GO:0035127,1,0.986811811721545,0,1,post-embryonic limb morphogenesis,BP,
9585,GO:0035128,1,0.986811811721545,0,1,post-embryonic forelimb morphogenesis,BP,
9586,GO:0035136,1,0.755136773140583,0,40,forelimb morphogenesis,BP,
9587,GO:0035137,1,0.778764483370886,0,36,hindlimb morphogenesis,BP,
9588,GO:0035145,1,0.891021404151842,0,18,exon-exon junction complex,CC,
9591,GO:0035162,1,0.854088912076879,0,22,embryonic hemopoiesis,BP,
9592,GO:0035166,1,0.978545517253813,0,3,post-embryonic hemopoiesis,BP,
9593,GO:0035173,1,0.901502166263415,0,15,histone kinase activity,MF,
9594,GO:0035174,1,0.963060425252549,0,6,histone serine kinase activity,MF,
9595,GO:0035175,1,0.995427264223568,0,1,histone kinase activity (H3-S10 specific),MF,
9596,GO:0035176,1,0.685904363014548,0,48,social behavior,BP,
9597,GO:0035184,1,0.963094724283262,0,5,histone threonine kinase activity,MF,
9598,GO:0035188,1,0.848447629171589,0,26,hatching,BP,
9599,GO:0035189,1,0.985755511687811,0,2,Rb-E2F complex,CC,
9600,GO:0035194,1,0.425267686252509,0,120,post-transcriptional gene silencing by RNA,BP,
9601,GO:0035195,1,0.455968918331166,0,111,gene silencing by miRNA,BP,
9602,GO:0035196,1,0.724592148388259,0,45,production of miRNAs involved in gene silencing by miRNA,BP,
9603,GO:0035197,1,0.926992482589832,0,10,siRNA binding,MF,
9604,GO:0035198,1,0.828361079843088,0,27,miRNA binding,MF,
9605,GO:0035226,1,0.993132956344955,0,1,glutamate-cysteine ligase catalytic subunit binding,MF,
9606,GO:0035227,1,0.993132956344955,0,1,regulation of glutamate-cysteine ligase activity,BP,
9607,GO:0035229,1,0.993132956344955,0,1,positive regulation of glutamate-cysteine ligase activity,BP,
9608,GO:0035234,1,0.948064194651291,0,7,ectopic germ cell programmed cell death,BP,
9610,GO:0035238,1,0.993485400251684,0,1,vitamin A biosynthetic process,BP,
9612,GO:0035240,1,0.956359372231832,0,8,dopamine binding,MF,
9613,GO:0035241,1,0.97169197351014,0,5,protein-arginine omega-N monomethyltransferase activity,MF,
9614,GO:0035242,1,0.971840475643314,0,5,protein-arginine omega-N asymmetric methyltransferase activity,MF,
9615,GO:0035243,1,0.97531469525887,0,4,protein-arginine omega-N symmetric methyltransferase activity,MF,
9616,GO:0035246,1,0.936042882898588,0,11,peptidyl-arginine N-methylation,BP,
9617,GO:0035247,1,0.947843524418117,0,9,peptidyl-arginine omega-N-methylation,BP,
9618,GO:0035248,1,0.993353520441149,0,1,alpha-1,4-N-acetylgalactosaminyltransferase activity,MF,
9620,GO:0035250,1,0.8672430793776,0,23,UDP-galactosyltransferase activity,MF,
9621,GO:0035251,1,0.940082609651248,0,9,UDP-glucosyltransferase activity,MF,
9622,GO:0035252,1,0.954427601481361,0,6,UDP-xylosyltransferase activity,MF,
9623,GO:0035253,1,0.919990317125399,0,11,ciliary rootlet,CC,
9625,GO:0035255,1,0.817765058438714,0,27,ionotropic glutamate receptor binding,MF,
9626,GO:0035256,1,0.93625884179732,0,11,G protein-coupled glutamate receptor binding,MF,
9627,GO:0035257,1,0.373249814872482,0,137,nuclear hormone receptor binding,MF,
9628,GO:0035258,1,0.572890879538019,0,76,steroid hormone receptor binding,MF,
9629,GO:0035259,1,0.888145124865636,0,15,glucocorticoid receptor binding,MF,
9630,GO:0035261,1,0.975379819875126,0,2,external genitalia morphogenesis,BP,
9631,GO:0035262,1,0.983062251691811,0,2,gonad morphogenesis,BP,
9634,GO:0035267,1,0.887992505912728,0,19,NuA4 histone acetyltransferase complex,CC,
9635,GO:0035268,1,0.868449892586695,0,20,protein mannosylation,BP,
9636,GO:0035269,1,0.905297328678985,0,15,protein O-linked mannosylation,BP,
9637,GO:0035270,1,0.451749655301206,0,119,endocrine system development,BP,
9638,GO:0035272,1,0.701224830978678,0,49,exocrine system development,BP,
9639,GO:0035276,1,0.986458585841272,0,2,ethanol binding,MF,
9640,GO:0035278,1,0.89303868827378,0,14,miRNA mediated inhibition of translation,BP,
9641,GO:0035279,1,0.986328762098842,0,2,mRNA cleavage involved in gene silencing by miRNA,BP,
9642,GO:0035280,1,0.949033715930271,0,7,miRNA loading onto RISC involved in gene silencing by miRNA,BP,
9643,GO:0035281,1,0.988093543584894,0,2,pre-miRNA export from nucleus,BP,
9645,GO:0035283,1,0.981709302573603,0,3,central nervous system segmentation,BP,
9646,GO:0035284,1,0.981709302573603,0,3,brain segmentation,BP,
9647,GO:0035290,1,0.970123473865668,0,4,trunk segmentation,BP,
9650,GO:0035299,1,0.992390747296983,0,1,inositol pentakisphosphate 2-kinase activity,MF,
9654,GO:0035306,1,0.67870653964503,0,54,positive regulation of dephosphorylation,BP,
9655,GO:0035307,1,0.751892405468485,0,41,positive regulation of protein dephosphorylation,BP,
9657,GO:0035312,1,0.949607680908905,0,8,5'-3' exodeoxyribonuclease activity,MF,
9658,GO:0035313,1,0.882926785706201,0,15,wound healing, spreading of epidermal cells,BP,
9660,GO:0035325,1,0.933509719232605,0,12,Toll-like receptor binding,MF,
9661,GO:0035327,1,0.875527508801268,0,20,transcriptionally active chromatin,CC,
9663,GO:0035330,1,0.879574297022837,0,16,regulation of hippo signaling,BP,
9664,GO:0035331,1,0.914387633375614,0,11,negative regulation of hippo signaling,BP,
9665,GO:0035332,1,0.973417148050065,0,3,positive regulation of hippo signaling,BP,
9666,GO:0035333,1,0.956362374163169,0,7,Notch receptor processing, ligand-dependent,BP,
9668,GO:0035336,1,0.86076716012256,0,23,long-chain fatty-acyl-CoA metabolic process,BP,
9669,GO:0035337,1,0.786976909407058,0,37,fatty-acyl-CoA metabolic process,BP,
9670,GO:0035338,1,0.888107813223063,0,18,long-chain fatty-acyl-CoA biosynthetic process,BP,
9671,GO:0035339,1,0.980595506064901,0,4,SPOTS complex,CC,
9672,GO:0035344,1,0.993879134071437,0,1,hypoxanthine transport,BP,
9673,GO:0035349,1,0.98747383123151,0,2,coenzyme A transmembrane transport,BP,
9674,GO:0035350,1,0.987573276862597,0,2,FAD transmembrane transport,BP,
9675,GO:0035351,1,0.993220829637341,0,1,heme transmembrane transport,BP,
9676,GO:0035352,1,0.994353828774869,0,1,NAD transmembrane transport,BP,
9677,GO:0035354,1,0.986324277157903,0,2,Toll-like receptor 1-Toll-like receptor 2 protein complex,CC,
9678,GO:0035355,1,0.99119377564533,0,1,Toll-like receptor 2-Toll-like receptor 6 protein complex,CC,
9679,GO:0035356,1,0.959818702967648,0,7,cellular triglyceride homeostasis,BP,
9680,GO:0035357,1,0.86635980399577,0,21,peroxisome proliferator activated receptor signaling pathway,BP,
9681,GO:0035358,1,0.916141866316415,0,14,regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9682,GO:0035359,1,0.982229001101573,0,3,negative regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9683,GO:0035360,1,0.945652733488463,0,9,positive regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9684,GO:0035363,1,0.975406218864764,0,4,histone locus body,CC,
9685,GO:0035364,1,0.993879134071437,0,1,thymine transport,BP,
9686,GO:0035368,1,0.970555725890158,0,5,selenocysteine insertion sequence binding,MF,
9687,GO:0035370,1,0.988117651556524,0,2,UBC13-UEV1A complex,CC,
9688,GO:0035371,1,0.82862636577571,0,22,microtubule plus-end,CC,
9689,GO:0035372,1,0.877741643293929,0,17,protein localization to microtubule,BP,
9690,GO:0035373,1,0.97182343876696,0,3,chondroitin sulfate proteoglycan binding,MF,
9691,GO:0035374,1,0.940662260933242,0,9,chondroitin sulfate binding,MF,
9692,GO:0035375,1,0.989603683767328,0,1,zymogen binding,MF,
9693,GO:0035376,1,0.945957737737673,0,8,sterol import,BP,
9694,GO:0035377,1,0.976656904597596,0,3,transepithelial water transport,BP,
9695,GO:0035378,1,0.993508103168564,0,1,carbon dioxide transmembrane transport,BP,
9696,GO:0035379,1,0.993508103168564,0,1,carbon dioxide transmembrane transporter activity,MF,
9697,GO:0035381,1,0.952859570060598,0,8,ATP-gated ion channel activity,MF,
9698,GO:0035383,1,0.562964852652021,0,93,thioester metabolic process,BP,
9699,GO:0035384,1,0.71905466655594,0,49,thioester biosynthetic process,BP,
9700,GO:0035385,1,0.958773223394356,0,5,Roundabout signaling pathway,BP,
9701,GO:0035397,1,0.99310439906465,0,1,helper T cell enhancement of adaptive immune response,BP,
9702,GO:0035400,1,0.991700669806181,0,1,histone tyrosine kinase activity,MF,
9703,GO:0035401,1,0.991700669806181,0,1,histone kinase activity (H3-Y41 specific),MF,
9704,GO:0035402,1,0.986829213155595,0,2,histone kinase activity (H3-T11 specific),MF,
9705,GO:0035403,1,0.980436044274027,0,2,histone kinase activity (H3-T6 specific),MF,
9706,GO:0035404,1,0.926471055800489,0,12,histone-serine phosphorylation,BP,
9707,GO:0035405,1,0.963094724283262,0,5,histone-threonine phosphorylation,BP,
9708,GO:0035406,1,0.991700669806181,0,1,histone-tyrosine phosphorylation,BP,
9709,GO:0035407,1,0.986829213155595,0,2,histone H3-T11 phosphorylation,BP,
9710,GO:0035408,1,0.980436044274027,0,2,histone H3-T6 phosphorylation,BP,
9711,GO:0035409,1,0.991700669806181,0,1,histone H3-Y41 phosphorylation,BP,
9712,GO:0035410,1,0.992831294497694,0,2,dihydrotestosterone 17-beta-dehydrogenase activity,MF,
9714,GO:0035425,1,0.962133727103545,0,7,autocrine signaling,BP,
9715,GO:0035426,1,0.963164795828872,0,5,extracellular matrix-cell signaling,BP,
9716,GO:0035434,1,0.957602512297765,0,6,copper ion transmembrane transport,BP,
9717,GO:0035435,1,0.914721004841497,0,13,phosphate ion transmembrane transport,BP,
9718,GO:0035437,1,0.915057440094841,0,14,maintenance of protein localization in endoplasmic reticulum,BP,
9719,GO:0035441,1,0.973307993572928,0,3,cell migration involved in vasculogenesis,BP,
9720,GO:0035442,1,0.969030844895767,0,4,dipeptide transmembrane transport,BP,
9721,GO:0035443,1,0.964848971274922,0,4,tripeptide transmembrane transport,BP,
9722,GO:0035444,1,0.992530547375531,0,1,nickel cation transmembrane transport,BP,
9723,GO:0035445,1,0.993097467101843,0,1,borate transmembrane transport,BP,
9724,GO:0035455,1,0.879839683289959,0,20,response to interferon-alpha,BP,
9725,GO:0035456,1,0.873338695813718,0,25,response to interferon-beta,BP,
9726,GO:0035457,1,0.928382357235415,0,10,cellular response to interferon-alpha,BP,
9727,GO:0035458,1,0.899525183401013,0,18,cellular response to interferon-beta,BP,
9728,GO:0035459,1,0.863725703246798,0,20,vesicle cargo loading,BP,
9730,GO:0035469,1,0.963427776061063,0,5,determination of pancreatic left/right asymmetry,BP,
9731,GO:0035470,1,0.979274140788564,0,4,positive regulation of vascular wound healing,BP,
9732,GO:0035473,1,0.966987795420018,0,4,lipase binding,MF,
9733,GO:0035480,1,0.97136385421617,0,4,regulation of Notch signaling pathway involved in heart induction,BP,
9734,GO:0035481,1,0.97136385421617,0,4,positive regulation of Notch signaling pathway involved in heart induction,BP,
9735,GO:0035482,1,0.977988239436431,0,6,gastric motility,BP,
9736,GO:0035483,1,0.982395193055784,0,5,gastric emptying,BP,
9737,GO:0035485,1,0.995179031985496,0,1,adenine/guanine mispair binding,MF,
9738,GO:0035490,1,0.993059151945929,0,1,regulation of leukotriene production involved in inflammatory response,BP,
9739,GO:0035491,1,0.993059151945929,0,1,positive regulation of leukotriene production involved in inflammatory response,BP,
9740,GO:0035493,1,0.900068759351023,0,17,SNARE complex assembly,BP,
9741,GO:0035494,1,0.981411960297033,0,3,SNARE complex disassembly,BP,
9743,GO:0035498,1,0.992636844474795,0,1,carnosine metabolic process,BP,
9744,GO:0035499,1,0.992636844474795,0,1,carnosine biosynthetic process,BP,
9745,GO:0035500,1,0.986172214112818,0,2,MH2 domain binding,MF,
9746,GO:0035501,1,0.993404800891667,0,1,MH1 domain binding,MF,
9747,GO:0035502,1,0.968332931323132,0,5,metanephric part of ureteric bud development,BP,
9748,GO:0035504,1,0.995789792855028,0,1,regulation of myosin light chain kinase activity,BP,
9749,GO:0035505,1,0.995789792855028,0,1,positive regulation of myosin light chain kinase activity,BP,
9750,GO:0035507,1,0.945113700419932,0,7,regulation of myosin-light-chain-phosphatase activity,BP,
9751,GO:0035508,1,0.991438456146558,0,1,positive regulation of myosin-light-chain-phosphatase activity,BP,
9752,GO:0035509,1,0.962562039635368,0,5,negative regulation of myosin-light-chain-phosphatase activity,BP,
9753,GO:0035510,1,0.815777457030555,0,30,DNA dealkylation,BP,
9754,GO:0035511,1,0.966725534720449,0,6,oxidative DNA demethylation,BP,
9755,GO:0035513,1,0.967969056322116,0,5,oxidative RNA demethylation,BP,
9756,GO:0035514,1,0.973547954092319,0,5,DNA demethylase activity,MF,
9757,GO:0035515,1,0.967969056322116,0,5,oxidative RNA demethylase activity,MF,
9758,GO:0035516,1,0.98111150553757,0,3,oxidative DNA demethylase activity,MF,
9759,GO:0035517,1,0.965533082447916,0,4,PR-DUB complex,CC,
9760,GO:0035518,1,0.894462501115173,0,16,histone H2A monoubiquitination,BP,
9761,GO:0035519,1,0.97975011505319,0,4,protein K29-linked ubiquitination,BP,
9762,GO:0035520,1,0.931161506732837,0,9,monoubiquitinated protein deubiquitination,BP,
9763,GO:0035521,1,0.972630955352485,0,4,monoubiquitinated histone deubiquitination,BP,
9764,GO:0035522,1,0.972630955352485,0,4,monoubiquitinated histone H2A deubiquitination,BP,
9765,GO:0035523,1,0.965084682575327,0,4,protein K29-linked deubiquitination,BP,
9766,GO:0035524,1,0.948808660419058,0,7,proline transmembrane transport,BP,
9767,GO:0035525,1,0.993780655446095,0,1,NF-kappaB p50/p65 complex,CC,
9768,GO:0035526,1,0.984663259629612,0,2,retrograde transport, plasma membrane to Golgi,BP,
9769,GO:0035529,1,0.955261440496581,0,8,NADH pyrophosphatase activity,MF,
9770,GO:0035538,1,0.992986679794249,0,1,carbohydrate response element binding,MF,
9771,GO:0035539,1,0.991757980238503,0,2,8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity,MF,
9772,GO:0035542,1,0.940225094062232,0,9,regulation of SNARE complex assembly,BP,
9773,GO:0035543,1,0.993053943534722,0,1,positive regulation of SNARE complex assembly,BP,
9774,GO:0035544,1,0.978535748014302,0,3,negative regulation of SNARE complex assembly,BP,
9775,GO:0035545,1,0.977281419689642,0,2,determination of left/right asymmetry in nervous system,BP,
9776,GO:0035552,1,0.988159304546497,0,2,oxidative single-stranded DNA demethylation,BP,
9777,GO:0035553,1,0.981122630560224,0,3,oxidative single-stranded RNA demethylation,BP,
9779,GO:0035561,1,0.863942763921349,0,21,regulation of chromatin binding,BP,
9780,GO:0035562,1,0.947218190986031,0,7,negative regulation of chromatin binding,BP,
9781,GO:0035563,1,0.918674295584584,0,13,positive regulation of chromatin binding,BP,
9782,GO:0035564,1,0.973683378007421,0,3,regulation of kidney size,BP,
9783,GO:0035566,1,0.992562811373111,0,1,regulation of metanephros size,BP,
9785,GO:0035568,1,0.993485400251684,0,1,N-terminal peptidyl-proline methylation,BP,
9786,GO:0035570,1,0.993485400251684,0,1,N-terminal peptidyl-serine methylation,BP,
9787,GO:0035572,1,0.993485400251684,0,1,N-terminal peptidyl-serine dimethylation,BP,
9788,GO:0035573,1,0.993485400251684,0,1,N-terminal peptidyl-serine trimethylation,BP,
9789,GO:0035574,1,0.984560947746542,0,2,histone H4-K20 demethylation,BP,
9790,GO:0035575,1,0.984560947746542,0,2,histone demethylase activity (H4-K20 specific),MF,
9791,GO:0035577,1,0.701856156141322,0,54,azurophil granule membrane,CC,
9792,GO:0035578,1,0.616918503319968,0,85,azurophil granule lumen,CC,
9794,GO:0035580,1,0.719837023125936,0,59,specific granule lumen,CC,
9795,GO:0035581,1,0.92579236062081,0,10,sequestering of extracellular ligand from receptor,BP,
9796,GO:0035582,1,0.97304539915355,0,4,sequestering of BMP in extracellular matrix,BP,
9797,GO:0035583,1,0.959346870565436,0,4,sequestering of TGFbeta in extracellular matrix,BP,
9798,GO:0035584,1,0.875037408370663,0,20,calcium-mediated signaling using intracellular calcium source,BP,
9799,GO:0035585,1,0.967746344668578,0,4,calcium-mediated signaling using extracellular calcium source,BP,
9800,GO:0035588,1,0.934572633673561,0,11,G protein-coupled purinergic receptor signaling pathway,BP,
9801,GO:0035589,1,0.932135356458548,0,13,G protein-coupled purinergic nucleotide receptor signaling pathway,BP,
9802,GO:0035590,1,0.840273236337319,0,30,purinergic nucleotide receptor signaling pathway,BP,
9803,GO:0035591,1,0.604660993111076,0,67,signaling adaptor activity,MF,
9805,GO:0035594,1,0.975662572165821,0,4,ganglioside binding,MF,
9806,GO:0035596,1,0.987833703088412,0,2,methylthiotransferase activity,MF,
9807,GO:0035597,1,0.994825836648059,0,1,N6-isopentenyladenosine methylthiotransferase activity,MF,
9808,GO:0035598,1,0.992971863369628,0,1,N6-threonylcarbomyladenosine methylthiotransferase activity,MF,
9809,GO:0035600,1,0.987833703088412,0,2,tRNA methylthiolation,BP,
9810,GO:0035601,1,0.481062679753635,0,102,protein deacylation,BP,
9811,GO:0035602,1,0.992569976628791,0,1,fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow cell,BP,
9812,GO:0035603,1,0.992569976628791,0,1,fibroblast growth factor receptor signaling pathway involved in hemopoiesis,BP,
9813,GO:0035604,1,0.992569976628791,0,1,fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow,BP,
9814,GO:0035605,1,0.99608471895368,0,1,peptidyl-cysteine S-nitrosylase activity,MF,
9815,GO:0035606,1,0.993171498706369,0,2,peptidyl-cysteine S-trans-nitrosylation,BP,
9816,GO:0035607,1,0.984036024285524,0,2,fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development,BP,
9817,GO:0035608,1,0.954249659911534,0,7,protein deglutamylation,BP,
9818,GO:0035609,1,0.974478306962725,0,4,C-terminal protein deglutamylation,BP,
9819,GO:0035610,1,0.971602805135793,0,4,protein side chain deglutamylation,BP,
9820,GO:0035611,1,0.993385470514545,0,1,protein branching point deglutamylation,BP,
9821,GO:0035612,1,0.921693625283204,0,9,AP-2 adaptor complex binding,MF,
9822,GO:0035613,1,0.913286546350123,0,12,RNA stem-loop binding,MF,
9823,GO:0035615,1,0.893739309863888,0,16,clathrin adaptor activity,MF,
9824,GO:0035616,1,0.977048525385622,0,3,histone H2B conserved C-terminal lysine deubiquitination,BP,
9825,GO:0035617,1,0.967176284860151,0,5,stress granule disassembly,BP,
9826,GO:0035621,1,0.987901836877342,0,2,ER to Golgi ceramide transport,BP,
9827,GO:0035622,1,0.979332544338575,0,2,intrahepatic bile duct development,BP,
9828,GO:0035623,1,0.992999080886178,0,1,renal glucose absorption,BP,
9829,GO:0035624,1,0.970133605451076,0,4,receptor transactivation,BP,
9830,GO:0035627,1,0.92372865674448,0,11,ceramide transport,BP,
9831,GO:0035630,1,0.943314489691608,0,8,bone mineralization involved in bone maturation,BP,
9832,GO:0035631,1,0.932176754741251,0,11,CD40 receptor complex,CC,
9833,GO:0035632,1,0.991127443358268,0,2,mitochondrial prohibitin complex,CC,
9835,GO:0035634,1,0.97517920111233,0,4,response to stilbenoid,BP,
9836,GO:0035635,1,0.893535970237893,0,14,entry of bacterium into host cell,BP,
9837,GO:0035637,1,0.230672302649975,0,195,multicellular organismal signaling,BP,
9841,GO:0035642,1,0.993229211605781,0,1,histone methyltransferase activity (H3-R17 specific),MF,
9842,GO:0035643,1,0.995447097289972,0,1,L-DOPA receptor activity,MF,
9843,GO:0035644,1,0.993198778467446,0,1,phosphoanandamide dephosphorylation,BP,
9844,GO:0035645,1,0.992467056528787,0,1,enteric smooth muscle cell differentiation,BP,
9845,GO:0035646,1,0.939983027753895,0,10,endosome to melanosome transport,BP,
9846,GO:0035650,1,0.971791954435139,0,5,AP-1 adaptor complex binding,MF,
9847,GO:0035651,1,0.984789479237093,0,3,AP-3 adaptor complex binding,MF,
9848,GO:0035655,1,0.95341046627466,0,8,interleukin-18-mediated signaling pathway,BP,
9849,GO:0035657,1,0.992096564299188,0,1,eRF1 methyltransferase complex,CC,
9850,GO:0035658,1,0.975057069691456,0,4,Mon1-Ccz1 complex,CC,
9851,GO:0035662,1,0.986761254576345,0,4,Toll-like receptor 4 binding,MF,
9852,GO:0035663,1,0.979994197288282,0,3,Toll-like receptor 2 binding,MF,
9853,GO:0035664,1,0.995291300945664,0,1,TIRAP-dependent toll-like receptor signaling pathway,BP,
9854,GO:0035665,1,0.995291300945664,0,1,TIRAP-dependent toll-like receptor 4 signaling pathway,BP,
9855,GO:0035666,1,0.846756986729583,0,28,TRIF-dependent toll-like receptor signaling pathway,BP,
9856,GO:0035668,1,0.975947265322139,0,3,TRAM-dependent toll-like receptor signaling pathway,BP,
9857,GO:0035669,1,0.975947265322139,0,3,TRAM-dependent toll-like receptor 4 signaling pathway,BP,
9858,GO:0035671,1,0.984304505967231,0,3,enone reductase activity,MF,
9859,GO:0035672,1,0.939458094099398,0,8,oligopeptide transmembrane transport,BP,
9860,GO:0035673,1,0.961282502670891,0,5,oligopeptide transmembrane transporter activity,MF,
9861,GO:0035674,1,0.98866269045805,0,2,tricarboxylic acid transmembrane transport,BP,
9862,GO:0035675,1,0.986129654634289,0,2,neuromast hair cell development,BP,
9863,GO:0035677,1,0.992413523228482,0,1,posterior lateral line neuromast hair cell development,BP,
9864,GO:0035683,1,0.984020430397589,0,2,memory T cell extravasation,BP,
9865,GO:0035684,1,0.982914914634564,0,3,helper T cell extravasation,BP,
9866,GO:0035685,1,0.986002342379019,0,2,helper T cell diapedesis,BP,
9867,GO:0035686,1,0.971515875394268,0,5,sperm fibrous sheath,CC,
9868,GO:0035690,1,0.652162093689646,0,68,cellular response to drug,BP,
9869,GO:0035691,1,0.983900970377561,0,3,macrophage migration inhibitory factor signaling pathway,BP,
9870,GO:0035692,1,0.988082821360526,0,2,macrophage migration inhibitory factor receptor complex,CC,
9871,GO:0035693,1,0.996086243927831,0,1,NOS2-CD74 complex,CC,
9872,GO:0035694,1,0.973919158147096,0,4,mitochondrial protein catabolic process,BP,
9873,GO:0035695,1,0.992453965041727,0,1,mitophagy by induced vacuole formation,BP,
9874,GO:0035696,1,0.957963314087018,0,6,monocyte extravasation,BP,
9875,GO:0035697,1,0.984187375125594,0,3,CD8-positive, alpha-beta T cell extravasation,BP,
9876,GO:0035698,1,0.990212416866869,0,2,CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
9877,GO:0035700,1,0.98924122772222,0,2,astrocyte chemotaxis,BP,
9878,GO:0035701,1,0.945009514209202,0,8,hematopoietic stem cell migration,BP,
9879,GO:0035702,1,0.98444068817823,0,2,monocyte homeostasis,BP,
9880,GO:0035704,1,0.993916002159667,0,1,helper T cell chemotaxis,BP,
9881,GO:0035705,1,0.993916002159667,0,1,T-helper 17 cell chemotaxis,BP,
9882,GO:0035708,1,0.992847714373444,0,1,interleukin-4-dependent isotype switching to IgE isotypes,BP,
9883,GO:0035709,1,0.982427236376551,0,3,memory T cell activation,BP,
9884,GO:0035710,1,0.572492731183255,0,87,CD4-positive, alpha-beta T cell activation,BP,
9885,GO:0035711,1,0.978936068274503,0,4,T-helper 1 cell activation,BP,
9886,GO:0035712,1,0.985874086515443,0,2,T-helper 2 cell activation,BP,
9887,GO:0035713,1,0.992847714373444,0,1,response to nitrogen dioxide,BP,
9888,GO:0035715,1,0.993916002159667,0,1,chemokine (C-C motif) ligand 2 binding,MF,
9889,GO:0035716,1,0.993916002159667,0,1,chemokine (C-C motif) ligand 12 binding,MF,
9890,GO:0035717,1,0.987582062115398,0,2,chemokine (C-C motif) ligand 7 binding,MF,
9891,GO:0035718,1,0.991910372305152,0,2,macrophage migration inhibitory factor binding,MF,
9892,GO:0035720,1,0.982947892673581,0,3,intraciliary anterograde transport,BP,
9893,GO:0035721,1,0.928084099559644,0,9,intraciliary retrograde transport,BP,
9894,GO:0035722,1,0.7789378426577,0,44,interleukin-12-mediated signaling pathway,BP,
9895,GO:0035723,1,0.912077608083155,0,13,interleukin-15-mediated signaling pathway,BP,
9896,GO:0035724,1,0.990388832501393,0,1,CD24 biosynthetic process,BP,
9898,GO:0035726,1,0.95678921176258,0,7,common myeloid progenitor cell proliferation,BP,
9899,GO:0035727,1,0.951281116176435,0,8,lysophosphatidic acid binding,MF,
9900,GO:0035728,1,0.872315843861434,0,19,response to hepatocyte growth factor,BP,
9901,GO:0035729,1,0.886703405009471,0,17,cellular response to hepatocyte growth factor stimulus,BP,
9902,GO:0035730,1,0.996590639909494,0,1,S-nitrosoglutathione binding,MF,
9903,GO:0035731,1,0.996590639909494,0,1,dinitrosyl-iron complex binding,MF,
9904,GO:0035732,1,0.996590639909494,0,1,nitric oxide storage,BP,
9905,GO:0035733,1,0.941643275977696,0,8,hepatic stellate cell activation,BP,
9906,GO:0035735,1,0.765888420912609,0,38,intraciliary transport involved in cilium assembly,BP,
9907,GO:0035739,1,0.946534819091738,0,11,CD4-positive, alpha-beta T cell proliferation,BP,
9908,GO:0035740,1,0.959026837225564,0,7,CD8-positive, alpha-beta T cell proliferation,BP,
9909,GO:0035743,1,0.897072303997651,0,19,CD4-positive, alpha-beta T cell cytokine production,BP,
9910,GO:0035744,1,0.963300485863505,0,7,T-helper 1 cell cytokine production,BP,
9911,GO:0035745,1,0.933955418733187,0,12,T-helper 2 cell cytokine production,BP,
9912,GO:0035746,1,0.996225422430372,0,1,granzyme A production,BP,
9913,GO:0035747,1,0.964249457732966,0,7,natural killer cell chemotaxis,BP,
9914,GO:0035748,1,0.956938133169263,0,6,myelin sheath abaxonal region,CC,
9915,GO:0035749,1,0.961133548447076,0,6,myelin sheath adaxonal region,CC,
9916,GO:0035750,1,0.991646797472469,0,1,protein localization to myelin sheath abaxonal region,BP,
9917,GO:0035751,1,0.928749590869024,0,13,regulation of lysosomal lumen pH,BP,
9918,GO:0035752,1,0.995061768613089,0,1,lysosomal lumen pH elevation,BP,
9919,GO:0035754,1,0.955864722874619,0,8,B cell chemotaxis,BP,
9920,GO:0035755,1,0.993791596739718,0,1,cardiolipin hydrolase activity,MF,
9921,GO:0035757,1,0.994541478353388,0,1,chemokine (C-C motif) ligand 19 binding,MF,
9922,GO:0035758,1,0.994541478353388,0,1,chemokine (C-C motif) ligand 21 binding,MF,
9923,GO:0035759,1,0.990283681033867,0,2,mesangial cell-matrix adhesion,BP,
9924,GO:0035766,1,0.966952678176986,0,5,cell chemotaxis to fibroblast growth factor,BP,
9925,GO:0035767,1,0.844981669055038,0,24,endothelial cell chemotaxis,BP,
9926,GO:0035768,1,0.966952678176986,0,5,endothelial cell chemotaxis to fibroblast growth factor,BP,
9927,GO:0035770,1,0.20057676382085,0,229,ribonucleoprotein granule,CC,
9928,GO:0035771,1,0.955261095335227,0,7,interleukin-4-mediated signaling pathway,BP,
9929,GO:0035772,1,0.995335877699745,0,1,interleukin-13-mediated signaling pathway,BP,
9932,GO:0035780,1,0.993443991447163,0,1,CD80 biosynthetic process,BP,
9933,GO:0035781,1,0.989004630885761,0,2,CD86 biosynthetic process,BP,
9934,GO:0035782,1,0.996225422430372,0,1,mature natural killer cell chemotaxis,BP,
9935,GO:0035783,1,0.98440526651626,0,3,CD4-positive, alpha-beta T cell costimulation,BP,
9936,GO:0035787,1,0.970143826686865,0,4,cell migration involved in kidney development,BP,
9937,GO:0035788,1,0.978302217119871,0,3,cell migration involved in metanephros development,BP,
9938,GO:0035789,1,0.978302217119871,0,3,metanephric mesenchymal cell migration,BP,
9939,GO:0035790,1,0.959817600262871,0,5,platelet-derived growth factor receptor-alpha signaling pathway,BP,
9940,GO:0035791,1,0.894240566514887,0,14,platelet-derived growth factor receptor-beta signaling pathway,BP,
9941,GO:0035793,1,0.978302217119871,0,3,positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,
9942,GO:0035794,1,0.705952147360806,0,59,positive regulation of mitochondrial membrane permeability,BP,
9943,GO:0035795,1,0.970916383956418,0,5,negative regulation of mitochondrial membrane permeability,BP,
9944,GO:0035799,1,0.971031757092183,0,4,ureter maturation,BP,
9945,GO:0035800,1,0.988685464371354,0,2,deubiquitinase activator activity,MF,
9946,GO:0035801,1,0.988516538873745,0,2,adrenal cortex development,BP,
9947,GO:0035802,1,0.988516538873745,0,2,adrenal cortex formation,BP,
9948,GO:0035803,1,0.986655340500295,0,3,egg coat formation,BP,
9949,GO:0035804,1,0.991874081913814,0,2,structural constituent of egg coat,MF,
9950,GO:0035805,1,0.985343345629228,0,3,egg coat,CC,
9951,GO:0035809,1,0.884038286407147,0,20,regulation of urine volume,BP,
9952,GO:0035810,1,0.916417863035138,0,14,positive regulation of urine volume,BP,
9953,GO:0035811,1,0.978586881707387,0,3,negative regulation of urine volume,BP,
9954,GO:0035812,1,0.89507371976631,0,19,renal sodium excretion,BP,
9955,GO:0035813,1,0.899595304247177,0,18,regulation of renal sodium excretion,BP,
9956,GO:0035814,1,0.977001208787987,0,4,negative regulation of renal sodium excretion,BP,
9957,GO:0035815,1,0.933613586322539,0,12,positive regulation of renal sodium excretion,BP,
9958,GO:0035821,1,0.537349254685954,0,96,modulation of process of other organism,BP,
9959,GO:0035822,1,0.970616439925519,0,4,gene conversion,BP,
9961,GO:0035838,1,0.975268633313062,0,3,growing cell tip,CC,
9962,GO:0035841,1,0.982618121709648,0,2,new growing cell tip,CC,
9963,GO:0035844,1,0.974274128785476,0,4,cloaca development,BP,
9964,GO:0035845,1,0.932147491705926,0,10,photoreceptor cell outer segment organization,BP,
9965,GO:0035850,1,0.725430058751953,0,43,epithelial cell differentiation involved in kidney development,BP,
9966,GO:0035851,1,0.987949913951985,0,2,Krueppel-associated box domain binding,MF,
9967,GO:0035853,1,0.992341074058759,0,1,chromosome passenger complex localization to spindle midzone,BP,
9968,GO:0035854,1,0.98876665776415,0,2,eosinophil fate commitment,BP,
9969,GO:0035855,1,0.883784949204429,0,16,megakaryocyte development,BP,
9970,GO:0035859,1,0.920432875826949,0,13,Seh1-associated complex,CC,
9971,GO:0035860,1,0.943286472451212,0,8,glial cell-derived neurotrophic factor receptor signaling pathway,BP,
9972,GO:0035861,1,0.71157632484106,0,50,site of double-strand break,CC,
9973,GO:0035862,1,0.991058898402959,0,1,dITP metabolic process,BP,
9974,GO:0035863,1,0.991058898402959,0,1,dITP catabolic process,BP,
9975,GO:0035864,1,0.915650152179014,0,12,response to potassium ion,BP,
9976,GO:0035865,1,0.934631674725626,0,9,cellular response to potassium ion,BP,
9977,GO:0035866,1,0.971262902053391,0,3,alphav-beta3 integrin-PKCalpha complex,CC,
9978,GO:0035867,1,0.959613101642807,0,4,alphav-beta3 integrin-IGF-1-IGF1R complex,CC,
9979,GO:0035868,1,0.975371660858294,0,3,alphav-beta3 integrin-HMGB1 complex,CC,
9981,GO:0035870,1,0.987487795119733,0,2,dITP diphosphatase activity,MF,
9982,GO:0035871,1,0.932961962421452,0,8,protein K11-linked deubiquitination,BP,
9983,GO:0035872,1,0.789648844332767,0,35,nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway,BP,
9984,GO:0035873,1,0.959256014309687,0,6,lactate transmembrane transport,BP,
9985,GO:0035877,1,0.98007158043272,0,3,death effector domain binding,MF,
9986,GO:0035878,1,0.947941210751701,0,8,nail development,BP,
9987,GO:0035879,1,0.979939583095746,0,3,plasma membrane lactate transport,BP,
9988,GO:0035880,1,0.982303454571844,0,3,embryonic nail plate morphogenesis,BP,
9989,GO:0035881,1,0.954645569796526,0,7,amacrine cell differentiation,BP,
9990,GO:0035883,1,0.83701550247045,0,26,enteroendocrine cell differentiation,BP,
9991,GO:0035886,1,0.84594101071588,0,25,vascular associated smooth muscle cell differentiation,BP,
9992,GO:0035887,1,0.995364425768994,0,1,aortic smooth muscle cell differentiation,BP,
9993,GO:0035890,1,0.807470085696356,0,32,exit from host,BP,
9994,GO:0035891,1,0.807470085696356,0,32,exit from host cell,BP,
9995,GO:0035898,1,0.979761874801127,0,3,parathyroid hormone secretion,BP,
9996,GO:0035900,1,0.965898541859695,0,6,response to isolation stress,BP,
9997,GO:0035902,1,0.877562848628908,0,21,response to immobilization stress,BP,
9998,GO:0035904,1,0.639811346431064,0,55,aorta development,BP,
9999,GO:0035905,1,0.966458966202305,0,5,ascending aorta development,BP,
10000,GO:0035906,1,0.992659962892898,0,1,descending aorta development,BP,
10001,GO:0035907,1,0.933734686515301,0,10,dorsal aorta development,BP,
10002,GO:0035909,1,0.791308355546244,0,30,aorta morphogenesis,BP,
10003,GO:0035910,1,0.973607182919432,0,4,ascending aorta morphogenesis,BP,
10004,GO:0035912,1,0.947078787354163,0,8,dorsal aorta morphogenesis,BP,
10005,GO:0035914,1,0.650924943667981,0,61,skeletal muscle cell differentiation,BP,
10006,GO:0035915,1,0.981589215895839,0,4,pore formation in membrane of other organism,BP,
10007,GO:0035921,1,0.994685556368899,0,1,desmosome disassembly,BP,
10008,GO:0035922,1,0.995622174644115,0,1,foramen ovale closure,BP,
10009,GO:0035924,1,0.699102896655013,0,52,cellular response to vascular endothelial growth factor stimulus,BP,
10010,GO:0035925,1,0.846382070643959,0,25,mRNA 3'-UTR AU-rich region binding,MF,
10011,GO:0035927,1,0.978268985573649,0,4,RNA import into mitochondrion,BP,
10012,GO:0035928,1,0.985258725378907,0,3,rRNA import into mitochondrion,BP,
10013,GO:0035929,1,0.902295082557815,0,18,steroid hormone secretion,BP,
10014,GO:0035930,1,0.930435609815983,0,13,corticosteroid hormone secretion,BP,
10015,GO:0035931,1,0.974924269148831,0,4,mineralocorticoid secretion,BP,
10016,GO:0035932,1,0.974924269148831,0,4,aldosterone secretion,BP,
10017,GO:0035933,1,0.954378393052841,0,9,glucocorticoid secretion,BP,
10018,GO:0035934,1,0.982559167839413,0,4,corticosterone secretion,BP,
10019,GO:0035935,1,0.992973903647485,0,1,androgen secretion,BP,
10020,GO:0035936,1,0.983315242092615,0,2,testosterone secretion,BP,
10021,GO:0035938,1,0.978874330728676,0,3,estradiol secretion,BP,
10022,GO:0035945,1,0.993944393327592,0,1,mitochondrial ncRNA surveillance,BP,
10023,GO:0035946,1,0.993944393327592,0,1,mitochondrial mRNA surveillance,BP,
10024,GO:0035962,1,0.981741385267246,0,3,response to interleukin-13,BP,
10025,GO:0035963,1,0.981741385267246,0,3,cellular response to interleukin-13,BP,
10026,GO:0035964,1,0.961449457538851,0,6,COPI-coated vesicle budding,BP,
10027,GO:0035965,1,0.957001437223157,0,7,cardiolipin acyl-chain remodeling,BP,
10031,GO:0035971,1,0.996225422430372,0,1,peptidyl-histidine dephosphorylation,BP,
10033,GO:0035976,1,0.978071608859966,0,4,transcription factor AP-1 complex,CC,
10034,GO:0035977,1,0.970344398838499,0,4,protein deglycosylation involved in glycoprotein catabolic process,BP,
10035,GO:0035978,1,0.987646897536069,0,2,histone H2A-S139 phosphorylation,BP,
10036,GO:0035981,1,0.988072188677281,0,2,tongue muscle cell differentiation,BP,
10037,GO:0035983,1,0.977326937455366,0,3,response to trichostatin A,BP,
10038,GO:0035984,1,0.977326937455366,0,3,cellular response to trichostatin A,BP,
10039,GO:0035985,1,0.979995814009763,0,4,senescence-associated heterochromatin focus,CC,
10040,GO:0035986,1,0.984718555452014,0,3,senescence-associated heterochromatin focus assembly,BP,
10041,GO:0035987,1,0.721631751951158,0,44,endodermal cell differentiation,BP,
10042,GO:0035988,1,0.895631187696126,0,16,chondrocyte proliferation,BP,
10043,GO:0035989,1,0.959750530262188,0,6,tendon development,BP,
10044,GO:0035990,1,0.986280726244563,0,3,tendon cell differentiation,BP,
10045,GO:0035992,1,0.986280726244563,0,3,tendon formation,BP,
10046,GO:0035993,1,0.989731340810533,0,2,deltoid tuberosity development,BP,
10047,GO:0035994,1,0.86395301383663,0,18,response to muscle stretch,BP,
10048,GO:0035995,1,0.957709642659159,0,4,detection of muscle stretch,BP,
10049,GO:0035998,1,0.99496635931707,0,1,7,8-dihydroneopterin 3'-triphosphate biosynthetic process,BP,
10050,GO:0035999,1,0.941653503065936,0,10,tetrahydrofolate interconversion,BP,
10051,GO:0036002,1,0.79309072800191,0,36,pre-mRNA binding,MF,
10053,GO:0036004,1,0.996206275343496,0,1,GAF domain binding,MF,
10054,GO:0036005,1,0.92428588899686,0,12,response to macrophage colony-stimulating factor,BP,
10055,GO:0036006,1,0.92428588899686,0,12,cellular response to macrophage colony-stimulating factor stimulus,BP,
10056,GO:0036009,1,0.988426555709621,0,2,protein-glutamine N-methyltransferase activity,MF,
10057,GO:0036010,1,0.837745418746417,0,23,protein localization to endosome,BP,
10058,GO:0036015,1,0.966023123391493,0,5,response to interleukin-3,BP,
10059,GO:0036016,1,0.966023123391493,0,5,cellular response to interleukin-3,BP,
10060,GO:0036017,1,0.970823024580806,0,7,response to erythropoietin,BP,
10061,GO:0036018,1,0.973496717454121,0,6,cellular response to erythropoietin,BP,
10062,GO:0036019,1,0.875198061611828,0,19,endolysosome,CC,
10063,GO:0036020,1,0.902993750851121,0,14,endolysosome membrane,CC,
10064,GO:0036021,1,0.969249197061495,0,5,endolysosome lumen,CC,
10065,GO:0036022,1,0.983271856440649,0,3,limb joint morphogenesis,BP,
10066,GO:0036023,1,0.983271856440649,0,3,embryonic skeletal limb joint morphogenesis,BP,
10067,GO:0036024,1,0.994261390993069,0,1,protein C inhibitor-TMPRSS7 complex,CC,
10068,GO:0036025,1,0.994261390993069,0,1,protein C inhibitor-TMPRSS11E complex,CC,
10069,GO:0036026,1,0.994261390993069,0,1,protein C inhibitor-PLAT complex,CC,
10070,GO:0036027,1,0.994261390993069,0,1,protein C inhibitor-PLAU complex,CC,
10071,GO:0036028,1,0.994261390993069,0,1,protein C inhibitor-thrombin complex,CC,
10072,GO:0036029,1,0.994261390993069,0,1,protein C inhibitor-KLK3 complex,CC,
10073,GO:0036030,1,0.994261390993069,0,1,protein C inhibitor-plasma kallikrein complex,CC,
10074,GO:0036033,1,0.947566018817292,0,5,mediator complex binding,MF,
10075,GO:0036034,1,0.994198568848389,0,1,mediator complex assembly,BP,
10076,GO:0036035,1,0.889234923781749,0,16,osteoclast development,BP,
10077,GO:0036037,1,0.856769604399834,0,25,CD8-positive, alpha-beta T cell activation,BP,
10078,GO:0036038,1,0.926232787620807,0,13,MKS complex,CC,
10079,GO:0036041,1,0.953667574480302,0,11,long-chain fatty acid binding,MF,
10080,GO:0036042,1,0.971083283514918,0,6,long-chain fatty acyl-CoA binding,MF,
10081,GO:0036046,1,0.993068080128229,0,1,protein demalonylation,BP,
10082,GO:0036047,1,0.993068080128229,0,1,peptidyl-lysine demalonylation,BP,
10083,GO:0036048,1,0.988512340876391,0,2,protein desuccinylation,BP,
10084,GO:0036049,1,0.988512340876391,0,2,peptidyl-lysine desuccinylation,BP,
10085,GO:0036053,1,0.993561439661167,0,1,glomerular endothelium fenestra,CC,
10086,GO:0036054,1,0.993068080128229,0,1,protein-malonyllysine demalonylase activity,MF,
10087,GO:0036055,1,0.988512340876391,0,2,protein-succinyllysine desuccinylase activity,MF,
10088,GO:0036056,1,0.935328440515148,0,8,filtration diaphragm,CC,
10089,GO:0036057,1,0.935328440515148,0,8,slit diaphragm,CC,
10090,GO:0036058,1,0.992603238590755,0,1,filtration diaphragm assembly,BP,
10091,GO:0036060,1,0.992603238590755,0,1,slit diaphragm assembly,BP,
10093,GO:0036065,1,0.898236917370379,0,15,fucosylation,BP,
10094,GO:0036066,1,0.973674759850646,0,4,protein O-linked fucosylation,BP,
10095,GO:0036071,1,0.986150920002366,0,2,N-glycan fucosylation,BP,
10096,GO:0036072,1,0.958132073474344,0,6,direct ossification,BP,
10097,GO:0036075,1,0.829589834980493,0,27,replacement ossification,BP,
10098,GO:0036080,1,0.9930210826683,0,1,purine nucleotide-sugar transmembrane transporter activity,MF,
10099,GO:0036085,1,0.9930210826683,0,1,GDP-fucose import into Golgi lumen,BP,
10100,GO:0036088,1,0.995619591821006,0,1,D-serine catabolic process,BP,
10101,GO:0036089,1,0.954035562214239,0,7,cleavage furrow formation,BP,
10102,GO:0036090,1,0.989709313495669,0,2,cleavage furrow ingression,BP,
10103,GO:0036091,1,0.966663765259742,0,5,positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,
10104,GO:0036092,1,0.885105063861478,0,14,phosphatidylinositol-3-phosphate biosynthetic process,BP,
10105,GO:0036093,1,0.970832679080745,0,6,germ cell proliferation,BP,
10107,GO:0036100,1,0.981742326100406,0,3,leukotriene catabolic process,BP,
10108,GO:0036101,1,0.981742326100406,0,3,leukotriene B4 catabolic process,BP,
10109,GO:0036102,1,0.981742326100406,0,3,leukotriene B4 metabolic process,BP,
10110,GO:0036105,1,0.9927862393797,0,1,peroxisome membrane class-1 targeting sequence binding,MF,
10111,GO:0036109,1,0.925940725181883,0,12,alpha-linolenic acid metabolic process,BP,
10112,GO:0036111,1,0.986408324703737,0,2,very long-chain fatty-acyl-CoA metabolic process,BP,
10113,GO:0036112,1,0.982672883372109,0,3,medium-chain fatty-acyl-CoA metabolic process,BP,
10114,GO:0036113,1,0.992762537164016,0,1,very long-chain fatty-acyl-CoA catabolic process,BP,
10115,GO:0036114,1,0.995739177558212,0,1,medium-chain fatty-acyl-CoA catabolic process,BP,
10116,GO:0036115,1,0.988532245232323,0,2,fatty-acyl-CoA catabolic process,BP,
10117,GO:0036116,1,0.995739177558212,0,1,long-chain fatty-acyl-CoA catabolic process,BP,
10118,GO:0036117,1,0.988540742697297,0,2,hyaluranon cable,CC,
10119,GO:0036118,1,0.981226721833443,0,3,hyaluranon cable assembly,BP,
10120,GO:0036119,1,0.864692399668811,0,19,response to platelet-derived growth factor,BP,
10121,GO:0036120,1,0.870583019734808,0,18,cellular response to platelet-derived growth factor stimulus,BP,
10122,GO:0036121,1,0.985876924424396,0,2,double-stranded DNA helicase activity,MF,
10123,GO:0036122,1,0.928616095710773,0,12,BMP binding,MF,
10124,GO:0036123,1,0.964895459159636,0,6,histone H3-K9 dimethylation,BP,
10125,GO:0036124,1,0.892411254088776,0,15,histone H3-K9 trimethylation,BP,
10126,GO:0036125,1,0.993156218721447,0,1,fatty acid beta-oxidation multienzyme complex,CC,
10127,GO:0036126,1,0.58072818660568,0,82,sperm flagellum,CC,
10128,GO:0036128,1,0.958003854768043,0,7,CatSper complex,CC,
10129,GO:0036130,1,0.996216597465047,0,1,prostaglandin H2 endoperoxidase reductase activity,MF,
10130,GO:0036131,1,0.996216597465047,0,1,prostaglandin D2 11-ketoreductase activity,MF,
10131,GO:0036132,1,0.981642524990753,0,3,13-prostaglandin reductase activity,MF,
10132,GO:0036134,1,0.994652943923879,0,1,12-hydroxyheptadecatrienoic acid synthase activity,MF,
10133,GO:0036135,1,0.96785487366334,0,3,Schwann cell migration,BP,
10134,GO:0036137,1,0.98846759873938,0,2,kynurenine aminotransferase activity,MF,
10135,GO:0036138,1,0.990280666500823,0,1,peptidyl-histidine hydroxylation,BP,
10136,GO:0036139,1,0.990280666500823,0,1,peptidyl-histidine dioxygenase activity,MF,
10137,GO:0036140,1,0.990280666500823,0,1,peptidyl-asparagine 3-dioxygenase activity,MF,
10138,GO:0036143,1,0.996734834813458,0,1,kringle domain binding,MF,
10139,GO:0036145,1,0.99529689691134,0,1,dendritic cell homeostasis,BP,
10140,GO:0036146,1,0.993485400251684,0,1,cellular response to mycotoxin,BP,
10141,GO:0036148,1,0.916437225575953,0,13,phosphatidylglycerol acyl-chain remodeling,BP,
10142,GO:0036149,1,0.929946806599742,0,11,phosphatidylinositol acyl-chain remodeling,BP,
10143,GO:0036150,1,0.913330661521135,0,14,phosphatidylserine acyl-chain remodeling,BP,
10144,GO:0036151,1,0.874156106416315,0,22,phosphatidylcholine acyl-chain remodeling,BP,
10145,GO:0036152,1,0.899230552737029,0,17,phosphatidylethanolamine acyl-chain remodeling,BP,
10146,GO:0036153,1,0.993430533589287,0,1,triglyceride acyl-chain remodeling,BP,
10147,GO:0036155,1,0.967707803852839,0,5,acylglycerol acyl-chain remodeling,BP,
10148,GO:0036156,1,0.960131389840416,0,3,inner dynein arm,CC,
10149,GO:0036157,1,0.901073294692141,0,11,outer dynein arm,CC,
10150,GO:0036158,1,0.880951995180486,0,16,outer dynein arm assembly,BP,
10151,GO:0036159,1,0.92843143953812,0,10,inner dynein arm assembly,BP,
10152,GO:0036164,1,0.996399107538128,0,1,cell-abiotic substrate adhesion,BP,
10153,GO:0036166,1,0.959944649260829,0,6,phenotypic switching,BP,
10154,GO:0036179,1,0.993503814292986,0,1,osteoclast maturation,BP,
10155,GO:0036186,1,0.985666155954144,0,2,early phagosome membrane,CC,
10156,GO:0036194,1,0.987186430440956,0,3,muscle cell projection,CC,
10157,GO:0036195,1,0.987186430440956,0,3,muscle cell projection membrane,CC,
10159,GO:0036213,1,0.99451787402331,0,1,contractile ring contraction,BP,
10160,GO:0036215,1,0.976835194343108,0,3,response to stem cell factor,BP,
10161,GO:0036216,1,0.976835194343108,0,3,cellular response to stem cell factor stimulus,BP,
10162,GO:0036218,1,0.974321598879488,0,4,dTTP diphosphatase activity,MF,
10163,GO:0036219,1,0.996906466060705,0,1,GTP diphosphatase activity,MF,
10164,GO:0036228,1,0.986669329351908,0,2,protein localization to nuclear inner membrane,BP,
10166,GO:0036245,1,0.987934974572397,0,2,cellular response to menadione,BP,
10167,GO:0036250,1,0.995016125422551,0,1,peroxisome transport along microtubule,BP,
10168,GO:0036255,1,0.992694159277601,0,1,response to methylamine,BP,
10169,GO:0036257,1,0.833307783283284,0,31,multivesicular body organization,BP,
10170,GO:0036258,1,0.838820719441352,0,30,multivesicular body assembly,BP,
10171,GO:0036260,1,0.832272250036608,0,32,RNA capping,BP,
10172,GO:0036261,1,0.992749748451312,0,1,7-methylguanosine cap hypermethylation,BP,
10173,GO:0036265,1,0.979559352446675,0,4,RNA (guanine-N7)-methylation,BP,
10174,GO:0036266,1,0.993828141368732,0,1,Cdc48p-Npl4p-Vms1p AAA ATPase complex,CC,
10175,GO:0036268,1,0.98869811524066,0,1,swimming,BP,
10176,GO:0036269,1,0.986576375119763,0,2,swimming behavior,BP,
10177,GO:0036284,1,0.985474627544618,0,2,tubulobulbar complex,CC,
10178,GO:0036289,1,0.940316667675857,0,8,peptidyl-serine autophosphorylation,BP,
10179,GO:0036290,1,0.992607280810635,0,1,protein trans-autophosphorylation,BP,
10180,GO:0036292,1,0.985834328306658,0,2,DNA rewinding,BP,
10182,GO:0036294,1,0.280504679055505,0,196,cellular response to decreased oxygen levels,BP,
10183,GO:0036295,1,0.921354782143796,0,13,cellular response to increased oxygen levels,BP,
10184,GO:0036296,1,0.848946481230887,0,26,response to increased oxygen levels,BP,
10185,GO:0036297,1,0.724952934204307,0,48,interstrand cross-link repair,BP,
10186,GO:0036298,1,0.986764838496335,0,2,recombinational interstrand cross-link repair,BP,
10187,GO:0036301,1,0.968481477899949,0,5,macrophage colony-stimulating factor production,BP,
10188,GO:0036302,1,0.94134735686156,0,7,atrioventricular canal development,BP,
10189,GO:0036303,1,0.846646860555145,0,20,lymph vessel morphogenesis,BP,
10190,GO:0036304,1,0.987956946376013,0,2,umbilical cord morphogenesis,BP,
10191,GO:0036306,1,0.995622174644115,0,1,embryonic heart tube elongation,BP,
10192,GO:0036309,1,0.968989777559887,0,2,protein localization to M-band,BP,
10193,GO:0036310,1,0.950541029548877,0,7,annealing helicase activity,MF,
10194,GO:0036312,1,0.930299746420653,0,8,phosphatidylinositol 3-kinase regulatory subunit binding,MF,
10195,GO:0036313,1,0.994036506529202,0,1,phosphatidylinositol 3-kinase catalytic subunit binding,MF,
10196,GO:0036314,1,0.794785321659395,0,29,response to sterol,BP,
10197,GO:0036315,1,0.847614187754858,0,21,cellular response to sterol,BP,
10198,GO:0036316,1,0.987377950523596,0,2,SREBP-SCAP complex retention in endoplasmic reticulum,BP,
10199,GO:0036317,1,0.993485400251684,0,1,tyrosyl-RNA phosphodiesterase activity,MF,
10200,GO:0036321,1,0.993485400251684,0,1,ghrelin secretion,BP,
10201,GO:0036323,1,0.992158207233012,0,1,vascular endothelial growth factor receptor-1 signaling pathway,BP,
10202,GO:0036324,1,0.967334631819594,0,5,vascular endothelial growth factor receptor-2 signaling pathway,BP,
10203,GO:0036325,1,0.994379049913537,0,1,vascular endothelial growth factor receptor-3 signaling pathway,BP,
10204,GO:0036326,1,0.992158207233012,0,1,VEGF-A-activated receptor activity,MF,
10205,GO:0036327,1,0.992158207233012,0,1,VEGF-B-activated receptor activity,MF,
10206,GO:0036328,1,0.99178607925523,0,1,VEGF-C-activated receptor activity,MF,
10207,GO:0036331,1,0.994408236705106,0,1,avascular cornea development in camera-type eye,BP,
10208,GO:0036332,1,0.992158207233012,0,1,placental growth factor-activated receptor activity,MF,
10209,GO:0036333,1,0.993690179389558,0,1,hepatocyte homeostasis,BP,
10210,GO:0036335,1,0.982721154795783,0,3,intestinal stem cell homeostasis,BP,
10211,GO:0036336,1,0.83863512820011,0,28,dendritic cell migration,BP,
10212,GO:0036337,1,0.964199197898057,0,5,Fas signaling pathway,BP,
10214,GO:0036343,1,0.980295354016722,0,4,psychomotor behavior,BP,
10215,GO:0036344,1,0.856263330528374,0,21,platelet morphogenesis,BP,
10216,GO:0036345,1,0.988788207628205,0,2,platelet maturation,BP,
10217,GO:0036351,1,0.994255653482727,0,1,histone H2A-K13 ubiquitination,BP,
10218,GO:0036352,1,0.994255653482727,0,1,histone H2A-K15 ubiquitination,BP,
10219,GO:0036353,1,0.951971185863656,0,7,histone H2A-K119 monoubiquitination,BP,
10220,GO:0036359,1,0.995061768613089,0,1,renal potassium excretion,BP,
10221,GO:0036361,1,0.993951530489555,0,1,racemase activity, acting on amino acids and derivatives,MF,
10222,GO:0036363,1,0.931581439996099,0,9,transforming growth factor beta activation,BP,
10223,GO:0036364,1,0.986054349736015,0,2,transforming growth factor beta1 activation,BP,
10224,GO:0036366,1,0.992483718844815,0,1,transforming growth factor beta3 activation,BP,
10225,GO:0036369,1,0.960263034335939,0,5,transcription factor catabolic process,BP,
10226,GO:0036371,1,0.983957023245904,0,2,protein localization to T-tubule,BP,
10227,GO:0036372,1,0.99656922422097,0,1,opsin transport,BP,
10228,GO:0036373,1,0.993485400251684,0,1,L-fucose mutarotase activity,MF,
10229,GO:0036374,1,0.981852885177212,0,3,glutathione hydrolase activity,MF,
10230,GO:0036376,1,0.907219798690561,0,15,sodium ion export across plasma membrane,BP,
10231,GO:0036378,1,0.983905102473661,0,3,calcitriol biosynthetic process from calciol,BP,
10232,GO:0036379,1,0.866530860902424,0,25,myofilament,CC,
10233,GO:0036387,1,0.984288498641211,0,3,pre-replicative complex,CC,
10234,GO:0036388,1,0.946940681308538,0,8,pre-replicative complex assembly,BP,
10235,GO:0036392,1,0.992742545978975,0,1,chemokine (C-C motif) ligand 20 production,BP,
10236,GO:0036393,1,0.99331972847616,0,1,thiocyanate peroxidase activity,MF,
10237,GO:0036396,1,0.961668212862613,0,6,RNA N6-methyladenosine methyltransferase complex,CC,
10238,GO:0036398,1,0.994027372818435,0,1,TCR signalosome,CC,
10239,GO:0036402,1,0.987389349200023,0,3,proteasome-activating ATPase activity,MF,
10240,GO:0036403,1,0.99370066887156,0,1,arachidonate 8(S)-lipoxygenase activity,MF,
10241,GO:0036404,1,0.987499776875702,0,1,conversion of ds siRNA to ss siRNA,BP,
10242,GO:0036409,1,0.985787489719424,0,2,histone H3-K14 acetyltransferase complex,CC,
10243,GO:0036413,1,0.986788637829744,0,2,histone H3-R26 citrullination,BP,
10244,GO:0036414,1,0.972737880113778,0,4,histone citrullination,BP,
10245,GO:0036415,1,0.983231381070286,0,2,regulation of tRNA stability,BP,
10246,GO:0036416,1,0.983231381070286,0,2,tRNA stabilization,BP,
10247,GO:0036435,1,0.977928524295547,0,4,K48-linked polyubiquitin modification-dependent protein binding,MF,
10248,GO:0036438,1,0.973950276174207,0,4,maintenance of lens transparency,BP,
10249,GO:0036440,1,0.993225008503437,0,1,citrate synthase activity,MF,
10250,GO:0036444,1,0.934048981560371,0,10,calcium import into the mitochondrion,BP,
10251,GO:0036446,1,0.969290398942716,0,4,myofibroblast differentiation,BP,
10253,GO:0036451,1,0.98701281886265,0,2,cap mRNA methylation,BP,
10254,GO:0036452,1,0.860346635268663,0,26,ESCRT complex,CC,
10255,GO:0036454,1,0.966314153073627,0,5,growth factor complex,CC,
10256,GO:0036456,1,0.995817718402562,0,1,L-methionine-(S)-S-oxide reductase activity,MF,
10257,GO:0036457,1,0.985613884296499,0,1,keratohyalin granule,CC,
10258,GO:0036458,1,0.994492341035676,0,1,hepatocyte growth factor binding,MF,
10259,GO:0036461,1,0.992209994420768,0,2,BLOC-2 complex binding,MF,
10260,GO:0036462,1,0.934663990037461,0,10,TRAIL-activated apoptotic signaling pathway,BP,
10261,GO:0036464,1,0.215603894277457,0,219,cytoplasmic ribonucleoprotein granule,CC,
10263,GO:0036466,1,0.95313874548381,0,6,synaptic vesicle recycling via endosome,BP,
10264,GO:0036468,1,0.994834712069726,0,1,L-dopa decarboxylase activity,MF,
10265,GO:0036470,1,0.996625193861694,0,1,tyrosine 3-monooxygenase activator activity,MF,
10266,GO:0036471,1,0.996625193861694,0,1,cellular response to glyoxal,BP,
10268,GO:0036474,1,0.854855547132124,0,25,cell death in response to hydrogen peroxide,BP,
10269,GO:0036475,1,0.828165495044488,0,26,neuron death in response to oxidative stress,BP,
10270,GO:0036476,1,0.977715872272208,0,4,neuron death in response to hydrogen peroxide,BP,
10272,GO:0036478,1,0.996625193861694,0,1,L-dopa decarboxylase activator activity,MF,
10273,GO:0036479,1,0.988303784808711,0,1,peroxidase inhibitor activity,MF,
10274,GO:0036480,1,0.95491896122366,0,7,neuron intrinsic apoptotic signaling pathway in response to oxidative stress,BP,
10275,GO:0036481,1,0.975486808763798,0,5,intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
10276,GO:0036482,1,0.990291290752773,0,2,neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
10277,GO:0036483,1,0.992289343459996,0,1,neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,
10278,GO:0036484,1,0.970123473865668,0,4,trunk neural crest cell migration,BP,
10279,GO:0036486,1,0.970123473865668,0,4,ventral trunk neural crest cell migration,BP,
10280,GO:0036487,1,0.988659840744814,0,1,nitric-oxide synthase inhibitor activity,MF,
10281,GO:0036488,1,0.991873032079343,0,2,CHOP-C/EBP complex,CC,
10282,GO:0036490,1,0.928926389329747,0,10,regulation of translation in response to endoplasmic reticulum stress,BP,
10283,GO:0036491,1,0.951383785015683,0,7,regulation of translation initiation in response to endoplasmic reticulum stress,BP,
10284,GO:0036492,1,0.956999458195881,0,6,eiF2alpha phosphorylation in response to endoplasmic reticulum stress,BP,
10285,GO:0036493,1,0.96465579626986,0,5,positive regulation of translation in response to endoplasmic reticulum stress,BP,
10286,GO:0036494,1,0.991451809016234,0,1,positive regulation of translation initiation in response to endoplasmic reticulum stress,BP,
10287,GO:0036496,1,0.989994432704815,0,2,regulation of translational initiation by eIF2 alpha dephosphorylation,BP,
10288,GO:0036497,1,0.994134570649157,0,1,eIF2alpha dephosphorylation in response to endoplasmic reticulum stress,BP,
10289,GO:0036498,1,0.660030827640504,0,62,IRE1-mediated unfolded protein response,BP,
10290,GO:0036499,1,0.885926859620245,0,20,PERK-mediated unfolded protein response,BP,
10291,GO:0036500,1,0.939834658318447,0,10,ATF6-mediated unfolded protein response,BP,
10292,GO:0036501,1,0.992402197234624,0,1,UFD1-NPL4 complex,CC,
10293,GO:0036502,1,0.993082165061408,0,1,Derlin-1-VIMP complex,CC,
10294,GO:0036503,1,0.546494916314823,0,92,ERAD pathway,BP,
10295,GO:0036505,1,0.987292603915261,0,2,prosaposin receptor activity,MF,
10296,GO:0036506,1,0.977734110149639,0,3,maintenance of unfolded protein,BP,
10297,GO:0036507,1,0.86716511679649,0,19,protein demannosylation,BP,
10298,GO:0036508,1,0.86716511679649,0,19,protein alpha-1,2-demannosylation,BP,
10299,GO:0036509,1,0.988593764194754,0,2,trimming of terminal mannose on B branch,BP,
10300,GO:0036510,1,0.97963832990689,0,3,trimming of terminal mannose on C branch,BP,
10301,GO:0036511,1,0.988593764194754,0,2,trimming of first mannose on A branch,BP,
10302,GO:0036512,1,0.988593764194754,0,2,trimming of second mannose on A branch,BP,
10303,GO:0036513,1,0.951538092012658,0,7,Derlin-1 retrotranslocation complex,CC,
10304,GO:0036514,1,0.955770517367718,0,5,dopaminergic neuron axon guidance,BP,
10305,GO:0036515,1,0.962254481930105,0,4,serotonergic neuron axon guidance,BP,
10306,GO:0036517,1,0.991228585807255,0,1,chemoattraction of serotonergic neuron axon,BP,
10307,GO:0036518,1,0.984551357033203,0,2,chemorepulsion of dopaminergic neuron axon,BP,
10308,GO:0036520,1,0.985366312658541,0,2,astrocyte-dopaminergic neuron signaling,BP,
10309,GO:0036524,1,0.996625193861694,0,1,protein deglycase activity,MF,
10310,GO:0036525,1,0.992535989358717,0,2,protein deglycation,BP,
10311,GO:0036526,1,0.996625193861694,0,1,peptidyl-cysteine deglycation,BP,
10312,GO:0036527,1,0.996625193861694,0,1,peptidyl-arginine deglycation,BP,
10313,GO:0036528,1,0.996625193861694,0,1,peptidyl-lysine deglycation,BP,
10314,GO:0036529,1,0.996625193861694,0,1,protein deglycation, glyoxal removal,BP,
10315,GO:0036530,1,0.996625193861694,0,1,protein deglycation, methylglyoxal removal,BP,
10316,GO:0036531,1,0.996625193861694,0,1,glutathione deglycation,BP,
10317,GO:0038001,1,0.963197481183198,0,4,paracrine signaling,BP,
10318,GO:0038002,1,0.991652466275178,0,1,endocrine signaling,BP,
10319,GO:0038003,1,0.934745633697208,0,12,opioid receptor signaling pathway,BP,
10320,GO:0038007,1,0.909284912868066,0,12,netrin-activated signaling pathway,BP,
10321,GO:0038009,1,0.995999097821548,0,1,regulation of signal transduction by receptor internalization,BP,
10322,GO:0038016,1,0.986531654713451,0,2,insulin receptor internalization,BP,
10323,GO:0038018,1,0.982964100922235,0,2,Wnt receptor catabolic process,BP,
10324,GO:0038020,1,0.98695583753521,0,1,insulin receptor recycling,BP,
10325,GO:0038021,1,0.992479948481579,0,1,leptin receptor activity,MF,
10328,GO:0038025,1,0.985345369532618,0,2,reelin receptor activity,MF,
10329,GO:0038026,1,0.943856059459109,0,7,reelin-mediated signaling pathway,BP,
10330,GO:0038027,1,0.955784950423057,0,5,apolipoprotein A-I-mediated signaling pathway,BP,
10331,GO:0038028,1,0.97161302976583,0,4,insulin receptor signaling pathway via phosphatidylinositol 3-kinase,BP,
10332,GO:0038030,1,0.95106473635951,0,7,non-canonical Wnt signaling pathway via MAPK cascade,BP,
10333,GO:0038031,1,0.958098955594203,0,6,non-canonical Wnt signaling pathway via JNK cascade,BP,
10334,GO:0038033,1,0.966696335983977,0,5,positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway,BP,
10335,GO:0038034,1,0.64903579514274,0,69,signal transduction in absence of ligand,BP,
10336,GO:0038036,1,0.953213282084568,0,8,sphingosine-1-phosphate receptor activity,MF,
10337,GO:0038037,1,0.952284405172577,0,7,G protein-coupled receptor dimeric complex,CC,
10338,GO:0038038,1,0.990291943772004,0,1,G protein-coupled receptor homodimeric complex,CC,
10339,GO:0038039,1,0.976385603614195,0,3,G protein-coupled receptor heterodimeric complex,CC,
10340,GO:0038041,1,0.988855588787875,0,2,cross-receptor inhibition within G protein-coupled receptor heterodimer,BP,
10341,GO:0038043,1,0.986945992337843,0,2,interleukin-5-mediated signaling pathway,BP,
10342,GO:0038046,1,0.995313644415106,0,1,enkephalin receptor activity,MF,
10343,GO:0038047,1,0.995137923412935,0,1,morphine receptor activity,MF,
10344,GO:0038048,1,0.991990491690117,0,1,dynorphin receptor activity,MF,
10346,GO:0038061,1,0.391874734590816,0,155,NIK/NF-kappaB signaling,BP,
10347,GO:0038062,1,0.979759292698107,0,3,protein tyrosine kinase collagen receptor activity,MF,
10348,GO:0038063,1,0.908938225769449,0,11,collagen-activated tyrosine kinase receptor signaling pathway,BP,
10349,GO:0038064,1,0.957676321108038,0,6,collagen receptor activity,MF,
10350,GO:0038065,1,0.888436321042937,0,14,collagen-activated signaling pathway,BP,
10351,GO:0038066,1,0.754029622511046,0,43,p38MAPK cascade,BP,
10353,GO:0038084,1,0.787763770999063,0,34,vascular endothelial growth factor signaling pathway,BP,
10354,GO:0038085,1,0.963097668246092,0,5,vascular endothelial growth factor binding,MF,
10355,GO:0038086,1,0.974926627016315,0,3,VEGF-activated platelet-derived growth factor receptor signaling pathway,BP,
10356,GO:0038089,1,0.948989161385555,0,7,positive regulation of cell migration by vascular endothelial growth factor signaling pathway,BP,
10357,GO:0038091,1,0.974926627016315,0,3,positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway,BP,
10358,GO:0038092,1,0.910369714782388,0,15,nodal signaling pathway,BP,
10359,GO:0038093,1,0.339681010247848,0,171,Fc receptor signaling pathway,BP,
10360,GO:0038094,1,0.591652026214389,0,78,Fc-gamma receptor signaling pathway,BP,
10361,GO:0038095,1,0.523395121027265,0,106,Fc-epsilon receptor signaling pathway,BP,
10362,GO:0038096,1,0.599680583047322,0,75,Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
10363,GO:0038097,1,0.991695043621099,0,1,positive regulation of mast cell activation by Fc-epsilon receptor signaling pathway,BP,
10364,GO:0038098,1,0.980015489156086,0,3,sequestering of BMP from receptor via BMP binding,BP,
10365,GO:0038100,1,0.980342274960722,0,3,nodal binding,MF,
10366,GO:0038101,1,0.995392777310413,0,1,sequestering of nodal from receptor via nodal binding,BP,
10367,GO:0038102,1,0.988518268361131,0,2,activin receptor antagonist activity,MF,
10368,GO:0038107,1,0.959860050978082,0,7,nodal signaling pathway involved in determination of left/right asymmetry,BP,
10369,GO:0038108,1,0.974200236590581,0,4,negative regulation of appetite by leptin-mediated signaling pathway,BP,
10370,GO:0038109,1,0.976835194343108,0,3,Kit signaling pathway,BP,
10371,GO:0038110,1,0.924541173480456,0,11,interleukin-2-mediated signaling pathway,BP,
10372,GO:0038111,1,0.889980542592707,0,16,interleukin-7-mediated signaling pathway,BP,
10373,GO:0038112,1,0.987481878191002,0,2,interleukin-8-mediated signaling pathway,BP,
10374,GO:0038113,1,0.949420524870727,0,7,interleukin-9-mediated signaling pathway,BP,
10375,GO:0038114,1,0.95146284288735,0,7,interleukin-21-mediated signaling pathway,BP,
10376,GO:0038115,1,0.994541478353388,0,1,chemokine (C-C motif) ligand 19 signaling pathway,BP,
10377,GO:0038116,1,0.971285056933129,0,4,chemokine (C-C motif) ligand 21 signaling pathway,BP,
10378,GO:0038117,1,0.994541478353388,0,1,C-C motif chemokine 19 receptor activity,MF,
10379,GO:0038118,1,0.996465856482775,0,1,C-C chemokine receptor CCR7 signaling pathway,BP,
10380,GO:0038121,1,0.994541478353388,0,1,C-C motif chemokine 21 receptor activity,MF,
10381,GO:0038123,1,0.975624868500534,0,4,toll-like receptor TLR1:TLR2 signaling pathway,BP,
10382,GO:0038124,1,0.974700304841995,0,4,toll-like receptor TLR6:TLR2 signaling pathway,BP,
10384,GO:0038128,1,0.797530043198462,0,31,ERBB2 signaling pathway,BP,
10385,GO:0038129,1,0.983040857554601,0,3,ERBB3 signaling pathway,BP,
10386,GO:0038131,1,0.988042991925799,0,2,neuregulin receptor activity,MF,
10387,GO:0038132,1,0.958553999617196,0,5,neuregulin binding,MF,
10388,GO:0038133,1,0.994794257199193,0,1,ERBB2-ERBB3 signaling pathway,BP,
10389,GO:0038143,1,0.985177950841829,0,2,ERBB3:ERBB2 complex,CC,
10390,GO:0038145,1,0.965572745977014,0,6,macrophage colony-stimulating factor signaling pathway,BP,
10391,GO:0038146,1,0.975803248220823,0,4,chemokine (C-X-C motif) ligand 12 signaling pathway,BP,
10392,GO:0038147,1,0.995298760750246,0,1,C-X-C motif chemokine 12 receptor activity,MF,
10393,GO:0038154,1,0.981119870888854,0,3,interleukin-11-mediated signaling pathway,BP,
10394,GO:0038155,1,0.955635610129729,0,7,interleukin-23-mediated signaling pathway,BP,
10395,GO:0038156,1,0.981166881758011,0,3,interleukin-3-mediated signaling pathway,BP,
10396,GO:0038158,1,0.98841720771972,0,2,granulocyte colony-stimulating factor signaling pathway,BP,
10397,GO:0038159,1,0.995298760750246,0,1,C-X-C chemokine receptor CXCR4 signaling pathway,BP,
10398,GO:0038160,1,0.995298760750246,0,1,CXCL12-activated CXCR4 signaling pathway,BP,
10399,GO:0038161,1,0.979897406955149,0,2,prolactin signaling pathway,BP,
10400,GO:0038162,1,0.983121398483749,0,3,erythropoietin-mediated signaling pathway,BP,
10401,GO:0038163,1,0.969444732909928,0,5,thrombopoietin-mediated signaling pathway,BP,
10402,GO:0038164,1,0.992770574781404,0,1,thrombopoietin receptor activity,MF,
10403,GO:0038165,1,0.94855052822847,0,6,oncostatin-M-mediated signaling pathway,BP,
10405,GO:0038167,1,0.991651594455798,0,1,epidermal growth factor receptor signaling pathway via positive regulation of NF-kappaB transcription factor activity,BP,
10406,GO:0038168,1,0.991651594455798,0,1,epidermal growth factor receptor signaling pathway via I-kappaB kinase/NF-kappaB cascade,BP,
10407,GO:0038169,1,0.977187061934357,0,4,somatostatin receptor signaling pathway,BP,
10408,GO:0038170,1,0.977187061934357,0,4,somatostatin signaling pathway,BP,
10410,GO:0038172,1,0.980807287215245,0,3,interleukin-33-mediated signaling pathway,BP,
10411,GO:0038177,1,0.99627866482343,0,1,death receptor agonist activity,MF,
10412,GO:0038178,1,0.987736458624979,0,2,complement component C5a signaling pathway,BP,
10413,GO:0038179,1,0.770695590659427,0,37,neurotrophin signaling pathway,BP,
10414,GO:0038180,1,0.920805921876013,0,12,nerve growth factor signaling pathway,BP,
10415,GO:0038181,1,0.982657530997107,0,3,bile acid receptor activity,MF,
10416,GO:0038182,1,0.995802959596816,0,1,G protein-coupled bile acid receptor activity,MF,
10417,GO:0038183,1,0.982657530997107,0,3,bile acid signaling pathway,BP,
10418,GO:0038184,1,0.995802959596816,0,1,cell surface bile acid receptor signaling pathway,BP,
10419,GO:0038185,1,0.994580882739056,0,1,intracellular bile acid receptor signaling pathway,BP,
10420,GO:0038186,1,0.99217686342847,0,1,lithocholic acid receptor activity,MF,
10421,GO:0038187,1,0.879217349821859,0,20,pattern recognition receptor activity,MF,
10422,GO:0038188,1,0.990141657417038,0,2,cholecystokinin signaling pathway,BP,
10423,GO:0038189,1,0.972997253872489,0,4,neuropilin signaling pathway,BP,
10424,GO:0038190,1,0.986817792328529,0,2,VEGF-activated neuropilin signaling pathway,BP,
10425,GO:0038191,1,0.968019547939992,0,4,neuropilin binding,MF,
10426,GO:0038192,1,0.994810050967163,0,1,gastric inhibitory peptide signaling pathway,BP,
10427,GO:0038193,1,0.994345115448986,0,1,thromboxane A2 signaling pathway,BP,
10428,GO:0038194,1,0.988889890537701,0,2,thyroid-stimulating hormone signaling pathway,BP,
10429,GO:0038195,1,0.995889063975349,0,1,urokinase plasminogen activator signaling pathway,BP,
10430,GO:0038201,1,0.886381944965876,0,15,TOR complex,CC,
10431,GO:0038202,1,0.756752105016971,0,39,TORC1 signaling,BP,
10432,GO:0038203,1,0.947437291017582,0,8,TORC2 signaling,BP,
10433,GO:0039003,1,0.985291956540197,0,2,pronephric field specification,BP,
10434,GO:0039007,1,0.991482478357323,0,1,pronephric nephron morphogenesis,BP,
10435,GO:0039008,1,0.991482478357323,0,1,pronephric nephron tubule morphogenesis,BP,
10436,GO:0039017,1,0.985291956540197,0,2,pattern specification involved in pronephros development,BP,
10437,GO:0039019,1,0.98431803712947,0,2,pronephric nephron development,BP,
10438,GO:0039020,1,0.991482478357323,0,1,pronephric nephron tubule development,BP,
10439,GO:0039022,1,0.991482478357323,0,1,pronephric duct development,BP,
10440,GO:0039023,1,0.991482478357323,0,1,pronephric duct morphogenesis,BP,
10441,GO:0039506,1,0.985329319020582,0,2,modulation by virus of host molecular function,BP,
10442,GO:0039507,1,0.985329319020582,0,2,suppression by virus of host molecular function,BP,
10443,GO:0039513,1,0.993496698938406,0,1,suppression by virus of host catalytic activity,BP,
10444,GO:0039514,1,0.991779691267581,0,1,suppression by virus of host JAK-STAT cascade,BP,
10445,GO:0039516,1,0.993496698938406,0,1,modulation by virus of host catalytic activity,BP,
10446,GO:0039519,1,0.979498195612089,0,3,modulation by virus of host autophagy,BP,
10447,GO:0039520,1,0.987422295996477,0,2,induction by virus of host autophagy,BP,
10448,GO:0039521,1,0.99197597420295,0,1,suppression by virus of host autophagy,BP,
10449,GO:0039526,1,0.976120092108652,0,4,modulation by virus of host apoptotic process,BP,
10450,GO:0039528,1,0.840359578054024,0,25,cytoplasmic pattern recognition receptor signaling pathway in response to virus,BP,
10451,GO:0039529,1,0.865441614101656,0,20,RIG-I signaling pathway,BP,
10452,GO:0039530,1,0.946740733933722,0,8,MDA-5 signaling pathway,BP,
10453,GO:0039531,1,0.88613823069507,0,16,regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,
10454,GO:0039532,1,0.941522798139787,0,9,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,
10455,GO:0039533,1,0.96264759836648,0,5,regulation of MDA-5 signaling pathway,BP,
10456,GO:0039534,1,0.982704321741415,0,3,negative regulation of MDA-5 signaling pathway,BP,
10457,GO:0039535,1,0.897484966128538,0,14,regulation of RIG-I signaling pathway,BP,
10458,GO:0039536,1,0.953571368859105,0,7,negative regulation of RIG-I signaling pathway,BP,
10459,GO:0039552,1,0.977737999876342,0,3,RIG-I binding,MF,
10460,GO:0039562,1,0.991779691267581,0,1,suppression by virus of host STAT activity,BP,
10461,GO:0039563,1,0.991779691267581,0,1,suppression by virus of host STAT1 activity,BP,
10462,GO:0039564,1,0.991779691267581,0,1,suppression by virus of host STAT2 activity,BP,
10463,GO:0039650,1,0.993496698938406,0,1,suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process,BP,
10464,GO:0039654,1,0.993485400251684,0,1,fusion of virus membrane with host endosome membrane,BP,
10465,GO:0039656,1,0.981868651221537,0,3,modulation by virus of host gene expression,BP,
10466,GO:0039663,1,0.958175572611546,0,7,membrane fusion involved in viral entry into host cell,BP,
10467,GO:0039689,1,0.980591883709002,0,3,negative stranded viral RNA replication,BP,
10470,GO:0039695,1,0.992243560850596,0,1,DNA-templated viral transcription,BP,
10471,GO:0039702,1,0.888277456076571,0,21,viral budding via host ESCRT complex,BP,
10472,GO:0039706,1,0.931195997123445,0,11,co-receptor binding,MF,
10473,GO:0039713,1,0.992874062631439,0,1,viral factory,CC,
10474,GO:0039714,1,0.992874062631439,0,1,cytoplasmic viral factory,CC,
10475,GO:0040001,1,0.77887789291198,0,35,establishment of mitotic spindle localization,BP,
10478,GO:0040009,1,0.951499301633761,0,6,regulation of growth rate,BP,
10479,GO:0040010,1,0.990127585845057,0,2,positive regulation of growth rate,BP,
10483,GO:0040014,1,0.648181289930764,0,63,regulation of multicellular organism growth,BP,
10484,GO:0040015,1,0.92636732421293,0,11,negative regulation of multicellular organism growth,BP,
10486,GO:0040017,1,0.0295420913990326,0,504,positive regulation of locomotion,BP,
10487,GO:0040018,1,0.80955888186617,0,30,positive regulation of multicellular organism growth,BP,
10488,GO:0040019,1,0.796433589553147,0,31,positive regulation of embryonic development,BP,
10489,GO:0040020,1,0.836789113585316,0,28,regulation of meiotic nuclear division,BP,
10490,GO:0040029,1,0.402831138320885,0,129,regulation of gene expression, epigenetic,BP,
10491,GO:0040030,1,0.989795781589659,0,2,regulation of molecular function, epigenetic,BP,
10492,GO:0040031,1,0.962494217195738,0,7,snRNA modification,BP,
10493,GO:0040032,1,0.995084983899905,0,1,post-embryonic body morphogenesis,BP,
10494,GO:0040033,1,0.89303868827378,0,14,negative regulation of translation, ncRNA-mediated,BP,
10495,GO:0040034,1,0.918313903867677,0,13,regulation of development, heterochronic,BP,
10498,GO:0040038,1,0.975493943092294,0,3,polar body extrusion after meiotic divisions,BP,
10499,GO:0040040,1,0.991020273112237,0,1,thermosensory behavior,BP,
10500,GO:0042000,1,0.994068639898304,0,1,translocation of peptides or proteins into host,BP,
10501,GO:0042007,1,0.988780454906511,0,2,interleukin-18 binding,MF,
10502,GO:0042008,1,0.986504898253184,0,2,interleukin-18 receptor activity,MF,
10503,GO:0042010,1,0.983803040133717,0,3,interleukin-15 receptor activity,MF,
10504,GO:0042011,1,0.99310439906465,0,1,interleukin-16 binding,MF,
10505,GO:0042012,1,0.99310439906465,0,1,interleukin-16 receptor activity,MF,
10506,GO:0042015,1,0.981109205540756,0,3,interleukin-20 binding,MF,
10507,GO:0042019,1,0.987918539004486,0,2,interleukin-23 binding,MF,
10508,GO:0042020,1,0.994901652363875,0,1,interleukin-23 receptor activity,MF,
10509,GO:0042022,1,0.987918539004486,0,2,interleukin-12 receptor complex,CC,
10510,GO:0042023,1,0.965573615731178,0,5,DNA endoreduplication,BP,
10512,GO:0042026,1,0.875682417876638,0,22,protein refolding,BP,
10513,GO:0042030,1,0.966500392764859,0,4,ATPase inhibitor activity,MF,
10514,GO:0042033,1,0.996332591136268,0,1,chemokine biosynthetic process,BP,
10515,GO:0042035,1,0.900188115893553,0,14,regulation of cytokine biosynthetic process,BP,
10516,GO:0042036,1,0.963856712542687,0,5,negative regulation of cytokine biosynthetic process,BP,
10517,GO:0042038,1,0.993485400251684,0,1,peptidyl-histidine methylation, to form tele-methylhistidine,BP,
10518,GO:0042040,1,0.9924770361683,0,1,metal incorporation into metallo-molybdopterin complex,BP,
10521,GO:0042045,1,0.939130930114033,0,8,epithelial fluid transport,BP,
10522,GO:0042048,1,0.928756824719524,0,9,olfactory behavior,BP,
10523,GO:0042053,1,0.89337399085185,0,18,regulation of dopamine metabolic process,BP,
10524,GO:0042054,1,0.678523402857818,0,53,histone methyltransferase activity,MF,
10525,GO:0042056,1,0.882972372444091,0,23,chemoattractant activity,MF,
10530,GO:0042069,1,0.89337399085185,0,18,regulation of catecholamine metabolic process,BP,
10531,GO:0042073,1,0.709534103482801,0,49,intraciliary transport,BP,
10532,GO:0042074,1,0.907971693251508,0,14,cell migration involved in gastrulation,BP,
10533,GO:0042078,1,0.98326760816779,0,3,germ-line stem cell division,BP,
10534,GO:0042083,1,0.995647054770847,0,1,5,10-methylenetetrahydrofolate-dependent methyltransferase activity,MF,
10535,GO:0042084,1,0.987253255200936,0,1,5-methyltetrahydrofolate-dependent methyltransferase activity,MF,
10536,GO:0042088,1,0.78296937368109,0,41,T-helper 1 type immune response,BP,
10537,GO:0042089,1,0.880706086099682,0,18,cytokine biosynthetic process,BP,
10538,GO:0042092,1,0.815822818262301,0,35,type 2 immune response,BP,
10539,GO:0042093,1,0.695113845976029,0,54,T-helper cell differentiation,BP,
10542,GO:0042101,1,0.91119408851435,0,17,T cell receptor complex,CC,
10545,GO:0042105,1,0.978829229232354,0,5,alpha-beta T cell receptor complex,CC,
10546,GO:0042107,1,0.876204176979212,0,19,cytokine metabolic process,BP,
10547,GO:0042108,1,0.977836267552832,0,3,positive regulation of cytokine biosynthetic process,BP,
10550,GO:0042116,1,0.559501528546237,0,87,macrophage activation,BP,
10551,GO:0042117,1,0.944544440018708,0,9,monocyte activation,BP,
10552,GO:0042118,1,0.938958623200984,0,9,endothelial cell activation,BP,
10554,GO:0042126,1,0.989705519094844,0,2,nitrate metabolic process,BP,
10557,GO:0042130,1,0.704313632409298,0,58,negative regulation of T cell proliferation,BP,
10558,GO:0042132,1,0.995723275739318,0,1,fructose 1,6-bisphosphate 1-phosphatase activity,MF,
10559,GO:0042133,1,0.832549363673429,0,28,neurotransmitter metabolic process,BP,
10560,GO:0042135,1,0.929434316950573,0,11,neurotransmitter catabolic process,BP,
10561,GO:0042136,1,0.897452408872563,0,16,neurotransmitter biosynthetic process,BP,
10563,GO:0042138,1,0.978885407081941,0,3,meiotic DNA double-strand break formation,BP,
10564,GO:0042140,1,0.993485400251684,0,1,late meiotic recombination nodule assembly,BP,
10565,GO:0042144,1,0.972699759822508,0,5,vacuole fusion, non-autophagic,BP,
10566,GO:0042147,1,0.569197119549047,0,79,retrograde transport, endosome to Golgi,BP,
10567,GO:0042148,1,0.967077263922675,0,5,strand invasion,BP,
10568,GO:0042149,1,0.723927636688438,0,47,cellular response to glucose starvation,BP,
10569,GO:0042157,1,0.440363626883736,0,125,lipoprotein metabolic process,BP,
10570,GO:0042158,1,0.552940344639627,0,93,lipoprotein biosynthetic process,BP,
10571,GO:0042159,1,0.899537947814628,0,15,lipoprotein catabolic process,BP,
10572,GO:0042160,1,0.98926368605863,0,2,lipoprotein modification,BP,
10573,GO:0042161,1,0.98926368605863,0,2,lipoprotein oxidation,BP,
10574,GO:0042162,1,0.779513801055208,0,35,telomeric DNA binding,MF,
10575,GO:0042163,1,0.995890670052125,0,1,interleukin-12 beta subunit binding,MF,
10578,GO:0042167,1,0.984319878948359,0,4,heme catabolic process,BP,
10579,GO:0042168,1,0.850445489509674,0,28,heme metabolic process,BP,
10580,GO:0042169,1,0.742676077224489,0,40,SH2 domain binding,MF,
10581,GO:0042171,1,0.89233792630929,0,16,lysophosphatidic acid acyltransferase activity,MF,
10585,GO:0042178,1,0.943506033250305,0,11,xenobiotic catabolic process,BP,
10587,GO:0042181,1,0.80471003551889,0,36,ketone biosynthetic process,BP,
10588,GO:0042182,1,0.947412695884687,0,10,ketone catabolic process,BP,
10589,GO:0042197,1,0.995497146143176,0,1,halogenated hydrocarbon metabolic process,BP,
10590,GO:0042214,1,0.982018316486303,0,3,terpene metabolic process,BP,
10591,GO:0042218,1,0.994806103234431,0,1,1-aminocyclopropane-1-carboxylate biosynthetic process,BP,
10592,GO:0042219,1,0.852175639989916,0,26,cellular modified amino acid catabolic process,BP,
10595,GO:0042245,1,0.986275739639682,0,2,RNA repair,BP,
10596,GO:0042246,1,0.680325431995752,0,63,tissue regeneration,BP,
10597,GO:0042247,1,0.993269816259471,0,1,establishment of planar polarity of follicular epithelium,BP,
10599,GO:0042253,1,0.985482625936055,0,2,granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
10600,GO:0042254,1,0.201856096568915,0,277,ribosome biogenesis,BP,
10601,GO:0042255,1,0.742115964239977,0,57,ribosome assembly,BP,
10602,GO:0042256,1,0.972612808042287,0,5,mature ribosome assembly,BP,
10603,GO:0042262,1,0.978692805159337,0,5,DNA protection,BP,
10604,GO:0042264,1,0.983129084477365,0,2,peptidyl-aspartic acid hydroxylation,BP,
10605,GO:0042265,1,0.990280666500823,0,1,peptidyl-asparagine hydroxylation,BP,
10606,GO:0042267,1,0.744304167891977,0,51,natural killer cell mediated cytotoxicity,BP,
10607,GO:0042268,1,0.989703865456895,0,2,regulation of cytolysis,BP,
10608,GO:0042269,1,0.819024120337424,0,35,regulation of natural killer cell mediated cytotoxicity,BP,
10609,GO:0042270,1,0.975296173625009,0,5,protection from natural killer cell mediated cytotoxicity,BP,
10610,GO:0042271,1,0.983842066730831,0,2,susceptibility to natural killer cell mediated cytotoxicity,BP,
10611,GO:0042272,1,0.995054985345219,0,1,nuclear RNA export factor complex,CC,
10612,GO:0042273,1,0.702347965400333,0,66,ribosomal large subunit biogenesis,BP,
10613,GO:0042274,1,0.684809426909572,0,68,ribosomal small subunit biogenesis,BP,
10614,GO:0042275,1,0.995755014292195,0,1,error-free postreplication DNA repair,BP,
10615,GO:0042276,1,0.877710255991254,0,21,error-prone translesion synthesis,BP,
10618,GO:0042281,1,0.992908502911506,0,1,dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity,MF,
10619,GO:0042282,1,0.992320893023391,0,1,hydroxymethylglutaryl-CoA reductase activity,MF,
10620,GO:0042283,1,0.995420028080158,0,1,dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase activity,MF,
10621,GO:0042284,1,0.991126778556872,0,2,sphingolipid delta-4 desaturase activity,MF,
10622,GO:0042285,1,0.954427601481361,0,6,xylosyltransferase activity,MF,
10623,GO:0042287,1,0.848355861729862,0,28,MHC protein binding,MF,
10624,GO:0042288,1,0.896846895042844,0,18,MHC class I protein binding,MF,
10625,GO:0042289,1,0.967225184815498,0,6,MHC class II protein binding,MF,
10626,GO:0042292,1,0.993998291325329,0,1,URM1 activating enzyme activity,MF,
10627,GO:0042296,1,0.980361690864861,0,4,ISG15 transferase activity,MF,
10628,GO:0042297,1,0.930134442417902,0,7,vocal learning,BP,
10629,GO:0042300,1,0.992482560620612,0,1,beta-amyrin synthase activity,MF,
10631,GO:0042303,1,0.502642261912617,0,97,molting cycle,BP,
10632,GO:0042304,1,0.776455455693137,0,40,regulation of fatty acid biosynthetic process,BP,
10633,GO:0042306,1,0.671713062280345,0,56,regulation of protein import into nucleus,BP,
10634,GO:0042307,1,0.752181726741393,0,39,positive regulation of protein import into nucleus,BP,
10635,GO:0042308,1,0.915966870032878,0,13,negative regulation of protein import into nucleus,BP,
10636,GO:0042309,1,0.993486806773018,0,1,homoiothermy,BP,
10638,GO:0042311,1,0.834963993279188,0,29,vasodilation,BP,
10639,GO:0042313,1,0.994682591125216,0,1,protein kinase C deactivation,BP,
10640,GO:0042316,1,0.991892418496674,0,1,penicillin metabolic process,BP,
10641,GO:0042320,1,0.981720343631268,0,4,regulation of circadian sleep/wake cycle, REM sleep,BP,
10642,GO:0042321,1,0.97604373443706,0,5,negative regulation of circadian sleep/wake cycle, sleep,BP,
10643,GO:0042322,1,0.993060517130425,0,2,negative regulation of circadian sleep/wake cycle, REM sleep,BP,
10644,GO:0042323,1,0.989144539781613,0,2,negative regulation of circadian sleep/wake cycle, non-REM sleep,BP,
10648,GO:0042328,1,0.985706354470282,0,2,heparan sulfate N-acetylglucosaminyltransferase activity,MF,
10649,GO:0042330,1,0.0173808475960522,0,586,taxis,BP,
10650,GO:0042335,1,0.976813358774554,0,3,cuticle development,BP,
10651,GO:0042339,1,0.812282917933462,0,31,keratan sulfate metabolic process,BP,
10652,GO:0042340,1,0.926523695841494,0,11,keratan sulfate catabolic process,BP,
10653,GO:0042350,1,0.995486473670405,0,1,GDP-L-fucose biosynthetic process,BP,
10654,GO:0042351,1,0.995486473670405,0,1,'de novo' GDP-L-fucose biosynthetic process,BP,
10655,GO:0042354,1,0.938685719831507,0,8,L-fucose metabolic process,BP,
10656,GO:0042355,1,0.938685719831507,0,8,L-fucose catabolic process,BP,
10657,GO:0042357,1,0.989470135139561,0,2,thiamine diphosphate metabolic process,BP,
10658,GO:0042359,1,0.883227715208343,0,18,vitamin D metabolic process,BP,
10659,GO:0042360,1,0.984641160443671,0,3,vitamin E metabolic process,BP,
10660,GO:0042361,1,0.981742326100406,0,3,menaquinone catabolic process,BP,
10661,GO:0042362,1,0.927824407566771,0,13,fat-soluble vitamin biosynthetic process,BP,
10662,GO:0042363,1,0.949114703603201,0,9,fat-soluble vitamin catabolic process,BP,
10663,GO:0042364,1,0.962383435660503,0,6,water-soluble vitamin biosynthetic process,BP,
10664,GO:0042365,1,0.991580074866949,0,2,water-soluble vitamin catabolic process,BP,
10665,GO:0042368,1,0.944985662639563,0,10,vitamin D biosynthetic process,BP,
10666,GO:0042369,1,0.987023665779597,0,2,vitamin D catabolic process,BP,
10667,GO:0042371,1,0.992771023838117,0,1,vitamin K biosynthetic process,BP,
10668,GO:0042373,1,0.964099315749177,0,7,vitamin K metabolic process,BP,
10669,GO:0042374,1,0.978194107128263,0,4,phylloquinone metabolic process,BP,
10670,GO:0042376,1,0.978194107128263,0,4,phylloquinone catabolic process,BP,
10671,GO:0042377,1,0.981742326100406,0,3,vitamin K catabolic process,BP,
10672,GO:0042379,1,0.821754044102017,0,44,chemokine receptor binding,MF,
10673,GO:0042382,1,0.958971044785959,0,6,paraspeckles,CC,
10676,GO:0042392,1,0.989238105477618,0,2,sphingosine-1-phosphate phosphatase activity,MF,
10677,GO:0042393,1,0.214407219795936,0,211,histone binding,MF,
10678,GO:0042396,1,0.978178398879015,0,5,phosphagen biosynthetic process,BP,
10679,GO:0042398,1,0.766372347819637,0,45,cellular modified amino acid biosynthetic process,BP,
10680,GO:0042401,1,0.900179670390887,0,20,cellular biogenic amine biosynthetic process,BP,
10681,GO:0042402,1,0.903361521905092,0,19,cellular biogenic amine catabolic process,BP,
10682,GO:0042403,1,0.856318865297897,0,22,thyroid hormone metabolic process,BP,
10683,GO:0042404,1,0.9854740276823,0,2,thyroid hormone catabolic process,BP,
10684,GO:0042405,1,0.904668375040812,0,11,nuclear inclusion body,CC,
10685,GO:0042406,1,0.970197199328542,0,5,extrinsic component of endoplasmic reticulum membrane,CC,
10686,GO:0042407,1,0.914134952729461,0,16,cristae formation,BP,
10687,GO:0042412,1,0.989205742720011,0,2,taurine biosynthetic process,BP,
10688,GO:0042413,1,0.99392661897898,0,1,carnitine catabolic process,BP,
10689,GO:0042414,1,0.980421344824936,0,3,epinephrine metabolic process,BP,
10690,GO:0042415,1,0.934141742238966,0,10,norepinephrine metabolic process,BP,
10691,GO:0042416,1,0.935574519998543,0,11,dopamine biosynthetic process,BP,
10692,GO:0042417,1,0.78974724786822,0,36,dopamine metabolic process,BP,
10693,GO:0042418,1,0.991396584359532,0,2,epinephrine biosynthetic process,BP,
10694,GO:0042420,1,0.956551717632545,0,7,dopamine catabolic process,BP,
10695,GO:0042421,1,0.963000746499038,0,6,norepinephrine biosynthetic process,BP,
10696,GO:0042423,1,0.890987850241059,0,19,catecholamine biosynthetic process,BP,
10697,GO:0042424,1,0.949998771566984,0,8,catecholamine catabolic process,BP,
10698,GO:0042426,1,0.95858792898587,0,6,choline catabolic process,BP,
10699,GO:0042427,1,0.984300949407283,0,3,serotonin biosynthetic process,BP,
10700,GO:0042428,1,0.925355295317434,0,10,serotonin metabolic process,BP,
10701,GO:0042430,1,0.882113626560462,0,20,indole-containing compound metabolic process,BP,
10702,GO:0042435,1,0.980206164532898,0,4,indole-containing compound biosynthetic process,BP,
10703,GO:0042436,1,0.961691891780708,0,8,indole-containing compound catabolic process,BP,
10704,GO:0042438,1,0.863322064105408,0,20,melanin biosynthetic process,BP,
10705,GO:0042439,1,0.953210758048856,0,8,ethanolamine-containing compound metabolic process,BP,
10706,GO:0042440,1,0.67494434968311,0,62,pigment metabolic process,BP,
10707,GO:0042441,1,0.988543175008776,0,2,eye pigment metabolic process,BP,
10710,GO:0042447,1,0.932645877237877,0,11,hormone catabolic process,BP,
10711,GO:0042448,1,0.923363379643215,0,14,progesterone metabolic process,BP,
10712,GO:0042450,1,0.9904439965848,0,2,arginine biosynthetic process via ornithine,BP,
10713,GO:0042451,1,0.902506250876973,0,21,purine nucleoside biosynthetic process,BP,
10714,GO:0042454,1,0.909454949986404,0,18,ribonucleoside catabolic process,BP,
10715,GO:0042455,1,0.902506250876973,0,21,ribonucleoside biosynthetic process,BP,
10718,GO:0042470,1,0.526173110051487,0,101,melanosome,CC,
10721,GO:0042473,1,0.945516744557006,0,9,outer ear morphogenesis,BP,
10722,GO:0042474,1,0.892756430197113,0,20,middle ear morphogenesis,BP,
10723,GO:0042475,1,0.570585125417717,0,79,odontogenesis of dentin-containing tooth,BP,
10724,GO:0042476,1,0.44050496836734,0,117,odontogenesis,BP,
10725,GO:0042478,1,0.984538231982592,0,2,regulation of eye photoreceptor cell development,BP,
10726,GO:0042480,1,0.984538231982592,0,2,negative regulation of eye photoreceptor cell development,BP,
10727,GO:0042481,1,0.872828203383026,0,22,regulation of odontogenesis,BP,
10728,GO:0042482,1,0.957444192771861,0,7,positive regulation of odontogenesis,BP,
10729,GO:0042483,1,0.972277928841549,0,4,negative regulation of odontogenesis,BP,
10730,GO:0042487,1,0.929032884704237,0,12,regulation of odontogenesis of dentin-containing tooth,BP,
10731,GO:0042488,1,0.986980252750357,0,2,positive regulation of odontogenesis of dentin-containing tooth,BP,
10732,GO:0042489,1,0.987309974726078,0,2,negative regulation of odontogenesis of dentin-containing tooth,BP,
10735,GO:0042492,1,0.92215471057932,0,11,gamma-delta T cell differentiation,BP,
10737,GO:0042494,1,0.959750635328989,0,5,detection of bacterial lipoprotein,BP,
10738,GO:0042495,1,0.986324277157903,0,2,detection of triacyl bacterial lipopeptide,BP,
10739,GO:0042496,1,0.984153675237718,0,2,detection of diacyl bacterial lipopeptide,BP,
10740,GO:0042497,1,0.992897977379383,0,1,triacyl lipopeptide binding,MF,
10741,GO:0042500,1,0.961655110287833,0,6,aspartic endopeptidase activity, intramembrane cleaving,MF,
10742,GO:0042501,1,0.95843259043863,0,7,serine phosphorylation of STAT protein,BP,
10743,GO:0042509,1,0.706490690933888,0,57,regulation of tyrosine phosphorylation of STAT protein,BP,
10744,GO:0042531,1,0.748040670883119,0,48,positive regulation of tyrosine phosphorylation of STAT protein,BP,
10745,GO:0042532,1,0.927604227450526,0,11,negative regulation of tyrosine phosphorylation of STAT protein,BP,
10746,GO:0042537,1,0.899716939748101,0,21,benzene-containing compound metabolic process,BP,
10747,GO:0042538,1,0.939575715046834,0,10,hyperosmotic salinity response,BP,
10748,GO:0042539,1,0.982911167754068,0,2,hypotonic salinity response,BP,
10749,GO:0042541,1,0.945540711061276,0,10,hemoglobin biosynthetic process,BP,
10751,GO:0042543,1,0.997108806340519,0,1,protein N-linked glycosylation via arginine,BP,
10752,GO:0042546,1,0.995309928040927,0,1,cell wall biogenesis,BP,
10753,GO:0042551,1,0.711180008739535,0,46,neuron maturation,BP,
10754,GO:0042552,1,0.380992536668833,0,132,myelination,BP,
10755,GO:0042554,1,0.831805903534514,0,31,superoxide anion generation,BP,
10756,GO:0042555,1,0.922257563359295,0,12,MCM complex,CC,
10758,GO:0042559,1,0.932303151443242,0,13,pteridine-containing compound biosynthetic process,BP,
10759,GO:0042560,1,0.979643098222895,0,3,pteridine-containing compound catabolic process,BP,
10760,GO:0042562,1,0.631535145914747,0,73,hormone binding,MF,
10761,GO:0042564,1,0.992423485405219,0,1,NLS-dependent protein nuclear import complex,CC,
10762,GO:0042565,1,0.988093543584894,0,2,RNA nuclear export complex,CC,
10763,GO:0042567,1,0.969628763227784,0,4,insulin-like growth factor ternary complex,CC,
10764,GO:0042568,1,0.996582622722969,0,1,insulin-like growth factor binary complex,CC,
10765,GO:0042571,1,0.990255982316738,0,2,immunoglobulin complex, circulating,CC,
10766,GO:0042572,1,0.800792671045451,0,39,retinol metabolic process,BP,
10767,GO:0042573,1,0.894282719431784,0,20,retinoic acid metabolic process,BP,
10768,GO:0042574,1,0.910087888313622,0,15,retinal metabolic process,BP,
10769,GO:0042575,1,0.874683445321909,0,21,DNA polymerase complex,CC,
10770,GO:0042577,1,0.97688866902581,0,4,lipid phosphatase activity,MF,
10772,GO:0042579,1,0.464109645782438,0,126,microbody,CC,
10774,GO:0042582,1,0.416593931927532,0,145,azurophil granule,CC,
10777,GO:0042585,1,0.994410185558726,0,1,germinal vesicle,CC,
10778,GO:0042586,1,0.996319719131459,0,1,peptide deformylase activity,MF,
10779,GO:0042587,1,0.950214351004375,0,7,glycogen granule,CC,
10780,GO:0042588,1,0.915775081685657,0,14,zymogen granule,CC,
10781,GO:0042589,1,0.935924543743946,0,10,zymogen granule membrane,CC,
10782,GO:0042590,1,0.69551440323062,0,74,antigen processing and presentation of exogenous peptide antigen via MHC class I,BP,
10785,GO:0042594,1,0.287627436340189,0,183,response to starvation,BP,
10786,GO:0042595,1,0.989361580860091,0,2,behavioral response to starvation,BP,
10787,GO:0042596,1,0.764290577547926,0,41,fear response,BP,
10788,GO:0042599,1,0.918999347500735,0,14,lamellar body,CC,
10789,GO:0042602,1,0.996725810085226,0,1,riboflavin reductase (NADPH) activity,MF,
10790,GO:0042605,1,0.895596457843128,0,21,peptide antigen binding,MF,
10791,GO:0042608,1,0.954538659228491,0,9,T cell receptor binding,MF,
10792,GO:0042609,1,0.948051640547302,0,9,CD4 receptor binding,MF,
10793,GO:0042610,1,0.98086576427874,0,4,CD8 receptor binding,MF,
10794,GO:0042611,1,0.912904252278408,0,22,MHC protein complex,CC,
10795,GO:0042612,1,0.967581269133427,0,8,MHC class I protein complex,CC,
10796,GO:0042613,1,0.943509190191532,0,14,MHC class II protein complex,CC,
10797,GO:0042622,1,0.899453321948258,0,16,photoreceptor outer segment membrane,CC,
10800,GO:0042627,1,0.949662213023377,0,9,chylomicron,CC,
10801,GO:0042628,1,0.994360611983039,0,1,mating plug formation,BP,
10802,GO:0042629,1,0.874478898985169,0,21,mast cell granule,CC,
10803,GO:0042631,1,0.985400415793257,0,2,cellular response to water deprivation,BP,
10804,GO:0042632,1,0.631679710010418,0,70,cholesterol homeostasis,BP,
10805,GO:0042633,1,0.502642261912617,0,97,hair cycle,BP,
10806,GO:0042634,1,0.833886463452428,0,26,regulation of hair cycle,BP,
10807,GO:0042635,1,0.931992806397604,0,12,positive regulation of hair cycle,BP,
10808,GO:0042636,1,0.963336904231771,0,5,negative regulation of hair cycle,BP,
10809,GO:0042637,1,0.975769361029115,0,4,catagen,BP,
10810,GO:0042640,1,0.963576343468304,0,5,anagen,BP,
10811,GO:0042641,1,0.571884984142678,0,72,actomyosin,CC,
10812,GO:0042645,1,0.772972885273056,0,40,mitochondrial nucleoid,CC,
10813,GO:0042658,1,0.996086243927831,0,1,MHC class II protein binding, via antigen binding groove,MF,
10815,GO:0042660,1,0.990404066014189,0,1,positive regulation of cell fate specification,BP,
10818,GO:0042663,1,0.99158986076347,0,2,regulation of endodermal cell fate specification,BP,
10819,GO:0042664,1,0.996316852701051,0,1,negative regulation of endodermal cell fate specification,BP,
10820,GO:0042665,1,0.992685567166604,0,1,regulation of ectodermal cell fate specification,BP,
10821,GO:0042666,1,0.992685567166604,0,1,negative regulation of ectodermal cell fate specification,BP,
10822,GO:0042667,1,0.992752379857304,0,1,auditory receptor cell fate specification,BP,
10823,GO:0042669,1,0.992752379857304,0,1,regulation of inner ear auditory receptor cell fate specification,BP,
10826,GO:0042693,1,0.932312351017344,0,12,muscle cell fate commitment,BP,
10827,GO:0042695,1,0.972810750166321,0,4,thelarche,BP,
10829,GO:0042699,1,0.989563484257934,0,2,follicle-stimulating hormone signaling pathway,BP,
10830,GO:0042700,1,0.992242130543691,0,1,luteinizing hormone signaling pathway,BP,
10831,GO:0042701,1,0.976640608464207,0,4,progesterone secretion,BP,
10832,GO:0042704,1,0.984889529679294,0,2,uterine wall breakdown,BP,
10833,GO:0042706,1,0.994738933398728,0,1,eye photoreceptor cell fate commitment,BP,
10834,GO:0042709,1,0.984652328196657,0,3,succinate-CoA ligase complex,CC,
10835,GO:0042710,1,0.994149557619953,0,1,biofilm formation,BP,
10836,GO:0042711,1,0.932590123873615,0,10,maternal behavior,BP,
10837,GO:0042713,1,0.969371494649915,0,4,sperm ejaculation,BP,
10838,GO:0042719,1,0.978593114876885,0,5,mitochondrial intermembrane space protein transporter complex,CC,
10839,GO:0042720,1,0.992571385628475,0,2,mitochondrial inner membrane peptidase complex,CC,
10840,GO:0042721,1,0.982361344641036,0,3,TIM22 mitochondrial import inner membrane insertion complex,CC,
10841,GO:0042723,1,0.964685644114702,0,6,thiamine-containing compound metabolic process,BP,
10842,GO:0042726,1,0.948287116110723,0,8,flavin-containing compound metabolic process,BP,
10843,GO:0042727,1,0.988538554390312,0,2,flavin-containing compound biosynthetic process,BP,
10844,GO:0042728,1,0.992675209673287,0,1,flavin-containing compound catabolic process,BP,
10845,GO:0042730,1,0.890081619992354,0,20,fibrinolysis,BP,
10846,GO:0042731,1,0.97347400493549,0,4,PH domain binding,MF,
10847,GO:0042732,1,0.985989983794981,0,3,D-xylose metabolic process,BP,
10850,GO:0042737,1,0.907541848717743,0,17,drug catabolic process,BP,
10851,GO:0042738,1,0.916682433963732,0,15,exogenous drug catabolic process,BP,
10853,GO:0042743,1,0.778163153853347,0,49,hydrogen peroxide metabolic process,BP,
10854,GO:0042744,1,0.868584225934831,0,29,hydrogen peroxide catabolic process,BP,
10855,GO:0042745,1,0.863900474288819,0,26,circadian sleep/wake cycle,BP,
10856,GO:0042746,1,0.983480566124891,0,3,circadian sleep/wake cycle, wakefulness,BP,
10857,GO:0042747,1,0.966889636608899,0,7,circadian sleep/wake cycle, REM sleep,BP,
10858,GO:0042748,1,0.946355114228994,0,9,circadian sleep/wake cycle, non-REM sleep,BP,
10859,GO:0042749,1,0.896659758453903,0,20,regulation of circadian sleep/wake cycle,BP,
10861,GO:0042753,1,0.903592306815292,0,16,positive regulation of circadian rhythm,BP,
10862,GO:0042754,1,0.912298894449913,0,14,negative regulation of circadian rhythm,BP,
10863,GO:0042755,1,0.859585980793509,0,25,eating behavior,BP,
10864,GO:0042756,1,0.954832931348991,0,8,drinking behavior,BP,
10865,GO:0042758,1,0.947709406758778,0,9,long-chain fatty acid catabolic process,BP,
10866,GO:0042759,1,0.833014959224586,0,30,long-chain fatty acid biosynthetic process,BP,
10867,GO:0042760,1,0.960001400740006,0,6,very long-chain fatty acid catabolic process,BP,
10868,GO:0042761,1,0.926655173439091,0,12,very long-chain fatty acid biosynthetic process,BP,
10869,GO:0042762,1,0.903777977418603,0,13,regulation of sulfur metabolic process,BP,
10870,GO:0042765,1,0.970267775101697,0,5,GPI-anchor transamidase complex,CC,
10871,GO:0042766,1,0.961746454107888,0,4,nucleosome mobilization,BP,
10872,GO:0042769,1,0.80915643940256,0,37,DNA damage response, detection of DNA damage,BP,
10874,GO:0042771,1,0.758700788838293,0,43,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
10876,GO:0042773,1,0.710633668603025,0,81,ATP synthesis coupled electron transport,BP,
10877,GO:0042774,1,0.993485400251684,0,1,plasma membrane ATP synthesis coupled electron transport,BP,
10878,GO:0042775,1,0.715309238146344,0,80,mitochondrial ATP synthesis coupled electron transport,BP,
10879,GO:0042776,1,0.983500094274323,0,4,mitochondrial ATP synthesis coupled proton transport,BP,
10880,GO:0042779,1,0.984003561207238,0,3,tRNA 3'-trailer cleavage,BP,
10881,GO:0042780,1,0.957803956916318,0,8,tRNA 3'-end processing,BP,
10882,GO:0042781,1,0.987157868047686,0,2,3'-tRNA processing endoribonuclease activity,MF,
10883,GO:0042788,1,0.865390152981999,0,32,polysomal ribosome,CC,
10884,GO:0042789,1,0.918730512706939,0,11,mRNA transcription by RNA polymerase II,BP,
10885,GO:0042790,1,0.919625473704793,0,13,nucleolar large rRNA transcription by RNA polymerase I,BP,
10886,GO:0042791,1,0.959995771404901,0,6,5S class rRNA transcription by RNA polymerase III,BP,
10887,GO:0042795,1,0.653190558807068,0,69,snRNA transcription by RNA polymerase II,BP,
10888,GO:0042796,1,0.951994332233757,0,8,snRNA transcription by RNA polymerase III,BP,
10889,GO:0042797,1,0.956831395073335,0,7,tRNA transcription by RNA polymerase III,BP,
10890,GO:0042799,1,0.985714832396897,0,1,histone methyltransferase activity (H4-K20 specific),MF,
10891,GO:0042800,1,0.88037059457547,0,17,histone methyltransferase activity (H3-K4 specific),MF,
10894,GO:0042805,1,0.759144496702384,0,35,actinin binding,MF,
10895,GO:0042806,1,0.973712932454937,0,5,fucose binding,MF,
10896,GO:0042809,1,0.893770472184239,0,15,vitamin D receptor binding,MF,
10897,GO:0042813,1,0.883574299094423,0,15,Wnt-activated receptor activity,MF,
10898,GO:0042816,1,0.964725574069812,0,5,vitamin B6 metabolic process,BP,
10899,GO:0042819,1,0.977534235846879,0,3,vitamin B6 biosynthetic process,BP,
10900,GO:0042820,1,0.994871164100436,0,1,vitamin B6 catabolic process,BP,
10901,GO:0042822,1,0.977764277767267,0,3,pyridoxal phosphate metabolic process,BP,
10902,GO:0042823,1,0.982805799570434,0,2,pyridoxal phosphate biosynthetic process,BP,
10903,GO:0042824,1,0.952949590904663,0,8,MHC class I peptide loading complex,CC,
10904,GO:0042825,1,0.98590552319136,0,2,TAP complex,CC,
10906,GO:0042827,1,0.898033072445069,0,18,platelet dense granule,CC,
10907,GO:0042832,1,0.869489800237179,0,24,defense response to protozoan,BP,
10908,GO:0042834,1,0.949516020276954,0,9,peptidoglycan binding,MF,
10909,GO:0042835,1,0.984830701398679,0,2,BRE binding,MF,
10910,GO:0042839,1,0.995831605285646,0,1,D-glucuronate metabolic process,BP,
10911,GO:0042840,1,0.995831605285646,0,1,D-glucuronate catabolic process,BP,
10912,GO:0042843,1,0.996421487456059,0,1,D-xylose catabolic process,BP,
10913,GO:0042851,1,0.983445728823466,0,3,L-alanine metabolic process,BP,
10914,GO:0042853,1,0.983445728823466,0,3,L-alanine catabolic process,BP,
10915,GO:0042866,1,0.965807593948206,0,6,pyruvate biosynthetic process,BP,
10916,GO:0042868,1,0.99346037055517,0,1,antisense RNA metabolic process,BP,
10917,GO:0042883,1,0.984850629899662,0,2,cysteine transport,BP,
10920,GO:0042903,1,0.987573182977198,0,2,tubulin deacetylase activity,MF,
10921,GO:0042904,1,0.976103689849764,0,4,9-cis-retinoic acid biosynthetic process,BP,
10922,GO:0042905,1,0.976103689849764,0,4,9-cis-retinoic acid metabolic process,BP,
10924,GO:0042910,1,0.825001167111684,0,27,xenobiotic transmembrane transporter activity,MF,
10925,GO:0042918,1,0.952526975444595,0,6,alkanesulfonate transport,BP,
10926,GO:0042921,1,0.909768064061517,0,13,glucocorticoid receptor signaling pathway,BP,
10927,GO:0042922,1,0.996779666664659,0,1,neuromedin U receptor binding,MF,
10928,GO:0042923,1,0.872493360526983,0,23,neuropeptide binding,MF,
10929,GO:0042924,1,0.987765296580378,0,2,neuromedin U binding,MF,
10930,GO:0042930,1,0.993485400251684,0,1,enterobactin transport,BP,
10931,GO:0042931,1,0.993485400251684,0,1,enterobactin transmembrane transporter activity,MF,
10932,GO:0042937,1,0.976579456270282,0,3,tripeptide transmembrane transporter activity,MF,
10933,GO:0042938,1,0.969030844895767,0,4,dipeptide transport,BP,
10934,GO:0042939,1,0.959894852049684,0,5,tripeptide transport,BP,
10935,GO:0042940,1,0.947362586538568,0,7,D-amino acid transport,BP,
10936,GO:0042941,1,0.994969292905976,0,1,D-alanine transport,BP,
10937,GO:0042942,1,0.982060012687918,0,3,D-serine transport,BP,
10938,GO:0042943,1,0.985994549380214,0,2,D-amino acid transmembrane transporter activity,MF,
10939,GO:0042945,1,0.993209461754585,0,1,D-serine transmembrane transporter activity,MF,
10940,GO:0042946,1,0.979956063283106,0,3,glucoside transport,BP,
10941,GO:0042947,1,0.979956063283106,0,3,glucoside transmembrane transporter activity,MF,
10942,GO:0042953,1,0.906538401382175,0,11,lipoprotein transport,BP,
10943,GO:0042959,1,0.9765820363949,0,3,alkanesulfonate transmembrane transporter activity,MF,
10944,GO:0042969,1,0.993485400251684,0,1,lactone transport,BP,
10945,GO:0042971,1,0.993485400251684,0,1,lactone transmembrane transporter activity,MF,
10946,GO:0042974,1,0.815331214452133,0,27,retinoic acid receptor binding,MF,
10947,GO:0042975,1,0.912637730886646,0,11,peroxisome proliferator activated receptor binding,MF,
10948,GO:0042976,1,0.932204312116322,0,10,activation of Janus kinase activity,BP,
10949,GO:0042978,1,0.986003094890145,0,2,ornithine decarboxylase activator activity,MF,
10950,GO:0042979,1,0.974296777004324,0,5,ornithine decarboxylase regulator activity,MF,
10952,GO:0042982,1,0.656760860538685,0,61,amyloid precursor protein metabolic process,BP,
10953,GO:0042983,1,0.918376572881432,0,13,amyloid precursor protein biosynthetic process,BP,
10954,GO:0042984,1,0.918376572881432,0,13,regulation of amyloid precursor protein biosynthetic process,BP,
10955,GO:0042985,1,0.963115413483,0,6,negative regulation of amyloid precursor protein biosynthetic process,BP,
10956,GO:0042986,1,0.970633337466942,0,4,positive regulation of amyloid precursor protein biosynthetic process,BP,
10957,GO:0042987,1,0.719211361722729,0,46,amyloid precursor protein catabolic process,BP,
10958,GO:0042988,1,0.991798829015532,0,1,X11-like protein binding,MF,
10959,GO:0042989,1,0.956886014567873,0,10,sequestering of actin monomers,BP,
10960,GO:0042994,1,0.903776709392998,0,16,cytoplasmic sequestering of transcription factor,BP,
10962,GO:0042996,1,0.950341468510102,0,8,regulation of Golgi to plasma membrane protein transport,BP,
10963,GO:0042997,1,0.969443309009952,0,5,negative regulation of Golgi to plasma membrane protein transport,BP,
10964,GO:0042998,1,0.980302127096326,0,3,positive regulation of Golgi to plasma membrane protein transport,BP,
10965,GO:0042999,1,0.992267328441447,0,1,regulation of Golgi to plasma membrane CFTR protein transport,BP,
10966,GO:0043000,1,0.976779255455224,0,3,Golgi to plasma membrane CFTR protein transport,BP,
10967,GO:0043001,1,0.760125569617233,0,38,Golgi to plasma membrane protein transport,BP,
10968,GO:0043002,1,0.992267328441447,0,1,negative regulation of Golgi to plasma membrane CFTR protein transport,BP,
10969,GO:0043004,1,0.992267328441447,0,1,cytoplasmic sequestering of CFTR protein,BP,
10971,GO:0043006,1,0.98859149707265,0,2,activation of phospholipase A2 activity by calcium-mediated signaling,BP,
10972,GO:0043007,1,0.986592529102228,0,2,maintenance of rDNA,BP,
10973,GO:0043008,1,0.950136929597475,0,8,ATP-dependent protein binding,MF,
10976,GO:0043011,1,0.906687237231883,0,16,myeloid dendritic cell differentiation,BP,
10977,GO:0043012,1,0.993754771323867,0,1,regulation of fusion of sperm to egg plasma membrane,BP,
10978,GO:0043014,1,0.792288101135715,0,34,alpha-tubulin binding,MF,
10979,GO:0043015,1,0.82603843646078,0,27,gamma-tubulin binding,MF,
10980,GO:0043020,1,0.938294201993713,0,11,NADPH oxidase complex,CC,
10981,GO:0043021,1,0.45665811993223,0,120,ribonucleoprotein complex binding,MF,
10982,GO:0043022,1,0.717299953663747,0,50,ribosome binding,MF,
10983,GO:0043023,1,0.926787485710433,0,12,ribosomal large subunit binding,MF,
10984,GO:0043024,1,0.899169832243485,0,17,ribosomal small subunit binding,MF,
10988,GO:0043029,1,0.795096855857981,0,36,T cell homeostasis,BP,
10989,GO:0043030,1,0.723549339683429,0,48,regulation of macrophage activation,BP,
10990,GO:0043031,1,0.913088949720959,0,15,negative regulation of macrophage activation,BP,
10991,GO:0043032,1,0.868478678267888,0,21,positive regulation of macrophage activation,BP,
10992,GO:0043033,1,0.990024972857022,0,1,isoamylase complex,CC,
10993,GO:0043034,1,0.840894831236367,0,19,costamere,CC,
10994,GO:0043035,1,0.96277956971757,0,5,chromatin insulator sequence binding,MF,
10995,GO:0043038,1,0.840856320283202,0,30,amino acid activation,BP,
10996,GO:0043039,1,0.8469573182088,0,29,tRNA aminoacylation,BP,
10997,GO:0043041,1,0.992808483982081,0,1,amino acid activation for nonribosomal peptide biosynthetic process,BP,
10999,GO:0043044,1,0.623510981601053,0,69,ATP-dependent chromatin remodeling,BP,
11000,GO:0043045,1,0.955039289025554,0,6,DNA methylation involved in embryo development,BP,
11001,GO:0043046,1,0.892912727790653,0,17,DNA methylation involved in gamete generation,BP,
11002,GO:0043047,1,0.930044527944611,0,11,single-stranded telomeric DNA binding,MF,
11003,GO:0043048,1,0.994482532380317,0,1,dolichyl monophosphate biosynthetic process,BP,
11004,GO:0043049,1,0.993139384115289,0,1,otic placode formation,BP,
11005,GO:0043060,1,0.993971236807866,0,1,meiotic metaphase I plate congression,BP,
11007,GO:0043063,1,0.992041116427977,0,1,intercellular bridge organization,BP,
11013,GO:0043073,1,0.922111487329023,0,12,germ cell nucleus,CC,
11014,GO:0043083,1,0.886045009853383,0,16,synaptic cleft,CC,
11018,GO:0043087,1,0.0377017830102469,0,437,regulation of GTPase activity,BP,
11020,GO:0043094,1,0.844139421836252,0,31,cellular metabolic compound salvage,BP,
11021,GO:0043095,1,0.996908940589292,0,1,regulation of GTP cyclohydrolase I activity,BP,
11022,GO:0043096,1,0.988569306668441,0,3,purine nucleobase salvage,BP,
11023,GO:0043097,1,0.949841172830489,0,10,pyrimidine nucleoside salvage,BP,
11024,GO:0043101,1,0.927028923547974,0,14,purine-containing compound salvage,BP,
11025,GO:0043102,1,0.961082271346592,0,7,amino acid salvage,BP,
11026,GO:0043103,1,0.991668113871442,0,2,hypoxanthine salvage,BP,
11027,GO:0043105,1,0.996908940589292,0,1,negative regulation of GTP cyclohydrolase I activity,BP,
11028,GO:0043111,1,0.972332719974017,0,4,replication fork arrest,BP,
11030,GO:0043113,1,0.656886128976959,0,55,receptor clustering,BP,
11032,GO:0043116,1,0.901517411349644,0,15,negative regulation of vascular permeability,BP,
11034,GO:0043120,1,0.966571981668615,0,5,tumor necrosis factor binding,MF,
11035,GO:0043121,1,0.932072492475754,0,9,neurotrophin binding,MF,
11036,GO:0043122,1,0.215143068621511,0,234,regulation of I-kappaB kinase/NF-kappaB signaling,BP,
11037,GO:0043123,1,0.3148585004748,0,179,positive regulation of I-kappaB kinase/NF-kappaB signaling,BP,
11038,GO:0043124,1,0.735317280593022,0,43,negative regulation of I-kappaB kinase/NF-kappaB signaling,BP,
11039,GO:0043125,1,0.967261575879074,0,5,ErbB-3 class receptor binding,MF,
11040,GO:0043126,1,0.995789792855028,0,1,regulation of 1-phosphatidylinositol 4-kinase activity,BP,
11041,GO:0043128,1,0.995789792855028,0,1,positive regulation of 1-phosphatidylinositol 4-kinase activity,BP,
11042,GO:0043129,1,0.950263471777071,0,8,surfactant homeostasis,BP,
11044,GO:0043131,1,0.991828016275873,0,1,erythrocyte enucleation,BP,
11045,GO:0043132,1,0.987467206238161,0,2,NAD transport,BP,
11046,GO:0043136,1,0.987989291953493,0,2,glycerol-3-phosphatase activity,MF,
11047,GO:0043137,1,0.978830028588886,0,4,DNA replication, removal of RNA primer,BP,
11048,GO:0043138,1,0.876235589294234,0,18,3'-5' DNA helicase activity,MF,
11049,GO:0043139,1,0.957986150848155,0,7,5'-3' DNA helicase activity,MF,
11050,GO:0043144,1,0.94798906772408,0,11,snoRNA processing,BP,
11051,GO:0043149,1,0.482187130420957,0,99,stress fiber assembly,BP,
11052,GO:0043152,1,0.978034036716721,0,4,induction of bacterial agglutination,BP,
11053,GO:0043153,1,0.841093579962061,0,27,entrainment of circadian clock by photoperiod,BP,
11055,GO:0043159,1,0.983738706644807,0,3,acrosomal matrix,CC,
11057,GO:0043162,1,0.871996846629398,0,22,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,
11058,GO:0043163,1,0.987115138105567,0,2,cell envelope organization,BP,
11063,GO:0043171,1,0.851544630700876,0,24,peptide catabolic process,BP,
11064,GO:0043173,1,0.938991944898374,0,12,nucleotide salvage,BP,
11065,GO:0043174,1,0.925936312123068,0,15,nucleoside salvage,BP,
11066,GO:0043175,1,0.739406172235212,0,44,RNA polymerase core enzyme binding,MF,
11067,GO:0043176,1,0.932004030628947,0,12,amine binding,MF,
11070,GO:0043179,1,0.994682591125216,0,1,rhythmic excitation,BP,
11071,GO:0043181,1,0.992791547042543,0,1,vacuolar sequestering,BP,
11072,GO:0043183,1,0.983807173603921,0,3,vascular endothelial growth factor receptor 1 binding,MF,
11073,GO:0043184,1,0.935499226347323,0,9,vascular endothelial growth factor receptor 2 binding,MF,
11074,GO:0043185,1,0.994715210865872,0,1,vascular endothelial growth factor receptor 3 binding,MF,
11075,GO:0043186,1,0.883661368124996,0,17,P granule,CC,
11076,GO:0043189,1,0.887992505912728,0,19,H4/H2A histone acetyltransferase complex,CC,
11077,GO:0043190,1,0.961919106299006,0,5,ATP-binding cassette (ABC) transporter complex,CC,
11078,GO:0043194,1,0.864416908868261,0,16,axon initial segment,CC,
11083,GO:0043199,1,0.972246944739588,0,4,sulfate binding,MF,
11085,GO:0043201,1,0.90916972381321,0,12,response to leucine,BP,
11086,GO:0043202,1,0.54898244448685,0,89,lysosomal lumen,CC,
11091,GO:0043209,1,0.741804458874621,0,45,myelin sheath,CC,
11092,GO:0043210,1,0.995238761465561,0,1,alkanesulfonate binding,MF,
11093,GO:0043217,1,0.881952638908221,0,16,myelin maintenance,BP,
11094,GO:0043218,1,0.915232135840399,0,14,compact myelin,CC,
11095,GO:0043219,1,0.974763602245743,0,4,lateral loop,CC,
11096,GO:0043220,1,0.928717414752951,0,11,Schmidt-Lanterman incisure,CC,
11097,GO:0043225,1,0.991637193618431,0,1,ATPase-coupled inorganic anion transmembrane transporter activity,MF,
11107,GO:0043236,1,0.82675577968008,0,27,laminin binding,MF,
11108,GO:0043237,1,0.963490037551935,0,5,laminin-1 binding,MF,
11109,GO:0043240,1,0.942370329681231,0,9,Fanconi anaemia nuclear complex,CC,
11113,GO:0043247,1,0.912655348260027,0,13,telomere maintenance in response to DNA damage,BP,
11114,GO:0043248,1,0.94584124129584,0,12,proteasome assembly,BP,
11115,GO:0043249,1,0.910642373463935,0,15,erythrocyte maturation,BP,
11116,GO:0043250,1,0.995784843676044,0,1,sodium-dependent organic anion transmembrane transporter activity,MF,
11117,GO:0043251,1,0.995784843676044,0,1,sodium-dependent organic anion transport,BP,
11118,GO:0043252,1,0.912120163776587,0,13,sodium-independent organic anion transport,BP,
11120,GO:0043255,1,0.540331351487657,0,82,regulation of carbohydrate biosynthetic process,BP,
11121,GO:0043256,1,0.895663466357331,0,12,laminin complex,CC,
11122,GO:0043257,1,0.991194667756848,0,1,laminin-8 complex,CC,
11123,GO:0043259,1,0.967518421463682,0,3,laminin-10 complex,CC,
11124,GO:0043260,1,0.967554153121143,0,3,laminin-11 complex,CC,
11125,GO:0043262,1,0.985983720843257,0,2,adenosine-diphosphatase activity,MF,
11126,GO:0043265,1,0.993076322747727,0,1,ectoplasm,CC,
11128,GO:0043267,1,0.817060335180989,0,30,negative regulation of potassium ion transport,BP,
11133,GO:0043273,1,0.991611813634978,0,1,CTPase activity,MF,
11134,GO:0043274,1,0.911809870554258,0,13,phospholipase binding,MF,
11135,GO:0043276,1,0.804795778909957,0,30,anoikis,BP,
11136,GO:0043277,1,0.724956086304978,0,48,apoptotic cell clearance,BP,
11139,GO:0043280,1,0.460825171918388,0,125,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,
11141,GO:0043291,1,0.970106524539298,0,3,RAVE complex,CC,
11143,GO:0043293,1,0.985514550460057,0,2,apoptosome,CC,
11144,GO:0043295,1,0.94414342007984,0,12,glutathione binding,MF,
11146,GO:0043297,1,0.616001422552167,0,72,apical junction assembly,BP,
11149,GO:0043301,1,0.931821271904185,0,12,negative regulation of leukocyte degranulation,BP,
11150,GO:0043302,1,0.869858468931629,0,23,positive regulation of leukocyte degranulation,BP,
11151,GO:0043303,1,0.762324857952262,0,43,mast cell degranulation,BP,
11152,GO:0043304,1,0.841983434565157,0,29,regulation of mast cell degranulation,BP,
11153,GO:0043305,1,0.969466112535722,0,6,negative regulation of mast cell degranulation,BP,
11154,GO:0043306,1,0.922312437181576,0,14,positive regulation of mast cell degranulation,BP,
11155,GO:0043307,1,0.973171120999906,0,5,eosinophil activation,BP,
11156,GO:0043308,1,0.977972329441864,0,4,eosinophil degranulation,BP,
11157,GO:0043309,1,0.983313549606182,0,3,regulation of eosinophil degranulation,BP,
11158,GO:0043310,1,0.993916002159667,0,1,negative regulation of eosinophil degranulation,BP,
11159,GO:0043311,1,0.989333295395267,0,2,positive regulation of eosinophil degranulation,BP,
11161,GO:0043313,1,0.942126082059912,0,8,regulation of neutrophil degranulation,BP,
11162,GO:0043314,1,0.982123378568389,0,2,negative regulation of neutrophil degranulation,BP,
11163,GO:0043315,1,0.97239601102779,0,4,positive regulation of neutrophil degranulation,BP,
11164,GO:0043316,1,0.982013426226013,0,3,cytotoxic T cell degranulation,BP,
11165,GO:0043317,1,0.988499460974755,0,2,regulation of cytotoxic T cell degranulation,BP,
11166,GO:0043318,1,0.988499460974755,0,2,negative regulation of cytotoxic T cell degranulation,BP,
11167,GO:0043320,1,0.962288317743027,0,6,natural killer cell degranulation,BP,
11168,GO:0043321,1,0.980414984008956,0,3,regulation of natural killer cell degranulation,BP,
11169,GO:0043322,1,0.99612869348273,0,1,negative regulation of natural killer cell degranulation,BP,
11170,GO:0043323,1,0.980414984008956,0,3,positive regulation of natural killer cell degranulation,BP,
11171,GO:0043324,1,0.988543175008776,0,2,pigment metabolic process involved in developmental pigmentation,BP,
11172,GO:0043325,1,0.82657075762794,0,24,phosphatidylinositol-3,4-bisphosphate binding,MF,
11173,GO:0043328,1,0.975008723461339,0,5,protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,
11174,GO:0043330,1,0.842040382484678,0,26,response to exogenous dsRNA,BP,
11175,GO:0043331,1,0.804468598616778,0,33,response to dsRNA,BP,
11176,GO:0043333,1,0.995773270779577,0,1,2-octaprenyl-6-methoxy-1,4-benzoquinone methylase activity,MF,
11177,GO:0043335,1,0.983985797858277,0,3,protein unfolding,BP,
11178,GO:0043337,1,0.992705087473751,0,1,CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity,MF,
11179,GO:0043353,1,0.944970442433743,0,8,enucleate erythrocyte differentiation,BP,
11180,GO:0043354,1,0.991828016275873,0,1,enucleate erythrocyte maturation,BP,
11181,GO:0043366,1,0.982053027525877,0,3,beta selection,BP,
11182,GO:0043367,1,0.623814423104516,0,70,CD4-positive, alpha-beta T cell differentiation,BP,
11183,GO:0043368,1,0.803529178116062,0,33,positive T cell selection,BP,
11184,GO:0043369,1,0.873607857470122,0,20,CD4-positive or CD8-positive, alpha-beta T cell lineage commitment,BP,
11185,GO:0043370,1,0.760090190320291,0,42,regulation of CD4-positive, alpha-beta T cell differentiation,BP,
11186,GO:0043371,1,0.87208849990291,0,19,negative regulation of CD4-positive, alpha-beta T cell differentiation,BP,
11187,GO:0043372,1,0.857475969529227,0,26,positive regulation of CD4-positive, alpha-beta T cell differentiation,BP,
11188,GO:0043373,1,0.893867777720754,0,17,CD4-positive, alpha-beta T cell lineage commitment,BP,
11189,GO:0043374,1,0.910066890515051,0,14,CD8-positive, alpha-beta T cell differentiation,BP,
11190,GO:0043375,1,0.985290570818691,0,2,CD8-positive, alpha-beta T cell lineage commitment,BP,
11191,GO:0043376,1,0.959042813326818,0,6,regulation of CD8-positive, alpha-beta T cell differentiation,BP,
11192,GO:0043377,1,0.989049961252552,0,2,negative regulation of CD8-positive, alpha-beta T cell differentiation,BP,
11193,GO:0043378,1,0.969663924777805,0,4,positive regulation of CD8-positive, alpha-beta T cell differentiation,BP,
11194,GO:0043379,1,0.946247736682461,0,8,memory T cell differentiation,BP,
11195,GO:0043380,1,0.956945264138582,0,7,regulation of memory T cell differentiation,BP,
11196,GO:0043381,1,0.992479366854662,0,1,negative regulation of memory T cell differentiation,BP,
11197,GO:0043382,1,0.971168988771319,0,5,positive regulation of memory T cell differentiation,BP,
11198,GO:0043383,1,0.924786973085364,0,12,negative T cell selection,BP,
11199,GO:0043385,1,0.989744192529501,0,2,mycotoxin metabolic process,BP,
11200,GO:0043387,1,0.989744192529501,0,2,mycotoxin catabolic process,BP,
11201,GO:0043388,1,0.702746816748223,0,54,positive regulation of DNA binding,BP,
11202,GO:0043392,1,0.726520279456346,0,50,negative regulation of DNA binding,BP,
11203,GO:0043393,1,0.264640597935182,0,194,regulation of protein binding,BP,
11204,GO:0043394,1,0.773312847392699,0,33,proteoglycan binding,MF,
11205,GO:0043395,1,0.889828044539058,0,15,heparan sulfate proteoglycan binding,MF,
11206,GO:0043396,1,0.985219738256224,0,2,corticotropin-releasing hormone secretion,BP,
11207,GO:0043397,1,0.985219738256224,0,2,regulation of corticotropin-releasing hormone secretion,BP,
11208,GO:0043398,1,0.976905078159246,0,4,HLH domain binding,MF,
11209,GO:0043400,1,0.974415827819183,0,5,cortisol secretion,BP,
11210,GO:0043401,1,0.396719331509306,0,128,steroid hormone mediated signaling pathway,BP,
11211,GO:0043402,1,0.969512218388078,0,3,glucocorticoid mediated signaling pathway,BP,
11212,GO:0043403,1,0.810472092149459,0,34,skeletal muscle tissue regeneration,BP,
11213,GO:0043404,1,0.989280054341,0,2,corticotropin-releasing hormone receptor activity,MF,
11215,GO:0043406,1,0.186778840779902,0,244,positive regulation of MAP kinase activity,BP,
11219,GO:0043410,1,0.0394777929555098,0,479,positive regulation of MAPK cascade,BP,
11222,GO:0043414,1,0.162118941005407,0,261,macromolecule methylation,BP,
11223,GO:0043415,1,0.969633022883912,0,5,positive regulation of skeletal muscle tissue regeneration,BP,
11224,GO:0043416,1,0.965486517702831,0,6,regulation of skeletal muscle tissue regeneration,BP,
11225,GO:0043417,1,0.995724952691867,0,1,negative regulation of skeletal muscle tissue regeneration,BP,
11226,GO:0043418,1,0.980879280244393,0,3,homocysteine catabolic process,BP,
11227,GO:0043420,1,0.983953387915273,0,3,anthranilate metabolic process,BP,
11228,GO:0043422,1,0.926845773747521,0,11,protein kinase B binding,MF,
11229,GO:0043423,1,0.992427812363247,0,1,3-phosphoinositide-dependent protein kinase binding,MF,
11230,GO:0043425,1,0.83035091074127,0,26,bHLH transcription factor binding,MF,
11231,GO:0043426,1,0.960159607267991,0,5,MRF binding,MF,
11232,GO:0043430,1,0.995773270779577,0,1,2-decaprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity,MF,
11233,GO:0043433,1,0.367847855959484,0,152,negative regulation of DNA-binding transcription factor activity,BP,
11235,GO:0043435,1,0.967937191918104,0,5,response to corticotropin-releasing hormone,BP,
11237,GO:0043438,1,0.993342513253874,0,1,acetoacetic acid metabolic process,BP,
11238,GO:0043449,1,0.986247923579919,0,2,cellular alkene metabolic process,BP,
11239,GO:0043455,1,0.923473970761834,0,10,regulation of secondary metabolic process,BP,
11240,GO:0043456,1,0.989204192992547,0,2,regulation of pentose-phosphate shunt,BP,
11241,GO:0043457,1,0.852202646948452,0,25,regulation of cellular respiration,BP,
11242,GO:0043461,1,0.978571480241212,0,4,proton-transporting ATP synthase complex assembly,BP,
11244,GO:0043465,1,0.986422572574789,0,2,regulation of fermentation,BP,
11245,GO:0043467,1,0.381399476288675,0,137,regulation of generation of precursor metabolites and energy,BP,
11246,GO:0043470,1,0.555930898359025,0,80,regulation of carbohydrate catabolic process,BP,
11247,GO:0043471,1,0.942230984671146,0,9,regulation of cellular carbohydrate catabolic process,BP,
11248,GO:0043473,1,0.516939990783777,0,94,pigmentation,BP,
11249,GO:0043474,1,0.988543175008776,0,2,pigment metabolic process involved in pigmentation,BP,
11250,GO:0043476,1,0.918221919804516,0,12,pigment accumulation,BP,
11251,GO:0043482,1,0.918221919804516,0,12,cellular pigment accumulation,BP,
11252,GO:0043484,1,0.364660599859391,0,145,regulation of RNA splicing,BP,
11253,GO:0043485,1,0.939983027753895,0,10,endosome to pigment granule transport,BP,
11254,GO:0043486,1,0.791849802841409,0,38,histone exchange,BP,
11255,GO:0043487,1,0.325822691112677,0,175,regulation of RNA stability,BP,
11256,GO:0043488,1,0.344439623780733,0,167,regulation of mRNA stability,BP,
11257,GO:0043489,1,0.734182976372878,0,44,RNA stabilization,BP,
11258,GO:0043490,1,0.974086122472654,0,4,malate-aspartate shuttle,BP,
11259,GO:0043491,1,0.208462352884828,0,227,protein kinase B signaling,BP,
11260,GO:0043495,1,0.884798504266044,0,18,protein-membrane adaptor activity,MF,
11261,GO:0043496,1,0.990997208401528,0,1,regulation of protein homodimerization activity,BP,
11263,GO:0043501,1,0.864723822214476,0,22,skeletal muscle adaptation,BP,
11265,GO:0043503,1,0.98068544010069,0,4,skeletal muscle fiber adaptation,BP,
11266,GO:0043504,1,0.959326501400979,0,6,mitochondrial DNA repair,BP,
11268,GO:0043507,1,0.605385562163854,0,68,positive regulation of JUN kinase activity,BP,
11270,GO:0043509,1,0.994537542124391,0,1,activin A complex,CC,
11271,GO:0043511,1,0.990479073452283,0,2,inhibin complex,CC,
11272,GO:0043512,1,0.990479073452283,0,2,inhibin A complex,CC,
11273,GO:0043513,1,0.995919463972863,0,1,inhibin B complex,CC,
11274,GO:0043514,1,0.995890670052125,0,1,interleukin-12 complex,CC,
11275,GO:0043515,1,0.955222065923514,0,6,kinetochore binding,MF,
11276,GO:0043516,1,0.822061536344341,0,31,regulation of DNA damage response, signal transduction by p53 class mediator,BP,
11277,GO:0043517,1,0.904993700495854,0,15,positive regulation of DNA damage response, signal transduction by p53 class mediator,BP,
11278,GO:0043518,1,0.92474902592054,0,13,negative regulation of DNA damage response, signal transduction by p53 class mediator,BP,
11279,GO:0043519,1,0.994661836853827,0,1,regulation of myosin II filament organization,BP,
11280,GO:0043522,1,0.955391127918893,0,8,leucine zipper domain binding,MF,
11284,GO:0043527,1,0.974145522965904,0,5,tRNA methyltransferase complex,CC,
11285,GO:0043531,1,0.783882027216998,0,33,ADP binding,MF,
11286,GO:0043532,1,0.990436297937554,0,1,angiostatin binding,MF,
11287,GO:0043533,1,0.958768225539719,0,5,inositol 1,3,4,5 tetrakisphosphate binding,MF,
11288,GO:0043534,1,0.46535502866329,0,109,blood vessel endothelial cell migration,BP,
11289,GO:0043535,1,0.555890341602801,0,84,regulation of blood vessel endothelial cell migration,BP,
11290,GO:0043536,1,0.707185104049982,0,50,positive regulation of blood vessel endothelial cell migration,BP,
11291,GO:0043537,1,0.799347744775304,0,32,negative regulation of blood vessel endothelial cell migration,BP,
11292,GO:0043538,1,0.993160020384076,0,1,regulation of actin phosphorylation,BP,
11293,GO:0043539,1,0.792287556806628,0,37,protein serine/threonine kinase activator activity,MF,
11294,GO:0043540,1,0.995369011896799,0,1,6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex,CC,
11295,GO:0043541,1,0.989224780389616,0,2,UDP-N-acetylglucosamine transferase complex,CC,
11296,GO:0043542,1,0.26355667851268,0,192,endothelial cell migration,BP,
11297,GO:0043543,1,0.206315610513194,0,229,protein acylation,BP,
11298,GO:0043544,1,0.992799951621767,0,1,lipoamide binding,MF,
11299,GO:0043545,1,0.963161630110255,0,6,molybdopterin cofactor metabolic process,BP,
11300,GO:0043546,1,0.970324944687376,0,4,molybdopterin cofactor binding,MF,
11301,GO:0043547,1,0.0658778047189703,0,365,positive regulation of GTPase activity,BP,
11302,GO:0043548,1,0.801658552339621,0,28,phosphatidylinositol 3-kinase binding,MF,
11305,GO:0043551,1,0.698815731202762,0,51,regulation of phosphatidylinositol 3-kinase activity,BP,
11306,GO:0043552,1,0.793532668315918,0,33,positive regulation of phosphatidylinositol 3-kinase activity,BP,
11307,GO:0043553,1,0.986422469205805,0,2,negative regulation of phosphatidylinositol 3-kinase activity,BP,
11308,GO:0043555,1,0.87162524080685,0,20,regulation of translation in response to stress,BP,
11309,GO:0043558,1,0.912502933838768,0,14,regulation of translational initiation in response to stress,BP,
11310,GO:0043559,1,0.946623833956046,0,6,insulin binding,MF,
11311,GO:0043560,1,0.918447568982475,0,10,insulin receptor substrate binding,MF,
11312,GO:0043562,1,0.9466537926883,0,11,cellular response to nitrogen levels,BP,
11313,GO:0043564,1,0.987506943167374,0,2,Ku70:Ku80 complex,CC,
11316,GO:0043568,1,0.935845959849563,0,9,positive regulation of insulin-like growth factor receptor signaling pathway,BP,
11317,GO:0043569,1,0.959081504502494,0,6,negative regulation of insulin-like growth factor receptor signaling pathway,BP,
11318,GO:0043570,1,0.957723553207313,0,6,maintenance of DNA repeat elements,BP,
11319,GO:0043574,1,0.649693134632036,0,72,peroxisomal transport,BP,
11320,GO:0043576,1,0.855738539622804,0,22,regulation of respiratory gaseous exchange,BP,
11321,GO:0043578,1,0.966994029650274,0,3,nuclear matrix organization,BP,
11323,GO:0043584,1,0.893560603374943,0,15,nose development,BP,
11324,GO:0043585,1,0.974109936595486,0,3,nose morphogenesis,BP,
11325,GO:0043586,1,0.852917209290557,0,22,tongue development,BP,
11326,GO:0043587,1,0.933265200016094,0,10,tongue morphogenesis,BP,
11327,GO:0043588,1,0.164964338472116,0,257,skin development,BP,
11328,GO:0043589,1,0.920541755683043,0,10,skin morphogenesis,BP,
11329,GO:0043596,1,0.774734344124004,0,40,nuclear replication fork,CC,
11330,GO:0043601,1,0.86765087458259,0,23,nuclear replisome,CC,
11331,GO:0043602,1,0.99390014550595,0,1,nitrate catabolic process,BP,
11334,GO:0043605,1,0.985887634713985,0,3,cellular amide catabolic process,BP,
11335,GO:0043606,1,0.975869498680549,0,4,formamide metabolic process,BP,
11336,GO:0043610,1,0.988705528950714,0,1,regulation of carbohydrate utilization,BP,
11337,GO:0043614,1,0.98428119841678,0,2,multi-eIF complex,CC,
11338,GO:0043615,1,0.960228118137303,0,7,astrocyte cell migration,BP,
11339,GO:0043616,1,0.755347475229705,0,38,keratinocyte proliferation,BP,
11341,GO:0043619,1,0.927359547029246,0,11,regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,
11343,GO:0043621,1,0.67224529896481,0,53,protein self-association,MF,
11344,GO:0043622,1,0.96984563514982,0,4,cortical microtubule organization,BP,
11346,GO:0043625,1,0.977972015755011,0,4,delta DNA polymerase complex,CC,
11347,GO:0043626,1,0.996048702633857,0,1,PCNA complex,CC,
11349,GO:0043628,1,0.813237664992702,0,36,ncRNA 3'-end processing,BP,
11350,GO:0043631,1,0.748580852892667,0,42,RNA polyadenylation,BP,
11352,GO:0043633,1,0.964909886870161,0,7,polyadenylation-dependent RNA catabolic process,BP,
11353,GO:0043634,1,0.972438046742623,0,6,polyadenylation-dependent ncRNA catabolic process,BP,
11354,GO:0043647,1,0.634322850628549,0,64,inositol phosphate metabolic process,BP,
11356,GO:0043649,1,0.908171416240011,0,17,dicarboxylic acid catabolic process,BP,
11357,GO:0043650,1,0.922962913528911,0,13,dicarboxylic acid biosynthetic process,BP,
11358,GO:0043651,1,0.896758773589825,0,18,linoleic acid metabolic process,BP,
11359,GO:0043652,1,0.897794737774812,0,16,engulfment of apoptotic cell,BP,
11360,GO:0043653,1,0.946646582368451,0,9,mitochondrial fragmentation involved in apoptotic process,BP,
11361,GO:0043654,1,0.961308788199027,0,6,recognition of apoptotic cell,BP,
11366,GO:0043682,1,0.979809998515861,0,2,copper transmembrane transporter activity, phosphorylative mechanism,MF,
11367,GO:0043686,1,0.98376009674401,0,3,co-translational protein modification,BP,
11369,GO:0043691,1,0.920432366946487,0,14,reverse cholesterol transport,BP,
11370,GO:0043696,1,0.942958368312799,0,8,dedifferentiation,BP,
11371,GO:0043697,1,0.942958368312799,0,8,cell dedifferentiation,BP,
11372,GO:0043715,1,0.994847526454866,0,1,2,3-diketo-5-methylthiopentyl-1-phosphate enolase activity,MF,
11373,GO:0043716,1,0.994847526454866,0,1,2-hydroxy-3-keto-5-methylthiopentenyl-1-phosphate phosphatase activity,MF,
11374,GO:0043727,1,0.992930320419855,0,1,5-amino-4-imidazole carboxylate lyase activity,MF,
11375,GO:0043733,1,0.996417301251183,0,1,DNA-3-methylbase glycosylase activity,MF,
11376,GO:0043734,1,0.984810961705503,0,3,DNA-N1-methyladenine dioxygenase activity,MF,
11377,GO:0043739,1,0.992994082977645,0,1,G/U mismatch-specific uracil-DNA glycosylase activity,MF,
11378,GO:0043754,1,0.987069903885068,0,1,dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity,MF,
11379,GO:0043783,1,0.994183440541481,0,1,oxidoreductase activity, oxidizing metal ions with flavin as acceptor,MF,
11380,GO:0043795,1,0.995946459027794,0,1,glyceraldehyde oxidoreductase activity,MF,
11381,GO:0043812,1,0.969379238898846,0,4,phosphatidylinositol-4-phosphate phosphatase activity,MF,
11382,GO:0043813,1,0.984245955279566,0,2,phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity,MF,
11383,GO:0043843,1,0.993813629352555,0,1,ADP-specific glucokinase activity,MF,
11384,GO:0043849,1,0.993294673187093,0,1,Ras palmitoyltransferase activity,MF,
11385,GO:0043855,1,0.936776976075879,0,9,cyclic nucleotide-gated ion channel activity,MF,
11386,GO:0043865,1,0.993470039179441,0,1,methionine transmembrane transporter activity,MF,
11387,GO:0043874,1,0.994847526454866,0,1,acireductone synthase activity,MF,
11388,GO:0043878,1,0.967144700705604,0,5,glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity,MF,
11389,GO:0043890,1,0.994151434173441,0,1,N-acetylgalactosamine-6-sulfatase activity,MF,
11390,GO:0043891,1,0.99608471895368,0,1,glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity,MF,
11392,GO:0043901,1,0.899006776817911,0,19,negative regulation of multi-organism process,BP,
11393,GO:0043902,1,0.794326991840233,0,34,positive regulation of multi-organism process,BP,
11395,GO:0043914,1,0.992651147972279,0,1,NADPH:sulfur oxidoreductase activity,MF,
11396,GO:0043915,1,0.995436291292378,0,1,L-seryl-tRNA(Sec) kinase activity,MF,
11397,GO:0043916,1,0.996417301251183,0,1,DNA-7-methylguanine glycosylase activity,MF,
11398,GO:0043921,1,0.986365094853187,0,2,modulation by host of viral transcription,BP,
11399,GO:0043922,1,0.929028833020564,0,11,negative regulation by host of viral transcription,BP,
11400,GO:0043923,1,0.885944083407666,0,17,positive regulation by host of viral transcription,BP,
11401,GO:0043924,1,0.983024810604684,0,1,suramin binding,MF,
11402,GO:0043928,1,0.833690085780224,0,32,exonucleolytic catabolism of deadenylated mRNA,BP,
11403,GO:0043931,1,0.863888490647096,0,16,ossification involved in bone maturation,BP,
11404,GO:0043932,1,0.973870275063785,0,5,ossification involved in bone remodeling,BP,
11406,GO:0043946,1,0.995360753171828,0,1,positive regulation of catalytic activity in other organism involved in symbiotic interaction,BP,
11407,GO:0043947,1,0.995360753171828,0,1,positive regulation by host of symbiont catalytic activity,BP,
11412,GO:0043966,1,0.682299598544055,0,56,histone H3 acetylation,BP,
11413,GO:0043967,1,0.619571624697155,0,69,histone H4 acetylation,BP,
11414,GO:0043968,1,0.901022412388117,0,16,histone H2A acetylation,BP,
11415,GO:0043969,1,0.975203733538444,0,3,histone H2B acetylation,BP,
11416,GO:0043970,1,0.911873552344757,0,13,histone H3-K9 acetylation,BP,
11417,GO:0043972,1,0.963287156975556,0,5,histone H3-K23 acetylation,BP,
11418,GO:0043973,1,0.994471750935033,0,1,histone H3-K4 acetylation,BP,
11419,GO:0043974,1,0.983195600069569,0,2,histone H3-K27 acetylation,BP,
11420,GO:0043977,1,0.993244115038388,0,1,histone H2A-K5 acetylation,BP,
11421,GO:0043979,1,0.993062381892642,0,1,histone H2B-K5 acetylation,BP,
11422,GO:0043980,1,0.993244115038388,0,1,histone H2B-K12 acetylation,BP,
11423,GO:0043981,1,0.897036804572664,0,16,histone H4-K5 acetylation,BP,
11424,GO:0043982,1,0.897036804572664,0,16,histone H4-K8 acetylation,BP,
11425,GO:0043983,1,0.958254681666484,0,7,histone H4-K12 acetylation,BP,
11426,GO:0043984,1,0.865690972820515,0,20,histone H4-K16 acetylation,BP,
11427,GO:0043985,1,0.964250644279219,0,6,histone H4-R3 methylation,BP,
11428,GO:0043987,1,0.969601714623482,0,5,histone H3-S10 phosphorylation,BP,
11429,GO:0043988,1,0.982490209130809,0,3,histone H3-S28 phosphorylation,BP,
11430,GO:0043990,1,0.993115838803639,0,1,histone H2A-S1 phosphorylation,BP,
11431,GO:0043994,1,0.963287156975556,0,5,histone acetyltransferase activity (H3-K23 specific),MF,
11432,GO:0043995,1,0.94003360977782,0,9,histone acetyltransferase activity (H4-K5 specific),MF,
11433,GO:0043996,1,0.94003360977782,0,9,histone acetyltransferase activity (H4-K8 specific),MF,
11434,GO:0043997,1,0.993089765470706,0,1,histone acetyltransferase activity (H4-K12 specific),MF,
11435,GO:0043998,1,0.992934687050292,0,1,H2A histone acetyltransferase activity,MF,
11436,GO:0044003,1,0.777832293616632,0,36,modulation by symbiont of host process,BP,
11437,GO:0044010,1,0.994149557619953,0,1,single-species biofilm formation,BP,
11438,GO:0044020,1,0.977892085063378,0,4,histone methyltransferase activity (H4-R3 specific),MF,
11439,GO:0044026,1,0.983252616941335,0,3,DNA hypermethylation,BP,
11440,GO:0044027,1,0.990472992124513,0,2,hypermethylation of CpG island,BP,
11441,GO:0044028,1,0.985851110010446,0,2,DNA hypomethylation,BP,
11442,GO:0044029,1,0.985851110010446,0,2,hypomethylation of CpG island,BP,
11443,GO:0044030,1,0.876740940870613,0,19,regulation of DNA methylation,BP,
11444,GO:0044033,1,0.995556216350364,0,1,multi-organism metabolic process,BP,
11445,GO:0044035,1,0.995556216350364,0,1,multi-organism catabolic process,BP,
11446,GO:0044036,1,0.991873648311604,0,2,cell wall macromolecule metabolic process,BP,
11447,GO:0044038,1,0.995309928040927,0,1,cell wall macromolecule biosynthetic process,BP,
11448,GO:0044042,1,0.616066426129562,0,65,glucan metabolic process,BP,
11449,GO:0044053,1,0.994068639898304,0,1,translocation of peptides or proteins into host cell cytoplasm,BP,
11451,GO:0044058,1,0.832181913629242,0,32,regulation of digestive system process,BP,
11452,GO:0044060,1,0.782909946419614,0,40,regulation of endocrine process,BP,
11453,GO:0044062,1,0.881219040483054,0,21,regulation of excretion,BP,
11454,GO:0044065,1,0.904299766755495,0,15,regulation of respiratory system process,BP,
11455,GO:0044068,1,0.844424535443299,0,25,modulation by symbiont of host cellular process,BP,
11459,GO:0044088,1,0.748081335604525,0,44,regulation of vacuole organization,BP,
11461,GO:0044090,1,0.929734717456471,0,10,positive regulation of vacuole organization,BP,
11462,GO:0044091,1,0.739257875393762,0,42,membrane biogenesis,BP,
11465,GO:0044094,1,0.971829458415979,0,4,host cell nuclear part,CC,
11466,GO:0044105,1,0.996757951334235,0,1,L-xylulose reductase (NAD+) activity,MF,
11467,GO:0044106,1,0.517078614296089,0,120,cellular amine metabolic process,BP,
11468,GO:0044107,1,0.983905102473661,0,3,cellular alcohol metabolic process,BP,
11469,GO:0044108,1,0.983905102473661,0,3,cellular alcohol biosynthetic process,BP,
11470,GO:0044110,1,0.996602635136203,0,1,growth involved in symbiotic interaction,BP,
11471,GO:0044111,1,0.98632748730113,0,2,development involved in symbiotic interaction,BP,
11472,GO:0044115,1,0.995556216350364,0,1,development of symbiont involved in interaction with host,BP,
11473,GO:0044117,1,0.996602635136203,0,1,growth of symbiont in host,BP,
11474,GO:0044145,1,0.995556216350364,0,1,modulation of development of symbiont involved in interaction with host,BP,
11475,GO:0044147,1,0.995556216350364,0,1,negative regulation of development of symbiont involved in interaction with host,BP,
11476,GO:0044154,1,0.906261488887228,0,14,histone H3-K14 acetylation,BP,
11477,GO:0044183,1,0.871885680067265,0,25,protein folding chaperone,MF,
11478,GO:0044190,1,0.995348794548339,0,1,host cell mitochondrial envelope,CC,
11479,GO:0044194,1,0.97356419807472,0,5,cytolytic granule,CC,
11480,GO:0044205,1,0.978618500377257,0,3,'de novo' UMP biosynthetic process,BP,
11481,GO:0044206,1,0.975544891642433,0,5,UMP salvage,BP,
11482,GO:0044207,1,0.992533795121121,0,1,translation initiation ternary complex,CC,
11483,GO:0044208,1,0.995822625406812,0,1,'de novo' AMP biosynthetic process,BP,
11484,GO:0044209,1,0.991658210415003,0,2,AMP salvage,BP,
11485,GO:0044210,1,0.986174206605414,0,2,'de novo' CTP biosynthetic process,BP,
11486,GO:0044211,1,0.986055004115608,0,3,CTP salvage,BP,
11487,GO:0044214,1,0.912599722204653,0,11,spanning component of plasma membrane,CC,
11488,GO:0044216,1,0.985206900264422,0,2,other organism cell,CC,
11489,GO:0044217,1,0.985206900264422,0,2,other organism part,CC,
11490,GO:0044218,1,0.993590783302321,0,1,other organism cell membrane,CC,
11491,GO:0044220,1,0.992083792353045,0,1,host cell perinuclear region of cytoplasm,CC,
11492,GO:0044224,1,0.920010630014125,0,10,juxtaparanode region of axon,CC,
11493,GO:0044228,1,0.992162326979536,0,1,host cell surface,CC,
11494,GO:0044232,1,0.847127505728375,0,25,organelle membrane contact site,CC,
11495,GO:0044233,1,0.902232185218331,0,16,mitochondria-associated endoplasmic reticulum membrane,CC,
11498,GO:0044241,1,0.928590116338836,0,12,lipid digestion,BP,
11500,GO:0044245,1,0.980569080731055,0,3,polysaccharide digestion,BP,
11501,GO:0044247,1,0.840608029886417,0,23,cellular polysaccharide catabolic process,BP,
11506,GO:0044258,1,0.994115901968501,0,1,intestinal lipid catabolic process,BP,
11508,GO:0044262,1,0.16721450007697,0,251,cellular carbohydrate metabolic process,BP,
11509,GO:0044264,1,0.513829032733285,0,90,cellular polysaccharide metabolic process,BP,
11512,GO:0044270,1,0.0359113755960164,0,553,cellular nitrogen compound catabolic process,BP,
11515,GO:0044273,1,0.736355299609455,0,49,sulfur compound catabolic process,BP,
11516,GO:0044275,1,0.763182289307622,0,38,cellular carbohydrate catabolic process,BP,
11517,GO:0044278,1,0.996783487168374,0,1,cell wall disruption in other organism,BP,
11522,GO:0044292,1,0.919293688102435,0,12,dendrite terminus,CC,
11523,GO:0044294,1,0.939004885914537,0,8,dendritic growth cone,CC,
11524,GO:0044295,1,0.804223993801444,0,27,axonal growth cone,CC,
11528,GO:0044301,1,0.988168998305568,0,2,climbing fiber,CC,
11529,GO:0044302,1,0.957074271942753,0,5,dentate gyrus mossy fiber,CC,
11531,GO:0044305,1,0.843073510968091,0,23,calyx of Held,CC,
11533,GO:0044307,1,0.965079016266046,0,3,dendritic branch,CC,
11534,GO:0044308,1,0.973085202057938,0,3,axonal spine,CC,
11536,GO:0044313,1,0.972999340979854,0,3,protein K6-linked deubiquitination,BP,
11537,GO:0044314,1,0.981890403814466,0,4,protein K27-linked ubiquitination,BP,
11538,GO:0044316,1,0.986576376316065,0,2,cone cell pedicle,CC,
11539,GO:0044317,1,0.995995194795129,0,1,rod spherule,CC,
11540,GO:0044319,1,0.819926049843561,0,27,wound healing, spreading of cells,BP,
11541,GO:0044320,1,0.897002395680111,0,17,cellular response to leptin stimulus,BP,
11542,GO:0044321,1,0.859635809093666,0,22,response to leptin,BP,
11543,GO:0044322,1,0.85556929243592,0,22,endoplasmic reticulum quality control compartment,CC,
11544,GO:0044323,1,0.959726063749254,0,6,retinoic acid-responsive element binding,MF,
11545,GO:0044324,1,0.996658137651145,0,1,regulation of transcription involved in anterior/posterior axis specification,BP,
11547,GO:0044326,1,0.950742548030427,0,7,dendritic spine neck,CC,
11549,GO:0044331,1,0.831133487666196,0,25,cell-cell adhesion mediated by cadherin,BP,
11550,GO:0044332,1,0.992354350453992,0,1,Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
11551,GO:0044333,1,0.995111019972932,0,1,Wnt signaling pathway involved in digestive tract morphogenesis,BP,
11552,GO:0044334,1,0.985559059083791,0,2,canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition,BP,
11553,GO:0044335,1,0.987636363987363,0,1,canonical Wnt signaling pathway involved in neural crest cell differentiation,BP,
11554,GO:0044336,1,0.978689074289493,0,3,canonical Wnt signaling pathway involved in negative regulation of apoptotic process,BP,
11555,GO:0044338,1,0.988258774011041,0,2,canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation,BP,
11556,GO:0044339,1,0.980291044306604,0,3,canonical Wnt signaling pathway involved in osteoblast differentiation,BP,
11557,GO:0044340,1,0.962404649183228,0,5,canonical Wnt signaling pathway involved in regulation of cell proliferation,BP,
11558,GO:0044341,1,0.964088366952863,0,6,sodium-dependent phosphate transport,BP,
11560,GO:0044343,1,0.992354350453992,0,1,canonical Wnt signaling pathway involved in regulation of type B pancreatic cell proliferation,BP,
11562,GO:0044345,1,0.992354350453992,0,1,stromal-epithelial cell signaling involved in prostate gland development,BP,
11563,GO:0044346,1,0.869199320326689,0,20,fibroblast apoptotic process,BP,
11564,GO:0044349,1,0.995396421293157,0,1,DNA excision,BP,
11565,GO:0044351,1,0.938305079327575,0,9,macropinocytosis,BP,
11566,GO:0044352,1,0.956409040517765,0,6,pinosome,CC,
11567,GO:0044354,1,0.956409040517765,0,6,macropinosome,CC,
11568,GO:0044355,1,0.995881023407096,0,1,clearance of foreign intracellular DNA,BP,
11569,GO:0044357,1,0.99520850060548,0,1,regulation of rRNA stability,BP,
11570,GO:0044359,1,0.955311459918512,0,8,modulation of molecular function in other organism,BP,
11571,GO:0044362,1,0.968796681441182,0,6,negative regulation of molecular function in other organism,BP,
11572,GO:0044374,1,0.992734953978799,0,1,sequence-specific DNA binding, bending,MF,
11573,GO:0044375,1,0.988419075035252,0,3,regulation of peroxisome size,BP,
11574,GO:0044377,1,0.992734953978799,0,1,RNA polymerase II cis-regulatory region sequence-specific DNA binding, bending,MF,
11575,GO:0044378,1,0.986821598001287,0,2,non-sequence-specific DNA binding, bending,MF,
11576,GO:0044379,1,0.992592874275698,0,1,protein localization to actin cortical patch,BP,
11577,GO:0044380,1,0.643682830841682,0,56,protein localization to cytoskeleton,BP,
11578,GO:0044381,1,0.986127238108265,0,2,glucose import in response to insulin stimulus,BP,
11579,GO:0044387,1,0.949302821174517,0,8,negative regulation of protein kinase activity by regulation of protein phosphorylation,BP,
11580,GO:0044388,1,0.976568179492326,0,5,small protein activating enzyme binding,MF,
11582,GO:0044390,1,0.774937850370939,0,36,ubiquitin-like protein conjugating enzyme binding,MF,
11583,GO:0044391,1,0.497029155468204,0,177,ribosomal subunit,CC,
11584,GO:0044393,1,0.971406303685024,0,4,microspike,CC,
11586,GO:0044406,1,0.932102562083232,0,11,adhesion of symbiont to host,BP,
11587,GO:0044407,1,0.994149557619953,0,1,single-species biofilm formation in or on host organism,BP,
11588,GO:0044409,1,0.414669308494962,0,131,entry into host,BP,
11589,GO:0044417,1,0.949735094953703,0,9,translocation of molecules into host,BP,
11591,GO:0044458,1,0.883723805373048,0,20,motile cilium assembly,BP,
11592,GO:0044466,1,0.991904377222391,0,2,glutaryl-CoA hydrolase activity,MF,
11593,GO:0044467,1,0.974375084906367,0,3,glial cell-derived neurotrophic factor secretion,BP,
11594,GO:0044501,1,0.984809428851082,0,2,modulation of signal transduction in other organism,BP,
11595,GO:0044508,1,0.993085530611049,0,1,glucagon-like peptide 1 receptor activity,MF,
11596,GO:0044524,1,0.995364425768994,0,1,protein sulfhydration,BP,
11597,GO:0044528,1,0.954989503479307,0,7,regulation of mitochondrial mRNA stability,BP,
11598,GO:0044530,1,0.977161284315009,0,3,supraspliceosomal complex,CC,
11599,GO:0044531,1,0.965047427480656,0,6,modulation of programmed cell death in other organism,BP,
11600,GO:0044532,1,0.965047427480656,0,6,modulation of apoptotic process in other organism,BP,
11601,GO:0044533,1,0.99608471895368,0,1,positive regulation of apoptotic process in other organism,BP,
11602,GO:0044539,1,0.893767792699534,0,16,long-chain fatty acid import into cell,BP,
11603,GO:0044540,1,0.995364425768994,0,1,L-cystine L-cysteine-lyase (deaminating),MF,
11604,GO:0044545,1,0.954184455401568,0,7,NSL complex,CC,
11605,GO:0044546,1,0.9058302249597,0,14,NLRP3 inflammasome complex assembly,BP,
11607,GO:0044548,1,0.914849625246435,0,14,S100 protein binding,MF,
11608,GO:0044549,1,0.996908940589292,0,1,GTP cyclohydrolase binding,MF,
11609,GO:0044550,1,0.857519289810705,0,21,secondary metabolite biosynthetic process,BP,
11610,GO:0044557,1,0.956508060506797,0,7,relaxation of smooth muscle,BP,
11611,GO:0044565,1,0.989112356247209,0,2,dendritic cell proliferation,BP,
11612,GO:0044571,1,0.979947510620745,0,5,[2Fe-2S] cluster assembly,BP,
11613,GO:0044594,1,0.993599927191694,0,1,17-beta-hydroxysteroid dehydrogenase (NAD+) activity,MF,
11614,GO:0044595,1,0.996157227255456,0,1,decaprenyldihydroxybenzoate methyltransferase activity,MF,
11615,GO:0044596,1,0.996157227255456,0,1,3-demethylubiquinol-10 3-O-methyltransferase activity,MF,
11616,GO:0044597,1,0.961205028700096,0,9,daunorubicin metabolic process,BP,
11617,GO:0044598,1,0.961205028700096,0,9,doxorubicin metabolic process,BP,
11618,GO:0044599,1,0.993485400251684,0,1,AP-5 adaptor complex,CC,
11619,GO:0044601,1,0.995536036961095,0,1,protein denucleotidylation,BP,
11620,GO:0044602,1,0.995536036961095,0,1,protein deadenylylation,BP,
11621,GO:0044603,1,0.995536036961095,0,1,protein adenylylhydrolase activity,MF,
11622,GO:0044609,1,0.988126717551518,0,2,DBIRD complex,CC,
11623,GO:0044610,1,0.994353828774869,0,1,FMN transmembrane transporter activity,MF,
11624,GO:0044611,1,0.974815112288255,0,3,nuclear pore inner ring,CC,
11625,GO:0044613,1,0.956833851256486,0,8,nuclear pore central transport channel,CC,
11626,GO:0044614,1,0.973200307853912,0,3,nuclear pore cytoplasmic filaments,CC,
11627,GO:0044615,1,0.92171936018377,0,12,nuclear pore nuclear basket,CC,
11628,GO:0044620,1,0.99696671272875,0,1,ACP phosphopantetheine attachment site binding,MF,
11629,GO:0044648,1,0.953954564571604,0,6,histone H3-K4 dimethylation,BP,
11630,GO:0044650,1,0.943624035030834,0,9,adhesion of symbiont to host cell,BP,
11631,GO:0044651,1,0.996130200687623,0,1,adhesion of symbiont to host epithelial cell,BP,
11632,GO:0044657,1,0.994358929697471,0,2,pore formation in membrane of other organism during symbiotic interaction,BP,
11633,GO:0044665,1,0.823453971970757,0,28,MLL1/2 complex,CC,
11634,GO:0044666,1,0.927428128905028,0,11,MLL3/4 complex,CC,
11635,GO:0044691,1,0.959924920839295,0,5,tooth eruption,BP,
11638,GO:0044715,1,0.996243010288813,0,1,8-oxo-dGDP phosphatase activity,MF,
11639,GO:0044721,1,0.995016125422551,0,1,protein import into peroxisome matrix, substrate release,BP,
11640,GO:0044722,1,0.992673043224518,0,1,renal phosphate excretion,BP,
11641,GO:0044725,1,0.986942677191125,0,1,chromatin reprogramming in the zygote,BP,
11642,GO:0044727,1,0.986942677191125,0,1,DNA demethylation of male pronucleus,BP,
11643,GO:0044728,1,0.561516144375418,0,82,DNA methylation or demethylation,BP,
11644,GO:0044729,1,0.986332382887372,0,2,hemi-methylated DNA-binding,MF,
11645,GO:0044730,1,0.995556216350364,0,1,bone sialoprotein binding,MF,
11646,GO:0044736,1,0.98701281886265,0,2,acid-sensing ion channel activity,MF,
11647,GO:0044743,1,0.828571962565539,0,33,protein transmembrane import into intracellular organelle,BP,
11648,GO:0044752,1,0.980234489772724,0,3,response to human chorionic gonadotropin,BP,
11649,GO:0044753,1,0.981693886855739,0,2,amphisome,CC,
11650,GO:0044754,1,0.947006209509577,0,9,autolysosome,CC,
11651,GO:0044764,1,0.892215365058228,0,16,multi-organism cellular process,BP,
11652,GO:0044766,1,0.65677949826988,0,61,multi-organism transport,BP,
11653,GO:0044769,1,0.89626007355428,0,19,ATPase activity, coupled to transmembrane movement of ions, rotational mechanism,MF,
11655,GO:0044771,1,0.96245726869492,0,6,meiotic cell cycle phase transition,BP,
11657,GO:0044773,1,0.532325043050307,0,94,mitotic DNA damage checkpoint,BP,
11659,GO:0044778,1,0.994586799295997,0,1,meiotic DNA integrity checkpoint,BP,
11660,GO:0044779,1,0.993174963603365,0,1,meiotic spindle checkpoint,BP,
11662,GO:0044783,1,0.659383086682326,0,62,G1 DNA damage checkpoint,BP,
11664,GO:0044785,1,0.988288360444546,0,2,metaphase/anaphase transition of meiotic cell cycle,BP,
11665,GO:0044786,1,0.660592518271592,0,63,cell cycle DNA replication,BP,
11666,GO:0044788,1,0.850902704688501,0,25,modulation by host of viral process,BP,
11667,GO:0044789,1,0.969273662071522,0,4,modulation by host of viral release from host cell,BP,
11668,GO:0044791,1,0.969273662071522,0,4,positive regulation by host of viral release from host cell,BP,
11669,GO:0044793,1,0.942797519084289,0,9,negative regulation by host of viral process,BP,
11670,GO:0044794,1,0.905309794045312,0,14,positive regulation by host of viral process,BP,
11671,GO:0044795,1,0.99631828618908,0,1,trans-Golgi network to recycling endosome transport,BP,
11672,GO:0044796,1,0.996048702633857,0,1,DNA polymerase processivity factor complex,CC,
11673,GO:0044800,1,0.958175572611546,0,7,multi-organism membrane fusion,BP,
11674,GO:0044803,1,0.936099914643784,0,10,multi-organism membrane organization,BP,
11675,GO:0044804,1,0.90100965101215,0,14,autophagy of nucleus,BP,
11676,GO:0044805,1,0.955325993832822,0,5,late nucleophagy,BP,
11677,GO:0044806,1,0.947595730768147,0,7,G-quadruplex DNA unwinding,BP,
11680,GO:0044819,1,0.659784651126041,0,62,mitotic G1/S transition checkpoint,BP,
11681,GO:0044821,1,0.987999883516934,0,2,meiotic telomere tethering at nuclear periphery,BP,
11682,GO:0044827,1,0.90656743775857,0,15,modulation by host of viral genome replication,BP,
11683,GO:0044828,1,0.966294011785772,0,5,negative regulation by host of viral genome replication,BP,
11684,GO:0044829,1,0.949899056484555,0,7,positive regulation by host of viral genome replication,BP,
11685,GO:0044830,1,0.981048837176229,0,3,modulation by host of viral RNA genome replication,BP,
11686,GO:0044837,1,0.951994166526738,0,7,actomyosin contractile ring organization,BP,
11689,GO:0044848,1,0.92576778856549,0,11,biological phase,BP,
11690,GO:0044849,1,0.908747820517103,0,15,estrous cycle,BP,
11691,GO:0044851,1,0.940219714894096,0,9,hair cycle phase,BP,
11692,GO:0044853,1,0.471956524543624,0,103,plasma membrane raft,CC,
11693,GO:0044854,1,0.972796195667116,0,5,plasma membrane raft assembly,BP,
11694,GO:0044855,1,0.985506870948593,0,2,plasma membrane raft distribution,BP,
11695,GO:0044856,1,0.985506870948593,0,2,plasma membrane raft localization,BP,
11696,GO:0044857,1,0.952918137017619,0,8,plasma membrane raft organization,BP,
11697,GO:0044858,1,0.993533411816083,0,1,plasma membrane raft polarization,BP,
11698,GO:0044860,1,0.973897247383732,0,4,protein localization to plasma membrane raft,BP,
11699,GO:0044861,1,0.986372222758281,0,2,protein transport into plasma membrane raft,BP,
11700,GO:0044866,1,0.995002487234698,0,1,modulation by host of viral exo-alpha-sialidase activity,BP,
11701,GO:0044867,1,0.995002487234698,0,1,modulation by host of viral catalytic activity,BP,
11702,GO:0044868,1,0.985729865407433,0,2,modulation by host of viral molecular function,BP,
11703,GO:0044869,1,0.995002487234698,0,1,negative regulation by host of viral exo-alpha-sialidase activity,BP,
11704,GO:0044870,1,0.995002487234698,0,1,modulation by host of viral glycoprotein metabolic process,BP,
11705,GO:0044871,1,0.995002487234698,0,1,negative regulation by host of viral glycoprotein metabolic process,BP,
11706,GO:0044872,1,0.893579109025902,0,12,lipoprotein localization,BP,
11707,GO:0044873,1,0.985718524314076,0,1,lipoprotein localization to membrane,BP,
11709,GO:0044878,1,0.980365723404536,0,4,mitotic cytokinesis checkpoint,BP,
11710,GO:0045002,1,0.962224684660262,0,6,double-strand break repair via single-strand annealing,BP,
11711,GO:0045003,1,0.944510812450291,0,9,double-strand break repair via synthesis-dependent strand annealing,BP,
11712,GO:0045004,1,0.982384264793498,0,2,DNA replication proofreading,BP,
11713,GO:0045005,1,0.751642020275007,0,40,DNA-dependent DNA replication maintenance of fidelity,BP,
11714,GO:0045006,1,0.940167067167333,0,13,DNA deamination,BP,
11715,GO:0045007,1,0.986696969853245,0,3,depurination,BP,
11716,GO:0045008,1,0.95931801784748,0,8,depyrimidination,BP,
11717,GO:0045009,1,0.930293597096598,0,13,chitosome,CC,
11718,GO:0045010,1,0.73545333662833,0,47,actin nucleation,BP,
11719,GO:0045016,1,0.992928461704654,0,1,mitochondrial magnesium ion transmembrane transport,BP,
11721,GO:0045019,1,0.910254561092147,0,14,negative regulation of nitric oxide biosynthetic process,BP,
11722,GO:0045022,1,0.769305785451839,0,37,early endosome to late endosome transport,BP,
11724,GO:0045025,1,0.986251419700675,0,2,mitochondrial degradosome,CC,
11726,GO:0045027,1,0.98758539488634,0,2,DNA end binding,MF,
11727,GO:0045028,1,0.932135356458548,0,13,G protein-coupled purinergic nucleotide receptor activity,MF,
11728,GO:0045029,1,0.989143830834807,0,2,G protein-coupled UDP receptor activity,MF,
11729,GO:0045030,1,0.990919725634656,0,2,G protein-coupled UTP receptor activity,MF,
11730,GO:0045031,1,0.988076307077036,0,2,G protein-coupled ATP receptor activity,MF,
11731,GO:0045039,1,0.971787922284789,0,7,protein insertion into mitochondrial inner membrane,BP,
11732,GO:0045040,1,0.974346362370881,0,5,protein insertion into mitochondrial outer membrane,BP,
11733,GO:0045041,1,0.984555893793466,0,3,protein import into mitochondrial intermembrane space,BP,
11734,GO:0045046,1,0.960896568549243,0,6,protein import into peroxisome membrane,BP,
11735,GO:0045047,1,0.64831240551192,0,107,protein targeting to ER,BP,
11736,GO:0045048,1,0.955659236341593,0,7,protein insertion into ER membrane,BP,
11737,GO:0045053,1,0.938316573090081,0,5,protein retention in Golgi apparatus,BP,
11738,GO:0045054,1,0.957539636105828,0,7,constitutive secretory pathway,BP,
11740,GO:0045056,1,0.862237799589335,0,19,transcytosis,BP,
11741,GO:0045058,1,0.733756620453428,0,46,T cell selection,BP,
11742,GO:0045059,1,0.925409068375334,0,13,positive thymic T cell selection,BP,
11743,GO:0045060,1,0.931613647417697,0,11,negative thymic T cell selection,BP,
11744,GO:0045061,1,0.872596494546011,0,21,thymic T cell selection,BP,
11745,GO:0045062,1,0.995429071245596,0,1,extrathymic T cell selection,BP,
11746,GO:0045063,1,0.881790683111358,0,19,T-helper 1 cell differentiation,BP,
11747,GO:0045064,1,0.920327841392119,0,14,T-helper 2 cell differentiation,BP,
11748,GO:0045065,1,0.981776589585021,0,3,cytotoxic T cell differentiation,BP,
11749,GO:0045066,1,0.823157252261206,0,30,regulatory T cell differentiation,BP,
11752,GO:0045071,1,0.729156970799918,0,52,negative regulation of viral genome replication,BP,
11754,GO:0045088,1,0.190388439887869,0,263,regulation of innate immune response,BP,
11755,GO:0045089,1,0.323276982944711,0,181,positive regulation of innate immune response,BP,
11757,GO:0045092,1,0.986504898253184,0,2,interleukin-18 receptor complex,CC,
11758,GO:0045095,1,0.881283810333258,0,22,keratin filament,CC,
11759,GO:0045098,1,0.984851080897422,0,3,type III intermediate filament,CC,
11762,GO:0045105,1,0.991480258096105,0,1,intermediate filament polymerization or depolymerization,BP,
11763,GO:0045106,1,0.991480258096105,0,1,intermediate filament depolymerization,BP,
11764,GO:0045108,1,0.991480258096105,0,1,regulation of intermediate filament polymerization or depolymerization,BP,
11768,GO:0045112,1,0.966637834407841,0,5,integrin biosynthetic process,BP,
11769,GO:0045113,1,0.977453748480184,0,4,regulation of integrin biosynthetic process,BP,
11770,GO:0045116,1,0.925331364914628,0,14,protein neddylation,BP,
11771,GO:0045117,1,0.931540847125877,0,11,azole transmembrane transport,BP,
11776,GO:0045125,1,0.919587112779572,0,15,bioactive lipid receptor activity,MF,
11777,GO:0045127,1,0.995660714447273,0,1,N-acetylglucosamine kinase activity,MF,
11778,GO:0045130,1,0.993560694886963,0,1,keratan sulfotransferase activity,MF,
11779,GO:0045131,1,0.9932239615194,0,1,pre-mRNA branch point binding,MF,
11781,GO:0045134,1,0.974667454920589,0,4,uridine-diphosphatase activity,MF,
11782,GO:0045136,1,0.948371682901678,0,8,development of secondary sexual characteristics,BP,
11784,GO:0045141,1,0.949454958878959,0,7,meiotic telomere clustering,BP,
11785,GO:0045142,1,0.984943193515473,0,2,triplex DNA binding,MF,
11786,GO:0045143,1,0.741066068824278,0,45,homologous chromosome segregation,BP,
11787,GO:0045144,1,0.948340504199476,0,9,meiotic sister chromatid segregation,BP,
11788,GO:0045145,1,0.976008666263211,0,4,single-stranded DNA 5'-3' exodeoxyribonuclease activity,MF,
11789,GO:0045153,1,0.996238621051559,0,1,electron transporter, transferring electrons within CoQH2-cytochrome c reductase complex activity,MF,
11790,GO:0045155,1,0.987795654859715,0,2,electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity,MF,
11791,GO:0045159,1,0.908885892937046,0,13,myosin II binding,MF,
11792,GO:0045161,1,0.905208750390165,0,12,neuronal ion channel clustering,BP,
11793,GO:0045162,1,0.941174900629841,0,7,clustering of voltage-gated sodium channels,BP,
11794,GO:0045163,1,0.971756665776835,0,3,clustering of voltage-gated potassium channels,BP,
11796,GO:0045167,1,0.995421838325247,0,1,asymmetric protein localization involved in cell fate determination,BP,
11797,GO:0045168,1,0.988846299020291,0,2,cell-cell signaling involved in cell fate commitment,BP,
11799,GO:0045174,1,0.992631497452783,0,2,glutathione dehydrogenase (ascorbate) activity,MF,
11800,GO:0045176,1,0.894906474479793,0,14,apical protein localization,BP,
11803,GO:0045179,1,0.951502987966968,0,8,apical cortex,CC,
11804,GO:0045180,1,0.954728177683938,0,5,basal cortex,CC,
11808,GO:0045185,1,0.527393509558856,0,92,maintenance of protein location,BP,
11809,GO:0045186,1,0.989773050928322,0,1,zonula adherens assembly,BP,
11810,GO:0045187,1,0.914175235752328,0,17,regulation of circadian sleep/wake cycle, sleep,BP,
11811,GO:0045188,1,0.957101061867599,0,8,regulation of circadian sleep/wake cycle, non-REM sleep,BP,
11812,GO:0045190,1,0.752461138214034,0,43,isotype switching,BP,
11813,GO:0045191,1,0.825142874351919,0,29,regulation of isotype switching,BP,
11814,GO:0045196,1,0.977428569535859,0,3,establishment or maintenance of neuroblast polarity,BP,
11815,GO:0045197,1,0.731048739754103,0,42,establishment or maintenance of epithelial cell apical/basal polarity,BP,
11816,GO:0045198,1,0.899685202054009,0,15,establishment of epithelial cell apical/basal polarity,BP,
11817,GO:0045199,1,0.932825718171913,0,11,maintenance of epithelial cell apical/basal polarity,BP,
11818,GO:0045200,1,0.977428569535859,0,3,establishment of neuroblast polarity,BP,
11820,GO:0045204,1,0.977211945812118,0,3,MAPK export from nucleus,BP,
11821,GO:0045208,1,0.992808961965524,0,1,MAPK phosphatase export from nucleus,BP,
11822,GO:0045209,1,0.992808961965524,0,1,MAPK phosphatase export from nucleus, leptomycin B sensitive,BP,
11823,GO:0045210,1,0.982810346593834,0,2,FasL biosynthetic process,BP,
11825,GO:0045212,1,0.993778976671205,0,1,neurotransmitter receptor biosynthetic process,BP,
11826,GO:0045213,1,0.983616270243729,0,3,neurotransmitter receptor metabolic process,BP,
11827,GO:0045214,1,0.734373496148767,0,42,sarcomere organization,BP,
11829,GO:0045217,1,0.920836456664759,0,12,cell-cell junction maintenance,BP,
11830,GO:0045218,1,0.978645391909677,0,3,zonula adherens maintenance,BP,
11831,GO:0045219,1,0.991572269753063,0,1,regulation of FasL production,BP,
11832,GO:0045221,1,0.991572269753063,0,1,negative regulation of FasL production,BP,
11833,GO:0045222,1,0.996315418666904,0,1,CD4 biosynthetic process,BP,
11834,GO:0045223,1,0.996315418666904,0,1,regulation of CD4 production,BP,
11835,GO:0045225,1,0.996315418666904,0,1,negative regulation of CD4 production,BP,
11836,GO:0045226,1,0.981400710266699,0,3,extracellular polysaccharide biosynthetic process,BP,
11837,GO:0045229,1,0.987115138105567,0,2,external encapsulating structure organization,BP,
11838,GO:0045234,1,0.995287566618931,0,1,protein palmitoleylation,BP,
11839,GO:0045236,1,0.926523115580994,0,16,CXCR chemokine receptor binding,MF,
11840,GO:0045237,1,0.992979387120577,0,1,CXCR1 chemokine receptor binding,MF,
11841,GO:0045239,1,0.914617179453051,0,14,tricarboxylic acid cycle enzyme complex,CC,
11842,GO:0045240,1,0.933295436986499,0,10,dihydrolipoyl dehydrogenase complex,CC,
11843,GO:0045244,1,0.994179664991472,0,1,succinate-CoA ligase complex (GDP-forming),CC,
11844,GO:0045252,1,0.961206827813318,0,6,oxoglutarate dehydrogenase complex,CC,
11845,GO:0045254,1,0.954963400311419,0,7,pyruvate dehydrogenase complex,CC,
11846,GO:0045257,1,0.98014761606796,0,4,succinate dehydrogenase complex (ubiquinone),CC,
11847,GO:0045259,1,0.994488416755265,0,1,proton-transporting ATP synthase complex,CC,
11848,GO:0045271,1,0.859390433798105,0,41,respiratory chain complex I,CC,
11849,GO:0045273,1,0.98014761606796,0,4,respiratory chain complex II,CC,
11850,GO:0045275,1,0.955384418711893,0,10,respiratory chain complex III,CC,
11851,GO:0045277,1,0.956058958532634,0,14,respiratory chain complex IV,CC,
11852,GO:0045281,1,0.98014761606796,0,4,succinate dehydrogenase complex,CC,
11853,GO:0045283,1,0.98014761606796,0,4,fumarate reductase complex,CC,
11854,GO:0045292,1,0.81760967167207,0,31,mRNA cis splicing, via spliceosome,BP,
11855,GO:0045293,1,0.961668212862613,0,6,mRNA editing complex,CC,
11856,GO:0045294,1,0.924809345614534,0,10,alpha-catenin binding,MF,
11857,GO:0045295,1,0.892809854770302,0,12,gamma-catenin binding,MF,
11859,GO:0045298,1,0.984226198965954,0,2,tubulin complex,CC,
11862,GO:0045322,1,0.941999629794063,0,8,unmethylated CpG binding,MF,
11863,GO:0045324,1,0.879641143127355,0,23,late endosome to vacuole transport,BP,
11864,GO:0045329,1,0.97042525025414,0,5,carnitine biosynthetic process,BP,
11865,GO:0045332,1,0.728162086261121,0,39,phospholipid translocation,BP,
11866,GO:0045333,1,0.435802870366147,0,161,cellular respiration,BP,
11867,GO:0045334,1,0.714034080324128,0,54,clathrin-coated endocytic vesicle,CC,
11868,GO:0045335,1,0.422983250424223,0,133,phagocytic vesicle,CC,
11869,GO:0045337,1,0.976382121967342,0,4,farnesyl diphosphate biosynthetic process,BP,
11870,GO:0045338,1,0.971168791080402,0,5,farnesyl diphosphate metabolic process,BP,
11871,GO:0045340,1,0.991996866966297,0,2,mercury ion binding,MF,
11872,GO:0045341,1,0.963146028951752,0,5,MHC class I biosynthetic process,BP,
11873,GO:0045342,1,0.915778534391129,0,14,MHC class II biosynthetic process,BP,
11874,GO:0045343,1,0.963146028951752,0,5,regulation of MHC class I biosynthetic process,BP,
11875,GO:0045344,1,0.994305540410032,0,1,negative regulation of MHC class I biosynthetic process,BP,
11876,GO:0045345,1,0.968663797053073,0,4,positive regulation of MHC class I biosynthetic process,BP,
11877,GO:0045346,1,0.922537365110533,0,13,regulation of MHC class II biosynthetic process,BP,
11878,GO:0045347,1,0.966784243292256,0,6,negative regulation of MHC class II biosynthetic process,BP,
11879,GO:0045348,1,0.950019762486725,0,8,positive regulation of MHC class II biosynthetic process,BP,
11880,GO:0045352,1,0.995295032329313,0,1,interleukin-1 type I receptor antagonist activity,MF,
11881,GO:0045353,1,0.995295032329313,0,1,interleukin-1 type II receptor antagonist activity,MF,
11882,GO:0045423,1,0.985482625936055,0,2,regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
11883,GO:0045425,1,0.985482625936055,0,2,positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
11884,GO:0045428,1,0.702881932156848,0,53,regulation of nitric oxide biosynthetic process,BP,
11885,GO:0045429,1,0.788951167385359,0,36,positive regulation of nitric oxide biosynthetic process,BP,
11887,GO:0045445,1,0.583878248824336,0,81,myoblast differentiation,BP,
11889,GO:0045448,1,0.975408134756125,0,4,mitotic cell cycle, embryonic,BP,
11891,GO:0045454,1,0.732293345581234,0,55,cell redox homeostasis,BP,
11893,GO:0045472,1,0.911459197427976,0,13,response to ether,BP,
11894,GO:0045475,1,0.89704973251957,0,13,locomotor rhythm,BP,
11895,GO:0045485,1,0.99238304595496,0,1,omega-6 fatty acid desaturase activity,MF,
11897,GO:0045495,1,0.87841929971955,0,18,pole plasm,CC,
11898,GO:0045499,1,0.80002611277112,0,28,chemorepellent activity,MF,
11899,GO:0045503,1,0.952838726290179,0,6,dynein light chain binding,MF,
11900,GO:0045504,1,0.935296695239471,0,10,dynein heavy chain binding,MF,
11901,GO:0045505,1,0.733811899145127,0,28,dynein intermediate chain binding,MF,
11902,GO:0045509,1,0.986061564489782,0,2,interleukin-27 receptor activity,MF,
11903,GO:0045513,1,0.995890670052125,0,1,interleukin-27 binding,MF,
11904,GO:0045515,1,0.996332591136268,0,1,interleukin-18 receptor binding,MF,
11905,GO:0045519,1,0.996480990173559,0,1,interleukin-23 receptor binding,MF,
11906,GO:0045523,1,0.99284494735489,0,2,interleukin-27 receptor binding,MF,
11907,GO:0045540,1,0.745223502264296,0,42,regulation of cholesterol biosynthetic process,BP,
11908,GO:0045541,1,0.973907194484427,0,5,negative regulation of cholesterol biosynthetic process,BP,
11909,GO:0045542,1,0.956925411123385,0,6,positive regulation of cholesterol biosynthetic process,BP,
11910,GO:0045545,1,0.948994132617867,0,7,syndecan binding,MF,
11911,GO:0045547,1,0.98512460860607,0,2,dehydrodolichyl diphosphate synthase activity,MF,
11912,GO:0045550,1,0.991854312057638,0,2,geranylgeranyl reductase activity,MF,
11913,GO:0045569,1,0.972372239321246,0,5,TRAIL binding,MF,
11914,GO:0045575,1,0.985615049688658,0,2,basophil activation,BP,
11916,GO:0045577,1,0.831983305420985,0,28,regulation of B cell differentiation,BP,
11917,GO:0045578,1,0.97195202783787,0,5,negative regulation of B cell differentiation,BP,
11918,GO:0045579,1,0.922018227664301,0,13,positive regulation of B cell differentiation,BP,
11919,GO:0045580,1,0.411951418755733,0,136,regulation of T cell differentiation,BP,
11920,GO:0045581,1,0.784398042984268,0,38,negative regulation of T cell differentiation,BP,
11921,GO:0045582,1,0.584021735557619,0,84,positive regulation of T cell differentiation,BP,
11922,GO:0045583,1,0.988330315963129,0,2,regulation of cytotoxic T cell differentiation,BP,
11923,GO:0045585,1,0.988330315963129,0,2,positive regulation of cytotoxic T cell differentiation,BP,
11924,GO:0045586,1,0.933697725594382,0,9,regulation of gamma-delta T cell differentiation,BP,
11925,GO:0045588,1,0.94707997292311,0,7,positive regulation of gamma-delta T cell differentiation,BP,
11926,GO:0045589,1,0.83958573849998,0,27,regulation of regulatory T cell differentiation,BP,
11927,GO:0045590,1,0.972552430304657,0,5,negative regulation of regulatory T cell differentiation,BP,
11928,GO:0045591,1,0.93681783100282,0,11,positive regulation of regulatory T cell differentiation,BP,
11933,GO:0045599,1,0.73906099398492,0,43,negative regulation of fat cell differentiation,BP,
11935,GO:0045601,1,0.78730208579392,0,33,regulation of endothelial cell differentiation,BP,
11936,GO:0045602,1,0.931811035471452,0,9,negative regulation of endothelial cell differentiation,BP,
11937,GO:0045603,1,0.894161622384355,0,16,positive regulation of endothelial cell differentiation,BP,
11938,GO:0045604,1,0.713068721370329,0,50,regulation of epidermal cell differentiation,BP,
11939,GO:0045605,1,0.939795204539353,0,10,negative regulation of epidermal cell differentiation,BP,
11940,GO:0045606,1,0.868730915756132,0,20,positive regulation of epidermal cell differentiation,BP,
11941,GO:0045607,1,0.953952498535401,0,7,regulation of inner ear auditory receptor cell differentiation,BP,
11942,GO:0045608,1,0.973424418626487,0,4,negative regulation of inner ear auditory receptor cell differentiation,BP,
11943,GO:0045616,1,0.794129411013086,0,32,regulation of keratinocyte differentiation,BP,
11944,GO:0045617,1,0.975276341587655,0,4,negative regulation of keratinocyte differentiation,BP,
11945,GO:0045618,1,0.901709591670276,0,14,positive regulation of keratinocyte differentiation,BP,
11946,GO:0045619,1,0.341944197124506,0,164,regulation of lymphocyte differentiation,BP,
11947,GO:0045620,1,0.755905234476145,0,45,negative regulation of lymphocyte differentiation,BP,
11948,GO:0045621,1,0.533481360185876,0,97,positive regulation of lymphocyte differentiation,BP,
11949,GO:0045622,1,0.81853000535122,0,31,regulation of T-helper cell differentiation,BP,
11950,GO:0045623,1,0.899194086289117,0,15,negative regulation of T-helper cell differentiation,BP,
11951,GO:0045624,1,0.893567514941327,0,19,positive regulation of T-helper cell differentiation,BP,
11952,GO:0045625,1,0.943325313444404,0,10,regulation of T-helper 1 cell differentiation,BP,
11953,GO:0045626,1,0.978687820875194,0,3,negative regulation of T-helper 1 cell differentiation,BP,
11954,GO:0045627,1,0.967284078730193,0,6,positive regulation of T-helper 1 cell differentiation,BP,
11955,GO:0045628,1,0.934376530523854,0,11,regulation of T-helper 2 cell differentiation,BP,
11956,GO:0045629,1,0.975675313404732,0,4,negative regulation of T-helper 2 cell differentiation,BP,
11957,GO:0045630,1,0.957681796288756,0,7,positive regulation of T-helper 2 cell differentiation,BP,
11958,GO:0045631,1,0.953952498535401,0,7,regulation of mechanoreceptor differentiation,BP,
11959,GO:0045632,1,0.973424418626487,0,4,negative regulation of mechanoreceptor differentiation,BP,
11960,GO:0045634,1,0.950536669418339,0,6,regulation of melanocyte differentiation,BP,
11961,GO:0045636,1,0.954717367562294,0,5,positive regulation of melanocyte differentiation,BP,
11962,GO:0045637,1,0.237138924047171,0,210,regulation of myeloid cell differentiation,BP,
11963,GO:0045638,1,0.612508432183315,0,74,negative regulation of myeloid cell differentiation,BP,
11964,GO:0045639,1,0.555481699338546,0,88,positive regulation of myeloid cell differentiation,BP,
11965,GO:0045643,1,0.992780976657409,0,1,regulation of eosinophil differentiation,BP,
11966,GO:0045645,1,0.992780976657409,0,1,positive regulation of eosinophil differentiation,BP,
11967,GO:0045646,1,0.721765165186929,0,47,regulation of erythrocyte differentiation,BP,
11968,GO:0045647,1,0.934221269338569,0,10,negative regulation of erythrocyte differentiation,BP,
11969,GO:0045648,1,0.803349965930889,0,31,positive regulation of erythrocyte differentiation,BP,
11970,GO:0045649,1,0.886063802842703,0,20,regulation of macrophage differentiation,BP,
11971,GO:0045650,1,0.967933197750049,0,6,negative regulation of macrophage differentiation,BP,
11972,GO:0045651,1,0.915444735973123,0,14,positive regulation of macrophage differentiation,BP,
11973,GO:0045652,1,0.69832928308316,0,52,regulation of megakaryocyte differentiation,BP,
11974,GO:0045653,1,0.98159138883755,0,4,negative regulation of megakaryocyte differentiation,BP,
11975,GO:0045654,1,0.949228897799934,0,9,positive regulation of megakaryocyte differentiation,BP,
11976,GO:0045655,1,0.881870465172987,0,19,regulation of monocyte differentiation,BP,
11977,GO:0045656,1,0.954226069191687,0,6,negative regulation of monocyte differentiation,BP,
11978,GO:0045657,1,0.935661076074409,0,11,positive regulation of monocyte differentiation,BP,
11979,GO:0045658,1,0.979879631730984,0,3,regulation of neutrophil differentiation,BP,
11980,GO:0045659,1,0.984912470484627,0,2,negative regulation of neutrophil differentiation,BP,
11981,GO:0045660,1,0.994890840079173,0,1,positive regulation of neutrophil differentiation,BP,
11982,GO:0045661,1,0.724810794084914,0,50,regulation of myoblast differentiation,BP,
11983,GO:0045662,1,0.864009271332198,0,25,negative regulation of myoblast differentiation,BP,
11984,GO:0045663,1,0.874823908703035,0,19,positive regulation of myoblast differentiation,BP,
11989,GO:0045668,1,0.755500389592316,0,41,negative regulation of osteoblast differentiation,BP,
11991,GO:0045670,1,0.683721586417875,0,55,regulation of osteoclast differentiation,BP,
11992,GO:0045671,1,0.828357434045295,0,26,negative regulation of osteoclast differentiation,BP,
11993,GO:0045672,1,0.874633250696297,0,20,positive regulation of osteoclast differentiation,BP,
11994,GO:0045682,1,0.618326873256501,0,72,regulation of epidermis development,BP,
11995,GO:0045683,1,0.911818169201016,0,14,negative regulation of epidermis development,BP,
11996,GO:0045684,1,0.808970188205735,0,33,positive regulation of epidermis development,BP,
11999,GO:0045687,1,0.765313463104559,0,42,positive regulation of glial cell differentiation,BP,
12000,GO:0045703,1,0.996216597465047,0,1,ketoreductase activity,MF,
12001,GO:0045713,1,0.940920471783195,0,9,low-density lipoprotein particle receptor biosynthetic process,BP,
12002,GO:0045714,1,0.945506575685643,0,8,regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
12003,GO:0045715,1,0.982364191911462,0,2,negative regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
12004,GO:0045716,1,0.978821890519636,0,4,positive regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
12005,GO:0045717,1,0.919096804112505,0,13,negative regulation of fatty acid biosynthetic process,BP,
12006,GO:0045719,1,0.960382784491012,0,5,negative regulation of glycogen biosynthetic process,BP,
12007,GO:0045720,1,0.988435307755659,0,2,negative regulation of integrin biosynthetic process,BP,
12008,GO:0045721,1,0.913643608429499,0,13,negative regulation of gluconeogenesis,BP,
12009,GO:0045722,1,0.913151371992923,0,12,positive regulation of gluconeogenesis,BP,
12010,GO:0045723,1,0.898570430001063,0,18,positive regulation of fatty acid biosynthetic process,BP,
12011,GO:0045724,1,0.862673321148845,0,19,positive regulation of cilium assembly,BP,
12012,GO:0045725,1,0.887263815369215,0,14,positive regulation of glycogen biosynthetic process,BP,
12013,GO:0045726,1,0.985011908034634,0,2,positive regulation of integrin biosynthetic process,BP,
12014,GO:0045727,1,0.452917769657644,0,124,positive regulation of translation,BP,
12015,GO:0045728,1,0.994561171467547,0,1,respiratory burst after phagocytosis,BP,
12016,GO:0045730,1,0.855550629067119,0,27,respiratory burst,BP,
12017,GO:0045732,1,0.231370373341995,0,211,positive regulation of protein catabolic process,BP,
12018,GO:0045736,1,0.825229298961749,0,29,negative regulation of cyclin-dependent protein serine/threonine kinase activity,BP,
12019,GO:0045737,1,0.828613708143653,0,29,positive regulation of cyclin-dependent protein serine/threonine kinase activity,BP,
12020,GO:0045738,1,0.814203287815387,0,28,negative regulation of DNA repair,BP,
12022,GO:0045740,1,0.76873868530105,0,39,positive regulation of DNA replication,BP,
12025,GO:0045743,1,0.957327966762907,0,6,positive regulation of fibroblast growth factor receptor signaling pathway,BP,
12029,GO:0045747,1,0.693986156646605,0,49,positive regulation of Notch signaling pathway,BP,
12030,GO:0045751,1,0.993000518145135,0,1,negative regulation of Toll signaling pathway,BP,
12032,GO:0045760,1,0.933487156960744,0,9,positive regulation of action potential,BP,
12035,GO:0045763,1,0.980672689286477,0,2,negative regulation of cellular amino acid metabolic process,BP,
12036,GO:0045764,1,0.985618430304295,0,3,positive regulation of cellular amino acid metabolic process,BP,
12040,GO:0045773,1,0.712523508294023,0,41,positive regulation of axon extension,BP,
12045,GO:0045780,1,0.88549783584371,0,17,positive regulation of bone resorption,BP,
12049,GO:0045792,1,0.93314316180998,0,10,negative regulation of cell size,BP,
12050,GO:0045793,1,0.93880623415507,0,9,positive regulation of cell size,BP,
12051,GO:0045794,1,0.959381039332291,0,5,negative regulation of cell volume,BP,
12052,GO:0045795,1,0.990309301234633,0,1,positive regulation of cell volume,BP,
12053,GO:0045796,1,0.993629231528571,0,1,negative regulation of intestinal cholesterol absorption,BP,
12054,GO:0045797,1,0.994278633367177,0,1,positive regulation of intestinal cholesterol absorption,BP,
12055,GO:0045798,1,0.964627001578888,0,4,negative regulation of chromatin assembly or disassembly,BP,
12056,GO:0045799,1,0.912409056231043,0,12,positive regulation of chromatin assembly or disassembly,BP,
12057,GO:0045806,1,0.769906394454988,0,41,negative regulation of endocytosis,BP,
12059,GO:0045813,1,0.995255708783232,0,1,positive regulation of Wnt signaling pathway, calcium modulating pathway,BP,
12060,GO:0045814,1,0.686167124273788,0,53,negative regulation of gene expression, epigenetic,BP,
12061,GO:0045815,1,0.736449784383667,0,45,positive regulation of gene expression, epigenetic,BP,
12062,GO:0045819,1,0.992647596787996,0,1,positive regulation of glycogen catabolic process,BP,
12063,GO:0045820,1,0.910791153931722,0,13,negative regulation of glycolytic process,BP,
12064,GO:0045821,1,0.853455777100588,0,20,positive regulation of glycolytic process,BP,
12065,GO:0045822,1,0.86643978949851,0,21,negative regulation of heart contraction,BP,
12066,GO:0045823,1,0.779941551981767,0,38,positive regulation of heart contraction,BP,
12067,GO:0045824,1,0.71846750342569,0,53,negative regulation of innate immune response,BP,
12068,GO:0045827,1,0.989495722117872,0,2,negative regulation of isoprenoid metabolic process,BP,
12069,GO:0045828,1,0.992827460529088,0,1,positive regulation of isoprenoid metabolic process,BP,
12070,GO:0045829,1,0.969005671200173,0,5,negative regulation of isotype switching,BP,
12071,GO:0045830,1,0.875531965703179,0,20,positive regulation of isotype switching,BP,
12074,GO:0045835,1,0.944905537109585,0,9,negative regulation of meiotic nuclear division,BP,
12075,GO:0045836,1,0.918470601104951,0,13,positive regulation of meiotic nuclear division,BP,
12076,GO:0045837,1,0.933489814846868,0,13,negative regulation of membrane potential,BP,
12077,GO:0045838,1,0.918523604464099,0,13,positive regulation of membrane potential,BP,
12081,GO:0045842,1,0.916142413783883,0,13,positive regulation of mitotic metaphase/anaphase transition,BP,
12083,GO:0045844,1,0.647637217304947,0,60,positive regulation of striated muscle tissue development,BP,
12084,GO:0045848,1,0.994580882739056,0,1,positive regulation of nitrogen utilization,BP,
12085,GO:0045851,1,0.720550943833769,0,56,pH reduction,BP,
12086,GO:0045852,1,0.964830669464023,0,5,pH elevation,BP,
12091,GO:0045869,1,0.920444074553009,0,14,negative regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
12093,GO:0045872,1,0.989460847452445,0,2,positive regulation of rhodopsin gene expression,BP,
12094,GO:0045875,1,0.962534350050506,0,4,negative regulation of sister chromatid cohesion,BP,
12095,GO:0045876,1,0.948937810897666,0,7,positive regulation of sister chromatid cohesion,BP,
12096,GO:0045879,1,0.782162945015999,0,32,negative regulation of smoothened signaling pathway,BP,
12097,GO:0045880,1,0.776634974055121,0,35,positive regulation of smoothened signaling pathway,BP,
12098,GO:0045887,1,0.989904756538075,0,1,positive regulation of synaptic growth at neuromuscular junction,BP,
12101,GO:0045898,1,0.919238267803681,0,13,regulation of RNA polymerase II transcription preinitiation complex assembly,BP,
12102,GO:0045899,1,0.938684343473308,0,10,positive regulation of RNA polymerase II transcription preinitiation complex assembly,BP,
12103,GO:0045900,1,0.973992202048808,0,4,negative regulation of translational elongation,BP,
12104,GO:0045901,1,0.970988511207527,0,5,positive regulation of translational elongation,BP,
12105,GO:0045903,1,0.984667119208701,0,3,positive regulation of translational fidelity,BP,
12106,GO:0045905,1,0.974315503907001,0,4,positive regulation of translational termination,BP,
12107,GO:0045906,1,0.941560772500941,0,7,negative regulation of vasoconstriction,BP,
12109,GO:0045910,1,0.816903052334323,0,28,negative regulation of DNA recombination,BP,
12110,GO:0045911,1,0.778061734909761,0,36,positive regulation of DNA recombination,BP,
12111,GO:0045912,1,0.741183079707986,0,42,negative regulation of carbohydrate metabolic process,BP,
12112,GO:0045913,1,0.601049525940249,0,68,positive regulation of carbohydrate metabolic process,BP,
12113,GO:0045914,1,0.979882274450982,0,3,negative regulation of catecholamine metabolic process,BP,
12114,GO:0045915,1,0.965035243173062,0,6,positive regulation of catecholamine metabolic process,BP,
12115,GO:0045916,1,0.944472047624927,0,8,negative regulation of complement activation,BP,
12116,GO:0045917,1,0.975829515036293,0,4,positive regulation of complement activation,BP,
12117,GO:0045918,1,0.994478610855959,0,1,negative regulation of cytolysis,BP,
12118,GO:0045919,1,0.995199010644939,0,1,positive regulation of cytolysis,BP,
12122,GO:0045923,1,0.814811706597191,0,31,positive regulation of fatty acid metabolic process,BP,
12123,GO:0045924,1,0.957106490152937,0,6,regulation of female receptivity,BP,
12124,GO:0045925,1,0.984402439305412,0,2,positive regulation of female receptivity,BP,
12129,GO:0045932,1,0.866028041748564,0,21,negative regulation of muscle contraction,BP,
12135,GO:0045938,1,0.972542989750221,0,6,positive regulation of circadian sleep/wake cycle, sleep,BP,
12136,GO:0045939,1,0.877021436101117,0,22,negative regulation of steroid metabolic process,BP,
12137,GO:0045940,1,0.875583664377539,0,22,positive regulation of steroid metabolic process,BP,
12138,GO:0045943,1,0.869388223004588,0,20,positive regulation of transcription by RNA polymerase I,BP,
12140,GO:0045945,1,0.919844893483022,0,11,positive regulation of transcription by RNA polymerase III,BP,
12141,GO:0045947,1,0.87986200052973,0,19,negative regulation of translational initiation,BP,
12142,GO:0045948,1,0.823494922007373,0,28,positive regulation of translational initiation,BP,
12143,GO:0045950,1,0.981791498293255,0,3,negative regulation of mitotic recombination,BP,
12144,GO:0045951,1,0.9945532919062,0,1,positive regulation of mitotic recombination,BP,
12145,GO:0045953,1,0.925387063799825,0,15,negative regulation of natural killer cell mediated cytotoxicity,BP,
12146,GO:0045954,1,0.887229691932214,0,20,positive regulation of natural killer cell mediated cytotoxicity,BP,
12149,GO:0045957,1,0.978564607090293,0,3,negative regulation of complement activation, alternative pathway,BP,
12150,GO:0045959,1,0.977561229052772,0,3,negative regulation of complement activation, classical pathway,BP,
12151,GO:0045963,1,0.979882274450982,0,3,negative regulation of dopamine metabolic process,BP,
12152,GO:0045964,1,0.965035243173062,0,6,positive regulation of dopamine metabolic process,BP,
12153,GO:0045967,1,0.974998000410726,0,2,negative regulation of growth rate,BP,
12154,GO:0045974,1,0.89303868827378,0,14,regulation of translation, ncRNA-mediated,BP,
12155,GO:0045976,1,0.985590715984728,0,2,negative regulation of mitotic cell cycle, embryonic,BP,
12156,GO:0045977,1,0.995868123078444,0,1,positive regulation of mitotic cell cycle, embryonic,BP,
12158,GO:0045981,1,0.769099572376117,0,37,positive regulation of nucleotide metabolic process,BP,
12159,GO:0045986,1,0.914423432471646,0,13,negative regulation of smooth muscle contraction,BP,
12161,GO:0045988,1,0.95042628054694,0,7,negative regulation of striated muscle contraction,BP,
12162,GO:0045989,1,0.927443424835154,0,13,positive regulation of striated muscle contraction,BP,
12163,GO:0045990,1,0.968092736168483,0,5,carbon catabolite regulation of transcription,BP,
12164,GO:0045991,1,0.968092736168483,0,5,carbon catabolite activation of transcription,BP,
12166,GO:0045993,1,0.992350051390767,0,1,negative regulation of translational initiation by iron,BP,
12167,GO:0045994,1,0.987048918374564,0,2,positive regulation of translational initiation by iron,BP,
12169,GO:0046005,1,0.997221714769688,0,1,positive regulation of circadian sleep/wake cycle, REM sleep,BP,
12171,GO:0046007,1,0.91688838440385,0,13,negative regulation of activated T cell proliferation,BP,
12172,GO:0046010,1,0.98133190273342,0,4,positive regulation of circadian sleep/wake cycle, non-REM sleep,BP,
12173,GO:0046013,1,0.989188508032595,0,2,regulation of T cell homeostatic proliferation,BP,
12174,GO:0046015,1,0.973183162682589,0,5,regulation of transcription by glucose,BP,
12175,GO:0046016,1,0.977591325335129,0,4,positive regulation of transcription by glucose,BP,
12176,GO:0046030,1,0.950886954379077,0,7,inositol trisphosphate phosphatase activity,MF,
12177,GO:0046031,1,0.453553054616048,0,113,ADP metabolic process,BP,
12178,GO:0046032,1,0.995732490011477,0,1,ADP catabolic process,BP,
12179,GO:0046033,1,0.933184894519645,0,12,AMP metabolic process,BP,
12180,GO:0046034,1,0.216104453970816,0,255,ATP metabolic process,BP,
12181,GO:0046036,1,0.941885908799881,0,13,CTP metabolic process,BP,
12183,GO:0046038,1,0.995924241798657,0,1,GMP catabolic process,BP,
12184,GO:0046039,1,0.874579040586639,0,23,GTP metabolic process,BP,
12185,GO:0046040,1,0.935342059240687,0,10,IMP metabolic process,BP,
12186,GO:0046041,1,0.990096106523237,0,2,ITP metabolic process,BP,
12187,GO:0046048,1,0.986693112048907,0,2,UDP metabolic process,BP,
12188,GO:0046049,1,0.942506878814426,0,10,UMP metabolic process,BP,
12189,GO:0046051,1,0.952930176818747,0,10,UTP metabolic process,BP,
12190,GO:0046053,1,0.990278762745527,0,2,dAMP metabolic process,BP,
12191,GO:0046054,1,0.99654903995315,0,1,dGMP metabolic process,BP,
12192,GO:0046056,1,0.986326905804596,0,2,dADP metabolic process,BP,
12194,GO:0046060,1,0.977182324367289,0,5,dATP metabolic process,BP,
12195,GO:0046061,1,0.985726326072482,0,3,dATP catabolic process,BP,
12196,GO:0046065,1,0.996375183284148,0,1,dCTP metabolic process,BP,
12197,GO:0046066,1,0.990056697489284,0,2,dGDP metabolic process,BP,
12198,GO:0046068,1,0.914525854577509,0,13,cGMP metabolic process,BP,
12199,GO:0046069,1,0.962228854939681,0,5,cGMP catabolic process,BP,
12200,GO:0046070,1,0.981417067508082,0,4,dGTP metabolic process,BP,
12201,GO:0046072,1,0.989589739756803,0,2,dTDP metabolic process,BP,
12202,GO:0046073,1,0.984530262433991,0,3,dTMP metabolic process,BP,
12203,GO:0046075,1,0.981415908662102,0,4,dTTP metabolic process,BP,
12204,GO:0046077,1,0.989589739756803,0,2,dUDP metabolic process,BP,
12205,GO:0046078,1,0.981360097080847,0,4,dUMP metabolic process,BP,
12206,GO:0046079,1,0.995645343956262,0,1,dUMP catabolic process,BP,
12207,GO:0046080,1,0.99512256248557,0,1,dUTP metabolic process,BP,
12208,GO:0046081,1,0.99512256248557,0,1,dUTP catabolic process,BP,
12209,GO:0046083,1,0.985733788058954,0,3,adenine metabolic process,BP,
12210,GO:0046084,1,0.985733788058954,0,3,adenine biosynthetic process,BP,
12211,GO:0046085,1,0.957699730391717,0,7,adenosine metabolic process,BP,
12212,GO:0046086,1,0.992589454310245,0,1,adenosine biosynthetic process,BP,
12213,GO:0046087,1,0.951145678103908,0,10,cytidine metabolic process,BP,
12214,GO:0046090,1,0.995726628919274,0,1,deoxyadenosine metabolic process,BP,
12215,GO:0046092,1,0.991913504405385,0,1,deoxycytidine metabolic process,BP,
12216,GO:0046098,1,0.98075061815001,0,3,guanine metabolic process,BP,
12217,GO:0046099,1,0.995924241798657,0,1,guanine biosynthetic process,BP,
12218,GO:0046100,1,0.986278058257513,0,3,hypoxanthine metabolic process,BP,
12219,GO:0046101,1,0.986278058257513,0,3,hypoxanthine biosynthetic process,BP,
12220,GO:0046102,1,0.983680611573635,0,3,inosine metabolic process,BP,
12221,GO:0046103,1,0.989547854460898,0,2,inosine biosynthetic process,BP,
12222,GO:0046104,1,0.977164007135977,0,4,thymidine metabolic process,BP,
12223,GO:0046105,1,0.996345419323911,0,1,thymidine biosynthetic process,BP,
12224,GO:0046108,1,0.989342743016558,0,2,uridine metabolic process,BP,
12225,GO:0046110,1,0.979162158370809,0,3,xanthine metabolic process,BP,
12226,GO:0046111,1,0.995726628919274,0,1,xanthine biosynthetic process,BP,
12227,GO:0046112,1,0.888230214145321,0,18,nucleobase biosynthetic process,BP,
12228,GO:0046113,1,0.957850059584086,0,6,nucleobase catabolic process,BP,
12229,GO:0046120,1,0.996345419323911,0,1,deoxyribonucleoside biosynthetic process,BP,
12230,GO:0046121,1,0.984292049161371,0,3,deoxyribonucleoside catabolic process,BP,
12231,GO:0046122,1,0.992261953728473,0,2,purine deoxyribonucleoside metabolic process,BP,
12232,GO:0046124,1,0.995726628919274,0,1,purine deoxyribonucleoside catabolic process,BP,
12233,GO:0046125,1,0.977164007135977,0,4,pyrimidine deoxyribonucleoside metabolic process,BP,
12234,GO:0046126,1,0.996345419323911,0,1,pyrimidine deoxyribonucleoside biosynthetic process,BP,
12235,GO:0046127,1,0.99308891600688,0,1,pyrimidine deoxyribonucleoside catabolic process,BP,
12237,GO:0046129,1,0.902506250876973,0,21,purine ribonucleoside biosynthetic process,BP,
12238,GO:0046130,1,0.966493042731489,0,6,purine ribonucleoside catabolic process,BP,
12239,GO:0046131,1,0.941004014206067,0,12,pyrimidine ribonucleoside metabolic process,BP,
12240,GO:0046133,1,0.941004014206067,0,12,pyrimidine ribonucleoside catabolic process,BP,
12241,GO:0046134,1,0.926122297226945,0,14,pyrimidine nucleoside biosynthetic process,BP,
12242,GO:0046135,1,0.897363480896405,0,21,pyrimidine nucleoside catabolic process,BP,
12243,GO:0046136,1,0.975625747192667,0,4,positive regulation of vitamin metabolic process,BP,
12244,GO:0046137,1,0.966908974010538,0,6,negative regulation of vitamin metabolic process,BP,
12245,GO:0046144,1,0.995619591821006,0,1,D-alanine family amino acid metabolic process,BP,
12246,GO:0046146,1,0.966781626497637,0,7,tetrahydrobiopterin metabolic process,BP,
12247,GO:0046148,1,0.705109984727556,0,54,pigment biosynthetic process,BP,
12248,GO:0046149,1,0.984319878948359,0,4,pigment catabolic process,BP,
12249,GO:0046160,1,0.983417040598346,0,2,heme a metabolic process,BP,
12250,GO:0046164,1,0.754149599817475,0,46,alcohol catabolic process,BP,
12251,GO:0046165,1,0.393605815033179,0,141,alcohol biosynthetic process,BP,
12252,GO:0046166,1,0.99053498440971,0,2,glyceraldehyde-3-phosphate biosynthetic process,BP,
12253,GO:0046167,1,0.980266611771767,0,2,glycerol-3-phosphate biosynthetic process,BP,
12254,GO:0046168,1,0.986049009323016,0,2,glycerol-3-phosphate catabolic process,BP,
12255,GO:0046173,1,0.699005684901436,0,57,polyol biosynthetic process,BP,
12256,GO:0046174,1,0.852055625192864,0,22,polyol catabolic process,BP,
12257,GO:0046176,1,0.988502672481922,0,2,aldonic acid catabolic process,BP,
12258,GO:0046177,1,0.988502672481922,0,2,D-gluconate catabolic process,BP,
12259,GO:0046184,1,0.911149157878183,0,13,aldehyde biosynthetic process,BP,
12260,GO:0046185,1,0.944994731423537,0,11,aldehyde catabolic process,BP,
12261,GO:0046189,1,0.760914595863579,0,41,phenol-containing compound biosynthetic process,BP,
12262,GO:0046203,1,0.995450692884757,0,1,spermidine catabolic process,BP,
12263,GO:0046204,1,0.9965839600578,0,1,nor-spermidine metabolic process,BP,
12264,GO:0046208,1,0.990204466342925,0,2,spermine catabolic process,BP,
12265,GO:0046209,1,0.631163797870848,0,68,nitric oxide metabolic process,BP,
12266,GO:0046210,1,0.99390014550595,0,1,nitric oxide catabolic process,BP,
12267,GO:0046218,1,0.961691891780708,0,8,indolalkylamine catabolic process,BP,
12268,GO:0046219,1,0.980206164532898,0,4,indolalkylamine biosynthetic process,BP,
12269,GO:0046222,1,0.989744192529501,0,2,aflatoxin metabolic process,BP,
12270,GO:0046223,1,0.989744192529501,0,2,aflatoxin catabolic process,BP,
12271,GO:0046226,1,0.991605096539668,0,2,coumarin catabolic process,BP,
12272,GO:0046247,1,0.986895344770984,0,2,terpene catabolic process,BP,
12273,GO:0046271,1,0.991605096539668,0,2,phenylpropanoid catabolic process,BP,
12274,GO:0046272,1,0.994464894599637,0,1,stilbene catabolic process,BP,
12275,GO:0046292,1,0.977169530624557,0,4,formaldehyde metabolic process,BP,
12276,GO:0046293,1,0.992133309959483,0,1,formaldehyde biosynthetic process,BP,
12277,GO:0046294,1,0.984918754489537,0,3,formaldehyde catabolic process,BP,
12278,GO:0046295,1,0.996625193861694,0,1,glycolate biosynthetic process,BP,
12279,GO:0046296,1,0.995356157800689,0,1,glycolate catabolic process,BP,
12280,GO:0046305,1,0.989205742720011,0,2,alkanesulfonate biosynthetic process,BP,
12281,GO:0046314,1,0.978178398879015,0,5,phosphocreatine biosynthetic process,BP,
12282,GO:0046316,1,0.993485400251684,0,1,gluconokinase activity,MF,
12283,GO:0046317,1,0.991864948073818,0,1,regulation of glucosylceramide biosynthetic process,BP,
12284,GO:0046318,1,0.991864948073818,0,1,negative regulation of glucosylceramide biosynthetic process,BP,
12286,GO:0046321,1,0.899249454047764,0,14,positive regulation of fatty acid oxidation,BP,
12288,GO:0046323,1,0.638061704926332,0,61,glucose import,BP,
12289,GO:0046324,1,0.702586004048906,0,48,regulation of glucose import,BP,
12290,GO:0046325,1,0.934151303900706,0,11,negative regulation of glucose import,BP,
12291,GO:0046326,1,0.778172989488417,0,32,positive regulation of glucose import,BP,
12292,GO:0046327,1,0.988581622702898,0,2,glycerol biosynthetic process from pyruvate,BP,
12295,GO:0046330,1,0.405480973613604,0,129,positive regulation of JNK cascade,BP,
12296,GO:0046331,1,0.988846299020291,0,2,lateral inhibition,BP,
12298,GO:0046333,1,0.986692831667053,0,2,octopamine metabolic process,BP,
12300,GO:0046338,1,0.979582321150787,0,3,phosphatidylethanolamine catabolic process,BP,
12301,GO:0046339,1,0.861065874203995,0,20,diacylglycerol metabolic process,BP,
12302,GO:0046340,1,0.984056402485789,0,2,diacylglycerol catabolic process,BP,
12303,GO:0046341,1,0.91600769129435,0,12,CDP-diacylglycerol metabolic process,BP,
12304,GO:0046348,1,0.939493179262693,0,12,amino sugar catabolic process,BP,
12305,GO:0046349,1,0.920130837755314,0,13,amino sugar biosynthetic process,BP,
12306,GO:0046351,1,0.978063149785434,0,4,disaccharide biosynthetic process,BP,
12307,GO:0046356,1,0.991139813494046,0,2,acetyl-CoA catabolic process,BP,
12308,GO:0046359,1,0.995029744833407,0,1,butyrate catabolic process,BP,
12309,GO:0046360,1,0.994648003987701,0,1,2-oxobutyrate biosynthetic process,BP,
12310,GO:0046361,1,0.990179596807601,0,2,2-oxobutyrate metabolic process,BP,
12311,GO:0046364,1,0.587822883629369,0,85,monosaccharide biosynthetic process,BP,
12312,GO:0046365,1,0.69284571148915,0,59,monosaccharide catabolic process,BP,
12313,GO:0046368,1,0.988483034421745,0,2,GDP-L-fucose metabolic process,BP,
12314,GO:0046370,1,0.989836290059458,0,2,fructose biosynthetic process,BP,
12315,GO:0046373,1,0.98701281886265,0,2,L-arabinose metabolic process,BP,
12316,GO:0046379,1,0.981400710266699,0,3,extracellular polysaccharide metabolic process,BP,
12317,GO:0046380,1,0.99270829998654,0,1,N-acetylneuraminate biosynthetic process,BP,
12318,GO:0046381,1,0.996195924714731,0,1,CMP-N-acetylneuraminate metabolic process,BP,
12319,GO:0046385,1,0.941204472280075,0,12,deoxyribose phosphate biosynthetic process,BP,
12320,GO:0046386,1,0.906626970283803,0,19,deoxyribose phosphate catabolic process,BP,
12322,GO:0046391,1,0.971416069917617,0,5,5-phosphoribose 1-diphosphate metabolic process,BP,
12325,GO:0046398,1,0.971240537214115,0,4,UDP-glucuronate metabolic process,BP,
12326,GO:0046403,1,0.995396421293157,0,1,polynucleotide 3'-phosphatase activity,MF,
12327,GO:0046404,1,0.981224261587406,0,3,ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity,MF,
12328,GO:0046415,1,0.952798763286737,0,8,urate metabolic process,BP,
12329,GO:0046416,1,0.985231253208969,0,3,D-amino acid metabolic process,BP,
12330,GO:0046425,1,0.560820554263985,0,91,regulation of receptor signaling pathway via JAK-STAT,BP,
12331,GO:0046426,1,0.882647762272687,0,19,negative regulation of receptor signaling pathway via JAK-STAT,BP,
12332,GO:0046427,1,0.670832806450077,0,64,positive regulation of receptor signaling pathway via JAK-STAT,BP,
12333,GO:0046434,1,0.435370886771325,0,132,organophosphate catabolic process,BP,
12334,GO:0046436,1,0.995619591821006,0,1,D-alanine metabolic process,BP,
12335,GO:0046437,1,0.993951530489555,0,1,D-amino acid biosynthetic process,BP,
12336,GO:0046439,1,0.978704026600772,0,4,L-cysteine metabolic process,BP,
12337,GO:0046440,1,0.973325119194182,0,4,L-lysine metabolic process,BP,
12338,GO:0046443,1,0.994929140826226,0,1,FAD metabolic process,BP,
12339,GO:0046444,1,0.993577168431364,0,1,FMN metabolic process,BP,
12340,GO:0046448,1,0.994016440850835,0,1,tropane alkaloid metabolic process,BP,
12341,GO:0046449,1,0.991376028637438,0,1,creatinine metabolic process,BP,
12342,GO:0046452,1,0.987374963974894,0,2,dihydrofolate metabolic process,BP,
12343,GO:0046456,1,0.795960124857555,0,42,icosanoid biosynthetic process,BP,
12344,GO:0046457,1,0.873826886495551,0,25,prostanoid biosynthetic process,BP,
12345,GO:0046458,1,0.992719661335156,0,1,hexadecanal metabolic process,BP,
12346,GO:0046459,1,0.913235660721174,0,16,short-chain fatty acid metabolic process,BP,
12349,GO:0046462,1,0.946974079304205,0,9,monoacylglycerol metabolic process,BP,
12352,GO:0046465,1,0.95845036890053,0,7,dolichyl diphosphate metabolic process,BP,
12353,GO:0046466,1,0.821908838196667,0,32,membrane lipid catabolic process,BP,
12355,GO:0046469,1,0.950354456455066,0,8,platelet activating factor metabolic process,BP,
12356,GO:0046470,1,0.646224811473601,0,73,phosphatidylcholine metabolic process,BP,
12357,GO:0046471,1,0.829792722847263,0,29,phosphatidylglycerol metabolic process,BP,
12358,GO:0046473,1,0.732149527608326,0,43,phosphatidic acid metabolic process,BP,
12360,GO:0046475,1,0.845833967280379,0,27,glycerophospholipid catabolic process,BP,
12361,GO:0046476,1,0.953373147809514,0,8,glycosylceramide biosynthetic process,BP,
12362,GO:0046477,1,0.952173829378412,0,8,glycosylceramide catabolic process,BP,
12363,GO:0046478,1,0.992101576207316,0,1,lactosylceramide metabolic process,BP,
12364,GO:0046479,1,0.918680437188334,0,14,glycosphingolipid catabolic process,BP,
12366,GO:0046485,1,0.889112823285447,0,17,ether lipid metabolic process,BP,
12368,GO:0046487,1,0.959023594835225,0,8,glyoxylate metabolic process,BP,
12369,GO:0046488,1,0.307580630049444,0,165,phosphatidylinositol metabolic process,BP,
12370,GO:0046490,1,0.980847921192071,0,4,isopentenyl diphosphate metabolic process,BP,
12371,GO:0046491,1,0.996710292900068,0,1,L-methylmalonyl-CoA metabolic process,BP,
12372,GO:0046495,1,0.99407140587962,0,1,nicotinamide riboside metabolic process,BP,
12373,GO:0046496,1,0.828618880636905,0,31,nicotinamide nucleotide metabolic process,BP,
12374,GO:0046498,1,0.987340692448464,0,3,S-adenosylhomocysteine metabolic process,BP,
12375,GO:0046499,1,0.992982499157848,0,1,S-adenosylmethioninamine metabolic process,BP,
12376,GO:0046500,1,0.905691752471288,0,16,S-adenosylmethionine metabolic process,BP,
12377,GO:0046501,1,0.933925243018066,0,11,protoporphyrinogen IX metabolic process,BP,
12378,GO:0046502,1,0.990580002549481,0,2,uroporphyrinogen III metabolic process,BP,
12380,GO:0046504,1,0.931375540592807,0,10,glycerol ether biosynthetic process,BP,
12381,GO:0046511,1,0.985158504197238,0,2,sphinganine biosynthetic process,BP,
12382,GO:0046512,1,0.91677645010379,0,13,sphingosine biosynthetic process,BP,
12383,GO:0046513,1,0.673493141969946,0,62,ceramide biosynthetic process,BP,
12384,GO:0046514,1,0.892074311200967,0,19,ceramide catabolic process,BP,
12385,GO:0046519,1,0.895797316309674,0,17,sphingoid metabolic process,BP,
12386,GO:0046520,1,0.91677645010379,0,13,sphingoid biosynthetic process,BP,
12387,GO:0046521,1,0.995137923412935,0,1,sphingoid catabolic process,BP,
12388,GO:0046523,1,0.993105707907295,0,1,S-methyl-5-thioribose-1-phosphate isomerase activity,MF,
12389,GO:0046525,1,0.995398242064802,0,1,xylosylprotein 4-beta-galactosyltransferase activity,MF,
12390,GO:0046526,1,0.993865211361605,0,1,D-xylulose reductase activity,MF,
12391,GO:0046527,1,0.893271671787445,0,16,glucosyltransferase activity,MF,
12393,GO:0046532,1,0.943667560211886,0,8,regulation of photoreceptor cell differentiation,BP,
12394,GO:0046533,1,0.943667560211886,0,8,negative regulation of photoreceptor cell differentiation,BP,
12395,GO:0046538,1,0.996728390595328,0,1,2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity,MF,
12396,GO:0046539,1,0.996663383576929,0,1,histamine N-methyltransferase activity,MF,
12397,GO:0046540,1,0.857903752391012,0,30,U4/U6 x U5 tri-snRNP complex,CC,
12399,GO:0046543,1,0.958609800856142,0,6,development of secondary female sexual characteristics,BP,
12400,GO:0046544,1,0.991868288509748,0,1,development of secondary male sexual characteristics,BP,
12403,GO:0046548,1,0.934923011962215,0,9,retinal rod cell development,BP,
12405,GO:0046552,1,0.994738933398728,0,1,photoreceptor cell fate commitment,BP,
12406,GO:0046554,1,0.996095380783937,0,1,malate dehydrogenase (NADP+) activity,MF,
12407,GO:0046556,1,0.98701281886265,0,2,alpha-L-arabinofuranosidase activity,MF,
12408,GO:0046570,1,0.996166192973706,0,1,methylthioribulose 1-phosphate dehydratase activity,MF,
12409,GO:0046573,1,0.987219477200711,0,3,lactonohydrolase activity,MF,
12410,GO:0046577,1,0.992719661335156,0,1,long-chain-alcohol oxidase activity,MF,
12412,GO:0046579,1,0.634106910297672,0,65,positive regulation of Ras protein signal transduction,BP,
12414,GO:0046581,1,0.954675402912955,0,6,intercellular canaliculus,CC,
12415,GO:0046586,1,0.989879512833968,0,2,regulation of calcium-dependent cell-cell adhesion,BP,
12416,GO:0046587,1,0.993196258754412,0,1,positive regulation of calcium-dependent cell-cell adhesion,BP,
12417,GO:0046588,1,0.996660761470416,0,1,negative regulation of calcium-dependent cell-cell adhesion,BP,
12418,GO:0046592,1,0.985020844540965,0,3,polyamine oxidase activity,MF,
12419,GO:0046596,1,0.829927849534975,0,32,regulation of viral entry into host cell,BP,
12420,GO:0046597,1,0.918197802339431,0,15,negative regulation of viral entry into host cell,BP,
12421,GO:0046598,1,0.947741762021284,0,10,positive regulation of viral entry into host cell,BP,
12422,GO:0046599,1,0.849036572045037,0,22,regulation of centriole replication,BP,
12423,GO:0046600,1,0.936124421033914,0,9,negative regulation of centriole replication,BP,
12424,GO:0046601,1,0.956828976787714,0,6,positive regulation of centriole replication,BP,
12425,GO:0046602,1,0.942302884863253,0,9,regulation of mitotic centrosome separation,BP,
12426,GO:0046603,1,0.995894682279424,0,1,negative regulation of mitotic centrosome separation,BP,
12427,GO:0046604,1,0.981511466935258,0,3,positive regulation of mitotic centrosome separation,BP,
12428,GO:0046605,1,0.660038746663598,0,58,regulation of centrosome cycle,BP,
12429,GO:0046606,1,0.905963335844544,0,15,negative regulation of centrosome cycle,BP,
12430,GO:0046607,1,0.92525459683154,0,11,positive regulation of centrosome cycle,BP,
12431,GO:0046618,1,0.984071866367428,0,2,drug export,BP,
12432,GO:0046619,1,0.983528740654196,0,2,optic placode formation involved in camera-type eye formation,BP,
12435,GO:0046622,1,0.714935821346347,0,46,positive regulation of organ growth,BP,
12436,GO:0046623,1,0.968900766938124,0,3,sphingolipid floppase activity,MF,
12437,GO:0046624,1,0.924064736287352,0,11,sphingolipid transporter activity,MF,
12439,GO:0046626,1,0.660621171608376,0,59,regulation of insulin receptor signaling pathway,BP,
12440,GO:0046627,1,0.814239343648762,0,30,negative regulation of insulin receptor signaling pathway,BP,
12441,GO:0046628,1,0.857273766729719,0,20,positive regulation of insulin receptor signaling pathway,BP,
12442,GO:0046629,1,0.887645990446756,0,17,gamma-delta T cell activation,BP,
12443,GO:0046631,1,0.425388905339915,0,134,alpha-beta T cell activation,BP,
12444,GO:0046632,1,0.521470141397418,0,97,alpha-beta T cell differentiation,BP,
12445,GO:0046633,1,0.821685974346034,0,34,alpha-beta T cell proliferation,BP,
12446,GO:0046634,1,0.578040280165495,0,89,regulation of alpha-beta T cell activation,BP,
12447,GO:0046635,1,0.698702931769229,0,59,positive regulation of alpha-beta T cell activation,BP,
12448,GO:0046636,1,0.798554527355945,0,36,negative regulation of alpha-beta T cell activation,BP,
12449,GO:0046637,1,0.684959237098857,0,58,regulation of alpha-beta T cell differentiation,BP,
12450,GO:0046638,1,0.764385910291044,0,43,positive regulation of alpha-beta T cell differentiation,BP,
12451,GO:0046639,1,0.851136777207966,0,23,negative regulation of alpha-beta T cell differentiation,BP,
12452,GO:0046640,1,0.839277780346459,0,31,regulation of alpha-beta T cell proliferation,BP,
12453,GO:0046641,1,0.89317619073157,0,20,positive regulation of alpha-beta T cell proliferation,BP,
12454,GO:0046642,1,0.953066735717502,0,10,negative regulation of alpha-beta T cell proliferation,BP,
12455,GO:0046643,1,0.920380178565796,0,11,regulation of gamma-delta T cell activation,BP,
12456,GO:0046645,1,0.933573459291231,0,9,positive regulation of gamma-delta T cell activation,BP,
12459,GO:0046653,1,0.897391385695516,0,17,tetrahydrofolate metabolic process,BP,
12460,GO:0046654,1,0.961440910160036,0,6,tetrahydrofolate biosynthetic process,BP,
12462,GO:0046657,1,0.996692114781991,0,1,folic acid catabolic process,BP,
12466,GO:0046666,1,0.97262434376354,0,5,retinal cell programmed cell death,BP,
12467,GO:0046668,1,0.98051378842645,0,3,regulation of retinal cell programmed cell death,BP,
12468,GO:0046671,1,0.992685782329349,0,1,negative regulation of retinal cell programmed cell death,BP,
12470,GO:0046677,1,0.748852662361014,0,45,response to antibiotic,BP,
12471,GO:0046680,1,0.994695440917437,0,1,response to DDT,BP,
12473,GO:0046684,1,0.978225083189445,0,4,response to pyrethroid,BP,
12474,GO:0046685,1,0.817434559745753,0,33,response to arsenic-containing substance,BP,
12475,GO:0046686,1,0.741589544017879,0,56,response to cadmium ion,BP,
12476,GO:0046687,1,0.996405415233167,0,1,response to chromate,BP,
12477,GO:0046688,1,0.839819644855515,0,33,response to copper ion,BP,
12478,GO:0046689,1,0.94955972275048,0,9,response to mercury ion,BP,
12479,GO:0046690,1,0.992850308233352,0,1,response to tellurium ion,BP,
12480,GO:0046691,1,0.985532622542067,0,2,intracellular canaliculus,CC,
12481,GO:0046695,1,0.984836510543802,0,3,SLIK (SAGA-like) complex,CC,
12482,GO:0046696,1,0.978515317665015,0,4,lipopolysaccharide receptor complex,CC,
12483,GO:0046697,1,0.858822092851626,0,24,decidualization,BP,
12484,GO:0046700,1,0.0361157969749166,0,552,heterocycle catabolic process,BP,
12485,GO:0046703,1,0.960580559405044,0,8,natural killer cell lectin-like receptor binding,MF,
12486,GO:0046704,1,0.993369666664661,0,1,CDP metabolic process,BP,
12487,GO:0046705,1,0.993369666664661,0,1,CDP biosynthetic process,BP,
12488,GO:0046707,1,0.986829165288674,0,2,IDP metabolic process,BP,
12489,GO:0046709,1,0.986829165288674,0,2,IDP catabolic process,BP,
12491,GO:0046711,1,0.99654903995315,0,1,GDP biosynthetic process,BP,
12492,GO:0046713,1,0.993097467101843,0,1,borate transport,BP,
12493,GO:0046715,1,0.993097467101843,0,1,active borate transmembrane transporter activity,MF,
12494,GO:0046716,1,0.883579106237131,0,19,muscle cell cellular homeostasis,BP,
12495,GO:0046717,1,0.781303721035459,0,38,acid secretion,BP,
12496,GO:0046718,1,0.456964690188806,0,119,viral entry into host cell,BP,
12497,GO:0046719,1,0.956795056103719,0,7,regulation by virus of viral protein levels in host cell,BP,
12498,GO:0046724,1,0.989298783566947,0,2,oxalic acid secretion,BP,
12499,GO:0046725,1,0.992807052590488,0,1,negative regulation by virus of viral protein levels in host cell,BP,
12500,GO:0046726,1,0.971405514114563,0,4,positive regulation by virus of viral protein levels in host cell,BP,
12501,GO:0046745,1,0.993485400251684,0,1,viral capsid secondary envelopment,BP,
12502,GO:0046755,1,0.85848093769156,0,26,viral budding,BP,
12504,GO:0046778,1,0.98844515514172,0,2,modification by virus of host mRNA processing,BP,
12505,GO:0046782,1,0.6775536407019,0,61,regulation of viral transcription,BP,
12506,GO:0046784,1,0.95540452340501,0,8,viral mRNA export from host cell nucleus,BP,
12508,GO:0046786,1,0.992027258864867,0,1,viral replication complex formation and maintenance,BP,
12509,GO:0046789,1,0.993029393211783,0,1,host cell surface receptor binding,MF,
12510,GO:0046790,1,0.948544257771593,0,7,virion binding,MF,
12511,GO:0046794,1,0.663710385944353,0,59,transport of virus,BP,
12512,GO:0046811,1,0.988399149030212,0,2,histone deacetylase inhibitor activity,MF,
12513,GO:0046812,1,0.993029393211783,0,1,host cell surface binding,MF,
12514,GO:0046813,1,0.967115870359303,0,5,receptor-mediated virion attachment to host cell,BP,
12515,GO:0046822,1,0.463109042324433,0,109,regulation of nucleocytoplasmic transport,BP,
12516,GO:0046823,1,0.869819796968347,0,21,negative regulation of nucleocytoplasmic transport,BP,
12517,GO:0046824,1,0.623428520011404,0,65,positive regulation of nucleocytoplasmic transport,BP,
12518,GO:0046825,1,0.752865777905631,0,41,regulation of protein export from nucleus,BP,
12519,GO:0046826,1,0.969677020430774,0,6,negative regulation of protein export from nucleus,BP,
12520,GO:0046827,1,0.860896254916667,0,21,positive regulation of protein export from nucleus,BP,
12521,GO:0046831,1,0.88004907772952,0,16,regulation of RNA export from nucleus,BP,
12522,GO:0046832,1,0.979365738976029,0,2,negative regulation of RNA export from nucleus,BP,
12523,GO:0046833,1,0.942532208328781,0,8,positive regulation of RNA export from nucleus,BP,
12524,GO:0046834,1,0.622114932837153,0,63,lipid phosphorylation,BP,
12525,GO:0046835,1,0.864948985861712,0,22,carbohydrate phosphorylation,BP,
12526,GO:0046836,1,0.9621929387698,0,7,glycolipid transport,BP,
12527,GO:0046838,1,0.890141822133077,0,16,phosphorylated carbohydrate dephosphorylation,BP,
12528,GO:0046839,1,0.791856901509053,0,31,phospholipid dephosphorylation,BP,
12530,GO:0046848,1,0.997124226371641,0,1,hydroxyapatite binding,MF,
12534,GO:0046852,1,0.88549783584371,0,17,positive regulation of bone remodeling,BP,
12535,GO:0046854,1,0.692384861357132,0,49,phosphatidylinositol phosphorylation,BP,
12536,GO:0046855,1,0.896319759442068,0,15,inositol phosphate dephosphorylation,BP,
12537,GO:0046856,1,0.804955958623764,0,28,phosphatidylinositol dephosphorylation,BP,
12538,GO:0046864,1,0.990032317049768,0,2,isoprenoid transport,BP,
12539,GO:0046865,1,0.990032317049768,0,2,terpenoid transport,BP,
12540,GO:0046870,1,0.97389915126833,0,4,cadmium ion binding,MF,
12543,GO:0046874,1,0.975984733839602,0,5,quinolinate metabolic process,BP,
12544,GO:0046875,1,0.827681145968952,0,27,ephrin receptor binding,MF,
12545,GO:0046877,1,0.968893763801653,0,6,regulation of saliva secretion,BP,
12546,GO:0046878,1,0.989876304043701,0,2,positive regulation of saliva secretion,BP,
12548,GO:0046880,1,0.959071610488656,0,6,regulation of follicle-stimulating hormone secretion,BP,
12549,GO:0046881,1,0.959071610488656,0,6,positive regulation of follicle-stimulating hormone secretion,BP,
12550,GO:0046882,1,0.983574174437778,0,3,negative regulation of follicle-stimulating hormone secretion,BP,
12552,GO:0046884,1,0.951538265141365,0,7,follicle-stimulating hormone secretion,BP,
12553,GO:0046885,1,0.879039688493277,0,18,regulation of hormone biosynthetic process,BP,
12554,GO:0046886,1,0.945479978838936,0,8,positive regulation of hormone biosynthetic process,BP,
12557,GO:0046889,1,0.628133996370222,0,72,positive regulation of lipid biosynthetic process,BP,
12558,GO:0046890,1,0.314507252204268,0,176,regulation of lipid biosynthetic process,BP,
12559,GO:0046898,1,0.970745465174957,0,4,response to cycloheximide,BP,
12560,GO:0046899,1,0.987202733474251,0,2,nucleoside triphosphate adenylate kinase activity,MF,
12561,GO:0046900,1,0.989760114505046,0,2,tetrahydrofolylpolyglutamate metabolic process,BP,
12562,GO:0046901,1,0.993931940906298,0,1,tetrahydrofolylpolyglutamate biosynthetic process,BP,
12565,GO:0046906,1,0.490083893467502,0,116,tetrapyrrole binding,MF,
12567,GO:0046911,1,0.996286622576736,0,1,metal chelating activity,MF,
12568,GO:0046912,1,0.964379589810304,0,5,transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer,MF,
12572,GO:0046920,1,0.942258698816664,0,8,alpha-(1->3)-fucosyltransferase activity,MF,
12573,GO:0046921,1,0.992965124727951,0,1,alpha-(1->6)-fucosyltransferase activity,MF,
12574,GO:0046922,1,0.986097060761253,0,2,peptide-O-fucosyltransferase activity,MF,
12575,GO:0046923,1,0.973155444102844,0,5,ER retention sequence binding,MF,
12578,GO:0046930,1,0.892301815479003,0,19,pore complex,CC,
12579,GO:0046931,1,0.880975562722025,0,19,pore complex assembly,BP,
12580,GO:0046933,1,0.996411712463578,0,1,proton-transporting ATP synthase activity, rotational mechanism,MF,
12581,GO:0046934,1,0.964746232209963,0,5,phosphatidylinositol-4,5-bisphosphate 3-kinase activity,MF,
12582,GO:0046935,1,0.912694033929021,0,13,1-phosphatidylinositol-3-kinase regulator activity,MF,
12583,GO:0046939,1,0.434544220283948,0,123,nucleotide phosphorylation,BP,
12584,GO:0046940,1,0.915718210074965,0,14,nucleoside monophosphate phosphorylation,BP,
12587,GO:0046946,1,0.985864109167883,0,2,hydroxylysine metabolic process,BP,
12588,GO:0046947,1,0.985864109167883,0,2,hydroxylysine biosynthetic process,BP,
12589,GO:0046949,1,0.828823947580415,0,29,fatty-acyl-CoA biosynthetic process,BP,
12590,GO:0046950,1,0.934815764522616,0,11,cellular ketone body metabolic process,BP,
12591,GO:0046951,1,0.946112760557372,0,9,ketone body biosynthetic process,BP,
12592,GO:0046952,1,0.975751670192165,0,4,ketone body catabolic process,BP,
12593,GO:0046958,1,0.954475761706075,0,6,nonassociative learning,BP,
12594,GO:0046959,1,0.966883601689263,0,4,habituation,BP,
12595,GO:0046960,1,0.987107517663807,0,2,sensitization,BP,
12596,GO:0046961,1,0.89626007355428,0,19,proton-transporting ATPase activity, rotational mechanism,MF,
12597,GO:0046963,1,0.989566198153265,0,2,3'-phosphoadenosine 5'-phosphosulfate transport,BP,
12598,GO:0046964,1,0.989566198153265,0,2,3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity,MF,
12599,GO:0046965,1,0.870507129555107,0,18,retinoid X receptor binding,MF,
12600,GO:0046966,1,0.803868981508737,0,29,thyroid hormone receptor binding,MF,
12601,GO:0046967,1,0.967510055650064,0,4,cytosol to endoplasmic reticulum transport,BP,
12602,GO:0046968,1,0.985161352769526,0,2,peptide antigen transport,BP,
12603,GO:0046969,1,0.988274593939241,0,2,NAD-dependent histone deacetylase activity (H3-K9 specific),MF,
12604,GO:0046970,1,0.994979066216479,0,1,NAD-dependent histone deacetylase activity (H4-K16 specific),MF,
12605,GO:0046972,1,0.93461872288517,0,10,histone acetyltransferase activity (H4-K16 specific),MF,
12606,GO:0046974,1,0.91624326204251,0,10,histone methyltransferase activity (H3-K9 specific),MF,
12607,GO:0046975,1,0.917748050354853,0,10,histone methyltransferase activity (H3-K36 specific),MF,
12608,GO:0046976,1,0.966281328452777,0,5,histone methyltransferase activity (H3-K27 specific),MF,
12609,GO:0046977,1,0.955652795994231,0,8,TAP binding,MF,
12610,GO:0046978,1,0.96805745952928,0,5,TAP1 binding,MF,
12611,GO:0046979,1,0.982321858917786,0,3,TAP2 binding,MF,
12612,GO:0046980,1,0.992604430620992,0,1,tapasin binding,MF,
12615,GO:0046984,1,0.976222251665302,0,4,regulation of hemoglobin biosynthetic process,BP,
12616,GO:0046985,1,0.983749110408551,0,3,positive regulation of hemoglobin biosynthetic process,BP,
12617,GO:0046986,1,0.992350051390767,0,1,negative regulation of hemoglobin biosynthetic process,BP,
12618,GO:0046997,1,0.98611660480074,0,2,oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor,MF,
12619,GO:0047006,1,0.991894556739882,0,2,17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity,MF,
12620,GO:0047012,1,0.995621313891515,0,1,sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity,MF,
12621,GO:0047015,1,0.996601969691748,0,1,3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity,MF,
12622,GO:0047016,1,0.994506084301174,0,1,cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity,MF,
12623,GO:0047017,1,0.996216597465047,0,1,prostaglandin-F synthase activity,MF,
12624,GO:0047020,1,0.992422342386619,0,2,15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity,MF,
12625,GO:0047021,1,0.996191479964394,0,1,15-hydroxyprostaglandin dehydrogenase (NADP+) activity,MF,
12626,GO:0047023,1,0.97127243414409,0,7,androsterone dehydrogenase activity,MF,
12627,GO:0047024,1,0.995753350320576,0,1,5alpha-androstane-3beta,17beta-diol dehydrogenase activity,MF,
12628,GO:0047025,1,0.989436652416901,0,2,3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity,MF,
12629,GO:0047035,1,0.979793355117016,0,5,testosterone dehydrogenase (NAD+) activity,MF,
12630,GO:0047042,1,0.995979542181895,0,1,androsterone dehydrogenase (B-specific) activity,MF,
12631,GO:0047044,1,0.986718567865123,0,3,androstan-3-alpha,17-beta-diol dehydrogenase activity,MF,
12632,GO:0047045,1,0.9844123589239,0,4,testosterone 17-beta-dehydrogenase (NADP+) activity,MF,
12633,GO:0047057,1,0.99296572539545,0,2,vitamin-K-epoxide reductase (warfarin-sensitive) activity,MF,
12634,GO:0047058,1,0.996616583637555,0,1,vitamin-K-epoxide reductase (warfarin-insensitive) activity,MF,
12635,GO:0047066,1,0.9931114359453,0,2,phospholipid-hydroperoxide glutathione peroxidase activity,MF,
12636,GO:0047086,1,0.984348042181253,0,4,ketosteroid monooxygenase activity,MF,
12637,GO:0047092,1,0.994104736380736,0,1,27-hydroxycholesterol 7-alpha-monooxygenase activity,MF,
12638,GO:0047102,1,0.993984738201082,0,1,aminomuconate-semialdehyde dehydrogenase activity,MF,
12639,GO:0047105,1,0.993905421826104,0,1,4-trimethylammoniobutyraldehyde dehydrogenase activity,MF,
12640,GO:0047115,1,0.98450710792381,0,4,trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity,MF,
12641,GO:0047117,1,0.988938770380431,0,1,enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity,MF,
12642,GO:0047127,1,0.995992851038889,0,1,thiomorpholine-carboxylate dehydrogenase activity,MF,
12643,GO:0047130,1,0.991183072183191,0,1,saccharopine dehydrogenase (NADP+, L-lysine-forming) activity,MF,
12644,GO:0047131,1,0.991183072183191,0,1,saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity,MF,
12645,GO:0047134,1,0.979289448702871,0,4,protein-disulfide reductase activity,MF,
12646,GO:0047144,1,0.986784665022677,0,2,2-acylglycerol-3-phosphate O-acyltransferase activity,MF,
12647,GO:0047150,1,0.993912471301853,0,1,betaine-homocysteine S-methyltransferase activity,MF,
12648,GO:0047159,1,0.984320741399286,0,2,1-alkenylglycerophosphocholine O-acyltransferase activity,MF,
12649,GO:0047166,1,0.995039461022932,0,1,1-alkenylglycerophosphoethanolamine O-acyltransferase activity,MF,
12650,GO:0047173,1,0.99204782065794,0,1,phosphatidylcholine-retinol O-acyltransferase activity,MF,
12651,GO:0047179,1,0.988761127174801,0,3,platelet-activating factor acetyltransferase activity,MF,
12652,GO:0047184,1,0.969098095844951,0,5,1-acylglycerophosphocholine O-acyltransferase activity,MF,
12653,GO:0047186,1,0.992666957797591,0,1,N-acetylneuraminate 7-O(or 9-O)-acetyltransferase activity,MF,
12654,GO:0047191,1,0.992639097546823,0,1,1-alkylglycerophosphocholine O-acyltransferase activity,MF,
12655,GO:0047192,1,0.979437209857502,0,3,1-alkylglycerophosphocholine O-acetyltransferase activity,MF,
12656,GO:0047220,1,0.99346174666947,0,1,galactosylxylosylprotein 3-beta-galactosyltransferase activity,MF,
12657,GO:0047223,1,0.993374064046072,0,1,beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity,MF,
12658,GO:0047237,1,0.97887894925848,0,3,glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,MF,
12659,GO:0047238,1,0.957150966575751,0,6,glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,MF,
12660,GO:0047256,1,0.992559194830865,0,1,lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity,MF,
12661,GO:0047263,1,0.993313246129226,0,1,N-acylsphingosine galactosyltransferase activity,MF,
12662,GO:0047273,1,0.99294804144329,0,1,galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity,MF,
12663,GO:0047275,1,0.987408663506405,0,2,glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity,MF,
12664,GO:0047276,1,0.993485400251684,0,1,N-acetyllactosaminide 3-alpha-galactosyltransferase activity,MF,
12665,GO:0047277,1,0.994975157885282,0,1,globoside alpha-N-acetylgalactosaminyltransferase activity,MF,
12666,GO:0047280,1,0.992272599785769,0,1,nicotinamide phosphoribosyltransferase activity,MF,
12667,GO:0047288,1,0.987757822049489,0,2,monosialoganglioside sialyltransferase activity,MF,
12668,GO:0047290,1,0.990040595253732,0,2,(alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3)-N-acetyl-galactosaminide 6-alpha-sialyltransferase activity,MF,
12669,GO:0047291,1,0.994267133521178,0,1,lactosylceramide alpha-2,3-sialyltransferase activity,MF,
12670,GO:0047293,1,0.995550085626571,0,1,4-hydroxybenzoate nonaprenyltransferase activity,MF,
12671,GO:0047298,1,0.992022490948624,0,1,(S)-3-amino-2-methylpropionate transaminase activity,MF,
12672,GO:0047322,1,0.98019290116397,0,2,[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity,MF,
12673,GO:0047323,1,0.994614426657296,0,1,[3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity,MF,
12674,GO:0047325,1,0.99298843235316,0,1,inositol tetrakisphosphate 1-kinase activity,MF,
12675,GO:0047326,1,0.995272600272908,0,1,inositol tetrakisphosphate 5-kinase activity,MF,
12676,GO:0047341,1,0.992882637749378,0,1,fucose-1-phosphate guanylyltransferase activity,MF,
12677,GO:0047369,1,0.993485400251684,0,1,succinate-hydroxymethylglutarate CoA-transferase activity,MF,
12678,GO:0047372,1,0.932610267213045,0,11,acylglycerol lipase activity,MF,
12679,GO:0047374,1,0.983841992481351,0,3,methylumbelliferyl-acetate deacetylase activity,MF,
12680,GO:0047381,1,0.995339572237529,0,1,dodecanoyl-[acyl-carrier-protein] hydrolase activity,MF,
12681,GO:0047389,1,0.984652016544447,0,2,glycerophosphocholine phosphodiesterase activity,MF,
12682,GO:0047390,1,0.992645815319127,0,1,glycerophosphocholine cholinephosphodiesterase activity,MF,
12683,GO:0047391,1,0.986148078763911,0,2,alkylglycerophosphoethanolamine phosphodiesterase activity,MF,
12684,GO:0047394,1,0.994405314123023,0,1,glycerophosphoinositol inositolphosphodiesterase activity,MF,
12685,GO:0047395,1,0.99327483731023,0,1,glycerophosphoinositol glycerophosphodiesterase activity,MF,
12686,GO:0047408,1,0.9881943254353,0,2,alkenylglycerophosphocholine hydrolase activity,MF,
12687,GO:0047409,1,0.9881943254353,0,2,alkenylglycerophosphoethanolamine hydrolase activity,MF,
12688,GO:0047412,1,0.995258527956675,0,1,N-(long-chain-acyl)ethanolamine deacylase activity,MF,
12689,GO:0047419,1,0.995194259872767,0,1,N-acetylgalactosamine-6-phosphate deacetylase activity,MF,
12690,GO:0047429,1,0.94704239158083,0,9,nucleoside-triphosphate diphosphatase activity,MF,
12691,GO:0047444,1,0.996195924714731,0,1,N-acylneuraminate-9-phosphate synthase activity,MF,
12692,GO:0047451,1,0.988938770380431,0,1,3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity,MF,
12693,GO:0047464,1,0.991921327404503,0,1,heparosan-N-sulfate-glucuronate 5-epimerase activity,MF,
12694,GO:0047484,1,0.913046025290697,0,14,regulation of response to osmotic stress,BP,
12695,GO:0047485,1,0.509064416741297,0,103,protein N-terminus binding,MF,
12696,GO:0047493,1,0.979595389389854,0,3,ceramide cholinephosphotransferase activity,MF,
12697,GO:0047496,1,0.708328886064282,0,45,vesicle transport along microtubule,BP,
12698,GO:0047497,1,0.851016758188827,0,22,mitochondrion transport along microtubule,BP,
12699,GO:0047498,1,0.945727375384162,0,9,calcium-dependent phospholipase A2 activity,MF,
12700,GO:0047499,1,0.953386906015523,0,8,calcium-independent phospholipase A2 activity,MF,
12701,GO:0047522,1,0.981642524990753,0,3,15-oxoprostaglandin 13-oxidase activity,MF,
12702,GO:0047536,1,0.994432623326744,0,1,2-aminoadipate transaminase activity,MF,
12703,GO:0047545,1,0.99099632162095,0,1,2-hydroxyglutarate dehydrogenase activity,MF,
12704,GO:0047555,1,0.929130244108361,0,10,3',5'-cyclic-GMP phosphodiesterase activity,MF,
12705,GO:0047560,1,0.99178820665718,0,1,3-dehydrosphinganine reductase activity,MF,
12706,GO:0047598,1,0.993655100153634,0,1,7-dehydrocholesterol reductase activity,MF,
12707,GO:0047603,1,0.996315418666904,0,1,acetoacetyl-CoA hydrolase activity,MF,
12708,GO:0047609,1,0.993603752887042,0,1,acetylputrescine deacetylase activity,MF,
12709,GO:0047611,1,0.993603752887042,0,1,acetylspermidine deacetylase activity,MF,
12710,GO:0047617,1,0.906150948498652,0,18,acyl-CoA hydrolase activity,MF,
12711,GO:0047620,1,0.99327483731023,0,1,acylglycerol kinase activity,MF,
12712,GO:0047621,1,0.995481126780028,0,1,acylpyruvate hydrolase activity,MF,
12713,GO:0047623,1,0.985215327750068,0,2,adenosine-phosphate deaminase activity,MF,
12714,GO:0047631,1,0.978738008587895,0,5,ADP-ribose diphosphatase activity,MF,
12715,GO:0047635,1,0.987776529860468,0,2,alanine-oxo-acid transaminase activity,MF,
12716,GO:0047655,1,0.983076042148433,0,4,allyl-alcohol dehydrogenase activity,MF,
12717,GO:0047658,1,0.995450692884757,0,1,alpha-amino-acid esterase activity,MF,
12718,GO:0047661,1,0.993951530489555,0,1,amino-acid racemase activity,MF,
12719,GO:0047676,1,0.927000253046355,0,11,arachidonate-CoA ligase activity,MF,
12720,GO:0047677,1,0.993894878504628,0,1,arachidonate 8(R)-lipoxygenase activity,MF,
12721,GO:0047685,1,0.995779061576149,0,1,amine sulfotransferase activity,MF,
12722,GO:0047693,1,0.996906466060705,0,1,ATP diphosphatase activity,MF,
12723,GO:0047696,1,0.987089313990864,0,2,beta-adrenergic receptor kinase activity,MF,
12724,GO:0047704,1,0.99489870426208,0,1,bile-salt sulfotransferase activity,MF,
12725,GO:0047708,1,0.991069631097337,0,2,biotinidase activity,MF,
12726,GO:0047710,1,0.988648835772748,0,2,bis(5'-adenosyl)-triphosphatase activity,MF,
12727,GO:0047718,1,0.987866276849783,0,3,indanol dehydrogenase activity,MF,
12728,GO:0047726,1,0.99390014550595,0,1,iron-cytochrome-c reductase activity,MF,
12729,GO:0047730,1,0.992636844474795,0,1,carnosine synthase activity,MF,
12730,GO:0047734,1,0.993485400251684,0,1,CDP-glycerol diphosphatase activity,MF,
12731,GO:0047743,1,0.996260516059963,0,1,chlordecone reductase activity,MF,
12732,GO:0047747,1,0.988444117003573,0,2,cholate-CoA ligase activity,MF,
12733,GO:0047749,1,0.994293996396013,0,1,cholestanetriol 26-monooxygenase activity,MF,
12734,GO:0047750,1,0.992900105596885,0,2,cholestenol delta-isomerase activity,MF,
12735,GO:0047751,1,0.988043120815176,0,2,cholestenone 5-alpha-reductase activity,MF,
12736,GO:0047756,1,0.981544367655197,0,3,chondroitin 4-sulfotransferase activity,MF,
12737,GO:0047757,1,0.980989080271011,0,2,chondroitin-glucuronate 5-epimerase activity,MF,
12738,GO:0047760,1,0.958428908218254,0,7,butyrate-CoA ligase activity,MF,
12739,GO:0047777,1,0.99128577301311,0,1,(S)-citramalyl-CoA lyase activity,MF,
12740,GO:0047780,1,0.986366143579771,0,2,citrate dehydratase activity,MF,
12741,GO:0047787,1,0.996216597465047,0,1,delta4-3-oxosteroid 5beta-reductase activity,MF,
12742,GO:0047800,1,0.99274058950944,0,1,cysteamine dioxygenase activity,MF,
12743,GO:0047801,1,0.994618375429374,0,1,L-cysteine:2-oxoglutarate aminotransferase activity,MF,
12744,GO:0047837,1,0.996421487456059,0,1,D-xylose 1-dehydrogenase (NADP+) activity,MF,
12745,GO:0047840,1,0.996375183284148,0,1,dCTP diphosphatase activity,MF,
12746,GO:0047844,1,0.961229953580724,0,8,deoxycytidine deaminase activity,MF,
12747,GO:0047860,1,0.996148240035882,0,1,diiodophenylpyruvate reductase activity,MF,
12748,GO:0047865,1,0.993117618240289,0,1,dimethylglycine dehydrogenase activity,MF,
12749,GO:0047874,1,0.994651955901444,0,1,dolichyldiphosphatase activity,MF,
12750,GO:0047886,1,0.995569321829469,0,1,farnesol dehydrogenase activity,MF,
12751,GO:0047888,1,0.994973203220735,0,1,fatty acid peroxidase activity,MF,
12752,GO:0047894,1,0.987787868279598,0,3,flavonol 3-sulfotransferase activity,MF,
12753,GO:0047915,1,0.995477558231945,0,1,ganglioside galactosyltransferase activity,MF,
12754,GO:0047933,1,0.988926317726174,0,1,glucose-1,6-bisphosphate synthase activity,MF,
12755,GO:0047936,1,0.988430011882112,0,1,glucose 1-dehydrogenase [NAD(P)] activity,MF,
12756,GO:0047939,1,0.995831605285646,0,1,L-glucuronate reductase activity,MF,
12757,GO:0047941,1,0.995831605285646,0,1,glucuronolactone reductase activity,MF,
12758,GO:0047946,1,0.994736956673654,0,1,glutamine N-acyltransferase activity,MF,
12759,GO:0047952,1,0.993343729418894,0,1,glycerol-3-phosphate dehydrogenase [NAD(P)+] activity,MF,
12760,GO:0047961,1,0.990745241096498,0,2,glycine N-acyltransferase activity,MF,
12761,GO:0047963,1,0.992882358566691,0,1,glycine N-choloyltransferase activity,MF,
12762,GO:0047975,1,0.993485400251684,0,1,guanosine phosphorylase activity,MF,
12763,GO:0047977,1,0.987805370407941,0,2,hepoxilin-epoxide hydrolase activity,MF,
12764,GO:0047988,1,0.995066610505164,0,1,hydroxyacid-oxoacid transhydrogenase activity,MF,
12765,GO:0047992,1,0.993485400251684,0,1,hydroxylysine kinase activity,MF,
12766,GO:0047994,1,0.996315418666904,0,1,hydroxymethylglutaryl-CoA hydrolase activity,MF,
12768,GO:0048003,1,0.961542055600509,0,6,antigen processing and presentation of lipid antigen via MHC class Ib,BP,
12769,GO:0048006,1,0.976420349168539,0,4,antigen processing and presentation, endogenous lipid antigen via MHC class Ib,BP,
12770,GO:0048007,1,0.961542055600509,0,6,antigen processing and presentation, exogenous lipid antigen via MHC class Ib,BP,
12771,GO:0048008,1,0.655602741925508,0,54,platelet-derived growth factor receptor signaling pathway,BP,
12773,GO:0048010,1,0.548265772700908,0,89,vascular endothelial growth factor receptor signaling pathway,BP,
12774,GO:0048011,1,0.808694148127479,0,31,neurotrophin TRK receptor signaling pathway,BP,
12775,GO:0048012,1,0.901698672322766,0,16,hepatocyte growth factor receptor signaling pathway,BP,
12777,GO:0048014,1,0.962694040513128,0,4,Tie signaling pathway,BP,
12778,GO:0048015,1,0.286375901576705,0,171,phosphatidylinositol-mediated signaling,BP,
12779,GO:0048016,1,0.679992063907203,0,52,inositol phosphate-mediated signaling,BP,
12780,GO:0048017,1,0.278401529202408,0,175,inositol lipid-mediated signaling,BP,
12782,GO:0048019,1,0.915875207570615,0,15,receptor antagonist activity,MF,
12783,GO:0048020,1,0.902558586290868,0,24,CCR chemokine receptor binding,MF,
12784,GO:0048021,1,0.923473970761834,0,10,regulation of melanin biosynthetic process,BP,
12785,GO:0048022,1,0.975263634899153,0,3,negative regulation of melanin biosynthetic process,BP,
12786,GO:0048023,1,0.958424234727706,0,6,positive regulation of melanin biosynthetic process,BP,
12787,GO:0048024,1,0.495458936620959,0,105,regulation of mRNA splicing, via spliceosome,BP,
12788,GO:0048025,1,0.871354898961529,0,22,negative regulation of mRNA splicing, via spliceosome,BP,
12789,GO:0048026,1,0.880899139041354,0,21,positive regulation of mRNA splicing, via spliceosome,BP,
12790,GO:0048027,1,0.851098286706257,0,26,mRNA 5'-UTR binding,MF,
12791,GO:0048029,1,0.670993885001094,0,64,monosaccharide binding,MF,
12792,GO:0048030,1,0.988012964023972,0,3,disaccharide binding,MF,
12793,GO:0048033,1,0.99320639275261,0,1,heme o metabolic process,BP,
12794,GO:0048034,1,0.99320639275261,0,1,heme O biosynthetic process,BP,
12795,GO:0048038,1,0.93040056680692,0,15,quinone binding,MF,
12796,GO:0048039,1,0.97225175719833,0,6,ubiquinone binding,MF,
12797,GO:0048040,1,0.994691487034644,0,1,UDP-glucuronate decarboxylase activity,MF,
12798,GO:0048041,1,0.530916214986677,0,81,focal adhesion assembly,BP,
12799,GO:0048048,1,0.7404162919986,0,37,embryonic eye morphogenesis,BP,
12800,GO:0048050,1,0.964191892428115,0,6,post-embryonic eye morphogenesis,BP,
12801,GO:0048066,1,0.735416864512408,0,43,developmental pigmentation,BP,
12802,GO:0048069,1,0.963484250823627,0,6,eye pigmentation,BP,
12803,GO:0048070,1,0.897546099512585,0,15,regulation of developmental pigmentation,BP,
12804,GO:0048073,1,0.979749096589562,0,3,regulation of eye pigmentation,BP,
12805,GO:0048074,1,0.994738933398728,0,1,negative regulation of eye pigmentation,BP,
12806,GO:0048075,1,0.99245156356705,0,1,positive regulation of eye pigmentation,BP,
12807,GO:0048086,1,0.994738933398728,0,1,negative regulation of developmental pigmentation,BP,
12808,GO:0048087,1,0.932186487515272,0,9,positive regulation of developmental pigmentation,BP,
12809,GO:0048096,1,0.909127529446819,0,13,chromatin-mediated maintenance of transcription,BP,
12810,GO:0048101,1,0.981085731261622,0,3,calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity,MF,
12811,GO:0048102,1,0.933345055829607,0,11,autophagic cell death,BP,
12812,GO:0048103,1,0.934427482907729,0,9,somatic stem cell division,BP,
12813,GO:0048104,1,0.963683528861398,0,4,establishment of body hair or bristle planar orientation,BP,
12814,GO:0048105,1,0.963683528861398,0,4,establishment of body hair planar orientation,BP,
12815,GO:0048133,1,0.98326760816779,0,3,male germ-line stem cell asymmetric division,BP,
12816,GO:0048143,1,0.866943992383132,0,22,astrocyte activation,BP,
12817,GO:0048144,1,0.597703053578512,0,77,fibroblast proliferation,BP,
12818,GO:0048145,1,0.602146544583792,0,76,regulation of fibroblast proliferation,BP,
12819,GO:0048146,1,0.727629969628149,0,47,positive regulation of fibroblast proliferation,BP,
12820,GO:0048147,1,0.845157758803949,0,27,negative regulation of fibroblast proliferation,BP,
12821,GO:0048148,1,0.930541602972534,0,12,behavioral response to cocaine,BP,
12822,GO:0048149,1,0.94096618319028,0,9,behavioral response to ethanol,BP,
12823,GO:0048156,1,0.730930676253815,0,44,tau protein binding,MF,
12824,GO:0048160,1,0.992242130543691,0,1,primary follicle stage,BP,
12825,GO:0048162,1,0.984695801673097,0,3,multi-layer follicle stage,BP,
12826,GO:0048165,1,0.978867026347393,0,3,fused antrum stage,BP,
12833,GO:0048175,1,0.993029393211783,0,1,hepatocyte growth factor biosynthetic process,BP,
12834,GO:0048176,1,0.993029393211783,0,1,regulation of hepatocyte growth factor biosynthetic process,BP,
12835,GO:0048178,1,0.993029393211783,0,1,negative regulation of hepatocyte growth factor biosynthetic process,BP,
12836,GO:0048179,1,0.947604600839666,0,6,activin receptor complex,CC,
12837,GO:0048180,1,0.994537542124391,0,1,activin complex,CC,
12838,GO:0048185,1,0.901643835064089,0,14,activin binding,MF,
12839,GO:0048188,1,0.921485681510433,0,11,Set1C/COMPASS complex,CC,
12841,GO:0048194,1,0.580905410752168,0,79,Golgi vesicle budding,BP,
12842,GO:0048199,1,0.618289489897452,0,72,vesicle targeting, to, from or within Golgi,BP,
12843,GO:0048200,1,0.961449457538851,0,6,Golgi transport vesicle coating,BP,
12844,GO:0048203,1,0.988406489678089,0,2,vesicle targeting, trans-Golgi to endosome,BP,
12845,GO:0048205,1,0.961449457538851,0,6,COPI coating of Golgi vesicle,BP,
12846,GO:0048207,1,0.652039273949794,0,64,vesicle targeting, rough ER to cis-Golgi,BP,
12847,GO:0048208,1,0.652039273949794,0,64,COPII vesicle coating,BP,
12848,GO:0048209,1,0.965604626534491,0,5,regulation of vesicle targeting, to, from or within Golgi,BP,
12849,GO:0048210,1,0.978325190501542,0,4,Golgi vesicle fusion to target membrane,BP,
12850,GO:0048211,1,0.986188276479958,0,2,Golgi vesicle docking,BP,
12851,GO:0048213,1,0.988769167293048,0,2,Golgi vesicle prefusion complex stabilization,BP,
12852,GO:0048219,1,0.992039141268111,0,1,inter-Golgi cisterna vesicle-mediated transport,BP,
12853,GO:0048227,1,0.949489159060786,0,8,plasma membrane to endosome transport,BP,
12855,GO:0048237,1,0.985900653928766,0,3,rough endoplasmic reticulum lumen,CC,
12856,GO:0048239,1,0.988002741957194,0,2,negative regulation of DNA recombination at telomere,BP,
12857,GO:0048240,1,0.906543358422845,0,17,sperm capacitation,BP,
12858,GO:0048241,1,0.956809203569026,0,8,epinephrine transport,BP,
12859,GO:0048242,1,0.976311981596237,0,5,epinephrine secretion,BP,
12860,GO:0048243,1,0.923760545797535,0,13,norepinephrine secretion,BP,
12861,GO:0048244,1,0.99550779028936,0,1,phytanoyl-CoA dioxygenase activity,MF,
12862,GO:0048245,1,0.950499698256553,0,11,eosinophil chemotaxis,BP,
12863,GO:0048246,1,0.819611818828256,0,35,macrophage chemotaxis,BP,
12864,GO:0048247,1,0.777833520214473,0,48,lymphocyte chemotaxis,BP,
12865,GO:0048248,1,0.979566782693988,0,5,CXCR3 chemokine receptor binding,MF,
12866,GO:0048250,1,0.990864072055161,0,2,iron import into the mitochondrion,BP,
12867,GO:0048251,1,0.924655306613275,0,10,elastic fiber assembly,BP,
12868,GO:0048254,1,0.97853066719563,0,4,snoRNA localization,BP,
12869,GO:0048255,1,0.765729576085222,0,38,mRNA stabilization,BP,
12870,GO:0048256,1,0.940263949606458,0,9,flap endonuclease activity,MF,
12871,GO:0048257,1,0.987604217992402,0,2,3'-flap endonuclease activity,MF,
12873,GO:0048260,1,0.719901033426141,0,47,positive regulation of receptor-mediated endocytosis,BP,
12874,GO:0048261,1,0.865976613322944,0,23,negative regulation of receptor-mediated endocytosis,BP,
12875,GO:0048262,1,0.948461501411815,0,9,determination of dorsal/ventral asymmetry,BP,
12876,GO:0048263,1,0.954960831591977,0,8,determination of dorsal identity,BP,
12877,GO:0048264,1,0.993197265540872,0,1,determination of ventral identity,BP,
12878,GO:0048265,1,0.829168223220229,0,28,response to pain,BP,
12879,GO:0048266,1,0.916443731941283,0,13,behavioral response to pain,BP,
12880,GO:0048268,1,0.890592693458489,0,16,clathrin coat assembly,BP,
12881,GO:0048269,1,0.98815544598452,0,2,methionine adenosyltransferase complex,CC,
12882,GO:0048270,1,0.994706314354456,0,1,methionine adenosyltransferase regulator activity,MF,
12883,GO:0048273,1,0.969310457458764,0,5,mitogen-activated protein kinase p38 binding,MF,
12885,GO:0048280,1,0.964530575034844,0,6,vesicle fusion with Golgi apparatus,BP,
12888,GO:0048286,1,0.734236676878692,0,40,lung alveolus development,BP,
12889,GO:0048289,1,0.96120774616289,0,6,isotype switching to IgE isotypes,BP,
12890,GO:0048290,1,0.96402522451761,0,6,isotype switching to IgA isotypes,BP,
12891,GO:0048291,1,0.921842513696874,0,12,isotype switching to IgG isotypes,BP,
12892,GO:0048293,1,0.96120774616289,0,6,regulation of isotype switching to IgE isotypes,BP,
12893,GO:0048294,1,0.979972906612113,0,3,negative regulation of isotype switching to IgE isotypes,BP,
12894,GO:0048295,1,0.980855183907437,0,3,positive regulation of isotype switching to IgE isotypes,BP,
12895,GO:0048296,1,0.970890831017053,0,5,regulation of isotype switching to IgA isotypes,BP,
12896,GO:0048297,1,0.994610478347674,0,1,negative regulation of isotype switching to IgA isotypes,BP,
12897,GO:0048298,1,0.976153096969673,0,4,positive regulation of isotype switching to IgA isotypes,BP,
12898,GO:0048302,1,0.927172532328675,0,11,regulation of isotype switching to IgG isotypes,BP,
12899,GO:0048304,1,0.945982486334155,0,8,positive regulation of isotype switching to IgG isotypes,BP,
12900,GO:0048305,1,0.904686860853121,0,19,immunoglobulin secretion,BP,
12902,GO:0048308,1,0.9108701829737,0,15,organelle inheritance,BP,
12903,GO:0048311,1,0.881091045608873,0,16,mitochondrion distribution,BP,
12904,GO:0048312,1,0.938000937094064,0,8,intracellular distribution of mitochondria,BP,
12905,GO:0048313,1,0.9108701829737,0,15,Golgi inheritance,BP,
12906,GO:0048318,1,0.95906465162361,0,7,axial mesoderm development,BP,
12907,GO:0048319,1,0.978092292325625,0,3,axial mesoderm morphogenesis,BP,
12908,GO:0048320,1,0.987384693478016,0,2,axial mesoderm formation,BP,
12909,GO:0048321,1,0.994709279864805,0,1,axial mesodermal cell differentiation,BP,
12910,GO:0048322,1,0.994709279864805,0,1,axial mesodermal cell fate commitment,BP,
12911,GO:0048327,1,0.994709279864805,0,1,axial mesodermal cell fate specification,BP,
12914,GO:0048338,1,0.992783259455901,0,1,mesoderm structural organization,BP,
12915,GO:0048339,1,0.883766342291093,0,17,paraxial mesoderm development,BP,
12916,GO:0048340,1,0.934045025642297,0,9,paraxial mesoderm morphogenesis,BP,
12917,GO:0048341,1,0.96138590631025,0,6,paraxial mesoderm formation,BP,
12918,GO:0048342,1,0.995490034314955,0,1,paraxial mesodermal cell differentiation,BP,
12919,GO:0048343,1,0.995490034314955,0,1,paraxial mesodermal cell fate commitment,BP,
12920,GO:0048352,1,0.992783259455901,0,1,paraxial mesoderm structural organization,BP,
12921,GO:0048365,1,0.611362069498355,0,65,Rac GTPase binding,MF,
12922,GO:0048368,1,0.911877922877772,0,15,lateral mesoderm development,BP,
12923,GO:0048369,1,0.973876129347516,0,4,lateral mesoderm morphogenesis,BP,
12924,GO:0048370,1,0.973876129347516,0,4,lateral mesoderm formation,BP,
12925,GO:0048371,1,0.97815928466544,0,3,lateral mesodermal cell differentiation,BP,
12926,GO:0048372,1,0.984247491530397,0,2,lateral mesodermal cell fate commitment,BP,
12927,GO:0048377,1,0.984247491530397,0,2,lateral mesodermal cell fate specification,BP,
12928,GO:0048378,1,0.984247491530397,0,2,regulation of lateral mesodermal cell fate specification,BP,
12929,GO:0048382,1,0.954967891458573,0,7,mesendoderm development,BP,
12930,GO:0048384,1,0.82076172605032,0,32,retinoic acid receptor signaling pathway,BP,
12931,GO:0048385,1,0.904327459173979,0,17,regulation of retinoic acid receptor signaling pathway,BP,
12932,GO:0048386,1,0.969330975729389,0,5,positive regulation of retinoic acid receptor signaling pathway,BP,
12933,GO:0048387,1,0.944805034842839,0,9,negative regulation of retinoic acid receptor signaling pathway,BP,
12934,GO:0048388,1,0.983734160371938,0,3,endosomal lumen acidification,BP,
12935,GO:0048389,1,0.990403938044236,0,2,intermediate mesoderm development,BP,
12936,GO:0048390,1,0.995293167006598,0,1,intermediate mesoderm morphogenesis,BP,
12937,GO:0048391,1,0.995293167006598,0,1,intermediate mesoderm formation,BP,
12938,GO:0048392,1,0.995293167006598,0,1,intermediate mesodermal cell differentiation,BP,
12939,GO:0048403,1,0.974608540690766,0,3,brain-derived neurotrophic factor binding,MF,
12940,GO:0048406,1,0.962774108882143,0,5,nerve growth factor binding,MF,
12941,GO:0048407,1,0.910612154525706,0,11,platelet-derived growth factor binding,MF,
12942,GO:0048408,1,0.98392108491618,0,3,epidermal growth factor binding,MF,
12944,GO:0048469,1,0.360922016255106,0,154,cell maturation,BP,
12947,GO:0048476,1,0.974703138423856,0,5,Holliday junction resolvase complex,CC,
12949,GO:0048478,1,0.944092963023431,0,8,replication fork protection,BP,
12950,GO:0048483,1,0.740185284630166,0,42,autonomic nervous system development,BP,
12951,GO:0048484,1,0.920356353106222,0,13,enteric nervous system development,BP,
12952,GO:0048485,1,0.863712660308519,0,20,sympathetic nervous system development,BP,
12953,GO:0048486,1,0.896919605467812,0,16,parasympathetic nervous system development,BP,
12954,GO:0048487,1,0.787901094672384,0,37,beta-tubulin binding,MF,
12957,GO:0048490,1,0.893916637454419,0,18,anterograde synaptic vesicle transport,BP,
12958,GO:0048495,1,0.944746108631339,0,7,Roundabout binding,MF,
12959,GO:0048496,1,0.964280189898092,0,4,maintenance of animal organ identity,BP,
12960,GO:0048499,1,0.97781757215222,0,4,synaptic vesicle membrane organization,BP,
12961,GO:0048500,1,0.953219723998018,0,9,signal recognition particle,CC,
12962,GO:0048505,1,0.921905313152029,0,12,regulation of timing of cell differentiation,BP,
12964,GO:0048512,1,0.74456502091644,0,45,circadian behavior,BP,
12970,GO:0048520,1,0.866997558153118,0,22,positive regulation of behavior,BP,
12971,GO:0048521,1,0.930505292497906,0,14,negative regulation of behavior,BP,
12975,GO:0048525,1,0.585341578674864,0,85,negative regulation of viral process,BP,
12976,GO:0048531,1,0.947072381068553,0,9,beta-1,3-galactosyltransferase activity,MF,
12977,GO:0048532,1,0.890299356082063,0,16,anatomical structure arrangement,BP,
12979,GO:0048535,1,0.906833142940858,0,16,lymph node development,BP,
12980,GO:0048536,1,0.807371084961643,0,32,spleen development,BP,
12981,GO:0048537,1,0.957296343702655,0,7,mucosa-associated lymphoid tissue development,BP,
12982,GO:0048538,1,0.731352321479327,0,44,thymus development,BP,
12983,GO:0048539,1,0.943567740925621,0,9,bone marrow development,BP,
12984,GO:0048541,1,0.957296343702655,0,7,Peyer's patch development,BP,
12987,GO:0048548,1,0.916982450644439,0,13,regulation of pinocytosis,BP,
12988,GO:0048549,1,0.945930321885119,0,8,positive regulation of pinocytosis,BP,
12989,GO:0048550,1,0.969414204380403,0,5,negative regulation of pinocytosis,BP,
12990,GO:0048557,1,0.897063281989338,0,16,embryonic digestive tract morphogenesis,BP,
12991,GO:0048560,1,0.988987515433822,0,2,establishment of anatomical structure orientation,BP,
12992,GO:0048561,1,0.994439461348745,0,1,establishment of animal organ orientation,BP,
12994,GO:0048563,1,0.946809096320303,0,8,post-embryonic animal organ morphogenesis,BP,
12996,GO:0048566,1,0.813027952529231,0,31,embryonic digestive tract development,BP,
12997,GO:0048567,1,0.99381533233784,0,1,ectodermal digestive tract morphogenesis,BP,
12999,GO:0048569,1,0.896908445422202,0,15,post-embryonic animal organ development,BP,
13000,GO:0048570,1,0.937414263200514,0,9,notochord morphogenesis,BP,
13008,GO:0048596,1,0.792045198638415,0,28,embryonic camera-type eye morphogenesis,BP,
13009,GO:0048597,1,0.98743765729172,0,3,post-embryonic camera-type eye morphogenesis,BP,
13011,GO:0048599,1,0.768121490797304,0,39,oocyte development,BP,
13014,GO:0048611,1,0.987099747161919,0,2,embryonic ectodermal digestive tract development,BP,
13015,GO:0048613,1,0.99381533233784,0,1,embryonic ectodermal digestive tract morphogenesis,BP,
13016,GO:0048617,1,0.927588784311108,0,9,embryonic foregut morphogenesis,BP,
13017,GO:0048619,1,0.980460486717513,0,3,embryonic hindgut morphogenesis,BP,
13018,GO:0048625,1,0.968378845178394,0,5,myoblast fate commitment,BP,
13019,GO:0048627,1,0.978704018880953,0,3,myoblast development,BP,
13020,GO:0048630,1,0.960491204954017,0,6,skeletal muscle tissue growth,BP,
13021,GO:0048631,1,0.969986991850009,0,4,regulation of skeletal muscle tissue growth,BP,
13022,GO:0048632,1,0.983890383208191,0,2,negative regulation of skeletal muscle tissue growth,BP,
13023,GO:0048633,1,0.985871239655358,0,2,positive regulation of skeletal muscle tissue growth,BP,
13026,GO:0048636,1,0.647637217304947,0,60,positive regulation of muscle organ development,BP,
13030,GO:0048641,1,0.742934299626957,0,42,regulation of skeletal muscle tissue development,BP,
13031,GO:0048642,1,0.925743185488934,0,11,negative regulation of skeletal muscle tissue development,BP,
13032,GO:0048643,1,0.878549228440841,0,19,positive regulation of skeletal muscle tissue development,BP,
13033,GO:0048644,1,0.564330914105741,0,74,muscle organ morphogenesis,BP,
13034,GO:0048645,1,0.654172927112994,0,63,animal organ formation,BP,
13036,GO:0048659,1,0.421348832144263,0,130,smooth muscle cell proliferation,BP,
13037,GO:0048660,1,0.42407504779908,0,129,regulation of smooth muscle cell proliferation,BP,
13038,GO:0048661,1,0.564246714639128,0,84,positive regulation of smooth muscle cell proliferation,BP,
13039,GO:0048662,1,0.767801329156349,0,43,negative regulation of smooth muscle cell proliferation,BP,
13041,GO:0048664,1,0.966950878697254,0,6,neuron fate determination,BP,
13045,GO:0048668,1,0.823289476049434,0,25,collateral sprouting,BP,
13046,GO:0048669,1,0.980463678953681,0,3,collateral sprouting in absence of injury,BP,
13047,GO:0048670,1,0.873936799497524,0,18,regulation of collateral sprouting,BP,
13048,GO:0048671,1,0.936786182515706,0,8,negative regulation of collateral sprouting,BP,
13049,GO:0048672,1,0.932951847554577,0,10,positive regulation of collateral sprouting,BP,
13050,GO:0048673,1,0.995650474160525,0,1,collateral sprouting of intact axon in response to injury,BP,
13051,GO:0048674,1,0.9840305255831,0,1,collateral sprouting of injured axon,BP,
13052,GO:0048675,1,0.393111321095386,0,119,axon extension,BP,
13053,GO:0048677,1,0.951701033768665,0,5,axon extension involved in regeneration,BP,
13054,GO:0048678,1,0.626176990400259,0,72,response to axon injury,BP,
13055,GO:0048679,1,0.833025488518795,0,25,regulation of axon regeneration,BP,
13056,GO:0048680,1,0.947228158913222,0,8,positive regulation of axon regeneration,BP,
13057,GO:0048681,1,0.90744482450221,0,13,negative regulation of axon regeneration,BP,
13058,GO:0048682,1,0.951701033768665,0,5,sprouting of injured axon,BP,
13059,GO:0048683,1,0.995650474160525,0,1,regulation of collateral sprouting of intact axon in response to injury,BP,
13060,GO:0048685,1,0.995650474160525,0,1,negative regulation of collateral sprouting of intact axon in response to injury,BP,
13061,GO:0048686,1,0.960123507332038,0,4,regulation of sprouting of injured axon,BP,
13062,GO:0048687,1,0.977483104107623,0,2,positive regulation of sprouting of injured axon,BP,
13063,GO:0048688,1,0.98224451407632,0,2,negative regulation of sprouting of injured axon,BP,
13064,GO:0048690,1,0.960123507332038,0,4,regulation of axon extension involved in regeneration,BP,
13065,GO:0048691,1,0.977483104107623,0,2,positive regulation of axon extension involved in regeneration,BP,
13066,GO:0048692,1,0.98224451407632,0,2,negative regulation of axon extension involved in regeneration,BP,
13067,GO:0048693,1,0.9840305255831,0,1,regulation of collateral sprouting of injured axon,BP,
13068,GO:0048694,1,0.9840305255831,0,1,positive regulation of collateral sprouting of injured axon,BP,
13069,GO:0048696,1,0.995796381866068,0,1,regulation of collateral sprouting in absence of injury,BP,
13070,GO:0048697,1,0.995796381866068,0,1,positive regulation of collateral sprouting in absence of injury,BP,
13072,GO:0048701,1,0.718138081981331,0,46,embryonic cranial skeleton morphogenesis,BP,
13073,GO:0048702,1,0.933673964119098,0,9,embryonic neurocranium morphogenesis,BP,
13074,GO:0048703,1,0.926523290174201,0,10,embryonic viscerocranium morphogenesis,BP,
13075,GO:0048704,1,0.545736046080257,0,91,embryonic skeletal system morphogenesis,BP,
13077,GO:0048706,1,0.440901759956361,0,122,embryonic skeletal system development,BP,
13078,GO:0048708,1,0.592886655889868,0,76,astrocyte differentiation,BP,
13080,GO:0048710,1,0.835808281150579,0,26,regulation of astrocyte differentiation,BP,
13081,GO:0048711,1,0.923866218227106,0,12,positive regulation of astrocyte differentiation,BP,
13082,GO:0048712,1,0.926206614516926,0,11,negative regulation of astrocyte differentiation,BP,
13084,GO:0048714,1,0.872040897873756,0,22,positive regulation of oligodendrocyte differentiation,BP,
13087,GO:0048730,1,0.828738278555221,0,28,epidermis morphogenesis,BP,
13090,GO:0048733,1,0.951400298398313,0,6,sebaceous gland development,BP,
13093,GO:0048739,1,0.902717981715702,0,10,cardiac muscle fiber development,BP,
13094,GO:0048741,1,0.836034379478518,0,26,skeletal muscle fiber development,BP,
13095,GO:0048742,1,0.945529837465798,0,8,regulation of skeletal muscle fiber development,BP,
13096,GO:0048743,1,0.969329127628286,0,5,positive regulation of skeletal muscle fiber development,BP,
13097,GO:0048745,1,0.84576752776152,0,22,smooth muscle tissue development,BP,
13098,GO:0048747,1,0.651829988245773,0,53,muscle fiber development,BP,
13099,GO:0048752,1,0.950577840380112,0,7,semicircular canal morphogenesis,BP,
13100,GO:0048753,1,0.829400130204521,0,28,pigment granule organization,BP,
13102,GO:0048755,1,0.923881253852808,0,10,branching morphogenesis of a nerve,BP,
13103,GO:0048757,1,0.939983027753895,0,10,pigment granule maturation,BP,
13105,GO:0048763,1,0.943374958823554,0,4,calcium-induced calcium release activity,MF,
13106,GO:0048769,1,0.955051791785021,0,3,sarcomerogenesis,BP,
13107,GO:0048770,1,0.526173110051487,0,101,pigment granule,CC,
13110,GO:0048787,1,0.801474097087572,0,30,presynaptic active zone membrane,CC,
13111,GO:0048788,1,0.939725172636749,0,5,cytoskeleton of presynaptic active zone,CC,
13112,GO:0048789,1,0.992020899761351,0,1,cytoskeletal matrix organization at active zone,BP,
13113,GO:0048790,1,0.945702017944477,0,5,maintenance of presynaptic active zone structure,BP,
13115,GO:0048792,1,0.992877638787398,0,1,spontaneous exocytosis of neurotransmitter,BP,
13116,GO:0048793,1,0.954791402992063,0,6,pronephros development,BP,
13117,GO:0048799,1,0.826076754490142,0,22,animal organ maturation,BP,
13118,GO:0048806,1,0.728019481396215,0,43,genitalia development,BP,
13119,GO:0048807,1,0.985937950174419,0,3,female genitalia morphogenesis,BP,
13120,GO:0048808,1,0.976748037961699,0,4,male genitalia morphogenesis,BP,
13124,GO:0048817,1,0.984350662984859,0,2,negative regulation of hair follicle maturation,BP,
13125,GO:0048818,1,0.969039338178916,0,5,positive regulation of hair follicle maturation,BP,
13126,GO:0048819,1,0.940219714894096,0,9,regulation of hair follicle maturation,BP,
13127,GO:0048820,1,0.883188104551297,0,16,hair follicle maturation,BP,
13128,GO:0048821,1,0.806956043196269,0,32,erythrocyte development,BP,
13129,GO:0048822,1,0.975854048962329,0,3,enucleate erythrocyte development,BP,
13131,GO:0048840,1,0.959002353706958,0,6,otolith development,BP,
13132,GO:0048841,1,0.774132524253936,0,31,regulation of axon extension involved in axon guidance,BP,
13133,GO:0048842,1,0.933148186125426,0,7,positive regulation of axon extension involved in axon guidance,BP,
13134,GO:0048843,1,0.819177406086518,0,25,negative regulation of axon extension involved in axon guidance,BP,
13135,GO:0048844,1,0.623315458950718,0,60,artery morphogenesis,BP,
13136,GO:0048845,1,0.9319164037059,0,9,venous blood vessel morphogenesis,BP,
13137,GO:0048846,1,0.74113598105913,0,36,axon extension involved in axon guidance,BP,
13138,GO:0048850,1,0.991228585807255,0,1,hypophysis morphogenesis,BP,
13139,GO:0048852,1,0.985825274328001,0,2,diencephalon morphogenesis,BP,
13140,GO:0048853,1,0.931289825059481,0,10,forebrain morphogenesis,BP,
13145,GO:0048859,1,0.972142076601607,0,5,formation of anatomical boundary,BP,
13146,GO:0048861,1,0.941930171878501,0,7,leukemia inhibitory factor signaling pathway,BP,
13147,GO:0048863,1,0.19136014563271,0,248,stem cell differentiation,BP,
13148,GO:0048864,1,0.555188371908663,0,83,stem cell development,BP,
13149,GO:0048865,1,0.956594243428113,0,8,stem cell fate commitment,BP,
13150,GO:0048866,1,0.97873717377328,0,4,stem cell fate specification,BP,
13151,GO:0048867,1,0.984912267378881,0,3,stem cell fate determination,BP,
13155,GO:0048872,1,0.202558491320362,0,240,homeostasis of number of cells,BP,
13156,GO:0048873,1,0.839592371596411,0,27,homeostasis of number of cells within a tissue,BP,
13157,GO:0048874,1,0.991778838884984,0,1,host-mediated regulation of intestinal microbiota composition,BP,
13158,GO:0048875,1,0.938514219681529,0,10,chemical homeostasis within a tissue,BP,
13161,GO:0048881,1,0.992413523228482,0,1,mechanosensory lateral line system development,BP,
13162,GO:0048882,1,0.986129654634289,0,2,lateral line development,BP,
13163,GO:0048884,1,0.986129654634289,0,2,neuromast development,BP,
13164,GO:0048886,1,0.986129654634289,0,2,neuromast hair cell differentiation,BP,
13165,GO:0048915,1,0.992413523228482,0,1,posterior lateral line system development,BP,
13166,GO:0048916,1,0.992413523228482,0,1,posterior lateral line development,BP,
13167,GO:0048919,1,0.992413523228482,0,1,posterior lateral line neuromast development,BP,
13168,GO:0048923,1,0.992413523228482,0,1,posterior lateral line neuromast hair cell differentiation,BP,
13169,GO:0048925,1,0.986129654634289,0,2,lateral line system development,BP,
13170,GO:0048934,1,0.905110043632846,0,13,peripheral nervous system neuron differentiation,BP,
13171,GO:0048935,1,0.905110043632846,0,13,peripheral nervous system neuron development,BP,
13172,GO:0048936,1,0.980668814306843,0,3,peripheral nervous system neuron axonogenesis,BP,
13174,GO:0050011,1,0.995636778667141,0,1,itaconyl-CoA hydratase activity,MF,
13175,GO:0050023,1,0.995143674960769,0,1,L-fuconate dehydratase activity,MF,
13176,GO:0050031,1,0.994069561690604,0,1,L-pipecolate oxidase activity,MF,
13177,GO:0050038,1,0.996757951334235,0,1,L-xylulose reductase (NADP+) activity,MF,
13178,GO:0050051,1,0.981742326100406,0,3,leukotriene-B4 20-monooxygenase activity,MF,
13179,GO:0050061,1,0.992719661335156,0,1,long-chain-aldehyde dehydrogenase activity,MF,
13180,GO:0050072,1,0.953523801017109,0,7,m7G(5')pppN diphosphatase activity,MF,
13181,GO:0050080,1,0.994494303577684,0,1,malonyl-CoA decarboxylase activity,MF,
13182,GO:0050104,1,0.995788143836214,0,1,L-gulonate 3-dehydrogenase activity,MF,
13183,GO:0050115,1,0.99204782065794,0,1,myosin-light-chain-phosphatase activity,MF,
13184,GO:0050121,1,0.995829158315924,0,1,N-acylglucosamine 2-epimerase activity,MF,
13185,GO:0050124,1,0.99270829998654,0,1,N-acylneuraminate-9-phosphatase activity,MF,
13186,GO:0050129,1,0.993028632191372,0,1,N-formylglutamate deformylase activity,MF,
13188,GO:0050136,1,0.870275933724654,0,38,NADH dehydrogenase (quinone) activity,MF,
13190,GO:0050152,1,0.996143738331454,0,1,omega-amidase activity,MF,
13191,GO:0050155,1,0.994909511305389,0,1,ornithine(lysine) transaminase activity,MF,
13192,GO:0050178,1,0.994094295580481,0,2,phenylpyruvate tautomerase activity,MF,
13193,GO:0050185,1,0.986826834601158,0,1,phosphatidylinositol deacylase activity,MF,
13194,GO:0050196,1,0.983872348543959,0,2,[phosphorylase] phosphatase activity,MF,
13195,GO:0050197,1,0.986995819638244,0,2,phytanate-CoA ligase activity,MF,
13196,GO:0050200,1,0.984320741399286,0,2,plasmalogen synthase activity,MF,
13197,GO:0050211,1,0.980316717828214,0,3,procollagen galactosyltransferase activity,MF,
13198,GO:0050218,1,0.974122859175966,0,4,propionate-CoA ligase activity,MF,
13199,GO:0050220,1,0.986035501687152,0,3,prostaglandin-E synthase activity,MF,
13200,GO:0050221,1,0.996191479964394,0,1,prostaglandin-E2 9-reductase activity,MF,
13201,GO:0050251,1,0.988907917102129,0,2,retinol isomerase activity,MF,
13202,GO:0050252,1,0.986781083874525,0,2,retinol O-fatty-acyltransferase activity,MF,
13203,GO:0050253,1,0.973011687300638,0,4,retinyl-palmitate esterase activity,MF,
13204,GO:0050254,1,0.984551791242815,0,3,rhodopsin kinase activity,MF,
13205,GO:0050255,1,0.993865211361605,0,1,ribitol 2-dehydrogenase activity,MF,
13206,GO:0050262,1,0.98701281886265,0,2,ribosylnicotinamide kinase activity,MF,
13207,GO:0050265,1,0.993402849735627,0,1,RNA uridylyltransferase activity,MF,
13208,GO:0050277,1,0.992688577582849,0,1,sedoheptulokinase activity,MF,
13209,GO:0050290,1,0.992154078894774,0,1,sphingomyelin phosphodiesterase D activity,MF,
13210,GO:0050291,1,0.961537336406604,0,6,sphingosine N-acyltransferase activity,MF,
13211,GO:0050294,1,0.982692716177192,0,4,steroid sulfotransferase activity,MF,
13212,GO:0050295,1,0.986915833873439,0,2,steryl-beta-glucosidase activity,MF,
13213,GO:0050308,1,0.950958610243454,0,8,sugar-phosphatase activity,MF,
13214,GO:0050309,1,0.981963345666009,0,3,sugar-terminal-phosphatase activity,MF,
13215,GO:0050313,1,0.9965839600578,0,1,sulfur dioxygenase activity,MF,
13216,GO:0050321,1,0.847729136705624,0,22,tau-protein kinase activity,MF,
13217,GO:0050333,1,0.995270726253176,0,1,thiamin-triphosphatase activity,MF,
13218,GO:0050337,1,0.997064675746922,0,1,thiosulfate-thiol sulfurtransferase activity,MF,
13219,GO:0050346,1,0.993485400251684,0,1,trans-L-3-hydroxyproline dehydratase activity,MF,
13220,GO:0050347,1,0.988428160009469,0,2,trans-octaprenyltranstransferase activity,MF,
13221,GO:0050353,1,0.993367163497724,0,1,trimethyllysine dioxygenase activity,MF,
13222,GO:0050355,1,0.992348393850973,0,1,triphosphatase activity,MF,
13223,GO:0050405,1,0.98019290116397,0,2,[acetyl-CoA carboxylase] kinase activity,MF,
13224,GO:0050421,1,0.99374152799939,0,1,nitrite reductase (NO-forming) activity,MF,
13226,GO:0050428,1,0.958947370877971,0,6,3'-phosphoadenosine 5'-phosphosulfate biosynthetic process,BP,
13227,GO:0050429,1,0.990674244987579,0,1,calcium-dependent phospholipase C activity,MF,
13228,GO:0050431,1,0.84617378875284,0,22,transforming growth factor beta binding,MF,
13231,GO:0050434,1,0.77180361580419,0,41,positive regulation of viral transcription,BP,
13232,GO:0050435,1,0.714142990767626,0,45,amyloid-beta metabolic process,BP,
13233,GO:0050436,1,0.973555201436357,0,3,microfibril binding,MF,
13234,GO:0050444,1,0.992963121628234,0,1,aquacobalamin reductase (NADPH) activity,MF,
13236,GO:0050462,1,0.996195924714731,0,1,N-acetylneuraminate synthase activity,MF,
13237,GO:0050473,1,0.981582095927638,0,3,arachidonate 15-lipoxygenase activity,MF,
13238,GO:0050479,1,0.993485400251684,0,1,glyceryl-ether monooxygenase activity,MF,
13239,GO:0050480,1,0.994600609725118,0,1,imidazolonepropionase activity,MF,
13241,GO:0050486,1,0.992942270753667,0,1,intramolecular transferase activity, transferring hydroxy groups,MF,
13242,GO:0050497,1,0.987833703088412,0,2,transferase activity, transferring alkylthio groups,MF,
13243,GO:0050501,1,0.976396250233391,0,4,hyaluronan synthase activity,MF,
13244,GO:0050508,1,0.978420124720381,0,3,glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
13245,GO:0050509,1,0.985706354470282,0,2,N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity,MF,
13246,GO:0050510,1,0.971307446534431,0,4,N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity,MF,
13247,GO:0050512,1,0.994699394861936,0,1,lactosylceramide 4-alpha-galactosyltransferase activity,MF,
13248,GO:0050528,1,0.994112177098516,0,1,acyloxyacyl hydrolase activity,MF,
13249,GO:0050542,1,0.975066324726153,0,6,icosanoid binding,MF,
13250,GO:0050543,1,0.976106803387446,0,6,icosatetraenoic acid binding,MF,
13251,GO:0050544,1,0.979630955608255,0,5,arachidonic acid binding,MF,
13252,GO:0050560,1,0.992920493834486,0,1,aspartate-tRNA(Asn) ligase activity,MF,
13253,GO:0050561,1,0.992654243017916,0,1,glutamate-tRNA(Gln) ligase activity,MF,
13254,GO:0050567,1,0.983397955973177,0,3,glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity,MF,
13255,GO:0050571,1,0.995604059194239,0,1,1,5-anhydro-D-fructose reductase activity,MF,
13256,GO:0050610,1,0.992631497452783,0,2,methylarsonate reductase activity,MF,
13257,GO:0050613,1,0.988379345748611,0,2,delta14-sterol reductase activity,MF,
13258,GO:0050614,1,0.992464098604673,0,1,delta24-sterol reductase activity,MF,
13259,GO:0050632,1,0.995917870026012,0,1,propionyl-CoA C2-trimethyltridecanoyltransferase activity,MF,
13260,GO:0050633,1,0.985684210812786,0,3,acetyl-CoA C-myristoyltransferase activity,MF,
13261,GO:0050646,1,0.995341418308426,0,1,5-oxo-6E,8Z,11Z,14Z-icosatetraenoic acid binding,MF,
13262,GO:0050647,1,0.995341418308426,0,1,5-hydroxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding,MF,
13263,GO:0050648,1,0.995341418308426,0,1,5(S)-hydroxyperoxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding,MF,
13264,GO:0050649,1,0.989980379811517,0,2,testosterone 6-beta-hydroxylase activity,MF,
13266,GO:0050651,1,0.895523426126534,0,15,dermatan sulfate proteoglycan biosynthetic process,BP,
13267,GO:0050652,1,0.992738419215014,0,1,dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
13268,GO:0050653,1,0.985429544393451,0,2,chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
13270,GO:0050655,1,0.890585756696337,0,16,dermatan sulfate proteoglycan metabolic process,BP,
13271,GO:0050656,1,0.957833333354206,0,6,3'-phosphoadenosine 5'-phosphosulfate binding,MF,
13272,GO:0050657,1,0.28193799978489,0,184,nucleic acid transport,BP,
13273,GO:0050658,1,0.28193799978489,0,184,RNA transport,BP,
13274,GO:0050659,1,0.983578381756774,0,2,N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity,MF,
13275,GO:0050660,1,0.597590360556377,0,78,flavin adenine dinucleotide binding,MF,
13276,GO:0050661,1,0.732976494583323,0,50,NADP binding,MF,
13277,GO:0050663,1,0.675200724166224,0,62,cytokine secretion,BP,
13278,GO:0050664,1,0.903188762922656,0,16,oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor,MF,
13279,GO:0050665,1,0.921988070394368,0,13,hydrogen peroxide biosynthetic process,BP,
13280,GO:0050666,1,0.98829166854641,0,2,regulation of homocysteine metabolic process,BP,
13281,GO:0050667,1,0.928232691553279,0,12,homocysteine metabolic process,BP,
13282,GO:0050668,1,0.994345115448986,0,1,positive regulation of homocysteine metabolic process,BP,
13285,GO:0050672,1,0.64622992425602,0,72,negative regulation of lymphocyte proliferation,BP,
13287,GO:0050674,1,0.997014122102647,0,1,urothelial cell proliferation,BP,
13288,GO:0050675,1,0.997014122102647,0,1,regulation of urothelial cell proliferation,BP,
13289,GO:0050677,1,0.997014122102647,0,1,positive regulation of urothelial cell proliferation,BP,
13293,GO:0050681,1,0.823827583650362,0,27,androgen receptor binding,MF,
13294,GO:0050682,1,0.973592184494969,0,3,AF-2 domain binding,MF,
13295,GO:0050683,1,0.992562296104272,0,1,AF-1 domain binding,MF,
13296,GO:0050684,1,0.381848114297307,0,143,regulation of mRNA processing,BP,
13297,GO:0050685,1,0.824146416406112,0,31,positive regulation of mRNA processing,BP,
13298,GO:0050686,1,0.818649153123106,0,31,negative regulation of mRNA processing,BP,
13299,GO:0050687,1,0.869233780663039,0,21,negative regulation of defense response to virus,BP,
13300,GO:0050688,1,0.654668166160134,0,63,regulation of defense response to virus,BP,
13301,GO:0050689,1,0.983906026199189,0,3,negative regulation of defense response to virus by host,BP,
13302,GO:0050690,1,0.834312111278473,0,29,regulation of defense response to virus by virus,BP,
13303,GO:0050691,1,0.814220206450884,0,32,regulation of defense response to virus by host,BP,
13304,GO:0050692,1,0.979927908055523,0,3,DNA binding domain binding,MF,
13305,GO:0050693,1,0.961552307409316,0,6,LBD domain binding,MF,
13306,GO:0050694,1,0.978128918908366,0,4,galactose 3-O-sulfotransferase activity,MF,
13307,GO:0050698,1,0.986839973230381,0,2,proteoglycan sulfotransferase activity,MF,
13308,GO:0050699,1,0.831027065992296,0,30,WW domain binding,MF,
13309,GO:0050700,1,0.911750057545499,0,14,CARD domain binding,MF,
13310,GO:0050707,1,0.729412188557802,0,50,regulation of cytokine secretion,BP,
13313,GO:0050710,1,0.912263414671993,0,15,negative regulation of cytokine secretion,BP,
13315,GO:0050715,1,0.847908263377216,0,27,positive regulation of cytokine secretion,BP,
13317,GO:0050728,1,0.467845643049442,0,123,negative regulation of inflammatory response,BP,
13322,GO:0050733,1,0.968385801862663,0,5,RS domain binding,MF,
13323,GO:0050746,1,0.91484787953842,0,14,regulation of lipoprotein metabolic process,BP,
13324,GO:0050747,1,0.968881550872311,0,5,positive regulation of lipoprotein metabolic process,BP,
13325,GO:0050748,1,0.971074988372696,0,5,negative regulation of lipoprotein metabolic process,BP,
13327,GO:0050755,1,0.996332591136268,0,1,chemokine metabolic process,BP,
13330,GO:0050760,1,0.993680546976758,0,1,negative regulation of thymidylate synthase biosynthetic process,BP,
13331,GO:0050764,1,0.581382074410085,0,85,regulation of phagocytosis,BP,
13332,GO:0050765,1,0.894115625478691,0,17,negative regulation of phagocytosis,BP,
13333,GO:0050766,1,0.678878623407559,0,62,positive regulation of phagocytosis,BP,
13337,GO:0050770,1,0.244779182860275,0,181,regulation of axonogenesis,BP,
13338,GO:0050771,1,0.59963903623306,0,68,negative regulation of axonogenesis,BP,
13339,GO:0050772,1,0.520780267863543,0,82,positive regulation of axonogenesis,BP,
13341,GO:0050774,1,0.890898888667243,0,16,negative regulation of dendrite morphogenesis,BP,
13342,GO:0050775,1,0.754669032922517,0,37,positive regulation of dendrite morphogenesis,BP,
13344,GO:0050777,1,0.445460502293342,0,132,negative regulation of immune response,BP,
13346,GO:0050779,1,0.776921019332717,0,34,RNA destabilization,BP,
13348,GO:0050783,1,0.994016440850835,0,1,cocaine metabolic process,BP,
13349,GO:0050785,1,0.996043308844349,0,1,advanced glycation end-product receptor activity,MF,
13350,GO:0050786,1,0.964596108309501,0,10,RAGE receptor binding,MF,
13351,GO:0050787,1,0.988544701181175,0,2,detoxification of mercury ion,BP,
13361,GO:0050802,1,0.890240163940497,0,21,circadian sleep/wake cycle, sleep,BP,
13368,GO:0050810,1,0.57326029670637,0,84,regulation of steroid biosynthetic process,BP,
13369,GO:0050811,1,0.88383820522049,0,17,GABA receptor binding,MF,
13370,GO:0050812,1,0.941382547616578,0,8,regulation of acyl-CoA biosynthetic process,BP,
13371,GO:0050815,1,0.950174565410228,0,8,phosphoserine residue binding,MF,
13372,GO:0050816,1,0.980126040356952,0,3,phosphothreonine residue binding,MF,
13373,GO:0050817,1,0.139325825059753,0,292,coagulation,BP,
13374,GO:0050818,1,0.61079926074061,0,78,regulation of coagulation,BP,
13376,GO:0050820,1,0.844699596722353,0,26,positive regulation of coagulation,BP,
13378,GO:0050822,1,0.992840527149174,0,1,peptide stabilization,BP,
13379,GO:0050823,1,0.992840527149174,0,1,peptide antigen stabilization,BP,
13380,GO:0050829,1,0.786426972382399,0,49,defense response to Gram-negative bacterium,BP,
13381,GO:0050830,1,0.737556934870935,0,60,defense response to Gram-positive bacterium,BP,
13382,GO:0050832,1,0.895154717543737,0,27,defense response to fungus,BP,
13383,GO:0050833,1,0.975279476750846,0,4,pyruvate transmembrane transporter activity,MF,
13385,GO:0050840,1,0.68471089457317,0,53,extracellular matrix binding,MF,
13386,GO:0050847,1,0.923457812089645,0,9,progesterone receptor signaling pathway,BP,
13387,GO:0050848,1,0.542380867503507,0,90,regulation of calcium-mediated signaling,BP,
13388,GO:0050849,1,0.826751333147524,0,29,negative regulation of calcium-mediated signaling,BP,
13391,GO:0050852,1,0.325629609135021,0,187,T cell receptor signaling pathway,BP,
13393,GO:0050854,1,0.658615696488263,0,65,regulation of antigen receptor-mediated signaling pathway,BP,
13394,GO:0050855,1,0.84508346050534,0,26,regulation of B cell receptor signaling pathway,BP,
13395,GO:0050856,1,0.767962689476758,0,42,regulation of T cell receptor signaling pathway,BP,
13396,GO:0050857,1,0.867837024304501,0,22,positive regulation of antigen receptor-mediated signaling pathway,BP,
13397,GO:0050858,1,0.838080629240322,0,30,negative regulation of antigen receptor-mediated signaling pathway,BP,
13398,GO:0050859,1,0.961482565124898,0,7,negative regulation of B cell receptor signaling pathway,BP,
13399,GO:0050860,1,0.871701617631762,0,23,negative regulation of T cell receptor signaling pathway,BP,
13400,GO:0050861,1,0.947936252720139,0,8,positive regulation of B cell receptor signaling pathway,BP,
13401,GO:0050862,1,0.91911776156725,0,14,positive regulation of T cell receptor signaling pathway,BP,
13407,GO:0050868,1,0.533554711142378,0,102,negative regulation of T cell activation,BP,
13408,GO:0050869,1,0.818740974701425,0,32,negative regulation of B cell activation,BP,
13411,GO:0050872,1,0.913986807256572,0,14,white fat cell differentiation,BP,
13412,GO:0050873,1,0.738390433425863,0,46,brown fat cell differentiation,BP,
13417,GO:0050882,1,0.929830036838103,0,7,voluntary musculoskeletal movement,BP,
13418,GO:0050883,1,0.989621714363206,0,2,musculoskeletal movement, spinal reflex action,BP,
13419,GO:0050884,1,0.900835315439765,0,15,neuromuscular process controlling posture,BP,
13421,GO:0050886,1,0.640610153758659,0,72,endocrine process,BP,
13425,GO:0050893,1,0.973744687439972,0,4,sensory processing,BP,
13426,GO:0050894,1,0.990500859303761,0,1,determination of affect,BP,
13428,GO:0050897,1,0.979584403182159,0,3,cobalt ion binding,MF,
13431,GO:0050902,1,0.986885517168139,0,2,leukocyte adhesive activation,BP,
13432,GO:0050904,1,0.963591711363988,0,5,diapedesis,BP,
13434,GO:0050906,1,0.567408589304704,0,95,detection of stimulus involved in sensory perception,BP,
13435,GO:0050907,1,0.820846104734398,0,42,detection of chemical stimulus involved in sensory perception,BP,
13436,GO:0050908,1,0.88338042141451,0,17,detection of light stimulus involved in visual perception,BP,
13437,GO:0050909,1,0.787491131392744,0,44,sensory perception of taste,BP,
13438,GO:0050910,1,0.929573342755932,0,11,detection of mechanical stimulus involved in sensory perception of sound,BP,
13439,GO:0050911,1,0.932061045763869,0,16,detection of chemical stimulus involved in sensory perception of smell,BP,
13440,GO:0050912,1,0.893202115164877,0,24,detection of chemical stimulus involved in sensory perception of taste,BP,
13441,GO:0050913,1,0.887316118724709,0,24,sensory perception of bitter taste,BP,
13442,GO:0050915,1,0.973859645834978,0,4,sensory perception of sour taste,BP,
13443,GO:0050916,1,0.966971172631797,0,5,sensory perception of sweet taste,BP,
13444,GO:0050917,1,0.960272615702338,0,6,sensory perception of umami taste,BP,
13445,GO:0050918,1,0.701923513692589,0,53,positive chemotaxis,BP,
13446,GO:0050919,1,0.690378882192428,0,46,negative chemotaxis,BP,
13447,GO:0050920,1,0.270314024420564,0,202,regulation of chemotaxis,BP,
13448,GO:0050921,1,0.441995060533264,0,133,positive regulation of chemotaxis,BP,
13449,GO:0050922,1,0.684821942720743,0,54,negative regulation of chemotaxis,BP,
13450,GO:0050923,1,0.966291636895934,0,4,regulation of negative chemotaxis,BP,
13451,GO:0050924,1,0.991971119219569,0,1,positive regulation of negative chemotaxis,BP,
13452,GO:0050925,1,0.98108884222429,0,2,negative regulation of negative chemotaxis,BP,
13453,GO:0050926,1,0.854117562942244,0,25,regulation of positive chemotaxis,BP,
13454,GO:0050927,1,0.861247701843072,0,24,positive regulation of positive chemotaxis,BP,
13455,GO:0050928,1,0.991733451649729,0,1,negative regulation of positive chemotaxis,BP,
13456,GO:0050929,1,0.991971119219569,0,1,induction of negative chemotaxis,BP,
13457,GO:0050930,1,0.934269653960228,0,13,induction of positive chemotaxis,BP,
13458,GO:0050931,1,0.774478820979928,0,34,pigment cell differentiation,BP,
13459,GO:0050932,1,0.938185658742752,0,8,regulation of pigment cell differentiation,BP,
13460,GO:0050942,1,0.942312575778357,0,7,positive regulation of pigment cell differentiation,BP,
13461,GO:0050951,1,0.867029036176922,0,21,sensory perception of temperature stimulus,BP,
13464,GO:0050955,1,0.968935875474005,0,4,thermoception,BP,
13466,GO:0050960,1,0.977339297227793,0,3,detection of temperature stimulus involved in thermoception,BP,
13467,GO:0050961,1,0.896692183070008,0,17,detection of temperature stimulus involved in sensory perception,BP,
13468,GO:0050962,1,0.88338042141451,0,17,detection of light stimulus involved in sensory perception,BP,
13469,GO:0050965,1,0.910659423818406,0,15,detection of temperature stimulus involved in sensory perception of pain,BP,
13470,GO:0050966,1,0.917262470583512,0,12,detection of mechanical stimulus involved in sensory perception of pain,BP,
13471,GO:0050968,1,0.986082984144528,0,2,detection of chemical stimulus involved in sensory perception of pain,BP,
13472,GO:0050974,1,0.832775027522264,0,27,detection of mechanical stimulus involved in sensory perception,BP,
13473,GO:0050975,1,0.969157637373443,0,5,sensory perception of touch,BP,
13474,GO:0050976,1,0.978336597620517,0,3,detection of mechanical stimulus involved in sensory perception of touch,BP,
13475,GO:0050982,1,0.73333028176423,0,40,detection of mechanical stimulus,BP,
13476,GO:0050992,1,0.994610478347674,0,1,dimethylallyl diphosphate biosynthetic process,BP,
13477,GO:0050993,1,0.994610478347674,0,1,dimethylallyl diphosphate metabolic process,BP,
13480,GO:0050996,1,0.874501994223124,0,20,positive regulation of lipid catabolic process,BP,
13484,GO:0051000,1,0.887308270264138,0,19,positive regulation of nitric-oxide synthase activity,BP,
13486,GO:0051004,1,0.911256115101,0,16,regulation of lipoprotein lipase activity,BP,
13487,GO:0051005,1,0.97526575319627,0,4,negative regulation of lipoprotein lipase activity,BP,
13488,GO:0051006,1,0.966118643311885,0,7,positive regulation of lipoprotein lipase activity,BP,
13489,GO:0051008,1,0.994976135093279,0,1,Hsp27 protein binding,MF,
13490,GO:0051010,1,0.841588356751584,0,20,microtubule plus-end binding,MF,
13491,GO:0051011,1,0.912420159457538,0,11,microtubule minus-end binding,MF,
13492,GO:0051012,1,0.983316539830277,0,2,microtubule sliding,BP,
13493,GO:0051013,1,0.925447033351209,0,11,microtubule severing,BP,
13494,GO:0051014,1,0.906404332644948,0,15,actin filament severing,BP,
13496,GO:0051016,1,0.873054298030972,0,20,barbed-end actin filament capping,BP,
13501,GO:0051021,1,0.975980269824029,0,4,GDP-dissociation inhibitor binding,MF,
13502,GO:0051022,1,0.980109177811987,0,3,Rho GDP-dissociation inhibitor binding,MF,
13503,GO:0051023,1,0.920944793626278,0,16,regulation of immunoglobulin secretion,BP,
13504,GO:0051024,1,0.958057258963222,0,9,positive regulation of immunoglobulin secretion,BP,
13505,GO:0051025,1,0.979903389901666,0,3,negative regulation of immunoglobulin secretion,BP,
13506,GO:0051026,1,0.968911298054473,0,5,chiasma assembly,BP,
13507,GO:0051028,1,0.376158990388812,0,140,mRNA transport,BP,
13508,GO:0051029,1,0.97035430511898,0,5,rRNA transport,BP,
13509,GO:0051030,1,0.982054418896692,0,4,snRNA transport,BP,
13510,GO:0051031,1,0.789898369055958,0,33,tRNA transport,BP,
13511,GO:0051032,1,0.984642996012103,0,2,nucleic acid transmembrane transporter activity,MF,
13512,GO:0051033,1,0.984642996012103,0,2,RNA transmembrane transporter activity,MF,
13513,GO:0051036,1,0.97182896028667,0,5,regulation of endosome size,BP,
13514,GO:0051040,1,0.986098093477605,0,2,regulation of calcium-independent cell-cell adhesion,BP,
13515,GO:0051041,1,0.992979387120577,0,1,positive regulation of calcium-independent cell-cell adhesion,BP,
13516,GO:0051042,1,0.993070540214286,0,1,negative regulation of calcium-independent cell-cell adhesion,BP,
13518,GO:0051044,1,0.921013013601424,0,13,positive regulation of membrane protein ectodomain proteolysis,BP,
13527,GO:0051053,1,0.49498102801276,0,98,negative regulation of DNA metabolic process,BP,
13529,GO:0051055,1,0.740626141784944,0,47,negative regulation of lipid biosynthetic process,BP,
13531,GO:0051057,1,0.595412296311841,0,72,positive regulation of small GTPase mediated signal transduction,BP,
13533,GO:0051059,1,0.818784995726906,0,31,NF-kappaB binding,MF,
13534,GO:0051066,1,0.990521139704879,0,2,dihydrobiopterin metabolic process,BP,
13535,GO:0051068,1,0.992799951621767,0,1,dihydrolipoamide metabolic process,BP,
13536,GO:0051081,1,0.897772886509515,0,16,nuclear envelope disassembly,BP,
13538,GO:0051083,1,0.989856072895073,0,2,'de novo' cotranslational protein folding,BP,
13539,GO:0051084,1,0.821011501974404,0,32,'de novo' posttranslational protein folding,BP,
13540,GO:0051085,1,0.844058961874032,0,28,chaperone cofactor-dependent protein refolding,BP,
13541,GO:0051086,1,0.994943845097996,0,1,chaperone mediated protein folding independent of cofactor,BP,
13543,GO:0051089,1,0.992645815319127,0,1,constitutive protein ectodomain proteolysis,BP,
13549,GO:0051095,1,0.928643048800788,0,12,regulation of helicase activity,BP,
13550,GO:0051096,1,0.956573980570348,0,7,positive regulation of helicase activity,BP,
13551,GO:0051097,1,0.970813851819596,0,5,negative regulation of helicase activity,BP,
13552,GO:0051098,1,0.101236783969614,0,340,regulation of binding,BP,
13553,GO:0051099,1,0.336700156573677,0,163,positive regulation of binding,BP,
13554,GO:0051100,1,0.370830226418927,0,152,negative regulation of binding,BP,
13555,GO:0051101,1,0.47271907871627,0,115,regulation of DNA binding,BP,
13556,GO:0051102,1,0.992591411405584,0,1,DNA ligation involved in DNA recombination,BP,
13557,GO:0051103,1,0.961190756049808,0,7,DNA ligation involved in DNA repair,BP,
13558,GO:0051105,1,0.962691269230382,0,6,regulation of DNA ligation,BP,
13559,GO:0051106,1,0.969168747072511,0,5,positive regulation of DNA ligation,BP,
13560,GO:0051107,1,0.993318546113577,0,1,negative regulation of DNA ligation,BP,
13562,GO:0051119,1,0.858178244346055,0,23,sugar transmembrane transporter activity,MF,
13563,GO:0051120,1,0.986594526395742,0,2,hepoxilin A3 synthase activity,MF,
13564,GO:0051121,1,0.952138031775193,0,9,hepoxilin metabolic process,BP,
13565,GO:0051122,1,0.952138031775193,0,9,hepoxilin biosynthetic process,BP,
13566,GO:0051123,1,0.86149715402857,0,24,RNA polymerase II preinitiation complex assembly,BP,
13567,GO:0051124,1,0.915595922209542,0,10,synaptic growth at neuromuscular junction,BP,
13568,GO:0051125,1,0.823649092780409,0,28,regulation of actin nucleation,BP,
13569,GO:0051126,1,0.954189756317337,0,8,negative regulation of actin nucleation,BP,
13570,GO:0051127,1,0.890750697240706,0,15,positive regulation of actin nucleation,BP,
13574,GO:0051131,1,0.896465995845252,0,20,chaperone-mediated protein complex assembly,BP,
13575,GO:0051132,1,0.951339273702756,0,9,NK T cell activation,BP,
13576,GO:0051133,1,0.962887674125578,0,7,regulation of NK T cell activation,BP,
13577,GO:0051134,1,0.987914180972693,0,2,negative regulation of NK T cell activation,BP,
13578,GO:0051135,1,0.974670371548945,0,5,positive regulation of NK T cell activation,BP,
13579,GO:0051136,1,0.959400660531847,0,6,regulation of NK T cell differentiation,BP,
13580,GO:0051138,1,0.971462627732487,0,4,positive regulation of NK T cell differentiation,BP,
13581,GO:0051139,1,0.908174891577711,0,13,metal ion:proton antiporter activity,MF,
13582,GO:0051140,1,0.978721446963667,0,4,regulation of NK T cell proliferation,BP,
13583,GO:0051141,1,0.992787389299418,0,1,negative regulation of NK T cell proliferation,BP,
13584,GO:0051142,1,0.98583288765717,0,3,positive regulation of NK T cell proliferation,BP,
13585,GO:0051145,1,0.697526593050034,0,54,smooth muscle cell differentiation,BP,
13589,GO:0051149,1,0.595021187216322,0,80,positive regulation of muscle cell differentiation,BP,
13590,GO:0051150,1,0.814811165312157,0,30,regulation of smooth muscle cell differentiation,BP,
13591,GO:0051151,1,0.892297560408271,0,16,negative regulation of smooth muscle cell differentiation,BP,
13592,GO:0051152,1,0.935794830280854,0,11,positive regulation of smooth muscle cell differentiation,BP,
13595,GO:0051155,1,0.722259026200004,0,51,positive regulation of striated muscle cell differentiation,BP,
13596,GO:0051156,1,0.861964892546049,0,24,glucose 6-phosphate metabolic process,BP,
13597,GO:0051160,1,0.993865211361605,0,1,L-xylitol catabolic process,BP,
13598,GO:0051164,1,0.993865211361605,0,1,L-xylitol metabolic process,BP,
13599,GO:0051167,1,0.975234285249958,0,5,xylulose 5-phosphate metabolic process,BP,
13600,GO:0051168,1,0.26733401656128,0,193,nuclear export,BP,
13601,GO:0051169,1,0.0984217525512901,0,335,nuclear transport,BP,
13602,GO:0051170,1,0.332550335782604,0,156,import into nucleus,BP,
13607,GO:0051176,1,0.97770369737209,0,3,positive regulation of sulfur metabolic process,BP,
13608,GO:0051177,1,0.948340504199476,0,9,meiotic sister chromatid cohesion,BP,
13611,GO:0051189,1,0.963161630110255,0,6,prosthetic group metabolic process,BP,
13612,GO:0051192,1,0.99696671272875,0,1,prosthetic group binding,MF,
13613,GO:0051204,1,0.786052948497435,0,43,protein insertion into mitochondrial membrane,BP,
13614,GO:0051205,1,0.715521132493551,0,59,protein insertion into membrane,BP,
13615,GO:0051208,1,0.442675690750363,0,112,sequestering of calcium ion,BP,
13616,GO:0051209,1,0.458435859244415,0,107,release of sequestered calcium ion into cytosol,BP,
13617,GO:0051213,1,0.552329861907768,0,86,dioxygenase activity,MF,
13620,GO:0051220,1,0.854423900289152,0,23,cytoplasmic sequestering of protein,BP,
13625,GO:0051228,1,0.984545296547343,0,2,mitotic spindle disassembly,BP,
13626,GO:0051230,1,0.984545296547343,0,2,spindle disassembly,BP,
13628,GO:0051232,1,0.994143932177958,0,1,meiotic spindle elongation,BP,
13629,GO:0051233,1,0.782272928496903,0,35,spindle midzone,CC,
13632,GO:0051236,1,0.273240571791647,0,187,establishment of RNA localization,BP,
13641,GO:0051250,1,0.435642533127757,0,136,negative regulation of lymphocyte activation,BP,
13648,GO:0051257,1,0.986556802324942,0,2,meiotic spindle midzone assembly,BP,
13654,GO:0051264,1,0.993430533589287,0,1,mono-olein transacylation activity,MF,
13655,GO:0051265,1,0.993430533589287,0,1,diolein transacylation activity,MF,
13656,GO:0051267,1,0.992996218770604,0,1,CP2 mannose-ethanolamine phosphotransferase activity,MF,
13659,GO:0051272,1,0.0293461190951383,0,505,positive regulation of cellular component movement,BP,
13661,GO:0051279,1,0.596478587640695,0,73,regulation of release of sequestered calcium ion into cytosol,BP,
13662,GO:0051280,1,0.933322259715873,0,12,negative regulation of release of sequestered calcium ion into cytosol,BP,
13663,GO:0051281,1,0.782672763120406,0,38,positive regulation of release of sequestered calcium ion into cytosol,BP,
13664,GO:0051282,1,0.452057430984954,0,109,regulation of sequestering of calcium ion,BP,
13665,GO:0051283,1,0.45533370202747,0,108,negative regulation of sequestering of calcium ion,BP,
13666,GO:0051284,1,0.91746811067102,0,13,positive regulation of sequestering of calcium ion,BP,
13667,GO:0051286,1,0.947527373586255,0,7,cell tip,CC,
13668,GO:0051287,1,0.731443356831249,0,54,NAD binding,MF,
13669,GO:0051289,1,0.693660163173317,0,55,protein homotetramerization,BP,
13672,GO:0051292,1,0.935183571577643,0,9,nuclear pore complex assembly,BP,
13673,GO:0051293,1,0.720361633021625,0,44,establishment of spindle localization,BP,
13675,GO:0051295,1,0.965485194986149,0,4,establishment of meiotic spindle localization,BP,
13676,GO:0051298,1,0.616542198551104,0,65,centrosome duplication,BP,
13677,GO:0051299,1,0.903380677363184,0,15,centrosome separation,BP,
13682,GO:0051305,1,0.946276557538787,0,7,chromosome movement towards spindle pole,BP,
13685,GO:0051308,1,0.993485400251684,0,1,male meiosis chromosome separation,BP,
13688,GO:0051311,1,0.993971236807866,0,1,meiotic metaphase plate congression,BP,
13689,GO:0051315,1,0.907342628156954,0,15,attachment of mitotic spindle microtubules to kinetochore,BP,
13690,GO:0051316,1,0.993485400251684,0,1,attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation,BP,
13691,GO:0051318,1,0.984638596256118,0,2,G1 phase,BP,
13693,GO:0051325,1,0.984638596256118,0,2,interphase,BP,
13694,GO:0051329,1,0.984638596256118,0,2,mitotic interphase,BP,
13698,GO:0051340,1,0.950564150606445,0,10,regulation of ligase activity,BP,
13700,GO:0051342,1,0.944384724822695,0,9,regulation of cyclic-nucleotide phosphodiesterase activity,BP,
13701,GO:0051343,1,0.976336066070779,0,4,positive regulation of cyclic-nucleotide phosphodiesterase activity,BP,
13702,GO:0051344,1,0.960673793575784,0,6,negative regulation of cyclic-nucleotide phosphodiesterase activity,BP,
13709,GO:0051351,1,0.961755045932338,0,8,positive regulation of ligase activity,BP,
13710,GO:0051352,1,0.988368606709149,0,2,negative regulation of ligase activity,BP,
13711,GO:0051353,1,0.737482989696451,0,48,positive regulation of oxidoreductase activity,BP,
13713,GO:0051355,1,0.992701874829351,0,1,proprioception involved in equilibrioception,BP,
13714,GO:0051365,1,0.980663896794802,0,3,cellular response to potassium ion starvation,BP,
13715,GO:0051371,1,0.885022600723838,0,14,muscle alpha-actinin binding,MF,
13716,GO:0051373,1,0.971467835775939,0,5,FATZ binding,MF,
13717,GO:0051377,1,0.974710183345495,0,4,mannose-ethanolamine phosphotransferase activity,MF,
13718,GO:0051378,1,0.932004030628947,0,12,serotonin binding,MF,
13719,GO:0051379,1,0.971941952453968,0,5,epinephrine binding,MF,
13720,GO:0051380,1,0.977362388426554,0,4,norepinephrine binding,MF,
13724,GO:0051385,1,0.848624661932116,0,27,response to mineralocorticoid,BP,
13725,GO:0051386,1,0.931543152420338,0,11,regulation of neurotrophin TRK receptor signaling pathway,BP,
13726,GO:0051387,1,0.982622178957523,0,3,negative regulation of neurotrophin TRK receptor signaling pathway,BP,
13727,GO:0051388,1,0.960098909877457,0,6,positive regulation of neurotrophin TRK receptor signaling pathway,BP,
13728,GO:0051389,1,0.978891101468007,0,2,inactivation of MAPKK activity,BP,
13729,GO:0051391,1,0.992637971907924,0,1,tRNA acetylation,BP,
13730,GO:0051393,1,0.80371287898596,0,26,alpha-actinin binding,MF,
13731,GO:0051394,1,0.995999097821548,0,1,regulation of nerve growth factor receptor activity,BP,
13732,GO:0051400,1,0.943146167697012,0,10,BH domain binding,MF,
13735,GO:0051409,1,0.937046262949868,0,10,response to nitrosative stress,BP,
13736,GO:0051410,1,0.98503857989468,0,3,detoxification of nitrogen compound,BP,
13737,GO:0051412,1,0.902324435389222,0,16,response to corticosterone,BP,
13738,GO:0051413,1,0.993896633132242,0,1,response to cortisone,BP,
13739,GO:0051414,1,0.962395075764008,0,5,response to cortisol,BP,
13740,GO:0051415,1,0.963870567261066,0,5,microtubule nucleation by interphase microtubule organizing center,BP,
13741,GO:0051418,1,0.928400240988473,0,9,microtubule nucleation by microtubule organizing center,BP,
13742,GO:0051424,1,0.989023938614154,0,2,corticotropin-releasing hormone binding,MF,
13743,GO:0051425,1,0.974488137038942,0,3,PTB domain binding,MF,
13744,GO:0051427,1,0.330376088227045,0,161,hormone receptor binding,MF,
13745,GO:0051428,1,0.916452530956009,0,17,peptide hormone receptor binding,MF,
13746,GO:0051429,1,0.976427064426567,0,5,corticotropin-releasing hormone receptor binding,MF,
13747,GO:0051430,1,0.980527107196799,0,4,corticotropin-releasing hormone receptor 1 binding,MF,
13748,GO:0051431,1,0.989030971518307,0,3,corticotropin-releasing hormone receptor 2 binding,MF,
13749,GO:0051433,1,0.992298332656825,0,1,BH2 domain binding,MF,
13750,GO:0051434,1,0.9719697158919,0,5,BH3 domain binding,MF,
13753,GO:0051444,1,0.913999086215078,0,16,negative regulation of ubiquitin-protein transferase activity,BP,
13755,GO:0051446,1,0.863369272633914,0,21,positive regulation of meiotic cell cycle,BP,
13756,GO:0051447,1,0.91739358752919,0,14,negative regulation of meiotic cell cycle,BP,
13757,GO:0051450,1,0.885902356024017,0,18,myoblast proliferation,BP,
13758,GO:0051451,1,0.91564477367563,0,13,myoblast migration,BP,
13759,GO:0051452,1,0.731413134449767,0,53,intracellular pH reduction,BP,
13761,GO:0051454,1,0.972630164009975,0,4,intracellular pH elevation,BP,
13762,GO:0051455,1,0.993485400251684,0,1,monopolar spindle attachment to meiosis I kinetochore,BP,
13763,GO:0051457,1,0.863931235881499,0,22,maintenance of protein location in nucleus,BP,
13764,GO:0051458,1,0.964672899280983,0,7,corticotropin secretion,BP,
13765,GO:0051459,1,0.97068631099933,0,6,regulation of corticotropin secretion,BP,
13766,GO:0051460,1,0.995187602399077,0,1,negative regulation of corticotropin secretion,BP,
13767,GO:0051461,1,0.975381403983244,0,5,positive regulation of corticotropin secretion,BP,
13768,GO:0051462,1,0.974415827819183,0,5,regulation of cortisol secretion,BP,
13769,GO:0051463,1,0.99082385706907,0,1,negative regulation of cortisol secretion,BP,
13770,GO:0051464,1,0.98344152917621,0,4,positive regulation of cortisol secretion,BP,
13771,GO:0051466,1,0.993014381373215,0,1,positive regulation of corticotropin-releasing hormone secretion,BP,
13773,GO:0051481,1,0.901691181418162,0,12,negative regulation of cytosolic calcium ion concentration,BP,
13774,GO:0051482,1,0.832858615213643,0,31,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway,BP,
13776,GO:0051490,1,0.98246223170601,0,3,negative regulation of filopodium assembly,BP,
13778,GO:0051492,1,0.535980105184402,0,84,regulation of stress fiber assembly,BP,
13782,GO:0051496,1,0.701102435329133,0,50,positive regulation of stress fiber assembly,BP,
13783,GO:0051497,1,0.818757912629899,0,26,negative regulation of stress fiber assembly,BP,
13784,GO:0051499,1,0.989515724804037,0,2,D-aminoacyl-tRNA deacylase activity,MF,
13785,GO:0051500,1,0.989515724804037,0,2,D-tyrosyl-tRNA(Tyr) deacylase activity,MF,
13786,GO:0051503,1,0.830273747523318,0,30,adenine nucleotide transport,BP,
13787,GO:0051525,1,0.963718868231282,0,5,NFAT protein binding,MF,
13789,GO:0051537,1,0.896696922086925,0,19,2 iron, 2 sulfur cluster binding,MF,
13790,GO:0051538,1,0.982748238776925,0,3,3 iron, 4 sulfur cluster binding,MF,
13791,GO:0051539,1,0.779871838036509,0,40,4 iron, 4 sulfur cluster binding,MF,
13793,GO:0051541,1,0.959595343193848,0,6,elastin metabolic process,BP,
13794,GO:0051542,1,0.983170191587946,0,2,elastin biosynthetic process,BP,
13795,GO:0051543,1,0.994175892091165,0,1,regulation of elastin biosynthetic process,BP,
13796,GO:0051545,1,0.994175892091165,0,1,negative regulation of elastin biosynthetic process,BP,
13797,GO:0051546,1,0.885205669720059,0,17,keratinocyte migration,BP,
13798,GO:0051547,1,0.906930216988991,0,13,regulation of keratinocyte migration,BP,
13799,GO:0051548,1,0.991484698260322,0,1,negative regulation of keratinocyte migration,BP,
13800,GO:0051549,1,0.914726295574259,0,12,positive regulation of keratinocyte migration,BP,
13801,GO:0051552,1,0.990795642075213,0,1,flavone metabolic process,BP,
13802,GO:0051560,1,0.856568932993986,0,24,mitochondrial calcium ion homeostasis,BP,
13803,GO:0051561,1,0.935952462187345,0,11,positive regulation of mitochondrial calcium ion concentration,BP,
13804,GO:0051562,1,0.974962895291795,0,4,negative regulation of mitochondrial calcium ion concentration,BP,
13805,GO:0051563,1,0.98392207416902,0,2,smooth endoplasmic reticulum calcium ion homeostasis,BP,
13806,GO:0051567,1,0.74644244261826,0,36,histone H3-K9 methylation,BP,
13807,GO:0051568,1,0.683610952000989,0,50,histone H3-K4 methylation,BP,
13809,GO:0051570,1,0.848512151369947,0,21,regulation of histone H3-K9 methylation,BP,
13810,GO:0051571,1,0.881222553535642,0,17,positive regulation of histone H3-K4 methylation,BP,
13811,GO:0051572,1,0.961350991637778,0,5,negative regulation of histone H3-K4 methylation,BP,
13812,GO:0051573,1,0.924912175610578,0,11,negative regulation of histone H3-K9 methylation,BP,
13813,GO:0051574,1,0.92885493151587,0,9,positive regulation of histone H3-K9 methylation,BP,
13814,GO:0051575,1,0.963825737348937,0,5,5'-deoxyribose-5-phosphate lyase activity,MF,
13815,GO:0051580,1,0.905375782727987,0,16,regulation of neurotransmitter uptake,BP,
13816,GO:0051581,1,0.978681663572752,0,3,negative regulation of neurotransmitter uptake,BP,
13817,GO:0051582,1,0.978274105902657,0,4,positive regulation of neurotransmitter uptake,BP,
13818,GO:0051583,1,0.942328681561569,0,11,dopamine uptake involved in synaptic transmission,BP,
13819,GO:0051584,1,0.95932684662044,0,8,regulation of dopamine uptake involved in synaptic transmission,BP,
13820,GO:0051585,1,0.993053943534722,0,1,negative regulation of dopamine uptake involved in synaptic transmission,BP,
13821,GO:0051586,1,0.985448495352671,0,3,positive regulation of dopamine uptake involved in synaptic transmission,BP,
13828,GO:0051594,1,0.978227282232147,0,4,detection of glucose,BP,
13829,GO:0051595,1,0.983126328414573,0,3,response to methylglyoxal,BP,
13830,GO:0051596,1,0.985589825050443,0,3,methylglyoxal catabolic process,BP,
13831,GO:0051597,1,0.951612684392115,0,7,response to methylmercury,BP,
13832,GO:0051598,1,0.987287502101869,0,2,meiotic recombination checkpoint,BP,
13833,GO:0051599,1,0.961235521685225,0,5,response to hydrostatic pressure,BP,
13834,GO:0051601,1,0.956028260344744,0,7,exocyst localization,BP,
13839,GO:0051607,1,0.258255357435091,0,213,defense response to virus,BP,
13840,GO:0051608,1,0.927142155490846,0,13,histamine transport,BP,
13841,GO:0051610,1,0.927560748930662,0,11,serotonin uptake,BP,
13842,GO:0051611,1,0.970884199842972,0,4,regulation of serotonin uptake,BP,
13843,GO:0051612,1,0.978681663572752,0,3,negative regulation of serotonin uptake,BP,
13844,GO:0051615,1,0.978776637093204,0,3,histamine uptake,BP,
13845,GO:0051620,1,0.948817195716167,0,8,norepinephrine uptake,BP,
13846,GO:0051621,1,0.988331064022044,0,2,regulation of norepinephrine uptake,BP,
13847,GO:0051622,1,0.993053943534722,0,1,negative regulation of norepinephrine uptake,BP,
13848,GO:0051623,1,0.995244416664347,0,1,positive regulation of norepinephrine uptake,BP,
13849,GO:0051625,1,0.98479502705366,0,2,epinephrine uptake,BP,
13850,GO:0051639,1,0.929300771546034,0,10,actin filament network formation,BP,
13854,GO:0051643,1,0.94583178480439,0,7,endoplasmic reticulum localization,BP,
13855,GO:0051645,1,0.909672960935524,0,13,Golgi localization,BP,
13856,GO:0051646,1,0.729586893464237,0,43,mitochondrion localization,BP,
13857,GO:0051647,1,0.780389454427616,0,28,nucleus localization,BP,
13863,GO:0051654,1,0.84395432999518,0,23,establishment of mitochondrion localization,BP,
13866,GO:0051659,1,0.987239409848185,0,2,maintenance of mitochondrion location,BP,
13867,GO:0051660,1,0.939027652715091,0,9,establishment of centrosome localization,BP,
13869,GO:0051665,1,0.959520423414116,0,7,membrane raft localization,BP,
13870,GO:0051666,1,0.995168540831618,0,1,actin cortical patch localization,BP,
13871,GO:0051668,1,0.51942630930447,0,92,localization within membrane,BP,
13872,GO:0051673,1,0.96621124365926,0,8,membrane disruption in other organism,BP,
13874,GO:0051683,1,0.957612950341968,0,7,establishment of Golgi localization,BP,
13875,GO:0051684,1,0.975383721982629,0,3,maintenance of Golgi location,BP,
13876,GO:0051685,1,0.993485400251684,0,1,maintenance of ER location,BP,
13877,GO:0051686,1,0.986002937131604,0,1,establishment of ER localization,BP,
13878,GO:0051691,1,0.995473093091466,0,1,cellular oligosaccharide metabolic process,BP,
13879,GO:0051692,1,0.995473093091466,0,1,cellular oligosaccharide catabolic process,BP,
13880,GO:0051693,1,0.764619237879495,0,35,actin filament capping,BP,
13881,GO:0051694,1,0.952819870464204,0,7,pointed-end actin filament capping,BP,
13882,GO:0051695,1,0.992301087082061,0,1,actin filament uncapping,BP,
13883,GO:0051697,1,0.993330445224042,0,1,protein delipidation,BP,
13884,GO:0051701,1,0.272057354173592,0,194,interaction with host,BP,
13885,GO:0051702,1,0.64507460351345,0,73,interaction with symbiont,BP,
13886,GO:0051703,1,0.681876408511658,0,49,intraspecies interaction between organisms,BP,
13889,GO:0051709,1,0.932423307576055,0,12,regulation of killing of cells of other organism,BP,
13890,GO:0051712,1,0.943155777988622,0,10,positive regulation of killing of cells of other organism,BP,
13891,GO:0051715,1,0.98671771621645,0,3,cytolysis in other organism,BP,
13893,GO:0051717,1,0.984921519642655,0,2,inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity,MF,
13894,GO:0051721,1,0.80957130139027,0,30,protein phosphatase 2A binding,MF,
13895,GO:0051722,1,0.993985640144654,0,1,protein C-terminal methylesterase activity,MF,
13896,GO:0051723,1,0.993985640144654,0,1,protein methylesterase activity,MF,
13897,GO:0051724,1,0.994353828774869,0,1,NAD transmembrane transporter activity,MF,
13898,GO:0051725,1,0.970378565497843,0,5,protein de-ADP-ribosylation,BP,
13900,GO:0051728,1,0.984067131802041,0,2,cell cycle switching, mitotic to meiotic cell cycle,BP,
13901,GO:0051729,1,0.984067131802041,0,2,germline cell cycle switching, mitotic to meiotic cell cycle,BP,
13902,GO:0051731,1,0.971853756741782,0,4,polynucleotide 5'-hydroxyl-kinase activity,MF,
13903,GO:0051732,1,0.995359834508863,0,1,polyribonucleotide kinase activity,MF,
13904,GO:0051733,1,0.981224261587406,0,3,polydeoxyribonucleotide kinase activity,MF,
13905,GO:0051734,1,0.981224261587406,0,3,ATP-dependent polynucleotide kinase activity,MF,
13906,GO:0051736,1,0.995359834508863,0,1,ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity,MF,
13907,GO:0051747,1,0.992292301655842,0,2,cytosine C-5 DNA demethylase activity,MF,
13908,GO:0051748,1,0.994590744420444,0,1,UTP-monosaccharide-1-phosphate uridylyltransferase activity,MF,
13909,GO:0051750,1,0.996157227255456,0,1,delta3,5-delta2,4-dienoyl-CoA isomerase activity,MF,
13910,GO:0051751,1,0.992447345405774,0,1,alpha-1,4-mannosyltransferase activity,MF,
13911,GO:0051754,1,0.973450671890471,0,4,meiotic sister chromatid cohesion, centromeric,BP,
13912,GO:0051758,1,0.990697960838536,0,1,homologous chromosome movement towards spindle pole in meiosis I anaphase,BP,
13913,GO:0051764,1,0.928435700354424,0,11,actin crosslink formation,BP,
13914,GO:0051765,1,0.988293849254624,0,2,inositol tetrakisphosphate kinase activity,MF,
13915,GO:0051766,1,0.967827398932267,0,5,inositol trisphosphate kinase activity,MF,
13916,GO:0051767,1,0.880482237291501,0,18,nitric-oxide synthase biosynthetic process,BP,
13917,GO:0051769,1,0.880482237291501,0,18,regulation of nitric-oxide synthase biosynthetic process,BP,
13918,GO:0051770,1,0.894007215426351,0,15,positive regulation of nitric-oxide synthase biosynthetic process,BP,
13919,GO:0051771,1,0.984888332882246,0,3,negative regulation of nitric-oxide synthase biosynthetic process,BP,
13920,GO:0051775,1,0.910967304708977,0,13,response to redox state,BP,
13921,GO:0051780,1,0.992547418446041,0,1,behavioral response to nutrient,BP,
13922,GO:0051781,1,0.619665528314468,0,73,positive regulation of cell division,BP,
13927,GO:0051786,1,0.99294804144329,0,1,all-trans-retinol 13,14-reductase activity,MF,
13928,GO:0051787,1,0.852211541899628,0,26,misfolded protein binding,MF,
13929,GO:0051788,1,0.847878292961592,0,24,response to misfolded protein,BP,
13930,GO:0051790,1,0.976551391852068,0,4,short-chain fatty acid biosynthetic process,BP,
13931,GO:0051791,1,0.933218678560021,0,12,medium-chain fatty acid metabolic process,BP,
13932,GO:0051792,1,0.966848138188271,0,6,medium-chain fatty acid biosynthetic process,BP,
13933,GO:0051793,1,0.969257247817695,0,5,medium-chain fatty acid catabolic process,BP,
13934,GO:0051794,1,0.975769361029115,0,4,regulation of timing of catagen,BP,
13935,GO:0051795,1,0.983177999499833,0,3,positive regulation of timing of catagen,BP,
13936,GO:0051796,1,0.992465874593964,0,1,negative regulation of timing of catagen,BP,
13937,GO:0051797,1,0.882219961408899,0,19,regulation of hair follicle development,BP,
13938,GO:0051798,1,0.938931347564525,0,11,positive regulation of hair follicle development,BP,
13939,GO:0051799,1,0.970248909568715,0,4,negative regulation of hair follicle development,BP,
13940,GO:0051800,1,0.991484698260322,0,1,phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity,MF,
13941,GO:0051801,1,0.98671771621645,0,3,cytolysis in other organism involved in symbiotic interaction,BP,
13942,GO:0051817,1,0.554902244727772,0,88,modulation of process of other organism involved in symbiotic interaction,BP,
13943,GO:0051823,1,0.931359796040537,0,9,regulation of synapse structural plasticity,BP,
13944,GO:0051835,1,0.969707214909396,0,4,positive regulation of synapse structural plasticity,BP,
13945,GO:0051838,1,0.98671771621645,0,3,cytolysis by host of symbiont cells,BP,
13946,GO:0051851,1,0.70790364880123,0,53,modulation by host of symbiont process,BP,
13948,GO:0051864,1,0.937753792245747,0,8,histone demethylase activity (H3-K36 specific),MF,
13949,GO:0051865,1,0.626902790924243,0,66,protein autoubiquitination,BP,
13950,GO:0051866,1,0.989008759791896,0,2,general adaptation syndrome,BP,
13951,GO:0051867,1,0.996154982470263,0,1,general adaptation syndrome, behavioral process,BP,
13953,GO:0051873,1,0.942898494879561,0,15,killing by host of symbiont cells,BP,
13954,GO:0051875,1,0.844034836571457,0,26,pigment granule localization,BP,
13955,GO:0051877,1,0.986845817026223,0,2,pigment granule aggregation in cell center,BP,
13956,GO:0051879,1,0.774532114706071,0,38,Hsp90 protein binding,MF,
13957,GO:0051880,1,0.926872912441207,0,10,G-quadruplex DNA binding,MF,
13958,GO:0051881,1,0.685940056277044,0,65,regulation of mitochondrial membrane potential,BP,
13959,GO:0051882,1,0.870199253882654,0,22,mitochondrial depolarization,BP,
13960,GO:0051883,1,0.932006825317802,0,17,killing of cells in other organism involved in symbiotic interaction,BP,
13961,GO:0051884,1,0.963576343468304,0,5,regulation of timing of anagen,BP,
13962,GO:0051885,1,0.985621851117997,0,2,positive regulation of timing of anagen,BP,
13963,GO:0051886,1,0.991823798393406,0,1,negative regulation of timing of anagen,BP,
13964,GO:0051890,1,0.951623195383501,0,7,regulation of cardioblast differentiation,BP,
13965,GO:0051891,1,0.958832512219025,0,6,positive regulation of cardioblast differentiation,BP,
13966,GO:0051892,1,0.992484297326678,0,1,negative regulation of cardioblast differentiation,BP,
13967,GO:0051893,1,0.616510912364402,0,62,regulation of focal adhesion assembly,BP,
13968,GO:0051894,1,0.82802287178943,0,24,positive regulation of focal adhesion assembly,BP,
13969,GO:0051895,1,0.869947691852491,0,18,negative regulation of focal adhesion assembly,BP,
13970,GO:0051896,1,0.24702871636448,0,203,regulation of protein kinase B signaling,BP,
13971,GO:0051897,1,0.356067492900506,0,150,positive regulation of protein kinase B signaling,BP,
13972,GO:0051898,1,0.74425970906369,0,42,negative regulation of protein kinase B signaling,BP,
13974,GO:0051900,1,0.877751728223608,0,21,regulation of mitochondrial depolarization,BP,
13975,GO:0051901,1,0.950358747062473,0,9,positive regulation of mitochondrial depolarization,BP,
13976,GO:0051902,1,0.959467362560402,0,7,negative regulation of mitochondrial depolarization,BP,
13977,GO:0051903,1,0.988616092184817,0,2,S-(hydroxymethyl)glutathione dehydrogenase activity,MF,
13978,GO:0051904,1,0.86360827912669,0,23,pigment granule transport,BP,
13979,GO:0051905,1,0.854803207469532,0,24,establishment of pigment granule localization,BP,
13980,GO:0051908,1,0.993028632191372,0,1,double-stranded DNA 5'-3' exodeoxyribonuclease activity,MF,
13981,GO:0051913,1,0.986182786629434,0,1,regulation of synaptic plasticity by chemical substance,BP,
13982,GO:0051914,1,0.986182786629434,0,1,positive regulation of synaptic plasticity by chemical substance,BP,
13983,GO:0051915,1,0.986182786629434,0,1,induction of synaptic plasticity by chemical substance,BP,
13984,GO:0051916,1,0.98737348740685,0,2,granulocyte colony-stimulating factor binding,MF,
13985,GO:0051917,1,0.941124568348409,0,10,regulation of fibrinolysis,BP,
13986,GO:0051918,1,0.957725070502909,0,7,negative regulation of fibrinolysis,BP,
13987,GO:0051919,1,0.983371637717996,0,3,positive regulation of fibrinolysis,BP,
13988,GO:0051920,1,0.974548735527792,0,7,peroxiredoxin activity,MF,
13989,GO:0051923,1,0.912306587496222,0,16,sulfation,BP,
13991,GO:0051926,1,0.724684818071225,0,52,negative regulation of calcium ion transport,BP,
13993,GO:0051930,1,0.83550984677663,0,29,regulation of sensory perception of pain,BP,
13994,GO:0051931,1,0.830133883961298,0,30,regulation of sensory perception,BP,
13996,GO:0051933,1,0.96780307501833,0,4,amino acid neurotransmitter reuptake,BP,
13997,GO:0051934,1,0.942328681561569,0,11,catecholamine uptake involved in synaptic transmission,BP,
13998,GO:0051935,1,0.96780307501833,0,4,glutamate reuptake,BP,
14001,GO:0051939,1,0.97259468642931,0,4,gamma-aminobutyric acid import,BP,
14002,GO:0051940,1,0.95932684662044,0,8,regulation of catecholamine uptake involved in synaptic transmission,BP,
14003,GO:0051941,1,0.975243410804733,0,3,regulation of amino acid uptake involved in synaptic transmission,BP,
14004,GO:0051943,1,0.992720734818585,0,1,positive regulation of amino acid uptake involved in synaptic transmission,BP,
14005,GO:0051944,1,0.985448495352671,0,3,positive regulation of catecholamine uptake involved in synaptic transmission,BP,
14006,GO:0051945,1,0.993053943534722,0,1,negative regulation of catecholamine uptake involved in synaptic transmission,BP,
14007,GO:0051946,1,0.975243410804733,0,3,regulation of glutamate uptake involved in transmission of nerve impulse,BP,
14008,GO:0051951,1,0.992720734818585,0,1,positive regulation of glutamate uptake involved in transmission of nerve impulse,BP,
14013,GO:0051956,1,0.924305758018767,0,13,negative regulation of amino acid transport,BP,
14015,GO:0051958,1,0.984104693415259,0,2,methotrexate transport,BP,
14016,GO:0051959,1,0.737672079938938,0,27,dynein light intermediate chain binding,MF,
14020,GO:0051963,1,0.481428783402333,0,95,regulation of synapse assembly,BP,
14021,GO:0051964,1,0.939267634309541,0,8,negative regulation of synapse assembly,BP,
14022,GO:0051965,1,0.645766792981184,0,58,positive regulation of synapse assembly,BP,
14024,GO:0051967,1,0.933591405744881,0,10,negative regulation of synaptic transmission, glutamatergic,BP,
14025,GO:0051968,1,0.79460472630729,0,31,positive regulation of synaptic transmission, glutamatergic,BP,
14026,GO:0051969,1,0.919124383330099,0,14,regulation of transmission of nerve impulse,BP,
14027,GO:0051970,1,0.978595319362849,0,4,negative regulation of transmission of nerve impulse,BP,
14028,GO:0051971,1,0.96208332988129,0,6,positive regulation of transmission of nerve impulse,BP,
14029,GO:0051972,1,0.739758644094844,0,47,regulation of telomerase activity,BP,
14030,GO:0051973,1,0.800155168422046,0,35,positive regulation of telomerase activity,BP,
14031,GO:0051974,1,0.934117372025867,0,11,negative regulation of telomerase activity,BP,
14032,GO:0051977,1,0.994501174542525,0,1,lysophospholipid transport,BP,
14033,GO:0051978,1,0.994501174542525,0,1,lysophospholipid:sodium symporter activity,MF,
14035,GO:0051984,1,0.809019329637156,0,30,positive regulation of chromosome segregation,BP,
14037,GO:0051987,1,0.96394923143646,0,6,positive regulation of attachment of spindle microtubules to kinetochore,BP,
14038,GO:0051988,1,0.914856058427543,0,13,regulation of attachment of spindle microtubules to kinetochore,BP,
14039,GO:0051990,1,0.993759758138751,0,1,(R)-2-hydroxyglutarate dehydrogenase activity,MF,
14040,GO:0051996,1,0.994661836853827,0,1,squalene synthase activity,MF,
14041,GO:0051998,1,0.969176995658934,0,5,protein carboxyl O-methyltransferase activity,MF,
14042,GO:0052025,1,0.994358929697471,0,2,modification by symbiont of host cell membrane,BP,
14043,GO:0052026,1,0.993347388179072,0,1,modulation by symbiont of host transcription,BP,
14044,GO:0052027,1,0.984809428851082,0,2,modulation by symbiont of host signal transduction pathway,BP,
14045,GO:0052029,1,0.991779691267581,0,1,suppression by symbiont of host signal transduction pathway,BP,
14046,GO:0052040,1,0.945255244509748,0,9,modulation by symbiont of host programmed cell death,BP,
14047,GO:0052041,1,0.976635648268054,0,4,negative regulation by symbiont of host programmed cell death,BP,
14048,GO:0052042,1,0.984584972926545,0,3,positive regulation by symbiont of host programmed cell death,BP,
14049,GO:0052043,1,0.994358929697471,0,2,modification by symbiont of host cellular component,BP,
14050,GO:0052053,1,0.993496698938406,0,1,negative regulation by symbiont of host catalytic activity,BP,
14051,GO:0052055,1,0.985329319020582,0,2,modulation by symbiont of host molecular function,BP,
14052,GO:0052056,1,0.985329319020582,0,2,negative regulation by symbiont of host molecular function,BP,
14053,GO:0052111,1,0.994358929697471,0,2,modification by symbiont of host structure,BP,
14054,GO:0052126,1,0.361561934467005,0,152,movement in host environment,BP,
14055,GO:0052148,1,0.993496698938406,0,1,modulation by symbiont of host catalytic activity,BP,
14056,GO:0052150,1,0.965047427480656,0,6,modulation by symbiont of host apoptotic process,BP,
14057,GO:0052151,1,0.984584972926545,0,3,positive regulation by symbiont of host apoptotic process,BP,
14058,GO:0052173,1,0.975432295825066,0,3,response to defenses of other organism,BP,
14059,GO:0052185,1,0.994358929697471,0,2,modification of structure of other organism involved in symbiotic interaction,BP,
14060,GO:0052188,1,0.994358929697471,0,2,modification of cellular component in other organism involved in symbiotic interaction,BP,
14061,GO:0052199,1,0.988531363042283,0,2,negative regulation of catalytic activity in other organism involved in symbiotic interaction,BP,
14062,GO:0052200,1,0.975432295825066,0,3,response to host defenses,BP,
14063,GO:0052203,1,0.983944793344702,0,3,modulation of catalytic activity in other organism involved in symbiotic interaction,BP,
14064,GO:0052204,1,0.968796681441182,0,6,negative regulation of molecular function in other organism involved in symbiotic interaction,BP,
14065,GO:0052205,1,0.955311459918512,0,8,modulation of molecular function in other organism involved in symbiotic interaction,BP,
14066,GO:0052214,1,0.995556216350364,0,1,metabolism of substance in other organism involved in symbiotic interaction,BP,
14067,GO:0052227,1,0.995556216350364,0,1,catabolism of substance in other organism involved in symbiotic interaction,BP,
14068,GO:0052229,1,0.995556216350364,0,1,metabolism of macromolecule in other organism involved in symbiotic interaction,BP,
14069,GO:0052248,1,0.965047427480656,0,6,modulation of programmed cell death in other organism involved in symbiotic interaction,BP,
14070,GO:0052312,1,0.993347388179072,0,1,modulation of transcription in other organism involved in symbiotic interaction,BP,
14071,GO:0052314,1,0.989918842209382,0,2,phytoalexin metabolic process,BP,
14072,GO:0052330,1,0.984584972926545,0,3,positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction,BP,
14073,GO:0052332,1,0.994358929697471,0,2,modification by organism of membrane in other organism involved in symbiotic interaction,BP,
14074,GO:0052360,1,0.995556216350364,0,1,catabolism by host of symbiont macromolecule,BP,
14075,GO:0052361,1,0.995556216350364,0,1,catabolism by organism of macromolecule in other organism involved in symbiotic interaction,BP,
14076,GO:0052362,1,0.995556216350364,0,1,catabolism by host of symbiont protein,BP,
14077,GO:0052363,1,0.995556216350364,0,1,catabolism by organism of protein in other organism involved in symbiotic interaction,BP,
14078,GO:0052364,1,0.995556216350364,0,1,catabolism by host of substance in symbiont,BP,
14079,GO:0052372,1,0.794404478430796,0,38,modulation by symbiont of entry into host,BP,
14080,GO:0052381,1,0.994614426657296,0,1,tRNA dimethylallyltransferase activity,MF,
14081,GO:0052403,1,0.995002487234698,0,1,negative regulation by host of symbiont catalytic activity,BP,
14082,GO:0052405,1,0.983223668318538,0,4,negative regulation by host of symbiont molecular function,BP,
14083,GO:0052416,1,0.995556216350364,0,1,metabolism by host of symbiont macromolecule,BP,
14084,GO:0052417,1,0.995556216350364,0,1,metabolism by host of symbiont protein,BP,
14085,GO:0052418,1,0.995556216350364,0,1,metabolism by organism of protein in other organism involved in symbiotic interaction,BP,
14086,GO:0052419,1,0.995556216350364,0,1,metabolism by host of substance in symbiont,BP,
14087,GO:0052422,1,0.990386193842217,0,2,modulation by host of symbiont catalytic activity,BP,
14088,GO:0052428,1,0.969539637191177,0,6,modulation by host of symbiont molecular function,BP,
14089,GO:0052433,1,0.965047427480656,0,6,modulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,
14090,GO:0052501,1,0.99608471895368,0,1,positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,
14093,GO:0052590,1,0.991148309844955,0,1,sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity,MF,
14094,GO:0052591,1,0.991148309844955,0,1,sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity,MF,
14095,GO:0052593,1,0.986362910581189,0,2,tryptamine:oxygen oxidoreductase (deaminating) activity,MF,
14096,GO:0052594,1,0.986362910581189,0,2,aminoacetone:oxygen oxidoreductase(deaminating) activity,MF,
14097,GO:0052595,1,0.986362910581189,0,2,aliphatic-amine oxidase activity,MF,
14098,GO:0052596,1,0.986362910581189,0,2,phenethylamine:oxygen oxidoreductase (deaminating) activity,MF,
14099,GO:0052629,1,0.945090050482448,0,7,phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity,MF,
14100,GO:0052630,1,0.994227043503112,0,1,UDP-N-acetylgalactosamine diphosphorylase activity,MF,
14101,GO:0052642,1,0.989727871307969,0,2,lysophosphatidic acid phosphatase activity,MF,
14102,GO:0052646,1,0.93284972993342,0,9,alditol phosphate metabolic process,BP,
14103,GO:0052650,1,0.94267207983645,0,12,NADP-retinol dehydrogenase activity,MF,
14104,GO:0052651,1,0.966161573019077,0,6,monoacylglycerol catabolic process,BP,
14109,GO:0052657,1,0.995924241798657,0,1,guanine phosphoribosyltransferase activity,MF,
14110,GO:0052658,1,0.957679557572498,0,6,inositol-1,4,5-trisphosphate 5-phosphatase activity,MF,
14111,GO:0052659,1,0.96506583518983,0,5,inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity,MF,
14112,GO:0052666,1,0.994955596711668,0,1,tRNA (cytosine-2'-O-)-methyltransferase activity,MF,
14113,GO:0052689,1,0.51558724702977,0,110,carboxylic ester hydrolase activity,MF,
14114,GO:0052692,1,0.995919463972863,0,1,raffinose alpha-galactosidase activity,MF,
14115,GO:0052695,1,0.980039188121698,0,3,cellular glucuronidation,BP,
14116,GO:0052717,1,0.986564208991496,0,2,tRNA-specific adenosine-34 deaminase activity,MF,
14117,GO:0052718,1,0.986564208991496,0,2,tRNA-specific adenosine-34 deaminase complex,CC,
14118,GO:0052723,1,0.969416120141538,0,4,inositol hexakisphosphate 1-kinase activity,MF,
14119,GO:0052724,1,0.969416120141538,0,4,inositol hexakisphosphate 3-kinase activity,MF,
14120,GO:0052725,1,0.99298843235316,0,1,inositol-1,3,4-trisphosphate 6-kinase activity,MF,
14121,GO:0052726,1,0.99298843235316,0,1,inositol-1,3,4-trisphosphate 5-kinase activity,MF,
14122,GO:0052731,1,0.994662825032432,0,1,phosphocholine phosphatase activity,MF,
14123,GO:0052732,1,0.994662825032432,0,1,phosphoethanolamine phosphatase activity,MF,
14124,GO:0052735,1,0.971829733445868,0,4,tRNA (cytosine-3-)-methyltransferase activity,MF,
14125,GO:0052739,1,0.965028787872394,0,6,phosphatidylserine 1-acylhydrolase activity,MF,
14126,GO:0052740,1,0.969546897147006,0,5,1-acyl-2-lysophosphatidylserine acylhydrolase activity,MF,
14127,GO:0052742,1,0.887767428317616,0,14,phosphatidylinositol kinase activity,MF,
14128,GO:0052743,1,0.950508976186727,0,7,inositol tetrakisphosphate phosphatase activity,MF,
14129,GO:0052744,1,0.866621961102131,0,18,phosphatidylinositol monophosphate phosphatase activity,MF,
14130,GO:0052745,1,0.914660057370016,0,13,inositol phosphate phosphatase activity,MF,
14131,GO:0052746,1,0.985432003155254,0,2,inositol phosphorylation,BP,
14132,GO:0052751,1,0.996511079884715,0,1,GDP-mannose hydrolase activity,MF,
14133,GO:0052794,1,0.98255002844889,0,3,exo-alpha-(2->3)-sialidase activity,MF,
14134,GO:0052795,1,0.98255002844889,0,3,exo-alpha-(2->6)-sialidase activity,MF,
14135,GO:0052796,1,0.98255002844889,0,3,exo-alpha-(2->8)-sialidase activity,MF,
14136,GO:0052798,1,0.994681602725893,0,1,beta-galactoside alpha-2,3-sialyltransferase activity,MF,
14137,GO:0052803,1,0.928109112402562,0,12,imidazole-containing compound metabolic process,BP,
14138,GO:0052805,1,0.959728703477385,0,7,imidazole-containing compound catabolic process,BP,
14139,GO:0052812,1,0.964746232209963,0,5,phosphatidylinositol-3,4-bisphosphate 5-kinase activity,MF,
14140,GO:0052813,1,0.964746232209963,0,5,phosphatidylinositol bisphosphate kinase activity,MF,
14141,GO:0052814,1,0.992719661335156,0,1,medium-chain-aldehyde dehydrogenase activity,MF,
14142,GO:0052815,1,0.989223741344258,0,2,medium-chain acyl-CoA hydrolase activity,MF,
14143,GO:0052816,1,0.992882358566691,0,1,long-chain acyl-CoA hydrolase activity,MF,
14144,GO:0052817,1,0.992882358566691,0,1,very long chain acyl-CoA hydrolase activity,MF,
14145,GO:0052821,1,0.996417301251183,0,1,DNA-7-methyladenine glycosylase activity,MF,
14146,GO:0052822,1,0.996417301251183,0,1,DNA-3-methylguanine glycosylase activity,MF,
14147,GO:0052824,1,0.994142058444901,0,1,dolichyl-pyrophosphate Man7GlcNAc2 alpha-1,6-mannosyltransferase activity,MF,
14148,GO:0052826,1,0.993381017686403,0,1,inositol hexakisphosphate 2-phosphatase activity,MF,
14149,GO:0052827,1,0.993381017686403,0,1,inositol pentakisphosphate phosphatase activity,MF,
14150,GO:0052832,1,0.981860926507983,0,3,inositol monophosphate 3-phosphatase activity,MF,
14151,GO:0052833,1,0.981860926507983,0,3,inositol monophosphate 4-phosphatase activity,MF,
14152,GO:0052834,1,0.981860926507983,0,3,inositol monophosphate phosphatase activity,MF,
14153,GO:0052840,1,0.977347175921527,0,4,inositol diphosphate tetrakisphosphate diphosphatase activity,MF,
14154,GO:0052842,1,0.977347175921527,0,4,inositol diphosphate pentakisphosphate diphosphatase activity,MF,
14155,GO:0052851,1,0.975679012882765,0,3,ferric-chelate reductase (NADPH) activity,MF,
14156,GO:0052852,1,0.991015556014037,0,2,very-long-chain-(S)-2-hydroxy-acid oxidase activity,MF,
14157,GO:0052853,1,0.991015556014037,0,2,long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity,MF,
14158,GO:0052854,1,0.991015556014037,0,2,medium-chain-(S)-2-hydroxy-acid oxidase activity,MF,
14159,GO:0052856,1,0.996557126198783,0,1,NADHX epimerase activity,MF,
14160,GO:0052857,1,0.996557126198783,0,1,NADPHX epimerase activity,MF,
14161,GO:0052858,1,0.992805149969613,0,1,peptidyl-lysine acetyltransferase activity,MF,
14162,GO:0052866,1,0.791685836165827,0,30,phosphatidylinositol phosphate phosphatase activity,MF,
14163,GO:0052869,1,0.992152575559795,0,1,arachidonic acid omega-hydroxylase activity,MF,
14164,GO:0052884,1,0.993716915438455,0,1,all-trans-retinyl-palmitate hydrolase, 11-cis retinol forming activity,MF,
14165,GO:0052885,1,0.993716915438455,0,1,all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity,MF,
14166,GO:0052890,1,0.987311118206781,0,2,oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor,MF,
14167,GO:0052894,1,0.994730037869166,0,1,norspermine:oxygen oxidoreductase activity,MF,
14168,GO:0052895,1,0.994730037869166,0,1,N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity,MF,
14169,GO:0052899,1,0.995450692884757,0,1,N(1),N(12)-diacetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
14170,GO:0052901,1,0.990204466342925,0,2,spermine:oxygen oxidoreductase (spermidine-forming) activity,MF,
14171,GO:0052902,1,0.995450692884757,0,1,spermidine:oxygen oxidoreductase (3-aminopropanal-forming) activity,MF,
14172,GO:0052903,1,0.995450692884757,0,1,N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
14173,GO:0052904,1,0.995450692884757,0,1,N1-acetylspermidine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
14174,GO:0052905,1,0.980581987539661,0,3,tRNA (guanine(9)-N(1))-methyltransferase activity,MF,
14175,GO:0052906,1,0.991722258369555,0,1,tRNA (guanine(37)-N(1))-methyltransferase activity,MF,
14176,GO:0052907,1,0.993485400251684,0,1,23S rRNA (adenine(1618)-N(6))-methyltransferase activity,MF,
14177,GO:0052909,1,0.993485400251684,0,1,18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity,MF,
14178,GO:0052917,1,0.994142058444901,0,1,dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity,MF,
14179,GO:0052918,1,0.99082165189146,0,1,dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
14180,GO:0052925,1,0.995759171086627,0,1,dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity,MF,
14181,GO:0052926,1,0.99082165189146,0,1,dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
14182,GO:0052927,1,0.994332545728782,0,1,CTP:tRNA cytidylyltransferase activity,MF,
14183,GO:0052928,1,0.994332545728782,0,1,CTP:3'-cytidine-tRNA cytidylyltransferase activity,MF,
14184,GO:0052929,1,0.994332545728782,0,1,ATP:3'-cytidine-cytidine-tRNA adenylyltransferase activity,MF,
14187,GO:0055003,1,0.832648049047497,0,18,cardiac myofibril assembly,BP,
14188,GO:0055005,1,0.979857915260488,0,3,ventricular cardiac myofibril assembly,BP,
14191,GO:0055008,1,0.625221706363171,0,59,cardiac muscle tissue morphogenesis,BP,
14192,GO:0055009,1,0.966225617224782,0,5,atrial cardiac muscle tissue morphogenesis,BP,
14193,GO:0055010,1,0.705245167677045,0,45,ventricular cardiac muscle tissue morphogenesis,BP,
14194,GO:0055011,1,0.990499245456818,0,2,atrial cardiac muscle cell differentiation,BP,
14195,GO:0055012,1,0.898577043342403,0,15,ventricular cardiac muscle cell differentiation,BP,
14197,GO:0055014,1,0.990499245456818,0,2,atrial cardiac muscle cell development,BP,
14198,GO:0055015,1,0.936437843945184,0,10,ventricular cardiac muscle cell development,BP,
14200,GO:0055018,1,0.995293167006598,0,1,regulation of cardiac muscle fiber development,BP,
14201,GO:0055020,1,0.995293167006598,0,1,positive regulation of cardiac muscle fiber development,BP,
14204,GO:0055023,1,0.785357421126214,0,32,positive regulation of cardiac muscle tissue growth,BP,
14206,GO:0055025,1,0.730665473646677,0,42,positive regulation of cardiac muscle tissue development,BP,
14208,GO:0055028,1,0.990030135300583,0,1,cortical microtubule,CC,
14209,GO:0055029,1,0.555558555016656,0,96,nuclear DNA-directed RNA polymerase complex,CC,
14210,GO:0055037,1,0.29982186181912,0,172,recycling endosome,CC,
14211,GO:0055038,1,0.584921242401458,0,80,recycling endosome membrane,CC,
14212,GO:0055048,1,0.990030135300583,0,1,anastral spindle assembly,BP,
14213,GO:0055056,1,0.958267968011668,0,6,D-glucose transmembrane transporter activity,MF,
14215,GO:0055059,1,0.956240210590661,0,6,asymmetric neuroblast division,BP,
14216,GO:0055062,1,0.940133832953563,0,8,phosphate ion homeostasis,BP,
14217,GO:0055064,1,0.907634507865731,0,13,chloride ion homeostasis,BP,
14221,GO:0055070,1,0.899857042683422,0,17,copper ion homeostasis,BP,
14222,GO:0055071,1,0.985252070939414,0,2,manganese ion homeostasis,BP,
14223,GO:0055072,1,0.612354127194898,0,76,iron ion homeostasis,BP,
14224,GO:0055073,1,0.982844863070295,0,3,cadmium ion homeostasis,BP,
14226,GO:0055075,1,0.822487449124964,0,27,potassium ion homeostasis,BP,
14228,GO:0055077,1,0.984933312277474,0,2,gap junction hemi-channel activity,MF,
14229,GO:0055078,1,0.755998851331612,0,43,sodium ion homeostasis,BP,
14231,GO:0055081,1,0.689884829663194,0,52,anion homeostasis,BP,
14233,GO:0055083,1,0.853246865483328,0,21,monovalent inorganic anion homeostasis,BP,
14236,GO:0055087,1,0.980699131235729,0,3,Ski complex,CC,
14237,GO:0055088,1,0.445839798453959,0,123,lipid homeostasis,BP,
14238,GO:0055089,1,0.907183285843382,0,14,fatty acid homeostasis,BP,
14239,GO:0055090,1,0.85195420340915,0,27,acylglycerol homeostasis,BP,
14240,GO:0055091,1,0.925768895647338,0,12,phospholipid homeostasis,BP,
14241,GO:0055092,1,0.627086985220581,0,71,sterol homeostasis,BP,
14242,GO:0055093,1,0.883688197661962,0,19,response to hyperoxia,BP,
14243,GO:0055094,1,0.821025862187233,0,29,response to lipoprotein particle,BP,
14244,GO:0055095,1,0.980279737080403,0,3,lipoprotein particle mediated signaling,BP,
14245,GO:0055096,1,0.980279737080403,0,3,low-density lipoprotein particle mediated signaling,BP,
14246,GO:0055100,1,0.980069087058824,0,3,adiponectin binding,MF,
14247,GO:0055102,1,0.950959011574566,0,11,lipase inhibitor activity,MF,
14248,GO:0055103,1,0.992996218770604,0,1,ligase regulator activity,MF,
14249,GO:0055105,1,0.977027020742991,0,6,ubiquitin-protein transferase inhibitor activity,MF,
14250,GO:0055106,1,0.912301097431752,0,17,ubiquitin-protein transferase regulator activity,MF,
14251,GO:0055108,1,0.994918347828145,0,1,Golgi to transport vesicle transport,BP,
14252,GO:0055111,1,0.991396558144678,0,1,ingression involved in gastrulation with mouth forming second,BP,
14253,GO:0055113,1,0.986929523268246,0,1,epiboly involved in gastrulation with mouth forming second,BP,
14255,GO:0055117,1,0.584684043952456,0,74,regulation of cardiac muscle contraction,BP,
14256,GO:0055118,1,0.958526488627763,0,6,negative regulation of cardiac muscle contraction,BP,
14257,GO:0055119,1,0.892757555514997,0,16,relaxation of cardiac muscle,BP,
14258,GO:0055120,1,0.996472742840655,0,1,striated muscle dense body,CC,
14260,GO:0055129,1,0.97210870081874,0,5,L-proline biosynthetic process,BP,
14261,GO:0055130,1,0.995619591821006,0,1,D-alanine catabolic process,BP,
14262,GO:0055131,1,0.965643680737261,0,6,C3HC4-type RING finger domain binding,MF,
14263,GO:0060001,1,0.988775639257374,0,1,minus-end directed microfilament motor activity,MF,
14264,GO:0060002,1,0.977938441284828,0,2,plus-end directed microfilament motor activity,MF,
14265,GO:0060003,1,0.977044854489461,0,3,copper ion export,BP,
14266,GO:0060004,1,0.883263790779069,0,18,reflex,BP,
14267,GO:0060005,1,0.97060477351981,0,4,vestibular reflex,BP,
14268,GO:0060007,1,0.992527828717562,0,1,linear vestibuloocular reflex,BP,
14269,GO:0060008,1,0.878379758710238,0,18,Sertoli cell differentiation,BP,
14270,GO:0060009,1,0.900694506925332,0,14,Sertoli cell development,BP,
14271,GO:0060010,1,0.992945788737528,0,1,Sertoli cell fate commitment,BP,
14272,GO:0060011,1,0.981452820075994,0,3,Sertoli cell proliferation,BP,
14273,GO:0060012,1,0.961132369374001,0,6,synaptic transmission, glycinergic,BP,
14274,GO:0060013,1,0.948258980015278,0,7,righting reflex,BP,
14275,GO:0060014,1,0.99330216760911,0,1,granulosa cell differentiation,BP,
14276,GO:0060017,1,0.958424905726502,0,6,parathyroid gland development,BP,
14277,GO:0060018,1,0.977931056308725,0,3,astrocyte fate commitment,BP,
14278,GO:0060019,1,0.932962737755666,0,12,radial glial cell differentiation,BP,
14279,GO:0060020,1,0.947360853941218,0,8,Bergmann glial cell differentiation,BP,
14280,GO:0060021,1,0.522616054720608,0,87,roof of mouth development,BP,
14281,GO:0060022,1,0.954595529858813,0,6,hard palate development,BP,
14282,GO:0060023,1,0.960890101813398,0,5,soft palate development,BP,
14283,GO:0060024,1,0.970778829480774,0,4,rhythmic synaptic transmission,BP,
14284,GO:0060025,1,0.976778775590999,0,3,regulation of synaptic activity,BP,
14286,GO:0060027,1,0.943521058333396,0,8,convergent extension involved in gastrulation,BP,
14288,GO:0060029,1,0.961100873368134,0,6,convergent extension involved in organogenesis,BP,
14289,GO:0060031,1,0.986291852023498,0,2,mediolateral intercalation,BP,
14290,GO:0060032,1,0.983319876524172,0,2,notochord regression,BP,
14291,GO:0060033,1,0.897162152571185,0,16,anatomical structure regression,BP,
14292,GO:0060034,1,0.992636844474795,0,1,notochord cell differentiation,BP,
14293,GO:0060035,1,0.992636844474795,0,1,notochord cell development,BP,
14294,GO:0060037,1,0.842995838254947,0,24,pharyngeal system development,BP,
14295,GO:0060038,1,0.694684563166245,0,50,cardiac muscle cell proliferation,BP,
14296,GO:0060039,1,0.851277806551175,0,19,pericardium development,BP,
14297,GO:0060040,1,0.971727056655956,0,5,retinal bipolar neuron differentiation,BP,
14300,GO:0060043,1,0.743179063363857,0,41,regulation of cardiac muscle cell proliferation,BP,
14301,GO:0060044,1,0.903305640571833,0,15,negative regulation of cardiac muscle cell proliferation,BP,
14302,GO:0060045,1,0.83159404012749,0,24,positive regulation of cardiac muscle cell proliferation,BP,
14303,GO:0060046,1,0.921602780760889,0,13,regulation of acrosome reaction,BP,
14304,GO:0060047,1,0.158560672473873,0,260,heart contraction,BP,
14305,GO:0060048,1,0.396177897516433,0,127,cardiac muscle contraction,BP,
14306,GO:0060049,1,0.903762247531846,0,14,regulation of protein glycosylation,BP,
14307,GO:0060050,1,0.936184191875091,0,9,positive regulation of protein glycosylation,BP,
14308,GO:0060051,1,0.98885397351403,0,2,negative regulation of protein glycosylation,BP,
14309,GO:0060052,1,0.961620286345823,0,6,neurofilament cytoskeleton organization,BP,
14310,GO:0060053,1,0.984484177498955,0,2,neurofilament cytoskeleton,CC,
14311,GO:0060054,1,0.967086708536997,0,6,positive regulation of epithelial cell proliferation involved in wound healing,BP,
14312,GO:0060055,1,0.839832841118318,0,26,angiogenesis involved in wound healing,BP,
14313,GO:0060056,1,0.956376798692443,0,7,mammary gland involution,BP,
14314,GO:0060057,1,0.9889865257519,0,2,apoptotic process involved in mammary gland involution,BP,
14315,GO:0060058,1,0.9889865257519,0,2,positive regulation of apoptotic process involved in mammary gland involution,BP,
14316,GO:0060059,1,0.942250738319987,0,6,embryonic retina morphogenesis in camera-type eye,BP,
14317,GO:0060060,1,0.982172825952773,0,2,post-embryonic retina morphogenesis in camera-type eye,BP,
14318,GO:0060061,1,0.981522151120282,0,3,Spemann organizer formation,BP,
14319,GO:0060064,1,0.995796381866068,0,1,Spemann organizer formation at the anterior end of the primitive streak,BP,
14320,GO:0060065,1,0.854679230263932,0,20,uterus development,BP,
14321,GO:0060066,1,0.988336180547256,0,2,oviduct development,BP,
14322,GO:0060067,1,0.991228585807255,0,1,cervix development,BP,
14323,GO:0060068,1,0.932953097254378,0,9,vagina development,BP,
14326,GO:0060072,1,0.990841062581587,0,1,large conductance calcium-activated potassium channel activity,MF,
14327,GO:0060073,1,0.951302474358037,0,7,micturition,BP,
14329,GO:0060075,1,0.937256650609514,0,9,regulation of resting membrane potential,BP,
14331,GO:0060077,1,0.887705978985835,0,17,inhibitory synapse,CC,
14334,GO:0060080,1,0.88562164354004,0,16,inhibitory postsynaptic potential,BP,
14335,GO:0060081,1,0.927092856216086,0,11,membrane hyperpolarization,BP,
14336,GO:0060082,1,0.995711516728321,0,1,eye blink reflex,BP,
14337,GO:0060083,1,0.983458153989386,0,2,smooth muscle contraction involved in micturition,BP,
14338,GO:0060084,1,0.979113649774702,0,3,synaptic transmission involved in micturition,BP,
14339,GO:0060086,1,0.979791030513493,0,3,circadian temperature homeostasis,BP,
14340,GO:0060087,1,0.965149180543818,0,6,relaxation of vascular associated smooth muscle,BP,
14341,GO:0060088,1,0.934345427083749,0,10,auditory receptor cell stereocilium organization,BP,
14344,GO:0060091,1,0.95663762404807,0,7,kinocilium,CC,
14345,GO:0060099,1,0.903627589912219,0,15,regulation of phagocytosis, engulfment,BP,
14346,GO:0060100,1,0.91393651882309,0,13,positive regulation of phagocytosis, engulfment,BP,
14347,GO:0060101,1,0.995091742462202,0,1,negative regulation of phagocytosis, engulfment,BP,
14348,GO:0060112,1,0.99210937186429,0,2,generation of ovulation cycle rhythm,BP,
14350,GO:0060117,1,0.883698955470859,0,17,auditory receptor cell development,BP,
14352,GO:0060120,1,0.967500818619679,0,4,inner ear receptor cell fate commitment,BP,
14354,GO:0060123,1,0.929316294413403,0,11,regulation of growth hormone secretion,BP,
14355,GO:0060124,1,0.958644857355281,0,8,positive regulation of growth hormone secretion,BP,
14356,GO:0060125,1,0.981851932519338,0,2,negative regulation of growth hormone secretion,BP,
14357,GO:0060126,1,0.983161842749043,0,3,somatotropin secreting cell differentiation,BP,
14358,GO:0060127,1,0.994412134781964,0,1,prolactin secreting cell differentiation,BP,
14359,GO:0060128,1,0.989569530618045,0,2,corticotropin hormone secreting cell differentiation,BP,
14360,GO:0060129,1,0.982306595925308,0,3,thyroid-stimulating hormone-secreting cell differentiation,BP,
14361,GO:0060133,1,0.995996756490492,0,1,somatotropin secreting cell development,BP,
14364,GO:0060136,1,0.962577585892103,0,6,embryonic process involved in female pregnancy,BP,
14365,GO:0060137,1,0.949600615693345,0,8,maternal process involved in parturition,BP,
14366,GO:0060139,1,0.98845550368595,0,2,positive regulation of apoptotic process by virus,BP,
14367,GO:0060142,1,0.881805893296126,0,23,regulation of syncytium formation by plasma membrane fusion,BP,
14368,GO:0060143,1,0.889583314112243,0,21,positive regulation of syncytium formation by plasma membrane fusion,BP,
14369,GO:0060147,1,0.562344930612286,0,84,regulation of posttranscriptional gene silencing,BP,
14370,GO:0060148,1,0.850475208156724,0,24,positive regulation of posttranscriptional gene silencing,BP,
14371,GO:0060149,1,0.868782698991374,0,20,negative regulation of posttranscriptional gene silencing,BP,
14372,GO:0060151,1,0.984776534987799,0,2,peroxisome localization,BP,
14373,GO:0060152,1,0.984776534987799,0,2,microtubule-based peroxisome localization,BP,
14374,GO:0060155,1,0.945110952279812,0,9,platelet dense granule organization,BP,
14375,GO:0060157,1,0.975157801319753,0,4,urinary bladder development,BP,
14376,GO:0060158,1,0.956233321042268,0,8,phospholipase C-activating dopamine receptor signaling pathway,BP,
14377,GO:0060159,1,0.929829476949013,0,11,regulation of dopamine receptor signaling pathway,BP,
14378,GO:0060160,1,0.975949386803412,0,4,negative regulation of dopamine receptor signaling pathway,BP,
14379,GO:0060161,1,0.964446874199025,0,5,positive regulation of dopamine receptor signaling pathway,BP,
14380,GO:0060163,1,0.990226279036615,0,2,subpallium neuron fate commitment,BP,
14381,GO:0060164,1,0.982910481312754,0,3,regulation of timing of neuron differentiation,BP,
14382,GO:0060165,1,0.993962265126325,0,1,regulation of timing of subpallium neuron differentiation,BP,
14383,GO:0060166,1,0.982819713312601,0,3,olfactory pit development,BP,
14384,GO:0060167,1,0.981080707565626,0,3,regulation of adenosine receptor signaling pathway,BP,
14385,GO:0060168,1,0.985291848669696,0,2,positive regulation of adenosine receptor signaling pathway,BP,
14386,GO:0060169,1,0.995726628919274,0,1,negative regulation of adenosine receptor signaling pathway,BP,
14387,GO:0060170,1,0.624554861929768,0,66,ciliary membrane,CC,
14388,GO:0060171,1,0.970399077964011,0,3,stereocilium membrane,CC,
14390,GO:0060174,1,0.920994187822179,0,11,limb bud formation,BP,
14391,GO:0060175,1,0.990103361111213,0,1,brain-derived neurotrophic factor-activated receptor activity,MF,
14392,GO:0060177,1,0.98848745318586,0,2,regulation of angiotensin metabolic process,BP,
14393,GO:0060178,1,0.994367400481405,0,1,regulation of exocyst localization,BP,
14394,GO:0060179,1,0.936984863809228,0,8,male mating behavior,BP,
14395,GO:0060180,1,0.950868600147937,0,7,female mating behavior,BP,
14396,GO:0060182,1,0.993311486956371,0,1,apelin receptor activity,MF,
14397,GO:0060183,1,0.986372127812577,0,2,apelin receptor signaling pathway,BP,
14398,GO:0060184,1,0.984067131802041,0,2,cell cycle switching,BP,
14399,GO:0060187,1,0.93229443273949,0,9,cell pole,CC,
14401,GO:0060192,1,0.930110743388505,0,12,negative regulation of lipase activity,BP,
14403,GO:0060197,1,0.982645289951555,0,3,cloacal septation,BP,
14410,GO:0060211,1,0.90677230304823,0,12,regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
14411,GO:0060212,1,0.995221760105399,0,1,negative regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
14412,GO:0060213,1,0.90677230304823,0,12,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
14413,GO:0060214,1,0.978652193236599,0,4,endocardium formation,BP,
14414,GO:0060215,1,0.945817883693378,0,8,primitive hemopoiesis,BP,
14415,GO:0060216,1,0.85981514715126,0,21,definitive hemopoiesis,BP,
14416,GO:0060217,1,0.991955693871497,0,1,hemangioblast cell differentiation,BP,
14417,GO:0060218,1,0.613109810148984,0,84,hematopoietic stem cell differentiation,BP,
14419,GO:0060220,1,0.994738933398728,0,1,camera-type eye photoreceptor cell fate commitment,BP,
14420,GO:0060221,1,0.917744153456708,0,12,retinal rod cell differentiation,BP,
14421,GO:0060228,1,0.990202166752871,0,3,phosphatidylcholine-sterol O-acyltransferase activator activity,MF,
14422,GO:0060229,1,0.936265039943938,0,11,lipase activator activity,MF,
14423,GO:0060230,1,0.993160859734928,0,2,lipoprotein lipase activator activity,MF,
14424,GO:0060231,1,0.883376895748935,0,20,mesenchymal to epithelial transition,BP,
14425,GO:0060232,1,0.971584401296766,0,4,delamination,BP,
14426,GO:0060234,1,0.989861933896093,0,1,neuroblast delamination,BP,
14427,GO:0060235,1,0.963798710485141,0,4,lens induction in camera-type eye,BP,
14429,GO:0060242,1,0.948027871127541,0,8,contact inhibition,BP,
14430,GO:0060243,1,0.99249492309276,0,1,negative regulation of cell growth involved in contact inhibition,BP,
14431,GO:0060244,1,0.981647869371906,0,3,negative regulation of cell proliferation involved in contact inhibition,BP,
14432,GO:0060245,1,0.948027871127541,0,8,detection of cell density,BP,
14434,GO:0060251,1,0.808194598446277,0,30,regulation of glial cell proliferation,BP,
14435,GO:0060252,1,0.907743803406182,0,15,positive regulation of glial cell proliferation,BP,
14436,GO:0060253,1,0.904462509832791,0,14,negative regulation of glial cell proliferation,BP,
14437,GO:0060254,1,0.995234987992997,0,1,regulation of N-terminal protein palmitoylation,BP,
14440,GO:0060260,1,0.782012943207015,0,35,regulation of transcription initiation from RNA polymerase II promoter,BP,
14441,GO:0060261,1,0.815901518079742,0,29,positive regulation of transcription initiation from RNA polymerase II promoter,BP,
14442,GO:0060262,1,0.995234987992997,0,1,negative regulation of N-terminal protein palmitoylation,BP,
14443,GO:0060263,1,0.925782678657685,0,13,regulation of respiratory burst,BP,
14444,GO:0060264,1,0.973825941436561,0,5,regulation of respiratory burst involved in inflammatory response,BP,
14445,GO:0060265,1,0.991950646190121,0,2,positive regulation of respiratory burst involved in inflammatory response,BP,
14446,GO:0060266,1,0.978524848175801,0,4,negative regulation of respiratory burst involved in inflammatory response,BP,
14447,GO:0060267,1,0.969718826078364,0,5,positive regulation of respiratory burst,BP,
14448,GO:0060268,1,0.969043184523609,0,5,negative regulation of respiratory burst,BP,
14450,GO:0060272,1,0.936435674026383,0,11,embryonic skeletal joint morphogenesis,BP,
14451,GO:0060278,1,0.981921350191271,0,3,regulation of ovulation,BP,
14452,GO:0060279,1,0.987604633415424,0,2,positive regulation of ovulation,BP,
14453,GO:0060280,1,0.994246102295014,0,1,negative regulation of ovulation,BP,
14454,GO:0060281,1,0.927828855401207,0,11,regulation of oocyte development,BP,
14455,GO:0060282,1,0.965031565646525,0,5,positive regulation of oocyte development,BP,
14456,GO:0060283,1,0.973547415532319,0,4,negative regulation of oocyte development,BP,
14459,GO:0060287,1,0.923352440487941,0,11,epithelial cilium movement involved in determination of left/right asymmetry,BP,
14460,GO:0060290,1,0.949499768747678,0,8,transdifferentiation,BP,
14463,GO:0060293,1,0.883661368124996,0,17,germ plasm,CC,
14465,GO:0060295,1,0.912827326697504,0,17,regulation of cilium movement involved in cell motility,BP,
14466,GO:0060296,1,0.962340438661337,0,6,regulation of cilium beat frequency involved in ciliary motility,BP,
14467,GO:0060297,1,0.950197105046486,0,6,regulation of sarcomere organization,BP,
14468,GO:0060298,1,0.977335400554163,0,3,positive regulation of sarcomere organization,BP,
14469,GO:0060299,1,0.995999097821548,0,1,negative regulation of sarcomere organization,BP,
14470,GO:0060300,1,0.977325854262337,0,4,regulation of cytokine activity,BP,
14471,GO:0060301,1,0.993942611467265,0,1,positive regulation of cytokine activity,BP,
14472,GO:0060302,1,0.990686251325401,0,2,negative regulation of cytokine activity,BP,
14473,GO:0060304,1,0.949593546847404,0,6,regulation of phosphatidylinositol dephosphorylation,BP,
14474,GO:0060305,1,0.993370920870107,0,1,regulation of cell diameter,BP,
14475,GO:0060306,1,0.791155836238606,0,31,regulation of membrane repolarization,BP,
14476,GO:0060307,1,0.863919319717933,0,20,regulation of ventricular cardiac muscle cell membrane repolarization,BP,
14477,GO:0060309,1,0.990337420830911,0,2,elastin catabolic process,BP,
14478,GO:0060310,1,0.996831585739888,0,1,regulation of elastin catabolic process,BP,
14479,GO:0060311,1,0.996831585739888,0,1,negative regulation of elastin catabolic process,BP,
14480,GO:0060312,1,0.953122712709112,0,7,regulation of blood vessel remodeling,BP,
14481,GO:0060313,1,0.97901104297536,0,3,negative regulation of blood vessel remodeling,BP,
14482,GO:0060314,1,0.846332932235928,0,25,regulation of ryanodine-sensitive calcium-release channel activity,BP,
14483,GO:0060315,1,0.940328743412898,0,11,negative regulation of ryanodine-sensitive calcium-release channel activity,BP,
14484,GO:0060316,1,0.949452922113011,0,8,positive regulation of ryanodine-sensitive calcium-release channel activity,BP,
14485,GO:0060317,1,0.812609098494851,0,31,cardiac epithelial to mesenchymal transition,BP,
14486,GO:0060318,1,0.960897379472489,0,6,definitive erythrocyte differentiation,BP,
14487,GO:0060319,1,0.974801843223476,0,4,primitive erythrocyte differentiation,BP,
14489,GO:0060323,1,0.772095166605116,0,35,head morphogenesis,BP,
14490,GO:0060324,1,0.706144850371468,0,46,face development,BP,
14491,GO:0060325,1,0.793403731945585,0,30,face morphogenesis,BP,
14492,GO:0060326,1,0.208465693625752,0,260,cell chemotaxis,BP,
14493,GO:0060327,1,0.984560733024397,0,2,cytoplasmic actin-based contraction involved in cell motility,BP,
14494,GO:0060330,1,0.867262682119143,0,23,regulation of response to interferon-gamma,BP,
14495,GO:0060331,1,0.966922700918334,0,6,negative regulation of response to interferon-gamma,BP,
14496,GO:0060332,1,0.957673186246326,0,6,positive regulation of response to interferon-gamma,BP,
14498,GO:0060334,1,0.867262682119143,0,23,regulation of interferon-gamma-mediated signaling pathway,BP,
14499,GO:0060335,1,0.957673186246326,0,6,positive regulation of interferon-gamma-mediated signaling pathway,BP,
14500,GO:0060336,1,0.966922700918334,0,6,negative regulation of interferon-gamma-mediated signaling pathway,BP,
14501,GO:0060337,1,0.629084995844477,0,76,type I interferon signaling pathway,BP,
14502,GO:0060338,1,0.811073604898161,0,31,regulation of type I interferon-mediated signaling pathway,BP,
14503,GO:0060339,1,0.922652042056837,0,12,negative regulation of type I interferon-mediated signaling pathway,BP,
14504,GO:0060340,1,0.921706673623897,0,11,positive regulation of type I interferon-mediated signaling pathway,BP,
14506,GO:0060342,1,0.974374658271154,0,4,photoreceptor inner segment membrane,CC,
14507,GO:0060343,1,0.846415450169719,0,24,trabecula formation,BP,
14508,GO:0060345,1,0.992922930638173,0,1,spleen trabecula formation,BP,
14509,GO:0060346,1,0.923313985053262,0,10,bone trabecula formation,BP,
14510,GO:0060347,1,0.92331780333604,0,13,heart trabecula formation,BP,
14513,GO:0060350,1,0.690856523223061,0,53,endochondral bone morphogenesis,BP,
14514,GO:0060351,1,0.819125958421718,0,29,cartilage development involved in endochondral bone morphogenesis,BP,
14515,GO:0060352,1,0.928075301800618,0,11,cell adhesion molecule production,BP,
14516,GO:0060353,1,0.942097265328896,0,9,regulation of cell adhesion molecule production,BP,
14517,GO:0060354,1,0.969164374706292,0,4,negative regulation of cell adhesion molecule production,BP,
14518,GO:0060355,1,0.977873621988816,0,4,positive regulation of cell adhesion molecule production,BP,
14519,GO:0060357,1,0.987141987238285,0,2,regulation of leucine import,BP,
14520,GO:0060358,1,0.987141987238285,0,2,negative regulation of leucine import,BP,
14522,GO:0060363,1,0.955670017490656,0,7,cranial suture morphogenesis,BP,
14523,GO:0060364,1,0.976851602738977,0,3,frontal suture morphogenesis,BP,
14524,GO:0060366,1,0.989166318178273,0,1,lambdoid suture morphogenesis,BP,
14525,GO:0060367,1,0.989166318178273,0,1,sagittal suture morphogenesis,BP,
14526,GO:0060368,1,0.923226577505522,0,11,regulation of Fc receptor mediated stimulatory signaling pathway,BP,
14527,GO:0060369,1,0.950421810917491,0,7,positive regulation of Fc receptor mediated stimulatory signaling pathway,BP,
14528,GO:0060370,1,0.991300522377682,0,1,susceptibility to T cell mediated cytotoxicity,BP,
14529,GO:0060371,1,0.950221922967464,0,6,regulation of atrial cardiac muscle cell membrane depolarization,BP,
14530,GO:0060372,1,0.945348617898167,0,7,regulation of atrial cardiac muscle cell membrane repolarization,BP,
14531,GO:0060373,1,0.96247579282617,0,5,regulation of ventricular cardiac muscle cell membrane depolarization,BP,
14532,GO:0060374,1,0.96206978365973,0,5,mast cell differentiation,BP,
14533,GO:0060375,1,0.985007694477983,0,2,regulation of mast cell differentiation,BP,
14534,GO:0060377,1,0.992996218770604,0,1,negative regulation of mast cell differentiation,BP,
14535,GO:0060378,1,0.984872246443424,0,2,regulation of brood size,BP,
14536,GO:0060379,1,0.926192702834774,0,10,cardiac muscle cell myoblast differentiation,BP,
14537,GO:0060380,1,0.994750792858357,0,1,regulation of single-stranded telomeric DNA binding,BP,
14538,GO:0060381,1,0.994750792858357,0,1,positive regulation of single-stranded telomeric DNA binding,BP,
14539,GO:0060382,1,0.983321308949049,0,2,regulation of DNA strand elongation,BP,
14540,GO:0060383,1,0.992571500217296,0,1,positive regulation of DNA strand elongation,BP,
14543,GO:0060386,1,0.991325103841504,0,1,synapse assembly involved in innervation,BP,
14544,GO:0060389,1,0.673281099395155,0,60,pathway-restricted SMAD protein phosphorylation,BP,
14545,GO:0060390,1,0.83777763469373,0,25,regulation of SMAD protein signal transduction,BP,
14546,GO:0060391,1,0.895109769082335,0,15,positive regulation of SMAD protein signal transduction,BP,
14547,GO:0060392,1,0.969551948617948,0,5,negative regulation of SMAD protein signal transduction,BP,
14548,GO:0060393,1,0.690350305013047,0,57,regulation of pathway-restricted SMAD protein phosphorylation,BP,
14549,GO:0060394,1,0.933039735446051,0,11,negative regulation of pathway-restricted SMAD protein phosphorylation,BP,
14550,GO:0060395,1,0.60030839442235,0,72,SMAD protein signal transduction,BP,
14551,GO:0060396,1,0.869254707492878,0,19,growth hormone receptor signaling pathway,BP,
14552,GO:0060397,1,0.916577070915404,0,11,growth hormone receptor signaling pathway via JAK-STAT,BP,
14553,GO:0060398,1,0.968545444696513,0,5,regulation of growth hormone receptor signaling pathway,BP,
14554,GO:0060399,1,0.97979515904758,0,3,positive regulation of growth hormone receptor signaling pathway,BP,
14555,GO:0060400,1,0.988520630364577,0,2,negative regulation of growth hormone receptor signaling pathway,BP,
14558,GO:0060404,1,0.992767886172341,0,1,axonemal microtubule depolymerization,BP,
14560,GO:0060406,1,0.973904763660185,0,4,positive regulation of penile erection,BP,
14561,GO:0060407,1,0.995726628919274,0,1,negative regulation of penile erection,BP,
14562,GO:0060411,1,0.585475611902541,0,70,cardiac septum morphogenesis,BP,
14563,GO:0060412,1,0.739048328607788,0,40,ventricular septum morphogenesis,BP,
14564,GO:0060413,1,0.903518963908601,0,13,atrial septum morphogenesis,BP,
14565,GO:0060414,1,0.974560169696462,0,3,aorta smooth muscle tissue morphogenesis,BP,
14566,GO:0060415,1,0.585759499060015,0,68,muscle tissue morphogenesis,BP,
14567,GO:0060416,1,0.794278197578772,0,32,response to growth hormone,BP,
14570,GO:0060421,1,0.761924800131261,0,36,positive regulation of heart growth,BP,
14571,GO:0060422,1,0.994295919122455,0,1,peptidyl-dipeptidase inhibitor activity,MF,
14572,GO:0060423,1,0.980752416775261,0,3,foregut regionalization,BP,
14573,GO:0060424,1,0.980752416775261,0,3,lung field specification,BP,
14574,GO:0060425,1,0.707103764539806,0,50,lung morphogenesis,BP,
14575,GO:0060426,1,0.969703252496055,0,5,lung vasculature development,BP,
14576,GO:0060428,1,0.791300051989622,0,35,lung epithelium development,BP,
14578,GO:0060430,1,0.944836254270915,0,8,lung saccule development,BP,
14579,GO:0060431,1,0.973716569317851,0,4,primary lung bud formation,BP,
14580,GO:0060432,1,0.997014122102647,0,1,lung pattern specification process,BP,
14581,GO:0060433,1,0.940631590862696,0,10,bronchus development,BP,
14582,GO:0060434,1,0.986074342202555,0,2,bronchus morphogenesis,BP,
14583,GO:0060435,1,0.993087533008282,0,2,bronchiole development,BP,
14584,GO:0060436,1,0.997014122102647,0,1,bronchiole morphogenesis,BP,
14585,GO:0060437,1,0.963982898337389,0,6,lung growth,BP,
14586,GO:0060438,1,0.877073489941254,0,19,trachea development,BP,
14587,GO:0060439,1,0.929417724383476,0,11,trachea morphogenesis,BP,
14588,GO:0060440,1,0.962592696977242,0,6,trachea formation,BP,
14589,GO:0060441,1,0.816999100380641,0,29,epithelial tube branching involved in lung morphogenesis,BP,
14590,GO:0060442,1,0.918470815059226,0,12,branching involved in prostate gland morphogenesis,BP,
14591,GO:0060443,1,0.725223975911566,0,43,mammary gland morphogenesis,BP,
14592,GO:0060444,1,0.836232490449383,0,23,branching involved in mammary gland duct morphogenesis,BP,
14593,GO:0060445,1,0.841980033191033,0,23,branching involved in salivary gland morphogenesis,BP,
14594,GO:0060447,1,0.98244082950653,0,3,bud outgrowth involved in lung branching,BP,
14595,GO:0060448,1,0.97430197522146,0,3,dichotomous subdivision of terminal units involved in lung branching,BP,
14596,GO:0060449,1,0.95888048225787,0,7,bud elongation involved in lung branching,BP,
14597,GO:0060452,1,0.937227534857924,0,11,positive regulation of cardiac muscle contraction,BP,
14598,GO:0060453,1,0.94713524665925,0,9,regulation of gastric acid secretion,BP,
14599,GO:0060454,1,0.985574584822104,0,2,positive regulation of gastric acid secretion,BP,
14600,GO:0060455,1,0.9812373634515,0,4,negative regulation of gastric acid secretion,BP,
14601,GO:0060456,1,0.951467441398707,0,9,positive regulation of digestive system process,BP,
14602,GO:0060457,1,0.930634191368159,0,13,negative regulation of digestive system process,BP,
14603,GO:0060458,1,0.989507695199636,0,2,right lung development,BP,
14604,GO:0060459,1,0.99039780658015,0,2,left lung development,BP,
14605,GO:0060460,1,0.994709279864805,0,1,left lung morphogenesis,BP,
14606,GO:0060461,1,0.99381533233784,0,1,right lung morphogenesis,BP,
14607,GO:0060462,1,0.959852346011423,0,6,lung lobe development,BP,
14608,GO:0060463,1,0.959852346011423,0,6,lung lobe morphogenesis,BP,
14609,GO:0060465,1,0.977630497835092,0,3,pharynx development,BP,
14610,GO:0060466,1,0.990388832501393,0,1,activation of meiosis involved in egg activation,BP,
14611,GO:0060467,1,0.983924051747494,0,3,negative regulation of fertilization,BP,
14612,GO:0060474,1,0.990160209491494,0,2,positive regulation of flagellated sperm motility involved in capacitation,BP,
14613,GO:0060478,1,0.955124067700028,0,7,acrosomal vesicle exocytosis,BP,
14614,GO:0060479,1,0.872629463460034,0,21,lung cell differentiation,BP,
14615,GO:0060480,1,0.987329647252461,0,3,lung goblet cell differentiation,BP,
14616,GO:0060481,1,0.980079954770431,0,4,lobar bronchus epithelium development,BP,
14617,GO:0060482,1,0.972882535851693,0,5,lobar bronchus development,BP,
14618,GO:0060484,1,0.943346145475515,0,9,lung-associated mesenchyme development,BP,
14620,GO:0060486,1,0.970922064594517,0,4,club cell differentiation,BP,
14621,GO:0060487,1,0.878893407224905,0,20,lung epithelial cell differentiation,BP,
14622,GO:0060488,1,0.978381144054425,0,2,orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis,BP,
14623,GO:0060489,1,0.978381144054425,0,2,planar dichotomous subdivision of terminal units involved in lung branching morphogenesis,BP,
14624,GO:0060490,1,0.978381144054425,0,2,lateral sprouting involved in lung morphogenesis,BP,
14626,GO:0060492,1,0.980752416775261,0,3,lung induction,BP,
14627,GO:0060495,1,0.997014122102647,0,1,cell-cell signaling involved in lung development,BP,
14628,GO:0060496,1,0.997014122102647,0,1,mesenchymal-epithelial cell signaling involved in lung development,BP,
14629,GO:0060501,1,0.960043206911459,0,6,positive regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
14630,GO:0060502,1,0.932406105761703,0,10,epithelial cell proliferation involved in lung morphogenesis,BP,
14631,GO:0060503,1,0.995293167006598,0,1,bud dilation involved in lung branching,BP,
14632,GO:0060509,1,0.957250121433276,0,5,type I pneumocyte differentiation,BP,
14633,GO:0060510,1,0.970023507021742,0,5,type II pneumocyte differentiation,BP,
14634,GO:0060512,1,0.824900489680557,0,27,prostate gland morphogenesis,BP,
14635,GO:0060513,1,0.935974465971301,0,10,prostatic bud formation,BP,
14636,GO:0060514,1,0.993164323925024,0,1,prostate induction,BP,
14637,GO:0060515,1,0.993164323925024,0,1,prostate field specification,BP,
14638,GO:0060516,1,0.988349388318176,0,2,primary prostatic bud elongation,BP,
14639,GO:0060517,1,0.992652033405997,0,1,epithelial cell proliferation involved in prostatic bud elongation,BP,
14640,GO:0060520,1,0.993164323925024,0,1,activation of prostate induction by androgen receptor signaling pathway,BP,
14641,GO:0060523,1,0.979153699572978,0,3,prostate epithelial cord elongation,BP,
14642,GO:0060525,1,0.915966219889874,0,11,prostate glandular acinus development,BP,
14643,GO:0060526,1,0.954322688667542,0,6,prostate glandular acinus morphogenesis,BP,
14644,GO:0060527,1,0.954322688667542,0,6,prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis,BP,
14645,GO:0060528,1,0.967340304803049,0,4,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,BP,
14646,GO:0060529,1,0.984861702376283,0,2,squamous basal epithelial stem cell differentiation involved in prostate gland acinus development,BP,
14647,GO:0060532,1,0.98515372524038,0,2,bronchus cartilage development,BP,
14648,GO:0060534,1,0.942342842505843,0,8,trachea cartilage development,BP,
14649,GO:0060535,1,0.96975309335351,0,4,trachea cartilage morphogenesis,BP,
14650,GO:0060536,1,0.927390911744988,0,11,cartilage morphogenesis,BP,
14653,GO:0060539,1,0.950876150444365,0,8,diaphragm development,BP,
14654,GO:0060541,1,0.240423703261364,0,195,respiratory system development,BP,
14655,GO:0060542,1,0.991283985265797,0,1,regulation of strand invasion,BP,
14656,GO:0060544,1,0.885517735501146,0,18,regulation of necroptotic process,BP,
14657,GO:0060545,1,0.98231264749711,0,3,positive regulation of necroptotic process,BP,
14658,GO:0060546,1,0.91175112486419,0,14,negative regulation of necroptotic process,BP,
14659,GO:0060547,1,0.906374030661924,0,16,negative regulation of necrotic cell death,BP,
14661,GO:0060556,1,0.954619790802403,0,8,regulation of vitamin D biosynthetic process,BP,
14662,GO:0060557,1,0.991314542687769,0,2,positive regulation of vitamin D biosynthetic process,BP,
14663,GO:0060558,1,0.964094271849893,0,6,regulation of calcidiol 1-monooxygenase activity,BP,
14664,GO:0060559,1,0.991314542687769,0,2,positive regulation of calcidiol 1-monooxygenase activity,BP,
14669,GO:0060566,1,0.986902461873921,0,1,positive regulation of DNA-templated transcription, termination,BP,
14670,GO:0060567,1,0.98701281886265,0,2,negative regulation of DNA-templated transcription, termination,BP,
14671,GO:0060571,1,0.852347366505425,0,25,morphogenesis of an epithelial fold,BP,
14672,GO:0060572,1,0.900179299431884,0,16,morphogenesis of an epithelial bud,BP,
14673,GO:0060573,1,0.929772167196724,0,11,cell fate specification involved in pattern specification,BP,
14674,GO:0060574,1,0.978962556595208,0,4,intestinal epithelial cell maturation,BP,
14675,GO:0060575,1,0.882324113413533,0,20,intestinal epithelial cell differentiation,BP,
14676,GO:0060576,1,0.924549898152051,0,13,intestinal epithelial cell development,BP,
14677,GO:0060577,1,0.995622174644115,0,1,pulmonary vein morphogenesis,BP,
14678,GO:0060579,1,0.906286288115007,0,15,ventral spinal cord interneuron fate commitment,BP,
14679,GO:0060580,1,0.994731026292765,0,1,ventral spinal cord interneuron fate determination,BP,
14680,GO:0060581,1,0.906286288115007,0,15,cell fate commitment involved in pattern specification,BP,
14681,GO:0060582,1,0.994731026292765,0,1,cell fate determination involved in pattern specification,BP,
14682,GO:0060584,1,0.977157924561561,0,4,regulation of prostaglandin-endoperoxide synthase activity,BP,
14683,GO:0060585,1,0.977157924561561,0,4,positive regulation of prostaglandin-endoperoxide synthase activity,BP,
14684,GO:0060586,1,0.947909818881939,0,8,multicellular organismal iron ion homeostasis,BP,
14685,GO:0060587,1,0.98926368605863,0,2,regulation of lipoprotein lipid oxidation,BP,
14686,GO:0060588,1,0.996355366728928,0,1,negative regulation of lipoprotein lipid oxidation,BP,
14689,GO:0060591,1,0.97764775234936,0,3,chondroblast differentiation,BP,
14690,GO:0060592,1,0.952807454876024,0,7,mammary gland formation,BP,
14691,GO:0060594,1,0.978883871570683,0,3,mammary gland specification,BP,
14692,GO:0060595,1,0.98960606242232,0,2,fibroblast growth factor receptor signaling pathway involved in mammary gland specification,BP,
14693,GO:0060596,1,0.977970848629692,0,3,mammary placode formation,BP,
14694,GO:0060598,1,0.996201842859797,0,1,dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis,BP,
14695,GO:0060599,1,0.984452273925652,0,2,lateral sprouting involved in mammary gland duct morphogenesis,BP,
14696,GO:0060600,1,0.923158798047447,0,10,dichotomous subdivision of an epithelial terminal unit,BP,
14697,GO:0060601,1,0.90891670261062,0,13,lateral sprouting from an epithelium,BP,
14698,GO:0060602,1,0.882026974756687,0,18,branch elongation of an epithelium,BP,
14699,GO:0060603,1,0.787349361453603,0,31,mammary gland duct morphogenesis,BP,
14700,GO:0060605,1,0.967391840276686,0,5,tube lumen cavitation,BP,
14702,GO:0060611,1,0.994043828815885,0,1,mammary gland fat development,BP,
14703,GO:0060612,1,0.748556442507556,0,41,adipose tissue development,BP,
14704,GO:0060613,1,0.950462174201608,0,7,fat pad development,BP,
14705,GO:0060615,1,0.98960606242232,0,2,mammary gland bud formation,BP,
14706,GO:0060620,1,0.977618933809684,0,2,regulation of cholesterol import,BP,
14707,GO:0060623,1,0.987513424506233,0,2,regulation of chromosome condensation,BP,
14709,GO:0060628,1,0.889471934078434,0,16,regulation of ER to Golgi vesicle-mediated transport,BP,
14710,GO:0060631,1,0.958923555074033,0,6,regulation of meiosis I,BP,
14711,GO:0060632,1,0.78578230791711,0,38,regulation of microtubule-based movement,BP,
14712,GO:0060633,1,0.966074054682428,0,5,negative regulation of transcription initiation from RNA polymerase II promoter,BP,
14713,GO:0060638,1,0.948449382839812,0,8,mesenchymal-epithelial cell signaling,BP,
14714,GO:0060644,1,0.888363903615165,0,16,mammary gland epithelial cell differentiation,BP,
14715,GO:0060648,1,0.984795917464633,0,3,mammary gland bud morphogenesis,BP,
14716,GO:0060661,1,0.991573698524442,0,2,submandibular salivary gland formation,BP,
14717,GO:0060662,1,0.967391840276686,0,5,salivary gland cavitation,BP,
14718,GO:0060664,1,0.97399469927006,0,5,epithelial cell proliferation involved in salivary gland morphogenesis,BP,
14719,GO:0060665,1,0.976127306924589,0,4,regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling,BP,
14720,GO:0060666,1,0.956533115440485,0,5,dichotomous subdivision of terminal units involved in salivary gland branching,BP,
14721,GO:0060667,1,0.98960606242232,0,2,branch elongation involved in salivary gland morphogenesis,BP,
14722,GO:0060668,1,0.992785091583836,0,1,regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling,BP,
14723,GO:0060669,1,0.862397582518883,0,22,embryonic placenta morphogenesis,BP,
14724,GO:0060670,1,0.939815515720185,0,10,branching involved in labyrinthine layer morphogenesis,BP,
14725,GO:0060671,1,0.98839657902009,0,2,epithelial cell differentiation involved in embryonic placenta development,BP,
14726,GO:0060672,1,0.98839657902009,0,2,epithelial cell morphogenesis involved in placental branching,BP,
14727,GO:0060674,1,0.802441318074495,0,30,placenta blood vessel development,BP,
14728,GO:0060675,1,0.647158071412268,0,60,ureteric bud morphogenesis,BP,
14729,GO:0060676,1,0.962816302446798,0,6,ureteric bud formation,BP,
14730,GO:0060677,1,0.935511298521752,0,8,ureteric bud elongation,BP,
14731,GO:0060678,1,0.994359642626978,0,1,dichotomous subdivision of terminal units involved in ureteric bud branching,BP,
14732,GO:0060681,1,0.972772730073672,0,4,branch elongation involved in ureteric bud branching,BP,
14733,GO:0060682,1,0.993528310786554,0,1,primary ureteric bud growth,BP,
14734,GO:0060683,1,0.99348119070896,0,1,regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling,BP,
14735,GO:0060684,1,0.966201728520196,0,6,epithelial-mesenchymal cell signaling,BP,
14736,GO:0060685,1,0.96001707101281,0,6,regulation of prostatic bud formation,BP,
14737,GO:0060686,1,0.970835871391929,0,4,negative regulation of prostatic bud formation,BP,
14738,GO:0060687,1,0.957530666597903,0,6,regulation of branching involved in prostate gland morphogenesis,BP,
14739,GO:0060688,1,0.707517954699073,0,53,regulation of morphogenesis of a branching structure,BP,
14740,GO:0060689,1,0.977662123935586,0,3,cell differentiation involved in salivary gland development,BP,
14741,GO:0060690,1,0.995249124695342,0,1,epithelial cell differentiation involved in salivary gland development,BP,
14742,GO:0060691,1,0.995249124695342,0,1,epithelial cell maturation involved in salivary gland development,BP,
14743,GO:0060693,1,0.94525296041605,0,9,regulation of branching involved in salivary gland morphogenesis,BP,
14744,GO:0060694,1,0.995152293069162,0,1,regulation of cholesterol transporter activity,BP,
14745,GO:0060696,1,0.96755591753928,0,6,regulation of phospholipid catabolic process,BP,
14746,GO:0060697,1,0.990374693401355,0,2,positive regulation of phospholipid catabolic process,BP,
14747,GO:0060698,1,0.985698910417684,0,2,endoribonuclease inhibitor activity,MF,
14748,GO:0060699,1,0.975922242790988,0,4,regulation of endoribonuclease activity,BP,
14749,GO:0060700,1,0.945055343934806,0,9,regulation of ribonuclease activity,BP,
14750,GO:0060701,1,0.985698910417684,0,2,negative regulation of ribonuclease activity,BP,
14751,GO:0060702,1,0.985698910417684,0,2,negative regulation of endoribonuclease activity,BP,
14752,GO:0060703,1,0.993565169304053,0,1,deoxyribonuclease inhibitor activity,MF,
14753,GO:0060706,1,0.863697971402228,0,23,cell differentiation involved in embryonic placenta development,BP,
14754,GO:0060707,1,0.920948902292167,0,13,trophoblast giant cell differentiation,BP,
14755,GO:0060710,1,0.961292898020243,0,6,chorio-allantoic fusion,BP,
14756,GO:0060711,1,0.750741158759462,0,43,labyrinthine layer development,BP,
14757,GO:0060712,1,0.981210437821459,0,3,spongiotrophoblast layer development,BP,
14758,GO:0060713,1,0.891171905757731,0,18,labyrinthine layer morphogenesis,BP,
14759,GO:0060715,1,0.979063135820125,0,3,syncytiotrophoblast cell differentiation involved in labyrinthine layer development,BP,
14760,GO:0060716,1,0.884510793689866,0,19,labyrinthine layer blood vessel development,BP,
14761,GO:0060717,1,0.949538503199365,0,7,chorion development,BP,
14762,GO:0060718,1,0.961456590926565,0,5,chorionic trophoblast cell differentiation,BP,
14763,GO:0060720,1,0.985967244877849,0,2,spongiotrophoblast cell proliferation,BP,
14764,GO:0060721,1,0.985967244877849,0,2,regulation of spongiotrophoblast cell proliferation,BP,
14765,GO:0060722,1,0.985967244877849,0,2,cell proliferation involved in embryonic placenta development,BP,
14766,GO:0060723,1,0.985967244877849,0,2,regulation of cell proliferation involved in embryonic placenta development,BP,
14767,GO:0060729,1,0.966699822862956,0,5,intestinal epithelial structure maintenance,BP,
14768,GO:0060730,1,0.986717298607271,0,2,regulation of intestinal epithelial structure maintenance,BP,
14769,GO:0060731,1,0.992971185204564,0,1,positive regulation of intestinal epithelial structure maintenance,BP,
14770,GO:0060732,1,0.938294004859922,0,10,positive regulation of inositol phosphate biosynthetic process,BP,
14771,GO:0060733,1,0.984271607257361,0,2,regulation of eIF2 alpha phosphorylation by amino acid starvation,BP,
14772,GO:0060734,1,0.992220525463082,0,1,regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,
14773,GO:0060735,1,0.996004555279508,0,1,regulation of eIF2 alpha phosphorylation by dsRNA,BP,
14774,GO:0060736,1,0.914191264877006,0,11,prostate gland growth,BP,
14775,GO:0060737,1,0.971957401489412,0,4,prostate gland morphogenetic growth,BP,
14776,GO:0060738,1,0.988802422067231,0,2,epithelial-mesenchymal signaling involved in prostate gland development,BP,
14777,GO:0060739,1,0.989673360889318,0,1,mesenchymal-epithelial cell signaling involved in prostate gland development,BP,
14778,GO:0060740,1,0.827229282119291,0,26,prostate gland epithelium morphogenesis,BP,
14779,GO:0060741,1,0.984579944922322,0,3,prostate gland stromal morphogenesis,BP,
14780,GO:0060742,1,0.921123737239744,0,11,epithelial cell differentiation involved in prostate gland development,BP,
14781,GO:0060743,1,0.980233137467627,0,3,epithelial cell maturation involved in prostate gland development,BP,
14782,GO:0060744,1,0.972810750166321,0,4,mammary gland branching involved in thelarche,BP,
14783,GO:0060745,1,0.944684437272027,0,6,mammary gland branching involved in pregnancy,BP,
14784,GO:0060746,1,0.932590123873615,0,10,parental behavior,BP,
14785,GO:0060748,1,0.971477380709427,0,3,tertiary branching involved in mammary gland duct morphogenesis,BP,
14786,GO:0060749,1,0.886334278689882,0,17,mammary gland alveolus development,BP,
14787,GO:0060750,1,0.967807708541212,0,4,epithelial cell proliferation involved in mammary gland duct elongation,BP,
14788,GO:0060751,1,0.967807708541212,0,4,branch elongation involved in mammary gland duct branching,BP,
14789,GO:0060752,1,0.993629231528571,0,1,intestinal phytosterol absorption,BP,
14790,GO:0060753,1,0.967658733106268,0,6,regulation of mast cell chemotaxis,BP,
14791,GO:0060754,1,0.971700036703632,0,5,positive regulation of mast cell chemotaxis,BP,
14792,GO:0060759,1,0.367198342077915,0,154,regulation of response to cytokine stimulus,BP,
14793,GO:0060760,1,0.706372627356181,0,53,positive regulation of response to cytokine stimulus,BP,
14794,GO:0060761,1,0.717629125598222,0,53,negative regulation of response to cytokine stimulus,BP,
14795,GO:0060762,1,0.975902074543393,0,4,regulation of branching involved in mammary gland duct morphogenesis,BP,
14796,GO:0060763,1,0.984824609004284,0,2,mammary duct terminal end bud growth,BP,
14797,GO:0060764,1,0.987932552788412,0,2,cell-cell signaling involved in mammary gland development,BP,
14798,GO:0060765,1,0.836524253127329,0,25,regulation of androgen receptor signaling pathway,BP,
14799,GO:0060766,1,0.903189219817113,0,14,negative regulation of androgen receptor signaling pathway,BP,
14800,GO:0060767,1,0.931152185751946,0,11,epithelial cell proliferation involved in prostate gland development,BP,
14801,GO:0060768,1,0.938049332941142,0,10,regulation of epithelial cell proliferation involved in prostate gland development,BP,
14802,GO:0060769,1,0.981820071348706,0,3,positive regulation of epithelial cell proliferation involved in prostate gland development,BP,
14803,GO:0060770,1,0.966781443238094,0,6,negative regulation of epithelial cell proliferation involved in prostate gland development,BP,
14804,GO:0060775,1,0.986291852023498,0,2,planar cell polarity pathway involved in gastrula mediolateral intercalation,BP,
14805,GO:0060781,1,0.995665824555013,0,1,mesenchymal cell proliferation involved in prostate gland development,BP,
14806,GO:0060782,1,0.995665824555013,0,1,regulation of mesenchymal cell proliferation involved in prostate gland development,BP,
14807,GO:0060783,1,0.995665824555013,0,1,mesenchymal smoothened signaling pathway involved in prostate gland development,BP,
14808,GO:0060784,1,0.992652033405997,0,1,regulation of cell proliferation involved in tissue homeostasis,BP,
14809,GO:0060788,1,0.922920874683887,0,11,ectodermal placode formation,BP,
14810,GO:0060789,1,0.974580555900378,0,4,hair follicle placode formation,BP,
14812,GO:0060796,1,0.994198568848389,0,1,regulation of transcription involved in primary germ layer cell fate commitment,BP,
14813,GO:0060800,1,0.979786972605796,0,3,regulation of cell differentiation involved in embryonic placenta development,BP,
14814,GO:0060802,1,0.994709279864805,0,1,epiblast cell-extraembryonic ectoderm cell signaling involved in anterior/posterior axis specification,BP,
14815,GO:0060803,1,0.995807885510191,0,1,BMP signaling pathway involved in mesodermal cell fate specification,BP,
14816,GO:0060804,1,0.993070540214286,0,1,positive regulation of Wnt signaling pathway by BMP signaling pathway,BP,
14817,GO:0060806,1,0.995466833565029,0,1,negative regulation of cell differentiation involved in embryonic placenta development,BP,
14818,GO:0060807,1,0.994198568848389,0,1,regulation of transcription from RNA polymerase II promoter involved in definitive endodermal cell fate specification,BP,
14819,GO:0060809,1,0.984818880248941,0,2,mesodermal to mesenchymal transition involved in gastrulation,BP,
14820,GO:0060816,1,0.980251947358068,0,2,random inactivation of X chromosome,BP,
14821,GO:0060819,1,0.981556286590451,0,2,inactivation of X chromosome by genetic imprinting,BP,
14822,GO:0060820,1,0.98875747710691,0,1,inactivation of X chromosome by heterochromatin assembly,BP,
14823,GO:0060821,1,0.98875747710691,0,1,inactivation of X chromosome by DNA methylation,BP,
14824,GO:0060823,1,0.992582544689823,0,1,canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
14825,GO:0060825,1,0.990626807596223,0,2,fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
14826,GO:0060827,1,0.992582544689823,0,1,regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
14828,GO:0060829,1,0.992582544689823,0,1,negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
14829,GO:0060830,1,0.98166035095716,0,3,ciliary receptor clustering involved in smoothened signaling pathway,BP,
14830,GO:0060831,1,0.898553647566351,0,14,smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
14831,GO:0060836,1,0.941531763385473,0,7,lymphatic endothelial cell differentiation,BP,
14832,GO:0060837,1,0.940461815604163,0,9,blood vessel endothelial cell differentiation,BP,
14833,GO:0060838,1,0.979493336925283,0,3,lymphatic endothelial cell fate commitment,BP,
14834,GO:0060839,1,0.954568176797906,0,7,endothelial cell fate commitment,BP,
14835,GO:0060840,1,0.496429821031308,0,87,artery development,BP,
14836,GO:0060841,1,0.882559151068154,0,15,venous blood vessel development,BP,
14837,GO:0060842,1,0.958880206813099,0,6,arterial endothelial cell differentiation,BP,
14838,GO:0060843,1,0.988259126454876,0,1,venous endothelial cell differentiation,BP,
14839,GO:0060844,1,0.987164945266855,0,2,arterial endothelial cell fate commitment,BP,
14840,GO:0060846,1,0.981184533263892,0,3,blood vessel endothelial cell fate commitment,BP,
14841,GO:0060847,1,0.981184533263892,0,3,endothelial cell fate specification,BP,
14842,GO:0060849,1,0.985846805159351,0,2,regulation of transcription involved in lymphatic endothelial cell fate commitment,BP,
14843,GO:0060850,1,0.899322464590959,0,16,regulation of transcription involved in cell fate commitment,BP,
14844,GO:0060853,1,0.992949333626043,0,1,Notch signaling pathway involved in arterial endothelial cell fate commitment,BP,
14845,GO:0060856,1,0.934114429342881,0,11,establishment of blood-brain barrier,BP,
14846,GO:0060857,1,0.994330613661051,0,1,establishment of glial blood-brain barrier,BP,
14847,GO:0060872,1,0.933605147280477,0,9,semicircular canal development,BP,
14848,GO:0060873,1,0.989166318178273,0,1,anterior semicircular canal development,BP,
14849,GO:0060875,1,0.989166318178273,0,1,lateral semicircular canal development,BP,
14850,GO:0060876,1,0.991053696463795,0,2,semicircular canal formation,BP,
14851,GO:0060879,1,0.997014122102647,0,1,semicircular canal fusion,BP,
14852,GO:0060896,1,0.939844925357902,0,8,neural plate pattern specification,BP,
14853,GO:0060897,1,0.958643211576626,0,6,neural plate regionalization,BP,
14854,GO:0060900,1,0.907999942467477,0,12,embryonic camera-type eye formation,BP,
14855,GO:0060901,1,0.992465874593964,0,1,regulation of hair cycle by canonical Wnt signaling pathway,BP,
14856,GO:0060903,1,0.965549239289206,0,5,positive regulation of meiosis I,BP,
14857,GO:0060904,1,0.99263231622234,0,1,regulation of protein folding in endoplasmic reticulum,BP,
14858,GO:0060907,1,0.945355017610508,0,9,positive regulation of macrophage cytokine production,BP,
14859,GO:0060911,1,0.942168677815862,0,10,cardiac cell fate commitment,BP,
14860,GO:0060912,1,0.987721387328525,0,2,cardiac cell fate specification,BP,
14861,GO:0060913,1,0.984164998343125,0,3,cardiac cell fate determination,BP,
14862,GO:0060914,1,0.818268247801184,0,29,heart formation,BP,
14863,GO:0060915,1,0.98960606242232,0,2,mesenchymal cell differentiation involved in lung development,BP,
14864,GO:0060916,1,0.963548372539905,0,5,mesenchymal cell proliferation involved in lung development,BP,
14865,GO:0060920,1,0.966815843256287,0,5,cardiac pacemaker cell differentiation,BP,
14866,GO:0060921,1,0.980143894968665,0,3,sinoatrial node cell differentiation,BP,
14867,GO:0060922,1,0.986404651705229,0,2,atrioventricular node cell differentiation,BP,
14868,GO:0060923,1,0.963614521147863,0,6,cardiac muscle cell fate commitment,BP,
14869,GO:0060926,1,0.97039101089848,0,4,cardiac pacemaker cell development,BP,
14870,GO:0060927,1,0.995029744833407,0,1,cardiac pacemaker cell fate commitment,BP,
14871,GO:0060928,1,0.986404651705229,0,2,atrioventricular node cell development,BP,
14872,GO:0060929,1,0.995029744833407,0,1,atrioventricular node cell fate commitment,BP,
14873,GO:0060931,1,0.983767849874798,0,2,sinoatrial node cell development,BP,
14874,GO:0060932,1,0.987216816763523,0,2,His-Purkinje system cell differentiation,BP,
14875,GO:0060935,1,0.977726907056449,0,3,cardiac fibroblast cell differentiation,BP,
14876,GO:0060936,1,0.977726907056449,0,3,cardiac fibroblast cell development,BP,
14877,GO:0060938,1,0.977726907056449,0,3,epicardium-derived cardiac fibroblast cell differentiation,BP,
14878,GO:0060939,1,0.977726907056449,0,3,epicardium-derived cardiac fibroblast cell development,BP,
14879,GO:0060940,1,0.986901366833821,0,2,epithelial to mesenchymal transition involved in cardiac fibroblast development,BP,
14880,GO:0060947,1,0.941691849698518,0,8,cardiac vascular smooth muscle cell differentiation,BP,
14881,GO:0060948,1,0.974924152625883,0,3,cardiac vascular smooth muscle cell development,BP,
14882,GO:0060956,1,0.954831950948893,0,6,endocardial cell differentiation,BP,
14883,GO:0060957,1,0.993247888109969,0,1,endocardial cell fate commitment,BP,
14884,GO:0060964,1,0.576814132261732,0,81,regulation of gene silencing by miRNA,BP,
14885,GO:0060965,1,0.88356814171959,0,18,negative regulation of gene silencing by miRNA,BP,
14886,GO:0060966,1,0.562344930612286,0,84,regulation of gene silencing by RNA,BP,
14887,GO:0060967,1,0.868782698991374,0,20,negative regulation of gene silencing by RNA,BP,
14888,GO:0060968,1,0.523885740673431,0,94,regulation of gene silencing,BP,
14889,GO:0060969,1,0.842604166446648,0,24,negative regulation of gene silencing,BP,
14890,GO:0060971,1,0.970194733712205,0,4,embryonic heart tube left/right pattern formation,BP,
14891,GO:0060972,1,0.847502605389502,0,22,left/right pattern formation,BP,
14892,GO:0060973,1,0.887268120708427,0,17,cell migration involved in heart development,BP,
14893,GO:0060974,1,0.992802456830217,0,2,cell migration involved in heart formation,BP,
14894,GO:0060975,1,0.996316852701051,0,1,cardioblast migration to the midline involved in heart field formation,BP,
14895,GO:0060976,1,0.689443598422058,0,45,coronary vasculature development,BP,
14896,GO:0060977,1,0.864887891189859,0,16,coronary vasculature morphogenesis,BP,
14897,GO:0060978,1,0.976217027595064,0,3,angiogenesis involved in coronary vascular morphogenesis,BP,
14898,GO:0060979,1,0.962256147755997,0,4,vasculogenesis involved in coronary vascular morphogenesis,BP,
14899,GO:0060980,1,0.992771023838117,0,1,cell migration involved in coronary vasculogenesis,BP,
14900,GO:0060981,1,0.991323316232565,0,1,cell migration involved in coronary angiogenesis,BP,
14901,GO:0060982,1,0.923036964911321,0,9,coronary artery morphogenesis,BP,
14902,GO:0060986,1,0.767538513720641,0,42,endocrine hormone secretion,BP,
14903,GO:0060987,1,0.994246102295014,0,1,lipid tube,CC,
14904,GO:0060988,1,0.980423162827396,0,3,lipid tube assembly,BP,
14905,GO:0060992,1,0.955765937704644,0,6,response to fungicide,BP,
14906,GO:0060993,1,0.520650425130524,0,88,kidney morphogenesis,BP,
14907,GO:0060994,1,0.992746250428739,0,1,regulation of transcription from RNA polymerase II promoter involved in kidney development,BP,
14908,GO:0060995,1,0.984937191584676,0,2,cell-cell signaling involved in kidney development,BP,
14910,GO:0060997,1,0.618789412983726,0,59,dendritic spine morphogenesis,BP,
14913,GO:0061000,1,0.908224303033423,0,12,negative regulation of dendritic spine development,BP,
14914,GO:0061001,1,0.690958600246265,0,45,regulation of dendritic spine morphogenesis,BP,
14915,GO:0061002,1,0.948223996102446,0,7,negative regulation of dendritic spine morphogenesis,BP,
14916,GO:0061003,1,0.85137784400441,0,20,positive regulation of dendritic spine morphogenesis,BP,
14917,GO:0061004,1,0.956351034675513,0,8,pattern specification involved in kidney development,BP,
14918,GO:0061005,1,0.680556611398517,0,52,cell differentiation involved in kidney development,BP,
14920,GO:0061009,1,0.963890707151796,0,5,common bile duct development,BP,
14921,GO:0061010,1,0.981861396067579,0,2,gall bladder development,BP,
14922,GO:0061013,1,0.289834679449951,0,189,regulation of mRNA catabolic process,BP,
14923,GO:0061014,1,0.692252099957259,0,49,positive regulation of mRNA catabolic process,BP,
14924,GO:0061015,1,0.991899545442652,0,2,snRNA import into nucleus,BP,
14927,GO:0061026,1,0.960004855820578,0,5,cardiac muscle tissue regeneration,BP,
14928,GO:0061027,1,0.987956946376013,0,2,umbilical cord development,BP,
14930,GO:0061029,1,0.911183622087605,0,13,eyelid development in camera-type eye,BP,
14931,GO:0061030,1,0.98254309432781,0,3,epithelial cell differentiation involved in mammary gland alveolus development,BP,
14932,GO:0061031,1,0.990235355866556,0,2,endodermal digestive tract morphogenesis,BP,
14933,GO:0061032,1,0.987404819884356,0,2,visceral serous pericardium development,BP,
14934,GO:0061033,1,0.984460470009031,0,3,secretion by lung epithelial cell involved in lung growth,BP,
14935,GO:0061034,1,0.991793308452133,0,1,olfactory bulb mitral cell layer development,BP,
14936,GO:0061035,1,0.648592432443176,0,60,regulation of cartilage development,BP,
14937,GO:0061036,1,0.813655095320166,0,28,positive regulation of cartilage development,BP,
14938,GO:0061037,1,0.848563706388082,0,25,negative regulation of cartilage development,BP,
14939,GO:0061038,1,0.950301667291347,0,6,uterus morphogenesis,BP,
14940,GO:0061040,1,0.988706352811282,0,1,female gonad morphogenesis,BP,
14942,GO:0061042,1,0.89442979664409,0,17,vascular wound healing,BP,
14943,GO:0061043,1,0.945518500067681,0,9,regulation of vascular wound healing,BP,
14944,GO:0061044,1,0.972956943441162,0,4,negative regulation of vascular wound healing,BP,
14945,GO:0061045,1,0.651266435468539,0,65,negative regulation of wound healing,BP,
14946,GO:0061046,1,0.96460508195381,0,6,regulation of branching involved in lung morphogenesis,BP,
14947,GO:0061047,1,0.976135282664159,0,4,positive regulation of branching involved in lung morphogenesis,BP,
14948,GO:0061048,1,0.995506018227838,0,1,negative regulation of branching involved in lung morphogenesis,BP,
14951,GO:0061051,1,0.944499504285876,0,8,positive regulation of cell growth involved in cardiac muscle cell development,BP,
14955,GO:0061055,1,0.971500671454279,0,4,myotome development,BP,
14958,GO:0061072,1,0.932400281991032,0,9,iris morphogenesis,BP,
14959,GO:0061073,1,0.966561753096702,0,4,ciliary body morphogenesis,BP,
14960,GO:0061074,1,0.962297479630316,0,6,regulation of neural retina development,BP,
14961,GO:0061075,1,0.988646125316627,0,2,positive regulation of neural retina development,BP,
14962,GO:0061076,1,0.993079653851905,0,1,negative regulation of neural retina development,BP,
14963,GO:0061077,1,0.723756247723885,0,54,chaperone-mediated protein folding,BP,
14964,GO:0061078,1,0.99709334258388,0,1,positive regulation of prostaglandin secretion involved in immune response,BP,
14965,GO:0061081,1,0.881048730697741,0,19,positive regulation of myeloid leukocyte cytokine production involved in immune response,BP,
14966,GO:0061082,1,0.818236425524777,0,30,myeloid leukocyte cytokine production,BP,
14967,GO:0061083,1,0.973907284788401,0,4,regulation of protein refolding,BP,
14968,GO:0061084,1,0.973907284788401,0,4,negative regulation of protein refolding,BP,
14969,GO:0061085,1,0.944668247874458,0,8,regulation of histone H3-K27 methylation,BP,
14970,GO:0061086,1,0.978233518378557,0,3,negative regulation of histone H3-K27 methylation,BP,
14971,GO:0061087,1,0.959677967641256,0,6,positive regulation of histone H3-K27 methylation,BP,
14973,GO:0061090,1,0.994093598152213,0,1,positive regulation of sequestering of zinc ion,BP,
14974,GO:0061091,1,0.967518368577895,0,4,regulation of phospholipid translocation,BP,
14975,GO:0061092,1,0.967518368577895,0,4,positive regulation of phospholipid translocation,BP,
14978,GO:0061099,1,0.847143361763235,0,25,negative regulation of protein tyrosine kinase activity,BP,
14979,GO:0061100,1,0.993962265126325,0,1,lung neuroendocrine cell differentiation,BP,
14980,GO:0061101,1,0.95715761363662,0,8,neuroendocrine cell differentiation,BP,
14981,GO:0061102,1,0.989855086650183,0,2,stomach neuroendocrine cell differentiation,BP,
14982,GO:0061103,1,0.993962265126325,0,1,carotid body glomus cell differentiation,BP,
14983,GO:0061104,1,0.987414941328659,0,2,adrenal chromaffin cell differentiation,BP,
14984,GO:0061105,1,0.995868123078444,0,1,regulation of stomach neuroendocrine cell differentiation,BP,
14985,GO:0061106,1,0.995868123078444,0,1,negative regulation of stomach neuroendocrine cell differentiation,BP,
14986,GO:0061107,1,0.982927151137652,0,3,seminal vesicle development,BP,
14987,GO:0061108,1,0.994360611983039,0,1,seminal vesicle epithelium development,BP,
14988,GO:0061110,1,0.976431979488443,0,3,dense core granule biogenesis,BP,
14989,GO:0061113,1,0.978007634614839,0,3,pancreas morphogenesis,BP,
14990,GO:0061114,1,0.993139384115289,0,1,branching involved in pancreas morphogenesis,BP,
14991,GO:0061115,1,0.997014122102647,0,1,lung proximal/distal axis specification,BP,
14996,GO:0061136,1,0.307575848911519,0,179,regulation of proteasomal protein catabolic process,BP,
14998,GO:0061140,1,0.951944234168985,0,9,lung secretory cell differentiation,BP,
14999,GO:0061141,1,0.979170022422298,0,3,lung ciliated cell differentiation,BP,
15000,GO:0061143,1,0.993379749425239,0,1,alveolar primary septum development,BP,
15001,GO:0061144,1,0.993107019638805,0,1,alveolar secondary septum development,BP,
15002,GO:0061145,1,0.98515372524038,0,2,lung smooth muscle development,BP,
15003,GO:0061146,1,0.980476221572885,0,3,Peyer's patch morphogenesis,BP,
15004,GO:0061149,1,0.995293167006598,0,1,BMP signaling pathway involved in ureter morphogenesis,BP,
15005,GO:0061150,1,0.995293167006598,0,1,renal system segmentation,BP,
15006,GO:0061151,1,0.995293167006598,0,1,BMP signaling pathway involved in renal system segmentation,BP,
15007,GO:0061152,1,0.989146077096348,0,2,trachea submucosa development,BP,
15008,GO:0061153,1,0.989146077096348,0,2,trachea gland development,BP,
15009,GO:0061154,1,0.893799599738141,0,18,endothelial tube morphogenesis,BP,
15010,GO:0061155,1,0.995293167006598,0,1,pulmonary artery endothelial tube morphogenesis,BP,
15011,GO:0061156,1,0.950110353704273,0,6,pulmonary artery morphogenesis,BP,
15012,GO:0061157,1,0.794494137762702,0,31,mRNA destabilization,BP,
15013,GO:0061158,1,0.885770847750269,0,17,3'-UTR-mediated mRNA destabilization,BP,
15014,GO:0061159,1,0.992006537170928,0,1,establishment of bipolar cell polarity involved in cell morphogenesis,BP,
15015,GO:0061162,1,0.853729822110069,0,21,establishment of monopolar cell polarity,BP,
15016,GO:0061171,1,0.992006537170928,0,1,establishment of bipolar cell polarity,BP,
15018,GO:0061179,1,0.961426277088563,0,8,negative regulation of insulin secretion involved in cellular response to glucose stimulus,BP,
15019,GO:0061180,1,0.6117095146115,0,66,mammary gland epithelium development,BP,
15020,GO:0061181,1,0.98137088763877,0,3,regulation of chondrocyte development,BP,
15021,GO:0061182,1,0.995637636038236,0,1,negative regulation of chondrocyte development,BP,
15023,GO:0061184,1,0.992661278022655,0,1,positive regulation of dermatome development,BP,
15025,GO:0061187,1,0.975795854619713,0,3,regulation of ribosomal DNA heterochromatin assembly,BP,
15026,GO:0061188,1,0.982740426713271,0,2,negative regulation of ribosomal DNA heterochromatin assembly,BP,
15027,GO:0061189,1,0.995665824555013,0,1,positive regulation of sclerotome development,BP,
15028,GO:0061190,1,0.995665824555013,0,1,regulation of sclerotome development,BP,
15029,GO:0061193,1,0.98917857349837,0,2,taste bud development,BP,
15030,GO:0061196,1,0.957669507507987,0,6,fungiform papilla development,BP,
15031,GO:0061197,1,0.963118806800751,0,5,fungiform papilla morphogenesis,BP,
15032,GO:0061198,1,0.978221648325381,0,3,fungiform papilla formation,BP,
15035,GO:0061205,1,0.977226958920289,0,3,paramesonephric duct development,BP,
15036,GO:0061209,1,0.976015322839775,0,4,cell proliferation involved in mesonephros development,BP,
15037,GO:0061213,1,0.883650492126144,0,19,positive regulation of mesonephros development,BP,
15038,GO:0061217,1,0.870109388763849,0,22,regulation of mesonephros development,BP,
15039,GO:0061218,1,0.983270775838925,0,3,negative regulation of mesonephros development,BP,
15040,GO:0061227,1,0.990403938044236,0,2,pattern specification involved in mesonephros development,BP,
15041,GO:0061245,1,0.716142708609802,0,45,establishment or maintenance of bipolar cell polarity,BP,
15042,GO:0061289,1,0.984937191584676,0,2,Wnt signaling pathway involved in kidney development,BP,
15043,GO:0061290,1,0.984937191584676,0,2,canonical Wnt signaling pathway involved in metanephric kidney development,BP,
15044,GO:0061298,1,0.859626315442716,0,18,retina vasculature development in camera-type eye,BP,
15045,GO:0061299,1,0.917838220179049,0,11,retina vasculature morphogenesis in camera-type eye,BP,
15046,GO:0061300,1,0.985679105985391,0,2,cerebellum vasculature development,BP,
15047,GO:0061301,1,0.98987991224769,0,1,cerebellum vasculature morphogenesis,BP,
15048,GO:0061302,1,0.971780973033676,0,5,smooth muscle cell-matrix adhesion,BP,
15049,GO:0061303,1,0.944403915143113,0,9,cornea development in camera-type eye,BP,
15050,GO:0061304,1,0.9470588259642,0,6,retinal blood vessel morphogenesis,BP,
15051,GO:0061307,1,0.936910530588779,0,11,cardiac neural crest cell differentiation involved in heart development,BP,
15052,GO:0061308,1,0.936910530588779,0,11,cardiac neural crest cell development involved in heart development,BP,
15053,GO:0061309,1,0.948400275672513,0,9,cardiac neural crest cell development involved in outflow tract morphogenesis,BP,
15054,GO:0061311,1,0.822400171255203,0,29,cell surface receptor signaling pathway involved in heart development,BP,
15055,GO:0061312,1,0.966372523582219,0,6,BMP signaling pathway involved in heart development,BP,
15056,GO:0061314,1,0.920159090813176,0,11,Notch signaling involved in heart development,BP,
15057,GO:0061316,1,0.982414390869165,0,3,canonical Wnt signaling pathway involved in heart development,BP,
15058,GO:0061317,1,0.989458018464504,0,2,canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
15059,GO:0061318,1,0.882315809539373,0,16,renal filtration cell differentiation,BP,
15060,GO:0061323,1,0.888902385016941,0,16,cell proliferation involved in heart morphogenesis,BP,
15061,GO:0061324,1,0.992882079557312,0,1,canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation,BP,
15062,GO:0061325,1,0.976948563243646,0,4,cell proliferation involved in outflow tract morphogenesis,BP,
15063,GO:0061326,1,0.520070765954256,0,88,renal tubule development,BP,
15064,GO:0061333,1,0.588720961779945,0,72,renal tubule morphogenesis,BP,
15065,GO:0061337,1,0.35017838507902,0,141,cardiac conduction,BP,
15066,GO:0061339,1,0.853729822110069,0,21,establishment or maintenance of monopolar cell polarity,BP,
15067,GO:0061341,1,0.982963477749564,0,2,non-canonical Wnt signaling pathway involved in heart development,BP,
15068,GO:0061343,1,0.961651498009718,0,5,cell adhesion involved in heart morphogenesis,BP,
15069,GO:0061346,1,0.982963477749564,0,2,planar cell polarity pathway involved in heart morphogenesis,BP,
15070,GO:0061347,1,0.991228585807255,0,1,planar cell polarity pathway involved in outflow tract morphogenesis,BP,
15071,GO:0061348,1,0.991228585807255,0,1,planar cell polarity pathway involved in ventricular septum morphogenesis,BP,
15072,GO:0061349,1,0.991228585807255,0,1,planar cell polarity pathway involved in cardiac right atrium morphogenesis,BP,
15073,GO:0061350,1,0.991228585807255,0,1,planar cell polarity pathway involved in cardiac muscle tissue morphogenesis,BP,
15075,GO:0061354,1,0.991228585807255,0,1,planar cell polarity pathway involved in pericardium morphogenesis,BP,
15076,GO:0061355,1,0.969531768531229,0,5,Wnt protein secretion,BP,
15077,GO:0061356,1,0.974123462734163,0,4,regulation of Wnt protein secretion,BP,
15078,GO:0061357,1,0.978883885396301,0,3,positive regulation of Wnt protein secretion,BP,
15079,GO:0061358,1,0.995137923412935,0,1,negative regulation of Wnt protein secretion,BP,
15080,GO:0061360,1,0.992562811373111,0,1,optic chiasma development,BP,
15081,GO:0061364,1,0.974957501994124,0,3,apoptotic process involved in luteolysis,BP,
15082,GO:0061365,1,0.966118643311885,0,7,positive regulation of triglyceride lipase activity,BP,
15083,GO:0061366,1,0.989713584316141,0,2,behavioral response to chemical pain,BP,
15084,GO:0061368,1,0.989713584316141,0,2,behavioral response to formalin induced pain,BP,
15085,GO:0061369,1,0.992661278022655,0,1,negative regulation of testicular blood vessel morphogenesis,BP,
15086,GO:0061370,1,0.968119784415916,0,6,testosterone biosynthetic process,BP,
15087,GO:0061371,1,0.644463657832745,0,63,determination of heart left/right asymmetry,BP,
15088,GO:0061373,1,0.988379455155735,0,1,mammillary axonal complex development,BP,
15089,GO:0061377,1,0.886334278689882,0,17,mammary gland lobule development,BP,
15090,GO:0061383,1,0.703331745239578,0,47,trabecula morphogenesis,BP,
15091,GO:0061384,1,0.791315565436159,0,32,heart trabecula morphogenesis,BP,
15092,GO:0061386,1,0.979755959119459,0,2,closure of optic fissure,BP,
15093,GO:0061387,1,0.441342109789411,0,107,regulation of extent of cell growth,BP,
15094,GO:0061394,1,0.990223716480077,0,2,regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP,
15095,GO:0061395,1,0.995413685864698,0,1,positive regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP,
15096,GO:0061400,1,0.993485400251684,0,1,positive regulation of transcription from RNA polymerase II promoter in response to calcium ion,BP,
15097,GO:0061402,1,0.987630764615455,0,2,positive regulation of transcription from RNA polymerase II promoter in response to acidic pH,BP,
15098,GO:0061408,1,0.994561171467547,0,1,positive regulation of transcription from RNA polymerase II promoter in response to heat stress,BP,
15099,GO:0061418,1,0.66842628792344,0,72,regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
15100,GO:0061419,1,0.955982523889252,0,6,positive regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
15101,GO:0061428,1,0.974119162636085,0,4,negative regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
15102,GO:0061430,1,0.899875726435258,0,13,bone trabecula morphogenesis,BP,
15103,GO:0061433,1,0.994979066216479,0,1,cellular response to caloric restriction,BP,
15104,GO:0061436,1,0.862952405688432,0,22,establishment of skin barrier,BP,
15105,GO:0061437,1,0.833940706880422,0,25,renal system vasculature development,BP,
15106,GO:0061438,1,0.940416521414626,0,7,renal system vasculature morphogenesis,BP,
15107,GO:0061439,1,0.940416521414626,0,7,kidney vasculature morphogenesis,BP,
15108,GO:0061440,1,0.833940706880422,0,25,kidney vasculature development,BP,
15109,GO:0061441,1,0.985894354121143,0,2,renal artery morphogenesis,BP,
15110,GO:0061443,1,0.984383773082786,0,2,endocardial cushion cell differentiation,BP,
15111,GO:0061444,1,0.991076227927554,0,1,endocardial cushion cell development,BP,
15112,GO:0061445,1,0.993247888109969,0,1,endocardial cushion cell fate commitment,BP,
15114,GO:0061450,1,0.930336462336734,0,12,trophoblast cell migration,BP,
15116,GO:0061459,1,0.955542448347689,0,6,L-arginine transmembrane transporter activity,MF,
15117,GO:0061462,1,0.757696776027935,0,40,protein localization to lysosome,BP,
15118,GO:0061463,1,0.993485400251684,0,1,O-acetyl-ADP-ribose deacetylase activity,MF,
15120,GO:0061470,1,0.964505000818326,0,5,T follicular helper cell differentiation,BP,
15121,GO:0061474,1,0.993839294278206,0,1,phagolysosome membrane,CC,
15122,GO:0061476,1,0.993116283172753,0,1,response to anticoagulant,BP,
15123,GO:0061481,1,0.99674640915843,0,1,response to TNF agonist,BP,
15124,GO:0061484,1,0.971095392328177,0,4,hematopoietic stem cell homeostasis,BP,
15125,GO:0061485,1,0.989780732688067,0,1,memory T cell proliferation,BP,
15126,GO:0061502,1,0.964477024667603,0,4,early endosome to recycling endosome transport,BP,
15127,GO:0061507,1,0.993391227483216,0,1,cyclic-GMP-AMP binding,MF,
15128,GO:0061508,1,0.993485400251684,0,1,CDP phosphorylation,BP,
15129,GO:0061511,1,0.952340070672234,0,7,centriole elongation,BP,
15130,GO:0061512,1,0.677140938295692,0,56,protein localization to cilium,BP,
15131,GO:0061513,1,0.980420757594002,0,3,glucose 6-phosphate:inorganic phosphate antiporter activity,MF,
15132,GO:0061514,1,0.995302486188903,0,1,interleukin-34-mediated signaling pathway,BP,
15133,GO:0061515,1,0.630579991612281,0,66,myeloid cell development,BP,
15134,GO:0061517,1,0.940306098849314,0,10,macrophage proliferation,BP,
15135,GO:0061518,1,0.959179053747516,0,7,microglial cell proliferation,BP,
15136,GO:0061519,1,0.992796668583945,0,1,macrophage homeostasis,BP,
15137,GO:0061523,1,0.992767886172341,0,1,cilium disassembly,BP,
15138,GO:0061525,1,0.940013990039048,0,8,hindgut development,BP,
15139,GO:0061526,1,0.975397935780096,0,4,acetylcholine secretion,BP,
15140,GO:0061528,1,0.982408334789349,0,2,aspartate secretion,BP,
15141,GO:0061534,1,0.985859218645581,0,1,gamma-aminobutyric acid secretion, neurotransmission,BP,
15142,GO:0061535,1,0.9629569850021,0,4,glutamate secretion, neurotransmission,BP,
15143,GO:0061536,1,0.993014381373215,0,1,glycine secretion,BP,
15144,GO:0061537,1,0.993014381373215,0,1,glycine secretion, neurotransmission,BP,
15145,GO:0061542,1,0.996157227255456,0,1,3-demethylubiquinol-n 3-O-methyltransferase activity,MF,
15146,GO:0061547,1,0.985996790926274,0,2,glycogen synthase activity, transferring glucose-1-phosphate,MF,
15147,GO:0061548,1,0.900224614652366,0,15,ganglion development,BP,
15148,GO:0061549,1,0.944102035596449,0,8,sympathetic ganglion development,BP,
15149,GO:0061550,1,0.9551965153511,0,6,cranial ganglion development,BP,
15150,GO:0061551,1,0.962046927435439,0,5,trigeminal ganglion development,BP,
15151,GO:0061552,1,0.985628222084199,0,2,ganglion morphogenesis,BP,
15153,GO:0061565,1,0.993485400251684,0,1,dAMP phosphorylation,BP,
15154,GO:0061566,1,0.993485400251684,0,1,CMP phosphorylation,BP,
15155,GO:0061567,1,0.993485400251684,0,1,dCMP phosphorylation,BP,
15156,GO:0061568,1,0.993485400251684,0,1,GDP phosphorylation,BP,
15157,GO:0061569,1,0.993485400251684,0,1,UDP phosphorylation,BP,
15158,GO:0061570,1,0.993485400251684,0,1,dCDP phosphorylation,BP,
15159,GO:0061571,1,0.993485400251684,0,1,TDP phosphorylation,BP,
15161,GO:0061574,1,0.973958078987754,0,4,ASAP complex,CC,
15162,GO:0061575,1,0.952518415257428,0,9,cyclin-dependent protein serine/threonine kinase activator activity,MF,
15163,GO:0061577,1,0.902661747304474,0,14,calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
15164,GO:0061578,1,0.920845895968898,0,11,Lys63-specific deubiquitinase activity,MF,
15165,GO:0061580,1,0.992557118135445,0,1,colon epithelial cell migration,BP,
15166,GO:0061582,1,0.983448595726009,0,2,intestinal epithelial cell migration,BP,
15167,GO:0061586,1,0.992927843812387,0,1,positive regulation of transcription by transcription factor localization,BP,
15168,GO:0061588,1,0.963536322785789,0,5,calcium activated phospholipid scrambling,BP,
15169,GO:0061589,1,0.972170065922788,0,4,calcium activated phosphatidylserine scrambling,BP,
15170,GO:0061590,1,0.963536322785789,0,5,calcium activated phosphatidylcholine scrambling,BP,
15171,GO:0061591,1,0.963536322785789,0,5,calcium activated galactosylceramide scrambling,BP,
15172,GO:0061598,1,0.9924770361683,0,1,molybdopterin adenylyltransferase activity,MF,
15173,GO:0061599,1,0.9924770361683,0,1,molybdopterin molybdotransferase activity,MF,
15174,GO:0061604,1,0.993998291325329,0,1,molybdopterin-synthase sulfurtransferase activity,MF,
15175,GO:0061605,1,0.993998291325329,0,1,molybdopterin-synthase adenylyltransferase activity,MF,
15176,GO:0061608,1,0.871886789382359,0,18,nuclear import signal receptor activity,MF,
15177,GO:0061609,1,0.99404199697747,0,1,fructose-1-phosphate aldolase activity,MF,
15178,GO:0061611,1,0.995309928040927,0,1,mannose to fructose-6-phosphate metabolic process,BP,
15179,GO:0061614,1,0.679395902221693,0,53,pri-miRNA transcription by RNA polymerase II,BP,
15180,GO:0061615,1,0.83760822746723,0,28,glycolytic process through fructose-6-phosphate,BP,
15181,GO:0061617,1,0.965413162540979,0,7,MICOS complex,CC,
15182,GO:0061620,1,0.844388897126858,0,27,glycolytic process through glucose-6-phosphate,BP,
15183,GO:0061621,1,0.847777778292187,0,26,canonical glycolysis,BP,
15184,GO:0061622,1,0.996009226819508,0,1,glycolytic process through glucose-1-phosphate,BP,
15185,GO:0061623,1,0.996009226819508,0,1,glycolytic process from galactose,BP,
15186,GO:0061624,1,0.975995231070314,0,4,fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate,BP,
15187,GO:0061626,1,0.954286411073822,0,7,pharyngeal arch artery morphogenesis,BP,
15188,GO:0061627,1,0.994886906618171,0,1,S-methylmethionine-homocysteine S-methyltransferase activity,MF,
15189,GO:0061628,1,0.972136107042582,0,3,H3K27me3 modified histone binding,MF,
15190,GO:0061629,1,0.171034192375904,0,257,RNA polymerase II-specific DNA-binding transcription factor binding,MF,
15193,GO:0061632,1,0.99367654782015,0,1,RNA lariat debranching enzyme activator activity,MF,
15194,GO:0061635,1,0.940312516212974,0,11,regulation of protein complex stability,BP,
15196,GO:0061641,1,0.860765336958018,0,26,CENP-A containing chromatin organization,BP,
15197,GO:0061642,1,0.964910757994247,0,4,chemoattraction of axon,BP,
15198,GO:0061643,1,0.955393674091227,0,6,chemorepulsion of axon,BP,
15199,GO:0061646,1,0.992000931569184,0,1,positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization,BP,
15200,GO:0061647,1,0.690022880864464,0,47,histone H3-K9 modification,BP,
15201,GO:0061649,1,0.977869067326536,0,3,ubiquitin modification-dependent histone binding,MF,
15203,GO:0061654,1,0.996027855260139,0,1,NEDD8 conjugating enzyme activity,MF,
15204,GO:0061656,1,0.996253231912534,0,1,SUMO conjugating enzyme activity,MF,
15205,GO:0061657,1,0.996366703194727,0,1,UFM1 conjugating enzyme activity,MF,
15207,GO:0061663,1,0.982748031773869,0,3,NEDD8 ligase activity,MF,
15208,GO:0061665,1,0.953283773954642,0,8,SUMO ligase activity,MF,
15209,GO:0061666,1,0.993485400251684,0,1,UFM1 ligase activity,MF,
15210,GO:0061668,1,0.96246249677306,0,6,mitochondrial ribosome assembly,BP,
15212,GO:0061670,1,0.995788143836214,0,1,evoked neurotransmitter secretion,BP,
15213,GO:0061673,1,0.947962396465784,0,8,mitotic spindle astral microtubule,CC,
15215,GO:0061682,1,0.994208044855637,0,1,seminal vesicle morphogenesis,BP,
15217,GO:0061685,1,0.993485400251684,0,1,diphthine methylesterase activity,MF,
15218,GO:0061687,1,0.948605424402748,0,13,detoxification of inorganic compound,BP,
15219,GO:0061689,1,0.972277989356171,0,4,tricellular tight junction,CC,
15220,GO:0061690,1,0.996299608113382,0,1,lipoamidase activity,MF,
15221,GO:0061695,1,0.210447153253355,0,233,transferase complex, transferring phosphorus-containing groups,CC,
15222,GO:0061697,1,0.988512340876391,0,2,protein-glutaryllysine deglutarylase activity,MF,
15223,GO:0061698,1,0.988512340876391,0,2,protein deglutarylation,BP,
15224,GO:0061699,1,0.988512340876391,0,2,peptidyl-lysine deglutarylation,BP,
15225,GO:0061700,1,0.944323140128668,0,9,GATOR2 complex,CC,
15226,GO:0061702,1,0.916710042501536,0,14,inflammasome complex,CC,
15227,GO:0061709,1,0.938750106231582,0,9,reticulophagy,BP,
15228,GO:0061711,1,0.989975576277284,0,2,N(6)-L-threonylcarbamoyladenine synthase activity,MF,
15229,GO:0061712,1,0.992971863369628,0,1,tRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase,MF,
15230,GO:0061713,1,0.9902559511826,0,2,anterior neural tube closure,BP,
15232,GO:0061715,1,0.992996218770604,0,1,miRNA 2'-O-methylation,BP,
15233,GO:0061718,1,0.847777778292187,0,26,glucose catabolic process to pyruvate,BP,
15234,GO:0061723,1,0.984547650408417,0,2,glycophagy,BP,
15235,GO:0061724,1,0.948920697023309,0,7,lipophagy,BP,
15236,GO:0061726,1,0.597053661199248,0,75,mitochondrion disassembly,BP,
15237,GO:0061727,1,0.985589825050443,0,3,methylglyoxal catabolic process to lactate,BP,
15239,GO:0061732,1,0.962641811443299,0,6,mitochondrial acetyl-CoA biosynthetic process from pyruvate,BP,
15240,GO:0061733,1,0.690913171521925,0,50,peptide-lysine-N-acetyltransferase activity,MF,
15241,GO:0061734,1,0.955695693908498,0,5,parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
15242,GO:0061736,1,0.99134074380901,0,1,engulfment of target by autophagosome,BP,
15243,GO:0061737,1,0.97444369862166,0,5,leukotriene signaling pathway,BP,
15244,GO:0061738,1,0.982336210586185,0,3,late endosomal microautophagy,BP,
15245,GO:0061739,1,0.981011018845315,0,3,protein lipidation involved in autophagosome assembly,BP,
15246,GO:0061740,1,0.980891438463797,0,3,protein targeting to lysosome involved in chaperone-mediated autophagy,BP,
15247,GO:0061741,1,0.988224381696495,0,2,chaperone-mediated protein transport involved in chaperone-mediated autophagy,BP,
15248,GO:0061743,1,0.973290830884783,0,5,motor learning,BP,
15249,GO:0061744,1,0.945261556181124,0,9,motor behavior,BP,
15250,GO:0061749,1,0.983652193313231,0,2,forked DNA-dependent helicase activity,MF,
15251,GO:0061750,1,0.994236565533486,0,1,acid sphingomyelin phosphodiesterase activity,MF,
15252,GO:0061751,1,0.991729149257186,0,1,neutral sphingomyelin phosphodiesterase activity,MF,
15253,GO:0061752,1,0.988322474722647,0,2,telomeric repeat-containing RNA binding,MF,
15254,GO:0061753,1,0.99134074380901,0,1,substrate localization to autophagosome,BP,
15256,GO:0061757,1,0.975822114873921,0,4,leukocyte adhesion to arterial endothelial cell,BP,
15257,GO:0061760,1,0.982566834571677,0,4,antifungal innate immune response,BP,
15258,GO:0061762,1,0.943215586433933,0,7,CAMKK-AMPK signaling cascade,BP,
15259,GO:0061763,1,0.98722509194983,0,2,multivesicular body-lysosome fusion,BP,
15260,GO:0061767,1,0.991164795113101,0,1,negative regulation of lung blood pressure,BP,
15261,GO:0061768,1,0.992068217627249,0,1,magnesium:sodium antiporter activity,MF,
15262,GO:0061769,1,0.98701281886265,0,2,ribosylnicotinate kinase activity,MF,
15263,GO:0061770,1,0.994561171467547,0,1,translation elongation factor binding,MF,
15264,GO:0061771,1,0.983081253855609,0,3,response to caloric restriction,BP,
15265,GO:0061772,1,0.99288656463313,0,1,xenobiotic transport across blood-nerve barrier,BP,
15266,GO:0061778,1,0.892766365203977,0,16,intracellular chloride channel activity,MF,
15267,GO:0061780,1,0.987591553011557,0,1,mitotic cohesin loading,BP,
15269,GO:0061783,1,0.988955590006583,0,3,peptidoglycan muralytic activity,MF,
15270,GO:0061789,1,0.968096390607825,0,3,dense core granule priming,BP,
15272,GO:0061795,1,0.986816046607511,0,2,Golgi lumen acidification,BP,
15273,GO:0061798,1,0.992535412985527,0,1,GTP 3',8'-cyclase activity,MF,
15274,GO:0061799,1,0.992535412985527,0,1,cyclic pyranopterin monophosphate synthase activity,MF,
15276,GO:0061811,1,0.995817718402562,0,1,ADP-ribosyl cyclase activity,MF,
15277,GO:0061812,1,0.995817718402562,0,1,cyclic ADP-ribose hydrolase,MF,
15278,GO:0061817,1,0.965556614150927,0,5,endoplasmic reticulum-plasma membrane tethering,BP,
15279,GO:0061819,1,0.978162491547223,0,3,telomeric DNA-containing double minutes formation,BP,
15280,GO:0061820,1,0.943827958622429,0,8,telomeric D-loop disassembly,BP,
15281,GO:0061821,1,0.969206706536086,0,4,telomeric D-loop binding,MF,
15282,GO:0061825,1,0.992649818073052,0,1,podosome core,CC,
15283,GO:0061827,1,0.938485003772914,0,10,sperm head,CC,
15284,GO:0061828,1,0.98964657606176,0,1,apical tubulobulbar complex,CC,
15285,GO:0061829,1,0.98964657606176,0,1,basal tubulobulbar complex,CC,
15286,GO:0061830,1,0.990875059135912,0,1,concave side of sperm head,CC,
15287,GO:0061831,1,0.989147080879768,0,1,apical ectoplasmic specialization,CC,
15288,GO:0061832,1,0.989494387999906,0,1,basal ectoplasmic specialization,CC,
15289,GO:0061833,1,0.986911196138565,0,2,protein localization to tricellular tight junction,BP,
15290,GO:0061837,1,0.991376028637438,0,1,neuropeptide processing,BP,
15292,GO:0061844,1,0.841139143074188,0,44,antimicrobial humoral immune response mediated by antimicrobial peptide,BP,
15293,GO:0061845,1,0.99298843235316,0,1,neuron projection branch point,CC,
15294,GO:0061846,1,0.99298843235316,0,1,dendritic spine cytoplasm,CC,
15295,GO:0061847,1,0.987134691065173,0,2,response to cholecystokinin,BP,
15296,GO:0061849,1,0.983652193313231,0,2,telomeric G-quadruplex DNA binding,MF,
15297,GO:0061850,1,0.996688208883873,0,1,growth cone leading edge,CC,
15298,GO:0061851,1,0.989402259758197,0,2,leading edge of lamellipodium,CC,
15299,GO:0061857,1,0.986207854273002,0,2,endoplasmic reticulum stress-induced pre-emptive quality control,BP,
15300,GO:0061860,1,0.982959514395674,0,2,DNA clamp unloader activity,MF,
15301,GO:0061863,1,0.990513525086702,0,1,microtubule plus end polymerase,MF,
15302,GO:0061868,1,0.989076927121571,0,1,hepatic stellate cell migration,BP,
15303,GO:0061869,1,0.989076927121571,0,1,regulation of hepatic stellate cell migration,BP,
15304,GO:0061870,1,0.989076927121571,0,1,positive regulation of hepatic stellate cell migration,BP,
15305,GO:0061880,1,0.995441697897154,0,1,regulation of anterograde axonal transport of mitochondrion,BP,
15306,GO:0061881,1,0.995441697897154,0,1,positive regulation of anterograde axonal transport of mitochondrion,BP,
15307,GO:0061884,1,0.987682832107994,0,2,regulation of mini excitatory postsynaptic potential,BP,
15308,GO:0061885,1,0.987682832107994,0,2,positive regulation of mini excitatory postsynaptic potential,BP,
15309,GO:0061888,1,0.971867156006553,0,4,regulation of astrocyte activation,BP,
15310,GO:0061889,1,0.98526447415634,0,2,negative regulation of astrocyte activation,BP,
15311,GO:0061890,1,0.99008697819904,0,1,positive regulation of astrocyte activation,BP,
15313,GO:0061896,1,0.992198643450586,0,1,all-trans retinol 3,4-desaturase activity,MF,
15314,GO:0061897,1,0.992198643450586,0,1,all-trans retinal 3,4-desaturase activity,MF,
15315,GO:0061898,1,0.992198643450586,0,1,all-trans retinoic acid 3,4-desaturase activity,MF,
15316,GO:0061899,1,0.992198643450586,0,1,11-cis-retinal 3,4-desaturase activity,MF,
15317,GO:0061900,1,0.713981806570435,0,50,glial cell activation,BP,
15318,GO:0061901,1,0.987367354365202,0,2,regulation of 1-phosphatidylinositol-3-kinase activity,BP,
15319,GO:0061903,1,0.987367354365202,0,2,positive regulation of 1-phosphatidylinositol-3-kinase activity,BP,
15320,GO:0061909,1,0.987713150924453,0,2,autophagosome-lysosome fusion,BP,
15323,GO:0061920,1,0.98869811524066,0,1,protein propionyltransferase activity,MF,
15324,GO:0061921,1,0.98869811524066,0,1,peptidyl-lysine propionylation,BP,
15325,GO:0061928,1,0.991967346642192,0,2,glutathione specific gamma-glutamylcyclotransferase activity,MF,
15326,GO:0061929,1,0.993485400251684,0,1,gamma-glutamylaminecyclotransferase activity,MF,
15327,GO:0061930,1,0.991828016275873,0,1,regulation of erythrocyte enucleation,BP,
15328,GO:0061931,1,0.991828016275873,0,1,positive regulation of erythrocyte enucleation,BP,
15329,GO:0061944,1,0.992435796844722,0,1,negative regulation of protein K48-linked ubiquitination,BP,
15330,GO:0061945,1,0.981102253393216,0,3,regulation of protein K48-linked ubiquitination,BP,
15331,GO:0061951,1,0.687756187141524,0,53,establishment of protein localization to plasma membrane,BP,
15332,GO:0061952,1,0.908149224675888,0,17,midbody abscission,BP,
15333,GO:0061953,1,0.981776037891359,0,3,mRNA (adenine-N1-)-methyltransferase activity,MF,
15334,GO:0061966,1,0.985673764358397,0,2,establishment of left/right asymmetry,BP,
15335,GO:0061975,1,0.982291748063827,0,3,articular cartilage development,BP,
15336,GO:0061980,1,0.770819427798612,0,36,regulatory RNA binding,MF,
15337,GO:0061981,1,0.995811985613003,0,1,3-hydroxykynureninase activity,MF,
15339,GO:0061983,1,0.941489928421275,0,10,meiosis II cell cycle process,BP,
15340,GO:0061986,1,0.994073250872503,0,1,negative regulation of transcription by glucose,BP,
15341,GO:0061987,1,0.994073250872503,0,1,negative regulation of transcription from RNA polymerase II promoter by glucose,BP,
15342,GO:0061999,1,0.993749795691468,0,1,regulation of cardiac endothelial to mesenchymal transition,BP,
15343,GO:0062000,1,0.993749795691468,0,1,positive regulation of cardiac endothelial to mesenchymal transition,BP,
15344,GO:0062002,1,0.993253855730633,0,1,regulation of all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity,BP,
15345,GO:0062003,1,0.993253855730633,0,1,negative regulation of all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity,BP,
15346,GO:0062009,1,0.836552625118711,0,22,secondary palate development,BP,
15348,GO:0062013,1,0.435461097111696,0,122,positive regulation of small molecule metabolic process,BP,
15351,GO:0062025,1,0.992157457263748,0,1,regulation of SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,BP,
15352,GO:0062026,1,0.992157457263748,0,1,negative regulation of SCF-dependent proteasomal ubiquitin-dependent catabolic process,BP,
15353,GO:0062028,1,0.962434572461573,0,5,regulation of stress granule assembly,BP,
15354,GO:0062029,1,0.98590844542053,0,2,positive regulation of stress granule assembly,BP,
15355,GO:0062030,1,0.995921057250272,0,1,negative regulation of stress granule assembly,BP,
15356,GO:0062033,1,0.871078753809627,0,19,positive regulation of mitotic sister chromatid segregation,BP,
15357,GO:0062035,1,0.99219717498862,0,1,sensory perception of cold stimulus,BP,
15358,GO:0062036,1,0.992421004225964,0,1,sensory perception of hot stimulus,BP,
15359,GO:0062037,1,0.969206706536086,0,4,D-loop DNA binding,MF,
15360,GO:0062042,1,0.933080724842173,0,9,regulation of cardiac epithelial to mesenchymal transition,BP,
15361,GO:0062043,1,0.937684266149044,0,8,positive regulation of cardiac epithelial to mesenchymal transition,BP,
15362,GO:0062044,1,0.986925576671656,0,2,negative regulation of cardiac epithelial to mesenchymal transition,BP,
15363,GO:0062050,1,0.993431871468457,0,1,GPI-mannose ethanolamine phosphate phosphodiesterase activity,MF,
15364,GO:0062061,1,0.988575753737831,0,2,TAP complex binding,MF,
15365,GO:0062064,1,0.992643135437148,0,1,box C/D snoRNP complex binding,MF,
15366,GO:0062065,1,0.992643135437148,0,1,box H/ACA snoRNP complex binding,MF,
15367,GO:0062069,1,0.992785780008114,0,1,GARP complex binding,MF,
15368,GO:0062072,1,0.99407140587962,0,1,H3K9me3 modified histone binding,MF,
15369,GO:0062094,1,0.981563294375552,0,3,stomach development,BP,
15370,GO:0062098,1,0.885517735501146,0,18,regulation of programmed necrotic cell death,BP,
15371,GO:0062099,1,0.91175112486419,0,14,negative regulation of programmed necrotic cell death,BP,
15372,GO:0062100,1,0.98231264749711,0,3,positive regulation of programmed necrotic cell death,BP,
15373,GO:0062105,1,0.974967820643198,0,4,RNA 2'-O-methyltransferase activity,MF,
15375,GO:0062125,1,0.849520409807346,0,28,regulation of mitochondrial gene expression,BP,
15376,GO:0062149,1,0.860372460263699,0,22,detection of stimulus involved in sensory perception of pain,BP,
15378,GO:0062207,1,0.561978305650162,0,83,regulation of pattern recognition receptor signaling pathway,BP,
15379,GO:0062208,1,0.790950116577353,0,34,positive regulation of pattern recognition receptor signaling pathway,BP,
15380,GO:0062232,1,0.982658261381615,0,3,prostanoid catabolic process,BP,
15382,GO:0065001,1,0.972880212122335,0,4,specification of axis polarity,BP,
15383,GO:0065002,1,0.744735196857759,0,49,intracellular protein transmembrane transport,BP,
15386,GO:0065005,1,0.839539053447224,0,27,protein-lipid complex assembly,BP,
15390,GO:0065010,1,0.972913572734798,0,5,extracellular membrane-bounded organelle,CC,
15391,GO:0070001,1,0.897874901585994,0,18,aspartic-type peptidase activity,MF,
15392,GO:0070003,1,0.905112581362902,0,23,threonine-type peptidase activity,MF,
15393,GO:0070004,1,0.981282106868726,0,3,cysteine-type exopeptidase activity,MF,
15394,GO:0070006,1,0.856776793104798,0,22,metalloaminopeptidase activity,MF,
15395,GO:0070008,1,0.94267705582354,0,9,serine-type exopeptidase activity,MF,
15396,GO:0070009,1,0.978067014620361,0,3,serine-type aminopeptidase activity,MF,
15397,GO:0070012,1,0.979009791417125,0,3,oligopeptidase activity,MF,
15399,GO:0070016,1,0.925730115864648,0,10,armadillo repeat domain binding,MF,
15400,GO:0070025,1,0.99374152799939,0,1,carbon monoxide binding,MF,
15401,GO:0070026,1,0.986173485153834,0,3,nitric oxide binding,MF,
15403,GO:0070033,1,0.981534047123182,0,3,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex,CC,
15404,GO:0070034,1,0.865734978016542,0,21,telomerase RNA binding,MF,
15405,GO:0070037,1,0.996467234745146,0,1,rRNA (pseudouridine) methyltransferase activity,MF,
15406,GO:0070042,1,0.993170590336915,0,1,rRNA (uridine-N3-)-methyltransferase activity,MF,
15407,GO:0070044,1,0.977268963505377,0,4,synaptobrevin 2-SNAP-25-syntaxin-1a complex,CC,
15409,GO:0070051,1,0.963085496724788,0,5,fibrinogen binding,MF,
15410,GO:0070052,1,0.984370750399074,0,2,collagen V binding,MF,
15411,GO:0070053,1,0.980277302195155,0,3,thrombospondin receptor activity,MF,
15412,GO:0070054,1,0.992607280810635,0,1,mRNA splicing, via endonucleolytic cleavage and ligation,BP,
15414,GO:0070060,1,0.988413693653963,0,1,'de novo' actin filament nucleation,BP,
15415,GO:0070061,1,0.970435107257823,0,5,fructose binding,MF,
15417,GO:0070063,1,0.659371023540054,0,61,RNA polymerase binding,MF,
15418,GO:0070064,1,0.8797390753824,0,17,proline-rich region binding,MF,
15419,GO:0070069,1,0.905731443916081,0,24,cytochrome complex,CC,
15420,GO:0070070,1,0.970589999649909,0,5,proton-transporting V-type ATPase complex assembly,BP,
15421,GO:0070071,1,0.949785543780104,0,9,proton-transporting two-sector ATPase complex assembly,BP,
15422,GO:0070072,1,0.970589999649909,0,5,vacuolar proton-transporting V-type ATPase complex assembly,BP,
15423,GO:0070075,1,0.997014122102647,0,1,tear secretion,BP,
15424,GO:0070076,1,0.803190686647768,0,26,histone lysine demethylation,BP,
15425,GO:0070077,1,0.992783259455901,0,1,histone arginine demethylation,BP,
15426,GO:0070078,1,0.992783259455901,0,1,histone H3-R2 demethylation,BP,
15427,GO:0070079,1,0.992783259455901,0,1,histone H4-R3 demethylation,BP,
15428,GO:0070080,1,0.988917713690658,0,2,titin Z domain binding,MF,
15431,GO:0070084,1,0.979935109167326,0,3,protein initiator methionine removal,BP,
15433,GO:0070086,1,0.969169615107054,0,5,ubiquitin-dependent endocytosis,BP,
15434,GO:0070087,1,0.946737575925275,0,6,chromo shadow domain binding,MF,
15435,GO:0070089,1,0.991143855779224,0,1,chloride-activated potassium channel activity,MF,
15436,GO:0070091,1,0.950989512623993,0,9,glucagon secretion,BP,
15437,GO:0070092,1,0.950989512623993,0,9,regulation of glucagon secretion,BP,
15438,GO:0070093,1,0.98188292384765,0,4,negative regulation of glucagon secretion,BP,
15439,GO:0070094,1,0.987297010749615,0,2,positive regulation of glucagon secretion,BP,
15440,GO:0070095,1,0.969972535347768,0,5,fructose-6-phosphate binding,MF,
15441,GO:0070096,1,0.992906731455803,0,1,mitochondrial outer membrane translocase complex assembly,BP,
15442,GO:0070097,1,0.944547422216284,0,7,delta-catenin binding,MF,
15443,GO:0070098,1,0.676840996016794,0,72,chemokine-mediated signaling pathway,BP,
15444,GO:0070099,1,0.939000716209488,0,9,regulation of chemokine-mediated signaling pathway,BP,
15445,GO:0070100,1,0.954424760445458,0,6,negative regulation of chemokine-mediated signaling pathway,BP,
15446,GO:0070101,1,0.983846910971457,0,3,positive regulation of chemokine-mediated signaling pathway,BP,
15447,GO:0070102,1,0.849921913616709,0,22,interleukin-6-mediated signaling pathway,BP,
15448,GO:0070103,1,0.977813635754852,0,4,regulation of interleukin-6-mediated signaling pathway,BP,
15449,GO:0070104,1,0.99543809429607,0,1,negative regulation of interleukin-6-mediated signaling pathway,BP,
15450,GO:0070105,1,0.982295575600684,0,3,positive regulation of interleukin-6-mediated signaling pathway,BP,
15451,GO:0070106,1,0.929311093741936,0,11,interleukin-27-mediated signaling pathway,BP,
15452,GO:0070110,1,0.980607899812806,0,3,ciliary neurotrophic factor receptor complex,CC,
15453,GO:0070119,1,0.992551632015137,0,1,ciliary neurotrophic factor binding,MF,
15454,GO:0070120,1,0.963658820925649,0,5,ciliary neurotrophic factor-mediated signaling pathway,BP,
15455,GO:0070121,1,0.991482478357323,0,1,Kupffer's vesicle development,BP,
15456,GO:0070122,1,0.907376779442492,0,17,isopeptidase activity,MF,
15457,GO:0070123,1,0.990704991095881,0,1,transforming growth factor beta receptor activity, type III,MF,
15458,GO:0070124,1,0.990001089291367,0,2,mitochondrial translational initiation,BP,
15459,GO:0070125,1,0.698281216012798,0,85,mitochondrial translational elongation,BP,
15460,GO:0070126,1,0.693505105068608,0,86,mitochondrial translational termination,BP,
15461,GO:0070127,1,0.955390365931425,0,7,tRNA aminoacylation for mitochondrial protein translation,BP,
15462,GO:0070129,1,0.86540103563851,0,25,regulation of mitochondrial translation,BP,
15463,GO:0070130,1,0.993485400251684,0,1,negative regulation of mitochondrial translation,BP,
15464,GO:0070131,1,0.911927090718518,0,16,positive regulation of mitochondrial translation,BP,
15465,GO:0070137,1,0.975806342663892,0,3,ubiquitin-like protein-specific endopeptidase activity,MF,
15466,GO:0070138,1,0.97800840584304,0,3,ubiquitin-like protein-specific isopeptidase activity,MF,
15467,GO:0070139,1,0.975806342663892,0,3,SUMO-specific endopeptidase activity,MF,
15468,GO:0070140,1,0.97800840584304,0,3,SUMO-specific isopeptidase activity,MF,
15469,GO:0070141,1,0.960343901679794,0,6,response to UV-A,BP,
15471,GO:0070143,1,0.992115397075961,0,1,mitochondrial alanyl-tRNA aminoacylation,BP,
15472,GO:0070145,1,0.992920493834486,0,1,mitochondrial asparaginyl-tRNA aminoacylation,BP,
15473,GO:0070158,1,0.994730037869166,0,1,mitochondrial seryl-tRNA aminoacylation,BP,
15474,GO:0070159,1,0.994127094388793,0,1,mitochondrial threonyl-tRNA aminoacylation,BP,
15477,GO:0070162,1,0.958226919215722,0,6,adiponectin secretion,BP,
15478,GO:0070163,1,0.958226919215722,0,6,regulation of adiponectin secretion,BP,
15479,GO:0070164,1,0.971543314348854,0,4,negative regulation of adiponectin secretion,BP,
15480,GO:0070165,1,0.986297492648876,0,2,positive regulation of adiponectin secretion,BP,
15481,GO:0070166,1,0.920391847269447,0,11,enamel mineralization,BP,
15482,GO:0070167,1,0.578517479476123,0,79,regulation of biomineral tissue development,BP,
15483,GO:0070168,1,0.856350947983202,0,22,negative regulation of biomineral tissue development,BP,
15485,GO:0070170,1,0.967202251746849,0,5,regulation of tooth mineralization,BP,
15486,GO:0070171,1,0.984776674031821,0,2,negative regulation of tooth mineralization,BP,
15487,GO:0070172,1,0.988436661692387,0,2,positive regulation of tooth mineralization,BP,
15488,GO:0070173,1,0.993647220646861,0,1,regulation of enamel mineralization,BP,
15489,GO:0070176,1,0.995263223110464,0,1,DRM complex,CC,
15490,GO:0070178,1,0.98959735302538,0,2,D-serine metabolic process,BP,
15491,GO:0070179,1,0.993951530489555,0,1,D-serine biosynthetic process,BP,
15492,GO:0070180,1,0.985996469517241,0,4,large ribosomal subunit rRNA binding,MF,
15493,GO:0070181,1,0.95562342830971,0,10,small ribosomal subunit rRNA binding,MF,
15494,GO:0070182,1,0.888881761181757,0,18,DNA polymerase binding,MF,
15495,GO:0070183,1,0.99341659294271,0,1,mitochondrial tryptophanyl-tRNA aminoacylation,BP,
15496,GO:0070184,1,0.994561171467547,0,1,mitochondrial tyrosyl-tRNA aminoacylation,BP,
15497,GO:0070187,1,0.963959228803564,0,6,shelterin complex,CC,
15498,GO:0070189,1,0.957529990075413,0,8,kynurenine metabolic process,BP,
15499,GO:0070191,1,0.993485400251684,0,1,methionine-R-sulfoxide reductase activity,MF,
15501,GO:0070193,1,0.888519000617673,0,19,synaptonemal complex organization,BP,
15502,GO:0070194,1,0.988060727709302,0,2,synaptonemal complex disassembly,BP,
15503,GO:0070195,1,0.992419139235533,0,1,growth hormone receptor complex,CC,
15504,GO:0070197,1,0.987999883516934,0,2,meiotic attachment of telomere to nuclear envelope,BP,
15505,GO:0070198,1,0.808667815472318,0,29,protein localization to chromosome, telomeric region,BP,
15506,GO:0070199,1,0.851916251474634,0,23,establishment of protein localization to chromosome,BP,
15507,GO:0070200,1,0.880195827664046,0,18,establishment of protein localization to telomere,BP,
15509,GO:0070202,1,0.932617929018782,0,12,regulation of establishment of protein localization to chromosome,BP,
15510,GO:0070203,1,0.93873728320093,0,11,regulation of establishment of protein localization to telomere,BP,
15511,GO:0070206,1,0.899937867191945,0,17,protein trimerization,BP,
15512,GO:0070207,1,0.911169276034575,0,15,protein homotrimerization,BP,
15513,GO:0070208,1,0.991566102241638,0,1,protein heterotrimerization,BP,
15514,GO:0070209,1,0.980034658989278,0,3,ASTRA complex,CC,
15515,GO:0070212,1,0.939044626804171,0,8,protein poly-ADP-ribosylation,BP,
15516,GO:0070213,1,0.919981984799328,0,11,protein auto-ADP-ribosylation,BP,
15517,GO:0070221,1,0.983064735014131,0,4,sulfide oxidation, using sulfide:quinone oxidoreductase,BP,
15518,GO:0070227,1,0.668179865914927,0,66,lymphocyte apoptotic process,BP,
15519,GO:0070228,1,0.747160305401633,0,49,regulation of lymphocyte apoptotic process,BP,
15520,GO:0070229,1,0.847314803206833,0,27,negative regulation of lymphocyte apoptotic process,BP,
15521,GO:0070230,1,0.925332428709724,0,14,positive regulation of lymphocyte apoptotic process,BP,
15522,GO:0070231,1,0.769904778960391,0,44,T cell apoptotic process,BP,
15523,GO:0070232,1,0.844807743178351,0,29,regulation of T cell apoptotic process,BP,
15524,GO:0070233,1,0.902153956137274,0,17,negative regulation of T cell apoptotic process,BP,
15525,GO:0070234,1,0.947904412593147,0,10,positive regulation of T cell apoptotic process,BP,
15526,GO:0070235,1,0.976125207344979,0,4,regulation of activation-induced cell death of T cells,BP,
15527,GO:0070236,1,0.981009643078341,0,3,negative regulation of activation-induced cell death of T cells,BP,
15528,GO:0070238,1,0.995495369367563,0,1,activated T cell autonomous cell death,BP,
15529,GO:0070239,1,0.995495369367563,0,1,regulation of activated T cell autonomous cell death,BP,
15530,GO:0070241,1,0.995495369367563,0,1,positive regulation of activated T cell autonomous cell death,BP,
15531,GO:0070242,1,0.897986860262091,0,17,thymocyte apoptotic process,BP,
15532,GO:0070243,1,0.929163800764042,0,12,regulation of thymocyte apoptotic process,BP,
15533,GO:0070244,1,0.958676678056851,0,7,negative regulation of thymocyte apoptotic process,BP,
15534,GO:0070245,1,0.96922777760233,0,5,positive regulation of thymocyte apoptotic process,BP,
15535,GO:0070246,1,0.996112074118588,0,1,natural killer cell apoptotic process,BP,
15536,GO:0070247,1,0.996112074118588,0,1,regulation of natural killer cell apoptotic process,BP,
15537,GO:0070251,1,0.994257565424587,0,1,pristanate-CoA ligase activity,MF,
15538,GO:0070252,1,0.424513794679674,0,111,actin-mediated cell contraction,BP,
15539,GO:0070253,1,0.980383632259735,0,4,somatostatin secretion,BP,
15540,GO:0070254,1,0.942790622941332,0,10,mucus secretion,BP,
15541,GO:0070255,1,0.945748522042106,0,9,regulation of mucus secretion,BP,
15542,GO:0070256,1,0.989144539781613,0,2,negative regulation of mucus secretion,BP,
15543,GO:0070257,1,0.962278644944594,0,6,positive regulation of mucus secretion,BP,
15544,GO:0070259,1,0.986305285381889,0,2,tyrosyl-DNA phosphodiesterase activity,MF,
15545,GO:0070260,1,0.993485400251684,0,1,5'-tyrosyl-DNA phosphodiesterase activity,MF,
15546,GO:0070262,1,0.883171448260807,0,20,peptidyl-serine dephosphorylation,BP,
15547,GO:0070265,1,0.742057758580365,0,49,necrotic cell death,BP,
15548,GO:0070266,1,0.791705500296455,0,36,necroptotic process,BP,
15549,GO:0070267,1,0.992799481448001,0,1,oncosis,BP,
15550,GO:0070268,1,0.676410276369789,0,63,cornification,BP,
15551,GO:0070269,1,0.942573806312254,0,10,pyroptosis,BP,
15552,GO:0070273,1,0.820048401129687,0,26,phosphatidylinositol-4-phosphate binding,MF,
15553,GO:0070274,1,0.99485934865256,0,1,RES complex,CC,
15556,GO:0070280,1,0.992694159277601,0,1,pyridoxal binding,MF,
15557,GO:0070286,1,0.813141153369812,0,26,axonemal dynein complex assembly,BP,
15558,GO:0070287,1,0.992780065780765,0,1,ferritin receptor activity,MF,
15559,GO:0070288,1,0.99293792104797,0,2,ferritin complex,CC,
15560,GO:0070290,1,0.976295026029626,0,3,N-acylphosphatidylethanolamine-specific phospholipase D activity,MF,
15561,GO:0070291,1,0.9723005677221,0,5,N-acylethanolamine metabolic process,BP,
15562,GO:0070292,1,0.985739110510759,0,2,N-acylphosphatidylethanolamine metabolic process,BP,
15563,GO:0070293,1,0.906772368136565,0,16,renal absorption,BP,
15564,GO:0070294,1,0.971759398621763,0,4,renal sodium ion absorption,BP,
15565,GO:0070295,1,0.982759364763878,0,3,renal water absorption,BP,
15566,GO:0070296,1,0.766556599993987,0,35,sarcoplasmic reticulum calcium ion transport,BP,
15568,GO:0070301,1,0.570514475332213,0,87,cellular response to hydrogen peroxide,BP,
15571,GO:0070304,1,0.340406821614494,0,155,positive regulation of stress-activated protein kinase signaling cascade,BP,
15572,GO:0070305,1,0.951605572099205,0,6,response to cGMP,BP,
15573,GO:0070306,1,0.794138452766321,0,32,lens fiber cell differentiation,BP,
15574,GO:0070307,1,0.922123091317439,0,12,lens fiber cell development,BP,
15575,GO:0070309,1,0.964703520474996,0,5,lens fiber cell morphogenesis,BP,
15576,GO:0070314,1,0.950129253213817,0,7,G1 to G0 transition,BP,
15577,GO:0070315,1,0.986092420945051,0,2,G1 to G0 transition involved in cell differentiation,BP,
15580,GO:0070318,1,0.97880905283851,0,3,positive regulation of G0 to G1 transition,BP,
15581,GO:0070319,1,0.982612089213578,0,2,Golgi to plasma membrane transport vesicle,CC,
15582,GO:0070320,1,0.993630009751703,0,1,inward rectifier potassium channel inhibitor activity,MF,
15583,GO:0070324,1,0.959352485702852,0,7,thyroid hormone binding,MF,
15585,GO:0070326,1,0.971456339907184,0,4,very-low-density lipoprotein particle receptor binding,MF,
15586,GO:0070327,1,0.943211817427751,0,9,thyroid hormone transport,BP,
15587,GO:0070328,1,0.85195420340915,0,27,triglyceride homeostasis,BP,
15588,GO:0070330,1,0.920901843952405,0,14,aromatase activity,MF,
15589,GO:0070335,1,0.990080082679038,0,1,aspartate binding,MF,
15590,GO:0070336,1,0.977922852043202,0,3,flap-structured DNA binding,MF,
15591,GO:0070337,1,0.991283985265797,0,1,3'-flap-structured DNA binding,MF,
15592,GO:0070339,1,0.963685247912533,0,6,response to bacterial lipopeptide,BP,
15593,GO:0070340,1,0.977637294612196,0,3,detection of bacterial lipopeptide,BP,
15594,GO:0070341,1,0.943664222042708,0,9,fat cell proliferation,BP,
15595,GO:0070343,1,0.98566648484487,0,3,white fat cell proliferation,BP,
15596,GO:0070344,1,0.943664222042708,0,9,regulation of fat cell proliferation,BP,
15597,GO:0070345,1,0.963595834871411,0,5,negative regulation of fat cell proliferation,BP,
15598,GO:0070346,1,0.986763040548768,0,3,positive regulation of fat cell proliferation,BP,
15599,GO:0070350,1,0.98566648484487,0,3,regulation of white fat cell proliferation,BP,
15600,GO:0070352,1,0.993154258946511,0,2,positive regulation of white fat cell proliferation,BP,
15601,GO:0070358,1,0.946316553325866,0,7,actin polymerization-dependent cell motility,BP,
15602,GO:0070365,1,0.922766721279892,0,13,hepatocyte differentiation,BP,
15603,GO:0070366,1,0.991139927891833,0,2,regulation of hepatocyte differentiation,BP,
15604,GO:0070367,1,0.994804129184635,0,1,negative regulation of hepatocyte differentiation,BP,
15605,GO:0070368,1,0.996316852701051,0,1,positive regulation of hepatocyte differentiation,BP,
15606,GO:0070369,1,0.974782305159048,0,3,beta-catenin-TCF7L2 complex,CC,
15607,GO:0070370,1,0.974971801786733,0,5,cellular heat acclimation,BP,
15611,GO:0070374,1,0.345574661662397,0,170,positive regulation of ERK1 and ERK2 cascade,BP,
15612,GO:0070375,1,0.985768841565723,0,2,ERK5 cascade,BP,
15613,GO:0070381,1,0.985651567938488,0,2,endosome to plasma membrane transport vesicle,CC,
15615,GO:0070383,1,0.954397262538341,0,9,DNA cytosine deamination,BP,
15616,GO:0070384,1,0.97611440794087,0,4,Harderian gland development,BP,
15617,GO:0070390,1,0.976665672232253,0,5,transcription export complex 2,CC,
15618,GO:0070391,1,0.943099588175589,0,10,response to lipoteichoic acid,BP,
15619,GO:0070392,1,0.996465856482775,0,1,detection of lipoteichoic acid,BP,
15620,GO:0070401,1,0.984389576847315,0,3,NADP+ binding,MF,
15621,GO:0070402,1,0.91143332601593,0,15,NADPH binding,MF,
15622,GO:0070403,1,0.923193833778879,0,14,NAD+ binding,MF,
15623,GO:0070404,1,0.986425734122053,0,3,NADH binding,MF,
15624,GO:0070407,1,0.993091468149164,0,1,oxidation-dependent protein catabolic process,BP,
15625,GO:0070408,1,0.991302757153353,0,1,carbamoyl phosphate metabolic process,BP,
15626,GO:0070409,1,0.991302757153353,0,1,carbamoyl phosphate biosynthetic process,BP,
15627,GO:0070410,1,0.902435799986688,0,12,co-SMAD binding,MF,
15628,GO:0070411,1,0.890198837144949,0,14,I-SMAD binding,MF,
15629,GO:0070412,1,0.82924207285167,0,23,R-SMAD binding,MF,
15630,GO:0070413,1,0.993251680226007,0,1,trehalose metabolism in response to stress,BP,
15631,GO:0070417,1,0.939267084174587,0,9,cellular response to cold,BP,
15632,GO:0070418,1,0.984245653710386,0,2,DNA-dependent protein kinase complex,CC,
15633,GO:0070419,1,0.949115840421025,0,7,nonhomologous end joining complex,CC,
15634,GO:0070421,1,0.992900295171655,0,1,DNA ligase III-XRCC1 complex,CC,
15635,GO:0070423,1,0.793794598184962,0,34,nucleotide-binding oligomerization domain containing signaling pathway,BP,
15636,GO:0070424,1,0.935127570583551,0,9,regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
15637,GO:0070425,1,0.98562605594622,0,2,negative regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
15638,GO:0070426,1,0.97351731052487,0,4,positive regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
15639,GO:0070427,1,0.967549413843537,0,5,nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15640,GO:0070428,1,0.977852563936519,0,3,regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15641,GO:0070429,1,0.992375939051885,0,1,negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15642,GO:0070430,1,0.98536615801691,0,2,positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15643,GO:0070431,1,0.925597565773243,0,12,nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15644,GO:0070432,1,0.965395827995949,0,5,regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15645,GO:0070433,1,0.98562605594622,0,2,negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15646,GO:0070434,1,0.979477682740809,0,3,positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15647,GO:0070435,1,0.98679090616212,0,2,Shc-EGFR complex,CC,
15648,GO:0070436,1,0.985473495441114,0,2,Grb2-EGFR complex,CC,
15649,GO:0070442,1,0.995981110367839,0,1,integrin alphaIIb-beta3 complex,CC,
15650,GO:0070444,1,0.93690373606653,0,8,oligodendrocyte progenitor proliferation,BP,
15651,GO:0070445,1,0.93690373606653,0,8,regulation of oligodendrocyte progenitor proliferation,BP,
15652,GO:0070446,1,0.994979066216479,0,1,negative regulation of oligodendrocyte progenitor proliferation,BP,
15653,GO:0070447,1,0.971252201014308,0,3,positive regulation of oligodendrocyte progenitor proliferation,BP,
15654,GO:0070453,1,0.992417445097932,0,2,regulation of heme biosynthetic process,BP,
15655,GO:0070458,1,0.98503857989468,0,3,cellular detoxification of nitrogen compound,BP,
15656,GO:0070459,1,0.961898217489527,0,7,prolactin secretion,BP,
15657,GO:0070460,1,0.978569943072333,0,3,thyroid-stimulating hormone secretion,BP,
15658,GO:0070461,1,0.854216730963742,0,23,SAGA-type complex,CC,
15659,GO:0070462,1,0.992767886172341,0,1,plus-end specific microtubule depolymerization,BP,
15660,GO:0070463,1,0.992855539916913,0,1,tubulin-dependent ATPase activity,MF,
15661,GO:0070469,1,0.729580682311545,0,78,respirasome,CC,
15662,GO:0070471,1,0.945010375191021,0,9,uterine smooth muscle contraction,BP,
15663,GO:0070472,1,0.95092829274316,0,8,regulation of uterine smooth muscle contraction,BP,
15664,GO:0070473,1,0.994969292905976,0,1,negative regulation of uterine smooth muscle contraction,BP,
15665,GO:0070474,1,0.96776398715017,0,5,positive regulation of uterine smooth muscle contraction,BP,
15666,GO:0070475,1,0.96201436171861,0,7,rRNA base methylation,BP,
15667,GO:0070476,1,0.997071857114582,0,1,rRNA (guanine-N7)-methylation,BP,
15668,GO:0070478,1,0.99251960654467,0,1,nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay,BP,
15669,GO:0070481,1,0.99329754746636,0,1,nuclear-transcribed mRNA catabolic process, non-stop decay,BP,
15671,GO:0070483,1,0.993040942839371,0,1,detection of hypoxia,BP,
15672,GO:0070486,1,0.9166801156678,0,14,leukocyte aggregation,BP,
15673,GO:0070487,1,0.957476585182577,0,6,monocyte aggregation,BP,
15674,GO:0070488,1,0.994357274346156,0,2,neutrophil aggregation,BP,
15675,GO:0070489,1,0.987651681304387,0,2,T cell aggregation,BP,
15676,GO:0070491,1,0.615769765546549,0,71,repressing transcription factor binding,MF,
15678,GO:0070493,1,0.919035087657346,0,12,thrombin-activated receptor signaling pathway,BP,
15679,GO:0070494,1,0.979279257598403,0,3,regulation of thrombin-activated receptor signaling pathway,BP,
15680,GO:0070495,1,0.979279257598403,0,3,negative regulation of thrombin-activated receptor signaling pathway,BP,
15681,GO:0070498,1,0.576723917006798,0,96,interleukin-1-mediated signaling pathway,BP,
15682,GO:0070506,1,0.987298851020148,0,2,high-density lipoprotein particle receptor activity,MF,
15684,GO:0070508,1,0.945957737737673,0,8,cholesterol import,BP,
15685,GO:0070509,1,0.575099542396757,0,74,calcium ion import,BP,
15686,GO:0070510,1,0.990094306343571,0,1,regulation of histone H4-K20 methylation,BP,
15687,GO:0070512,1,0.990094306343571,0,1,positive regulation of histone H4-K20 methylation,BP,
15688,GO:0070513,1,0.948946138428108,0,10,death domain binding,MF,
15689,GO:0070516,1,0.982395265783632,0,4,CAK-ERCC2 complex,CC,
15690,GO:0070522,1,0.971788752378951,0,4,ERCC4-ERCC1 complex,CC,
15691,GO:0070524,1,0.995934573145987,0,1,11-beta-hydroxysteroid dehydrogenase (NADP+) activity,MF,
15692,GO:0070525,1,0.929213786217387,0,14,tRNA threonylcarbamoyladenosine metabolic process,BP,
15693,GO:0070527,1,0.67329137025307,0,58,platelet aggregation,BP,
15694,GO:0070528,1,0.827170274031118,0,29,protein kinase C signaling,BP,
15695,GO:0070530,1,0.884018272065367,0,17,K63-linked polyubiquitin modification-dependent protein binding,MF,
15696,GO:0070531,1,0.961675224105135,0,6,BRCA1-A complex,CC,
15697,GO:0070534,1,0.703751720999475,0,52,protein K63-linked ubiquitination,BP,
15698,GO:0070535,1,0.95231521192967,0,6,histone H2A K63-linked ubiquitination,BP,
15699,GO:0070536,1,0.816327623850394,0,27,protein K63-linked deubiquitination,BP,
15700,GO:0070537,1,0.980410361097428,0,3,histone H2A K63-linked deubiquitination,BP,
15701,GO:0070538,1,0.992335719078527,0,2,oleic acid binding,MF,
15702,GO:0070539,1,0.992834452342843,0,1,linoleic acid binding,MF,
15703,GO:0070541,1,0.979160673536491,0,3,response to platinum ion,BP,
15704,GO:0070542,1,0.573181234926023,0,83,response to fatty acid,BP,
15705,GO:0070543,1,0.994733003118225,0,1,response to linoleic acid,BP,
15706,GO:0070544,1,0.937753792245747,0,8,histone H3-K36 demethylation,BP,
15707,GO:0070545,1,0.988679642318202,0,2,PeBoW complex,CC,
15708,GO:0070547,1,0.993492449495572,0,1,L-tyrosine aminotransferase activity,MF,
15709,GO:0070548,1,0.982063112729023,0,2,L-glutamine aminotransferase activity,MF,
15710,GO:0070550,1,0.987591553011557,0,1,rDNA condensation,BP,
15711,GO:0070551,1,0.993485400251684,0,1,endoribonuclease activity, cleaving siRNA-paired mRNA,MF,
15712,GO:0070552,1,0.981339297628665,0,3,BRISC complex,CC,
15713,GO:0070553,1,0.993485400251684,0,1,nicotinic acid receptor activity,MF,
15714,GO:0070554,1,0.986833767165695,0,2,synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex,CC,
15716,GO:0070557,1,0.990545983529193,0,2,PCNA-p21 complex,CC,
15717,GO:0070560,1,0.986899077907185,0,2,protein secretion by platelet,BP,
15718,GO:0070561,1,0.937548215323941,0,9,vitamin D receptor signaling pathway,BP,
15719,GO:0070562,1,0.957718261898983,0,6,regulation of vitamin D receptor signaling pathway,BP,
15720,GO:0070563,1,0.986614854581882,0,2,negative regulation of vitamin D receptor signaling pathway,BP,
15721,GO:0070564,1,0.988578722307375,0,2,positive regulation of vitamin D receptor signaling pathway,BP,
15722,GO:0070566,1,0.872312479590862,0,20,adenylyltransferase activity,MF,
15723,GO:0070567,1,0.954182299329428,0,8,cytidylyltransferase activity,MF,
15724,GO:0070568,1,0.9771335313107,0,4,guanylyltransferase activity,MF,
15725,GO:0070569,1,0.971508367470471,0,5,uridylyltransferase activity,MF,
15726,GO:0070570,1,0.817733812979672,0,28,regulation of neuron projection regeneration,BP,
15727,GO:0070571,1,0.90209170410054,0,14,negative regulation of neuron projection regeneration,BP,
15728,GO:0070572,1,0.942354286420384,0,9,positive regulation of neuron projection regeneration,BP,
15729,GO:0070573,1,0.959766359118733,0,7,metallodipeptidase activity,MF,
15730,GO:0070574,1,0.965726406398626,0,5,cadmium ion transmembrane transport,BP,
15731,GO:0070576,1,0.986823120774259,0,2,vitamin D 24-hydroxylase activity,MF,
15732,GO:0070577,1,0.843267739946626,0,21,lysine-acetylated histone binding,MF,
15733,GO:0070578,1,0.941665211272947,0,9,RISC-loading complex,CC,
15734,GO:0070579,1,0.957582746008248,0,4,methylcytosine dioxygenase activity,MF,
15735,GO:0070584,1,0.875508417106971,0,22,mitochondrion morphogenesis,BP,
15736,GO:0070585,1,0.449076846424732,0,134,protein localization to mitochondrion,BP,
15737,GO:0070586,1,0.938521240012285,0,10,cell-cell adhesion involved in gastrulation,BP,
15738,GO:0070587,1,0.944585900455041,0,9,regulation of cell-cell adhesion involved in gastrulation,BP,
15740,GO:0070589,1,0.995309928040927,0,1,cellular component macromolecule biosynthetic process,BP,
15741,GO:0070593,1,0.885191329471092,0,16,dendrite self-avoidance,BP,
15742,GO:0070601,1,0.937751126298775,0,10,centromeric sister chromatid cohesion,BP,
15743,GO:0070602,1,0.975003913776698,0,4,regulation of centromeric sister chromatid cohesion,BP,
15744,GO:0070603,1,0.599693897801615,0,72,SWI/SNF superfamily-type complex,CC,
15745,GO:0070611,1,0.993684554591547,0,1,histone methyltransferase activity (H3-R2 specific),MF,
15746,GO:0070612,1,0.993684554591547,0,1,histone methyltransferase activity (H2A-R3 specific),MF,
15747,GO:0070613,1,0.709009421003354,0,54,regulation of protein processing,BP,
15748,GO:0070615,1,0.982546749844378,0,2,nucleosome-dependent ATPase activity,MF,
15749,GO:0070618,1,0.993604519131794,0,1,Grb2-Sos complex,CC,
15750,GO:0070625,1,0.994715210865872,0,1,zymogen granule exocytosis,BP,
15751,GO:0070626,1,0.995822625406812,0,1,(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity,MF,
15752,GO:0070628,1,0.898219367911182,0,16,proteasome binding,MF,
15753,GO:0070633,1,0.833294015208854,0,24,transepithelial transport,BP,
15754,GO:0070634,1,0.985344278490037,0,2,transepithelial ammonium transport,BP,
15755,GO:0070637,1,0.99407140587962,0,1,pyridine nucleoside metabolic process,BP,
15756,GO:0070638,1,0.99407140587962,0,1,pyridine nucleoside catabolic process,BP,
15757,GO:0070640,1,0.975444910119607,0,4,vitamin D3 metabolic process,BP,
15758,GO:0070643,1,0.983031941346125,0,3,vitamin D 25-hydroxylase activity,MF,
15759,GO:0070644,1,0.976342696031501,0,3,vitamin D response element binding,MF,
15760,GO:0070646,1,0.175839805267261,0,256,protein modification by small protein removal,BP,
15762,GO:0070649,1,0.975493943092294,0,3,formin-nucleated actin cable assembly,BP,
15763,GO:0070651,1,0.99329754746636,0,1,nonfunctional rRNA decay,BP,
15764,GO:0070652,1,0.951238961119046,0,8,HAUS complex,CC,
15765,GO:0070653,1,0.996673854950561,0,1,high-density lipoprotein particle receptor binding,MF,
15767,GO:0070662,1,0.963886666596534,0,5,mast cell proliferation,BP,
15769,GO:0070664,1,0.623468107994896,0,78,negative regulation of leukocyte proliferation,BP,
15771,GO:0070666,1,0.971854741885522,0,4,regulation of mast cell proliferation,BP,
15772,GO:0070667,1,0.980067501956121,0,3,negative regulation of mast cell proliferation,BP,
15773,GO:0070668,1,0.984822314114694,0,2,positive regulation of mast cell proliferation,BP,
15774,GO:0070669,1,0.91516558678467,0,13,response to interleukin-2,BP,
15775,GO:0070670,1,0.820472718540055,0,32,response to interleukin-4,BP,
15776,GO:0070671,1,0.761892639250169,0,47,response to interleukin-12,BP,
15777,GO:0070672,1,0.904589876046599,0,14,response to interleukin-15,BP,
15778,GO:0070673,1,0.934765695240238,0,11,response to interleukin-18,BP,
15779,GO:0070676,1,0.985689733735506,0,3,intralumenal vesicle formation,BP,
15780,GO:0070678,1,0.993615285044185,0,1,preprotein binding,MF,
15782,GO:0070681,1,0.983397955973177,0,3,glutaminyl-tRNAGln biosynthesis via transamidation,BP,
15783,GO:0070682,1,0.982980953850144,0,3,proteasome regulatory particle assembly,BP,
15784,GO:0070684,1,0.99634826411623,0,1,seminal clot liquefaction,BP,
15785,GO:0070685,1,0.994654920019438,0,1,macropinocytic cup,CC,
15786,GO:0070694,1,0.993485400251684,0,1,deoxyribonucleoside 5'-monophosphate N-glycosidase activity,MF,
15787,GO:0070695,1,0.957308407072549,0,5,FHF complex,CC,
15788,GO:0070696,1,0.881628784149774,0,20,transmembrane receptor protein serine/threonine kinase binding,MF,
15789,GO:0070697,1,0.953328293383529,0,8,activin receptor binding,MF,
15790,GO:0070698,1,0.982992738136742,0,3,type I activin receptor binding,MF,
15791,GO:0070699,1,0.978163880554905,0,3,type II activin receptor binding,MF,
15792,GO:0070700,1,0.924824903034882,0,12,BMP receptor binding,MF,
15793,GO:0070704,1,0.985917575114615,0,2,sterol desaturase activity,MF,
15794,GO:0070715,1,0.992971185204564,0,1,sodium-dependent organic cation transport,BP,
15795,GO:0070716,1,0.99397663109162,0,1,mismatch repair involved in maintenance of fidelity involved in DNA-dependent DNA replication,BP,
15796,GO:0070717,1,0.810955860996873,0,29,poly-purine tract binding,MF,
15797,GO:0070723,1,0.821223305040892,0,25,response to cholesterol,BP,
15798,GO:0070724,1,0.97898262174625,0,3,BMP receptor complex,CC,
15800,GO:0070728,1,0.950608324561129,0,7,leucine binding,MF,
15801,GO:0070733,1,0.995536036961095,0,1,protein adenylyltransferase activity,MF,
15802,GO:0070734,1,0.89120378348224,0,15,histone H3-K27 methylation,BP,
15803,GO:0070735,1,0.992891664482637,0,1,protein-glycine ligase activity,MF,
15804,GO:0070736,1,0.992891664482637,0,1,protein-glycine ligase activity, initiating,MF,
15805,GO:0070739,1,0.949167307367704,0,8,protein-glutamic acid ligase activity,MF,
15806,GO:0070740,1,0.949167307367704,0,8,tubulin-glutamic acid ligase activity,MF,
15807,GO:0070741,1,0.750015230309239,0,41,response to interleukin-6,BP,
15808,GO:0070742,1,0.903468976330046,0,14,C2H2 zinc finger domain binding,MF,
15809,GO:0070743,1,0.996480990173559,0,1,interleukin-23 complex,CC,
15810,GO:0070757,1,0.927210413145071,0,11,interleukin-35-mediated signaling pathway,BP,
15811,GO:0070761,1,0.970075120231877,0,5,pre-snoRNP complex,CC,
15812,GO:0070762,1,0.993485400251684,0,1,nuclear pore transmembrane ring,CC,
15813,GO:0070765,1,0.961771976849444,0,6,gamma-secretase complex,CC,
15814,GO:0070772,1,0.99310439906465,0,1,PAS complex,CC,
15815,GO:0070774,1,0.986583345179583,0,2,phytoceramidase activity,MF,
15816,GO:0070775,1,0.936819675355953,0,9,H3 histone acetyltransferase complex,CC,
15817,GO:0070776,1,0.942966319025636,0,8,MOZ/MORF histone acetyltransferase complex,CC,
15818,GO:0070777,1,0.964675009566798,0,4,D-aspartate transport,BP,
15819,GO:0070778,1,0.924510022236229,0,11,L-aspartate transmembrane transport,BP,
15820,GO:0070779,1,0.964675009566798,0,4,D-aspartate import across plasma membrane,BP,
15821,GO:0070781,1,0.986641136313997,0,2,response to biotin,BP,
15822,GO:0070782,1,0.96675579700713,0,5,phosphatidylserine exposure on apoptotic cell surface,BP,
15823,GO:0070813,1,0.97150388201525,0,5,hydrogen sulfide metabolic process,BP,
15824,GO:0070814,1,0.974834806586505,0,4,hydrogen sulfide biosynthetic process,BP,
15825,GO:0070815,1,0.97208093991679,0,4,peptidyl-lysine 5-dioxygenase activity,MF,
15826,GO:0070816,1,0.922138276580577,0,12,phosphorylation of RNA polymerase II C-terminal domain,BP,
15827,GO:0070818,1,0.995362589881229,0,1,protoporphyrinogen oxidase activity,MF,
15830,GO:0070822,1,0.897286613883642,0,15,Sin3-type complex,CC,
15831,GO:0070826,1,0.992530547375531,0,1,paraferritin complex,CC,
15832,GO:0070827,1,0.959050762112438,0,5,chromatin maintenance,BP,
15833,GO:0070828,1,0.701852723049777,0,47,heterochromatin organization,BP,
15834,GO:0070829,1,0.973498796444591,0,3,heterochromatin maintenance,BP,
15835,GO:0070830,1,0.653025729134247,0,64,bicellular tight junction assembly,BP,
15836,GO:0070831,1,0.885402278105604,0,15,basement membrane assembly,BP,
15837,GO:0070836,1,0.977495784318717,0,4,caveola assembly,BP,
15838,GO:0070837,1,0.956251401941651,0,7,dehydroascorbic acid transport,BP,
15840,GO:0070839,1,0.916746068792277,0,11,divalent metal ion export,BP,
15842,GO:0070841,1,0.856486440723238,0,22,inclusion body assembly,BP,
15843,GO:0070842,1,0.968558207217809,0,5,aggresome assembly,BP,
15844,GO:0070843,1,0.992557118135445,0,1,misfolded protein transport,BP,
15845,GO:0070844,1,0.992557118135445,0,1,polyubiquitinated protein transport,BP,
15846,GO:0070845,1,0.992557118135445,0,1,polyubiquitinated misfolded protein transport,BP,
15847,GO:0070846,1,0.992557118135445,0,1,Hsp90 deacetylation,BP,
15848,GO:0070847,1,0.954806375929607,0,8,core mediator complex,CC,
15850,GO:0070849,1,0.717419956030781,0,45,response to epidermal growth factor,BP,
15851,GO:0070851,1,0.468230184246754,0,116,growth factor receptor binding,MF,
15852,GO:0070852,1,0.948060399278934,0,7,cell body fiber,CC,
15853,GO:0070853,1,0.979672274988378,0,2,myosin VI binding,MF,
15854,GO:0070856,1,0.991008738730779,0,1,myosin VI light chain binding,MF,
15855,GO:0070857,1,0.94476635711535,0,9,regulation of bile acid biosynthetic process,BP,
15856,GO:0070858,1,0.986669034635987,0,2,negative regulation of bile acid biosynthetic process,BP,
15857,GO:0070859,1,0.981583660929887,0,3,positive regulation of bile acid biosynthetic process,BP,
15858,GO:0070860,1,0.994272881001173,0,1,RNA polymerase I core factor complex,CC,
15859,GO:0070861,1,0.820529656394515,0,27,regulation of protein exit from endoplasmic reticulum,BP,
15860,GO:0070862,1,0.93759018470619,0,10,negative regulation of protein exit from endoplasmic reticulum,BP,
15861,GO:0070863,1,0.899212508035326,0,14,positive regulation of protein exit from endoplasmic reticulum,BP,
15862,GO:0070868,1,0.962551296954907,0,4,heterochromatin organization involved in chromatin silencing,BP,
15863,GO:0070873,1,0.792178787009056,0,30,regulation of glycogen metabolic process,BP,
15864,GO:0070874,1,0.960382784491012,0,5,negative regulation of glycogen metabolic process,BP,
15865,GO:0070875,1,0.880732523825631,0,15,positive regulation of glycogen metabolic process,BP,
15866,GO:0070876,1,0.973054506634497,0,4,SOSS complex,CC,
15867,GO:0070877,1,0.985900163890347,0,2,microprocessor complex,CC,
15868,GO:0070878,1,0.944035330088287,0,8,primary miRNA binding,MF,
15869,GO:0070881,1,0.992831943700993,0,1,regulation of proline transport,BP,
15870,GO:0070883,1,0.960080395299765,0,6,pre-miRNA binding,MF,
15871,GO:0070884,1,0.798529295203427,0,31,regulation of calcineurin-NFAT signaling cascade,BP,
15872,GO:0070885,1,0.908130687793159,0,14,negative regulation of calcineurin-NFAT signaling cascade,BP,
15873,GO:0070886,1,0.909708790884073,0,13,positive regulation of calcineurin-NFAT signaling cascade,BP,
15875,GO:0070888,1,0.753830354549111,0,43,E-box binding,MF,
15876,GO:0070889,1,0.987900945939982,0,2,platelet alpha granule organization,BP,
15877,GO:0070890,1,0.984466788442784,0,2,sodium-dependent L-ascorbate transmembrane transporter activity,MF,
15878,GO:0070891,1,0.980408320235254,0,4,lipoteichoic acid binding,MF,
15879,GO:0070892,1,0.994733003118225,0,1,lipoteichoic acid immune receptor activity,MF,
15880,GO:0070893,1,0.985128787689247,0,2,transposon integration,BP,
15881,GO:0070894,1,0.985128787689247,0,2,regulation of transposon integration,BP,
15882,GO:0070895,1,0.985128787689247,0,2,negative regulation of transposon integration,BP,
15883,GO:0070897,1,0.79375742149253,0,35,transcription preinitiation complex assembly,BP,
15884,GO:0070898,1,0.979722229338241,0,2,RNA polymerase III preinitiation complex assembly,BP,
15885,GO:0070899,1,0.993201307352175,0,1,mitochondrial tRNA wobble uridine modification,BP,
15886,GO:0070900,1,0.955989927452986,0,8,mitochondrial tRNA modification,BP,
15887,GO:0070901,1,0.977178908681047,0,4,mitochondrial tRNA methylation,BP,
15888,GO:0070902,1,0.995504245381794,0,1,mitochondrial tRNA pseudouridine synthesis,BP,
15889,GO:0070904,1,0.984466788442784,0,2,transepithelial L-ascorbic acid transport,BP,
15890,GO:0070905,1,0.9757739144862,0,4,serine binding,MF,
15891,GO:0070911,1,0.847744525758754,0,26,global genome nucleotide-excision repair,BP,
15892,GO:0070914,1,0.922553368083366,0,12,UV-damage excision repair,BP,
15893,GO:0070915,1,0.971707635145204,0,5,lysophosphatidic acid receptor activity,MF,
15894,GO:0070918,1,0.704919750766777,0,49,production of small RNA involved in gene silencing by RNA,BP,
15895,GO:0070920,1,0.855724646124803,0,23,regulation of production of small RNA involved in gene silencing by RNA,BP,
15896,GO:0070922,1,0.937296638409843,0,9,small RNA loading onto RISC,BP,
15898,GO:0070926,1,0.992676940465912,0,1,regulation of ATP:ADP antiporter activity,BP,
15899,GO:0070931,1,0.991321975506199,0,1,Golgi-associated vesicle lumen,CC,
15900,GO:0070932,1,0.865801615693759,0,20,histone H3 deacetylation,BP,
15901,GO:0070933,1,0.925403910229534,0,11,histone H4 deacetylation,BP,
15902,GO:0070934,1,0.95828055299726,0,5,CRD-mediated mRNA stabilization,BP,
15903,GO:0070935,1,0.878967445956523,0,19,3'-UTR-mediated mRNA stabilization,BP,
15905,GO:0070937,1,0.951141657800588,0,6,CRD-mediated mRNA stability complex,CC,
15906,GO:0070938,1,0.924311240935782,0,10,contractile ring,CC,
15907,GO:0070939,1,0.97664666974352,0,3,Dsl1/NZR complex,CC,
15908,GO:0070940,1,0.967530065086772,0,5,dephosphorylation of RNA polymerase II C-terminal domain,BP,
15909,GO:0070942,1,0.959820944884263,0,9,neutrophil mediated cytotoxicity,BP,
15910,GO:0070943,1,0.970518195336973,0,7,neutrophil-mediated killing of symbiont cell,BP,
15911,GO:0070944,1,0.974542778360924,0,6,neutrophil-mediated killing of bacterium,BP,
15912,GO:0070945,1,0.981115121804622,0,4,neutrophil-mediated killing of gram-negative bacterium,BP,
15913,GO:0070946,1,0.996638404032529,0,1,neutrophil-mediated killing of gram-positive bacterium,BP,
15914,GO:0070947,1,0.992524809412378,0,2,neutrophil-mediated killing of fungus,BP,
15915,GO:0070948,1,0.973956323007732,0,5,regulation of neutrophil mediated cytotoxicity,BP,
15916,GO:0070949,1,0.984809512471699,0,3,regulation of neutrophil mediated killing of symbiont cell,BP,
15917,GO:0070950,1,0.988892758523409,0,2,regulation of neutrophil mediated killing of bacterium,BP,
15918,GO:0070951,1,0.988892758523409,0,2,regulation of neutrophil mediated killing of gram-negative bacterium,BP,
15919,GO:0070953,1,0.995871352257771,0,1,regulation of neutrophil mediated killing of fungus,BP,
15920,GO:0070960,1,0.989239868558792,0,2,positive regulation of neutrophil mediated cytotoxicity,BP,
15921,GO:0070961,1,0.989239868558792,0,2,positive regulation of neutrophil mediated killing of symbiont cell,BP,
15922,GO:0070962,1,0.993341298796606,0,1,positive regulation of neutrophil mediated killing of bacterium,BP,
15923,GO:0070963,1,0.993341298796606,0,1,positive regulation of neutrophil mediated killing of gram-negative bacterium,BP,
15924,GO:0070965,1,0.995871352257771,0,1,positive regulation of neutrophil mediated killing of fungus,BP,
15925,GO:0070966,1,0.970325655309168,0,4,nuclear-transcribed mRNA catabolic process, no-go decay,BP,
15926,GO:0070971,1,0.82599921731399,0,24,endoplasmic reticulum exit site,CC,
15927,GO:0070972,1,0.512269277256192,0,138,protein localization to endoplasmic reticulum,BP,
15928,GO:0070973,1,0.937896079883141,0,7,protein localization to endoplasmic reticulum exit site,BP,
15929,GO:0070974,1,0.993164323925024,0,1,POU domain binding,MF,
15930,GO:0070975,1,0.989881625012248,0,1,FHA domain binding,MF,
15931,GO:0070976,1,0.993569657533476,0,1,TIR domain binding,MF,
15932,GO:0070977,1,0.850761044193388,0,18,bone maturation,BP,
15934,GO:0070981,1,0.994232754936512,0,1,L-asparagine biosynthetic process,BP,
15935,GO:0070982,1,0.989672627592568,0,2,L-asparagine metabolic process,BP,
15936,GO:0070984,1,0.992532173248594,0,1,SET domain binding,MF,
15937,GO:0070985,1,0.987776055244066,0,3,transcription factor TFIIK complex,CC,
15938,GO:0070986,1,0.893827194147775,0,14,left/right axis specification,BP,
15939,GO:0070987,1,0.879209639065486,0,21,error-free translesion synthesis,BP,
15940,GO:0070988,1,0.634991746732268,0,61,demethylation,BP,
15941,GO:0070989,1,0.900516667502462,0,15,oxidative demethylation,BP,
15942,GO:0070990,1,0.970962530246386,0,7,snRNP binding,MF,
15943,GO:0070991,1,0.980424281644764,0,3,medium-chain-acyl-CoA dehydrogenase activity,MF,
15944,GO:0070992,1,0.997311409978168,0,1,translation initiation complex,CC,
15945,GO:0070993,1,0.915793519521832,0,17,translation preinitiation complex,CC,
15946,GO:0070995,1,0.973658146699636,0,4,NADPH oxidation,BP,
15949,GO:0071000,1,0.989362602446243,0,2,response to magnetism,BP,
15950,GO:0071001,1,0.982816171764665,0,3,U4/U6 snRNP,CC,
15951,GO:0071004,1,0.914046136163205,0,16,U2-type prespliceosome,CC,
15952,GO:0071005,1,0.760019968727259,0,49,U2-type precatalytic spliceosome,CC,
15953,GO:0071006,1,0.939893069045409,0,9,U2-type catalytic step 1 spliceosome,CC,
15954,GO:0071007,1,0.848193460160444,0,30,U2-type catalytic step 2 spliceosome,CC,
15955,GO:0071008,1,0.980119116157603,0,3,U2-type post-mRNA release spliceosomal complex,CC,
15956,GO:0071010,1,0.914046136163205,0,16,prespliceosome,CC,
15957,GO:0071011,1,0.749564159481254,0,51,precatalytic spliceosome,CC,
15958,GO:0071012,1,0.939893069045409,0,9,catalytic step 1 spliceosome,CC,
15959,GO:0071013,1,0.606674495244198,0,83,catalytic step 2 spliceosome,CC,
15960,GO:0071014,1,0.92396992226308,0,13,post-mRNA release spliceosomal complex,CC,
15961,GO:0071020,1,0.990778690434514,0,2,post-spliceosomal complex,CC,
15962,GO:0071021,1,0.995429071245596,0,1,U2-type post-spliceosomal complex,CC,
15963,GO:0071025,1,0.922865715934947,0,15,RNA surveillance,BP,
15964,GO:0071026,1,0.993944393327592,0,1,cytoplasmic RNA surveillance,BP,
15965,GO:0071027,1,0.934761879936021,0,13,nuclear RNA surveillance,BP,
15966,GO:0071028,1,0.934761879936021,0,13,nuclear mRNA surveillance,BP,
15967,GO:0071029,1,0.972438046742623,0,6,nuclear ncRNA surveillance,BP,
15968,GO:0071030,1,0.988919036309169,0,2,nuclear mRNA surveillance of spliceosomal pre-mRNA splicing,BP,
15969,GO:0071031,1,0.990840658628373,0,2,nuclear mRNA surveillance of mRNA 3'-end processing,BP,
15970,GO:0071033,1,0.975373311527833,0,5,nuclear retention of pre-mRNA at the site of transcription,BP,
15971,GO:0071034,1,0.974200306080474,0,4,CUT catabolic process,BP,
15972,GO:0071035,1,0.972438046742623,0,6,nuclear polyadenylation-dependent rRNA catabolic process,BP,
15973,GO:0071036,1,0.99346037055517,0,1,nuclear polyadenylation-dependent snoRNA catabolic process,BP,
15974,GO:0071037,1,0.99346037055517,0,1,nuclear polyadenylation-dependent snRNA catabolic process,BP,
15975,GO:0071038,1,0.972438046742623,0,6,nuclear polyadenylation-dependent tRNA catabolic process,BP,
15976,GO:0071039,1,0.99346037055517,0,1,nuclear polyadenylation-dependent CUT catabolic process,BP,
15977,GO:0071040,1,0.99346037055517,0,1,nuclear polyadenylation-dependent antisense transcript catabolic process,BP,
15978,GO:0071041,1,0.99346037055517,0,1,antisense RNA transcript catabolic process,BP,
15979,GO:0071042,1,0.980243611669629,0,4,nuclear polyadenylation-dependent mRNA catabolic process,BP,
15980,GO:0071043,1,0.974200306080474,0,4,CUT metabolic process,BP,
15981,GO:0071044,1,0.930598881975342,0,9,histone mRNA catabolic process,BP,
15982,GO:0071045,1,0.995544823186114,0,1,nuclear histone mRNA catabolic process,BP,
15983,GO:0071046,1,0.972438046742623,0,6,nuclear polyadenylation-dependent ncRNA catabolic process,BP,
15984,GO:0071047,1,0.980243611669629,0,4,polyadenylation-dependent mRNA catabolic process,BP,
15985,GO:0071048,1,0.988919036309169,0,2,nuclear retention of unspliced pre-mRNA at the site of transcription,BP,
15986,GO:0071049,1,0.990840658628373,0,2,nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription,BP,
15987,GO:0071051,1,0.966590793637619,0,7,polyadenylation-dependent snoRNA 3'-end processing,BP,
15988,GO:0071062,1,0.980121544658181,0,3,alphav-beta3 integrin-vitronectin complex,CC,
15989,GO:0071065,1,0.98635777462188,0,2,alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex,CC,
15990,GO:0071071,1,0.896223337066136,0,17,regulation of phospholipid biosynthetic process,BP,
15991,GO:0071072,1,0.962041900450689,0,5,negative regulation of phospholipid biosynthetic process,BP,
15992,GO:0071073,1,0.937026555558757,0,11,positive regulation of phospholipid biosynthetic process,BP,
15993,GO:0071074,1,0.986368614622144,0,2,eukaryotic initiation factor eIF2 binding,MF,
15994,GO:0071077,1,0.974097870350758,0,4,adenosine 3',5'-bisphosphate transmembrane transporter activity,MF,
15996,GO:0071104,1,0.94623668228181,0,8,response to interleukin-9,BP,
15997,GO:0071105,1,0.988801636072673,0,2,response to interleukin-11,BP,
15998,GO:0071106,1,0.98747383123151,0,2,adenosine 3',5'-bisphosphate transmembrane transport,BP,
15999,GO:0071107,1,0.936130557809931,0,9,response to parathyroid hormone,BP,
16000,GO:0071108,1,0.79631768077973,0,27,protein K48-linked deubiquitination,BP,
16001,GO:0071109,1,0.97802425034683,0,2,superior temporal gyrus development,BP,
16002,GO:0071110,1,0.991069117274906,0,1,histone biotinylation,BP,
16003,GO:0071133,1,0.993068898952965,0,1,alpha9-beta1 integrin-ADAM8 complex,CC,
16004,GO:0071139,1,0.98460475670783,0,2,resolution of recombination intermediates,BP,
16005,GO:0071140,1,0.98460475670783,0,2,resolution of mitotic recombination intermediates,BP,
16006,GO:0071141,1,0.924644747241716,0,9,SMAD protein complex,CC,
16007,GO:0071144,1,0.930787864534711,0,8,heteromeric SMAD protein complex,CC,
16008,GO:0071148,1,0.979970722953719,0,2,TEAD-1-YAP complex,CC,
16009,GO:0071149,1,0.986299737521573,0,2,TEAD-2-YAP complex,CC,
16011,GO:0071157,1,0.887129511601092,0,20,negative regulation of cell cycle arrest,BP,
16012,GO:0071158,1,0.604230044194137,0,77,positive regulation of cell cycle arrest,BP,
16013,GO:0071159,1,0.990547097730119,0,2,NF-kappaB complex,CC,
16014,GO:0071163,1,0.984950654476892,0,3,DNA replication preinitiation complex assembly,BP,
16015,GO:0071164,1,0.992749748451312,0,1,RNA trimethylguanosine synthase activity,MF,
16016,GO:0071166,1,0.438491014582193,0,123,ribonucleoprotein complex localization,BP,
16017,GO:0071168,1,0.866444147902125,0,21,protein localization to chromatin,BP,
16018,GO:0071169,1,0.974260137247408,0,4,establishment of protein localization to chromatin,BP,
16021,GO:0071203,1,0.96203380329264,0,5,WASH complex,CC,
16022,GO:0071204,1,0.964505774179584,0,6,histone pre-mRNA 3'end processing complex,CC,
16023,GO:0071205,1,0.950025924667116,0,5,protein localization to juxtaparanode region of axon,BP,
16024,GO:0071206,1,0.989646151093056,0,1,establishment of protein localization to juxtaparanode region of axon,BP,
16025,GO:0071207,1,0.987679918153391,0,2,histone pre-mRNA stem-loop binding,MF,
16026,GO:0071208,1,0.984619402689029,0,4,histone pre-mRNA DCP binding,MF,
16027,GO:0071209,1,0.986583295700899,0,3,U7 snRNA binding,MF,
16028,GO:0071211,1,0.97239601759774,0,4,protein targeting to vacuole involved in autophagy,BP,
16030,GO:0071215,1,0.992424723643522,0,1,cellular response to abscisic acid stimulus,BP,
16031,GO:0071216,1,0.276461808727082,0,209,cellular response to biotic stimulus,BP,
16032,GO:0071218,1,0.858038082492969,0,22,cellular response to misfolded protein,BP,
16033,GO:0071219,1,0.321864079074591,0,188,cellular response to molecule of bacterial origin,BP,
16034,GO:0071220,1,0.963685247912533,0,6,cellular response to bacterial lipoprotein,BP,
16035,GO:0071221,1,0.963685247912533,0,6,cellular response to bacterial lipopeptide,BP,
16036,GO:0071222,1,0.336896692213665,0,180,cellular response to lipopolysaccharide,BP,
16037,GO:0071223,1,0.943099588175589,0,10,cellular response to lipoteichoic acid,BP,
16038,GO:0071224,1,0.966757149155721,0,6,cellular response to peptidoglycan,BP,
16039,GO:0071225,1,0.94494029548983,0,9,cellular response to muramyl dipeptide,BP,
16040,GO:0071226,1,0.973435407632641,0,4,cellular response to molecule of fungal origin,BP,
16041,GO:0071228,1,0.996408914983695,0,1,cellular response to tumor cell,BP,
16045,GO:0071233,1,0.929753977878807,0,9,cellular response to leucine,BP,
16046,GO:0071236,1,0.913485268311701,0,13,cellular response to antibiotic,BP,
16049,GO:0071243,1,0.89230009854602,0,20,cellular response to arsenic-containing substance,BP,
16050,GO:0071245,1,0.992774400747657,0,1,cellular response to carbon monoxide,BP,
16051,GO:0071247,1,0.996405415233167,0,1,cellular response to chromate,BP,
16053,GO:0071250,1,0.990795642075213,0,1,cellular response to nitrite,BP,
16054,GO:0071253,1,0.968702017964344,0,5,connexin binding,MF,
16055,GO:0071256,1,0.972873283405405,0,6,translocon complex,CC,
16057,GO:0071258,1,0.992547418446041,0,1,cellular response to gravity,BP,
16058,GO:0071259,1,0.989362602446243,0,2,cellular response to magnetism,BP,
16059,GO:0071260,1,0.605206668772609,0,77,cellular response to mechanical stimulus,BP,
16060,GO:0071261,1,0.99720771736519,0,1,Ssh1 translocon complex,CC,
16061,GO:0071262,1,0.984271607257361,0,2,regulation of translational initiation in response to starvation,BP,
16062,GO:0071264,1,0.984271607257361,0,2,positive regulation of translational initiation in response to starvation,BP,
16063,GO:0071265,1,0.961082271346592,0,7,L-methionine biosynthetic process,BP,
16064,GO:0071267,1,0.961082271346592,0,7,L-methionine salvage,BP,
16065,GO:0071276,1,0.846895021149492,0,33,cellular response to cadmium ion,BP,
16067,GO:0071279,1,0.980490310623953,0,3,cellular response to cobalt ion,BP,
16068,GO:0071280,1,0.897789640086027,0,21,cellular response to copper ion,BP,
16069,GO:0071281,1,0.929832018249072,0,11,cellular response to iron ion,BP,
16070,GO:0071283,1,0.991269308084796,0,2,cellular response to iron(III) ion,BP,
16071,GO:0071284,1,0.967580033475411,0,4,cellular response to lead ion,BP,
16072,GO:0071285,1,0.921199138470866,0,14,cellular response to lithium ion,BP,
16073,GO:0071286,1,0.935349212778484,0,7,cellular response to magnesium ion,BP,
16074,GO:0071287,1,0.916480535907622,0,12,cellular response to manganese ion,BP,
16075,GO:0071288,1,0.987971659501896,0,2,cellular response to mercury ion,BP,
16076,GO:0071294,1,0.909494097837281,0,19,cellular response to zinc ion,BP,
16078,GO:0071298,1,0.992882637749378,0,1,cellular response to L-ascorbic acid,BP,
16079,GO:0071300,1,0.644059695355467,0,63,cellular response to retinoic acid,BP,
16080,GO:0071301,1,0.989888477010802,0,1,cellular response to vitamin B1,BP,
16081,GO:0071305,1,0.872783681144119,0,20,cellular response to vitamin D,BP,
16082,GO:0071306,1,0.986304099898423,0,2,cellular response to vitamin E,BP,
16083,GO:0071307,1,0.986955086161735,0,2,cellular response to vitamin K,BP,
16085,GO:0071312,1,0.787443867849049,0,33,cellular response to alkaloid,BP,
16086,GO:0071313,1,0.906924013227571,0,10,cellular response to caffeine,BP,
16087,GO:0071314,1,0.98484702529383,0,3,cellular response to cocaine,BP,
16088,GO:0071315,1,0.969630333238689,0,5,cellular response to morphine,BP,
16089,GO:0071316,1,0.952688486124476,0,9,cellular response to nicotine,BP,
16090,GO:0071317,1,0.969630333238689,0,5,cellular response to isoquinoline alkaloid,BP,
16091,GO:0071318,1,0.888547345303791,0,18,cellular response to ATP,BP,
16092,GO:0071320,1,0.689382243937162,0,49,cellular response to cAMP,BP,
16093,GO:0071321,1,0.951605572099205,0,6,cellular response to cGMP,BP,
16095,GO:0071324,1,0.99195325125763,0,1,cellular response to disaccharide stimulus,BP,
16097,GO:0071329,1,0.99195325125763,0,1,cellular response to sucrose stimulus,BP,
16099,GO:0071332,1,0.967965505244822,0,5,cellular response to fructose stimulus,BP,
16101,GO:0071335,1,0.997014122102647,0,1,hair follicle cell proliferation,BP,
16102,GO:0071336,1,0.997014122102647,0,1,regulation of hair follicle cell proliferation,BP,
16103,GO:0071338,1,0.997014122102647,0,1,positive regulation of hair follicle cell proliferation,BP,
16104,GO:0071339,1,0.823453971970757,0,28,MLL1 complex,CC,
16105,GO:0071340,1,0.928663185058779,0,11,skeletal muscle acetylcholine-gated channel clustering,BP,
16106,GO:0071344,1,0.991747511176535,0,2,diphosphate metabolic process,BP,
16109,GO:0071347,1,0.396736875433339,0,157,cellular response to interleukin-1,BP,
16110,GO:0071348,1,0.992127228810389,0,1,cellular response to interleukin-11,BP,
16111,GO:0071349,1,0.766688375491829,0,46,cellular response to interleukin-12,BP,
16112,GO:0071350,1,0.912077608083155,0,13,cellular response to interleukin-15,BP,
16113,GO:0071351,1,0.95341046627466,0,8,cellular response to interleukin-18,BP,
16114,GO:0071352,1,0.918245916165088,0,12,cellular response to interleukin-2,BP,
16115,GO:0071353,1,0.829999202115273,0,30,cellular response to interleukin-4,BP,
16116,GO:0071354,1,0.765624134109042,0,37,cellular response to interleukin-6,BP,
16117,GO:0071355,1,0.949420524870727,0,7,cellular response to interleukin-9,BP,
16118,GO:0071356,1,0.228828955270838,0,253,cellular response to tumor necrosis factor,BP,
16119,GO:0071357,1,0.629084995844477,0,76,cellular response to type I interferon,BP,
16120,GO:0071359,1,0.887563831444745,0,18,cellular response to dsRNA,BP,
16121,GO:0071360,1,0.917597943837227,0,13,cellular response to exogenous dsRNA,BP,
16122,GO:0071361,1,0.908678122541347,0,13,cellular response to ethanol,BP,
16123,GO:0071362,1,0.949759880311006,0,7,cellular response to ether,BP,
16125,GO:0071364,1,0.739632461890788,0,41,cellular response to epidermal growth factor stimulus,BP,
16126,GO:0071371,1,0.888999114253433,0,16,cellular response to gonadotropin stimulus,BP,
16127,GO:0071372,1,0.926883958986541,0,10,cellular response to follicle-stimulating hormone stimulus,BP,
16128,GO:0071373,1,0.987115550236141,0,2,cellular response to luteinizing hormone stimulus,BP,
16129,GO:0071374,1,0.949307909117529,0,7,cellular response to parathyroid hormone stimulus,BP,
16131,GO:0071376,1,0.967937191918104,0,5,cellular response to corticotropin-releasing hormone stimulus,BP,
16133,GO:0071378,1,0.863711182220762,0,20,cellular response to growth hormone stimulus,BP,
16134,GO:0071379,1,0.854658007492843,0,21,cellular response to prostaglandin stimulus,BP,
16135,GO:0071380,1,0.897685522234261,0,15,cellular response to prostaglandin E stimulus,BP,
16136,GO:0071383,1,0.266423733174887,0,190,cellular response to steroid hormone stimulus,BP,
16137,GO:0071384,1,0.687308992464397,0,58,cellular response to corticosteroid stimulus,BP,
16138,GO:0071385,1,0.698353093092171,0,55,cellular response to glucocorticoid stimulus,BP,
16139,GO:0071386,1,0.973433505755988,0,3,cellular response to corticosterone stimulus,BP,
16140,GO:0071387,1,0.991787355812672,0,1,cellular response to cortisol stimulus,BP,
16141,GO:0071389,1,0.956613958005958,0,6,cellular response to mineralocorticoid stimulus,BP,
16142,GO:0071391,1,0.907157495164851,0,14,cellular response to estrogen stimulus,BP,
16143,GO:0071392,1,0.791943087630465,0,35,cellular response to estradiol stimulus,BP,
16144,GO:0071393,1,0.975843242423654,0,3,cellular response to progesterone stimulus,BP,
16145,GO:0071394,1,0.943231822981911,0,9,cellular response to testosterone stimulus,BP,
16146,GO:0071395,1,0.984348042181253,0,4,cellular response to jasmonic acid stimulus,BP,
16148,GO:0071397,1,0.875791076026968,0,17,cellular response to cholesterol,BP,
16149,GO:0071398,1,0.687989930472688,0,53,cellular response to fatty acid,BP,
16150,GO:0071400,1,0.980631733068135,0,3,cellular response to oleic acid,BP,
16151,GO:0071401,1,0.994306503233258,0,1,cellular response to triglyceride,BP,
16152,GO:0071402,1,0.809574788134663,0,31,cellular response to lipoprotein particle stimulus,BP,
16153,GO:0071403,1,0.986080001195011,0,2,cellular response to high density lipoprotein particle stimulus,BP,
16154,GO:0071404,1,0.88171253612777,0,19,cellular response to low-density lipoprotein particle stimulus,BP,
16156,GO:0071409,1,0.976619711474717,0,3,cellular response to cycloheximide,BP,
16157,GO:0071412,1,0.99432096041645,0,1,cellular response to genistein,BP,
16158,GO:0071413,1,0.99432096041645,0,1,cellular response to hydroxyisoflavone,BP,
16159,GO:0071415,1,0.888541521303093,0,13,cellular response to purine-containing compound,BP,
16161,GO:0071418,1,0.991247227125692,0,2,cellular response to amine stimulus,BP,
16163,GO:0071421,1,0.938839994462048,0,9,manganese ion transmembrane transport,BP,
16164,GO:0071422,1,0.96489695670597,0,6,succinate transmembrane transport,BP,
16165,GO:0071423,1,0.978943369093154,0,4,malate transmembrane transport,BP,
16166,GO:0071424,1,0.993485400251684,0,1,rRNA (cytosine-N4-)-methyltransferase activity,MF,
16168,GO:0071426,1,0.440937726854004,0,122,ribonucleoprotein complex export from nucleus,BP,
16169,GO:0071427,1,0.489378854869266,0,105,mRNA-containing ribonucleoprotein complex export from nucleus,BP,
16170,GO:0071428,1,0.913923974848557,0,15,rRNA-containing ribonucleoprotein complex export from nucleus,BP,
16171,GO:0071431,1,0.798987105798413,0,31,tRNA-containing ribonucleoprotein complex export from nucleus,BP,
16172,GO:0071437,1,0.904177125312356,0,14,invadopodium,CC,
16173,GO:0071438,1,0.967115322674207,0,5,invadopodium membrane,CC,
16174,GO:0071439,1,0.9428561718717,0,8,clathrin complex,CC,
16175,GO:0071440,1,0.961480553028868,0,6,regulation of histone H3-K14 acetylation,BP,
16176,GO:0071441,1,0.992687072864748,0,1,negative regulation of histone H3-K14 acetylation,BP,
16177,GO:0071442,1,0.974918671602096,0,4,positive regulation of histone H3-K14 acetylation,BP,
16178,GO:0071444,1,0.997497418251315,0,1,cellular response to pheromone,BP,
16179,GO:0071447,1,0.950524637811414,0,8,cellular response to hydroperoxide,BP,
16180,GO:0071449,1,0.996648940741353,0,1,cellular response to lipid hydroperoxide,BP,
16181,GO:0071450,1,0.877978002616069,0,24,cellular response to oxygen radical,BP,
16182,GO:0071451,1,0.877978002616069,0,24,cellular response to superoxide,BP,
16183,GO:0071453,1,0.253342183121945,0,212,cellular response to oxygen levels,BP,
16184,GO:0071454,1,0.989841399897807,0,1,cellular response to anoxia,BP,
16185,GO:0071455,1,0.959028205374606,0,6,cellular response to hyperoxia,BP,
16186,GO:0071456,1,0.305015508341479,0,186,cellular response to hypoxia,BP,
16187,GO:0071458,1,0.968069898040855,0,5,integral component of cytoplasmic side of endoplasmic reticulum membrane,CC,
16188,GO:0071459,1,0.88779976918796,0,20,protein localization to chromosome, centromeric region,BP,
16189,GO:0071460,1,0.992357494241734,0,2,cellular response to cell-matrix adhesion,BP,
16190,GO:0071461,1,0.981506458339558,0,3,cellular response to redox state,BP,
16191,GO:0071462,1,0.977420642231707,0,3,cellular response to water stimulus,BP,
16192,GO:0071464,1,0.991903183909612,0,1,cellular response to hydrostatic pressure,BP,
16193,GO:0071466,1,0.601576782389988,0,91,cellular response to xenobiotic stimulus,BP,
16194,GO:0071467,1,0.89067026284217,0,19,cellular response to pH,BP,
16195,GO:0071468,1,0.936902552399865,0,10,cellular response to acidic pH,BP,
16196,GO:0071469,1,0.98781176927002,0,2,cellular response to alkaline pH,BP,
16197,GO:0071470,1,0.746303428995629,0,42,cellular response to osmotic stress,BP,
16198,GO:0071471,1,0.992333039689406,0,1,cellular response to non-ionic osmotic stress,BP,
16199,GO:0071472,1,0.92201795155651,0,12,cellular response to salt stress,BP,
16200,GO:0071474,1,0.908011354099134,0,15,cellular hyperosmotic response,BP,
16201,GO:0071475,1,0.957379666407357,0,7,cellular hyperosmotic salinity response,BP,
16202,GO:0071476,1,0.943980138506149,0,8,cellular hypotonic response,BP,
16203,GO:0071477,1,0.982911167754068,0,2,cellular hypotonic salinity response,BP,
16208,GO:0071482,1,0.473360220408871,0,113,cellular response to light stimulus,BP,
16209,GO:0071483,1,0.985581877608286,0,2,cellular response to blue light,BP,
16210,GO:0071484,1,0.991729149257186,0,1,cellular response to light intensity,BP,
16211,GO:0071486,1,0.991729149257186,0,1,cellular response to high light intensity,BP,
16212,GO:0071492,1,0.980178396304742,0,3,cellular response to UV-A,BP,
16213,GO:0071493,1,0.956442810478618,0,8,cellular response to UV-B,BP,
16214,GO:0071494,1,0.956754389833702,0,7,cellular response to UV-C,BP,
16217,GO:0071498,1,0.887922925449606,0,18,cellular response to fluid shear stress,BP,
16218,GO:0071499,1,0.958250532904795,0,7,cellular response to laminar fluid shear stress,BP,
16219,GO:0071500,1,0.962508633186618,0,6,cellular response to nitrosative stress,BP,
16220,GO:0071501,1,0.90641118737016,0,14,cellular response to sterol depletion,BP,
16221,GO:0071502,1,0.970036830012797,0,5,cellular response to temperature stimulus,BP,
16222,GO:0071503,1,0.970391365849544,0,4,response to heparin,BP,
16223,GO:0071504,1,0.970391365849544,0,4,cellular response to heparin,BP,
16224,GO:0071505,1,0.986470507098902,0,2,response to mycophenolic acid,BP,
16225,GO:0071506,1,0.986470507098902,0,2,cellular response to mycophenolic acid,BP,
16226,GO:0071513,1,0.99444337062802,0,1,phosphopantothenoylcysteine decarboxylase complex,CC,
16227,GO:0071514,1,0.841276709136905,0,24,genetic imprinting,BP,
16228,GO:0071515,1,0.987515183603508,0,1,genetic imprinting at mating-type locus,BP,
16229,GO:0071517,1,0.987515183603508,0,1,maintenance of imprinting at mating-type locus,BP,
16230,GO:0071526,1,0.718732753353971,0,40,semaphorin-plexin signaling pathway,BP,
16231,GO:0071527,1,0.994162708088277,0,1,semaphorin-plexin signaling pathway involved in outflow tract morphogenesis,BP,
16232,GO:0071528,1,0.992669134635434,0,1,tRNA re-export from nucleus,BP,
16233,GO:0071529,1,0.9937731104816,0,1,cementum mineralization,BP,
16234,GO:0071532,1,0.959730018283172,0,5,ankyrin repeat binding,MF,
16235,GO:0071535,1,0.975035865870118,0,4,RING-like zinc finger domain binding,MF,
16236,GO:0071539,1,0.779191804194329,0,31,protein localization to centrosome,BP,
16237,GO:0071540,1,0.98748578703563,0,2,eukaryotic translation initiation factor 3 complex, eIF3e,CC,
16238,GO:0071541,1,0.964683120809438,0,7,eukaryotic translation initiation factor 3 complex, eIF3m,CC,
16240,GO:0071543,1,0.977347175921527,0,4,diphosphoinositol polyphosphate metabolic process,BP,
16241,GO:0071544,1,0.996030951058853,0,1,diphosphoinositol polyphosphate catabolic process,BP,
16242,GO:0071545,1,0.886102859720334,0,17,inositol phosphate catabolic process,BP,
16243,GO:0071546,1,0.958409269056407,0,6,pi-body,CC,
16244,GO:0071547,1,0.968109711547756,0,5,piP-body,CC,
16245,GO:0071548,1,0.784464443580685,0,39,response to dexamethasone,BP,
16246,GO:0071549,1,0.832626253746921,0,30,cellular response to dexamethasone stimulus,BP,
16247,GO:0071550,1,0.952079838336054,0,9,death-inducing signaling complex assembly,BP,
16248,GO:0071553,1,0.984752136173482,0,3,G protein-coupled pyrimidinergic nucleotide receptor activity,MF,
16249,GO:0071554,1,0.991873648311604,0,2,cell wall organization or biogenesis,BP,
16250,GO:0071556,1,0.885209639070478,0,25,integral component of lumenal side of endoplasmic reticulum membrane,CC,
16251,GO:0071557,1,0.958907322334243,0,5,histone H3-K27 demethylation,BP,
16252,GO:0071558,1,0.958907322334243,0,5,histone demethylase activity (H3-K27 specific),MF,
16253,GO:0071559,1,0.179641433214796,0,235,response to transforming growth factor beta,BP,
16254,GO:0071560,1,0.190727894057576,0,229,cellular response to transforming growth factor beta stimulus,BP,
16255,GO:0071561,1,0.991913092173499,0,1,nucleus-vacuole junction,CC,
16256,GO:0071564,1,0.919455098894926,0,12,npBAF complex,CC,
16257,GO:0071565,1,0.897911808005382,0,15,nBAF complex,CC,
16258,GO:0071566,1,0.993261519387091,0,1,UFM1 activating enzyme activity,MF,
16259,GO:0071567,1,0.994146744105705,0,1,UFM1 hydrolase activity,MF,
16260,GO:0071568,1,0.989875536821673,0,2,UFM1 transferase activity,MF,
16261,GO:0071569,1,0.968532559294876,0,6,protein ufmylation,BP,
16262,GO:0071573,1,0.993276518185936,0,1,shelterin complex assembly,BP,
16264,GO:0071578,1,0.954170533020699,0,7,zinc ion import across plasma membrane,BP,
16265,GO:0071579,1,0.988254059472068,0,2,regulation of zinc ion transport,BP,
16266,GO:0071580,1,0.994845555469451,0,1,regulation of zinc ion transmembrane transport,BP,
16267,GO:0071581,1,0.994845555469451,0,1,regulation of zinc ion transmembrane import,BP,
16268,GO:0071582,1,0.994845555469451,0,1,negative regulation of zinc ion transport,BP,
16269,GO:0071583,1,0.994845555469451,0,1,negative regulation of zinc ion transmembrane transport,BP,
16270,GO:0071584,1,0.994845555469451,0,1,negative regulation of zinc ion transmembrane import,BP,
16271,GO:0071585,1,0.994845555469451,0,1,detoxification of cadmium ion,BP,
16272,GO:0071586,1,0.988926664674978,0,2,CAAX-box protein processing,BP,
16273,GO:0071593,1,0.970307173907746,0,5,lymphocyte aggregation,BP,
16274,GO:0071595,1,0.98701281886265,0,2,Nem1-Spo7 phosphatase complex,CC,
16275,GO:0071596,1,0.970881894325914,0,3,ubiquitin-dependent protein catabolic process via the N-end rule pathway,BP,
16276,GO:0071598,1,0.982388738124656,0,3,neuronal ribonucleoprotein granule,CC,
16277,GO:0071599,1,0.9069118659071,0,15,otic vesicle development,BP,
16278,GO:0071600,1,0.941403456594204,0,10,otic vesicle morphogenesis,BP,
16279,GO:0071602,1,0.992400931110111,0,1,phytosphingosine biosynthetic process,BP,
16280,GO:0071603,1,0.977912422755022,0,3,endothelial cell-cell adhesion,BP,
16281,GO:0071604,1,0.778370839570931,0,36,transforming growth factor beta production,BP,
16282,GO:0071605,1,0.930018421781778,0,13,monocyte chemotactic protein-1 production,BP,
16283,GO:0071606,1,0.994912457386172,0,1,chemokine (C-C motif) ligand 4 production,BP,
16284,GO:0071608,1,0.963554764244589,0,6,macrophage inflammatory protein-1 alpha production,BP,
16285,GO:0071609,1,0.929545311343807,0,11,chemokine (C-C motif) ligand 5 production,BP,
16286,GO:0071610,1,0.993896633132242,0,1,chemokine (C-C motif) ligand 1 production,BP,
16287,GO:0071611,1,0.970999185657397,0,5,granulocyte colony-stimulating factor production,BP,
16288,GO:0071612,1,0.986347998297633,0,1,IP-10 production,BP,
16289,GO:0071613,1,0.983406531924291,0,3,granzyme B production,BP,
16290,GO:0071614,1,0.99514750660631,0,1,linoleic acid epoxygenase activity,MF,
16291,GO:0071616,1,0.71905466655594,0,49,acyl-CoA biosynthetic process,BP,
16292,GO:0071617,1,0.882820347520432,0,18,lysophospholipid acyltransferase activity,MF,
16293,GO:0071619,1,0.99433737793695,0,1,phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
16294,GO:0071621,1,0.565478208572505,0,103,granulocyte chemotaxis,BP,
16295,GO:0071622,1,0.768022391752222,0,45,regulation of granulocyte chemotaxis,BP,
16296,GO:0071623,1,0.978267948711097,0,3,negative regulation of granulocyte chemotaxis,BP,
16297,GO:0071624,1,0.869954260158994,0,26,positive regulation of granulocyte chemotaxis,BP,
16298,GO:0071625,1,0.856334318893888,0,18,vocalization behavior,BP,
16299,GO:0071626,1,0.989664437987985,0,2,mastication,BP,
16300,GO:0071629,1,0.995544823186114,0,1,cytoplasm protein quality control by the ubiquitin-proteasome system,BP,
16301,GO:0071630,1,0.975255954246673,0,3,nuclear protein quality control by the ubiquitin-proteasome system,BP,
16302,GO:0071633,1,0.980044805987888,0,3,dihydroceramidase activity,MF,
16303,GO:0071634,1,0.789601640232156,0,34,regulation of transforming growth factor beta production,BP,
16304,GO:0071635,1,0.9519258333695,0,8,negative regulation of transforming growth factor beta production,BP,
16305,GO:0071636,1,0.883027980219488,0,19,positive regulation of transforming growth factor beta production,BP,
16306,GO:0071637,1,0.930018421781778,0,13,regulation of monocyte chemotactic protein-1 production,BP,
16307,GO:0071638,1,0.972935813156428,0,5,negative regulation of monocyte chemotactic protein-1 production,BP,
16308,GO:0071639,1,0.955900620213507,0,8,positive regulation of monocyte chemotactic protein-1 production,BP,
16309,GO:0071640,1,0.963554764244589,0,6,regulation of macrophage inflammatory protein 1 alpha production,BP,
16310,GO:0071641,1,0.980442282425458,0,3,negative regulation of macrophage inflammatory protein 1 alpha production,BP,
16311,GO:0071642,1,0.986265070671324,0,2,positive regulation of macrophage inflammatory protein 1 alpha production,BP,
16312,GO:0071643,1,0.994912457386172,0,1,regulation of chemokine (C-C motif) ligand 4 production,BP,
16313,GO:0071644,1,0.994912457386172,0,1,negative regulation of chemokine (C-C motif) ligand 4 production,BP,
16314,GO:0071649,1,0.933767779233443,0,10,regulation of chemokine (C-C motif) ligand 5 production,BP,
16315,GO:0071650,1,0.977235766243374,0,4,negative regulation of chemokine (C-C motif) ligand 5 production,BP,
16316,GO:0071651,1,0.955529459570713,0,6,positive regulation of chemokine (C-C motif) ligand 5 production,BP,
16317,GO:0071652,1,0.993896633132242,0,1,regulation of chemokine (C-C motif) ligand 1 production,BP,
16318,GO:0071654,1,0.993896633132242,0,1,positive regulation of chemokine (C-C motif) ligand 1 production,BP,
16319,GO:0071655,1,0.975496408041324,0,4,regulation of granulocyte colony-stimulating factor production,BP,
16320,GO:0071656,1,0.994244193778852,0,1,negative regulation of granulocyte colony-stimulating factor production,BP,
16321,GO:0071657,1,0.98114475969107,0,3,positive regulation of granulocyte colony-stimulating factor production,BP,
16322,GO:0071658,1,0.986347998297633,0,1,regulation of IP-10 production,BP,
16323,GO:0071660,1,0.986347998297633,0,1,positive regulation of IP-10 production,BP,
16324,GO:0071661,1,0.983406531924291,0,3,regulation of granzyme B production,BP,
16325,GO:0071663,1,0.983406531924291,0,3,positive regulation of granzyme B production,BP,
16326,GO:0071664,1,0.967874273388599,0,4,catenin-TCF7L2 complex,CC,
16327,GO:0071665,1,0.992915058490255,0,1,gamma-catenin-TCF7L2 complex,CC,
16328,GO:0071670,1,0.948597133469482,0,9,smooth muscle cell chemotaxis,BP,
16329,GO:0071671,1,0.963555296116691,0,7,regulation of smooth muscle cell chemotaxis,BP,
16330,GO:0071672,1,0.980736962414258,0,4,negative regulation of smooth muscle cell chemotaxis,BP,
16331,GO:0071673,1,0.979534667968079,0,4,positive regulation of smooth muscle cell chemotaxis,BP,
16332,GO:0071674,1,0.680268022810411,0,71,mononuclear cell migration,BP,
16333,GO:0071675,1,0.773231839779033,0,44,regulation of mononuclear cell migration,BP,
16334,GO:0071676,1,0.953005128850019,0,7,negative regulation of mononuclear cell migration,BP,
16335,GO:0071677,1,0.903061862881957,0,20,positive regulation of mononuclear cell migration,BP,
16336,GO:0071678,1,0.989601986290849,0,1,olfactory bulb axon guidance,BP,
16337,GO:0071679,1,0.911632293708136,0,12,commissural neuron axon guidance,BP,
16338,GO:0071680,1,0.961307508407338,0,5,response to indole-3-methanol,BP,
16339,GO:0071681,1,0.961307508407338,0,5,cellular response to indole-3-methanol,BP,
16340,GO:0071682,1,0.89934480292275,0,20,endocytic vesicle lumen,CC,
16341,GO:0071684,1,0.848447629171589,0,26,organism emergence from protective structure,BP,
16342,GO:0071688,1,0.95592359410678,0,3,striated muscle myosin thick filament assembly,BP,
16343,GO:0071691,1,0.959733700414791,0,3,cardiac muscle thin filament assembly,BP,
16345,GO:0071694,1,0.946400499749393,0,7,maintenance of protein location in extracellular region,BP,
16346,GO:0071695,1,0.240141812716752,0,204,anatomical structure maturation,BP,
16347,GO:0071696,1,0.917325912330444,0,12,ectodermal placode development,BP,
16348,GO:0071697,1,0.922920874683887,0,11,ectodermal placode morphogenesis,BP,
16349,GO:0071698,1,0.977808526879279,0,3,olfactory placode development,BP,
16350,GO:0071699,1,0.977808526879279,0,3,olfactory placode morphogenesis,BP,
16351,GO:0071701,1,0.992072120812667,0,1,regulation of MAPK export from nucleus,BP,
16355,GO:0071706,1,0.530290326042971,0,103,tumor necrosis factor superfamily cytokine production,BP,
16356,GO:0071707,1,0.996154233909636,0,1,immunoglobulin heavy chain V-D-J recombination,BP,
16357,GO:0071709,1,0.761162130772773,0,37,membrane assembly,BP,
16358,GO:0071711,1,0.800776362261566,0,29,basement membrane organization,BP,
16359,GO:0071712,1,0.92906776170643,0,11,ER-associated misfolded protein catabolic process,BP,
16360,GO:0071714,1,0.992498905753414,0,1,icosanoid transmembrane transporter activity,MF,
16362,GO:0071716,1,0.982688592630475,0,2,leukotriene transport,BP,
16363,GO:0071723,1,0.945850836491061,0,9,lipopeptide binding,MF,
16364,GO:0071724,1,0.974700304841995,0,4,response to diacyl bacterial lipopeptide,BP,
16365,GO:0071725,1,0.982023515780104,0,3,response to triacyl bacterial lipopeptide,BP,
16366,GO:0071726,1,0.974700304841995,0,4,cellular response to diacyl bacterial lipopeptide,BP,
16367,GO:0071727,1,0.982023515780104,0,3,cellular response to triacyl bacterial lipopeptide,BP,
16370,GO:0071733,1,0.972470227114433,0,4,transcriptional activation by promoter-enhancer looping,BP,
16371,GO:0071763,1,0.960432486584317,0,6,nuclear membrane organization,BP,
16372,GO:0071765,1,0.992506246451695,0,1,nuclear inner membrane organization,BP,
16376,GO:0071782,1,0.880638829209436,0,20,endoplasmic reticulum tubular network,CC,
16377,GO:0071786,1,0.89370268935603,0,17,endoplasmic reticulum tubular network organization,BP,
16378,GO:0071787,1,0.975690235863982,0,4,endoplasmic reticulum tubular network formation,BP,
16379,GO:0071791,1,0.98649817627984,0,2,chemokine (C-C motif) ligand 5 binding,MF,
16380,GO:0071796,1,0.996119637507407,0,1,K6-linked polyubiquitin modification-dependent protein binding,MF,
16381,GO:0071797,1,0.975342666397451,0,4,LUBAC complex,CC,
16382,GO:0071798,1,0.967009812333247,0,5,response to prostaglandin D,BP,
16383,GO:0071799,1,0.967009812333247,0,5,cellular response to prostaglandin D stimulus,BP,
16384,GO:0071800,1,0.887831923705675,0,17,podosome assembly,BP,
16385,GO:0071801,1,0.914021913781979,0,13,regulation of podosome assembly,BP,
16386,GO:0071802,1,0.992517950252308,0,1,negative regulation of podosome assembly,BP,
16387,GO:0071803,1,0.938645064090017,0,9,positive regulation of podosome assembly,BP,
16389,GO:0071806,1,0.707901693331207,0,57,protein transmembrane transport,BP,
16390,GO:0071812,1,0.993086375094789,0,1,positive regulation of fever generation by positive regulation of prostaglandin secretion,BP,
16391,GO:0071813,1,0.845476838785475,0,24,lipoprotein particle binding,MF,
16392,GO:0071814,1,0.845476838785475,0,24,protein-lipid complex binding,MF,
16393,GO:0071816,1,0.976905853647173,0,4,tail-anchored membrane protein insertion into ER membrane,BP,
16394,GO:0071817,1,0.976144068538608,0,4,MMXD complex,CC,
16395,GO:0071818,1,0.982562284643226,0,3,BAT3 complex,CC,
16396,GO:0071819,1,0.989892901222461,0,2,DUBm complex,CC,
16397,GO:0071820,1,0.995868123078444,0,1,N-box binding,MF,
16398,GO:0071821,1,0.986743208818112,0,2,FANCM-MHF complex,CC,
16400,GO:0071825,1,0.754715460599166,0,44,protein-lipid complex subunit organization,BP,
16401,GO:0071826,1,0.325720080639543,0,185,ribonucleoprotein complex subunit organization,BP,
16402,GO:0071827,1,0.769825295612344,0,41,plasma lipoprotein particle organization,BP,
16403,GO:0071830,1,0.956816671131806,0,7,triglyceride-rich lipoprotein particle clearance,BP,
16404,GO:0071831,1,0.996286622576736,0,1,intermediate-density lipoprotein particle clearance,BP,
16405,GO:0071837,1,0.893513475392228,0,16,HMG box domain binding,MF,
16406,GO:0071838,1,0.952148295444843,0,7,cell proliferation in bone marrow,BP,
16407,GO:0071839,1,0.9641269008297,0,6,apoptotic process in bone marrow cell,BP,
16409,GO:0071846,1,0.989551374357782,0,2,actin filament debranching,BP,
16410,GO:0071847,1,0.986435540408941,0,2,TNFSF11-mediated signaling pathway,BP,
16411,GO:0071848,1,0.993086375094789,0,1,positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling,BP,
16412,GO:0071850,1,0.902606931049876,0,16,mitotic cell cycle arrest,BP,
16414,GO:0071863,1,0.958942001913392,0,6,regulation of cell proliferation in bone marrow,BP,
16415,GO:0071864,1,0.958942001913392,0,6,positive regulation of cell proliferation in bone marrow,BP,
16416,GO:0071865,1,0.969961497998382,0,5,regulation of apoptotic process in bone marrow cell,BP,
16417,GO:0071866,1,0.969961497998382,0,5,negative regulation of apoptotic process in bone marrow cell,BP,
16422,GO:0071871,1,0.889030071880824,0,15,response to epinephrine,BP,
16423,GO:0071872,1,0.905944748035797,0,12,cellular response to epinephrine stimulus,BP,
16424,GO:0071873,1,0.977801044409674,0,3,response to norepinephrine,BP,
16425,GO:0071874,1,0.986885887881788,0,2,cellular response to norepinephrine stimulus,BP,
16426,GO:0071875,1,0.832908746801995,0,26,adrenergic receptor signaling pathway,BP,
16427,GO:0071877,1,0.996030951058853,0,1,regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway,BP,
16428,GO:0071878,1,0.975909171448899,0,3,negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
16429,GO:0071879,1,0.984640587515861,0,2,positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
16430,GO:0071880,1,0.846801687153063,0,23,adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
16431,GO:0071881,1,0.988736667590738,0,2,adenylate cyclase-inhibiting adrenergic receptor signaling pathway,BP,
16432,GO:0071882,1,0.992676940465912,0,1,phospholipase C-activating adrenergic receptor signaling pathway,BP,
16433,GO:0071885,1,0.990127097973297,0,2,N-terminal protein N-methyltransferase activity,MF,
16434,GO:0071886,1,0.98524033198002,0,2,1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding,MF,
16435,GO:0071887,1,0.539867712470545,0,99,leukocyte apoptotic process,BP,
16436,GO:0071888,1,0.944446055920929,0,9,macrophage apoptotic process,BP,
16437,GO:0071889,1,0.803395599385144,0,30,14-3-3 protein binding,MF,
16438,GO:0071890,1,0.991772867958887,0,1,bicarbonate binding,MF,
16439,GO:0071893,1,0.995293167006598,0,1,BMP signaling pathway involved in nephric duct formation,BP,
16440,GO:0071894,1,0.987533610006321,0,2,histone H2B conserved C-terminal lysine ubiquitination,BP,
16441,GO:0071895,1,0.968361055783924,0,5,odontoblast differentiation,BP,
16442,GO:0071896,1,0.951336350112596,0,6,protein localization to adherens junction,BP,
16444,GO:0071898,1,0.981716705362533,0,3,regulation of estrogen receptor binding,BP,
16445,GO:0071899,1,0.981716705362533,0,3,negative regulation of estrogen receptor binding,BP,
16448,GO:0071902,1,0.114726745480323,0,317,positive regulation of protein serine/threonine kinase activity,BP,
16449,GO:0071907,1,0.947193449159218,0,7,determination of digestive tract left/right asymmetry,BP,
16450,GO:0071908,1,0.991624076780836,0,1,determination of intestine left/right asymmetry,BP,
16451,GO:0071909,1,0.991624076780836,0,1,determination of stomach left/right asymmetry,BP,
16452,GO:0071910,1,0.955624186353788,0,6,determination of liver left/right asymmetry,BP,
16454,GO:0071913,1,0.995616145417115,0,1,citrate secondary active transmembrane transporter activity,MF,
16455,GO:0071914,1,0.985391602836146,0,2,prominosome,CC,
16456,GO:0071916,1,0.991535205056401,0,1,dipeptide transmembrane transporter activity,MF,
16458,GO:0071919,1,0.992914758433867,0,1,G-quadruplex DNA formation,BP,
16459,GO:0071920,1,0.988410166433208,0,2,cleavage body,CC,
16460,GO:0071921,1,0.962635824904757,0,5,cohesin loading,BP,
16461,GO:0071922,1,0.968950130963047,0,4,regulation of cohesin loading,BP,
16463,GO:0071929,1,0.986619736047442,0,2,alpha-tubulin acetylation,BP,
16464,GO:0071930,1,0.977186220972239,0,3,negative regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
16465,GO:0071931,1,0.982783903989111,0,3,positive regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
16466,GO:0071932,1,0.97613047141691,0,3,replication fork reversal,BP,
16467,GO:0071933,1,0.918275921071869,0,12,Arp2/3 complex binding,MF,
16468,GO:0071934,1,0.981158290205886,0,3,thiamine transmembrane transport,BP,
16469,GO:0071936,1,0.92882738850324,0,9,coreceptor activity involved in Wnt signaling pathway,MF,
16470,GO:0071938,1,0.993379749425239,0,1,vitamin A transport,BP,
16471,GO:0071939,1,0.993379749425239,0,1,vitamin A import,BP,
16472,GO:0071941,1,0.93720424845033,0,12,nitrogen cycle metabolic process,BP,
16473,GO:0071942,1,0.981870240477539,0,3,XPC complex,CC,
16475,GO:0071947,1,0.963872647657979,0,4,protein deubiquitination involved in ubiquitin-dependent protein catabolic process,BP,
16476,GO:0071949,1,0.808458386578655,0,31,FAD binding,MF,
16477,GO:0071951,1,0.993513844472955,0,1,conversion of methionyl-tRNA to N-formyl-methionyl-tRNA,BP,
16478,GO:0071953,1,0.97578763200454,0,4,elastic fiber,CC,
16479,GO:0071954,1,0.992847714373444,0,1,chemokine (C-C motif) ligand 11 production,BP,
16480,GO:0071955,1,0.972570370953148,0,3,recycling endosome to Golgi transport,BP,
16481,GO:0071960,1,0.996688208883873,0,1,maintenance of mitotic sister chromatid cohesion, centromeric,BP,
16482,GO:0071962,1,0.984763908106206,0,3,mitotic sister chromatid cohesion, centromeric,BP,
16483,GO:0071963,1,0.987705625538629,0,2,establishment or maintenance of cell polarity regulating cell shape,BP,
16484,GO:0071971,1,0.956049495013484,0,7,extracellular exosome assembly,BP,
16485,GO:0071976,1,0.992961126974786,0,1,cell gliding,BP,
16487,GO:0071986,1,0.961879961695921,0,6,Ragulator complex,CC,
16488,GO:0071987,1,0.969231703373585,0,4,WD40-repeat domain binding,MF,
16489,GO:0071988,1,0.983579841772419,0,2,protein localization to spindle pole body,BP,
16491,GO:0072003,1,0.981202698374814,0,3,kidney rudiment formation,BP,
16492,GO:0072004,1,0.985291956540197,0,2,kidney field specification,BP,
16493,GO:0072006,1,0.370991039183185,0,132,nephron development,BP,
16494,GO:0072007,1,0.955406580283052,0,7,mesangial cell differentiation,BP,
16495,GO:0072008,1,0.960124743736469,0,6,glomerular mesangial cell differentiation,BP,
16496,GO:0072009,1,0.476196445075042,0,100,nephron epithelium development,BP,
16497,GO:0072010,1,0.864868688816414,0,19,glomerular epithelium development,BP,
16498,GO:0072011,1,0.989080222443907,0,2,glomerular endothelium development,BP,
16499,GO:0072012,1,0.845892399285398,0,23,glomerulus vasculature development,BP,
16500,GO:0072014,1,0.94825240428392,0,6,proximal tubule development,BP,
16501,GO:0072015,1,0.915616154393331,0,10,glomerular visceral epithelial cell development,BP,
16502,GO:0072016,1,0.993686159997233,0,1,glomerular parietal epithelial cell development,BP,
16503,GO:0072017,1,0.908810575279428,0,11,distal tubule development,BP,
16504,GO:0072019,1,0.994600609725118,0,1,proximal convoluted tubule development,BP,
16505,GO:0072021,1,0.97249977156086,0,3,ascending thin limb development,BP,
16506,GO:0072023,1,0.995793088772465,0,1,thick ascending limb development,BP,
16507,GO:0072024,1,0.995793088772465,0,1,macula densa development,BP,
16508,GO:0072025,1,0.975112444456008,0,4,distal convoluted tubule development,BP,
16509,GO:0072027,1,0.993851358037755,0,1,connecting tubule development,BP,
16510,GO:0072028,1,0.590350015728935,0,72,nephron morphogenesis,BP,
16511,GO:0072033,1,0.93368957670542,0,8,renal vesicle formation,BP,
16512,GO:0072034,1,0.978626763394948,0,3,renal vesicle induction,BP,
16513,GO:0072036,1,0.992730633679347,0,1,mesenchymal to epithelial transition involved in renal vesicle formation,BP,
16514,GO:0072038,1,0.968661211734816,0,5,mesenchymal stem cell maintenance involved in nephron morphogenesis,BP,
16515,GO:0072039,1,0.978001734578819,0,3,regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
16516,GO:0072040,1,0.978001734578819,0,3,negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
16517,GO:0072044,1,0.896387572922901,0,14,collecting duct development,BP,
16518,GO:0072046,1,0.995850313555608,0,1,establishment of planar polarity involved in nephron morphogenesis,BP,
16519,GO:0072047,1,0.980755598167634,0,4,proximal/distal pattern formation involved in nephron development,BP,
16520,GO:0072048,1,0.956351034675513,0,8,renal system pattern specification,BP,
16521,GO:0072049,1,0.971577663447279,0,5,comma-shaped body morphogenesis,BP,
16522,GO:0072050,1,0.957155812110943,0,7,S-shaped body morphogenesis,BP,
16523,GO:0072051,1,0.995793088772465,0,1,juxtaglomerular apparatus development,BP,
16524,GO:0072053,1,0.985591589532698,0,2,renal inner medulla development,BP,
16525,GO:0072054,1,0.985591589532698,0,2,renal outer medulla development,BP,
16526,GO:0072055,1,0.991903183909612,0,1,renal cortex development,BP,
16527,GO:0072059,1,0.991903183909612,0,1,cortical collecting duct development,BP,
16528,GO:0072060,1,0.99265776707409,0,1,outer medullary collecting duct development,BP,
16529,GO:0072061,1,0.98198089827724,0,3,inner medullary collecting duct development,BP,
16530,GO:0072069,1,0.981146306966022,0,3,DCT cell differentiation,BP,
16531,GO:0072070,1,0.936302140937406,0,9,loop of Henle development,BP,
16532,GO:0072071,1,0.990976097851965,0,2,kidney interstitial fibroblast differentiation,BP,
16533,GO:0072073,1,0.375508545065632,0,132,kidney epithelium development,BP,
16534,GO:0072074,1,0.884874276204454,0,18,kidney mesenchyme development,BP,
16535,GO:0072075,1,0.904892192550838,0,14,metanephric mesenchyme development,BP,
16536,GO:0072076,1,0.975854687231727,0,3,nephrogenic mesenchyme development,BP,
16537,GO:0072077,1,0.881374451326943,0,18,renal vesicle morphogenesis,BP,
16538,GO:0072078,1,0.608868811644073,0,68,nephron tubule morphogenesis,BP,
16539,GO:0072079,1,0.902771580930261,0,17,nephron tubule formation,BP,
16540,GO:0072080,1,0.528601271950393,0,86,nephron tubule development,BP,
16541,GO:0072081,1,0.980755598167634,0,4,specification of nephron tubule identity,BP,
16542,GO:0072086,1,0.985597673275846,0,3,specification of loop of Henle identity,BP,
16543,GO:0072087,1,0.877039573874038,0,19,renal vesicle development,BP,
16544,GO:0072088,1,0.600005512809636,0,70,nephron epithelium morphogenesis,BP,
16547,GO:0072092,1,0.967972449004692,0,3,ureteric bud invasion,BP,
16548,GO:0072093,1,0.960933623793655,0,4,metanephric renal vesicle formation,BP,
16549,GO:0072095,1,0.979929391373879,0,3,regulation of branch elongation involved in ureteric bud branching,BP,
16550,GO:0072096,1,0.995293167006598,0,1,negative regulation of branch elongation involved in ureteric bud branching,BP,
16551,GO:0072097,1,0.995293167006598,0,1,negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway,BP,
16552,GO:0072098,1,0.990403938044236,0,2,anterior/posterior pattern specification involved in kidney development,BP,
16553,GO:0072099,1,0.995293167006598,0,1,anterior/posterior pattern specification involved in ureteric bud development,BP,
16554,GO:0072100,1,0.995293167006598,0,1,specification of ureteric bud anterior/posterior symmetry,BP,
16555,GO:0072101,1,0.995293167006598,0,1,specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway,BP,
16556,GO:0072102,1,0.930982085488229,0,8,glomerulus morphogenesis,BP,
16557,GO:0072103,1,0.953877887430907,0,5,glomerulus vasculature morphogenesis,BP,
16558,GO:0072104,1,0.953877887430907,0,5,glomerular capillary formation,BP,
16559,GO:0072106,1,0.974826489141289,0,4,regulation of ureteric bud formation,BP,
16560,GO:0072107,1,0.974826489141289,0,4,positive regulation of ureteric bud formation,BP,
16561,GO:0072108,1,0.975069902903552,0,4,positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
16562,GO:0072109,1,0.904259103708598,0,15,glomerular mesangium development,BP,
16563,GO:0072110,1,0.935562571734641,0,10,glomerular mesangial cell proliferation,BP,
16564,GO:0072111,1,0.881986367871,0,19,cell proliferation involved in kidney development,BP,
16565,GO:0072112,1,0.882315809539373,0,16,glomerular visceral epithelial cell differentiation,BP,
16566,GO:0072114,1,0.991482478357323,0,1,pronephros morphogenesis,BP,
16567,GO:0072124,1,0.943755961276758,0,9,regulation of glomerular mesangial cell proliferation,BP,
16568,GO:0072125,1,0.981213745694216,0,3,negative regulation of glomerular mesangial cell proliferation,BP,
16569,GO:0072126,1,0.961832152673987,0,6,positive regulation of glomerular mesangial cell proliferation,BP,
16570,GO:0072127,1,0.994359642626978,0,1,renal capsule development,BP,
16571,GO:0072128,1,0.994359642626978,0,1,renal capsule morphogenesis,BP,
16572,GO:0072129,1,0.994359642626978,0,1,renal capsule formation,BP,
16573,GO:0072130,1,0.994359642626978,0,1,renal capsule specification,BP,
16574,GO:0072131,1,0.970873153454825,0,4,kidney mesenchyme morphogenesis,BP,
16575,GO:0072132,1,0.697659924869053,0,51,mesenchyme morphogenesis,BP,
16576,GO:0072133,1,0.970873153454825,0,4,metanephric mesenchyme morphogenesis,BP,
16577,GO:0072134,1,0.981391120321522,0,2,nephrogenic mesenchyme morphogenesis,BP,
16578,GO:0072135,1,0.981189992444891,0,3,kidney mesenchymal cell proliferation,BP,
16579,GO:0072136,1,0.981189992444891,0,3,metanephric mesenchymal cell proliferation involved in metanephros development,BP,
16580,GO:0072137,1,0.965314662322078,0,3,condensed mesenchymal cell proliferation,BP,
16581,GO:0072138,1,0.982757450950755,0,3,mesenchymal cell proliferation involved in ureteric bud development,BP,
16582,GO:0072139,1,0.986381925138197,0,2,glomerular parietal epithelial cell differentiation,BP,
16583,GO:0072141,1,0.990976097851965,0,2,renal interstitial fibroblast development,BP,
16584,GO:0072143,1,0.961600319027038,0,6,mesangial cell development,BP,
16585,GO:0072144,1,0.966348761608368,0,5,glomerular mesangial cell development,BP,
16586,GO:0072148,1,0.905672611087388,0,14,epithelial cell fate commitment,BP,
16587,GO:0072156,1,0.967803459806339,0,3,distal tubule morphogenesis,BP,
16588,GO:0072160,1,0.899045743270533,0,13,nephron tubule epithelial cell differentiation,BP,
16589,GO:0072161,1,0.957268122890384,0,7,mesenchymal cell differentiation involved in kidney development,BP,
16590,GO:0072162,1,0.973383983551755,0,4,metanephric mesenchymal cell differentiation,BP,
16591,GO:0072163,1,0.506448450453194,0,94,mesonephric epithelium development,BP,
16592,GO:0072164,1,0.506448450453194,0,94,mesonephric tubule development,BP,
16593,GO:0072165,1,0.995087881137857,0,1,anterior mesonephric tubule development,BP,
16594,GO:0072166,1,0.988323766502795,0,2,posterior mesonephric tubule development,BP,
16595,GO:0072167,1,0.995087881137857,0,1,specification of mesonephric tubule identity,BP,
16596,GO:0072168,1,0.995087881137857,0,1,specification of anterior mesonephric tubule identity,BP,
16597,GO:0072169,1,0.995087881137857,0,1,specification of posterior mesonephric tubule identity,BP,
16598,GO:0072170,1,0.849385427901669,0,22,metanephric tubule development,BP,
16599,GO:0072171,1,0.64396531441702,0,61,mesonephric tubule morphogenesis,BP,
16600,GO:0072172,1,0.954107589010275,0,8,mesonephric tubule formation,BP,
16601,GO:0072173,1,0.924028285152996,0,11,metanephric tubule morphogenesis,BP,
16602,GO:0072174,1,0.960227284240388,0,6,metanephric tubule formation,BP,
16604,GO:0072176,1,0.89892493099526,0,14,nephric duct development,BP,
16605,GO:0072177,1,0.948853695940283,0,7,mesonephric duct development,BP,
16606,GO:0072178,1,0.93347749532172,0,10,nephric duct morphogenesis,BP,
16607,GO:0072179,1,0.977041553716094,0,4,nephric duct formation,BP,
16608,GO:0072180,1,0.985305355312453,0,3,mesonephric duct morphogenesis,BP,
16609,GO:0072181,1,0.995850313555608,0,1,mesonephric duct formation,BP,
16610,GO:0072182,1,0.914762455247888,0,11,regulation of nephron tubule epithelial cell differentiation,BP,
16611,GO:0072183,1,0.987929914880584,0,2,negative regulation of nephron tubule epithelial cell differentiation,BP,
16612,GO:0072184,1,0.995087881137857,0,1,renal vesicle progenitor cell differentiation,BP,
16613,GO:0072185,1,0.989284595860429,0,2,metanephric cap development,BP,
16614,GO:0072186,1,0.989284595860429,0,2,metanephric cap morphogenesis,BP,
16615,GO:0072189,1,0.889690633335166,0,17,ureter development,BP,
16616,GO:0072190,1,0.983125783272548,0,3,ureter urothelium development,BP,
16617,GO:0072191,1,0.977412160664165,0,4,ureter smooth muscle development,BP,
16618,GO:0072192,1,0.995293167006598,0,1,ureter epithelial cell differentiation,BP,
16619,GO:0072193,1,0.977412160664165,0,4,ureter smooth muscle cell differentiation,BP,
16620,GO:0072194,1,0.982751920958095,0,3,kidney smooth muscle tissue development,BP,
16621,GO:0072195,1,0.995665824555013,0,1,kidney smooth muscle cell differentiation,BP,
16622,GO:0072197,1,0.961831125443191,0,6,ureter morphogenesis,BP,
16623,GO:0072198,1,0.984648440360429,0,3,mesenchymal cell proliferation involved in ureter development,BP,
16624,GO:0072199,1,0.984648440360429,0,3,regulation of mesenchymal cell proliferation involved in ureter development,BP,
16625,GO:0072200,1,0.995293167006598,0,1,negative regulation of mesenchymal cell proliferation involved in ureter development,BP,
16626,GO:0072201,1,0.946719626887808,0,8,negative regulation of mesenchymal cell proliferation,BP,
16627,GO:0072202,1,0.851738313610936,0,23,cell differentiation involved in metanephros development,BP,
16628,GO:0072203,1,0.933755016322028,0,10,cell proliferation involved in metanephros development,BP,
16629,GO:0072204,1,0.984937191584676,0,2,cell-cell signaling involved in metanephros development,BP,
16630,GO:0072205,1,0.925071898104448,0,10,metanephric collecting duct development,BP,
16631,GO:0072206,1,0.995793088772465,0,1,metanephric juxtaglomerular apparatus development,BP,
16632,GO:0072207,1,0.836192765426916,0,24,metanephric epithelium development,BP,
16633,GO:0072208,1,0.987030442252434,0,2,metanephric smooth muscle tissue development,BP,
16634,GO:0072209,1,0.98694578813374,0,2,metanephric mesangial cell differentiation,BP,
16635,GO:0072210,1,0.776775829464974,0,35,metanephric nephron development,BP,
16636,GO:0072213,1,0.994359642626978,0,1,metanephric capsule development,BP,
16637,GO:0072214,1,0.991903183909612,0,1,metanephric cortex development,BP,
16638,GO:0072215,1,0.869779592072494,0,20,regulation of metanephros development,BP,
16639,GO:0072216,1,0.9235439337917,0,12,positive regulation of metanephros development,BP,
16640,GO:0072217,1,0.956874565241931,0,7,negative regulation of metanephros development,BP,
16641,GO:0072218,1,0.97249977156086,0,3,metanephric ascending thin limb development,BP,
16642,GO:0072219,1,0.991903183909612,0,1,metanephric cortical collecting duct development,BP,
16643,GO:0072221,1,0.975112444456008,0,4,metanephric distal convoluted tubule development,BP,
16644,GO:0072223,1,0.965006210213295,0,5,metanephric glomerular mesangium development,BP,
16645,GO:0072224,1,0.92070513622451,0,11,metanephric glomerulus development,BP,
16646,GO:0072227,1,0.995793088772465,0,1,metanephric macula densa development,BP,
16647,GO:0072229,1,0.994600609725118,0,1,metanephric proximal convoluted tubule development,BP,
16648,GO:0072233,1,0.995793088772465,0,1,metanephric thick ascending limb development,BP,
16649,GO:0072234,1,0.864881542224879,0,19,metanephric nephron tubule development,BP,
16650,GO:0072235,1,0.95229815948349,0,6,metanephric distal tubule development,BP,
16651,GO:0072236,1,0.965357470244099,0,4,metanephric loop of Henle development,BP,
16652,GO:0072237,1,0.979265496776108,0,2,metanephric proximal tubule development,BP,
16653,GO:0072239,1,0.951197719108085,0,7,metanephric glomerulus vasculature development,BP,
16654,GO:0072240,1,0.981146306966022,0,3,metanephric DCT cell differentiation,BP,
16655,GO:0072243,1,0.857286670610585,0,20,metanephric nephron epithelium development,BP,
16656,GO:0072244,1,0.991231264999943,0,1,metanephric glomerular epithelium development,BP,
16657,GO:0072248,1,0.991231264999943,0,1,metanephric glomerular visceral epithelial cell differentiation,BP,
16658,GO:0072249,1,0.991231264999943,0,1,metanephric glomerular visceral epithelial cell development,BP,
16659,GO:0072254,1,0.98694578813374,0,2,metanephric glomerular mesangial cell differentiation,BP,
16660,GO:0072255,1,0.993341905811881,0,1,metanephric glomerular mesangial cell development,BP,
16661,GO:0072257,1,0.939183894023783,0,7,metanephric nephron tubule epithelial cell differentiation,BP,
16662,GO:0072258,1,0.995087881137857,0,1,metanephric interstitial fibroblast differentiation,BP,
16663,GO:0072259,1,0.995087881137857,0,1,metanephric interstitial fibroblast development,BP,
16664,GO:0072262,1,0.977773117107429,0,3,metanephric glomerular mesangial cell proliferation involved in metanephros development,BP,
16665,GO:0072265,1,0.994359642626978,0,1,metanephric capsule morphogenesis,BP,
16666,GO:0072266,1,0.994359642626978,0,1,metanephric capsule formation,BP,
16667,GO:0072267,1,0.994359642626978,0,1,metanephric capsule specification,BP,
16668,GO:0072268,1,0.984680602284297,0,3,pattern specification involved in metanephros development,BP,
16669,GO:0072272,1,0.995155163282006,0,1,proximal/distal pattern formation involved in metanephric nephron development,BP,
16670,GO:0072273,1,0.833685939985985,0,25,metanephric nephron morphogenesis,BP,
16671,GO:0072274,1,0.991231264999943,0,1,metanephric glomerular basement membrane development,BP,
16672,GO:0072275,1,0.981966446911394,0,2,metanephric glomerulus morphogenesis,BP,
16673,GO:0072276,1,0.981966446911394,0,2,metanephric glomerulus vasculature morphogenesis,BP,
16674,GO:0072277,1,0.981966446911394,0,2,metanephric glomerular capillary formation,BP,
16675,GO:0072278,1,0.97942889515667,0,3,metanephric comma-shaped body morphogenesis,BP,
16676,GO:0072282,1,0.94087185975904,0,8,metanephric nephron tubule morphogenesis,BP,
16677,GO:0072283,1,0.900644058865863,0,15,metanephric renal vesicle morphogenesis,BP,
16678,GO:0072284,1,0.964891665389817,0,5,metanephric S-shaped body morphogenesis,BP,
16679,GO:0072285,1,0.992730633679347,0,1,mesenchymal to epithelial transition involved in metanephric renal vesicle formation,BP,
16680,GO:0072286,1,0.993851358037755,0,1,metanephric connecting tubule development,BP,
16681,GO:0072287,1,0.984582464611643,0,1,metanephric distal tubule morphogenesis,BP,
16682,GO:0072289,1,0.971360601326103,0,4,metanephric nephron tubule formation,BP,
16683,GO:0072298,1,0.971197833239865,0,4,regulation of metanephric glomerulus development,BP,
16684,GO:0072299,1,0.993202829097475,0,1,negative regulation of metanephric glomerulus development,BP,
16685,GO:0072300,1,0.97784590231571,0,3,positive regulation of metanephric glomerulus development,BP,
16686,GO:0072301,1,0.986332382887372,0,2,regulation of metanephric glomerular mesangial cell proliferation,BP,
16687,GO:0072302,1,0.993202829097475,0,1,negative regulation of metanephric glomerular mesangial cell proliferation,BP,
16688,GO:0072303,1,0.993083004594728,0,1,positive regulation of glomerular metanephric mesangial cell proliferation,BP,
16689,GO:0072304,1,0.985291956540197,0,2,regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
16690,GO:0072305,1,0.985291956540197,0,2,negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
16691,GO:0072307,1,0.939183894023783,0,7,regulation of metanephric nephron tubule epithelial cell differentiation,BP,
16692,GO:0072308,1,0.992807052590488,0,1,negative regulation of metanephric nephron tubule epithelial cell differentiation,BP,
16693,GO:0072309,1,0.985291956540197,0,2,mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis,BP,
16694,GO:0072310,1,0.909830021583564,0,11,glomerular epithelial cell development,BP,
16695,GO:0072311,1,0.876738054404758,0,17,glomerular epithelial cell differentiation,BP,
16696,GO:0072312,1,0.991231264999943,0,1,metanephric glomerular epithelial cell differentiation,BP,
16697,GO:0072313,1,0.991231264999943,0,1,metanephric glomerular epithelial cell development,BP,
16698,GO:0072318,1,0.956855037506788,0,6,clathrin coat disassembly,BP,
16699,GO:0072319,1,0.951607129426606,0,7,vesicle uncoating,BP,
16700,GO:0072320,1,0.972758148948109,0,4,volume-sensitive chloride channel activity,MF,
16701,GO:0072321,1,0.945227018541648,0,11,chaperone-mediated protein transport,BP,
16703,GO:0072330,1,0.270342678764327,0,212,monocarboxylic acid biosynthetic process,BP,
16705,GO:0072332,1,0.625462752309831,0,74,intrinsic apoptotic signaling pathway by p53 class mediator,BP,
16706,GO:0072334,1,0.981607297380756,0,4,UDP-galactose transmembrane transport,BP,
16708,GO:0072338,1,0.978863418680797,0,3,cellular lactam metabolic process,BP,
16709,GO:0072340,1,0.995450692884757,0,1,cellular lactam catabolic process,BP,
16711,GO:0072343,1,0.991305562308781,0,2,pancreatic stellate cell proliferation,BP,
16712,GO:0072344,1,0.973484078653536,0,4,rescue of stalled ribosome,BP,
16713,GO:0072345,1,0.965344611630729,0,5,NAADP-sensitive calcium-release channel activity,MF,
16714,GO:0072348,1,0.727903148682583,0,45,sulfur compound transport,BP,
16715,GO:0072349,1,0.869901100468547,0,19,modified amino acid transmembrane transporter activity,MF,
16716,GO:0072350,1,0.924404281809516,0,13,tricarboxylic acid metabolic process,BP,
16717,GO:0072354,1,0.995427264223568,0,1,histone kinase activity (H3-T3 specific),MF,
16718,GO:0072355,1,0.995427264223568,0,1,histone H3-T3 phosphorylation,BP,
16719,GO:0072356,1,0.992604430620992,0,1,chromosome passenger complex localization to kinetochore,BP,
16720,GO:0072357,1,0.951374806579617,0,7,PTW/PP1 phosphatase complex,CC,
16722,GO:0072376,1,0.873944634808458,0,22,protein activation cascade,BP,
16723,GO:0072378,1,0.873944634808458,0,22,blood coagulation, fibrin clot formation,BP,
16724,GO:0072379,1,0.968665674216499,0,5,ER membrane insertion complex,CC,
16725,GO:0072380,1,0.985859234339635,0,2,TRC complex,CC,
16726,GO:0072382,1,0.984417073517457,0,1,minus-end-directed vesicle transport along microtubule,BP,
16727,GO:0072383,1,0.940710905517452,0,7,plus-end-directed vesicle transport along microtubule,BP,
16728,GO:0072384,1,0.553228151579545,0,79,organelle transport along microtubule,BP,
16729,GO:0072385,1,0.955493184386634,0,5,minus-end-directed organelle transport along microtubule,BP,
16730,GO:0072386,1,0.932512982903038,0,8,plus-end-directed organelle transport along microtubule,BP,
16731,GO:0072387,1,0.987641124133375,0,2,flavin adenine dinucleotide metabolic process,BP,
16732,GO:0072388,1,0.994929140826226,0,1,flavin adenine dinucleotide biosynthetic process,BP,
16733,GO:0072389,1,0.992675209673287,0,1,flavin adenine dinucleotide catabolic process,BP,
16734,GO:0072393,1,0.900630022877089,0,12,microtubule anchoring at microtubule organizing center,BP,
16735,GO:0072394,1,0.995531636571884,0,1,detection of stimulus involved in cell cycle checkpoint,BP,
16736,GO:0072395,1,0.626357528036841,0,69,signal transduction involved in cell cycle checkpoint,BP,
16737,GO:0072396,1,0.953792183011427,0,6,response to cell cycle checkpoint signaling,BP,
16738,GO:0072401,1,0.63351215858061,0,68,signal transduction involved in DNA integrity checkpoint,BP,
16739,GO:0072402,1,0.953792183011427,0,6,response to DNA integrity checkpoint signaling,BP,
16740,GO:0072413,1,0.687738546628639,0,56,signal transduction involved in mitotic cell cycle checkpoint,BP,
16741,GO:0072414,1,0.990140469691909,0,1,response to mitotic cell cycle checkpoint signaling,BP,
16742,GO:0072421,1,0.995531636571884,0,1,detection of DNA damage stimulus involved in DNA damage checkpoint,BP,
16743,GO:0072422,1,0.63351215858061,0,68,signal transduction involved in DNA damage checkpoint,BP,
16744,GO:0072423,1,0.953792183011427,0,6,response to DNA damage checkpoint signaling,BP,
16745,GO:0072425,1,0.918755745931293,0,11,signal transduction involved in G2 DNA damage checkpoint,BP,
16746,GO:0072428,1,0.995132167028412,0,1,signal transduction involved in intra-S DNA damage checkpoint,BP,
16747,GO:0072429,1,0.981888032465249,0,3,response to intra-S DNA damage checkpoint signaling,BP,
16748,GO:0072431,1,0.692450005074025,0,55,signal transduction involved in mitotic G1 DNA damage checkpoint,BP,
16749,GO:0072432,1,0.990140469691909,0,1,response to G1 DNA damage checkpoint signaling,BP,
16750,GO:0072434,1,0.980156759844257,0,2,signal transduction involved in mitotic G2 DNA damage checkpoint,BP,
16751,GO:0072487,1,0.973159152952939,0,4,MSL complex,CC,
16752,GO:0072488,1,0.943503674373163,0,8,ammonium transmembrane transport,BP,
16753,GO:0072492,1,0.995348794548339,0,1,host cell mitochondrial intermembrane space,CC,
16754,GO:0072497,1,0.939143607214548,0,8,mesenchymal stem cell differentiation,BP,
16755,GO:0072498,1,0.914463103415345,0,15,embryonic skeletal joint development,BP,
16756,GO:0072501,1,0.961432770787388,0,5,cellular divalent inorganic anion homeostasis,BP,
16757,GO:0072502,1,0.961432770787388,0,5,cellular trivalent inorganic anion homeostasis,BP,
16759,GO:0072505,1,0.940133832953563,0,8,divalent inorganic anion homeostasis,BP,
16760,GO:0072506,1,0.940133832953563,0,8,trivalent inorganic anion homeostasis,BP,
16764,GO:0072513,1,0.979177087672737,0,3,positive regulation of secondary heart field cardioblast proliferation,BP,
16765,GO:0072517,1,0.992874062631439,0,1,host cell viral assembly compartment,CC,
16766,GO:0072518,1,0.981281154622772,0,2,Rho-dependent protein serine/threonine kinase activity,MF,
16767,GO:0072520,1,0.924090165077581,0,11,seminiferous tubule development,BP,
16770,GO:0072523,1,0.740470721026661,0,47,purine-containing compound catabolic process,BP,
16771,GO:0072524,1,0.79458626456304,0,37,pyridine-containing compound metabolic process,BP,
16772,GO:0072525,1,0.825366749642965,0,31,pyridine-containing compound biosynthetic process,BP,
16773,GO:0072526,1,0.959476577438615,0,7,pyridine-containing compound catabolic process,BP,
16774,GO:0072527,1,0.636850201333274,0,78,pyrimidine-containing compound metabolic process,BP,
16775,GO:0072528,1,0.814322028063474,0,37,pyrimidine-containing compound biosynthetic process,BP,
16776,GO:0072529,1,0.812347719483022,0,36,pyrimidine-containing compound catabolic process,BP,
16777,GO:0072530,1,0.948687093746499,0,9,purine-containing compound transmembrane transport,BP,
16778,GO:0072531,1,0.935258799777068,0,11,pyrimidine-containing compound transmembrane transport,BP,
16779,GO:0072534,1,0.98107076964816,0,2,perineuronal net,CC,
16780,GO:0072535,1,0.987258603588318,0,2,tumor necrosis factor (ligand) superfamily member 11 production,BP,
16781,GO:0072536,1,0.987918539004486,0,2,interleukin-23 receptor complex,CC,
16782,GO:0072537,1,0.922961804825357,0,11,fibroblast activation,BP,
16783,GO:0072538,1,0.843257600739083,0,25,T-helper 17 type immune response,BP,
16784,GO:0072539,1,0.859367596339272,0,22,T-helper 17 cell differentiation,BP,
16785,GO:0072540,1,0.94477379521458,0,10,T-helper 17 cell lineage commitment,BP,
16786,GO:0072542,1,0.925510153401883,0,12,protein phosphatase activator activity,MF,
16787,GO:0072544,1,0.995447097289972,0,1,L-DOPA binding,MF,
16788,GO:0072545,1,0.990032784323817,0,2,tyrosine binding,MF,
16789,GO:0072546,1,0.936040310820872,0,10,ER membrane protein complex,CC,
16790,GO:0072553,1,0.966794314899187,0,5,terminal button organization,BP,
16791,GO:0072554,1,0.987119086999337,0,2,blood vessel lumenization,BP,
16792,GO:0072557,1,0.976490958196428,0,4,IPAF inflammasome complex,CC,
16793,GO:0072558,1,0.980998394223777,0,4,NLRP1 inflammasome complex,CC,
16794,GO:0072559,1,0.953338335682201,0,8,NLRP3 inflammasome complex,CC,
16795,GO:0072560,1,0.989490858899935,0,2,type B pancreatic cell maturation,BP,
16796,GO:0072562,1,0.589425553906089,0,92,blood microparticle,CC,
16797,GO:0072563,1,0.988721111115737,0,2,endothelial microparticle,CC,
16798,GO:0072564,1,0.990262455066593,0,2,blood microparticle formation,BP,
16799,GO:0072566,1,0.98135422995309,0,3,chemokine (C-X-C motif) ligand 1 production,BP,
16800,GO:0072567,1,0.924794465086708,0,13,chemokine (C-X-C motif) ligand 2 production,BP,
16801,GO:0072570,1,0.984229630627631,0,2,ADP-D-ribose binding,MF,
16802,GO:0072571,1,0.991169697725422,0,1,mono-ADP-D-ribose binding,MF,
16803,GO:0072572,1,0.994598636388974,0,1,poly-ADP-D-ribose binding,MF,
16804,GO:0072573,1,0.992375939051885,0,1,tolerance induction to lipopolysaccharide,BP,
16805,GO:0072574,1,0.8841825374674,0,19,hepatocyte proliferation,BP,
16806,GO:0072575,1,0.8841825374674,0,19,epithelial cell proliferation involved in liver morphogenesis,BP,
16807,GO:0072576,1,0.875669867959443,0,20,liver morphogenesis,BP,
16808,GO:0072577,1,0.69877807822354,0,52,endothelial cell apoptotic process,BP,
16809,GO:0072578,1,0.896002497826216,0,13,neurotransmitter-gated ion channel clustering,BP,
16810,GO:0072579,1,0.9924770361683,0,1,glycine receptor clustering,BP,
16811,GO:0072583,1,0.711432995444697,0,44,clathrin-dependent endocytosis,BP,
16812,GO:0072584,1,0.923814486824984,0,12,caveolin-mediated endocytosis,BP,
16815,GO:0072588,1,0.976898336148395,0,5,box H/ACA RNP complex,CC,
16816,GO:0072589,1,0.984139673719446,0,4,box H/ACA scaRNP complex,CC,
16817,GO:0072590,1,0.978609373167907,0,2,N-acetyl-L-aspartate-L-glutamate ligase activity,MF,
16818,GO:0072591,1,0.99123305123551,0,1,citrate-L-glutamate ligase activity,MF,
16819,GO:0072592,1,0.974888827005249,0,5,oxygen metabolic process,BP,
16822,GO:0072595,1,0.764372686964141,0,41,maintenance of protein localization in organelle,BP,
16823,GO:0072599,1,0.621142084619889,0,111,establishment of protein localization to endoplasmic reticulum,BP,
16824,GO:0072655,1,0.455487959139345,0,132,establishment of protein localization to mitochondrion,BP,
16825,GO:0072656,1,0.967093127090885,0,5,maintenance of protein location in mitochondrion,BP,
16827,GO:0072658,1,0.975778175864374,0,2,maintenance of protein location in membrane,BP,
16829,GO:0072660,1,0.975778175864374,0,2,maintenance of protein location in plasma membrane,BP,
16830,GO:0072662,1,0.668410816567974,0,68,protein localization to peroxisome,BP,
16831,GO:0072663,1,0.668410816567974,0,68,establishment of protein localization to peroxisome,BP,
16832,GO:0072665,1,0.63411532457856,0,64,protein localization to vacuole,BP,
16833,GO:0072666,1,0.701720356004781,0,49,establishment of protein localization to vacuole,BP,
16834,GO:0072669,1,0.966819206288357,0,7,tRNA-splicing ligase complex,CC,
16835,GO:0072671,1,0.993828141368732,0,1,mitochondria-associated ubiquitin-dependent protein catabolic process,BP,
16836,GO:0072672,1,0.944044195477865,0,9,neutrophil extravasation,BP,
16837,GO:0072673,1,0.883080998065229,0,17,lamellipodium morphogenesis,BP,
16838,GO:0072674,1,0.945268016278323,0,7,multinuclear osteoclast differentiation,BP,
16839,GO:0072675,1,0.951851998118762,0,6,osteoclast fusion,BP,
16840,GO:0072676,1,0.573114358320609,0,95,lymphocyte migration,BP,
16841,GO:0072677,1,0.932590288938661,0,14,eosinophil migration,BP,
16842,GO:0072678,1,0.706495162191759,0,58,T cell migration,BP,
16843,GO:0072679,1,0.967962440156391,0,6,thymocyte migration,BP,
16844,GO:0072680,1,0.993068898952965,0,1,extracellular matrix-dependent thymocyte migration,BP,
16845,GO:0072681,1,0.993068898952965,0,1,fibronectin-dependent thymocyte migration,BP,
16846,GO:0072682,1,0.992889958085752,0,1,eosinophil extravasation,BP,
16847,GO:0072683,1,0.931893379487924,0,11,T cell extravasation,BP,
16848,GO:0072684,1,0.992697589750396,0,1,mitochondrial tRNA 3'-trailer cleavage, endonucleolytic,BP,
16851,GO:0072695,1,0.988002741957194,0,2,regulation of DNA recombination at telomere,BP,
16852,GO:0072697,1,0.926182300061655,0,11,protein localization to cell cortex,BP,
16853,GO:0072698,1,0.663839859113133,0,52,protein localization to microtubule cytoskeleton,BP,
16854,GO:0072702,1,0.991412167848896,0,1,response to methyl methanesulfonate,BP,
16855,GO:0072703,1,0.991412167848896,0,1,cellular response to methyl methanesulfonate,BP,
16856,GO:0072706,1,0.993795818341372,0,1,response to sodium dodecyl sulfate,BP,
16857,GO:0072707,1,0.993795818341372,0,1,cellular response to sodium dodecyl sulfate,BP,
16858,GO:0072708,1,0.970397140230187,0,5,response to sorbitol,BP,
16859,GO:0072709,1,0.983036285017253,0,3,cellular response to sorbitol,BP,
16860,GO:0072710,1,0.930450652930209,0,10,response to hydroxyurea,BP,
16861,GO:0072711,1,0.936555926046774,0,9,cellular response to hydroxyurea,BP,
16862,GO:0072714,1,0.995372677108658,0,1,response to selenite ion,BP,
16863,GO:0072715,1,0.995372677108658,0,1,cellular response to selenite ion,BP,
16864,GO:0072716,1,0.974442108953985,0,4,response to actinomycin D,BP,
16865,GO:0072717,1,0.980833076615884,0,3,cellular response to actinomycin D,BP,
16866,GO:0072718,1,0.939338842327304,0,9,response to cisplatin,BP,
16867,GO:0072719,1,0.960833528724197,0,6,cellular response to cisplatin,BP,
16868,GO:0072720,1,0.98701281886265,0,2,response to dithiothreitol,BP,
16869,GO:0072721,1,0.993485400251684,0,1,cellular response to dithiothreitol,BP,
16870,GO:0072733,1,0.983297827495272,0,3,response to staurosporine,BP,
16871,GO:0072734,1,0.983297827495272,0,3,cellular response to staurosporine,BP,
16872,GO:0072737,1,0.988370310700001,0,2,response to diamide,BP,
16873,GO:0072738,1,0.988370310700001,0,2,cellular response to diamide,BP,
16874,GO:0072739,1,0.988599205207209,0,2,response to anisomycin,BP,
16875,GO:0072740,1,0.995082085604262,0,1,cellular response to anisomycin,BP,
16876,GO:0072749,1,0.995244416664347,0,1,cellular response to cytochalasin B,BP,
16877,GO:0072750,1,0.99612869348273,0,1,cellular response to leptomycin B,BP,
16878,GO:0072752,1,0.984235762981474,0,2,cellular response to rapamycin,BP,
16879,GO:0072755,1,0.992722023538788,0,1,cellular response to benomyl,BP,
16880,GO:0072757,1,0.973207804694456,0,4,cellular response to camptothecin,BP,
16881,GO:0075044,1,0.95127237793006,0,7,positive regulation by symbiont of host autophagy,BP,
16882,GO:0075071,1,0.95127237793006,0,7,modulation by symbiont of host autophagy,BP,
16883,GO:0075136,1,0.975432295825066,0,3,response to host,BP,
16884,GO:0075294,1,0.947741762021284,0,10,positive regulation by symbiont of entry into host,BP,
16885,GO:0075341,1,0.994294957694884,0,1,host cell PML body,CC,
16886,GO:0075506,1,0.984835566439441,0,2,entry of viral genome into host nucleus through nuclear pore complex via importin,BP,
16887,GO:0075509,1,0.946937639822054,0,7,endocytosis involved in viral entry into host cell,BP,
16888,GO:0075512,1,0.990437169521598,0,1,clathrin-dependent endocytosis of virus by host cell,BP,
16889,GO:0075519,1,0.99692868868657,0,1,microtubule-dependent intracellular transport of viral material,BP,
16890,GO:0075521,1,0.99692868868657,0,1,microtubule-dependent intracellular transport of viral material towards nucleus,BP,
16891,GO:0075522,1,0.934150046919624,0,10,IRES-dependent viral translational initiation,BP,
16892,GO:0075525,1,0.971431711497925,0,5,viral translational termination-reinitiation,BP,
16893,GO:0075606,1,0.99692868868657,0,1,transport of viral material towards nucleus,BP,
16894,GO:0075713,1,0.955007346758394,0,8,establishment of integrated proviral latency,BP,
16895,GO:0075732,1,0.968832983801009,0,4,viral penetration into host nucleus,BP,
16896,GO:0075733,1,0.701037830261965,0,52,intracellular transport of virus,BP,
16897,GO:0080008,1,0.808941864779205,0,31,Cul4-RING E3 ubiquitin ligase complex,CC,
16898,GO:0080009,1,0.904936423451265,0,15,mRNA methylation,BP,
16899,GO:0080019,1,0.986440709098555,0,2,fatty-acyl-CoA reductase (alcohol-forming) activity,MF,
16900,GO:0080025,1,0.837421611341721,0,25,phosphatidylinositol-3,5-bisphosphate binding,MF,
16901,GO:0080030,1,0.973902734532164,0,4,methyl indole-3-acetate esterase activity,MF,
16902,GO:0080033,1,0.990795642075213,0,1,response to nitrite,BP,
16903,GO:0080048,1,0.993485400251684,0,1,GDP-D-glucose phosphorylase activity,MF,
16904,GO:0080058,1,0.996013892574913,0,1,protein deglutathionylation,BP,
16905,GO:0080084,1,0.974724218472902,0,3,5S rDNA binding,MF,
16907,GO:0080101,1,0.996544990523016,0,1,phosphatidyl-N-dimethylethanolamine N-methyltransferase activity,MF,
16908,GO:0080111,1,0.844890690853956,0,24,DNA demethylation,BP,
16909,GO:0080120,1,0.988926664674978,0,2,CAAX-box protein maturation,BP,
16910,GO:0080121,1,0.98747383123151,0,2,AMP transport,BP,
16911,GO:0080122,1,0.98747383123151,0,2,AMP transmembrane transporter activity,MF,
16912,GO:0080129,1,0.996408914983695,0,1,proteasome core complex assembly,BP,
16913,GO:0080132,1,0.994047495011617,0,1,fatty acid alpha-hydroxylase activity,MF,
16916,GO:0080144,1,0.966964215148565,0,4,amino acid homeostasis,BP,
16917,GO:0080146,1,0.995364425768994,0,1,L-cysteine desulfhydrase activity,MF,
16918,GO:0080154,1,0.882145200529802,0,20,regulation of fertilization,BP,
16919,GO:0080163,1,0.994109385414291,0,1,regulation of protein serine/threonine phosphatase activity,BP,
16920,GO:0080170,1,0.995885849786332,0,1,hydrogen peroxide transmembrane transport,BP,
16921,GO:0080171,1,0.65593327961811,0,62,lytic vacuole organization,BP,
16922,GO:0080182,1,0.86347948783678,0,18,histone H3-K4 trimethylation,BP,
16923,GO:0080184,1,0.972933123338812,0,5,response to phenylpropanoid,BP,
16924,GO:0085017,1,0.990252924108507,0,1,entry into host cell by a symbiont-containing vacuole,BP,
16925,GO:0085018,1,0.993508103168564,0,1,maintenance of symbiont-containing vacuole by host,BP,
16926,GO:0085020,1,0.956383030451218,0,8,protein K6-linked ubiquitination,BP,
16927,GO:0085029,1,0.729315913985726,0,42,extracellular matrix assembly,BP,
16928,GO:0085032,1,0.992972542497239,0,1,modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade,BP,
16929,GO:0086001,1,0.58471320878619,0,67,cardiac muscle cell action potential,BP,
16930,GO:0086002,1,0.67604359350402,0,49,cardiac muscle cell action potential involved in contraction,BP,
16931,GO:0086003,1,0.587042407850481,0,67,cardiac muscle cell contraction,BP,
16932,GO:0086004,1,0.73650867801659,0,37,regulation of cardiac muscle cell contraction,BP,
16933,GO:0086005,1,0.775358912285072,0,32,ventricular cardiac muscle cell action potential,BP,
16934,GO:0086006,1,0.961263985415498,0,5,voltage-gated sodium channel activity involved in cardiac muscle cell action potential,MF,
16935,GO:0086007,1,0.950468663395461,0,5,voltage-gated calcium channel activity involved in cardiac muscle cell action potential,MF,
16936,GO:0086008,1,0.912957652670815,0,14,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization,MF,
16937,GO:0086009,1,0.738012889355641,0,42,membrane repolarization,BP,
16939,GO:0086011,1,0.845505673205632,0,25,membrane repolarization during action potential,BP,
16940,GO:0086012,1,0.836128401213329,0,21,membrane depolarization during cardiac muscle cell action potential,BP,
16941,GO:0086013,1,0.862767436279166,0,22,membrane repolarization during cardiac muscle cell action potential,BP,
16942,GO:0086014,1,0.851992204075933,0,18,atrial cardiac muscle cell action potential,BP,
16943,GO:0086015,1,0.918093009499959,0,8,SA node cell action potential,BP,
16944,GO:0086016,1,0.912788301038795,0,9,AV node cell action potential,BP,
16945,GO:0086017,1,0.977808987590303,0,3,Purkinje myocyte action potential,BP,
16946,GO:0086018,1,0.918093009499959,0,8,SA node cell to atrial cardiac muscle cell signaling,BP,
16947,GO:0086019,1,0.784817124876571,0,29,cell-cell signaling involved in cardiac conduction,BP,
16948,GO:0086020,1,0.989658052428888,0,1,gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling,MF,
16949,GO:0086021,1,0.989658052428888,0,1,SA node cell to atrial cardiac muscle cell communication by electrical coupling,BP,
16950,GO:0086023,1,0.939486923574447,0,7,adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
16951,GO:0086024,1,0.989243390156733,0,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in positive regulation of heart rate,BP,
16952,GO:0086026,1,0.851992204075933,0,18,atrial cardiac muscle cell to AV node cell signaling,BP,
16953,GO:0086027,1,0.912788301038795,0,9,AV node cell to bundle of His cell signaling,BP,
16954,GO:0086028,1,0.956297485808884,0,6,bundle of His cell to Purkinje myocyte signaling,BP,
16955,GO:0086029,1,0.955033606912034,0,5,Purkinje myocyte to ventricular cardiac muscle cell signaling,BP,
16956,GO:0086030,1,0.99478833270677,0,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in cardiac muscle relaxation,BP,
16957,GO:0086036,1,0.953376612909558,0,7,regulation of cardiac muscle cell membrane potential,BP,
16958,GO:0086038,1,0.993485400251684,0,1,calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential,MF,
16959,GO:0086039,1,0.989147080879768,0,1,calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential,MF,
16960,GO:0086040,1,0.99227750305533,0,1,sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential,MF,
16961,GO:0086041,1,0.990007770839036,0,1,voltage-gated potassium channel activity involved in SA node cell action potential depolarization,MF,
16962,GO:0086042,1,0.945395461317128,0,7,cardiac muscle cell-cardiac muscle cell adhesion,BP,
16963,GO:0086043,1,0.956297485808884,0,6,bundle of His cell action potential,BP,
16964,GO:0086045,1,0.94977156237787,0,5,membrane depolarization during AV node cell action potential,BP,
16965,GO:0086046,1,0.948550967147638,0,5,membrane depolarization during SA node cell action potential,BP,
16966,GO:0086047,1,0.977808987590303,0,3,membrane depolarization during Purkinje myocyte cell action potential,BP,
16967,GO:0086048,1,0.974415914318806,0,3,membrane depolarization during bundle of His cell action potential,BP,
16968,GO:0086050,1,0.993364667310368,0,1,membrane repolarization during bundle of His cell action potential,BP,
16969,GO:0086052,1,0.993364667310368,0,1,membrane repolarization during SA node cell action potential,BP,
16970,GO:0086053,1,0.989658052428888,0,1,AV node cell to bundle of His cell communication by electrical coupling,BP,
16971,GO:0086056,1,0.967579962860922,0,3,voltage-gated calcium channel activity involved in AV node cell action potential,MF,
16972,GO:0086057,1,0.99268169031653,0,1,voltage-gated calcium channel activity involved in bundle of His cell action potential,MF,
16973,GO:0086059,1,0.979380950933389,0,2,voltage-gated calcium channel activity involved SA node cell action potential,MF,
16974,GO:0086060,1,0.988937109726198,0,1,voltage-gated sodium channel activity involved in AV node cell action potential,MF,
16975,GO:0086061,1,0.988937109726198,0,1,voltage-gated sodium channel activity involved in bundle of His cell action potential,MF,
16976,GO:0086062,1,0.985117140775921,0,2,voltage-gated sodium channel activity involved in Purkinje myocyte action potential,MF,
16977,GO:0086063,1,0.988937109726198,0,1,voltage-gated sodium channel activity involved in SA node cell action potential,MF,
16978,GO:0086064,1,0.83617425704814,0,23,cell communication by electrical coupling involved in cardiac conduction,BP,
16979,GO:0086065,1,0.661079973680293,0,53,cell communication involved in cardiac conduction,BP,
16980,GO:0086066,1,0.851992204075933,0,18,atrial cardiac muscle cell to AV node cell communication,BP,
16981,GO:0086067,1,0.903339738720444,0,10,AV node cell to bundle of His cell communication,BP,
16982,GO:0086068,1,0.955033606912034,0,5,Purkinje myocyte to ventricular cardiac muscle cell communication,BP,
16983,GO:0086069,1,0.903235584045105,0,13,bundle of His cell to Purkinje myocyte communication,BP,
16984,GO:0086070,1,0.90859008386711,0,9,SA node cell to atrial cardiac muscle cell communication,BP,
16985,GO:0086072,1,0.993965850965614,0,1,AV node cell-bundle of His cell adhesion involved in cell communication,BP,
16986,GO:0086073,1,0.951137633516274,0,6,bundle of His cell-Purkinje myocyte adhesion involved in cell communication,BP,
16987,GO:0086075,1,0.982817734865119,0,2,gap junction channel activity involved in cardiac conduction electrical coupling,MF,
16988,GO:0086077,1,0.989658052428888,0,1,gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling,MF,
16989,GO:0086080,1,0.900464802776283,0,13,protein binding involved in heterotypic cell-cell adhesion,MF,
16990,GO:0086082,1,0.993965850965614,0,1,cell adhesive protein binding involved in AV node cell-bundle of His cell communication,MF,
16991,GO:0086083,1,0.957834396720486,0,5,cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication,MF,
16992,GO:0086087,1,0.993364667310368,0,1,voltage-gated potassium channel activity involved in bundle of His cell action potential repolarization,MF,
16993,GO:0086089,1,0.973362338675628,0,4,voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,MF,
16994,GO:0086090,1,0.993364667310368,0,1,voltage-gated potassium channel activity involved in SA node cell action potential repolarization,MF,
16995,GO:0086091,1,0.745222380115718,0,37,regulation of heart rate by cardiac conduction,BP,
16996,GO:0086092,1,0.987739728944838,0,2,regulation of the force of heart contraction by cardiac conduction,BP,
16997,GO:0086096,1,0.996030951058853,0,1,adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
16998,GO:0086097,1,0.986581584077268,0,2,phospholipase C-activating angiotensin-activated signaling pathway,BP,
16999,GO:0086098,1,0.986267902566224,0,2,angiotensin-activated signaling pathway involved in heart process,BP,
17000,GO:0086100,1,0.951033944220757,0,7,endothelin receptor signaling pathway,BP,
17001,GO:0086103,1,0.919241394988075,0,11,G protein-coupled receptor signaling pathway involved in heart process,BP,
17002,GO:0089700,1,0.970065383317947,0,4,protein kinase D signaling,BP,
17003,GO:0089701,1,0.982413813450183,0,4,U2AF complex,CC,
17004,GO:0089709,1,0.96049642540731,0,6,L-histidine transmembrane transport,BP,
17005,GO:0089717,1,0.868156627603596,0,17,spanning component of membrane,CC,
17006,GO:0089718,1,0.755277487732417,0,38,amino acid import across plasma membrane,BP,
17007,GO:0089720,1,0.95087761102273,0,10,caspase binding,MF,
17008,GO:0090009,1,0.945030087151958,0,8,primitive streak formation,BP,
17009,GO:0090010,1,0.994709279864805,0,1,transforming growth factor beta receptor signaling pathway involved in primitive streak formation,BP,
17010,GO:0090022,1,0.839906981324923,0,31,regulation of neutrophil chemotaxis,BP,
17011,GO:0090023,1,0.873029440404323,0,25,positive regulation of neutrophil chemotaxis,BP,
17012,GO:0090024,1,0.978267948711097,0,3,negative regulation of neutrophil chemotaxis,BP,
17013,GO:0090025,1,0.887682300354474,0,21,regulation of monocyte chemotaxis,BP,
17014,GO:0090026,1,0.92382646466244,0,15,positive regulation of monocyte chemotaxis,BP,
17015,GO:0090027,1,0.967542074710032,0,5,negative regulation of monocyte chemotaxis,BP,
17016,GO:0090030,1,0.922787494625117,0,11,regulation of steroid hormone biosynthetic process,BP,
17017,GO:0090031,1,0.979803313139647,0,3,positive regulation of steroid hormone biosynthetic process,BP,
17018,GO:0090032,1,0.967054418134866,0,5,negative regulation of steroid hormone biosynthetic process,BP,
17019,GO:0090034,1,0.995616145417115,0,1,regulation of chaperone-mediated protein complex assembly,BP,
17020,GO:0090035,1,0.995616145417115,0,1,positive regulation of chaperone-mediated protein complex assembly,BP,
17021,GO:0090036,1,0.882206843973149,0,17,regulation of protein kinase C signaling,BP,
17022,GO:0090037,1,0.941978892480883,0,9,positive regulation of protein kinase C signaling,BP,
17023,GO:0090038,1,0.968280092568917,0,4,negative regulation of protein kinase C signaling,BP,
17024,GO:0090042,1,0.899645957611418,0,13,tubulin deacetylation,BP,
17025,GO:0090043,1,0.921209816993869,0,10,regulation of tubulin deacetylation,BP,
17026,GO:0090044,1,0.995616145417115,0,1,positive regulation of tubulin deacetylation,BP,
17027,GO:0090045,1,0.943866031171835,0,8,positive regulation of deacetylase activity,BP,
17028,GO:0090049,1,0.777706673608397,0,36,regulation of cell migration involved in sprouting angiogenesis,BP,
17029,GO:0090050,1,0.878839276329961,0,19,positive regulation of cell migration involved in sprouting angiogenesis,BP,
17030,GO:0090051,1,0.897857425291462,0,15,negative regulation of cell migration involved in sprouting angiogenesis,BP,
17031,GO:0090063,1,0.962581605166002,0,5,positive regulation of microtubule nucleation,BP,
17032,GO:0090065,1,0.988517951500449,0,2,regulation of production of siRNA involved in RNA interference,BP,
17034,GO:0090067,1,0.992303149335604,0,1,regulation of thalamus size,BP,
17036,GO:0090069,1,0.901270284372785,0,15,regulation of ribosome biogenesis,BP,
17037,GO:0090070,1,0.944622793422231,0,9,positive regulation of ribosome biogenesis,BP,
17038,GO:0090071,1,0.962071902607352,0,5,negative regulation of ribosome biogenesis,BP,
17039,GO:0090074,1,0.990997208401528,0,1,negative regulation of protein homodimerization activity,BP,
17040,GO:0090075,1,0.837129058375976,0,27,relaxation of muscle,BP,
17041,GO:0090076,1,0.984519343586796,0,2,relaxation of skeletal muscle,BP,
17042,GO:0090077,1,0.803461513140472,0,31,foam cell differentiation,BP,
17044,GO:0090080,1,0.980168863905335,0,3,positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway,BP,
17045,GO:0090081,1,0.977995858207054,0,4,regulation of heart induction by regulation of canonical Wnt signaling pathway,BP,
17046,GO:0090082,1,0.977995858207054,0,4,positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway,BP,
17047,GO:0090083,1,0.898041129929202,0,15,regulation of inclusion body assembly,BP,
17048,GO:0090084,1,0.92530404071473,0,10,negative regulation of inclusion body assembly,BP,
17049,GO:0090085,1,0.931175469492854,0,11,regulation of protein deubiquitination,BP,
17050,GO:0090086,1,0.987803854533044,0,3,negative regulation of protein deubiquitination,BP,
17052,GO:0090088,1,0.989185824013201,0,2,regulation of oligopeptide transport,BP,
17053,GO:0090089,1,0.989185824013201,0,2,regulation of dipeptide transport,BP,
17055,GO:0090091,1,0.956476376404401,0,6,positive regulation of extracellular matrix disassembly,BP,
17057,GO:0090094,1,0.989284595860429,0,2,metanephric cap mesenchymal cell proliferation involved in metanephros development,BP,
17058,GO:0090095,1,0.994168354317737,0,1,regulation of metanephric cap mesenchymal cell proliferation,BP,
17059,GO:0090096,1,0.994168354317737,0,1,positive regulation of metanephric cap mesenchymal cell proliferation,BP,
17060,GO:0090100,1,0.480757447547059,0,102,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,
17063,GO:0090103,1,0.85711464308283,0,23,cochlea morphogenesis,BP,
17064,GO:0090107,1,0.978248051594438,0,3,regulation of high-density lipoprotein particle assembly,BP,
17065,GO:0090108,1,0.982156109446099,0,2,positive regulation of high-density lipoprotein particle assembly,BP,
17066,GO:0090109,1,0.616510912364402,0,62,regulation of cell-substrate junction assembly,BP,
17067,GO:0090110,1,0.894274927949391,0,15,COPII-coated vesicle cargo loading,BP,
17068,GO:0090113,1,0.973615156569554,0,4,regulation of ER to Golgi vesicle-mediated transport by GTP hydrolysis,BP,
17069,GO:0090114,1,0.615883973418107,0,71,COPII-coated vesicle budding,BP,
17070,GO:0090116,1,0.976891592287495,0,3,C-5 methylation of cytosine,BP,
17071,GO:0090118,1,0.951146782867608,0,6,receptor-mediated endocytosis involved in cholesterol transport,BP,
17072,GO:0090119,1,0.987191483667213,0,2,vesicle-mediated cholesterol transport,BP,
17073,GO:0090122,1,0.994843584313651,0,1,cholesterol ester hydrolysis involved in cholesterol transport,BP,
17076,GO:0090130,1,0.145782390791848,0,271,tissue migration,BP,
17077,GO:0090131,1,0.974337132270406,0,5,mesenchyme migration,BP,
17078,GO:0090132,1,0.149696773766952,0,266,epithelium migration,BP,
17079,GO:0090133,1,0.996474806337136,0,1,mesendoderm migration,BP,
17080,GO:0090134,1,0.996474806337136,0,1,cell migration involved in mesendoderm migration,BP,
17081,GO:0090135,1,0.981110667884658,0,3,actin filament branching,BP,
17082,GO:0090136,1,0.891432711055656,0,15,epithelial cell-cell adhesion,BP,
17083,GO:0090138,1,0.992762537164016,0,1,regulation of actin cytoskeleton organization by cell-cell adhesion,BP,
17084,GO:0090140,1,0.84432680312283,0,23,regulation of mitochondrial fission,BP,
17085,GO:0090141,1,0.9017419094733,0,15,positive regulation of mitochondrial fission,BP,
17086,GO:0090143,1,0.996947126019585,0,1,nucleoid organization,BP,
17087,GO:0090144,1,0.996947126019585,0,1,mitochondrial nucleoid organization,BP,
17089,GO:0090149,1,0.986576954307463,0,2,mitochondrial membrane fission,BP,
17091,GO:0090151,1,0.768911280606095,0,47,establishment of protein localization to mitochondrial membrane,BP,
17092,GO:0090152,1,0.992614342582376,0,1,establishment of protein localization to mitochondrial membrane involved in mitochondrial fission,BP,
17093,GO:0090153,1,0.904919034380718,0,16,regulation of sphingolipid biosynthetic process,BP,
17094,GO:0090154,1,0.944549675223671,0,9,positive regulation of sphingolipid biosynthetic process,BP,
17095,GO:0090155,1,0.962123317342119,0,6,negative regulation of sphingolipid biosynthetic process,BP,
17096,GO:0090156,1,0.968925170364199,0,5,cellular sphingolipid homeostasis,BP,
17097,GO:0090158,1,0.97060834519282,0,5,endoplasmic reticulum membrane organization,BP,
17098,GO:0090160,1,0.940596115947637,0,9,Golgi to lysosome transport,BP,
17099,GO:0090161,1,0.891010639195253,0,14,Golgi ribbon formation,BP,
17100,GO:0090162,1,0.799626572713047,0,30,establishment of epithelial cell polarity,BP,
17101,GO:0090164,1,0.983383409363046,0,2,asymmetric Golgi ribbon formation,BP,
17102,GO:0090166,1,0.95765650334407,0,7,Golgi disassembly,BP,
17103,GO:0090168,1,0.973363812380304,0,4,Golgi reassembly,BP,
17104,GO:0090169,1,0.845234150114611,0,24,regulation of spindle assembly,BP,
17105,GO:0090170,1,0.977200427116709,0,4,regulation of Golgi inheritance,BP,
17106,GO:0090171,1,0.992692442912543,0,1,chondrocyte morphogenesis,BP,
17109,GO:0090176,1,0.977543583820831,0,3,microtubule cytoskeleton organization involved in establishment of planar polarity,BP,
17113,GO:0090181,1,0.684073682267326,0,56,regulation of cholesterol metabolic process,BP,
17114,GO:0090182,1,0.990447031624044,0,2,regulation of secretion of lysosomal enzymes,BP,
17115,GO:0090183,1,0.719965876047301,0,49,regulation of kidney development,BP,
17116,GO:0090184,1,0.795554514203679,0,35,positive regulation of kidney development,BP,
17117,GO:0090185,1,0.918303169366227,0,14,negative regulation of kidney development,BP,
17118,GO:0090186,1,0.965997546157414,0,5,regulation of pancreatic juice secretion,BP,
17119,GO:0090187,1,0.994734979912661,0,1,positive regulation of pancreatic juice secretion,BP,
17120,GO:0090188,1,0.971111965831957,0,4,negative regulation of pancreatic juice secretion,BP,
17121,GO:0090189,1,0.886312084315117,0,19,regulation of branching involved in ureteric bud morphogenesis,BP,
17122,GO:0090190,1,0.900102775772996,0,16,positive regulation of branching involved in ureteric bud morphogenesis,BP,
17123,GO:0090191,1,0.99006251877398,0,2,negative regulation of branching involved in ureteric bud morphogenesis,BP,
17124,GO:0090192,1,0.924705739726329,0,12,regulation of glomerulus development,BP,
17125,GO:0090193,1,0.942420699444955,0,9,positive regulation of glomerulus development,BP,
17126,GO:0090194,1,0.981213745694216,0,3,negative regulation of glomerulus development,BP,
17127,GO:0090199,1,0.770944137617805,0,46,regulation of release of cytochrome c from mitochondria,BP,
17128,GO:0090200,1,0.864158367831521,0,27,positive regulation of release of cytochrome c from mitochondria,BP,
17129,GO:0090201,1,0.891502997643143,0,19,negative regulation of release of cytochrome c from mitochondria,BP,
17130,GO:0090202,1,0.972470227114433,0,4,gene looping,BP,
17131,GO:0090204,1,0.982647202411278,0,3,protein localization to nuclear pore,BP,
17132,GO:0090205,1,0.945582452335539,0,8,positive regulation of cholesterol metabolic process,BP,
17133,GO:0090206,1,0.973907194484427,0,5,negative regulation of cholesterol metabolic process,BP,
17134,GO:0090207,1,0.822902400593709,0,31,regulation of triglyceride metabolic process,BP,
17135,GO:0090208,1,0.895085327291357,0,19,positive regulation of triglyceride metabolic process,BP,
17136,GO:0090209,1,0.949221633776362,0,7,negative regulation of triglyceride metabolic process,BP,
17137,GO:0090210,1,0.97877128412594,0,3,regulation of establishment of blood-brain barrier,BP,
17138,GO:0090212,1,0.986288650463655,0,2,negative regulation of establishment of blood-brain barrier,BP,
17139,GO:0090214,1,0.985967244877849,0,2,spongiotrophoblast layer developmental growth,BP,
17140,GO:0090215,1,0.992785780008114,0,1,regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity,BP,
17141,GO:0090216,1,0.992785780008114,0,1,positive regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity,BP,
17143,GO:0090219,1,0.979596804955186,0,3,negative regulation of lipid kinase activity,BP,
17144,GO:0090220,1,0.949454958878959,0,7,chromosome localization to nuclear envelope involved in homologous chromosome segregation,BP,
17145,GO:0090222,1,0.979932024441921,0,2,centrosome-templated microtubule nucleation,BP,
17147,GO:0090226,1,0.996761791636752,0,1,regulation of microtubule nucleation by Ran protein signal transduction,BP,
17148,GO:0090230,1,0.969723768044718,0,4,regulation of centromere complex assembly,BP,
17149,GO:0090231,1,0.912526272271999,0,14,regulation of spindle checkpoint,BP,
17150,GO:0090232,1,0.953160434560764,0,7,positive regulation of spindle checkpoint,BP,
17151,GO:0090233,1,0.993618374144912,0,1,negative regulation of spindle checkpoint,BP,
17152,GO:0090234,1,0.977426910386872,0,3,regulation of kinetochore assembly,BP,
17154,GO:0090237,1,0.96329501806387,0,6,regulation of arachidonic acid secretion,BP,
17155,GO:0090238,1,0.971136011663668,0,5,positive regulation of arachidonic acid secretion,BP,
17156,GO:0090239,1,0.917004170390358,0,14,regulation of histone H4 acetylation,BP,
17157,GO:0090240,1,0.958121447856916,0,7,positive regulation of histone H4 acetylation,BP,
17158,GO:0090241,1,0.966688725434492,0,6,negative regulation of histone H4 acetylation,BP,
17159,GO:0090242,1,0.99297526867013,0,1,retinoic acid receptor signaling pathway involved in somitogenesis,BP,
17161,GO:0090245,1,0.964419002874994,0,4,axis elongation involved in somitogenesis,BP,
17162,GO:0090246,1,0.992354350453992,0,1,convergent extension involved in somitogenesis,BP,
17163,GO:0090247,1,0.993759758138751,0,1,cell motility involved in somitogenic axis elongation,BP,
17164,GO:0090249,1,0.993759758138751,0,1,regulation of cell motility involved in somitogenic axis elongation,BP,
17165,GO:0090251,1,0.986608106700097,0,1,protein localization involved in establishment of planar polarity,BP,
17167,GO:0090258,1,0.972493024421272,0,4,negative regulation of mitochondrial fission,BP,
17168,GO:0090259,1,0.964925430882044,0,5,regulation of retinal ganglion cell axon guidance,BP,
17169,GO:0090260,1,0.98463315678473,0,2,negative regulation of retinal ganglion cell axon guidance,BP,
17170,GO:0090261,1,0.980038176718949,0,4,positive regulation of inclusion body assembly,BP,
17172,GO:0090264,1,0.984689125298498,0,3,regulation of immune complex clearance by monocytes and macrophages,BP,
17173,GO:0090265,1,0.989029631072687,0,2,positive regulation of immune complex clearance by monocytes and macrophages,BP,
17174,GO:0090266,1,0.912526272271999,0,14,regulation of mitotic cell cycle spindle assembly checkpoint,BP,
17175,GO:0090267,1,0.953160434560764,0,7,positive regulation of mitotic cell cycle spindle assembly checkpoint,BP,
17176,GO:0090269,1,0.943237381691554,0,8,fibroblast growth factor production,BP,
17177,GO:0090270,1,0.943237381691554,0,8,regulation of fibroblast growth factor production,BP,
17178,GO:0090271,1,0.962457315577176,0,5,positive regulation of fibroblast growth factor production,BP,
17179,GO:0090272,1,0.980037911555248,0,3,negative regulation of fibroblast growth factor production,BP,
17180,GO:0090273,1,0.986582562819912,0,2,regulation of somatostatin secretion,BP,
17181,GO:0090274,1,0.993052350907243,0,1,positive regulation of somatostatin secretion,BP,
17182,GO:0090275,1,0.993485400251684,0,1,negative regulation of somatostatin secretion,BP,
17186,GO:0090279,1,0.804318627012302,0,34,regulation of calcium ion import,BP,
17187,GO:0090280,1,0.890580208479424,0,18,positive regulation of calcium ion import,BP,
17188,GO:0090281,1,0.977833790542957,0,5,negative regulation of calcium ion import,BP,
17189,GO:0090282,1,0.993188256968927,0,1,positive regulation of transcription involved in G2/M transition of mitotic cell cycle,BP,
17190,GO:0090283,1,0.978958413584037,0,3,regulation of protein glycosylation in Golgi,BP,
17191,GO:0090284,1,0.989994016010219,0,1,positive regulation of protein glycosylation in Golgi,BP,
17192,GO:0090285,1,0.98885397351403,0,2,negative regulation of protein glycosylation in Golgi,BP,
17195,GO:0090289,1,0.981519751126954,0,3,regulation of osteoclast proliferation,BP,
17196,GO:0090290,1,0.996482363007194,0,1,positive regulation of osteoclast proliferation,BP,
17197,GO:0090291,1,0.984985095638803,0,2,negative regulation of osteoclast proliferation,BP,
17198,GO:0090292,1,0.966994029650274,0,3,nuclear matrix anchoring at nuclear membrane,BP,
17199,GO:0090293,1,0.994580882739056,0,1,nitrogen catabolite regulation of transcription,BP,
17200,GO:0090294,1,0.994580882739056,0,1,nitrogen catabolite activation of transcription,BP,
17201,GO:0090296,1,0.974023781998797,0,4,regulation of mitochondrial DNA replication,BP,
17202,GO:0090297,1,0.996139231213715,0,1,positive regulation of mitochondrial DNA replication,BP,
17203,GO:0090298,1,0.984932672680955,0,2,negative regulation of mitochondrial DNA replication,BP,
17204,GO:0090299,1,0.995511332060727,0,1,regulation of neural crest formation,BP,
17205,GO:0090301,1,0.995511332060727,0,1,negative regulation of neural crest formation,BP,
17206,GO:0090303,1,0.715115778926529,0,51,positive regulation of wound healing,BP,
17208,GO:0090305,1,0.163630365027242,0,280,nucleic acid phosphodiester bond hydrolysis,BP,
17211,GO:0090308,1,0.917988031487281,0,11,regulation of DNA methylation-dependent heterochromatin assembly,BP,
17212,GO:0090309,1,0.935234299541842,0,9,positive regulation of DNA methylation-dependent heterochromatin assembly,BP,
17213,GO:0090310,1,0.981571627852799,0,2,negative regulation of DNA methylation-dependent heterochromatin assembly,BP,
17214,GO:0090311,1,0.734818735096463,0,42,regulation of protein deacetylation,BP,
17215,GO:0090312,1,0.866208393356746,0,20,positive regulation of protein deacetylation,BP,
17218,GO:0090315,1,0.968995693585302,0,5,negative regulation of protein targeting to membrane,BP,
17220,GO:0090317,1,0.770407902828929,0,41,negative regulation of intracellular protein transport,BP,
17221,GO:0090322,1,0.833422950170584,0,32,regulation of superoxide metabolic process,BP,
17222,GO:0090323,1,0.99709334258388,0,1,prostaglandin secretion involved in immune response,BP,
17223,GO:0090324,1,0.962261039850264,0,6,negative regulation of oxidative phosphorylation,BP,
17224,GO:0090325,1,0.975015642504464,0,4,regulation of locomotion involved in locomotory behavior,BP,
17225,GO:0090326,1,0.992961790923873,0,1,positive regulation of locomotion involved in locomotory behavior,BP,
17226,GO:0090327,1,0.992535412985527,0,1,negative regulation of locomotion involved in locomotory behavior,BP,
17227,GO:0090329,1,0.715423422753985,0,50,regulation of DNA-dependent DNA replication,BP,
17228,GO:0090330,1,0.866559082187223,0,20,regulation of platelet aggregation,BP,
17229,GO:0090331,1,0.920765345964158,0,12,negative regulation of platelet aggregation,BP,
17230,GO:0090335,1,0.842633734472909,0,23,regulation of brown fat cell differentiation,BP,
17231,GO:0090336,1,0.888074274153648,0,16,positive regulation of brown fat cell differentiation,BP,
17232,GO:0090340,1,0.994734979912661,0,1,positive regulation of secretion of lysosomal enzymes,BP,
17233,GO:0090341,1,0.995689583688793,0,1,negative regulation of secretion of lysosomal enzymes,BP,
17235,GO:0090343,1,0.928890384437323,0,14,positive regulation of cell aging,BP,
17237,GO:0090345,1,0.989573487988021,0,2,cellular organohalogen metabolic process,BP,
17238,GO:0090346,1,0.989573487988021,0,2,cellular organofluorine metabolic process,BP,
17239,GO:0090347,1,0.995647054770847,0,1,regulation of cellular organohalogen metabolic process,BP,
17240,GO:0090348,1,0.995647054770847,0,1,regulation of cellular organofluorine metabolic process,BP,
17241,GO:0090349,1,0.995647054770847,0,1,negative regulation of cellular organohalogen metabolic process,BP,
17242,GO:0090350,1,0.995647054770847,0,1,negative regulation of cellular organofluorine metabolic process,BP,
17243,GO:0090357,1,0.996176625938231,0,1,regulation of tryptophan metabolic process,BP,
17244,GO:0090360,1,0.98185064250639,0,3,platelet-derived growth factor production,BP,
17245,GO:0090361,1,0.98185064250639,0,3,regulation of platelet-derived growth factor production,BP,
17246,GO:0090362,1,0.987038339381158,0,2,positive regulation of platelet-derived growth factor production,BP,
17247,GO:0090370,1,0.969677273648056,0,4,negative regulation of cholesterol efflux,BP,
17248,GO:0090381,1,0.953497226406413,0,7,regulation of heart induction,BP,
17249,GO:0090382,1,0.756250158812589,0,46,phagosome maturation,BP,
17250,GO:0090383,1,0.860062947651435,0,27,phagosome acidification,BP,
17251,GO:0090384,1,0.995061768613089,0,1,phagosome-lysosome docking,BP,
17252,GO:0090385,1,0.948315603349128,0,9,phagosome-lysosome fusion,BP,
17253,GO:0090386,1,0.982143654068157,0,2,phagosome maturation involved in apoptotic cell clearance,BP,
17254,GO:0090387,1,0.982143654068157,0,2,phagolysosome assembly involved in apoptotic cell clearance,BP,
17255,GO:0090389,1,0.98964742601672,0,1,phagosome-lysosome fusion involved in apoptotic cell clearance,BP,
17256,GO:0090394,1,0.92164524509895,0,11,negative regulation of excitatory postsynaptic potential,BP,
17257,GO:0090398,1,0.655642611328201,0,64,cellular senescence,BP,
17258,GO:0090399,1,0.908914106593686,0,13,replicative senescence,BP,
17259,GO:0090400,1,0.947929937541976,0,8,stress-induced premature senescence,BP,
17260,GO:0090402,1,0.988359254858549,0,2,oncogene-induced cell senescence,BP,
17261,GO:0090403,1,0.972613502935093,0,4,oxidative stress-induced premature senescence,BP,
17263,GO:0090409,1,0.994307466181525,0,1,malonyl-CoA synthetase activity,MF,
17264,GO:0090410,1,0.994307466181525,0,1,malonate catabolic process,BP,
17265,GO:0090416,1,0.993803435828213,0,1,nicotinate transmembrane transporter activity,MF,
17266,GO:0090420,1,0.995946459027794,0,1,naphthalene-containing compound metabolic process,BP,
17267,GO:0090422,1,0.989241324832522,0,2,thiamine pyrophosphate transmembrane transporter activity,MF,
17268,GO:0090425,1,0.993139384115289,0,1,acinar cell differentiation,BP,
17269,GO:0090427,1,0.979997051702648,0,3,activation of meiosis,BP,
17270,GO:0090429,1,0.995531636571884,0,1,detection of endogenous biotic stimulus,BP,
17271,GO:0090435,1,0.950916776450807,0,8,protein localization to nuclear envelope,BP,
17272,GO:0090443,1,0.978586609265337,0,3,FAR/SIN/STRIPAK complex,CC,
17273,GO:0090461,1,0.966964215148565,0,4,glutamate homeostasis,BP,
17274,GO:0090472,1,0.992520708549764,0,1,dibasic protein processing,BP,
17275,GO:0090480,1,0.9930210826683,0,1,purine nucleotide-sugar transmembrane transport,BP,
17276,GO:0090481,1,0.935471384033093,0,11,pyrimidine nucleotide-sugar transmembrane transport,BP,
17277,GO:0090482,1,0.837745228929603,0,27,vitamin transmembrane transporter activity,MF,
17278,GO:0090486,1,0.993485400251684,0,1,small RNA 2'-O-methyltransferase,MF,
17279,GO:0090493,1,0.908983828350792,0,17,catecholamine uptake,BP,
17280,GO:0090494,1,0.913331187539381,0,16,dopamine uptake,BP,
17281,GO:0090498,1,0.971566236238783,0,4,extrinsic component of Golgi membrane,CC,
17282,GO:0090500,1,0.978039344964527,0,4,endocardial cushion to mesenchymal transition,BP,
17283,GO:0090501,1,0.400743206950594,0,144,RNA phosphodiester bond hydrolysis,BP,
17284,GO:0090502,1,0.616908045659166,0,75,RNA phosphodiester bond hydrolysis, endonucleolytic,BP,
17285,GO:0090503,1,0.759698142739754,0,42,RNA phosphodiester bond hydrolysis, exonucleolytic,BP,
17286,GO:0090504,1,0.809188107934054,0,28,epiboly,BP,
17287,GO:0090505,1,0.819926049843561,0,27,epiboly involved in wound healing,BP,
17288,GO:0090520,1,0.93166087561158,0,11,sphingolipid mediated signaling pathway,BP,
17289,GO:0090521,1,0.969668433147004,0,4,glomerular visceral epithelial cell migration,BP,
17290,GO:0090522,1,0.993309731517387,0,1,vesicle tethering involved in exocytosis,BP,
17291,GO:0090527,1,0.933095764667324,0,10,actin filament reorganization,BP,
17292,GO:0090529,1,0.995168540831618,0,1,cell septum assembly,BP,
17293,GO:0090533,1,0.897430962571862,0,18,cation-transporting ATPase complex,CC,
17294,GO:0090534,1,0.995427264223568,0,1,calcium ion-transporting ATPase complex,CC,
17295,GO:0090537,1,0.984036091913787,0,2,CERF complex,CC,
17296,GO:0090541,1,0.985941619466469,0,2,MIT domain binding,MF,
17297,GO:0090543,1,0.803786846408031,0,30,Flemming body,CC,
17298,GO:0090545,1,0.886794617438606,0,15,CHD-type complex,CC,
17299,GO:0090554,1,0.956332325558131,0,5,phosphatidylcholine floppase activity,MF,
17300,GO:0090555,1,0.982008950513387,0,2,phosphatidylethanolamine flippase activity,MF,
17301,GO:0090556,1,0.977805565933432,0,2,phosphatidylserine floppase activity,MF,
17304,GO:0090560,1,0.994566097678582,0,1,2-(3-amino-3-carboxypropyl)histidine synthase activity,MF,
17305,GO:0090571,1,0.966399864106861,0,6,RNA polymerase II transcription repressor complex,CC,
17306,GO:0090575,1,0.362426958381288,0,152,RNA polymerase II transcription regulator complex,CC,
17307,GO:0090576,1,0.935744552343205,0,9,RNA polymerase III transcription regulator complex,CC,
17308,GO:0090579,1,0.972470227114433,0,4,dsDNA loop formation,BP,
17309,GO:0090594,1,0.93149668442599,0,13,inflammatory response to wounding,BP,
17311,GO:0090598,1,0.976748037961699,0,4,male anatomical structure morphogenesis,BP,
17312,GO:0090599,1,0.959032857019971,0,5,alpha-glucosidase activity,MF,
17313,GO:0090600,1,0.992659962892898,0,1,alpha-1,3-glucosidase activity,MF,
17314,GO:0090601,1,0.991828016275873,0,1,enucleation,BP,
17315,GO:0090611,1,0.96992556031417,0,5,ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway,BP,
17316,GO:0090615,1,0.987330383321514,0,2,mitochondrial mRNA processing,BP,
17317,GO:0090616,1,0.992260625091134,0,1,mitochondrial mRNA 3'-end processing,BP,
17318,GO:0090618,1,0.982959514395674,0,2,DNA clamp unloading,BP,
17319,GO:0090624,1,0.98701281886265,0,2,endoribonuclease activity, cleaving miRNA-paired mRNA,MF,
17320,GO:0090625,1,0.993485400251684,0,1,mRNA cleavage involved in gene silencing by siRNA,BP,
17321,GO:0090630,1,0.490773902884517,0,95,activation of GTPase activity,BP,
17322,GO:0090634,1,0.985070361477399,0,3,microglial cell mediated cytotoxicity,BP,
17323,GO:0090646,1,0.931362415501269,0,12,mitochondrial tRNA processing,BP,
17324,GO:0090647,1,0.948563736800754,0,8,modulation of age-related behavioral decline,BP,
17325,GO:0090648,1,0.990867991998989,0,1,response to environmental enrichment,BP,
17326,GO:0090649,1,0.932758450287871,0,10,response to oxygen-glucose deprivation,BP,
17327,GO:0090650,1,0.94038171082438,0,8,cellular response to oxygen-glucose deprivation,BP,
17328,GO:0090651,1,0.979984961018202,0,3,apical cytoplasm,CC,
17329,GO:0090656,1,0.904165083853675,0,14,t-circle formation,BP,
17330,GO:0090657,1,0.93066343948584,0,10,telomeric loop disassembly,BP,
17331,GO:0090659,1,0.802205927311037,0,29,walking behavior,BP,
17332,GO:0090660,1,0.97523605427067,0,4,cerebrospinal fluid circulation,BP,
17333,GO:0090661,1,0.984139673719446,0,4,box H/ACA telomerase RNP complex,CC,
17334,GO:0090663,1,0.992448893968116,0,2,galanin-activated signaling pathway,BP,
17335,GO:0090665,1,0.873734664468442,0,19,glycoprotein complex,CC,
17336,GO:0090666,1,0.972456359526584,0,5,scaRNA localization to Cajal body,BP,
17337,GO:0090667,1,0.989462688882402,0,1,cell chemotaxis to vascular endothelial growth factor,BP,
17338,GO:0090668,1,0.989462688882402,0,1,endothelial cell chemotaxis to vascular endothelial growth factor,BP,
17339,GO:0090669,1,0.975267358982539,0,4,telomerase RNA stabilization,BP,
17340,GO:0090670,1,0.897816454323126,0,19,RNA localization to Cajal body,BP,
17341,GO:0090671,1,0.897816454323126,0,19,telomerase RNA localization to Cajal body,BP,
17342,GO:0090672,1,0.897816454323126,0,19,telomerase RNA localization,BP,
17343,GO:0090673,1,0.965604527725195,0,5,endothelial cell-matrix adhesion,BP,
17344,GO:0090674,1,0.975450186813801,0,4,endothelial cell-matrix adhesion via fibronectin,BP,
17345,GO:0090675,1,0.99249492309276,0,1,intermicrovillar adhesion,BP,
17346,GO:0090677,1,0.969284158327501,0,5,reversible differentiation,BP,
17347,GO:0090678,1,0.988519496290071,0,2,cell dedifferentiation involved in phenotypic switching,BP,
17348,GO:0090679,1,0.980543491812181,0,3,cell differentiation involved in phenotypic switching,BP,
17349,GO:0090685,1,0.897816454323126,0,19,RNA localization to nucleus,BP,
17350,GO:0090694,1,0.981156989793675,0,2,Scc2-Scc4 cohesin loading complex,CC,
17351,GO:0090713,1,0.933909903788607,0,11,immunological memory process,BP,
17352,GO:0090715,1,0.946247736682461,0,8,immunological memory formation process,BP,
17353,GO:0090716,1,0.986968473171057,0,3,adaptive immune memory response,BP,
17354,GO:0090720,1,0.988388418482625,0,1,primary adaptive immune response,BP,
17355,GO:0090721,1,0.988388418482625,0,1,primary adaptive immune response involving T cells and B cells,BP,
17356,GO:0090722,1,0.974709622627506,0,4,receptor-receptor interaction,MF,
17357,GO:0090724,1,0.97458438832241,0,4,central region of growth cone,CC,
17358,GO:0090725,1,0.996688208883873,0,1,peripheral region of growth cone,CC,
17359,GO:0090730,1,0.99401462191154,0,1,Las1 complex,CC,
17360,GO:0090731,1,0.996286622576736,0,1,cellular response to very-low-density lipoprotein particle stimulus,BP,
17361,GO:0090734,1,0.620676167991508,0,68,site of DNA damage,CC,
17362,GO:0090735,1,0.966410526655501,0,6,DNA repair complex assembly,BP,
17363,GO:0090737,1,0.904165083853675,0,14,telomere maintenance via telomere trimming,BP,
17364,GO:0090741,1,0.930293597096598,0,13,pigment granule membrane,CC,
17366,GO:0097001,1,0.923365161267775,0,13,ceramide binding,MF,
17367,GO:0097003,1,0.987285499534316,0,2,adipokinetic hormone receptor activity,MF,
17368,GO:0097006,1,0.609160094585361,0,77,regulation of plasma lipoprotein particle levels,BP,
17370,GO:0097010,1,0.978400958928554,0,3,eukaryotic translation initiation factor 4F complex assembly,BP,
17371,GO:0097011,1,0.949709298562706,0,8,cellular response to granulocyte macrophage colony-stimulating factor stimulus,BP,
17372,GO:0097012,1,0.949709298562706,0,8,response to granulocyte macrophage colony-stimulating factor,BP,
17373,GO:0097013,1,0.980614695801347,0,4,phagocytic vesicle lumen,CC,
17375,GO:0097016,1,0.977266074124958,0,4,L27 domain binding,MF,
17376,GO:0097017,1,0.987476104486697,0,2,renal protein absorption,BP,
17377,GO:0097018,1,0.99390366202136,0,1,renal albumin absorption,BP,
17378,GO:0097020,1,0.992916863025035,0,1,COPII adaptor activity,MF,
17379,GO:0097021,1,0.958148477982167,0,6,lymphocyte migration into lymphoid organs,BP,
17380,GO:0097022,1,0.982056619331215,0,2,lymphocyte migration into lymph node,BP,
17381,GO:0097025,1,0.969224135978139,0,5,MPP7-DLG1-LIN7 complex,CC,
17382,GO:0097026,1,0.977610675539519,0,4,dendritic cell dendrite assembly,BP,
17383,GO:0097027,1,0.953114440679957,0,8,ubiquitin-protein transferase activator activity,MF,
17384,GO:0097028,1,0.791326684199937,0,41,dendritic cell differentiation,BP,
17385,GO:0097029,1,0.98148717202044,0,4,mature conventional dendritic cell differentiation,BP,
17386,GO:0097035,1,0.687733758542704,0,48,regulation of membrane lipid distribution,BP,
17387,GO:0097036,1,0.995890670052125,0,1,regulation of plasma membrane sterol distribution,BP,
17388,GO:0097037,1,0.982624031019153,0,3,heme export,BP,
17389,GO:0097038,1,0.866672134859064,0,20,perinuclear endoplasmic reticulum,CC,
17390,GO:0097039,1,0.97094436398259,0,4,protein linear polyubiquitination,BP,
17391,GO:0097045,1,0.992125324867527,0,1,phosphatidylserine exposure on blood platelet,BP,
17392,GO:0097048,1,0.937193289494245,0,11,dendritic cell apoptotic process,BP,
17393,GO:0097049,1,0.949193705240618,0,8,motor neuron apoptotic process,BP,
17394,GO:0097050,1,0.92835329600356,0,10,type B pancreatic cell apoptotic process,BP,
17395,GO:0097051,1,0.974820192693759,0,3,establishment of protein localization to endoplasmic reticulum membrane,BP,
17396,GO:0097052,1,0.970514803273346,0,5,L-kynurenine metabolic process,BP,
17397,GO:0097053,1,0.989821664662049,0,2,L-kynurenine catabolic process,BP,
17398,GO:0097055,1,0.988005467760038,0,2,agmatine biosynthetic process,BP,
17399,GO:0097056,1,0.981669376503526,0,3,selenocysteinyl-tRNA(Sec) biosynthetic process,BP,
17400,GO:0097057,1,0.990930768819027,0,2,TRAF2-GSTP1 complex,CC,
17401,GO:0097058,1,0.990538365571774,0,2,CRLF-CLCF1 complex,CC,
17402,GO:0097059,1,0.990190607142775,0,2,CNTFR-CLCF1 complex,CC,
17406,GO:0097064,1,0.779047172868812,0,35,ncRNA export from nucleus,BP,
17407,GO:0097065,1,0.959168010070109,0,6,anterior head development,BP,
17408,GO:0097066,1,0.854229886420762,0,23,response to thyroid hormone,BP,
17409,GO:0097067,1,0.890303616430261,0,16,cellular response to thyroid hormone stimulus,BP,
17410,GO:0097068,1,0.971987525232483,0,4,response to thyroxine,BP,
17411,GO:0097069,1,0.985919454616231,0,2,cellular response to thyroxine stimulus,BP,
17412,GO:0097070,1,0.96290235858687,0,5,ductus arteriosus closure,BP,
17413,GO:0097079,1,0.993003767187949,0,1,selenite:proton symporter activity,MF,
17414,GO:0097080,1,0.993003767187949,0,1,plasma membrane selenite transport,BP,
17415,GO:0097084,1,0.94420744315095,0,9,vascular associated smooth muscle cell development,BP,
17416,GO:0097086,1,0.992766099088992,0,1,amniotic stem cell differentiation,BP,
17417,GO:0097089,1,0.984641678916319,0,3,methyl-branched fatty acid metabolic process,BP,
17418,GO:0097090,1,0.911108268951845,0,11,presynaptic membrane organization,BP,
17419,GO:0097091,1,0.876726403326116,0,16,synaptic vesicle clustering,BP,
17420,GO:0097094,1,0.894982605309988,0,15,craniofacial suture morphogenesis,BP,
17421,GO:0097100,1,0.971430150574218,0,5,supercoiled DNA binding,MF,
17422,GO:0097101,1,0.981184533263892,0,3,blood vessel endothelial cell fate specification,BP,
17423,GO:0097102,1,0.986934229417105,0,2,endothelial tip cell fate specification,BP,
17424,GO:0097104,1,0.901851092180837,0,12,postsynaptic membrane assembly,BP,
17425,GO:0097105,1,0.920648351738363,0,10,presynaptic membrane assembly,BP,
17426,GO:0097106,1,0.765926257212169,0,32,postsynaptic density organization,BP,
17427,GO:0097107,1,0.860731692853299,0,18,postsynaptic density assembly,BP,
17428,GO:0097108,1,0.975112407508708,0,3,hedgehog family protein binding,MF,
17429,GO:0097109,1,0.959448914984064,0,5,neuroligin family protein binding,MF,
17430,GO:0097110,1,0.639684121570657,0,60,scaffold protein binding,MF,
17431,GO:0097111,1,0.981093343981798,0,2,endoplasmic reticulum-Golgi intermediate compartment organization,BP,
17432,GO:0097112,1,0.969104953017663,0,4,gamma-aminobutyric acid receptor clustering,BP,
17433,GO:0097113,1,0.928906321995667,0,9,AMPA glutamate receptor clustering,BP,
17434,GO:0097114,1,0.965255983328937,0,4,NMDA glutamate receptor clustering,BP,
17435,GO:0097115,1,0.992020899761351,0,1,neurexin clustering involved in presynaptic membrane assembly,BP,
17436,GO:0097116,1,0.971450223823631,0,3,gephyrin clustering involved in postsynaptic density assembly,BP,
17437,GO:0097117,1,0.990065434711878,0,1,guanylate kinase-associated protein clustering,BP,
17438,GO:0097118,1,0.962195161014617,0,4,neuroligin clustering involved in postsynaptic membrane assembly,BP,
17439,GO:0097119,1,0.924713214896762,0,9,postsynaptic density protein 95 clustering,BP,
17441,GO:0097123,1,0.989483793682359,0,2,cyclin A1-CDK2 complex,CC,
17442,GO:0097124,1,0.978970316902769,0,4,cyclin A2-CDK2 complex,CC,
17443,GO:0097125,1,0.990079644038872,0,2,cyclin B1-CDK1 complex,CC,
17444,GO:0097129,1,0.992050193856074,0,2,cyclin D2-CDK4 complex,CC,
17445,GO:0097132,1,0.986420371999679,0,1,cyclin D2-CDK6 complex,CC,
17446,GO:0097134,1,0.983160194504703,0,3,cyclin E1-CDK2 complex,CC,
17447,GO:0097135,1,0.98797481559109,0,2,cyclin E2-CDK2 complex,CC,
17448,GO:0097136,1,0.963334911521013,0,6,Bcl-2 family protein complex,CC,
17449,GO:0097144,1,0.996784759901968,0,1,BAX complex,CC,
17450,GO:0097145,1,0.991296588678177,0,2,BAK complex,CC,
17451,GO:0097149,1,0.978598299221373,0,3,centralspindlin complex,CC,
17453,GO:0097151,1,0.942243496827028,0,7,positive regulation of inhibitory postsynaptic potential,BP,
17454,GO:0097152,1,0.927492086575262,0,12,mesenchymal cell apoptotic process,BP,
17455,GO:0097153,1,0.93525353871693,0,13,cysteine-type endopeptidase activity involved in apoptotic process,MF,
17456,GO:0097154,1,0.921059784151078,0,13,GABAergic neuron differentiation,BP,
17457,GO:0097155,1,0.970465810311665,0,3,fasciculation of sensory neuron axon,BP,
17458,GO:0097156,1,0.983320419875596,0,2,fasciculation of motor neuron axon,BP,
17459,GO:0097157,1,0.9216511253395,0,12,pre-mRNA intronic binding,MF,
17460,GO:0097158,1,0.990536104327511,0,2,pre-mRNA intronic pyrimidine-rich binding,MF,
17462,GO:0097161,1,0.990765690448049,0,1,DH domain binding,MF,
17463,GO:0097162,1,0.992973903647485,0,1,MADS box domain binding,MF,
17464,GO:0097163,1,0.99571067543421,0,1,sulfur carrier activity,MF,
17465,GO:0097164,1,0.844056905288379,0,24,ammonium ion metabolic process,BP,
17466,GO:0097165,1,0.961521970228806,0,6,nuclear stress granule,CC,
17467,GO:0097166,1,0.983736271071255,0,2,lens epithelial cell proliferation,BP,
17468,GO:0097167,1,0.973307501500385,0,4,circadian regulation of translation,BP,
17469,GO:0097168,1,0.973619572293969,0,5,mesenchymal stem cell proliferation,BP,
17470,GO:0097169,1,0.985068761793181,0,4,AIM2 inflammasome complex,CC,
17471,GO:0097176,1,0.973356583242962,0,5,epoxide metabolic process,BP,
17472,GO:0097177,1,0.981145113592862,0,4,mitochondrial ribosome binding,MF,
17473,GO:0097178,1,0.77900382043732,0,39,ruffle assembly,BP,
17474,GO:0097179,1,0.983234098660023,0,4,protease inhibitor complex,CC,
17475,GO:0097180,1,0.989826286371668,0,2,serine protease inhibitor complex,CC,
17476,GO:0097181,1,0.994261390993069,0,1,protein C inhibitor-coagulation factor V complex,CC,
17477,GO:0097182,1,0.994261390993069,0,1,protein C inhibitor-coagulation factor Xa complex,CC,
17478,GO:0097183,1,0.994261390993069,0,1,protein C inhibitor-coagulation factor XI complex,CC,
17479,GO:0097186,1,0.885464502966206,0,17,amelogenesis,BP,
17480,GO:0097187,1,0.959817181903588,0,6,dentinogenesis,BP,
17481,GO:0097188,1,0.993773947599345,0,1,dentin mineralization,BP,
17484,GO:0097192,1,0.64903579514274,0,69,extrinsic apoptotic signaling pathway in absence of ligand,BP,
17487,GO:0097195,1,0.981609163486804,0,3,pilomotor reflex,BP,
17488,GO:0097196,1,0.988509461117589,0,2,Shu complex,CC,
17489,GO:0097197,1,0.937634080394989,0,10,tetraspanin-enriched microdomain,CC,
17490,GO:0097198,1,0.957995985781555,0,5,histone H3-K36 trimethylation,BP,
17491,GO:0097199,1,0.951209570754864,0,9,cysteine-type endopeptidase activity involved in apoptotic signaling pathway,MF,
17492,GO:0097200,1,0.951897284553278,0,8,cysteine-type endopeptidase activity involved in execution phase of apoptosis,MF,
17493,GO:0097201,1,0.92682505833493,0,12,negative regulation of transcription from RNA polymerase II promoter in response to stress,BP,
17494,GO:0097202,1,0.905068595449168,0,15,activation of cysteine-type endopeptidase activity,BP,
17495,GO:0097205,1,0.873976290898664,0,19,renal filtration,BP,
17496,GO:0097208,1,0.96610231729958,0,6,alveolar lamellar body,CC,
17497,GO:0097209,1,0.972775181119093,0,4,epidermal lamellar body,CC,
17498,GO:0097210,1,0.968114713009654,0,5,response to gonadotropin-releasing hormone,BP,
17499,GO:0097211,1,0.968114713009654,0,5,cellular response to gonadotropin-releasing hormone,BP,
17500,GO:0097212,1,0.986451200655531,0,3,lysosomal membrane organization,BP,
17501,GO:0097213,1,0.991490038806373,0,2,regulation of lysosomal membrane permeability,BP,
17502,GO:0097214,1,0.997069464423729,0,1,positive regulation of lysosomal membrane permeability,BP,
17503,GO:0097222,1,0.992260625091134,0,1,mitochondrial mRNA polyadenylation,BP,
17504,GO:0097224,1,0.957300565392084,0,7,sperm connecting piece,CC,
17505,GO:0097225,1,0.874432747117936,0,22,sperm midpiece,CC,
17506,GO:0097227,1,0.990875059135912,0,1,sperm annulus,CC,
17507,GO:0097228,1,0.875143773717282,0,20,sperm principal piece,CC,
17508,GO:0097229,1,0.989571045144924,0,2,sperm end piece,CC,
17509,GO:0097232,1,0.983508192535227,0,2,lamellar body membrane,CC,
17510,GO:0097233,1,0.983508192535227,0,2,alveolar lamellar body membrane,CC,
17512,GO:0097238,1,0.992585195838444,0,2,cellular response to methylglyoxal,BP,
17513,GO:0097240,1,0.987999883516934,0,2,chromosome attachment to the nuclear envelope,BP,
17514,GO:0097241,1,0.97662540278701,0,4,hematopoietic stem cell migration to bone marrow,BP,
17515,GO:0097242,1,0.771373725722098,0,33,amyloid-beta clearance,BP,
17516,GO:0097243,1,0.991345921731315,0,2,flavonoid binding,MF,
17517,GO:0097250,1,0.977842771034614,0,6,mitochondrial respirasome assembly,BP,
17518,GO:0097252,1,0.969857628293418,0,4,oligodendrocyte apoptotic process,BP,
17519,GO:0097254,1,0.99464899193912,0,1,renal tubular secretion,BP,
17520,GO:0097255,1,0.976488687072154,0,5,R2TP complex,CC,
17521,GO:0097264,1,0.960474065738387,0,6,self proteolysis,BP,
17522,GO:0097267,1,0.973003672731281,0,4,omega-hydroxylase P450 pathway,BP,
17523,GO:0097268,1,0.978700184799638,0,3,cytoophidium,CC,
17524,GO:0097272,1,0.986858613558802,0,2,ammonium homeostasis,BP,
17525,GO:0097273,1,0.991287560777608,0,1,creatinine homeostasis,BP,
17526,GO:0097274,1,0.984209975685978,0,2,urea homeostasis,BP,
17527,GO:0097275,1,0.991287560777608,0,1,cellular ammonium homeostasis,BP,
17528,GO:0097276,1,0.991287560777608,0,1,cellular creatinine homeostasis,BP,
17529,GO:0097277,1,0.991287560777608,0,1,cellular urea homeostasis,BP,
17530,GO:0097278,1,0.947127866743092,0,8,complement-dependent cytotoxicity,BP,
17531,GO:0097281,1,0.995531636571884,0,1,immune complex formation,BP,
17532,GO:0097283,1,0.971030687778387,0,5,keratinocyte apoptotic process,BP,
17533,GO:0097284,1,0.92406493070755,0,12,hepatocyte apoptotic process,BP,
17534,GO:0097291,1,0.994867226400395,0,1,renal phosphate ion absorption,BP,
17535,GO:0097296,1,0.973404055789908,0,4,activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
17536,GO:0097298,1,0.992649818073052,0,1,regulation of nucleus size,BP,
17537,GO:0097300,1,0.771945903133159,0,41,programmed necrotic cell death,BP,
17540,GO:0097309,1,0.98701281886265,0,2,cap1 mRNA methylation,BP,
17541,GO:0097310,1,0.993485400251684,0,1,cap2 mRNA methylation,BP,
17542,GO:0097320,1,0.883568578548842,0,18,plasma membrane tubulation,BP,
17543,GO:0097322,1,0.948059644413509,0,8,7SK snRNA binding,MF,
17544,GO:0097323,1,0.989531097153526,0,2,B cell adhesion,BP,
17545,GO:0097324,1,0.980277256884863,0,2,melanocyte migration,BP,
17546,GO:0097325,1,0.978294219223943,0,3,melanocyte proliferation,BP,
17547,GO:0097326,1,0.991803495022634,0,1,melanocyte adhesion,BP,
17548,GO:0097327,1,0.965982748811228,0,6,response to antineoplastic agent,BP,
17549,GO:0097332,1,0.989373630763171,0,2,response to antipsychotic drug,BP,
17550,GO:0097338,1,0.977860869612718,0,3,response to clozapine,BP,
17551,GO:0097340,1,0.940908682074341,0,10,inhibition of cysteine-type endopeptidase activity,BP,
17552,GO:0097341,1,0.940908682074341,0,10,zymogen inhibition,BP,
17553,GO:0097342,1,0.961773142678763,0,6,ripoptosome,CC,
17554,GO:0097343,1,0.974470069948528,0,3,ripoptosome assembly,BP,
17555,GO:0097344,1,0.988861752874016,0,2,Rix1 complex,CC,
17556,GO:0097345,1,0.731544370250788,0,53,mitochondrial outer membrane permeabilization,BP,
17557,GO:0097346,1,0.852331114942082,0,25,INO80-type complex,CC,
17558,GO:0097350,1,0.968084042823515,0,5,neutrophil clearance,BP,
17560,GO:0097354,1,0.932874242294015,0,10,prenylation,BP,
17561,GO:0097355,1,0.995555341111532,0,1,protein localization to heterochromatin,BP,
17562,GO:0097356,1,0.983433164297616,0,2,perinucleolar compartment,CC,
17563,GO:0097359,1,0.979106992063603,0,2,UDP-glucosylation,BP,
17564,GO:0097360,1,0.968185526020019,0,4,chorionic trophoblast cell proliferation,BP,
17565,GO:0097361,1,0.985401115930272,0,2,CIA complex,CC,
17566,GO:0097362,1,0.986764838496335,0,2,MCM8-MCM9 complex,CC,
17567,GO:0097363,1,0.978664722762862,0,3,protein O-GlcNAc transferase activity,MF,
17569,GO:0097368,1,0.961344110633006,0,5,establishment of Sertoli cell barrier,BP,
17570,GO:0097370,1,0.993485400251684,0,1,protein O-GlcNAcylation via threonine,BP,
17571,GO:0097371,1,0.948429332753794,0,7,MDM2/MDM4 family protein binding,MF,
17572,GO:0097372,1,0.995412779025815,0,1,NAD-dependent histone deacetylase activity (H3-K18 specific),MF,
17573,GO:0097374,1,0.981759619509189,0,3,sensory neuron axon guidance,BP,
17574,GO:0097376,1,0.990234597226806,0,2,interneuron axon guidance,BP,
17575,GO:0097377,1,0.99429207418561,0,1,spinal cord interneuron axon guidance,BP,
17576,GO:0097378,1,0.99429207418561,0,1,dorsal spinal cord interneuron axon guidance,BP,
17577,GO:0097380,1,0.99429207418561,0,1,dorsal spinal cord interneuron anterior axon guidance,BP,
17578,GO:0097381,1,0.89906757600053,0,16,photoreceptor disc membrane,CC,
17579,GO:0097384,1,0.931375540592807,0,10,cellular lipid biosynthetic process,BP,
17581,GO:0097393,1,0.986811811721545,0,1,telomeric repeat-containing RNA transcription,BP,
17582,GO:0097394,1,0.986811811721545,0,1,telomeric repeat-containing RNA transcription by RNA polymerase II,BP,
17583,GO:0097396,1,0.962231426449242,0,6,response to interleukin-17,BP,
17584,GO:0097398,1,0.962231426449242,0,6,cellular response to interleukin-17,BP,
17585,GO:0097400,1,0.962231426449242,0,6,interleukin-17-mediated signaling pathway,BP,
17587,GO:0097402,1,0.983723556855875,0,2,neuroblast migration,BP,
17588,GO:0097403,1,0.993187263281211,0,1,cellular response to raffinose,BP,
17589,GO:0097409,1,0.99495657552065,0,1,glial cytoplasmic inclusion,CC,
17590,GO:0097411,1,0.964085336027403,0,5,hypoxia-inducible factor-1alpha signaling pathway,BP,
17591,GO:0097413,1,0.960741693733316,0,7,Lewy body,CC,
17592,GO:0097414,1,0.99495657552065,0,1,classical Lewy body,CC,
17595,GO:0097422,1,0.967259407942587,0,5,tubular endosome,CC,
17596,GO:0097427,1,0.957546066103884,0,6,microtubule bundle,CC,
17597,GO:0097428,1,0.955170170592316,0,10,protein maturation by iron-sulfur cluster transfer,BP,
17599,GO:0097433,1,0.969650491510968,0,5,dense body,CC,
17604,GO:0097443,1,0.954980556409408,0,6,sorting endosome,CC,
17605,GO:0097444,1,0.974336426655738,0,4,spine apparatus,CC,
17608,GO:0097450,1,0.950972072666833,0,7,astrocyte end-foot,CC,
17609,GO:0097451,1,0.98524474539478,0,2,glial limiting end-foot,CC,
17610,GO:0097452,1,0.982925526312876,0,3,GAIT complex,CC,
17611,GO:0097453,1,0.994080638833962,0,1,mesaxon,CC,
17612,GO:0097454,1,0.97685833647629,0,3,Schwann cell microvillus,CC,
17613,GO:0097457,1,0.963676443456083,0,4,hippocampal mossy fiber,CC,
17614,GO:0097462,1,0.99495657552065,0,1,Lewy neurite,CC,
17615,GO:0097466,1,0.970344398838499,0,4,ubiquitin-dependent glycoprotein ERAD pathway,BP,
17616,GO:0097468,1,0.936275893121832,0,11,programmed cell death in response to reactive oxygen species,BP,
17618,GO:0097472,1,0.836885942833039,0,28,cyclin-dependent protein kinase activity,MF,
17619,GO:0097473,1,0.991729149257186,0,1,retinal rod cell apoptotic process,BP,
17620,GO:0097474,1,0.984538231982592,0,2,retinal cone cell apoptotic process,BP,
17621,GO:0097475,1,0.967367603975231,0,4,motor neuron migration,BP,
17622,GO:0097476,1,0.980292576801674,0,2,spinal cord motor neuron migration,BP,
17623,GO:0097477,1,0.980292576801674,0,2,lateral motor column neuron migration,BP,
17626,GO:0097485,1,0.117311047774523,0,272,neuron projection guidance,BP,
17627,GO:0097486,1,0.980469884413304,0,5,multivesicular body lumen,CC,
17628,GO:0097487,1,0.973281332990473,0,4,multivesicular body, internal vesicle,CC,
17629,GO:0097489,1,0.993808527349901,0,1,multivesicular body, internal vesicle lumen,CC,
17630,GO:0097490,1,0.970123473865668,0,4,sympathetic neuron projection extension,BP,
17631,GO:0097491,1,0.970123473865668,0,4,sympathetic neuron projection guidance,BP,
17632,GO:0097493,1,0.88266086075374,0,11,structural molecule activity conferring elasticity,MF,
17633,GO:0097494,1,0.945083124643446,0,9,regulation of vesicle size,BP,
17634,GO:0097497,1,0.993062786970625,0,1,blood vessel endothelial cell delamination,BP,
17635,GO:0097498,1,0.986275147555727,0,2,endothelial tube lumen extension,BP,
17636,GO:0097499,1,0.923225291054788,0,11,protein localization to non-motile cilium,BP,
17637,GO:0097500,1,0.970025521631694,0,4,receptor localization to non-motile cilium,BP,
17638,GO:0097501,1,0.949313348069123,0,13,stress response to metal ion,BP,
17639,GO:0097502,1,0.80458689816477,0,33,mannosylation,BP,
17641,GO:0097504,1,0.928328059326905,0,12,Gemini of coiled bodies,CC,
17642,GO:0097505,1,0.991310802262006,0,1,Rad6-Rad18 complex,CC,
17643,GO:0097506,1,0.979403425052703,0,4,deaminated base DNA N-glycosylase activity,MF,
17644,GO:0097510,1,0.994773517703667,0,1,base-excision repair, AP site formation via deaminated base removal,BP,
17646,GO:0097513,1,0.97002609668252,0,3,myosin II filament,CC,
17647,GO:0097517,1,0.628277616541083,0,62,contractile actin filament bundle,CC,
17648,GO:0097519,1,0.990576053608635,0,1,DNA recombinase complex,CC,
17649,GO:0097524,1,0.956684478030883,0,6,sperm plasma membrane,CC,
17650,GO:0097525,1,0.742498817590334,0,55,spliceosomal snRNP complex,CC,
17651,GO:0097526,1,0.857903752391012,0,30,spliceosomal tri-snRNP complex,CC,
17652,GO:0097527,1,0.955820258845096,0,8,necroptotic signaling pathway,BP,
17653,GO:0097528,1,0.98953461691113,0,2,execution phase of necroptosis,BP,
17654,GO:0097529,1,0.356041375453629,0,180,myeloid leukocyte migration,BP,
17655,GO:0097530,1,0.511690232203445,0,119,granulocyte migration,BP,
17656,GO:0097531,1,0.933493722151997,0,11,mast cell migration,BP,
17657,GO:0097532,1,0.98840688990455,0,2,stress response to acid chemical,BP,
17658,GO:0097533,1,0.98840688990455,0,2,cellular stress response to acid chemical,BP,
17659,GO:0097534,1,0.989601986290849,0,1,lymphoid lineage cell migration,BP,
17660,GO:0097535,1,0.989601986290849,0,1,lymphoid lineage cell migration into thymus,BP,
17661,GO:0097536,1,0.99464899193912,0,1,thymus epithelium morphogenesis,BP,
17663,GO:0097541,1,0.993485400251684,0,1,axonemal basal plate,CC,
17664,GO:0097542,1,0.746909338853049,0,42,ciliary tip,CC,
17665,GO:0097543,1,0.986181388270795,0,2,ciliary inversin compartment,CC,
17666,GO:0097546,1,0.837908924701011,0,27,ciliary base,CC,
17667,GO:0097549,1,0.615349272518441,0,67,chromatin organization involved in negative regulation of transcription,BP,
17668,GO:0097550,1,0.95156112328689,0,9,transcription preinitiation complex,CC,
17670,GO:0097573,1,0.996013892574913,0,1,glutathione oxidoreductase activity,MF,
17671,GO:0097574,1,0.983262410213887,0,2,lateral part of cell,CC,
17672,GO:0097575,1,0.983262410213887,0,2,lateral cell cortex,CC,
17673,GO:0097576,1,0.972699759822508,0,5,vacuole fusion,BP,
17674,GO:0097577,1,0.984646859441646,0,4,sequestering of iron ion,BP,
17675,GO:0097581,1,0.580635670792053,0,76,lamellipodium organization,BP,
17676,GO:0097598,1,0.985154800685558,0,2,sperm cytoplasmic droplet,CC,
17677,GO:0097602,1,0.857047442079579,0,23,cullin family protein binding,MF,
17678,GO:0097603,1,0.987825282766438,0,2,temperature-gated ion channel activity,MF,
17679,GO:0097604,1,0.995240647202282,0,1,temperature-gated cation channel activity,MF,
17680,GO:0097617,1,0.913058977942057,0,13,annealing activity,MF,
17681,GO:0097621,1,0.994288231322732,0,1,monoamine oxidase activity,MF,
17682,GO:0097623,1,0.900987800710325,0,16,potassium ion export across plasma membrane,BP,
17683,GO:0097629,1,0.97822752186436,0,3,extrinsic component of omegasome membrane,CC,
17684,GO:0097630,1,0.993485400251684,0,1,intrinsic component of omegasome membrane,CC,
17685,GO:0097631,1,0.993485400251684,0,1,integral component of omegasome membrane,CC,
17686,GO:0097632,1,0.98529093833704,0,2,extrinsic component of phagophore assembly site membrane,CC,
17687,GO:0097635,1,0.984037111806804,0,2,extrinsic component of autophagosome membrane,CC,
17688,GO:0097636,1,0.985909249940746,0,2,intrinsic component of autophagosome membrane,CC,
17689,GO:0097637,1,0.985909249940746,0,2,integral component of autophagosome membrane,CC,
17690,GO:0097638,1,0.955485239540203,0,6,L-arginine import across plasma membrane,BP,
17691,GO:0097639,1,0.988214744716702,0,2,L-lysine import across plasma membrane,BP,
17692,GO:0097640,1,0.994400445035496,0,1,L-ornithine import across plasma membrane,BP,
17693,GO:0097642,1,0.968261607952236,0,6,calcitonin family receptor activity,MF,
17694,GO:0097643,1,0.982420208643568,0,4,amylin receptor activity,MF,
17695,GO:0097644,1,0.978387053660252,0,4,calcitonin family binding,MF,
17696,GO:0097646,1,0.970492204671135,0,6,calcitonin family receptor signaling pathway,BP,
17697,GO:0097647,1,0.978366591563436,0,5,amylin receptor signaling pathway,BP,
17698,GO:0097648,1,0.942253364769681,0,9,G protein-coupled receptor complex,CC,
17699,GO:0097651,1,0.96835373326631,0,4,phosphatidylinositol 3-kinase complex, class I,CC,
17700,GO:0097655,1,0.993485400251684,0,1,serpin family protein binding,MF,
17702,GO:0097676,1,0.963116797112268,0,4,histone H3-K36 dimethylation,BP,
17703,GO:0097677,1,0.943495525360315,0,7,STAT family protein binding,MF,
17704,GO:0097680,1,0.957106249391164,0,6,double-strand break repair via classical nonhomologous end joining,BP,
17705,GO:0097681,1,0.960668668898803,0,4,double-strand break repair via alternative nonhomologous end joining,BP,
17706,GO:0097682,1,0.994665789650669,0,1,intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity,MF,
17707,GO:0097688,1,0.928906321995667,0,9,glutamate receptor clustering,BP,
17708,GO:0097692,1,0.939070114737472,0,8,histone H3-K4 monomethylation,BP,
17709,GO:0097694,1,0.96953295146494,0,3,establishment of RNA localization to telomere,BP,
17710,GO:0097695,1,0.96953295146494,0,3,establishment of protein-containing complex localization to telomere,BP,
17711,GO:0097696,1,0.474178835563994,0,114,receptor signaling pathway via STAT,BP,
17712,GO:0097698,1,0.995804602270463,0,1,telomere maintenance via base-excision repair,BP,
17713,GO:0097699,1,0.992356329486066,0,1,vascular endothelial cell response to fluid shear stress,BP,
17714,GO:0097707,1,0.989636315815314,0,2,ferroptosis,BP,
17716,GO:0097709,1,0.940772794784305,0,9,connective tissue replacement,BP,
17717,GO:0097711,1,0.510208426867698,0,94,ciliary basal body-plasma membrane docking,BP,
17718,GO:0097712,1,0.993485400251684,0,1,vesicle targeting, trans-Golgi to periciliary membrane compartment,BP,
17719,GO:0097718,1,0.79597223402298,0,30,disordered domain specific binding,MF,
17720,GO:0097720,1,0.738578372731554,0,42,calcineurin-mediated signaling,BP,
17722,GO:0097726,1,0.996368825000812,0,1,LEM domain binding,MF,
17723,GO:0097728,1,0.984521580103797,0,1,9+0 motile cilium,CC,
17724,GO:0097729,1,0.55116968359295,0,87,9+2 motile cilium,CC,
17727,GO:0097732,1,0.95663762404807,0,7,9+2 non-motile cilium,CC,
17729,GO:0097734,1,0.896313976883251,0,18,extracellular exosome biogenesis,BP,
17730,GO:0097742,1,0.972122525386454,0,4,de novo centriole assembly,BP,
17731,GO:0097744,1,0.992370090901832,0,1,urate salt excretion,BP,
17732,GO:0097745,1,0.990109285826032,0,2,mitochondrial tRNA 5'-end processing,BP,
17734,GO:0097747,1,0.800001091074571,0,39,RNA polymerase activity,MF,
17735,GO:0097749,1,0.968768882467417,0,4,membrane tubulation,BP,
17736,GO:0097750,1,0.98417579608192,0,2,endosome membrane tubulation,BP,
17737,GO:0097752,1,0.988844009428621,0,2,regulation of DNA stability,BP,
17738,GO:0097753,1,0.986293839470608,0,2,membrane bending,BP,
17739,GO:0097755,1,0.712833206924634,0,53,positive regulation of blood vessel diameter,BP,
17741,GO:0098038,1,0.99287051459055,0,1,non-replicative transposition, DNA-mediated,BP,
17742,GO:0098502,1,0.991974809355823,0,2,DNA dephosphorylation,BP,
17743,GO:0098505,1,0.938291202808275,0,10,G-rich strand telomeric DNA binding,MF,
17744,GO:0098506,1,0.995396421293157,0,1,polynucleotide 3' dephosphorylation,BP,
17745,GO:0098507,1,0.987930449596804,0,2,polynucleotide 5' dephosphorylation,BP,
17746,GO:0098508,1,0.988394634960187,0,2,endothelial to hematopoietic transition,BP,
17747,GO:0098518,1,0.983381882121395,0,3,polynucleotide phosphatase activity,MF,
17748,GO:0098519,1,0.973436654288706,0,4,nucleotide phosphatase activity, acting on free nucleotides,MF,
17749,GO:0098528,1,0.96042610238337,0,6,skeletal muscle fiber differentiation,BP,
17750,GO:0098530,1,0.991283985265797,0,1,positive regulation of strand invasion,BP,
17751,GO:0098531,1,0.692928784042853,0,49,ligand-activated transcription factor activity,MF,
17752,GO:0098532,1,0.965004163386701,0,4,histone H3-K27 trimethylation,BP,
17753,GO:0098533,1,0.863219702142978,0,23,ATPase dependent transmembrane transport complex,CC,
17754,GO:0098534,1,0.763289136906452,0,37,centriole assembly,BP,
17755,GO:0098535,1,0.972122525386454,0,4,de novo centriole assembly involved in multi-ciliated epithelial cell differentiation,BP,
17756,GO:0098536,1,0.973073259892457,0,4,deuterosome,CC,
17758,GO:0098543,1,0.895453148313012,0,16,detection of other organism,BP,
17759,GO:0098547,1,0.994382936352926,0,1,lumenal side of Golgi membrane,CC,
17761,GO:0098553,1,0.885209639070478,0,25,lumenal side of endoplasmic reticulum membrane,CC,
17762,GO:0098554,1,0.923807249918145,0,14,cytoplasmic side of endoplasmic reticulum membrane,CC,
17763,GO:0098556,1,0.984119511284541,0,5,cytoplasmic side of rough endoplasmic reticulum membrane,CC,
17764,GO:0098559,1,0.981514941878634,0,3,cytoplasmic side of early endosome membrane,CC,
17765,GO:0098560,1,0.987358457608308,0,2,cytoplasmic side of late endosome membrane,CC,
17770,GO:0098575,1,0.989223754492921,0,2,lumenal side of lysosomal membrane,CC,
17771,GO:0098576,1,0.861013847346624,0,30,lumenal side of membrane,CC,
17772,GO:0098577,1,0.990356648416623,0,1,inactive sex chromosome,CC,
17773,GO:0098581,1,0.87228327862225,0,21,detection of external biotic stimulus,BP,
17774,GO:0098582,1,0.992773273326414,0,1,innate vocalization behavior,BP,
17775,GO:0098583,1,0.989664437987985,0,2,learned vocalization behavior,BP,
17776,GO:0098586,1,0.731986601164672,0,47,cellular response to virus,BP,
17780,GO:0098591,1,0.958822838763731,0,5,external side of apical plasma membrane,CC,
17781,GO:0098592,1,0.979024184104161,0,3,cytoplasmic side of apical plasma membrane,CC,
17782,GO:0098594,1,0.996874173010108,0,1,mucin granule,CC,
17783,GO:0098595,1,0.994388769034289,0,1,perivitelline space,CC,
17784,GO:0098596,1,0.930134442417902,0,7,imitative learning,BP,
17785,GO:0098597,1,0.916972179986478,0,8,observational learning,BP,
17786,GO:0098598,1,0.920514053434691,0,9,learned vocalization behavior or vocal learning,BP,
17787,GO:0098599,1,0.932782559931559,0,12,palmitoyl hydrolase activity,MF,
17789,GO:0098629,1,0.993485400251684,0,1,trans-Golgi network membrane organization,BP,
17790,GO:0098630,1,0.994149557619953,0,1,aggregation of unicellular organisms,BP,
17791,GO:0098631,1,0.658074785448245,0,60,cell adhesion mediator activity,MF,
17792,GO:0098632,1,0.701222401148863,0,51,cell-cell adhesion mediator activity,MF,
17793,GO:0098633,1,0.986983340752506,0,2,collagen fibril binding,MF,
17794,GO:0098634,1,0.947770362513119,0,7,cell-matrix adhesion mediator activity,MF,
17795,GO:0098636,1,0.762890825255583,0,36,protein complex involved in cell adhesion,CC,
17796,GO:0098637,1,0.992648041532267,0,1,protein complex involved in cell-matrix adhesion,CC,
17797,GO:0098639,1,0.958683935488341,0,5,collagen binding involved in cell-matrix adhesion,MF,
17798,GO:0098640,1,0.988620862355296,0,2,integrin binding involved in cell-matrix adhesion,MF,
17799,GO:0098641,1,0.904856464892171,0,18,cadherin binding involved in cell-cell adhesion,MF,
17800,GO:0098642,1,0.935016865269742,0,7,network-forming collagen trimer,CC,
17801,GO:0098643,1,0.899387678403549,0,12,banded collagen fibril,CC,
17802,GO:0098644,1,0.831021147058057,0,20,complex of collagen trimers,CC,
17803,GO:0098645,1,0.935016865269742,0,7,collagen network,CC,
17804,GO:0098646,1,0.993701478078327,0,1,collagen sheet,CC,
17805,GO:0098647,1,0.977135432263037,0,3,collagen beaded filament,CC,
17806,GO:0098648,1,0.988292410678583,0,1,collagen anchoring fibril,CC,
17807,GO:0098651,1,0.927246807378045,0,8,basement membrane collagen trimer,CC,
17808,GO:0098652,1,0.988292410678583,0,1,collagen type VII anchoring fibril,CC,
17812,GO:0098658,1,0.98271123867143,0,2,inorganic anion import across plasma membrane,BP,
17818,GO:0098674,1,0.988639694604596,0,1,extrinsic component of neuronal dense core vesicle membrane,CC,
17820,GO:0098680,1,0.992614810239926,0,1,template-free RNA nucleotidyltransferase,MF,
17821,GO:0098683,1,0.989563817798169,0,1,cochlear hair cell ribbon synapse,CC,
17826,GO:0098688,1,0.889038175245244,0,16,parallel fiber to Purkinje cell synapse,CC,
17827,GO:0098690,1,0.954706845429856,0,7,glycinergic synapse,CC,
17828,GO:0098691,1,0.928700011479686,0,12,dopaminergic synapse,CC,
17830,GO:0098694,1,0.993065630855463,0,1,regulation of synaptic vesicle budding from presynaptic endocytic zone membrane,BP,
17831,GO:0098695,1,0.98759591198364,0,1,inositol 1,4,5-trisphosphate receptor activity involved in regulation of postsynaptic cytosolic calcium levels,MF,
17832,GO:0098696,1,0.946003997689179,0,8,regulation of neurotransmitter receptor localization to postsynaptic specialization membrane,BP,
17833,GO:0098698,1,0.843772661198211,0,21,postsynaptic specialization assembly,BP,
17835,GO:0098703,1,0.863981886115347,0,20,calcium ion import across plasma membrane,BP,
17836,GO:0098704,1,0.959187501693079,0,6,carbohydrate import across plasma membrane,BP,
17837,GO:0098705,1,0.992132171079246,0,1,copper ion import across plasma membrane,BP,
17838,GO:0098708,1,0.964740507377076,0,5,glucose import across plasma membrane,BP,
17839,GO:0098711,1,0.984427252505075,0,3,iron ion import across plasma membrane,BP,
17840,GO:0098712,1,0.899869829531197,0,13,L-glutamate import across plasma membrane,BP,
17841,GO:0098713,1,0.966956011386995,0,5,leucine import across plasma membrane,BP,
17842,GO:0098718,1,0.992455462665037,0,1,serine import across plasma membrane,BP,
17843,GO:0098719,1,0.878483443218687,0,17,sodium ion import across plasma membrane,BP,
17844,GO:0098722,1,0.940232922611834,0,9,asymmetric stem cell division,BP,
17845,GO:0098725,1,0.993485400251684,0,1,symmetric cell division,BP,
17847,GO:0098728,1,0.98326760816779,0,3,germline stem cell asymmetric division,BP,
17848,GO:0098732,1,0.473617464961588,0,105,macromolecule deacylation,BP,
17849,GO:0098734,1,0.932782559931559,0,12,macromolecule depalmitoylation,BP,
17850,GO:0098735,1,0.957103712776052,0,4,positive regulation of the force of heart contraction,BP,
17851,GO:0098736,1,0.988659840744814,0,1,negative regulation of the force of heart contraction,BP,
17852,GO:0098737,1,0.996659449775114,0,1,protein insertion into plasma membrane,BP,
17855,GO:0098743,1,0.869511157044242,0,19,cell aggregation,BP,
17856,GO:0098745,1,0.995369011896799,0,1,Dcp1-Dcp2 complex,CC,
17858,GO:0098749,1,0.978355515409758,0,3,cerebellar neuron development,BP,
17859,GO:0098751,1,0.785778433526816,0,32,bone cell development,BP,
17860,GO:0098753,1,0.994200462783525,0,1,anchored component of the cytoplasmic side of the plasma membrane,CC,
17861,GO:0098754,1,0.551962617376796,0,116,detoxification,BP,
17862,GO:0098756,1,0.95146284288735,0,7,response to interleukin-21,BP,
17863,GO:0098757,1,0.95146284288735,0,7,cellular response to interleukin-21,BP,
17864,GO:0098758,1,0.980650613118918,0,3,response to interleukin-8,BP,
17865,GO:0098759,1,0.980650613118918,0,3,cellular response to interleukin-8,BP,
17866,GO:0098760,1,0.832801652159911,0,27,response to interleukin-7,BP,
17867,GO:0098761,1,0.832801652159911,0,27,cellular response to interleukin-7,BP,
17868,GO:0098763,1,0.984638596256118,0,2,mitotic cell cycle phase,BP,
17869,GO:0098770,1,0.979249597537403,0,2,FBXO family protein binding,MF,
17872,GO:0098773,1,0.556333961114347,0,82,skin epidermis development,BP,
17873,GO:0098779,1,0.92744669359343,0,9,positive regulation of mitophagy in response to mitochondrial depolarization,BP,
17874,GO:0098780,1,0.869166794112891,0,19,response to mitochondrial depolarisation,BP,
17875,GO:0098781,1,0.541119183209064,0,98,ncRNA transcription,BP,
17876,GO:0098782,1,0.995240647202282,0,1,mechanosensitived potassium channel activity,MF,
17877,GO:0098787,1,0.912634034255527,0,13,mRNA cleavage involved in mRNA processing,BP,
17878,GO:0098789,1,0.919436859861919,0,12,pre-mRNA cleavage required for polyadenylation,BP,
17880,GO:0098792,1,0.940586219567299,0,9,xenophagy,BP,
17883,GO:0098795,1,0.986328762098842,0,2,mRNA cleavage involved in gene silencing,BP,
17886,GO:0098798,1,0.367734173993581,0,217,mitochondrial protein complex,CC,
17887,GO:0098799,1,0.897765198976808,0,20,outer mitochondrial membrane protein complex,CC,
17888,GO:0098800,1,0.653390177843543,0,97,inner mitochondrial membrane protein complex,CC,
17889,GO:0098801,1,0.829967648326077,0,30,regulation of renal system process,BP,
17891,GO:0098803,1,0.778186318027112,0,66,respiratory chain complex,CC,
17893,GO:0098808,1,0.988475477106969,0,2,mRNA cap binding,MF,
17894,GO:0098809,1,0.99374152799939,0,1,nitrite reductase activity,MF,
17895,GO:0098810,1,0.814141257064943,0,31,neurotransmitter reuptake,BP,
17898,GO:0098815,1,0.715101082148458,0,44,modulation of excitatory postsynaptic potential,BP,
17899,GO:0098816,1,0.987682832107994,0,2,mini excitatory postsynaptic potential,BP,
17900,GO:0098821,1,0.958959341074503,0,5,BMP receptor activity,MF,
17901,GO:0098822,1,0.993998291325329,0,1,peptidyl-cysteine modification to L-cysteine persulfide,BP,
17902,GO:0098826,1,0.975581032132698,0,4,endoplasmic reticulum tubular network membrane,CC,
17903,GO:0098827,1,0.854031024735245,0,24,endoplasmic reticulum subcompartment,CC,
17904,GO:0098828,1,0.942243496827028,0,7,modulation of inhibitory postsynaptic potential,BP,
17905,GO:0098829,1,0.990652301361985,0,1,intestinal folate absorption,BP,
17906,GO:0098830,1,0.992093861001259,0,1,presynaptic endosome,CC,
17907,GO:0098831,1,0.862379789909636,0,15,presynaptic active zone cytoplasmic component,CC,
17910,GO:0098837,1,0.946971183100035,0,8,postsynaptic recycling endosome,CC,
17913,GO:0098840,1,0.62994634348938,0,64,protein transport along microtubule,BP,
17914,GO:0098842,1,0.981691072968461,0,3,postsynaptic early endosome,CC,
17917,GO:0098845,1,0.911120415801689,0,14,postsynaptic endosome,CC,
17918,GO:0098847,1,0.920692195950986,0,13,sequence-specific single stranded DNA binding,MF,
17919,GO:0098850,1,0.977185845870418,0,4,extrinsic component of synaptic vesicle membrane,CC,
17921,GO:0098855,1,0.974753121950705,0,3,HCN channel complex,CC,
17922,GO:0098856,1,0.936152450235734,0,11,intestinal lipid absorption,BP,
17926,GO:0098867,1,0.993682950533083,0,1,intramembranous bone growth,BP,
17927,GO:0098868,1,0.807781430877043,0,31,bone growth,BP,
17928,GO:0098869,1,0.635545750534963,0,87,cellular oxidant detoxification,BP,
17929,GO:0098870,1,0.94225224883136,0,8,action potential propagation,BP,
17930,GO:0098871,1,0.961134196159587,0,5,postsynaptic actin cytoskeleton,CC,
17931,GO:0098872,1,0.990291943772004,0,1,G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration,MF,
17932,GO:0098874,1,0.991861604744795,0,1,spike train,BP,
17933,GO:0098875,1,0.992159331654274,0,1,epididymosome,CC,
17937,GO:0098879,1,0.973901692218808,0,3,structural constituent of postsynaptic specialization,MF,
17938,GO:0098880,1,0.948256752304715,0,6,maintenance of postsynaptic specialization structure,BP,
17939,GO:0098882,1,0.949704095725035,0,4,structural constituent of presynaptic active zone,MF,
17940,GO:0098883,1,0.939674837521351,0,11,synapse pruning,BP,
17942,GO:0098885,1,0.922344401844249,0,11,modification of postsynaptic actin cytoskeleton,BP,
17943,GO:0098886,1,0.985381594424914,0,2,modification of dendritic spine,BP,
17944,GO:0098887,1,0.946005689655428,0,8,neurotransmitter receptor transport, endosome to postsynaptic membrane,BP,
17945,GO:0098888,1,0.951423526246812,0,6,extrinsic component of presynaptic membrane,CC,
17947,GO:0098890,1,0.923472846731108,0,9,extrinsic component of postsynaptic membrane,CC,
17948,GO:0098891,1,0.992108497401354,0,1,extrinsic component of presynaptic active zone membrane,CC,
17949,GO:0098892,1,0.947625243422855,0,6,extrinsic component of postsynaptic specialization membrane,CC,
17950,GO:0098894,1,0.985015564396608,0,2,extrinsic component of presynaptic endocytic zone membrane,CC,
17951,GO:0098895,1,0.972832633002942,0,4,postsynaptic endosome membrane,CC,
17952,GO:0098896,1,0.993065223691111,0,1,postsynaptic early endosome membrane,CC,
17953,GO:0098897,1,0.991798829015532,0,1,spine apparatus membrane,CC,
17954,GO:0098898,1,0.983350907360742,0,2,dense core granule lumen,CC,
17956,GO:0098901,1,0.78993332839625,0,27,regulation of cardiac muscle cell action potential,BP,
17958,GO:0098903,1,0.940439796361854,0,8,regulation of membrane repolarization during action potential,BP,
17959,GO:0098904,1,0.977092081553984,0,2,regulation of AV node cell action potential,BP,
17960,GO:0098905,1,0.996761791636752,0,1,regulation of bundle of His cell action potential,BP,
17961,GO:0098907,1,0.972455599688142,0,2,regulation of SA node cell action potential,BP,
17962,GO:0098908,1,0.970460632638689,0,5,regulation of neuronal action potential,BP,
17963,GO:0098909,1,0.939896075005887,0,8,regulation of cardiac muscle cell action potential involved in regulation of contraction,BP,
17964,GO:0098910,1,0.947484136075221,0,5,regulation of atrial cardiac muscle cell action potential,BP,
17965,GO:0098911,1,0.876300993140621,0,15,regulation of ventricular cardiac muscle cell action potential,BP,
17966,GO:0098912,1,0.966823389574115,0,3,membrane depolarization during atrial cardiac muscle cell action potential,BP,
17967,GO:0098914,1,0.957645845156632,0,6,membrane repolarization during atrial cardiac muscle cell action potential,BP,
17968,GO:0098915,1,0.910987146102665,0,14,membrane repolarization during ventricular cardiac muscle cell action potential,BP,
17971,GO:0098918,1,0.871149550425145,0,15,structural constituent of synapse,MF,
17972,GO:0098919,1,0.973901692218808,0,3,structural constituent of postsynaptic density,MF,
17975,GO:0098922,1,0.988639694604596,0,1,extrinsic component of dense core granule membrane,CC,
17976,GO:0098923,1,0.990076635485235,0,1,retrograde trans-synaptic signaling by soluble gas,BP,
17977,GO:0098924,1,0.990076635485235,0,1,retrograde trans-synaptic signaling by nitric oxide,BP,
17979,GO:0098927,1,0.749655610210608,0,40,vesicle-mediated transport between endosomal compartments,BP,
17980,GO:0098928,1,0.965259428606322,0,2,presynaptic signal transduction,BP,
17982,GO:0098935,1,0.92408908942467,0,10,dendritic transport,BP,
17984,GO:0098937,1,0.952045225737378,0,6,anterograde dendritic transport,BP,
17985,GO:0098939,1,0.983781745452268,0,2,dendritic transport of mitochondrion,BP,
17986,GO:0098942,1,0.983440246828375,0,2,retrograde trans-synaptic signaling by trans-synaptic protein complex,BP,
17987,GO:0098943,1,0.963202005942358,0,7,neurotransmitter receptor transport, postsynaptic endosome to lysosome,BP,
17988,GO:0098944,1,0.98701281886265,0,2,postsynaptic recycling endosome membrane,CC,
17989,GO:0098945,1,0.872343842774265,0,18,intrinsic component of presynaptic active zone membrane,CC,
17991,GO:0098949,1,0.98701281886265,0,2,intrinsic component of postsynaptic endosome membrane,CC,
17992,GO:0098951,1,0.98701281886265,0,2,intrinsic component of postsynaptic recycling endosome membrane,CC,
17993,GO:0098952,1,0.991798829015532,0,1,intrinsic component of spine apparatus membrane,CC,
17994,GO:0098953,1,0.946837117044614,0,9,receptor diffusion trapping,BP,
17996,GO:0098957,1,0.964489953136276,0,5,anterograde axonal transport of mitochondrion,BP,
17997,GO:0098958,1,0.987260712889359,0,2,retrograde axonal transport of mitochondrion,BP,
17999,GO:0098961,1,0.977387266494213,0,3,dendritic transport of ribonucleoprotein complex,BP,
18001,GO:0098963,1,0.977387266494213,0,3,dendritic transport of messenger ribonucleoprotein complex,BP,
18002,GO:0098966,1,0.960027118074013,0,4,perisynaptic extracellular matrix,CC,
18004,GO:0098968,1,0.991779691267581,0,1,neurotransmitter receptor transport postsynaptic membrane to endosome,BP,
18006,GO:0098970,1,0.946837117044614,0,9,postsynaptic neurotransmitter receptor diffusion trapping,BP,
18007,GO:0098971,1,0.967184139935988,0,4,anterograde dendritic transport of neurotransmitter receptor complex,BP,
18008,GO:0098972,1,0.990609335054567,0,1,anterograde dendritic transport of mitochondrion,BP,
18009,GO:0098973,1,0.983375867456694,0,3,structural constituent of postsynaptic actin cytoskeleton,MF,
18010,GO:0098974,1,0.919951183512197,0,11,postsynaptic actin cytoskeleton organization,BP,
18012,GO:0098977,1,0.991714495892221,0,1,inhibitory chemical synaptic transmission,BP,
18014,GO:0098981,1,0.94129891911236,0,9,cholinergic synapse,CC,
18016,GO:0098983,1,0.968386402651294,0,4,symmetric, GABA-ergic, inhibitory synapse,CC,
18018,GO:0098985,1,0.949821197911112,0,6,asymmetric, glutamatergic, excitatory synapse,CC,
18019,GO:0098988,1,0.944745888160209,0,7,G protein-coupled glutamate receptor activity,MF,
18020,GO:0098989,1,0.98583544087632,0,2,NMDA selective glutamate receptor signaling pathway,BP,
18022,GO:0098993,1,0.93356467227617,0,13,anchored component of synaptic vesicle membrane,CC,
18023,GO:0098998,1,0.993065223691111,0,1,extrinsic component of postsynaptic early endosome membrane,CC,
18024,GO:0098999,1,0.985635094195204,0,2,extrinsic component of postsynaptic endosome membrane,CC,
18026,GO:0099004,1,0.940480239273928,0,8,calmodulin dependent kinase signaling pathway,BP,
18027,GO:0099010,1,0.885643180942061,0,17,modification of postsynaptic structure,BP,
18030,GO:0099013,1,0.983350907360742,0,2,neuronal dense core vesicle lumen,CC,
18031,GO:0099020,1,0.993382287712882,0,1,perinuclear endoplasmic reticulum lumen,CC,
18032,GO:0099022,1,0.944996615371469,0,8,vesicle tethering,BP,
18033,GO:0099023,1,0.63986045387436,0,64,vesicle tethering complex,CC,
18034,GO:0099024,1,0.675474637271502,0,60,plasma membrane invagination,BP,
18035,GO:0099025,1,0.962753485625769,0,5,anchored component of postsynaptic membrane,CC,
18036,GO:0099026,1,0.940070512616558,0,9,anchored component of presynaptic membrane,CC,
18037,GO:0099029,1,0.974942569467922,0,4,anchored component of presynaptic active zone membrane,CC,
18038,GO:0099030,1,0.979806000147014,0,3,anchored component of postsynaptic specialization membrane,CC,
18039,GO:0099031,1,0.979806000147014,0,3,anchored component of postsynaptic density membrane,CC,
18040,GO:0099033,1,0.98701281886265,0,2,anchored component of postsynaptic recycling endosome membrane,CC,
18041,GO:0099034,1,0.98701281886265,0,2,anchored component of postsynaptic endosome membrane,CC,
18042,GO:0099038,1,0.981311562283698,0,2,ceramide floppase activity,MF,
18043,GO:0099039,1,0.959908187928505,0,4,sphingolipid translocation,BP,
18044,GO:0099040,1,0.981311562283698,0,2,ceramide translocation,BP,
18045,GO:0099041,1,0.961949745542872,0,5,vesicle tethering to Golgi,BP,
18046,GO:0099044,1,0.989000465485292,0,2,vesicle tethering to endoplasmic reticulum,BP,
18047,GO:0099046,1,0.995881023407096,0,1,clearance of foreign intracellular nucleic acids,BP,
18048,GO:0099050,1,0.993541466958776,0,1,vesicle scission,BP,
18049,GO:0099053,1,0.979879032808037,0,3,activating signal cointegrator 1 complex,CC,
18050,GO:0099054,1,0.678888799030577,0,48,presynapse assembly,BP,
18053,GO:0099059,1,0.894789584829671,0,14,integral component of presynaptic active zone membrane,CC,
18056,GO:0099065,1,0.991798829015532,0,1,integral component of spine apparatus membrane,CC,
18058,GO:0099068,1,0.779020156841881,0,31,postsynapse assembly,BP,
18060,GO:0099073,1,0.985313791832868,0,2,mitochondrion-derived vesicle,CC,
18061,GO:0099074,1,0.986650939091186,0,2,mitochondrion to lysosome transport,BP,
18062,GO:0099075,1,0.986650939091186,0,2,mitochondrion-derived vesicle mediated transport,BP,
18063,GO:0099077,1,0.991290689400061,0,1,histone-dependent DNA binding,MF,
18064,GO:0099078,1,0.982065546958802,0,4,BORC complex,CC,
18068,GO:0099083,1,0.992609644676588,0,1,retrograde trans-synaptic signaling by neuropeptide, modulating synaptic transmission,BP,
18069,GO:0099084,1,0.756873675173166,0,34,postsynaptic specialization organization,BP,
18070,GO:0099086,1,0.813067716638307,0,32,synaptonemal structure,CC,
18071,GO:0099087,1,0.993317365421639,0,1,anterograde axonal transport of messenger ribonucleoprotein complex,BP,
18072,GO:0099088,1,0.993317365421639,0,1,axonal transport of messenger ribonucleoprotein complex,BP,
18073,GO:0099089,1,0.986002937131604,0,1,establishment of endoplasmic reticulum localization to postsynapse,BP,
18074,GO:0099091,1,0.862109432920705,0,21,postsynaptic specialization, intracellular component,CC,
18075,GO:0099092,1,0.884827423166136,0,17,postsynaptic density, intracellular component,CC,
18076,GO:0099093,1,0.985096263521018,0,2,calcium export from the mitochondrion,BP,
18079,GO:0099098,1,0.993009229448717,0,1,microtubule polymerization based movement,BP,
18080,GO:0099103,1,0.977911785539585,0,4,channel activator activity,MF,
18081,GO:0099104,1,0.977911785539585,0,4,potassium channel activator activity,MF,
18082,GO:0099106,1,0.500022735545492,0,111,ion channel regulator activity,MF,
18084,GO:0099115,1,0.982425188878487,0,2,chromosome, subtelomeric region,CC,
18085,GO:0099116,1,0.927083228486104,0,15,tRNA 5'-end processing,BP,
18086,GO:0099118,1,0.62994634348938,0,64,microtubule-based protein transport,BP,
18087,GO:0099122,1,0.943308306972557,0,8,RNA polymerase II C-terminal domain binding,MF,
18088,GO:0099142,1,0.99094935654551,0,1,intracellularly ATP-gated ion channel activity,MF,
18089,GO:0099144,1,0.918240137850068,0,12,anchored component of synaptic membrane,CC,
18091,GO:0099147,1,0.952480871522324,0,5,extrinsic component of postsynaptic density membrane,CC,
18093,GO:0099150,1,0.907032594842096,0,13,regulation of postsynaptic specialization assembly,BP,
18094,GO:0099151,1,0.911538144216919,0,12,regulation of postsynaptic density assembly,BP,
18095,GO:0099152,1,0.986595352570193,0,2,regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane,BP,
18096,GO:0099154,1,0.988630955062213,0,2,serotonergic synapse,CC,
18097,GO:0099156,1,0.992927843812387,0,1,cell-cell signaling via exosome,BP,
18098,GO:0099158,1,0.993065223691111,0,1,regulation of recycling endosome localization within postsynapse,BP,
18099,GO:0099159,1,0.943101693758046,0,8,regulation of modification of postsynaptic structure,BP,
18100,GO:0099160,1,0.992741893474036,0,1,postsynaptic intermediate filament cytoskeleton,CC,
18102,GO:0099163,1,0.990076635485235,0,1,synaptic signaling by nitric oxide,BP,
18105,GO:0099172,1,0.66755655123581,0,51,presynapse organization,BP,
18107,GO:0099174,1,0.777468777960131,0,34,regulation of presynapse organization,BP,
18110,GO:0099178,1,0.987390454359369,0,2,regulation of retrograde trans-synaptic signaling by endocanabinoid,BP,
18111,GO:0099179,1,0.967994945152111,0,4,regulation of synaptic membrane adhesion,BP,
18113,GO:0099181,1,0.992579055161486,0,1,structural constituent of presynapse,MF,
18115,GO:0099184,1,0.985801359152645,0,2,structural constituent of postsynaptic intermediate filament cytoskeleton,MF,
18116,GO:0099185,1,0.985801359152645,0,2,postsynaptic intermediate filament cytoskeleton organization,BP,
18117,GO:0099186,1,0.934061438668292,0,9,structural constituent of postsynapse,MF,
18118,GO:0099188,1,0.913268530996896,0,12,postsynaptic cytoskeleton organization,BP,
18119,GO:0099189,1,0.989438619495371,0,1,postsynaptic spectrin-associated cytoskeleton,CC,
18122,GO:0099243,1,0.896803634371837,0,13,extrinsic component of synaptic membrane,CC,
18123,GO:0099400,1,0.988303784808711,0,1,caveola neck,CC,
18124,GO:0099403,1,0.974987423844138,0,2,maintenance of mitotic sister chromatid cohesion, telomeric,BP,
18125,GO:0099404,1,0.974987423844138,0,2,mitotic sister chromatid cohesion, telomeric,BP,
18132,GO:0099507,1,0.973811154482696,0,3,ligand-gated ion channel activity involved in regulation of presynaptic membrane potential,MF,
18135,GO:0099510,1,0.989792492466949,0,2,calcium ion binding involved in regulation of cytosolic calcium ion concentration,MF,
18139,GO:0099514,1,0.893916637454419,0,18,synaptic vesicle cytoskeletal transport,BP,
18140,GO:0099515,1,0.829958563803654,0,20,actin filament-based transport,BP,
18141,GO:0099517,1,0.893916637454419,0,18,synaptic vesicle transport along microtubule,BP,
18144,GO:0099520,1,0.992809440378492,0,1,ion antiporter activity involved in regulation of presynaptic membrane potential,MF,
18145,GO:0099522,1,0.824828620098761,0,25,region of cytosol,CC,
18146,GO:0099523,1,0.892569131323619,0,14,presynaptic cytosol,CC,
18147,GO:0099524,1,0.872790835988817,0,18,postsynaptic cytosol,CC,
18149,GO:0099526,1,0.965259428606322,0,2,presynapse to nucleus signaling pathway,BP,
18150,GO:0099527,1,0.94431030001716,0,8,postsynapse to nucleus signaling pathway,BP,
18153,GO:0099530,1,0.965954933432349,0,4,G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential,MF,
18154,GO:0099532,1,0.930669297433129,0,9,synaptic vesicle endosomal processing,BP,
18156,GO:0099534,1,0.989792492466949,0,2,calcium ion binding involved in regulation of presynaptic cytosolic calcium ion concentration,MF,
18157,GO:0099535,1,0.960027118074013,0,4,synapse-associated extracellular matrix,CC,
18164,GO:0099543,1,0.990076635485235,0,1,trans-synaptic signaling by soluble gas,BP,
18165,GO:0099544,1,0.953050892686842,0,5,perisynaptic space,CC,
18166,GO:0099545,1,0.939829787450556,0,8,trans-synaptic signaling by trans-synaptic complex,BP,
18167,GO:0099546,1,0.991349679257538,0,1,protein catabolic process, modulating synaptic transmission,BP,
18168,GO:0099547,1,0.976405095739602,0,3,regulation of translation at synapse, modulating synaptic transmission,BP,
18169,GO:0099548,1,0.990076635485235,0,1,trans-synaptic signaling by nitric oxide,BP,
18171,GO:0099551,1,0.982785421424254,0,2,trans-synaptic signaling by neuropeptide, modulating synaptic transmission,BP,
18174,GO:0099557,1,0.979541105760778,0,3,trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission,BP,
18175,GO:0099558,1,0.873061121548873,0,16,maintenance of synapse structure,BP,
18176,GO:0099560,1,0.79426819155768,0,28,synaptic membrane adhesion,BP,
18177,GO:0099562,1,0.96673885616754,0,4,maintenance of postsynaptic density structure,BP,
18178,GO:0099563,1,0.847208725247623,0,23,modification of synaptic structure,BP,
18179,GO:0099564,1,0.99298843235316,0,1,modification of synaptic structure, modulating synaptic transmission,BP,
18181,GO:0099566,1,0.885475930843041,0,13,regulation of postsynaptic cytosolic calcium ion concentration,BP,
18182,GO:0099567,1,0.993851358037755,0,1,calcium ion binding involved in regulation of postsynaptic cytosolic calcium ion concentration,MF,
18184,GO:0099569,1,0.939725172636749,0,5,presynaptic cytoskeleton,CC,
18185,GO:0099571,1,0.944073532818565,0,7,postsynaptic cytoskeleton,CC,
18187,GO:0099575,1,0.981918844133325,0,3,regulation of protein catabolic process at presynapse, modulating synaptic transmission,BP,
18188,GO:0099576,1,0.966426331697174,0,4,regulation of protein catabolic process at postsynapse, modulating synaptic transmission,BP,
18189,GO:0099578,1,0.987560455442067,0,2,regulation of translation at postsynapse, modulating synaptic transmission,BP,
18190,GO:0099579,1,0.985836714467405,0,2,G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential,MF,
18191,GO:0099580,1,0.982865238034184,0,2,ion antiporter activity involved in regulation of postsynaptic membrane potential,MF,
18192,GO:0099582,1,0.993389945047484,0,1,neurotransmitter receptor activity involved in regulation of presynaptic cytosolic calcium ion concentration,MF,
18193,GO:0099583,1,0.971324098394152,0,3,neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration,MF,
18195,GO:0099588,1,0.991843585539094,0,1,positive regulation of postsynaptic cytosolic calcium concentration,BP,
18199,GO:0099602,1,0.957918553653623,0,9,neurotransmitter receptor regulator activity,MF,
18201,GO:0099606,1,0.988805383188817,0,1,microtubule plus-end directed mitotic chromosome migration,BP,
18202,GO:0099607,1,0.985044933998544,0,2,lateral attachment of mitotic spindle microtubules to kinetochore,BP,
18203,GO:0099608,1,0.991861604744795,0,1,regulation of action potential firing pattern,BP,
18204,GO:0099609,1,0.982532113359193,0,2,microtubule lateral binding,MF,
18205,GO:0099612,1,0.914583647539628,0,10,protein localization to axon,BP,
18206,GO:0099617,1,0.988852607187915,0,2,matrix side of mitochondrial inner membrane,CC,
18207,GO:0099622,1,0.786477529802987,0,34,cardiac muscle cell membrane repolarization,BP,
18208,GO:0099623,1,0.837020316630399,0,24,regulation of cardiac muscle cell membrane repolarization,BP,
18209,GO:0099624,1,0.928005503412803,0,10,atrial cardiac muscle cell membrane repolarization,BP,
18210,GO:0099625,1,0.842004146465328,0,24,ventricular cardiac muscle cell membrane repolarization,BP,
18212,GO:0099628,1,0.946837117044614,0,9,neurotransmitter receptor diffusion trapping,BP,
18213,GO:0099629,1,0.982087180919593,0,2,postsynaptic specialization of symmetric synapse,CC,
18214,GO:0099631,1,0.992644992012471,0,2,postsynaptic endocytic zone cytoplasmic component,CC,
18215,GO:0099633,1,0.86808433930263,0,21,protein localization to postsynaptic specialization membrane,BP,
18219,GO:0099638,1,0.930230662942235,0,10,endosome to plasma membrane protein transport,BP,
18220,GO:0099639,1,0.946005689655428,0,8,neurotransmitter receptor transport, endosome to plasma membrane,BP,
18221,GO:0099640,1,0.90331477288161,0,13,axo-dendritic protein transport,BP,
18222,GO:0099641,1,0.931020179827375,0,9,anterograde axonal protein transport,BP,
18223,GO:0099642,1,0.977470086320489,0,2,retrograde axonal protein transport,BP,
18225,GO:0099645,1,0.86808433930263,0,21,neurotransmitter receptor localization to postsynaptic specialization membrane,BP,
18228,GO:0099738,1,0.72151571457771,0,41,cell cortex region,CC,
18229,GO:0100001,1,0.981221820879381,0,2,regulation of skeletal muscle contraction by action potential,BP,
18230,GO:0100002,1,0.993358457280109,0,1,negative regulation of protein kinase activity by protein phosphorylation,BP,
18231,GO:0100012,1,0.977995858207054,0,4,regulation of heart induction by canonical Wnt signaling pathway,BP,
18232,GO:0100026,1,0.992601804639769,0,1,positive regulation of DNA repair by transcription from RNA polymerase II promoter,BP,
18233,GO:0101002,1,0.491259363410381,0,123,ficolin-1-rich granule,CC,
18234,GO:0101003,1,0.682987226761371,0,56,ficolin-1-rich granule membrane,CC,
18235,GO:0101005,1,0.541006733370505,0,80,ubiquitinyl hydrolase activity,MF,
18236,GO:0101006,1,0.985229543441978,0,3,protein histidine phosphatase activity,MF,
18237,GO:0101020,1,0.970872983753479,0,5,estrogen 16-alpha-hydroxylase activity,MF,
18238,GO:0101021,1,0.99373000630199,0,1,estrogen 2-hydroxylase activity,MF,
18239,GO:0101023,1,0.863757457271869,0,20,vascular endothelial cell proliferation,BP,
18240,GO:0101030,1,0.99004096862669,0,2,tRNA-guanine transglycosylation,BP,
18242,GO:0102007,1,0.987219477200711,0,3,acyl-L-homoserine-lactone lactonohydrolase activity,MF,
18243,GO:0102008,1,0.991945095553522,0,1,cytosolic dipeptidase activity,MF,
18244,GO:0102009,1,0.995080152823623,0,1,proline dipeptidase activity,MF,
18245,GO:0102076,1,0.993367163497724,0,1,beta,beta-carotene-9',10'-cleaving oxygenase activity,MF,
18246,GO:0102077,1,0.989538571713001,0,2,oleamide hydrolase activity,MF,
18247,GO:0102084,1,0.987535891920397,0,2,L-dopa O-methyltransferase activity,MF,
18248,GO:0102092,1,0.983174063366186,0,2,5-diphosphoinositol pentakisphosphate 3-kinase activity,MF,
18249,GO:0102102,1,0.992636844474795,0,1,homocarnosine synthase activity,MF,
18250,GO:0102113,1,0.990280666500823,0,1,hypoxia-inducible factor-asparagine oxygenase activity,MF,
18251,GO:0102121,1,0.973978998821357,0,4,ceramidase activity,MF,
18252,GO:0102131,1,0.988938770380431,0,1,3-oxo-glutaryl-[acp] methyl ester reductase activity,MF,
18253,GO:0102132,1,0.988938770380431,0,1,3-oxo-pimeloyl-[acp] methyl ester reductase activity,MF,
18254,GO:0102140,1,0.980538821424588,0,2,heparan sulfate N-deacetylase activity,MF,
18255,GO:0102148,1,0.989098910287057,0,2,N-acetyl-beta-D-galactosaminidase activity,MF,
18256,GO:0102158,1,0.974192639685168,0,4,very-long-chain 3-hydroxyacyl-CoA dehydratase activity,MF,
18257,GO:0102193,1,0.991134486750839,0,2,protein-ribulosamine 3-kinase activity,MF,
18258,GO:0102194,1,0.995897087585259,0,1,protein-fructosamine 3-kinase activity,MF,
18259,GO:0102200,1,0.991778838884984,0,1,N-acetylphosphatidylethanolamine-hydrolysing phospholipase activity,MF,
18260,GO:0102250,1,0.978968368666867,0,3,linear malto-oligosaccharide phosphorylase activity,MF,
18261,GO:0102258,1,0.992701446424895,0,1,1,3-diacylglycerol acylhydrolase activity,MF,
18262,GO:0102259,1,0.992701446424895,0,1,1,2-diacylglycerol acylhydrolase activity,MF,
18263,GO:0102264,1,0.993485400251684,0,1,tRNA-dihydrouridine20 synthase activity,MF,
18264,GO:0102279,1,0.99204782065794,0,1,lecithin:11-cis retinol acyltransferase activity,MF,
18265,GO:0102336,1,0.961072995080493,0,6,3-oxo-arachidoyl-CoA synthase activity,MF,
18266,GO:0102337,1,0.961072995080493,0,6,3-oxo-cerotoyl-CoA synthase activity,MF,
18267,GO:0102338,1,0.961072995080493,0,6,3-oxo-lignoceronyl-CoA synthase activity,MF,
18268,GO:0102339,1,0.993842735499689,0,1,3-oxo-arachidoyl-CoA reductase activity,MF,
18269,GO:0102340,1,0.993842735499689,0,1,3-oxo-behenoyl-CoA reductase activity,MF,
18270,GO:0102341,1,0.993842735499689,0,1,3-oxo-lignoceroyl-CoA reductase activity,MF,
18271,GO:0102342,1,0.993842735499689,0,1,3-oxo-cerotoyl-CoA reductase activity,MF,
18272,GO:0102343,1,0.974192639685168,0,4,3-hydroxy-arachidoyl-CoA dehydratase activity,MF,
18273,GO:0102344,1,0.974192639685168,0,4,3-hydroxy-behenoyl-CoA dehydratase activity,MF,
18274,GO:0102345,1,0.974192639685168,0,4,3-hydroxy-lignoceroyl-CoA dehydratase activity,MF,
18275,GO:0102389,1,0.993648007022561,0,1,polyprenol reductase activity,MF,
18276,GO:0102390,1,0.99367654782015,0,1,mycophenolic acid acyl-glucuronide esterase activity,MF,
18277,GO:0102391,1,0.940576326845839,0,9,decanoate-CoA ligase activity,MF,
18278,GO:0102420,1,0.984190711702597,0,2,sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity,MF,
18279,GO:0102483,1,0.995473093091466,0,1,scopolin beta-glucosidase activity,MF,
18280,GO:0102485,1,0.973916246502817,0,3,dATP phosphohydrolase activity,MF,
18281,GO:0102486,1,0.973916246502817,0,3,dCTP phosphohydrolase activity,MF,
18282,GO:0102487,1,0.973916246502817,0,3,dUTP phosphohydrolase activity,MF,
18283,GO:0102488,1,0.973916246502817,0,3,dTTP phosphohydrolase activity,MF,
18284,GO:0102489,1,0.973916246502817,0,3,GTP phosphohydrolase activity,MF,
18285,GO:0102490,1,0.973916246502817,0,3,8-oxo-dGTP phosphohydrolase activity,MF,
18286,GO:0102491,1,0.973916246502817,0,3,dGTP phosphohydrolase activity,MF,
18287,GO:0102499,1,0.978968368666867,0,3,SHG alpha-glucan phosphorylase activity,MF,
18288,GO:0102500,1,0.990024972857022,0,1,beta-maltose 4-alpha-glucanotransferase activity,MF,
18289,GO:0102521,1,0.992933435184299,0,1,tRNA-4-demethylwyosine synthase activity,MF,
18290,GO:0102522,1,0.994455106262183,0,1,tRNA 4-demethylwyosine alpha-amino-alpha-carboxypropyltransferase activity,MF,
18291,GO:0102524,1,0.993485400251684,0,1,tRNAPhe (7-(3-amino-3-carboxypropyl)wyosine37-C2)-hydroxylase activity,MF,
18292,GO:0102545,1,0.93551889518047,0,10,phosphatidyl phospholipase B activity,MF,
18293,GO:0102552,1,0.99548914444974,0,1,lipoyl synthase activity (acting on glycine-cleavage complex H protein,MF,
18294,GO:0102553,1,0.99548914444974,0,1,lipoyl synthase activity (acting on pyruvate dehydrogenase E2 protein),MF,
18295,GO:0102555,1,0.996594642379455,0,1,octanoyl transferase activity (acting on glycine-cleavage complex H protein),MF,
18296,GO:0102559,1,0.991203590195071,0,1,protein-(glutamine-N5) methyltransferase activity,MF,
18297,GO:0102567,1,0.91643874842273,0,14,phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine),MF,
18298,GO:0102568,1,0.91643874842273,0,14,phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine),MF,
18299,GO:0102704,1,0.993309147199726,0,1,GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity,MF,
18300,GO:0102707,1,0.993817036477932,0,1,S-adenosyl-L-methionine:beta-alanine N-methyltransferase activity,MF,
18301,GO:0102732,1,0.995272600272908,0,1,myo-inositol-1,2,3,4,6-heptakisphosphate 5-kinase activity,MF,
18302,GO:0102751,1,0.988205016753309,0,2,UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity,MF,
18303,GO:0102752,1,0.99310265842407,0,1,1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis),MF,
18304,GO:0102756,1,0.961072995080493,0,6,very-long-chain 3-ketoacyl-CoA synthase activity,MF,
18305,GO:0102758,1,0.996298167489228,0,1,very-long-chain enoyl-CoA reductase activity,MF,
18306,GO:0102769,1,0.995564084830786,0,1,dihydroceramide glucosyltransferase activity,MF,
18307,GO:0102773,1,0.985688591029876,0,2,dihydroceramide kinase activity,MF,
18308,GO:0102797,1,0.991988077097088,0,1,geranial:oxygen oxidoreductase activity,MF,
18309,GO:0102798,1,0.991988077097088,0,1,heptaldehyde:oxygen oxidoreductase activity,MF,
18310,GO:0102867,1,0.993532681904863,0,1,molybdenum cofactor sulfurtransferase activity,MF,
18311,GO:0102938,1,0.987535891920397,0,2,orcinol O-methyltransferase activity,MF,
18312,GO:0102953,1,0.981852885177212,0,3,hypoglycin A gamma-glutamyl transpeptidase activity,MF,
18313,GO:0102965,1,0.986440709098555,0,2,alcohol-forming fatty acyl-CoA reductase activity,MF,
18314,GO:0102991,1,0.949070250058818,0,10,myristoyl-CoA hydrolase activity,MF,
18315,GO:0103025,1,0.990105373091556,0,2,alpha-amylase activity (releasing maltohexaose),MF,
18316,GO:0103045,1,0.994731026292765,0,1,methione N-acyltransferase activity,MF,
18317,GO:0103046,1,0.991945095553522,0,1,alanylglutamate dipeptidase activity,MF,
18318,GO:0103053,1,0.990400937060729,0,2,1-ethyladenine demethylase activity,MF,
18319,GO:0103066,1,0.995621313891515,0,1,4alpha-carboxy-4beta-methyl-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-oxidoreductase (decarboxylating) activity,MF,
18320,GO:0103067,1,0.995621313891515,0,1,4alpha-carboxy-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-dehydrogenase (decarboxylating) activity,MF,
18321,GO:0103068,1,0.981852885177212,0,3,leukotriene C4 gamma-glutamyl transferase activity,MF,
18322,GO:0103073,1,0.989538571713001,0,2,anandamide amidohydrolase activity,MF,
18324,GO:0106001,1,0.959165019523037,0,6,intestinal hexose absorption,BP,
18325,GO:0106003,1,0.990489508022642,0,1,amyloid-beta complex,CC,
18326,GO:0106004,1,0.991462479728688,0,2,tRNA (guanine-N7)-methylation,BP,
18327,GO:0106005,1,0.990897153807632,0,1,RNA 5'-cap (guanine-N7)-methylation,BP,
18328,GO:0106006,1,0.976914622698174,0,3,cytoskeletal protein-membrane anchor activity,MF,
18329,GO:0106014,1,0.974292386910287,0,5,regulation of inflammatory response to wounding,BP,
18330,GO:0106015,1,0.986017613982099,0,3,negative regulation of inflammatory response to wounding,BP,
18331,GO:0106016,1,0.990954142708917,0,2,positive regulation of inflammatory response to wounding,BP,
18332,GO:0106017,1,0.974731823680084,0,3,phosphatidylinositol-3,4-bisphosphate phosphatase activity,MF,
18333,GO:0106018,1,0.930192724613324,0,9,phosphatidylinositol-3,5-bisphosphate phosphatase activity,MF,
18334,GO:0106019,1,0.917164077322888,0,11,phosphatidylinositol-4,5-bisphosphate phosphatase activity,MF,
18335,GO:0106020,1,0.987062827487229,0,2,regulation of vesicle docking,BP,
18336,GO:0106022,1,0.992654463673339,0,1,positive regulation of vesicle docking,BP,
18338,GO:0106028,1,0.992054507271752,0,1,neuron projection retraction,BP,
18339,GO:0106029,1,0.983469621027473,0,3,tRNA pseudouridine synthase activity,MF,
18341,GO:0106035,1,0.996453429729681,0,1,protein maturation by [4Fe-4S] cluster transfer,BP,
18342,GO:0106040,1,0.991053123922732,0,1,regulation of GABA-A receptor activity,BP,
18343,GO:0106044,1,0.996625193861694,0,1,guanine deglycation,BP,
18344,GO:0106045,1,0.996625193861694,0,1,guanine deglycation, methylglyoxal removal,BP,
18345,GO:0106046,1,0.996625193861694,0,1,guanine deglycation, glyoxal removal,BP,
18346,GO:0106047,1,0.993603752887042,0,1,polyamine deacetylation,BP,
18347,GO:0106048,1,0.993603752887042,0,1,spermidine deacetylation,BP,
18348,GO:0106049,1,0.933622071903063,0,11,regulation of cellular response to osmotic stress,BP,
18349,GO:0106050,1,0.988473532192682,0,2,tRNA 2'-O-methyltransferase activity,MF,
18350,GO:0106056,1,0.792015984213661,0,32,regulation of calcineurin-mediated signaling,BP,
18351,GO:0106057,1,0.908130687793159,0,14,negative regulation of calcineurin-mediated signaling,BP,
18352,GO:0106058,1,0.909708790884073,0,13,positive regulation of calcineurin-mediated signaling,BP,
18353,GO:0106064,1,0.99128577301311,0,1,regulation of cobalamin metabolic process,BP,
18354,GO:0106068,1,0.964849849868264,0,7,SUMO ligase complex,CC,
18358,GO:0106073,1,0.980834483949973,0,2,dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity,MF,
18359,GO:0106074,1,0.950013952191131,0,8,aminoacyl-tRNA metabolism involved in translational fidelity,BP,
18360,GO:0106075,1,0.993089765470706,0,1,peptide N-succinyltransferase activity,MF,
18361,GO:0106077,1,0.972013745602573,0,4,histone succinylation,BP,
18362,GO:0106078,1,0.993089765470706,0,1,histone succinyltransferase activity,MF,
18363,GO:0106083,1,0.923604611743795,0,8,nuclear membrane protein complex,CC,
18364,GO:0106088,1,0.990316246872485,0,1,regulation of cell adhesion involved in sprouting angiogenesis,BP,
18365,GO:0106089,1,0.990316246872485,0,1,negative regulation of cell adhesion involved in sprouting angiogenesis,BP,
18366,GO:0106091,1,0.991256863869913,0,2,glial cell projection elongation,BP,
18367,GO:0106094,1,0.923604611743795,0,8,nuclear membrane microtubule tethering complex,CC,
18368,GO:0106096,1,0.991323316232565,0,1,response to ceramide,BP,
18369,GO:0106101,1,0.995175219064203,0,1,ER-dependent peroxisome localization,BP,
18370,GO:0106104,1,0.956329895096221,0,5,regulation of glutamate receptor clustering,BP,
18371,GO:0106105,1,0.993485400251684,0,1,Ala-tRNA(Thr) hydrolase activity,MF,
18372,GO:0106106,1,0.391606817152058,0,135,cold-induced thermogenesis,BP,
18373,GO:0106118,1,0.745223502264296,0,42,regulation of sterol biosynthetic process,BP,
18374,GO:0106119,1,0.973907194484427,0,5,negative regulation of sterol biosynthetic process,BP,
18375,GO:0106120,1,0.956925411123385,0,6,positive regulation of sterol biosynthetic process,BP,
18376,GO:0106121,1,0.99128577301311,0,1,positive regulation of cobalamin metabolic process,BP,
18377,GO:0106130,1,0.992812268622064,0,2,purine phosphoribosyltransferase activity,MF,
18378,GO:0106134,1,0.970713057455536,0,4,positive regulation of cardiac muscle cell contraction,BP,
18379,GO:0106135,1,0.987427328526505,0,2,negative regulation of cardiac muscle cell contraction,BP,
18380,GO:0106137,1,0.992811838951132,0,1,IkappaB kinase complex binding,MF,
18381,GO:0106138,1,0.99094935654551,0,1,Sec61 translocon complex binding,MF,
18382,GO:0106140,1,0.979247347788609,0,3,P-TEFb complex binding,MF,
18383,GO:0106153,1,0.99632043539818,0,1,phosphorylated histone binding,MF,
18384,GO:0110008,1,0.993154798824933,0,1,ncRNA deadenylation,BP,
18385,GO:0110009,1,0.975493943092294,0,3,formin-nucleated actin cable organization,BP,
18386,GO:0110011,1,0.954196505358285,0,5,regulation of basement membrane organization,BP,
18387,GO:0110017,1,0.992286823610893,0,2,cap-independent translational initiation of linear mRNA,BP,
18388,GO:0110020,1,0.499610645217768,0,92,regulation of actomyosin structure organization,BP,
18389,GO:0110021,1,0.980408452580267,0,3,cardiac muscle myoblast proliferation,BP,
18390,GO:0110022,1,0.980408452580267,0,3,regulation of cardiac muscle myoblast proliferation,BP,
18391,GO:0110024,1,0.980408452580267,0,3,positive regulation of cardiac muscle myoblast proliferation,BP,
18392,GO:0110025,1,0.98622722178172,0,2,DNA strand resection involved in replication fork processing,BP,
18393,GO:0110026,1,0.993150557794785,0,1,regulation of DNA strand resection involved in replication fork processing,BP,
18394,GO:0110028,1,0.990030135300583,0,1,positive regulation of mitotic spindle organization,BP,
18395,GO:0110030,1,0.980518317012783,0,3,regulation of G2/MI transition of meiotic cell cycle,BP,
18396,GO:0110032,1,0.980518317012783,0,3,positive regulation of G2/MI transition of meiotic cell cycle,BP,
18397,GO:0110053,1,0.168572251231111,0,251,regulation of actin filament organization,BP,
18398,GO:0110057,1,0.991540508482845,0,1,regulation of blood vessel endothelial cell differentiation,BP,
18399,GO:0110059,1,0.991540508482845,0,1,negative regulation of blood vessel endothelial cell differentiation,BP,
18400,GO:0110061,1,0.981281154622772,0,2,regulation of angiotensin-activated signaling pathway,BP,
18401,GO:0110070,1,0.995002487234698,0,1,cellularization cleavage furrow,CC,
18402,GO:0110075,1,0.989636315815314,0,2,regulation of ferroptosis,BP,
18403,GO:0110076,1,0.989636315815314,0,2,negative regulation of ferroptosis,BP,
18404,GO:0110077,1,0.993269260357739,0,1,vesicle-mediated intercellular transport,BP,
18405,GO:0110088,1,0.9754826532148,0,4,hippocampal neuron apoptotic process,BP,
18406,GO:0110089,1,0.9754826532148,0,4,regulation of hippocampal neuron apoptotic process,BP,
18407,GO:0110090,1,0.989261997254693,0,2,positive regulation of hippocampal neuron apoptotic process,BP,
18408,GO:0110091,1,0.986072581181147,0,2,negative regulation of hippocampal neuron apoptotic process,BP,
18409,GO:0110095,1,0.962452985305372,0,8,cellular detoxification of aldehyde,BP,
18410,GO:0110096,1,0.953236594426874,0,10,cellular response to aldehyde,BP,
18411,GO:0110097,1,0.994277674303003,0,1,regulation of calcium import into the mitochondrion,BP,
18412,GO:0110104,1,0.975907255799141,0,3,mRNA alternative polyadenylation,BP,
18413,GO:0110110,1,0.597790383838407,0,77,positive regulation of animal organ morphogenesis,BP,
18414,GO:0110111,1,0.794104240755369,0,32,negative regulation of animal organ morphogenesis,BP,
18415,GO:0110112,1,0.988639270414666,0,2,regulation of lipid transporter activity,BP,
18416,GO:0110113,1,0.993455567656276,0,1,positive regulation of lipid transporter activity,BP,
18417,GO:0110148,1,0.388635405160107,0,138,biomineralization,BP,
18418,GO:0110149,1,0.578517479476123,0,79,regulation of biomineralization,BP,
18419,GO:0110150,1,0.856350947983202,0,22,negative regulation of biomineralization,BP,
18421,GO:0110154,1,0.92579167196907,0,12,RNA decapping,BP,
18422,GO:0110156,1,0.92579167196907,0,12,methylguanosine-cap decapping,BP,
18424,GO:0120001,1,0.991489886805966,0,2,apical plasma membrane urothelial plaque,CC,
18425,GO:0120003,1,0.996659449775114,0,1,hinge region between urothelial plaques of apical plasma membrane,CC,
18426,GO:0120009,1,0.789653287406977,0,36,intermembrane lipid transfer,BP,
18427,GO:0120013,1,0.803484474296923,0,34,lipid transfer activity,MF,
18428,GO:0120014,1,0.900350108871833,0,17,phospholipid transfer activity,MF,
18429,GO:0120015,1,0.887539587727416,0,18,sterol transfer activity,MF,
18430,GO:0120016,1,0.965110311326887,0,6,sphingolipid transfer activity,MF,
18431,GO:0120017,1,0.965110311326887,0,6,ceramide transfer activity,MF,
18432,GO:0120019,1,0.995485583015882,0,1,phosphatidylcholine transfer activity,MF,
18433,GO:0120020,1,0.894812802762104,0,17,cholesterol transfer activity,MF,
18437,GO:0120033,1,0.858452688616465,0,24,negative regulation of plasma membrane bounded cell projection assembly,BP,
18442,GO:0120040,1,0.962386183172525,0,6,regulation of macrophage proliferation,BP,
18443,GO:0120041,1,0.968518700377519,0,5,positive regulation of macrophage proliferation,BP,
18444,GO:0120042,1,0.993670166857566,0,1,negative regulation of macrophage proliferation,BP,
18445,GO:0120043,1,0.992328329479869,0,1,stereocilium shaft,CC,
18446,GO:0120044,1,0.983873646415305,0,2,stereocilium base,CC,
18447,GO:0120045,1,0.993936382665502,0,1,stereocilium maintenance,BP,
18448,GO:0120048,1,0.993485400251684,0,1,U6 snRNA (adenine-(43)-N(6))-methyltransferase activity,MF,
18449,GO:0120049,1,0.986291094955015,0,2,snRNA (adenine-N6)-methylation,BP,
18450,GO:0120054,1,0.996906466060705,0,1,intestinal motility,BP,
18451,GO:0120055,1,0.996906466060705,0,1,small intestinal transit,BP,
18452,GO:0120057,1,0.996906466060705,0,1,regulation of small intestinal transit,BP,
18453,GO:0120058,1,0.996906466060705,0,1,positive regulation of small intestinal transit,BP,
18454,GO:0120060,1,0.992715315442011,0,2,regulation of gastric emptying,BP,
18455,GO:0120061,1,0.992715315442011,0,2,negative regulation of gastric emptying,BP,
18456,GO:0120063,1,0.988609294021039,0,2,stomach smooth muscle contraction,BP,
18457,GO:0120064,1,0.991803495022634,0,1,stomach pylorus smooth muscle contraction,BP,
18458,GO:0120065,1,0.991803495022634,0,1,pyloric antrum smooth muscle contraction,BP,
18459,GO:0120068,1,0.996779666664659,0,1,regulation of stomach fundus smooth muscle contraction,BP,
18460,GO:0120069,1,0.996779666664659,0,1,positive regulation of stomach fundus smooth muscle contraction,BP,
18461,GO:0120071,1,0.991803495022634,0,1,regulation of pyloric antrum smooth muscle contraction,BP,
18462,GO:0120072,1,0.991803495022634,0,1,positive regulation of pyloric antrum smooth muscle contraction,BP,
18463,GO:0120077,1,0.990316246872485,0,1,angiogenic sprout fusion,BP,
18464,GO:0120078,1,0.990316246872485,0,1,cell adhesion involved in sprouting angiogenesis,BP,
18465,GO:0120092,1,0.992917466140823,0,1,crotonyl-CoA hydratase activity,MF,
18466,GO:0120093,1,0.992917466140823,0,1,regulation of peptidyl-lysine crotonylation,BP,
18467,GO:0120094,1,0.992917466140823,0,1,negative regulation of peptidyl-lysine crotonylation,BP,
18468,GO:0120103,1,0.933649478666527,0,9,centriolar subdistal appendage,CC,
18470,GO:0120114,1,0.667276649024185,0,73,Sm-like protein family complex,CC,
18471,GO:0120115,1,0.971979458517833,0,7,Lsm2-8 complex,CC,
18472,GO:0120117,1,0.992961126974786,0,1,T cell meandering migration,BP,
18473,GO:0120127,1,0.994385852243475,0,1,response to zinc ion starvation,BP,
18474,GO:0120134,1,0.984521580103797,0,1,proximal portion of axoneme,CC,
18475,GO:0120135,1,0.988948320935813,0,1,distal portion of axoneme,CC,
18476,GO:0120146,1,0.973383269916111,0,5,sulfatide binding,MF,
18477,GO:0120147,1,0.994669742655853,0,1,Formylglycine-generating oxidase activity,MF,
18478,GO:0120153,1,0.996040223201871,0,1,calcium-dependent carbohydrate binding,MF,
18479,GO:0120160,1,0.984692004171059,0,2,intraciliary transport particle A binding,MF,
18480,GO:0120161,1,0.391606817152058,0,135,regulation of cold-induced thermogenesis,BP,
18481,GO:0120162,1,0.535124826186943,0,90,positive regulation of cold-induced thermogenesis,BP,
18482,GO:0120163,1,0.738580558705675,0,44,negative regulation of cold-induced thermogenesis,BP,
18483,GO:0120168,1,0.992421004225964,0,1,detection of hot stimulus involved in thermoception,BP,
18484,GO:0120169,1,0.99219717498862,0,1,detection of cold stimulus involved in thermoception,BP,
18485,GO:0120170,1,0.965312465309272,0,5,intraciliary transport particle B binding,MF,
18486,GO:0120178,1,0.797667219983571,0,38,steroid hormone biosynthetic process,BP,
18487,GO:0120180,1,0.959927991608127,0,5,cell-substrate junction disassembly,BP,
18488,GO:0120181,1,0.959927991608127,0,5,focal adhesion disassembly,BP,
18489,GO:0120182,1,0.959927991608127,0,5,regulation of focal adhesion disassembly,BP,
18490,GO:0120183,1,0.959927991608127,0,5,positive regulation of focal adhesion disassembly,BP,
18491,GO:0120187,1,0.987591553011557,0,1,positive regulation of protein localization to chromatin,BP,
18492,GO:0120188,1,0.986999995023382,0,2,regulation of bile acid secretion,BP,
18493,GO:0120189,1,0.992116162369238,0,1,positive regulation of bile acid secretion,BP,
18494,GO:0120191,1,0.98701281886265,0,2,negative regulation of termination of RNA polymerase II transcription,BP,
18495,GO:0120192,1,0.646136277770892,0,66,tight junction assembly,BP,
18496,GO:0120193,1,0.626652930932996,0,69,tight junction organization,BP,
18497,GO:0120222,1,0.989980696770108,0,1,regulation of blastocyst development,BP,
18498,GO:0120227,1,0.880840451529345,0,22,acyl-CoA binding,MF,
18499,GO:0120252,1,0.949719177492373,0,9,hydrocarbon metabolic process,BP,
18500,GO:0120253,1,0.981432055996827,0,3,hydrocarbon catabolic process,BP,
18501,GO:0120254,1,0.539089156615444,0,102,olefinic compound metabolic process,BP,
18502,GO:0120255,1,0.836207311169431,0,28,olefinic compound biosynthetic process,BP,
18503,GO:0120256,1,0.994464894599637,0,1,olefinic compound catabolic process,BP,
18504,GO:0140007,1,0.977045470972218,0,4,KICSTOR complex,CC,
18505,GO:0140009,1,0.973246388304933,0,4,L-aspartate import across plasma membrane,BP,
18506,GO:0140010,1,0.992736252445123,0,1,D-aspartate transmembrane transporter activity,MF,
18510,GO:0140030,1,0.380285531842267,0,134,modification-dependent protein binding,MF,
18511,GO:0140031,1,0.973338189252817,0,4,phosphorylation-dependent protein binding,MF,
18512,GO:0140033,1,0.843267739946626,0,21,acetylation-dependent protein binding,MF,
18513,GO:0140034,1,0.641230156229391,0,62,methylation-dependent protein binding,MF,
18514,GO:0140035,1,0.926595542567868,0,11,ubiquitination-like modification-dependent protein binding,MF,
18515,GO:0140036,1,0.93871386936262,0,9,ubiquitin-dependent protein binding,MF,
18516,GO:0140037,1,0.987098607677646,0,2,sumo-dependent protein binding,MF,
18517,GO:0140039,1,0.984299945557237,0,2,cell-cell adhesion in response to extracellular stimulus,BP,
18518,GO:0140041,1,0.996625193861694,0,1,cellular detoxification of methylglyoxal,BP,
18519,GO:0140042,1,0.949042927374599,0,9,lipid droplet formation,BP,
18520,GO:0140049,1,0.99551487069965,0,1,regulation of endocardial cushion to mesenchymal transition,BP,
18521,GO:0140051,1,0.99551487069965,0,1,positive regulation of endocardial cushion to mesenchymal transition,BP,
18522,GO:0140052,1,0.929802177066699,0,10,cellular response to oxidised low-density lipoprotein particle stimulus,BP,
18523,GO:0140053,1,0.452101938225844,0,156,mitochondrial gene expression,BP,
18525,GO:0140058,1,0.803999592441745,0,26,neuron projection arborization,BP,
18526,GO:0140059,1,0.956268164711729,0,7,dendrite arborization,BP,
18527,GO:0140064,1,0.98869811524066,0,1,peptide crotonyltransferase activity,MF,
18528,GO:0140065,1,0.98869811524066,0,1,peptide butyryltransferase activity,MF,
18529,GO:0140066,1,0.981694835500259,0,2,peptidyl-lysine crotonylation,BP,
18530,GO:0140067,1,0.98869811524066,0,1,peptidyl-lysine butyrylation,BP,
18531,GO:0140068,1,0.98869811524066,0,1,histone crotonyltransferase activity,MF,
18532,GO:0140069,1,0.98869811524066,0,1,histone butyryltransferase activity,MF,
18533,GO:0140074,1,0.985602326517936,0,2,cardiac endothelial to mesenchymal transition,BP,
18534,GO:0140078,1,0.966268413389458,0,7,class I DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,
18535,GO:0140081,1,0.989999826126708,0,2,glycosylated region protein binding,MF,
18536,GO:0140090,1,0.98287575765611,0,3,membrane curvature sensor activity,MF,
18539,GO:0140098,1,0.11847774667711,0,333,catalytic activity, acting on RNA,MF,
18540,GO:0140101,1,0.562330525753473,0,96,catalytic activity, acting on a tRNA,MF,
18541,GO:0140102,1,0.91044988569222,0,17,catalytic activity, acting on a rRNA,MF,
18542,GO:0140103,1,0.883099354665871,0,19,catalytic activity, acting on a glycoprotein,MF,
18543,GO:0140104,1,0.945227280703876,0,10,molecular carrier activity,MF,
18545,GO:0140112,1,0.885760036752737,0,20,extracellular vesicle biogenesis,BP,
18546,GO:0140115,1,0.676086185936266,0,57,export across plasma membrane,BP,
18547,GO:0140131,1,0.903843903999083,0,17,positive regulation of lymphocyte chemotaxis,BP,
18548,GO:0140135,1,0.973851179212943,0,4,mechanosensitive cation channel activity,MF,
18549,GO:0140142,1,0.805110123506024,0,28,nucleocytoplasmic carrier activity,MF,
18550,GO:0140157,1,0.973889433796484,0,3,ammonium import across plasma membrane,BP,
18551,GO:0140161,1,0.950228357477561,0,9,monocarboxylate:sodium symporter activity,MF,
18552,GO:0140192,1,0.973491175298128,0,3,regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
18553,GO:0140193,1,0.996030951058853,0,1,regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
18554,GO:0140194,1,0.996030951058853,0,1,negative regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
18555,GO:0140196,1,0.990076635485235,0,1,positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
18556,GO:0140199,1,0.983249960204204,0,2,negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
18557,GO:0140200,1,0.989243390156733,0,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in regulation of heart rate,BP,
18558,GO:0140205,1,0.979626870180175,0,2,oligopeptide import across plasma membrane,BP,
18559,GO:0140206,1,0.979626870180175,0,2,dipeptide import across plasma membrane,BP,
18560,GO:0140212,1,0.956658792911,0,6,regulation of long-chain fatty acid import into cell,BP,
18561,GO:0140213,1,0.966966618957471,0,4,negative regulation of long-chain fatty acid import into cell,BP,
18562,GO:0140214,1,0.989343600570854,0,2,positive regulation of long-chain fatty acid import into cell,BP,
18563,GO:0140223,1,0.794842100975314,0,40,general transcription initiation factor activity,MF,
18566,GO:0140243,1,0.976405095739602,0,3,regulation of translation at synapse,BP,
18567,GO:0140245,1,0.987560455442067,0,2,regulation of translation at postsynapse,BP,
18568,GO:0140246,1,0.991349679257538,0,1,protein catabolic process at synapse,BP,
18569,GO:0140253,1,0.737293006477514,0,45,cell-cell fusion,BP,
18570,GO:0140261,1,0.990753805546624,0,1,BCOR complex,CC,
18571,GO:0140271,1,0.959187501693079,0,6,hexose import across plasma membrane,BP,
18572,GO:0140272,1,0.64139506662304,0,65,exogenous protein binding,MF,
18573,GO:0140296,1,0.748311545430029,0,44,general transcription initiation factor binding,MF,
18574,GO:0140297,1,0.102084070772444,0,329,DNA-binding transcription factor binding,MF,
18576,GO:0140303,1,0.858554382220693,0,19,intramembrane lipid transporter activity,MF,
18577,GO:0140312,1,0.887401744794047,0,17,cargo adaptor activity,MF,
18578,GO:0140318,1,0.90498320714094,0,17,protein transporter activity,MF,
18579,GO:0140321,1,0.99197597420295,0,1,negative regulation by symbiont of host autophagy,BP,
18581,GO:0140326,1,0.906662267064978,0,11,ATPase-coupled intramembrane lipid transporter activity,MF,
18582,GO:0140327,1,0.950820583023341,0,6,flippase activity,MF,
18583,GO:0140328,1,0.945986351386219,0,6,floppase activity,MF,
18584,GO:0140333,1,0.982008950513387,0,2,glycerophospholipid flippase activity,MF,
18586,GO:0140353,1,0.818799887928639,0,33,lipid export from cell,BP,
18587,GO:0140354,1,0.893767792699534,0,16,lipid import into cell,BP,
18588,GO:0140375,1,0.489317354299824,0,118,immune receptor activity,MF,
18590,GO:0140414,1,0.99696671272875,0,1,phosphopantetheine-dependent carrier activity,MF,
18591,GO:0140445,1,0.932600309076918,0,11,chromosome, telomeric repeat region,CC,
18593,GO:0140455,1,0.995544823186114,0,1,cytoplasm protein quality control,BP,
18594,GO:0140457,1,0.807472524202449,0,25,protein demethylase activity,MF,
18595,GO:0140461,1,0.995555341111532,0,1,subtelomeric heterochromatin organization,BP,
18596,GO:0140462,1,0.989431794717242,0,2,pericentric heterochromatin organization,BP,
18597,GO:0140467,1,0.885926859620245,0,20,integrated stress response signaling,BP,
18598,GO:0140507,1,0.973972771193132,0,5,granzyme-mediated programmed cell death signaling pathway,BP,
18599,GO:0150001,1,0.978985092618987,0,2,primary dendrite,CC,
18600,GO:0150002,1,0.984179621003918,0,2,distal dendrite,CC,
18601,GO:0150003,1,0.952788594571047,0,6,regulation of spontaneous synaptic transmission,BP,
18602,GO:0150005,1,0.981026911589919,0,4,enzyme activator complex,CC,
18603,GO:0150007,1,0.982215056368677,0,2,clathrin-dependent synaptic vesicle endocytosis,BP,
18604,GO:0150011,1,0.886991220638713,0,14,regulation of neuron projection arborization,BP,
18605,GO:0150012,1,0.938540140326614,0,8,positive regulation of neuron projection arborization,BP,
18606,GO:0150014,1,0.991381385518801,0,1,apical distal dendrite,CC,
18607,GO:0150018,1,0.977620789736378,0,3,basal dendrite development,BP,
18608,GO:0150019,1,0.977620789736378,0,3,basal dendrite morphogenesis,BP,
18609,GO:0150020,1,0.977620789736378,0,3,basal dendrite arborization,BP,
18610,GO:0150024,1,0.994733003118225,0,1,oxidised low-density lipoprotein particle clearance,BP,
18611,GO:0150025,1,0.994733003118225,0,1,oxidised low-density lipoprotein particle receptor activity,MF,
18612,GO:0150031,1,0.985542367867208,0,2,regulation of protein localization to lysosome,BP,
18613,GO:0150032,1,0.994790307640305,0,1,positive regulation of protein localization to lysosome,BP,
18614,GO:0150033,1,0.990704112230237,0,1,negative regulation of protein localization to lysosome,BP,
18616,GO:0150051,1,0.948989258728729,0,5,postsynaptic Golgi apparatus,CC,
18617,GO:0150052,1,0.907032594842096,0,13,regulation of postsynapse assembly,BP,
18618,GO:0150056,1,0.98947146428854,0,2,amylin receptor complex 1,CC,
18619,GO:0150057,1,0.989628504384512,0,2,amylin receptor complex 2,CC,
18620,GO:0150058,1,0.988855588787875,0,2,amylin receptor complex 3,CC,
18621,GO:0150062,1,0.977043162144476,0,4,complement-mediated synapse pruning,BP,
18623,GO:0150064,1,0.980509104812486,0,3,vertebrate eye-specific patterning,BP,
18624,GO:0150065,1,0.918392121815056,0,11,regulation of deacetylase activity,BP,
18625,GO:0150066,1,0.980333394920134,0,2,negative regulation of deacetylase activity,BP,
18626,GO:0150070,1,0.994379049913537,0,1,regulation of arginase activity,BP,
18627,GO:0150072,1,0.994379049913537,0,1,positive regulation of arginase activity,BP,
18628,GO:0150073,1,0.994379049913537,0,1,regulation of protein-glutamine gamma-glutamyltransferase activity,BP,
18629,GO:0150074,1,0.994379049913537,0,1,positive regulation of protein-glutamine gamma-glutamyltransferase activity,BP,
18631,GO:0150077,1,0.825824399766086,0,29,regulation of neuroinflammatory response,BP,
18632,GO:0150078,1,0.931240424209116,0,12,positive regulation of neuroinflammatory response,BP,
18633,GO:0150079,1,0.927904603977629,0,11,negative regulation of neuroinflammatory response,BP,
18634,GO:0150089,1,0.993044849330838,0,1,multiple spine synapse organization,BP,
18635,GO:0150090,1,0.993044849330838,0,1,multiple spine synapse organization, single dendrite,BP,
18636,GO:0150093,1,0.946035316248871,0,7,amyloid-beta clearance by transcytosis,BP,
18637,GO:0150094,1,0.935150995062776,0,7,amyloid-beta clearance by cellular catabolic process,BP,
18638,GO:0150098,1,0.985366312658541,0,2,glial cell-neuron signaling,BP,
18639,GO:0150100,1,0.992308224547309,0,2,RNA binding involved in posttranscriptional gene silencing,MF,
18640,GO:0150104,1,0.93583345910078,0,11,transport across blood-brain barrier,BP,
18641,GO:0150105,1,0.903002836806441,0,13,protein localization to cell-cell junction,BP,
18642,GO:0150106,1,0.991618385621772,0,1,regulation of protein localization to cell-cell junction,BP,
18643,GO:0150115,1,0.444150071583634,0,100,cell-substrate junction organization,BP,
18644,GO:0150116,1,0.602158413030675,0,65,regulation of cell-substrate junction organization,BP,
18645,GO:0150117,1,0.802771524322158,0,28,positive regulation of cell-substrate junction organization,BP,
18646,GO:0150118,1,0.869947691852491,0,18,negative regulation of cell-substrate junction organization,BP,
18647,GO:0150146,1,0.882710727962189,0,19,cell junction disassembly,BP,
18648,GO:0150147,1,0.978639817642769,0,3,cell-cell junction disassembly,BP,
18649,GO:0150172,1,0.953816027979165,0,8,regulation of phosphatidylcholine metabolic process,BP,
18650,GO:0150173,1,0.981402825787448,0,3,positive regulation of phosphatidylcholine metabolic process,BP,
18651,GO:0150200,1,0.996286622576736,0,1,regulation of transport across blood-brain barrier,BP,
18652,GO:0150201,1,0.996286622576736,0,1,positive regulation of transport across blood-brain barrier,BP,
18654,GO:1900003,1,0.975507042398789,0,4,regulation of serine-type endopeptidase activity,BP,
18655,GO:1900004,1,0.975507042398789,0,4,negative regulation of serine-type endopeptidase activity,BP,
18656,GO:1900005,1,0.988255070026608,0,1,positive regulation of serine-type endopeptidase activity,BP,
18658,GO:1900010,1,0.995187602399077,0,1,regulation of corticotropin-releasing hormone receptor activity,BP,
18659,GO:1900011,1,0.995187602399077,0,1,negative regulation of corticotropin-releasing hormone receptor activity,BP,
18660,GO:1900015,1,0.767012148656408,0,40,regulation of cytokine production involved in inflammatory response,BP,
18661,GO:1900016,1,0.912610521989777,0,14,negative regulation of cytokine production involved in inflammatory response,BP,
18662,GO:1900017,1,0.88756607447244,0,18,positive regulation of cytokine production involved in inflammatory response,BP,
18663,GO:1900019,1,0.971400820446977,0,4,regulation of protein kinase C activity,BP,
18664,GO:1900020,1,0.971400820446977,0,4,positive regulation of protein kinase C activity,BP,
18665,GO:1900022,1,0.992835963822036,0,1,regulation of D-erythro-sphingosine kinase activity,BP,
18666,GO:1900024,1,0.728829919211985,0,48,regulation of substrate adhesion-dependent cell spreading,BP,
18667,GO:1900025,1,0.921128280582078,0,12,negative regulation of substrate adhesion-dependent cell spreading,BP,
18668,GO:1900026,1,0.797447094938186,0,35,positive regulation of substrate adhesion-dependent cell spreading,BP,
18670,GO:1900028,1,0.965267978272603,0,6,negative regulation of ruffle assembly,BP,
18671,GO:1900029,1,0.928574153684739,0,12,positive regulation of ruffle assembly,BP,
18673,GO:1900035,1,0.993561439661167,0,1,negative regulation of cellular response to heat,BP,
18674,GO:1900036,1,0.994217536508852,0,1,positive regulation of cellular response to heat,BP,
18675,GO:1900037,1,0.92190904497925,0,13,regulation of cellular response to hypoxia,BP,
18676,GO:1900038,1,0.957244747622393,0,7,negative regulation of cellular response to hypoxia,BP,
18677,GO:1900039,1,0.989213003349748,0,2,positive regulation of cellular response to hypoxia,BP,
18678,GO:1900044,1,0.910065749944364,0,12,regulation of protein K63-linked ubiquitination,BP,
18679,GO:1900045,1,0.947901060841295,0,7,negative regulation of protein K63-linked ubiquitination,BP,
18680,GO:1900046,1,0.621962352894264,0,75,regulation of hemostasis,BP,
18681,GO:1900047,1,0.758812129387775,0,45,negative regulation of hemostasis,BP,
18682,GO:1900048,1,0.85238030030237,0,25,positive regulation of hemostasis,BP,
18683,GO:1900052,1,0.989070924165233,0,2,regulation of retinoic acid biosynthetic process,BP,
18684,GO:1900053,1,0.996216597465047,0,1,negative regulation of retinoic acid biosynthetic process,BP,
18685,GO:1900054,1,0.992827460529088,0,1,positive regulation of retinoic acid biosynthetic process,BP,
18686,GO:1900060,1,0.972643995553611,0,5,negative regulation of ceramide biosynthetic process,BP,
18687,GO:1900062,1,0.992741893474036,0,1,regulation of replicative cell aging,BP,
18688,GO:1900063,1,0.97370444083,0,3,regulation of peroxisome organization,BP,
18689,GO:1900069,1,0.973442307887067,0,4,regulation of cellular hyperosmotic salinity response,BP,
18690,GO:1900073,1,0.995659862112946,0,1,regulation of neuromuscular synaptic transmission,BP,
18691,GO:1900075,1,0.995659862112946,0,1,positive regulation of neuromuscular synaptic transmission,BP,
18692,GO:1900076,1,0.623276273902141,0,68,regulation of cellular response to insulin stimulus,BP,
18693,GO:1900077,1,0.802631265588076,0,32,negative regulation of cellular response to insulin stimulus,BP,
18694,GO:1900078,1,0.842000715534305,0,23,positive regulation of cellular response to insulin stimulus,BP,
18695,GO:1900079,1,0.995061768613089,0,1,regulation of arginine biosynthetic process,BP,
18696,GO:1900081,1,0.988659840744814,0,1,regulation of arginine catabolic process,BP,
18697,GO:1900082,1,0.988659840744814,0,1,negative regulation of arginine catabolic process,BP,
18698,GO:1900084,1,0.962496061410748,0,5,regulation of peptidyl-tyrosine autophosphorylation,BP,
18699,GO:1900085,1,0.993630009751703,0,1,negative regulation of peptidyl-tyrosine autophosphorylation,BP,
18700,GO:1900086,1,0.968668427140932,0,4,positive regulation of peptidyl-tyrosine autophosphorylation,BP,
18701,GO:1900087,1,0.787511589956213,0,36,positive regulation of G1/S transition of mitotic cell cycle,BP,
18702,GO:1900094,1,0.959860050978082,0,7,regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry,BP,
18703,GO:1900095,1,0.987245036588617,0,1,regulation of dosage compensation by inactivation of X chromosome,BP,
18704,GO:1900098,1,0.995249124695342,0,1,regulation of plasma cell differentiation,BP,
18705,GO:1900100,1,0.995249124695342,0,1,positive regulation of plasma cell differentiation,BP,
18706,GO:1900101,1,0.854177103620723,0,25,regulation of endoplasmic reticulum unfolded protein response,BP,
18707,GO:1900102,1,0.92678665482875,0,12,negative regulation of endoplasmic reticulum unfolded protein response,BP,
18708,GO:1900103,1,0.923185181026653,0,12,positive regulation of endoplasmic reticulum unfolded protein response,BP,
18709,GO:1900104,1,0.981226721833443,0,3,regulation of hyaluranon cable assembly,BP,
18710,GO:1900106,1,0.981226721833443,0,3,positive regulation of hyaluranon cable assembly,BP,
18711,GO:1900107,1,0.957842969714898,0,7,regulation of nodal signaling pathway,BP,
18712,GO:1900108,1,0.984991564131839,0,3,negative regulation of nodal signaling pathway,BP,
18713,GO:1900109,1,0.985637331429692,0,3,regulation of histone H3-K9 dimethylation,BP,
18714,GO:1900110,1,0.991657028840465,0,2,negative regulation of histone H3-K9 dimethylation,BP,
18715,GO:1900111,1,0.993930165935714,0,1,positive regulation of histone H3-K9 dimethylation,BP,
18716,GO:1900112,1,0.929279826647076,0,10,regulation of histone H3-K9 trimethylation,BP,
18717,GO:1900113,1,0.97041122158651,0,5,negative regulation of histone H3-K9 trimethylation,BP,
18718,GO:1900114,1,0.976758775467731,0,3,positive regulation of histone H3-K9 trimethylation,BP,
18719,GO:1900115,1,0.916608964269376,0,12,extracellular regulation of signal transduction,BP,
18720,GO:1900116,1,0.916608964269376,0,12,extracellular negative regulation of signal transduction,BP,
18721,GO:1900117,1,0.843175665540814,0,28,regulation of execution phase of apoptosis,BP,
18722,GO:1900118,1,0.930269402269302,0,11,negative regulation of execution phase of apoptosis,BP,
18723,GO:1900119,1,0.920581614841116,0,15,positive regulation of execution phase of apoptosis,BP,
18724,GO:1900120,1,0.855250734326616,0,24,regulation of receptor binding,BP,
18725,GO:1900121,1,0.917300846837107,0,13,negative regulation of receptor binding,BP,
18726,GO:1900122,1,0.945328974875807,0,9,positive regulation of receptor binding,BP,
18727,GO:1900125,1,0.940423634251974,0,8,regulation of hyaluronan biosynthetic process,BP,
18728,GO:1900126,1,0.968281555247131,0,4,negative regulation of hyaluronan biosynthetic process,BP,
18729,GO:1900127,1,0.971238654064478,0,4,positive regulation of hyaluronan biosynthetic process,BP,
18730,GO:1900130,1,0.9927862393797,0,1,regulation of lipid binding,BP,
18731,GO:1900131,1,0.9927862393797,0,1,negative regulation of lipid binding,BP,
18732,GO:1900133,1,0.97964978657053,0,3,regulation of renin secretion into blood stream,BP,
18733,GO:1900134,1,0.99270315995283,0,1,negative regulation of renin secretion into blood stream,BP,
18734,GO:1900135,1,0.986851634399658,0,2,positive regulation of renin secretion into blood stream,BP,
18735,GO:1900138,1,0.987895561954879,0,2,negative regulation of phospholipase A2 activity,BP,
18736,GO:1900139,1,0.991922972061398,0,1,negative regulation of arachidonic acid secretion,BP,
18737,GO:1900141,1,0.983046520323917,0,2,regulation of oligodendrocyte apoptotic process,BP,
18738,GO:1900142,1,0.99390366202136,0,1,negative regulation of oligodendrocyte apoptotic process,BP,
18739,GO:1900143,1,0.989076927121571,0,1,positive regulation of oligodendrocyte apoptotic process,BP,
18740,GO:1900145,1,0.969725809060987,0,5,regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,
18741,GO:1900146,1,0.991664550188161,0,2,negative regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,
18742,GO:1900147,1,0.96785487366334,0,3,regulation of Schwann cell migration,BP,
18743,GO:1900148,1,0.993485400251684,0,1,negative regulation of Schwann cell migration,BP,
18744,GO:1900149,1,0.97420306758751,0,2,positive regulation of Schwann cell migration,BP,
18745,GO:1900150,1,0.984319315675894,0,3,regulation of defense response to fungus,BP,
18746,GO:1900151,1,0.873939579933148,0,18,regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
18747,GO:1900152,1,0.995221760105399,0,1,negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
18748,GO:1900153,1,0.873939579933148,0,18,positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
18749,GO:1900154,1,0.988044306181265,0,2,regulation of bone trabecula formation,BP,
18750,GO:1900155,1,0.988044306181265,0,2,negative regulation of bone trabecula formation,BP,
18751,GO:1900157,1,0.986745636204012,0,2,regulation of bone mineralization involved in bone maturation,BP,
18752,GO:1900158,1,0.992552942793789,0,1,negative regulation of bone mineralization involved in bone maturation,BP,
18753,GO:1900159,1,0.994149557619953,0,1,positive regulation of bone mineralization involved in bone maturation,BP,
18754,GO:1900161,1,0.993455567656276,0,1,regulation of phospholipid scramblase activity,BP,
18755,GO:1900163,1,0.993455567656276,0,1,positive regulation of phospholipid scramblase activity,BP,
18756,GO:1900164,1,0.959860050978082,0,7,nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18757,GO:1900166,1,0.974375084906367,0,3,regulation of glial cell-derived neurotrophic factor secretion,BP,
18758,GO:1900168,1,0.974375084906367,0,3,positive regulation of glial cell-derived neurotrophic factor secretion,BP,
18759,GO:1900169,1,0.978774070619484,0,2,regulation of glucocorticoid mediated signaling pathway,BP,
18760,GO:1900170,1,0.993485400251684,0,1,negative regulation of glucocorticoid mediated signaling pathway,BP,
18761,GO:1900175,1,0.969725809060987,0,5,regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18762,GO:1900176,1,0.991664550188161,0,2,negative regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18763,GO:1900180,1,0.449070794481524,0,117,regulation of protein localization to nucleus,BP,
18764,GO:1900181,1,0.825016256709903,0,27,negative regulation of protein localization to nucleus,BP,
18765,GO:1900182,1,0.590019316113051,0,77,positive regulation of protein localization to nucleus,BP,
18766,GO:1900186,1,0.976070380019104,0,4,negative regulation of clathrin-dependent endocytosis,BP,
18767,GO:1900190,1,0.994149557619953,0,1,regulation of single-species biofilm formation,BP,
18768,GO:1900191,1,0.994149557619953,0,1,negative regulation of single-species biofilm formation,BP,
18769,GO:1900193,1,0.953468443678212,0,8,regulation of oocyte maturation,BP,
18770,GO:1900194,1,0.983402059023072,0,3,negative regulation of oocyte maturation,BP,
18771,GO:1900195,1,0.981751743673576,0,3,positive regulation of oocyte maturation,BP,
18772,GO:1900200,1,0.985291956540197,0,2,mesenchymal cell apoptotic process involved in metanephros development,BP,
18773,GO:1900204,1,0.985291956540197,0,2,apoptotic process involved in metanephric collecting duct development,BP,
18774,GO:1900205,1,0.985291956540197,0,2,apoptotic process involved in metanephric nephron tubule development,BP,
18775,GO:1900208,1,0.983208229787054,0,4,regulation of cardiolipin metabolic process,BP,
18776,GO:1900210,1,0.99129764885802,0,2,positive regulation of cardiolipin metabolic process,BP,
18777,GO:1900211,1,0.985291956540197,0,2,regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,
18778,GO:1900212,1,0.985291956540197,0,2,negative regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,
18779,GO:1900214,1,0.985291956540197,0,2,regulation of apoptotic process involved in metanephric collecting duct development,BP,
18780,GO:1900215,1,0.985291956540197,0,2,negative regulation of apoptotic process involved in metanephric collecting duct development,BP,
18781,GO:1900217,1,0.985291956540197,0,2,regulation of apoptotic process involved in metanephric nephron tubule development,BP,
18782,GO:1900218,1,0.985291956540197,0,2,negative regulation of apoptotic process involved in metanephric nephron tubule development,BP,
18783,GO:1900220,1,0.982370379986663,0,2,semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis,BP,
18784,GO:1900221,1,0.904166820358946,0,14,regulation of amyloid-beta clearance,BP,
18785,GO:1900222,1,0.954951316695922,0,7,negative regulation of amyloid-beta clearance,BP,
18786,GO:1900223,1,0.954103317316088,0,6,positive regulation of amyloid-beta clearance,BP,
18787,GO:1900224,1,0.982136203169237,0,2,positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18788,GO:1900225,1,0.916552599347766,0,12,regulation of NLRP3 inflammasome complex assembly,BP,
18789,GO:1900226,1,0.972308724851805,0,4,negative regulation of NLRP3 inflammasome complex assembly,BP,
18790,GO:1900227,1,0.948771419175647,0,7,positive regulation of NLRP3 inflammasome complex assembly,BP,
18791,GO:1900228,1,0.994149557619953,0,1,regulation of single-species biofilm formation in or on host organism,BP,
18792,GO:1900229,1,0.994149557619953,0,1,negative regulation of single-species biofilm formation in or on host organism,BP,
18793,GO:1900234,1,0.99161006016666,0,1,regulation of Kit signaling pathway,BP,
18794,GO:1900235,1,0.99161006016666,0,1,negative regulation of Kit signaling pathway,BP,
18795,GO:1900238,1,0.978302217119871,0,3,regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,
18796,GO:1900239,1,0.959944649260829,0,6,regulation of phenotypic switching,BP,
18797,GO:1900240,1,0.983983797078526,0,2,negative regulation of phenotypic switching,BP,
18798,GO:1900241,1,0.989869210494854,0,2,positive regulation of phenotypic switching,BP,
18800,GO:1900243,1,0.991748911561887,0,1,negative regulation of synaptic vesicle endocytosis,BP,
18802,GO:1900245,1,0.973423331457561,0,3,positive regulation of MDA-5 signaling pathway,BP,
18803,GO:1900246,1,0.949120594073316,0,6,positive regulation of RIG-I signaling pathway,BP,
18804,GO:1900247,1,0.941341017514674,0,9,regulation of cytoplasmic translational elongation,BP,
18805,GO:1900248,1,0.982747108270364,0,2,negative regulation of cytoplasmic translational elongation,BP,
18806,GO:1900259,1,0.995082085604262,0,1,regulation of RNA-directed 5'-3' RNA polymerase activity,BP,
18807,GO:1900260,1,0.995082085604262,0,1,negative regulation of RNA-directed 5'-3' RNA polymerase activity,BP,
18808,GO:1900262,1,0.954338980038343,0,9,regulation of DNA-directed DNA polymerase activity,BP,
18809,GO:1900264,1,0.954338980038343,0,9,positive regulation of DNA-directed DNA polymerase activity,BP,
18811,GO:1900272,1,0.923429753247994,0,12,negative regulation of long-term synaptic potentiation,BP,
18813,GO:1900274,1,0.732704176300072,0,46,regulation of phospholipase C activity,BP,
18814,GO:1900275,1,0.984341507283909,0,2,negative regulation of phospholipase C activity,BP,
18815,GO:1900276,1,0.992874062631439,0,1,regulation of proteinase activated receptor activity,BP,
18816,GO:1900279,1,0.988567820439955,0,2,regulation of CD4-positive, alpha-beta T cell costimulation,BP,
18817,GO:1900280,1,0.995689583688793,0,1,negative regulation of CD4-positive, alpha-beta T cell costimulation,BP,
18818,GO:1900281,1,0.992847714373444,0,1,positive regulation of CD4-positive, alpha-beta T cell costimulation,BP,
18819,GO:1900363,1,0.893033185440314,0,16,regulation of mRNA polyadenylation,BP,
18820,GO:1900364,1,0.945511210104213,0,8,negative regulation of mRNA polyadenylation,BP,
18821,GO:1900365,1,0.971554134982467,0,4,positive regulation of mRNA polyadenylation,BP,
18822,GO:1900368,1,0.971026043358262,0,4,regulation of RNA interference,BP,
18823,GO:1900369,1,0.983286721812571,0,2,negative regulation of RNA interference,BP,
18824,GO:1900370,1,0.991625827041623,0,1,positive regulation of RNA interference,BP,
18827,GO:1900373,1,0.901307788856432,0,17,positive regulation of purine nucleotide biosynthetic process,BP,
18828,GO:1900376,1,0.923473970761834,0,10,regulation of secondary metabolite biosynthetic process,BP,
18829,GO:1900377,1,0.975263634899153,0,3,negative regulation of secondary metabolite biosynthetic process,BP,
18830,GO:1900378,1,0.958424234727706,0,6,positive regulation of secondary metabolite biosynthetic process,BP,
18831,GO:1900383,1,0.992982846175729,0,1,regulation of synaptic plasticity by receptor localization to synapse,BP,
18832,GO:1900407,1,0.622272167513527,0,72,regulation of cellular response to oxidative stress,BP,
18833,GO:1900408,1,0.764379772351657,0,41,negative regulation of cellular response to oxidative stress,BP,
18834,GO:1900409,1,0.89787510286619,0,17,positive regulation of cellular response to oxidative stress,BP,
18835,GO:1900424,1,0.912482220603056,0,15,regulation of defense response to bacterium,BP,
18836,GO:1900425,1,0.967299543306025,0,5,negative regulation of defense response to bacterium,BP,
18837,GO:1900426,1,0.956861011534024,0,8,positive regulation of defense response to bacterium,BP,
18839,GO:1900450,1,0.978206636839414,0,3,negative regulation of glutamate receptor signaling pathway,BP,
18840,GO:1900451,1,0.898268722589781,0,15,positive regulation of glutamate receptor signaling pathway,BP,
18841,GO:1900452,1,0.898861170497562,0,14,regulation of long-term synaptic depression,BP,
18842,GO:1900453,1,0.98195060639717,0,3,negative regulation of long-term synaptic depression,BP,
18843,GO:1900454,1,0.954847214221282,0,6,positive regulation of long-term synaptic depression,BP,
18844,GO:1900477,1,0.994721141785787,0,1,negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter,BP,
18845,GO:1900480,1,0.993548831134825,0,1,regulation of diacylglycerol biosynthetic process,BP,
18846,GO:1900533,1,0.995739177558212,0,1,palmitic acid metabolic process,BP,
18847,GO:1900535,1,0.995739177558212,0,1,palmitic acid biosynthetic process,BP,
18850,GO:1900544,1,0.769099572376117,0,37,positive regulation of purine nucleotide metabolic process,BP,
18851,GO:1900619,1,0.974849006870859,0,4,acetate ester metabolic process,BP,
18852,GO:1900620,1,0.987679388903247,0,2,acetate ester biosynthetic process,BP,
18853,GO:1900623,1,0.976815683741017,0,3,regulation of monocyte aggregation,BP,
18854,GO:1900625,1,0.976815683741017,0,3,positive regulation of monocyte aggregation,BP,
18855,GO:1900673,1,0.980788183186867,0,3,olefin metabolic process,BP,
18856,GO:1900736,1,0.980926490934699,0,4,regulation of phospholipase C-activating G protein-coupled receptor signaling pathway,BP,
18857,GO:1900737,1,0.992874062631439,0,1,negative regulation of phospholipase C-activating G protein-coupled receptor signaling pathway,BP,
18858,GO:1900738,1,0.987967536436566,0,3,positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway,BP,
18859,GO:1900739,1,0.857786164783776,0,26,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,
18860,GO:1900740,1,0.857786164783776,0,26,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,
18861,GO:1900744,1,0.781884266706555,0,37,regulation of p38MAPK cascade,BP,
18862,GO:1900745,1,0.851855651080679,0,25,positive regulation of p38MAPK cascade,BP,
18863,GO:1900746,1,0.896631903874672,0,16,regulation of vascular endothelial growth factor signaling pathway,BP,
18864,GO:1900747,1,0.955684208721863,0,7,negative regulation of vascular endothelial growth factor signaling pathway,BP,
18865,GO:1900748,1,0.957847682531595,0,5,positive regulation of vascular endothelial growth factor signaling pathway,BP,
18866,GO:1900749,1,0.992971185204564,0,1,(R)-carnitine transport,BP,
18867,GO:1900750,1,0.938232693598427,0,13,oligopeptide binding,MF,
18868,GO:1900753,1,0.992422865697812,0,1,doxorubicin transport,BP,
18869,GO:1900756,1,0.983341429699792,0,2,protein processing in phagocytic vesicle,BP,
18870,GO:1900825,1,0.973137498289506,0,4,regulation of membrane depolarization during cardiac muscle cell action potential,BP,
18871,GO:1900826,1,0.995999097821548,0,1,negative regulation of membrane depolarization during cardiac muscle cell action potential,BP,
18872,GO:1900827,1,0.987756477458287,0,1,positive regulation of membrane depolarization during cardiac muscle cell action potential,BP,
18873,GO:1900864,1,0.955989927452986,0,8,mitochondrial RNA modification,BP,
18874,GO:1900923,1,0.989078711413377,0,2,regulation of glycine import across plasma membrane,BP,
18875,GO:1900924,1,0.989078711413377,0,2,negative regulation of glycine import across plasma membrane,BP,
18876,GO:1901000,1,0.973442307887067,0,4,regulation of response to salt stress,BP,
18877,GO:1901003,1,0.986422572574789,0,2,negative regulation of fermentation,BP,
18878,GO:1901004,1,0.996146740068436,0,1,ubiquinone-6 metabolic process,BP,
18879,GO:1901006,1,0.996146740068436,0,1,ubiquinone-6 biosynthetic process,BP,
18881,GO:1901017,1,0.87860056597949,0,19,negative regulation of potassium ion transmembrane transporter activity,BP,
18884,GO:1901020,1,0.82563261986448,0,32,negative regulation of calcium ion transmembrane transporter activity,BP,
18886,GO:1901026,1,0.974470069948528,0,3,ripoptosome assembly involved in necroptotic process,BP,
18887,GO:1901028,1,0.77503479700724,0,44,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,
18888,GO:1901029,1,0.951203241955015,0,9,negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,
18889,GO:1901030,1,0.818830446504768,0,34,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,
18890,GO:1901031,1,0.811295750330141,0,33,regulation of response to reactive oxygen species,BP,
18891,GO:1901032,1,0.908628333849325,0,15,negative regulation of response to reactive oxygen species,BP,
18892,GO:1901033,1,0.948220967613265,0,9,positive regulation of response to reactive oxygen species,BP,
18893,GO:1901052,1,0.98941813159439,0,2,sarcosine metabolic process,BP,
18894,GO:1901053,1,0.992950953916412,0,1,sarcosine catabolic process,BP,
18896,GO:1901069,1,0.995924241798657,0,1,guanosine-containing compound catabolic process,BP,
18897,GO:1901070,1,0.94538088046573,0,13,guanosine-containing compound biosynthetic process,BP,
18898,GO:1901071,1,0.869347809466183,0,22,glucosamine-containing compound metabolic process,BP,
18899,GO:1901072,1,0.958076373677873,0,8,glucosamine-containing compound catabolic process,BP,
18900,GO:1901073,1,0.984471462329873,0,2,glucosamine-containing compound biosynthetic process,BP,
18901,GO:1901074,1,0.980519916829153,0,3,regulation of engulfment of apoptotic cell,BP,
18902,GO:1901076,1,0.986828968150811,0,2,positive regulation of engulfment of apoptotic cell,BP,
18903,GO:1901077,1,0.941573644514373,0,10,regulation of relaxation of muscle,BP,
18904,GO:1901078,1,0.971648657444114,0,4,negative regulation of relaxation of muscle,BP,
18905,GO:1901079,1,0.988947588322015,0,2,positive regulation of relaxation of muscle,BP,
18906,GO:1901086,1,0.991892418496674,0,1,benzylpenicillin metabolic process,BP,
18908,GO:1901097,1,0.971476586019102,0,4,negative regulation of autophagosome maturation,BP,
18909,GO:1901098,1,0.944730750172353,0,7,positive regulation of autophagosome maturation,BP,
18910,GO:1901099,1,0.823430008405753,0,33,negative regulation of signal transduction in absence of ligand,BP,
18912,GO:1901136,1,0.342356185005308,0,171,carbohydrate derivative catabolic process,BP,
18914,GO:1901142,1,0.963968723752386,0,5,insulin metabolic process,BP,
18915,GO:1901143,1,0.984702033849355,0,2,insulin catabolic process,BP,
18916,GO:1901145,1,0.978001734578819,0,3,mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
18917,GO:1901147,1,0.985291956540197,0,2,mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
18918,GO:1901159,1,0.975234285249958,0,5,xylulose 5-phosphate biosynthetic process,BP,
18919,GO:1901160,1,0.902271269038985,0,14,primary amino compound metabolic process,BP,
18920,GO:1901162,1,0.972492860886388,0,5,primary amino compound biosynthetic process,BP,
18921,GO:1901163,1,0.930336462336734,0,12,regulation of trophoblast cell migration,BP,
18922,GO:1901164,1,0.964981344775155,0,6,negative regulation of trophoblast cell migration,BP,
18923,GO:1901165,1,0.964110445491799,0,6,positive regulation of trophoblast cell migration,BP,
18924,GO:1901166,1,0.959468558166955,0,5,neural crest cell migration involved in autonomic nervous system development,BP,
18928,GO:1901187,1,0.984986018428466,0,2,regulation of ephrin receptor signaling pathway,BP,
18929,GO:1901189,1,0.994174949282388,0,1,positive regulation of ephrin receptor signaling pathway,BP,
18930,GO:1901193,1,0.9963596218915,0,1,regulation of formation of translation preinitiation complex,BP,
18931,GO:1901194,1,0.9963596218915,0,1,negative regulation of formation of translation preinitiation complex,BP,
18932,GO:1901201,1,0.892645052955375,0,14,regulation of extracellular matrix assembly,BP,
18933,GO:1901202,1,0.994187218721693,0,1,negative regulation of extracellular matrix assembly,BP,
18934,GO:1901203,1,0.920711330656062,0,10,positive regulation of extracellular matrix assembly,BP,
18935,GO:1901207,1,0.985588929392875,0,2,regulation of heart looping,BP,
18936,GO:1901208,1,0.992908502911506,0,1,negative regulation of heart looping,BP,
18937,GO:1901210,1,0.992908502911506,0,1,regulation of cardiac chamber formation,BP,
18938,GO:1901211,1,0.992908502911506,0,1,negative regulation of cardiac chamber formation,BP,
18939,GO:1901213,1,0.945739399716303,0,7,regulation of transcription from RNA polymerase II promoter involved in heart development,BP,
18943,GO:1901219,1,0.992908502911506,0,1,regulation of cardiac chamber morphogenesis,BP,
18944,GO:1901220,1,0.992908502911506,0,1,negative regulation of cardiac chamber morphogenesis,BP,
18945,GO:1901222,1,0.522337023168156,0,100,regulation of NIK/NF-kappaB signaling,BP,
18946,GO:1901223,1,0.863515785448122,0,20,negative regulation of NIK/NF-kappaB signaling,BP,
18947,GO:1901224,1,0.614965356676753,0,76,positive regulation of NIK/NF-kappaB signaling,BP,
18948,GO:1901228,1,0.969466441130706,0,4,positive regulation of transcription from RNA polymerase II promoter involved in heart development,BP,
18949,GO:1901229,1,0.993759758138751,0,1,regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,
18950,GO:1901231,1,0.993759758138751,0,1,positive regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,
18951,GO:1901232,1,0.993759758138751,0,1,regulation of convergent extension involved in axis elongation,BP,
18952,GO:1901233,1,0.993759758138751,0,1,negative regulation of convergent extension involved in axis elongation,BP,
18953,GO:1901235,1,0.992971185204564,0,1,(R)-carnitine transmembrane transporter activity,MF,
18954,GO:1901246,1,0.98984504006435,0,2,regulation of lung ciliated cell differentiation,BP,
18955,GO:1901247,1,0.996134718669981,0,1,negative regulation of lung ciliated cell differentiation,BP,
18956,GO:1901248,1,0.993686159997233,0,1,positive regulation of lung ciliated cell differentiation,BP,
18957,GO:1901249,1,0.996134718669981,0,1,regulation of lung goblet cell differentiation,BP,
18958,GO:1901251,1,0.996134718669981,0,1,positive regulation of lung goblet cell differentiation,BP,
18959,GO:1901252,1,0.989056244769535,0,2,regulation of intracellular transport of viral material,BP,
18960,GO:1901253,1,0.996618572272435,0,1,negative regulation of intracellular transport of viral material,BP,
18961,GO:1901254,1,0.992412270956236,0,1,positive regulation of intracellular transport of viral material,BP,
18962,GO:1901255,1,0.986096811320679,0,2,nucleotide-excision repair involved in interstrand cross-link repair,BP,
18963,GO:1901256,1,0.968481477899949,0,5,regulation of macrophage colony-stimulating factor production,BP,
18964,GO:1901257,1,0.994244193778852,0,1,negative regulation of macrophage colony-stimulating factor production,BP,
18965,GO:1901258,1,0.98114475969107,0,3,positive regulation of macrophage colony-stimulating factor production,BP,
18966,GO:1901264,1,0.594630106249779,0,86,carbohydrate derivative transport,BP,
18968,GO:1901291,1,0.995042373882419,0,1,negative regulation of double-strand break repair via single-strand annealing,BP,
18969,GO:1901292,1,0.652983365590912,0,70,nucleoside phosphate catabolic process,BP,
18971,GO:1901295,1,0.989458018464504,0,2,regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
18972,GO:1901296,1,0.995255708783232,0,1,negative regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
18973,GO:1901297,1,0.994174949282388,0,1,positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
18974,GO:1901298,1,0.945043012751764,0,9,regulation of hydrogen peroxide-mediated programmed cell death,BP,
18975,GO:1901299,1,0.970243633895442,0,5,negative regulation of hydrogen peroxide-mediated programmed cell death,BP,
18976,GO:1901300,1,0.974034246806374,0,4,positive regulation of hydrogen peroxide-mediated programmed cell death,BP,
18977,GO:1901301,1,0.985868764852009,0,2,regulation of cargo loading into COPII-coated vesicle,BP,
18978,GO:1901303,1,0.993565169304053,0,1,negative regulation of cargo loading into COPII-coated vesicle,BP,
18979,GO:1901304,1,0.995450692884757,0,1,regulation of spermidine biosynthetic process,BP,
18980,GO:1901307,1,0.995450692884757,0,1,positive regulation of spermidine biosynthetic process,BP,
18981,GO:1901308,1,0.994278633367177,0,1,regulation of sterol regulatory element binding protein cleavage,BP,
18982,GO:1901310,1,0.994278633367177,0,1,positive regulation of sterol regulatory element binding protein cleavage,BP,
18983,GO:1901314,1,0.966031350252639,0,4,regulation of histone H2A K63-linked ubiquitination,BP,
18984,GO:1901315,1,0.966031350252639,0,4,negative regulation of histone H2A K63-linked ubiquitination,BP,
18985,GO:1901317,1,0.948568534475592,0,11,regulation of flagellated sperm motility,BP,
18986,GO:1901318,1,0.995017098870267,0,1,negative regulation of flagellated sperm motility,BP,
18987,GO:1901321,1,0.953497226406413,0,7,positive regulation of heart induction,BP,
18988,GO:1901328,1,0.995244416664347,0,1,response to cytochalasin B,BP,
18989,GO:1901329,1,0.980819465331335,0,3,regulation of odontoblast differentiation,BP,
18990,GO:1901331,1,0.993059151945929,0,1,positive regulation of odontoblast differentiation,BP,
18991,GO:1901337,1,0.986456059991618,0,2,thioester transport,BP,
18992,GO:1901338,1,0.928380912337035,0,13,catecholamine binding,MF,
18993,GO:1901339,1,0.951936651473256,0,7,regulation of store-operated calcium channel activity,BP,
18994,GO:1901340,1,0.992553204608084,0,1,negative regulation of store-operated calcium channel activity,BP,
18995,GO:1901341,1,0.965780717933186,0,5,positive regulation of store-operated calcium channel activity,BP,
18998,GO:1901344,1,0.99612869348273,0,1,response to leptomycin B,BP,
18999,GO:1901346,1,0.994408236705106,0,1,negative regulation of vasculature development involved in avascular cornea development in camera-type eye,BP,
19000,GO:1901355,1,0.978883764621053,0,3,response to rapamycin,BP,
19002,GO:1901361,1,0.0279659553204545,0,596,organic cyclic compound catabolic process,BP,
19005,GO:1901373,1,0.995917870026012,0,1,lipid hydroperoxide transport,BP,
19006,GO:1901374,1,0.964918465151408,0,6,acetate ester transport,BP,
19007,GO:1901375,1,0.989258873748319,0,2,acetate ester transmembrane transporter activity,MF,
19008,GO:1901376,1,0.989744192529501,0,2,organic heteropentacyclic compound metabolic process,BP,
19009,GO:1901377,1,0.989744192529501,0,2,organic heteropentacyclic compound catabolic process,BP,
19011,GO:1901380,1,0.856046209309372,0,23,negative regulation of potassium ion transmembrane transport,BP,
19013,GO:1901382,1,0.968185526020019,0,4,regulation of chorionic trophoblast cell proliferation,BP,
19014,GO:1901383,1,0.983536323069286,0,2,negative regulation of chorionic trophoblast cell proliferation,BP,
19016,GO:1901386,1,0.925346011882786,0,13,negative regulation of voltage-gated calcium channel activity,BP,
19018,GO:1901388,1,0.944998562389363,0,7,regulation of transforming growth factor beta activation,BP,
19019,GO:1901389,1,0.993837575347301,0,1,negative regulation of transforming growth factor beta activation,BP,
19020,GO:1901390,1,0.992520708549764,0,1,positive regulation of transforming growth factor beta activation,BP,
19021,GO:1901392,1,0.992520708549764,0,1,regulation of transforming growth factor beta1 activation,BP,
19022,GO:1901394,1,0.992520708549764,0,1,positive regulation of transforming growth factor beta1 activation,BP,
19023,GO:1901398,1,0.992483718844815,0,1,regulation of transforming growth factor beta3 activation,BP,
19024,GO:1901401,1,0.983768637831043,0,3,regulation of tetrapyrrole metabolic process,BP,
19025,GO:1901403,1,0.99128577301311,0,1,positive regulation of tetrapyrrole metabolic process,BP,
19026,GO:1901407,1,0.980440067389532,0,3,regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,
19027,GO:1901409,1,0.99433737793695,0,1,positive regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,
19028,GO:1901419,1,0.992424723643522,0,1,regulation of response to alcohol,BP,
19029,GO:1901421,1,0.992424723643522,0,1,positive regulation of response to alcohol,BP,
19030,GO:1901423,1,0.996405415233167,0,1,response to benzene,BP,
19031,GO:1901463,1,0.992417445097932,0,2,regulation of tetrapyrrole biosynthetic process,BP,
19032,GO:1901474,1,0.937017568666987,0,10,azole transmembrane transporter activity,MF,
19033,GO:1901475,1,0.975279476750846,0,4,pyruvate transmembrane transport,BP,
19034,GO:1901480,1,0.994501174542525,0,1,oleate transmembrane transporter activity,MF,
19035,GO:1901483,1,0.980259295741755,0,3,regulation of transcription factor catabolic process,BP,
19036,GO:1901485,1,0.980259295741755,0,3,positive regulation of transcription factor catabolic process,BP,
19037,GO:1901490,1,0.962687267333044,0,5,regulation of lymphangiogenesis,BP,
19038,GO:1901491,1,0.976744277363753,0,3,negative regulation of lymphangiogenesis,BP,
19039,GO:1901492,1,0.985611659457135,0,2,positive regulation of lymphangiogenesis,BP,
19040,GO:1901494,1,0.987991015504381,0,1,regulation of cysteine metabolic process,BP,
19041,GO:1901503,1,0.925609621628897,0,11,ether biosynthetic process,BP,
19042,GO:1901505,1,0.712763741322806,0,55,carbohydrate derivative transmembrane transporter activity,MF,
19043,GO:1901506,1,0.994278633367177,0,1,regulation of acylglycerol transport,BP,
19044,GO:1901508,1,0.994278633367177,0,1,positive regulation of acylglycerol transport,BP,
19045,GO:1901509,1,0.960795269534622,0,6,regulation of endothelial tube morphogenesis,BP,
19046,GO:1901522,1,0.842350335068557,0,23,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus,BP,
19047,GO:1901523,1,0.964714095214234,0,6,icosanoid catabolic process,BP,
19048,GO:1901524,1,0.871692429345379,0,16,regulation of mitophagy,BP,
19049,GO:1901525,1,0.95609449559352,0,6,negative regulation of mitophagy,BP,
19050,GO:1901526,1,0.911759835798179,0,10,positive regulation of mitophagy,BP,
19051,GO:1901529,1,0.969374967582012,0,4,positive regulation of anion channel activity,BP,
19052,GO:1901532,1,0.612711856995896,0,83,regulation of hematopoietic progenitor cell differentiation,BP,
19053,GO:1901533,1,0.952735807472628,0,8,negative regulation of hematopoietic progenitor cell differentiation,BP,
19054,GO:1901534,1,0.962862894169802,0,5,positive regulation of hematopoietic progenitor cell differentiation,BP,
19055,GO:1901535,1,0.9476546424588,0,6,regulation of DNA demethylation,BP,
19056,GO:1901536,1,0.986423326706161,0,2,negative regulation of DNA demethylation,BP,
19057,GO:1901537,1,0.960702981036979,0,4,positive regulation of DNA demethylation,BP,
19058,GO:1901538,1,0.955039289025554,0,6,changes to DNA methylation involved in embryo development,BP,
19059,GO:1901545,1,0.993187263281211,0,1,response to raffinose,BP,
19060,GO:1901550,1,0.90154460825399,0,15,regulation of endothelial cell development,BP,
19061,GO:1901551,1,0.985399941309208,0,2,negative regulation of endothelial cell development,BP,
19062,GO:1901552,1,0.960856509395625,0,6,positive regulation of endothelial cell development,BP,
19063,GO:1901555,1,0.990251191013679,0,1,response to paclitaxel,BP,
19064,GO:1901557,1,0.992622242279326,0,1,response to fenofibrate,BP,
19065,GO:1901558,1,0.985992112018464,0,2,response to metformin,BP,
19066,GO:1901561,1,0.992722023538788,0,1,response to benomyl,BP,
19067,GO:1901563,1,0.965288568645885,0,5,response to camptothecin,BP,
19071,GO:1901567,1,0.870580003622655,0,26,fatty acid derivative binding,MF,
19072,GO:1901568,1,0.435788012767356,0,141,fatty acid derivative metabolic process,BP,
19073,GO:1901569,1,0.930511837231077,0,12,fatty acid derivative catabolic process,BP,
19074,GO:1901570,1,0.618607230741413,0,81,fatty acid derivative biosynthetic process,BP,
19078,GO:1901580,1,0.986811811721545,0,1,regulation of telomeric RNA transcription from RNA pol II promoter,BP,
19079,GO:1901581,1,0.986811811721545,0,1,negative regulation of telomeric RNA transcription from RNA pol II promoter,BP,
19080,GO:1901582,1,0.986811811721545,0,1,positive regulation of telomeric RNA transcription from RNA pol II promoter,BP,
19081,GO:1901585,1,0.993410678678999,0,1,regulation of acid-sensing ion channel activity,BP,
19082,GO:1901588,1,0.974681420694243,0,3,dendritic microtubule,CC,
19083,GO:1901594,1,0.992549528859517,0,1,response to capsazepine,BP,
19085,GO:1901606,1,0.572907784673672,0,96,alpha-amino acid catabolic process,BP,
19087,GO:1901608,1,0.973736991572173,0,4,regulation of vesicle transport along microtubule,BP,
19088,GO:1901609,1,0.996058699186367,0,1,negative regulation of vesicle transport along microtubule,BP,
19089,GO:1901610,1,0.977590844226496,0,3,positive regulation of vesicle transport along microtubule,BP,
19090,GO:1901611,1,0.923724292434405,0,13,phosphatidylglycerol binding,MF,
19091,GO:1901612,1,0.943622121589637,0,9,cardiolipin binding,MF,
19092,GO:1901615,1,0.040018674340085,0,486,organic hydroxy compound metabolic process,BP,
19093,GO:1901616,1,0.676923918792982,0,63,organic hydroxy compound catabolic process,BP,
19094,GO:1901617,1,0.226051174816411,0,227,organic hydroxy compound biosynthetic process,BP,
19095,GO:1901618,1,0.765835314644335,0,41,organic hydroxy compound transmembrane transporter activity,MF,
19096,GO:1901620,1,0.947270041707896,0,8,regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
19097,GO:1901621,1,0.958880527270623,0,6,negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
19098,GO:1901622,1,0.9937731104816,0,1,positive regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
19099,GO:1901623,1,0.881195420772104,0,22,regulation of lymphocyte chemotaxis,BP,
19100,GO:1901624,1,0.985011191579487,0,3,negative regulation of lymphocyte chemotaxis,BP,
19101,GO:1901626,1,0.906150379206487,0,13,regulation of postsynaptic membrane organization,BP,
19102,GO:1901627,1,0.994215636941164,0,1,negative regulation of postsynaptic membrane organization,BP,
19103,GO:1901628,1,0.971964638266398,0,4,positive regulation of postsynaptic membrane organization,BP,
19104,GO:1901629,1,0.989342531273032,0,1,regulation of presynaptic membrane organization,BP,
19105,GO:1901631,1,0.989342531273032,0,1,positive regulation of presynaptic membrane organization,BP,
19106,GO:1901639,1,0.991058898402959,0,1,XDP catabolic process,BP,
19107,GO:1901640,1,0.991058898402959,0,1,XTP binding,MF,
19108,GO:1901641,1,0.991058898402959,0,1,ITP binding,MF,
19109,GO:1901642,1,0.965588784684936,0,6,nucleoside transmembrane transport,BP,
19110,GO:1901645,1,0.995506018227838,0,1,regulation of synoviocyte proliferation,BP,
19111,GO:1901647,1,0.995506018227838,0,1,positive regulation of synoviocyte proliferation,BP,
19116,GO:1901656,1,0.972529307516319,0,4,glycoside transport,BP,
19118,GO:1901658,1,0.819559430042016,0,37,glycosyl compound catabolic process,BP,
19119,GO:1901659,1,0.81889987485529,0,38,glycosyl compound biosynthetic process,BP,
19120,GO:1901660,1,0.92351196460332,0,10,calcium ion export,BP,
19121,GO:1901661,1,0.850093162272343,0,32,quinone metabolic process,BP,
19122,GO:1901662,1,0.978194107128263,0,4,quinone catabolic process,BP,
19123,GO:1901663,1,0.926564452613002,0,15,quinone biosynthetic process,BP,
19124,GO:1901664,1,0.981981312234816,0,3,regulation of NAD+ ADP-ribosyltransferase activity,BP,
19125,GO:1901666,1,0.981981312234816,0,3,positive regulation of NAD+ ADP-ribosyltransferase activity,BP,
19126,GO:1901668,1,0.974298475747889,0,5,regulation of superoxide dismutase activity,BP,
19127,GO:1901671,1,0.980688512140587,0,4,positive regulation of superoxide dismutase activity,BP,
19128,GO:1901673,1,0.898598941934811,0,17,regulation of mitotic spindle assembly,BP,
19129,GO:1901674,1,0.983195600069569,0,2,regulation of histone H3-K27 acetylation,BP,
19130,GO:1901675,1,0.990471179820593,0,1,negative regulation of histone H3-K27 acetylation,BP,
19131,GO:1901676,1,0.992655125312564,0,1,positive regulation of histone H3-K27 acetylation,BP,
19132,GO:1901678,1,0.923674271746071,0,13,iron coordination entity transport,BP,
19133,GO:1901679,1,0.958954281833005,0,7,nucleotide transmembrane transport,BP,
19134,GO:1901680,1,0.987991015504381,0,1,sulfur-containing amino acid secondary active transmembrane transporter activity,MF,
19136,GO:1901682,1,0.766745196321456,0,38,sulfur compound transmembrane transporter activity,MF,
19137,GO:1901685,1,0.92765644560442,0,19,glutathione derivative metabolic process,BP,
19138,GO:1901687,1,0.92765644560442,0,19,glutathione derivative biosynthetic process,BP,
19139,GO:1901696,1,0.99370066887156,0,1,cannabinoid biosynthetic process,BP,
19144,GO:1901702,1,0.983046735754748,0,3,salt transmembrane transporter activity,MF,
19145,GO:1901706,1,0.99376308886203,0,1,mesenchymal cell differentiation involved in bone development,BP,
19146,GO:1901707,1,0.99612869348273,0,1,leptomycin B binding,MF,
19147,GO:1901722,1,0.925803557737262,0,12,regulation of cell proliferation involved in kidney development,BP,
19148,GO:1901723,1,0.968204047438491,0,5,negative regulation of cell proliferation involved in kidney development,BP,
19149,GO:1901724,1,0.956220910641207,0,7,positive regulation of cell proliferation involved in kidney development,BP,
19150,GO:1901725,1,0.926220857541151,0,9,regulation of histone deacetylase activity,BP,
19151,GO:1901726,1,0.980333394920134,0,2,negative regulation of histone deacetylase activity,BP,
19152,GO:1901727,1,0.951909704457249,0,6,positive regulation of histone deacetylase activity,BP,
19153,GO:1901731,1,0.979272822126449,0,3,positive regulation of platelet aggregation,BP,
19154,GO:1901739,1,0.911919328851324,0,17,regulation of myoblast fusion,BP,
19155,GO:1901740,1,0.991267432012994,0,2,negative regulation of myoblast fusion,BP,
19156,GO:1901741,1,0.91995962872973,0,15,positive regulation of myoblast fusion,BP,
19157,GO:1901748,1,0.981852885177212,0,3,leukotriene D4 metabolic process,BP,
19158,GO:1901750,1,0.981852885177212,0,3,leukotriene D4 biosynthetic process,BP,
19159,GO:1901751,1,0.988010220748979,0,2,leukotriene A4 metabolic process,BP,
19160,GO:1901753,1,0.993813629352555,0,1,leukotriene A4 biosynthetic process,BP,
19162,GO:1901797,1,0.84905097786569,0,27,negative regulation of signal transduction by p53 class mediator,BP,
19163,GO:1901798,1,0.871753566486343,0,22,positive regulation of signal transduction by p53 class mediator,BP,
19164,GO:1901799,1,0.715072546184985,0,51,negative regulation of proteasomal protein catabolic process,BP,
19165,GO:1901800,1,0.50557759363754,0,104,positive regulation of proteasomal protein catabolic process,BP,
19166,GO:1901804,1,0.989589472563843,0,2,beta-glucoside metabolic process,BP,
19167,GO:1901805,1,0.989589472563843,0,2,beta-glucoside catabolic process,BP,
19168,GO:1901810,1,0.993485400251684,0,1,beta-carotene metabolic process,BP,
19169,GO:1901825,1,0.993716915438455,0,1,zeaxanthin metabolic process,BP,
19170,GO:1901827,1,0.993716915438455,0,1,zeaxanthin biosynthetic process,BP,
19171,GO:1901834,1,0.995369011896799,0,1,regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
19172,GO:1901835,1,0.995369011896799,0,1,positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
19173,GO:1901836,1,0.936941474081636,0,10,regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
19174,GO:1901838,1,0.941261862021228,0,9,positive regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
19175,GO:1901841,1,0.922255693380398,0,13,regulation of high voltage-gated calcium channel activity,BP,
19176,GO:1901842,1,0.9765193533705,0,4,negative regulation of high voltage-gated calcium channel activity,BP,
19177,GO:1901843,1,0.972537228350141,0,4,positive regulation of high voltage-gated calcium channel activity,BP,
19178,GO:1901844,1,0.941260687977536,0,9,regulation of cell communication by electrical coupling involved in cardiac conduction,BP,
19179,GO:1901846,1,0.992323602077945,0,1,positive regulation of cell communication by electrical coupling involved in cardiac conduction,BP,
19180,GO:1901856,1,0.974603774177148,0,4,negative regulation of cellular respiration,BP,
19181,GO:1901857,1,0.964295130124831,0,7,positive regulation of cellular respiration,BP,
19182,GO:1901858,1,0.974224324280093,0,4,regulation of mitochondrial DNA metabolic process,BP,
19183,GO:1901859,1,0.993559206495364,0,1,negative regulation of mitochondrial DNA metabolic process,BP,
19184,GO:1901860,1,0.990795642075213,0,1,positive regulation of mitochondrial DNA metabolic process,BP,
19187,GO:1901863,1,0.64165033188974,0,61,positive regulation of muscle tissue development,BP,
19188,GO:1901873,1,0.967141234037588,0,4,regulation of post-translational protein modification,BP,
19189,GO:1901874,1,0.977716227393383,0,3,negative regulation of post-translational protein modification,BP,
19190,GO:1901876,1,0.992340336533608,0,2,regulation of calcium ion binding,BP,
19191,GO:1901877,1,0.992340336533608,0,2,negative regulation of calcium ion binding,BP,
19195,GO:1901888,1,0.242069735353735,0,187,regulation of cell junction assembly,BP,
19196,GO:1901889,1,0.783283011773352,0,32,negative regulation of cell junction assembly,BP,
19197,GO:1901890,1,0.498073660548269,0,93,positive regulation of cell junction assembly,BP,
19198,GO:1901894,1,0.937798794693348,0,9,regulation of ATPase-coupled calcium transmembrane transporter activity,BP,
19199,GO:1901895,1,0.979105605899483,0,3,negative regulation of ATPase-coupled calcium transmembrane transporter activity,BP,
19200,GO:1901896,1,0.960801007860054,0,5,positive regulation of ATPase-coupled calcium transmembrane transporter activity,BP,
19201,GO:1901897,1,0.959298667421381,0,6,regulation of relaxation of cardiac muscle,BP,
19202,GO:1901898,1,0.981797945422651,0,2,negative regulation of relaxation of cardiac muscle,BP,
19203,GO:1901899,1,0.988947588322015,0,2,positive regulation of relaxation of cardiac muscle,BP,
19204,GO:1901906,1,0.977347175921527,0,4,diadenosine pentaphosphate metabolic process,BP,
19205,GO:1901907,1,0.977347175921527,0,4,diadenosine pentaphosphate catabolic process,BP,
19206,GO:1901908,1,0.977347175921527,0,4,diadenosine hexaphosphate metabolic process,BP,
19207,GO:1901909,1,0.977347175921527,0,4,diadenosine hexaphosphate catabolic process,BP,
19208,GO:1901910,1,0.977347175921527,0,4,adenosine 5'-(hexahydrogen pentaphosphate) metabolic process,BP,
19209,GO:1901911,1,0.977347175921527,0,4,adenosine 5'-(hexahydrogen pentaphosphate) catabolic process,BP,
19210,GO:1901917,1,0.993513844472955,0,1,regulation of exoribonuclease activity,BP,
19211,GO:1901919,1,0.993513844472955,0,1,positive regulation of exoribonuclease activity,BP,
19213,GO:1901951,1,0.984511871467944,0,2,regulation of anterograde dense core granule transport,BP,
19214,GO:1901953,1,0.984511871467944,0,2,positive regulation of anterograde dense core granule transport,BP,
19215,GO:1901962,1,0.994425789488496,0,1,S-adenosyl-L-methionine transmembrane transport,BP,
19216,GO:1901963,1,0.988208416048481,0,2,regulation of cell proliferation involved in outflow tract morphogenesis,BP,
19217,GO:1901964,1,0.995293167006598,0,1,positive regulation of cell proliferation involved in outflow tract morphogenesis,BP,
19218,GO:1901970,1,0.916142413783883,0,13,positive regulation of mitotic sister chromatid separation,BP,
19219,GO:1901976,1,0.819475431615704,0,31,regulation of cell cycle checkpoint,BP,
19220,GO:1901977,1,0.96351271801865,0,6,negative regulation of cell cycle checkpoint,BP,
19221,GO:1901978,1,0.940447830754855,0,9,positive regulation of cell cycle checkpoint,BP,
19222,GO:1901979,1,0.967667671537221,0,5,regulation of inward rectifier potassium channel activity,BP,
19223,GO:1901980,1,0.984167637383925,0,2,positive regulation of inward rectifier potassium channel activity,BP,
19225,GO:1901983,1,0.618123535779863,0,71,regulation of protein acetylation,BP,
19226,GO:1901984,1,0.870026480243088,0,22,negative regulation of protein acetylation,BP,
19227,GO:1901985,1,0.754685944297248,0,41,positive regulation of protein acetylation,BP,
19235,GO:1901993,1,0.96245726869492,0,6,regulation of meiotic cell cycle phase transition,BP,
19236,GO:1901994,1,0.986437475226523,0,2,negative regulation of meiotic cell cycle phase transition,BP,
19237,GO:1901995,1,0.97569336893784,0,4,positive regulation of meiotic cell cycle phase transition,BP,
19239,GO:1901999,1,0.995861656502991,0,1,homogentisate metabolic process,BP,
19240,GO:1902000,1,0.995861656502991,0,1,homogentisate catabolic process,BP,
19241,GO:1902001,1,0.852816608911846,0,21,fatty acid transmembrane transport,BP,
19242,GO:1902003,1,0.798753385910859,0,30,regulation of amyloid-beta formation,BP,
19243,GO:1902004,1,0.877670918561929,0,18,positive regulation of amyloid-beta formation,BP,
19244,GO:1902010,1,0.992848231990321,0,1,negative regulation of translation in response to endoplasmic reticulum stress,BP,
19245,GO:1902017,1,0.712135698156815,0,48,regulation of cilium assembly,BP,
19246,GO:1902018,1,0.930730339716176,0,11,negative regulation of cilium assembly,BP,
19247,GO:1902019,1,0.912827326697504,0,17,regulation of cilium-dependent cell motility,BP,
19248,GO:1902020,1,0.995017098870267,0,1,negative regulation of cilium-dependent cell motility,BP,
19249,GO:1902022,1,0.962518679770267,0,5,L-lysine transport,BP,
19250,GO:1902023,1,0.933260178181422,0,10,L-arginine transport,BP,
19251,GO:1902031,1,0.974633481785796,0,4,regulation of NADP metabolic process,BP,
19252,GO:1902033,1,0.94352977415911,0,9,regulation of hematopoietic stem cell proliferation,BP,
19253,GO:1902035,1,0.962598935759607,0,6,positive regulation of hematopoietic stem cell proliferation,BP,
19254,GO:1902036,1,0.671364319831401,0,70,regulation of hematopoietic stem cell differentiation,BP,
19255,GO:1902037,1,0.980659782357075,0,3,negative regulation of hematopoietic stem cell differentiation,BP,
19256,GO:1902038,1,0.992872694700859,0,1,positive regulation of hematopoietic stem cell differentiation,BP,
19259,GO:1902043,1,0.896406582601847,0,15,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,
19260,GO:1902044,1,0.979605571964978,0,3,regulation of Fas signaling pathway,BP,
19261,GO:1902045,1,0.994179664991472,0,1,negative regulation of Fas signaling pathway,BP,
19262,GO:1902047,1,0.96709999803619,0,6,polyamine transmembrane transport,BP,
19263,GO:1902064,1,0.992789695625989,0,1,regulation of transcription from RNA polymerase II promoter involved in spermatogenesis,BP,
19265,GO:1902071,1,0.996289512131313,0,1,regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,
19266,GO:1902073,1,0.996289512131313,0,1,positive regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,
19269,GO:1902076,1,0.986450745137245,0,1,regulation of lateral motor column neuron migration,BP,
19270,GO:1902078,1,0.986450745137245,0,1,positive regulation of lateral motor column neuron migration,BP,
19271,GO:1902080,1,0.988285963989531,0,2,regulation of calcium ion import into sarcoplasmic reticulum,BP,
19272,GO:1902081,1,0.995427264223568,0,1,negative regulation of calcium ion import into sarcoplasmic reticulum,BP,
19273,GO:1902082,1,0.992826222446352,0,1,positive regulation of calcium ion import into sarcoplasmic reticulum,BP,
19274,GO:1902083,1,0.957364679498602,0,5,negative regulation of peptidyl-cysteine S-nitrosylation,BP,
19275,GO:1902093,1,0.956378035888487,0,9,positive regulation of flagellated sperm motility,BP,
19276,GO:1902098,1,0.99217686342847,0,1,calcitriol binding,MF,
19279,GO:1902101,1,0.911631189762507,0,14,positive regulation of metaphase/anaphase transition of cell cycle,BP,
19280,GO:1902102,1,0.988288360444546,0,2,regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
19281,GO:1902103,1,0.993174963603365,0,1,negative regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
19282,GO:1902104,1,0.995080152823623,0,1,positive regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
19283,GO:1902105,1,0.182472848586679,0,258,regulation of leukocyte differentiation,BP,
19284,GO:1902106,1,0.561775196967025,0,89,negative regulation of leukocyte differentiation,BP,
19285,GO:1902107,1,0.389884128315837,0,145,positive regulation of leukocyte differentiation,BP,
19287,GO:1902109,1,0.990749432960675,0,2,negative regulation of mitochondrial membrane permeability involved in apoptotic process,BP,
19288,GO:1902110,1,0.722857402583801,0,55,positive regulation of mitochondrial membrane permeability involved in apoptotic process,BP,
19289,GO:1902115,1,0.276138474389977,0,176,regulation of organelle assembly,BP,
19290,GO:1902116,1,0.787413700233605,0,36,negative regulation of organelle assembly,BP,
19291,GO:1902117,1,0.623950609947722,0,61,positive regulation of organelle assembly,BP,
19292,GO:1902121,1,0.99217686342847,0,1,lithocholic acid binding,MF,
19293,GO:1902122,1,0.994580882739056,0,1,chenodeoxycholic acid binding,MF,
19294,GO:1902159,1,0.987775519005022,0,2,regulation of cyclic nucleotide-gated ion channel activity,BP,
19295,GO:1902161,1,0.99094935654551,0,1,positive regulation of cyclic nucleotide-gated ion channel activity,BP,
19296,GO:1902162,1,0.98620034207348,0,3,regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
19297,GO:1902164,1,0.98620034207348,0,3,positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
19298,GO:1902165,1,0.915151114157488,0,16,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
19299,GO:1902166,1,0.924083305719891,0,14,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
19300,GO:1902167,1,0.997067070635775,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
19302,GO:1902172,1,0.971030687778387,0,5,regulation of keratinocyte apoptotic process,BP,
19303,GO:1902174,1,0.982242518599146,0,3,positive regulation of keratinocyte apoptotic process,BP,
19304,GO:1902175,1,0.867110712407709,0,24,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
19305,GO:1902176,1,0.908060940388143,0,17,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
19306,GO:1902177,1,0.972056354584651,0,5,positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
19307,GO:1902178,1,0.992458151977042,0,1,fibroblast growth factor receptor apoptotic signaling pathway,BP,
19308,GO:1902186,1,0.825996494212964,0,28,regulation of viral release from host cell,BP,
19309,GO:1902187,1,0.902553847984934,0,14,negative regulation of viral release from host cell,BP,
19310,GO:1902188,1,0.915995380351677,0,14,positive regulation of viral release from host cell,BP,
19311,GO:1902202,1,0.975440302897894,0,4,regulation of hepatocyte growth factor receptor signaling pathway,BP,
19312,GO:1902203,1,0.991978398747101,0,1,negative regulation of hepatocyte growth factor receptor signaling pathway,BP,
19313,GO:1902204,1,0.994854423526827,0,1,positive regulation of hepatocyte growth factor receptor signaling pathway,BP,
19314,GO:1902205,1,0.99543809429607,0,1,regulation of interleukin-2-mediated signaling pathway,BP,
19315,GO:1902206,1,0.99543809429607,0,1,negative regulation of interleukin-2-mediated signaling pathway,BP,
19316,GO:1902211,1,0.993485400251684,0,1,regulation of prolactin signaling pathway,BP,
19317,GO:1902213,1,0.993485400251684,0,1,positive regulation of prolactin signaling pathway,BP,
19318,GO:1902214,1,0.980480017178435,0,3,regulation of interleukin-4-mediated signaling pathway,BP,
19319,GO:1902215,1,0.99543809429607,0,1,negative regulation of interleukin-4-mediated signaling pathway,BP,
19320,GO:1902216,1,0.984974055365591,0,2,positive regulation of interleukin-4-mediated signaling pathway,BP,
19321,GO:1902217,1,0.996063304026813,0,1,erythrocyte apoptotic process,BP,
19322,GO:1902218,1,0.963865705640116,0,6,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
19323,GO:1902219,1,0.967344061391432,0,5,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
19324,GO:1902220,1,0.996405415233167,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
19325,GO:1902221,1,0.951556116547658,0,10,erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process,BP,
19326,GO:1902222,1,0.951556116547658,0,10,erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process,BP,
19327,GO:1902224,1,0.928588057895855,0,12,ketone body metabolic process,BP,
19328,GO:1902225,1,0.993485400251684,0,1,negative regulation of acrosome reaction,BP,
19329,GO:1902226,1,0.985316152664638,0,3,regulation of macrophage colony-stimulating factor signaling pathway,BP,
19330,GO:1902227,1,0.991220552000599,0,2,negative regulation of macrophage colony-stimulating factor signaling pathway,BP,
19331,GO:1902228,1,0.994043828815885,0,1,positive regulation of macrophage colony-stimulating factor signaling pathway,BP,
19334,GO:1902231,1,0.971772838053317,0,6,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,
19335,GO:1902232,1,0.988022582704496,0,2,regulation of positive thymic T cell selection,BP,
19336,GO:1902233,1,0.99543809429607,0,1,negative regulation of positive thymic T cell selection,BP,
19339,GO:1902237,1,0.946973880765196,0,10,positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,
19340,GO:1902238,1,0.992518502787351,0,1,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
19341,GO:1902239,1,0.992518502787351,0,1,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
19342,GO:1902250,1,0.996063304026813,0,1,regulation of erythrocyte apoptotic process,BP,
19343,GO:1902251,1,0.996063304026813,0,1,negative regulation of erythrocyte apoptotic process,BP,
19344,GO:1902253,1,0.858085455361505,0,27,regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
19345,GO:1902254,1,0.888283830268654,0,19,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
19346,GO:1902255,1,0.982694956383006,0,5,positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
19347,GO:1902256,1,0.980280900691806,0,3,regulation of apoptotic process involved in outflow tract morphogenesis,BP,
19348,GO:1902257,1,0.988394552971933,0,2,negative regulation of apoptotic process involved in outflow tract morphogenesis,BP,
19349,GO:1902259,1,0.88705135537092,0,18,regulation of delayed rectifier potassium channel activity,BP,
19350,GO:1902260,1,0.938873708972466,0,10,negative regulation of delayed rectifier potassium channel activity,BP,
19351,GO:1902261,1,0.969447331332042,0,4,positive regulation of delayed rectifier potassium channel activity,BP,
19352,GO:1902262,1,0.972202657906653,0,5,apoptotic process involved in blood vessel morphogenesis,BP,
19353,GO:1902263,1,0.977220806881062,0,3,apoptotic process involved in embryonic digit morphogenesis,BP,
19354,GO:1902267,1,0.974296777004324,0,5,regulation of polyamine transmembrane transport,BP,
19355,GO:1902268,1,0.988129170436588,0,3,negative regulation of polyamine transmembrane transport,BP,
19356,GO:1902269,1,0.986003094890145,0,2,positive regulation of polyamine transmembrane transport,BP,
19357,GO:1902270,1,0.992971185204564,0,1,(R)-carnitine transmembrane transport,BP,
19358,GO:1902271,1,0.987804661796491,0,2,D3 vitamins binding,MF,
19360,GO:1902282,1,0.932357583721115,0,11,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,MF,
19361,GO:1902283,1,0.992607280810635,0,1,negative regulation of primary amine oxidase activity,BP,
19362,GO:1902284,1,0.74113598105913,0,36,neuron projection extension involved in neuron projection guidance,BP,
19363,GO:1902285,1,0.887846457026313,0,13,semaphorin-plexin signaling pathway involved in neuron projection guidance,BP,
19364,GO:1902287,1,0.895343844354147,0,12,semaphorin-plexin signaling pathway involved in axon guidance,BP,
19365,GO:1902292,1,0.964369268706089,0,5,cell cycle DNA replication initiation,BP,
19366,GO:1902296,1,0.992964456086491,0,1,DNA strand elongation involved in cell cycle DNA replication,BP,
19367,GO:1902298,1,0.981092121335279,0,2,cell cycle DNA replication maintenance of fidelity,BP,
19368,GO:1902299,1,0.946940681308538,0,8,pre-replicative complex assembly involved in cell cycle DNA replication,BP,
19370,GO:1902306,1,0.908212031456623,0,13,negative regulation of sodium ion transmembrane transport,BP,
19371,GO:1902307,1,0.85729539146697,0,21,positive regulation of sodium ion transmembrane transport,BP,
19372,GO:1902308,1,0.968248502551888,0,5,regulation of peptidyl-serine dephosphorylation,BP,
19373,GO:1902309,1,0.978320543588465,0,3,negative regulation of peptidyl-serine dephosphorylation,BP,
19374,GO:1902310,1,0.989707009637376,0,2,positive regulation of peptidyl-serine dephosphorylation,BP,
19375,GO:1902311,1,0.995313644415106,0,1,regulation of copper ion transmembrane transport,BP,
19376,GO:1902315,1,0.964369268706089,0,5,nuclear cell cycle DNA replication initiation,BP,
19377,GO:1902319,1,0.992964456086491,0,1,DNA strand elongation involved in nuclear cell cycle DNA replication,BP,
19378,GO:1902336,1,0.986817792328529,0,2,positive regulation of retinal ganglion cell axon guidance,BP,
19379,GO:1902337,1,0.925068292177742,0,11,regulation of apoptotic process involved in morphogenesis,BP,
19380,GO:1902338,1,0.966649076883925,0,5,negative regulation of apoptotic process involved in morphogenesis,BP,
19381,GO:1902339,1,0.964921738236613,0,5,positive regulation of apoptotic process involved in morphogenesis,BP,
19382,GO:1902356,1,0.978943369093154,0,4,oxaloacetate(2-) transmembrane transport,BP,
19383,GO:1902358,1,0.909175194681615,0,14,sulfate transmembrane transport,BP,
19384,GO:1902359,1,0.988298218074093,0,2,Notch signaling pathway involved in somitogenesis,BP,
19385,GO:1902362,1,0.993442637783967,0,1,melanocyte apoptotic process,BP,
19386,GO:1902363,1,0.990030135300583,0,1,regulation of protein localization to spindle pole body,BP,
19387,GO:1902365,1,0.990030135300583,0,1,positive regulation of protein localization to spindle pole body,BP,
19388,GO:1902366,1,0.988298218074093,0,2,regulation of Notch signaling pathway involved in somitogenesis,BP,
19389,GO:1902367,1,0.988298218074093,0,2,negative regulation of Notch signaling pathway involved in somitogenesis,BP,
19390,GO:1902369,1,0.680976476034858,0,54,negative regulation of RNA catabolic process,BP,
19391,GO:1902370,1,0.983231381070286,0,2,regulation of tRNA catabolic process,BP,
19392,GO:1902371,1,0.983231381070286,0,2,negative regulation of tRNA catabolic process,BP,
19393,GO:1902373,1,0.726553842265582,0,45,negative regulation of mRNA catabolic process,BP,
19394,GO:1902374,1,0.99520850060548,0,1,regulation of rRNA catabolic process,BP,
19395,GO:1902378,1,0.993942611467265,0,1,VEGF-activated neuropilin signaling pathway involved in axon guidance,BP,
19396,GO:1902379,1,0.988204654398097,0,2,chemoattractant activity involved in axon guidance,MF,
19397,GO:1902380,1,0.994054837410308,0,1,positive regulation of endoribonuclease activity,BP,
19398,GO:1902387,1,0.970182752175553,0,5,ceramide 1-phosphate binding,MF,
19399,GO:1902388,1,0.96948834145864,0,5,ceramide 1-phosphate transfer activity,MF,
19400,GO:1902389,1,0.96948834145864,0,5,ceramide 1-phosphate transport,BP,
19401,GO:1902396,1,0.952335460795952,0,6,protein localization to bicellular tight junction,BP,
19402,GO:1902400,1,0.692450005074025,0,55,intracellular signal transduction involved in G1 DNA damage checkpoint,BP,
19403,GO:1902402,1,0.687738546628639,0,56,signal transduction involved in mitotic DNA damage checkpoint,BP,
19404,GO:1902403,1,0.687738546628639,0,56,signal transduction involved in mitotic DNA integrity checkpoint,BP,
19405,GO:1902410,1,0.873619442559011,0,23,mitotic cytokinetic process,BP,
19406,GO:1902412,1,0.957144828564225,0,6,regulation of mitotic cytokinesis,BP,
19408,GO:1902415,1,0.943042335986716,0,10,regulation of mRNA binding,BP,
19409,GO:1902416,1,0.953890391188714,0,8,positive regulation of mRNA binding,BP,
19410,GO:1902423,1,0.981241243794285,0,3,regulation of attachment of mitotic spindle microtubules to kinetochore,BP,
19411,GO:1902425,1,0.981241243794285,0,3,positive regulation of attachment of mitotic spindle microtubules to kinetochore,BP,
19412,GO:1902426,1,0.993618374144912,0,1,deactivation of mitotic spindle assembly checkpoint,BP,
19413,GO:1902430,1,0.906001280360902,0,13,negative regulation of amyloid-beta formation,BP,
19414,GO:1902435,1,0.979140533583581,0,2,regulation of male mating behavior,BP,
19415,GO:1902437,1,0.979140533583581,0,2,positive regulation of male mating behavior,BP,
19416,GO:1902440,1,0.993485400251684,0,1,protein localization to mitotic spindle pole body,BP,
19417,GO:1902442,1,0.992731496818518,0,1,regulation of ripoptosome assembly involved in necroptotic process,BP,
19418,GO:1902443,1,0.992731496818518,0,1,negative regulation of ripoptosome assembly involved in necroptotic process,BP,
19419,GO:1902444,1,0.996274317114142,0,1,riboflavin binding,MF,
19420,GO:1902445,1,0.987706942730008,0,3,regulation of mitochondrial membrane permeability involved in programmed necrotic cell death,BP,
19421,GO:1902455,1,0.960565103157376,0,6,negative regulation of stem cell population maintenance,BP,
19422,GO:1902459,1,0.939373776867431,0,8,positive regulation of stem cell population maintenance,BP,
19423,GO:1902460,1,0.9789275546653,0,4,regulation of mesenchymal stem cell proliferation,BP,
19424,GO:1902462,1,0.9789275546653,0,4,positive regulation of mesenchymal stem cell proliferation,BP,
19425,GO:1902463,1,0.980219870728629,0,3,protein localization to cell leading edge,BP,
19426,GO:1902464,1,0.992388827038755,0,1,regulation of histone H3-K27 trimethylation,BP,
19427,GO:1902466,1,0.992388827038755,0,1,positive regulation of histone H3-K27 trimethylation,BP,
19428,GO:1902473,1,0.837619319071193,0,25,regulation of protein localization to synapse,BP,
19429,GO:1902474,1,0.919596493725585,0,11,positive regulation of protein localization to synapse,BP,
19432,GO:1902480,1,0.994049329364037,0,1,protein localization to mitotic spindle,BP,
19433,GO:1902488,1,0.988705528950714,0,1,cholangiocyte apoptotic process,BP,
19434,GO:1902490,1,0.994912457386172,0,1,regulation of sperm capacitation,BP,
19435,GO:1902493,1,0.56283719385438,0,85,acetyltransferase complex,CC,
19438,GO:1902498,1,0.958690717256084,0,5,regulation of protein autoubiquitination,BP,
19439,GO:1902499,1,0.978953868681221,0,3,positive regulation of protein autoubiquitination,BP,
19440,GO:1902504,1,0.993220829637341,0,1,regulation of signal transduction involved in mitotic G2 DNA damage checkpoint,BP,
19441,GO:1902510,1,0.942918620189779,0,11,regulation of apoptotic DNA fragmentation,BP,
19442,GO:1902511,1,0.979899484992877,0,3,negative regulation of apoptotic DNA fragmentation,BP,
19443,GO:1902512,1,0.980887466956453,0,5,positive regulation of apoptotic DNA fragmentation,BP,
19444,GO:1902513,1,0.934966287501176,0,10,regulation of organelle transport along microtubule,BP,
19445,GO:1902514,1,0.92233720970251,0,12,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
19446,GO:1902523,1,0.970213033212358,0,4,positive regulation of protein K63-linked ubiquitination,BP,
19447,GO:1902524,1,0.988580936040038,0,2,positive regulation of protein K48-linked ubiquitination,BP,
19448,GO:1902525,1,0.96460254711618,0,6,regulation of protein monoubiquitination,BP,
19449,GO:1902527,1,0.971651409569294,0,5,positive regulation of protein monoubiquitination,BP,
19450,GO:1902528,1,0.989006104573618,0,1,regulation of protein linear polyubiquitination,BP,
19451,GO:1902530,1,0.989006104573618,0,1,positive regulation of protein linear polyubiquitination,BP,
19455,GO:1902544,1,0.989763059064623,0,2,regulation of DNA N-glycosylase activity,BP,
19456,GO:1902546,1,0.99674640915843,0,1,positive regulation of DNA N-glycosylase activity,BP,
19457,GO:1902547,1,0.879333628601286,0,18,regulation of cellular response to vascular endothelial growth factor stimulus,BP,
19458,GO:1902548,1,0.937258294328944,0,9,negative regulation of cellular response to vascular endothelial growth factor stimulus,BP,
19459,GO:1902551,1,0.993402849735627,0,1,regulation of catalase activity,BP,
19460,GO:1902553,1,0.993402849735627,0,1,positive regulation of catalase activity,BP,
19461,GO:1902554,1,0.567826593612075,0,84,serine/threonine protein kinase complex,CC,
19462,GO:1902555,1,0.844192269657682,0,29,endoribonuclease complex,CC,
19463,GO:1902559,1,0.989566198153265,0,2,3'-phospho-5'-adenylyl sulfate transmembrane transport,BP,
19464,GO:1902560,1,0.9908874434528,0,2,GMP reductase complex,CC,
19465,GO:1902562,1,0.757640122396734,0,42,H4 histone acetyltransferase complex,CC,
19466,GO:1902563,1,0.924872941394757,0,12,regulation of neutrophil activation,BP,
19467,GO:1902564,1,0.967427186713584,0,5,negative regulation of neutrophil activation,BP,
19468,GO:1902565,1,0.97239601102779,0,4,positive regulation of neutrophil activation,BP,
19469,GO:1902566,1,0.978486381969496,0,4,regulation of eosinophil activation,BP,
19470,GO:1902567,1,0.98903730908516,0,2,negative regulation of eosinophil activation,BP,
19471,GO:1902568,1,0.989333295395267,0,2,positive regulation of eosinophil activation,BP,
19472,GO:1902569,1,0.995091742462202,0,1,negative regulation of activation of Janus kinase activity,BP,
19473,GO:1902570,1,0.923851190074638,0,13,protein localization to nucleolus,BP,
19474,GO:1902571,1,0.975507042398789,0,4,regulation of serine-type peptidase activity,BP,
19475,GO:1902572,1,0.975507042398789,0,4,negative regulation of serine-type peptidase activity,BP,
19476,GO:1902573,1,0.988255070026608,0,1,positive regulation of serine-type peptidase activity,BP,
19477,GO:1902576,1,0.974789451970617,0,4,negative regulation of nuclear cell cycle DNA replication,BP,
19478,GO:1902579,1,0.65677949826988,0,61,multi-organism localization,BP,
19479,GO:1902586,1,0.99441603432747,0,1,multi-organism intercellular transport,BP,
19480,GO:1902595,1,0.989564410697739,0,2,regulation of DNA replication origin binding,BP,
19482,GO:1902603,1,0.98249083445578,0,3,carnitine transmembrane transport,BP,
19483,GO:1902605,1,0.993523954028305,0,1,heterotrimeric G-protein complex assembly,BP,
19484,GO:1902606,1,0.992951090327305,0,2,regulation of large conductance calcium-activated potassium channel activity,BP,
19485,GO:1902608,1,0.992951090327305,0,2,positive regulation of large conductance calcium-activated potassium channel activity,BP,
19486,GO:1902612,1,0.993516724854332,0,1,regulation of anti-Mullerian hormone signaling pathway,BP,
19487,GO:1902613,1,0.993516724854332,0,1,negative regulation of anti-Mullerian hormone signaling pathway,BP,
19488,GO:1902616,1,0.976664738078989,0,4,acyl carnitine transmembrane transport,BP,
19489,GO:1902617,1,0.967054189209047,0,5,response to fluoride,BP,
19490,GO:1902618,1,0.991109134683439,0,1,cellular response to fluoride,BP,
19491,GO:1902622,1,0.803533153676575,0,38,regulation of neutrophil migration,BP,
19492,GO:1902623,1,0.97137859441139,0,4,negative regulation of neutrophil migration,BP,
19493,GO:1902624,1,0.853900799522153,0,28,positive regulation of neutrophil migration,BP,
19494,GO:1902626,1,0.989389926993464,0,3,assembly of large subunit precursor of preribosome,BP,
19495,GO:1902629,1,0.996004555279508,0,1,regulation of mRNA stability involved in cellular response to UV,BP,
19496,GO:1902630,1,0.975226626332235,0,3,regulation of membrane hyperpolarization,BP,
19497,GO:1902631,1,0.990226504695322,0,1,negative regulation of membrane hyperpolarization,BP,
19498,GO:1902636,1,0.984226682142738,0,3,kinociliary basal body,CC,
19499,GO:1902644,1,0.897182132315295,0,18,tertiary alcohol metabolic process,BP,
19500,GO:1902645,1,0.938177131568854,0,8,tertiary alcohol biosynthetic process,BP,
19501,GO:1902652,1,0.410601881258493,0,136,secondary alcohol metabolic process,BP,
19502,GO:1902653,1,0.653630613251219,0,63,secondary alcohol biosynthetic process,BP,
19503,GO:1902656,1,0.857805248093049,0,21,calcium ion import into cytosol,BP,
19504,GO:1902659,1,0.983387518708023,0,3,regulation of glucose mediated signaling pathway,BP,
19505,GO:1902661,1,0.983387518708023,0,3,positive regulation of glucose mediated signaling pathway,BP,
19506,GO:1902667,1,0.704066656647659,0,43,regulation of axon guidance,BP,
19507,GO:1902668,1,0.806564322665971,0,27,negative regulation of axon guidance,BP,
19508,GO:1902669,1,0.928331324354002,0,8,positive regulation of axon guidance,BP,
19511,GO:1902683,1,0.895519307933866,0,16,regulation of receptor localization to synapse,BP,
19512,GO:1902684,1,0.996058699186367,0,1,negative regulation of receptor localization to synapse,BP,
19513,GO:1902685,1,0.968821600058301,0,4,positive regulation of receptor localization to synapse,BP,
19514,GO:1902686,1,0.714235127445768,0,57,mitochondrial outer membrane permeabilization involved in programmed cell death,BP,
19515,GO:1902688,1,0.986422572574789,0,2,regulation of NAD metabolic process,BP,
19516,GO:1902689,1,0.986422572574789,0,2,negative regulation of NAD metabolic process,BP,
19517,GO:1902691,1,0.993107019638805,0,1,respiratory basal cell differentiation,BP,
19521,GO:1902722,1,0.982704606461729,0,3,positive regulation of prolactin secretion,BP,
19522,GO:1902723,1,0.972502144575631,0,4,negative regulation of skeletal muscle satellite cell proliferation,BP,
19523,GO:1902724,1,0.98374978634202,0,2,positive regulation of skeletal muscle satellite cell proliferation,BP,
19524,GO:1902725,1,0.970497979257729,0,4,negative regulation of satellite cell differentiation,BP,
19525,GO:1902728,1,0.98374978634202,0,2,positive regulation of growth factor dependent skeletal muscle satellite cell proliferation,BP,
19526,GO:1902729,1,0.992497201459322,0,1,negative regulation of proteoglycan biosynthetic process,BP,
19527,GO:1902730,1,0.971789791242374,0,4,positive regulation of proteoglycan biosynthetic process,BP,
19528,GO:1902731,1,0.970980442937991,0,3,negative regulation of chondrocyte proliferation,BP,
19529,GO:1902732,1,0.971245239953665,0,5,positive regulation of chondrocyte proliferation,BP,
19530,GO:1902737,1,0.970808388838361,0,4,dendritic filopodium,CC,
19532,GO:1902743,1,0.740050674391706,0,42,regulation of lamellipodium organization,BP,
19533,GO:1902744,1,0.968451391610834,0,4,negative regulation of lamellipodium organization,BP,
19534,GO:1902745,1,0.808634608476911,0,29,positive regulation of lamellipodium organization,BP,
19535,GO:1902746,1,0.937382429756581,0,9,regulation of lens fiber cell differentiation,BP,
19536,GO:1902747,1,0.963310175659151,0,6,negative regulation of lens fiber cell differentiation,BP,
19537,GO:1902748,1,0.978893930499461,0,2,positive regulation of lens fiber cell differentiation,BP,
19539,GO:1902750,1,0.587040128424277,0,94,negative regulation of cell cycle G2/M phase transition,BP,
19540,GO:1902751,1,0.827662768684732,0,29,positive regulation of cell cycle G2/M phase transition,BP,
19541,GO:1902761,1,0.993124788493426,0,1,positive regulation of chondrocyte development,BP,
19542,GO:1902766,1,0.991116292384453,0,2,skeletal muscle satellite cell migration,BP,
19543,GO:1902767,1,0.986977439378386,0,2,isoprenoid biosynthetic process via mevalonate,BP,
19544,GO:1902769,1,0.98695583753521,0,1,regulation of choline O-acetyltransferase activity,BP,
19545,GO:1902771,1,0.98695583753521,0,1,positive regulation of choline O-acetyltransferase activity,BP,
19546,GO:1902773,1,0.993168173133196,0,1,GTPase activator complex,CC,
19547,GO:1902774,1,0.951643307755331,0,7,late endosome to lysosome transport,BP,
19548,GO:1902775,1,0.97676597703351,0,3,mitochondrial large ribosomal subunit assembly,BP,
19549,GO:1902803,1,0.962992488946525,0,5,regulation of synaptic vesicle transport,BP,
19550,GO:1902804,1,0.996058699186367,0,1,negative regulation of synaptic vesicle transport,BP,
19551,GO:1902805,1,0.991381385518801,0,1,positive regulation of synaptic vesicle transport,BP,
19552,GO:1902806,1,0.345729181239389,0,158,regulation of cell cycle G1/S phase transition,BP,
19553,GO:1902807,1,0.505047187737332,0,102,negative regulation of cell cycle G1/S phase transition,BP,
19554,GO:1902808,1,0.748446981249202,0,44,positive regulation of cell cycle G1/S phase transition,BP,
19555,GO:1902809,1,0.975611672663541,0,4,regulation of skeletal muscle fiber differentiation,BP,
19556,GO:1902811,1,0.982157495078283,0,3,positive regulation of skeletal muscle fiber differentiation,BP,
19557,GO:1902816,1,0.959997947470682,0,5,regulation of protein localization to microtubule,BP,
19558,GO:1902817,1,0.959997947470682,0,5,negative regulation of protein localization to microtubule,BP,
19559,GO:1902822,1,0.972932015324457,0,4,regulation of late endosome to lysosome transport,BP,
19560,GO:1902823,1,0.981347081956693,0,2,negative regulation of late endosome to lysosome transport,BP,
19561,GO:1902824,1,0.991426592928788,0,2,positive regulation of late endosome to lysosome transport,BP,
19562,GO:1902834,1,0.992831943700993,0,1,regulation of proline import across plasma membrane,BP,
19563,GO:1902836,1,0.992831943700993,0,1,positive regulation of proline import across plasma membrane,BP,
19564,GO:1902838,1,0.991828016275873,0,1,regulation of nuclear migration along microtubule,BP,
19565,GO:1902841,1,0.9672623625963,0,4,regulation of netrin-activated signaling pathway,BP,
19566,GO:1902842,1,0.9672623625963,0,4,negative regulation of netrin-activated signaling pathway,BP,
19567,GO:1902846,1,0.990030135300583,0,1,positive regulation of mitotic spindle elongation,BP,
19568,GO:1902847,1,0.993382287712882,0,1,regulation of neuronal signal transduction,BP,
19570,GO:1902855,1,0.93454590352577,0,9,regulation of non-motile cilium assembly,BP,
19571,GO:1902856,1,0.977457611611828,0,3,negative regulation of non-motile cilium assembly,BP,
19572,GO:1902857,1,0.961966693273266,0,5,positive regulation of non-motile cilium assembly,BP,
19573,GO:1902858,1,0.994600609725118,0,1,propionyl-CoA metabolic process,BP,
19574,GO:1902860,1,0.994600609725118,0,1,propionyl-CoA biosynthetic process,BP,
19575,GO:1902866,1,0.955164307446492,0,7,regulation of retina development in camera-type eye,BP,
19576,GO:1902867,1,0.993079653851905,0,1,negative regulation of retina development in camera-type eye,BP,
19577,GO:1902868,1,0.988646125316627,0,2,positive regulation of retina development in camera-type eye,BP,
19578,GO:1902869,1,0.981803573105119,0,3,regulation of amacrine cell differentiation,BP,
19579,GO:1902870,1,0.993079653851905,0,1,negative regulation of amacrine cell differentiation,BP,
19580,GO:1902871,1,0.988646125316627,0,2,positive regulation of amacrine cell differentiation,BP,
19581,GO:1902882,1,0.594651774317981,0,79,regulation of response to oxidative stress,BP,
19582,GO:1902883,1,0.7539765432023,0,43,negative regulation of response to oxidative stress,BP,
19583,GO:1902884,1,0.892708415572447,0,18,positive regulation of response to oxidative stress,BP,
19584,GO:1902889,1,0.990356648416623,0,1,protein localization to spindle microtubule,BP,
19585,GO:1902893,1,0.692243803088989,0,51,regulation of pri-miRNA transcription by RNA polymerase II,BP,
19586,GO:1902894,1,0.899475892260998,0,14,negative regulation of pri-miRNA transcription by RNA polymerase II,BP,
19587,GO:1902895,1,0.754158501234087,0,40,positive regulation of pri-miRNA transcription by RNA polymerase II,BP,
19588,GO:1902896,1,0.979464972972944,0,3,terminal web assembly,BP,
19589,GO:1902897,1,0.979853546759786,0,3,regulation of postsynaptic density protein 95 clustering,BP,
19590,GO:1902902,1,0.927269411652498,0,12,negative regulation of autophagosome assembly,BP,
19594,GO:1902908,1,0.98794693274121,0,2,regulation of melanosome transport,BP,
19595,GO:1902910,1,0.992465874593964,0,1,positive regulation of melanosome transport,BP,
19596,GO:1902911,1,0.507496138955269,0,98,protein kinase complex,CC,
19597,GO:1902912,1,0.993485400251684,0,1,pyruvate kinase complex,CC,
19598,GO:1902913,1,0.993059151945929,0,1,positive regulation of neuroepithelial cell differentiation,BP,
19599,GO:1902914,1,0.85139565629651,0,22,regulation of protein polyubiquitination,BP,
19600,GO:1902915,1,0.93162326808495,0,9,negative regulation of protein polyubiquitination,BP,
19601,GO:1902916,1,0.928666558644599,0,11,positive regulation of protein polyubiquitination,BP,
19602,GO:1902930,1,0.621165879125359,0,69,regulation of alcohol biosynthetic process,BP,
19603,GO:1902931,1,0.923768499525146,0,13,negative regulation of alcohol biosynthetic process,BP,
19604,GO:1902932,1,0.877407886705834,0,20,positive regulation of alcohol biosynthetic process,BP,
19606,GO:1902937,1,0.980078782876661,0,3,inward rectifier potassium channel complex,CC,
19607,GO:1902938,1,0.976486035285513,0,3,regulation of intracellular calcium activated chloride channel activity,BP,
19608,GO:1902939,1,0.99332447466991,0,1,negative regulation of intracellular calcium activated chloride channel activity,BP,
19609,GO:1902941,1,0.983563557548083,0,2,regulation of voltage-gated chloride channel activity,BP,
19610,GO:1902943,1,0.983563557548083,0,2,positive regulation of voltage-gated chloride channel activity,BP,
19611,GO:1902945,1,0.992645815319127,0,1,metalloendopeptidase activity involved in amyloid precursor protein catabolic process,MF,
19612,GO:1902946,1,0.919703342837159,0,10,protein localization to early endosome,BP,
19613,GO:1902947,1,0.932172473033741,0,10,regulation of tau-protein kinase activity,BP,
19614,GO:1902948,1,0.979178349358575,0,2,negative regulation of tau-protein kinase activity,BP,
19615,GO:1902949,1,0.962499093557548,0,6,positive regulation of tau-protein kinase activity,BP,
19618,GO:1902952,1,0.980878773411441,0,3,positive regulation of dendritic spine maintenance,BP,
19619,GO:1902953,1,0.969131061997471,0,4,positive regulation of ER to Golgi vesicle-mediated transport,BP,
19620,GO:1902954,1,0.97678273240526,0,2,regulation of early endosome to recycling endosome transport,BP,
19621,GO:1902955,1,0.98695583753521,0,1,positive regulation of early endosome to recycling endosome transport,BP,
19622,GO:1902956,1,0.973443513087686,0,5,regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
19623,GO:1902957,1,0.986575798970718,0,2,negative regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
19624,GO:1902958,1,0.98669081430041,0,3,positive regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
19625,GO:1902959,1,0.937374938675083,0,9,regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19626,GO:1902960,1,0.98127625195399,0,2,negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19627,GO:1902961,1,0.955269262003726,0,7,positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19628,GO:1902962,1,0.979755775119635,0,2,regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19629,GO:1902963,1,0.979755775119635,0,2,negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19630,GO:1902965,1,0.932987394579166,0,8,regulation of protein localization to early endosome,BP,
19631,GO:1902966,1,0.932987394579166,0,8,positive regulation of protein localization to early endosome,BP,
19632,GO:1902969,1,0.896405948612699,0,15,mitotic DNA replication,BP,
19633,GO:1902975,1,0.964369268706089,0,5,mitotic DNA replication initiation,BP,
19634,GO:1902977,1,0.99502585553813,0,1,mitotic DNA replication preinitiation complex assembly,BP,
19635,GO:1902983,1,0.992964456086491,0,1,DNA strand elongation involved in mitotic DNA replication,BP,
19636,GO:1902988,1,0.971883102980284,0,3,neurofibrillary tangle assembly,BP,
19637,GO:1902990,1,0.980820541813568,0,3,mitotic telomere maintenance via semi-conservative replication,BP,
19638,GO:1902991,1,0.768910719413057,0,36,regulation of amyloid precursor protein catabolic process,BP,
19639,GO:1902992,1,0.893700134828873,0,15,negative regulation of amyloid precursor protein catabolic process,BP,
19640,GO:1902993,1,0.864114181035715,0,21,positive regulation of amyloid precursor protein catabolic process,BP,
19641,GO:1902994,1,0.983369262990106,0,3,regulation of phospholipid efflux,BP,
19642,GO:1902995,1,0.983369262990106,0,3,positive regulation of phospholipid efflux,BP,
19643,GO:1902996,1,0.980423594391337,0,2,regulation of neurofibrillary tangle assembly,BP,
19644,GO:1902997,1,0.98695583753521,0,1,negative regulation of neurofibrillary tangle assembly,BP,
19645,GO:1902998,1,0.993382287712882,0,1,positive regulation of neurofibrillary tangle assembly,BP,
19646,GO:1903000,1,0.996286622576736,0,1,regulation of lipid transport across blood-brain barrier,BP,
19647,GO:1903002,1,0.996286622576736,0,1,positive regulation of lipid transport across blood-brain barrier,BP,
19648,GO:1903003,1,0.960985549589513,0,6,positive regulation of protein deubiquitination,BP,
19649,GO:1903004,1,0.992675209673287,0,1,regulation of protein K63-linked deubiquitination,BP,
19650,GO:1903006,1,0.992675209673287,0,1,positive regulation of protein K63-linked deubiquitination,BP,
19651,GO:1903007,1,0.992675209673287,0,1,positive regulation of Lys63-specific deubiquitinase activity,BP,
19652,GO:1903008,1,0.496066592468354,0,104,organelle disassembly,BP,
19653,GO:1903010,1,0.868798731106014,0,20,regulation of bone development,BP,
19654,GO:1903011,1,0.954998576555887,0,6,negative regulation of bone development,BP,
19655,GO:1903012,1,0.956431025853858,0,8,positive regulation of bone development,BP,
19656,GO:1903015,1,0.99049797790381,0,2,regulation of exo-alpha-sialidase activity,BP,
19657,GO:1903016,1,0.995002487234698,0,1,negative regulation of exo-alpha-sialidase activity,BP,
19658,GO:1903017,1,0.995473093091466,0,1,positive regulation of exo-alpha-sialidase activity,BP,
19659,GO:1903018,1,0.752120727950115,0,44,regulation of glycoprotein metabolic process,BP,
19660,GO:1903019,1,0.920787044977005,0,14,negative regulation of glycoprotein metabolic process,BP,
19661,GO:1903020,1,0.845999550520484,0,24,positive regulation of glycoprotein metabolic process,BP,
19662,GO:1903025,1,0.918624289373025,0,12,regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
19663,GO:1903026,1,0.973270545487241,0,5,negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
19664,GO:1903027,1,0.979312525159733,0,3,regulation of opsonization,BP,
19665,GO:1903028,1,0.984827964317816,0,2,positive regulation of opsonization,BP,
19666,GO:1903031,1,0.988862306205393,0,2,regulation of microtubule plus-end binding,BP,
19667,GO:1903033,1,0.988862306205393,0,2,positive regulation of microtubule plus-end binding,BP,
19669,GO:1903035,1,0.589813479558352,0,79,negative regulation of response to wounding,BP,
19670,GO:1903036,1,0.667491917059262,0,61,positive regulation of response to wounding,BP,
19672,GO:1903038,1,0.494544398893071,0,113,negative regulation of leukocyte cell-cell adhesion,BP,
19674,GO:1903041,1,0.993124788493426,0,1,regulation of chondrocyte hypertrophy,BP,
19675,GO:1903043,1,0.993124788493426,0,1,positive regulation of chondrocyte hypertrophy,BP,
19676,GO:1903044,1,0.952423269771013,0,8,protein localization to membrane raft,BP,
19677,GO:1903045,1,0.991382278244404,0,1,neural crest cell migration involved in sympathetic nervous system development,BP,
19680,GO:1903050,1,0.249672026884659,0,209,regulation of proteolysis involved in cellular protein catabolic process,BP,
19681,GO:1903051,1,0.649037519941806,0,65,negative regulation of proteolysis involved in cellular protein catabolic process,BP,
19682,GO:1903052,1,0.451054377870959,0,120,positive regulation of proteolysis involved in cellular protein catabolic process,BP,
19683,GO:1903053,1,0.757450048550668,0,38,regulation of extracellular matrix organization,BP,
19684,GO:1903054,1,0.929395780300727,0,11,negative regulation of extracellular matrix organization,BP,
19685,GO:1903055,1,0.876216022952412,0,18,positive regulation of extracellular matrix organization,BP,
19686,GO:1903056,1,0.983878934854202,0,2,regulation of melanosome organization,BP,
19687,GO:1903059,1,0.957511037274477,0,7,regulation of protein lipidation,BP,
19688,GO:1903060,1,0.992126387162066,0,2,negative regulation of protein lipidation,BP,
19689,GO:1903061,1,0.97224160140001,0,4,positive regulation of protein lipidation,BP,
19690,GO:1903069,1,0.946922216505565,0,9,regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
19691,GO:1903070,1,0.982874056802965,0,3,negative regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
19692,GO:1903071,1,0.95788056188882,0,7,positive regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
19693,GO:1903072,1,0.996625193861694,0,1,regulation of death-inducing signaling complex assembly,BP,
19694,GO:1903073,1,0.996625193861694,0,1,negative regulation of death-inducing signaling complex assembly,BP,
19698,GO:1903080,1,0.996465856482775,0,1,regulation of C-C chemokine receptor CCR7 signaling pathway,BP,
19699,GO:1903082,1,0.996465856482775,0,1,positive regulation of C-C chemokine receptor CCR7 signaling pathway,BP,
19700,GO:1903093,1,0.982965532055176,0,3,regulation of protein K48-linked deubiquitination,BP,
19701,GO:1903094,1,0.992757795684453,0,2,negative regulation of protein K48-linked deubiquitination,BP,
19702,GO:1903095,1,0.985900163890347,0,2,ribonuclease III complex,CC,
19703,GO:1903096,1,0.993174963603365,0,1,protein localization to meiotic spindle midzone,BP,
19704,GO:1903108,1,0.981675685168773,0,3,regulation of mitochondrial transcription,BP,
19705,GO:1903109,1,0.988836661670251,0,2,positive regulation of mitochondrial transcription,BP,
19706,GO:1903115,1,0.719233681550032,0,41,regulation of actin filament-based movement,BP,
19707,GO:1903116,1,0.970713057455536,0,4,positive regulation of actin filament-based movement,BP,
19708,GO:1903119,1,0.992592874275698,0,1,protein localization to actin cytoskeleton,BP,
19709,GO:1903121,1,0.974670685178251,0,4,regulation of TRAIL-activated apoptotic signaling pathway,BP,
19710,GO:1903122,1,0.996625193861694,0,1,negative regulation of TRAIL-activated apoptotic signaling pathway,BP,
19711,GO:1903123,1,0.988303784808711,0,1,regulation of thioredoxin peroxidase activity,BP,
19712,GO:1903124,1,0.988303784808711,0,1,negative regulation of thioredoxin peroxidase activity,BP,
19713,GO:1903125,1,0.988303784808711,0,1,negative regulation of thioredoxin peroxidase activity by peptidyl-threonine phosphorylation,BP,
19714,GO:1903126,1,0.99461245244345,0,1,negative regulation of centriole-centriole cohesion,BP,
19715,GO:1903131,1,0.792009623482069,0,34,mononuclear cell differentiation,BP,
19716,GO:1903135,1,0.977633928822902,0,4,cupric ion binding,MF,
19717,GO:1903136,1,0.962740826327645,0,7,cuprous ion binding,MF,
19718,GO:1903140,1,0.90154460825399,0,15,regulation of establishment of endothelial barrier,BP,
19719,GO:1903141,1,0.985399941309208,0,2,negative regulation of establishment of endothelial barrier,BP,
19720,GO:1903142,1,0.960856509395625,0,6,positive regulation of establishment of endothelial barrier,BP,
19721,GO:1903143,1,0.98488448751741,0,3,adrenomedullin receptor complex,CC,
19722,GO:1903146,1,0.741782094493971,0,40,regulation of autophagy of mitochondrion,BP,
19723,GO:1903147,1,0.947021983226464,0,8,negative regulation of autophagy of mitochondrion,BP,
19724,GO:1903165,1,0.993594586753154,0,1,response to polycyclic arene,BP,
19725,GO:1903167,1,0.996625193861694,0,1,regulation of pyrroline-5-carboxylate reductase activity,BP,
19726,GO:1903168,1,0.996625193861694,0,1,positive regulation of pyrroline-5-carboxylate reductase activity,BP,
19728,GO:1903170,1,0.804422382628125,0,35,negative regulation of calcium ion transmembrane transport,BP,
19729,GO:1903173,1,0.987869742493981,0,2,fatty alcohol metabolic process,BP,
19730,GO:1903176,1,0.996625193861694,0,1,regulation of tyrosine 3-monooxygenase activity,BP,
19731,GO:1903178,1,0.996625193861694,0,1,positive regulation of tyrosine 3-monooxygenase activity,BP,
19732,GO:1903179,1,0.989610500432165,0,2,regulation of dopamine biosynthetic process,BP,
19733,GO:1903181,1,0.989610500432165,0,2,positive regulation of dopamine biosynthetic process,BP,
19734,GO:1903182,1,0.996253231912534,0,1,regulation of SUMO transferase activity,BP,
19735,GO:1903184,1,0.996625193861694,0,1,L-dopa metabolic process,BP,
19736,GO:1903185,1,0.996625193861694,0,1,L-dopa biosynthetic process,BP,
19737,GO:1903189,1,0.996625193861694,0,1,glyoxal metabolic process,BP,
19738,GO:1903190,1,0.996625193861694,0,1,glyoxal catabolic process,BP,
19739,GO:1903195,1,0.996625193861694,0,1,regulation of L-dopa biosynthetic process,BP,
19740,GO:1903197,1,0.996625193861694,0,1,positive regulation of L-dopa biosynthetic process,BP,
19741,GO:1903198,1,0.996625193861694,0,1,regulation of L-dopa decarboxylase activity,BP,
19742,GO:1903200,1,0.996625193861694,0,1,positive regulation of L-dopa decarboxylase activity,BP,
19743,GO:1903201,1,0.680207479262613,0,58,regulation of oxidative stress-induced cell death,BP,
19744,GO:1903202,1,0.764379772351657,0,41,negative regulation of oxidative stress-induced cell death,BP,
19745,GO:1903203,1,0.843697149723401,0,23,regulation of oxidative stress-induced neuron death,BP,
19746,GO:1903204,1,0.88457945768756,0,17,negative regulation of oxidative stress-induced neuron death,BP,
19747,GO:1903205,1,0.872793273764036,0,21,regulation of hydrogen peroxide-induced cell death,BP,
19748,GO:1903206,1,0.908628333849325,0,15,negative regulation of hydrogen peroxide-induced cell death,BP,
19749,GO:1903207,1,0.977715872272208,0,4,regulation of hydrogen peroxide-induced neuron death,BP,
19750,GO:1903208,1,0.977715872272208,0,4,negative regulation of hydrogen peroxide-induced neuron death,BP,
19751,GO:1903209,1,0.912479013677794,0,14,positive regulation of oxidative stress-induced cell death,BP,
19752,GO:1903210,1,0.982792222088233,0,2,glomerular visceral epithelial cell apoptotic process,BP,
19753,GO:1903214,1,0.751566115158269,0,43,regulation of protein targeting to mitochondrion,BP,
19754,GO:1903215,1,0.954975059454957,0,7,negative regulation of protein targeting to mitochondrion,BP,
19755,GO:1903216,1,0.984646243573775,0,2,regulation of protein processing involved in protein targeting to mitochondrion,BP,
19756,GO:1903217,1,0.984646243573775,0,2,negative regulation of protein processing involved in protein targeting to mitochondrion,BP,
19757,GO:1903223,1,0.961368919679498,0,5,positive regulation of oxidative stress-induced neuron death,BP,
19758,GO:1903224,1,0.971031874491302,0,4,regulation of endodermal cell differentiation,BP,
19759,GO:1903225,1,0.975661836929831,0,3,negative regulation of endodermal cell differentiation,BP,
19760,GO:1903231,1,0.992308224547309,0,2,mRNA binding involved in posttranscriptional gene silencing,MF,
19761,GO:1903232,1,0.975312066711426,0,5,melanosome assembly,BP,
19764,GO:1903236,1,0.918808369076901,0,13,regulation of leukocyte tethering or rolling,BP,
19765,GO:1903237,1,0.985256379436482,0,4,negative regulation of leukocyte tethering or rolling,BP,
19766,GO:1903238,1,0.946222040485573,0,8,positive regulation of leukocyte tethering or rolling,BP,
19767,GO:1903241,1,0.980959705213369,0,3,U2-type prespliceosome assembly,BP,
19768,GO:1903242,1,0.937634123867378,0,8,regulation of cardiac muscle hypertrophy in response to stress,BP,
19769,GO:1903243,1,0.951775257571991,0,6,negative regulation of cardiac muscle hypertrophy in response to stress,BP,
19770,GO:1903244,1,0.985149640035517,0,2,positive regulation of cardiac muscle hypertrophy in response to stress,BP,
19771,GO:1903248,1,0.988659840744814,0,1,regulation of citrulline biosynthetic process,BP,
19772,GO:1903249,1,0.988659840744814,0,1,negative regulation of citrulline biosynthetic process,BP,
19773,GO:1903251,1,0.956704300980573,0,7,multi-ciliated epithelial cell differentiation,BP,
19774,GO:1903265,1,0.941157188668475,0,10,positive regulation of tumor necrosis factor-mediated signaling pathway,BP,
19775,GO:1903276,1,0.980468004095789,0,4,regulation of sodium ion export across plasma membrane,BP,
19776,GO:1903278,1,0.980468004095789,0,4,positive regulation of sodium ion export across plasma membrane,BP,
19777,GO:1903279,1,0.979082992476445,0,3,regulation of calcium:sodium antiporter activity,BP,
19778,GO:1903280,1,0.991552872452267,0,1,negative regulation of calcium:sodium antiporter activity,BP,
19779,GO:1903281,1,0.987424947426279,0,2,positive regulation of calcium:sodium antiporter activity,BP,
19780,GO:1903282,1,0.993053943534722,0,1,regulation of glutathione peroxidase activity,BP,
19781,GO:1903284,1,0.993053943534722,0,1,positive regulation of glutathione peroxidase activity,BP,
19782,GO:1903285,1,0.98531423780793,0,2,positive regulation of hydrogen peroxide catabolic process,BP,
19783,GO:1903286,1,0.936843129784127,0,8,regulation of potassium ion import,BP,
19784,GO:1903288,1,0.944460400106288,0,7,positive regulation of potassium ion import across plasma membrane,BP,
19785,GO:1903292,1,0.986146168364397,0,2,protein localization to Golgi membrane,BP,
19786,GO:1903293,1,0.732330693527853,0,46,phosphatase complex,CC,
19787,GO:1903294,1,0.97677252801718,0,3,regulation of glutamate secretion, neurotransmission,BP,
19788,GO:1903296,1,0.97677252801718,0,3,positive regulation of glutamate secretion, neurotransmission,BP,
19789,GO:1903297,1,0.970619032997994,0,5,regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,
19790,GO:1903298,1,0.970619032997994,0,5,negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,
19791,GO:1903299,1,0.944998901492222,0,9,regulation of hexokinase activity,BP,
19792,GO:1903300,1,0.977822122017368,0,4,negative regulation of hexokinase activity,BP,
19793,GO:1903301,1,0.966439723350853,0,5,positive regulation of hexokinase activity,BP,
19794,GO:1903302,1,0.994784382543754,0,1,regulation of pyruvate kinase activity,BP,
19798,GO:1903311,1,0.122758233612684,0,316,regulation of mRNA metabolic process,BP,
19799,GO:1903312,1,0.59864305784833,0,75,negative regulation of mRNA metabolic process,BP,
19800,GO:1903313,1,0.579387859829769,0,78,positive regulation of mRNA metabolic process,BP,
19801,GO:1903314,1,0.994580882739056,0,1,regulation of nitrogen cycle metabolic process,BP,
19802,GO:1903317,1,0.698641271427658,0,56,regulation of protein maturation,BP,
19803,GO:1903318,1,0.846040003610998,0,27,negative regulation of protein maturation,BP,
19804,GO:1903319,1,0.870258552209909,0,21,positive regulation of protein maturation,BP,
19806,GO:1903321,1,0.595057396199727,0,81,negative regulation of protein modification by small protein conjugation or removal,BP,
19808,GO:1903326,1,0.983231381070286,0,2,regulation of tRNA metabolic process,BP,
19809,GO:1903327,1,0.983231381070286,0,2,negative regulation of tRNA metabolic process,BP,
19810,GO:1903332,1,0.929202142806633,0,12,regulation of protein folding,BP,
19811,GO:1903333,1,0.967609162284254,0,6,negative regulation of protein folding,BP,
19812,GO:1903334,1,0.973465864936342,0,4,positive regulation of protein folding,BP,
19813,GO:1903335,1,0.972932015324457,0,4,regulation of vacuolar transport,BP,
19814,GO:1903336,1,0.981347081956693,0,2,negative regulation of vacuolar transport,BP,
19815,GO:1903337,1,0.991426592928788,0,2,positive regulation of vacuolar transport,BP,
19816,GO:1903341,1,0.991034474838015,0,1,regulation of meiotic DNA double-strand break formation,BP,
19817,GO:1903343,1,0.991034474838015,0,1,positive regulation of meiotic DNA double-strand break formation,BP,
19818,GO:1903347,1,0.969686878854713,0,4,negative regulation of bicellular tight junction assembly,BP,
19819,GO:1903348,1,0.962679376344246,0,6,positive regulation of bicellular tight junction assembly,BP,
19820,GO:1903349,1,0.971853363166598,0,4,omegasome membrane,CC,
19823,GO:1903352,1,0.957470407397696,0,6,L-ornithine transmembrane transport,BP,
19824,GO:1903353,1,0.992057255422863,0,1,regulation of nucleus organization,BP,
19825,GO:1903358,1,0.90038103988443,0,15,regulation of Golgi organization,BP,
19826,GO:1903361,1,0.959223111577183,0,8,protein localization to basolateral plasma membrane,BP,
19827,GO:1903362,1,0.193143396808609,0,243,regulation of cellular protein catabolic process,BP,
19828,GO:1903363,1,0.600891029311783,0,77,negative regulation of cellular protein catabolic process,BP,
19829,GO:1903364,1,0.379122181620507,0,142,positive regulation of cellular protein catabolic process,BP,
19830,GO:1903365,1,0.950179064362811,0,9,regulation of fear response,BP,
19831,GO:1903366,1,0.99637377125583,0,1,negative regulation of fear response,BP,
19832,GO:1903367,1,0.962799064956972,0,7,positive regulation of fear response,BP,
19833,GO:1903371,1,0.960809907822197,0,5,regulation of endoplasmic reticulum tubular network organization,BP,
19834,GO:1903373,1,0.976434472350612,0,3,positive regulation of endoplasmic reticulum tubular network organization,BP,
19835,GO:1903375,1,0.977133129279142,0,3,facioacoustic ganglion development,BP,
19836,GO:1903376,1,0.95491896122366,0,7,regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19837,GO:1903377,1,0.976222665790945,0,4,negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19838,GO:1903378,1,0.985459633480306,0,2,positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19839,GO:1903381,1,0.992289343459996,0,1,regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19840,GO:1903382,1,0.992289343459996,0,1,negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19841,GO:1903383,1,0.990291290752773,0,2,regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,
19842,GO:1903384,1,0.990291290752773,0,2,negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,
19843,GO:1903385,1,0.978218486691867,0,3,regulation of homophilic cell adhesion,BP,
19844,GO:1903387,1,0.991718809705519,0,1,positive regulation of homophilic cell adhesion,BP,
19845,GO:1903391,1,0.963151029568317,0,5,regulation of adherens junction organization,BP,
19846,GO:1903392,1,0.978426674954915,0,3,negative regulation of adherens junction organization,BP,
19847,GO:1903393,1,0.984390917146584,0,2,positive regulation of adherens junction organization,BP,
19848,GO:1903394,1,0.994187218721693,0,1,protein localization to kinetochore involved in kinetochore assembly,BP,
19849,GO:1903400,1,0.944046602213294,0,8,L-arginine transmembrane transport,BP,
19850,GO:1903401,1,0.962518679770267,0,5,L-lysine transmembrane transport,BP,
19851,GO:1903402,1,0.992673043224518,0,1,regulation of renal phosphate excretion,BP,
19852,GO:1903403,1,0.992673043224518,0,1,negative regulation of renal phosphate excretion,BP,
19853,GO:1903405,1,0.933728032690416,0,12,protein localization to nuclear body,BP,
19854,GO:1903406,1,0.992774400747657,0,1,regulation of sodium:potassium-exchanging ATPase activity,BP,
19855,GO:1903408,1,0.992774400747657,0,1,positive regulation of sodium:potassium-exchanging ATPase activity,BP,
19856,GO:1903409,1,0.514998164111319,0,98,reactive oxygen species biosynthetic process,BP,
19857,GO:1903412,1,0.976244425470971,0,5,response to bile acid,BP,
19858,GO:1903413,1,0.976244425470971,0,5,cellular response to bile acid,BP,
19859,GO:1903416,1,0.967054479482251,0,5,response to glycoside,BP,
19860,GO:1903420,1,0.990719935461533,0,1,protein localization to endoplasmic reticulum tubular network,BP,
19862,GO:1903422,1,0.984109477841685,0,2,negative regulation of synaptic vesicle recycling,BP,
19864,GO:1903426,1,0.592262994392857,0,79,regulation of reactive oxygen species biosynthetic process,BP,
19865,GO:1903427,1,0.84126864101971,0,27,negative regulation of reactive oxygen species biosynthetic process,BP,
19866,GO:1903428,1,0.738466177297774,0,45,positive regulation of reactive oxygen species biosynthetic process,BP,
19867,GO:1903429,1,0.856105480521646,0,22,regulation of cell maturation,BP,
19868,GO:1903430,1,0.964205652813937,0,6,negative regulation of cell maturation,BP,
19869,GO:1903431,1,0.926985807187052,0,10,positive regulation of cell maturation,BP,
19870,GO:1903432,1,0.814720150941578,0,31,regulation of TORC1 signaling,BP,
19871,GO:1903433,1,0.986167202786079,0,2,regulation of constitutive secretory pathway,BP,
19872,GO:1903434,1,0.992680396243652,0,1,negative regulation of constitutive secretory pathway,BP,
19873,GO:1903435,1,0.993439261261492,0,1,positive regulation of constitutive secretory pathway,BP,
19874,GO:1903436,1,0.983794978325213,0,2,regulation of mitotic cytokinetic process,BP,
19875,GO:1903438,1,0.983794978325213,0,2,positive regulation of mitotic cytokinetic process,BP,
19876,GO:1903439,1,0.97451352221672,0,5,calcitonin family receptor complex,CC,
19877,GO:1903440,1,0.982420208643568,0,4,amylin receptor complex,CC,
19878,GO:1903441,1,0.922727458423893,0,11,protein localization to ciliary membrane,BP,
19879,GO:1903442,1,0.992694159277601,0,1,response to lipoic acid,BP,
19880,GO:1903444,1,0.986666230853542,0,2,negative regulation of brown fat cell differentiation,BP,
19881,GO:1903445,1,0.985658194499066,0,3,protein transport from ciliary membrane to plasma membrane,BP,
19882,GO:1903450,1,0.988822747607759,0,1,regulation of G1 to G0 transition,BP,
19883,GO:1903452,1,0.988822747607759,0,1,positive regulation of G1 to G0 transition,BP,
19884,GO:1903457,1,0.994801167887543,0,1,lactate catabolic process,BP,
19885,GO:1903461,1,0.993106144829843,0,1,Okazaki fragment processing involved in mitotic DNA replication,BP,
19886,GO:1903463,1,0.972700459978581,0,4,regulation of mitotic cell cycle DNA replication,BP,
19887,GO:1903464,1,0.987992225045989,0,2,negative regulation of mitotic cell cycle DNA replication,BP,
19888,GO:1903465,1,0.991402803225509,0,1,positive regulation of mitotic cell cycle DNA replication,BP,
19889,GO:1903487,1,0.984414487580974,0,3,regulation of lactation,BP,
19890,GO:1903489,1,0.991533741924172,0,2,positive regulation of lactation,BP,
19891,GO:1903490,1,0.983794978325213,0,2,positive regulation of mitotic cytokinesis,BP,
19892,GO:1903492,1,0.996783487168374,0,1,response to acetylsalicylate,BP,
19893,GO:1903494,1,0.996565195709483,0,1,response to dehydroepiandrosterone,BP,
19894,GO:1903496,1,0.996565195709483,0,1,response to 11-deoxycorticosterone,BP,
19895,GO:1903504,1,0.912526272271999,0,14,regulation of mitotic spindle checkpoint,BP,
19901,GO:1903512,1,0.994798206330893,0,1,phytanic acid metabolic process,BP,
19902,GO:1903513,1,0.845089728905266,0,26,endoplasmic reticulum to cytosol transport,BP,
19903,GO:1903514,1,0.787719069435772,0,31,release of sequestered calcium ion into cytosol by endoplasmic reticulum,BP,
19904,GO:1903515,1,0.981344171805764,0,2,calcium ion transport from cytosol to endoplasmic reticulum,BP,
19905,GO:1903516,1,0.980707121504284,0,3,regulation of single strand break repair,BP,
19906,GO:1903517,1,0.993317365421639,0,1,negative regulation of single strand break repair,BP,
19907,GO:1903518,1,0.987305765284994,0,2,positive regulation of single strand break repair,BP,
19908,GO:1903519,1,0.9889865257519,0,2,regulation of mammary gland involution,BP,
19909,GO:1903521,1,0.9889865257519,0,2,positive regulation of mammary gland involution,BP,
19911,GO:1903523,1,0.806560135551194,0,30,negative regulation of blood circulation,BP,
19913,GO:1903525,1,0.953921623718772,0,6,regulation of membrane tubulation,BP,
19914,GO:1903526,1,0.985210017939241,0,2,negative regulation of membrane tubulation,BP,
19915,GO:1903527,1,0.968246555895255,0,4,positive regulation of membrane tubulation,BP,
19920,GO:1903537,1,0.987590213072112,0,2,meiotic cell cycle process involved in oocyte maturation,BP,
19921,GO:1903538,1,0.987590213072112,0,2,regulation of meiotic cell cycle process involved in oocyte maturation,BP,
19924,GO:1903541,1,0.917323919332638,0,14,regulation of exosomal secretion,BP,
19925,GO:1903542,1,0.987362567105629,0,2,negative regulation of exosomal secretion,BP,
19926,GO:1903543,1,0.917323919332638,0,14,positive regulation of exosomal secretion,BP,
19927,GO:1903544,1,0.99288656463313,0,1,response to butyrate,BP,
19928,GO:1903545,1,0.99288656463313,0,1,cellular response to butyrate,BP,
19929,GO:1903546,1,0.960706467171249,0,5,protein localization to photoreceptor outer segment,BP,
19930,GO:1903547,1,0.992662576462111,0,2,regulation of growth hormone activity,BP,
19931,GO:1903551,1,0.962247359971613,0,6,regulation of extracellular exosome assembly,BP,
19932,GO:1903553,1,0.972963283193431,0,4,positive regulation of extracellular exosome assembly,BP,
19933,GO:1903555,1,0.545872176957089,0,98,regulation of tumor necrosis factor superfamily cytokine production,BP,
19934,GO:1903556,1,0.757444468758475,0,47,negative regulation of tumor necrosis factor superfamily cytokine production,BP,
19935,GO:1903557,1,0.742429960287509,0,47,positive regulation of tumor necrosis factor superfamily cytokine production,BP,
19937,GO:1903564,1,0.945687414894552,0,7,regulation of protein localization to cilium,BP,
19938,GO:1903565,1,0.985855250096169,0,2,negative regulation of protein localization to cilium,BP,
19939,GO:1903566,1,0.965941170668773,0,4,positive regulation of protein localization to cilium,BP,
19940,GO:1903567,1,0.987091400419913,0,2,regulation of protein localization to ciliary membrane,BP,
19941,GO:1903568,1,0.992895096867418,0,1,negative regulation of protein localization to ciliary membrane,BP,
19942,GO:1903569,1,0.99415518937502,0,1,positive regulation of protein localization to ciliary membrane,BP,
19943,GO:1903570,1,0.992832193980316,0,1,regulation of protein kinase D signaling,BP,
19944,GO:1903572,1,0.992832193980316,0,1,positive regulation of protein kinase D signaling,BP,
19946,GO:1903575,1,0.973939975999583,0,5,cornified envelope assembly,BP,
19947,GO:1903576,1,0.994738933398728,0,1,response to L-arginine,BP,
19948,GO:1903578,1,0.479147770407363,0,107,regulation of ATP metabolic process,BP,
19949,GO:1903579,1,0.844378536177568,0,25,negative regulation of ATP metabolic process,BP,
19950,GO:1903580,1,0.770887931991376,0,38,positive regulation of ATP metabolic process,BP,
19951,GO:1903584,1,0.992406616605623,0,1,regulation of histone deubiquitination,BP,
19952,GO:1903586,1,0.992406616605623,0,1,positive regulation of histone deubiquitination,BP,
19953,GO:1903587,1,0.922250231874445,0,12,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
19954,GO:1903588,1,0.969435296972617,0,5,negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
19955,GO:1903589,1,0.960563190499451,0,6,positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
19956,GO:1903593,1,0.981378304959001,0,4,regulation of histamine secretion by mast cell,BP,
19957,GO:1903595,1,0.981378304959001,0,4,positive regulation of histamine secretion by mast cell,BP,
19958,GO:1903596,1,0.969326657221243,0,5,regulation of gap junction assembly,BP,
19959,GO:1903597,1,0.98873768337808,0,2,negative regulation of gap junction assembly,BP,
19960,GO:1903598,1,0.980370073243033,0,3,positive regulation of gap junction assembly,BP,
19961,GO:1903599,1,0.853858647416089,0,19,positive regulation of autophagy of mitochondrion,BP,
19962,GO:1903608,1,0.961510060798244,0,6,protein localization to cytoplasmic stress granule,BP,
19963,GO:1903609,1,0.993630009751703,0,1,negative regulation of inward rectifier potassium channel activity,BP,
19964,GO:1903610,1,0.995017098870267,0,1,regulation of calcium-dependent ATPase activity,BP,
19965,GO:1903611,1,0.995017098870267,0,1,negative regulation of calcium-dependent ATPase activity,BP,
19966,GO:1903613,1,0.964746288019025,0,6,regulation of protein tyrosine phosphatase activity,BP,
19967,GO:1903614,1,0.984586834274246,0,3,negative regulation of protein tyrosine phosphatase activity,BP,
19968,GO:1903615,1,0.979851961502635,0,3,positive regulation of protein tyrosine phosphatase activity,BP,
19969,GO:1903618,1,0.992614810239926,0,1,regulation of transdifferentiation,BP,
19970,GO:1903620,1,0.992614810239926,0,1,positive regulation of transdifferentiation,BP,
19971,GO:1903621,1,0.994981996582074,0,1,protein localization to photoreceptor connecting cilium,BP,
19972,GO:1903624,1,0.925869812365372,0,13,regulation of DNA catabolic process,BP,
19973,GO:1903625,1,0.975015752793723,0,4,negative regulation of DNA catabolic process,BP,
19974,GO:1903626,1,0.96798401617093,0,6,positive regulation of DNA catabolic process,BP,
19975,GO:1903627,1,0.995017098870267,0,1,regulation of dUTP diphosphatase activity,BP,
19976,GO:1903629,1,0.995017098870267,0,1,positive regulation of dUTP diphosphatase activity,BP,
19977,GO:1903630,1,0.99126552473659,0,2,regulation of aminoacyl-tRNA ligase activity,BP,
19978,GO:1903631,1,0.995017098870267,0,1,negative regulation of aminoacyl-tRNA ligase activity,BP,
19979,GO:1903632,1,0.996229827135008,0,1,positive regulation of aminoacyl-tRNA ligase activity,BP,
19980,GO:1903633,1,0.995017098870267,0,1,regulation of leucine-tRNA ligase activity,BP,
19981,GO:1903634,1,0.995017098870267,0,1,negative regulation of leucine-tRNA ligase activity,BP,
19982,GO:1903636,1,0.99709334258388,0,1,regulation of protein insertion into mitochondrial outer membrane,BP,
19983,GO:1903638,1,0.99709334258388,0,1,positive regulation of protein insertion into mitochondrial outer membrane,BP,
19984,GO:1903644,1,0.973432242944443,0,5,regulation of chaperone-mediated protein folding,BP,
19985,GO:1903645,1,0.993534849062245,0,2,negative regulation of chaperone-mediated protein folding,BP,
19986,GO:1903646,1,0.985859234339635,0,2,positive regulation of chaperone-mediated protein folding,BP,
19987,GO:1903649,1,0.845518098215875,0,23,regulation of cytoplasmic transport,BP,
19988,GO:1903650,1,0.986195633168509,0,3,negative regulation of cytoplasmic transport,BP,
19989,GO:1903651,1,0.91565805586457,0,11,positive regulation of cytoplasmic transport,BP,
19990,GO:1903659,1,0.961228619193616,0,6,regulation of complement-dependent cytotoxicity,BP,
19991,GO:1903660,1,0.989995875950636,0,2,negative regulation of complement-dependent cytotoxicity,BP,
19992,GO:1903661,1,0.994410185558726,0,1,positive regulation of complement-dependent cytotoxicity,BP,
19995,GO:1903672,1,0.777769271747285,0,37,positive regulation of sprouting angiogenesis,BP,
19996,GO:1903673,1,0.99503363252735,0,1,mitotic cleavage furrow formation,BP,
19997,GO:1903674,1,0.99504722656296,0,1,regulation of cap-dependent translational initiation,BP,
19998,GO:1903676,1,0.99504722656296,0,1,positive regulation of cap-dependent translational initiation,BP,
19999,GO:1903677,1,0.98349876941561,0,3,regulation of cap-independent translational initiation,BP,
20000,GO:1903679,1,0.98349876941561,0,3,positive regulation of cap-independent translational initiation,BP,
20001,GO:1903689,1,0.94101894556861,0,6,regulation of wound healing, spreading of epidermal cells,BP,
20002,GO:1903690,1,0.962472903496979,0,4,negative regulation of wound healing, spreading of epidermal cells,BP,
20003,GO:1903691,1,0.977717955553227,0,2,positive regulation of wound healing, spreading of epidermal cells,BP,
20004,GO:1903697,1,0.992924766863793,0,1,negative regulation of microvillus assembly,BP,
20005,GO:1903699,1,0.986321524038015,0,1,tarsal gland development,BP,
20006,GO:1903701,1,0.991792033530994,0,1,substantia propria of cornea development,BP,
20007,GO:1903704,1,0.992614810239926,0,1,negative regulation of production of siRNA involved in RNA interference,BP,
20008,GO:1903706,1,0.0619112239853162,0,428,regulation of hemopoiesis,BP,
20009,GO:1903707,1,0.446892753969305,0,126,negative regulation of hemopoiesis,BP,
20010,GO:1903708,1,0.296131424213799,0,186,positive regulation of hemopoiesis,BP,
20011,GO:1903709,1,0.986321524038015,0,1,uterine gland development,BP,
20012,GO:1903710,1,0.992615277517046,0,1,spermine transmembrane transport,BP,
20013,GO:1903712,1,0.992736252445123,0,1,cysteine transmembrane transport,BP,
20014,GO:1903713,1,0.994875100991796,0,1,asparagine transmembrane transport,BP,
20015,GO:1903714,1,0.991633698096644,0,1,isoleucine transmembrane transport,BP,
20016,GO:1903715,1,0.9604069261292,0,6,regulation of aerobic respiration,BP,
20017,GO:1903719,1,0.95868847386835,0,7,regulation of I-kappaB phosphorylation,BP,
20018,GO:1903720,1,0.992563326181184,0,1,negative regulation of I-kappaB phosphorylation,BP,
20019,GO:1903721,1,0.965873847873779,0,6,positive regulation of I-kappaB phosphorylation,BP,
20020,GO:1903722,1,0.961176154448235,0,6,regulation of centriole elongation,BP,
20021,GO:1903723,1,0.990170303586028,0,2,negative regulation of centriole elongation,BP,
20022,GO:1903724,1,0.970720869737602,0,4,positive regulation of centriole elongation,BP,
20023,GO:1903725,1,0.567328256375441,0,84,regulation of phospholipid metabolic process,BP,
20024,GO:1903726,1,0.946325748574879,0,8,negative regulation of phospholipid metabolic process,BP,
20025,GO:1903727,1,0.730763272770641,0,48,positive regulation of phospholipid metabolic process,BP,
20027,GO:1903742,1,0.9874737152512,0,2,regulation of anterograde synaptic vesicle transport,BP,
20028,GO:1903743,1,0.996058699186367,0,1,negative regulation of anterograde synaptic vesicle transport,BP,
20029,GO:1903744,1,0.991381385518801,0,1,positive regulation of anterograde synaptic vesicle transport,BP,
20030,GO:1903747,1,0.636016834345146,0,71,regulation of establishment of protein localization to mitochondrion,BP,
20031,GO:1903748,1,0.942600096335147,0,9,negative regulation of establishment of protein localization to mitochondrion,BP,
20032,GO:1903749,1,0.690536258281144,0,58,positive regulation of establishment of protein localization to mitochondrion,BP,
20033,GO:1903750,1,0.984617324128882,0,3,regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
20034,GO:1903751,1,0.984617324128882,0,3,negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
20035,GO:1903753,1,0.957065635199583,0,6,negative regulation of p38MAPK cascade,BP,
20036,GO:1903755,1,0.996253231912534,0,1,positive regulation of SUMO transferase activity,BP,
20037,GO:1903760,1,0.977094997696791,0,3,regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,
20038,GO:1903762,1,0.9850361970435,0,2,positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,
20039,GO:1903763,1,0.966609138065747,0,5,gap junction channel activity involved in cell communication by electrical coupling,MF,
20040,GO:1903764,1,0.955387199093889,0,7,regulation of potassium ion export across plasma membrane,BP,
20041,GO:1903765,1,0.97979845888638,0,3,negative regulation of potassium ion export across plasma membrane,BP,
20042,GO:1903766,1,0.98301552029795,0,3,positive regulation of potassium ion export across plasma membrane,BP,
20043,GO:1903767,1,0.993813629352555,0,1,sweet taste receptor complex,CC,
20044,GO:1903768,1,0.993813629352555,0,1,taste receptor complex,CC,
20045,GO:1903770,1,0.993317365421639,0,1,negative regulation of beta-galactosidase activity,BP,
20046,GO:1903772,1,0.980147267940206,0,4,regulation of viral budding via host ESCRT complex,BP,
20047,GO:1903774,1,0.983852838563849,0,3,positive regulation of viral budding via host ESCRT complex,BP,
20048,GO:1903775,1,0.987562326230504,0,2,regulation of DNA double-strand break processing,BP,
20049,GO:1903778,1,0.990750724986114,0,1,protein localization to vacuolar membrane,BP,
20050,GO:1903779,1,0.601450039137576,0,67,regulation of cardiac conduction,BP,
20051,GO:1903781,1,0.977700943827262,0,3,positive regulation of cardiac conduction,BP,
20052,GO:1903786,1,0.981596275776976,0,2,regulation of glutathione biosynthetic process,BP,
20053,GO:1903788,1,0.993528310786554,0,1,positive regulation of glutathione biosynthetic process,BP,
20054,GO:1903789,1,0.920777891633236,0,12,regulation of amino acid transmembrane transport,BP,
20055,GO:1903792,1,0.830503080806476,0,27,negative regulation of anion transport,BP,
20057,GO:1903795,1,0.949580373587598,0,6,regulation of inorganic anion transmembrane transport,BP,
20058,GO:1903796,1,0.982104653990809,0,2,negative regulation of inorganic anion transmembrane transport,BP,
20059,GO:1903797,1,0.983563557548083,0,2,positive regulation of inorganic anion transmembrane transport,BP,
20060,GO:1903798,1,0.862100839218588,0,22,regulation of production of miRNAs involved in gene silencing by miRNA,BP,
20061,GO:1903799,1,0.903528858611643,0,14,negative regulation of production of miRNAs involved in gene silencing by miRNA,BP,
20062,GO:1903800,1,0.943388109452493,0,10,positive regulation of production of miRNAs involved in gene silencing by miRNA,BP,
20063,GO:1903801,1,0.966956011386995,0,5,L-leucine import across plasma membrane,BP,
20064,GO:1903803,1,0.99501807222187,0,1,L-glutamine import across plasma membrane,BP,
20065,GO:1903804,1,0.975635874150306,0,4,glycine import across plasma membrane,BP,
20066,GO:1903806,1,0.991633698096644,0,1,L-isoleucine import across plasma membrane,BP,
20067,GO:1903810,1,0.989904756538075,0,1,L-histidine import across plasma membrane,BP,
20068,GO:1903812,1,0.992455462665037,0,1,L-serine import across plasma membrane,BP,
20069,GO:1903814,1,0.996733546774485,0,1,regulation of collecting lymphatic vessel constriction,BP,
20070,GO:1903815,1,0.996733546774485,0,1,negative regulation of collecting lymphatic vessel constriction,BP,
20071,GO:1903817,1,0.932889330491236,0,11,negative regulation of voltage-gated potassium channel activity,BP,
20073,GO:1903823,1,0.993317365421639,0,1,telomere single strand break repair,BP,
20074,GO:1903824,1,0.993317365421639,0,1,negative regulation of telomere single strand break repair,BP,
20076,GO:1903826,1,0.944046602213294,0,8,arginine transmembrane transport,BP,
20080,GO:1903830,1,0.900231986912014,0,15,magnesium ion transmembrane transport,BP,
20081,GO:1903837,1,0.993962265126325,0,1,regulation of mRNA 3'-UTR binding,BP,
20082,GO:1903839,1,0.993962265126325,0,1,positive regulation of mRNA 3'-UTR binding,BP,
20083,GO:1903840,1,0.992041511279008,0,1,response to arsenite(3-),BP,
20084,GO:1903841,1,0.992041511279008,0,1,cellular response to arsenite(3-),BP,
20085,GO:1903842,1,0.972363872088881,0,4,response to arsenite ion,BP,
20086,GO:1903843,1,0.972363872088881,0,4,cellular response to arsenite ion,BP,
20087,GO:1903844,1,0.424662005864258,0,117,regulation of cellular response to transforming growth factor beta stimulus,BP,
20088,GO:1903845,1,0.562517677682146,0,79,negative regulation of cellular response to transforming growth factor beta stimulus,BP,
20089,GO:1903846,1,0.807442683438512,0,29,positive regulation of cellular response to transforming growth factor beta stimulus,BP,
20090,GO:1903847,1,0.980794866807076,0,2,regulation of aorta morphogenesis,BP,
20091,GO:1903849,1,0.980794866807076,0,2,positive regulation of aorta morphogenesis,BP,
20092,GO:1903850,1,0.980386356988599,0,4,regulation of cristae formation,BP,
20093,GO:1903852,1,0.985266884671543,0,3,positive regulation of cristae formation,BP,
20095,GO:1903860,1,0.989939132785455,0,2,negative regulation of dendrite extension,BP,
20097,GO:1903862,1,0.95633100030745,0,9,positive regulation of oxidative phosphorylation,BP,
20098,GO:1903867,1,0.937360628870124,0,9,extraembryonic membrane development,BP,
20099,GO:1903881,1,0.992742545978975,0,1,regulation of interleukin-17-mediated signaling pathway,BP,
20100,GO:1903883,1,0.992742545978975,0,1,positive regulation of interleukin-17-mediated signaling pathway,BP,
20101,GO:1903884,1,0.992742545978975,0,1,regulation of chemokine (C-C motif) ligand 20 production,BP,
20102,GO:1903886,1,0.992742545978975,0,1,positive regulation of chemokine (C-C motif) ligand 20 production,BP,
20103,GO:1903891,1,0.97330349409323,0,4,regulation of ATF6-mediated unfolded protein response,BP,
20104,GO:1903892,1,0.986528498801972,0,2,negative regulation of ATF6-mediated unfolded protein response,BP,
20105,GO:1903893,1,0.993919537071461,0,1,positive regulation of ATF6-mediated unfolded protein response,BP,
20106,GO:1903894,1,0.922038240838774,0,13,regulation of IRE1-mediated unfolded protein response,BP,
20107,GO:1903895,1,0.969976440969738,0,5,negative regulation of IRE1-mediated unfolded protein response,BP,
20108,GO:1903896,1,0.958878498303497,0,6,positive regulation of IRE1-mediated unfolded protein response,BP,
20109,GO:1903897,1,0.941120415428001,0,9,regulation of PERK-mediated unfolded protein response,BP,
20110,GO:1903898,1,0.968538446594542,0,5,negative regulation of PERK-mediated unfolded protein response,BP,
20111,GO:1903899,1,0.978914112351246,0,3,positive regulation of PERK-mediated unfolded protein response,BP,
20113,GO:1903901,1,0.642734071432368,0,71,negative regulation of viral life cycle,BP,
20115,GO:1903903,1,0.977168056619212,0,3,regulation of establishment of T cell polarity,BP,
20116,GO:1903905,1,0.983529187097214,0,2,positive regulation of establishment of T cell polarity,BP,
20117,GO:1903906,1,0.993533411816083,0,1,regulation of plasma membrane raft polarization,BP,
20118,GO:1903909,1,0.918931220196636,0,11,regulation of receptor clustering,BP,
20119,GO:1903910,1,0.994215636941164,0,1,negative regulation of receptor clustering,BP,
20120,GO:1903911,1,0.967871302707346,0,5,positive regulation of receptor clustering,BP,
20121,GO:1903912,1,0.972787904602757,0,4,negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,
20122,GO:1903916,1,0.994134570649157,0,1,regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,
20123,GO:1903917,1,0.994134570649157,0,1,positive regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,
20124,GO:1903918,1,0.989742342890417,0,1,regulation of actin filament severing,BP,
20125,GO:1903919,1,0.989742342890417,0,1,negative regulation of actin filament severing,BP,
20126,GO:1903921,1,0.983341429699792,0,2,regulation of protein processing in phagocytic vesicle,BP,
20127,GO:1903923,1,0.983341429699792,0,2,positive regulation of protein processing in phagocytic vesicle,BP,
20128,GO:1903924,1,0.994433599933319,0,1,estradiol binding,MF,
20129,GO:1903925,1,0.995132167028412,0,1,response to bisphenol A,BP,
20130,GO:1903926,1,0.995132167028412,0,1,cellular response to bisphenol A,BP,
20131,GO:1903929,1,0.987259178684091,0,2,primary palate development,BP,
20132,GO:1903935,1,0.972452706430047,0,5,response to sodium arsenite,BP,
20133,GO:1903936,1,0.972452706430047,0,5,cellular response to sodium arsenite,BP,
20134,GO:1903939,1,0.984000848608704,0,2,regulation of TORC2 signaling,BP,
20135,GO:1903943,1,0.994953638863496,0,1,regulation of hepatocyte apoptotic process,BP,
20136,GO:1903944,1,0.994953638863496,0,1,negative regulation of hepatocyte apoptotic process,BP,
20137,GO:1903946,1,0.987427328526505,0,2,negative regulation of ventricular cardiac muscle cell action potential,BP,
20138,GO:1903947,1,0.9850361970435,0,2,positive regulation of ventricular cardiac muscle cell action potential,BP,
20139,GO:1903949,1,0.98526535023548,0,2,positive regulation of atrial cardiac muscle cell action potential,BP,
20140,GO:1903952,1,0.992628671375866,0,1,regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP,
20141,GO:1903954,1,0.992628671375866,0,1,positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP,
20142,GO:1903955,1,0.805289467225992,0,32,positive regulation of protein targeting to mitochondrion,BP,
20143,GO:1903959,1,0.79985506244788,0,30,regulation of anion transmembrane transport,BP,
20144,GO:1903960,1,0.898271098011766,0,15,negative regulation of anion transmembrane transport,BP,
20145,GO:1903961,1,0.928974941808839,0,10,positive regulation of anion transmembrane transport,BP,
20147,GO:1903964,1,0.981415528325666,0,3,monounsaturated fatty acid metabolic process,BP,
20148,GO:1903965,1,0.995987376604659,0,1,monounsaturated fatty acid catabolic process,BP,
20149,GO:1903966,1,0.985370029714152,0,2,monounsaturated fatty acid biosynthetic process,BP,
20150,GO:1903969,1,0.969900395080758,0,5,regulation of response to macrophage colony-stimulating factor,BP,
20151,GO:1903970,1,0.991220552000599,0,2,negative regulation of response to macrophage colony-stimulating factor,BP,
20152,GO:1903971,1,0.978492884534542,0,3,positive regulation of response to macrophage colony-stimulating factor,BP,
20153,GO:1903972,1,0.969900395080758,0,5,regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
20154,GO:1903973,1,0.991220552000599,0,2,negative regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
20155,GO:1903974,1,0.978492884534542,0,3,positive regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
20156,GO:1903975,1,0.904127648240025,0,15,regulation of glial cell migration,BP,
20157,GO:1903976,1,0.977750431418151,0,4,negative regulation of glial cell migration,BP,
20158,GO:1903977,1,0.929090983390919,0,10,positive regulation of glial cell migration,BP,
20159,GO:1903978,1,0.891597651047858,0,16,regulation of microglial cell activation,BP,
20160,GO:1903979,1,0.953684576129134,0,7,negative regulation of microglial cell activation,BP,
20161,GO:1903980,1,0.955581496416525,0,6,positive regulation of microglial cell activation,BP,
20162,GO:1903981,1,0.991158139982773,0,2,enterobactin binding,MF,
20163,GO:1903984,1,0.977971886608595,0,3,positive regulation of TRAIL-activated apoptotic signaling pathway,BP,
20164,GO:1903988,1,0.992922930638173,0,1,iron ion export across plasma membrane,BP,
20165,GO:1903995,1,0.946088643841854,0,8,regulation of non-membrane spanning protein tyrosine kinase activity,BP,
20166,GO:1903996,1,0.99581935476896,0,1,negative regulation of non-membrane spanning protein tyrosine kinase activity,BP,
20167,GO:1903997,1,0.950062552210529,0,7,positive regulation of non-membrane spanning protein tyrosine kinase activity,BP,
20168,GO:1903998,1,0.963111150955874,0,6,regulation of eating behavior,BP,
20169,GO:1903999,1,0.977139660819227,0,4,negative regulation of eating behavior,BP,
20170,GO:1904000,1,0.985646587183938,0,2,positive regulation of eating behavior,BP,
20174,GO:1904016,1,0.968247739810791,0,4,response to Thyroglobulin triiodothyronine,BP,
20175,GO:1904017,1,0.981301236556204,0,2,cellular response to Thyroglobulin triiodothyronine,BP,
20177,GO:1904019,1,0.510227858257901,0,97,epithelial cell apoptotic process,BP,
20178,GO:1904020,1,0.98161473576044,0,3,regulation of G protein-coupled receptor internalization,BP,
20179,GO:1904021,1,0.988520960886062,0,2,negative regulation of G protein-coupled receptor internalization,BP,
20180,GO:1904022,1,0.993014381373215,0,1,positive regulation of G protein-coupled receptor internalization,BP,
20181,GO:1904023,1,0.986422572574789,0,2,regulation of glucose catabolic process to lactate via pyruvate,BP,
20182,GO:1904024,1,0.986422572574789,0,2,negative regulation of glucose catabolic process to lactate via pyruvate,BP,
20183,GO:1904026,1,0.965173017268148,0,5,regulation of collagen fibril organization,BP,
20184,GO:1904027,1,0.986551022749897,0,2,negative regulation of collagen fibril organization,BP,
20185,GO:1904028,1,0.985656969557578,0,2,positive regulation of collagen fibril organization,BP,
20186,GO:1904029,1,0.54354576618503,0,98,regulation of cyclin-dependent protein kinase activity,BP,
20187,GO:1904030,1,0.82043104076157,0,30,negative regulation of cyclin-dependent protein kinase activity,BP,
20188,GO:1904031,1,0.805201357336164,0,33,positive regulation of cyclin-dependent protein kinase activity,BP,
20189,GO:1904035,1,0.615860672719192,0,74,regulation of epithelial cell apoptotic process,BP,
20190,GO:1904036,1,0.774393509713728,0,38,negative regulation of epithelial cell apoptotic process,BP,
20191,GO:1904037,1,0.81369394124398,0,32,positive regulation of epithelial cell apoptotic process,BP,
20192,GO:1904041,1,0.992963121628234,0,1,regulation of cystathionine beta-synthase activity,BP,
20193,GO:1904042,1,0.992963121628234,0,1,negative regulation of cystathionine beta-synthase activity,BP,
20194,GO:1904044,1,0.973901212606571,0,5,response to aldosterone,BP,
20195,GO:1904045,1,0.994459020673898,0,1,cellular response to aldosterone,BP,
20196,GO:1904046,1,0.996688208883873,0,1,negative regulation of vascular endothelial growth factor production,BP,
20197,GO:1904047,1,0.926644028266257,0,13,S-adenosyl-L-methionine binding,MF,
20198,GO:1904048,1,0.980027507744878,0,2,regulation of spontaneous neurotransmitter secretion,BP,
20199,GO:1904049,1,0.987635570247677,0,1,negative regulation of spontaneous neurotransmitter secretion,BP,
20200,GO:1904050,1,0.992297643203493,0,1,positive regulation of spontaneous neurotransmitter secretion,BP,
20201,GO:1904054,1,0.98455542132348,0,2,regulation of cholangiocyte proliferation,BP,
20202,GO:1904056,1,0.98455542132348,0,2,positive regulation of cholangiocyte proliferation,BP,
20203,GO:1904057,1,0.995571065959689,0,1,negative regulation of sensory perception of pain,BP,
20204,GO:1904058,1,0.963925933652626,0,6,positive regulation of sensory perception of pain,BP,
20205,GO:1904059,1,0.966450050393768,0,3,regulation of locomotor rhythm,BP,
20207,GO:1904063,1,0.601410565059461,0,79,negative regulation of cation transmembrane transport,BP,
20209,GO:1904071,1,0.947348545024251,0,4,presynaptic active zone assembly,BP,
20210,GO:1904073,1,0.989980696770108,0,1,regulation of trophectodermal cell proliferation,BP,
20211,GO:1904075,1,0.989980696770108,0,1,positive regulation of trophectodermal cell proliferation,BP,
20212,GO:1904090,1,0.983234098660023,0,4,peptidase inhibitor complex,CC,
20213,GO:1904092,1,0.976035790711536,0,4,regulation of autophagic cell death,BP,
20214,GO:1904093,1,0.996465856482775,0,1,negative regulation of autophagic cell death,BP,
20215,GO:1904098,1,0.980711591059941,0,3,regulation of protein O-linked glycosylation,BP,
20216,GO:1904100,1,0.980711591059941,0,3,positive regulation of protein O-linked glycosylation,BP,
20218,GO:1904108,1,0.992776661088813,0,1,protein localization to ciliary inversin compartment,BP,
20219,GO:1904109,1,0.9840305255831,0,1,positive regulation of cholesterol import,BP,
20221,GO:1904116,1,0.977365961649988,0,3,response to vasopressin,BP,
20222,GO:1904117,1,0.977365961649988,0,3,cellular response to vasopressin,BP,
20223,GO:1904118,1,0.99310265842407,0,1,regulation of otic vesicle morphogenesis,BP,
20224,GO:1904120,1,0.99310265842407,0,1,positive regulation of otic vesicle morphogenesis,BP,
20225,GO:1904121,1,0.995485583015882,0,1,phosphatidylethanolamine transfer activity,MF,
20226,GO:1904124,1,0.963493644496122,0,7,microglial cell migration,BP,
20227,GO:1904139,1,0.963493644496122,0,7,regulation of microglial cell migration,BP,
20228,GO:1904140,1,0.995763323408883,0,1,negative regulation of microglial cell migration,BP,
20229,GO:1904141,1,0.967594379891148,0,6,positive regulation of microglial cell migration,BP,
20230,GO:1904149,1,0.985070361477399,0,3,regulation of microglial cell mediated cytotoxicity,BP,
20231,GO:1904151,1,0.985070361477399,0,3,positive regulation of microglial cell mediated cytotoxicity,BP,
20232,GO:1904152,1,0.919854758916825,0,13,regulation of retrograde protein transport, ER to cytosol,BP,
20233,GO:1904153,1,0.943666026728016,0,9,negative regulation of retrograde protein transport, ER to cytosol,BP,
20234,GO:1904154,1,0.981817770214475,0,3,positive regulation of retrograde protein transport, ER to cytosol,BP,
20235,GO:1904155,1,0.984908911510504,0,2,DN2 thymocyte differentiation,BP,
20236,GO:1904156,1,0.992930630942919,0,1,DN3 thymocyte differentiation,BP,
20237,GO:1904158,1,0.973339684201768,0,3,axonemal central apparatus assembly,BP,
20238,GO:1904161,1,0.988439137119371,0,2,DNA synthesis involved in UV-damage excision repair,BP,
20239,GO:1904170,1,0.985253226397854,0,2,regulation of bleb assembly,BP,
20240,GO:1904172,1,0.985253226397854,0,2,positive regulation of bleb assembly,BP,
20241,GO:1904177,1,0.943291576090426,0,8,regulation of adipose tissue development,BP,
20242,GO:1904178,1,0.98866544729484,0,2,negative regulation of adipose tissue development,BP,
20243,GO:1904179,1,0.954111050310629,0,6,positive regulation of adipose tissue development,BP,
20244,GO:1904180,1,0.955627038268806,0,8,negative regulation of membrane depolarization,BP,
20245,GO:1904181,1,0.931749845000445,0,11,positive regulation of membrane depolarization,BP,
20246,GO:1904182,1,0.946641429062043,0,8,regulation of pyruvate dehydrogenase activity,BP,
20247,GO:1904183,1,0.964391665213348,0,5,negative regulation of pyruvate dehydrogenase activity,BP,
20248,GO:1904184,1,0.985247323265339,0,2,positive regulation of pyruvate dehydrogenase activity,BP,
20249,GO:1904192,1,0.988705528950714,0,1,regulation of cholangiocyte apoptotic process,BP,
20250,GO:1904193,1,0.988705528950714,0,1,negative regulation of cholangiocyte apoptotic process,BP,
20251,GO:1904195,1,0.988705528950714,0,1,regulation of granulosa cell proliferation,BP,
20252,GO:1904197,1,0.988705528950714,0,1,positive regulation of granulosa cell proliferation,BP,
20253,GO:1904199,1,0.992582544689823,0,1,positive regulation of regulation of vascular associated smooth muscle cell membrane depolarization,BP,
20254,GO:1904200,1,0.981586927922111,0,2,iodide transmembrane transport,BP,
20255,GO:1904201,1,0.988705528950714,0,1,regulation of iodide transport,BP,
20256,GO:1904202,1,0.988705528950714,0,1,negative regulation of iodide transport,BP,
20257,GO:1904204,1,0.979680884465437,0,2,regulation of skeletal muscle hypertrophy,BP,
20258,GO:1904205,1,0.990873292208147,0,1,negative regulation of skeletal muscle hypertrophy,BP,
20259,GO:1904206,1,0.988705528950714,0,1,positive regulation of skeletal muscle hypertrophy,BP,
20260,GO:1904210,1,0.995973262917059,0,1,VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
20261,GO:1904211,1,0.987292169231813,0,2,membrane protein proteolysis involved in retrograde protein transport, ER to cytosol,BP,
20262,GO:1904212,1,0.988705528950714,0,1,regulation of iodide transmembrane transport,BP,
20263,GO:1904213,1,0.988705528950714,0,1,negative regulation of iodide transmembrane transport,BP,
20264,GO:1904217,1,0.98303965860038,0,3,regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,
20265,GO:1904219,1,0.98303965860038,0,3,positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,
20266,GO:1904220,1,0.976634456175895,0,4,regulation of serine C-palmitoyltransferase activity,BP,
20267,GO:1904222,1,0.98303965860038,0,3,positive regulation of serine C-palmitoyltransferase activity,BP,
20268,GO:1904226,1,0.994510013234754,0,1,regulation of glycogen synthase activity, transferring glucose-1-phosphate,BP,
20269,GO:1904227,1,0.994510013234754,0,1,negative regulation of glycogen synthase activity, transferring glucose-1-phosphate,BP,
20270,GO:1904229,1,0.983197421087866,0,2,regulation of succinate dehydrogenase activity,BP,
20271,GO:1904231,1,0.990061127783499,0,1,positive regulation of succinate dehydrogenase activity,BP,
20272,GO:1904232,1,0.986461480557979,0,2,regulation of aconitate hydratase activity,BP,
20273,GO:1904234,1,0.986461480557979,0,2,positive regulation of aconitate hydratase activity,BP,
20274,GO:1904235,1,0.979908116209561,0,2,regulation of substrate-dependent cell migration, cell attachment to substrate,BP,
20275,GO:1904237,1,0.979908116209561,0,2,positive regulation of substrate-dependent cell migration, cell attachment to substrate,BP,
20276,GO:1904238,1,0.948368576119555,0,8,pericyte cell differentiation,BP,
20277,GO:1904239,1,0.995973262917059,0,1,regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
20278,GO:1904240,1,0.995973262917059,0,1,negative regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
20279,GO:1904245,1,0.988532544194753,0,2,regulation of polynucleotide adenylyltransferase activity,BP,
20280,GO:1904246,1,0.995369011896799,0,1,negative regulation of polynucleotide adenylyltransferase activity,BP,
20281,GO:1904247,1,0.993132043468753,0,1,positive regulation of polynucleotide adenylyltransferase activity,BP,
20282,GO:1904251,1,0.925280174925651,0,12,regulation of bile acid metabolic process,BP,
20283,GO:1904252,1,0.986669034635987,0,2,negative regulation of bile acid metabolic process,BP,
20284,GO:1904253,1,0.981583660929887,0,3,positive regulation of bile acid metabolic process,BP,
20285,GO:1904259,1,0.954196505358285,0,5,regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,
20286,GO:1904261,1,0.954196505358285,0,5,positive regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,
20287,GO:1904262,1,0.92756873616442,0,11,negative regulation of TORC1 signaling,BP,
20288,GO:1904263,1,0.909403043524508,0,15,positive regulation of TORC1 signaling,BP,
20289,GO:1904266,1,0.990014650515166,0,1,regulation of Schwann cell chemotaxis,BP,
20290,GO:1904268,1,0.990014650515166,0,1,positive regulation of Schwann cell chemotaxis,BP,
20291,GO:1904270,1,0.995814443572498,0,1,pyroptosome complex assembly,BP,
20292,GO:1904271,1,0.978588626525745,0,3,L-proline import across plasma membrane,BP,
20293,GO:1904273,1,0.979708162087377,0,3,L-alanine import across plasma membrane,BP,
20294,GO:1904274,1,0.994435553401407,0,1,tricellular tight junction assembly,BP,
20295,GO:1904282,1,0.994981019878227,0,1,regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
20296,GO:1904283,1,0.994981019878227,0,1,negative regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
20297,GO:1904288,1,0.969455981215646,0,4,BAT3 complex binding,MF,
20298,GO:1904289,1,0.985581087055298,0,2,regulation of mitotic DNA damage checkpoint,BP,
20299,GO:1904290,1,0.992308633676121,0,1,negative regulation of mitotic DNA damage checkpoint,BP,
20300,GO:1904292,1,0.819507264176352,0,30,regulation of ERAD pathway,BP,
20301,GO:1904293,1,0.916385898409213,0,14,negative regulation of ERAD pathway,BP,
20302,GO:1904294,1,0.902521966013993,0,15,positive regulation of ERAD pathway,BP,
20303,GO:1904298,1,0.976695784271739,0,2,regulation of transcytosis,BP,
20304,GO:1904300,1,0.976695784271739,0,2,positive regulation of transcytosis,BP,
20305,GO:1904301,1,0.992547418446041,0,1,regulation of maternal process involved in parturition,BP,
20306,GO:1904303,1,0.992547418446041,0,1,positive regulation of maternal process involved in parturition,BP,
20307,GO:1904304,1,0.971830671236093,0,5,regulation of gastro-intestinal system smooth muscle contraction,BP,
20308,GO:1904306,1,0.971830671236093,0,5,positive regulation of gastro-intestinal system smooth muscle contraction,BP,
20309,GO:1904313,1,0.99263231622234,0,1,response to methamphetamine hydrochloride,BP,
20311,GO:1904316,1,0.992547418446041,0,1,response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,
20312,GO:1904317,1,0.992547418446041,0,1,cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,
20315,GO:1904323,1,0.993311486956371,0,1,regulation of inhibitory G protein-coupled receptor phosphorylation,BP,
20316,GO:1904325,1,0.993311486956371,0,1,positive regulation of inhibitory G protein-coupled receptor phosphorylation,BP,
20317,GO:1904327,1,0.983999841765468,0,2,protein localization to cytosolic proteasome complex,BP,
20318,GO:1904328,1,0.993556234347918,0,1,regulation of myofibroblast contraction,BP,
20320,GO:1904339,1,0.985825396824543,0,2,negative regulation of dopaminergic neuron differentiation,BP,
20321,GO:1904340,1,0.980313396045266,0,4,positive regulation of dopaminergic neuron differentiation,BP,
20322,GO:1904341,1,0.991803495022634,0,1,regulation of colon smooth muscle contraction,BP,
20323,GO:1904343,1,0.991803495022634,0,1,positive regulation of colon smooth muscle contraction,BP,
20324,GO:1904344,1,0.990889009442754,0,2,regulation of gastric mucosal blood circulation,BP,
20325,GO:1904346,1,0.990889009442754,0,2,positive regulation of gastric mucosal blood circulation,BP,
20326,GO:1904347,1,0.988735064383307,0,2,regulation of small intestine smooth muscle contraction,BP,
20327,GO:1904349,1,0.988735064383307,0,2,positive regulation of small intestine smooth muscle contraction,BP,
20328,GO:1904350,1,0.910549735887424,0,11,regulation of protein catabolic process in the vacuole,BP,
20329,GO:1904351,1,0.972208985528883,0,4,negative regulation of protein catabolic process in the vacuole,BP,
20330,GO:1904352,1,0.949486106027479,0,5,positive regulation of protein catabolic process in the vacuole,BP,
20331,GO:1904353,1,0.828174221720633,0,26,regulation of telomere capping,BP,
20332,GO:1904354,1,0.934485920678124,0,8,negative regulation of telomere capping,BP,
20333,GO:1904355,1,0.893838794056997,0,17,positive regulation of telomere capping,BP,
20334,GO:1904356,1,0.666010268699729,0,58,regulation of telomere maintenance via telomere lengthening,BP,
20335,GO:1904357,1,0.83321735114181,0,24,negative regulation of telomere maintenance via telomere lengthening,BP,
20336,GO:1904358,1,0.78222347947581,0,37,positive regulation of telomere maintenance via telomere lengthening,BP,
20337,GO:1904370,1,0.992592874275698,0,1,regulation of protein localization to actin cortical patch,BP,
20338,GO:1904372,1,0.992592874275698,0,1,positive regulation of protein localization to actin cortical patch,BP,
20339,GO:1904373,1,0.988339178817606,0,2,response to kainic acid,BP,
20343,GO:1904378,1,0.977734110149639,0,3,maintenance of unfolded protein involved in ERAD pathway,BP,
20344,GO:1904379,1,0.983999841765468,0,2,protein localization to cytosolic proteasome complex involved in ERAD pathway,BP,
20345,GO:1904380,1,0.895774897771322,0,15,endoplasmic reticulum mannose trimming,BP,
20346,GO:1904381,1,0.977368566616354,0,3,Golgi apparatus mannose trimming,BP,
20347,GO:1904382,1,0.970344398838499,0,4,mannose trimming involved in glycoprotein ERAD pathway,BP,
20348,GO:1904383,1,0.987943911834804,0,2,response to sodium phosphate,BP,
20350,GO:1904386,1,0.964785854442069,0,5,response to L-phenylalanine derivative,BP,
20351,GO:1904387,1,0.985919454616231,0,2,cellular response to L-phenylalanine derivative,BP,
20352,GO:1904389,1,0.995714880083141,0,1,rod bipolar cell differentiation,BP,
20353,GO:1904391,1,0.995714880083141,0,1,response to ciliary neurotrophic factor,BP,
20354,GO:1904393,1,0.971257380431353,0,4,regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
20355,GO:1904394,1,0.994215636941164,0,1,negative regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
20356,GO:1904395,1,0.985102626405224,0,2,positive regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
20357,GO:1904396,1,0.927364555196002,0,10,regulation of neuromuscular junction development,BP,
20358,GO:1904397,1,0.989955056576663,0,2,negative regulation of neuromuscular junction development,BP,
20359,GO:1904398,1,0.967792957782315,0,4,positive regulation of neuromuscular junction development,BP,
20360,GO:1904399,1,0.982432057651668,0,3,heparan sulfate binding,MF,
20361,GO:1904400,1,0.993116283172753,0,1,response to Thyroid stimulating hormone,BP,
20362,GO:1904404,1,0.989888477010802,0,1,response to formaldehyde,BP,
20363,GO:1904406,1,0.910254561092147,0,14,negative regulation of nitric oxide metabolic process,BP,
20364,GO:1904407,1,0.783766561918347,0,37,positive regulation of nitric oxide metabolic process,BP,
20365,GO:1904408,1,0.996339723294794,0,1,melatonin binding,MF,
20366,GO:1904412,1,0.992783259455901,0,1,regulation of cardiac ventricle development,BP,
20367,GO:1904414,1,0.992783259455901,0,1,positive regulation of cardiac ventricle development,BP,
20368,GO:1904415,1,0.960940570479433,0,6,regulation of xenophagy,BP,
20369,GO:1904417,1,0.960940570479433,0,6,positive regulation of xenophagy,BP,
20370,GO:1904423,1,0.98512460860607,0,2,dehydrodolichyl diphosphate synthase complex,CC,
20371,GO:1904424,1,0.915394404798695,0,12,regulation of GTP binding,BP,
20372,GO:1904425,1,0.98659973609108,0,2,negative regulation of GTP binding,BP,
20373,GO:1904426,1,0.984270965049421,0,2,positive regulation of GTP binding,BP,
20375,GO:1904428,1,0.946964497833368,0,6,negative regulation of tubulin deacetylation,BP,
20376,GO:1904429,1,0.959094196670878,0,6,regulation of t-circle formation,BP,
20377,GO:1904430,1,0.978619068605913,0,3,negative regulation of t-circle formation,BP,
20378,GO:1904431,1,0.98005281442738,0,3,positive regulation of t-circle formation,BP,
20379,GO:1904432,1,0.99155391321383,0,2,regulation of ferrous iron binding,BP,
20380,GO:1904434,1,0.99155391321383,0,2,positive regulation of ferrous iron binding,BP,
20381,GO:1904435,1,0.99155391321383,0,2,regulation of transferrin receptor binding,BP,
20382,GO:1904437,1,0.99155391321383,0,2,positive regulation of transferrin receptor binding,BP,
20383,GO:1904438,1,0.996364580196844,0,1,regulation of iron ion import across plasma membrane,BP,
20384,GO:1904439,1,0.996364580196844,0,1,negative regulation of iron ion import across plasma membrane,BP,
20386,GO:1904448,1,0.982408334789349,0,2,regulation of aspartate secretion,BP,
20387,GO:1904450,1,0.982408334789349,0,2,positive regulation of aspartate secretion,BP,
20388,GO:1904456,1,0.995126405873321,0,1,negative regulation of neuronal action potential,BP,
20389,GO:1904457,1,0.994089891580228,0,1,positive regulation of neuronal action potential,BP,
20390,GO:1904464,1,0.964857465081513,0,5,regulation of matrix metallopeptidase secretion,BP,
20391,GO:1904465,1,0.989786575517654,0,2,negative regulation of matrix metallopeptidase secretion,BP,
20392,GO:1904466,1,0.984356803664029,0,2,positive regulation of matrix metallopeptidase secretion,BP,
20393,GO:1904470,1,0.996043308844349,0,1,regulation of endothelin production,BP,
20394,GO:1904472,1,0.996043308844349,0,1,positive regulation of endothelin production,BP,
20395,GO:1904475,1,0.974490871893523,0,3,regulation of Ras GTPase binding,BP,
20396,GO:1904477,1,0.990765690448049,0,1,positive regulation of Ras GTPase binding,BP,
20397,GO:1904478,1,0.966431967064861,0,6,regulation of intestinal absorption,BP,
20398,GO:1904479,1,0.990900806344933,0,2,negative regulation of intestinal absorption,BP,
20399,GO:1904480,1,0.994278633367177,0,1,positive regulation of intestinal absorption,BP,
20400,GO:1904481,1,0.988423017874078,0,2,response to tetrahydrofolate,BP,
20401,GO:1904482,1,0.988423017874078,0,2,cellular response to tetrahydrofolate,BP,
20402,GO:1904491,1,0.961636949913834,0,7,protein localization to ciliary transition zone,BP,
20403,GO:1904492,1,0.993743179023583,0,1,Ac-Asp-Glu binding,MF,
20404,GO:1904493,1,0.993743179023583,0,1,tetrahydrofolyl-poly(glutamate) polymer binding,MF,
20405,GO:1904499,1,0.992882079557312,0,1,regulation of chromatin-mediated maintenance of transcription,BP,
20406,GO:1904501,1,0.992882079557312,0,1,positive regulation of chromatin-mediated maintenance of transcription,BP,
20407,GO:1904502,1,0.958465178301445,0,5,regulation of lipophagy,BP,
20408,GO:1904504,1,0.958465178301445,0,5,positive regulation of lipophagy,BP,
20409,GO:1904505,1,0.970606632389868,0,4,regulation of telomere maintenance in response to DNA damage,BP,
20410,GO:1904506,1,0.970606632389868,0,4,negative regulation of telomere maintenance in response to DNA damage,BP,
20411,GO:1904508,1,0.995711516728321,0,1,regulation of protein localization to basolateral plasma membrane,BP,
20412,GO:1904510,1,0.995711516728321,0,1,positive regulation of protein localization to basolateral plasma membrane,BP,
20413,GO:1904515,1,0.984000848608704,0,2,positive regulation of TORC2 signaling,BP,
20414,GO:1904526,1,0.933717952237911,0,10,regulation of microtubule binding,BP,
20415,GO:1904527,1,0.982863741412818,0,2,negative regulation of microtubule binding,BP,
20416,GO:1904528,1,0.96411766518857,0,6,positive regulation of microtubule binding,BP,
20417,GO:1904529,1,0.984577275528082,0,2,regulation of actin filament binding,BP,
20418,GO:1904530,1,0.99311185413785,0,1,negative regulation of actin filament binding,BP,
20419,GO:1904531,1,0.991406817090502,0,1,positive regulation of actin filament binding,BP,
20420,GO:1904533,1,0.9790176906601,0,3,regulation of telomeric loop disassembly,BP,
20421,GO:1904534,1,0.986638367949322,0,2,negative regulation of telomeric loop disassembly,BP,
20422,GO:1904535,1,0.992277153357096,0,1,positive regulation of telomeric loop disassembly,BP,
20423,GO:1904538,1,0.991983241902544,0,1,regulation of glycolytic process through fructose-6-phosphate,BP,
20424,GO:1904539,1,0.991983241902544,0,1,negative regulation of glycolytic process through fructose-6-phosphate,BP,
20425,GO:1904542,1,0.993644863627652,0,1,regulation of free ubiquitin chain polymerization,BP,
20426,GO:1904544,1,0.993644863627652,0,1,positive regulation of free ubiquitin chain polymerization,BP,
20427,GO:1904550,1,0.994740910085464,0,1,response to arachidonic acid,BP,
20428,GO:1904555,1,0.978588626525745,0,3,L-proline transmembrane transport,BP,
20429,GO:1904556,1,0.98631622495794,0,2,L-tryptophan transmembrane transport,BP,
20430,GO:1904557,1,0.974686229171267,0,4,L-alanine transmembrane transport,BP,
20431,GO:1904562,1,0.97978134356041,0,2,phosphatidylinositol 5-phosphate metabolic process,BP,
20432,GO:1904565,1,0.993088491743011,0,1,response to 1-oleoyl-sn-glycerol 3-phosphate,BP,
20433,GO:1904566,1,0.993088491743011,0,1,cellular response to 1-oleoyl-sn-glycerol 3-phosphate,BP,
20434,GO:1904567,1,0.993196258754412,0,1,response to wortmannin,BP,
20435,GO:1904568,1,0.993196258754412,0,1,cellular response to wortmannin,BP,
20436,GO:1904569,1,0.992544166657121,0,2,regulation of selenocysteine incorporation,BP,
20437,GO:1904570,1,0.995372677108658,0,1,negative regulation of selenocysteine incorporation,BP,
20438,GO:1904571,1,0.997158472596596,0,1,positive regulation of selenocysteine incorporation,BP,
20439,GO:1904572,1,0.995372677108658,0,1,negative regulation of mRNA binding,BP,
20440,GO:1904573,1,0.995372677108658,0,1,regulation of selenocysteine insertion sequence binding,BP,
20441,GO:1904574,1,0.995372677108658,0,1,negative regulation of selenocysteine insertion sequence binding,BP,
20442,GO:1904576,1,0.988940574886509,0,2,response to tunicamycin,BP,
20443,GO:1904577,1,0.988940574886509,0,2,cellular response to tunicamycin,BP,
20444,GO:1904578,1,0.982651870779408,0,3,response to thapsigargin,BP,
20445,GO:1904579,1,0.982651870779408,0,3,cellular response to thapsigargin,BP,
20446,GO:1904580,1,0.981458678590465,0,3,regulation of intracellular mRNA localization,BP,
20447,GO:1904582,1,0.981458678590465,0,3,positive regulation of intracellular mRNA localization,BP,
20448,GO:1904585,1,0.99456314181792,0,1,response to putrescine,BP,
20449,GO:1904586,1,0.99456314181792,0,1,cellular response to putrescine,BP,
20450,GO:1904587,1,0.959987041991631,0,6,response to glycoprotein,BP,
20451,GO:1904588,1,0.996187029935837,0,1,cellular response to glycoprotein,BP,
20452,GO:1904589,1,0.6605966139236,0,59,regulation of protein import,BP,
20453,GO:1904590,1,0.915966870032878,0,13,negative regulation of protein import,BP,
20454,GO:1904591,1,0.743619784404581,0,41,positive regulation of protein import,BP,
20455,GO:1904594,1,0.974083704580955,0,3,regulation of termination of RNA polymerase II transcription,BP,
20456,GO:1904595,1,0.986902461873921,0,1,positive regulation of termination of RNA polymerase II transcription,BP,
20457,GO:1904596,1,0.996043308844349,0,1,regulation of connective tissue replacement involved in inflammatory response wound healing,BP,
20458,GO:1904597,1,0.996043308844349,0,1,negative regulation of connective tissue replacement involved in inflammatory response wound healing,BP,
20459,GO:1904602,1,0.989654452355412,0,2,serotonin-activated cation-selective channel complex,CC,
20460,GO:1904606,1,0.988027152283719,0,2,fat cell apoptotic process,BP,
20461,GO:1904612,1,0.969529869305917,0,4,response to 2,3,7,8-tetrachlorodibenzodioxine,BP,
20462,GO:1904613,1,0.983439878066036,0,2,cellular response to 2,3,7,8-tetrachlorodibenzodioxine,BP,
20463,GO:1904616,1,0.984577275528082,0,2,regulation of actin binding,BP,
20464,GO:1904617,1,0.99311185413785,0,1,negative regulation of actin binding,BP,
20465,GO:1904618,1,0.991406817090502,0,1,positive regulation of actin binding,BP,
20466,GO:1904627,1,0.976143999095686,0,4,response to phorbol 13-acetate 12-myristate,BP,
20467,GO:1904628,1,0.976143999095686,0,4,cellular response to phorbol 13-acetate 12-myristate,BP,
20468,GO:1904631,1,0.994401418663315,0,1,response to glucoside,BP,
20469,GO:1904633,1,0.982792222088233,0,2,regulation of glomerular visceral epithelial cell apoptotic process,BP,
20470,GO:1904635,1,0.982792222088233,0,2,positive regulation of glomerular visceral epithelial cell apoptotic process,BP,
20471,GO:1904636,1,0.972225008078076,0,4,response to ionomycin,BP,
20472,GO:1904637,1,0.972225008078076,0,4,cellular response to ionomycin,BP,
20473,GO:1904638,1,0.983973337616242,0,2,response to resveratrol,BP,
20474,GO:1904639,1,0.990795642075213,0,1,cellular response to resveratrol,BP,
20475,GO:1904640,1,0.981206243516795,0,3,response to methionine,BP,
20476,GO:1904643,1,0.990747204703597,0,1,response to curcumin,BP,
20478,GO:1904646,1,0.749319595939074,0,38,cellular response to amyloid-beta,BP,
20479,GO:1904647,1,0.98840023800434,0,1,response to rotenone,BP,
20480,GO:1904649,1,0.988027152283719,0,2,regulation of fat cell apoptotic process,BP,
20481,GO:1904651,1,0.992882637749378,0,1,positive regulation of fat cell apoptotic process,BP,
20482,GO:1904659,1,0.520600583770542,0,92,glucose transmembrane transport,BP,
20484,GO:1904667,1,0.962561532510305,0,9,negative regulation of ubiquitin protein ligase activity,BP,
20486,GO:1904672,1,0.946421717396256,0,8,regulation of somatic stem cell population maintenance,BP,
20487,GO:1904673,1,0.978001734578819,0,3,negative regulation of somatic stem cell population maintenance,BP,
20488,GO:1904674,1,0.985561143469993,0,2,positive regulation of somatic stem cell population maintenance,BP,
20489,GO:1904675,1,0.99327483731023,0,1,regulation of somatic stem cell division,BP,
20490,GO:1904677,1,0.99327483731023,0,1,positive regulation of somatic stem cell division,BP,
20491,GO:1904679,1,0.986491424219674,0,1,myo-inositol import across plasma membrane,BP,
20492,GO:1904680,1,0.838720613318514,0,27,peptide transmembrane transporter activity,MF,
20493,GO:1904681,1,0.993594586753154,0,1,response to 3-methylcholanthrene,BP,
20494,GO:1904683,1,0.950932301569236,0,6,regulation of metalloendopeptidase activity,BP,
20495,GO:1904684,1,0.96406206986649,0,4,negative regulation of metalloendopeptidase activity,BP,
20496,GO:1904685,1,0.98638572985286,0,2,positive regulation of metalloendopeptidase activity,BP,
20497,GO:1904688,1,0.968847979693575,0,5,regulation of cytoplasmic translational initiation,BP,
20498,GO:1904689,1,0.9963596218915,0,1,negative regulation of cytoplasmic translational initiation,BP,
20499,GO:1904690,1,0.972388834490347,0,4,positive regulation of cytoplasmic translational initiation,BP,
20500,GO:1904691,1,0.99132878755876,0,2,negative regulation of type B pancreatic cell proliferation,BP,
20502,GO:1904693,1,0.974659670569609,0,3,midbrain morphogenesis,BP,
20503,GO:1904694,1,0.972457002123211,0,3,negative regulation of vascular associated smooth muscle contraction,BP,
20505,GO:1904697,1,0.996783487168374,0,1,regulation of acinar cell proliferation,BP,
20506,GO:1904699,1,0.996783487168374,0,1,positive regulation of acinar cell proliferation,BP,
20507,GO:1904700,1,0.990174154571919,0,2,granulosa cell apoptotic process,BP,
20508,GO:1904701,1,0.995255708783232,0,1,Wnt-Frizzled-LRP5/6 complex assembly,BP,
20509,GO:1904702,1,0.991618385621772,0,1,regulation of protein localization to adherens junction,BP,
20510,GO:1904705,1,0.710727762299426,0,50,regulation of vascular associated smooth muscle cell proliferation,BP,
20511,GO:1904706,1,0.901491812666436,0,17,negative regulation of vascular associated smooth muscle cell proliferation,BP,
20512,GO:1904707,1,0.785084342227925,0,34,positive regulation of vascular associated smooth muscle cell proliferation,BP,
20513,GO:1904708,1,0.990174154571919,0,2,regulation of granulosa cell apoptotic process,BP,
20514,GO:1904710,1,0.996405415233167,0,1,positive regulation of granulosa cell apoptotic process,BP,
20515,GO:1904711,1,0.995255708783232,0,1,regulation of Wnt-Frizzled-LRP5/6 complex assembly,BP,
20516,GO:1904713,1,0.981864627231076,0,2,beta-catenin destruction complex binding,MF,
20518,GO:1904715,1,0.982559199867268,0,3,negative regulation of chaperone-mediated autophagy,BP,
20519,GO:1904716,1,0.994158947353131,0,1,positive regulation of chaperone-mediated autophagy,BP,
20520,GO:1904717,1,0.956329895096221,0,5,regulation of AMPA glutamate receptor clustering,BP,
20521,GO:1904719,1,0.986665317813161,0,2,positive regulation of AMPA glutamate receptor clustering,BP,
20522,GO:1904723,1,0.995255708783232,0,1,negative regulation of Wnt-Frizzled-LRP5/6 complex assembly,BP,
20523,GO:1904724,1,0.771186981630176,0,52,tertiary granule lumen,CC,
20524,GO:1904729,1,0.977648263166429,0,4,regulation of intestinal lipid absorption,BP,
20525,GO:1904730,1,0.993629231528571,0,1,negative regulation of intestinal lipid absorption,BP,
20526,GO:1904731,1,0.994278633367177,0,1,positive regulation of intestinal lipid absorption,BP,
20527,GO:1904732,1,0.971477695626769,0,5,regulation of electron transfer activity,BP,
20528,GO:1904734,1,0.997255416501482,0,1,positive regulation of electron transfer activity,BP,
20529,GO:1904738,1,0.832840518678092,0,21,vascular associated smooth muscle cell migration,BP,
20530,GO:1904742,1,0.969965293426408,0,4,regulation of telomeric DNA binding,BP,
20531,GO:1904743,1,0.978541363007231,0,2,negative regulation of telomeric DNA binding,BP,
20532,GO:1904744,1,0.991237757151271,0,2,positive regulation of telomeric DNA binding,BP,
20533,GO:1904746,1,0.966649076883925,0,5,negative regulation of apoptotic process involved in development,BP,
20534,GO:1904747,1,0.964921738236613,0,5,positive regulation of apoptotic process involved in development,BP,
20535,GO:1904748,1,0.925068292177742,0,11,regulation of apoptotic process involved in development,BP,
20536,GO:1904749,1,0.95002129812044,0,8,regulation of protein localization to nucleolus,BP,
20537,GO:1904750,1,0.990498239420871,0,1,negative regulation of protein localization to nucleolus,BP,
20538,GO:1904751,1,0.977950148553216,0,4,positive regulation of protein localization to nucleolus,BP,
20539,GO:1904752,1,0.832840518678092,0,21,regulation of vascular associated smooth muscle cell migration,BP,
20540,GO:1904753,1,0.963229329729848,0,5,negative regulation of vascular associated smooth muscle cell migration,BP,
20541,GO:1904754,1,0.864680756977277,0,16,positive regulation of vascular associated smooth muscle cell migration,BP,
20542,GO:1904760,1,0.969290398942716,0,4,regulation of myofibroblast differentiation,BP,
20543,GO:1904761,1,0.976501934718339,0,3,negative regulation of myofibroblast differentiation,BP,
20544,GO:1904762,1,0.992616677084315,0,1,positive regulation of myofibroblast differentiation,BP,
20545,GO:1904764,1,0.994808077162758,0,1,chaperone-mediated autophagy translocation complex disassembly,BP,
20546,GO:1904766,1,0.990286738380387,0,1,negative regulation of macroautophagy by TORC1 signaling,BP,
20547,GO:1904768,1,0.988896890803594,0,2,all-trans-retinol binding,MF,
20548,GO:1904772,1,0.993690179389558,0,1,response to tetrachloromethane,BP,
20549,GO:1904776,1,0.936203907719686,0,9,regulation of protein localization to cell cortex,BP,
20550,GO:1904777,1,0.993485400251684,0,1,negative regulation of protein localization to cell cortex,BP,
20551,GO:1904778,1,0.953746989469069,0,6,positive regulation of protein localization to cell cortex,BP,
20552,GO:1904779,1,0.921835128039982,0,10,regulation of protein localization to centrosome,BP,
20553,GO:1904780,1,0.984773331442604,0,2,negative regulation of protein localization to centrosome,BP,
20554,GO:1904781,1,0.941693057345969,0,7,positive regulation of protein localization to centrosome,BP,
20555,GO:1904782,1,0.985123842342584,0,2,negative regulation of NMDA glutamate receptor activity,BP,
20556,GO:1904783,1,0.970693398966431,0,5,positive regulation of NMDA glutamate receptor activity,BP,
20557,GO:1904784,1,0.991536973163998,0,1,NLRP1 inflammasome complex assembly,BP,
20558,GO:1904790,1,0.993276518185936,0,1,regulation of shelterin complex assembly,BP,
20559,GO:1904792,1,0.993276518185936,0,1,positive regulation of shelterin complex assembly,BP,
20560,GO:1904793,1,0.992882079557312,0,1,regulation of euchromatin binding,BP,
20561,GO:1904796,1,0.95284844678699,0,7,regulation of core promoter binding,BP,
20562,GO:1904797,1,0.98705281375237,0,2,negative regulation of core promoter binding,BP,
20563,GO:1904798,1,0.965351409971199,0,5,positive regulation of core promoter binding,BP,
20564,GO:1904799,1,0.992637295665196,0,1,regulation of neuron remodeling,BP,
20565,GO:1904800,1,0.992637295665196,0,1,negative regulation of neuron remodeling,BP,
20566,GO:1904803,1,0.997067070635775,0,1,regulation of translation involved in cellular response to UV,BP,
20567,GO:1904806,1,0.98701281886265,0,2,regulation of protein oxidation,BP,
20568,GO:1904808,1,0.98701281886265,0,2,positive regulation of protein oxidation,BP,
20569,GO:1904809,1,0.984511871467944,0,2,regulation of dense core granule transport,BP,
20570,GO:1904811,1,0.984511871467944,0,2,positive regulation of dense core granule transport,BP,
20571,GO:1904812,1,0.992637971907924,0,1,rRNA acetylation involved in maturation of SSU-rRNA,BP,
20572,GO:1904813,1,0.491259363410381,0,123,ficolin-1-rich granule lumen,CC,
20573,GO:1904814,1,0.924810753976862,0,13,regulation of protein localization to chromosome, telomeric region,BP,
20574,GO:1904815,1,0.993276518185936,0,1,negative regulation of protein localization to chromosome, telomeric region,BP,
20575,GO:1904816,1,0.931075279844515,0,12,positive regulation of protein localization to chromosome, telomeric region,BP,
20576,GO:1904823,1,0.982512339031232,0,3,purine nucleobase transmembrane transport,BP,
20577,GO:1904825,1,0.975962193701565,0,4,protein localization to microtubule plus-end,BP,
20578,GO:1904826,1,0.989670383650049,0,1,regulation of hydrogen sulfide biosynthetic process,BP,
20579,GO:1904828,1,0.989670383650049,0,1,positive regulation of hydrogen sulfide biosynthetic process,BP,
20580,GO:1904829,1,0.995364425768994,0,1,regulation of aortic smooth muscle cell differentiation,BP,
20581,GO:1904831,1,0.995364425768994,0,1,positive regulation of aortic smooth muscle cell differentiation,BP,
20582,GO:1904833,1,0.980688512140587,0,4,positive regulation of removal of superoxide radicals,BP,
20583,GO:1904835,1,0.985628222084199,0,2,dorsal root ganglion morphogenesis,BP,
20584,GO:1904837,1,0.797344080829373,0,30,beta-catenin-TCF complex assembly,BP,
20585,GO:1904841,1,0.990243667264613,0,2,TORC2 complex binding,MF,
20586,GO:1904842,1,0.99003099501432,0,2,response to nitroglycerin,BP,
20587,GO:1904843,1,0.994561171467547,0,1,cellular response to nitroglycerin,BP,
20588,GO:1904844,1,0.984020953448046,0,3,response to L-glutamine,BP,
20589,GO:1904845,1,0.984020953448046,0,3,cellular response to L-glutamine,BP,
20590,GO:1904847,1,0.966952678176986,0,5,regulation of cell chemotaxis to fibroblast growth factor,BP,
20591,GO:1904848,1,0.996253231912534,0,1,negative regulation of cell chemotaxis to fibroblast growth factor,BP,
20592,GO:1904849,1,0.97773110681106,0,3,positive regulation of cell chemotaxis to fibroblast growth factor,BP,
20593,GO:1904850,1,0.993276518185936,0,1,negative regulation of establishment of protein localization to telomere,BP,
20594,GO:1904851,1,0.945095192199873,0,10,positive regulation of establishment of protein localization to telomere,BP,
20595,GO:1904854,1,0.993037838150083,0,1,proteasome core complex binding,MF,
20596,GO:1904855,1,0.996119637507407,0,1,proteasome regulatory particle binding,MF,
20597,GO:1904861,1,0.812783429421936,0,26,excitatory synapse assembly,BP,
20599,GO:1904863,1,0.992704659145791,0,1,regulation of beta-catenin-TCF complex assembly,BP,
20600,GO:1904864,1,0.992704659145791,0,1,negative regulation of beta-catenin-TCF complex assembly,BP,
20601,GO:1904867,1,0.933728032690416,0,12,protein localization to Cajal body,BP,
20602,GO:1904868,1,0.976097304033916,0,2,telomerase catalytic core complex assembly,BP,
20603,GO:1904869,1,0.938279432406155,0,11,regulation of protein localization to Cajal body,BP,
20604,GO:1904871,1,0.938279432406155,0,11,positive regulation of protein localization to Cajal body,BP,
20605,GO:1904872,1,0.902194528910385,0,18,regulation of telomerase RNA localization to Cajal body,BP,
20606,GO:1904874,1,0.924992533737856,0,15,positive regulation of telomerase RNA localization to Cajal body,BP,
20607,GO:1904875,1,0.98800391639485,0,2,regulation of DNA ligase activity,BP,
20608,GO:1904876,1,0.993318546113577,0,1,negative regulation of DNA ligase activity,BP,
20609,GO:1904877,1,0.994649979908754,0,1,positive regulation of DNA ligase activity,BP,
20610,GO:1904878,1,0.981670227859019,0,2,negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
20611,GO:1904879,1,0.986769841753916,0,2,positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
20612,GO:1904880,1,0.978743610794256,0,3,response to hydrogen sulfide,BP,
20613,GO:1904881,1,0.98471458436643,0,2,cellular response to hydrogen sulfide,BP,
20614,GO:1904882,1,0.976097304033916,0,2,regulation of telomerase catalytic core complex assembly,BP,
20615,GO:1904884,1,0.976097304033916,0,2,positive regulation of telomerase catalytic core complex assembly,BP,
20616,GO:1904885,1,0.957371046582612,0,5,beta-catenin destruction complex assembly,BP,
20617,GO:1904886,1,0.878497529900842,0,17,beta-catenin destruction complex disassembly,BP,
20618,GO:1904887,1,0.988303784808711,0,1,Wnt signalosome assembly,BP,
20619,GO:1904888,1,0.629551357461766,0,63,cranial skeletal system development,BP,
20620,GO:1904889,1,0.895128124812998,0,15,regulation of excitatory synapse assembly,BP,
20621,GO:1904891,1,0.982013953831745,0,3,positive regulation of excitatory synapse assembly,BP,
20622,GO:1904892,1,0.546789535048777,0,94,regulation of receptor signaling pathway via STAT,BP,
20623,GO:1904893,1,0.869969291517847,0,20,negative regulation of receptor signaling pathway via STAT,BP,
20624,GO:1904894,1,0.66363864079699,0,66,positive regulation of receptor signaling pathway via STAT,BP,
20625,GO:1904895,1,0.995506018227838,0,1,ESCRT complex assembly,BP,
20626,GO:1904896,1,0.941827244492989,0,10,ESCRT complex disassembly,BP,
20627,GO:1904897,1,0.99294514711195,0,1,regulation of hepatic stellate cell proliferation,BP,
20628,GO:1904899,1,0.99294514711195,0,1,positive regulation of hepatic stellate cell proliferation,BP,
20629,GO:1904902,1,0.995506018227838,0,1,ESCRT III complex assembly,BP,
20630,GO:1904903,1,0.941827244492989,0,10,ESCRT III complex disassembly,BP,
20631,GO:1904904,1,0.975450186813801,0,4,regulation of endothelial cell-matrix adhesion via fibronectin,BP,
20632,GO:1904906,1,0.975450186813801,0,4,positive regulation of endothelial cell-matrix adhesion via fibronectin,BP,
20633,GO:1904907,1,0.974987423844138,0,2,regulation of maintenance of mitotic sister chromatid cohesion, telomeric,BP,
20634,GO:1904908,1,0.974987423844138,0,2,negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric,BP,
20635,GO:1904910,1,0.993276518185936,0,1,regulation of establishment of RNA localization to telomere,BP,
20636,GO:1904911,1,0.993276518185936,0,1,negative regulation of establishment of RNA localization to telomere,BP,
20637,GO:1904913,1,0.993276518185936,0,1,regulation of establishment of protein-containing complex localization to telomere,BP,
20638,GO:1904914,1,0.993276518185936,0,1,negative regulation of establishment of protein-containing complex localization to telomere,BP,
20639,GO:1904923,1,0.901988234358585,0,13,regulation of autophagy of mitochondrion in response to mitochondrial depolarization,BP,
20640,GO:1904924,1,0.99408526275215,0,1,negative regulation of mitophagy in response to mitochondrial depolarization,BP,
20641,GO:1904925,1,0.907360234660596,0,12,positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization,BP,
20642,GO:1904928,1,0.972108526840605,0,3,coreceptor activity involved in canonical Wnt signaling pathway,MF,
20643,GO:1904929,1,0.955489344230471,0,6,coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway,MF,
20644,GO:1904933,1,0.991228585807255,0,1,regulation of cell proliferation in midbrain,BP,
20645,GO:1904934,1,0.991228585807255,0,1,negative regulation of cell proliferation in midbrain,BP,
20646,GO:1904936,1,0.957961629700173,0,6,interneuron migration,BP,
20647,GO:1904938,1,0.955770517367718,0,5,planar cell polarity pathway involved in axon guidance,BP,
20648,GO:1904947,1,0.993181331459016,0,1,folate import into mitochondrion,BP,
20650,GO:1904949,1,0.582678252976401,0,76,ATPase complex,CC,
20653,GO:1904953,1,0.932905315248433,0,10,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
20654,GO:1904954,1,0.982132268943548,0,3,canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
20655,GO:1904955,1,0.991228585807255,0,1,planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation,BP,
20657,GO:1904958,1,0.983740794667008,0,3,positive regulation of midbrain dopaminergic neuron differentiation,BP,
20658,GO:1904959,1,0.971477695626769,0,5,regulation of cytochrome-c oxidase activity,BP,
20659,GO:1904960,1,0.997255416501482,0,1,positive regulation of cytochrome-c oxidase activity,BP,
20661,GO:1904971,1,0.992243560850596,0,1,regulation of viral translation,BP,
20662,GO:1904973,1,0.992243560850596,0,1,positive regulation of viral translation,BP,
20663,GO:1904975,1,0.984524812753115,0,2,response to bleomycin,BP,
20664,GO:1904976,1,0.984524812753115,0,2,cellular response to bleomycin,BP,
20665,GO:1904977,1,0.988744481096042,0,2,lymphatic endothelial cell migration,BP,
20666,GO:1904978,1,0.976864121303293,0,3,regulation of endosome organization,BP,
20667,GO:1904979,1,0.99441603432747,0,1,negative regulation of endosome organization,BP,
20668,GO:1904980,1,0.990124930555408,0,1,positive regulation of endosome organization,BP,
20669,GO:1904983,1,0.994626274282703,0,1,glycine import into mitochondrion,BP,
20670,GO:1904984,1,0.996176625938231,0,1,regulation of quinolinate biosynthetic process,BP,
20671,GO:1904985,1,0.996176625938231,0,1,negative regulation of quinolinate biosynthetic process,BP,
20672,GO:1904990,1,0.99402463689544,0,1,regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
20673,GO:1904992,1,0.99402463689544,0,1,positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
20674,GO:1904994,1,0.842513403597307,0,26,regulation of leukocyte adhesion to vascular endothelial cell,BP,
20675,GO:1904995,1,0.978634921708885,0,5,negative regulation of leukocyte adhesion to vascular endothelial cell,BP,
20676,GO:1904996,1,0.873550631237115,0,20,positive regulation of leukocyte adhesion to vascular endothelial cell,BP,
20677,GO:1904997,1,0.982698498390552,0,3,regulation of leukocyte adhesion to arterial endothelial cell,BP,
20678,GO:1904998,1,0.993280454265375,0,1,negative regulation of leukocyte adhesion to arterial endothelial cell,BP,
20679,GO:1904999,1,0.989347172033809,0,2,positive regulation of leukocyte adhesion to arterial endothelial cell,BP,
20680,GO:1905000,1,0.988901013355668,0,1,regulation of membrane repolarization during atrial cardiac muscle cell action potential,BP,
20681,GO:1905003,1,0.996176625938231,0,1,picolinic acid metabolic process,BP,
20682,GO:1905004,1,0.996176625938231,0,1,picolinic acid biosynthetic process,BP,
20683,GO:1905005,1,0.956972066822571,0,6,regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
20684,GO:1905006,1,0.986925576671656,0,2,negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
20685,GO:1905007,1,0.961692284047643,0,5,positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
20686,GO:1905008,1,0.993779815907898,0,1,regulation of L-lysine import across plasma membrane,BP,
20687,GO:1905010,1,0.993779815907898,0,1,positive regulation of L-lysine import across plasma membrane,BP,
20688,GO:1905012,1,0.996176625938231,0,1,regulation of 'de novo' NAD biosynthetic process from tryptophan,BP,
20689,GO:1905024,1,0.970392689191225,0,4,regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
20690,GO:1905025,1,0.993142159138566,0,1,negative regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
20691,GO:1905026,1,0.9850361970435,0,2,positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
20692,GO:1905030,1,0.981133430663437,0,2,voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential,MF,
20693,GO:1905031,1,0.959619099786811,0,5,regulation of membrane repolarization during cardiac muscle cell action potential,BP,
20694,GO:1905032,1,0.993142159138566,0,1,negative regulation of membrane repolarization during cardiac muscle cell action potential,BP,
20695,GO:1905033,1,0.9850361970435,0,2,positive regulation of membrane repolarization during cardiac muscle cell action potential,BP,
20696,GO:1905034,1,0.988400549592661,0,2,regulation of antifungal innate immune response,BP,
20697,GO:1905035,1,0.993283843736227,0,1,negative regulation of antifungal innate immune response,BP,
20698,GO:1905036,1,0.995084017918469,0,1,positive regulation of antifungal innate immune response,BP,
20699,GO:1905037,1,0.535860909584087,0,91,autophagosome organization,BP,
20700,GO:1905038,1,0.904919034380718,0,16,regulation of membrane lipid metabolic process,BP,
20702,GO:1905040,1,0.993942611467265,0,1,otic placode development,BP,
20703,GO:1905041,1,0.994398498066526,0,1,regulation of epithelium regeneration,BP,
20704,GO:1905042,1,0.994398498066526,0,1,negative regulation of epithelium regeneration,BP,
20705,GO:1905044,1,0.993485400251684,0,1,regulation of Schwann cell proliferation involved in axon regeneration,BP,
20706,GO:1905045,1,0.993485400251684,0,1,negative regulation of Schwann cell proliferation involved in axon regeneration,BP,
20707,GO:1905048,1,0.897764052275883,0,15,regulation of metallopeptidase activity,BP,
20708,GO:1905049,1,0.93863990241576,0,7,negative regulation of metallopeptidase activity,BP,
20709,GO:1905050,1,0.956478997983461,0,8,positive regulation of metallopeptidase activity,BP,
20710,GO:1905051,1,0.992078849857966,0,2,regulation of base-excision repair,BP,
20711,GO:1905053,1,0.992078849857966,0,2,positive regulation of base-excision repair,BP,
20712,GO:1905056,1,0.969850154765549,0,3,calcium-transporting ATPase activity involved in regulation of presynaptic cytosolic calcium ion concentration,MF,
20713,GO:1905059,1,0.988596160335335,0,1,calcium-transporting ATPase activity involved in regulation of postsynaptic cytosolic calcium ion concentration,MF,
20714,GO:1905060,1,0.974864917225237,0,3,calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration,MF,
20715,GO:1905062,1,0.993574159509486,0,1,positive regulation of cardioblast proliferation,BP,
20716,GO:1905063,1,0.906677257732281,0,14,regulation of vascular associated smooth muscle cell differentiation,BP,
20717,GO:1905064,1,0.943270979102965,0,8,negative regulation of vascular associated smooth muscle cell differentiation,BP,
20718,GO:1905065,1,0.961227705853532,0,6,positive regulation of vascular associated smooth muscle cell differentiation,BP,
20719,GO:1905066,1,0.989458018464504,0,2,regulation of canonical Wnt signaling pathway involved in heart development,BP,
20720,GO:1905067,1,0.995255708783232,0,1,negative regulation of canonical Wnt signaling pathway involved in heart development,BP,
20721,GO:1905068,1,0.994174949282388,0,1,positive regulation of canonical Wnt signaling pathway involved in heart development,BP,
20722,GO:1905069,1,0.98718154902229,0,2,allantois development,BP,
20723,GO:1905071,1,0.983869384215396,0,2,tight junction disassembly,BP,
20724,GO:1905073,1,0.983869384215396,0,2,regulation of tight junction disassembly,BP,
20725,GO:1905075,1,0.983869384215396,0,2,positive regulation of tight junction disassembly,BP,
20726,GO:1905089,1,0.985955562068834,0,1,regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
20727,GO:1905090,1,0.985955562068834,0,1,negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
20728,GO:1905097,1,0.948400127476518,0,7,regulation of guanyl-nucleotide exchange factor activity,BP,
20729,GO:1905098,1,0.973233100102279,0,4,negative regulation of guanyl-nucleotide exchange factor activity,BP,
20730,GO:1905099,1,0.990765690448049,0,1,positive regulation of guanyl-nucleotide exchange factor activity,BP,
20731,GO:1905103,1,0.978694577149509,0,3,integral component of lysosomal membrane,CC,
20733,GO:1905115,1,0.996197405127411,0,1,regulation of lateral attachment of mitotic spindle microtubules to kinetochore,BP,
20734,GO:1905116,1,0.996197405127411,0,1,positive regulation of lateral attachment of mitotic spindle microtubules to kinetochore,BP,
20735,GO:1905123,1,0.984821493787718,0,2,regulation of glucosylceramidase activity,BP,
20736,GO:1905132,1,0.988288360444546,0,2,regulation of meiotic chromosome separation,BP,
20737,GO:1905133,1,0.993174963603365,0,1,negative regulation of meiotic chromosome separation,BP,
20738,GO:1905134,1,0.995080152823623,0,1,positive regulation of meiotic chromosome separation,BP,
20739,GO:1905135,1,0.985821327972476,0,2,biotin import across plasma membrane,BP,
20740,GO:1905143,1,0.995699722002113,0,1,eukaryotic translation initiation factor 2 complex assembly,BP,
20743,GO:1905146,1,0.883769359891547,0,15,lysosomal protein catabolic process,BP,
20744,GO:1905150,1,0.954988399691044,0,7,regulation of voltage-gated sodium channel activity,BP,
20745,GO:1905152,1,0.991165240775082,0,1,positive regulation of voltage-gated sodium channel activity,BP,
20746,GO:1905153,1,0.896164156310436,0,16,regulation of membrane invagination,BP,
20747,GO:1905154,1,0.986880750005904,0,2,negative regulation of membrane invagination,BP,
20748,GO:1905155,1,0.91393651882309,0,13,positive regulation of membrane invagination,BP,
20749,GO:1905161,1,0.991748911561887,0,1,protein localization to phagocytic vesicle,BP,
20750,GO:1905162,1,0.981999037857858,0,3,regulation of phagosome maturation,BP,
20751,GO:1905164,1,0.995084017918469,0,1,positive regulation of phagosome maturation,BP,
20752,GO:1905165,1,0.920390253551911,0,9,regulation of lysosomal protein catabolic process,BP,
20753,GO:1905166,1,0.972208985528883,0,4,negative regulation of lysosomal protein catabolic process,BP,
20754,GO:1905167,1,0.959743097219579,0,3,positive regulation of lysosomal protein catabolic process,BP,
20755,GO:1905168,1,0.92691197173085,0,10,positive regulation of double-strand break repair via homologous recombination,BP,
20756,GO:1905169,1,0.991748911561887,0,1,regulation of protein localization to phagocytic vesicle,BP,
20757,GO:1905171,1,0.991748911561887,0,1,positive regulation of protein localization to phagocytic vesicle,BP,
20758,GO:1905172,1,0.976877212644319,0,3,RISC complex binding,MF,
20759,GO:1905174,1,0.988519496290071,0,2,regulation of vascular associated smooth muscle cell dedifferentiation,BP,
20760,GO:1905176,1,0.993341905811881,0,1,positive regulation of vascular associated smooth muscle cell dedifferentiation,BP,
20761,GO:1905178,1,0.988585008997272,0,2,regulation of cardiac muscle tissue regeneration,BP,
20762,GO:1905179,1,0.988585008997272,0,2,negative regulation of cardiac muscle tissue regeneration,BP,
20763,GO:1905184,1,0.993178384945694,0,1,positive regulation of protein serine/threonine phosphatase activity,BP,
20764,GO:1905186,1,0.995080152823623,0,1,regulation of metaphase/anaphase transition of meiosis I,BP,
20765,GO:1905188,1,0.995080152823623,0,1,positive regulation of metaphase/anaphase transition of meiosis I,BP,
20766,GO:1905198,1,0.985979282119088,0,2,manchette assembly,BP,
20767,GO:1905199,1,0.993944393327592,0,1,manchette disassembly,BP,
20768,GO:1905202,1,0.986634701249976,0,2,methylcrotonoyl-CoA carboxylase complex,CC,
20769,GO:1905203,1,0.969795255768019,0,4,regulation of connective tissue replacement,BP,
20770,GO:1905204,1,0.996043308844349,0,1,negative regulation of connective tissue replacement,BP,
20771,GO:1905205,1,0.973648711143827,0,3,positive regulation of connective tissue replacement,BP,
20772,GO:1905206,1,0.966899466767599,0,5,positive regulation of hydrogen peroxide-induced cell death,BP,
20775,GO:1905209,1,0.82753000843149,0,27,positive regulation of cardiocyte differentiation,BP,
20776,GO:1905214,1,0.926415478626439,0,12,regulation of RNA binding,BP,
20777,GO:1905215,1,0.995372677108658,0,1,negative regulation of RNA binding,BP,
20778,GO:1905216,1,0.945893581290424,0,9,positive regulation of RNA binding,BP,
20779,GO:1905217,1,0.993116283172753,0,1,response to astaxanthin,BP,
20780,GO:1905219,1,0.977913039580076,0,2,regulation of platelet formation,BP,
20781,GO:1905221,1,0.977913039580076,0,2,positive regulation of platelet formation,BP,
20782,GO:1905222,1,0.993080071618333,0,1,atrioventricular canal morphogenesis,BP,
20783,GO:1905223,1,0.980799264039314,0,2,epicardium morphogenesis,BP,
20784,GO:1905224,1,0.976927254039356,0,3,clathrin-coated pit assembly,BP,
20785,GO:1905225,1,0.989329298888622,0,2,response to thyrotropin-releasing hormone,BP,
20786,GO:1905226,1,0.996130200687623,0,1,regulation of adhesion of symbiont to host epithelial cell,BP,
20787,GO:1905229,1,0.996187029935837,0,1,cellular response to thyrotropin-releasing hormone,BP,
20788,GO:1905232,1,0.965546333099597,0,5,cellular response to L-glutamate,BP,
20789,GO:1905239,1,0.991938556002587,0,1,regulation of canonical Wnt signaling pathway involved in osteoblast differentiation,BP,
20790,GO:1905240,1,0.991938556002587,0,1,negative regulation of canonical Wnt signaling pathway involved in osteoblast differentiation,BP,
20791,GO:1905242,1,0.986563793607584,0,2,response to 3,3',5-triiodo-L-thyronine,BP,
20792,GO:1905243,1,0.993612201760886,0,1,cellular response to 3,3',5-triiodo-L-thyronine,BP,
20793,GO:1905244,1,0.915377412043536,0,12,regulation of modification of synaptic structure,BP,
20794,GO:1905245,1,0.931992239926746,0,10,regulation of aspartic-type peptidase activity,BP,
20795,GO:1905246,1,0.98127625195399,0,2,negative regulation of aspartic-type peptidase activity,BP,
20796,GO:1905247,1,0.949784842122936,0,8,positive regulation of aspartic-type peptidase activity,BP,
20797,GO:1905255,1,0.990681270094271,0,1,regulation of RNA binding transcription factor activity,BP,
20798,GO:1905258,1,0.992359413395107,0,2,regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,
20799,GO:1905259,1,0.992359413395107,0,2,negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,
20800,GO:1905267,1,0.983515883492282,0,3,endonucleolytic cleavage involved in tRNA processing,BP,
20801,GO:1905268,1,0.702922283892324,0,48,negative regulation of chromatin organization,BP,
20802,GO:1905269,1,0.493750064874401,0,98,positive regulation of chromatin organization,BP,
20803,GO:1905271,1,0.997012912219984,0,1,regulation of proton-transporting ATP synthase activity, rotational mechanism,BP,
20804,GO:1905273,1,0.997012912219984,0,1,positive regulation of proton-transporting ATP synthase activity, rotational mechanism,BP,
20805,GO:1905274,1,0.960857366926841,0,5,regulation of modification of postsynaptic actin cytoskeleton,BP,
20807,GO:1905277,1,0.993140770101177,0,1,negative regulation of epithelial tube formation,BP,
20808,GO:1905278,1,0.974826489141289,0,4,positive regulation of epithelial tube formation,BP,
20809,GO:1905279,1,0.975198039535334,0,3,regulation of retrograde transport, endosome to Golgi,BP,
20810,GO:1905280,1,0.993211515187534,0,1,negative regulation of retrograde transport, endosome to Golgi,BP,
20811,GO:1905285,1,0.992783259455901,0,1,fibrous ring of heart morphogenesis,BP,
20812,GO:1905286,1,0.981502500611305,0,3,serine-type peptidase complex,CC,
20813,GO:1905288,1,0.938159755329279,0,9,vascular associated smooth muscle cell apoptotic process,BP,
20814,GO:1905289,1,0.970074521594556,0,3,regulation of CAMKK-AMPK signaling cascade,BP,
20815,GO:1905291,1,0.996465856482775,0,1,positive regulation of CAMKK-AMPK signaling cascade,BP,
20816,GO:1905292,1,0.979829459983969,0,3,regulation of neural crest cell differentiation,BP,
20817,GO:1905294,1,0.979829459983969,0,3,positive regulation of neural crest cell differentiation,BP,
20818,GO:1905301,1,0.976493625172462,0,3,regulation of macropinocytosis,BP,
20819,GO:1905302,1,0.992297643203493,0,1,negative regulation of macropinocytosis,BP,
20820,GO:1905303,1,0.984074529220143,0,2,positive regulation of macropinocytosis,BP,
20821,GO:1905304,1,0.988706352811282,0,1,regulation of cardiac myofibril assembly,BP,
20822,GO:1905305,1,0.988706352811282,0,1,negative regulation of cardiac myofibril assembly,BP,
20823,GO:1905309,1,0.987591553011557,0,1,positive regulation of cohesin loading,BP,
20824,GO:1905310,1,0.979829459983969,0,3,regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
20825,GO:1905312,1,0.979829459983969,0,3,positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
20826,GO:1905313,1,0.994478610855959,0,1,transforming growth factor beta receptor signaling pathway involved in heart development,BP,
20827,GO:1905314,1,0.765667264634535,0,36,semi-lunar valve development,BP,
20828,GO:1905317,1,0.992214717025153,0,1,inferior endocardial cushion morphogenesis,BP,
20829,GO:1905319,1,0.983412518662974,0,3,mesenchymal stem cell migration,BP,
20830,GO:1905320,1,0.983412518662974,0,3,regulation of mesenchymal stem cell migration,BP,
20831,GO:1905322,1,0.983412518662974,0,3,positive regulation of mesenchymal stem cell migration,BP,
20832,GO:1905323,1,0.953801281124397,0,6,telomerase holoenzyme complex assembly,BP,
20833,GO:1905327,1,0.995665824555013,0,1,tracheoesophageal septum formation,BP,
20835,GO:1905331,1,0.890784236966443,0,16,negative regulation of morphogenesis of an epithelium,BP,
20836,GO:1905332,1,0.796525792066398,0,33,positive regulation of morphogenesis of an epithelium,BP,
20837,GO:1905333,1,0.985204946634635,0,4,regulation of gastric motility,BP,
20840,GO:1905340,1,0.977199453229811,0,4,regulation of protein localization to kinetochore,BP,
20841,GO:1905341,1,0.993618374144912,0,1,negative regulation of protein localization to kinetochore,BP,
20842,GO:1905342,1,0.977199453229811,0,4,positive regulation of protein localization to kinetochore,BP,
20843,GO:1905344,1,0.982658261381615,0,3,prostaglandin catabolic process,BP,
20844,GO:1905347,1,0.965515245780462,0,6,endodeoxyribonuclease complex,CC,
20845,GO:1905348,1,0.815031974874867,0,35,endonuclease complex,CC,
20846,GO:1905349,1,0.993425864935053,0,1,ciliary transition zone assembly,BP,
20847,GO:1905354,1,0.871397563067455,0,24,exoribonuclease complex,CC,
20848,GO:1905355,1,0.991843585539094,0,1,spine apparatus assembly,BP,
20849,GO:1905359,1,0.993174963603365,0,1,protein localization to meiotic spindle,BP,
20850,GO:1905360,1,0.8295989846533,0,32,GTPase complex,CC,
20851,GO:1905364,1,0.995137923412935,0,1,regulation of endosomal vesicle fusion,BP,
20852,GO:1905365,1,0.99441603432747,0,1,regulation of intralumenal vesicle formation,BP,
20853,GO:1905366,1,0.99441603432747,0,1,negative regulation of intralumenal vesicle formation,BP,
20854,GO:1905368,1,0.64119070062272,0,83,peptidase complex,CC,
20855,GO:1905369,1,0.717738842566713,0,65,endopeptidase complex,CC,
20856,GO:1905370,1,0.99408526275215,0,1,serine-type endopeptidase complex,CC,
20857,GO:1905371,1,0.986776380106973,0,2,ceramide phosphoethanolamine metabolic process,BP,
20858,GO:1905373,1,0.986776380106973,0,2,ceramide phosphoethanolamine biosynthetic process,BP,
20859,GO:1905377,1,0.992272599785769,0,1,response to D-galactose,BP,
20860,GO:1905380,1,0.976654718569518,0,4,regulation of snRNA transcription by RNA polymerase II,BP,
20861,GO:1905382,1,0.976654718569518,0,4,positive regulation of snRNA transcription by RNA polymerase II,BP,
20862,GO:1905383,1,0.920520596363566,0,11,protein localization to presynapse,BP,
20863,GO:1905384,1,0.988730508078075,0,2,regulation of protein localization to presynapse,BP,
20864,GO:1905386,1,0.988730508078075,0,2,positive regulation of protein localization to presynapse,BP,
20865,GO:1905394,1,0.958226221687143,0,5,retromer complex binding,MF,
20866,GO:1905395,1,0.985295858517372,0,3,response to flavonoid,BP,
20867,GO:1905396,1,0.996054857504184,0,1,cellular response to flavonoid,BP,
20868,GO:1905397,1,0.990657274017292,0,2,activated CD8-positive, alpha-beta T cell apoptotic process,BP,
20869,GO:1905402,1,0.990657274017292,0,2,regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
20870,GO:1905403,1,0.994912457386172,0,1,negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
20871,GO:1905404,1,0.995723275739318,0,1,positive regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
20872,GO:1905405,1,0.987591553011557,0,1,regulation of mitotic cohesin loading,BP,
20873,GO:1905406,1,0.987591553011557,0,1,positive regulation of mitotic cohesin loading,BP,
20874,GO:1905407,1,0.988089889193731,0,2,regulation of creatine transmembrane transporter activity,BP,
20875,GO:1905408,1,0.988089889193731,0,2,negative regulation of creatine transmembrane transporter activity,BP,
20876,GO:1905413,1,0.992295572815088,0,1,regulation of dense core granule exocytosis,BP,
20879,GO:1905420,1,0.980543491812181,0,3,vascular associated smooth muscle cell differentiation involved in phenotypic switching,BP,
20880,GO:1905424,1,0.988430743254792,0,2,regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,
20881,GO:1905426,1,0.988430743254792,0,2,positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,
20882,GO:1905429,1,0.980136805092278,0,3,response to glycine,BP,
20883,GO:1905430,1,0.987572990139139,0,2,cellular response to glycine,BP,
20886,GO:1905435,1,0.986283218596379,0,2,regulation of histone H3-K4 trimethylation,BP,
20887,GO:1905437,1,0.986283218596379,0,2,positive regulation of histone H3-K4 trimethylation,BP,
20888,GO:1905438,1,0.987114935971672,0,2,non-canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
20889,GO:1905443,1,0.992331023139531,0,1,regulation of clathrin coat assembly,BP,
20890,GO:1905445,1,0.992331023139531,0,1,positive regulation of clathrin coat assembly,BP,
20891,GO:1905446,1,0.963784015898152,0,7,regulation of mitochondrial ATP synthesis coupled electron transport,BP,
20892,GO:1905447,1,0.986575798970718,0,2,negative regulation of mitochondrial ATP synthesis coupled electron transport,BP,
20893,GO:1905448,1,0.97690118187438,0,5,positive regulation of mitochondrial ATP synthesis coupled electron transport,BP,
20894,GO:1905449,1,0.946479679105153,0,7,regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
20895,GO:1905450,1,0.982779193989689,0,2,negative regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
20896,GO:1905451,1,0.9630707136264,0,5,positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
20897,GO:1905453,1,0.99407140587962,0,1,regulation of myeloid progenitor cell differentiation,BP,
20898,GO:1905454,1,0.99407140587962,0,1,negative regulation of myeloid progenitor cell differentiation,BP,
20899,GO:1905456,1,0.940037731489727,0,8,regulation of lymphoid progenitor cell differentiation,BP,
20900,GO:1905457,1,0.980337821040942,0,3,negative regulation of lymphoid progenitor cell differentiation,BP,
20901,GO:1905458,1,0.985076040661967,0,2,positive regulation of lymphoid progenitor cell differentiation,BP,
20902,GO:1905459,1,0.938159755329279,0,9,regulation of vascular associated smooth muscle cell apoptotic process,BP,
20903,GO:1905460,1,0.98167181626311,0,2,negative regulation of vascular associated smooth muscle cell apoptotic process,BP,
20904,GO:1905461,1,0.955683560840438,0,7,positive regulation of vascular associated smooth muscle cell apoptotic process,BP,
20907,GO:1905464,1,0.984607165100632,0,3,positive regulation of DNA duplex unwinding,BP,
20908,GO:1905468,1,0.991748911561887,0,1,regulation of clathrin-coated pit assembly,BP,
20909,GO:1905469,1,0.991748911561887,0,1,negative regulation of clathrin-coated pit assembly,BP,
20910,GO:1905474,1,0.995796381866068,0,1,canonical Wnt signaling pathway involved in stem cell proliferation,BP,
20914,GO:1905483,1,0.986450745137245,0,1,regulation of motor neuron migration,BP,
20915,GO:1905485,1,0.986450745137245,0,1,positive regulation of motor neuron migration,BP,
20916,GO:1905492,1,0.992811838951132,0,1,positive regulation of branching morphogenesis of a nerve,BP,
20917,GO:1905502,1,0.986545071732352,0,2,acetyl-CoA binding,MF,
20918,GO:1905503,1,0.995298760750246,0,1,regulation of motile cilium assembly,BP,
20919,GO:1905505,1,0.995298760750246,0,1,positive regulation of motile cilium assembly,BP,
20920,GO:1905508,1,0.766365692872527,0,33,protein localization to microtubule organizing center,BP,
20921,GO:1905512,1,0.993803435828213,0,1,regulation of short-term synaptic potentiation,BP,
20922,GO:1905513,1,0.993803435828213,0,1,negative regulation of short-term synaptic potentiation,BP,
20923,GO:1905515,1,0.699424109088564,0,50,non-motile cilium assembly,BP,
20924,GO:1905516,1,0.923697710043729,0,12,positive regulation of fertilization,BP,
20925,GO:1905517,1,0.761781626893253,0,48,macrophage migration,BP,
20926,GO:1905518,1,0.992020899761351,0,1,regulation of presynaptic active zone assembly,BP,
20927,GO:1905520,1,0.992020899761351,0,1,positive regulation of presynaptic active zone assembly,BP,
20928,GO:1905521,1,0.807333783647669,0,36,regulation of macrophage migration,BP,
20929,GO:1905522,1,0.950416548352102,0,9,negative regulation of macrophage migration,BP,
20930,GO:1905523,1,0.874426110273222,0,22,positive regulation of macrophage migration,BP,
20931,GO:1905524,1,0.989612597053827,0,1,negative regulation of protein autoubiquitination,BP,
20932,GO:1905526,1,0.986816046607511,0,2,regulation of Golgi lumen acidification,BP,
20933,GO:1905528,1,0.992316819013709,0,1,positive regulation of Golgi lumen acidification,BP,
20934,GO:1905532,1,0.987141987238285,0,2,regulation of leucine import across plasma membrane,BP,
20935,GO:1905533,1,0.987141987238285,0,2,negative regulation of leucine import across plasma membrane,BP,
20936,GO:1905535,1,0.991760904106951,0,1,regulation of eukaryotic translation initiation factor 4F complex assembly,BP,
20937,GO:1905537,1,0.991760904106951,0,1,positive regulation of eukaryotic translation initiation factor 4F complex assembly,BP,
20938,GO:1905538,1,0.964247756066745,0,5,polysome binding,MF,
20939,GO:1905541,1,0.993779815907898,0,1,regulation of L-arginine import across plasma membrane,BP,
20940,GO:1905546,1,0.99432096041645,0,1,cellular response to phenylpropanoid,BP,
20941,GO:1905547,1,0.995555341111532,0,1,regulation of subtelomeric heterochromatin assembly,BP,
20942,GO:1905549,1,0.995555341111532,0,1,positive regulation of subtelomeric heterochromatin assembly,BP,
20943,GO:1905550,1,0.990219008106623,0,2,regulation of protein localization to endoplasmic reticulum,BP,
20944,GO:1905552,1,0.990219008106623,0,2,positive regulation of protein localization to endoplasmic reticulum,BP,
20945,GO:1905553,1,0.979828283700899,0,4,regulation of blood vessel branching,BP,
20946,GO:1905555,1,0.983716636957739,0,3,positive regulation blood vessel branching,BP,
20947,GO:1905562,1,0.863757457271869,0,20,regulation of vascular endothelial cell proliferation,BP,
20948,GO:1905563,1,0.964977778209891,0,5,negative regulation of vascular endothelial cell proliferation,BP,
20949,GO:1905564,1,0.895141412132209,0,15,positive regulation of vascular endothelial cell proliferation,BP,
20950,GO:1905572,1,0.993395085478887,0,1,ganglioside GM1 transport to membrane,BP,
20951,GO:1905573,1,0.988470842577427,0,2,ganglioside GM1 binding,MF,
20952,GO:1905574,1,0.993395085478887,0,1,ganglioside GM2 binding,MF,
20953,GO:1905575,1,0.993395085478887,0,1,ganglioside GM3 binding,MF,
20954,GO:1905576,1,0.982619049630493,0,3,ganglioside GT1b binding,MF,
20955,GO:1905577,1,0.993395085478887,0,1,ganglioside GP1c binding,MF,
20956,GO:1905578,1,0.994018260667134,0,1,regulation of ERBB3 signaling pathway,BP,
20957,GO:1905580,1,0.994018260667134,0,1,positive regulation of ERBB3 signaling pathway,BP,
20958,GO:1905581,1,0.988859527560835,0,2,positive regulation of low-density lipoprotein particle clearance,BP,
20959,GO:1905589,1,0.993779815907898,0,1,positive regulation of L-arginine import across plasma membrane,BP,
20960,GO:1905590,1,0.993085530611049,0,1,fibronectin fibril organization,BP,
20961,GO:1905594,1,0.996339723294794,0,1,resveratrol binding,MF,
20962,GO:1905595,1,0.988362181858417,0,2,regulation of low-density lipoprotein particle receptor binding,BP,
20963,GO:1905596,1,0.992774175118473,0,1,negative regulation of low-density lipoprotein particle receptor binding,BP,
20964,GO:1905597,1,0.995556216350364,0,1,positive regulation of low-density lipoprotein particle receptor binding,BP,
20965,GO:1905598,1,0.982037944097064,0,2,negative regulation of low-density lipoprotein receptor activity,BP,
20966,GO:1905599,1,0.995556216350364,0,1,positive regulation of low-density lipoprotein receptor activity,BP,
20967,GO:1905600,1,0.971095606025978,0,4,regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
20968,GO:1905601,1,0.982037944097064,0,2,negative regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
20969,GO:1905602,1,0.988859527560835,0,2,positive regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
20971,GO:1905604,1,0.986419494774016,0,2,negative regulation of blood-brain barrier permeability,BP,
20973,GO:1905606,1,0.783238350734615,0,33,regulation of presynapse assembly,BP,
20974,GO:1905607,1,0.995255708783232,0,1,negative regulation of presynapse assembly,BP,
20975,GO:1905608,1,0.992020899761351,0,1,positive regulation of presynapse assembly,BP,
20976,GO:1905610,1,0.991760904106951,0,1,regulation of mRNA cap binding,BP,
20977,GO:1905612,1,0.991760904106951,0,1,positive regulation of mRNA cap binding,BP,
20978,GO:1905616,1,0.977399374942233,0,3,regulation of miRNA mediated inhibition of translation,BP,
20979,GO:1905618,1,0.977399374942233,0,3,positive regulation of miRNA mediated inhibition of translation,BP,
20980,GO:1905634,1,0.958267651953858,0,5,regulation of protein localization to chromatin,BP,
20981,GO:1905636,1,0.978501670148758,0,3,positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
20982,GO:1905642,1,0.993485400251684,0,1,negative regulation of DNA methylation,BP,
20983,GO:1905643,1,0.978635221785164,0,3,positive regulation of DNA methylation,BP,
20984,GO:1905647,1,0.978588626525745,0,3,proline import across plasma membrane,BP,
20985,GO:1905651,1,0.97753196791069,0,3,regulation of artery morphogenesis,BP,
20986,GO:1905653,1,0.97753196791069,0,3,positive regulation of artery morphogenesis,BP,
20987,GO:1905661,1,0.981597917612336,0,3,regulation of telomerase RNA reverse transcriptase activity,BP,
20988,GO:1905662,1,0.99416929595018,0,1,negative regulation of telomerase RNA reverse transcriptase activity,BP,
20989,GO:1905663,1,0.987355626888238,0,2,positive regulation of telomerase RNA reverse transcriptase activity,BP,
20990,GO:1905664,1,0.977281589786142,0,4,regulation of calcium ion import across plasma membrane,BP,
20991,GO:1905665,1,0.988855588787875,0,2,positive regulation of calcium ion import across plasma membrane,BP,
20992,GO:1905666,1,0.903449492744058,0,13,regulation of protein localization to endosome,BP,
20993,GO:1905667,1,0.992655566135115,0,1,negative regulation of protein localization to endosome,BP,
20994,GO:1905668,1,0.910140225502771,0,12,positive regulation of protein localization to endosome,BP,
20995,GO:1905671,1,0.976550180377839,0,4,regulation of lysosome organization,BP,
20996,GO:1905673,1,0.994261390993069,0,1,positive regulation of lysosome organization,BP,
20997,GO:1905674,1,0.986968473171057,0,3,regulation of adaptive immune memory response,BP,
20998,GO:1905675,1,0.991141757012701,0,2,negative regulation of adaptive immune memory response,BP,
20999,GO:1905676,1,0.995789792855028,0,1,positive regulation of adaptive immune memory response,BP,
21001,GO:1905687,1,0.991290689400061,0,1,regulation of diacylglycerol kinase activity,BP,
21002,GO:1905689,1,0.991290689400061,0,1,positive regulation of diacylglycerol kinase activity,BP,
21003,GO:1905693,1,0.994580882739056,0,1,regulation of phosphatidic acid biosynthetic process,BP,
21004,GO:1905695,1,0.994580882739056,0,1,positive regulation of phosphatidic acid biosynthetic process,BP,
21005,GO:1905696,1,0.984067737775576,0,2,regulation of polysome binding,BP,
21006,GO:1905698,1,0.992243560850596,0,1,positive regulation of polysome binding,BP,
21007,GO:1905702,1,0.972479542983718,0,4,regulation of inhibitory synapse assembly,BP,
21008,GO:1905703,1,0.994829781657961,0,1,negative regulation of inhibitory synapse assembly,BP,
21009,GO:1905704,1,0.985365507355293,0,2,positive regulation of inhibitory synapse assembly,BP,
21010,GO:1905705,1,0.990251191013679,0,1,cellular response to paclitaxel,BP,
21011,GO:1905706,1,0.993863475875992,0,1,regulation of mitochondrial ATP synthesis coupled proton transport,BP,
21012,GO:1905709,1,0.952871715635126,0,7,negative regulation of membrane permeability,BP,
21013,GO:1905710,1,0.703876092851528,0,60,positive regulation of membrane permeability,BP,
21014,GO:1905711,1,0.992705087473751,0,1,response to phosphatidylethanolamine,BP,
21015,GO:1905719,1,0.986824555645219,0,2,protein localization to perinuclear region of cytoplasm,BP,
21016,GO:1905720,1,0.990030135300583,0,1,cytoplasmic microtubule bundle,CC,
21017,GO:1905721,1,0.982419544478677,0,3,mitotic spindle astral microtubule end,CC,
21018,GO:1905725,1,0.975962193701565,0,4,protein localization to microtubule end,BP,
21019,GO:1905735,1,0.992831943700993,0,1,regulation of L-proline import across plasma membrane,BP,
21020,GO:1905737,1,0.992831943700993,0,1,positive regulation of L-proline import across plasma membrane,BP,
21021,GO:1905747,1,0.989664437987985,0,2,negative regulation of saliva secretion,BP,
21022,GO:1905748,1,0.989664437987985,0,2,hard palate morphogenesis,BP,
21023,GO:1905749,1,0.970150323209877,0,4,regulation of endosome to plasma membrane protein transport,BP,
21024,GO:1905751,1,0.98333376453119,0,2,positive regulation of endosome to plasma membrane protein transport,BP,
21025,GO:1905764,1,0.978162491547223,0,3,regulation of protection from non-homologous end joining at telomere,BP,
21026,GO:1905765,1,0.978162491547223,0,3,negative regulation of protection from non-homologous end joining at telomere,BP,
21027,GO:1905767,1,0.990408419780956,0,1,regulation of double-stranded telomeric DNA binding,BP,
21028,GO:1905768,1,0.990408419780956,0,1,negative regulation of double-stranded telomeric DNA binding,BP,
21031,GO:1905772,1,0.99308891600688,0,1,positive regulation of mesodermal cell differentiation,BP,
21032,GO:1905773,1,0.976343934435258,0,3,8-hydroxy-2'-deoxyguanosine DNA binding,MF,
21033,GO:1905774,1,0.973672089807987,0,5,regulation of DNA helicase activity,BP,
21034,GO:1905775,1,0.988895686974494,0,2,negative regulation of DNA helicase activity,BP,
21035,GO:1905776,1,0.984607165100632,0,3,positive regulation of DNA helicase activity,BP,
21036,GO:1905777,1,0.980238020005293,0,3,regulation of exonuclease activity,BP,
21037,GO:1905778,1,0.986638367949322,0,2,negative regulation of exonuclease activity,BP,
21038,GO:1905779,1,0.993513844472955,0,1,positive regulation of exonuclease activity,BP,
21039,GO:1905784,1,0.988383304992387,0,2,regulation of anaphase-promoting complex-dependent catabolic process,BP,
21040,GO:1905786,1,0.988383304992387,0,2,positive regulation of anaphase-promoting complex-dependent catabolic process,BP,
21041,GO:1905787,1,0.993577168431364,0,1,regulation of detection of mechanical stimulus involved in sensory perception of touch,BP,
21042,GO:1905788,1,0.993577168431364,0,1,negative regulation of detection of mechanical stimulus involved in sensory perception of touch,BP,
21043,GO:1905793,1,0.9789045351942,0,2,protein localization to pericentriolar material,BP,
21044,GO:1905794,1,0.987630014700747,0,1,response to puromycin,BP,
21045,GO:1905795,1,0.987630014700747,0,1,cellular response to puromycin,BP,
21046,GO:1905799,1,0.992021695472284,0,1,regulation of intraciliary retrograde transport,BP,
21047,GO:1905802,1,0.993374693996666,0,1,regulation of cellular response to manganese ion,BP,
21051,GO:1905820,1,0.902533988805366,0,15,positive regulation of chromosome separation,BP,
21052,GO:1905828,1,0.993499540149923,0,1,regulation of prostaglandin catabolic process,BP,
21053,GO:1905832,1,0.956135493406175,0,5,positive regulation of spindle assembly,BP,
21054,GO:1905834,1,0.995338648902122,0,1,response to pyrimidine ribonucleotide,BP,
21055,GO:1905835,1,0.995338648902122,0,1,cellular response to pyrimidine ribonucleotide,BP,
21056,GO:1905838,1,0.986638367949322,0,2,regulation of telomeric D-loop disassembly,BP,
21057,GO:1905839,1,0.986638367949322,0,2,negative regulation of telomeric D-loop disassembly,BP,
21058,GO:1905843,1,0.986847649426531,0,1,regulation of cellular response to gamma radiation,BP,
21059,GO:1905853,1,0.996286622576736,0,1,regulation of heparan sulfate binding,BP,
21060,GO:1905855,1,0.996286622576736,0,1,positive regulation of heparan sulfate binding,BP,
21061,GO:1905856,1,0.99376308886203,0,1,negative regulation of pentose-phosphate shunt,BP,
21062,GO:1905858,1,0.996286622576736,0,1,regulation of heparan sulfate proteoglycan binding,BP,
21063,GO:1905860,1,0.996286622576736,0,1,positive regulation of heparan sulfate proteoglycan binding,BP,
21064,GO:1905863,1,0.98151625329424,0,2,invadopodium organization,BP,
21065,GO:1905867,1,0.973683588196448,0,5,epididymis development,BP,
21066,GO:1905868,1,0.982568055688986,0,3,regulation of 3'-UTR-mediated mRNA stabilization,BP,
21067,GO:1905869,1,0.993485400251684,0,1,negative regulation of 3'-UTR-mediated mRNA stabilization,BP,
21068,GO:1905870,1,0.989011781620253,0,2,positive regulation of 3'-UTR-mediated mRNA stabilization,BP,
21069,GO:1905874,1,0.887148175737051,0,16,regulation of postsynaptic density organization,BP,
21070,GO:1905875,1,0.993279890763127,0,1,negative regulation of postsynaptic density organization,BP,
21071,GO:1905878,1,0.98788271045617,0,1,invadopodium disassembly,BP,
21072,GO:1905879,1,0.927828855401207,0,11,regulation of oogenesis,BP,
21073,GO:1905880,1,0.973547415532319,0,4,negative regulation of oogenesis,BP,
21074,GO:1905881,1,0.965031565646525,0,5,positive regulation of oogenesis,BP,
21075,GO:1905883,1,0.994278633367177,0,1,regulation of triglyceride transport,BP,
21076,GO:1905885,1,0.994278633367177,0,1,positive regulation of triglyceride transport,BP,
21077,GO:1905890,1,0.996286622576736,0,1,regulation of cellular response to very-low-density lipoprotein particle stimulus,BP,
21078,GO:1905891,1,0.993382287712882,0,1,regulation of cellular response to thapsigargin,BP,
21079,GO:1905892,1,0.993382287712882,0,1,negative regulation of cellular response to thapsigargin,BP,
21080,GO:1905894,1,0.993382287712882,0,1,regulation of cellular response to tunicamycin,BP,
21081,GO:1905895,1,0.993382287712882,0,1,negative regulation of cellular response to tunicamycin,BP,
21083,GO:1905898,1,0.795679967830517,0,36,positive regulation of response to endoplasmic reticulum stress,BP,
21084,GO:1905899,1,0.995665824555013,0,1,regulation of smooth muscle tissue development,BP,
21085,GO:1905900,1,0.995665824555013,0,1,negative regulation of smooth muscle tissue development,BP,
21086,GO:1905901,1,0.995665824555013,0,1,positive regulation of smooth muscle tissue development,BP,
21089,GO:1905904,1,0.99308891600688,0,1,positive regulation of mesoderm formation,BP,
21092,GO:1905908,1,0.973779389046849,0,4,positive regulation of amyloid fibril formation,BP,
21093,GO:1905912,1,0.989077929147978,0,2,regulation of calcium ion export across plasma membrane,BP,
21094,GO:1905913,1,0.995179984847799,0,1,negative regulation of calcium ion export across plasma membrane,BP,
21095,GO:1905915,1,0.980543491812181,0,3,regulation of cell differentiation involved in phenotypic switching,BP,
21096,GO:1905916,1,0.983983797078526,0,2,negative regulation of cell differentiation involved in phenotypic switching,BP,
21097,GO:1905917,1,0.996504261929267,0,1,positive regulation of cell differentiation involved in phenotypic switching,BP,
21098,GO:1905918,1,0.991452690203082,0,2,regulation of CoA-transferase activity,BP,
21099,GO:1905920,1,0.991452690203082,0,2,positive regulation of CoA-transferase activity,BP,
21100,GO:1905927,1,0.98788271045617,0,1,regulation of invadopodium disassembly,BP,
21101,GO:1905929,1,0.98788271045617,0,1,positive regulation of invadopodium disassembly,BP,
21102,GO:1905930,1,0.980543491812181,0,3,regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching,BP,
21103,GO:1905931,1,0.983983797078526,0,2,negative regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching,BP,
21104,GO:1905932,1,0.996504261929267,0,1,positive regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching,BP,
21105,GO:1905933,1,0.995868123078444,0,1,regulation of cell fate determination,BP,
21106,GO:1905934,1,0.995868123078444,0,1,negative regulation of cell fate determination,BP,
21107,GO:1905936,1,0.982396990343297,0,4,regulation of germ cell proliferation,BP,
21108,GO:1905937,1,0.985783449553537,0,3,negative regulation of germ cell proliferation,BP,
21109,GO:1905938,1,0.996565195709483,0,1,positive regulation of germ cell proliferation,BP,
21110,GO:1905939,1,0.8899002924136,0,19,regulation of gonad development,BP,
21111,GO:1905940,1,0.968437349251004,0,5,negative regulation of gonad development,BP,
21112,GO:1905941,1,0.935918524734384,0,11,positive regulation of gonad development,BP,
21113,GO:1905952,1,0.440284461067147,0,126,regulation of lipid localization,BP,
21114,GO:1905953,1,0.774899838844799,0,36,negative regulation of lipid localization,BP,
21115,GO:1905954,1,0.59221555626788,0,82,positive regulation of lipid localization,BP,
21116,GO:1905956,1,0.98641475827357,0,2,positive regulation of endothelial tube morphogenesis,BP,
21117,GO:1905957,1,0.992424723643522,0,1,regulation of cellular response to alcohol,BP,
21118,GO:1905959,1,0.992424723643522,0,1,positive regulation of cellular response to alcohol,BP,
21119,GO:1905961,1,0.951162598145237,0,8,protein-cysteine S-palmitoyltransferase complex,CC,
21120,GO:1905962,1,0.971727056655956,0,5,glutamatergic neuron differentiation,BP,
21122,GO:1990001,1,0.962212520901613,0,6,inhibition of cysteine-type endopeptidase activity involved in apoptotic process,BP,
21123,GO:1990005,1,0.988938564229329,0,2,granular vesicle,CC,
21124,GO:1990008,1,0.995423647763866,0,1,neurosecretory vesicle,CC,
21125,GO:1990009,1,0.969314071059518,0,4,retinal cell apoptotic process,BP,
21126,GO:1990015,1,0.994080638833962,0,1,ensheathing process,CC,
21127,GO:1990023,1,0.901806307695376,0,13,mitotic spindle midzone,CC,
21128,GO:1990026,1,0.984822036047331,0,2,hippocampal mossy fiber expansion,CC,
21129,GO:1990030,1,0.986675304672674,0,2,pericellular basket,CC,
21130,GO:1990031,1,0.993060360955018,0,1,pinceau fiber,CC,
21131,GO:1990032,1,0.992340740314052,0,1,parallel fiber,CC,
21132,GO:1990034,1,0.948252061159796,0,7,calcium ion export across plasma membrane,BP,
21133,GO:1990036,1,0.970775456853904,0,4,calcium ion import into sarcoplasmic reticulum,BP,
21134,GO:1990037,1,0.984972915441639,0,3,Lewy body core,CC,
21135,GO:1990038,1,0.99495657552065,0,1,Lewy body corona,CC,
21136,GO:1990044,1,0.995605788068793,0,1,protein localization to lipid droplet,BP,
21137,GO:1990046,1,0.996139231213715,0,1,stress-induced mitochondrial fusion,BP,
21138,GO:1990047,1,0.994324820285714,0,1,spindle matrix,CC,
21139,GO:1990048,1,0.937275881817034,0,7,anterograde neuronal dense core vesicle transport,BP,
21140,GO:1990049,1,0.951230541539826,0,5,retrograde neuronal dense core vesicle transport,BP,
21141,GO:1990050,1,0.982744854842654,0,4,phosphatidic acid transfer activity,MF,
21142,GO:1990051,1,0.969333288076254,0,5,activation of protein kinase C activity,BP,
21143,GO:1990070,1,0.996839131325988,0,1,TRAPPI protein complex,CC,
21144,GO:1990071,1,0.987088885264218,0,2,TRAPPII protein complex,CC,
21145,GO:1990072,1,0.990344917747388,0,2,TRAPPIII protein complex,CC,
21146,GO:1990074,1,0.992833949570397,0,1,polyuridylation-dependent mRNA catabolic process,BP,
21147,GO:1990075,1,0.964745704263549,0,4,periciliary membrane compartment,CC,
21148,GO:1990079,1,0.979048268320768,0,3,cartilage homeostasis,BP,
21149,GO:1990086,1,0.97177619557674,0,4,lens fiber cell apoptotic process,BP,
21152,GO:1990092,1,0.992996218770604,0,1,calcium-dependent self proteolysis,BP,
21153,GO:1990108,1,0.975107136933763,0,3,protein linear deubiquitination,BP,
21154,GO:1990111,1,0.979321475633111,0,4,spermatoproteasome complex,CC,
21155,GO:1990112,1,0.98701281886265,0,2,RQC complex,CC,
21156,GO:1990114,1,0.995541311022079,0,1,RNA polymerase II core complex assembly,BP,
21157,GO:1990116,1,0.98701281886265,0,2,ribosome-associated ubiquitin-dependent protein catabolic process,BP,
21158,GO:1990117,1,0.996784759901968,0,1,B cell receptor apoptotic signaling pathway,BP,
21159,GO:1990120,1,0.975907255799141,0,3,messenger ribonucleoprotein complex assembly,BP,
21160,GO:1990124,1,0.930076783147607,0,10,messenger ribonucleoprotein complex,CC,
21161,GO:1990126,1,0.853885228212818,0,22,retrograde transport, endosome to plasma membrane,BP,
21162,GO:1990127,1,0.992518502787351,0,1,intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
21163,GO:1990130,1,0.968363981894183,0,5,GATOR1 complex,CC,
21164,GO:1990131,1,0.97817308137824,0,4,Gtr1-Gtr2 GTPase complex,CC,
21165,GO:1990134,1,0.991924205028107,0,1,epithelial cell apoptotic process involved in palatal shelf morphogenesis,BP,
21166,GO:1990136,1,0.993894878504628,0,1,linoleate 9S-lipoxygenase activity,MF,
21168,GO:1990144,1,0.960444990415876,0,7,intrinsic apoptotic signaling pathway in response to hypoxia,BP,
21169,GO:1990145,1,0.9859721897063,0,2,maintenance of translational fidelity,BP,
21170,GO:1990147,1,0.992953231823748,0,1,talin binding,MF,
21171,GO:1990164,1,0.974040882037403,0,4,histone H2A phosphorylation,BP,
21172,GO:1990165,1,0.994833726064617,0,1,single-strand break-containing DNA binding,MF,
21173,GO:1990166,1,0.99416929595018,0,1,protein localization to site of double-strand break,BP,
21174,GO:1990167,1,0.981569935150659,0,2,protein K27-linked deubiquitination,BP,
21175,GO:1990168,1,0.975429441205642,0,3,protein K33-linked deubiquitination,BP,
21176,GO:1990169,1,0.96131969105366,0,11,stress response to copper ion,BP,
21177,GO:1990170,1,0.994845555469451,0,1,stress response to cadmium ion,BP,
21178,GO:1990172,1,0.99119377564533,0,1,G protein-coupled receptor catabolic process,BP,
21179,GO:1990173,1,0.926138608782552,0,13,protein localization to nucleoplasm,BP,
21180,GO:1990174,1,0.983805374214697,0,2,phosphodiesterase decapping endonuclease activity,MF,
21181,GO:1990175,1,0.992648930286223,0,1,EH domain binding,MF,
21182,GO:1990180,1,0.984497329680274,0,3,mitochondrial tRNA 3'-end processing,BP,
21183,GO:1990182,1,0.902128352825517,0,17,exosomal secretion,BP,
21184,GO:1990183,1,0.996733546774485,0,1,lymphatic vascular process in circulatory system,BP,
21185,GO:1990184,1,0.986697822403913,0,2,amino acid transport complex,CC,
21186,GO:1990186,1,0.996733546774485,0,1,regulation of lymphatic vessel size,BP,
21187,GO:1990188,1,0.993703097482815,0,1,euchromatin binding,MF,
21188,GO:1990189,1,0.985459380857773,0,3,peptide-serine-N-acetyltransferase activity,MF,
21189,GO:1990190,1,0.992472035501039,0,2,peptide-glutamate-N-acetyltransferase activity,MF,
21190,GO:1990192,1,0.996733546774485,0,1,collecting lymphatic vessel constriction,BP,
21192,GO:1990221,1,0.985920000314024,0,2,L-cysteine desulfurase complex,CC,
21193,GO:1990226,1,0.957841941027192,0,7,histone methyltransferase binding,MF,
21195,GO:1990238,1,0.990576053608635,0,1,double-stranded DNA endodeoxyribonuclease activity,MF,
21196,GO:1990239,1,0.958061589895231,0,6,steroid hormone binding,MF,
21197,GO:1990246,1,0.967844510386765,0,5,uniplex complex,CC,
21198,GO:1990247,1,0.946897041537481,0,7,N6-methyladenosine-containing RNA binding,MF,
21199,GO:1990248,1,0.99376308886203,0,1,regulation of transcription from RNA polymerase II promoter in response to DNA damage,BP,
21200,GO:1990253,1,0.942195070434099,0,8,cellular response to leucine starvation,BP,
21201,GO:1990254,1,0.968142728195961,0,5,keratin filament binding,MF,
21202,GO:1990256,1,0.986298853200795,0,1,signal clustering,BP,
21203,GO:1990258,1,0.979418271350277,0,3,histone glutamine methylation,BP,
21204,GO:1990259,1,0.996301048185786,0,1,histone-glutamine methyltransferase activity,MF,
21205,GO:1990261,1,0.993485400251684,0,1,pre-mRNA catabolic process,BP,
21206,GO:1990262,1,0.993516724854332,0,1,anti-Mullerian hormone signaling pathway,BP,
21207,GO:1990264,1,0.92973885456659,0,8,peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity,BP,
21208,GO:1990266,1,0.584484095202724,0,98,neutrophil migration,BP,
21209,GO:1990267,1,0.987668507533086,0,2,response to transition metal nanoparticle,BP,
21210,GO:1990268,1,0.993012904054279,0,1,response to gold nanoparticle,BP,
21211,GO:1990269,1,0.973733658185328,0,4,RNA polymerase II C-terminal domain phosphoserine binding,MF,
21212,GO:1990275,1,0.993333446322789,0,1,preribosome binding,MF,
21213,GO:1990276,1,0.993519611695845,0,1,RNA 5'-methyltransferase activity,MF,
21214,GO:1990280,1,0.990356648416623,0,1,RNA localization to chromatin,BP,
21215,GO:1990298,1,0.994572010576078,0,1,bub1-bub3 complex,CC,
21216,GO:1990314,1,0.943515181621259,0,7,cellular response to insulin-like growth factor stimulus,BP,
21217,GO:1990316,1,0.937576639149804,0,8,Atg1/ULK1 kinase complex,CC,
21218,GO:1990332,1,0.992607280810635,0,1,Ire1 complex,CC,
21219,GO:1990349,1,0.975889236198013,0,4,gap junction-mediated intercellular transport,BP,
21221,GO:1990356,1,0.996253231912534,0,1,sumoylated E2 ligase complex,CC,
21222,GO:1990357,1,0.975464743088873,0,4,terminal web,CC,
21223,GO:1990379,1,0.968961601445103,0,6,lipid transport across blood-brain barrier,BP,
21224,GO:1990380,1,0.912161111802334,0,10,Lys48-specific deubiquitinase activity,MF,
21225,GO:1990381,1,0.896110950991327,0,17,ubiquitin-specific protease binding,MF,
21226,GO:1990384,1,0.957205488307013,0,7,hyaloid vascular plexus regression,BP,
21227,GO:1990385,1,0.992541043837825,0,1,meiotic spindle midzone,CC,
21228,GO:1990386,1,0.994918347828145,0,1,mitotic cleavage furrow ingression,BP,
21229,GO:1990390,1,0.992858707685603,0,1,protein K33-linked ubiquitination,BP,
21230,GO:1990391,1,0.784764641941401,0,33,DNA repair complex,CC,
21231,GO:1990393,1,0.963171101517487,0,5,3M complex,CC,
21232,GO:1990399,1,0.994398498066526,0,1,epithelium regeneration,BP,
21233,GO:1990401,1,0.987485986143022,0,2,embryonic lung development,BP,
21234,GO:1990402,1,0.990640440871489,0,2,embryonic liver development,BP,
21235,GO:1990403,1,0.920933457912203,0,12,embryonic brain development,BP,
21236,GO:1990404,1,0.886821754974921,0,16,protein ADP-ribosylase activity,MF,
21237,GO:1990405,1,0.948197036947429,0,7,protein antigen binding,MF,
21238,GO:1990406,1,0.988641915731193,0,2,CGRP receptor complex,CC,
21239,GO:1990407,1,0.996662072737535,0,1,calcitonin gene-related peptide binding,MF,
21240,GO:1990408,1,0.988641915731193,0,2,calcitonin gene-related peptide receptor signaling pathway,BP,
21241,GO:1990409,1,0.988798825476292,0,2,adrenomedullin binding,MF,
21242,GO:1990410,1,0.980820804751575,0,4,adrenomedullin receptor signaling pathway,BP,
21243,GO:1990414,1,0.946178779286085,0,8,replication-born double-strand break repair via sister chromatid exchange,BP,
21244,GO:1990415,1,0.981072868255372,0,3,Pex17p-Pex14p docking complex,CC,
21245,GO:1990416,1,0.924178061112683,0,10,cellular response to brain-derived neurotrophic factor stimulus,BP,
21246,GO:1990418,1,0.982058627939653,0,3,response to insulin-like growth factor stimulus,BP,
21247,GO:1990422,1,0.996625193861694,0,1,glyoxalase (glycolic acid-forming) activity,MF,
21248,GO:1990423,1,0.97669101402011,0,3,RZZ complex,CC,
21249,GO:1990425,1,0.970178059664208,0,3,ryanodine receptor complex,CC,
21250,GO:1990426,1,0.981092121335279,0,2,mitotic recombination-dependent replication fork processing,BP,
21251,GO:1990427,1,0.989876487000643,0,1,stereocilia tip-link density,CC,
21252,GO:1990428,1,0.980800813211505,0,3,miRNA transport,BP,
21253,GO:1990429,1,0.981072868255372,0,3,peroxisomal importomer complex,CC,
21254,GO:1990430,1,0.962658668765594,0,5,extracellular matrix protein binding,MF,
21255,GO:1990435,1,0.989876487000643,0,1,upper tip-link density,CC,
21256,GO:1990437,1,0.994423837746377,0,1,snRNA 2'-O-methylation,BP,
21257,GO:1990438,1,0.994423837746377,0,1,U6 2'-O-snRNA methylation,BP,
21260,GO:1990441,1,0.975635252220206,0,4,negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,
21261,GO:1990442,1,0.989042829545,0,3,intrinsic apoptotic signaling pathway in response to nitrosative stress,BP,
21263,GO:1990444,1,0.986385124621518,0,2,F-box domain binding,MF,
21264,GO:1990446,1,0.98005613154431,0,5,U1 snRNP binding,MF,
21265,GO:1990447,1,0.996422881834318,0,1,U2 snRNP binding,MF,
21266,GO:1990448,1,0.990536685812041,0,1,exon-exon junction complex binding,MF,
21267,GO:1990452,1,0.985792490553145,0,2,Parkin-FBXW7-Cul1 ubiquitin ligase complex,CC,
21268,GO:1990454,1,0.916033961149048,0,12,L-type voltage-gated calcium channel complex,CC,
21269,GO:1990456,1,0.977905595828298,0,3,mitochondrion-endoplasmic reticulum membrane tethering,BP,
21270,GO:1990459,1,0.942153561101833,0,9,transferrin receptor binding,MF,
21271,GO:1990460,1,0.971057501633568,0,4,leptin receptor binding,MF,
21272,GO:1990462,1,0.985778282592898,0,2,omegasome,CC,
21273,GO:1990467,1,0.994578910864439,0,1,NuA3a histone acetyltransferase complex,CC,
21274,GO:1990468,1,0.994578910864439,0,1,NuA3b histone acetyltransferase complex,CC,
21275,GO:1990478,1,0.99033420624911,0,2,response to ultrasound,BP,
21276,GO:1990481,1,0.970547476736498,0,5,mRNA pseudouridine synthesis,BP,
21277,GO:1990498,1,0.972932003634909,0,3,mitotic spindle microtubule,CC,
21280,GO:1990505,1,0.981092121335279,0,2,mitotic DNA replication maintenance of fidelity,BP,
21281,GO:1990511,1,0.97193995864851,0,4,piRNA biosynthetic process,BP,
21282,GO:1990513,1,0.98391696751108,0,2,CLOCK-BMAL transcription complex,CC,
21283,GO:1990518,1,0.97847532144342,0,3,single-stranded 3'-5' DNA helicase activity,MF,
21284,GO:1990519,1,0.988101881709564,0,2,pyrimidine nucleotide import into mitochondrion,BP,
21285,GO:1990523,1,0.980276464520964,0,3,bone regeneration,BP,
21286,GO:1990529,1,0.992447345405774,0,1,glycosylphosphatidylinositol-mannosyltransferase I complex,CC,
21287,GO:1990535,1,0.925596094599548,0,9,neuron projection maintenance,BP,
21288,GO:1990539,1,0.994246102295014,0,1,fructose import across plasma membrane,BP,
21289,GO:1990540,1,0.993003767187949,0,1,mitochondrial manganese ion transmembrane transport,BP,
21290,GO:1990542,1,0.644223139423497,0,73,mitochondrial transmembrane transport,BP,
21291,GO:1990546,1,0.995616145417115,0,1,mitochondrial tricarboxylic acid transmembrane transport,BP,
21292,GO:1990548,1,0.993181331459016,0,1,mitochondrial FAD transmembrane transport,BP,
21293,GO:1990564,1,0.973316779623759,0,5,protein polyufmylation,BP,
21294,GO:1990565,1,0.989356893376738,0,2,HSP90-CDC37 chaperone complex,CC,
21295,GO:1990569,1,0.965820949401527,0,5,UDP-N-acetylglucosamine transmembrane transport,BP,
21296,GO:1990572,1,0.992614810239926,0,1,TERT-RMRP complex,CC,
21298,GO:1990575,1,0.982794297508632,0,3,mitochondrial L-ornithine transmembrane transport,BP,
21299,GO:1990578,1,0.985301179649486,0,2,perinuclear endoplasmic reticulum membrane,CC,
21300,GO:1990579,1,0.992607280810635,0,1,peptidyl-serine trans-autophosphorylation,BP,
21301,GO:1990583,1,0.994918347828145,0,1,phospholipase D activator activity,MF,
21302,GO:1990584,1,0.990049481818153,0,3,cardiac Troponin complex,CC,
21303,GO:1990589,1,0.983375740822484,0,2,ATF4-CREB1 transcription factor complex,CC,
21304,GO:1990590,1,0.989464547193962,0,2,ATF1-ATF4 transcription factor complex,CC,
21305,GO:1990592,1,0.973316779623759,0,5,protein K69-linked ufmylation,BP,
21306,GO:1990597,1,0.985004082373711,0,2,AIP1-IRE1 complex,CC,
21307,GO:1990599,1,0.978162491547223,0,3,3' overhang single-stranded DNA endodeoxyribonuclease activity,MF,
21308,GO:1990604,1,0.978849659162555,0,3,IRE1-TRAF2-ASK1 complex,CC,
21309,GO:1990613,1,0.992830444728566,0,1,mitochondrial membrane fusion,BP,
21310,GO:1990617,1,0.992086997011544,0,2,CHOP-ATF4 complex,CC,
21311,GO:1990619,1,0.988274593939241,0,2,histone H3-K9 deacetylation,BP,
21312,GO:1990622,1,0.991461744441287,0,2,CHOP-ATF3 complex,CC,
21313,GO:1990630,1,0.992607280810635,0,1,IRE1-RACK1-PP2A complex,CC,
21314,GO:1990635,1,0.95628931902474,0,6,proximal dendrite,CC,
21315,GO:1990637,1,0.978606285593307,0,3,response to prolactin,BP,
21316,GO:1990641,1,0.984657677269669,0,3,response to iron ion starvation,BP,
21317,GO:1990646,1,0.993196258754412,0,1,cellular response to prolactin,BP,
21318,GO:1990654,1,0.992022093239794,0,1,sebum secreting cell proliferation,BP,
21319,GO:1990665,1,0.99203624802613,0,2,AnxA2-p11 complex,CC,
21320,GO:1990666,1,0.984559075931585,0,2,PCSK9-LDLR complex,CC,
21321,GO:1990667,1,0.988362181858417,0,2,PCSK9-AnxA2 complex,CC,
21322,GO:1990668,1,0.970060521312862,0,5,vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane,BP,
21323,GO:1990678,1,0.992490345943061,0,1,histone H4-K16 deacetylation,BP,
21324,GO:1990682,1,0.986702654108931,0,2,CSF1-CSF1R complex,CC,
21325,GO:1990696,1,0.980588412282683,0,2,USH2 complex,CC,
21326,GO:1990697,1,0.99443750720736,0,1,protein depalmitoleylation,BP,
21327,GO:1990698,1,0.987959437797492,0,2,palmitoleoyltransferase activity,MF,
21328,GO:1990699,1,0.99443750720736,0,1,palmitoleyl hydrolase activity,MF,
21329,GO:1990700,1,0.992643135437148,0,1,nucleolar chromatin organization,BP,
21330,GO:1990705,1,0.971343500990651,0,3,cholangiocyte proliferation,BP,
21331,GO:1990707,1,0.986811811721545,0,1,nuclear subtelomeric heterochromatin,CC,
21332,GO:1990708,1,0.992973222589242,0,1,conditioned place preference,BP,
21333,GO:1990709,1,0.921100951080702,0,8,presynaptic active zone organization,BP,
21334,GO:1990712,1,0.955235029271345,0,7,HFE-transferrin receptor complex,CC,
21335,GO:1990715,1,0.981580642086031,0,3,mRNA CDS binding,MF,
21336,GO:1990716,1,0.97363468660253,0,3,axonemal central apparatus,CC,
21337,GO:1990718,1,0.987940020563945,0,1,axonemal central pair projection,CC,
21338,GO:1990723,1,0.979636001056033,0,2,cytoplasmic periphery of the nuclear pore complex,CC,
21339,GO:1990726,1,0.981791402731028,0,5,Lsm1-7-Pat1 complex,CC,
21340,GO:1990729,1,0.994953638863496,0,1,primary miRNA modification,BP,
21341,GO:1990730,1,0.985543973411807,0,2,VCP-NSFL1C complex,CC,
21342,GO:1990731,1,0.992785550449173,0,1,UV-damage excision repair, DNA incision,BP,
21343,GO:1990736,1,0.992582544689823,0,1,regulation of vascular associated smooth muscle cell membrane depolarization,BP,
21344,GO:1990737,1,0.980294481101713,0,3,response to manganese-induced endoplasmic reticulum stress,BP,
21345,GO:1990739,1,0.988705528950714,0,1,granulosa cell proliferation,BP,
21347,GO:1990743,1,0.970295400918797,0,4,protein sialylation,BP,
21348,GO:1990744,1,0.994953638863496,0,1,primary miRNA methylation,BP,
21349,GO:1990745,1,0.977532901281339,0,3,EARP complex,CC,
21350,GO:1990748,1,0.598303167656688,0,98,cellular detoxification,BP,
21351,GO:1990751,1,0.990014650515166,0,1,Schwann cell chemotaxis,BP,
21353,GO:1990755,1,0.993485400251684,0,1,mitotic spindle microtubule depolymerization,BP,
21354,GO:1990756,1,0.924233255322311,0,14,ubiquitin ligase-substrate adaptor activity,MF,
21355,GO:1990757,1,0.979503790812248,0,3,ubiquitin ligase activator activity,MF,
21356,GO:1990758,1,0.995197110795753,0,1,mitotic sister chromatid biorientation,BP,
21357,GO:1990760,1,0.977139162087525,0,3,osmolarity-sensing cation channel activity,MF,
21358,GO:1990761,1,0.974380127283551,0,3,growth cone lamellipodium,CC,
21359,GO:1990763,1,0.942357085594034,0,9,arrestin family protein binding,MF,
21360,GO:1990764,1,0.993556234347918,0,1,myofibroblast contraction,BP,
21361,GO:1990765,1,0.991803495022634,0,1,colon smooth muscle contraction,BP,
21362,GO:1990768,1,0.990889009442754,0,2,gastric mucosal blood circulation,BP,
21363,GO:1990769,1,0.97431019043101,0,4,proximal neuron projection,CC,
21364,GO:1990770,1,0.988735064383307,0,2,small intestine smooth muscle contraction,BP,
21365,GO:1990771,1,0.990997208401528,0,1,clathrin-dependent extracellular exosome endocytosis,BP,
21366,GO:1990773,1,0.964857465081513,0,5,matrix metallopeptidase secretion,BP,
21367,GO:1990774,1,0.979708646503423,0,3,tumor necrosis factor secretion,BP,
21368,GO:1990775,1,0.996043308844349,0,1,endothelin production,BP,
21370,GO:1990777,1,0.848077766852947,0,30,lipoprotein particle,CC,
21372,GO:1990780,1,0.992592874275698,0,1,cytoplasmic side of dendritic spine plasma membrane,CC,
21374,GO:1990784,1,0.98613230072332,0,2,response to dsDNA,BP,
21375,GO:1990785,1,0.969906430363002,0,4,response to water-immersion restraint stress,BP,
21376,GO:1990786,1,0.98613230072332,0,2,cellular response to dsDNA,BP,
21377,GO:1990787,1,0.989810624268325,0,1,negative regulation of hh target transcription factor activity,BP,
21378,GO:1990791,1,0.953688040025706,0,7,dorsal root ganglion development,BP,
21379,GO:1990798,1,0.996783487168374,0,1,pancreas regeneration,BP,
21380,GO:1990809,1,0.97557913084067,0,4,endoplasmic reticulum tubular network membrane organization,BP,
21381,GO:1990811,1,0.993485400251684,0,1,MWP complex,CC,
21382,GO:1990812,1,0.971235827733063,0,4,growth cone filopodium,CC,
21383,GO:1990814,1,0.995940124533707,0,1,DNA/DNA annealing activity,MF,
21384,GO:1990817,1,0.994332545728782,0,1,RNA adenylyltransferase activity,MF,
21385,GO:1990822,1,0.924732547620541,0,11,basic amino acid transmembrane transport,BP,
21387,GO:1990825,1,0.940002158187392,0,10,sequence-specific mRNA binding,MF,
21388,GO:1990828,1,0.99456314181792,0,1,hepatocyte dedifferentiation,BP,
21389,GO:1990829,1,0.988049930794966,0,2,C-rich single-stranded DNA binding,MF,
21391,GO:1990832,1,0.994808077162758,0,1,slow axonal transport,BP,
21392,GO:1990833,1,0.994808077162758,0,1,clathrin-uncoating ATPase activity,MF,
21393,GO:1990834,1,0.974161345570819,0,4,response to odorant,BP,
21394,GO:1990836,1,0.992580553497669,0,1,lysosomal matrix,CC,
21396,GO:1990838,1,0.993485400251684,0,1,poly(U)-specific exoribonuclease activity, producing 3' uridine cyclic phosphate ends,MF,
21397,GO:1990839,1,0.986780748935015,0,2,response to endothelin,BP,
21398,GO:1990841,1,0.669971947027272,0,55,promoter-specific chromatin binding,MF,
21399,GO:1990843,1,0.990795642075213,0,1,subsarcolemmal mitochondrion,CC,
21400,GO:1990844,1,0.990795642075213,0,1,interfibrillar mitochondrion,CC,
21401,GO:1990845,1,0.364706802543593,0,144,adaptive thermogenesis,BP,
21402,GO:1990851,1,0.972759203535438,0,3,Wnt-Frizzled-LRP5/6 complex,CC,
21403,GO:1990859,1,0.994270964628365,0,1,cellular response to endothelin,BP,
21404,GO:1990863,1,0.996783487168374,0,1,acinar cell proliferation,BP,
21405,GO:1990864,1,0.996783487168374,0,1,response to growth hormone-releasing hormone,BP,
21406,GO:1990867,1,0.996783487168374,0,1,response to gastrin,BP,
21407,GO:1990868,1,0.640016798124382,0,80,response to chemokine,BP,
21408,GO:1990869,1,0.640016798124382,0,80,cellular response to chemokine,BP,
21409,GO:1990874,1,0.710727762299426,0,50,vascular associated smooth muscle cell proliferation,BP,
21410,GO:1990876,1,0.990527069899023,0,1,cytoplasmic side of nuclear pore,CC,
21411,GO:1990878,1,0.996783487168374,0,1,cellular response to gastrin,BP,
21412,GO:1990879,1,0.98701281886265,0,2,CST complex,CC,
21413,GO:1990882,1,0.992637971907924,0,1,rRNA acetylation,BP,
21414,GO:1990883,1,0.992637971907924,0,1,rRNA cytidine N-acetyltransferase activity,MF,
21415,GO:1990884,1,0.992637971907924,0,1,RNA acetylation,BP,
21416,GO:1990889,1,0.988095699682406,0,2,H4K20me3 modified histone binding,MF,
21417,GO:1990890,1,0.985559980046392,0,2,netrin receptor binding,MF,
21419,GO:1990907,1,0.915510474118567,0,11,beta-catenin-TCF complex,CC,
21420,GO:1990909,1,0.908980904712702,0,11,Wnt signalosome,CC,
21421,GO:1990910,1,0.977229337064145,0,4,response to hypobaric hypoxia,BP,
21422,GO:1990911,1,0.975745422350328,0,4,response to psychosocial stress,BP,
21423,GO:1990913,1,0.974641409888087,0,4,sperm head plasma membrane,CC,
21424,GO:1990917,1,0.993837575347301,0,1,ooplasm,CC,
21425,GO:1990918,1,0.970636429419564,0,4,double-strand break repair involved in meiotic recombination,BP,
21426,GO:1990922,1,0.99294514711195,0,1,hepatic stellate cell proliferation,BP,
21427,GO:1990923,1,0.981654319839959,0,3,PET complex,CC,
21428,GO:1990926,1,0.979515292116869,0,3,short-term synaptic potentiation,BP,
21429,GO:1990927,1,0.984120378523644,0,2,calcium ion regulated lysosome exocytosis,BP,
21430,GO:1990928,1,0.750259513848314,0,45,response to amino acid starvation,BP,
21431,GO:1990930,1,0.995665824555013,0,1,RNA N1-methyladenosine dioxygenase activity,MF,
21432,GO:1990931,1,0.985394129467855,0,2,RNA N6-methyladenosine dioxygenase activity,MF,
21433,GO:1990935,1,0.986627481838076,0,3,splicing factor binding,MF,
21434,GO:1990936,1,0.988519496290071,0,2,vascular associated smooth muscle cell dedifferentiation,BP,
21435,GO:1990938,1,0.992615277517046,0,1,peptidyl-aspartic acid autophosphorylation,BP,
21436,GO:1990939,1,0.691956762218739,0,34,ATP-dependent microtubule motor activity,MF,
21437,GO:1990948,1,0.982146564793115,0,5,ubiquitin ligase inhibitor activity,MF,
21438,GO:1990949,1,0.995080152823623,0,1,metaphase/anaphase transition of meiosis I,BP,
21439,GO:1990955,1,0.992571500217296,0,1,G-rich single-stranded DNA binding,MF,
21440,GO:1990959,1,0.992770574781404,0,1,eosinophil homeostasis,BP,
21441,GO:1990960,1,0.992770574781404,0,1,basophil homeostasis,BP,
21442,GO:1990961,1,0.951985880105055,0,8,xenobiotic detoxification by transmembrane export across the plasma membrane,BP,
21443,GO:1990962,1,0.965821275562137,0,5,xenobiotic transport across blood-brain barrier,BP,
21444,GO:1990963,1,0.994866241851328,0,1,establishment of blood-retinal barrier,BP,
21445,GO:1990966,1,0.974297384644832,0,4,ATP generation from poly-ADP-D-ribose,BP,
21446,GO:1990968,1,0.990681270094271,0,1,modulation by host of RNA binding by virus,BP,
21447,GO:1990969,1,0.990681270094271,0,1,modulation by host of viral RNA-binding transcription factor activity,BP,
21448,GO:1990971,1,0.992648041532267,0,1,EMILIN complex,CC,
21449,GO:1990983,1,0.993768094168258,0,1,tRNA demethylation,BP,
21450,GO:1990984,1,0.986275739639682,0,2,tRNA demethylase activity,MF,
21451,GO:2000001,1,0.904328313334457,0,16,regulation of DNA damage checkpoint,BP,
21452,GO:2000002,1,0.969702897682116,0,5,negative regulation of DNA damage checkpoint,BP,
21453,GO:2000003,1,0.993485400251684,0,1,positive regulation of DNA damage checkpoint,BP,
21454,GO:2000004,1,0.995293167006598,0,1,regulation of metanephric S-shaped body morphogenesis,BP,
21455,GO:2000005,1,0.995293167006598,0,1,negative regulation of metanephric S-shaped body morphogenesis,BP,
21456,GO:2000006,1,0.995293167006598,0,1,regulation of metanephric comma-shaped body morphogenesis,BP,
21457,GO:2000007,1,0.995293167006598,0,1,negative regulation of metanephric comma-shaped body morphogenesis,BP,
21458,GO:2000008,1,0.764787705505797,0,39,regulation of protein localization to cell surface,BP,
21459,GO:2000009,1,0.919123780775326,0,13,negative regulation of protein localization to cell surface,BP,
21460,GO:2000010,1,0.888279706170231,0,17,positive regulation of protein localization to cell surface,BP,
21461,GO:2000011,1,0.994472730706653,0,1,regulation of adaxial/abaxial pattern formation,BP,
21462,GO:2000015,1,0.978103638626609,0,4,regulation of determination of dorsal identity,BP,
21463,GO:2000016,1,0.991814058342737,0,2,negative regulation of determination of dorsal identity,BP,
21464,GO:2000017,1,0.986177551550516,0,2,positive regulation of determination of dorsal identity,BP,
21465,GO:2000018,1,0.942428291660201,0,9,regulation of male gonad development,BP,
21466,GO:2000019,1,0.992661278022655,0,1,negative regulation of male gonad development,BP,
21467,GO:2000020,1,0.949399273285381,0,8,positive regulation of male gonad development,BP,
21471,GO:2000036,1,0.799787366624461,0,31,regulation of stem cell population maintenance,BP,
21474,GO:2000042,1,0.903244616338283,0,13,negative regulation of double-strand break repair via homologous recombination,BP,
21475,GO:2000043,1,0.994198568848389,0,1,regulation of cardiac cell fate specification,BP,
21476,GO:2000045,1,0.376855586911156,0,146,regulation of G1/S transition of mitotic cell cycle,BP,
21477,GO:2000047,1,0.877132569085224,0,18,regulation of cell-cell adhesion mediated by cadherin,BP,
21478,GO:2000048,1,0.937578779646551,0,9,negative regulation of cell-cell adhesion mediated by cadherin,BP,
21479,GO:2000049,1,0.935569618571767,0,9,positive regulation of cell-cell adhesion mediated by cadherin,BP,
21482,GO:2000052,1,0.914964845172419,0,13,positive regulation of non-canonical Wnt signaling pathway,BP,
21483,GO:2000053,1,0.992354350453992,0,1,regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
21484,GO:2000054,1,0.992354350453992,0,1,negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
21485,GO:2000056,1,0.995111019972932,0,1,regulation of Wnt signaling pathway involved in digestive tract morphogenesis,BP,
21486,GO:2000057,1,0.995111019972932,0,1,negative regulation of Wnt signaling pathway involved in digestive tract morphogenesis,BP,
21487,GO:2000058,1,0.365090989334286,0,151,regulation of ubiquitin-dependent protein catabolic process,BP,
21488,GO:2000059,1,0.742514700031652,0,45,negative regulation of ubiquitin-dependent protein catabolic process,BP,
21489,GO:2000060,1,0.52186197983142,0,97,positive regulation of ubiquitin-dependent protein catabolic process,BP,
21490,GO:2000061,1,0.995665824555013,0,1,regulation of ureter smooth muscle cell differentiation,BP,
21491,GO:2000062,1,0.995665824555013,0,1,negative regulation of ureter smooth muscle cell differentiation,BP,
21492,GO:2000063,1,0.995665824555013,0,1,positive regulation of ureter smooth muscle cell differentiation,BP,
21493,GO:2000064,1,0.94836579012132,0,7,regulation of cortisol biosynthetic process,BP,
21494,GO:2000065,1,0.974143970854964,0,4,negative regulation of cortisol biosynthetic process,BP,
21495,GO:2000066,1,0.992661278022655,0,1,positive regulation of cortisol biosynthetic process,BP,
21496,GO:2000074,1,0.950953532629211,0,8,regulation of type B pancreatic cell development,BP,
21497,GO:2000077,1,0.984680895577556,0,2,negative regulation of type B pancreatic cell development,BP,
21498,GO:2000078,1,0.985933673758087,0,3,positive regulation of type B pancreatic cell development,BP,
21499,GO:2000079,1,0.992354350453992,0,1,regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,
21500,GO:2000080,1,0.992354350453992,0,1,negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,
21502,GO:2000096,1,0.941079063319486,0,9,positive regulation of Wnt signaling pathway, planar cell polarity pathway,BP,
21503,GO:2000097,1,0.983379244096542,0,3,regulation of smooth muscle cell-matrix adhesion,BP,
21504,GO:2000098,1,0.989439563297896,0,2,negative regulation of smooth muscle cell-matrix adhesion,BP,
21505,GO:2000101,1,0.99327483731023,0,1,regulation of mammary stem cell proliferation,BP,
21506,GO:2000103,1,0.99327483731023,0,1,positive regulation of mammary stem cell proliferation,BP,
21507,GO:2000104,1,0.883804268462053,0,18,negative regulation of DNA-dependent DNA replication,BP,
21508,GO:2000105,1,0.912549433404946,0,12,positive regulation of DNA-dependent DNA replication,BP,
21509,GO:2000106,1,0.619572178739483,0,77,regulation of leukocyte apoptotic process,BP,
21510,GO:2000107,1,0.768879396942382,0,43,negative regulation of leukocyte apoptotic process,BP,
21511,GO:2000108,1,0.856246118852154,0,25,positive regulation of leukocyte apoptotic process,BP,
21512,GO:2000109,1,0.954851569238763,0,7,regulation of macrophage apoptotic process,BP,
21513,GO:2000110,1,0.980210731604727,0,3,negative regulation of macrophage apoptotic process,BP,
21514,GO:2000111,1,0.979947566249235,0,3,positive regulation of macrophage apoptotic process,BP,
21517,GO:2000114,1,0.864845374482222,0,18,regulation of establishment of cell polarity,BP,
21520,GO:2000118,1,0.976598233072373,0,4,regulation of sodium-dependent phosphate transport,BP,
21521,GO:2000119,1,0.993234499746785,0,1,negative regulation of sodium-dependent phosphate transport,BP,
21522,GO:2000120,1,0.990634495648102,0,2,positive regulation of sodium-dependent phosphate transport,BP,
21523,GO:2000121,1,0.937997107741948,0,11,regulation of removal of superoxide radicals,BP,
21525,GO:2000134,1,0.511974277330094,0,100,negative regulation of G1/S transition of mitotic cell cycle,BP,
21526,GO:2000136,1,0.893902984899833,0,15,regulation of cell proliferation involved in heart morphogenesis,BP,
21527,GO:2000137,1,0.969942415979229,0,3,negative regulation of cell proliferation involved in heart morphogenesis,BP,
21528,GO:2000138,1,0.964886711449118,0,5,positive regulation of cell proliferation involved in heart morphogenesis,BP,
21529,GO:2000142,1,0.729930320197779,0,44,regulation of DNA-templated transcription, initiation,BP,
21530,GO:2000143,1,0.959029794920915,0,6,negative regulation of DNA-templated transcription, initiation,BP,
21531,GO:2000144,1,0.772828491167869,0,36,positive regulation of DNA-templated transcription, initiation,BP,
21534,GO:2000147,1,0.0327822380113987,0,490,positive regulation of cell motility,BP,
21535,GO:2000152,1,0.974274754637142,0,5,regulation of ubiquitin-specific protease activity,BP,
21536,GO:2000155,1,0.956378035888487,0,9,positive regulation of cilium-dependent cell motility,BP,
21537,GO:2000156,1,0.986063947383987,0,2,regulation of retrograde vesicle-mediated transport, Golgi to ER,BP,
21538,GO:2000157,1,0.992757795684453,0,2,negative regulation of ubiquitin-specific protease activity,BP,
21539,GO:2000158,1,0.988685464371354,0,2,positive regulation of ubiquitin-specific protease activity,BP,
21540,GO:2000167,1,0.991624076780836,0,1,regulation of planar cell polarity pathway involved in neural tube closure,BP,
21541,GO:2000169,1,0.940621590369545,0,8,regulation of peptidyl-cysteine S-nitrosylation,BP,
21542,GO:2000170,1,0.98251882189713,0,3,positive regulation of peptidyl-cysteine S-nitrosylation,BP,
21543,GO:2000171,1,0.812190814074484,0,27,negative regulation of dendrite development,BP,
21544,GO:2000172,1,0.961433161289855,0,5,regulation of branching morphogenesis of a nerve,BP,
21545,GO:2000173,1,0.992637295665196,0,1,negative regulation of branching morphogenesis of a nerve,BP,
21546,GO:2000174,1,0.992629128099668,0,1,regulation of pro-T cell differentiation,BP,
21547,GO:2000176,1,0.992629128099668,0,1,positive regulation of pro-T cell differentiation,BP,
21549,GO:2000178,1,0.855737009521049,0,22,negative regulation of neural precursor cell proliferation,BP,
21551,GO:2000180,1,0.992661278022655,0,1,negative regulation of androgen biosynthetic process,BP,
21553,GO:2000182,1,0.972260891570121,0,4,regulation of progesterone biosynthetic process,BP,
21554,GO:2000184,1,0.986707815084262,0,2,positive regulation of progesterone biosynthetic process,BP,
21555,GO:2000191,1,0.891122264336859,0,18,regulation of fatty acid transport,BP,
21556,GO:2000192,1,0.959153792636885,0,5,negative regulation of fatty acid transport,BP,
21557,GO:2000193,1,0.929094802775537,0,13,positive regulation of fatty acid transport,BP,
21558,GO:2000194,1,0.930687864923901,0,12,regulation of female gonad development,BP,
21559,GO:2000195,1,0.975598759443051,0,4,negative regulation of female gonad development,BP,
21560,GO:2000196,1,0.98580808739651,0,3,positive regulation of female gonad development,BP,
21561,GO:2000197,1,0.9468575287847,0,7,regulation of ribonucleoprotein complex localization,BP,
21562,GO:2000199,1,0.993112295578502,0,1,positive regulation of ribonucleoprotein complex localization,BP,
21563,GO:2000200,1,0.993112295578502,0,1,regulation of ribosomal subunit export from nucleus,BP,
21564,GO:2000202,1,0.993112295578502,0,1,positive regulation of ribosomal subunit export from nucleus,BP,
21565,GO:2000206,1,0.993112295578502,0,1,regulation of ribosomal small subunit export from nucleus,BP,
21566,GO:2000208,1,0.993112295578502,0,1,positive regulation of ribosomal small subunit export from nucleus,BP,
21567,GO:2000209,1,0.860625425010697,0,21,regulation of anoikis,BP,
21568,GO:2000210,1,0.972780829594082,0,5,positive regulation of anoikis,BP,
21569,GO:2000211,1,0.974697359783888,0,3,regulation of glutamate metabolic process,BP,
21570,GO:2000212,1,0.991922149833017,0,1,negative regulation of glutamate metabolic process,BP,
21571,GO:2000213,1,0.994580882739056,0,1,positive regulation of glutamate metabolic process,BP,
21572,GO:2000224,1,0.985439916288249,0,3,regulation of testosterone biosynthetic process,BP,
21573,GO:2000225,1,0.989182800493848,0,2,negative regulation of testosterone biosynthetic process,BP,
21574,GO:2000226,1,0.995868123078444,0,1,regulation of pancreatic A cell differentiation,BP,
21575,GO:2000227,1,0.995868123078444,0,1,negative regulation of pancreatic A cell differentiation,BP,
21576,GO:2000229,1,0.991305562308781,0,2,regulation of pancreatic stellate cell proliferation,BP,
21577,GO:2000230,1,0.995152293069162,0,1,negative regulation of pancreatic stellate cell proliferation,BP,
21578,GO:2000231,1,0.996134718669981,0,1,positive regulation of pancreatic stellate cell proliferation,BP,
21579,GO:2000232,1,0.914984234369121,0,13,regulation of rRNA processing,BP,
21580,GO:2000233,1,0.976701403836714,0,3,negative regulation of rRNA processing,BP,
21581,GO:2000234,1,0.944622793422231,0,9,positive regulation of rRNA processing,BP,
21583,GO:2000242,1,0.752217039832401,0,47,negative regulation of reproductive process,BP,
21584,GO:2000243,1,0.626961323023942,0,72,positive regulation of reproductive process,BP,
21585,GO:2000249,1,0.777490586195424,0,39,regulation of actin cytoskeleton reorganization,BP,
21586,GO:2000250,1,0.990150401479357,0,1,negative regulation of actin cytoskeleton reorganization,BP,
21587,GO:2000251,1,0.90065891110149,0,19,positive regulation of actin cytoskeleton reorganization,BP,
21588,GO:2000252,1,0.96052773936962,0,8,negative regulation of feeding behavior,BP,
21589,GO:2000253,1,0.963494504694862,0,5,positive regulation of feeding behavior,BP,
21590,GO:2000254,1,0.982396990343297,0,4,regulation of male germ cell proliferation,BP,
21591,GO:2000255,1,0.985783449553537,0,3,negative regulation of male germ cell proliferation,BP,
21592,GO:2000256,1,0.996565195709483,0,1,positive regulation of male germ cell proliferation,BP,
21593,GO:2000269,1,0.887697525158313,0,17,regulation of fibroblast apoptotic process,BP,
21594,GO:2000270,1,0.95001785378847,0,7,negative regulation of fibroblast apoptotic process,BP,
21595,GO:2000271,1,0.943493371886983,0,8,positive regulation of fibroblast apoptotic process,BP,
21596,GO:2000272,1,0.771204021435908,0,42,negative regulation of signaling receptor activity,BP,
21598,GO:2000275,1,0.9812570251225,0,4,regulation of oxidative phosphorylation uncoupler activity,BP,
21599,GO:2000276,1,0.990027761145284,0,2,negative regulation of oxidative phosphorylation uncoupler activity,BP,
21600,GO:2000277,1,0.996625193861694,0,1,positive regulation of oxidative phosphorylation uncoupler activity,BP,
21601,GO:2000278,1,0.506913687558653,0,102,regulation of DNA biosynthetic process,BP,
21602,GO:2000279,1,0.797968872686933,0,33,negative regulation of DNA biosynthetic process,BP,
21603,GO:2000282,1,0.980456454143667,0,3,regulation of cellular amino acid biosynthetic process,BP,
21604,GO:2000283,1,0.988659840744814,0,1,negative regulation of cellular amino acid biosynthetic process,BP,
21605,GO:2000284,1,0.996625193861694,0,1,positive regulation of cellular amino acid biosynthetic process,BP,
21606,GO:2000286,1,0.980326752785287,0,3,receptor internalization involved in canonical Wnt signaling pathway,BP,
21607,GO:2000287,1,0.994394605283783,0,1,positive regulation of myotome development,BP,
21608,GO:2000288,1,0.941448019455707,0,9,positive regulation of myoblast proliferation,BP,
21609,GO:2000290,1,0.994394605283783,0,1,regulation of myotome development,BP,
21610,GO:2000291,1,0.910700667825918,0,14,regulation of myoblast proliferation,BP,
21611,GO:2000295,1,0.978531638835071,0,4,regulation of hydrogen peroxide catabolic process,BP,
21612,GO:2000296,1,0.993117326139104,0,2,negative regulation of hydrogen peroxide catabolic process,BP,
21613,GO:2000297,1,0.977576426855394,0,3,negative regulation of synapse maturation,BP,
21614,GO:2000298,1,0.968725353533356,0,4,regulation of Rho-dependent protein serine/threonine kinase activity,BP,
21615,GO:2000299,1,0.974469778576496,0,3,negative regulation of Rho-dependent protein serine/threonine kinase activity,BP,
21619,GO:2000303,1,0.914820285504014,0,15,regulation of ceramide biosynthetic process,BP,
21620,GO:2000304,1,0.944549675223671,0,9,positive regulation of ceramide biosynthetic process,BP,
21621,GO:2000307,1,0.987258603588318,0,2,regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,
21622,GO:2000308,1,0.994149557619953,0,1,negative regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,
21623,GO:2000309,1,0.993068898952965,0,1,positive regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,
21625,GO:2000311,1,0.830052808985431,0,25,regulation of AMPA receptor activity,BP,
21626,GO:2000312,1,0.977082765147754,0,3,regulation of kainate selective glutamate receptor activity,BP,
21627,GO:2000313,1,0.990626807596223,0,2,regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
21628,GO:2000314,1,0.995511332060727,0,1,negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
21629,GO:2000316,1,0.895248106347893,0,16,regulation of T-helper 17 type immune response,BP,
21630,GO:2000317,1,0.935099000031956,0,9,negative regulation of T-helper 17 type immune response,BP,
21631,GO:2000318,1,0.957411204535741,0,7,positive regulation of T-helper 17 type immune response,BP,
21632,GO:2000319,1,0.907965539477795,0,14,regulation of T-helper 17 cell differentiation,BP,
21633,GO:2000320,1,0.941712400601867,0,8,negative regulation of T-helper 17 cell differentiation,BP,
21634,GO:2000321,1,0.964185490263887,0,6,positive regulation of T-helper 17 cell differentiation,BP,
21635,GO:2000322,1,0.946407518799785,0,8,regulation of glucocorticoid receptor signaling pathway,BP,
21636,GO:2000323,1,0.958316653648279,0,6,negative regulation of glucocorticoid receptor signaling pathway,BP,
21637,GO:2000324,1,0.987578117013143,0,2,positive regulation of glucocorticoid receptor signaling pathway,BP,
21638,GO:2000325,1,0.976347823954001,0,3,regulation of nuclear receptor transcription coactivator activity,BP,
21639,GO:2000327,1,0.980575339755157,0,2,positive regulation of nuclear receptor transcription coactivator activity,BP,
21640,GO:2000328,1,0.978429743685242,0,4,regulation of T-helper 17 cell lineage commitment,BP,
21641,GO:2000329,1,0.98691795368404,0,2,negative regulation of T-helper 17 cell lineage commitment,BP,
21642,GO:2000330,1,0.991400404383455,0,2,positive regulation of T-helper 17 cell lineage commitment,BP,
21643,GO:2000331,1,0.985664588180955,0,2,regulation of terminal button organization,BP,
21644,GO:2000332,1,0.990262455066593,0,2,regulation of blood microparticle formation,BP,
21645,GO:2000334,1,0.990262455066593,0,2,positive regulation of blood microparticle formation,BP,
21646,GO:2000338,1,0.98135422995309,0,3,regulation of chemokine (C-X-C motif) ligand 1 production,BP,
21647,GO:2000340,1,0.98135422995309,0,3,positive regulation of chemokine (C-X-C motif) ligand 1 production,BP,
21648,GO:2000341,1,0.924794465086708,0,13,regulation of chemokine (C-X-C motif) ligand 2 production,BP,
21649,GO:2000342,1,0.987482930760553,0,2,negative regulation of chemokine (C-X-C motif) ligand 2 production,BP,
21650,GO:2000343,1,0.949637006987575,0,9,positive regulation of chemokine (C-X-C motif) ligand 2 production,BP,
21651,GO:2000344,1,0.944184682164139,0,9,positive regulation of acrosome reaction,BP,
21652,GO:2000345,1,0.920206330983819,0,13,regulation of hepatocyte proliferation,BP,
21653,GO:2000346,1,0.980348017162381,0,3,negative regulation of hepatocyte proliferation,BP,
21654,GO:2000347,1,0.952583307879384,0,8,positive regulation of hepatocyte proliferation,BP,
21655,GO:2000348,1,0.964076885743299,0,6,regulation of CD40 signaling pathway,BP,
21656,GO:2000349,1,0.987285817008646,0,2,negative regulation of CD40 signaling pathway,BP,
21657,GO:2000350,1,0.996465856482775,0,1,positive regulation of CD40 signaling pathway,BP,
21658,GO:2000351,1,0.738188264709292,0,46,regulation of endothelial cell apoptotic process,BP,
21659,GO:2000352,1,0.836551657298604,0,26,negative regulation of endothelial cell apoptotic process,BP,
21660,GO:2000353,1,0.886604165466745,0,19,positive regulation of endothelial cell apoptotic process,BP,
21661,GO:2000354,1,0.966170455200774,0,6,regulation of ovarian follicle development,BP,
21662,GO:2000355,1,0.989856016256125,0,2,negative regulation of ovarian follicle development,BP,
21663,GO:2000356,1,0.995665824555013,0,1,regulation of kidney smooth muscle cell differentiation,BP,
21664,GO:2000357,1,0.995665824555013,0,1,negative regulation of kidney smooth muscle cell differentiation,BP,
21665,GO:2000358,1,0.995665824555013,0,1,positive regulation of kidney smooth muscle cell differentiation,BP,
21666,GO:2000359,1,0.990376581374943,0,2,regulation of binding of sperm to zona pellucida,BP,
21667,GO:2000360,1,0.990376581374943,0,2,negative regulation of binding of sperm to zona pellucida,BP,
21668,GO:2000361,1,0.977902480861524,0,3,regulation of prostaglandin-E synthase activity,BP,
21669,GO:2000363,1,0.977902480861524,0,3,positive regulation of prostaglandin-E synthase activity,BP,
21670,GO:2000367,1,0.98369628083269,0,3,regulation of acrosomal vesicle exocytosis,BP,
21671,GO:2000368,1,0.990976190586822,0,2,positive regulation of acrosomal vesicle exocytosis,BP,
21672,GO:2000369,1,0.866709157266612,0,18,regulation of clathrin-dependent endocytosis,BP,
21673,GO:2000370,1,0.961540285193686,0,5,positive regulation of clathrin-dependent endocytosis,BP,
21676,GO:2000374,1,0.988495940067969,0,3,regulation of oxygen metabolic process,BP,
21677,GO:2000376,1,0.99367398616226,0,2,positive regulation of oxygen metabolic process,BP,
21680,GO:2000379,1,0.564326963892932,0,88,positive regulation of reactive oxygen species metabolic process,BP,
21683,GO:2000382,1,0.968273665838648,0,5,positive regulation of mesoderm development,BP,
21684,GO:2000383,1,0.992685567166604,0,1,regulation of ectoderm development,BP,
21685,GO:2000384,1,0.992685567166604,0,1,negative regulation of ectoderm development,BP,
21686,GO:2000386,1,0.988586160308451,0,2,positive regulation of ovarian follicle development,BP,
21687,GO:2000387,1,0.99596539912855,0,1,regulation of antral ovarian follicle growth,BP,
21688,GO:2000388,1,0.99596539912855,0,1,positive regulation of antral ovarian follicle growth,BP,
21689,GO:2000389,1,0.969089035978131,0,5,regulation of neutrophil extravasation,BP,
21690,GO:2000391,1,0.974864681136073,0,4,positive regulation of neutrophil extravasation,BP,
21691,GO:2000392,1,0.921146088802825,0,11,regulation of lamellipodium morphogenesis,BP,
21692,GO:2000393,1,0.98536319255427,0,2,negative regulation of lamellipodium morphogenesis,BP,
21693,GO:2000394,1,0.94852996077383,0,7,positive regulation of lamellipodium morphogenesis,BP,
21694,GO:2000395,1,0.992268357047503,0,2,regulation of ubiquitin-dependent endocytosis,BP,
21695,GO:2000397,1,0.992268357047503,0,2,positive regulation of ubiquitin-dependent endocytosis,BP,
21696,GO:2000401,1,0.710407154610617,0,56,regulation of lymphocyte migration,BP,
21697,GO:2000402,1,0.920733027495724,0,13,negative regulation of lymphocyte migration,BP,
21698,GO:2000403,1,0.824558245652568,0,33,positive regulation of lymphocyte migration,BP,
21699,GO:2000404,1,0.791104919161472,0,39,regulation of T cell migration,BP,
21700,GO:2000405,1,0.971178929924182,0,5,negative regulation of T cell migration,BP,
21701,GO:2000406,1,0.845060322555642,0,28,positive regulation of T cell migration,BP,
21702,GO:2000407,1,0.970302249025705,0,5,regulation of T cell extravasation,BP,
21703,GO:2000408,1,0.992981459590117,0,1,negative regulation of T cell extravasation,BP,
21704,GO:2000409,1,0.982051652160512,0,3,positive regulation of T cell extravasation,BP,
21705,GO:2000410,1,0.978038021474876,0,4,regulation of thymocyte migration,BP,
21706,GO:2000412,1,0.983300555543071,0,3,positive regulation of thymocyte migration,BP,
21707,GO:2000413,1,0.993068898952965,0,1,regulation of fibronectin-dependent thymocyte migration,BP,
21708,GO:2000415,1,0.993068898952965,0,1,positive regulation of fibronectin-dependent thymocyte migration,BP,
21709,GO:2000416,1,0.974974434531263,0,4,regulation of eosinophil migration,BP,
21710,GO:2000417,1,0.988016251300398,0,2,negative regulation of eosinophil migration,BP,
21711,GO:2000418,1,0.986801578896909,0,2,positive regulation of eosinophil migration,BP,
21712,GO:2000419,1,0.992889958085752,0,1,regulation of eosinophil extravasation,BP,
21713,GO:2000420,1,0.992889958085752,0,1,negative regulation of eosinophil extravasation,BP,
21714,GO:2000422,1,0.993689374840525,0,1,regulation of eosinophil chemotaxis,BP,
21715,GO:2000424,1,0.993689374840525,0,1,positive regulation of eosinophil chemotaxis,BP,
21716,GO:2000425,1,0.936002233943258,0,10,regulation of apoptotic cell clearance,BP,
21717,GO:2000426,1,0.988251937654573,0,2,negative regulation of apoptotic cell clearance,BP,
21718,GO:2000427,1,0.948783491709514,0,8,positive regulation of apoptotic cell clearance,BP,
21719,GO:2000431,1,0.992649818073052,0,1,regulation of cytokinesis, actomyosin contractile ring assembly,BP,
21720,GO:2000434,1,0.986645548346309,0,3,regulation of protein neddylation,BP,
21721,GO:2000435,1,0.993535537164852,0,2,negative regulation of protein neddylation,BP,
21722,GO:2000436,1,0.993065630855463,0,1,positive regulation of protein neddylation,BP,
21723,GO:2000437,1,0.973234484131186,0,4,regulation of monocyte extravasation,BP,
21724,GO:2000438,1,0.990388832501393,0,1,negative regulation of monocyte extravasation,BP,
21725,GO:2000439,1,0.982680835481867,0,3,positive regulation of monocyte extravasation,BP,
21726,GO:2000446,1,0.983900970377561,0,3,regulation of macrophage migration inhibitory factor signaling pathway,BP,
21727,GO:2000448,1,0.991403220357889,0,2,positive regulation of macrophage migration inhibitory factor signaling pathway,BP,
21728,GO:2000449,1,0.984187375125594,0,3,regulation of CD8-positive, alpha-beta T cell extravasation,BP,
21729,GO:2000451,1,0.989111746968567,0,2,positive regulation of CD8-positive, alpha-beta T cell extravasation,BP,
21730,GO:2000452,1,0.990212416866869,0,2,regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
21731,GO:2000454,1,0.995166631463258,0,1,positive regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
21732,GO:2000458,1,0.98924122772222,0,2,regulation of astrocyte chemotaxis,BP,
21733,GO:2000463,1,0.804131600894494,0,28,positive regulation of excitatory postsynaptic potential,BP,
21734,GO:2000464,1,0.993916002159667,0,1,positive regulation of astrocyte chemotaxis,BP,
21735,GO:2000465,1,0.949096448204172,0,7,regulation of glycogen (starch) synthase activity,BP,
21736,GO:2000466,1,0.977801232851791,0,3,negative regulation of glycogen (starch) synthase activity,BP,
21737,GO:2000467,1,0.971861713340171,0,4,positive regulation of glycogen (starch) synthase activity,BP,
21738,GO:2000468,1,0.974962264249546,0,3,regulation of peroxidase activity,BP,
21739,GO:2000469,1,0.988303784808711,0,1,negative regulation of peroxidase activity,BP,
21740,GO:2000470,1,0.986502162401469,0,2,positive regulation of peroxidase activity,BP,
21741,GO:2000471,1,0.985886401099802,0,2,regulation of hematopoietic stem cell migration,BP,
21742,GO:2000473,1,0.985886401099802,0,2,positive regulation of hematopoietic stem cell migration,BP,
21743,GO:2000474,1,0.986669485165206,0,2,regulation of opioid receptor signaling pathway,BP,
21744,GO:2000479,1,0.878456959499479,0,19,regulation of cAMP-dependent protein kinase activity,BP,
21745,GO:2000480,1,0.946439350960831,0,9,negative regulation of cAMP-dependent protein kinase activity,BP,
21746,GO:2000481,1,0.960599454380724,0,5,positive regulation of cAMP-dependent protein kinase activity,BP,
21747,GO:2000485,1,0.986907078026234,0,2,regulation of glutamine transport,BP,
21748,GO:2000486,1,0.992882637749378,0,1,negative regulation of glutamine transport,BP,
21749,GO:2000487,1,0.993982033751052,0,1,positive regulation of glutamine transport,BP,
21750,GO:2000489,1,0.958633385928086,0,6,regulation of hepatic stellate cell activation,BP,
21751,GO:2000490,1,0.987746467910194,0,2,negative regulation of hepatic stellate cell activation,BP,
21752,GO:2000491,1,0.970529333739082,0,4,positive regulation of hepatic stellate cell activation,BP,
21753,GO:2000492,1,0.993220829637341,0,1,regulation of interleukin-18-mediated signaling pathway,BP,
21754,GO:2000494,1,0.993220829637341,0,1,positive regulation of interleukin-18-mediated signaling pathway,BP,
21755,GO:2000501,1,0.980631565456144,0,5,regulation of natural killer cell chemotaxis,BP,
21756,GO:2000502,1,0.992541648422494,0,2,negative regulation of natural killer cell chemotaxis,BP,
21757,GO:2000503,1,0.988001316779946,0,3,positive regulation of natural killer cell chemotaxis,BP,
21758,GO:2000504,1,0.994179664991472,0,1,positive regulation of blood vessel remodeling,BP,
21759,GO:2000508,1,0.954692471731615,0,9,regulation of dendritic cell chemotaxis,BP,
21760,GO:2000509,1,0.992959140717592,0,1,negative regulation of dendritic cell chemotaxis,BP,
21761,GO:2000510,1,0.961464662714497,0,8,positive regulation of dendritic cell chemotaxis,BP,
21762,GO:2000511,1,0.996225422430372,0,1,regulation of granzyme A production,BP,
21763,GO:2000513,1,0.996225422430372,0,1,positive regulation of granzyme A production,BP,
21764,GO:2000514,1,0.711577864373566,0,55,regulation of CD4-positive, alpha-beta T cell activation,BP,
21765,GO:2000515,1,0.841000285204766,0,27,negative regulation of CD4-positive, alpha-beta T cell activation,BP,
21766,GO:2000516,1,0.828897349799837,0,32,positive regulation of CD4-positive, alpha-beta T cell activation,BP,
21767,GO:2000517,1,0.996225422430372,0,1,regulation of T-helper 1 cell activation,BP,
21768,GO:2000518,1,0.996225422430372,0,1,negative regulation of T-helper 1 cell activation,BP,
21769,GO:2000520,1,0.984803419972752,0,3,regulation of immunological synapse formation,BP,
21770,GO:2000521,1,0.990209028668889,0,2,negative regulation of immunological synapse formation,BP,
21771,GO:2000522,1,0.994541478353388,0,1,positive regulation of immunological synapse formation,BP,
21772,GO:2000523,1,0.983171082149184,0,3,regulation of T cell costimulation,BP,
21773,GO:2000524,1,0.995689583688793,0,1,negative regulation of T cell costimulation,BP,
21774,GO:2000525,1,0.987427845542114,0,2,positive regulation of T cell costimulation,BP,
21775,GO:2000526,1,0.994541478353388,0,1,positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation,BP,
21776,GO:2000527,1,0.99670121397455,0,1,regulation of myeloid dendritic cell chemotaxis,BP,
21777,GO:2000529,1,0.99670121397455,0,1,positive regulation of myeloid dendritic cell chemotaxis,BP,
21778,GO:2000532,1,0.99390366202136,0,1,regulation of renal albumin absorption,BP,
21779,GO:2000533,1,0.99390366202136,0,1,negative regulation of renal albumin absorption,BP,
21780,GO:2000535,1,0.957275047010352,0,6,regulation of entry of bacterium into host cell,BP,
21781,GO:2000536,1,0.990252924108507,0,1,negative regulation of entry of bacterium into host cell,BP,
21782,GO:2000537,1,0.98868153186364,0,2,regulation of B cell chemotaxis,BP,
21783,GO:2000538,1,0.98868153186364,0,2,positive regulation of B cell chemotaxis,BP,
21784,GO:2000539,1,0.993908944517492,0,1,regulation of protein geranylgeranylation,BP,
21785,GO:2000541,1,0.993908944517492,0,1,positive regulation of protein geranylgeranylation,BP,
21787,GO:2000543,1,0.97069954724629,0,5,positive regulation of gastrulation,BP,
21788,GO:2000544,1,0.966952678176986,0,5,regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
21789,GO:2000545,1,0.996253231912534,0,1,negative regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
21790,GO:2000546,1,0.97773110681106,0,3,positive regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
21791,GO:2000547,1,0.988232842533878,0,3,regulation of dendritic cell dendrite assembly,BP,
21792,GO:2000548,1,0.99670121397455,0,1,negative regulation of dendritic cell dendrite assembly,BP,
21793,GO:2000549,1,0.996945899134573,0,1,positive regulation of dendritic cell dendrite assembly,BP,
21794,GO:2000551,1,0.952067060779967,0,9,regulation of T-helper 2 cell cytokine production,BP,
21795,GO:2000552,1,0.989686646121312,0,2,negative regulation of T-helper 2 cell cytokine production,BP,
21796,GO:2000553,1,0.961992258145229,0,7,positive regulation of T-helper 2 cell cytokine production,BP,
21797,GO:2000554,1,0.973480147770224,0,5,regulation of T-helper 1 cell cytokine production,BP,
21798,GO:2000556,1,0.973480147770224,0,5,positive regulation of T-helper 1 cell cytokine production,BP,
21799,GO:2000557,1,0.996225422430372,0,1,regulation of immunoglobulin production in mucosal tissue,BP,
21800,GO:2000558,1,0.996225422430372,0,1,positive regulation of immunoglobulin production in mucosal tissue,BP,
21801,GO:2000559,1,0.990388832501393,0,1,regulation of CD24 production,BP,
21802,GO:2000560,1,0.990388832501393,0,1,positive regulation of CD24 production,BP,
21803,GO:2000561,1,0.946534819091738,0,11,regulation of CD4-positive, alpha-beta T cell proliferation,BP,
21804,GO:2000562,1,0.964399934525058,0,8,negative regulation of CD4-positive, alpha-beta T cell proliferation,BP,
21805,GO:2000563,1,0.973371184379508,0,5,positive regulation of CD4-positive, alpha-beta T cell proliferation,BP,
21806,GO:2000564,1,0.959026837225564,0,7,regulation of CD8-positive, alpha-beta T cell proliferation,BP,
21807,GO:2000566,1,0.980748365666039,0,4,positive regulation of CD8-positive, alpha-beta T cell proliferation,BP,
21808,GO:2000567,1,0.995704781268359,0,1,regulation of memory T cell activation,BP,
21809,GO:2000568,1,0.995704781268359,0,1,positive regulation of memory T cell activation,BP,
21810,GO:2000569,1,0.992976637579993,0,1,regulation of T-helper 2 cell activation,BP,
21811,GO:2000570,1,0.992976637579993,0,1,positive regulation of T-helper 2 cell activation,BP,
21812,GO:2000571,1,0.992847714373444,0,1,regulation of interleukin-4-dependent isotype switching to IgE isotypes,BP,
21813,GO:2000572,1,0.992847714373444,0,1,positive regulation of interleukin-4-dependent isotype switching to IgE isotypes,BP,
21814,GO:2000573,1,0.644539685721111,0,68,positive regulation of DNA biosynthetic process,BP,
21815,GO:2000574,1,0.945315581975047,0,9,regulation of microtubule motor activity,BP,
21816,GO:2000575,1,0.991381385518801,0,1,negative regulation of microtubule motor activity,BP,
21817,GO:2000576,1,0.982055915249772,0,4,positive regulation of microtubule motor activity,BP,
21818,GO:2000580,1,0.988496317471621,0,3,regulation of ATP-dependent microtubule motor activity, plus-end-directed,BP,
21819,GO:2000582,1,0.988496317471621,0,3,positive regulation of ATP-dependent microtubule motor activity, plus-end-directed,BP,
21820,GO:2000583,1,0.968965513225691,0,4,regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,
21821,GO:2000584,1,0.992686427690166,0,1,negative regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,
21822,GO:2000586,1,0.932509773771015,0,8,regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
21823,GO:2000587,1,0.963401877046039,0,4,negative regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
21824,GO:2000588,1,0.975105201264886,0,3,positive regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
21825,GO:2000589,1,0.978302217119871,0,3,regulation of metanephric mesenchymal cell migration,BP,
21826,GO:2000591,1,0.978302217119871,0,3,positive regulation of metanephric mesenchymal cell migration,BP,
21827,GO:2000592,1,0.985291956540197,0,2,regulation of metanephric DCT cell differentiation,BP,
21828,GO:2000594,1,0.985291956540197,0,2,positive regulation of metanephric DCT cell differentiation,BP,
21829,GO:2000595,1,0.992562811373111,0,1,regulation of optic nerve formation,BP,
21830,GO:2000597,1,0.992562811373111,0,1,positive regulation of optic nerve formation,BP,
21831,GO:2000601,1,0.935823887371076,0,9,positive regulation of Arp2/3 complex-mediated actin nucleation,BP,
21832,GO:2000606,1,0.993140770101177,0,1,regulation of cell proliferation involved in mesonephros development,BP,
21833,GO:2000607,1,0.993140770101177,0,1,negative regulation of cell proliferation involved in mesonephros development,BP,
21834,GO:2000609,1,0.968982408093542,0,5,regulation of thyroid hormone generation,BP,
21835,GO:2000611,1,0.973751830808158,0,4,positive regulation of thyroid hormone generation,BP,
21836,GO:2000612,1,0.992675209673287,0,1,regulation of thyroid-stimulating hormone secretion,BP,
21837,GO:2000615,1,0.924930111863144,0,11,regulation of histone H3-K9 acetylation,BP,
21838,GO:2000616,1,0.991808156178064,0,1,negative regulation of histone H3-K9 acetylation,BP,
21839,GO:2000617,1,0.944735106992252,0,8,positive regulation of histone H3-K9 acetylation,BP,
21840,GO:2000618,1,0.956926826074732,0,6,regulation of histone H4-K16 acetylation,BP,
21841,GO:2000619,1,0.981969029482127,0,3,negative regulation of histone H4-K16 acetylation,BP,
21842,GO:2000620,1,0.981311793417524,0,2,positive regulation of histone H4-K16 acetylation,BP,
21843,GO:2000622,1,0.968897408446662,0,4,regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
21844,GO:2000623,1,0.968897408446662,0,4,negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
21845,GO:2000625,1,0.977518499709988,0,3,regulation of miRNA catabolic process,BP,
21846,GO:2000627,1,0.977518499709988,0,3,positive regulation of miRNA catabolic process,BP,
21847,GO:2000628,1,0.928488505156744,0,10,regulation of miRNA metabolic process,BP,
21848,GO:2000630,1,0.96067162251889,0,6,positive regulation of miRNA metabolic process,BP,
21849,GO:2000631,1,0.984581338076404,0,2,regulation of pre-miRNA processing,BP,
21850,GO:2000632,1,0.984581338076404,0,2,negative regulation of pre-miRNA processing,BP,
21851,GO:2000634,1,0.979918171709591,0,3,regulation of primary miRNA processing,BP,
21852,GO:2000635,1,0.979918171709591,0,3,negative regulation of primary miRNA processing,BP,
21853,GO:2000637,1,0.85766845328372,0,23,positive regulation of gene silencing by miRNA,BP,
21854,GO:2000638,1,0.960584376093304,0,6,regulation of SREBP signaling pathway,BP,
21855,GO:2000639,1,0.98020028260109,0,3,negative regulation of SREBP signaling pathway,BP,
21856,GO:2000640,1,0.98710687859582,0,2,positive regulation of SREBP signaling pathway,BP,
21857,GO:2000641,1,0.89236404961212,0,17,regulation of early endosome to late endosome transport,BP,
21858,GO:2000642,1,0.992936645927986,0,2,negative regulation of early endosome to late endosome transport,BP,
21859,GO:2000643,1,0.942373213230118,0,8,positive regulation of early endosome to late endosome transport,BP,
21860,GO:2000644,1,0.928930226263872,0,10,regulation of receptor catabolic process,BP,
21861,GO:2000645,1,0.980364426191456,0,3,negative regulation of receptor catabolic process,BP,
21862,GO:2000646,1,0.954096266068334,0,6,positive regulation of receptor catabolic process,BP,
21863,GO:2000647,1,0.925459477164638,0,11,negative regulation of stem cell proliferation,BP,
21866,GO:2000650,1,0.911029579372524,0,12,negative regulation of sodium ion transmembrane transporter activity,BP,
21867,GO:2000651,1,0.883342069672538,0,16,positive regulation of sodium ion transmembrane transporter activity,BP,
21868,GO:2000653,1,0.966348904471744,0,4,regulation of genetic imprinting,BP,
21869,GO:2000654,1,0.992687072864748,0,1,regulation of cellular response to testosterone stimulus,BP,
21870,GO:2000655,1,0.992687072864748,0,1,negative regulation of cellular response to testosterone stimulus,BP,
21871,GO:2000656,1,0.995111019972932,0,1,regulation of apolipoprotein binding,BP,
21872,GO:2000657,1,0.995111019972932,0,1,negative regulation of apolipoprotein binding,BP,
21873,GO:2000659,1,0.954465460874479,0,8,regulation of interleukin-1-mediated signaling pathway,BP,
21874,GO:2000660,1,0.972374971025572,0,5,negative regulation of interleukin-1-mediated signaling pathway,BP,
21875,GO:2000661,1,0.992027258864867,0,1,positive regulation of interleukin-1-mediated signaling pathway,BP,
21876,GO:2000668,1,0.937193289494245,0,11,regulation of dendritic cell apoptotic process,BP,
21877,GO:2000669,1,0.963205329038933,0,7,negative regulation of dendritic cell apoptotic process,BP,
21878,GO:2000670,1,0.97300428545891,0,4,positive regulation of dendritic cell apoptotic process,BP,
21879,GO:2000671,1,0.967525124853273,0,5,regulation of motor neuron apoptotic process,BP,
21880,GO:2000672,1,0.974616404050849,0,4,negative regulation of motor neuron apoptotic process,BP,
21881,GO:2000674,1,0.944393636298017,0,9,regulation of type B pancreatic cell apoptotic process,BP,
21882,GO:2000675,1,0.95948692941257,0,6,negative regulation of type B pancreatic cell apoptotic process,BP,
21883,GO:2000676,1,0.984275869549799,0,3,positive regulation of type B pancreatic cell apoptotic process,BP,
21884,GO:2000677,1,0.730385264725735,0,46,regulation of transcription regulatory region DNA binding,BP,
21885,GO:2000678,1,0.889142456346617,0,19,negative regulation of transcription regulatory region DNA binding,BP,
21886,GO:2000679,1,0.867235217914301,0,21,positive regulation of transcription regulatory region DNA binding,BP,
21887,GO:2000683,1,0.986590359716217,0,2,regulation of cellular response to X-ray,BP,
21888,GO:2000685,1,0.993404800891667,0,1,positive regulation of cellular response to X-ray,BP,
21889,GO:2000690,1,0.992484297326678,0,1,regulation of cardiac muscle cell myoblast differentiation,BP,
21890,GO:2000691,1,0.992484297326678,0,1,negative regulation of cardiac muscle cell myoblast differentiation,BP,
21891,GO:2000696,1,0.891780849309339,0,16,regulation of epithelial cell differentiation involved in kidney development,BP,
21892,GO:2000697,1,0.97194147903659,0,5,negative regulation of epithelial cell differentiation involved in kidney development,BP,
21893,GO:2000698,1,0.967901159223589,0,5,positive regulation of epithelial cell differentiation involved in kidney development,BP,
21894,GO:2000699,1,0.993140770101177,0,1,fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
21895,GO:2000701,1,0.993140770101177,0,1,glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
21896,GO:2000702,1,0.993140770101177,0,1,regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
21897,GO:2000703,1,0.993140770101177,0,1,negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
21898,GO:2000705,1,0.976431979488443,0,3,regulation of dense core granule biogenesis,BP,
21899,GO:2000706,1,0.992766099088992,0,1,negative regulation of dense core granule biogenesis,BP,
21900,GO:2000707,1,0.98354804350638,0,2,positive regulation of dense core granule biogenesis,BP,
21901,GO:2000718,1,0.996688208883873,0,1,regulation of maintenance of mitotic sister chromatid cohesion, centromeric,BP,
21902,GO:2000719,1,0.996688208883873,0,1,negative regulation of maintenance of mitotic sister chromatid cohesion, centromeric,BP,
21903,GO:2000721,1,0.975798529235593,0,3,positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,
21904,GO:2000722,1,0.977647272276797,0,3,regulation of cardiac vascular smooth muscle cell differentiation,BP,
21905,GO:2000723,1,0.99363078833264,0,1,negative regulation of cardiac vascular smooth muscle cell differentiation,BP,
21906,GO:2000724,1,0.983915047971108,0,2,positive regulation of cardiac vascular smooth muscle cell differentiation,BP,
21909,GO:2000727,1,0.882508916521405,0,18,positive regulation of cardiac muscle cell differentiation,BP,
21910,GO:2000729,1,0.989305436310238,0,2,positive regulation of mesenchymal cell proliferation involved in ureter development,BP,
21911,GO:2000730,1,0.993062381892642,0,1,regulation of termination of RNA polymerase I transcription,BP,
21912,GO:2000733,1,0.993140770101177,0,1,regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
21913,GO:2000734,1,0.993140770101177,0,1,negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
21914,GO:2000736,1,0.497248544957192,0,112,regulation of stem cell differentiation,BP,
21915,GO:2000737,1,0.865473023064964,0,19,negative regulation of stem cell differentiation,BP,
21916,GO:2000738,1,0.865942975724069,0,21,positive regulation of stem cell differentiation,BP,
21917,GO:2000739,1,0.950307029796632,0,6,regulation of mesenchymal stem cell differentiation,BP,
21918,GO:2000740,1,0.992766099088992,0,1,negative regulation of mesenchymal stem cell differentiation,BP,
21919,GO:2000741,1,0.966358123207188,0,4,positive regulation of mesenchymal stem cell differentiation,BP,
21920,GO:2000742,1,0.994705325851602,0,1,regulation of anterior head development,BP,
21921,GO:2000744,1,0.994705325851602,0,1,positive regulation of anterior head development,BP,
21922,GO:2000752,1,0.993455567656276,0,1,regulation of glucosylceramide catabolic process,BP,
21923,GO:2000753,1,0.993455567656276,0,1,positive regulation of glucosylceramide catabolic process,BP,
21924,GO:2000754,1,0.993455567656276,0,1,regulation of sphingomyelin catabolic process,BP,
21925,GO:2000755,1,0.993455567656276,0,1,positive regulation of sphingomyelin catabolic process,BP,
21926,GO:2000756,1,0.666545344271011,0,60,regulation of peptidyl-lysine acetylation,BP,
21927,GO:2000757,1,0.885600549935218,0,19,negative regulation of peptidyl-lysine acetylation,BP,
21928,GO:2000758,1,0.802074771264762,0,32,positive regulation of peptidyl-lysine acetylation,BP,
21929,GO:2000759,1,0.992058824436193,0,1,regulation of N-terminal peptidyl-lysine acetylation,BP,
21930,GO:2000761,1,0.992058824436193,0,1,positive regulation of N-terminal peptidyl-lysine acetylation,BP,
21931,GO:2000763,1,0.994162708088277,0,1,positive regulation of transcription from RNA polymerase II promoter involved in norepinephrine biosynthetic process,BP,
21932,GO:2000764,1,0.994162708088277,0,1,positive regulation of semaphorin-plexin signaling pathway involved in outflow tract morphogenesis,BP,
21933,GO:2000765,1,0.836335194186308,0,26,regulation of cytoplasmic translation,BP,
21934,GO:2000766,1,0.942159244759553,0,8,negative regulation of cytoplasmic translation,BP,
21935,GO:2000767,1,0.932213693199849,0,10,positive regulation of cytoplasmic translation,BP,
21936,GO:2000768,1,0.992649818073052,0,1,positive regulation of nephron tubule epithelial cell differentiation,BP,
21937,GO:2000772,1,0.761652153118609,0,41,regulation of cellular senescence,BP,
21938,GO:2000773,1,0.869232855961846,0,19,negative regulation of cellular senescence,BP,
21939,GO:2000774,1,0.941244916430183,0,12,positive regulation of cellular senescence,BP,
21940,GO:2000775,1,0.994695440917437,0,1,histone H3-S10 phosphorylation involved in chromosome condensation,BP,
21941,GO:2000777,1,0.989167049030863,0,2,positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia,BP,
21943,GO:2000780,1,0.822372757863194,0,26,negative regulation of double-strand break repair,BP,
21945,GO:2000785,1,0.791171165719367,0,34,regulation of autophagosome assembly,BP,
21946,GO:2000786,1,0.939281082193154,0,8,positive regulation of autophagosome assembly,BP,
21947,GO:2000790,1,0.981981073083156,0,2,regulation of mesenchymal cell proliferation involved in lung development,BP,
21948,GO:2000791,1,0.981981073083156,0,2,negative regulation of mesenchymal cell proliferation involved in lung development,BP,
21949,GO:2000793,1,0.959198607133524,0,4,cell proliferation involved in heart valve development,BP,
21950,GO:2000794,1,0.942704593303447,0,8,regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
21951,GO:2000795,1,0.989216560220255,0,1,negative regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
21952,GO:2000797,1,0.992766099088992,0,1,regulation of amniotic stem cell differentiation,BP,
21953,GO:2000798,1,0.992766099088992,0,1,negative regulation of amniotic stem cell differentiation,BP,
21954,GO:2000800,1,0.99551487069965,0,1,regulation of endocardial cushion to mesenchymal transition involved in heart valve formation,BP,
21955,GO:2000802,1,0.99551487069965,0,1,positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation,BP,
21956,GO:2000804,1,0.974083704580955,0,3,regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,
21957,GO:2000805,1,0.98701281886265,0,2,negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,
21958,GO:2000806,1,0.986902461873921,0,1,positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,
21959,GO:2000807,1,0.928727191121278,0,9,regulation of synaptic vesicle clustering,BP,
21960,GO:2000808,1,0.991484698260322,0,1,negative regulation of synaptic vesicle clustering,BP,
21961,GO:2000809,1,0.960249089875075,0,5,positive regulation of synaptic vesicle clustering,BP,
21962,GO:2000810,1,0.851505295833173,0,23,regulation of bicellular tight junction assembly,BP,
21963,GO:2000811,1,0.889588496063565,0,16,negative regulation of anoikis,BP,
21964,GO:2000812,1,0.992670873273376,0,1,regulation of barbed-end actin filament capping,BP,
21965,GO:2000815,1,0.985603933411921,0,2,regulation of mRNA stability involved in response to oxidative stress,BP,
21967,GO:2000818,1,0.988707827738155,0,2,negative regulation of myoblast proliferation,BP,
21968,GO:2000819,1,0.979954675667127,0,3,regulation of nucleotide-excision repair,BP,
21969,GO:2000820,1,0.979176931260106,0,3,negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,
21970,GO:2000821,1,0.966255174535741,0,5,regulation of grooming behavior,BP,
21971,GO:2000822,1,0.950179064362811,0,9,regulation of behavioral fear response,BP,
21972,GO:2000825,1,0.979144275829809,0,4,positive regulation of androgen receptor activity,BP,
21973,GO:2000826,1,0.760636550319152,0,38,regulation of heart morphogenesis,BP,
21974,GO:2000827,1,0.993944393327592,0,1,mitochondrial RNA surveillance,BP,
21975,GO:2000828,1,0.986529622659676,0,2,regulation of parathyroid hormone secretion,BP,
21976,GO:2000830,1,0.991402803225509,0,1,positive regulation of parathyroid hormone secretion,BP,
21977,GO:2000831,1,0.916539246530234,0,16,regulation of steroid hormone secretion,BP,
21978,GO:2000832,1,0.983869768187195,0,2,negative regulation of steroid hormone secretion,BP,
21979,GO:2000833,1,0.957332571340373,0,9,positive regulation of steroid hormone secretion,BP,
21980,GO:2000834,1,0.992973903647485,0,1,regulation of androgen secretion,BP,
21981,GO:2000836,1,0.992973903647485,0,1,positive regulation of androgen secretion,BP,
21982,GO:2000843,1,0.983315242092615,0,2,regulation of testosterone secretion,BP,
21983,GO:2000845,1,0.983315242092615,0,2,positive regulation of testosterone secretion,BP,
21984,GO:2000846,1,0.930435609815983,0,13,regulation of corticosteroid hormone secretion,BP,
21985,GO:2000847,1,0.983869768187195,0,2,negative regulation of corticosteroid hormone secretion,BP,
21986,GO:2000848,1,0.966826496760433,0,7,positive regulation of corticosteroid hormone secretion,BP,
21987,GO:2000849,1,0.954378393052841,0,9,regulation of glucocorticoid secretion,BP,
21988,GO:2000850,1,0.983869768187195,0,2,negative regulation of glucocorticoid secretion,BP,
21989,GO:2000851,1,0.979846161254036,0,5,positive regulation of glucocorticoid secretion,BP,
21990,GO:2000852,1,0.982559167839413,0,4,regulation of corticosterone secretion,BP,
21991,GO:2000854,1,0.992500904455618,0,2,positive regulation of corticosterone secretion,BP,
21992,GO:2000855,1,0.974924269148831,0,4,regulation of mineralocorticoid secretion,BP,
21993,GO:2000857,1,0.986715234317013,0,2,positive regulation of mineralocorticoid secretion,BP,
21994,GO:2000858,1,0.974924269148831,0,4,regulation of aldosterone secretion,BP,
21995,GO:2000860,1,0.986715234317013,0,2,positive regulation of aldosterone secretion,BP,
21996,GO:2000864,1,0.978874330728676,0,3,regulation of estradiol secretion,BP,
21997,GO:2000866,1,0.988038405825223,0,2,positive regulation of estradiol secretion,BP,
21998,GO:2000870,1,0.99204613818693,0,2,regulation of progesterone secretion,BP,
21999,GO:2000872,1,0.997190176137772,0,1,positive regulation of progesterone secretion,BP,
22000,GO:2000878,1,0.989185824013201,0,2,positive regulation of oligopeptide transport,BP,
22001,GO:2000880,1,0.989185824013201,0,2,positive regulation of dipeptide transport,BP,
22002,GO:2000896,1,0.993065630855463,0,1,amylopectin metabolic process,BP,
22003,GO:2000909,1,0.977618933809684,0,2,regulation of sterol import,BP,
22004,GO:2000911,1,0.9840305255831,0,1,positive regulation of sterol import,BP,
22005,GO:2000969,1,0.940974503069872,0,8,positive regulation of AMPA receptor activity,BP,
22006,GO:2000970,1,0.994073250872503,0,1,regulation of detection of glucose,BP,
22007,GO:2000971,1,0.994073250872503,0,1,negative regulation of detection of glucose,BP,
22008,GO:2000973,1,0.947021891855825,0,7,regulation of pro-B cell differentiation,BP,
22009,GO:2000974,1,0.980337821040942,0,3,negative regulation of pro-B cell differentiation,BP,
22010,GO:2000975,1,0.992391386628437,0,1,positive regulation of pro-B cell differentiation,BP,
22011,GO:2000977,1,0.974824976420514,0,5,regulation of forebrain neuron differentiation,BP,
22012,GO:2000978,1,0.988568637430424,0,3,negative regulation of forebrain neuron differentiation,BP,
22013,GO:2000979,1,0.993139384115289,0,1,positive regulation of forebrain neuron differentiation,BP,
22014,GO:2000980,1,0.953952498535401,0,7,regulation of inner ear receptor cell differentiation,BP,
22015,GO:2000981,1,0.973424418626487,0,4,negative regulation of inner ear receptor cell differentiation,BP,
22016,GO:2000983,1,0.996225422430372,0,1,regulation of ATP citrate synthase activity,BP,
22017,GO:2000984,1,0.996225422430372,0,1,negative regulation of ATP citrate synthase activity,BP,
22018,GO:2000986,1,0.99637377125583,0,1,negative regulation of behavioral fear response,BP,
22019,GO:2000987,1,0.962799064956972,0,7,positive regulation of behavioral fear response,BP,
22020,GO:2001012,1,0.957268122890384,0,7,mesenchymal cell differentiation involved in renal system development,BP,
22021,GO:2001013,1,0.968209764696414,0,4,epithelial cell proliferation involved in renal tubule morphogenesis,BP,
22022,GO:2001014,1,0.874886143697082,0,19,regulation of skeletal muscle cell differentiation,BP,
22023,GO:2001015,1,0.957638379731063,0,6,negative regulation of skeletal muscle cell differentiation,BP,
22024,GO:2001016,1,0.959735866117614,0,6,positive regulation of skeletal muscle cell differentiation,BP,
22028,GO:2001023,1,0.958183517527546,0,5,regulation of response to drug,BP,
22029,GO:2001025,1,0.993485400251684,0,1,positive regulation of response to drug,BP,
22030,GO:2001026,1,0.876398157179009,0,18,regulation of endothelial cell chemotaxis,BP,
22031,GO:2001027,1,0.975945897234607,0,3,negative regulation of endothelial cell chemotaxis,BP,
22032,GO:2001028,1,0.904634246019419,0,14,positive regulation of endothelial cell chemotaxis,BP,
22033,GO:2001029,1,0.991503330704664,0,1,regulation of cellular glucuronidation,BP,
22034,GO:2001031,1,0.991503330704664,0,1,positive regulation of cellular glucuronidation,BP,
22035,GO:2001032,1,0.86077927562211,0,21,regulation of double-strand break repair via nonhomologous end joining,BP,
22036,GO:2001033,1,0.961657290474465,0,6,negative regulation of double-strand break repair via nonhomologous end joining,BP,
22037,GO:2001034,1,0.919014359711376,0,11,positive regulation of double-strand break repair via nonhomologous end joining,BP,
22038,GO:2001035,1,0.988072188677281,0,2,regulation of tongue muscle cell differentiation,BP,
22039,GO:2001037,1,0.988072188677281,0,2,positive regulation of tongue muscle cell differentiation,BP,
22040,GO:2001038,1,0.977344293693507,0,3,regulation of cellular response to drug,BP,
22041,GO:2001040,1,0.993485400251684,0,1,positive regulation of cellular response to drug,BP,
22042,GO:2001044,1,0.908865887084953,0,15,regulation of integrin-mediated signaling pathway,BP,
22043,GO:2001045,1,0.976298529153517,0,3,negative regulation of integrin-mediated signaling pathway,BP,
22044,GO:2001046,1,0.95502140600207,0,7,positive regulation of integrin-mediated signaling pathway,BP,
22045,GO:2001049,1,0.994892806470944,0,1,regulation of tendon cell differentiation,BP,
22046,GO:2001051,1,0.994892806470944,0,1,positive regulation of tendon cell differentiation,BP,
22047,GO:2001053,1,0.935824534503054,0,11,regulation of mesenchymal cell apoptotic process,BP,
22048,GO:2001054,1,0.945752522016626,0,9,negative regulation of mesenchymal cell apoptotic process,BP,
22049,GO:2001055,1,0.989508380519049,0,2,positive regulation of mesenchymal cell apoptotic process,BP,
22051,GO:2001057,1,0.628487936137777,0,69,reactive nitrogen species metabolic process,BP,
22052,GO:2001065,1,0.996040223201871,0,1,mannan binding,MF,
22053,GO:2001069,1,0.954057601815647,0,7,glycogen binding,MF,
22054,GO:2001070,1,0.985610345718632,0,2,starch binding,MF,
22055,GO:2001074,1,0.988522108104562,0,2,regulation of metanephric ureteric bud development,BP,
22056,GO:2001076,1,0.988522108104562,0,2,positive regulation of metanephric ureteric bud development,BP,
22057,GO:2001106,1,0.974490871893523,0,3,regulation of Rho guanyl-nucleotide exchange factor activity,BP,
22058,GO:2001108,1,0.990765690448049,0,1,positive regulation of Rho guanyl-nucleotide exchange factor activity,BP,
22059,GO:2001109,1,0.983736271071255,0,2,regulation of lens epithelial cell proliferation,BP,
22060,GO:2001111,1,0.983736271071255,0,2,positive regulation of lens epithelial cell proliferation,BP,
22061,GO:2001112,1,0.991978398747101,0,1,regulation of cellular response to hepatocyte growth factor stimulus,BP,
22062,GO:2001113,1,0.991978398747101,0,1,negative regulation of cellular response to hepatocyte growth factor stimulus,BP,
22063,GO:2001135,1,0.927186843460151,0,10,regulation of endocytic recycling,BP,
22064,GO:2001136,1,0.992926610535964,0,1,negative regulation of endocytic recycling,BP,
22065,GO:2001137,1,0.965365638194684,0,4,positive regulation of endocytic recycling,BP,
22066,GO:2001138,1,0.937060221257925,0,11,regulation of phospholipid transport,BP,
22067,GO:2001140,1,0.937060221257925,0,11,positive regulation of phospholipid transport,BP,
22069,GO:2001142,1,0.993803435828213,0,1,nicotinate transport,BP,
22070,GO:2001144,1,0.994515908467109,0,1,regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,BP,
22071,GO:2001145,1,0.994515908467109,0,1,negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,BP,
22072,GO:2001148,1,0.989185824013201,0,2,regulation of dipeptide transmembrane transport,BP,
22073,GO:2001150,1,0.989185824013201,0,2,positive regulation of dipeptide transmembrane transport,BP,
22074,GO:2001151,1,0.993014381373215,0,1,regulation of renal water transport,BP,
22075,GO:2001153,1,0.993014381373215,0,1,positive regulation of renal water transport,BP,
22076,GO:2001160,1,0.988731460952169,0,2,regulation of histone H3-K79 methylation,BP,
22077,GO:2001162,1,0.988731460952169,0,2,positive regulation of histone H3-K79 methylation,BP,
22078,GO:2001163,1,0.99433737793695,0,1,regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
22079,GO:2001165,1,0.99433737793695,0,1,positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
22080,GO:2001166,1,0.966592796426828,0,5,regulation of histone H2B ubiquitination,BP,
22081,GO:2001168,1,0.971830070008689,0,4,positive regulation of histone H2B ubiquitination,BP,
22082,GO:2001169,1,0.909858511634844,0,15,regulation of ATP biosynthetic process,BP,
22083,GO:2001170,1,0.979875910614345,0,3,negative regulation of ATP biosynthetic process,BP,
22084,GO:2001171,1,0.940730241603419,0,10,positive regulation of ATP biosynthetic process,BP,
22085,GO:2001173,1,0.99461245244345,0,1,regulation of histone H2B conserved C-terminal lysine ubiquitination,BP,
22086,GO:2001176,1,0.994198568848389,0,1,regulation of mediator complex assembly,BP,
22087,GO:2001178,1,0.994198568848389,0,1,positive regulation of mediator complex assembly,BP,
22088,GO:2001185,1,0.899748475079866,0,17,regulation of CD8-positive, alpha-beta T cell activation,BP,
22089,GO:2001186,1,0.97336806111988,0,5,negative regulation of CD8-positive, alpha-beta T cell activation,BP,
22090,GO:2001187,1,0.950990609682296,0,8,positive regulation of CD8-positive, alpha-beta T cell activation,BP,
22091,GO:2001188,1,0.971193234373683,0,6,regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
22092,GO:2001189,1,0.983633094031195,0,3,negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
22093,GO:2001190,1,0.987355229072914,0,3,positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
22094,GO:2001191,1,0.993359695814939,0,1,regulation of gamma-delta T cell activation involved in immune response,BP,
22095,GO:2001193,1,0.993359695814939,0,1,positive regulation of gamma-delta T cell activation involved in immune response,BP,
22096,GO:2001197,1,0.954196505358285,0,5,basement membrane assembly involved in embryonic body morphogenesis,BP,
22097,GO:2001198,1,0.939890653128297,0,12,regulation of dendritic cell differentiation,BP,
22098,GO:2001199,1,0.970000015592252,0,6,negative regulation of dendritic cell differentiation,BP,
22099,GO:2001200,1,0.97702712304832,0,4,positive regulation of dendritic cell differentiation,BP,
22100,GO:2001204,1,0.929875519633537,0,10,regulation of osteoclast development,BP,
22101,GO:2001205,1,0.966986650952548,0,4,negative regulation of osteoclast development,BP,
22102,GO:2001206,1,0.97884741822777,0,4,positive regulation of osteoclast development,BP,
22103,GO:2001207,1,0.992701874829351,0,1,regulation of transcription elongation from RNA polymerase I promoter,BP,
22104,GO:2001208,1,0.992701874829351,0,1,negative regulation of transcription elongation by RNA polymerase I,BP,
22105,GO:2001212,1,0.901606214262863,0,16,regulation of vasculogenesis,BP,
22106,GO:2001213,1,0.991308120580807,0,1,negative regulation of vasculogenesis,BP,
22107,GO:2001214,1,0.928225950809937,0,12,positive regulation of vasculogenesis,BP,
22109,GO:2001223,1,0.931552048460639,0,9,negative regulation of neuron migration,BP,
22110,GO:2001224,1,0.881417477775074,0,14,positive regulation of neuron migration,BP,
22111,GO:2001225,1,0.931114101806113,0,10,regulation of chloride transport,BP,
22112,GO:2001226,1,0.979462239960246,0,3,negative regulation of chloride transport,BP,
22113,GO:2001228,1,0.972077882338628,0,2,regulation of response to gamma radiation,BP,
22114,GO:2001229,1,0.985035346598227,0,1,negative regulation of response to gamma radiation,BP,
22117,GO:2001235,1,0.36763386658766,0,166,positive regulation of apoptotic signaling pathway,BP,
22120,GO:2001238,1,0.723433484496037,0,50,positive regulation of extrinsic apoptotic signaling pathway,BP,
22121,GO:2001239,1,0.765377660570951,0,44,regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,
22122,GO:2001240,1,0.823430008405753,0,33,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,
22123,GO:2001241,1,0.930864727658068,0,11,positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,
22126,GO:2001244,1,0.755514742865373,0,53,positive regulation of intrinsic apoptotic signaling pathway,BP,
22127,GO:2001245,1,0.970672736259707,0,5,regulation of phosphatidylcholine biosynthetic process,BP,
22128,GO:2001246,1,0.992639097546823,0,1,negative regulation of phosphatidylcholine biosynthetic process,BP,
22129,GO:2001247,1,0.981402825787448,0,3,positive regulation of phosphatidylcholine biosynthetic process,BP,
22130,GO:2001248,1,0.994580882739056,0,1,regulation of ammonia assimilation cycle,BP,
22131,GO:2001250,1,0.994580882739056,0,1,positive regulation of ammonia assimilation cycle,BP,
22133,GO:2001252,1,0.306350017513921,0,168,positive regulation of chromosome organization,BP,
22134,GO:2001253,1,0.978123964747473,0,3,regulation of histone H3-K36 trimethylation,BP,
22135,GO:2001255,1,0.98482448466248,0,2,positive regulation of histone H3-K36 trimethylation,BP,
22136,GO:2001256,1,0.921861424884941,0,13,regulation of store-operated calcium entry,BP,
22138,GO:2001258,1,0.78028689885275,0,41,negative regulation of cation channel activity,BP,
22140,GO:2001260,1,0.982337422693705,0,3,regulation of semaphorin-plexin signaling pathway,BP,
22141,GO:2001262,1,0.994162708088277,0,1,positive regulation of semaphorin-plexin signaling pathway,BP,
22142,GO:2001267,1,0.905798105561286,0,17,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
22143,GO:2001268,1,0.970413377245858,0,6,negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
22144,GO:2001269,1,0.933434035719918,0,11,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
22145,GO:2001270,1,0.971170776495549,0,5,regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
22146,GO:2001271,1,0.978449196199767,0,3,negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
22147,GO:2001272,1,0.992562887480491,0,2,positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
22148,GO:2001279,1,0.935583676927248,0,11,regulation of unsaturated fatty acid biosynthetic process,BP,
22149,GO:2001280,1,0.951923811285679,0,8,positive regulation of unsaturated fatty acid biosynthetic process,BP,
22150,GO:2001286,1,0.953157480837395,0,7,regulation of caveolin-mediated endocytosis,BP,
22151,GO:2001287,1,0.988480920345266,0,2,negative regulation of caveolin-mediated endocytosis,BP,
22152,GO:2001288,1,0.971468513792394,0,4,positive regulation of caveolin-mediated endocytosis,BP,
22153,GO:2001293,1,0.982840841591119,0,2,malonyl-CoA metabolic process,BP,
22154,GO:2001294,1,0.994494303577684,0,1,malonyl-CoA catabolic process,BP,
22155,GO:2001295,1,0.988282664984535,0,1,malonyl-CoA biosynthetic process,BP,
22156,GO:2001300,1,0.963036717138031,0,7,lipoxin metabolic process,BP,
22157,GO:2001301,1,0.963036717138031,0,7,lipoxin biosynthetic process,BP,
22158,GO:2001302,1,0.981582095927638,0,3,lipoxin A4 metabolic process,BP,
22159,GO:2001303,1,0.981582095927638,0,3,lipoxin A4 biosynthetic process,BP,
22160,GO:2001304,1,0.994160827377298,0,1,lipoxin B4 metabolic process,BP,
22161,GO:2001306,1,0.994160827377298,0,1,lipoxin B4 biosynthetic process,BP,
22162,GO:2001311,1,0.98937126186405,0,2,lysobisphosphatidic acid metabolic process,BP,
11148,GO:0043300,1,0.761945359206149,0,44,regulation of leukocyte degranulation,BP,
13674,GO:0051294,1,0.783622029028244,0,35,establishment of spindle orientation,BP,
12347,GO:0046460,1,0.779158410052114,0,37,neutral lipid biosynthetic process,BP,
12350,GO:0046463,1,0.779158410052114,0,37,acylglycerol biosynthetic process,BP,
8855,GO:0033173,1.00000000000001,0.753888118511466,0,39,calcineurin-NFAT signaling cascade,BP,
11679,GO:0044818,1.00000000000001,0.82700722526768,0,27,mitotic G2/M transition checkpoint,BP,
10923,GO:0042908,1.00000000000001,0.788260183552324,0,34,xenobiotic transport,BP,
4755,GO:0010543,1.00000000000001,0.795160897211363,0,33,regulation of platelet activation,BP,
13808,GO:0051569,1.00000000000001,0.823180175426289,0,27,regulation of histone H3-K4 methylation,BP,
18907,GO:1901096,1.00000000000001,0.915460108498887,0,12,regulation of autophagosome maturation,BP,
